,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
5123,GO:0014003,0,1,9,38,oligodendrocyte development,BP,SOX10;FA2H;MAG;ASPA;PLP1;MYRF;NKX6-2;CNTN2;LPAR1
7013,GO:0022010,0,1,8,17,central nervous system myelination,BP,SOX10;FA2H;MAG;ASPA;PLP1;MYRF;NKX6-2;CNTN2
8307,GO:0032291,0,1,8,17,axon ensheathment in central nervous system,BP,SOX10;FA2H;MAG;ASPA;PLP1;MYRF;NKX6-2;CNTN2
3709,GO:0007272,4.11500794439125e-13,1,13,113,ensheathment of neurons,BP,CLDN11;SOX10;FA2H;MAG;ASPA;PLP1;MYRF;NKX6-2;KLK6;MAL;CNTN2;MBP;LPAR1
4059,GO:0008366,4.11500794439125e-13,1,13,113,axon ensheathment,BP,CLDN11;SOX10;FA2H;MAG;ASPA;PLP1;MYRF;NKX6-2;KLK6;MAL;CNTN2;MBP;LPAR1
10791,GO:0042552,7.3794645126369e-12,1,12,111,myelination,BP,SOX10;FA2H;MAG;ASPA;PLP1;MYRF;NKX6-2;KLK6;MAL;CNTN2;MBP;LPAR1
13200,GO:0048709,1.60804311923711e-10,0.999999999993018,10,87,oligodendrocyte differentiation,BP,SOX10;FA2H;MAG;ASPA;PLP1;MYRF;NKX6-2;BOK;CNTN2;LPAR1
11129,GO:0043209,2.62886934024981e-10,0.999999999984585,12,158,myelin sheath,CC,CLDN11;MAG;SEPT4;PLP1;PACSIN1;HSPA2;ERMN;MOBP;TPPP;CNTN2;MBP;GJC2
3751,GO:0007399,9.1791247997858e-10,0.999999999785973,38,2100,nervous system development,BP,CLDN11;CAMK2A;LRP2;SOX10;CPNE6;FA2H;NEFM;SLC17A7;MAG;ASPA;SEPT4;RASAL1;PADI2;GDA;PLP1;PACSIN1;MYRF;HAPLN2;RAPGEF5;MOG;SLC39A12;NKX6-2;NRGN;S100A1;SERPINI1;HHIP;KLK6;MOBP;GJB1;MAL;BOK;S1PR5;CNTN2;CCK;MBP;LPAR1;ZNF536;GJC2
3762,GO:0007417,6.77153383134696e-09,0.999999998738852,23,878,central nervous system development,BP,LRP2;SOX10;FA2H;SLC17A7;MAG;ASPA;SEPT4;PADI2;PLP1;MYRF;HAPLN2;MOG;NKX6-2;NRGN;S100A1;SERPINI1;KLK6;MAL;BOK;CNTN2;MBP;LPAR1;GJC2
6898,GO:0021782,8.24357622418686e-09,0.999999999609723,9,92,glial cell development,BP,SOX10;FA2H;MAG;ASPA;PLP1;MYRF;NKX6-2;CNTN2;LPAR1
10551,GO:0042063,5.39982373554636e-08,0.999999994479672,12,244,gliogenesis,BP,LRP2;SOX10;FA2H;MAG;ASPA;PLP1;MYRF;NKX6-2;BOK;CNTN2;LPAR1;GJC2
6707,GO:0019911,2.54654138575435e-07,0.999999998224227,4,10,structural constituent of myelin sheath,MF,PLP1;MOBP;MAL;MBP
4663,GO:0010001,4.00781692698579e-07,0.999999961678518,10,190,glial cell differentiation,BP,SOX10;FA2H;MAG;ASPA;PLP1;MYRF;NKX6-2;BOK;CNTN2;LPAR1
5132,GO:0014015,1.14160616786475e-06,0.999999953170835,6,54,positive regulation of gliogenesis,BP,LRP2;SOX10;MAG;ASPA;NKX6-2;GJC2
5130,GO:0014013,3.03411438905422e-06,0.999999794435665,7,98,regulation of gliogenesis,BP,LRP2;SOX10;MAG;ASPA;NKX6-2;CNTN2;GJC2
11581,GO:0044304,3.62618754260266e-06,0.999999816119922,6,62,main axon,CC,MAG;ERMN;CNTN2;CCK;MBP;GJC2
14178,GO:0051960,8.86284506306261e-06,0.999997923385228,17,768,regulation of nervous system development,BP,LRP2;SOX10;CPNE6;MAG;ASPA;RASAL1;PACSIN1;MYRF;SLC39A12;NKX6-2;SERPINI1;KLK6;S1PR5;CNTN2;LPAR1;ZNF536;GJC2
13475,GO:0050767,9.38748238115868e-06,0.999997896491043,16,689,regulation of neurogenesis,BP,LRP2;SOX10;CPNE6;MAG;ASPA;RASAL1;PACSIN1;SLC39A12;NKX6-2;SERPINI1;KLK6;S1PR5;CNTN2;LPAR1;ZNF536;GJC2
11004,GO:0043005,1.0420176614194e-05,0.999997122513991,21,1140,neuron projection,CC,CAMK2A;LRP2;CPNE6;NEFM;SLC17A7;MAG;EPHB6;FBXO2;PACSIN1;ERMN;CNTNAP4;NRGN;S100A1;LGI3;CNTN2;SV2B;CCK;MBP;LPAR1;GRM3;GJC2
14666,GO:0060284,1.15236340113267e-05,0.999997242251045,17,785,regulation of cell development,BP,LRP2;SOX10;CPNE6;MAG;ASPA;RASAL1;PACSIN1;DOCK5;SLC39A12;NKX6-2;SERPINI1;KLK6;S1PR5;CNTN2;LPAR1;ZNF536;GJC2
13063,GO:0048468,1.19455289827853e-05,0.999996085777559,28,1852,cell development,BP,CAMK2A;LRP2;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;MAG;ASPA;SEPT4;RASAL1;PLP1;PACSIN1;MYRF;HSPA2;HAPLN2;DOCK5;SLC39A12;NKX6-2;SERPINI1;KLK6;S1PR5;CNTN2;CCK;MYBPC1;LPAR1;ZNF536;GJC2
7011,GO:0022008,1.36545912673483e-05,0.99999583710185,24,1446,neurogenesis,BP,CAMK2A;LRP2;SOX10;CPNE6;FA2H;NEFM;MAG;ASPA;RASAL1;PLP1;PACSIN1;MYRF;SLC39A12;NKX6-2;SERPINI1;HHIP;KLK6;BOK;S1PR5;CNTN2;CCK;LPAR1;ZNF536;GJC2
13209,GO:0048731,2.57872125355119e-05,0.999989641229959,45,4025,system development,BP,CLDN11;CAMK2A;LRP2;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;SLC17A7;MAG;ASPA;SEPT4;RASAL1;FGF1;PADI2;GDA;PLP1;PACSIN1;MYRF;TOP2A;HAPLN2;RAPGEF5;ENPP2;MOG;CXCL14;SLC39A12;NKX6-2;NRGN;S100A1;SERPINI1;HHIP;GREM1;KLK6;MOBP;GJB1;MAL;BOK;S1PR5;CNTN2;CCK;MBP;LPAR1;ZNF536;RYR2;GJC2
17793,GO:0097458,3.06297269128723e-05,0.999990374727326,23,1425,neuron part,CC,CAMK2A;LRP2;CPNE6;NEFM;SLC17A7;MAG;EPHB6;FBXO2;PACSIN1;PPP1R1B;ERMN;CNTNAP4;NRGN;S100A1;SERPINI1;LGI3;CNTN2;SV2B;CCK;MBP;LPAR1;GRM3;GJC2
7362,GO:0030424,3.10220096652735e-05,0.999993532585959,13,516,axon,CC,LRP2;CPNE6;NEFM;SLC17A7;MAG;PACSIN1;ERMN;NRGN;CNTN2;CCK;MBP;GRM3;GJC2
14180,GO:0051962,4.31565094477714e-05,0.999991360028075,12,460,positive regulation of nervous system development,BP,LRP2;SOX10;CPNE6;MAG;ASPA;RASAL1;PACSIN1;MYRF;NKX6-2;SERPINI1;LPAR1;GJC2
4902,GO:0010720,4.5233842014768e-05,0.999990898375327,12,463,positive regulation of cell development,BP,LRP2;SOX10;CPNE6;MAG;ASPA;RASAL1;PACSIN1;DOCK5;NKX6-2;SERPINI1;LPAR1;GJC2
7976,GO:0031641,6.49780709803819e-05,0.999997587127193,4,34,regulation of myelination,BP,SOX10;MAG;MYRF;NKX6-2
13477,GO:0050769,6.64249542360554e-05,0.999987181004671,11,406,positive regulation of neurogenesis,BP,LRP2;SOX10;CPNE6;MAG;ASPA;RASAL1;PACSIN1;NKX6-2;SERPINI1;LPAR1;GJC2
8942,GO:0033270,6.68974923254816e-05,0.999998990674958,3,12,paranode region of axon,CC,MAG;ERMN;GJC2
7978,GO:0031643,6.98770126484469e-05,0.999998910942486,3,13,positive regulation of myelination,BP,SOX10;MAG;MYRF
6693,GO:0019888,8.24912333596047e-05,0.999994599285099,5,71,protein phosphatase regulator activity,MF,PPP2R2C;PPP1R16B;PPP1R1B;PPP1R14A;RCAN2
13269,GO:0048856,9.79126053563533e-05,0.999957337416696,50,4939,anatomical structure development,BP,CLDN11;CAMK2A;LRP2;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;SLC17A7;MAG;EPHB6;ASPA;SEPT4;RASAL1;FGF1;PADI2;GDA;PLP1;PACSIN1;MYRF;HSPA2;TOP2A;HAPLN2;RAPGEF5;ERMN;ENPP2;MOG;CXCL14;DOCK5;SLC39A12;NKX6-2;NRGN;S100A1;SERPINI1;HHIP;GREM1;KLK6;MOBP;GJB1;MAL;BOK;S1PR5;CNTN2;CCK;MYBPC1;MBP;LPAR1;ZNF536;RYR2;GJC2
6882,GO:0021762,0.000101183646404296,0.999995738931733,4,39,substantia nigra development,BP,PADI2;PLP1;S100A1;MBP
13192,GO:0048699,0.000140195103335886,0.999953189913895,21,1353,generation of neurons,BP,CAMK2A;LRP2;SOX10;CPNE6;NEFM;MAG;ASPA;RASAL1;PLP1;PACSIN1;SLC39A12;NKX6-2;SERPINI1;HHIP;KLK6;S1PR5;CNTN2;CCK;LPAR1;ZNF536;GJC2
15812,GO:0070447,0.000161465093009921,0.999999608332531,2,3,positive regulation of oligodendrocyte progenitor proliferation,BP,LRP2;GJC2
16633,GO:0071944,0.000191828685338616,0.99991460814702,45,4376,cell periphery,CC,CD22;CLDN11;CAMK2A;LRP2;FOLH1;TF;CPNE6;PPP1R16B;SLC17A7;MAG;ADAP1;EPHB6;SEPT4;RASAL1;FGF1;PLP1;PACSIN1;HSPA2;ERMN;ENPP2;MOG;DOCK5;SLC39A12;CNTNAP4;SLC24A2;SLC5A11;PAQR6;HHIP;MOBP;GJB1;GPR37;MAL;S1PR5;GPR62;CNTN2;SV2B;NKAIN2;OPALIN;MBP;LPAR1;RYR2;GRM3;GJC2;TMEM235;FXYD1
6462,GO:0019208,0.000195984461050376,0.999984440197051,5,84,phosphatase regulator activity,MF,PPP2R2C;PPP1R16B;PPP1R1B;PPP1R14A;RCAN2
8941,GO:0033269,0.000232308400953944,0.999999043664419,2,4,internode region of axon,CC,ERMN;MBP
10300,GO:0036477,0.000235003548674528,0.999936244576853,14,725,somatodendritic compartment,CC,LRP2;CPNE6;FBXO2;PPP1R1B;ERMN;CNTNAP4;NRGN;SERPINI1;CNTN2;CCK;MBP;LPAR1;GRM3;GJC2
8302,GO:0032286,0.00023623493378951,0.999999019249993,2,4,central nervous system myelin maintenance,BP,FA2H;MYRF
3711,GO:0007275,0.000245345318475671,0.999888963685314,46,4533,multicellular organism development,BP,CLDN11;CAMK2A;LRP2;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;SLC17A7;MAG;EPHB6;ASPA;SEPT4;RASAL1;FGF1;PADI2;GDA;PLP1;PACSIN1;MYRF;TOP2A;HAPLN2;RAPGEF5;ENPP2;MOG;CXCL14;SLC39A12;NKX6-2;NRGN;S100A1;SERPINI1;HHIP;GREM1;KLK6;MOBP;GJB1;MAL;BOK;S1PR5;CNTN2;CCK;MBP;LPAR1;ZNF536;RYR2;GJC2
19095,GO:1901896,0.000287656886418887,0.999998681085657,2,4,positive regulation of calcium-transporting ATPase activity,BP,HSPA2;RYR2
10995,GO:0042995,0.000299150512896734,0.999885217589865,25,1877,cell projection,CC,CAMK2A;LRP2;CPNE6;PPP1R16B;NEFM;SLC17A7;MAG;EPHB6;SEPT4;FBXO2;PACSIN1;ERMN;CNTNAP4;NRGN;S100A1;HHIP;LGI3;CNTN2;SV2B;CCK;DNAH17;MBP;LPAR1;GRM3;GJC2
8469,GO:0032502,0.000301727880168535,0.999860432336153,51,5296,developmental process,BP,CLDN11;CAMK2A;PPP2R2C;LRP2;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;SLC17A7;MAG;EPHB6;ASPA;SEPT4;RASAL1;FGF1;PADI2;GDA;PLP1;PACSIN1;MYRF;HSPA2;TOP2A;HAPLN2;RAPGEF5;ERMN;ENPP2;MOG;CXCL14;DOCK5;SLC39A12;NKX6-2;NRGN;S100A1;SERPINI1;HHIP;GREM1;KLK6;MOBP;GJB1;MAL;BOK;S1PR5;CNTN2;CCK;MYBPC1;MBP;LPAR1;ZNF536;RYR2;GJC2
7743,GO:0031224,0.000328215262174999,0.999850659747574,43,4249,intrinsic component of membrane,CC,HHATL;CD22;CLDN11;LRP2;FOLH1;FA2H;SLC17A7;MAG;EPHB6;RASAL1;PLP1;MYRF;HSPA2;EVI2A;ENPP2;MOG;SLC39A12;CNTNAP4;SLC24A2;SLC5A11;PAQR6;TMEM144;HHIP;GJB1;GPR37;MAL;BOK;TMEM125;TMEM151A;S1PR5;GPR62;HS3ST4;CNTN2;SV2B;NKAIN2;OPALIN;LPAR1;RYR2;GRM3;GJC2;TMEM235;TMEM88B;FXYD1
7826,GO:0031344,0.000339020083267484,0.999914872051229,12,571,regulation of cell projection organization,BP,CPNE6;PPP1R16B;MAG;RASAL1;PACSIN1;ERMN;ENPP2;SLC39A12;SERPINI1;KLK6;CNTN2;LPAR1
14155,GO:0051928,0.000341324750694874,0.999969296422477,5,95,positive regulation of calcium ion transport,BP,CAMK2A;HSPA2;S100A1;RYR2;GJC2
8468,GO:0032501,0.000357955451003771,0.999832516900567,55,5937,multicellular organismal process,BP,CLDN11;CAMK2A;LRP2;TF;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;SLC17A7;MAG;EPHB6;PTGDS;ASPA;SEPT4;RASAL1;FGF1;PADI2;GDA;PLP1;PACSIN1;MYRF;HSPA2;TOP2A;PPP1R1B;HAPLN2;RAPGEF5;ERMN;ENPP2;MOG;CXCL14;DOCK5;SLC39A12;NKX6-2;NRGN;SLC24A2;S100A1;SERPINI1;HHIP;GREM1;KLK6;MOBP;GJB1;MAL;BOK;S1PR5;CNTN2;CCK;MYBPC1;MBP;LPAR1;ZNF536;RYR2;GJC2;FXYD1
13690,GO:0051094,0.000377886924681441,0.999874197835689,18,1161,positive regulation of developmental process,BP,LRP2;SOX10;CPNE6;PPP1R16B;MAG;ASPA;RASAL1;FGF1;PACSIN1;MYRF;ENPP2;DOCK5;NKX6-2;S100A1;SERPINI1;GREM1;LPAR1;GJC2
5663,GO:0016021,0.000385260847297055,0.99982385377936,42,4139,integral component of membrane,CC,HHATL;CD22;CLDN11;LRP2;FOLH1;FA2H;SLC17A7;MAG;EPHB6;PLP1;MYRF;HSPA2;EVI2A;ENPP2;MOG;SLC39A12;CNTNAP4;SLC24A2;SLC5A11;PAQR6;TMEM144;HHIP;GJB1;GPR37;MAL;BOK;TMEM125;TMEM151A;S1PR5;GPR62;HS3ST4;CNTN2;SV2B;NKAIN2;OPALIN;LPAR1;RYR2;GRM3;GJC2;TMEM235;TMEM88B;FXYD1
7981,GO:0031646,0.000413943113693085,0.999987121585643,3,23,positive regulation of neurological system process,BP,SOX10;MAG;MYRF
18467,GO:0120025,0.000426152106767311,0.999835083193594,24,1807,plasma membrane bounded cell projection,CC,CAMK2A;LRP2;CPNE6;NEFM;SLC17A7;MAG;EPHB6;SEPT4;FBXO2;PACSIN1;ERMN;CNTNAP4;NRGN;S100A1;HHIP;LGI3;CNTN2;SV2B;CCK;DNAH17;MBP;LPAR1;GRM3;GJC2
11020,GO:0043025,0.000441842322736864,0.999901719334504,10,428,neuronal cell body,CC,CPNE6;PPP1R1B;ERMN;NRGN;SERPINI1;CNTN2;CCK;MBP;LPAR1;GJC2
21182,GO:2000026,0.000443701274399202,0.999830906994735,23,1712,regulation of multicellular organismal development,BP,LRP2;SOX10;CPNE6;PPP1R16B;MAG;ASPA;RASAL1;FGF1;PACSIN1;MYRF;ENPP2;SLC39A12;NKX6-2;S100A1;SERPINI1;GREM1;KLK6;S1PR5;CNTN2;MBP;LPAR1;ZNF536;GJC2
13789,GO:0051240,0.000443873992494459,0.999841600412638,20,1393,positive regulation of multicellular organismal process,BP,LRP2;SOX10;CPNE6;PPP1R16B;MAG;ASPA;RASAL1;FGF1;PACSIN1;MYRF;ENPP2;DOCK5;NKX6-2;S100A1;SERPINI1;GREM1;MBP;LPAR1;RYR2;GJC2
13270,GO:0048857,0.00045682011573646,0.999970763012376,4,57,neural nucleus development,BP,PADI2;PLP1;S100A1;MBP
11402,GO:0043666,0.000475934333828167,0.999953860995767,5,101,regulation of phosphoprotein phosphatase activity,BP,PPP2R2C;PPP1R16B;PPP1R1B;PPP1R14A;RCAN2
11172,GO:0043270,0.000475948330494411,0.999926098304902,7,217,positive regulation of ion transport,BP,CAMK2A;HSPA2;S100A1;CCK;RYR2;GJC2;FXYD1
13788,GO:0051239,0.00049544056188044,0.999789238442844,30,2566,regulation of multicellular organismal process,BP,LRP2;SOX10;CPNE6;PPP1R16B;FA2H;MAG;PTGDS;ASPA;RASAL1;FGF1;PACSIN1;MYRF;ENPP2;MOG;DOCK5;SLC39A12;NKX6-2;S100A1;SERPINI1;GREM1;KLK6;S1PR5;CNTN2;CCK;MBP;LPAR1;ZNF536;RYR2;GJC2;FXYD1
20220,GO:1904427,0.000534542855125551,0.99996427100572,4,59,positive regulation of calcium ion transmembrane transport,BP,HSPA2;S100A1;RYR2;GJC2
7100,GO:0023052,0.000580566001143048,0.999721738214625,51,5462,signaling,BP,CAMK2A;LRP2;SOX10;CPNE6;PPP1R16B;SLC17A7;ADAP1;EPHB6;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;PADI2;PLP1;EVI2A;PPP1R1B;RAPGEF5;ENPP2;MOG;CXCL14;DOCK5;ST18;SLC39A12;CNTNAP4;NRGN;SLC24A2;S100A1;PAQR6;VSNL1;HHIP;GREM1;KLK6;GJB1;GPR37;MAL;RCAN2;BOK;S1PR5;GPR62;CNTN2;SV2B;CCK;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;FXYD1
12138,GO:0045685,0.000596957101919294,0.99995884616106,4,61,regulation of glial cell differentiation,BP,MAG;ASPA;NKX6-2;CNTN2
7979,GO:0031644,0.000738538347083204,0.999945992984412,4,64,regulation of neurological system process,BP,SOX10;MAG;MYRF;CCK
13279,GO:0048869,0.000807940769352104,0.999621691971753,38,3667,cellular developmental process,BP,CAMK2A;LRP2;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;MAG;EPHB6;ASPA;SEPT4;RASAL1;FGF1;PLP1;PACSIN1;MYRF;HSPA2;TOP2A;HAPLN2;ERMN;ENPP2;CXCL14;DOCK5;SLC39A12;NKX6-2;SERPINI1;HHIP;GREM1;KLK6;MAL;BOK;S1PR5;CNTN2;CCK;MYBPC1;LPAR1;ZNF536;GJC2
8288,GO:0032268,0.000873433795507732,0.999627046870748,27,2295,regulation of cellular protein metabolic process,BP,HHATL;PPP2R2C;LRP2;PPP1R16B;EPHB6;SEPT4;TPD52L1;FGF1;FBXO2;HSPA2;PPP1R1B;ENPP2;ST18;CNDP1;SERPINI1;GREM1;PPP1R14A;GPR37;RCAN2;BOK;CNTN2;CCK;SPOCK3;MBP;LPAR1;GJC2;FXYD1
20062,GO:1904064,0.000942694453183065,0.999893217046369,5,117,positive regulation of cation transmembrane transport,BP,HSPA2;S100A1;RYR2;GJC2;FXYD1
9688,GO:0035304,0.000981321056128249,0.99988779139515,5,119,regulation of protein dephosphorylation,BP,PPP2R2C;PPP1R16B;PPP1R1B;PPP1R14A;RCAN2
19855,GO:1903672,0.000990297364756237,0.999957287282193,3,31,positive regulation of sprouting angiogenesis,BP,PPP1R16B;FGF1;S100A1
18791,GO:1901021,0.00106619701330938,0.99995281763688,3,31,positive regulation of calcium ion transmembrane transporter activity,BP,HSPA2;S100A1;RYR2
18472,GO:0120035,0.00108948777312207,0.999705835898799,11,562,regulation of plasma membrane bounded cell projection organization,BP,CPNE6;PPP1R16B;MAG;RASAL1;PACSIN1;ENPP2;SLC39A12;SERPINI1;KLK6;CNTN2;LPAR1
13791,GO:0051246,0.00111579659666595,0.999509005678444,28,2458,regulation of protein metabolic process,BP,HHATL;PPP2R2C;LRP2;PPP1R16B;EPHB6;SEPT4;TPD52L1;FGF1;FBXO2;NECAB1;HSPA2;PPP1R1B;ENPP2;ST18;CNDP1;SERPINI1;GREM1;PPP1R14A;GPR37;RCAN2;BOK;CNTN2;CCK;SPOCK3;MBP;LPAR1;GJC2;FXYD1
5085,GO:0010959,0.00112208216685305,0.999768207781258,8,325,regulation of metal ion transport,BP,CAMK2A;TF;HSPA2;S100A1;NKAIN2;RYR2;GJC2;FXYD1
12126,GO:0045664,0.00117334386121779,0.999680207748659,11,568,regulation of neuron differentiation,BP,CPNE6;MAG;RASAL1;PACSIN1;SLC39A12;SERPINI1;KLK6;S1PR5;CNTN2;LPAR1;ZNF536
3764,GO:0007420,0.00117380224485753,0.999659451240346,12,656,brain development,BP,LRP2;SLC17A7;SEPT4;PADI2;PLP1;NRGN;S100A1;BOK;CNTN2;MBP;LPAR1;GJC2
19093,GO:1901894,0.00118493386060513,0.999984591597958,2,8,regulation of calcium-transporting ATPase activity,BP,HSPA2;RYR2
11575,GO:0044297,0.00119601780084541,0.999696355224155,10,490,cell body,CC,CPNE6;PPP1R1B;ERMN;NRGN;SERPINI1;CNTN2;CCK;MBP;LPAR1;GJC2
3624,GO:0007154,0.0012241749870558,0.999388543320664,50,5474,cell communication,BP,CAMK2A;LRP2;SOX10;CPNE6;PPP1R16B;SLC17A7;ADAP1;EPHB6;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;PADI2;PLP1;EVI2A;PPP1R1B;RAPGEF5;ENPP2;MOG;CXCL14;DOCK5;ST18;SLC39A12;CNTNAP4;NRGN;SLC24A2;S100A1;PAQR6;VSNL1;HHIP;GREM1;KLK6;GJB1;GPR37;MAL;RCAN2;BOK;S1PR5;GPR62;CNTN2;SV2B;CCK;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2
15809,GO:0070444,0.00125997825614492,0.999983096859077,2,8,oligodendrocyte progenitor proliferation,BP,LRP2;GJC2
15810,GO:0070445,0.00125997825614492,0.999983096859077,2,8,regulation of oligodendrocyte progenitor proliferation,BP,LRP2;GJC2
7191,GO:0030154,0.00128130823879607,0.999389585571871,36,3484,cell differentiation,BP,CAMK2A;LRP2;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;MAG;EPHB6;ASPA;SEPT4;RASAL1;FGF1;PLP1;PACSIN1;MYRF;HSPA2;TOP2A;HAPLN2;CXCL14;DOCK5;SLC39A12;NKX6-2;SERPINI1;HHIP;GREM1;KLK6;MAL;BOK;S1PR5;CNTN2;CCK;MYBPC1;LPAR1;ZNF536;GJC2
13496,GO:0050793,0.00130258140955589,0.999434581655429,26,2208,regulation of developmental process,BP,LRP2;SOX10;CPNE6;PPP1R16B;MAG;ASPA;RASAL1;FGF1;PACSIN1;MYRF;ERMN;ENPP2;CXCL14;DOCK5;SLC39A12;NKX6-2;S100A1;SERPINI1;GREM1;KLK6;S1PR5;CNTN2;MBP;LPAR1;ZNF536;GJC2
9540,GO:0034767,0.0014231102474393,0.999822769038702,5,128,positive regulation of ion transmembrane transport,BP,HSPA2;S100A1;RYR2;GJC2;FXYD1
7105,GO:0030001,0.00145226918474627,0.999544455044723,13,781,metal ion transport,BP,CAMK2A;LRP2;TF;SLC17A7;HSPA2;SLC39A12;SLC24A2;SLC5A11;S100A1;NKAIN2;RYR2;GJC2;FXYD1
3765,GO:0007422,0.00148765624522003,0.999867842530275,4,74,peripheral nervous system development,BP,SOX10;FA2H;HAPLN2;SERPINI1
2284,GO:0004865,0.0015030166498782,0.999976818315544,2,10,protein serine/threonine phosphatase inhibitor activity,MF,PPP1R1B;PPP1R14A
12140,GO:0045687,0.00159486904192331,0.999917857547544,3,37,positive regulation of glial cell differentiation,BP,MAG;ASPA;NKX6-2
2506,GO:0005243,0.00168078433081404,0.99997256014073,2,10,gap junction channel activity,MF,GJB1;GJC2
3705,GO:0007268,0.00168916331197128,0.999517655858871,11,603,chemical synaptic transmission,BP,CAMK2A;CPNE6;SLC17A7;PLP1;CNTNAP4;NRGN;SLC24A2;CNTN2;SV2B;MBP;GRM3
18128,GO:0098916,0.00168916331197128,0.999517655858871,11,603,anterograde trans-synaptic signaling,BP,CAMK2A;CPNE6;SLC17A7;PLP1;CNTNAP4;NRGN;SLC24A2;CNTN2;SV2B;MBP;GRM3
7099,GO:0023051,0.00174340428531386,0.99916965382938,33,3168,regulation of signaling,BP,CAMK2A;LRP2;SOX10;PPP1R16B;ADAP1;EPHB6;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;PADI2;CXCL14;ST18;CNTNAP4;NRGN;SLC24A2;VSNL1;HHIP;GREM1;KLK6;GPR37;MAL;RCAN2;BOK;GPR62;CNTN2;CCK;LPAR1;ZNF536;RYR2;GRM3;FXYD1
13846,GO:0051336,0.00174585260297316,0.999370263783349,16,1111,regulation of hydrolase activity,BP,PPP2R2C;PPP1R16B;ADAP1;RASAL1;HSPA2;PPP1R1B;ST18;SERPINI1;PPP1R14A;RCAN2;BOK;CCK;SPOCK3;MBP;LPAR1;RYR2
18264,GO:0099537,0.00176110043474289,0.999494406301646,11,606,trans-synaptic signaling,BP,CAMK2A;CPNE6;SLC17A7;PLP1;CNTNAP4;NRGN;SLC24A2;CNTN2;SV2B;MBP;GRM3
18263,GO:0099536,0.00178743253774747,0.999485864185124,11,607,synaptic signaling,BP,CAMK2A;CPNE6;SLC17A7;PLP1;CNTNAP4;NRGN;SLC24A2;CNTN2;SV2B;MBP;GRM3
7730,GO:0031175,0.00185674863890253,0.999373819448409,14,886,neuron projection development,BP,CAMK2A;LRP2;CPNE6;NEFM;MAG;RASAL1;PLP1;PACSIN1;SLC39A12;SERPINI1;KLK6;CNTN2;CCK;LPAR1
7586,GO:0030901,0.00188362270620763,0.999820881795492,4,83,midbrain development,BP,PADI2;PLP1;S100A1;MBP
14696,GO:0060322,0.00189428596837966,0.999417725499739,12,695,head development,BP,LRP2;SLC17A7;SEPT4;PADI2;PLP1;NRGN;S100A1;BOK;CNTN2;MBP;LPAR1;GJC2
5097,GO:0010975,0.00200737437108739,0.999496468524208,9,428,regulation of neuron projection development,BP,CPNE6;MAG;RASAL1;PACSIN1;SLC39A12;SERPINI1;KLK6;CNTN2;LPAR1
11441,GO:0043949,0.0020237572016943,0.999886203754754,3,40,regulation of cAMP-mediated signaling,BP,PEX5L;GPR62;LPAR1
18051,GO:0098793,0.00207405671522662,0.999527212880036,8,357,presynapse,CC,CAMK2A;SLC17A7;PACSIN1;CNTNAP4;LGI3;SV2B;CCK;GRM3
2827,GO:0005886,0.00210617087977829,0.998937253097326,41,4280,plasma membrane,CC,CD22;CLDN11;CAMK2A;LRP2;FOLH1;TF;CPNE6;PPP1R16B;SLC17A7;MAG;ADAP1;EPHB6;RASAL1;PLP1;PACSIN1;HSPA2;ENPP2;MOG;DOCK5;SLC39A12;CNTNAP4;SLC24A2;SLC5A11;PAQR6;HHIP;GJB1;GPR37;MAL;S1PR5;GPR62;CNTN2;SV2B;NKAIN2;OPALIN;MBP;LPAR1;RYR2;GRM3;GJC2;TMEM235;FXYD1
4012,GO:0008289,0.00213662100324603,0.999371011365573,11,626,lipid binding,MF,CPNE6;MAG;ADAP1;PTGDS;RASAL1;PACSIN1;HSPA2;NRGN;PAQR6;MAL;LPAR1
21264,GO:2000179,0.00227296956510111,0.99986686076298,3,40,positive regulation of neural precursor cell proliferation,BP,LRP2;SOX10;GJC2
7214,GO:0030182,0.00236234202907185,0.999094573556414,17,1230,neuron differentiation,BP,CAMK2A;LRP2;CPNE6;NEFM;MAG;RASAL1;PLP1;PACSIN1;SLC39A12;NKX6-2;SERPINI1;KLK6;S1PR5;CNTN2;CCK;LPAR1;ZNF536
12072,GO:0045597,0.00257358424441333,0.999137286657313,13,834,positive regulation of cell differentiation,BP,LRP2;SOX10;CPNE6;MAG;ASPA;RASAL1;PACSIN1;DOCK5;NKX6-2;SERPINI1;GREM1;LPAR1;GJC2
11649,GO:0044425,0.00258704069773644,0.998651958591979,48,5383,membrane part,CC,HHATL;CD22;CLDN11;CAMK2A;LRP2;FOLH1;TF;SOX10;FA2H;SLC17A7;MAG;EPHB6;PTGDS;RASAL1;PLP1;PACSIN1;MYRF;HSPA2;EVI2A;ENPP2;MOG;SLC39A12;CNTNAP4;SLC24A2;SLC5A11;PAQR6;TMEM144;HHIP;GJB1;GPR37;MAL;BOK;TMEM125;TMEM151A;S1PR5;GPR62;HS3ST4;CNTN2;SV2B;NKAIN2;OPALIN;LPAR1;RYR2;GRM3;GJC2;TMEM235;TMEM88B;FXYD1
4862,GO:0010646,0.00269131162457741,0.998688504931431,32,3117,regulation of cell communication,BP,CAMK2A;LRP2;SOX10;PPP1R16B;ADAP1;EPHB6;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;PADI2;CXCL14;ST18;CNTNAP4;NRGN;SLC24A2;VSNL1;HHIP;GREM1;KLK6;GPR37;MAL;RCAN2;BOK;GPR62;CNTN2;CCK;LPAR1;ZNF536;RYR2;GRM3
11133,GO:0043218,0.00292819514370177,0.99993377897624,2,13,compact myelin,CC,MAG;MBP
11677,GO:0044463,0.00302226289808926,0.99881268669535,17,1261,cell projection part,CC,LRP2;CPNE6;MAG;SEPT4;FBXO2;PACSIN1;ERMN;CNTNAP4;NRGN;HHIP;CNTN2;CCK;DNAH17;MBP;LPAR1;GRM3;GJC2
18474,GO:0120038,0.00302226289808926,0.99881268669535,17,1261,plasma membrane bounded cell projection part,CC,LRP2;CPNE6;MAG;SEPT4;FBXO2;PACSIN1;ERMN;CNTNAP4;NRGN;HHIP;CNTN2;CCK;DNAH17;MBP;LPAR1;GRM3;GJC2
1201,GO:0002689,0.0032199228798148,0.999922807335616,2,14,negative regulation of leukocyte chemotaxis,BP,PADI2;GREM1
2849,GO:0005922,0.00322171991553631,0.999922742196356,2,14,connexin complex,CC,GJB1;GJC2
833,GO:0002040,0.00328049980847704,0.99963519970015,4,94,sprouting angiogenesis,BP,PPP1R16B;FGF1;S100A1;GREM1
13665,GO:0051050,0.00328504732054782,0.99886640383579,13,862,positive regulation of transport,BP,CAMK2A;TF;HSPA2;S100A1;VSNL1;GREM1;BOK;CCK;MYBPC1;MBP;RYR2;GJC2;FXYD1
7123,GO:0030030,0.00342042438114858,0.998604030958516,18,1386,cell projection organization,BP,CAMK2A;LRP2;CPNE6;PPP1R16B;NEFM;MAG;SEPT4;RASAL1;PLP1;PACSIN1;ERMN;ENPP2;SLC39A12;SERPINI1;KLK6;CNTN2;CCK;LPAR1
18041,GO:0098772,0.00344026456124191,0.998562167852942,19,1545,molecular function regulator,MF,CAMK2A;PPP2R2C;PPP1R16B;ADAP1;RASAL1;FGF1;PPP1R1B;RAPGEF5;CXCL14;DOCK5;SERPINI1;GREM1;PPP1R14A;MAL;RCAN2;CCK;SPOCK3;GRM3;FXYD1
11696,GO:0044548,0.00344429159847964,0.999914530946762,2,14,S100 protein binding,MF,FGF1;S100A1
21840,GO:2001235,0.00348480054686405,0.999464419996584,5,164,positive regulation of apoptotic signaling pathway,BP,SEPT4;TPD52L1;ST18;MAL;BOK
5057,GO:0010921,0.00351515261011219,0.999459115553474,5,156,regulation of phosphatase activity,BP,PPP2R2C;PPP1R16B;PPP1R1B;PPP1R14A;RCAN2
11885,GO:0045125,0.00359014546467735,0.999908237917702,2,15,bioactive lipid receptor activity,MF,S1PR5;LPAR1
7463,GO:0030665,0.00365204981075332,0.999581025908649,4,99,clathrin-coated vesicle membrane,CC,LRP2;TF;SLC17A7;NRGN
2608,GO:0005509,0.00377447135157233,0.998876062199538,10,560,calcium ion binding,MF,LRP2;CPNE6;PADI2;NECAB1;ENPP2;SLC24A2;S100A1;VSNL1;SPOCK3;RYR2
9692,GO:0035308,0.00388171951490255,0.999722344332232,3,50,negative regulation of protein dephosphorylation,BP,PPP1R16B;PPP1R1B;PPP1R14A
6867,GO:0021700,0.00392311010893008,0.999239180906667,6,232,developmental maturation,BP,SOX10;SLC17A7;SEPT4;PLP1;GREM1;CNTN2
12070,GO:0045595,0.00415012690812665,0.998234039626435,19,1545,regulation of cell differentiation,BP,LRP2;SOX10;CPNE6;MAG;ASPA;RASAL1;PACSIN1;CXCL14;DOCK5;SLC39A12;NKX6-2;SERPINI1;GREM1;KLK6;S1PR5;CNTN2;LPAR1;ZNF536;GJC2
6064,GO:0016805,0.00426604488717957,0.999880016070525,2,16,dipeptidase activity,MF,FOLH1;CNDP1
15702,GO:0070262,0.00426850624577917,0.999879911281687,2,16,peptidyl-serine dephosphorylation,BP,PPP2R2C;PPP1R16B
11132,GO:0043217,0.00437710983746997,0.99987717270529,2,14,myelin maintenance,BP,FA2H;MYRF
3704,GO:0007267,0.00440251574361447,0.998157487294754,18,1447,cell-cell signaling,BP,CAMK2A;SOX10;CPNE6;SLC17A7;PLP1;CXCL14;CNTNAP4;NRGN;SLC24A2;VSNL1;GREM1;GJB1;CNTN2;SV2B;MBP;RYR2;GRM3;GJC2
18996,GO:1901623,0.00465158773390353,0.999862366382091,2,17,regulation of lymphocyte chemotaxis,BP,PADI2;CXCL14
7180,GO:0030136,0.00469580009091003,0.999225655813562,5,169,clathrin-coated vesicle,CC,LRP2;TF;CPNE6;SLC17A7;NRGN
14113,GO:0051861,0.00472434621328163,0.999859093753256,2,17,glycolipid binding,MF,MAG;HSPA2
7061,GO:0022829,0.00475849610488284,0.999857548644574,2,17,wide pore channel activity,MF,GJB1;GJC2
7849,GO:0031399,0.00486189028602332,0.997899022689893,19,1579,regulation of protein modification process,BP,HHATL;PPP2R2C;PPP1R16B;EPHB6;SEPT4;TPD52L1;FGF1;FBXO2;HSPA2;PPP1R1B;ENPP2;GREM1;PPP1R14A;GPR37;RCAN2;CCK;LPAR1;GJC2;FXYD1
13088,GO:0048518,0.00486519716947462,0.997374757846873,45,5067,positive regulation of biological process,BP,CAMK2A;LRP2;TF;SOX10;CPNE6;PPP1R16B;MAG;EPHB6;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;PADI2;PLP1;PACSIN1;MYRF;HSPA2;TOP2A;ENPP2;MOG;CXCL14;DOCK5;ST18;NKX6-2;NRGN;SLC24A2;S100A1;VSNL1;SERPINI1;GREM1;KLK6;GPR37;TPPP;MAL;BOK;GPR62;CNTN2;CCK;MYBPC1;MBP;LPAR1;RYR2;GJC2;FXYD1
9537,GO:0034764,0.00510180927499739,0.999141903007195,5,171,positive regulation of transmembrane transport,BP,HSPA2;S100A1;RYR2;GJC2;FXYD1
19853,GO:1903670,0.00538760034341915,0.99956512052757,3,55,regulation of sprouting angiogenesis,BP,PPP1R16B;FGF1;S100A1
13476,GO:0050768,0.00539684227749718,0.998881801433484,6,245,negative regulation of neurogenesis,BP,SOX10;MAG;NKX6-2;CNTN2;LPAR1;ZNF536
14140,GO:0051900,0.00550832811620367,0.999821219733537,2,18,regulation of mitochondrial depolarization,BP,BOK;CCK
13554,GO:0050877,0.00559933944909549,0.998027212287778,12,810,nervous system process,BP,LRP2;SOX10;SLC17A7;MAG;MYRF;PPP1R1B;NKX6-2;NRGN;SLC24A2;CNTN2;CCK;MBP
13163,GO:0048666,0.00562891192395169,0.997845612259671,14,1004,neuron development,BP,CAMK2A;LRP2;CPNE6;NEFM;MAG;RASAL1;PLP1;PACSIN1;SLC39A12;SERPINI1;KLK6;CNTN2;CCK;LPAR1
13589,GO:0050920,0.00565558399212455,0.999024400496273,5,181,regulation of chemotaxis,BP,FGF1;PADI2;CXCL14;GREM1;LPAR1
19950,GO:1903861,0.00567558217091641,0.999813955607452,2,17,positive regulation of dendrite extension,BP,CPNE6;RASAL1
6649,GO:0019807,0.00575312201789463,1,1,1,aspartoacylase activity,MF,ASPA
8045,GO:0031751,0.00583556823472174,1,1,1,D4 dopamine receptor binding,MF,PPP1R1B
7348,GO:0030382,0.00585650478924504,1,1,1,sperm mitochondrion organization,BP,SEPT4
14646,GO:0060254,0.00587700814649701,1,1,1,regulation of N-terminal protein palmitoylation,BP,HHATL
14651,GO:0060262,0.00587700814649701,1,1,1,negative regulation of N-terminal protein palmitoylation,BP,HHATL
19563,GO:1903060,0.00587700814649701,1,1,1,negative regulation of protein lipidation,BP,HHATL
11674,GO:0044456,0.00589270919160445,0.998013358444375,11,704,synapse part,CC,CAMK2A;SLC17A7;FBXO2;PACSIN1;CNTNAP4;NRGN;LGI3;SV2B;CCK;LPAR1;GRM3
13092,GO:0048522,0.00595369913197582,0.99677920910529,41,4532,positive regulation of cellular process,BP,CAMK2A;LRP2;TF;SOX10;CPNE6;PPP1R16B;MAG;EPHB6;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;PADI2;PACSIN1;MYRF;HSPA2;TOP2A;ENPP2;CXCL14;DOCK5;ST18;NKX6-2;NRGN;SLC24A2;VSNL1;SERPINI1;GREM1;KLK6;GPR37;TPPP;MAL;BOK;GPR62;CNTN2;CCK;MYBPC1;MBP;LPAR1;RYR2;GJC2
17790,GO:0097453,0.00604867408584739,1,1,1,mesaxon,CC,MAG
20881,GO:1990015,0.00604867408584739,1,1,1,ensheathing process,CC,MAG
764,GO:0001949,0.00605385854054394,1,1,1,sebaceous gland cell differentiation,BP,FA2H
17099,GO:0080132,0.00605385854054394,1,1,1,fatty acid alpha-hydroxylase activity,MF,FA2H
20346,GO:1904700,0.00610335786013833,1,1,1,granulosa cell apoptotic process,BP,BOK
20351,GO:1904708,0.00610335786013833,1,1,1,regulation of granulosa cell apoptotic process,BP,BOK
20248,GO:1904492,0.00610393295780042,1,1,1,Ac-Asp-Glu binding,MF,FOLH1
20249,GO:1904493,0.00610393295780042,1,1,1,tetrahydrofolyl-poly(glutamate) polymer binding,MF,FOLH1
11126,GO:0043204,0.00610915490170766,0.999187422586161,4,114,perikaryon,CC,CPNE6;SERPINI1;CCK;GJC2
13355,GO:0050459,0.00615391836942351,1,1,1,ethanolamine-phosphate phospho-lyase activity,MF,ETNPPL
3877,GO:0008068,0.00621324728463858,1,1,1,extracellularly glutamate-gated chloride channel activity,MF,SLC17A7
17764,GO:0097401,0.00621324728463858,1,1,1,synaptic vesicle lumen acidification,BP,SLC17A7
20273,GO:1904565,0.00625458497686684,1,1,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,LPAR1
20274,GO:1904566,0.00625458497686684,1,1,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,LPAR1
18473,GO:0120036,0.00636955550613908,0.997296987524413,17,1355,plasma membrane bounded cell projection organization,BP,CAMK2A;LRP2;CPNE6;PPP1R16B;NEFM;MAG;SEPT4;RASAL1;PLP1;PACSIN1;ENPP2;SLC39A12;SERPINI1;KLK6;CNTN2;CCK;LPAR1
2999,GO:0006173,0.00638908483487864,1,1,1,dADP biosynthetic process,BP,AK5
7179,GO:0030135,0.00644550829922574,0.998613403588697,6,260,coated vesicle,CC,LRP2;TF;CPNE6;SLC17A7;PACSIN1;NRGN
9777,GO:0035498,0.00649203189906862,1,1,1,carnosine metabolic process,BP,CARNS1
9778,GO:0035499,0.00649203189906862,1,1,1,carnosine biosynthetic process,BP,CARNS1
12854,GO:0047730,0.00649203189906862,1,1,1,carnosine synthase activity,MF,CARNS1
18337,GO:0102102,0.00649203189906862,1,1,1,homocarnosine synthase activity,MF,CARNS1
18659,GO:1900158,0.00654151485143334,1,1,1,negative regulation of bone mineralization involved in bone maturation,BP,GREM1
14125,GO:0051882,0.00680393040447163,0.999751449673703,2,20,mitochondrial depolarization,BP,BOK;CCK
2985,GO:0006147,0.006917346815644,1,1,1,guanine catabolic process,BP,GDA
4272,GO:0008892,0.006917346815644,1,1,1,guanine deaminase activity,MF,GDA
8939,GO:0033267,0.00697209011370163,0.998250435203539,7,340,axon part,CC,MAG;PACSIN1;ERMN;CNTN2;CCK;MBP;GJC2
9687,GO:0035303,0.00698405963353076,0.998732688479201,5,184,regulation of dephosphorylation,BP,PPP2R2C;PPP1R16B;PPP1R1B;PPP1R14A;RCAN2
6400,GO:0019035,0.00700018550255685,1,1,1,viral integration complex,CC,TOP2A
12230,GO:0045870,0.00700018550255685,1,1,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,TOP2A
20709,GO:1905463,0.00700018550255685,1,1,1,negative regulation of DNA duplex unwinding,BP,TOP2A
3824,GO:0007610,0.00728417148537936,0.997771873881952,9,529,behavior,BP,SLC17A7;PTGDS;PPP1R1B;CNTNAP4;NRGN;SLC24A2;GPR37;CNTN2;CCK
13494,GO:0050790,0.00737094385008358,0.996504232316383,22,2016,regulation of catalytic activity,BP,PPP2R2C;PPP1R16B;ADAP1;EPHB6;RASAL1;TPD52L1;FGF1;HSPA2;PPP1R1B;ST18;S100A1;SERPINI1;GREM1;PPP1R14A;RCAN2;BOK;CCK;SPOCK3;MBP;LPAR1;RYR2;GRM3
16182,GO:0071206,0.00755773557604591,1,1,1,establishment of protein localization to juxtaparanode region of axon,BP,CNTN2
8784,GO:0032989,0.00756115412550781,0.997002462322961,14,1033,cellular component morphogenesis,BP,CAMK2A;LRP2;CPNE6;MAG;RASAL1;PACSIN1;ERMN;ENPP2;DOCK5;GREM1;CNTN2;CCK;MYBPC1;LPAR1
19948,GO:1903859,0.00759135665599757,0.999706517223887,2,20,regulation of dendrite extension,BP,CPNE6;RASAL1
14179,GO:0051961,0.00766339220787125,0.998290236171795,6,264,negative regulation of nervous system development,BP,SOX10;MAG;NKX6-2;CNTN2;LPAR1;ZNF536
7040,GO:0022603,0.00766740091078291,0.997064309342426,13,945,regulation of anatomical structure morphogenesis,BP,CPNE6;PPP1R16B;MAG;RASAL1;FGF1;ERMN;ENPP2;DOCK5;S100A1;GREM1;CNTN2;MBP;LPAR1
622,GO:0001763,0.00768174860283499,0.998573483941965,5,187,morphogenesis of a branching structure,BP,SOX10;FGF1;ERMN;HHIP;GREM1
11929,GO:0045202,0.00793295566481951,0.997074348490536,12,835,synapse,CC,CAMK2A;SLC17A7;FBXO2;PACSIN1;CNTNAP4;NRGN;LGI3;CNTN2;SV2B;CCK;LPAR1;GRM3
326,GO:0000902,0.00839982862791967,0.99674673804837,13,941,cell morphogenesis,BP,CAMK2A;LRP2;CPNE6;MAG;RASAL1;PACSIN1;ERMN;ENPP2;DOCK5;GREM1;CNTN2;CCK;LPAR1
19602,GO:1903169,0.00858815724627335,0.998738659585529,4,125,regulation of calcium ion transmembrane transport,BP,HSPA2;S100A1;RYR2;GJC2
7041,GO:0022604,0.00859166438468205,0.997514155410356,8,442,regulation of cell morphogenesis,BP,CPNE6;MAG;RASAL1;ERMN;ENPP2;DOCK5;CNTN2;LPAR1
11676,GO:0044459,0.00901111823993494,0.995473682473604,25,2421,plasma membrane part,CC,CAMK2A;LRP2;FOLH1;TF;MAG;EPHB6;RASAL1;PACSIN1;HSPA2;ENPP2;MOG;SLC39A12;CNTNAP4;SLC24A2;SLC5A11;HHIP;GJB1;GPR37;MAL;CNTN2;LPAR1;GRM3;GJC2;TMEM235;FXYD1
3434,GO:0006812,0.00903397574567901,0.996468116050827,13,976,cation transport,BP,CAMK2A;LRP2;TF;SLC17A7;HSPA2;SLC39A12;SLC24A2;SLC5A11;S100A1;NKAIN2;RYR2;GJC2;FXYD1
14153,GO:0051924,0.0092427410760684,0.998203285067147,5,201,regulation of calcium ion transport,BP,CAMK2A;HSPA2;S100A1;RYR2;GJC2
11043,GO:0043065,0.00938508749402903,0.997009576411128,9,563,positive regulation of apoptotic process,BP,CAMK2A;SEPT4;TPD52L1;TOP2A;ST18;MAL;BOK;CCK;LPAR1
13199,GO:0048708,0.00943571761567925,0.999061111406026,3,67,astrocyte differentiation,BP,MAG;PLP1;CNTN2
13497,GO:0050794,0.00948591940950014,0.994807728396421,70,9170,regulation of cellular process,BP,HHATL;CAMK2A;PPP2R2C;LRP2;TF;SOX10;CPNE6;PPP1R16B;FA2H;SLC17A7;MAG;ADAP1;EPHB6;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;FBXO2;PADI2;NECAB1;PLP1;PACSIN1;MYRF;HSPA2;EVI2A;TOP2A;PPP1R1B;RAPGEF5;ERMN;ENPP2;MOG;CXCL14;DOCK5;ST18;SLC39A12;MKI67;NKX6-2;CNDP1;CNTNAP4;NRGN;SLC24A2;S100A1;PAQR6;VSNL1;SERPINI1;HHIP;GREM1;PPP1R14A;KLK6;LGI3;GPR37;TPPP;MAL;RCAN2;BOK;S1PR5;GPR62;CNTN2;CCK;MYBPC1;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;FXYD1
4903,GO:0010721,0.00950514908120698,0.997779271674457,6,277,negative regulation of cell development,BP,SOX10;MAG;NKX6-2;CNTN2;LPAR1;ZNF536
2848,GO:0005921,0.00957100687605379,0.999577015216936,2,24,gap junction,CC,GJB1;GJC2
11171,GO:0043269,0.00962289087192396,0.996921561332087,9,559,regulation of ion transport,BP,CAMK2A;TF;HSPA2;S100A1;CCK;NKAIN2;RYR2;GJC2;FXYD1
15281,GO:0061351,0.00997946166231034,0.998468732622079,4,128,neural precursor cell proliferation,BP,LRP2;SOX10;HHIP;GJC2
11046,GO:0043068,0.010044949957377,0.996763848251818,9,569,positive regulation of programmed cell death,BP,CAMK2A;SEPT4;TPD52L1;TOP2A;ST18;MAL;BOK;CCK;LPAR1
11482,GO:0044057,0.010061483087326,0.997006706376771,8,465,regulation of system process,BP,SOX10;MAG;MYRF;DOCK5;S100A1;CCK;RYR2;FXYD1
11434,GO:0043924,0.010126256765845,1,1,1,suramin binding,MF,RYR2
3436,GO:0006814,0.010372200247162,0.997926101367878,5,202,sodium ion transport,BP,SLC17A7;SLC24A2;SLC5A11;NKAIN2;FXYD1
3826,GO:0007612,0.0105008002771957,0.9983645427477,4,129,learning,BP,PPP1R1B;NRGN;SLC24A2;CNTN2
14048,GO:0051716,0.0111941647655689,0.993553568239341,51,6193,cellular response to stimulus,BP,CAMK2A;LRP2;TF;SOX10;CPNE6;PPP1R16B;SLC17A7;MAG;ADAP1;EPHB6;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;FBXO2;PADI2;PLP1;HSPA2;EVI2A;TOP2A;PPP1R1B;RAPGEF5;ENPP2;MOG;CXCL14;DOCK5;ST18;SLC39A12;NRGN;S100A1;PAQR6;VSNL1;HHIP;GREM1;PPP1R14A;KLK6;GPR37;MAL;RCAN2;BOK;S1PR5;GPR62;CNTN2;CCK;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3
21262,GO:2000177,0.0112811585002964,0.99879966039871,3,71,regulation of neural precursor cell proliferation,BP,LRP2;SOX10;GJC2
2139,GO:0004667,0.0113755778875375,0.999967795936841,1,2,prostaglandin-D synthase activity,MF,PTGDS
1370,GO:0003008,0.0114291924199778,0.99483150434281,17,1463,system process,BP,LRP2;SOX10;SLC17A7;MAG;MYRF;PPP1R1B;DOCK5;NKX6-2;NRGN;SLC24A2;S100A1;CNTN2;CCK;MYBPC1;MBP;RYR2;FXYD1
4912,GO:0010731,0.0115028622254282,0.999967069089891,1,2,protein glutathionylation,BP,FXYD1
4913,GO:0010732,0.0115028622254282,0.999967069089891,1,2,regulation of protein glutathionylation,BP,FXYD1
4914,GO:0010734,0.0115028622254282,0.999967069089891,1,2,negative regulation of protein glutathionylation,BP,FXYD1
3203,GO:0006500,0.0118122435849401,0.999965268370961,1,2,N-terminal protein palmitoylation,BP,HHATL
5730,GO:0016151,0.0118199697953318,0.999965222784294,1,2,nickel cation binding,MF,SLC24A2
8044,GO:0031750,0.0119643513206577,0.999964365362257,1,2,D3 dopamine receptor binding,MF,PPP1R1B
4406,GO:0009183,0.0119924759301434,0.999964197119372,1,2,purine deoxyribonucleoside diphosphate biosynthetic process,BP,AK5
8290,GO:0032270,0.0120120027141696,0.994665757005702,16,1366,positive regulation of cellular protein metabolic process,BP,LRP2;PPP1R16B;EPHB6;SEPT4;TPD52L1;FGF1;HSPA2;ENPP2;ST18;GREM1;GPR37;BOK;CNTN2;CCK;MBP;LPAR1
10593,GO:0042137,0.0120802263920522,0.999963669629101,1,2,sequestering of neurotransmitter,BP,SLC17A7
15658,GO:0070194,0.0120949902427252,0.999963580498414,1,2,synaptonemal complex disassembly,BP,HSPA2
10324,GO:0036505,0.0122296335812448,0.999962762574062,1,2,prosaposin receptor activity,MF,GPR37
20108,GO:1904207,0.0122525456914779,0.999962622478792,1,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,MBP
20109,GO:1904209,0.0122525456914779,0.999962622478792,1,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,MBP
18656,GO:1900154,0.0123457522928895,0.999962049841826,1,2,regulation of bone trabecula formation,BP,GREM1
18657,GO:1900155,0.0123457522928895,0.999962049841826,1,2,negative regulation of bone trabecula formation,BP,GREM1
2998,GO:0006172,0.0123639973756122,0.99996193723613,1,2,ADP biosynthetic process,BP,AK5
12329,GO:0046056,0.012504084027505,0.999961067051105,1,2,dADP metabolic process,BP,AK5
13713,GO:0051128,0.0125219826631236,0.993670090406322,23,2217,regulation of cellular component organization,BP,TF;CPNE6;PPP1R16B;MAG;RASAL1;PADI2;PACSIN1;HSPA2;TOP2A;ERMN;ENPP2;DOCK5;SLC39A12;MKI67;SERPINI1;GREM1;KLK6;TPPP;BOK;CNTN2;CCK;MYBPC1;LPAR1
18658,GO:1900157,0.0125404324955822,0.999960839645767,1,2,regulation of bone mineralization involved in bone maturation,BP,GREM1
9100,GO:0033693,0.0125703297825303,0.999960652101154,1,2,neurofilament bundle assembly,BP,NEFM
12168,GO:0045745,0.0125814529911599,0.99935399433075,2,27,positive regulation of G-protein coupled receptor protein signaling pathway,BP,KLK6;CNTN2
10272,GO:0036413,0.0125818721348359,0.999960579575751,1,2,histone H3-R26 citrullination,BP,PADI2
2404,GO:0005052,0.0126166152679444,0.999960360864577,1,2,peroxisome matrix targeting signal-1 binding,MF,PEX5L
549,GO:0001641,0.0126540713361304,0.999960124393099,1,2,group II metabotropic glutamate receptor activity,MF,GRM3
16305,GO:0071393,0.0126586205408045,0.999960095624393,1,2,cellular response to progesterone stimulus,BP,SOX10
20337,GO:1904685,0.0127478574397901,0.999959529188076,1,2,positive regulation of metalloendopeptidase activity,BP,MBP
17660,GO:0097194,0.012752776917617,0.998577445193603,3,77,execution phase of apoptosis,BP,TOP2A;BOK;AIFM3
7263,GO:0030246,0.012765155945838,0.997310783896423,5,223,carbohydrate binding,MF,CD22;MAG;FBXO2;ENPP2;CNTN2
4995,GO:0010848,0.0128675207794115,0.999958763311411,1,2,regulation of chromatin disassembly,BP,PADI2
3556,GO:0007009,0.0129002609584084,0.99855683074435,3,73,plasma membrane organization,BP,FA2H;PACSIN1;MYRF
13201,GO:0048710,0.0129476010138853,0.999325139502235,2,27,regulation of astrocyte differentiation,BP,MAG;CNTN2
17382,GO:0090291,0.0131263823049026,0.999957081802847,1,2,negative regulation of osteoclast proliferation,BP,GREM1
3635,GO:0007165,0.0131821068948529,0.992404572361211,43,5032,signal transduction,BP,CAMK2A;LRP2;SOX10;PPP1R16B;SLC17A7;ADAP1;EPHB6;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;PADI2;PLP1;EVI2A;PPP1R1B;RAPGEF5;ENPP2;MOG;CXCL14;DOCK5;ST18;SLC39A12;NRGN;S100A1;PAQR6;HHIP;GREM1;KLK6;GPR37;MAL;RCAN2;BOK;S1PR5;GPR62;CNTN2;CCK;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3
3658,GO:0007193,0.0132174768696783,0.998505996150318,3,77,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,GPR37;LPAR1;GRM3
14700,GO:0060326,0.0133520508061051,0.997155096056024,5,227,cell chemotaxis,BP,FGF1;PADI2;CXCL14;GREM1;LPAR1
2484,GO:0005198,0.0133634342553362,0.995488124332545,9,596,structural molecule activity,MF,CLDN11;NEFM;SEPT4;PLP1;HAPLN2;MOBP;MAL;MYBPC1;MBP
4489,GO:0009330,0.0133873783728055,0.999955352177863,1,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,TOP2A
18789,GO:1901019,0.0134512706902441,0.998469684923477,3,77,regulation of calcium ion transmembrane transporter activity,BP,HSPA2;S100A1;RYR2
20708,GO:1905462,0.0134861406715326,0.999954688706499,1,2,regulation of DNA duplex unwinding,BP,TOP2A
7804,GO:0031315,0.0135033781698643,0.999954572402369,1,2,extrinsic component of mitochondrial outer membrane,CC,SOX10
9562,GO:0034986,0.0135337483704534,0.999954367124617,1,2,iron chaperone activity,MF,TF
13064,GO:0048469,0.0137279509250552,0.997683164648491,4,146,cell maturation,BP,SOX10;SEPT4;PLP1;CNTN2
12179,GO:0045766,0.0137538708653585,0.997677988887222,4,144,positive regulation of angiogenesis,BP,PPP1R16B;FGF1;S100A1;GREM1
1689,GO:0003918,0.0138071636640405,0.999952498077486,1,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,TOP2A
15335,GO:0061505,0.0138071636640405,0.999952498077486,1,2,DNA topoisomerase II activity,MF,TOP2A
4860,GO:0010644,0.0141683127836361,0.999225809578224,2,27,cell communication by electrical coupling,BP,RYR2;GJC2
4688,GO:0010092,0.0146390880567991,0.999182986286717,2,29,specification of animal organ identity,BP,LRP2;FGF1
10887,GO:0042734,0.0150298232417744,0.998218324293225,3,77,presynaptic membrane,CC,CAMK2A;CNTNAP4;GRM3
3503,GO:0006921,0.015249027336827,0.999128944976146,2,30,cellular component disassembly involved in execution phase of apoptosis,BP,TOP2A;BOK
17805,GO:0097484,0.0153526617975577,0.999121469297081,2,29,dendrite extension,BP,CPNE6;RASAL1
5077,GO:0010950,0.0158727194930001,0.997201764685059,4,154,positive regulation of endopeptidase activity,BP,ST18;BOK;CCK;MBP
5073,GO:0010942,0.0160836304163652,0.994398953242771,9,616,positive regulation of cell death,BP,CAMK2A;SEPT4;TPD52L1;TOP2A;ST18;MAL;BOK;CCK;LPAR1
18118,GO:0098904,0.016132260149532,0.999935075512397,1,2,regulation of AV node cell action potential,BP,RYR2
3825,GO:0007611,0.01623963326108,0.996367041998041,5,225,learning or memory,BP,SLC17A7;PPP1R1B;NRGN;SLC24A2;CNTN2
11119,GO:0043197,0.0165506436382985,0.997047241501329,4,149,dendritic spine,CC,FBXO2;NRGN;LPAR1;GRM3
3447,GO:0006835,0.0167064827055314,0.997936414915593,3,83,dicarboxylic acid transport,BP,LRP2;SLC17A7;CCK
13504,GO:0050804,0.0169030460895518,0.995520618066226,6,317,modulation of chemical synaptic transmission,BP,CAMK2A;CNTNAP4;NRGN;SLC24A2;CNTN2;GRM3
18230,GO:0099177,0.0169030460895518,0.995520618066226,6,317,regulation of trans-synaptic signaling,BP,CAMK2A;CNTNAP4;NRGN;SLC24A2;CNTN2;GRM3
20229,GO:1904447,0.0170833073506604,0.999927159440574,1,2,folic acid import across plasma membrane,BP,LRP2
21472,GO:2000503,0.0171147486123416,0.999902614231949,1,3,positive regulation of natural killer cell chemotaxis,BP,CXCL14
5275,GO:0014911,0.017132898562908,0.998959455183007,2,30,positive regulation of smooth muscle cell migration,BP,DOCK5;LPAR1
2283,GO:0004864,0.0172148652506159,0.998948466373212,2,32,protein phosphatase inhibitor activity,MF,PPP1R1B;PPP1R14A
16002,GO:0070838,0.0173097304147306,0.994815850501091,7,412,divalent metal ion transport,BP,CAMK2A;HSPA2;SLC39A12;SLC24A2;S100A1;RYR2;GJC2
11586,GO:0044309,0.0173693808198952,0.996855763292986,4,151,neuron spine,CC,FBXO2;NRGN;LPAR1;GRM3
1198,GO:0002686,0.0175349536447757,0.998916883177276,2,33,negative regulation of leukocyte migration,BP,PADI2;GREM1
18737,GO:1900390,0.0176111280717116,0.999896860073016,1,3,regulation of iron ion import,BP,TF
6084,GO:0016838,0.017636846046695,0.999896557407481,1,3,carbon-oxygen lyase activity, acting on phosphates,MF,ETNPPL
3228,GO:0006533,0.017678305066461,0.999896068550163,1,3,aspartate catabolic process,BP,ASPA
11098,GO:0043168,0.0176794144040608,0.990552596419851,25,2541,anion binding,MF,CAMK2A;FOLH1;CPNE6;MAG;ADAP1;EPHB6;PTGDS;SEPT4;RASAL1;FGF1;CDK18;PACSIN1;HSPA2;TOP2A;IQCA1;HAPLN2;MKI67;AK5;NRGN;ETNPPL;CARNS1;AIFM3;DNAH17;LPAR1;RYR2
18120,GO:0098907,0.0177427513816802,0.99992140084497,1,2,regulation of SA node cell action potential,BP,RYR2
8392,GO:0032414,0.0178271516819013,0.997743328581143,3,84,positive regulation of ion transmembrane transporter activity,BP,HSPA2;S100A1;RYR2
8849,GO:0033106,0.0178679666495673,0.999893817372143,1,3,cis-Golgi network membrane,CC,BOK
4380,GO:0009153,0.0178684726792707,0.999893811333325,1,3,purine deoxyribonucleotide biosynthetic process,BP,AK5
18997,GO:1901624,0.0178811846971518,0.999893659574846,1,3,negative regulation of lymphocyte chemotaxis,BP,PADI2
5340,GO:0015144,0.0178984405874474,0.998882398993895,2,33,carbohydrate transmembrane transporter activity,MF,SLC5A11;TMEM144
16932,GO:0072511,0.0179110421255388,0.994598915383926,7,415,divalent inorganic cation transport,BP,CAMK2A;HSPA2;SLC39A12;SLC24A2;S100A1;RYR2;GJC2
1483,GO:0003220,0.0179304906985574,0.999919720984738,1,2,left ventricular cardiac muscle tissue morphogenesis,BP,RYR2
4363,GO:0009136,0.0179340354445901,0.999893027461309,1,3,purine nucleoside diphosphate biosynthetic process,BP,AK5
4403,GO:0009180,0.0179340354445901,0.999893027461309,1,3,purine ribonucleoside diphosphate biosynthetic process,BP,AK5
4410,GO:0009188,0.0179340354445901,0.999893027461309,1,3,ribonucleoside diphosphate biosynthetic process,BP,AK5
4114,GO:0008453,0.0180157824757868,0.999892046018435,1,3,alanine-glyoxylate transaminase activity,MF,ETNPPL
20750,GO:1905576,0.0180178012484116,0.999892021724177,1,3,ganglioside GT1b binding,MF,MAG
21093,GO:1990769,0.0180328368866216,0.999891840696015,1,3,proximal neuron projection,CC,GJC2
4405,GO:0009182,0.0180733400568054,0.999891352279774,1,3,purine deoxyribonucleoside diphosphate metabolic process,BP,AK5
4198,GO:0008597,0.0180901671762797,0.999891149040135,1,3,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,RCAN2
16492,GO:0071673,0.0181818031839406,0.999890038890464,1,3,positive regulation of smooth muscle cell chemotaxis,BP,LPAR1
12814,GO:0047391,0.0182934603674195,0.999888678512591,1,3,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,ENPP2
8043,GO:0031749,0.0184144312633421,0.999887195142982,1,3,D2 dopamine receptor binding,MF,PPP1R1B
6967,GO:0021912,0.0185466007729921,0.999885563135865,1,3,regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification,BP,NKX6-2
3875,GO:0008065,0.0186180711006606,0.999884675708084,1,3,establishment of blood-nerve barrier,BP,HAPLN2
17380,GO:0090289,0.0187061308015429,0.999883577541037,1,3,regulation of osteoclast proliferation,BP,GREM1
14281,GO:0052548,0.0187368641351773,0.994917539226313,6,337,regulation of endopeptidase activity,BP,ST18;SERPINI1;BOK;CCK;SPOCK3;MBP
4645,GO:0009953,0.0187421309191513,0.997579605600935,3,89,dorsal/ventral pattern formation,BP,NKX6-2;HHIP;GREM1
5420,GO:0015319,0.0188030322836229,0.999882363045354,1,3,sodium:inorganic phosphate symporter activity,MF,SLC17A7
5310,GO:0015091,0.0190696492965103,0.999878988647796,1,3,ferric iron transmembrane transporter activity,MF,TF
16931,GO:0072510,0.0190696492965103,0.999878988647796,1,3,trivalent inorganic cation transmembrane transporter activity,MF,TF
6466,GO:0019212,0.0192068652875531,0.998753457699937,2,34,phosphatase inhibitor activity,MF,PPP1R1B;PPP1R14A
14595,GO:0060168,0.0193353889384752,0.999875577456479,1,3,positive regulation of adenosine receptor signaling pathway,BP,CNTN2
19968,GO:1903899,0.0194007846760533,0.999874730664224,1,3,positive regulation of PERK-mediated unfolded protein response,BP,BOK
13493,GO:0050789,0.0194583748638597,0.988889086247903,72,9735,regulation of biological process,BP,HHATL;CAMK2A;PPP2R2C;LRP2;TF;SOX10;CPNE6;PPP1R16B;FA2H;SLC17A7;MAG;ADAP1;EPHB6;PTGDS;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;FBXO2;PADI2;NECAB1;PLP1;PACSIN1;MYRF;HSPA2;EVI2A;TOP2A;PPP1R1B;RAPGEF5;ERMN;ENPP2;MOG;CXCL14;DOCK5;ST18;SLC39A12;MKI67;NKX6-2;CNDP1;CNTNAP4;NRGN;SLC24A2;S100A1;PAQR6;VSNL1;SERPINI1;HHIP;GREM1;PPP1R14A;KLK6;LGI3;GPR37;TPPP;MAL;RCAN2;BOK;S1PR5;GPR62;CNTN2;CCK;NKAIN2;MYBPC1;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;FXYD1
8046,GO:0031752,0.0194910559983933,0.999873557004533,1,3,D5 dopamine receptor binding,MF,PPP1R1B
13065,GO:0048471,0.0195562305269689,0.992960556218964,9,630,perinuclear region of cytoplasm,CC,HHATL;TF;PPP1R16B;PTGDS;TPD52L1;PACSIN1;SLC39A12;MOBP;TPPP
7461,GO:0030662,0.0195761806892386,0.996323845191401,4,162,coated vesicle membrane,CC,LRP2;TF;SLC17A7;NRGN
19260,GO:1902309,0.0196403869797407,0.999871603360898,1,3,negative regulation of peptidyl-serine dephosphorylation,BP,PPP1R16B
19899,GO:1903763,0.0196790198601235,0.99987109548037,1,3,gap junction channel activity involved in cell communication by electrical coupling,MF,GJC2
3834,GO:0007621,0.0197577356367423,0.999870057526742,1,3,negative regulation of female receptivity,BP,PPP1R1B
18475,GO:0120039,0.0197804760165587,0.992867109828042,9,612,plasma membrane bounded cell projection morphogenesis,BP,CAMK2A;LRP2;CPNE6;MAG;RASAL1;PACSIN1;ENPP2;CNTN2;CCK
7870,GO:0031430,0.0198256219614138,0.998701688768112,2,29,M band,CC,S100A1;MYBPC1
13271,GO:0048858,0.0199495170121221,0.99279566281664,9,613,cell projection morphogenesis,BP,CAMK2A;LRP2;CPNE6;MAG;RASAL1;PACSIN1;ENPP2;CNTN2;CCK
20032,GO:1904018,0.0199778421696336,0.996225814889823,4,161,positive regulation of vasculature development,BP,PPP1R16B;FGF1;S100A1;GREM1
2632,GO:0005547,0.0200023633718349,0.998675457190937,2,33,phosphatidylinositol-3,4,5-trisphosphate binding,MF,ADAP1;NRGN
1504,GO:0003257,0.0203142675351159,0.99986259920592,1,3,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,GREM1
18860,GO:1901228,0.0203142675351159,0.99986259920592,1,3,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,GREM1
17605,GO:0097108,0.0203635372252371,0.999861928801121,1,3,hedgehog family protein binding,MF,HHIP
7828,GO:0031346,0.0205323071209671,0.99431722658387,6,326,positive regulation of cell projection organization,BP,CPNE6;RASAL1;PACSIN1;ENPP2;SERPINI1;LPAR1
4656,GO:0009986,0.0207059468954511,0.992473314072749,9,638,cell surface,CC,LRP2;FOLH1;TF;HSPA2;MOG;HHIP;GREM1;CNTN2;LPAR1
13792,GO:0051247,0.0207552460644565,0.990166228510617,16,1455,positive regulation of protein metabolic process,BP,LRP2;PPP1R16B;EPHB6;SEPT4;TPD52L1;FGF1;HSPA2;ENPP2;ST18;GREM1;GPR37;BOK;CNTN2;CCK;MBP;LPAR1
5662,GO:0016020,0.0208710744174575,0.987475779988954,59,7647,membrane,CC,HHATL;CD22;CLDN11;CAMK2A;LRP2;FOLH1;TF;SOX10;CPNE6;PPP1R16B;FA2H;SLC17A7;MAG;ADAP1;EPHB6;PTGDS;RASAL1;PEX5L;FBXO2;PLP1;PACSIN1;MYRF;HSPA2;EVI2A;ENPP2;MOG;DOCK5;SLC39A12;MKI67;CNTNAP4;NRGN;SLC24A2;SLC5A11;PAQR6;VSNL1;TMEM144;HHIP;GJB1;GPR37;MAL;BOK;TMEM125;TMEM151A;S1PR5;GPR62;HS3ST4;AIFM3;CNTN2;SV2B;NKAIN2;OPALIN;MBP;LPAR1;RYR2;GRM3;GJC2;TMEM235;TMEM88B;FXYD1
12178,GO:0045765,0.0211649361393157,0.994932374011596,5,246,regulation of angiogenesis,BP,PPP1R16B;FGF1;ENPP2;S100A1;GREM1
20344,GO:1904694,0.0213146509890435,0.999848664291484,1,3,negative regulation of vascular smooth muscle contraction,BP,DOCK5
7411,GO:0030544,0.0213549808243243,0.998530346643408,2,36,Hsp70 protein binding,MF,FGF1;GPR37
11904,GO:0045163,0.0216654147874077,0.999843617389859,1,3,clustering of voltage-gated potassium channels,BP,CNTN2
1866,GO:0004180,0.0218792021072946,0.998473031577137,2,37,carboxypeptidase activity,MF,FOLH1;CNDP1
5131,GO:0014014,0.0220559252685637,0.998455865377028,2,36,negative regulation of gliogenesis,BP,SOX10;NKX6-2
3652,GO:0007186,0.0220993413383433,0.99140035754222,10,771,G-protein coupled receptor signaling pathway,BP,CAMK2A;ENPP2;KLK6;GPR37;S1PR5;GPR62;CNTN2;CCK;LPAR1;GRM3
5079,GO:0010952,0.0223406207119179,0.995631639198197,4,171,positive regulation of peptidase activity,BP,ST18;BOK;CCK;MBP
1200,GO:0002688,0.0225680092268236,0.996867281191855,3,100,regulation of leukocyte chemotaxis,BP,PADI2;CXCL14;GREM1
12706,GO:0046915,0.0226912964792257,0.998385400043437,2,37,transition metal ion transmembrane transporter activity,MF,TF;SLC39A12
12947,GO:0048167,0.0227074958072282,0.995540369701918,4,164,regulation of synaptic plasticity,BP,CAMK2A;NRGN;SLC24A2;CNTN2
5098,GO:0010976,0.0227076204422352,0.99446471914981,5,244,positive regulation of neuron projection development,BP,CPNE6;RASAL1;PACSIN1;SERPINI1;LPAR1
8389,GO:0032411,0.0228677898109018,0.99681418668343,3,93,positive regulation of transporter activity,BP,HSPA2;S100A1;RYR2
2489,GO:0005215,0.0228765813621558,0.989883389215675,13,1100,transporter activity,MF,LRP2;TF;CPNE6;SLC17A7;SLC39A12;SLC24A2;SLC5A11;TMEM144;GJB1;SV2B;RYR2;GJC2;FXYD1
8785,GO:0032990,0.0232790235034148,0.991366605928836,9,631,cell part morphogenesis,BP,CAMK2A;LRP2;CPNE6;MAG;RASAL1;PACSIN1;ENPP2;CNTN2;CCK
19646,GO:1903276,0.0233995459322072,0.999794752781015,1,4,regulation of sodium ion export across plasma membrane,BP,FXYD1
19647,GO:1903278,0.0233995459322072,0.999794752781015,1,4,positive regulation of sodium ion export across plasma membrane,BP,FXYD1
3489,GO:0006898,0.0234841604710581,0.994223576913627,5,254,receptor-mediated endocytosis,BP,LRP2;TF;ENPP2;GREM1;CNTN2
11106,GO:0043177,0.0235545104497212,0.995319312101478,4,173,organic acid binding,MF,MAG;PTGDS;HAPLN2;RYR2
20833,GO:1905867,0.0236147795925007,0.999790940345014,1,4,epididymis development,BP,GJB1
4411,GO:0009189,0.0237128982549896,0.999789190607882,1,4,deoxyribonucleoside diphosphate biosynthetic process,BP,AK5
12900,GO:0048016,0.0238189877458582,0.998262836808027,2,36,inositol phosphate-mediated signaling,BP,RCAN2;GPR62
10930,GO:0042802,0.0239476203418629,0.988452954281182,16,1494,identical protein binding,MF,CLDN11;CAMK2A;SOX10;MAG;ASPA;SEPT4;TPD52L1;PACSIN1;TOP2A;S100A1;ETNPPL;GREM1;GJB1;BOK;CNTN2;RYR2
9689,GO:0035305,0.0240736575286629,0.996578829010108,3,95,negative regulation of dephosphorylation,BP,PPP1R16B;PPP1R1B;PPP1R14A
9843,GO:0035594,0.0242257848334219,0.9997799244598,1,4,ganglioside binding,MF,MAG
17307,GO:0090191,0.0242652865770756,0.99977920244357,1,4,negative regulation of branching involved in ureteric bud morphogenesis,BP,GREM1
6968,GO:0021913,0.024327615149355,0.999778060766723,1,4,regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification,BP,NKX6-2
14614,GO:0060199,0.0244876058931763,0.999775116585991,1,4,clathrin-sculpted glutamate transport vesicle,CC,SLC17A7
14617,GO:0060203,0.0244876058931763,0.999775116585991,1,4,clathrin-sculpted glutamate transport vesicle membrane,CC,SLC17A7
131,GO:0000268,0.0246051876779805,0.999772940324776,1,4,peroxisome targeting sequence binding,MF,PEX5L
12353,GO:0046098,0.0246056191737417,0.999772932318939,1,4,guanine metabolic process,BP,GDA
9856,GO:0035609,0.0246481297272442,0.999772142892218,1,4,C-terminal protein deglutamylation,BP,FOLH1
8707,GO:0032879,0.0247421305355743,0.986621713143604,23,2369,regulation of localization,BP,CAMK2A;TF;FGF1;PADI2;PACSIN1;HSPA2;ENPP2;CXCL14;DOCK5;S100A1;VSNL1;GREM1;LGI3;BOK;CCK;NKAIN2;MYBPC1;SPOCK3;MBP;LPAR1;RYR2;GJC2;FXYD1
12983,GO:0048247,0.0248172489971875,0.998140562813837,2,41,lymphocyte chemotaxis,BP,PADI2;CXCL14
5928,GO:0016560,0.0249822732923232,0.99976588958789,1,4,protein import into peroxisome matrix, docking,BP,PEX5L
14594,GO:0060167,0.0250217305946281,0.999765145519095,1,4,regulation of adenosine receptor signaling pathway,BP,CNTN2
18943,GO:1901509,0.0250700460039773,0.999764232782791,1,4,regulation of endothelial tube morphogenesis,BP,FGF1
2140,GO:0004668,0.0251217654564026,0.999763253757212,1,4,protein-arginine deiminase activity,MF,PADI2
6287,GO:0018101,0.0251217654564026,0.999763253757212,1,4,protein citrullination,BP,PADI2
10273,GO:0036414,0.0251217654564026,0.999763253757212,1,4,histone citrullination,BP,PADI2
17201,GO:0090027,0.0251348434932764,0.999763005871171,1,4,negative regulation of monocyte chemotaxis,BP,GREM1
14280,GO:0052547,0.0251349035724796,0.992713324540251,6,360,regulation of peptidase activity,BP,ST18;SERPINI1;BOK;CCK;SPOCK3;MBP
21412,GO:2000401,0.025170807501067,0.998101530348618,2,40,regulation of lymphocyte migration,BP,PADI2;CXCL14
14939,GO:0060681,0.0253470042021343,0.999758966180112,1,4,branch elongation involved in ureteric bud branching,BP,FGF1
13462,GO:0050748,0.0254300013804953,0.999757376463481,1,4,negative regulation of lipoprotein metabolic process,BP,HHATL
7363,GO:0030425,0.0254749588368679,0.991026155233749,8,543,dendrite,CC,LRP2;CPNE6;FBXO2;CNTNAP4;NRGN;CCK;LPAR1;GRM3
15544,GO:0065009,0.0256151830957835,0.985560643005011,27,2938,regulation of molecular function,BP,CAMK2A;PPP2R2C;PPP1R16B;ADAP1;EPHB6;RASAL1;TPD52L1;FGF1;HSPA2;PPP1R1B;RAPGEF5;CXCL14;DOCK5;ST18;S100A1;SERPINI1;GREM1;PPP1R14A;RCAN2;BOK;CCK;SPOCK3;MBP;LPAR1;RYR2;GRM3;FXYD1
17785,GO:0097447,0.025687623766496,0.99093702230581,8,544,dendritic tree,CC,LRP2;CPNE6;FBXO2;CNTNAP4;NRGN;CCK;LPAR1;GRM3
9874,GO:0035633,0.0256997609969608,0.999752173035543,1,4,maintenance of permeability of blood-brain barrier,BP,MBP
3999,GO:0008273,0.0258600218280684,0.999749055312189,1,4,calcium, potassium:sodium antiporter activity,MF,SLC24A2
7273,GO:0030263,0.0258704008305185,0.999748852719083,1,4,apoptotic chromosome condensation,BP,TOP2A
11595,GO:0044323,0.0260415708787822,0.999745499639861,1,4,retinoic acid-responsive element binding,MF,ZNF536
7720,GO:0031133,0.0260571173514711,0.999745193983567,1,4,regulation of axon diameter,BP,CNTN2
13564,GO:0050890,0.0260647409282302,0.993413840352554,5,255,cognition,BP,SLC17A7;PPP1R1B;NRGN;SLC24A2;CNTN2
20573,GO:1905167,0.026264216843417,0.999769698938647,1,3,positive regulation of lysosomal protein catabolic process,BP,LRP2
2540,GO:0005315,0.0263793255151155,0.999738817342998,1,4,inorganic phosphate transmembrane transporter activity,MF,SLC17A7
1502,GO:0003254,0.0265032874656236,0.997947198682901,2,39,regulation of membrane depolarization,BP,BOK;CCK
2984,GO:0006145,0.0266900478498449,0.999732592513917,1,4,purine nucleobase catabolic process,BP,GDA
17740,GO:0097360,0.0268895776968108,0.999728556151765,1,4,chorionic trophoblast cell proliferation,BP,BOK
18924,GO:1901382,0.0268895776968108,0.999728556151765,1,4,regulation of chorionic trophoblast cell proliferation,BP,BOK
15206,GO:0061138,0.0272508599479856,0.994338736310021,4,174,morphogenesis of a branching epithelium,BP,SOX10;FGF1;HHIP;GREM1
15602,GO:0070100,0.0275154003657546,0.999715697698708,1,4,negative regulation of chemokine-mediated signaling pathway,BP,PADI2
13715,GO:0051130,0.0276238652566095,0.987458818487339,13,1122,positive regulation of cellular component organization,BP,TF;CPNE6;RASAL1;PACSIN1;ENPP2;DOCK5;SERPINI1;GREM1;TPPP;BOK;CCK;MYBPC1;LPAR1
7255,GO:0030234,0.0278064012470693,0.988244225981117,11,903,enzyme regulator activity,MF,PPP2R2C;PPP1R16B;ADAP1;RASAL1;PPP1R1B;SERPINI1;GREM1;PPP1R14A;MAL;RCAN2;SPOCK3
8920,GO:0033218,0.0282259663828209,0.992714237390216,5,273,amide binding,MF,FOLH1;MAG;PEX5L;FBXO2;GPR37
21470,GO:2000501,0.0282671097031842,0.999679999205135,1,5,regulation of natural killer cell chemotaxis,BP,CXCL14
1777,GO:0004046,0.0289549653353583,0.999664140574473,1,5,aminoacylase activity,MF,ASPA
5153,GO:0014047,0.0290863332700721,0.997627741240398,2,41,glutamate secretion,BP,SLC17A7;CCK
11147,GO:0043235,0.0291540492918328,0.991257867241655,6,354,receptor complex,CC,LRP2;TF;EPHB6;PEX5L;GPR37;GPR62
18907,GO:1901342,0.0295530575145483,0.992280690946167,5,269,regulation of vasculature development,BP,PPP1R16B;FGF1;ENPP2;S100A1;GREM1
4408,GO:0009186,0.0297223567088474,0.999645990076185,1,5,deoxyribonucleoside diphosphate metabolic process,BP,AK5
16055,GO:0070915,0.0298036577172878,0.999644038802062,1,5,lysophosphatidic acid receptor activity,MF,LPAR1
5819,GO:0016324,0.0300189082191996,0.9921273886233,5,267,apical plasma membrane,CC,LRP2;TF;MAL;TMEM235;FXYD1
9936,GO:0035727,0.0302076177308731,0.999634262998278,1,5,lysophosphatidic acid binding,MF,LPAR1
5547,GO:0015798,0.0303244621571705,0.9996542682872,1,4,myo-inositol transport,BP,SLC5A11
15246,GO:0061218,0.0303531610580643,0.999630708001975,1,5,negative regulation of mesonephros development,BP,GREM1
907,GO:0002158,0.0306157848466767,0.999624249179192,1,5,osteoclast proliferation,BP,GREM1
9531,GO:0034756,0.0306177184161863,0.999624201415792,1,5,regulation of iron ion transport,BP,TF
10045,GO:0035926,0.0307063249896819,0.999622009341284,1,5,chemokine (C-C motif) ligand 2 secretion,BP,MBP
12459,GO:0046394,0.0307537989128453,0.990660192787638,6,375,carboxylic acid biosynthetic process,BP,FOLH1;FA2H;PTGDS;ASPA;PLP1;CARNS1
13854,GO:0051345,0.0307777557395225,0.988010241966423,9,682,positive regulation of hydrolase activity,BP,ADAP1;RASAL1;HSPA2;ST18;BOK;CCK;MBP;LPAR1;RYR2
18022,GO:0098735,0.030940314553324,0.999639987530483,1,4,positive regulation of the force of heart contraction,BP,RYR2
5421,GO:0015321,0.0310498208769464,0.999613450423958,1,5,sodium-dependent phosphate transmembrane transporter activity,MF,SLC17A7
5682,GO:0016053,0.0310908914408434,0.99053384286414,6,376,organic acid biosynthetic process,BP,FOLH1;FA2H;PTGDS;ASPA;PLP1;CARNS1
19816,GO:1903589,0.0311279306276521,0.999611490612403,1,5,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,PPP1R16B
12676,GO:0046870,0.0311561276311336,0.99961078190285,1,5,cadmium ion binding,MF,SLC24A2
19259,GO:1902308,0.0312434180194935,0.999608583780265,1,5,regulation of peptidyl-serine dephosphorylation,BP,PPP1R16B
17682,GO:0097227,0.0312580039295361,0.999608215870545,1,5,sperm annulus,CC,SEPT4
7182,GO:0030139,0.0313729258225053,0.991674232770585,5,276,endocytic vesicle,CC,CAMK2A;LRP2;TF;CPNE6;LPAR1
19562,GO:1903059,0.0315254852920895,0.999601437972598,1,5,regulation of protein lipidation,BP,HHATL
11875,GO:0045110,0.031558563429233,0.999600595691078,1,5,intermediate filament bundle assembly,BP,NEFM
12261,GO:0045924,0.0315755203522754,0.999600163561123,1,5,regulation of female receptivity,BP,PPP1R1B
1436,GO:0003158,0.0316284253959179,0.99500119369558,3,106,endothelium development,BP,PPP1R16B;FGF1;HAPLN2
9961,GO:0035766,0.0318137153416671,0.99959406838651,1,5,cell chemotaxis to fibroblast growth factor,BP,FGF1
9963,GO:0035768,0.0318137153416671,0.99959406838651,1,5,endothelial cell chemotaxis to fibroblast growth factor,BP,FGF1
20424,GO:1904847,0.0318137153416671,0.99959406838651,1,5,regulation of cell chemotaxis to fibroblast growth factor,BP,FGF1
21501,GO:2000544,0.0318137153416671,0.99959406838651,1,5,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGF1
17771,GO:0097418,0.0318344804372598,0.999593534814477,1,5,neurofibrillary tangle,CC,NEFM
17033,GO:0072687,0.031907926899843,0.999591644712974,1,5,meiotic spindle,CC,HSPA2
20060,GO:1904062,0.0319224284381272,0.991490195298345,5,274,regulation of cation transmembrane transport,BP,HSPA2;S100A1;RYR2;GJC2;FXYD1
12071,GO:0045596,0.0319322718276281,0.988255799576843,8,576,negative regulation of cell differentiation,BP,SOX10;MAG;CXCL14;NKX6-2;GREM1;CNTN2;LPAR1;ZNF536
12048,GO:0045542,0.0319371810978758,0.999590890636304,1,5,positive regulation of cholesterol biosynthetic process,BP,FGF1
12992,GO:0048260,0.0320101841049342,0.997244682643687,2,44,positive regulation of receptor-mediated endocytosis,BP,TF;GREM1
6933,GO:0021853,0.0320758988323507,0.999587305355743,1,5,cerebral cortex GABAergic interneuron migration,BP,CNTN2
20477,GO:1904936,0.0320758988323507,0.999587305355743,1,5,interneuron migration,BP,CNTN2
21683,GO:2000821,0.0321490026423729,0.999585409546817,1,5,regulation of grooming behavior,BP,CNTNAP4
7671,GO:0031072,0.0325815468338649,0.994788102511611,3,110,heat shock protein binding,MF,FGF1;HSPA2;GPR37
11051,GO:0043085,0.0326521580302979,0.98438422636713,14,1279,positive regulation of catalytic activity,BP,ADAP1;EPHB6;RASAL1;TPD52L1;FGF1;HSPA2;ST18;S100A1;GREM1;BOK;CCK;MBP;LPAR1;RYR2
11578,GO:0044300,0.0328073528546634,0.999568138085096,1,5,cerebellar mossy fiber,CC,SLC17A7
18608,GO:1900086,0.0330306872990774,0.999562197869113,1,5,positive regulation of peptidyl-tyrosine autophosphorylation,BP,GREM1
4219,GO:0008637,0.0330808924180919,0.994674045939324,3,114,apoptotic mitochondrial changes,BP,CAMK2A;BOK;CCK
7999,GO:0031672,0.0332225313100252,0.997095070086972,2,39,A band,CC,S100A1;MYBPC1
3437,GO:0006816,0.0333282042412461,0.989688839942023,6,371,calcium ion transport,BP,CAMK2A;HSPA2;SLC24A2;S100A1;RYR2;GJC2
15134,GO:0061024,0.0333918835630806,0.986094022812018,10,806,membrane organization,BP,CAMK2A;LRP2;TF;FA2H;PACSIN1;MYRF;MAL;BOK;CNTN2;MBP
4844,GO:0010626,0.0336528403991289,0.999545432995405,1,5,negative regulation of Schwann cell proliferation,BP,SOX10
11323,GO:0043533,0.0339236209472709,0.999538036632695,1,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,ADAP1
21849,GO:2001244,0.0339683141273127,0.9969726970804,2,48,positive regulation of intrinsic apoptotic signaling pathway,BP,SEPT4;BOK
8477,GO:0032515,0.0340990001819506,0.996958796590629,2,46,negative regulation of phosphoprotein phosphatase activity,BP,PPP1R1B;PPP1R14A
13591,GO:0050922,0.0341625819825623,0.996952228185771,2,45,negative regulation of chemotaxis,BP,PADI2;GREM1
6174,GO:0017034,0.0342078302418136,0.99953020835038,1,5,Rap guanyl-nucleotide exchange factor activity,MF,RAPGEF5
10986,GO:0042982,0.0346282047459826,0.996885830302363,2,46,amyloid precursor protein metabolic process,BP,NECAB1;KLK6
2492,GO:0005219,0.0350296146244286,0.999537720822185,1,4,ryanodine-sensitive calcium-release channel activity,MF,RYR2
7396,GO:0030514,0.0352161198564995,0.996806307082625,2,45,negative regulation of BMP signaling pathway,BP,LRP2;GREM1
5659,GO:0016015,0.0352733729567194,0.999479651912596,1,6,morphogen activity,MF,GREM1
4360,GO:0009133,0.0353893264049282,0.999476200765813,1,6,nucleoside diphosphate biosynthetic process,BP,AK5
7078,GO:0022857,0.0354022159777911,0.984453248198764,11,931,transmembrane transporter activity,MF,TF;SLC17A7;SLC39A12;SLC24A2;SLC5A11;TMEM144;GJB1;SV2B;RYR2;GJC2;FXYD1
15897,GO:0070588,0.035646361412879,0.990215636490138,5,277,calcium ion transmembrane transport,BP,HSPA2;SLC24A2;S100A1;RYR2;GJC2
4124,GO:0008467,0.035736517124516,0.999465798060803,1,6,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,HS3ST4
17140,GO:0086029,0.0357973851917013,0.999485194891578,1,5,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,RYR2
17168,GO:0086068,0.0357973851917013,0.999485194891578,1,5,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,RYR2
4754,GO:0010455,0.0359212995191253,0.999460219205565,1,6,positive regulation of cell fate commitment,BP,NKX6-2
11458,GO:0043987,0.0359230930320199,0.999460164912679,1,6,histone H3-S10 phosphorylation,BP,PPP1R1B
3972,GO:0008219,0.0359838798182062,0.980751824841667,19,1956,cell death,BP,CAMK2A;SOX10;MAG;EPHB6;SEPT4;TPD52L1;TOP2A;ST18;SLC5A11;HHIP;GREM1;KLK6;GPR37;MAL;BOK;AIFM3;CCK;LPAR1;RYR2
3181,GO:0006470,0.0359902596946037,0.99009429876003,5,283,protein dephosphorylation,BP,PPP2R2C;PPP1R16B;PPP1R1B;PPP1R14A;RCAN2
3954,GO:0008199,0.0360567636757804,0.999456110663231,1,6,ferric iron binding,MF,TF
16490,GO:0071671,0.0360654242343009,0.999455847456476,1,6,regulation of smooth muscle cell chemotaxis,BP,LPAR1
13227,GO:0048763,0.0361715692650353,0.999506846070591,1,4,calcium-induced calcium release activity,MF,RYR2
2401,GO:0005047,0.0361738032626915,0.999452548200221,1,6,signal recognition particle binding,MF,TF
14142,GO:0051902,0.0361929568611208,0.999451964077569,1,6,negative regulation of mitochondrial depolarization,BP,BOK
20094,GO:1904180,0.0361929568611208,0.999451964077569,1,6,negative regulation of membrane depolarization,BP,BOK
12252,GO:0045915,0.0362122693917824,0.999451374788041,1,6,positive regulation of catecholamine metabolic process,BP,GPR37
12289,GO:0045964,0.0362122693917824,0.999451374788041,1,6,positive regulation of dopamine metabolic process,BP,GPR37
6647,GO:0019800,0.0363619130744546,0.999446797771362,1,6,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,SPOCK3
2579,GO:0005412,0.0364498548018244,0.999444098976331,1,6,glucose:sodium symporter activity,MF,SLC5A11
2584,GO:0005436,0.0367132886501597,0.999435974717833,1,6,sodium:phosphate symporter activity,MF,SLC17A7
2628,GO:0005543,0.0367546420422707,0.988364079551231,6,380,phospholipid binding,MF,CPNE6;ADAP1;RASAL1;PACSIN1;NRGN;LPAR1
14404,GO:0055010,0.0367547574981186,0.996588813504379,2,45,ventricular cardiac muscle tissue morphogenesis,BP,LRP2;RYR2
14936,GO:0060676,0.0369208009731317,0.999429532953463,1,6,ureteric bud formation,BP,GREM1
16181,GO:0071205,0.0370338913199241,0.999448733451146,1,5,protein localization to juxtaparanode region of axon,BP,CNTN2
6473,GO:0019220,0.0373215260915108,0.980968076336433,16,1554,regulation of phosphate metabolic process,BP,PPP2R2C;PPP1R16B;EPHB6;TPD52L1;FGF1;HSPA2;PPP1R1B;ENPP2;GREM1;PPP1R14A;GPR37;RCAN2;CCK;LPAR1;GRM3;GJC2
2040,GO:0004528,0.0373273592425359,0.999416804613591,1,6,phosphodiesterase I activity,MF,ENPP2
14605,GO:0060180,0.0375370711420628,0.999410183313416,1,6,female mating behavior,BP,PPP1R1B
6957,GO:0021894,0.0375554593746891,0.999409600926584,1,6,cerebral cortex GABAergic interneuron development,BP,CNTN2
9952,GO:0035749,0.037730416357749,0.999404045144594,1,6,myelin sheath adaxonal region,CC,MAG
20179,GO:1904352,0.0378550856031906,0.999423818347268,1,5,positive regulation of protein catabolic process in the vacuole,BP,LRP2
4863,GO:0010647,0.0378760362831547,0.980648041446733,16,1567,positive regulation of cell communication,BP,EPHB6;SEPT4;TPD52L1;FGF1;ST18;NRGN;SLC24A2;VSNL1;GREM1;KLK6;GPR37;MAL;BOK;GPR62;CNTN2;LPAR1
17320,GO:0090205,0.0379415032429595,0.99939730688895,1,6,positive regulation of cholesterol metabolic process,BP,FGF1
16495,GO:0071676,0.0380496150556592,0.999393840880019,1,6,negative regulation of mononuclear cell migration,BP,GREM1
18123,GO:0098910,0.0380739033729018,0.999417085012205,1,5,regulation of atrial cardiac muscle cell action potential,BP,RYR2
10509,GO:0040016,0.0382687061378297,0.99938678598564,1,6,embryonic cleavage,BP,TOP2A
12364,GO:0046113,0.0382913115350921,0.99938605571619,1,6,nucleobase catabolic process,BP,GDA
1687,GO:0003916,0.0383650585393431,0.999383670244034,1,6,DNA topoisomerase activity,MF,TOP2A
17775,GO:0097427,0.0385183767306545,0.999378695872157,1,6,microtubule bundle,CC,TPPP
3201,GO:0006498,0.0385614060899616,0.999377296145863,1,6,N-terminal protein lipidation,BP,HHATL
8643,GO:0032781,0.0386787156020589,0.996295549887007,2,51,positive regulation of ATPase activity,BP,HSPA2;RYR2
3312,GO:0006633,0.0388789015207423,0.993330782887292,3,120,fatty acid biosynthetic process,BP,FA2H;PTGDS;PLP1
18606,GO:1900084,0.0389546219771718,0.999364430897671,1,6,regulation of peptidyl-tyrosine autophosphorylation,BP,GREM1
12127,GO:0045665,0.0391604203020229,0.990885783041306,4,196,negative regulation of neuron differentiation,BP,MAG;CNTN2;LPAR1;ZNF536
7101,GO:0023056,0.0391853312907834,0.97989046401844,16,1574,positive regulation of signaling,BP,EPHB6;SEPT4;TPD52L1;FGF1;ST18;NRGN;SLC24A2;VSNL1;GREM1;KLK6;GPR37;MAL;BOK;GPR62;CNTN2;LPAR1
4842,GO:0010624,0.0395121055964465,0.999345962073781,1,6,regulation of Schwann cell proliferation,BP,SOX10
2611,GO:0005516,0.0395134365357181,0.990782835154758,4,186,calmodulin binding,MF,CAMK2A;NRGN;MBP;RYR2
10931,GO:0042803,0.0398034011384034,0.983757447505215,9,731,protein homodimerization activity,MF,CAMK2A;MAG;SEPT4;TPD52L1;TOP2A;S100A1;GREM1;GJB1;BOK
17779,GO:0097435,0.0399002240143728,0.984676634458941,8,592,supramolecular fiber organization,BP,NEFM;PACSIN1;ERMN;SLC39A12;GREM1;TPPP;MYBPC1;LPAR1
13747,GO:0051174,0.0400661958776435,0.979379068019369,16,1568,regulation of phosphorus metabolic process,BP,PPP2R2C;PPP1R16B;EPHB6;TPD52L1;FGF1;HSPA2;PPP1R1B;ENPP2;GREM1;PPP1R14A;GPR37;RCAN2;CCK;LPAR1;GRM3;GJC2
548,GO:0001640,0.0401119410289761,0.999325789964711,1,6,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,GRM3
18167,GO:0098988,0.0401119410289761,0.999325789964711,1,6,G-protein coupled glutamate receptor activity,MF,GRM3
1503,GO:0003256,0.0401739132275318,0.999323688130789,1,6,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,GREM1
13979,GO:0051592,0.0402633333288182,0.993003753397691,3,114,response to calcium ion,BP,CPNE6;RASAL1;RYR2
11180,GO:0043280,0.0403154785758696,0.992984045506298,3,122,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,ST18;BOK;CCK
13211,GO:0048733,0.0403617033859724,0.999317298784807,1,6,sebaceous gland development,BP,FA2H
20335,GO:1904683,0.0406164242690309,0.999308583400119,1,6,regulation of metalloendopeptidase activity,BP,MBP
15220,GO:0061156,0.0411510422048306,0.99929010845506,1,6,pulmonary artery morphogenesis,BP,LRP2
5408,GO:0015293,0.0413463820671846,0.992735883683222,3,119,symporter activity,MF,SLC17A7;SLC24A2;SLC5A11
9950,GO:0035747,0.0416493880363614,0.999252137347003,1,7,natural killer cell chemotaxis,BP,CXCL14
3243,GO:0006548,0.0418523679213756,0.999244769353819,1,7,histidine catabolic process,BP,CARNS1
14333,GO:0052805,0.0418523679213756,0.999244769353819,1,7,imidazole-containing compound catabolic process,BP,CARNS1
11125,GO:0043203,0.0420778931401375,0.99923653991886,1,7,axon hillock,CC,CCK
10164,GO:0036128,0.0421241591861616,0.999234846061969,1,7,CatSper complex,CC,HSPA2
11128,GO:0043208,0.0422030210842934,0.999231954431883,1,7,glycosphingolipid binding,MF,MAG
20534,GO:1905050,0.0422131737735757,0.999231581760207,1,7,positive regulation of metallopeptidase activity,BP,MBP
684,GO:0001836,0.0422651345461008,0.995745581146381,2,54,release of cytochrome c from mitochondria,BP,BOK;CCK
21413,GO:2000402,0.0425887047461852,0.999217732678186,1,7,negative regulation of lymphocyte migration,BP,PADI2
5914,GO:0016530,0.0428300076791785,0.999208767362379,1,7,metallochaperone activity,MF,TF
11912,GO:0045178,0.0429009622549339,0.995658203531824,2,49,basal part of cell,CC,CLDN11;TF
9855,GO:0035608,0.0429527394821677,0.999204187479321,1,7,protein deglutamylation,BP,FOLH1
21009,GO:1990459,0.0430306151549703,0.999201274485066,1,7,transferrin receptor binding,MF,TF
8042,GO:0031748,0.043149806358725,0.999196805571981,1,7,D1 dopamine receptor binding,MF,PPP1R1B
4850,GO:0010634,0.0432585700149981,0.992263096336875,3,120,positive regulation of epithelial cell migration,BP,FGF1;ENPP2;DOCK5
16425,GO:0071578,0.0432690185413883,0.999192323187325,1,7,zinc ion import across plasma membrane,BP,SLC39A12
21067,GO:1990712,0.0432764610065895,0.99919204292946,1,7,HFE-transferrin receptor complex,CC,TF
9438,GO:0034605,0.0433729996012483,0.992233643892503,3,121,cellular response to heat,BP,CAMK2A;FGF1;HSPA2
11609,GO:0044341,0.0433736463505085,0.999188378721474,1,7,sodium-dependent phosphate transport,BP,SLC17A7
11111,GO:0043184,0.0434162386871746,0.99918677019204,1,7,vascular endothelial growth factor receptor 2 binding,MF,GREM1
10979,GO:0042954,0.043837645399456,0.999193513361457,1,6,lipoprotein transporter activity,MF,LRP2
7750,GO:0031232,0.0440667808363085,0.999162000641618,1,7,extrinsic component of external side of plasma membrane,CC,TF
6712,GO:0019932,0.0441878042388519,0.987145212791069,5,300,second-messenger-mediated signaling,BP,PEX5L;RCAN2;GPR62;LPAR1;RYR2
13246,GO:0048812,0.0441933890823637,0.982682298127201,8,598,neuron projection morphogenesis,BP,CAMK2A;LRP2;CPNE6;MAG;RASAL1;PACSIN1;CNTN2;CCK
7297,GO:0030297,0.0443874082144597,0.999149653560777,1,7,transmembrane receptor protein tyrosine kinase activator activity,MF,GREM1
9872,GO:0035630,0.0444544528843533,0.99914706011209,1,7,bone mineralization involved in bone maturation,BP,GREM1
8669,GO:0032808,0.044964438974765,0.999127201050815,1,7,lacrimal gland development,BP,SOX10
1389,GO:0003056,0.044983262953237,0.999126463585825,1,7,regulation of vascular smooth muscle contraction,BP,DOCK5
15601,GO:0070099,0.0450377495985615,0.999124327181527,1,7,regulation of chemokine-mediated signaling pathway,BP,PADI2
21409,GO:2000394,0.0451385594733543,0.999120367454333,1,7,positive regulation of lamellipodium morphogenesis,BP,ENPP2
19531,GO:1903011,0.0455898703037019,0.999102528845009,1,7,negative regulation of bone development,BP,GREM1
12948,GO:0048168,0.0458886615739348,0.995173825385156,2,52,regulation of neuronal synaptic plasticity,BP,CAMK2A;CNTN2
1489,GO:0003229,0.0459438400340505,0.995167474008305,2,51,ventricular cardiac muscle tissue development,BP,LRP2;RYR2
5127,GO:0014010,0.0463017247189746,0.999074021239978,1,7,Schwann cell proliferation,BP,SOX10
717,GO:0001885,0.0463960759361789,0.995088468901838,2,53,endothelial cell development,BP,PPP1R16B;HAPLN2
21366,GO:2000343,0.0464694326899313,0.99904807802691,1,8,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,MBP
2824,GO:0005883,0.0466250263533389,0.999060924073452,1,7,neurofilament,CC,NEFM
18794,GO:1901029,0.0466760787129264,0.999039515260859,1,8,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK
6713,GO:0019933,0.0467799371470879,0.991365573916937,3,126,cAMP-mediated signaling,BP,PEX5L;GPR62;LPAR1
9197,GO:0034115,0.0469972989618088,0.999026127372814,1,8,negative regulation of heterotypic cell-cell adhesion,BP,MBP
15896,GO:0070587,0.0469972989618088,0.999026127372814,1,8,regulation of cell-cell adhesion involved in gastrulation,BP,MBP
2764,GO:0005785,0.047042127797243,0.99902425148258,1,8,signal recognition particle receptor complex,CC,TF
14873,GO:0060562,0.0473786183900135,0.985953649412015,5,301,epithelial tube morphogenesis,BP,LRP2;FGF1;HHIP;GREM1;RYR2
1367,GO:0003002,0.047415665965971,0.985937306495576,5,308,regionalization,BP,LRP2;FGF1;NKX6-2;HHIP;GREM1
3755,GO:0007405,0.0477031164364105,0.994872738545853,2,53,neuroblast proliferation,BP,SOX10;HHIP
12245,GO:0045906,0.047710019427993,0.999016285204342,1,7,negative regulation of vasoconstriction,BP,DOCK5
9457,GO:0034638,0.0477462380292418,0.9989945462997,1,8,phosphatidylcholine catabolic process,BP,ENPP2
12995,GO:0048263,0.0477732052687033,0.998993399576417,1,8,determination of dorsal identity,BP,GREM1
14141,GO:0051901,0.0477976706867456,0.998992358661622,1,8,positive regulation of mitochondrial depolarization,BP,CCK
18928,GO:1901387,0.0478097426120193,0.998991844843051,1,8,positive regulation of voltage-gated calcium channel activity,BP,S100A1
14937,GO:0060677,0.0478220191186411,0.999011617160771,1,7,ureteric bud elongation,BP,FGF1
10362,GO:0038036,0.0479222422850358,0.998987050092325,1,8,sphingosine-1-phosphate receptor activity,MF,S1PR5
16760,GO:0072172,0.048136444470866,0.998977888724672,1,8,mesonephric tubule formation,BP,GREM1
18007,GO:0098700,0.0481556464952869,0.998977065407029,1,8,neurotransmitter loading into synaptic vesicle,BP,SLC17A7
560,GO:0001658,0.0481754942865021,0.994791329004154,2,54,branching involved in ureteric bud morphogenesis,BP,FGF1;GREM1
13498,GO:0050795,0.0482255053242063,0.994780437571618,2,55,regulation of behavior,BP,PTGDS;CNTNAP4
3501,GO:0006915,0.0483363691263231,0.974031214862202,17,1756,apoptotic process,BP,CAMK2A;SOX10;MAG;EPHB6;SEPT4;TPD52L1;TOP2A;ST18;SLC5A11;HHIP;GREM1;MAL;BOK;AIFM3;CCK;LPAR1;RYR2
16489,GO:0071670,0.048803359789294,0.998949095772117,1,8,smooth muscle cell chemotaxis,BP,LPAR1
14871,GO:0060560,0.0488845530435623,0.987788461426574,4,207,developmental growth involved in morphogenesis,BP,CPNE6;MAG;RASAL1;FGF1
1755,GO:0004017,0.0489585033014652,0.998942339266796,1,8,adenylate kinase activity,MF,AK5
18299,GO:0099612,0.048991341196567,0.998962208092875,1,7,protein localization to axon,BP,CNTN2
4650,GO:0009966,0.0493702106628158,0.970741583298954,25,2831,regulation of signal transduction,BP,LRP2;SOX10;PPP1R16B;ADAP1;EPHB6;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;PADI2;CXCL14;ST18;HHIP;GREM1;KLK6;GPR37;MAL;RCAN2;BOK;GPR62;CNTN2;CCK;LPAR1;ZNF536
13053,GO:0048387,0.0494915377579478,0.998918957410578,1,8,negative regulation of retinoic acid receptor signaling pathway,BP,ZNF536
5155,GO:0014049,0.049795289519939,0.998905516583944,1,8,positive regulation of glutamate secretion,BP,CCK
8390,GO:0032412,0.0498814735275993,0.987455345205368,4,213,regulation of ion transmembrane transporter activity,BP,HSPA2;S100A1;RYR2;FXYD1
14444,GO:0055085,0.0499383013854016,0.974645497761105,14,1359,transmembrane transport,BP,LRP2;SLC17A7;PEX5L;HSPA2;SLC39A12;SLC24A2;SLC5A11;S100A1;TMEM144;GJB1;SV2B;RYR2;GJC2;FXYD1
11599,GO:0044327,0.0499576118910455,0.998898299205104,1,8,dendritic spine head,CC,NRGN
11379,GO:0043621,0.0501266114880529,0.994466716818418,2,52,protein self-association,MF,CNTN2;RYR2
6921,GO:0021826,0.0501435060062191,0.998890004039675,1,8,substrate-independent telencephalic tangential migration,BP,CNTN2
6924,GO:0021830,0.0501435060062191,0.998890004039675,1,8,interneuron migration from the subpallium to the cortex,BP,CNTN2
6929,GO:0021843,0.0501435060062191,0.998890004039675,1,8,substrate-independent telencephalic tangential interneuron migration,BP,CNTN2
14124,GO:0051881,0.0502391191125194,0.994429321990278,2,59,regulation of mitochondrial membrane potential,BP,BOK;CCK
20571,GO:1905165,0.0502506445366015,0.998907622133596,1,7,regulation of lysosomal protein catabolic process,BP,LRP2
17142,GO:0086036,0.0502856343556028,0.998883640434463,1,8,regulation of cardiac muscle cell membrane potential,BP,FXYD1
19172,GO:1902108,0.0505156946419539,0.994381743537507,2,59,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,CAMK2A;BOK
5347,GO:0015166,0.0507892306671481,0.998860943256484,1,8,polyol transmembrane transporter activity,MF,SLC5A11
7136,GO:0030048,0.05085181157284,0.990304219565499,3,121,actin filament-based movement,BP,MOBP;MYBPC1;RYR2
9647,GO:0035239,0.0510071744037584,0.978211886536046,9,736,tube morphogenesis,BP,LRP2;SOX10;PPP1R16B;FGF1;ENPP2;S100A1;HHIP;GREM1;RYR2
5603,GO:0015884,0.0516927083843326,0.998819639197849,1,8,folic acid transport,BP,LRP2
5395,GO:0015267,0.0517073937498282,0.982233819589669,6,413,channel activity,MF,SLC17A7;SLC24A2;GJB1;RYR2;GJC2;FXYD1
7057,GO:0022803,0.0517073937498282,0.982233819589669,6,413,passive transmembrane transporter activity,MF,SLC17A7;SLC24A2;GJB1;RYR2;GJC2;FXYD1
12228,GO:0045862,0.0517255574249415,0.984286016886962,5,320,positive regulation of proteolysis,BP,ST18;BOK;CNTN2;CCK;MBP
13154,GO:0048645,0.0517798568080294,0.994164819500621,2,58,animal organ formation,BP,LRP2;FGF1
7117,GO:0030018,0.0520640166765663,0.98998089522672,3,120,Z disc,CC,S100A1;MYBPC1;RYR2
5274,GO:0014910,0.0521590644685908,0.994106354655969,2,55,regulation of smooth muscle cell migration,BP,DOCK5;LPAR1
9098,GO:0033691,0.0525304648677765,0.998780668802665,1,8,sialic acid binding,MF,MAG
2762,GO:0005783,0.0525669450453872,0.971950783248682,16,1648,endoplasmic reticulum,CC,HHATL;LRP2;TF;FA2H;PTGDS;FBXO2;MYRF;S100A1;KLK6;GJB1;GPR37;MAL;BOK;AIFM3;RYR2;TMEM235
8137,GO:0031987,0.0525714536501629,0.998778745526673,1,8,locomotion involved in locomotory behavior,BP,GPR37
15895,GO:0070586,0.0528448895668041,0.998746603647883,1,9,cell-cell adhesion involved in gastrulation,BP,MBP
7084,GO:0022898,0.0532134677858614,0.986333917336805,4,218,regulation of transmembrane transporter activity,BP,HSPA2;S100A1;RYR2;FXYD1
3511,GO:0006935,0.0532901102409008,0.979795836092816,7,530,chemotaxis,BP,FGF1;PADI2;ENPP2;CXCL14;GREM1;CNTN2;LPAR1
8930,GO:0033240,0.053297712686734,0.99872480688431,1,9,positive regulation of cellular amine metabolic process,BP,GPR37
2282,GO:0004862,0.0533301574140084,0.998723237785013,1,9,cAMP-dependent protein kinase inhibitor activity,MF,PPP1R1B
7138,GO:0030050,0.0533692960452189,0.998741000930349,1,8,vesicle transport along actin filament,BP,MOBP
13093,GO:0048523,0.0534224555069654,0.966360697440649,34,4134,negative regulation of cellular process,BP,HHATL;LRP2;SOX10;PPP1R16B;MAG;EPHB6;RASAL1;FBXO2;PADI2;PACSIN1;HSPA2;TOP2A;PPP1R1B;CXCL14;ST18;NKX6-2;SLC24A2;S100A1;VSNL1;SERPINI1;HHIP;GREM1;PPP1R14A;GPR37;BOK;CNTN2;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;FXYD1
625,GO:0001766,0.0535297806062889,0.998713561890344,1,9,membrane raft polarization,BP,MAL
7945,GO:0031580,0.0535297806062889,0.998713561890344,1,9,membrane raft distribution,BP,MAL
10683,GO:0042330,0.0536847560542849,0.979612972088229,7,531,taxis,BP,FGF1;PADI2;ENPP2;CXCL14;GREM1;CNTN2;LPAR1
3242,GO:0006547,0.0536907726123001,0.998705731315842,1,9,histidine metabolic process,BP,CARNS1
12994,GO:0048262,0.0536999359151339,0.998705284887517,1,9,determination of dorsal/ventral asymmetry,BP,GREM1
13883,GO:0051400,0.0542005550628853,0.998680775689337,1,9,BH domain binding,MF,BOK
10428,GO:0038166,0.0544625925392059,0.998667853345217,1,9,angiotensin-activated signaling pathway,BP,CAMK2A
21764,GO:2001056,0.0545627690766063,0.989283014257739,3,137,positive regulation of cysteine-type endopeptidase activity,BP,ST18;BOK;CCK
6066,GO:0016810,0.0545664995770106,0.989281989076894,3,137,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,ASPA;PADI2;GDA
4218,GO:0008635,0.0546948678467929,0.998656344936921,1,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,BOK
18000,GO:0098662,0.0552115498881439,0.97737084908555,8,644,inorganic cation transmembrane transport,BP,SLC17A7;HSPA2;SLC39A12;SLC24A2;S100A1;RYR2;GJC2;FXYD1
6715,GO:0019935,0.0553177450943698,0.989076961787036,3,135,cyclic-nucleotide-mediated signaling,BP,PEX5L;GPR62;LPAR1
5072,GO:0010941,0.055378275902993,0.97081950419789,15,1524,regulation of cell death,BP,CAMK2A;SOX10;MAG;EPHB6;SEPT4;TPD52L1;TOP2A;ST18;HHIP;GREM1;GPR37;MAL;BOK;CCK;LPAR1
19814,GO:1903587,0.0555261757954149,0.998614742237803,1,9,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,PPP1R16B
13664,GO:0051049,0.0555809724362376,0.970118332594344,16,1637,regulation of transport,BP,CAMK2A;TF;PACSIN1;HSPA2;S100A1;VSNL1;GREM1;LGI3;BOK;CCK;NKAIN2;MYBPC1;MBP;RYR2;GJC2;FXYD1
19966,GO:1903897,0.0557463736865144,0.998603613894469,1,9,regulation of PERK-mediated unfolded protein response,BP,BOK
3044,GO:0006265,0.0558315940755373,0.998599294823405,1,9,DNA topological change,BP,TOP2A
10159,GO:0036122,0.0559750985373097,0.998592006445635,1,9,BMP binding,MF,GREM1
5548,GO:0015800,0.0564406194961552,0.993327352574169,2,59,acidic amino acid transport,BP,SLC17A7;CCK
4875,GO:0010663,0.0565548925427461,0.998562362746604,1,9,positive regulation of striated muscle cell apoptotic process,BP,CAMK2A
4878,GO:0010666,0.0565548925427461,0.998562362746604,1,9,positive regulation of cardiac muscle cell apoptotic process,BP,CAMK2A
12678,GO:0046873,0.0566896750668946,0.980079276671954,6,418,metal ion transmembrane transporter activity,MF,TF;SLC17A7;SLC39A12;SLC24A2;SLC5A11;RYR2
14935,GO:0060675,0.056882562266313,0.993246052754166,2,59,ureteric bud morphogenesis,BP,FGF1;GREM1
10985,GO:0042981,0.0568915895987288,0.97056092836514,14,1399,regulation of apoptotic process,BP,CAMK2A;SOX10;MAG;EPHB6;SEPT4;TPD52L1;TOP2A;ST18;HHIP;GREM1;MAL;BOK;CCK;LPAR1
12929,GO:0048096,0.0571200368868932,0.998533164209462,1,9,chromatin-mediated maintenance of transcription,BP,PADI2
16227,GO:0071277,0.0572129971175768,0.993185028745269,2,59,cellular response to calcium ion,BP,CPNE6;RASAL1
1425,GO:0003139,0.0577074152700358,0.998502498826464,1,9,secondary heart field specification,BP,LRP2
9934,GO:0035725,0.0577983298334115,0.988387213748246,3,133,sodium ion transmembrane transport,BP,SLC17A7;SLC24A2;FXYD1
1486,GO:0003223,0.0578487723656863,0.998518173790371,1,8,ventricular compact myocardium morphogenesis,BP,LRP2
9096,GO:0033689,0.0579612097621715,0.998489148551954,1,9,negative regulation of osteoblast proliferation,BP,GREM1
21364,GO:2000341,0.0581057024078824,0.998462882680974,1,10,regulation of chemokine (C-X-C motif) ligand 2 production,BP,MBP
4753,GO:0010454,0.0582029613422561,0.998457674753294,1,10,negative regulation of cell fate commitment,BP,NKX6-2
16759,GO:0072171,0.0584329183157245,0.992955173618491,2,60,mesonephric tubule morphogenesis,BP,FGF1;GREM1
15566,GO:0070050,0.0587737913242328,0.998426926909799,1,10,neuron cellular homeostasis,BP,SLC17A7
4378,GO:0009151,0.0588294663728662,0.998423911351446,1,10,purine deoxyribonucleotide metabolic process,BP,AK5
12128,GO:0045666,0.0591629302465647,0.98134718447242,5,321,positive regulation of neuron differentiation,BP,CPNE6;RASAL1;PACSIN1;SERPINI1;LPAR1
3226,GO:0006531,0.059166031123082,0.998405618908109,1,10,aspartate metabolic process,BP,ASPA
19224,GO:1902237,0.0591999090891455,0.998403771644974,1,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,BOK
571,GO:0001672,0.0592474110788621,0.998420558826101,1,9,regulation of chromatin assembly or disassembly,BP,PADI2
14332,GO:0052803,0.059307581156148,0.998397893347958,1,10,imidazole-containing compound metabolic process,BP,CARNS1
14531,GO:0060068,0.0593474332116604,0.998415159621624,1,9,vagina development,BP,LRP2
14021,GO:0051665,0.0593621620505013,0.99839490931275,1,10,membrane raft localization,BP,MAL
6069,GO:0016813,0.059424579112479,0.998391493378887,1,10,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,PADI2
17545,GO:0097001,0.0594952501566383,0.998387621240544,1,10,ceramide binding,MF,MAG
5913,GO:0016529,0.0596798213260152,0.992723089250377,2,59,sarcoplasmic reticulum,CC,S100A1;RYR2
17128,GO:0086015,0.0597946634448467,0.998415589973155,1,8,SA node cell action potential,BP,RYR2
17131,GO:0086018,0.0597946634448467,0.998415589973155,1,8,SA node cell to atrial cardiac muscle cell signaling,BP,RYR2
11569,GO:0044283,0.0598476362246158,0.975059667086382,8,674,small molecule biosynthetic process,BP,FOLH1;FA2H;PTGDS;ASPA;FGF1;GDA;PLP1;CARNS1
14755,GO:0060394,0.0599761552920837,0.998361145466151,1,10,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,GREM1
5435,GO:0015370,0.0600400494793953,0.992648938223806,2,61,solute:sodium symporter activity,MF,SLC17A7;SLC5A11
11045,GO:0043067,0.060249610710296,0.968558581883478,14,1411,regulation of programmed cell death,BP,CAMK2A;SOX10;MAG;EPHB6;SEPT4;TPD52L1;TOP2A;ST18;HHIP;GREM1;MAL;BOK;CCK;LPAR1
11911,GO:0045177,0.0602601017296697,0.980902714179564,5,324,apical part of cell,CC,LRP2;TF;MAL;TMEM235;FXYD1
10987,GO:0042983,0.0603320776928428,0.99834140841208,1,10,amyloid precursor protein biosynthetic process,BP,NECAB1
10988,GO:0042984,0.0603320776928428,0.99834140841208,1,10,regulation of amyloid precursor protein biosynthetic process,BP,NECAB1
17313,GO:0090197,0.0603712508394987,0.998339228747956,1,10,positive regulation of chemokine secretion,BP,MBP
6955,GO:0021892,0.0605523066407234,0.998329135446143,1,10,cerebral cortex GABAergic interneuron differentiation,BP,CNTN2
3661,GO:0007196,0.0605537868681009,0.998349297697217,1,9,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,GRM3
16230,GO:0071281,0.0606384810937136,0.998324320493336,1,10,cellular response to iron ion,BP,TF
2572,GO:0005381,0.0606524170798365,0.998323541161273,1,10,iron ion transmembrane transporter activity,MF,TF
14864,GO:0060546,0.0608182602011277,0.998314252600437,1,10,negative regulation of necroptotic process,BP,BOK
2475,GO:0005172,0.0612204668382788,0.99829161664852,1,10,vascular endothelial growth factor receptor binding,MF,GREM1
16247,GO:0071313,0.061442362031843,0.998325976642727,1,8,cellular response to caffeine,BP,RYR2
16211,GO:0071248,0.0614653362536119,0.987331061279206,3,142,cellular response to metal ion,BP,TF;CPNE6;RASAL1
20177,GO:1904350,0.0615588520579807,0.998293376678155,1,9,regulation of protein catabolic process in the vacuole,BP,LRP2
5785,GO:0016264,0.0617535003433062,0.99826137965077,1,10,gap junction assembly,BP,GJB1
20095,GO:1904181,0.061797575663498,0.99825886726467,1,10,positive regulation of membrane depolarization,BP,CCK
15108,GO:0060982,0.0621458550214318,0.998260274901343,1,9,coronary artery morphogenesis,BP,LRP2
13071,GO:0048484,0.0622738269790746,0.998231601441066,1,10,enteric nervous system development,BP,SOX10
11135,GO:0043220,0.062419428503411,0.998223222313721,1,10,Schmidt-Lanterman incisure,CC,MAG
4639,GO:0009931,0.0625689423085371,0.998214596930091,1,10,calcium-dependent protein serine/threonine kinase activity,MF,CAMK2A
8387,GO:0032409,0.062815133436602,0.982968127216521,4,231,regulation of transporter activity,BP,HSPA2;S100A1;RYR2;FXYD1
8001,GO:0031674,0.0628727309774366,0.986935224905523,3,131,I band,CC,S100A1;MYBPC1;RYR2
1417,GO:0003128,0.0632456318651717,0.99817529142095,1,10,heart field specification,BP,LRP2
4469,GO:0009265,0.0632566898785521,0.99815657463867,1,11,2'-deoxyribonucleotide biosynthetic process,BP,AK5
12455,GO:0046385,0.0632566898785521,0.99815657463867,1,11,deoxyribose phosphate biosynthetic process,BP,AK5
9503,GO:0034704,0.0633255253020813,0.992016896867961,2,60,calcium channel complex,CC,HSPA2;RYR2
11571,GO:0044291,0.06375291776454,0.991926786374438,2,62,cell-cell contact zone,CC,OPALIN;FXYD1
14742,GO:0060379,0.064109269795725,0.998124489873252,1,10,cardiac muscle cell myoblast differentiation,BP,GREM1
17378,GO:0090287,0.0644244680897265,0.982385979992799,4,232,regulation of cellular response to growth factor stimulus,BP,LRP2;FGF1;HHIP;GREM1
10652,GO:0042277,0.0645861692133135,0.982321758076119,4,241,peptide binding,MF,FOLH1;PEX5L;FBXO2;GPR37
5544,GO:0015791,0.0646894340734988,0.998089961494436,1,10,polyol transport,BP,SLC5A11
6527,GO:0019371,0.0648222222946111,0.99806303515416,1,11,cyclooxygenase pathway,BP,PTGDS
17235,GO:0090084,0.0649688439007136,0.998073217259142,1,10,negative regulation of inclusion body assembly,BP,HSPA2
8202,GO:0032096,0.0650622877628903,0.998048481564153,1,11,negative regulation of response to food,BP,CCK
8205,GO:0032099,0.0650622877628903,0.998048481564153,1,11,negative regulation of appetite,BP,CCK
5179,GO:0014701,0.0652612797686155,0.998079134235428,1,9,junctional sarcoplasmic reticulum membrane,CC,RYR2
568,GO:0001667,0.065277824887408,0.978840869197548,5,333,ameboidal-type cell migration,BP,SOX10;FGF1;ENPP2;DOCK5;GREM1
11865,GO:0045091,0.0653953241256997,0.998028199283617,1,11,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,TOP2A
2830,GO:0005890,0.0654066227617882,0.998027509298805,1,11,sodium:potassium-exchanging ATPase complex,CC,FXYD1
5273,GO:0014909,0.065573774647896,0.991561903332425,2,63,smooth muscle cell migration,BP,DOCK5;LPAR1
14717,GO:0060346,0.0655741705764275,0.998036684710556,1,10,bone trabecula formation,BP,GREM1
17129,GO:0086016,0.0656064352260105,0.998058499673556,1,9,AV node cell action potential,BP,RYR2
17138,GO:0086027,0.0656064352260105,0.998058499673556,1,9,AV node cell to bundle of His cell signaling,BP,RYR2
10726,GO:0042416,0.0656529294598897,0.998012437091001,1,11,dopamine biosynthetic process,BP,GPR37
7851,GO:0031401,0.0661469927986825,0.96778897465397,11,1039,positive regulation of protein modification process,BP,PPP1R16B;EPHB6;SEPT4;TPD52L1;FGF1;HSPA2;ENPP2;GREM1;GPR37;CCK;LPAR1
17312,GO:0090196,0.0661853574925985,0.997979655258587,1,11,regulation of chemokine secretion,BP,MBP
3433,GO:0006811,0.0665253855490314,0.96476791234469,14,1419,ion transport,BP,CAMK2A;LRP2;TF;SLC17A7;HSPA2;SLC39A12;SLC24A2;SLC5A11;S100A1;CCK;NKAIN2;RYR2;GJC2;FXYD1
8303,GO:0032287,0.0665514902953135,0.998001422139236,1,9,peripheral nervous system myelin maintenance,BP,FA2H
11539,GO:0044224,0.066569719494038,0.997975836044934,1,10,juxtaparanode region of axon,CC,CNTN2
5117,GO:0012501,0.0665779233344365,0.962683148644945,17,1832,programmed cell death,BP,CAMK2A;SOX10;MAG;EPHB6;SEPT4;TPD52L1;TOP2A;ST18;SLC5A11;HHIP;GREM1;MAL;BOK;AIFM3;CCK;LPAR1;RYR2
7391,GO:0030509,0.0665913086958387,0.985822845613492,3,142,BMP signaling pathway,BP,LRP2;GREM1;RYR2
572,GO:0001673,0.0667613090997776,0.99794388395334,1,11,male germ cell nucleus,CC,HSPA2
2323,GO:0004930,0.0668035467208171,0.978196516695715,5,355,G-protein coupled receptor activity,MF,GPR37;S1PR5;GPR62;LPAR1;GRM3
18052,GO:0098794,0.0668870046151819,0.975510415211878,6,435,postsynapse,CC,CAMK2A;SLC17A7;FBXO2;NRGN;LPAR1;GRM3
17170,GO:0086070,0.0669011227138873,0.997980090674014,1,9,SA node cell to atrial cardiac muscle cell communication,BP,RYR2
7386,GO:0030502,0.0670773406292398,0.997924118972639,1,11,negative regulation of bone mineralization,BP,GREM1
12669,GO:0046851,0.0672316941659265,0.99791443026343,1,11,negative regulation of bone remodeling,BP,GREM1
20563,GO:1905146,0.0673717389535409,0.99792612291214,1,10,lysosomal protein catabolic process,BP,LRP2
13457,GO:0050731,0.0675158240697709,0.985538426415902,3,148,positive regulation of peptidyl-tyrosine phosphorylation,BP,ENPP2;GREM1;CCK
18247,GO:0099515,0.067893281008498,0.99789346297451,1,10,actin filament-based transport,BP,MOBP
8487,GO:0032536,0.0679945042181001,0.997866209067394,1,11,regulation of cell projection size,BP,CNTN2
16320,GO:0071415,0.0680649500282372,0.997908246562953,1,9,cellular response to purine-containing compound,BP,RYR2
5002,GO:0010857,0.0683111695095657,0.997846024842345,1,11,calcium-dependent protein kinase activity,MF,CAMK2A
12643,GO:0046785,0.0683414684585326,0.990991386779324,2,66,microtubule polymerization,BP,SLC39A12;TPPP
6761,GO:0021521,0.0683853731804106,0.997841281000158,1,11,ventral spinal cord interneuron specification,BP,NKX6-2
14878,GO:0060573,0.0683853731804106,0.997841281000158,1,11,cell fate specification involved in pattern specification,BP,NKX6-2
14075,GO:0051775,0.0685830630195026,0.997828616538918,1,11,response to redox state,BP,RYR2
13223,GO:0048754,0.0687255022043116,0.985177379861504,3,144,branching morphogenesis of an epithelial tube,BP,FGF1;HHIP;GREM1
5306,GO:0015081,0.0688040289412305,0.985154759518819,3,143,sodium ion transmembrane transporter activity,MF,SLC17A7;SLC24A2;SLC5A11
8183,GO:0032060,0.0688727158494134,0.997809992039568,1,11,bleb assembly,BP,LPAR1
12699,GO:0046902,0.0689392690802187,0.990857224683663,2,70,regulation of mitochondrial membrane permeability,BP,CAMK2A;BOK
18778,GO:1900750,0.0691914705437782,0.997771385840575,1,12,oligopeptide binding,MF,FOLH1
21407,GO:2000392,0.0696599752164262,0.997758959047814,1,11,regulation of lamellipodium morphogenesis,BP,ENPP2
17023,GO:0072676,0.0696671368698936,0.990703662190482,2,71,lymphocyte migration,BP,PADI2;CXCL14
5433,GO:0015368,0.0696672964001283,0.997758481629333,1,11,calcium:cation antiporter activity,MF,SLC24A2
5322,GO:0015114,0.0698164025772714,0.997748746969236,1,11,phosphate ion transmembrane transporter activity,MF,SLC17A7
7413,GO:0030546,0.0698539343342327,0.997746293229393,1,11,receptor activator activity,MF,GREM1
11278,GO:0043462,0.0698852848512516,0.990658224631985,2,71,regulation of ATPase activity,BP,HSPA2;RYR2
16971,GO:0072567,0.0699094908738319,0.997724265949453,1,12,chemokine (C-X-C motif) ligand 2 production,BP,MBP
6791,GO:0021554,0.0704086770728224,0.99770986530273,1,11,optic nerve development,BP,LPAR1
4847,GO:0010631,0.070466942198881,0.980152455550883,4,239,epithelial cell migration,BP,FGF1;ENPP2;DOCK5;GREM1
21838,GO:2001233,0.0704873841581783,0.976642940151356,5,355,regulation of apoptotic signaling pathway,BP,SEPT4;TPD52L1;ST18;MAL;BOK
18566,GO:1900006,0.0706910087524791,0.990506846597235,2,65,positive regulation of dendrite development,BP,PACSIN1;LPAR1
18540,GO:0140131,0.0707242334155949,0.997670185412279,1,12,positive regulation of lymphocyte chemotaxis,BP,CXCL14
4025,GO:0008306,0.0708073369044323,0.990476382617803,2,67,associative learning,BP,PPP1R1B;NRGN
10492,GO:0039692,0.0708589708356983,0.997661179018611,1,12,single stranded viral RNA replication via double stranded DNA intermediate,BP,TOP2A
14613,GO:0060198,0.0709261758357344,0.997656680092943,1,12,clathrin-sculpted vesicle,CC,SLC17A7
5743,GO:0016188,0.0709317533585275,0.997675241915872,1,11,synaptic vesicle maturation,BP,SLC17A7
17265,GO:0090132,0.0712083649800307,0.979873431851597,4,240,epithelium migration,BP,FGF1;ENPP2;DOCK5;GREM1
1570,GO:0003376,0.0712492859853494,0.997634988015778,1,12,sphingosine-1-phosphate signaling pathway,BP,S1PR5
17470,GO:0090520,0.0712492859853494,0.997634988015778,1,12,sphingolipid mediated signaling pathway,BP,S1PR5
786,GO:0001973,0.0713938105900122,0.997625252082884,1,12,adenosine receptor signaling pathway,BP,CNTN2
18631,GO:1900119,0.0715642528677524,0.997613743791097,1,12,positive regulation of execution phase of apoptosis,BP,BOK
2841,GO:0005905,0.0717213170009853,0.99028691877814,2,66,clathrin-coated pit,CC,LRP2;TF
9763,GO:0035461,0.0717625156231391,0.997619703437573,1,11,vitamin transmembrane transport,BP,LRP2
3625,GO:0007155,0.0718274936869251,0.963404943558284,12,1161,cell adhesion,BP,CD22;CLDN11;MAG;HAPLN2;MOG;DOCK5;CNTNAP4;SERPINI1;GREM1;CNTN2;MYBPC1;MBP
17632,GO:0097154,0.0720849373663519,0.997578409999132,1,12,GABAergic neuron differentiation,BP,CNTN2
5926,GO:0016558,0.0721756399884932,0.997572227597135,1,12,protein import into peroxisome matrix,BP,PEX5L
9740,GO:0035404,0.0724041452189472,0.997556616483531,1,12,histone-serine phosphorylation,BP,PPP1R1B
17167,GO:0086067,0.0726694117238327,0.997582167198911,1,10,AV node cell to bundle of His cell communication,BP,RYR2
2857,GO:0005940,0.0732374444441682,0.997499250923831,1,12,septin ring,CC,SEPT4
7698,GO:0031105,0.0732374444441682,0.997499250923831,1,12,septin complex,CC,SEPT4
8235,GO:0032160,0.0732374444441682,0.997499250923831,1,12,septin filament array,CC,SEPT4
16698,GO:0072078,0.0732783062356711,0.989949542556814,2,68,nephron tubule morphogenesis,BP,FGF1;GREM1
1197,GO:0002685,0.0735348084091308,0.983678657825103,3,159,regulation of leukocyte migration,BP,PADI2;CXCL14;GREM1
6760,GO:0021520,0.0736143829390613,0.997473077056822,1,12,spinal cord motor neuron cell fate specification,BP,NKX6-2
13460,GO:0050746,0.0737225114873795,0.997465542956803,1,12,regulation of lipoprotein metabolic process,BP,HHATL
20917,GO:1990138,0.0738399118816675,0.983598447511924,3,146,neuron projection extension,BP,CPNE6;MAG;RASAL1
20380,GO:1904754,0.0740383248840126,0.997464105422075,1,11,positive regulation of vascular associated smooth muscle cell migration,BP,DOCK5
12296,GO:0045986,0.0740497654742616,0.997442670509057,1,12,negative regulation of smooth muscle contraction,BP,DOCK5
11910,GO:0045176,0.0740817437617717,0.997461087589381,1,11,apical protein localization,BP,MAL
14402,GO:0055008,0.0742690299680585,0.989749597200487,2,64,cardiac muscle tissue morphogenesis,BP,LRP2;RYR2
1474,GO:0003208,0.07427717131727,0.989734772799016,2,68,cardiac ventricle morphogenesis,BP,LRP2;RYR2
7044,GO:0022610,0.0743171619299988,0.961922031045428,12,1168,biological adhesion,BP,CD22;CLDN11;MAG;HAPLN2;MOG;DOCK5;CNTNAP4;SERPINI1;GREM1;CNTN2;MYBPC1;MBP
18851,GO:1901213,0.0744848392742532,0.997412098637757,1,12,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,GREM1
18024,GO:0098739,0.0747005686711733,0.989640168375887,2,69,import across plasma membrane,BP,LRP2;SLC39A12
17263,GO:0090130,0.0751864912329471,0.978358838306934,4,245,tissue migration,BP,FGF1;ENPP2;DOCK5;GREM1
4568,GO:0009653,0.0753983286319882,0.954787068957479,21,2350,anatomical structure morphogenesis,BP,CAMK2A;LRP2;SOX10;CPNE6;PPP1R16B;MAG;RASAL1;FGF1;PACSIN1;ERMN;ENPP2;DOCK5;S100A1;HHIP;GREM1;CNTN2;CCK;MYBPC1;MBP;LPAR1;RYR2
17573,GO:0097050,0.0755625574829846,0.997335564111925,1,12,type B pancreatic cell apoptotic process,BP,RYR2
10904,GO:0042759,0.07631046100308,0.997281776584533,1,12,long-chain fatty acid biosynthetic process,BP,PLP1
14865,GO:0060547,0.0765212613289466,0.997247871251963,1,13,negative regulation of necrotic cell death,BP,BOK
14163,GO:0051938,0.0765316571148569,0.997265762618021,1,12,L-glutamate import,BP,SLC17A7
13089,GO:0048519,0.0766061021306481,0.949678216233367,36,4564,negative regulation of biological process,BP,HHATL;LRP2;SOX10;PPP1R16B;MAG;EPHB6;RASAL1;FBXO2;PADI2;PACSIN1;HSPA2;TOP2A;PPP1R1B;CXCL14;DOCK5;ST18;NKX6-2;SLC24A2;S100A1;VSNL1;SERPINI1;HHIP;GREM1;PPP1R14A;GPR37;BOK;CNTN2;CCK;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;FXYD1
5912,GO:0016528,0.0769474650187458,0.98915228928188,2,68,sarcoplasm,CC,S100A1;RYR2
16704,GO:0072088,0.0769741639056536,0.989140108184723,2,70,nephron epithelium morphogenesis,BP,FGF1;GREM1
8211,GO:0032105,0.0769757150908293,0.997214600295091,1,13,negative regulation of response to extracellular stimulus,BP,CCK
8214,GO:0032108,0.0769757150908293,0.997214600295091,1,13,negative regulation of response to nutrient levels,BP,CCK
19910,GO:1903779,0.0770119346076591,0.989134880591551,2,69,regulation of cardiac conduction,BP,RYR2;FXYD1
7852,GO:0031402,0.0773004376133771,0.997209728348909,1,12,sodium ion binding,MF,SLC24A2
1547,GO:0003337,0.0778923285687881,0.997146867760077,1,13,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,GREM1
17311,GO:0090195,0.0779349090901024,0.997143700930359,1,13,chemokine secretion,BP,MBP
11048,GO:0043073,0.0779700044674189,0.997141089431072,1,13,germ cell nucleus,CC,HSPA2
12991,GO:0048259,0.078009825947379,0.988904714440333,2,72,regulation of receptor-mediated endocytosis,BP,TF;GREM1
11496,GO:0044093,0.0781949510588473,0.956693420656631,15,1584,positive regulation of molecular function,BP,CAMK2A;ADAP1;EPHB6;RASAL1;TPD52L1;FGF1;HSPA2;ST18;S100A1;GREM1;BOK;CCK;MBP;LPAR1;RYR2
14670,GO:0060291,0.0783380095559344,0.988837730548775,2,70,long-term synaptic potentiation,BP,NRGN;SLC24A2
15640,GO:0070168,0.0783801261779234,0.997110480540794,1,13,negative regulation of biomineral tissue development,BP,GREM1
5921,GO:0016540,0.078484702148343,0.997102648784684,1,13,protein autoprocessing,BP,KLK6
17595,GO:0097090,0.0786076877131287,0.997113101842895,1,12,presynaptic membrane organization,BP,CNTN2
16534,GO:0071772,0.0788052733398566,0.982012253786903,3,153,response to BMP,BP,LRP2;GREM1;RYR2
16535,GO:0071773,0.0788052733398566,0.982012253786903,3,153,cellular response to BMP stimulus,BP,LRP2;GREM1;RYR2
16587,GO:0071872,0.0789036546538878,0.997090989866894,1,12,cellular response to epinephrine stimulus,BP,RYR2
5033,GO:0010893,0.079137721375386,0.99705349673069,1,13,positive regulation of steroid biosynthetic process,BP,FGF1
17710,GO:0097286,0.0791406909154586,0.997053272243517,1,13,iron ion import,BP,TF
18616,GO:1900103,0.0793287965216712,0.997039034136237,1,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,BOK
8234,GO:0032156,0.0793295324222615,0.997038978364932,1,13,septin cytoskeleton,CC,SEPT4
7745,GO:0031226,0.0793853287958602,0.956812333200451,14,1460,intrinsic component of plasma membrane,CC,FOLH1;MAG;EPHB6;RASAL1;ENPP2;SLC39A12;SLC24A2;SLC5A11;HHIP;GPR37;CNTN2;LPAR1;GRM3;FXYD1
334,GO:0000921,0.0794791767719398,0.997027626101078,1,13,septin ring assembly,BP,SEPT4
13488,GO:0050780,0.0794896313128983,0.99702683216598,1,13,dopamine receptor binding,MF,PPP1R1B
11902,GO:0045161,0.0795127911036633,0.997045207022998,1,12,neuronal ion channel clustering,BP,CNTN2
2517,GO:0005254,0.0795434351785242,0.988558643954593,2,73,chloride channel activity,MF,SLC17A7;FXYD1
15203,GO:0061134,0.0797949117843782,0.981682671257431,3,161,peptidase regulator activity,MF,SERPINI1;MAL;SPOCK3
4225,GO:0008652,0.0801891819023286,0.988407161048253,2,75,cellular amino acid biosynthetic process,BP,FOLH1;ASPA
13811,GO:0051270,0.0802786792837232,0.962571681845015,9,813,regulation of cellular component movement,BP,FGF1;PADI2;ENPP2;CXCL14;DOCK5;GREM1;SPOCK3;LPAR1;RYR2
252,GO:0000712,0.0803029347892908,0.996964733554315,1,13,resolution of meiotic recombination intermediates,BP,TOP2A
17485,GO:0090559,0.0803296868268508,0.98837256022698,2,76,regulation of membrane permeability,BP,CAMK2A;BOK
20532,GO:1905048,0.0804226156442548,0.996955539641251,1,13,regulation of metallopeptidase activity,BP,MBP
13280,GO:0048870,0.0808222220973216,0.956899078374182,13,1317,cell motility,BP,SOX10;MAG;FGF1;PADI2;ENPP2;CXCL14;DOCK5;GREM1;CNTN2;CCK;DNAH17;SPOCK3;LPAR1
14025,GO:0051674,0.0808222220973216,0.956899078374182,13,1317,localization of cell,BP,SOX10;MAG;FGF1;PADI2;ENPP2;CXCL14;DOCK5;GREM1;CNTN2;CCK;DNAH17;SPOCK3;LPAR1
16670,GO:0072028,0.080919421749688,0.988250473481156,2,72,nephron morphogenesis,BP,FGF1;GREM1
2609,GO:0005513,0.0810131486148218,0.996909964832333,1,13,detection of calcium ion,BP,RYR2
15271,GO:0061333,0.0812181863090567,0.988182495313182,2,72,renal tubule morphogenesis,BP,FGF1;GREM1
4467,GO:0009263,0.0812924440195652,0.99687025418365,1,14,deoxyribonucleotide biosynthetic process,BP,AK5
4511,GO:0009408,0.0815173130951208,0.981124119551087,3,159,response to heat,BP,CAMK2A;FGF1;HSPA2
6460,GO:0019206,0.0817255874976976,0.996836289780815,1,14,nucleoside kinase activity,MF,AK5
3640,GO:0007171,0.0818750478364014,0.996842820175703,1,13,activation of transmembrane receptor protein tyrosine kinase activity,BP,GREM1
11116,GO:0043194,0.081931291372416,0.996859792477,1,12,axon initial segment,CC,CCK
5592,GO:0015868,0.0824107974653951,0.996782173688156,1,14,purine ribonucleotide transport,BP,GJB1
3458,GO:0006855,0.0825817559450945,0.987864121108114,2,74,drug transmembrane transport,BP,LRP2;SLC17A7
12027,GO:0045445,0.083705825134984,0.987598344544291,2,76,myoblast differentiation,BP,CXCL14;GREM1
3470,GO:0006875,0.0841329091119084,0.967341412438463,6,479,cellular metal ion homeostasis,BP,TF;SLC39A12;SLC24A2;BOK;LPAR1;RYR2
1479,GO:0003214,0.08422950064896,0.996655602557337,1,13,cardiac left ventricle morphogenesis,BP,RYR2
5154,GO:0014048,0.0843857126654264,0.996623549093782,1,14,regulation of glutamate secretion,BP,CCK
3322,GO:0006646,0.0844032299981191,0.996622124476558,1,14,phosphatidylethanolamine biosynthetic process,BP,ETNPPL
13202,GO:0048711,0.0845867504138373,0.99660718081496,1,14,positive regulation of astrocyte differentiation,BP,MAG
14175,GO:0051957,0.0849153272978776,0.996580340439323,1,14,positive regulation of amino acid transport,BP,CCK
15309,GO:0061430,0.0849164121116862,0.996599932332683,1,13,bone trabecula morphogenesis,BP,GREM1
5121,GO:0012510,0.0849689288783295,0.996575951539514,1,14,trans-Golgi network transport vesicle membrane,CC,NRGN
5214,GO:0014812,0.085852223209893,0.987102624903628,2,74,muscle cell migration,BP,DOCK5;LPAR1
13820,GO:0051284,0.0859830134030414,0.9964923703226,1,14,positive regulation of sequestering of calcium ion,BP,RYR2
7459,GO:0030659,0.0865094899469753,0.961045820260984,8,714,cytoplasmic vesicle membrane,CC,CAMK2A;LRP2;TF;SLC17A7;PACSIN1;NRGN;SV2B;RYR2
16206,GO:0071241,0.0866025503011408,0.979431156113824,3,164,cellular response to inorganic substance,BP,TF;CPNE6;RASAL1
3424,GO:0006796,0.0867530337568927,0.94563591400782,24,2861,phosphate-containing compound metabolic process,BP,CAMK2A;PPP2R2C;CPNE6;PPP1R16B;EPHB6;RASAL1;TPD52L1;FGF1;CDK18;GDA;HSPA2;PPP1R1B;ENPP2;AK5;ETNPPL;GREM1;PPP1R14A;GPR37;RCAN2;CCK;MBP;LPAR1;GRM3;GJC2
7434,GO:0030595,0.0872371739609834,0.979208995650017,3,171,leukocyte chemotaxis,BP,PADI2;CXCL14;GREM1
2636,GO:0005576,0.0873014028278689,0.943204070833294,30,3793,extracellular region,CC,CD22;CLDN11;BCAS1;LRP2;FOLH1;TF;CPNE6;EPHB6;PTGDS;ASPA;FGF1;FBXO2;PADI2;GDA;HSPA2;HAPLN2;ERMN;ENPP2;CXCL14;SLC39A12;CNDP1;S100A1;SERPINI1;HHIP;GREM1;KLK6;LGI3;CCK;SPOCK3;RYR2
9405,GO:0034483,0.0874053702945214,0.99637338365512,1,14,heparan sulfate sulfotransferase activity,MF,HS3ST4
7059,GO:0022821,0.0875036085462949,0.996365089828841,1,14,potassium ion antiporter activity,MF,SLC24A2
19771,GO:1903522,0.0878937334374067,0.973328776272964,4,260,regulation of blood circulation,BP,DOCK5;S100A1;RYR2;FXYD1
9264,GO:0034236,0.0881405139030618,0.996311081070798,1,14,protein kinase A catalytic subunit binding,MF,RYR2
7872,GO:0031432,0.088194190775321,0.996306510522652,1,14,titin binding,MF,MYBPC1
2538,GO:0005313,0.0882060727854409,0.996305498382232,1,14,L-glutamate transmembrane transporter activity,MF,SLC17A7
5350,GO:0015172,0.0882060727854409,0.996305498382232,1,14,acidic amino acid transmembrane transporter activity,MF,SLC17A7
7613,GO:0030955,0.0883551263119154,0.996292789434283,1,14,potassium ion binding,MF,SLC24A2
19312,GO:1902476,0.0883562415320303,0.986498095073951,2,77,chloride transmembrane transport,BP,SLC17A7;FXYD1
3852,GO:0008021,0.0884984301459778,0.978786934253888,3,167,synaptic vesicle,CC,SLC17A7;LGI3;SV2B
5589,GO:0015865,0.0885422665527568,0.996258260169,1,15,purine nucleotide transport,BP,GJB1
14645,GO:0060253,0.0887471485315056,0.996259256180513,1,14,negative regulation of glial cell proliferation,BP,SOX10
17301,GO:0090185,0.0887825374094481,0.996237579521271,1,15,negative regulation of kidney development,BP,GREM1
17474,GO:0090533,0.088833452198951,0.996233189603367,1,15,cation-transporting ATPase complex,CC,FXYD1
8264,GO:0032225,0.0889922411021645,0.996219481682381,1,15,regulation of synaptic transmission, dopaminergic,BP,CNTNAP4
13051,GO:0048385,0.0890304227404454,0.996216181699302,1,15,regulation of retinoic acid receptor signaling pathway,BP,ZNF536
3576,GO:0007039,0.0893630381973508,0.996206258026398,1,14,protein catabolic process in the vacuole,BP,LRP2
1437,GO:0003159,0.0893666670010312,0.996187056297006,1,15,morphogenesis of an endothelium,BP,FGF1
15218,GO:0061154,0.0893666670010312,0.996187056297006,1,15,endothelial tube morphogenesis,BP,FGF1
3948,GO:0008191,0.0894224077570919,0.99618221688361,1,15,metalloendopeptidase inhibitor activity,MF,SPOCK3
3838,GO:0007625,0.089785691162893,0.996150598826351,1,15,grooming behavior,BP,CNTNAP4
15542,GO:0065007,0.0899441845586654,0.941194130646037,72,10285,biological regulation,BP,HHATL;CAMK2A;PPP2R2C;LRP2;TF;SOX10;CPNE6;PPP1R16B;FA2H;SLC17A7;MAG;ADAP1;EPHB6;PTGDS;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;FBXO2;PADI2;NECAB1;PLP1;PACSIN1;MYRF;HSPA2;EVI2A;TOP2A;PPP1R1B;RAPGEF5;ERMN;ENPP2;MOG;CXCL14;DOCK5;ST18;SLC39A12;MKI67;NKX6-2;CNDP1;CNTNAP4;NRGN;SLC24A2;S100A1;PAQR6;VSNL1;SERPINI1;HHIP;GREM1;PPP1R14A;KLK6;LGI3;GPR37;TPPP;MAL;RCAN2;BOK;S1PR5;GPR62;CNTN2;CCK;NKAIN2;MYBPC1;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;FXYD1
10259,GO:0036376,0.0899730845510502,0.996134236461161,1,15,sodium ion export across plasma membrane,BP,FXYD1
2397,GO:0005041,0.0903867674890022,0.996139613693358,1,13,low-density lipoprotein particle receptor activity,MF,LRP2
12941,GO:0048148,0.0906668698433902,0.996073345562221,1,15,behavioral response to cocaine,BP,PPP1R1B
14884,GO:0060579,0.0911739945295847,0.99602852555671,1,15,ventral spinal cord interneuron fate commitment,BP,NKX6-2
14886,GO:0060581,0.0911739945295847,0.99602852555671,1,15,cell fate commitment involved in pattern specification,BP,NKX6-2
4805,GO:0010562,0.0912361888216741,0.954556914987755,10,974,positive regulation of phosphorus metabolic process,BP,PPP1R16B;EPHB6;TPD52L1;FGF1;HSPA2;ENPP2;GREM1;GPR37;CCK;LPAR1
12272,GO:0045937,0.0912361888216741,0.954556914987755,10,974,positive regulation of phosphate metabolic process,BP,PPP1R16B;EPHB6;TPD52L1;FGF1;HSPA2;ENPP2;GREM1;GPR37;CCK;LPAR1
10978,GO:0042953,0.0914801207651765,0.996043982602009,1,13,lipoprotein transport,BP,LRP2
11800,GO:0044872,0.0914801207651765,0.996043982602009,1,13,lipoprotein localization,BP,LRP2
17998,GO:0098660,0.0915691480056652,0.958257819010637,8,719,inorganic ion transmembrane transport,BP,SLC17A7;HSPA2;SLC39A12;SLC24A2;S100A1;RYR2;GJC2;FXYD1
7699,GO:0031106,0.0916507429444149,0.995986150073427,1,15,septin ring organization,BP,SEPT4
14772,GO:0060415,0.0916817549043359,0.985705680383163,2,73,muscle tissue morphogenesis,BP,LRP2;RYR2
7856,GO:0031406,0.0920097313854677,0.97757931464643,3,171,carboxylic acid binding,MF,MAG;PTGDS;HAPLN2
836,GO:0002043,0.0922803727810737,0.995929828939314,1,15,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,PPP1R16B
7023,GO:0022038,0.0923080407562899,0.995927344685037,1,15,corpus callosum development,BP,LPAR1
16837,GO:0072283,0.0929503211556685,0.995869454905477,1,15,metanephric renal vesicle morphogenesis,BP,GREM1
7753,GO:0031235,0.0932354104419039,0.995864185487676,1,14,intrinsic component of the cytoplasmic side of the plasma membrane,CC,RASAL1
2770,GO:0005791,0.0932728467659251,0.985281147207396,2,83,rough endoplasmic reticulum,CC,TF;PTGDS
17234,GO:0090083,0.0934468056757188,0.995824415882373,1,15,regulation of inclusion body assembly,BP,HSPA2
2051,GO:0004551,0.0936340973617169,0.995789219193135,1,16,nucleotide diphosphatase activity,MF,ENPP2
3654,GO:0007188,0.0936716064327721,0.977002790667037,3,171,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,GPR37;LPAR1;GRM3
12574,GO:0046625,0.0938228063241425,0.995771924329289,1,16,sphingolipid binding,MF,MAG
7296,GO:0030296,0.0938617574853957,0.995786579016233,1,15,protein tyrosine kinase activator activity,MF,GREM1
4864,GO:0010648,0.0944461944369936,0.949604170686692,12,1238,negative regulation of cell communication,BP,LRP2;SOX10;EPHB6;RASAL1;PADI2;SLC24A2;VSNL1;HHIP;GREM1;BOK;LPAR1;ZNF536
751,GO:0001934,0.094726131809363,0.954339403237782,9,855,positive regulation of protein phosphorylation,BP,EPHB6;TPD52L1;FGF1;HSPA2;ENPP2;GREM1;GPR37;CCK;LPAR1
18124,GO:0098911,0.0947990549174517,0.995721719912901,1,14,regulation of ventricular cardiac muscle cell action potential,BP,RYR2
17994,GO:0098655,0.0948904902662862,0.956406096425012,8,727,cation transmembrane transport,BP,SLC17A7;HSPA2;SLC39A12;SLC24A2;S100A1;RYR2;GJC2;FXYD1
11436,GO:0043931,0.0954619474369569,0.995660567801485,1,14,ossification involved in bone maturation,BP,GREM1
5621,GO:0015919,0.0958247593543188,0.995586185442996,1,16,peroxisomal membrane transport,BP,PEX5L
3677,GO:0007216,0.0960312890774989,0.99558587098554,1,15,G-protein coupled glutamate receptor signaling pathway,BP,GRM3
7102,GO:0023057,0.0961050072534113,0.948564750120065,12,1242,negative regulation of signaling,BP,LRP2;SOX10;EPHB6;RASAL1;PADI2;SLC24A2;VSNL1;HHIP;GREM1;BOK;LPAR1;ZNF536
16586,GO:0071871,0.0962277633391342,0.995567455534147,1,15,response to epinephrine,BP,RYR2
9189,GO:0034104,0.0963765995617104,0.995534258290788,1,16,negative regulation of tissue remodeling,BP,GREM1
2050,GO:0004550,0.0967187857220746,0.995484825563154,1,17,nucleoside diphosphate kinase activity,MF,AK5
822,GO:0002028,0.0968287923283362,0.984395631087603,2,81,regulation of sodium ion transport,BP,NKAIN2;FXYD1
15050,GO:0060850,0.0968484110776979,0.995489611883839,1,16,regulation of transcription involved in cell fate commitment,BP,NKX6-2
11920,GO:0045187,0.097179613851309,0.995440894587045,1,17,regulation of circadian sleep/wake cycle, sleep,BP,PTGDS
5119,GO:0012506,0.0972150854846375,0.955100475786802,8,733,vesicle membrane,CC,CAMK2A;LRP2;TF;SLC17A7;PACSIN1;NRGN;SV2B;RYR2
8241,GO:0032185,0.0972461193536272,0.995451798723551,1,16,septin cytoskeleton organization,BP,SEPT4
10353,GO:0038024,0.0973196014030006,0.98427101785797,2,81,cargo receptor activity,MF,LRP2;ENPP2
13839,GO:0051307,0.0982722551627866,0.995353479463166,1,16,meiotic chromosome separation,BP,TOP2A
18025,GO:0098742,0.0982910035122489,0.975383105461274,3,166,cell-cell adhesion via plasma-membrane adhesion molecules,BP,CLDN11;MAG;MBP
9196,GO:0034114,0.098622328122012,0.995301932466429,1,17,regulation of heterotypic cell-cell adhesion,BP,MBP
8201,GO:0032095,0.0988186364297364,0.995282856687165,1,17,regulation of response to food,BP,CCK
4664,GO:0010002,0.099142033747384,0.995269286751091,1,16,cardioblast differentiation,BP,GREM1
3502,GO:0006919,0.0991441219322571,0.983788820138751,2,86,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,BOK;CCK
21624,GO:2000727,0.0994614463406229,0.995238171215875,1,16,positive regulation of cardiac muscle cell differentiation,BP,GREM1
7392,GO:0030510,0.0996590551123208,0.983671834460687,2,81,regulation of BMP signaling pathway,BP,LRP2;GREM1
575,GO:0001676,0.099697412279415,0.983646171355191,2,86,long-chain fatty acid metabolic process,BP,PTGDS;PLP1
8940,GO:0033268,0.0998343569644604,0.995222336540147,1,15,node of Ranvier,CC,CNTN2
19482,GO:1902932,0.100823615086155,0.995085728522578,1,17,positive regulation of alcohol biosynthetic process,BP,FGF1
15103,GO:0060977,0.100852630439719,0.995122463147886,1,15,coronary vasculature morphogenesis,BP,LRP2
13205,GO:0048714,0.100955864161486,0.995072578498265,1,17,positive regulation of oligodendrocyte differentiation,BP,ASPA
7964,GO:0031623,0.101148723337087,0.983272786786214,2,85,receptor internalization,BP,GREM1;CNTN2
3307,GO:0006625,0.101285934358202,0.995039678725208,1,17,protein targeting to peroxisome,BP,PEX5L
17013,GO:0072662,0.101285934358202,0.995039678725208,1,17,protein localization to peroxisome,BP,PEX5L
17014,GO:0072663,0.101285934358202,0.995039678725208,1,17,establishment of protein localization to peroxisome,BP,PEX5L
16032,GO:0070884,0.101418393445363,0.995045221300114,1,16,regulation of calcineurin-NFAT signaling cascade,BP,RCAN2
18424,GO:0106056,0.101418393445363,0.995045221300114,1,16,regulation of calcineurin-mediated signaling,BP,RCAN2
16095,GO:0070977,0.101428868573247,0.995065469269916,1,15,bone maturation,BP,GREM1
13626,GO:0051000,0.101447970144968,0.995023486165249,1,17,positive regulation of nitric-oxide synthase activity,BP,S100A1
17306,GO:0090190,0.10148121346461,0.99502016070398,1,17,positive regulation of branching involved in ureteric bud morphogenesis,BP,GREM1
21743,GO:2001026,0.101484002335757,0.99503868343431,1,16,regulation of endothelial cell chemotaxis,BP,FGF1
18797,GO:1901032,0.101562539272807,0.995012020494457,1,17,negative regulation of response to reactive oxygen species,BP,GPR37
19622,GO:1903206,0.101562539272807,0.995012020494457,1,17,negative regulation of hydrogen peroxide-induced cell death,BP,GPR37
21754,GO:2001039,0.101562539272807,0.995012020494457,1,17,negative regulation of cellular response to drug,BP,GPR37
4135,GO:0008483,0.101759924739246,0.994992234697969,1,17,transaminase activity,MF,ETNPPL
5902,GO:0016505,0.101867639153377,0.994981420304385,1,17,peptidase activator activity involved in apoptotic process,MF,MAL
7410,GO:0030540,0.101933551462151,0.994993765737446,1,16,female genitalia development,BP,LRP2
3506,GO:0006928,0.101944271552447,0.940247696999975,16,1753,movement of cell or subcellular component,BP,SOX10;MAG;FGF1;PADI2;ENPP2;CXCL14;DOCK5;GREM1;MOBP;CNTN2;CCK;DNAH17;MYBPC1;SPOCK3;LPAR1;RYR2
13121,GO:0048583,0.101988414191899,0.932819403334408,29,3641,regulation of response to stimulus,BP,CAMK2A;LRP2;SOX10;PPP1R16B;ADAP1;EPHB6;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;PADI2;MOG;CXCL14;ST18;S100A1;VSNL1;HHIP;GREM1;KLK6;GPR37;MAL;RCAN2;BOK;GPR62;CNTN2;CCK;LPAR1;ZNF536
7288,GO:0030285,0.102212072908262,0.994946758206954,1,17,integral component of synaptic vesicle membrane,CC,SLC17A7
8327,GO:0032331,0.10232838865649,0.994935024759679,1,17,negative regulation of chondrocyte differentiation,BP,GREM1
5319,GO:0015108,0.10239042807701,0.982951348210137,2,84,chloride transmembrane transporter activity,MF,SLC17A7;FXYD1
3213,GO:0006516,0.102396964849337,0.994928100451433,1,17,glycoprotein catabolic process,BP,FBXO2
11443,GO:0043951,0.102752810823758,0.994892090833076,1,17,negative regulation of cAMP-mediated signaling,BP,LPAR1
2578,GO:0005402,0.102874767509886,0.994879719025254,1,17,carbohydrate:cation symporter activity,MF,SLC5A11
5826,GO:0016338,0.103149940328445,0.994834484927698,1,18,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,CLDN11
6755,GO:0021514,0.103172382615581,0.994849462350908,1,17,ventral spinal cord interneuron differentiation,BP,NKX6-2
9664,GO:0035258,0.103187684228309,0.982741680572325,2,84,steroid hormone receptor binding,MF,LRP2;PADI2
10897,GO:0042749,0.103296303486422,0.994819525452268,1,18,regulation of circadian sleep/wake cycle,BP,PTGDS
13153,GO:0048644,0.103380375701843,0.982708332757602,2,79,muscle organ morphogenesis,BP,LRP2;RYR2
16503,GO:0071688,0.103523301980397,0.994910043600503,1,13,striated muscle myosin thick filament assembly,BP,MYBPC1
11874,GO:0045109,0.103802449708143,0.994785101449282,1,17,intermediate filament organization,BP,NEFM
17961,GO:0098590,0.103917949887716,0.946933399590777,10,977,plasma membrane region,CC,CAMK2A;LRP2;TF;PACSIN1;CNTNAP4;HHIP;MAL;GRM3;TMEM235;FXYD1
20368,GO:1904738,0.104175337106784,0.994766629017078,1,16,vascular associated smooth muscle cell migration,BP,DOCK5
20378,GO:1904752,0.104175337106784,0.994766629017078,1,16,regulation of vascular associated smooth muscle cell migration,BP,DOCK5
17719,GO:0097320,0.104193137469651,0.994744984151445,1,17,plasma membrane tubulation,BP,PACSIN1
809,GO:0002009,0.104250294745394,0.957203942907597,6,498,morphogenesis of an epithelium,BP,LRP2;SOX10;FGF1;HHIP;GREM1;RYR2
17199,GO:0090025,0.104417691450072,0.994704164065555,1,18,regulation of monocyte chemotaxis,BP,GREM1
2516,GO:0005253,0.104483231066868,0.982392346210581,2,86,anion channel activity,MF,SLC17A7;FXYD1
621,GO:0001759,0.104678295535386,0.994677165479181,1,18,organ induction,BP,FGF1
2914,GO:0006029,0.104766992006869,0.982323432430251,2,84,proteoglycan metabolic process,BP,HS3ST4;SPOCK3
7198,GO:0030162,0.1050565513389,0.95342907202135,7,636,regulation of proteolysis,BP,ST18;SERPINI1;BOK;CNTN2;CCK;SPOCK3;MBP
17020,GO:0072673,0.105091955138368,0.994652082780812,1,17,lamellipodium morphogenesis,BP,ENPP2
16699,GO:0072079,0.105274633507175,0.99461511609362,1,18,nephron tubule formation,BP,GREM1
19148,GO:1902043,0.105304925362886,0.994629946125036,1,17,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,MAL
18519,GO:0140058,0.105491323855098,0.994630850346097,1,16,neuron projection arborization,BP,LRP2
11394,GO:0043649,0.10549979626451,0.994591590426523,1,18,dicarboxylic acid catabolic process,BP,ASPA
16867,GO:0072337,0.105585544902445,0.99460070516277,1,17,modified amino acid transport,BP,LRP2
21866,GO:2001269,0.105628045904639,0.994578166669912,1,18,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,ST18
21247,GO:2000145,0.105688845596025,0.950279566639163,8,741,regulation of cell motility,BP,FGF1;PADI2;ENPP2;CXCL14;DOCK5;GREM1;SPOCK3;LPAR1
2378,GO:0005005,0.105739845323258,0.994584591618858,1,17,transmembrane-ephrin receptor activity,MF,EPHB6
2625,GO:0005539,0.1060268881918,0.972561176929551,3,180,glycosaminoglycan binding,MF,FGF1;HAPLN2;SPOCK3
10545,GO:0042053,0.10613730882355,0.994524691703474,1,18,regulation of dopamine metabolic process,BP,GPR37
10552,GO:0042069,0.10613730882355,0.994524691703474,1,18,regulation of catecholamine metabolic process,BP,GPR37
18717,GO:1900273,0.106223889554345,0.994554482368462,1,16,positive regulation of long-term synaptic potentiation,BP,NRGN
15773,GO:0070382,0.106373138304302,0.972432105605437,3,181,exocytic vesicle,CC,SLC17A7;LGI3;SV2B
2106,GO:0004622,0.106492651107289,0.994487217285363,1,18,lysophospholipase activity,MF,ENPP2
3830,GO:0007617,0.106774062061258,0.994457445239955,1,18,mating behavior,BP,PPP1R1B
4023,GO:0008301,0.106786867884938,0.994456088453921,1,18,DNA binding, bending,MF,TOP2A
7252,GO:0030228,0.107040519320653,0.99446868879647,1,16,lipoprotein particle receptor activity,MF,LRP2
11355,GO:0043574,0.107052496329837,0.994427905938743,1,18,peroxisomal transport,BP,PEX5L
15604,GO:0070102,0.107137304858557,0.99443751654845,1,17,interleukin-6-mediated signaling pathway,BP,ST18
3619,GO:0007141,0.107140556015612,0.994418546602288,1,18,male meiosis I,BP,HSPA2
16700,GO:0072080,0.107272033189942,0.98164868870548,2,85,nephron tubule development,BP,FGF1;GREM1
5409,GO:0015294,0.107608563442961,0.981554386322894,2,86,solute:cation symporter activity,MF,SLC17A7;SLC5A11
12434,GO:0046337,0.107646333786866,0.994364632080291,1,18,phosphatidylethanolamine metabolic process,BP,ETNPPL
5080,GO:0010954,0.108405690061967,0.99428317975579,1,18,positive regulation of protein processing,BP,CNTN2
16926,GO:0072503,0.108774726339406,0.959086969534639,5,397,cellular divalent inorganic cation homeostasis,BP,SLC39A12;SLC24A2;BOK;LPAR1;RYR2
20033,GO:1904019,0.108784289506731,0.981231922276122,2,87,epithelial cell apoptotic process,BP,BOK;RYR2
8204,GO:0032098,0.108866326395961,0.994216270301354,1,19,regulation of appetite,BP,CCK
2483,GO:0005184,0.108877901353039,0.99419953248949,1,20,neuropeptide hormone activity,MF,CCK
9835,GO:0035584,0.109134408507053,0.994204441025997,1,18,calcium-mediated signaling using intracellular calcium source,BP,RYR2
7649,GO:0031034,0.109281925263263,0.99428260255977,1,14,myosin filament assembly,BP,MYBPC1
16967,GO:0072562,0.109852443114623,0.980921315292758,2,93,blood microparticle,CC,TF;HSPA2
2828,GO:0005887,0.10990349122015,0.938343021335186,13,1405,integral component of plasma membrane,CC,FOLH1;MAG;EPHB6;ENPP2;SLC39A12;SLC24A2;SLC5A11;HHIP;GPR37;CNTN2;LPAR1;GRM3;FXYD1
3749,GO:0007389,0.110106249004731,0.958436214521989,5,395,pattern specification process,BP,LRP2;FGF1;NKX6-2;HHIP;GREM1
15113,GO:0060993,0.11011224611944,0.980872275372097,2,86,kidney morphogenesis,BP,FGF1;GREM1
11442,GO:0043950,0.110217883895854,0.994068699548178,1,19,positive regulation of cAMP-mediated signaling,BP,GPR62
4575,GO:0009713,0.110228154672745,0.994067570705747,1,19,catechol-containing compound biosynthetic process,BP,GPR37
10731,GO:0042423,0.110228154672745,0.994067570705747,1,19,catecholamine biosynthetic process,BP,GPR37
16697,GO:0072077,0.110263872914328,0.994081291594998,1,18,renal vesicle morphogenesis,BP,GREM1
18208,GO:0099095,0.110436282392074,0.994062374413344,1,18,ligand-gated anion channel activity,MF,SLC17A7
3438,GO:0006817,0.110643803671761,0.994039562932979,1,18,phosphate ion transport,BP,SLC17A7
15724,GO:0070300,0.110782673950264,0.994024272339943,1,18,phosphatidic acid binding,MF,NRGN
20647,GO:1905331,0.110788855954109,0.994023591182927,1,18,negative regulation of morphogenesis of an epithelium,BP,GREM1
3839,GO:0007626,0.110857520546693,0.970766507769192,3,177,locomotory behavior,BP,PPP1R1B;GPR37;CNTN2
12275,GO:0045940,0.111034687291221,0.993978576370937,1,19,positive regulation of steroid metabolic process,BP,FGF1
19258,GO:1902307,0.111207555539259,0.993977362997894,1,18,positive regulation of sodium ion transmembrane transport,BP,FXYD1
15270,GO:0061326,0.111591074054437,0.980461410394329,2,87,renal tubule development,BP,FGF1;GREM1
3423,GO:0006793,0.11183579710588,0.927707417588284,24,2947,phosphorus metabolic process,BP,CAMK2A;PPP2R2C;CPNE6;PPP1R16B;EPHB6;RASAL1;TPD52L1;FGF1;CDK18;GDA;HSPA2;PPP1R1B;ENPP2;AK5;ETNPPL;GREM1;PPP1R14A;GPR37;RCAN2;CCK;MBP;LPAR1;GRM3;GJC2
12495,GO:0046475,0.111985275811119,0.993872799111115,1,19,glycerophospholipid catabolic process,BP,ENPP2
6111,GO:0016881,0.112330846983273,0.993834107286624,1,19,acid-amino acid ligase activity,MF,CARNS1
6038,GO:0016769,0.112369085228774,0.993829818138205,1,19,transferase activity, transferring nitrogenous groups,MF,ETNPPL
2574,GO:0005385,0.112434555305111,0.993822470807258,1,19,zinc ion transmembrane transporter activity,MF,SLC39A12
708,GO:0001871,0.112456994374496,0.993819951549442,1,19,pattern binding,MF,ENPP2
7264,GO:0030247,0.112456994374496,0.993819951549442,1,19,polysaccharide binding,MF,ENPP2
2563,GO:0005355,0.112504151348276,0.993814655439849,1,19,glucose transmembrane transporter activity,MF,SLC5A11
79,GO:0000159,0.11283072714969,0.993777913364923,1,19,protein phosphatase type 2A complex,CC,PPP2R2C
15657,GO:0070193,0.112995357828239,0.993759348198713,1,19,synaptonemal complex organization,BP,HSPA2
21656,GO:2000778,0.113044710241521,0.993753777173597,1,19,positive regulation of interleukin-6 secretion,BP,MBP
10504,GO:0040011,0.113114838436993,0.934911977062812,14,1527,locomotion,BP,SOX10;MAG;FGF1;PADI2;ENPP2;CXCL14;DOCK5;GREM1;GPR37;CNTN2;CCK;DNAH17;SPOCK3;LPAR1
7468,GO:0030672,0.113293985850821,0.979974674081277,2,91,synaptic vesicle membrane,CC,SLC17A7;SV2B
18240,GO:0099501,0.113293985850821,0.979974674081277,2,91,exocytic vesicle membrane,CC,SLC17A7;SV2B
7458,GO:0030658,0.113778997120144,0.96964776641094,3,186,transport vesicle membrane,CC,SLC17A7;NRGN;SV2B
5022,GO:0010881,0.114091418678504,0.993653906087423,1,18,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,RYR2
5059,GO:0010923,0.11411062744348,0.979752606871311,2,89,negative regulation of phosphatase activity,BP,PPP1R1B;PPP1R14A
18966,GO:1901564,0.114253891151171,0.92058195391962,44,5974,organonitrogen compound metabolic process,BP,HHATL;CAMK2A;PPP2R2C;LRP2;FOLH1;TF;PPP1R16B;FA2H;EPHB6;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;FBXO2;PADI2;CDK18;GDA;NECAB1;MYRF;HSPA2;TOP2A;PPP1R1B;ENPP2;ST18;CNDP1;AK5;SERPINI1;GREM1;PPP1R14A;KLK6;GPR37;RCAN2;CARNS1;BOK;HS3ST4;CNTN2;CCK;SPOCK3;MBP;LPAR1;GRM3;GJC2;FXYD1
4873,GO:0010661,0.114355949106351,0.99360481053585,1,19,positive regulation of muscle cell apoptotic process,BP,CAMK2A
7648,GO:0031033,0.114598537058987,0.993668597717414,1,15,myosin filament organization,BP,MYBPC1
12267,GO:0045932,0.115050400814894,0.993525172748956,1,19,negative regulation of muscle contraction,BP,DOCK5
2856,GO:0005938,0.11505277626228,0.961680428615161,4,280,cell cortex,CC,SEPT4;FGF1;ERMN;MOBP
10694,GO:0042359,0.115161896672513,0.993512338750624,1,19,vitamin D metabolic process,BP,LRP2
12976,GO:0048240,0.115267159759762,0.99348285555261,1,20,sperm capacitation,BP,SEPT4
14862,GO:0060544,0.115441279592862,0.993462714420837,1,20,regulation of necroptotic process,BP,BOK
16703,GO:0072087,0.115518886231287,0.993471157299591,1,19,renal vesicle development,BP,GREM1
14904,GO:0060602,0.11561322300318,0.99346025209638,1,19,branch elongation of an epithelium,BP,FGF1
13942,GO:0051537,0.115627513313043,0.993441136093471,1,20,2 iron, 2 sulfur cluster binding,MF,AIFM3
13122,GO:0048584,0.115691353628118,0.929883886380382,17,1979,positive regulation of response to stimulus,BP,EPHB6;SEPT4;TPD52L1;FGF1;MOG;CXCL14;ST18;S100A1;VSNL1;GREM1;KLK6;GPR37;MAL;BOK;GPR62;CNTN2;LPAR1
5227,GO:0014829,0.115779845238182,0.993440967560665,1,19,vascular smooth muscle contraction,BP,DOCK5
9655,GO:0035249,0.115881499170515,0.979256888025056,2,88,synaptic transmission, glutamatergic,BP,SLC17A7;GRM3
19530,GO:1903010,0.116262292415085,0.993384962705004,1,19,regulation of bone development,BP,GREM1
3461,GO:0006862,0.116284792571562,0.993364682182382,1,20,nucleotide transport,BP,GJB1
7909,GO:0031498,0.116341738478758,0.993375716348943,1,19,chromatin disassembly,BP,PADI2
18983,GO:1901606,0.116365330802333,0.979093549765439,2,96,alpha-amino acid catabolic process,BP,ASPA;CARNS1
10319,GO:0036499,0.1165984648828,0.993328032987109,1,20,PERK-mediated unfolded protein response,BP,BOK
2376,GO:0005003,0.116717984893376,0.993331835097113,1,19,ephrin receptor activity,MF,EPHB6
2626,GO:0005540,0.116723517603395,0.993331188692731,1,19,hyaluronic acid binding,MF,HAPLN2
10681,GO:0042327,0.116891784849605,0.941150205000302,9,894,positive regulation of phosphorylation,BP,EPHB6;TPD52L1;FGF1;HSPA2;ENPP2;GREM1;GPR37;CCK;LPAR1
14632,GO:0060231,0.117003711511857,0.993280528109342,1,20,mesenchymal to epithelial transition,BP,GREM1
12028,GO:0045446,0.117046642621613,0.978918862681686,2,90,endothelial cell differentiation,BP,PPP1R16B;HAPLN2
17305,GO:0090189,0.117391054153639,0.993234957327003,1,20,regulation of branching involved in ureteric bud morphogenesis,BP,GREM1
9265,GO:0034237,0.117848570116897,0.993219226032838,1,18,protein kinase A regulatory subunit binding,MF,RYR2
15243,GO:0061213,0.117865892834269,0.993178872920486,1,20,positive regulation of mesonephros development,BP,GREM1
5342,GO:0015149,0.117890619099557,0.993175945806123,1,20,hexose transmembrane transporter activity,MF,SLC5A11
4651,GO:0009967,0.118027278487056,0.932976652676336,13,1428,positive regulation of signal transduction,BP,EPHB6;SEPT4;TPD52L1;FGF1;ST18;GREM1;KLK6;GPR37;MAL;BOK;GPR62;CNTN2;LPAR1
20196,GO:1904385,0.118047882771201,0.993157313440582,1,20,cellular response to angiotensin,BP,CAMK2A
2425,GO:0005104,0.118193021142947,0.99314009408789,1,20,fibroblast growth factor receptor binding,MF,FGF1
13086,GO:0048514,0.118377985719327,0.949723183272016,6,515,blood vessel morphogenesis,BP,LRP2;PPP1R16B;FGF1;ENPP2;S100A1;GREM1
4848,GO:0010632,0.11853077904976,0.967823494785029,3,184,regulation of epithelial cell migration,BP,FGF1;ENPP2;DOCK5
13641,GO:0051020,0.118618150035598,0.945852483878081,7,623,GTPase binding,MF,CAMK2A;ADAP1;FGF1;PEX5L;RAPGEF5;DOCK5;MOBP
10898,GO:0042752,0.118619659359166,0.978461765309431,2,92,regulation of circadian rhythm,BP,PTGDS;TOP2A
7865,GO:0031420,0.118639866944264,0.99310532362065,1,19,alkali metal ion binding,MF,SLC24A2
16424,GO:0071577,0.118700895605864,0.993079661190047,1,20,zinc ion transmembrane transport,BP,SLC39A12
4438,GO:0009220,0.118888845577753,0.9930405251765,1,21,pyrimidine ribonucleotide biosynthetic process,BP,AK5
10711,GO:0042391,0.119310689821334,0.953856158389118,5,401,regulation of membrane potential,BP,SLC17A7;BOK;CCK;RYR2;FXYD1
17127,GO:0086014,0.119415918860093,0.993033438658181,1,18,atrial cardiac muscle cell action potential,BP,RYR2
17137,GO:0086026,0.119415918860093,0.993033438658181,1,18,atrial cardiac muscle cell to AV node cell signaling,BP,RYR2
17166,GO:0086066,0.119415918860093,0.993033438658181,1,18,atrial cardiac muscle cell to AV node cell communication,BP,RYR2
3980,GO:0008238,0.119448246065486,0.978213192068919,2,95,exopeptidase activity,MF,FOLH1;CNDP1
7633,GO:0031000,0.119684942274513,0.99300128538838,1,18,response to caffeine,BP,RYR2
10212,GO:0036270,0.119684942274513,0.99300128538838,1,18,response to diuretic,BP,RYR2
19674,GO:1903319,0.11992323094796,0.992933076113538,1,20,positive regulation of protein maturation,BP,CNTN2
13502,GO:0050802,0.120066930999107,0.99289870355359,1,21,circadian sleep/wake cycle, sleep,BP,PTGDS
559,GO:0001657,0.120108660810438,0.978032030942464,2,92,ureteric bud development,BP,FGF1;GREM1
14139,GO:0051899,0.120334468839571,0.977977204325082,2,89,membrane depolarization,BP,BOK;CCK
4315,GO:0009068,0.120689068670133,0.992823204434606,1,21,aspartate family amino acid catabolic process,BP,ASPA
2424,GO:0005102,0.121412823844619,0.932286199274615,12,1311,signaling receptor binding,MF,CAMK2A;LRP2;TF;MAG;FGF1;PADI2;PPP1R1B;MOG;CXCL14;GREM1;BOK;CCK
9538,GO:0034765,0.121436673235305,0.952779981053083,5,404,regulation of ion transmembrane transport,BP,HSPA2;S100A1;RYR2;GJC2;FXYD1
8433,GO:0032461,0.121519564121444,0.992721768648423,1,21,positive regulation of protein oligomerization,BP,CCK
778,GO:0001965,0.121968718178927,0.992666598826889,1,21,G-protein alpha-subunit binding,MF,LPAR1
17999,GO:0098661,0.122027263486066,0.977469964634356,2,93,inorganic anion transmembrane transport,BP,SLC17A7;FXYD1
2842,GO:0005911,0.122241289958973,0.952372802107721,5,402,cell-cell junction,CC,CLDN11;GJB1;OPALIN;GJC2;FXYD1
16005,GO:0070841,0.122283653202822,0.992645454457903,1,20,inclusion body assembly,BP,HSPA2
3613,GO:0007127,0.12259968222091,0.977292198313129,2,96,meiosis I,BP,HSPA2;TOP2A
7082,GO:0022890,0.122959595373012,0.947236121979734,6,523,inorganic cation transmembrane transporter activity,MF,TF;SLC17A7;SLC39A12;SLC24A2;SLC5A11;RYR2
16751,GO:0072163,0.123233613346475,0.977115874770145,2,93,mesonephric epithelium development,BP,FGF1;GREM1
16752,GO:0072164,0.123233613346475,0.977115874770145,2,93,mesonephric tubule development,BP,FGF1;GREM1
839,GO:0002052,0.123299332371064,0.992519841880441,1,20,positive regulation of neuroblast proliferation,BP,SOX10
2503,GO:0005234,0.123359557879624,0.992532237767999,1,19,extracellularly glutamate-gated ion channel activity,MF,SLC17A7
3953,GO:0008198,0.123364391268684,0.992493774476333,1,21,ferrous iron binding,MF,TF
8779,GO:0032982,0.123386719819385,0.992528870245693,1,19,myosin filament,CC,MYBPC1
16929,GO:0072507,0.123415333541291,0.951769114100108,5,413,divalent inorganic cation homeostasis,BP,SLC39A12;SLC24A2;BOK;LPAR1;RYR2
2807,GO:0005858,0.123507132556206,0.992560836998729,1,17,axonemal dynein complex,CC,DNAH17
18629,GO:1900117,0.123529911832049,0.992473138355334,1,21,regulation of execution phase of apoptosis,BP,BOK
7328,GO:0030335,0.123858570039817,0.951544717844255,5,410,positive regulation of cell migration,BP,FGF1;ENPP2;CXCL14;DOCK5;LPAR1
5341,GO:0015145,0.12438997455806,0.992365432737348,1,21,monosaccharide transmembrane transporter activity,MF,SLC5A11
13242,GO:0048799,0.12444506877171,0.992397036904949,1,19,animal organ maturation,BP,GREM1
3659,GO:0007194,0.124531292885206,0.992347658709056,1,21,negative regulation of adenylate cyclase activity,BP,GRM3
9698,GO:0035327,0.124573539557023,0.992342341011725,1,21,transcriptionally active chromatin,CC,PADI2
480,GO:0001516,0.124853874724542,0.992290262882647,1,22,prostaglandin biosynthetic process,BP,PTGDS
12480,GO:0046457,0.124853874724542,0.992290262882647,1,22,prostanoid biosynthetic process,BP,PTGDS
12139,GO:0045686,0.125219617898985,0.992260776126175,1,21,negative regulation of glial cell differentiation,BP,NKX6-2
9839,GO:0035588,0.125666356023714,0.992187150799697,1,22,G-protein coupled purinergic receptor signaling pathway,BP,CNTN2
6310,GO:0018195,0.125938641152318,0.992152434318617,1,22,peptidyl-arginine modification,BP,PADI2
7033,GO:0022410,0.126030113616472,0.99214075341939,1,22,circadian sleep/wake cycle process,BP,PTGDS
3653,GO:0007187,0.126056334695949,0.964839927395074,3,197,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,GPR37;LPAR1;GRM3
2675,GO:0005640,0.126172504634715,0.99215846247549,1,20,nuclear outer membrane,CC,BOK
11179,GO:0043279,0.126704404485444,0.976074559741661,2,96,response to alkaloid,BP,PPP1R1B;RYR2
15528,GO:0061982,0.126891138313413,0.976011905397194,2,98,meiosis I cell cycle process,BP,HSPA2;TOP2A
7944,GO:0031579,0.127222442867733,0.991987660741827,1,22,membrane raft organization,BP,MAL
12707,GO:0046916,0.127289043309368,0.975885973805549,2,100,cellular transition metal ion homeostasis,BP,TF;SLC39A12
2983,GO:0006144,0.127317326022606,0.991975411355501,1,22,purine nucleobase metabolic process,BP,GDA
13689,GO:0051093,0.12733455053843,0.937525801679379,8,778,negative regulation of developmental process,BP,SOX10;MAG;CXCL14;NKX6-2;GREM1;CNTN2;LPAR1;ZNF536
3666,GO:0007202,0.127406616747139,0.991963874980469,1,22,activation of phospholipase C activity,BP,LPAR1
7850,GO:0031400,0.127421006296664,0.944784382534981,6,537,negative regulation of protein modification process,BP,HHATL;PPP1R16B;PPP1R1B;GREM1;PPP1R14A;FXYD1
6579,GO:0019538,0.128067207732666,0.910793753204147,38,5080,protein metabolic process,BP,HHATL;CAMK2A;PPP2R2C;LRP2;FOLH1;TF;PPP1R16B;EPHB6;SEPT4;RASAL1;TPD52L1;FGF1;FBXO2;PADI2;CDK18;NECAB1;MYRF;HSPA2;TOP2A;PPP1R1B;ENPP2;ST18;CNDP1;SERPINI1;GREM1;PPP1R14A;KLK6;GPR37;RCAN2;BOK;HS3ST4;CNTN2;CCK;SPOCK3;MBP;LPAR1;GJC2;FXYD1
8717,GO:0032892,0.128338354910798,0.991842975142625,1,22,positive regulation of organic acid transport,BP,CCK
5239,GO:0014850,0.128734410606737,0.991809097046712,1,21,response to muscle activity,BP,RYR2
3440,GO:0006821,0.128875071373329,0.975417129936292,2,97,chloride transport,BP,SLC17A7;FXYD1
3760,GO:0007413,0.128963696293488,0.991798818673909,1,20,axonal fasciculation,BP,CNTN2
18418,GO:0106030,0.128963696293488,0.991798818673909,1,20,neuron projection fasciculation,BP,CNTN2
672,GO:0001823,0.129051233864788,0.975367197860915,2,96,mesonephros development,BP,FGF1;GREM1
5811,GO:0016311,0.129167524794863,0.948813332021857,5,414,dephosphorylation,BP,PPP2R2C;PPP1R16B;PPP1R1B;PPP1R14A;RCAN2
15147,GO:0061037,0.12931905078862,0.991714698415375,1,22,negative regulation of cartilage development,BP,GREM1
12629,GO:0046717,0.129376464151292,0.97525834101548,2,99,acid secretion,BP,SLC17A7;CCK
13213,GO:0048738,0.129464551488902,0.963485986366721,3,186,cardiac muscle tissue development,BP,LRP2;GREM1;RYR2
15069,GO:0060914,0.129525781723822,0.991687523472748,1,22,heart formation,BP,LRP2
7777,GO:0031280,0.129579603650796,0.991680440869503,1,22,negative regulation of cyclase activity,BP,GRM3
22,GO:0000041,0.129590337470844,0.975190079161295,2,100,transition metal ion transport,BP,TF;SLC39A12
4436,GO:0009218,0.129720254267827,0.991645418090989,1,23,pyrimidine ribonucleotide metabolic process,BP,AK5
9684,GO:0035295,0.129820391443467,0.933172608197147,9,899,tube development,BP,LRP2;SOX10;PPP1R16B;FGF1;ENPP2;S100A1;HHIP;GREM1;RYR2
7520,GO:0030818,0.12993595981513,0.991633466842014,1,22,negative regulation of cAMP biosynthetic process,BP,GRM3
7116,GO:0030017,0.130382925063112,0.963115444062111,3,185,sarcomere,CC,S100A1;MYBPC1;RYR2
17935,GO:0098533,0.130437892601393,0.991567067509933,1,22,ATPase dependent transmembrane transport complex,CC,FXYD1
2768,GO:0005789,0.130677757248594,0.93262989866768,9,932,endoplasmic reticulum membrane,CC,HHATL;TF;FA2H;PTGDS;MYRF;GJB1;GPR37;BOK;RYR2
291,GO:0000793,0.130847599533267,0.962912243371103,3,194,condensed chromosome,CC,HSPA2;TOP2A;MKI67
4675,GO:0010038,0.131100096535576,0.954251656563038,4,306,response to metal ion,BP,TF;CPNE6;RASAL1;RYR2
13124,GO:0048588,0.131105957588202,0.962813349737815,3,190,developmental cell growth,BP,CPNE6;MAG;RASAL1
3553,GO:0007006,0.131146236804428,0.974705587146554,2,103,mitochondrial membrane organization,BP,CAMK2A;BOK
10085,GO:0035994,0.131244944130174,0.991546099783524,1,18,response to muscle stretch,BP,RYR2
3045,GO:0006266,0.13140338940871,0.991421638396832,1,23,DNA ligation,BP,TOP2A
21864,GO:2001267,0.13151880336352,0.991406179724873,1,23,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,ST18
4758,GO:0010460,0.131868340166856,0.991376323493731,1,22,positive regulation of heart rate,BP,RYR2
14429,GO:0055065,0.131928559642171,0.942283623372662,6,543,metal ion homeostasis,BP,TF;SLC39A12;SLC24A2;BOK;LPAR1;RYR2
17656,GO:0097190,0.131953883316436,0.942265878612812,6,552,apoptotic signaling pathway,BP,SEPT4;TPD52L1;ST18;MAL;BOK;CCK
2602,GO:0005501,0.132007668487626,0.991340538326208,1,23,retinoid binding,MF,PTGDS
4176,GO:0008543,0.132051719302488,0.974440522250492,2,99,fibroblast growth factor receptor signaling pathway,BP,FGF1;HHIP
12902,GO:0048018,0.132066508021597,0.953778936904061,4,324,receptor ligand activity,MF,FGF1;CXCL14;GREM1;CCK
3716,GO:0007286,0.132068906145324,0.974431873774726,2,100,spermatid development,BP,SEPT4;HSPA2
874,GO:0002092,0.13216370063536,0.991336659007456,1,22,positive regulation of receptor internalization,BP,GREM1
18055,GO:0098797,0.132331254954088,0.942062048313346,6,536,plasma membrane protein complex,CC,TF;HSPA2;GJB1;CNTN2;GJC2;FXYD1
4752,GO:0010453,0.132333761081742,0.991296606857536,1,23,regulation of cell fate commitment,BP,NKX6-2
17812,GO:0097493,0.132511953642681,0.991406324127863,1,17,structural molecule activity conferring elasticity,MF,MYBPC1
19318,GO:1902495,0.132849309594177,0.953427910630085,4,299,transmembrane transporter complex,CC,HSPA2;CNTN2;RYR2;FXYD1
8635,GO:0032770,0.132878568710926,0.991222949049854,1,23,positive regulation of monooxygenase activity,BP,S100A1
6958,GO:0021895,0.132899124023979,0.991237481692486,1,22,cerebral cortex neuron differentiation,BP,CNTN2
18073,GO:0098827,0.133112590014448,0.931101925821357,9,936,endoplasmic reticulum subcompartment,CC,HHATL;TF;FA2H;PTGDS;MYRF;GJB1;GPR37;BOK;RYR2
7700,GO:0031109,0.133285882117802,0.974063185521097,2,98,microtubule polymerization or depolymerization,BP,SLC39A12;TPPP
8210,GO:0032104,0.133452693105723,0.991144974223335,1,23,regulation of response to extracellular stimulus,BP,CCK
8213,GO:0032107,0.133452693105723,0.991144974223335,1,23,regulation of response to nutrient levels,BP,CCK
15245,GO:0061217,0.13348852278308,0.991140095979855,1,23,regulation of mesonephros development,BP,GREM1
3179,GO:0006468,0.133615311990439,0.919598541099551,15,1717,protein phosphorylation,BP,CAMK2A;EPHB6;RASAL1;TPD52L1;FGF1;CDK18;HSPA2;PPP1R1B;ENPP2;GREM1;GPR37;CCK;MBP;LPAR1;GJC2
12124,GO:0045662,0.133684409283554,0.991113400862969,1,23,negative regulation of myoblast differentiation,BP,CXCL14
11054,GO:0043090,0.133919745447826,0.991098858970783,1,22,amino acid import,BP,SLC17A7
13866,GO:0051371,0.13424351388323,0.991145013352787,1,18,muscle alpha-actinin binding,MF,MYBPC1
18539,GO:0140115,0.134245829281146,0.991036657237231,1,23,export across plasma membrane,BP,FXYD1
21249,GO:2000147,0.134267729555032,0.946150257298683,5,422,positive regulation of cell motility,BP,FGF1;ENPP2;CXCL14;DOCK5;LPAR1
13569,GO:0050896,0.13464108482682,0.904473826352052,53,7420,response to stimulus,BP,CAMK2A;LRP2;TF;SOX10;CPNE6;PPP1R16B;SLC17A7;MAG;ADAP1;EPHB6;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;FBXO2;PADI2;PLP1;HSPA2;EVI2A;TOP2A;PPP1R1B;RAPGEF5;ENPP2;MOG;CXCL14;DOCK5;ST18;SLC39A12;NRGN;SLC24A2;S100A1;PAQR6;VSNL1;HHIP;GREM1;PPP1R14A;KLK6;GPR37;MAL;RCAN2;BOK;S1PR5;GPR62;CNTN2;CCK;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2
11181,GO:0043281,0.134641744527332,0.961343241784806,3,204,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,ST18;BOK;CCK
19415,GO:1902745,0.134937960358701,0.990959421669762,1,22,positive regulation of lamellipodium organization,BP,ENPP2
7505,GO:0030803,0.134953421315368,0.99093943771771,1,23,negative regulation of cyclic nucleotide biosynthetic process,BP,GRM3
3445,GO:0006829,0.135121531568335,0.990916259058415,1,23,zinc ion transport,BP,SLC39A12
2605,GO:0005504,0.135236743918533,0.990883920316047,1,24,fatty acid binding,MF,PTGDS
16930,GO:0072509,0.135316507222619,0.990889337207513,1,23,divalent inorganic cation transmembrane transporter activity,MF,SLC39A12
6754,GO:0021513,0.135391621032019,0.990878954448904,1,23,spinal cord dorsal/ventral patterning,BP,NKX6-2
13456,GO:0050730,0.135430326617371,0.961020420311404,3,202,regulation of peptidyl-tyrosine phosphorylation,BP,ENPP2;GREM1;CCK
7496,GO:0030742,0.135571519126676,0.990854062354402,1,23,GTP-dependent protein binding,MF,RAPGEF5
9578,GO:0035025,0.136058520547403,0.990786497787457,1,23,positive regulation of Rho protein signal transduction,BP,LPAR1
21098,GO:1990776,0.136188146341503,0.990768469904475,1,23,response to angiotensin,BP,CAMK2A
2288,GO:0004871,0.13626430325634,0.924343564484433,11,1194,signal transducer activity,MF,SLC17A7;EPHB6;EVI2A;PAQR6;GREM1;GPR37;S1PR5;GPR62;LPAR1;RYR2;GRM3
10893,GO:0042745,0.136430038172809,0.990718051885367,1,24,circadian sleep/wake cycle,BP,PTGDS
6665,GO:0019840,0.137345693745395,0.990589706822325,1,24,isoprenoid binding,MF,PTGDS
9095,GO:0033688,0.13741062230121,0.990597539032275,1,23,regulation of osteoblast proliferation,BP,GREM1
16656,GO:0072009,0.137501720879705,0.972742121780998,2,99,nephron epithelium development,BP,FGF1;GREM1
2278,GO:0004857,0.137768507511391,0.951054740374538,4,317,enzyme inhibitor activity,MF,PPP1R1B;SERPINI1;PPP1R14A;SPOCK3
17164,GO:0086064,0.138013696635169,0.990531283565527,1,22,cell communication by electrical coupling involved in cardiac conduction,BP,RYR2
7313,GO:0030318,0.138575899719251,0.990451896664187,1,22,melanocyte differentiation,BP,SOX10
16787,GO:0072202,0.138854904405211,0.990393463719941,1,23,cell differentiation involved in metanephros development,BP,GREM1
1867,GO:0004181,0.139134023041583,0.990336361386054,1,24,metallocarboxypeptidase activity,MF,FOLH1
14715,GO:0060343,0.139412933017547,0.990313996009314,1,23,trabecula formation,BP,GREM1
7769,GO:0031267,0.139565284120443,0.937996837777035,6,529,small GTPase binding,MF,CAMK2A;ADAP1;FGF1;PEX5L;RAPGEF5;MOBP
9962,GO:0035767,0.139621075450484,0.990284266454091,1,23,endothelial cell chemotaxis,BP,FGF1
13859,GO:0051350,0.140014994616826,0.990210252497952,1,24,negative regulation of lyase activity,BP,GRM3
5560,GO:0015813,0.140176568569133,0.990204688529335,1,23,L-glutamate transmembrane transport,BP,SLC17A7
7139,GO:0030054,0.140341482873724,0.921638307568776,11,1176,cell junction,CC,CLDN11;CAMK2A;SLC17A7;PACSIN1;CNTNAP4;LGI3;GJB1;SV2B;OPALIN;GJC2;FXYD1
9257,GO:0034219,0.140397774610581,0.971811244311166,2,102,carbohydrate transmembrane transport,BP,SLC5A11;TMEM144
7107,GO:0030003,0.14040739596128,0.937507860132093,6,554,cellular cation homeostasis,BP,TF;SLC39A12;SLC24A2;BOK;LPAR1;RYR2
9906,GO:0035690,0.140439410669966,0.94976307752187,4,314,cellular response to drug,BP,SOX10;PPP1R14A;GPR37;RYR2
13704,GO:0051119,0.140520646518579,0.990137480029405,1,24,sugar transmembrane transporter activity,MF,SLC5A11
19621,GO:1903205,0.14068491399903,0.990113777767502,1,24,regulation of hydrogen peroxide-induced cell death,BP,GPR37
5406,GO:0015291,0.140857402966829,0.958754356858511,3,202,secondary active transmembrane transporter activity,MF,SLC17A7;SLC24A2;SLC5A11
4186,GO:0008569,0.141190564884484,0.99017806213642,1,18,ATP-dependent microtubule motor activity, minus-end-directed,MF,DNAH17
20965,GO:1990351,0.141367989919934,0.949317179376379,4,307,transporter complex,CC,HSPA2;CNTN2;RYR2;FXYD1
5402,GO:0015278,0.141575896400375,0.990043892196986,1,21,calcium-release channel activity,MF,RYR2
10613,GO:0042175,0.142324225916692,0.925259490139021,9,949,nuclear outer membrane-endoplasmic reticulum membrane network,CC,HHATL;TF;FA2H;PTGDS;MYRF;GJB1;GPR37;BOK;RYR2
9968,GO:0035774,0.142424810354244,0.989844114526986,1,25,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,VSNL1
13087,GO:0048515,0.142836931616493,0.971016201898561,2,105,spermatid differentiation,BP,SEPT4;HSPA2
6614,GO:0019725,0.142933168496858,0.927970118564292,8,813,cellular homeostasis,BP,TF;SLC17A7;SLC39A12;SLC24A2;VSNL1;BOK;LPAR1;RYR2
7181,GO:0030137,0.143297096816614,0.989715851335911,1,25,COPI-coated vesicle,CC,PACSIN1
14442,GO:0055082,0.143365259525357,0.931380726591131,7,682,cellular chemical homeostasis,BP,TF;SLC39A12;SLC24A2;VSNL1;BOK;LPAR1;RYR2
5023,GO:0010882,0.14370819232366,0.989690739670544,1,23,regulation of cardiac muscle contraction by calcium ion signaling,BP,RYR2
10901,GO:0042755,0.144534679604298,0.989532414492795,1,25,eating behavior,BP,CCK
13501,GO:0050801,0.144731386297833,0.930560346265034,7,683,ion homeostasis,BP,TF;SLC39A12;SLC24A2;BOK;CCK;LPAR1;RYR2
20587,GO:1905209,0.144751316550414,0.989517448548572,1,24,positive regulation of cardiocyte differentiation,BP,GREM1
788,GO:0001975,0.144760432767459,0.989516090938215,1,24,response to amphetamine,BP,PPP1R1B
13813,GO:0051272,0.14509233969535,0.940385302588645,5,433,positive regulation of cellular component movement,BP,FGF1;ENPP2;CXCL14;DOCK5;LPAR1
15694,GO:0070252,0.145104109548512,0.970305022058905,2,98,actin-mediated cell contraction,BP,MYBPC1;RYR2
18614,GO:1900101,0.145234667829415,0.989427901926122,1,25,regulation of endoplasmic reticulum unfolded protein response,BP,BOK
17248,GO:0090101,0.146017657547197,0.969987014511677,2,103,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,LRP2;GREM1
8892,GO:0033173,0.146629242105907,0.989235819518861,1,24,calcineurin-NFAT signaling cascade,BP,RCAN2
21741,GO:2001024,0.146870452756464,0.989181527794899,1,25,negative regulation of response to drug,BP,GPR37
4310,GO:0009063,0.147057545112845,0.969621054529443,2,110,cellular amino acid catabolic process,BP,ASPA;CARNS1
16705,GO:0072089,0.14716790936029,0.96960511419864,2,104,stem cell proliferation,BP,SOX10;HHIP
776,GO:0001963,0.147494225746746,0.989070190039925,1,26,synaptic transmission, dopaminergic,BP,CNTNAP4
11097,GO:0043167,0.147529597319208,0.895060568531692,41,5527,ion binding,MF,CAMK2A;LRP2;FOLH1;TF;CPNE6;FA2H;MAG;ADAP1;EPHB6;PTGDS;ASPA;SEPT4;RASAL1;FGF1;PADI2;CDK18;GDA;NECAB1;PACSIN1;HSPA2;TOP2A;IQCA1;HAPLN2;ENPP2;ST18;MKI67;CNDP1;AK5;NRGN;SLC24A2;S100A1;VSNL1;ETNPPL;HHIP;CARNS1;AIFM3;DNAH17;SPOCK3;LPAR1;ZNF536;RYR2
21414,GO:2000403,0.147681191351037,0.989041665877667,1,26,positive regulation of lymphocyte migration,BP,CXCL14
2413,GO:0005085,0.147811901251994,0.946147270448845,4,306,guanyl-nucleotide exchange factor activity,MF,CAMK2A;FGF1;RAPGEF5;DOCK5
10505,GO:0040012,0.147925555563947,0.924856023018385,8,805,regulation of locomotion,BP,FGF1;PADI2;ENPP2;CXCL14;DOCK5;GREM1;SPOCK3;LPAR1
13125,GO:0048589,0.148384992465711,0.932939347524571,6,545,developmental growth,BP,SOX10;CPNE6;MAG;RASAL1;FGF1;KLK6
10535,GO:0042026,0.148576331433397,0.988904554820412,1,26,protein refolding,BP,HSPA2
6752,GO:0021511,0.148581220835055,0.98892064611866,1,25,spinal cord patterning,BP,NKX6-2
5881,GO:0016477,0.148836971580836,0.915935849137894,11,1198,cell migration,BP,SOX10;MAG;FGF1;PADI2;ENPP2;CXCL14;DOCK5;GREM1;CNTN2;CCK;LPAR1
10679,GO:0042325,0.148863584504816,0.913819218329931,12,1343,regulation of phosphorylation,BP,EPHB6;TPD52L1;FGF1;HSPA2;PPP1R1B;ENPP2;GREM1;PPP1R14A;GPR37;CCK;LPAR1;GJC2
16014,GO:0070851,0.149291260435633,0.968887615957114,2,108,growth factor receptor binding,MF,FGF1;GREM1
6456,GO:0019201,0.149332883771594,0.988804981315077,1,25,nucleotide kinase activity,MF,AK5
17949,GO:0098563,0.149468320936975,0.988767028398851,1,26,intrinsic component of synaptic vesicle membrane,CC,SLC17A7
487,GO:0001525,0.149479821087109,0.93800665108328,5,434,angiogenesis,BP,PPP1R16B;FGF1;ENPP2;S100A1;GREM1
10845,GO:0042634,0.149744770274452,0.988741331008293,1,25,regulation of hair cycle,BP,FA2H
14083,GO:0051787,0.150074183878128,0.98867310511554,1,26,misfolded protein binding,MF,HSPA2
5070,GO:0010939,0.150169804824682,0.98864231598453,1,27,regulation of necrotic cell death,BP,BOK
3468,GO:0006873,0.150192309754825,0.931883431821728,6,565,cellular ion homeostasis,BP,TF;SLC39A12;SLC24A2;BOK;LPAR1;RYR2
8118,GO:0031954,0.150306917340711,0.988654151915601,1,25,positive regulation of protein autophosphorylation,BP,GREM1
10297,GO:0036474,0.150723989039946,0.988571909262131,1,26,cell death in response to hydrogen peroxide,BP,GPR37
3668,GO:0007205,0.151006162292913,0.988545214102534,1,25,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,CCK
10493,GO:0039694,0.15127279400537,0.98848607092828,1,26,viral RNA genome replication,BP,TOP2A
7517,GO:0030815,0.151724752608329,0.988415124670539,1,26,negative regulation of cAMP metabolic process,BP,GRM3
820,GO:0002026,0.151818481452272,0.988417967235034,1,25,regulation of the force of heart contraction,BP,RYR2
16830,GO:0072273,0.152040008481586,0.988383136504581,1,25,metanephric nephron morphogenesis,BP,GREM1
5489,GO:0015672,0.152333968600154,0.936440725822511,5,443,monovalent inorganic cation transport,BP,SLC17A7;SLC24A2;SLC5A11;NKAIN2;FXYD1
1430,GO:0003148,0.152384829469613,0.988328809911543,1,25,outflow tract septum morphogenesis,BP,LRP2
19932,GO:1903825,0.152593966267276,0.967783995353259,2,107,organic acid transmembrane transport,BP,LRP2;SLC17A7
20526,GO:1905039,0.152593966267276,0.967783995353259,2,107,carboxylic acid transmembrane transport,BP,LRP2;SLC17A7
13927,GO:0051482,0.152971704001727,0.988201658415451,1,27,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,LPAR1
9094,GO:0033687,0.152975188961086,0.988217633098084,1,26,osteoblast proliferation,BP,GREM1
3827,GO:0007613,0.153340791834151,0.967538887942521,2,105,memory,BP,SLC17A7;SLC24A2
10352,GO:0038023,0.153617807057433,0.921261740224411,8,829,signaling receptor activity,MF,EPHB6;EVI2A;PAQR6;GPR37;S1PR5;GPR62;LPAR1;GRM3
14549,GO:0060089,0.153617807057433,0.921261740224411,8,829,molecular transducer activity,MF,EPHB6;EVI2A;PAQR6;GPR37;S1PR5;GPR62;LPAR1;GRM3
11667,GO:0044449,0.153746521267507,0.953207162703665,3,200,contractile fiber part,CC,S100A1;MYBPC1;RYR2
14643,GO:0060251,0.153763079697934,0.988110323604948,1,25,regulation of glial cell proliferation,BP,SOX10
13681,GO:0051085,0.15383262391531,0.988064473903225,1,27,chaperone cofactor-dependent protein refolding,BP,HSPA2
10520,GO:0040036,0.15399102112866,0.98805589074353,1,26,regulation of fibroblast growth factor receptor signaling pathway,BP,HHIP
4631,GO:0009897,0.154164920930575,0.952998324474494,3,215,external side of plasma membrane,CC,LRP2;TF;MOG
9502,GO:0034703,0.156033083024344,0.952187578078662,3,206,cation channel complex,CC,HSPA2;CNTN2;RYR2
12750,GO:0046983,0.156253209764573,0.913378719392604,10,1108,protein dimerization activity,MF,CAMK2A;MAG;SEPT4;TPD52L1;TOP2A;SLC24A2;S100A1;GREM1;GJB1;BOK
3512,GO:0006936,0.156499915311449,0.941767930672313,4,321,muscle contraction,BP,DOCK5;MYBPC1;RYR2;FXYD1
82,GO:0000165,0.156564320312342,0.919390641399333,8,827,MAPK cascade,BP,CAMK2A;EPHB6;RASAL1;TPD52L1;FGF1;GPR37;MBP;LPAR1
7502,GO:0030800,0.15661782598757,0.987614892530336,1,27,negative regulation of cyclic nucleotide metabolic process,BP,GRM3
5021,GO:0010880,0.156733170541783,0.987632174982244,1,25,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,RYR2
7559,GO:0030867,0.156842661380877,0.987562084171519,1,28,rough endoplasmic reticulum membrane,CC,TF
17902,GO:0097720,0.157342061524717,0.987514026570248,1,26,calcineurin-mediated signaling,BP,RCAN2
21753,GO:2001038,0.157500302203019,0.987470602855806,1,27,regulation of cellular response to drug,BP,GPR37
7412,GO:0030545,0.157910551335461,0.941026288364244,4,347,receptor regulator activity,MF,FGF1;CXCL14;GREM1;CCK
6315,GO:0018200,0.158135666090795,0.987349769736154,1,28,peptidyl-glutamic acid modification,BP,FOLH1
7154,GO:0030100,0.158467024842137,0.951090306350549,3,215,regulation of endocytosis,BP,TF;PACSIN1;GREM1
4501,GO:0009394,0.158783006090208,0.987227367706142,1,29,2'-deoxyribonucleotide metabolic process,BP,AK5
4470,GO:0009266,0.158857375062039,0.950914323500757,3,216,response to temperature stimulus,BP,CAMK2A;FGF1;HSPA2
2808,GO:0005859,0.159553004738916,0.987212861465364,1,23,muscle myosin complex,CC,MYBPC1
3840,GO:0007628,0.159576657261182,0.987145587510348,1,26,adult walking behavior,BP,CNTN2
8093,GO:0031904,0.159712488137651,0.987104992264463,1,27,endosome lumen,CC,LRP2
3404,GO:0006760,0.160032419630251,0.987034860600491,1,28,folic acid-containing compound metabolic process,BP,FOLH1
4827,GO:0010604,0.160052776191631,0.893088861395436,22,2772,positive regulation of macromolecule metabolic process,BP,LRP2;SOX10;PPP1R16B;EPHB6;SEPT4;TPD52L1;FGF1;PADI2;PLP1;MYRF;HSPA2;TOP2A;ENPP2;ST18;GREM1;GPR37;BOK;CNTN2;CCK;MBP;LPAR1;GJC2
5831,GO:0016358,0.16011330707909,0.950366746154235,3,207,dendrite development,BP,CAMK2A;PACSIN1;LPAR1
13050,GO:0048384,0.160247977861706,0.986998811884751,1,28,retinoic acid receptor signaling pathway,BP,ZNF536
14172,GO:0051954,0.160717014877953,0.986920188871647,1,28,positive regulation of amine transport,BP,CCK
749,GO:0001932,0.161193142414667,0.907508667560962,11,1230,regulation of protein phosphorylation,BP,EPHB6;TPD52L1;FGF1;HSPA2;PPP1R1B;ENPP2;GREM1;GPR37;CCK;LPAR1;GJC2
3324,GO:0006650,0.161319458551001,0.939293323558215,4,331,glycerophospholipid metabolic process,BP,CPNE6;FGF1;ENPP2;ETNPPL
7014,GO:0022011,0.161698268737379,0.986810447175712,1,25,myelination in peripheral nervous system,BP,FA2H
8308,GO:0032292,0.161698268737379,0.986810447175712,1,25,peripheral nervous system axon ensheathment,BP,FA2H
7115,GO:0030016,0.161721290717655,0.949647060253137,3,205,myofibril,CC,S100A1;MYBPC1;RYR2
6300,GO:0018149,0.162045192703175,0.986696182398543,1,28,peptide cross-linking,BP,SPOCK3
6431,GO:0019098,0.162066156182263,0.986692630531562,1,28,reproductive behavior,BP,PPP1R1B
16996,GO:0072604,0.16245230593564,0.986627114446939,1,28,interleukin-6 secretion,BP,MBP
14173,GO:0051955,0.162645289418189,0.986594307714656,1,28,regulation of amino acid transport,BP,CCK
7272,GO:0030262,0.162918524196019,0.986547785256657,1,28,apoptotic nuclear changes,BP,TOP2A
4877,GO:0010665,0.16298960430773,0.986535668699499,1,28,regulation of cardiac muscle cell apoptotic process,BP,CAMK2A
21622,GO:2000725,0.163002740713146,0.986550850994996,1,27,regulation of cardiac muscle cell differentiation,BP,GREM1
19772,GO:1903523,0.163107218905718,0.986533051495751,1,27,negative regulation of blood circulation,BP,DOCK5
14914,GO:0060627,0.163587612256339,0.930181300369962,5,452,regulation of vesicle-mediated transport,BP,TF;PACSIN1;VSNL1;GREM1;LGI3
18115,GO:0098901,0.163631850165542,0.986482820327082,1,25,regulation of cardiac muscle cell action potential,BP,RYR2
7718,GO:0031128,0.164023378963301,0.986358791145473,1,28,developmental induction,BP,FGF1
10510,GO:0040017,0.164184302835928,0.929845258839468,5,452,positive regulation of locomotion,BP,FGF1;ENPP2;CXCL14;DOCK5;LPAR1
19395,GO:1902692,0.164584101928061,0.986280099354845,1,27,regulation of neuroblast proliferation,BP,SOX10
7833,GO:0031365,0.164779549549737,0.986228632351763,1,28,N-terminal protein amino acid modification,BP,HHATL
19222,GO:1902235,0.164955548294037,0.986181634517022,1,29,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,BOK
2149,GO:0004683,0.165394139079469,0.986122358421713,1,28,calmodulin-dependent protein kinase activity,MF,CAMK2A
7327,GO:0030334,0.165526890299084,0.917800359356216,7,698,regulation of cell migration,BP,FGF1;PADI2;ENPP2;CXCL14;DOCK5;GREM1;LPAR1
17514,GO:0090659,0.165939216672557,0.986045795191369,1,27,walking behavior,BP,CNTN2
5463,GO:0015491,0.166344766696658,0.985957119263845,1,28,cation:cation antiporter activity,MF,SLC24A2
18283,GO:0099568,0.16657833985727,0.928499844037974,5,441,cytoplasmic region,CC,SEPT4;FGF1;ERMN;MOBP;DNAH17
1491,GO:0003231,0.167208389737714,0.962684119047274,2,111,cardiac ventricle development,BP,LRP2;RYR2
9838,GO:0035587,0.167495952195527,0.98572251797295,1,30,purinergic receptor signaling pathway,BP,CNTN2
6949,GO:0021884,0.167534556410348,0.985748838484255,1,28,forebrain neuron development,BP,CNTN2
1472,GO:0003206,0.168245712276885,0.962304133108799,2,113,cardiac chamber morphogenesis,BP,LRP2;RYR2
17996,GO:0098657,0.168327066043303,0.91604088006155,7,709,import into cell,BP,LRP2;TF;PACSIN1;ENPP2;SLC39A12;GREM1;CNTN2
14671,GO:0060292,0.168341064742842,0.985606723086358,1,28,long term synaptic depression,BP,SLC24A2
4035,GO:0008324,0.168555545230256,0.921014609314038,6,578,cation transmembrane transporter activity,MF,TF;SLC17A7;SLC39A12;SLC24A2;SLC5A11;RYR2
6485,GO:0019239,0.168601707433045,0.985527091810862,1,30,deaminase activity,MF,GDA
6762,GO:0021522,0.168835971143053,0.985501743672786,1,29,spinal cord motor neuron differentiation,BP,NKX6-2
6605,GO:0019692,0.168983375591492,0.985444094840965,1,31,deoxyribose phosphate metabolic process,BP,AK5
21234,GO:2000116,0.169065683933911,0.946261023809866,3,227,regulation of cysteine-type endopeptidase activity,BP,ST18;BOK;CCK
3846,GO:0008009,0.169206653958597,0.985390024027588,1,32,chemokine activity,MF,CXCL14
3026,GO:0006221,0.169356550314087,0.985377589076225,1,31,pyrimidine nucleotide biosynthetic process,BP,AK5
14795,GO:0060441,0.169521083800465,0.985379894018888,1,29,epithelial tube branching involved in lung morphogenesis,BP,HHIP
3849,GO:0008016,0.169675277550434,0.945992518619831,3,219,regulation of heart contraction,BP,S100A1;RYR2;FXYD1
6070,GO:0016814,0.169844256759654,0.985305796632993,1,30,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,GDA
5810,GO:0016310,0.169901212496033,0.890748720562812,17,2081,phosphorylation,BP,CAMK2A;EPHB6;RASAL1;TPD52L1;FGF1;CDK18;HSPA2;PPP1R1B;ENPP2;AK5;GREM1;PPP1R14A;GPR37;CCK;MBP;LPAR1;GJC2
6292,GO:0018108,0.169950138375285,0.934798488016001,4,335,peptidyl-tyrosine phosphorylation,BP,FGF1;ENPP2;GREM1;CCK
3876,GO:0008066,0.170173545160911,0.985300008535477,1,27,glutamate receptor activity,MF,GRM3
4190,GO:0008584,0.170786476682359,0.961374338017336,2,116,male gonad development,BP,LRP2;BOK
8230,GO:0032148,0.171289435197552,0.985062868366671,1,29,activation of protein kinase B activity,BP,FGF1
12494,GO:0046474,0.171380685275963,0.945196106612189,3,223,glycerophospholipid biosynthetic process,BP,CPNE6;FGF1;ETNPPL
11403,GO:0043679,0.171430002332794,0.9611365662244,2,117,axon terminus,CC,PACSIN1;CCK
5176,GO:0014072,0.171898820241216,0.98493594671061,1,30,response to isoquinoline alkaloid,BP,PPP1R1B
11178,GO:0043278,0.171898820241216,0.98493594671061,1,30,response to morphine,BP,PPP1R1B
21312,GO:2000273,0.172271555180897,0.984885226157352,1,29,positive regulation of signaling receptor activity,BP,GREM1
13590,GO:0050921,0.172332628119888,0.960793211061751,2,121,positive regulation of chemotaxis,BP,CXCL14;LPAR1
7368,GO:0030431,0.172513560331008,0.984824329750925,1,30,sleep,BP,PTGDS
12539,GO:0046546,0.173207310385994,0.960486761266329,2,117,development of primary male sexual characteristics,BP,LRP2;BOK
2509,GO:0005246,0.173263697392678,0.984687532213235,1,30,calcium channel regulator activity,MF,GRM3
12039,GO:0045503,0.173274137996191,0.984809660524269,1,24,dynein light chain binding,MF,DNAH17
1574,GO:0003401,0.173361003038836,0.984686856918601,1,29,axis elongation,BP,FGF1
12174,GO:0045761,0.1734963844089,0.984644965213823,1,30,regulation of adenylate cyclase activity,BP,GRM3
12234,GO:0045879,0.173526864420046,0.984656535152503,1,29,negative regulation of smoothened signaling pathway,BP,HHIP
4874,GO:0010662,0.173528190819731,0.984639141743798,1,30,regulation of striated muscle cell apoptotic process,BP,CAMK2A
6324,GO:0018212,0.173600726477511,0.93286681459427,4,338,peptidyl-tyrosine modification,BP,FGF1;ENPP2;GREM1;CCK
11646,GO:0044421,0.173682936227584,0.880358533593923,25,3312,extracellular region part,CC,CD22;CLDN11;BCAS1;LRP2;FOLH1;TF;CPNE6;PTGDS;ASPA;FGF1;FBXO2;PADI2;GDA;HSPA2;HAPLN2;ERMN;ENPP2;CXCL14;SLC39A12;SERPINI1;GREM1;KLK6;CCK;SPOCK3;RYR2
4673,GO:0010035,0.173815335549136,0.924351294226447,5,466,response to inorganic substance,BP,TF;CPNE6;RASAL1;GPR37;RYR2
4871,GO:0010659,0.174394874138604,0.984480005093358,1,30,cardiac muscle cell apoptotic process,BP,CAMK2A
5639,GO:0015949,0.175014103941162,0.984334153886387,1,32,nucleobase-containing small molecule interconversion,BP,AK5
5211,GO:0014808,0.17515440447052,0.984376019616364,1,28,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,RYR2
2285,GO:0004866,0.175420160930303,0.959653894108833,2,122,endopeptidase inhibitor activity,MF,SERPINI1;SPOCK3
13751,GO:0051180,0.175427259409805,0.984289297303276,1,30,vitamin transport,BP,LRP2
20648,GO:1905332,0.175468946300949,0.984281570489735,1,30,positive regulation of morphogenesis of an epithelium,BP,GREM1
11597,GO:0044325,0.175643518924247,0.959592641029248,2,116,ion channel binding,MF,RYR2;FXYD1
2300,GO:0004888,0.176096276782954,0.911116797149068,7,729,transmembrane signaling receptor activity,MF,EPHB6;EVI2A;GPR37;S1PR5;GPR62;LPAR1;GRM3
13162,GO:0048665,0.176497359783831,0.984073711136658,1,31,neuron fate specification,BP,NKX6-2
18926,GO:1901385,0.17658621312063,0.984057111366117,1,31,regulation of voltage-gated calcium channel activity,BP,S100A1
3475,GO:0006882,0.176678169448377,0.984024334525012,1,32,cellular zinc ion homeostasis,BP,SLC39A12
4502,GO:0009395,0.176918247320406,0.983994998060847,1,31,phospholipid catabolic process,BP,ENPP2
7183,GO:0030140,0.177445929227242,0.983912792682149,1,30,trans-Golgi network transport vesicle,CC,NRGN
3571,GO:0007031,0.177459453660784,0.983893477827752,1,31,peroxisome organization,BP,PEX5L
18295,GO:0099604,0.177506106108521,0.983959329247233,1,27,ligand-gated calcium channel activity,MF,RYR2
14538,GO:0060076,0.177631934449893,0.983895831007141,1,29,excitatory synapse,CC,SLC17A7
293,GO:0000795,0.177684317668473,0.983851196403285,1,31,synaptonemal complex,CC,HSPA2
18204,GO:0099086,0.177684317668473,0.983851196403285,1,31,synaptonemal structure,CC,HSPA2
11559,GO:0044267,0.177837876999488,0.872628535819935,34,4620,cellular protein metabolic process,BP,HHATL;CAMK2A;PPP2R2C;LRP2;FOLH1;TF;PPP1R16B;EPHB6;SEPT4;RASAL1;TPD52L1;FGF1;FBXO2;PADI2;CDK18;HSPA2;TOP2A;PPP1R1B;ENPP2;ST18;CNDP1;SERPINI1;GREM1;PPP1R14A;GPR37;RCAN2;BOK;CNTN2;CCK;SPOCK3;MBP;LPAR1;GJC2;FXYD1
11183,GO:0043292,0.178048598060892,0.942082542436158,3,216,contractile fiber,CC,S100A1;MYBPC1;RYR2
2520,GO:0005262,0.178191274614442,0.958660859022564,2,112,calcium channel activity,MF,SLC24A2;RYR2
5150,GO:0014044,0.178457011518363,0.983759992793156,1,28,Schwann cell development,BP,FA2H
8267,GO:0032228,0.179031415999724,0.983613730302653,1,30,regulation of synaptic transmission, GABAergic,BP,CNTNAP4
17112,GO:0085029,0.179153779664604,0.983590526708866,1,30,extracellular matrix assembly,BP,HAPLN2
3177,GO:0006464,0.179157874999865,0.874220144998547,28,3694,cellular protein modification process,BP,HHATL;CAMK2A;PPP2R2C;FOLH1;TF;PPP1R16B;EPHB6;SEPT4;RASAL1;TPD52L1;FGF1;FBXO2;PADI2;CDK18;HSPA2;TOP2A;PPP1R1B;ENPP2;GREM1;PPP1R14A;GPR37;RCAN2;CCK;SPOCK3;MBP;LPAR1;GJC2;FXYD1
10193,GO:0036211,0.179157874999865,0.874220144998547,28,3694,protein modification process,BP,HHATL;CAMK2A;PPP2R2C;FOLH1;TF;PPP1R16B;EPHB6;SEPT4;RASAL1;TPD52L1;FGF1;FBXO2;PADI2;CDK18;HSPA2;TOP2A;PPP1R1B;ENPP2;GREM1;PPP1R14A;GPR37;RCAN2;CCK;SPOCK3;MBP;LPAR1;GJC2;FXYD1
7087,GO:0023014,0.179168601146992,0.90470792145012,8,855,signal transduction by protein phosphorylation,BP,CAMK2A;EPHB6;RASAL1;TPD52L1;FGF1;GPR37;MBP;LPAR1
4627,GO:0009893,0.179423533482928,0.877350214393738,23,2964,positive regulation of metabolic process,BP,LRP2;SOX10;PPP1R16B;EPHB6;SEPT4;TPD52L1;FGF1;PADI2;PLP1;MYRF;HSPA2;TOP2A;ENPP2;ST18;S100A1;GREM1;GPR37;BOK;CNTN2;CCK;MBP;LPAR1;GJC2
686,GO:0001838,0.179466874634352,0.958159453093991,2,118,embryonic epithelial tube formation,BP,LRP2;GREM1
17118,GO:0086005,0.179621954309875,0.983519960288669,1,29,ventricular cardiac muscle cell action potential,BP,RYR2
18576,GO:1900026,0.179714983606184,0.983466676147964,1,31,positive regulation of substrate adhesion-dependent cell spreading,BP,DOCK5
4466,GO:0009262,0.179834428653134,0.983412590404038,1,33,deoxyribonucleotide metabolic process,BP,AK5
19764,GO:1903514,0.180021558766149,0.983443923094326,1,29,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,RYR2
7271,GO:0030261,0.180161073698159,0.983458421026486,1,27,chromosome condensation,BP,TOP2A
14156,GO:0051930,0.180374765886201,0.983340697366144,1,31,regulation of sensory perception of pain,BP,CCK
14157,GO:0051931,0.180374765886201,0.983340697366144,1,31,regulation of sensory perception,BP,CCK
8200,GO:0032094,0.180609664480499,0.983279433859626,1,32,response to food,BP,CCK
14437,GO:0055076,0.180654950013618,0.957690666672181,2,124,transition metal ion homeostasis,BP,TF;SLC39A12
5775,GO:0016247,0.180942397427881,0.957585593048852,2,123,channel regulator activity,MF,GRM3;FXYD1
17901,GO:0097718,0.181001473144659,0.983238010670764,1,30,disordered domain specific binding,MF,HSPA2
1434,GO:0003156,0.181280322076117,0.983150545931865,1,32,regulation of animal organ formation,BP,FGF1
5413,GO:0015298,0.181342700271406,0.983154951483523,1,31,solute:cation antiporter activity,MF,SLC24A2
13680,GO:0051084,0.181389260540658,0.983129559848372,1,32,'de novo' posttranslational protein folding,BP,HSPA2
4003,GO:0008277,0.18141131537536,0.9574083045821,2,123,regulation of G-protein coupled receptor protein signaling pathway,BP,KLK6;CNTN2
14667,GO:0060285,0.181542203194785,0.983134085799514,1,30,cilium-dependent cell motility,BP,DNAH17
17132,GO:0086019,0.181563926370561,0.983148677768135,1,29,cell-cell signaling involved in cardiac conduction,BP,RYR2
6351,GO:0018345,0.18203205509125,0.98300544543597,1,32,protein palmitoylation,BP,HHATL
3831,GO:0007618,0.182128613028284,0.98298675929868,1,32,mating,BP,PPP1R1B
14431,GO:0055069,0.182145295000147,0.982967969955216,1,33,zinc ion homeostasis,BP,SLC39A12
5006,GO:0010863,0.182279894739149,0.982974051123267,1,31,positive regulation of phospholipase C activity,BP,LPAR1
21248,GO:2000146,0.182505497355489,0.939938786314801,3,228,negative regulation of cell motility,BP,PADI2;GREM1;SPOCK3
13750,GO:0051179,0.182507634354687,0.867025374222098,41,5679,localization,BP,CAMK2A;LRP2;TF;SOX10;CPNE6;SLC17A7;MAG;ADAP1;SEPT4;FGF1;PEX5L;PADI2;PACSIN1;HSPA2;ENPP2;CXCL14;DOCK5;SLC39A12;SLC24A2;SLC5A11;S100A1;VSNL1;TMEM144;GREM1;MOBP;LGI3;GJB1;MAL;BOK;CNTN2;SV2B;CCK;DNAH17;NKAIN2;MYBPC1;SPOCK3;MBP;LPAR1;RYR2;GJC2;FXYD1
16277,GO:0071354,0.182615858616246,0.982908949662711,1,31,cellular response to interleukin-6,BP,ST18
515,GO:0001568,0.18263818340999,0.912410537324677,6,586,blood vessel development,BP,LRP2;PPP1R16B;FGF1;ENPP2;S100A1;GREM1
4676,GO:0010039,0.18282027107316,0.982852585541145,1,32,response to iron ion,BP,TF
4941,GO:0010765,0.182927642963882,0.982848414244327,1,31,positive regulation of sodium ion transport,BP,FXYD1
7801,GO:0031312,0.183244925920183,0.982769926927539,1,32,extrinsic component of organelle membrane,CC,SOX10
4646,GO:0009954,0.183352136057849,0.98274902483972,1,32,proximal/distal pattern formation,BP,GREM1
7917,GO:0031514,0.183401694344777,0.956652399993152,2,123,motile cilium,CC,SEPT4;DNAH17
1548,GO:0003338,0.18443191735799,0.982554731455731,1,31,metanephros morphogenesis,BP,GREM1
5174,GO:0014069,0.184456729090944,0.939013378969594,3,221,postsynaptic density,CC,CAMK2A;NRGN;GRM3
3448,GO:0006836,0.184590735384585,0.938933001573666,3,230,neurotransmitter transport,BP,CAMK2A;SLC17A7;SV2B
7227,GO:0030201,0.184678278284963,0.982506378536841,1,31,heparan sulfate proteoglycan metabolic process,BP,HS3ST4
4870,GO:0010658,0.184791305727585,0.982467120662766,1,32,striated muscle cell apoptotic process,BP,CAMK2A
4766,GO:0010470,0.185219108985156,0.982382849159802,1,32,regulation of gastrulation,BP,MBP
7292,GO:0030291,0.185643103543917,0.98228295127106,1,33,protein serine/threonine kinase inhibitor activity,MF,PPP1R1B
12197,GO:0045807,0.185772049042082,0.955745054993118,2,123,positive regulation of endocytosis,BP,TF;GREM1
9258,GO:0034220,0.186250009876629,0.89613265200602,9,990,ion transmembrane transport,BP,LRP2;SLC17A7;HSPA2;SLC39A12;SLC24A2;S100A1;RYR2;GJC2;FXYD1
5122,GO:0014002,0.186414668456712,0.982163538350161,1,31,astrocyte development,BP,PLP1
16246,GO:0071312,0.186420486330406,0.982162383629885,1,31,cellular response to alkaloid,BP,RYR2
6775,GO:0021537,0.186421775718939,0.938053193305291,3,227,telencephalon development,BP,NRGN;CNTN2;LPAR1
7177,GO:0030133,0.186543383973705,0.925873438360901,4,356,transport vesicle,CC,SLC17A7;NRGN;LGI3;SV2B
18286,GO:0099572,0.187570924602159,0.937502738622687,3,223,postsynaptic specialization,CC,CAMK2A;NRGN;GRM3
15204,GO:0061135,0.188010736117818,0.954863264188575,2,128,endopeptidase regulator activity,MF,SERPINI1;SPOCK3
13571,GO:0050900,0.188136192524772,0.924995464567744,4,361,leukocyte migration,BP,MAG;PADI2;CXCL14;GREM1
6199,GO:0017080,0.188202295756452,0.981772545916966,1,33,sodium channel regulator activity,MF,FXYD1
11845,GO:0045070,0.188274044644521,0.981774746836353,1,32,positive regulation of viral genome replication,BP,TOP2A
7358,GO:0030414,0.188348937869143,0.954735527892773,2,127,peptidase inhibitor activity,MF,SERPINI1;SPOCK3
3360,GO:0006692,0.188425639022662,0.981711963949775,1,34,prostanoid metabolic process,BP,PTGDS
3361,GO:0006693,0.188425639022662,0.981711963949775,1,34,prostaglandin metabolic process,BP,PTGDS
13714,GO:0051129,0.188715039357857,0.908622295211983,6,600,negative regulation of cellular component organization,BP,MAG;PACSIN1;HSPA2;TOP2A;BOK;LPAR1
495,GO:0001539,0.18898325292614,0.981649817250499,1,31,cilium or flagellum-dependent cell motility,BP,DNAH17
13204,GO:0048713,0.189056666605978,0.981600412733601,1,33,regulation of oligodendrocyte differentiation,BP,ASPA
11612,GO:0044344,0.189086903858219,0.954455857009433,2,125,cellular response to fibroblast growth factor stimulus,BP,FGF1;HHIP
10624,GO:0042221,0.189418796138255,0.866039984879638,28,3764,response to chemical,BP,CAMK2A;LRP2;TF;SOX10;CPNE6;SLC17A7;RASAL1;FGF1;FBXO2;PADI2;HSPA2;PPP1R1B;ENPP2;CXCL14;ST18;PAQR6;VSNL1;HHIP;GREM1;PPP1R14A;GPR37;BOK;CNTN2;CCK;MBP;LPAR1;RYR2;GJC2
2769,GO:0005790,0.189639681599712,0.981517270143125,1,31,smooth endoplasmic reticulum,CC,RYR2
18715,GO:1900271,0.189652726848031,0.981514630819664,1,31,regulation of long-term synaptic potentiation,BP,NRGN
16494,GO:0071675,0.189677477629164,0.981458912396999,1,34,regulation of mononuclear cell migration,BP,GREM1
13207,GO:0048729,0.190625781343272,0.907428237582526,6,593,tissue morphogenesis,BP,LRP2;SOX10;FGF1;HHIP;GREM1;RYR2
15723,GO:0070296,0.190765965998093,0.981288651481494,1,31,sarcoplasmic reticulum calcium ion transport,BP,RYR2
11665,GO:0044447,0.19077057407232,0.981327820500534,1,29,axoneme part,CC,DNAH17
13600,GO:0050931,0.190828268817011,0.981257780259219,1,32,pigment cell differentiation,BP,SOX10
10794,GO:0042558,0.190955942270234,0.981198544906433,1,34,pteridine-containing compound metabolic process,BP,FOLH1
2812,GO:0005865,0.191107035045706,0.981238572893087,1,30,striated muscle thin filament,CC,MYBPC1
16583,GO:0071868,0.191993660818133,0.981019319274909,1,32,cellular response to monoamine stimulus,BP,RYR2
16585,GO:0071870,0.191993660818133,0.981019319274909,1,32,cellular response to catecholamine stimulus,BP,RYR2
1355,GO:0002931,0.192131681128266,0.980973660178358,1,33,response to ischemia,BP,CAMK2A
4652,GO:0009968,0.192636548803052,0.888333684609342,10,1145,negative regulation of signal transduction,BP,LRP2;SOX10;EPHB6;RASAL1;PADI2;HHIP;GREM1;BOK;LPAR1;ZNF536
8299,GO:0032279,0.192837892934798,0.934919134775763,3,226,asymmetric synapse,CC,CAMK2A;NRGN;GRM3
6092,GO:0016853,0.192907835088754,0.952934726904747,2,132,isomerase activity,MF,PTGDS;TOP2A
18718,GO:1900274,0.193157612443133,0.98076203507098,1,33,regulation of phospholipase C activity,BP,LPAR1
2156,GO:0004693,0.19327534888078,0.980721184425822,1,34,cyclin-dependent protein serine/threonine kinase activity,MF,CDK18
2606,GO:0005506,0.193338452616192,0.952771509756887,2,130,iron ion binding,MF,TF;FA2H
3464,GO:0006865,0.193434734898913,0.952747686681555,2,126,amino acid transport,BP,SLC17A7;CCK
19916,GO:1903793,0.194220371692511,0.980524836435154,1,34,positive regulation of anion transport,BP,CCK
12205,GO:0045823,0.19424895792924,0.980518880327486,1,34,positive regulation of heart contraction,BP,RYR2
5875,GO:0016460,0.194353885401811,0.980591872613379,1,29,myosin II complex,CC,MYBPC1
10727,GO:0042417,0.194447110070016,0.98047756716751,1,34,dopamine metabolic process,BP,GPR37
11870,GO:0045104,0.194843687719667,0.980411493751467,1,33,intermediate filament cytoskeleton organization,BP,NEFM
5934,GO:0016572,0.19485448384968,0.980392484575789,1,34,histone phosphorylation,BP,PPP1R1B
10144,GO:0036094,0.195030466166018,0.8703742020198,18,2253,small molecule binding,MF,CAMK2A;MAG;ADAP1;EPHB6;PTGDS;SEPT4;CDK18;HSPA2;TOP2A;IQCA1;HAPLN2;MKI67;AK5;ETNPPL;CARNS1;AIFM3;DNAH17;RYR2
9535,GO:0034762,0.195266338168491,0.911724436987146,5,476,regulation of transmembrane transport,BP,HSPA2;S100A1;RYR2;GJC2;FXYD1
2491,GO:0005217,0.196005032575435,0.980205249977246,1,31,intracellular ligand-gated ion channel activity,MF,RYR2
9032,GO:0033572,0.196006010453129,0.980134919316594,1,35,transferrin transport,BP,TF
12041,GO:0045505,0.196221530045241,0.980225692826929,1,28,dynein intermediate chain binding,MF,DNAH17
11256,GO:0043410,0.196290616888434,0.911102707188006,5,484,positive regulation of MAPK cascade,BP,EPHB6;TPD52L1;FGF1;GPR37;LPAR1
10261,GO:0036379,0.19631335040794,0.980140465904685,1,31,myofilament,CC,MYBPC1
9815,GO:0035556,0.196468680780952,0.866863762233957,20,2556,intracellular signal transduction,BP,CAMK2A;PPP1R16B;ADAP1;EPHB6;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;PPP1R1B;RAPGEF5;DOCK5;S100A1;GPR37;RCAN2;BOK;GPR62;MBP;LPAR1;RYR2
14191,GO:0051973,0.196513487949853,0.980027863332919,1,35,positive regulation of telomerase activity,BP,GREM1
17995,GO:0098656,0.196805464968383,0.932934757843207,3,236,anion transmembrane transport,BP,LRP2;SLC17A7;FXYD1
18796,GO:1901031,0.196890806114277,0.979948063939304,1,35,regulation of response to reactive oxygen species,BP,GPR37
5901,GO:0016504,0.196900866099792,0.979945933990588,1,35,peptidase activator activity,MF,MAL
17300,GO:0090184,0.19729303502928,0.979862806840032,1,35,positive regulation of kidney development,BP,GREM1
16763,GO:0072175,0.197515649888323,0.951124154274749,2,126,epithelial tube formation,BP,LRP2;GREM1
6308,GO:0018193,0.197522979708882,0.884872450081626,10,1147,peptidyl-amino acid modification,BP,CAMK2A;FOLH1;FGF1;PADI2;TOP2A;PPP1R1B;ENPP2;GREM1;CCK;SPOCK3
18165,GO:0098984,0.197661670891417,0.93252023799423,3,229,neuron to neuron synapse,CC,CAMK2A;NRGN;GRM3
20846,GO:1905898,0.197859309523648,0.979742447065825,1,35,positive regulation of response to endoplasmic reticulum stress,BP,BOK
10714,GO:0042398,0.198000206425754,0.979697040241959,1,36,cellular modified amino acid biosynthetic process,BP,CARNS1
17798,GO:0097472,0.198256525773885,0.979657788733556,1,35,cyclin-dependent protein kinase activity,MF,CDK18
3861,GO:0008038,0.198270297163795,0.979706978382147,1,32,neuron recognition,BP,CNTN2
17379,GO:0090288,0.198906129927916,0.950565766079517,2,126,negative regulation of cellular response to growth factor stimulus,BP,LRP2;GREM1
7585,GO:0030900,0.199070657401332,0.918925912436213,4,351,forebrain development,BP,LRP2;NRGN;CNTN2;LPAR1
15360,GO:0061564,0.199078897757655,0.909428085492512,5,471,axon development,BP,NEFM;MAG;PLP1;CNTN2;CCK
564,GO:0001662,0.199458434403895,0.979400464226291,1,35,behavioral fear response,BP,CCK
933,GO:0002209,0.199458434403895,0.979400464226291,1,35,behavioral defense response,BP,CCK
14783,GO:0060429,0.199606978485713,0.886882624275976,9,1008,epithelium development,BP,LRP2;SOX10;PPP1R16B;FA2H;FGF1;HAPLN2;HHIP;GREM1;RYR2
872,GO:0002090,0.199708659143425,0.979346671957134,1,35,regulation of receptor internalization,BP,GREM1
4221,GO:0008643,0.199860832996828,0.950169574786797,2,129,carbohydrate transport,BP,SLC5A11;TMEM144
11869,GO:0045103,0.199965854962319,0.979307933937862,1,34,intermediate filament-based process,BP,NEFM
11740,GO:0044743,0.20024194018342,0.979201130635812,1,37,protein transmembrane import into intracellular organelle,BP,PEX5L
7399,GO:0030517,0.200285636631912,0.979239031566995,1,34,negative regulation of axon extension,BP,MAG
5126,GO:0014009,0.200561378825851,0.97917951873881,1,34,glial cell proliferation,BP,SOX10
15704,GO:0070266,0.200791544271782,0.979097167093196,1,36,necroptotic process,BP,BOK
4638,GO:0009925,0.201015165301216,0.979099205783907,1,33,basal plasma membrane,CC,TF
4203,GO:0008610,0.201091623758932,0.900780475599294,6,625,lipid biosynthetic process,BP,CPNE6;FA2H;PTGDS;FGF1;PLP1;ETNPPL
16536,GO:0071774,0.201133840321725,0.949650603610687,2,130,response to fibroblast growth factor,BP,FGF1;HHIP
13123,GO:0048585,0.201310675144311,0.876463032538528,12,1437,negative regulation of response to stimulus,BP,LRP2;SOX10;EPHB6;RASAL1;PADI2;HHIP;GREM1;GPR37;BOK;CCK;LPAR1;ZNF536
15968,GO:0070741,0.201841358902816,0.978885111132269,1,35,response to interleukin-6,BP,ST18
14440,GO:0055080,0.202048773607103,0.90017034351558,6,620,cation homeostasis,BP,TF;SLC39A12;SLC24A2;BOK;LPAR1;RYR2
10710,GO:0042383,0.20207571270229,0.949290998805732,2,124,sarcolemma,CC,RYR2;FXYD1
8431,GO:0032459,0.202535620113847,0.97871755535201,1,36,regulation of protein oligomerization,BP,CCK
2537,GO:0005310,0.202701306146907,0.978697437699609,1,35,dicarboxylic acid transmembrane transporter activity,MF,SLC17A7
11318,GO:0043524,0.202877948812338,0.948937308744431,2,131,negative regulation of neuron apoptotic process,BP,MAG;BOK
12397,GO:0046189,0.203470941533802,0.97851245075854,1,36,phenol-containing compound biosynthetic process,BP,GPR37
3829,GO:0007616,0.203730174896936,0.978488979448515,1,34,long-term memory,BP,SLC17A7
13855,GO:0051346,0.203774360849076,0.916248708167006,4,367,negative regulation of hydrolase activity,BP,PPP1R1B;SERPINI1;PPP1R14A;SPOCK3
14177,GO:0051959,0.204027005912714,0.978528190256793,1,29,dynein light intermediate chain binding,MF,DNAH17
16653,GO:0072006,0.204067496963437,0.948466037472166,2,127,nephron development,BP,FGF1;GREM1
18795,GO:1901030,0.204253858282445,0.978324449397179,1,37,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK
11120,GO:0043198,0.204426733865369,0.978318168680292,1,35,dendritic shaft,CC,LPAR1
16297,GO:0071383,0.204523847525693,0.929037467169245,3,243,cellular response to steroid hormone stimulus,BP,SOX10;PADI2;PAQR6
4802,GO:0010559,0.204558211878148,0.97827268561154,1,36,regulation of glycoprotein biosynthetic process,BP,NECAB1
12547,GO:0046578,0.204717163644638,0.928955249565578,3,234,regulation of Ras protein signal transduction,BP,ADAP1;RASAL1;LPAR1
18242,GO:0099504,0.20478999771607,0.948165850076687,2,128,synaptic vesicle cycle,BP,SLC17A7;PACSIN1
21573,GO:2000648,0.204991476192352,0.978193243640007,1,35,positive regulation of stem cell proliferation,BP,SOX10
760,GO:0001944,0.205455474571393,0.897987052104523,6,610,vasculature development,BP,LRP2;PPP1R16B;FGF1;ENPP2;S100A1;GREM1
510,GO:0001558,0.205489181995827,0.91527392741392,4,365,regulation of cell growth,BP,CPNE6;MAG;RASAL1;GREM1
7511,GO:0030809,0.205528884972756,0.978057413721349,1,36,negative regulation of nucleotide biosynthetic process,BP,GRM3
18730,GO:1900372,0.205528884972756,0.978057413721349,1,36,negative regulation of purine nucleotide biosynthetic process,BP,GRM3
12605,GO:0046676,0.205635578822514,0.978033681397638,1,36,negative regulation of insulin secretion,BP,VSNL1
12479,GO:0046456,0.205643473774204,0.978001335797463,1,38,icosanoid biosynthetic process,BP,PTGDS
3469,GO:0006874,0.205733128386257,0.915133660220841,4,366,cellular calcium ion homeostasis,BP,SLC24A2;BOK;LPAR1;RYR2
17117,GO:0086004,0.206055328180904,0.977993243097486,1,33,regulation of cardiac muscle cell contraction,BP,RYR2
5419,GO:0015318,0.206511333545047,0.891228884970961,7,750,inorganic molecular entity transmembrane transporter activity,MF,TF;SLC17A7;SLC39A12;SLC24A2;SLC5A11;RYR2;FXYD1
13688,GO:0051092,0.206853920773041,0.947289462949847,2,135,positive regulation of NF-kappaB transcription factor activity,BP,CAMK2A;GREM1
3410,GO:0006775,0.206854394344846,0.97774569418555,1,37,fat-soluble vitamin metabolic process,BP,LRP2
11583,GO:0044306,0.206875445407784,0.947291367531678,2,132,neuron projection terminus,CC,PACSIN1;CCK
98,GO:0000187,0.206944592539052,0.947259108721723,2,133,activation of MAPK activity,BP,FGF1;LPAR1
4008,GO:0008284,0.207189523950243,0.89077021406322,7,761,positive regulation of cell proliferation,BP,LRP2;SOX10;PPP1R16B;FGF1;GREM1;CCK;GJC2
11662,GO:0044444,0.207190658282223,0.846577029528544,59,8623,cytoplasmic part,CC,HHATL;CAMK2A;PPP2R2C;LRP2;TF;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;SLC17A7;ADAP1;EPHB6;PTGDS;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;FBXO2;PADI2;GDA;NECAB1;PACSIN1;MYRF;HSPA2;TOP2A;PPP1R1B;ERMN;CXCL14;DOCK5;SLC39A12;CNDP1;AK5;NRGN;S100A1;VSNL1;SERPINI1;ETNPPL;PPP1R14A;KLK6;MOBP;LGI3;GJB1;GPR37;TPPP;MAL;CARNS1;BOK;HS3ST4;AIFM3;SV2B;DNAH17;MYBPC1;OPALIN;LPAR1;RYR2;TMEM235
16582,GO:0071867,0.207210891596902,0.977698520280076,1,35,response to monoamine,BP,RYR2
16584,GO:0071869,0.207210891596902,0.977698520280076,1,35,response to catecholamine,BP,RYR2
11813,GO:0045017,0.207720257297752,0.927400502571186,3,246,glycerolipid biosynthetic process,BP,CPNE6;FGF1;ETNPPL
9691,GO:0035307,0.207871516722975,0.977533129614102,1,36,positive regulation of protein dephosphorylation,BP,PPP1R16B
2416,GO:0005088,0.207886041889074,0.927335229017742,3,235,Ras guanyl-nucleotide exchange factor activity,MF,CAMK2A;FGF1;RAPGEF5
7407,GO:0030534,0.209150019467509,0.946354769791349,2,130,adult behavior,BP,PPP1R1B;CNTN2
11520,GO:0044183,0.209189266118264,0.977203610977291,1,38,protein binding involved in protein folding,MF,HSPA2
3559,GO:0007015,0.209242941835233,0.913128517421117,4,360,actin filament organization,BP,PACSIN1;ERMN;MYBPC1;LPAR1
5178,GO:0014075,0.209319299575388,0.977205752245926,1,36,response to amine,BP,PPP1R1B
10824,GO:0042596,0.209320474546555,0.977189211559588,1,37,fear response,BP,CCK
16693,GO:0072073,0.209441385056651,0.946233327407881,2,130,kidney epithelium development,BP,FGF1;GREM1
13234,GO:0048786,0.209822944587639,0.977126859518606,1,34,presynaptic active zone,CC,SLC17A7
16795,GO:0072210,0.210099759912673,0.977028204580684,1,36,metanephric nephron development,BP,GREM1
13481,GO:0050773,0.210890485475155,0.945635560349003,2,128,regulation of dendrite development,BP,PACSIN1;LPAR1
644,GO:0001786,0.210955728918204,0.97681608993784,1,37,phosphatidylserine binding,MF,CPNE6
16945,GO:0072528,0.210964597760925,0.976783545823779,1,39,pyrimidine-containing compound biosynthetic process,BP,AK5
3552,GO:0007005,0.211323200154177,0.901898604529699,5,513,mitochondrion organization,BP,CAMK2A;SEPT4;BOK;CCK;MYBPC1
19335,GO:1902533,0.211371597426212,0.882864355416091,8,901,positive regulation of intracellular signal transduction,BP,EPHB6;SEPT4;TPD52L1;FGF1;GPR37;BOK;GPR62;LPAR1
5493,GO:0015682,0.211658530345475,0.976638957124486,1,38,ferric iron transport,BP,TF
16933,GO:0072512,0.211658530345475,0.976638957124486,1,38,trivalent inorganic cation transport,BP,TF
405,GO:0001078,0.212162497728845,0.945074606275968,2,135,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NKX6-2;ZNF536
13744,GO:0051171,0.212733959003447,0.842880407518503,38,5304,regulation of nitrogen compound metabolic process,BP,HHATL;CAMK2A;PPP2R2C;LRP2;SOX10;PPP1R16B;EPHB6;SEPT4;TPD52L1;FGF1;FBXO2;PADI2;NECAB1;MYRF;HSPA2;TOP2A;PPP1R1B;ENPP2;ST18;NKX6-2;CNDP1;S100A1;SERPINI1;GREM1;PPP1R14A;GPR37;RCAN2;BOK;CNTN2;CCK;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;FXYD1
1129,GO:0002548,0.213249198684231,0.976241642498332,1,40,monocyte chemotaxis,BP,GREM1
18040,GO:0098771,0.213401397339455,0.892822963839524,6,631,inorganic ion homeostasis,BP,TF;SLC39A12;SLC24A2;BOK;LPAR1;RYR2
16882,GO:0072358,0.213492210525433,0.89277038249421,6,618,cardiovascular system development,BP,LRP2;PPP1R16B;FGF1;ENPP2;S100A1;GREM1
2635,GO:0005575,0.214270522176018,0.946076616134042,97,15065,cellular_component,CC,HHATL;CD22;CLDN11;BCAS1;CAMK2A;PPP2R2C;LRP2;FOLH1;TF;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;SLC17A7;MAG;ADAP1;EPHB6;PTGDS;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;FBXO2;PADI2;CDK18;GDA;NECAB1;PLP1;PACSIN1;MYRF;HSPA2;EVI2A;TOP2A;PPP1R1B;HAPLN2;RAPGEF5;ERMN;ENPP2;MOG;CXCL14;DOCK5;ST18;SLC39A12;MKI67;NKX6-2;CNDP1;CNTNAP4;AK5;NRGN;SLC24A2;SLC5A11;S100A1;PAQR6;VSNL1;SERPINI1;ETNPPL;TMEM144;HHIP;GREM1;PPP1R14A;KLK6;MOBP;LGI3;GJB1;GPR37;TPPP;MAL;RCAN2;CARNS1;BOK;TMEM125;TMEM151A;S1PR5;GPR62;HS3ST4;AIFM3;CNTN2;SV2B;MPPED1;CCK;DNAH17;NKAIN2;MYBPC1;SPOCK3;OPALIN;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;TMEM235;TMEM88B;FXYD1
11252,GO:0043406,0.214584676340944,0.923846108185068,3,249,positive regulation of MAP kinase activity,BP,TPD52L1;FGF1;LPAR1
623,GO:0001764,0.21537037491773,0.943737041458282,2,130,neuron migration,BP,CNTN2;CCK
4343,GO:0009112,0.215608391787433,0.975704574858453,1,39,nucleobase metabolic process,BP,GDA
3821,GO:0007605,0.215713584896638,0.943579235990713,2,133,sensory perception of sound,BP,LRP2;MBP
7325,GO:0030331,0.215815167980532,0.975687836616554,1,37,estrogen receptor binding,MF,PADI2
17745,GO:0097367,0.215980597138801,0.857120416912643,16,1994,carbohydrate derivative binding,MF,CAMK2A;MAG;EPHB6;SEPT4;FGF1;CDK18;HSPA2;TOP2A;IQCA1;HAPLN2;MKI67;AK5;CARNS1;DNAH17;SPOCK3;LPAR1
17678,GO:0097223,0.216071283493186,0.943401202274012,2,140,sperm part,CC,SEPT4;SV2B
5400,GO:0015276,0.21614810744085,0.943394174558459,2,133,ligand-gated ion channel activity,MF,SLC17A7;RYR2
7063,GO:0022834,0.21614810744085,0.943394174558459,2,133,ligand-gated channel activity,MF,SLC17A7;RYR2
3314,GO:0006636,0.216660511642082,0.975441528699065,1,40,unsaturated fatty acid biosynthetic process,BP,PTGDS
3488,GO:0006897,0.21692414473436,0.890515918833237,6,632,endocytosis,BP,LRP2;TF;PACSIN1;ENPP2;GREM1;CNTN2
13084,GO:0048512,0.216999403263686,0.975376179478926,1,39,circadian behavior,BP,PTGDS
13625,GO:0050999,0.217574410076086,0.975239727565514,1,39,regulation of nitric-oxide synthase activity,BP,S100A1
15186,GO:0061098,0.217655479326013,0.975236263881889,1,38,positive regulation of protein tyrosine kinase activity,BP,GREM1
5099,GO:0010977,0.217703339600408,0.942725828248112,2,134,negative regulation of neuron projection development,BP,MAG;LPAR1
18740,GO:1900408,0.218112116919823,0.975111755124789,1,39,negative regulation of cellular response to oxidative stress,BP,GPR37
19618,GO:1903202,0.218112116919823,0.975111755124789,1,39,negative regulation of oxidative stress-induced cell death,BP,GPR37
4335,GO:0009100,0.218244340561207,0.90788689455481,4,374,glycoprotein metabolic process,BP,FBXO2;NECAB1;HS3ST4;SPOCK3
8804,GO:0033017,0.218473299084666,0.975076031858786,1,36,sarcoplasmic reticulum membrane,CC,RYR2
12130,GO:0045668,0.218919341650657,0.97493495376896,1,38,negative regulation of osteoblast differentiation,BP,GREM1
14435,GO:0055074,0.219016098730324,0.90743211228513,4,376,calcium ion homeostasis,BP,SLC24A2;BOK;LPAR1;RYR2
13882,GO:0051393,0.219152014004283,0.974973996508336,1,33,alpha-actinin binding,MF,MYBPC1
10708,GO:0042379,0.219411103843028,0.974757526017669,1,42,chemokine receptor binding,MF,CXCL14
18536,GO:0140104,0.219633516130264,0.974732428465075,1,40,molecular carrier activity,MF,TF
15138,GO:0061028,0.21963505592929,0.97476344267646,1,38,establishment of endothelial barrier,BP,PPP1R16B
8207,GO:0032101,0.219761238565814,0.888641554777474,6,646,regulation of response to external stimulus,BP,FGF1;PADI2;CXCL14;GREM1;CCK;LPAR1
19413,GO:1902743,0.219887387737366,0.974702822648926,1,38,regulation of lamellipodium organization,BP,ENPP2
5806,GO:0016303,0.219950659040666,0.974704625962164,1,37,1-phosphatidylinositol-3-kinase activity,MF,FGF1
5144,GO:0014037,0.220144710339076,0.974675963002145,1,36,Schwann cell differentiation,BP,FA2H
21847,GO:2001242,0.220301160333072,0.941572090641195,2,144,regulation of intrinsic apoptotic signaling pathway,BP,SEPT4;BOK
7137,GO:0030049,0.220420526949142,0.974628682729987,1,35,muscle filament sliding,BP,MYBPC1
8945,GO:0033275,0.220420526949142,0.974628682729987,1,35,actin-myosin filament sliding,BP,MYBPC1
21121,GO:1990841,0.220575601380764,0.974537083101372,1,38,promoter-specific chromatin binding,MF,SOX10
3835,GO:0007622,0.221848956862451,0.974196849576393,1,40,rhythmic behavior,BP,PTGDS
2402,GO:0005048,0.221959187882732,0.974185654271045,1,39,signal sequence binding,MF,PEX5L
3618,GO:0007140,0.222281536060108,0.974107216581287,1,39,male meiotic nuclear division,BP,HSPA2
6525,GO:0019369,0.222407433230123,0.974045960752203,1,41,arachidonic acid metabolic process,BP,PTGDS
9445,GO:0034620,0.222614712382844,0.940579357331195,2,141,cellular response to unfolded protein,BP,HSPA2;BOK
19536,GO:1903018,0.223122691446522,0.973886147339049,1,40,regulation of glycoprotein metabolic process,BP,NECAB1
14417,GO:0055025,0.223266731867618,0.973883310731595,1,38,positive regulation of cardiac muscle tissue development,BP,GREM1
3683,GO:0007223,0.223551940057467,0.973813492460358,1,38,Wnt signaling pathway, calcium modulating pathway,BP,CAMK2A
2436,GO:0005125,0.223557472478987,0.940141162820565,2,149,cytokine activity,MF,CXCL14;GREM1
4765,GO:0010469,0.223748146239274,0.904619653705486,4,397,regulation of signaling receptor activity,BP,FGF1;CXCL14;GREM1;CCK
19117,GO:1901981,0.223788332590859,0.940078815988509,2,138,phosphatidylinositol phosphate binding,MF,ADAP1;NRGN
18992,GO:1901618,0.223790661809964,0.97372239669164,1,40,organic hydroxy compound transmembrane transporter activity,MF,SLC5A11
12668,GO:0046850,0.224001543769922,0.973686484164577,1,39,regulation of bone remodeling,BP,GREM1
17714,GO:0097300,0.224223284287951,0.973600888895601,1,41,programmed necrotic cell death,BP,BOK
8208,GO:0032102,0.224249882751845,0.918728390868435,3,259,negative regulation of response to external stimulus,BP,PADI2;GREM1;CCK
8116,GO:0031952,0.224300795134641,0.973612905373573,1,39,regulation of protein autophosphorylation,BP,GREM1
12601,GO:0046661,0.224488751612072,0.939768864290607,2,139,male sex differentiation,BP,LRP2;BOK
20585,GO:1905207,0.224724181875847,0.973508612701194,1,39,regulation of cardiocyte differentiation,BP,GREM1
13070,GO:0048483,0.224811390935701,0.973487102585611,1,39,autonomic nervous system development,BP,SOX10
8507,GO:0032570,0.225838285022551,0.973201567595237,1,41,response to progesterone,BP,SOX10
14512,GO:0060047,0.225855477585026,0.917885439558046,3,250,heart contraction,BP,S100A1;RYR2;FXYD1
13928,GO:0051489,0.226166856803904,0.973151548641918,1,39,regulation of filopodium assembly,BP,PPP1R16B
10790,GO:0042551,0.227199255088436,0.972894421922111,1,39,neuron maturation,BP,CNTN2
16507,GO:0071695,0.227597285964012,0.938405751632464,2,138,anatomical structure maturation,BP,GREM1;CNTN2
13862,GO:0051353,0.227627943968154,0.972755226435893,1,41,positive regulation of oxidoreductase activity,BP,S100A1
19458,GO:1902883,0.227925292092291,0.972680676625354,1,41,negative regulation of response to oxidative stress,BP,GPR37
6043,GO:0016776,0.227949712826002,0.972674549009128,1,41,phosphotransferase activity, phosphate group as acceptor,MF,AK5
13752,GO:0051181,0.228140174577495,0.972626732786781,1,41,cofactor transport,BP,LRP2
18504,GO:0140013,0.228673014343803,0.937910878251227,2,143,meiotic nuclear division,BP,HSPA2;TOP2A
15272,GO:0061337,0.228690774144904,0.93792574623184,2,137,cardiac conduction,BP,RYR2;FXYD1
13812,GO:0051271,0.228980208872603,0.916195520841477,3,255,negative regulation of cellular component movement,BP,PADI2;GREM1;SPOCK3
19581,GO:1903115,0.229732263278911,0.972275469002707,1,38,regulation of actin filament-based movement,BP,RYR2
17369,GO:0090278,0.229774147108246,0.972214634353678,1,41,negative regulation of peptide hormone secretion,BP,VSNL1
6097,GO:0016860,0.230146858210579,0.972090470561722,1,43,intramolecular oxidoreductase activity,MF,PTGDS
6758,GO:0021517,0.230366593968933,0.972064381456678,1,41,ventral spinal cord development,BP,NKX6-2
5307,GO:0015085,0.230371403670055,0.93719534128527,2,133,calcium ion transmembrane transporter activity,MF,SLC24A2;RYR2
9625,GO:0035148,0.230965734710059,0.936902034289651,2,140,tube formation,BP,LRP2;GREM1
1377,GO:0003015,0.231519661315376,0.914824012665,3,253,heart process,BP,S100A1;RYR2;FXYD1
10623,GO:0042220,0.23287440117995,0.971423439966443,1,41,response to cocaine,BP,PPP1R1B
7776,GO:0031279,0.232951721588717,0.971387980924065,1,42,regulation of cyclase activity,BP,GRM3
3540,GO:0006984,0.232973772118998,0.97138230478735,1,42,ER-nucleus signaling pathway,BP,BOK
13848,GO:0051339,0.23313218216613,0.971341509499149,1,42,regulation of lyase activity,BP,GRM3
15119,GO:0060999,0.233551619759071,0.971282703353493,1,39,positive regulation of dendritic spine development,BP,LPAR1
13506,GO:0050806,0.233683307084242,0.935679981741998,2,141,positive regulation of synaptic transmission,BP,NRGN;SLC24A2
12046,GO:0045540,0.233733183451611,0.971202118618489,1,41,regulation of cholesterol biosynthetic process,BP,FGF1
3513,GO:0006937,0.233740223966606,0.935646758239615,2,143,regulation of muscle contraction,BP,DOCK5;RYR2
13075,GO:0048488,0.233751022601528,0.971213974247974,1,40,synaptic vesicle endocytosis,BP,PACSIN1
7304,GO:0030307,0.233821571491127,0.935613903907852,2,142,positive regulation of cell growth,BP,CPNE6;RASAL1
4226,GO:0008654,0.234774262055435,0.913031536926285,3,263,phospholipid biosynthetic process,BP,CPNE6;FGF1;ETNPPL
13243,GO:0048806,0.234818961641663,0.970937567242101,1,40,genitalia development,BP,LRP2
7230,GO:0030204,0.23505587414917,0.970859405645192,1,41,chondroitin sulfate metabolic process,BP,SPOCK3
7519,GO:0030817,0.235191835077227,0.970793050447768,1,43,regulation of cAMP biosynthetic process,BP,GRM3
7704,GO:0031113,0.235280637659643,0.970800947300504,1,41,regulation of microtubule polymerization,BP,SLC39A12
8715,GO:0032890,0.235325044285313,0.97077350175704,1,42,regulation of organic acid transport,BP,CCK
3025,GO:0006220,0.235909683865547,0.970577395986208,1,45,pyrimidine nucleotide metabolic process,BP,AK5
17744,GO:0097366,0.236241390672712,0.970534328950066,1,42,response to bronchodilator,BP,PPP1R1B
7643,GO:0031018,0.236594385014363,0.970441908997642,1,42,endocrine pancreas development,BP,NKX6-2
9999,GO:0035850,0.23670963808773,0.970427774277902,1,41,epithelial cell differentiation involved in kidney development,BP,GREM1
6783,GO:0021545,0.237956415435048,0.970083813570617,1,42,cranial nerve development,BP,LPAR1
5822,GO:0016331,0.238307206666753,0.93357644220811,2,143,morphogenesis of embryonic epithelium,BP,LRP2;GREM1
4512,GO:0009409,0.238400105837223,0.969951104810024,1,43,response to cold,BP,HSPA2
9663,GO:0035257,0.238448009527465,0.933508335148991,2,144,nuclear hormone receptor binding,MF,LRP2;PADI2
9660,GO:0035254,0.238588191569722,0.969933235682253,1,41,glutamate receptor binding,MF,CAMK2A
3921,GO:0008144,0.23898908359175,0.845451592765263,13,1592,drug binding,MF,CAMK2A;LRP2;EPHB6;CDK18;HSPA2;TOP2A;IQCA1;MKI67;AK5;ETNPPL;CARNS1;DNAH17;RYR2
2831,GO:0005891,0.23919839928078,0.969788859636833,1,40,voltage-gated calcium channel complex,CC,HSPA2
12923,GO:0048066,0.239275490043124,0.969734748909954,1,42,developmental pigmentation,BP,SOX10
8326,GO:0032330,0.239546196613084,0.969662836515949,1,42,regulation of chondrocyte differentiation,BP,GREM1
16863,GO:0072330,0.240077923412755,0.910100395393801,3,269,monocarboxylic acid biosynthetic process,BP,FA2H;PTGDS;PLP1
7921,GO:0031526,0.24157200925064,0.96912169977681,1,42,brush border membrane,CC,LRP2
15102,GO:0060976,0.241822707310698,0.969071140045202,1,41,coronary vasculature development,BP,LRP2
2412,GO:0005080,0.241849205835564,0.969031249382649,1,43,protein kinase C binding,MF,TOP2A
774,GO:0001960,0.241985497462522,0.968979303412534,1,44,negative regulation of cytokine-mediated signaling pathway,BP,PADI2
5316,GO:0015103,0.242054939060059,0.93184490596736,2,146,inorganic anion transmembrane transporter activity,MF,SLC17A7;FXYD1
2490,GO:0005216,0.243380509711859,0.892765174734822,4,386,ion channel activity,MF,SLC17A7;SLC24A2;RYR2;FXYD1
3450,GO:0006839,0.243486446815655,0.90819094433054,3,277,mitochondrial transport,BP,CAMK2A;BOK;MYBPC1
7205,GO:0030170,0.243614702525579,0.968524192800581,1,45,pyridoxal phosphate binding,MF,ETNPPL
15711,GO:0070279,0.243614702525579,0.968524192800581,1,45,vitamin B6 binding,MF,ETNPPL
12196,GO:0045806,0.243804948848834,0.968472530327531,1,45,negative regulation of endocytosis,BP,PACSIN1
13387,GO:0050654,0.244076590145525,0.968429086574158,1,43,chondroitin sulfate proteoglycan metabolic process,BP,SPOCK3
3616,GO:0007131,0.244127758533724,0.968399624037177,1,44,reciprocal meiotic recombination,BP,TOP2A
9994,GO:0035825,0.244127758533724,0.968399624037177,1,44,homologous recombination,BP,TOP2A
4011,GO:0008287,0.244824932308249,0.968209696637576,1,44,protein serine/threonine phosphatase complex,CC,PPP2R2C
19657,GO:1903293,0.244824932308249,0.968209696637576,1,44,phosphatase complex,CC,PPP2R2C
18574,GO:1900024,0.245079317485198,0.968140239379186,1,44,regulation of substrate adhesion-dependent cell spreading,BP,DOCK5
3011,GO:0006195,0.245682675916464,0.967975163861745,1,44,purine nucleotide catabolic process,BP,GDA
14190,GO:0051972,0.245732530482275,0.967946446373419,1,45,regulation of telomerase activity,BP,GREM1
18793,GO:1901028,0.245954184856717,0.967871216949747,1,46,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK
5302,GO:0015075,0.246484434702423,0.863629308039804,7,793,ion transmembrane transporter activity,MF,TF;SLC17A7;SLC39A12;SLC24A2;SLC5A11;RYR2;FXYD1
4974,GO:0010823,0.246631957123986,0.967699325473171,1,45,negative regulation of mitochondrion organization,BP,BOK
14158,GO:0051932,0.246670954894841,0.967719636377157,1,43,synaptic transmission, GABAergic,BP,CNTNAP4
5580,GO:0015849,0.246694962992044,0.906404741288174,3,270,organic acid transport,BP,LRP2;SLC17A7;CCK
12721,GO:0046942,0.246694962992044,0.906404741288174,3,270,carboxylic acid transport,BP,LRP2;SLC17A7;CCK
4945,GO:0010769,0.246929275031593,0.906291235340424,3,260,regulation of cell morphogenesis involved in differentiation,BP,MAG;DOCK5;CNTN2
12502,GO:0046486,0.24718197881581,0.89040332347553,4,397,glycerolipid metabolic process,BP,CPNE6;FGF1;ENPP2;ETNPPL
19311,GO:1902475,0.24840495853658,0.967224497839375,1,44,L-alpha-amino acid transmembrane transport,BP,SLC17A7
10506,GO:0040013,0.248637321599493,0.905315381295867,3,267,negative regulation of locomotion,BP,PADI2;GREM1;SPOCK3
13605,GO:0050954,0.248678143426921,0.928754635246933,2,147,sensory perception of mechanical stimulus,BP,LRP2;MBP
13746,GO:0051173,0.248877055018234,0.82489743907862,20,2668,positive regulation of nitrogen compound metabolic process,BP,LRP2;SOX10;PPP1R16B;EPHB6;SEPT4;TPD52L1;FGF1;PADI2;MYRF;HSPA2;TOP2A;ENPP2;ST18;GREM1;GPR37;BOK;CNTN2;CCK;MBP;LPAR1
7225,GO:0030199,0.249144200281811,0.967035188757846,1,43,collagen fibril organization,BP,GREM1
14323,GO:0052742,0.249674977005178,0.966887265784924,1,43,phosphatidylinositol kinase activity,MF,FGF1
11257,GO:0043412,0.249797488926019,0.816505515658032,28,3860,macromolecule modification,BP,HHATL;CAMK2A;PPP2R2C;FOLH1;TF;PPP1R16B;EPHB6;SEPT4;RASAL1;TPD52L1;FGF1;FBXO2;PADI2;CDK18;HSPA2;TOP2A;PPP1R1B;ENPP2;GREM1;PPP1R14A;GPR37;RCAN2;CCK;SPOCK3;MBP;LPAR1;GJC2;FXYD1
1471,GO:0003205,0.250231073287594,0.928026329510429,2,146,cardiac chamber development,BP,LRP2;RYR2
11656,GO:0044433,0.250500404556323,0.842350701456805,11,1376,cytoplasmic vesicle part,CC,CAMK2A;LRP2;TF;SLC17A7;PADI2;PACSIN1;NRGN;SERPINI1;BOK;SV2B;RYR2
11552,GO:0044255,0.250525656987575,0.854931914048123,8,953,cellular lipid metabolic process,BP,LRP2;CPNE6;FA2H;PTGDS;FGF1;PLP1;ENPP2;ETNPPL
4786,GO:0010518,0.251352845705696,0.966385013492996,1,45,positive regulation of phospholipase activity,BP,LPAR1
1374,GO:0003012,0.25312008341403,0.886702142347105,4,394,muscle system process,BP,DOCK5;MYBPC1;RYR2;FXYD1
18755,GO:1900543,0.253383690776941,0.965795377649649,1,46,negative regulation of purine nucleotide metabolic process,BP,GRM3
835,GO:0002042,0.253427820438075,0.965798143841708,1,45,cell migration involved in sprouting angiogenesis,BP,GREM1
6756,GO:0021515,0.253802219885677,0.965676295661409,1,46,cell differentiation in spinal cord,BP,NKX6-2
12123,GO:0045661,0.253913218150976,0.965644675394072,1,46,regulation of myoblast differentiation,BP,CXCL14
4175,GO:0008542,0.254099769241226,0.965622981521113,1,44,visual learning,BP,PPP1R1B
7305,GO:0030308,0.254282542181932,0.926069963919057,2,154,negative regulation of cell growth,BP,MAG;GREM1
13562,GO:0050885,0.254308592975993,0.96556345022236,1,44,neuromuscular process controlling balance,BP,NKX6-2
15703,GO:0070265,0.255021066944871,0.965299130945588,1,48,necrotic cell death,BP,BOK
9195,GO:0034113,0.25512194968549,0.965299296563848,1,46,heterotypic cell-cell adhesion,BP,MBP
7066,GO:0022838,0.255297665389905,0.885332316896674,4,395,substrate-specific channel activity,MF,SLC17A7;SLC24A2;RYR2;FXYD1
8153,GO:0032011,0.255660591146171,0.96517664099141,1,44,ARF protein signal transduction,BP,ADAP1
8154,GO:0032012,0.255660591146171,0.96517664099141,1,44,regulation of ARF protein signal transduction,BP,ADAP1
3278,GO:0006584,0.256099827605097,0.965003510973684,1,47,catecholamine metabolic process,BP,GPR37
4574,GO:0009712,0.256099827605097,0.965003510973684,1,47,catechol-containing compound metabolic process,BP,GPR37
13790,GO:0051241,0.256452340433147,0.8505810900618,8,950,negative regulation of multicellular organismal process,BP,SOX10;MAG;DOCK5;NKX6-2;GREM1;CNTN2;LPAR1;ZNF536
13106,GO:0048546,0.256650343157068,0.964875534385263,1,45,digestive tract morphogenesis,BP,SOX10
3269,GO:0006575,0.256663047450264,0.924909928134523,2,159,cellular modified amino acid metabolic process,BP,FOLH1;CARNS1
3208,GO:0006508,0.25693063014191,0.834203695024296,12,1529,proteolysis,BP,FOLH1;FBXO2;MYRF;ST18;CNDP1;SERPINI1;KLK6;BOK;CNTN2;CCK;SPOCK3;MBP
14421,GO:0055037,0.257050969341196,0.924748494723333,2,152,recycling endosome,CC,TF;BOK
10142,GO:0036092,0.25723759662579,0.964722425765401,1,44,phosphatidylinositol-3-phosphate biosynthetic process,BP,FGF1
3922,GO:0008146,0.257408566767085,0.964625560094087,1,47,sulfotransferase activity,MF,HS3ST4
617,GO:0001755,0.257431463680486,0.964634050072146,1,46,neural crest cell migration,BP,SOX10
4973,GO:0010822,0.257524577674284,0.924505262893771,2,156,positive regulation of mitochondrion organization,BP,BOK;MYBPC1
12294,GO:0045980,0.257599089565418,0.964570351028581,1,47,negative regulation of nucleotide metabolic process,BP,GRM3
12548,GO:0046579,0.257793819818465,0.964529038118564,1,46,positive regulation of Ras protein signal transduction,BP,LPAR1
2502,GO:0005231,0.257821767811362,0.964520931519545,1,46,excitatory extracellular ligand-gated ion channel activity,MF,SLC17A7
13736,GO:0051155,0.257998411059201,0.964454481832838,1,47,positive regulation of striated muscle cell differentiation,BP,GREM1
15537,GO:0065002,0.258595982501169,0.964252049642659,1,49,intracellular protein transmembrane transport,BP,PEX5L
3175,GO:0006458,0.25878992396484,0.964209547722853,1,48,'de novo' protein folding,BP,HSPA2
10932,GO:0042805,0.258803693438547,0.964323086511965,1,41,actinin binding,MF,MYBPC1
18062,GO:0098805,0.259150819643853,0.832465718349187,12,1523,whole membrane,CC,CAMK2A;LRP2;TF;SOX10;SLC17A7;MAG;PEX5L;NRGN;MAL;BOK;SV2B;FXYD1
21574,GO:2000649,0.260120646896224,0.963850591864202,1,46,regulation of sodium ion transmembrane transporter activity,BP,FXYD1
10067,GO:0035967,0.260137701148696,0.923235939691817,2,157,cellular response to topologically incorrect protein,BP,HSPA2;BOK
19553,GO:1903046,0.260200242729735,0.923209184248724,2,156,meiotic cell cycle process,BP,HSPA2;TOP2A
15002,GO:0060761,0.260261630560316,0.963778990751286,1,48,negative regulation of response to cytokine stimulus,BP,PADI2
2544,GO:0005326,0.260471507123162,0.963732189941803,1,47,neurotransmitter transporter activity,MF,SLC17A7
18114,GO:0098900,0.260700723704884,0.963713474950171,1,44,regulation of action potential,BP,RYR2
13935,GO:0051496,0.261094130361868,0.963549073349866,1,47,positive regulation of stress fiber assembly,BP,LPAR1
12271,GO:0045936,0.261517099393667,0.869370447071371,5,540,negative regulation of phosphate metabolic process,BP,PPP1R16B;PPP1R1B;GREM1;PPP1R14A;GRM3
4806,GO:0010563,0.26265596039601,0.868600092411683,5,541,negative regulation of phosphorus metabolic process,BP,PPP1R16B;PPP1R1B;GREM1;PPP1R14A;GRM3
12549,GO:0046580,0.262895636805761,0.963032116711683,1,46,negative regulation of Ras protein signal transduction,BP,RASAL1
13148,GO:0048639,0.263356199889734,0.921687369925835,2,151,positive regulation of developmental growth,BP,CPNE6;RASAL1
17299,GO:0090183,0.263376727264831,0.962858194504607,1,48,regulation of kidney development,BP,GREM1
18250,GO:0099518,0.263467453976067,0.962862192921303,1,46,vesicle cytoskeletal trafficking,BP,MOBP
9674,GO:0035272,0.263945988981794,0.962703763175006,1,47,exocrine system development,BP,SOX10
15297,GO:0061383,0.263977608954545,0.962710226571958,1,46,trabecula morphogenesis,BP,GREM1
8633,GO:0032768,0.264424725134914,0.962530861829741,1,49,regulation of monooxygenase activity,BP,S100A1
7310,GO:0030315,0.264431259230007,0.962608882972104,1,44,T-tubule,CC,FXYD1
6109,GO:0016879,0.264612806278027,0.962489251216635,1,48,ligase activity, forming carbon-nitrogen bonds,MF,CARNS1
7186,GO:0030145,0.264785543159063,0.962437531116109,1,48,manganese ion binding,MF,SLC24A2
21843,GO:2001238,0.264852923768961,0.962402639706138,1,49,positive regulation of extrinsic apoptotic signaling pathway,BP,MAL
11937,GO:0045214,0.264989546243719,0.96246029813039,1,43,sarcomere organization,BP,MYBPC1
12516,GO:0046503,0.264995758204728,0.962359814298099,1,49,glycerolipid catabolic process,BP,ENPP2
6459,GO:0019205,0.265165327674386,0.962308937772525,1,49,nucleobase-containing compound kinase activity,MF,AK5
15224,GO:0061178,0.266458871459367,0.961919570157024,1,49,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,VSNL1
4057,GO:0008360,0.266691045944365,0.920032697123367,2,154,regulation of cell shape,BP,ERMN;LPAR1
6612,GO:0019722,0.267403669220195,0.919675778668747,2,155,calcium-mediated signaling,BP,RCAN2;RYR2
17997,GO:0098659,0.267558145130601,0.961601930381393,1,48,inorganic cation import across plasma membrane,BP,SLC39A12
18290,GO:0099587,0.267558145130601,0.961601930381393,1,48,inorganic ion import across plasma membrane,BP,SLC39A12
8602,GO:0032722,0.267637197062109,0.96154852828953,1,50,positive regulation of chemokine production,BP,MBP
17241,GO:0090090,0.267975022290116,0.919369806405831,2,161,negative regulation of canonical Wnt signaling pathway,BP,SOX10;GREM1
10632,GO:0042246,0.268216075211029,0.961372584829201,1,50,tissue regeneration,BP,KLK6
11490,GO:0044087,0.268390978570197,0.847837159547348,7,809,regulation of cellular component biogenesis,BP,PPP1R16B;HSPA2;SLC39A12;GREM1;TPPP;CCK;LPAR1
11064,GO:0043112,0.269038323584154,0.918848150824325,2,159,receptor metabolic process,BP,GREM1;CNTN2
4026,GO:0008307,0.269123960747927,0.96121201312581,1,43,structural constituent of muscle,MF,MYBPC1
3321,GO:0006644,0.269146747784059,0.876477940831957,4,414,phospholipid metabolic process,BP,CPNE6;FGF1;ENPP2;ETNPPL
17115,GO:0086002,0.269185241702642,0.961139140382979,1,46,cardiac muscle cell action potential involved in contraction,BP,RYR2
5180,GO:0014704,0.269307042283063,0.961085421006006,1,47,intercalated disc,CC,FXYD1
17092,GO:0080090,0.269457730225685,0.794887259012507,38,5437,regulation of primary metabolic process,BP,HHATL;CAMK2A;PPP2R2C;LRP2;SOX10;PPP1R16B;EPHB6;SEPT4;TPD52L1;FGF1;FBXO2;PADI2;NECAB1;MYRF;HSPA2;TOP2A;PPP1R1B;ENPP2;ST18;NKX6-2;CNDP1;S100A1;SERPINI1;GREM1;PPP1R14A;GPR37;RCAN2;BOK;CNTN2;CCK;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;FXYD1
16940,GO:0072523,0.269468663730041,0.961004948601655,1,49,purine-containing compound catabolic process,BP,GDA
19333,GO:1902531,0.26961770526662,0.821308667307246,13,1671,regulation of intracellular signal transduction,BP,PPP1R16B;ADAP1;EPHB6;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;GPR37;RCAN2;BOK;GPR62;LPAR1
9690,GO:0035306,0.269658743476484,0.96096202038595,1,48,positive regulation of dephosphorylation,BP,PPP1R16B
4657,GO:0009987,0.269752627875156,0.822148948955479,87,13331,cellular process,BP,HHATL;CLDN11;CAMK2A;PPP2R2C;LRP2;FOLH1;TF;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;SLC17A7;MAG;ADAP1;EPHB6;PTGDS;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;FBXO2;PADI2;CDK18;GDA;NECAB1;PLP1;PACSIN1;MYRF;HSPA2;EVI2A;TOP2A;PPP1R1B;HAPLN2;RAPGEF5;ERMN;ENPP2;MOG;CXCL14;DOCK5;ST18;SLC39A12;MKI67;NKX6-2;CNDP1;CNTNAP4;AK5;NRGN;SLC24A2;SLC5A11;S100A1;PAQR6;VSNL1;SERPINI1;ETNPPL;HHIP;GREM1;PPP1R14A;KLK6;MOBP;LGI3;GJB1;GPR37;TPPP;MAL;RCAN2;CARNS1;BOK;S1PR5;GPR62;HS3ST4;AIFM3;CNTN2;SV2B;CCK;DNAH17;MYBPC1;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;FXYD1
13410,GO:0050679,0.269769815747444,0.918487131655242,2,158,positive regulation of epithelial cell proliferation,BP,PPP1R16B;FGF1
328,GO:0000910,0.270805456217708,0.917973301009161,2,157,cytokinesis,BP,SEPT4;PACSIN1
8956,GO:0033293,0.270833047227007,0.960557408385271,1,51,monocarboxylic acid binding,MF,PTGDS
9082,GO:0033674,0.2708941011901,0.862989962334363,5,543,positive regulation of kinase activity,BP,EPHB6;TPD52L1;FGF1;GREM1;LPAR1
9501,GO:0034702,0.271951775051577,0.891790248322011,3,276,ion channel complex,CC,HSPA2;CNTN2;RYR2
10033,GO:0035904,0.272382811022323,0.960139584113681,1,47,aorta development,BP,LRP2
7827,GO:0031345,0.272863077976302,0.916936723145879,2,158,negative regulation of cell projection organization,BP,MAG;LPAR1
13925,GO:0051480,0.273049280513791,0.891122806774092,3,284,regulation of cytosolic calcium ion concentration,BP,BOK;LPAR1;RYR2
14780,GO:0060425,0.274082293103434,0.959564255834332,1,50,lung morphogenesis,BP,HHIP
19243,GO:1902275,0.274116050771136,0.91630891963197,2,157,regulation of chromatin organization,BP,PADI2;MKI67
2728,GO:0005741,0.274382794780843,0.916151550187358,2,163,mitochondrial outer membrane,CC,SOX10;BOK
13639,GO:0051018,0.274604666574272,0.959448424847276,1,47,protein kinase A binding,MF,RYR2
17919,GO:0097755,0.274648535993765,0.959372678161455,1,51,positive regulation of blood vessel diameter,BP,DOCK5
2399,GO:0005044,0.275062706532702,0.959257514190096,1,50,scavenger receptor activity,MF,ENPP2
3979,GO:0008237,0.275358107028442,0.915661604739046,2,162,metallopeptidase activity,MF,FOLH1;CNDP1
2776,GO:0005798,0.276062399998052,0.915300683399188,2,163,Golgi-associated vesicle,CC,PACSIN1;NRGN
9544,GO:0034774,0.276392600115756,0.88909931574344,3,299,secretory granule lumen,CC,TF;PADI2;SERPINI1
10291,GO:0036465,0.276511450873522,0.958817244982865,1,49,synaptic vesicle recycling,BP,PACSIN1
5504,GO:0015698,0.276534494758749,0.915072063895247,2,160,inorganic anion transport,BP,SLC17A7;FXYD1
7020,GO:0022029,0.276565332090447,0.958800249918328,1,49,telencephalon cell migration,BP,CNTN2
14945,GO:0060688,0.276823988389183,0.95868839329743,1,51,regulation of morphogenesis of a branching structure,BP,GREM1
13286,GO:0048878,0.27684249603251,0.83535553625836,8,971,chemical homeostasis,BP,TF;SLC39A12;SLC24A2;VSNL1;BOK;CCK;LPAR1;RYR2
7318,GO:0030324,0.277123141691082,0.914776468673268,2,159,lung development,BP,FGF1;HHIP
17734,GO:0097345,0.277587843944485,0.958418518752058,1,53,mitochondrial outer membrane permeabilization,BP,BOK
10583,GO:0042127,0.27765636861073,0.821176214498446,11,1410,regulation of cell proliferation,BP,LRP2;SOX10;PPP1R16B;FA2H;FGF1;FBXO2;ST18;GREM1;BOK;CCK;GJC2
11882,GO:0045121,0.27780535540219,0.88827353335808,3,286,membrane raft,CC,MAG;MAL;FXYD1
13147,GO:0048638,0.277812829632532,0.888280169537471,3,280,regulation of developmental growth,BP,CPNE6;MAG;RASAL1
11666,GO:0044448,0.2786763166293,0.913992066225649,2,157,cell cortex part,CC,SEPT4;MOBP
3842,GO:0007632,0.278729059465015,0.958114522215978,1,49,visual behavior,BP,PPP1R1B
18093,GO:0098857,0.279579804994466,0.887202833188779,3,287,membrane microdomain,CC,MAG;MAL;FXYD1
17297,GO:0090181,0.279887534109886,0.957713882800549,1,51,regulation of cholesterol metabolic process,BP,FGF1
15125,GO:0061005,0.280431245360486,0.957554787027827,1,50,cell differentiation involved in kidney development,BP,GREM1
16553,GO:0071806,0.280486511703714,0.957479650902388,1,54,protein transmembrane transport,BP,PEX5L
727,GO:0001895,0.280800656236548,0.957406307816316,1,52,retina homeostasis,BP,TF
4872,GO:0010660,0.281756311099312,0.957098416181831,1,52,regulation of muscle cell apoptotic process,BP,CAMK2A
17942,GO:0098552,0.282234456690104,0.867914048448129,4,426,side of membrane,CC,LRP2;TF;RASAL1;MOG
6321,GO:0018209,0.282559061781153,0.885401280458479,3,286,peptidyl-serine modification,BP,CAMK2A;PPP1R1B;SPOCK3
13896,GO:0051427,0.283471525878585,0.911498091269316,2,164,hormone receptor binding,MF,LRP2;PADI2
8289,GO:0032269,0.28368597698887,0.830160670732188,8,978,negative regulation of cellular protein metabolic process,BP,HHATL;PPP1R16B;PPP1R1B;SERPINI1;GREM1;PPP1R14A;SPOCK3;FXYD1
16493,GO:0071674,0.284105444202127,0.956294588384797,1,55,mononuclear cell migration,BP,GREM1
3516,GO:0006941,0.285042313048921,0.910698694770948,2,160,striated muscle contraction,BP,MYBPC1;RYR2
13020,GO:0048306,0.285660867424668,0.955785343475314,1,55,calcium-dependent protein binding,MF,S100A1
6479,GO:0019229,0.286251184824132,0.955618879251808,1,53,regulation of vasoconstriction,BP,DOCK5
19174,GO:1902110,0.286345125051458,0.955560265821423,1,55,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,BOK
4785,GO:0010517,0.286366604526257,0.955595536267814,1,52,regulation of phospholipase activity,BP,LPAR1
7317,GO:0030323,0.286604640581263,0.909873156968863,2,163,respiratory tube development,BP,FGF1;HHIP
15572,GO:0070059,0.287684954134477,0.955131397494914,1,54,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,BOK
3443,GO:0006826,0.28793750346709,0.955047720213216,1,54,iron ion transport,BP,TF
14532,GO:0060070,0.287967520733584,0.882086485243755,3,293,canonical Wnt signaling pathway,BP,SOX10;GREM1;RYR2
5354,GO:0015179,0.288181460259309,0.954981089742543,1,53,L-amino acid transmembrane transporter activity,MF,SLC17A7
1368,GO:0003006,0.288260821376418,0.850916849494021,5,559,developmental process involved in reproduction,BP,LRP2;SEPT4;HSPA2;GJB1;BOK
7289,GO:0030286,0.288895685669837,0.954824559545328,1,48,dynein complex,CC,DNAH17
4313,GO:0009066,0.289083888823163,0.954652934322221,1,55,aspartate family amino acid metabolic process,BP,ASPA
10382,GO:0038083,0.289405145944707,0.954589068216615,1,52,peptidyl-tyrosine autophosphorylation,BP,GREM1
12712,GO:0046928,0.289822803066375,0.954449731287346,1,52,regulation of neurotransmitter secretion,BP,CAMK2A
3541,GO:0006986,0.290178533927961,0.907969116162806,2,171,response to unfolded protein,BP,HSPA2;BOK
6989,GO:0021953,0.29047057762856,0.90783742187948,2,165,central nervous system neuron differentiation,BP,NKX6-2;CNTN2
6950,GO:0021885,0.29053453265509,0.954211732175697,1,52,forebrain cell migration,BP,CNTN2
7122,GO:0030029,0.290549547792449,0.839328618039351,6,680,actin filament-based process,BP,PACSIN1;ERMN;MOBP;MYBPC1;LPAR1;RYR2
14611,GO:0060193,0.290781501961056,0.95409934306809,1,54,positive regulation of lipase activity,BP,LPAR1
7846,GO:0031396,0.290998383619821,0.907540261595769,2,170,regulation of protein ubiquitination,BP,SEPT4;FBXO2
6946,GO:0021879,0.291022165659008,0.95403314072087,1,53,forebrain neuron differentiation,BP,CNTN2
5118,GO:0012505,0.291122836017129,0.781305216655035,28,3974,endomembrane system,CC,HHATL;LRP2;TF;CPNE6;FA2H;SLC17A7;PTGDS;FBXO2;PADI2;PACSIN1;MYRF;CXCL14;NRGN;S100A1;SERPINI1;KLK6;LGI3;GJB1;GPR37;MAL;BOK;HS3ST4;AIFM3;SV2B;OPALIN;LPAR1;RYR2;TMEM235
6397,GO:0019005,0.291590994900995,0.95381327361625,1,55,SCF ubiquitin ligase complex,CC,FBXO2
6116,GO:0016887,0.291914329568219,0.861482338809493,4,410,ATPase activity,MF,HSPA2;TOP2A;CARNS1;DNAH17
13673,GO:0051058,0.291978350050343,0.953726774648018,1,52,negative regulation of small GTPase mediated signal transduction,BP,RASAL1
13478,GO:0050770,0.2919999673435,0.907041347721706,2,162,regulation of axonogenesis,BP,MAG;CNTN2
3977,GO:0008235,0.292956650578837,0.953352237409195,1,55,metalloexopeptidase activity,MF,FOLH1
14647,GO:0060255,0.292980923921049,0.77445787389592,38,5491,regulation of macromolecule metabolic process,BP,HHATL;CAMK2A;PPP2R2C;LRP2;SOX10;PPP1R16B;EPHB6;SEPT4;TPD52L1;FGF1;FBXO2;PADI2;NECAB1;PLP1;MYRF;HSPA2;TOP2A;PPP1R1B;ENPP2;ST18;NKX6-2;CNDP1;S100A1;SERPINI1;GREM1;PPP1R14A;GPR37;RCAN2;BOK;CNTN2;CCK;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GJC2;FXYD1
3515,GO:0006940,0.292992671798183,0.95334004186821,1,55,regulation of smooth muscle contraction,BP,DOCK5
19146,GO:1902041,0.293790197515544,0.953069565636356,1,55,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,MAL
13672,GO:0051057,0.293991353094769,0.953030382954063,1,53,positive regulation of small GTPase mediated signal transduction,BP,LPAR1
7401,GO:0030520,0.294021867331127,0.953005151527024,1,54,intracellular estrogen receptor signaling pathway,BP,PADI2
3701,GO:0007264,0.294155042110939,0.846755383142165,5,553,small GTPase mediated signal transduction,BP,ADAP1;RASAL1;RAPGEF5;DOCK5;LPAR1
1578,GO:0003407,0.294302050057516,0.952924746906608,1,53,neural retina development,BP,SLC17A7
9967,GO:0035773,0.294666850483901,0.952771233979371,1,55,insulin secretion involved in cellular response to glucose stimulus,BP,VSNL1
20646,GO:1905330,0.294717033966068,0.905563680027118,2,171,regulation of morphogenesis of an epithelium,BP,FGF1;GREM1
19971,GO:1903902,0.294985571625347,0.952662505751327,1,55,positive regulation of viral life cycle,BP,TOP2A
19393,GO:1902686,0.294997904131478,0.952630985703862,1,57,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,BOK
2777,GO:0005801,0.295229518626418,0.952593628119098,1,54,cis-Golgi network,CC,BOK
17165,GO:0086065,0.295272409725291,0.952609529073113,1,52,cell communication involved in cardiac conduction,BP,RYR2
16111,GO:0070997,0.295658915457039,0.877320958424078,3,297,neuron death,BP,MAG;KLK6;BOK
4869,GO:0010657,0.295952296226868,0.952331852971072,1,55,muscle cell apoptotic process,BP,CAMK2A
17960,GO:0098589,0.295978579689208,0.877123438898519,3,296,membrane region,CC,MAG;MAL;FXYD1
2997,GO:0006171,0.296294995026101,0.95221432559272,1,55,cAMP biosynthetic process,BP,GRM3
21153,GO:1990939,0.296729477164312,0.952179961874669,1,48,ATP-dependent microtubule motor activity,MF,DNAH17
496,GO:0001540,0.297163115936796,0.9519158732398,1,55,amyloid-beta binding,MF,FBXO2
14754,GO:0060393,0.297597748644746,0.951751911961394,1,56,regulation of pathway-restricted SMAD protein phosphorylation,BP,GREM1
11332,GO:0043542,0.297827758570637,0.903906368153775,2,169,endothelial cell migration,BP,FGF1;GREM1
4558,GO:0009636,0.298656127202149,0.856890989818585,4,442,response to toxic substance,BP,PPP1R1B;GPR37;MBP;GJC2
8823,GO:0033044,0.299058603919414,0.875198149190467,3,295,regulation of chromosome organization,BP,PADI2;TOP2A;MKI67
21861,GO:2001259,0.299277126697383,0.951199522367752,1,54,positive regulation of cation channel activity,BP,S100A1
14133,GO:0051893,0.299864849516321,0.951010643402185,1,53,regulation of focal adhesion assembly,BP,GREM1
17253,GO:0090109,0.299864849516321,0.951010643402185,1,53,regulation of cell-substrate junction assembly,BP,GREM1
2667,GO:0005615,0.300533041959415,0.779024654341875,22,3125,extracellular space,CC,CD22;CLDN11;BCAS1;LRP2;FOLH1;TF;CPNE6;PTGDS;ASPA;FGF1;FBXO2;PADI2;GDA;HSPA2;ERMN;ENPP2;CXCL14;SERPINI1;GREM1;KLK6;CCK;RYR2
12665,GO:0046847,0.300535902107793,0.950761294685398,1,54,filopodium assembly,BP,PPP1R16B
6698,GO:0019899,0.30062084056597,0.788670619272756,16,2133,enzyme binding,MF,CAMK2A;MAG;ADAP1;EPHB6;FGF1;PEX5L;HSPA2;TOP2A;RAPGEF5;DOCK5;S100A1;MOBP;GPR37;BOK;MBP;RYR2
8272,GO:0032233,0.302130670523635,0.950173215262221,1,56,positive regulation of actin filament bundle assembly,BP,LPAR1
12692,GO:0046888,0.302811524827394,0.949919475828035,1,57,negative regulation of hormone secretion,BP,VSNL1
19617,GO:1903201,0.302848138402291,0.94990656836216,1,57,regulation of oxidative stress-induced cell death,BP,GPR37
2759,GO:0005778,0.302921600896815,0.949880664767212,1,57,peroxisomal membrane,CC,PEX5L
8092,GO:0031903,0.302921600896815,0.949880664767212,1,57,microbody membrane,CC,PEX5L
12200,GO:0045815,0.302931639090244,0.949877124611399,1,57,positive regulation of gene expression, epigenetic,BP,PADI2
15166,GO:0061061,0.302991018666488,0.840436691620317,5,559,muscle structure development,BP,LRP2;CXCL14;GREM1;MYBPC1;RYR2
14618,GO:0060205,0.303132589342912,0.872595625415398,3,315,cytoplasmic vesicle lumen,CC,TF;PADI2;SERPINI1
19256,GO:1902305,0.30322751375829,0.949801554286605,1,55,regulation of sodium ion transmembrane transport,BP,FXYD1
9977,GO:0035794,0.303739146946618,0.949564906894352,1,59,positive regulation of mitochondrial membrane permeability,BP,BOK
8134,GO:0031983,0.304800422850619,0.871536929798438,3,316,vesicle lumen,CC,TF;PADI2;SERPINI1
18248,GO:0099516,0.304917904048131,0.949188153139779,1,56,ion antiporter activity,MF,SLC24A2
5221,GO:0014823,0.305127812269821,0.949113523635636,1,56,response to activity,BP,RYR2
15145,GO:0061035,0.305319654075354,0.949045262891231,1,56,regulation of cartilage development,BP,GREM1
17640,GO:0097164,0.305369364674427,0.899775395697505,2,180,ammonium ion metabolic process,BP,ENPP2;GPR37
3473,GO:0006879,0.305570673335398,0.948927606266181,1,58,cellular iron ion homeostasis,BP,TF
12693,GO:0046889,0.306020951309,0.948766942575432,1,58,positive regulation of lipid biosynthetic process,BP,FGF1
7808,GO:0031325,0.306228625745207,0.776842352126052,20,2766,positive regulation of cellular metabolic process,BP,LRP2;SOX10;PPP1R16B;EPHB6;SEPT4;TPD52L1;FGF1;PADI2;MYRF;HSPA2;TOP2A;ENPP2;ST18;GREM1;GPR37;BOK;CNTN2;CCK;MBP;LPAR1
1611,GO:0003707,0.306576110484117,0.948596906234872,1,56,steroid hormone receptor activity,MF,PAQR6
7504,GO:0030802,0.306867517582309,0.948450578647385,1,59,regulation of cyclic nucleotide biosynthetic process,BP,GRM3
3432,GO:0006810,0.307028573873102,0.765407187572558,31,4455,transport,BP,CAMK2A;LRP2;TF;CPNE6;SLC17A7;ADAP1;PEX5L;PADI2;PACSIN1;HSPA2;ENPP2;SLC39A12;SLC24A2;SLC5A11;S100A1;VSNL1;TMEM144;GREM1;MOBP;LGI3;GJB1;BOK;CNTN2;SV2B;CCK;NKAIN2;MYBPC1;MBP;RYR2;GJC2;FXYD1
5609,GO:0015893,0.307128937446877,0.898816678556594,2,178,drug transport,BP,LRP2;SLC17A7
5821,GO:0016328,0.307431527678287,0.948290378160866,1,56,lateral plasma membrane,CC,GJB1
8229,GO:0032147,0.307534575989023,0.869819474664132,3,303,activation of protein kinase activity,BP,FGF1;GREM1;LPAR1
20797,GO:1905710,0.307596952442575,0.948175627688238,1,60,positive regulation of membrane permeability,BP,BOK
11983,GO:0045334,0.307700640328191,0.948165078537939,1,58,clathrin-coated endocytic vesicle,CC,CPNE6
6244,GO:0017157,0.307728945048,0.898497342849268,2,175,regulation of exocytosis,BP,VSNL1;LGI3
3646,GO:0007178,0.308448812108563,0.869241165777396,3,300,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,LRP2;GREM1;RYR2
2171,GO:0004713,0.309011706799024,0.897808876494082,2,170,protein tyrosine kinase activity,MF,EPHB6;FGF1
5678,GO:0016049,0.309352825199605,0.849563018176045,4,437,cell growth,BP,CPNE6;MAG;RASAL1;GREM1
18853,GO:1901215,0.309621688581254,0.897448659795079,2,176,negative regulation of neuron death,BP,MAG;BOK
18241,GO:0099503,0.310521994870535,0.81616372575345,7,879,secretory vesicle,CC,TF;SLC17A7;PADI2;SERPINI1;KLK6;LGI3;SV2B
7759,GO:0031253,0.310679423299833,0.867816128896955,3,298,cell projection membrane,CC,LRP2;PACSIN1;HHIP
16706,GO:0072091,0.310829288851693,0.947047700124546,1,57,regulation of stem cell proliferation,BP,SOX10
14750,GO:0060389,0.312008040817372,0.946589356111466,1,59,pathway-restricted SMAD protein phosphorylation,BP,GREM1
13636,GO:0051015,0.31334361823125,0.89541522245483,2,167,actin filament binding,MF,ERMN;MYBPC1
16035,GO:0070887,0.313370746168457,0.770707704677109,20,2805,cellular response to chemical stimulus,BP,CAMK2A;LRP2;TF;SOX10;CPNE6;RASAL1;FGF1;PADI2;HSPA2;CXCL14;ST18;PAQR6;VSNL1;HHIP;GREM1;PPP1R14A;GPR37;BOK;LPAR1;RYR2
6171,GO:0017022,0.313575739044325,0.946028356480769,1,58,myosin binding,MF,MOBP
19708,GO:1903391,0.313844149973834,0.945959354724871,1,56,regulation of adherens junction organization,BP,GREM1
19480,GO:1902930,0.31525609833117,0.945393890425829,1,59,regulation of alcohol biosynthetic process,BP,FGF1
17116,GO:0086003,0.315324135433731,0.945413029867857,1,56,cardiac muscle cell contraction,BP,RYR2
10769,GO:0042493,0.315327698900159,0.812450007087649,7,876,response to drug,BP,LRP2;SOX10;SLC17A7;PPP1R1B;PPP1R14A;GPR37;RYR2
13085,GO:0048513,0.315380407444058,0.767542903007395,21,2913,animal organ development,BP,LRP2;SOX10;FA2H;SLC17A7;SEPT4;FGF1;PADI2;PLP1;TOP2A;CXCL14;NKX6-2;NRGN;S100A1;HHIP;GREM1;BOK;CNTN2;MBP;LPAR1;RYR2;GJC2
9188,GO:0034103,0.315613654277863,0.945261365850504,1,59,regulation of tissue remodeling,BP,GREM1
2286,GO:0004867,0.315620392993874,0.945231682515269,1,61,serine-type endopeptidase inhibitor activity,MF,SERPINI1
15600,GO:0070098,0.315826142458289,0.945129816005317,1,63,chemokine-mediated signaling pathway,BP,PADI2
13941,GO:0051536,0.31624141818491,0.945000957318765,1,61,iron-sulfur cluster binding,MF,AIFM3
13945,GO:0051540,0.31624141818491,0.945000957318765,1,61,metal cluster binding,MF,AIFM3
8158,GO:0032024,0.316552684926719,0.944885105875207,1,61,positive regulation of insulin secretion,BP,VSNL1
4961,GO:0010810,0.316585262854472,0.893569770148431,2,174,regulation of cell-substrate adhesion,BP,DOCK5;GREM1
13160,GO:0048663,0.316795274114146,0.94480818253159,1,60,neuron fate commitment,BP,NKX6-2
10500,GO:0040007,0.316881526118806,0.811252182386024,7,858,growth,BP,SOX10;CPNE6;MAG;RASAL1;FGF1;GREM1;KLK6
7516,GO:0030814,0.31764984772918,0.944475636807875,1,61,regulation of cAMP metabolic process,BP,GRM3
6692,GO:0019887,0.31790846014181,0.892790216352246,2,183,protein kinase regulator activity,MF,PPP1R1B;GREM1
19773,GO:1903524,0.318492506297106,0.944159972672172,1,61,positive regulation of blood circulation,BP,RYR2
8128,GO:0031968,0.319502960468,0.891895137456296,2,181,organelle outer membrane,CC,SOX10;BOK
5554,GO:0015807,0.320371190848418,0.943466282154833,1,60,L-amino acid transport,BP,SLC17A7
7384,GO:0030500,0.32100591800097,0.943226163277616,1,60,regulation of bone mineralization,BP,GREM1
11655,GO:0044432,0.321136994716883,0.795195197884593,9,1174,endoplasmic reticulum part,CC,HHATL;TF;FA2H;PTGDS;MYRF;GJB1;GPR37;BOK;RYR2
7283,GO:0030279,0.321307817605598,0.94311174914793,1,60,negative regulation of ossification,BP,GREM1
7058,GO:0022804,0.321669816651413,0.860667508465885,3,308,active transmembrane transporter activity,MF,SLC17A7;SLC24A2;SLC5A11
11248,GO:0043401,0.322437330727848,0.890233120024107,2,179,steroid hormone mediated signaling pathway,BP,PADI2;PAQR6
17582,GO:0097060,0.323687427185521,0.859351986244103,3,303,synaptic membrane,CC,CAMK2A;CNTNAP4;GRM3
20556,GO:1905114,0.324678530081856,0.824572260156475,5,584,cell surface receptor signaling pathway involved in cell-cell signaling,BP,CAMK2A;SOX10;SLC17A7;GREM1;RYR2
6682,GO:0019867,0.324916115630253,0.888798758824653,2,183,outer membrane,CC,SOX10;BOK
7806,GO:0031323,0.325080296362909,0.746104718972884,38,5557,regulation of cellular metabolic process,BP,HHATL;CAMK2A;PPP2R2C;LRP2;SOX10;PPP1R16B;EPHB6;SEPT4;TPD52L1;FGF1;FBXO2;PADI2;NECAB1;MYRF;HSPA2;TOP2A;PPP1R1B;ENPP2;ST18;NKX6-2;CNDP1;S100A1;SERPINI1;GREM1;PPP1R14A;GPR37;RCAN2;BOK;CNTN2;CCK;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;FXYD1
3836,GO:0007623,0.325738729654906,0.888329499658856,2,182,circadian rhythm,BP,PTGDS;TOP2A
13261,GO:0048844,0.325856433288507,0.941401836247896,1,58,artery morphogenesis,BP,LRP2
12221,GO:0045844,0.326259723313132,0.941216177894658,1,60,positive regulation of striated muscle tissue development,BP,GREM1
13146,GO:0048636,0.326259723313132,0.941216177894658,1,60,positive regulation of muscle organ development,BP,GREM1
11251,GO:0043405,0.327407644141242,0.856872902776209,3,315,regulation of MAP kinase activity,BP,TPD52L1;FGF1;LPAR1
13479,GO:0050771,0.327420901542054,0.940766511151745,1,60,negative regulation of axonogenesis,BP,MAG
21527,GO:2000573,0.327439217706283,0.940717660246417,1,63,positive regulation of DNA biosynthetic process,BP,GREM1
12677,GO:0046872,0.328266615918184,0.750571468400536,26,3677,metal ion binding,MF,CAMK2A;LRP2;FOLH1;TF;CPNE6;FA2H;ADAP1;ASPA;SEPT4;RASAL1;PADI2;GDA;NECAB1;TOP2A;ENPP2;ST18;CNDP1;SLC24A2;S100A1;VSNL1;HHIP;CARNS1;AIFM3;SPOCK3;ZNF536;RYR2
3363,GO:0006695,0.328350715807164,0.940376585061391,1,62,cholesterol biosynthetic process,BP,FGF1
10163,GO:0036126,0.328550659785627,0.940271966767949,1,64,sperm flagellum,CC,SEPT4
17906,GO:0097729,0.328550659785627,0.940271966767949,1,64,9+2 motile cilium,CC,SEPT4
1428,GO:0003143,0.32886295512393,0.940190834756697,1,61,embryonic heart tube morphogenesis,BP,RYR2
12717,GO:0046934,0.329029294719787,0.940125892534742,1,61,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,FGF1
11317,GO:0043523,0.329368812131417,0.886220277839311,2,185,regulation of neuron apoptotic process,BP,MAG;BOK
14170,GO:0051952,0.329417544820003,0.939933257568895,1,64,regulation of amine transport,BP,CCK
5078,GO:0010951,0.329731432036067,0.885995369208149,2,189,negative regulation of endopeptidase activity,BP,SERPINI1;SPOCK3
3817,GO:0007600,0.329961649950859,0.83504767519467,4,457,sensory perception,BP,LRP2;SLC24A2;CCK;MBP
8623,GO:0032755,0.330026353361867,0.939694724616115,1,64,positive regulation of interleukin-6 production,BP,MBP
18877,GO:1901264,0.330050313699839,0.939672485674544,1,65,carbohydrate derivative transport,BP,GJB1
6082,GO:0016835,0.330981086598002,0.939294129325581,1,66,carbon-oxygen lyase activity,MF,ETNPPL
4083,GO:0008406,0.331070534631802,0.885234125593566,2,184,gonad development,BP,LRP2;BOK
19082,GO:1901863,0.331112246218162,0.939309228958565,1,61,positive regulation of muscle tissue development,BP,GREM1
1551,GO:0003341,0.331773963603133,0.939048454189485,1,61,cilium movement,BP,DNAH17
4007,GO:0008283,0.331895668159293,0.770033392248331,13,1774,cell proliferation,BP,LRP2;SOX10;PPP1R16B;FA2H;FGF1;FBXO2;ST18;MKI67;HHIP;GREM1;BOK;CCK;GJC2
3853,GO:0008022,0.332004168030441,0.884693133494491,2,183,protein C-terminus binding,MF,TOP2A;MKI67
10066,GO:0035966,0.332036224746883,0.884652487018432,2,189,response to topologically incorrect protein,BP,HSPA2;BOK
19381,GO:1902653,0.332377294354914,0.938781935780115,1,63,secondary alcohol biosynthetic process,BP,FGF1
15639,GO:0070167,0.333194434597682,0.938458157231401,1,63,regulation of biomineral tissue development,BP,GREM1
3311,GO:0006631,0.333411948250912,0.852850484271882,3,327,fatty acid metabolic process,BP,FA2H;PTGDS;PLP1
13793,GO:0051248,0.334075721821726,0.790624555345978,8,1031,negative regulation of protein metabolic process,BP,HHATL;PPP1R16B;PPP1R1B;SERPINI1;GREM1;PPP1R14A;SPOCK3;FXYD1
7424,GO:0030574,0.334224156065204,0.938077243670897,1,61,collagen catabolic process,BP,KLK6
849,GO:0002064,0.334366081021867,0.883313558233191,2,182,epithelial cell development,BP,PPP1R16B;HAPLN2
16874,GO:0072347,0.334434677371831,0.937951249355187,1,64,response to anesthetic,BP,PPP1R1B
139,GO:0000287,0.334858827338452,0.883008878822399,2,186,magnesium ion binding,MF,SEPT4;TOP2A
6362,GO:0018410,0.335334240754382,0.937578701416368,1,65,C-terminal protein amino acid modification,BP,FOLH1
13226,GO:0048762,0.335590580997527,0.882578193854431,2,186,mesenchymal cell differentiation,BP,SOX10;GREM1
20043,GO:1904035,0.335788883125434,0.93740990287197,1,64,regulation of epithelial cell apoptotic process,BP,BOK
11078,GO:0043130,0.3359251429545,0.937341987701264,1,65,ubiquitin binding,MF,TOP2A
541,GO:0001618,0.336267834539993,0.937217790565814,1,64,virus receptor activity,MF,MOG
18404,GO:0104005,0.336267834539993,0.937217790565814,1,64,hijacked molecular function,MF,MOG
6943,GO:0021872,0.336668953011576,0.937070413488145,1,63,forebrain generation of neurons,BP,CNTN2
6048,GO:0016782,0.336864989086432,0.936951459043236,1,66,transferase activity, transferring sulfur-containing groups,MF,HS3ST4
1517,GO:0003281,0.337118783626583,0.936918429774124,1,61,ventricular septum development,BP,LRP2
14860,GO:0060541,0.337532993154938,0.881438941332007,2,184,respiratory system development,BP,FGF1;HHIP
14866,GO:0060548,0.337721357493299,0.794849231125666,7,896,negative regulation of cell death,BP,SOX10;MAG;EPHB6;HHIP;GREM1;GPR37;BOK
7647,GO:0031032,0.338079818115778,0.881134854069735,2,179,actomyosin structure organization,BP,MYBPC1;LPAR1
2481,GO:0005179,0.338373410239358,0.936305668504295,1,69,hormone activity,MF,CCK
8553,GO:0032642,0.339624901198256,0.935822135205854,1,67,regulation of chemokine production,BP,MBP
19779,GO:1903532,0.340036823508359,0.848389404278845,3,324,positive regulation of secretion by cell,BP,VSNL1;CCK;MBP
18739,GO:1900407,0.340528782082828,0.935466772954854,1,66,regulation of cellular response to oxidative stress,BP,GPR37
17447,GO:0090407,0.340839275749032,0.812425165503201,5,611,organophosphate biosynthetic process,BP,CPNE6;FGF1;AK5;ETNPPL;GRM3
6393,GO:0018995,0.341146416727749,0.935227804216135,1,65,host,CC,TOP2A
11401,GO:0043657,0.341146416727749,0.935227804216135,1,65,host cell,CC,TOP2A
14768,GO:0060411,0.341199824312797,0.935233822715053,1,63,cardiac septum morphogenesis,BP,LRP2
14337,GO:0052813,0.341988062198535,0.934896973036184,1,64,phosphatidylinositol bisphosphate kinase activity,MF,FGF1
11893,GO:0045137,0.342277626476235,0.878597022911339,2,189,development of primary sexual characteristics,BP,LRP2;BOK
137,GO:0000281,0.342623306914461,0.934636227218568,1,64,mitotic cytokinesis,BP,SEPT4
3713,GO:0007281,0.34348352867865,0.877867152681363,2,191,germ cell development,BP,SEPT4;HSPA2
14184,GO:0051966,0.343695455875625,0.934209125389312,1,63,regulation of synaptic transmission, glutamatergic,BP,GRM3
16610,GO:0071900,0.344200743364312,0.824744612151426,4,466,regulation of protein serine/threonine kinase activity,BP,TPD52L1;FGF1;PPP1R1B;LPAR1
10361,GO:0038034,0.344202397077763,0.933944853984427,1,67,signal transduction in absence of ligand,BP,BOK
17658,GO:0097192,0.344202397077763,0.933944853984427,1,67,extrinsic apoptotic signaling pathway in absence of ligand,BP,BOK
14422,GO:0055038,0.345048303016005,0.933594498591519,1,67,recycling endosome membrane,CC,BOK
7724,GO:0031146,0.345385645657991,0.933417122473403,1,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,FBXO2
7858,GO:0031410,0.345545365077882,0.752715745772305,15,2091,cytoplasmic vesicle,CC,CAMK2A;LRP2;TF;CPNE6;SLC17A7;PADI2;PACSIN1;NRGN;SERPINI1;KLK6;LGI3;BOK;SV2B;LPAR1;RYR2
9020,GO:0033555,0.345810250593006,0.933291235595867,1,66,multicellular organismal response to stress,BP,CCK
7213,GO:0030178,0.345913553023113,0.876394168990526,2,194,negative regulation of Wnt signaling pathway,BP,SOX10;GREM1
13804,GO:0051259,0.346034372813745,0.823398124628944,4,470,protein complex oligomerization,BP,SEPT4;GJB1;BOK;CCK
16285,GO:0071363,0.346539791109363,0.808089901926512,5,602,cellular response to growth factor stimulus,BP,LRP2;FGF1;HHIP;GREM1;RYR2
448,GO:0001190,0.346784423379971,0.932913254747177,1,64,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,SOX10
4762,GO:0010466,0.347127170468875,0.875653751118757,2,196,negative regulation of peptidase activity,BP,SERPINI1;SPOCK3
16870,GO:0072341,0.347681088748066,0.932484173630222,1,68,modified amino acid binding,MF,CPNE6
17897,GO:0097708,0.347722885599765,0.750829901067769,15,2094,intracellular vesicle,CC,CAMK2A;LRP2;TF;CPNE6;SLC17A7;PADI2;PACSIN1;NRGN;SERPINI1;KLK6;LGI3;BOK;SV2B;LPAR1;RYR2
15930,GO:0070664,0.347868942918388,0.932405462966101,1,68,negative regulation of leukocyte proliferation,BP,GREM1
15118,GO:0060998,0.347946368037744,0.932442178715533,1,63,regulation of dendritic spine development,BP,LPAR1
16612,GO:0071902,0.348084705353784,0.84288357191682,3,328,positive regulation of protein serine/threonine kinase activity,BP,TPD52L1;FGF1;LPAR1
2178,GO:0004722,0.348667146033819,0.932083481638436,1,67,protein serine/threonine phosphatase activity,MF,PPP2R2C
19675,GO:1903320,0.3489507217205,0.874551500909872,2,195,regulation of protein modification by small protein conjugation or removal,BP,SEPT4;FBXO2
19777,GO:1903530,0.349344945959685,0.805933770185824,5,611,regulation of secretion by cell,BP,CAMK2A;VSNL1;LGI3;CCK;MBP
3216,GO:0006520,0.349633258353394,0.841793615574001,3,341,cellular amino acid metabolic process,BP,FOLH1;ASPA;CARNS1
365,GO:0000980,0.349672215103033,0.931660312308999,1,67,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,SOX10
17114,GO:0086001,0.349708538028672,0.931701716986698,1,63,cardiac muscle cell action potential,BP,RYR2
15185,GO:0061097,0.349899053304524,0.931564593797522,1,67,regulation of protein tyrosine kinase activity,BP,GREM1
8291,GO:0032271,0.35003480205472,0.873899179868063,2,193,regulation of protein polymerization,BP,SLC39A12;TPPP
12491,GO:0046470,0.35075201560506,0.931165465862063,1,70,phosphatidylcholine metabolic process,BP,ENPP2
3848,GO:0008015,0.351066008810604,0.819702737062769,4,464,blood circulation,BP,DOCK5;S100A1;RYR2;FXYD1
14416,GO:0055024,0.351262829370742,0.931001132409228,1,66,regulation of cardiac muscle tissue development,BP,GREM1
13505,GO:0050805,0.351332315744622,0.930971657236544,1,66,negative regulation of synaptic transmission,BP,SLC24A2
10671,GO:0042310,0.351519650415205,0.930865211296777,1,68,vasoconstriction,BP,DOCK5
8928,GO:0033238,0.352000376679596,0.930611361274631,1,72,regulation of cellular amine metabolic process,BP,GPR37
5720,GO:0016126,0.352077175199632,0.930628208372205,1,68,sterol biosynthetic process,BP,FGF1
18982,GO:1901605,0.353160749106277,0.871959937026106,2,201,alpha-amino acid metabolic process,BP,ASPA;CARNS1
11117,GO:0043195,0.353444788329427,0.93005824834004,1,67,terminal bouton,CC,CCK
15172,GO:0061077,0.354260725221603,0.929657284580897,1,71,chaperone-mediated protein folding,BP,HSPA2
2172,GO:0004714,0.354633127378853,0.929577374303593,1,65,transmembrane receptor protein tyrosine kinase activity,MF,EPHB6
5140,GO:0014032,0.354828139569767,0.929451845467356,1,68,neural crest cell development,BP,SOX10
7295,GO:0030295,0.354998668273462,0.929365406927684,1,69,protein kinase activator activity,MF,GREM1
2437,GO:0005126,0.355626368248597,0.870432720798439,2,204,cytokine receptor binding,MF,CXCL14;GREM1
13784,GO:0051234,0.355697890174514,0.722093671501994,31,4549,establishment of localization,BP,CAMK2A;LRP2;TF;CPNE6;SLC17A7;ADAP1;PEX5L;PADI2;PACSIN1;HSPA2;ENPP2;SLC39A12;SLC24A2;SLC5A11;S100A1;VSNL1;TMEM144;GREM1;MOBP;LGI3;GJB1;BOK;CNTN2;SV2B;CCK;NKAIN2;MYBPC1;MBP;RYR2;GJC2;FXYD1
2501,GO:0005230,0.355761857477634,0.92904994422664,1,68,extracellular ligand-gated ion channel activity,MF,SLC17A7
7259,GO:0030239,0.355904755573324,0.929060636648887,1,63,myofibril assembly,BP,MYBPC1
7701,GO:0031110,0.356436143006138,0.928772519247795,1,67,regulation of microtubule polymerization or depolymerization,BP,SLC39A12
7370,GO:0030433,0.356699750024397,0.928618760186896,1,70,ubiquitin-dependent ERAD pathway,BP,FBXO2
13197,GO:0048705,0.357027026465296,0.869602424424949,2,194,skeletal system morphogenesis,BP,HHIP;GREM1
3865,GO:0008047,0.357060787072346,0.815249166474542,4,469,enzyme activator activity,MF,ADAP1;RASAL1;GREM1;MAL
5573,GO:0015837,0.357183737235079,0.928396595615804,1,71,amine transport,BP,CCK
1375,GO:0003013,0.35762673249535,0.814828315726402,4,468,circulatory system process,BP,DOCK5;S100A1;RYR2;FXYD1
13856,GO:0051347,0.358088701292863,0.799180172958646,5,614,positive regulation of transferase activity,BP,EPHB6;TPD52L1;FGF1;GREM1;LPAR1
7641,GO:0031016,0.359338263782057,0.927484732575646,1,69,pancreas development,BP,NKX6-2
2726,GO:0005739,0.359565424200166,0.753749676786698,11,1557,mitochondrion,CC,CAMK2A;SOX10;SEPT4;HSPA2;NRGN;ETNPPL;KLK6;MOBP;TPPP;BOK;AIFM3
11890,GO:0045132,0.35965730424204,0.927332234593455,1,70,meiotic chromosome segregation,BP,TOP2A
9877,GO:0035637,0.360606120769894,0.867393983977034,2,190,multicellular organismal signaling,BP,RYR2;FXYD1
5684,GO:0016055,0.360696002261766,0.812528877853096,4,472,Wnt signaling pathway,BP,CAMK2A;SOX10;GREM1;RYR2
486,GO:0001523,0.360706308685328,0.926872687658429,1,70,retinoid metabolic process,BP,LRP2
11107,GO:0043178,0.360786792725849,0.926850532151365,1,69,alcohol binding,MF,ADAP1
5303,GO:0015077,0.360847182615608,0.833986578711574,3,335,monovalent inorganic cation transmembrane transporter activity,MF,SLC17A7;SLC24A2;SLC5A11
14609,GO:0060191,0.36122310982352,0.92664566376258,1,70,regulation of lipase activity,BP,LPAR1
11533,GO:0044215,0.361492095977208,0.926527338529407,1,70,other organism,CC,TOP2A
11534,GO:0044216,0.361492095977208,0.926527338529407,1,70,other organism cell,CC,TOP2A
11535,GO:0044217,0.361492095977208,0.926527338529407,1,70,other organism part,CC,TOP2A
6990,GO:0021954,0.361694436518535,0.926465123044611,1,68,central nervous system neuron development,BP,CNTN2
9588,GO:0035050,0.362461791597462,0.926113140952979,1,69,embryonic heart tube development,BP,RYR2
14077,GO:0051781,0.363204977458233,0.925758258916544,1,71,positive regulation of cell division,BP,FGF1
18562,GO:0198738,0.363610233793479,0.81033783226624,4,474,cell-cell signaling by wnt,BP,CAMK2A;SOX10;GREM1;RYR2
8473,GO:0032508,0.364326725452385,0.925273598655176,1,70,DNA duplex unwinding,BP,TOP2A
2823,GO:0005882,0.364679832434188,0.925103475594197,1,71,intermediate filament,CC,NEFM
6461,GO:0019207,0.364680449039075,0.864792407222974,2,203,kinase regulator activity,MF,PPP1R1B;GREM1
13815,GO:0051279,0.365390415768486,0.924813424987332,1,69,regulation of release of sequestered calcium ion into cytosol,BP,RYR2
8525,GO:0032602,0.366481294467453,0.9242616496099,1,74,chemokine production,BP,MBP
9569,GO:0035004,0.366521732366309,0.924307783143678,1,69,phosphatidylinositol 3-kinase activity,MF,FGF1
19797,GO:1903561,0.366710223241569,0.729500082740006,17,2458,extracellular vesicle,CC,CD22;CLDN11;BCAS1;LRP2;FOLH1;TF;CPNE6;PTGDS;ASPA;FBXO2;PADI2;GDA;HSPA2;ERMN;SLC39A12;SERPINI1;RYR2
14465,GO:0055117,0.367368561598061,0.923927988748235,1,69,regulation of cardiac muscle contraction,BP,RYR2
1544,GO:0003333,0.367398591725105,0.92388758357718,1,71,amino acid transmembrane transport,BP,SLC17A7
12226,GO:0045860,0.367417795577165,0.807458031751137,4,479,positive regulation of protein kinase activity,BP,TPD52L1;FGF1;GREM1;LPAR1
13845,GO:0051321,0.367760205511087,0.862850154404832,2,202,meiotic cell cycle,BP,HSPA2;TOP2A
11143,GO:0043230,0.367928862857904,0.728419477947091,17,2460,extracellular organelle,CC,CD22;CLDN11;BCAS1;LRP2;FOLH1;TF;CPNE6;PTGDS;ASPA;FBXO2;PADI2;GDA;HSPA2;ERMN;SLC39A12;SERPINI1;RYR2
13528,GO:0050848,0.368317657007552,0.923473951241953,1,71,regulation of calcium-mediated signaling,BP,RCAN2
17920,GO:0097756,0.368368928345931,0.923437874212173,1,72,negative regulation of blood vessel diameter,BP,DOCK5
5349,GO:0015171,0.369068249921807,0.923122150945178,1,72,amino acid transmembrane transporter activity,MF,SLC17A7
13671,GO:0051056,0.369271493201078,0.828028623613384,3,326,regulation of small GTPase mediated signal transduction,BP,ADAP1;RASAL1;LPAR1
20845,GO:1905897,0.369508220182934,0.922910441448082,1,73,regulation of response to endoplasmic reticulum stress,BP,BOK
4549,GO:0009612,0.36977487223708,0.861588554082284,2,197,response to mechanical stimulus,BP,MAG;RYR2
10296,GO:0036473,0.369921343509916,0.922723256603788,1,73,cell death in response to oxidative stress,BP,GPR37
18972,GO:1901570,0.370340967410584,0.92250839421404,1,75,fatty acid derivative biosynthetic process,BP,PTGDS
7874,GO:0031434,0.370492917029044,0.922517060582926,1,69,mitogen-activated protein kinase kinase binding,MF,EPHB6
5874,GO:0016459,0.370555300990192,0.922564665411918,1,64,myosin complex,CC,MYBPC1
1433,GO:0003151,0.370654188399245,0.922416431302014,1,71,outflow tract morphogenesis,BP,LRP2
17351,GO:0090257,0.371010351204012,0.860789620494657,2,200,regulation of muscle system process,BP,DOCK5;RYR2
13703,GO:0051117,0.371032194027867,0.922218607275587,1,73,ATPase binding,MF,S100A1
11099,GO:0043169,0.371179181616375,0.712194259946662,26,3756,cation binding,MF,CAMK2A;LRP2;FOLH1;TF;CPNE6;FA2H;ADAP1;ASPA;SEPT4;RASAL1;PADI2;GDA;NECAB1;TOP2A;ENPP2;ST18;CNDP1;SLC24A2;S100A1;VSNL1;HHIP;CARNS1;AIFM3;SPOCK3;ZNF536;RYR2
8133,GO:0031982,0.371255994988878,0.712120892881885,26,3837,vesicle,CC,CD22;CLDN11;BCAS1;CAMK2A;LRP2;FOLH1;TF;CPNE6;SLC17A7;PTGDS;ASPA;FBXO2;PADI2;GDA;PACSIN1;HSPA2;ERMN;SLC39A12;NRGN;SERPINI1;KLK6;LGI3;BOK;SV2B;LPAR1;RYR2
17852,GO:0097581,0.371292531185391,0.922126028204321,1,71,lamellipodium organization,BP,ENPP2
13275,GO:0048864,0.371726498707894,0.921915041143017,1,72,stem cell development,BP,SOX10
13730,GO:0051149,0.371859246601503,0.921841627280719,1,73,positive regulation of muscle cell differentiation,BP,GREM1
20000,GO:1903955,0.371911986368226,0.921805053352103,1,74,positive regulation of protein targeting to mitochondrion,BP,MYBPC1
5139,GO:0014031,0.372254148906993,0.921674116415362,1,72,mesenchymal cell development,BP,SOX10
19457,GO:1902882,0.372408244306202,0.921578263549833,1,74,regulation of response to oxidative stress,BP,GPR37
21740,GO:2001023,0.37272028302418,0.921435463538704,1,74,regulation of response to drug,BP,GPR37
2039,GO:0004527,0.373470380374197,0.921104166120347,1,73,exonuclease activity,MF,ENPP2
2487,GO:0005201,0.373606461934461,0.92111031635731,1,68,extracellular matrix structural constituent,MF,HAPLN2
5182,GO:0014706,0.373631297120366,0.824890232760849,3,332,striated muscle tissue development,BP,LRP2;GREM1;RYR2
17657,GO:0097191,0.374323427502808,0.858644834257745,2,206,extrinsic apoptotic signaling pathway,BP,MAL;BOK
14597,GO:0060170,0.374411645786586,0.92068444617566,1,72,ciliary membrane,CC,HHIP
6846,GO:0021675,0.374438923775999,0.920685271577105,1,71,nerve development,BP,LPAR1
4541,GO:0009593,0.374548730733614,0.920559580482121,1,77,detection of chemical stimulus,BP,RYR2
12667,GO:0046849,0.374799230601961,0.920492836607099,1,73,bone remodeling,BP,GREM1
13662,GO:0051047,0.375559991164506,0.823475308506611,3,345,positive regulation of secretion,BP,VSNL1;CCK;MBP
18244,GO:0099512,0.375763960100527,0.773337558715126,6,752,supramolecular fiber,CC,NEFM;S100A1;TPPP;DNAH17;MYBPC1;RYR2
11488,GO:0044070,0.375794040600887,0.92003335548172,1,73,regulation of anion transport,BP,CCK
565,GO:0001664,0.376266281293148,0.857371847016168,2,212,G-protein coupled receptor binding,MF,PPP1R1B;CXCL14
4590,GO:0009755,0.376492048625843,0.857257410609785,2,203,hormone-mediated signaling pathway,BP,PADI2;PAQR6
16944,GO:0072527,0.37735558954949,0.919259524457391,1,77,pyrimidine-containing compound metabolic process,BP,AK5
16012,GO:0070848,0.377757966602273,0.783693894454338,5,626,response to growth factor,BP,LRP2;FGF1;HHIP;GREM1;RYR2
3557,GO:0007010,0.377831336158964,0.748107888573524,9,1189,cytoskeleton organization,BP,NEFM;SEPT4;PACSIN1;ERMN;SLC39A12;TPPP;CNTN2;MYBPC1;LPAR1
17243,GO:0090092,0.377853516955051,0.856376272172135,2,203,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,LRP2;GREM1
1202,GO:0002690,0.379223769001169,0.918364258999629,1,79,positive regulation of leukocyte chemotaxis,BP,CXCL14
4972,GO:0010821,0.379229520232083,0.855461584179563,2,209,regulation of mitochondrion organization,BP,BOK;MYBPC1
6463,GO:0019209,0.37956779025965,0.918250423092594,1,75,kinase activator activity,MF,GREM1
3582,GO:0007045,0.38056137739038,0.91783691127965,1,71,cell-substrate adherens junction assembly,BP,GREM1
12920,GO:0048041,0.38056137739038,0.91783691127965,1,71,focal adhesion assembly,BP,GREM1
12469,GO:0046434,0.381519738655514,0.853972348430706,2,208,organophosphate catabolic process,BP,GDA;ENPP2
16218,GO:0071260,0.381663920549377,0.91725182988162,1,76,cellular response to mechanical stimulus,BP,MAG
4192,GO:0008589,0.381681862936237,0.917281764223912,1,73,regulation of smoothened signaling pathway,BP,HHIP
12705,GO:0046914,0.382812773065837,0.75801754192932,7,931,transition metal ion binding,MF,TF;FA2H;GDA;ENPP2;ST18;SLC24A2;HHIP
13884,GO:0051402,0.38300912512585,0.852997605947174,2,208,neuron apoptotic process,BP,MAG;BOK
13850,GO:0051341,0.383244697082916,0.916491170965346,1,77,regulation of oxidoreductase activity,BP,S100A1
1527,GO:0003300,0.383722798855923,0.916372074602601,1,69,cardiac muscle hypertrophy,BP,RYR2
16378,GO:0071495,0.383935373065837,0.742871442409282,9,1217,cellular response to endogenous stimulus,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;PAQR6;HHIP;GREM1;RYR2
4212,GO:0008625,0.383996684749178,0.916133687832545,1,77,extrinsic apoptotic signaling pathway via death domain receptors,BP,MAL
592,GO:0001708,0.384058382441216,0.916116601507627,1,76,cell fate specification,BP,NKX6-2
13836,GO:0051304,0.384212249086445,0.916055960588356,1,75,chromosome separation,BP,TOP2A
2838,GO:0005901,0.384485058332324,0.915952308168507,1,73,caveola,CC,FXYD1
18200,GO:0099081,0.384972701593227,0.765784474526076,6,759,supramolecular polymer,CC,NEFM;S100A1;TPPP;DNAH17;MYBPC1;RYR2
5141,GO:0014033,0.38507707417612,0.915643525442193,1,75,neural crest cell differentiation,BP,SOX10
12258,GO:0045921,0.385115849643418,0.915612324975043,1,76,positive regulation of exocytosis,BP,VSNL1
7556,GO:0030864,0.385266745747613,0.915593100412868,1,72,cortical actin cytoskeleton,CC,MOBP
19031,GO:1901681,0.385455825701332,0.851382404022592,2,210,sulfur compound binding,MF,FGF1;RYR2
13393,GO:0050660,0.385681090249012,0.915329655184995,1,77,flavin adenine dinucleotide binding,MF,AIFM3
13442,GO:0050714,0.385761659030093,0.851184333780432,2,209,positive regulation of protein secretion,BP,VSNL1;MBP
4412,GO:0009190,0.385789559697536,0.915277722219942,1,77,cyclic nucleotide biosynthetic process,BP,GRM3
14301,GO:0052652,0.385789559697536,0.915277722219942,1,77,cyclic purine nucleotide metabolic process,BP,GRM3
18199,GO:0099080,0.386424089385036,0.764586612645522,6,760,supramolecular complex,CC,NEFM;S100A1;TPPP;DNAH17;MYBPC1;RYR2
18580,GO:1900034,0.386692743986233,0.914869792007786,1,75,regulation of cellular response to heat,BP,CAMK2A
17368,GO:0090277,0.386761183928378,0.914787724452668,1,79,positive regulation of peptide hormone secretion,BP,VSNL1
13509,GO:0050810,0.387198119926647,0.914601612297028,1,77,regulation of steroid biosynthetic process,BP,FGF1
5705,GO:0016101,0.387709129537808,0.914355536879418,1,77,diterpenoid metabolic process,BP,LRP2
2638,GO:0005578,0.387872288401209,0.814495979889571,3,340,proteinaceous extracellular matrix,CC,FGF1;HAPLN2;SPOCK3
5412,GO:0015297,0.388135206681115,0.914162578521416,1,76,antiporter activity,MF,SLC24A2
4184,GO:0008565,0.388410248351139,0.914017229029841,1,77,protein transporter activity,MF,LRP2
13931,GO:0051492,0.38857027538354,0.913965371813722,1,75,regulation of stress fiber assembly,BP,LPAR1
14433,GO:0055072,0.389451344849349,0.913501108609709,1,78,iron ion homeostasis,BP,TF
4047,GO:0008344,0.390514544784341,0.91300976989216,1,76,adult locomotory behavior,BP,CNTN2
3636,GO:0007166,0.391147026117365,0.705546342710179,18,2604,cell surface receptor signaling pathway,BP,CAMK2A;LRP2;SOX10;SLC17A7;ADAP1;EPHB6;FGF1;PADI2;PLP1;MOG;ST18;HHIP;GREM1;MAL;BOK;CNTN2;RYR2;GRM3
5266,GO:0014897,0.391803887391242,0.912450514353173,1,71,striated muscle hypertrophy,BP,RYR2
18991,GO:1901617,0.392056730634232,0.846983768072411,2,215,organic hydroxy compound biosynthetic process,BP,FGF1;GPR37
3435,GO:0006813,0.392101628671686,0.846967772816203,2,211,potassium ion transport,BP,SLC24A2;FXYD1
2599,GO:0005496,0.392797895142747,0.911869495767687,1,78,steroid binding,MF,PAQR6
8231,GO:0032153,0.393121381959165,0.911723341285665,1,77,cell division site,CC,SEPT4
16865,GO:0072332,0.393158818564123,0.911680229227642,1,79,intrinsic apoptotic signaling pathway by p53 class mediator,BP,BOK
8516,GO:0032588,0.393182022750793,0.911668837445377,1,79,trans-Golgi network membrane,CC,BOK
15402,GO:0061640,0.394248762089279,0.911169062156762,1,77,cytoskeleton-dependent cytokinesis,BP,SEPT4
4899,GO:0010717,0.396967787271567,0.909810940422634,1,78,regulation of epithelial to mesenchymal transition,BP,GREM1
755,GO:0001938,0.397781329953438,0.909406001119912,1,78,positive regulation of endothelial cell proliferation,BP,PPP1R16B
5765,GO:0016234,0.398188484883395,0.909215775977969,1,77,inclusion body,CC,NEFM
5265,GO:0014896,0.398945765635105,0.908892509587433,1,73,muscle hypertrophy,BP,RYR2
7501,GO:0030799,0.399011188466106,0.90875500745232,1,81,regulation of cyclic nucleotide metabolic process,BP,GRM3
14857,GO:0060537,0.399036514452964,0.806170073573397,3,346,muscle tissue development,BP,LRP2;GREM1;RYR2
16883,GO:0072359,0.399227887975692,0.744159756126322,7,921,circulatory system development,BP,LRP2;PPP1R16B;FGF1;ENPP2;S100A1;GREM1;RYR2
3786,GO:0007517,0.400639603001307,0.804961394491557,3,347,muscle organ development,BP,LRP2;GREM1;RYR2
3892,GO:0008094,0.401092772558334,0.907746509411457,1,78,DNA-dependent ATPase activity,MF,TOP2A
11844,GO:0045069,0.401204829944329,0.907652871234812,1,81,regulation of viral genome replication,BP,TOP2A
9378,GO:0034446,0.401320517386687,0.907619003460259,1,79,substrate adhesion-dependent cell spreading,BP,DOCK5
8374,GO:0032392,0.40317958969291,0.906666103911616,1,80,DNA geometric change,BP,TOP2A
19627,GO:1903214,0.403245365421333,0.906608624862703,1,82,regulation of protein targeting to mitochondrion,BP,MYBPC1
523,GO:0001578,0.403442162572789,0.906558167584962,1,78,microtubule bundle formation,BP,TPPP
15042,GO:0060840,0.403843922299325,0.906380789594267,1,76,artery development,BP,LRP2
12263,GO:0045926,0.403863847668553,0.838977312870136,2,219,negative regulation of growth,BP,MAG;GREM1
13105,GO:0048545,0.404296798657215,0.802168586110976,3,362,response to steroid hormone,BP,SOX10;PADI2;PAQR6
11254,GO:0043408,0.404471030547668,0.762009269719532,5,654,regulation of MAPK cascade,BP,EPHB6;TPD52L1;FGF1;GPR37;LPAR1
15725,GO:0070301,0.404869945836124,0.905781691729962,1,82,cellular response to hydrogen peroxide,BP,GPR37
569,GO:0001669,0.405873473025425,0.905256931499655,1,83,acrosomal vesicle,CC,SV2B
14705,GO:0060333,0.405998806024009,0.905181250109602,1,84,interferon-gamma-mediated signaling pathway,BP,CAMK2A
9829,GO:0035578,0.406010373979333,0.905164106567653,1,85,azurophil granule lumen,CC,PADI2
6167,GO:0017016,0.406675726995788,0.776861191730867,4,487,Ras GTPase binding,MF,CAMK2A;FGF1;RAPGEF5;MOBP
13661,GO:0051046,0.407203462289067,0.759749212349588,5,657,regulation of secretion,BP,CAMK2A;VSNL1;LGI3;CCK;MBP
19554,GO:1903047,0.407494887580568,0.746950100781514,6,802,mitotic cell cycle process,BP,CAMK2A;SEPT4;TPD52L1;TOP2A;MKI67;GJC2
11044,GO:0043066,0.407882857257102,0.746616052443894,6,812,negative regulation of apoptotic process,BP,SOX10;MAG;EPHB6;HHIP;GREM1;BOK
7329,GO:0030336,0.408997936855931,0.83544987770956,2,216,negative regulation of cell migration,BP,PADI2;GREM1
2168,GO:0004709,0.409167044284095,0.903624089927622,1,78,MAP kinase kinase kinase activity,MF,EPHB6
13734,GO:0051153,0.409232066503328,0.903539577420958,1,82,regulation of striated muscle cell differentiation,BP,GREM1
3358,GO:0006690,0.409487958684225,0.903360875114344,1,86,icosanoid metabolic process,BP,PTGDS
9023,GO:0033559,0.409707295822284,0.903247155053081,1,86,unsaturated fatty acid metabolic process,BP,PTGDS
10835,GO:0042623,0.409735991940372,0.79804851385725,3,349,ATPase activity, coupled,MF,HSPA2;TOP2A;DNAH17
3517,GO:0006942,0.409784257294614,0.903278350774397,1,80,regulation of striated muscle contraction,BP,RYR2
19090,GO:1901888,0.411101196339126,0.902594133398039,1,80,regulation of cell junction assembly,BP,GREM1
6067,GO:0016811,0.411209488620684,0.902488868896769,1,84,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,ASPA
11339,GO:0043549,0.411601890508793,0.743466614028901,6,803,regulation of kinase activity,BP,EPHB6;TPD52L1;FGF1;PPP1R1B;GREM1;LPAR1
3975,GO:0008233,0.411850892567319,0.772663139410155,4,518,peptidase activity,MF,FOLH1;MYRF;CNDP1;KLK6
460,GO:0001227,0.412009637563016,0.833338948933237,2,221,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,NKX6-2;ZNF536
3841,GO:0007631,0.41269875735329,0.901699412176805,1,85,feeding behavior,BP,CCK
8238,GO:0032182,0.413022507498273,0.901553271345949,1,83,ubiquitin-like protein binding,MF,TOP2A
2104,GO:0004620,0.413890699302669,0.901085721304708,1,84,phospholipase activity,MF,ENPP2
558,GO:0001656,0.414532329352201,0.900784912589941,1,81,metanephros development,BP,GREM1
8756,GO:0032947,0.414589636171857,0.900767612556603,1,80,protein-containing complex scaffold activity,MF,SEPT4
19011,GO:1901655,0.414737541065045,0.900651999701521,1,83,cellular response to ketone,BP,SOX10
18447,GO:0110020,0.41518837451594,0.900439142410439,1,81,regulation of actomyosin structure organization,BP,LPAR1
5885,GO:0016485,0.415654754371865,0.830770567314741,2,226,protein processing,BP,KLK6;CNTN2
6387,GO:0018958,0.416262856222521,0.89983419118854,1,84,phenol-containing compound metabolic process,BP,GPR37
2750,GO:0005768,0.416600578813093,0.739199608396274,6,813,endosome,CC,LRP2;TF;CPNE6;PACSIN1;BOK;LPAR1
3379,GO:0006721,0.41664124606728,0.899621879982478,1,85,terpenoid metabolic process,BP,LRP2
3884,GO:0008081,0.417129824738838,0.899386514251467,1,83,phosphoric diester hydrolase activity,MF,ENPP2
6481,GO:0019233,0.417147306873807,0.899365122779534,1,84,sensory perception of pain,BP,CCK
4824,GO:0010595,0.417397833908904,0.899244136497689,1,83,positive regulation of endothelial cell migration,BP,FGF1
13155,GO:0048646,0.417695924684753,0.728260333864135,7,942,anatomical structure formation involved in morphogenesis,BP,LRP2;PPP1R16B;FGF1;ENPP2;S100A1;GREM1;MYBPC1
2840,GO:0005903,0.417750537663423,0.899069018227209,1,82,brush border,CC,LRP2
13975,GO:0051588,0.418552031662833,0.898617395852383,1,84,regulation of neurotransmitter transport,BP,CAMK2A
7200,GO:0030165,0.418559000543585,0.898638351158865,1,82,PDZ domain binding,MF,LPAR1
9295,GO:0034329,0.418825123540002,0.828571381184543,2,216,cell junction assembly,BP,GREM1;GJB1
6454,GO:0019199,0.419376622128363,0.898227681766422,1,80,transmembrane receptor protein kinase activity,MF,EPHB6
5530,GO:0015748,0.419434396739516,0.898146000843008,1,84,organophosphate ester transport,BP,GJB1
292,GO:0000794,0.420094926116394,0.89781709992537,1,82,condensed nuclear chromosome,CC,HSPA2
11047,GO:0043069,0.420236562882909,0.736079059728596,6,823,negative regulation of programmed cell death,BP,SOX10;MAG;EPHB6;HHIP;GREM1;BOK
9299,GO:0034333,0.4202601867082,0.897741391902646,1,81,adherens junction assembly,BP,GREM1
2618,GO:0005524,0.42234061073319,0.703535696970007,10,1377,ATP binding,MF,CAMK2A;EPHB6;CDK18;HSPA2;TOP2A;IQCA1;MKI67;AK5;CARNS1;DNAH17
18212,GO:0099106,0.422399455166541,0.896528266515071,1,86,ion channel regulator activity,MF,GRM3
7398,GO:0030516,0.422885895704347,0.896314470356181,1,82,regulation of axon extension,BP,MAG
1276,GO:0002793,0.423430129985838,0.825260120147324,2,227,positive regulation of peptide secretion,BP,VSNL1;MBP
136,GO:0000280,0.423529775865025,0.787337284529176,3,367,nuclear division,BP,HSPA2;TOP2A;MKI67
437,GO:0001158,0.423938617407187,0.895694824060258,1,86,enhancer sequence-specific DNA binding,MF,SOX10
12330,GO:0046058,0.42495874401899,0.89514019166996,1,86,cAMP metabolic process,BP,GRM3
11658,GO:0044438,0.425253533555103,0.894945245179839,1,89,microbody part,CC,PEX5L
11659,GO:0044439,0.425253533555103,0.894945245179839,1,89,peroxisomal part,CC,PEX5L
15905,GO:0070613,0.425731877597079,0.894706917849176,1,87,regulation of protein processing,BP,CNTN2
13687,GO:0051091,0.426293276705187,0.823206494684797,2,228,positive regulation of DNA binding transcription factor activity,BP,CAMK2A;GREM1
3924,GO:0008150,0.426858804066457,0.723714199483926,92,14380,biological_process,BP,HHATL;CD22;CLDN11;CAMK2A;PPP2R2C;LRP2;FOLH1;TF;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;SLC17A7;MAG;ADAP1;EPHB6;PTGDS;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;FBXO2;PADI2;CDK18;GDA;NECAB1;PLP1;PACSIN1;MYRF;HSPA2;EVI2A;TOP2A;PPP1R1B;HAPLN2;RAPGEF5;ERMN;ENPP2;MOG;CXCL14;DOCK5;ST18;SLC39A12;MKI67;NKX6-2;CNDP1;CNTNAP4;AK5;NRGN;SLC24A2;SLC5A11;S100A1;PAQR6;VSNL1;SERPINI1;ETNPPL;TMEM144;HHIP;GREM1;PPP1R14A;KLK6;MOBP;LGI3;GJB1;GPR37;TPPP;MAL;RCAN2;CARNS1;BOK;TMEM125;S1PR5;GPR62;HS3ST4;AIFM3;CNTN2;SV2B;MPPED1;CCK;DNAH17;NKAIN2;MYBPC1;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;FXYD1
13149,GO:0048640,0.426977955249931,0.89404916077491,1,85,negative regulation of developmental growth,BP,MAG
12897,GO:0048013,0.427095586046216,0.893960792240705,1,87,ephrin receptor signaling pathway,BP,EPHB6
6475,GO:0019222,0.427593759746496,0.651646887090918,39,5923,regulation of metabolic process,BP,HHATL;CAMK2A;PPP2R2C;LRP2;SOX10;PPP1R16B;EPHB6;SEPT4;TPD52L1;FGF1;FBXO2;PADI2;NECAB1;PLP1;MYRF;HSPA2;TOP2A;PPP1R1B;ENPP2;ST18;NKX6-2;CNDP1;S100A1;SERPINI1;GREM1;PPP1R14A;GPR37;RCAN2;BOK;CNTN2;CCK;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;FXYD1
16308,GO:0071396,0.427979628958318,0.759487805078786,4,523,cellular response to lipid,BP,SOX10;PADI2;PAQR6;LPAR1
2280,GO:0004860,0.42853989637131,0.893144092673898,1,89,protein kinase inhibitor activity,MF,PPP1R1B
6787,GO:0021549,0.428715020521385,0.893094646399146,1,85,cerebellum development,BP,LPAR1
21183,GO:2000027,0.429072174828674,0.821194855642317,2,231,regulation of organ morphogenesis,BP,FGF1;GREM1
12264,GO:0045927,0.429168956156753,0.821149234592456,2,224,positive regulation of growth,BP,CPNE6;RASAL1
3880,GO:0008076,0.429172944225792,0.892818026662528,1,87,voltage-gated potassium channel complex,CC,CNTN2
8515,GO:0032587,0.429248222026523,0.892800604701879,1,85,ruffle membrane,CC,PACSIN1
691,GO:0001843,0.430349394956991,0.892191785099382,1,85,neural tube closure,BP,LRP2
9603,GO:0035091,0.430350992323473,0.82029434355172,2,224,phosphatidylinositol binding,MF,ADAP1;NRGN
7130,GO:0030038,0.430660301676703,0.892007225662862,1,86,contractile actin filament bundle assembly,BP,LPAR1
11089,GO:0043149,0.430660301676703,0.892007225662862,1,86,stress fiber assembly,BP,LPAR1
135,GO:0000278,0.431397236551778,0.716255760063415,7,974,mitotic cell cycle,BP,CAMK2A;PPP2R2C;SEPT4;TPD52L1;TOP2A;MKI67;GJC2
10323,GO:0036503,0.431484372196339,0.891514421247696,1,89,ERAD pathway,BP,FBXO2
821,GO:0002027,0.43150211626637,0.891539877325181,1,86,regulation of heart rate,BP,RYR2
4947,GO:0010771,0.43164758115004,0.891458994859706,1,86,negative regulation of cell morphogenesis involved in differentiation,BP,MAG
8270,GO:0032231,0.431698124564663,0.891430882703177,1,86,regulation of actin filament bundle assembly,BP,LPAR1
5877,GO:0016462,0.432325450756727,0.725637277755158,6,811,pyrophosphatase activity,MF,SEPT4;HSPA2;TOP2A;ENPP2;CARNS1;DNAH17
6137,GO:0016925,0.433068466924674,0.890643018629478,1,88,protein sumoylation,BP,TOP2A
19672,GO:1903317,0.43318338245155,0.890567206251056,1,89,regulation of protein maturation,BP,CNTN2
15116,GO:0060996,0.433262581796477,0.890583681320099,1,84,dendritic spine development,BP,LPAR1
13274,GO:0048863,0.433433149664925,0.818020801617553,2,234,stem cell differentiation,BP,SOX10;GREM1
14907,GO:0060606,0.433519748057214,0.890414724031756,1,86,tube closure,BP,LRP2
3676,GO:0007215,0.434316349905933,0.889981017778588,1,85,glutamate receptor signaling pathway,BP,GRM3
6072,GO:0016817,0.434347741888902,0.723874258988789,6,813,hydrolase activity, acting on acid anhydrides,MF,SEPT4;HSPA2;TOP2A;ENPP2;CARNS1;DNAH17
6073,GO:0016818,0.434347741888902,0.723874258988789,6,813,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,SEPT4;HSPA2;TOP2A;ENPP2;CARNS1;DNAH17
4790,GO:0010522,0.435290680086651,0.88939705802049,1,88,regulation of calcium ion transport into cytosol,BP,RYR2
13683,GO:0051087,0.435448892127646,0.889284861063033,1,90,chaperone binding,MF,LRP2
7034,GO:0022411,0.436093828144901,0.752741683363497,4,530,cellular component disassembly,BP,PADI2;HSPA2;TOP2A;BOK
7817,GO:0031334,0.436361303272428,0.815887257293517,2,232,positive regulation of protein complex assembly,BP,TPPP;CCK
5674,GO:0016043,0.436578512071805,0.643924252783002,37,5585,cellular component organization,BP,CAMK2A;LRP2;TF;CPNE6;PPP1R16B;FA2H;NEFM;SLC17A7;MAG;SEPT4;RASAL1;PEX5L;PADI2;PLP1;PACSIN1;MYRF;HSPA2;TOP2A;PPP1R1B;HAPLN2;ERMN;ENPP2;DOCK5;SLC39A12;MKI67;SERPINI1;GREM1;KLK6;GJB1;TPPP;MAL;BOK;CNTN2;CCK;MYBPC1;MBP;LPAR1
5171,GO:0014066,0.436853606709813,0.888515562044935,1,88,regulation of phosphatidylinositol 3-kinase signaling,BP,PPP1R16B
11938,GO:0045216,0.437524625341324,0.81505813501726,2,225,cell-cell junction organization,BP,GREM1;GJB1
11661,GO:0044441,0.437682637523795,0.77611569382097,3,374,ciliary part,CC,SEPT4;HHIP;DNAH17
4379,GO:0009152,0.437975754848715,0.814688305315254,2,236,purine ribonucleotide biosynthetic process,BP,AK5;GRM3
3439,GO:0006820,0.438289253486717,0.750906541029985,4,529,anion transport,BP,LRP2;SLC17A7;CCK;FXYD1
4513,GO:0009410,0.438936683724966,0.813980824647751,2,236,response to xenobiotic stimulus,BP,PPP1R1B;RYR2
14825,GO:0060485,0.439620009549027,0.813490433938495,2,232,mesenchyme development,BP,SOX10;GREM1
13575,GO:0050905,0.439648631059113,0.886928436067653,1,88,neuromuscular process,BP,NKX6-2
11052,GO:0043086,0.439661800288496,0.732307866834093,5,688,negative regulation of catalytic activity,BP,PPP1R1B;SERPINI1;PPP1R14A;SPOCK3;GRM3
12639,GO:0046777,0.4398727568939,0.813325106109048,2,226,protein autophosphorylation,BP,CAMK2A;GREM1
19483,GO:1902936,0.440037142948823,0.886683097976815,1,90,phosphatidylinositol bisphosphate binding,MF,ADAP1
1369,GO:0003007,0.440617177658725,0.812782471298552,2,224,heart morphogenesis,BP,LRP2;RYR2
7187,GO:0030148,0.440781135521689,0.886235037828687,1,92,sphingolipid biosynthetic process,BP,FA2H
3798,GO:0007548,0.441829319569822,0.811856460412752,2,232,sex differentiation,BP,LRP2;BOK
847,GO:0002062,0.442251902610828,0.885425705197202,1,89,chondrocyte differentiation,BP,GREM1
327,GO:0000904,0.442500467438747,0.729878561130664,5,661,cell morphogenesis involved in differentiation,BP,CAMK2A;MAG;DOCK5;CNTN2;CCK
6464,GO:0019210,0.443415269316859,0.884709700304569,1,93,kinase inhibitor activity,MF,PPP1R1B
13775,GO:0051222,0.444814073529711,0.770351991236332,3,384,positive regulation of protein transport,BP,VSNL1;MYBPC1;MBP
15840,GO:0070498,0.445833532117057,0.883276317548801,1,96,interleukin-1-mediated signaling pathway,BP,ST18
21111,GO:1990823,0.445913617481671,0.883273200942796,1,92,response to leukemia inhibitory factor,BP,PADI2
21115,GO:1990830,0.445913617481671,0.883273200942796,1,92,cellular response to leukemia inhibitory factor,BP,PADI2
2991,GO:0006164,0.446171657605143,0.808596516838523,2,240,purine nucleotide biosynthetic process,BP,AK5;GRM3
14195,GO:0051983,0.446173933378252,0.883144942440882,1,90,regulation of chromosome segregation,BP,MKI67
13132,GO:0048608,0.446193659212609,0.769238079891723,3,381,reproductive structure development,BP,LRP2;GJB1;BOK
5387,GO:0015238,0.446196373445478,0.883097429625735,1,93,drug transmembrane transporter activity,MF,SLC17A7
1610,GO:0003705,0.446239468996848,0.883083573210666,1,92,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,SOX10
3581,GO:0007044,0.44795712039645,0.882141358567493,1,87,cell-substrate junction assembly,BP,GREM1
13666,GO:0051051,0.448217501563268,0.767572721860753,3,392,negative regulation of transport,BP,PACSIN1;VSNL1;BOK
2486,GO:0005200,0.448828695558764,0.88157001996663,1,92,structural constituent of cytoskeleton,MF,NEFM
7285,GO:0030282,0.449363345113404,0.881244598246023,1,93,bone mineralization,BP,GREM1
3665,GO:0007200,0.449363900411237,0.881201073342485,1,97,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,LPAR1
11406,GO:0043687,0.449583036781418,0.766455497195663,3,394,post-translational protein modification,BP,FOLH1;TF;FBXO2
15322,GO:0061458,0.451027141103844,0.76529212057307,3,384,reproductive system development,BP,LRP2;GJB1;BOK
7548,GO:0030855,0.451036658356107,0.740126792478707,4,536,epithelial cell differentiation,BP,PPP1R16B;FA2H;HAPLN2;GREM1
40,GO:0000082,0.451168196255057,0.804841284006926,2,240,G1/S transition of mitotic cell cycle,BP,CAMK2A;GJC2
12671,GO:0046854,0.451307250930446,0.880121600262799,1,91,phosphatidylinositol phosphorylation,BP,FGF1
11271,GO:0043436,0.45175150795297,0.698105332865901,7,1020,oxoacid metabolic process,BP,FOLH1;FA2H;PTGDS;ASPA;PLP1;CARNS1;SPOCK3
3514,GO:0006939,0.452177561801673,0.879571714948824,1,94,smooth muscle contraction,BP,DOCK5
7036,GO:0022414,0.452635052483959,0.688881509563243,8,1156,reproductive process,BP,CLDN11;LRP2;SEPT4;HSPA2;TOP2A;PPP1R1B;GJB1;BOK
11282,GO:0043473,0.452854726451012,0.879181038130779,1,93,pigmentation,BP,SOX10
6751,GO:0021510,0.45333804700917,0.878893636854084,1,93,spinal cord development,BP,NKX6-2
8209,GO:0032103,0.453356594711463,0.803161923648511,2,247,positive regulation of response to external stimulus,BP,CXCL14;LPAR1
6052,GO:0016787,0.453771421860776,0.655104415132426,15,2236,hydrolase activity,MF,PPP2R2C;FOLH1;ASPA;SEPT4;PADI2;GDA;MYRF;HSPA2;TOP2A;ENPP2;CNDP1;KLK6;CARNS1;MPPED1;DNAH17
16993,GO:0072599,0.454386407019113,0.878155605941135,1,104,establishment of protein localization to endoplasmic reticulum,BP,RYR2
8502,GO:0032559,0.454403109408483,0.674358905398373,10,1413,adenyl ribonucleotide binding,MF,CAMK2A;EPHB6;CDK18;HSPA2;TOP2A;IQCA1;MKI67;AK5;CARNS1;DNAH17
13727,GO:0051146,0.454855388145862,0.802070249541985,2,233,striated muscle cell differentiation,BP,GREM1;MYBPC1
9504,GO:0034705,0.454912071852623,0.877943309888163,1,94,potassium channel complex,CC,CNTN2
6719,GO:0019955,0.45519603770259,0.877751294948586,1,96,cytokine binding,MF,GREM1
5135,GO:0014020,0.455234131043447,0.877773731494153,1,92,primary neural tube formation,BP,LRP2
2,GO:0000003,0.455335375420005,0.686422167974535,8,1159,reproduction,BP,CLDN11;LRP2;SEPT4;HSPA2;TOP2A;PPP1R1B;GJB1;BOK
8575,GO:0032675,0.455454592339004,0.877585728702957,1,97,regulation of interleukin-6 production,BP,MBP
11393,GO:0043648,0.45562782875884,0.877471389521252,1,98,dicarboxylic acid metabolic process,BP,ASPA
16316,GO:0071407,0.455857706762854,0.736003622563703,4,536,cellular response to organic cyclic compound,BP,SOX10;PADI2;PAQR6;RYR2
20324,GO:1904659,0.457072512966173,0.876647146920263,1,94,glucose transmembrane transport,BP,SLC5A11
7022,GO:0022037,0.457219426775349,0.876570219032514,1,93,metencephalon development,BP,LPAR1
7848,GO:0031398,0.457647238649508,0.876267704994469,1,97,positive regulation of protein ubiquitination,BP,SEPT4
3113,GO:0006368,0.457648187074612,0.876267132985782,1,97,transcription elongation from RNA polymerase II promoter,BP,SOX10
7210,GO:0030175,0.457999170291085,0.876124030676724,1,91,filopodium,CC,ERMN
11786,GO:0044853,0.458503337118207,0.875795613413614,1,93,plasma membrane raft,CC,FXYD1
21316,GO:2000278,0.458710992568761,0.875635989010619,1,96,regulation of DNA biosynthetic process,BP,GREM1
21240,GO:2000134,0.458730834196552,0.875623984159872,1,96,negative regulation of G1/S transition of mitotic cell cycle,BP,GJC2
6471,GO:0019218,0.459314219633345,0.875259782569473,1,97,regulation of steroid metabolic process,BP,FGF1
6745,GO:0020037,0.460001723771572,0.874821385791833,1,99,heme binding,MF,FA2H
5683,GO:0016054,0.460810946205265,0.797451490202767,2,251,organic acid catabolic process,BP,ASPA;CARNS1
12460,GO:0046395,0.460810946205265,0.797451490202767,2,251,carboxylic acid catabolic process,BP,ASPA;CARNS1
3688,GO:0007229,0.461093203604614,0.874212195151689,1,94,integrin-mediated signaling pathway,BP,PLP1
7268,GO:0030258,0.461627603816737,0.796848031447749,2,243,lipid modification,BP,FA2H;FGF1
15034,GO:0060828,0.462110052460672,0.796472441914344,2,244,regulation of canonical Wnt signaling pathway,BP,SOX10;GREM1
15575,GO:0070062,0.462264245847753,0.64435284761699,16,2442,extracellular exosome,CC,CD22;CLDN11;BCAS1;LRP2;FOLH1;TF;CPNE6;PTGDS;ASPA;FBXO2;PADI2;GDA;HSPA2;ERMN;SERPINI1;RYR2
1516,GO:0003279,0.463343530810277,0.872848232255438,1,93,cardiac septum development,BP,LRP2
2947,GO:0006082,0.463890691871481,0.687105264862405,7,1032,organic acid metabolic process,BP,FOLH1;FA2H;PTGDS;ASPA;PLP1;CARNS1;SPOCK3
7421,GO:0030554,0.46452926426079,0.664974050099719,10,1425,adenyl nucleotide binding,MF,CAMK2A;EPHB6;CDK18;HSPA2;TOP2A;IQCA1;MKI67;AK5;CARNS1;DNAH17
4216,GO:0008630,0.46458642083593,0.87201673521791,1,99,intrinsic apoptotic signaling pathway in response to DNA damage,BP,BOK
4464,GO:0009260,0.464864564301058,0.794323843327561,2,249,ribonucleotide biosynthetic process,BP,AK5;GRM3
3714,GO:0007283,0.465947116967905,0.752909212024946,3,399,spermatogenesis,BP,CLDN11;SEPT4;HSPA2
20481,GO:1904949,0.466154064671893,0.871081814596125,1,96,ATPase complex,CC,FXYD1
13443,GO:0050715,0.466512862553505,0.870816074001478,1,100,positive regulation of cytokine secretion,BP,MBP
12749,GO:0046982,0.467622550110749,0.751494882453622,3,404,protein heterodimerization activity,MF,TPD52L1;TOP2A;BOK
13130,GO:0048598,0.467633369484638,0.725811636478037,4,542,embryonic morphogenesis,BP,LRP2;GREM1;MBP;RYR2
13094,GO:0048524,0.468048396389877,0.869862464658752,1,100,positive regulation of viral process,BP,TOP2A
19433,GO:1902807,0.468555081660488,0.869557495461716,1,99,negative regulation of cell cycle G1/S phase transition,BP,GJC2
16939,GO:0072522,0.468757440621464,0.791284028217113,2,251,purine-containing compound biosynthetic process,BP,AK5;GRM3
12314,GO:0046031,0.469110459554566,0.869221910223891,1,98,ADP metabolic process,BP,AK5
15535,GO:0062014,0.469238790205661,0.869120170492897,1,100,negative regulation of small molecule metabolic process,BP,GRM3
4222,GO:0008645,0.47037389700223,0.868431584247309,1,98,hexose transmembrane transport,BP,SLC5A11
12457,GO:0046390,0.470866217842096,0.78962787921788,2,252,ribose phosphate biosynthetic process,BP,AK5;GRM3
11324,GO:0043534,0.4710353701414,0.868016616231658,1,98,blood vessel endothelial cell migration,BP,GREM1
10665,GO:0042303,0.47106305338888,0.867999231554831,1,98,molting cycle,BP,FA2H
10844,GO:0042633,0.47106305338888,0.867999231554831,1,98,hair cycle,BP,FA2H
4719,GO:0010256,0.47215405479925,0.747694345658198,3,392,endomembrane system organization,BP,FA2H;PACSIN1;MYRF
15300,GO:0061387,0.473211828372727,0.866668306664437,1,96,regulation of extent of cell growth,BP,MAG
5531,GO:0015749,0.474296447011848,0.865947658560906,1,99,monosaccharide transmembrane transport,BP,SLC5A11
13437,GO:0050709,0.47471108848234,0.865652407187346,1,102,negative regulation of protein secretion,BP,VSNL1
5511,GO:0015711,0.475230187072583,0.745065804461051,3,403,organic anion transport,BP,LRP2;SLC17A7;CCK
9697,GO:0035326,0.475388842838865,0.865242836110481,1,100,enhancer binding,MF,SOX10
13803,GO:0051258,0.475422860939079,0.786039234500416,2,250,protein polymerization,BP,SLC39A12;TPPP
13395,GO:0050662,0.476703206378758,0.784997742514735,2,258,coenzyme binding,MF,ETNPPL;AIFM3
11782,GO:0044843,0.476857085303678,0.784894472017101,2,252,cell cycle G1/S phase transition,BP,CAMK2A;GJC2
18207,GO:0099094,0.477147111694459,0.864143507980919,1,98,ligand-gated cation channel activity,MF,RYR2
3378,GO:0006720,0.47743561597511,0.863904743042274,1,103,isoprenoid metabolic process,BP,LRP2
19889,GO:1903749,0.478244108324017,0.863376232407042,1,104,positive regulation of establishment of protein localization to mitochondrion,BP,MYBPC1
8135,GO:0031984,0.478486929156533,0.651889425625061,10,1497,organelle subcompartment,CC,HHATL;TF;FA2H;PTGDS;MYRF;GJB1;GPR37;BOK;HS3ST4;RYR2
14401,GO:0055007,0.478725003705353,0.863167526941699,1,95,cardiac muscle cell differentiation,BP,GREM1
363,GO:0000978,0.478811520601938,0.742011890546743,3,403,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,SOX10;NKX6-2;ZNF536
13164,GO:0048667,0.479125832132459,0.715718523491998,4,538,cell morphogenesis involved in neuron differentiation,BP,CAMK2A;MAG;CNTN2;CCK
11160,GO:0043254,0.47924410513922,0.741640148902218,3,404,regulation of protein complex assembly,BP,SLC39A12;TPPP;CCK
766,GO:0001952,0.480945465931298,0.861700747628544,1,98,regulation of cell-matrix adhesion,BP,GREM1
671,GO:0001822,0.482726779027693,0.780223001475173,2,246,kidney development,BP,FGF1;GREM1
1633,GO:0003779,0.482808284872015,0.738614115777017,3,386,actin binding,MF,ERMN;MOBP;MYBPC1
6597,GO:0019637,0.482957767567681,0.669553977644488,7,1043,organophosphate metabolic process,BP,CPNE6;FGF1;GDA;ENPP2;AK5;ETNPPL;GRM3
8548,GO:0032635,0.482970409097902,0.86031115157295,1,105,interleukin-6 production,BP,MBP
4962,GO:0010811,0.483243278297492,0.860175684795261,1,101,positive regulation of cell-substrate adhesion,BP,DOCK5
689,GO:0001841,0.483993179791164,0.859697869967998,1,100,neural tube formation,BP,LRP2
13833,GO:0051301,0.48436116063253,0.711041005080078,4,561,cell division,BP,SEPT4;FGF1;PACSIN1;TOP2A
12630,GO:0046718,0.486509460123055,0.857995471031873,1,105,viral entry into host cell,BP,MOG
13770,GO:0051209,0.486700624908473,0.857923730693731,1,100,release of sequestered calcium ion into cytosol,BP,RYR2
13819,GO:0051283,0.486700624908473,0.857923730693731,1,100,negative regulation of sequestering of calcium ion,BP,RYR2
3890,GO:0008092,0.486906405907881,0.676651450453496,6,846,cytoskeletal protein binding,MF,NEFM;PACSIN1;ERMN;MOBP;TPPP;MYBPC1
13678,GO:0051082,0.487321193218044,0.857430840896991,1,108,unfolded protein binding,MF,HSPA2
5062,GO:0010927,0.487788317111014,0.857254484702549,1,96,cellular component assembly involved in morphogenesis,BP,MYBPC1
7460,GO:0030660,0.488069931641233,0.856956484642169,1,106,Golgi-associated vesicle membrane,CC,NRGN
12600,GO:0046660,0.489373901094913,0.856124670325693,1,103,female sex differentiation,BP,LRP2
5803,GO:0016298,0.48981585155566,0.855799818077058,1,106,lipase activity,MF,ENPP2
13818,GO:0051282,0.489982912609942,0.855742500336121,1,101,regulation of sequestering of calcium ion,BP,RYR2
6421,GO:0019079,0.490101646847319,0.855609914759801,1,106,viral genome replication,BP,TOP2A
10943,GO:0042826,0.490469764390457,0.855385962904083,1,104,histone deacetylase binding,MF,TOP2A
12225,GO:0045859,0.490883036243756,0.686743547746577,5,720,regulation of protein kinase activity,BP,TPD52L1;FGF1;PPP1R1B;GREM1;LPAR1
13006,GO:0048285,0.490901172966019,0.731568981153901,3,407,organelle fission,BP,HSPA2;TOP2A;MKI67
3667,GO:0007204,0.491137551720693,0.773369312493075,2,257,positive regulation of cytosolic calcium ion concentration,BP,LPAR1;RYR2
8764,GO:0032963,0.49123208617822,0.854878156111286,1,104,collagen metabolic process,BP,KLK6
11751,GO:0044774,0.491480701456166,0.854691331528577,1,106,mitotic DNA integrity checkpoint,BP,TOP2A
12701,GO:0046906,0.491552195115639,0.854623412629327,1,108,tetrapyrrole binding,MF,FA2H
14727,GO:0060359,0.491933869697686,0.854388667179466,1,106,response to ammonium ion,BP,PPP1R1B
2855,GO:0005930,0.492346822840334,0.854166675338254,1,101,axoneme,CC,DNAH17
9558,GO:0034976,0.492451174043213,0.772281698851233,2,261,response to endoplasmic reticulum stress,BP,FBXO2;BOK
12660,GO:0046834,0.493618628081854,0.853291938947073,1,103,lipid phosphorylation,BP,FGF1
19362,GO:1902600,0.493664747518228,0.8531794161068,1,111,proton transmembrane transport,BP,SLC17A7
1275,GO:0002792,0.493679040958326,0.853198976465536,1,108,negative regulation of peptide secretion,BP,VSNL1
3957,GO:0008202,0.493930030519736,0.771062093556502,2,263,steroid metabolic process,BP,LRP2;FGF1
12129,GO:0045667,0.494449065452649,0.852711998382661,1,105,regulation of osteoblast differentiation,BP,GREM1
13083,GO:0048511,0.494865826438615,0.770308428282749,2,258,rhythmic process,BP,PTGDS;TOP2A
3850,GO:0008017,0.49553933847141,0.769794630570993,2,246,microtubule binding,MF,NEFM;TPPP
17553,GO:0097014,0.495629990746997,0.851948503061764,1,102,ciliary plasm,CC,DNAH17
6289,GO:0018105,0.495931729691339,0.769440074860724,2,255,peptidyl-serine phosphorylation,BP,CAMK2A;PPP1R1B
18561,GO:0150034,0.496052384920243,0.76934055248026,2,255,distal axon,CC,PACSIN1;CCK
7555,GO:0030863,0.496091390367116,0.851648077419005,1,101,cortical cytoskeleton,CC,MOBP
11499,GO:0044106,0.497044783166454,0.850878280236708,1,113,cellular amine metabolic process,BP,GPR37
5746,GO:0016192,0.497430410354988,0.624124214987046,12,1818,vesicle-mediated transport,BP,LRP2;TF;CPNE6;ADAP1;PADI2;PACSIN1;HSPA2;ENPP2;VSNL1;GREM1;LGI3;CNTN2
12973,GO:0048232,0.497513759613914,0.725758797320644,3,418,male gamete generation,BP,CLDN11;SEPT4;HSPA2
753,GO:0001936,0.497541098918929,0.850610338770807,1,106,regulation of endothelial cell proliferation,BP,PPP1R16B
14541,GO:0060079,0.497855294362113,0.85040743169686,1,105,excitatory postsynaptic potential,BP,SLC17A7
11876,GO:0045111,0.499141597147577,0.849520494839642,1,106,intermediate filament cytoskeleton,CC,NEFM
1199,GO:0002687,0.499254866238569,0.849373601051455,1,113,positive regulation of leukocyte migration,BP,CXCL14
13769,GO:0051208,0.499802506691249,0.849090619548073,1,104,sequestering of calcium ion,BP,RYR2
20483,GO:1904951,0.500204262349464,0.723383614315909,3,419,positive regulation of establishment of protein localization,BP,VSNL1;MYBPC1;MBP
11016,GO:0043021,0.500551346507502,0.848525264510946,1,109,ribonucleoprotein complex binding,MF,TF
369,GO:0000987,0.500888266773539,0.722783620366326,3,416,proximal promoter sequence-specific DNA binding,MF,SOX10;NKX6-2;ZNF536
18054,GO:0098796,0.501398403684741,0.652255300846925,7,1052,membrane protein complex,CC,TF;HSPA2;GJB1;CNTN2;RYR2;GJC2;FXYD1
7403,GO:0030522,0.501994313681599,0.764390791739529,2,261,intracellular receptor signaling pathway,BP,PADI2;ZNF536
2992,GO:0006165,0.502707674125063,0.847042585851803,1,109,nucleoside diphosphate phosphorylation,BP,AK5
7035,GO:0022412,0.502905968042586,0.763619763614468,2,264,cellular process involved in reproduction in multicellular organism,BP,SEPT4;HSPA2
12691,GO:0046887,0.503115894702624,0.846731167861149,1,112,positive regulation of hormone secretion,BP,VSNL1
12916,GO:0048037,0.503286762097706,0.72062960601894,3,433,cofactor binding,MF,FA2H;ETNPPL;AIFM3
17659,GO:0097193,0.504324735568651,0.76241651999561,2,269,intrinsic apoptotic signaling pathway,BP,SEPT4;BOK
7184,GO:0030141,0.5048697411556,0.673792888306345,5,750,secretory granule,CC,TF;PADI2;SERPINI1;KLK6;SV2B
16261,GO:0071333,0.505494754512995,0.845102263796143,1,110,cellular response to glucose stimulus,BP,VSNL1
2725,GO:0005737,0.505525923589485,0.579299706471714,65,10204,cytoplasm,CC,HHATL;BCAS1;CAMK2A;PPP2R2C;LRP2;FOLH1;TF;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;SLC17A7;MAG;ADAP1;EPHB6;PTGDS;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;FBXO2;PADI2;CDK18;GDA;NECAB1;PACSIN1;MYRF;HSPA2;TOP2A;PPP1R1B;ERMN;CXCL14;DOCK5;SLC39A12;CNDP1;AK5;NRGN;S100A1;VSNL1;SERPINI1;ETNPPL;HHIP;PPP1R14A;KLK6;MOBP;LGI3;GJB1;GPR37;TPPP;MAL;RCAN2;CARNS1;BOK;HS3ST4;AIFM3;SV2B;DNAH17;MYBPC1;OPALIN;LPAR1;RYR2;TMEM235
19762,GO:1903510,0.505944693566315,0.844799367089839,1,109,mucopolysaccharide metabolic process,BP,SPOCK3
12211,GO:0045834,0.508200412456939,0.843203370956822,1,111,positive regulation of lipid metabolic process,BP,FGF1
12305,GO:0045995,0.508651175347244,0.842918101228208,1,108,regulation of embryonic development,BP,MBP
11567,GO:0044281,0.508896377381037,0.613026542785213,12,1880,small molecule metabolic process,BP,LRP2;FOLH1;FA2H;PTGDS;ASPA;FGF1;GDA;PLP1;AK5;CARNS1;SPOCK3;GRM3
9296,GO:0034330,0.509016331506019,0.758504677731572,2,257,cell junction organization,BP,GREM1;GJB1
18852,GO:1901214,0.50938335699861,0.758164660419081,2,266,regulation of neuron death,BP,MAG;BOK
3580,GO:0007043,0.509808905502172,0.84209388870444,1,109,cell-cell junction assembly,BP,GJB1
9685,GO:0035296,0.509827486007623,0.84204058790131,1,113,regulation of tube diameter,BP,DOCK5
17914,GO:0097746,0.509827486007623,0.84204058790131,1,113,regulation of blood vessel diameter,BP,DOCK5
4166,GO:0008528,0.510186675443097,0.841749991324565,1,117,G-protein coupled peptide receptor activity,MF,GPR37
16259,GO:0071331,0.511524364571273,0.840852513149749,1,112,cellular response to hexose stimulus,BP,VSNL1
19780,GO:1903533,0.512034181265343,0.840471923383779,1,114,regulation of protein targeting,BP,MYBPC1
6697,GO:0019898,0.512115119736914,0.755846336986372,2,266,extrinsic component of membrane,CC,TF;SOX10
19677,GO:1903322,0.512920864935696,0.839842680067919,1,114,positive regulation of protein modification by small protein conjugation or removal,BP,SEPT4
7741,GO:0031214,0.513308638823098,0.839586635977012,1,112,biomineral tissue development,BP,GREM1
555,GO:0001653,0.513317604760753,0.839523316010482,1,118,peptide receptor activity,MF,GPR37
2850,GO:0005923,0.513750937155696,0.83930271264807,1,109,bicellular tight junction,CC,CLDN11
19887,GO:1903747,0.51385667492197,0.839167246237379,1,115,regulation of establishment of protein localization to mitochondrion,BP,MYBPC1
16257,GO:0071326,0.514643877180196,0.838625119207192,1,113,cellular response to monosaccharide stimulus,BP,VSNL1
13172,GO:0048675,0.515323463556,0.838202096193379,1,107,axon extension,BP,MAG
13847,GO:0051338,0.516188680799148,0.649122488333766,6,898,regulation of transferase activity,BP,EPHB6;TPD52L1;FGF1;PPP1R1B;GREM1;LPAR1
16650,GO:0072001,0.516823820877845,0.751834847523087,2,262,renal system development,BP,FGF1;GREM1
7192,GO:0030155,0.517189412130241,0.681095502427112,4,583,regulation of cell adhesion,BP,DOCK5;SERPINI1;GREM1;MBP
12227,GO:0045861,0.518501676121261,0.750350753689441,2,275,negative regulation of proteolysis,BP,SERPINI1;SPOCK3
2423,GO:0005096,0.518815778899043,0.750118123896735,2,263,GTPase activator activity,MF,ADAP1;RASAL1
2480,GO:0005178,0.519598219087021,0.835072358620196,1,112,integrin binding,MF,FGF1
4362,GO:0009135,0.520209444192118,0.834619146013902,1,113,purine nucleoside diphosphate metabolic process,BP,AK5
4402,GO:0009179,0.520209444192118,0.834619146013902,1,113,purine ribonucleoside diphosphate metabolic process,BP,AK5
12719,GO:0046939,0.520653305282217,0.83427708350705,1,115,nucleotide phosphorylation,BP,AK5
815,GO:0002020,0.520704491419326,0.834280267787141,1,111,protease binding,MF,MBP
4481,GO:0009308,0.52114629241787,0.833863032533275,1,121,amine metabolic process,BP,GPR37
8126,GO:0031966,0.52193060106357,0.676629604499193,4,619,mitochondrial membrane,CC,SOX10;NRGN;BOK;AIFM3
14023,GO:0051668,0.522338500132542,0.833059693963389,1,114,localization within membrane,BP,MAL
8293,GO:0032273,0.52317219636234,0.832430724275589,1,116,positive regulation of protein polymerization,BP,TPPP
18989,GO:1901615,0.523286840912851,0.70258351111244,3,436,organic hydroxy compound metabolic process,BP,LRP2;FGF1;GPR37
15632,GO:0070160,0.523373492190682,0.832323424111747,1,112,occluding junction,CC,CLDN11
4598,GO:0009790,0.523488161341638,0.642134289825109,6,892,embryo development,BP,LRP2;SOX10;TOP2A;GREM1;MBP;RYR2
6623,GO:0019752,0.524434343229813,0.641202285582776,6,932,carboxylic acid metabolic process,BP,FOLH1;FA2H;PTGDS;ASPA;PLP1;CARNS1
6667,GO:0019842,0.524644307556071,0.831322782334699,1,119,vitamin binding,MF,ETNPPL
6291,GO:0018107,0.52468639316928,0.831350158428844,1,113,peptidyl-threonine phosphorylation,BP,CAMK2A
4409,GO:0009187,0.525932112690997,0.830403068204982,1,116,cyclic nucleotide metabolic process,BP,GRM3
4407,GO:0009185,0.525945190665317,0.830403262489103,1,115,ribonucleoside diphosphate metabolic process,BP,AK5
3860,GO:0008037,0.526169274722939,0.830228085246736,1,116,cell recognition,BP,CNTN2
10501,GO:0040008,0.526818329225192,0.672060021921505,4,592,regulation of growth,BP,CPNE6;MAG;RASAL1;GREM1
12430,GO:0046330,0.528225434044239,0.828706050949944,1,116,positive regulation of JNK cascade,BP,TPD52L1
5750,GO:0016202,0.528855832060992,0.828247568203119,1,115,regulation of striated muscle tissue development,BP,GREM1
3310,GO:0006629,0.529334695872107,0.616511612807366,8,1245,lipid metabolic process,BP,LRP2;CPNE6;FA2H;PTGDS;FGF1;PLP1;ENPP2;ETNPPL
12265,GO:0045930,0.529829846256182,0.740465865032951,2,282,negative regulation of mitotic cell cycle,BP,TOP2A;GJC2
14309,GO:0052689,0.529880551948805,0.827426990339164,1,121,carboxylic ester hydrolase activity,MF,ENPP2
4616,GO:0009855,0.530945446053556,0.826669058068364,1,117,determination of bilateral symmetry,BP,GREM1
7686,GO:0031090,0.532099145593502,0.574094330619839,17,2684,organelle membrane,CC,CAMK2A;LRP2;TF;SOX10;FA2H;SLC17A7;PTGDS;PEX5L;FBXO2;PACSIN1;NRGN;HHIP;BOK;HS3ST4;AIFM3;SV2B;RYR2
7638,GO:0031012,0.532437651129106,0.694151133902034,3,431,extracellular matrix,CC,FGF1;HAPLN2;SPOCK3
9673,GO:0035270,0.532570709086791,0.825430950966275,1,119,endocrine system development,BP,NKX6-2
13557,GO:0050880,0.532835416785565,0.825213214517025,1,121,regulation of blood vessel size,BP,DOCK5
2758,GO:0005777,0.533588541916773,0.824636871614998,1,122,peroxisome,CC,PEX5L
10809,GO:0042579,0.533588541916773,0.824636871614998,1,122,microbody,CC,PEX5L
4603,GO:0009799,0.533719170378665,0.824575843046918,1,118,specification of symmetry,BP,GREM1
3958,GO:0008203,0.533747178695808,0.82454511264626,1,119,cholesterol metabolic process,BP,FGF1
5170,GO:0014065,0.533940756707086,0.824428413881622,1,116,phosphatidylinositol 3-kinase signaling,BP,PPP1R16B
13144,GO:0048634,0.53459156495912,0.82392693695051,1,117,regulation of muscle organ development,BP,GREM1
21855,GO:2001251,0.534941041832312,0.823672600239728,1,116,negative regulation of chromosome organization,BP,TOP2A
13990,GO:0051604,0.535220665025735,0.735684928502363,2,286,protein maturation,BP,KLK6;CNTN2
9626,GO:0035150,0.535554576384194,0.823150396332224,1,122,regulation of tube size,BP,DOCK5
19080,GO:1901861,0.535630894855005,0.823140094216039,1,117,regulation of muscle tissue development,BP,GREM1
16090,GO:0070972,0.535967151149834,0.822776949609178,1,129,protein localization to endoplasmic reticulum,BP,RYR2
3101,GO:0006354,0.536178739444898,0.822676749238958,1,122,DNA-templated transcription, elongation,BP,SOX10
8125,GO:0031965,0.537106811716497,0.734028760867007,2,278,nuclear membrane,CC,PTGDS;BOK
13409,GO:0050678,0.537168686985319,0.733973543240859,2,278,regulation of epithelial cell proliferation,BP,PPP1R16B;FGF1
3913,GO:0008134,0.537262926931943,0.662133832047757,4,597,transcription factor binding,MF,LRP2;SOX10;PADI2;ENPP2
10787,GO:0042542,0.537667748295753,0.821534320716959,1,123,response to hydrogen peroxide,BP,GPR37
17101,GO:0080135,0.537736832686273,0.661675317598781,4,602,regulation of cellular response to stress,BP,CAMK2A;TPD52L1;GPR37;BOK
7270,GO:0030260,0.53789772767254,0.821377236556098,1,121,entry into host cell,BP,MOG
11638,GO:0044409,0.53789772767254,0.821377236556098,1,121,entry into host,BP,MOG
14098,GO:0051806,0.53789772767254,0.821377236556098,1,121,entry into cell of other organism involved in symbiotic interaction,BP,MOG
14105,GO:0051828,0.53789772767254,0.821377236556098,1,121,entry into other organism involved in symbiotic interaction,BP,MOG
16255,GO:0071322,0.538774913573246,0.820706950893407,1,121,cellular response to carbohydrate stimulus,BP,VSNL1
16572,GO:0071840,0.538817024661708,0.544347242684476,37,5788,cellular component organization or biogenesis,BP,CAMK2A;LRP2;TF;CPNE6;PPP1R16B;FA2H;NEFM;SLC17A7;MAG;SEPT4;RASAL1;PEX5L;PADI2;PLP1;PACSIN1;MYRF;HSPA2;TOP2A;PPP1R1B;HAPLN2;ERMN;ENPP2;DOCK5;SLC39A12;MKI67;SERPINI1;GREM1;KLK6;GJB1;TPPP;MAL;BOK;CNTN2;CCK;MYBPC1;MBP;LPAR1
1140,GO:0002576,0.539235550810294,0.820373396336451,1,119,platelet degranulation,BP,TF
17846,GO:0097553,0.539450514881741,0.820238589147141,1,116,calcium ion transmembrane import into cytosol,BP,RYR2
3405,GO:0006766,0.539596024520643,0.820059510114475,1,123,vitamin metabolic process,BP,LRP2
2781,GO:0005814,0.539824555703672,0.819931651459643,1,118,centriole,CC,TOP2A
752,GO:0001935,0.540087742825131,0.819710168780412,1,120,endothelial cell proliferation,BP,PPP1R16B
4009,GO:0008285,0.543296867887977,0.656326740947682,4,610,negative regulation of cell proliferation,BP,SOX10;FBXO2;ST18;GREM1
9879,GO:0035639,0.543795257615911,0.583299487243548,11,1684,purine ribonucleoside triphosphate binding,MF,CAMK2A;EPHB6;SEPT4;CDK18;HSPA2;TOP2A;IQCA1;MKI67;AK5;CARNS1;DNAH17
7744,GO:0031225,0.54430406174433,0.816397709095532,1,126,anchored component of membrane,CC,CNTN2
7618,GO:0030968,0.545012543455142,0.815864445252136,1,124,endoplasmic reticulum unfolded protein response,BP,BOK
19969,GO:1903900,0.545140936721672,0.815755392887041,1,125,regulation of viral life cycle,BP,TOP2A
19380,GO:1902652,0.545310933707877,0.815641184289742,1,123,secondary alcohol metabolic process,BP,FGF1
18281,GO:0099565,0.546269472636964,0.814921758689101,1,120,chemical synaptic transmission, postsynaptic,BP,SLC17A7
576,GO:0001678,0.546273654794154,0.814889866293964,1,123,cellular glucose homeostasis,BP,VSNL1
18095,GO:0098862,0.546487145745539,0.814751625452977,1,120,cluster of actin-based cell projections,CC,LRP2
939,GO:0002224,0.546962073880056,0.814333008338158,1,125,toll-like receptor signaling pathway,BP,S100A1
2161,GO:0004702,0.547114516786193,0.814280640282657,1,118,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,EPHB6
16611,GO:0071901,0.548782527282047,0.81290386956827,1,125,negative regulation of protein serine/threonine kinase activity,BP,PPP1R1B
17959,GO:0098588,0.549228059833308,0.573229532861808,12,1891,bounding membrane of organelle,CC,CAMK2A;LRP2;TF;SOX10;SLC17A7;PEX5L;NRGN;HHIP;BOK;HS3ST4;SV2B;RYR2
473,GO:0001505,0.549248169298523,0.723047598269185,2,285,regulation of neurotransmitter levels,BP,CAMK2A;SLC17A7
3702,GO:0007265,0.549612831282459,0.677971332674928,3,441,Ras protein signal transduction,BP,ADAP1;RASAL1;LPAR1
6222,GO:0017124,0.550055869844779,0.811937611599359,1,121,SH3 domain binding,MF,LRP2
12387,GO:0046165,0.550464872862311,0.811567579519955,1,126,alcohol biosynthetic process,BP,FGF1
685,GO:0001837,0.550478066751757,0.811575428176269,1,124,epithelial to mesenchymal transition,BP,GREM1
13115,GO:0048565,0.550528516595871,0.81155441764023,1,122,digestive tract development,BP,SOX10
3757,GO:0007409,0.551627463579223,0.676057527806281,3,435,axonogenesis,BP,MAG;CNTN2;CCK
74,GO:0000151,0.552297063416871,0.720243723381382,2,289,ubiquitin ligase complex,CC,FBXO2;GPR37
1632,GO:0003777,0.552744542894668,0.809901840433041,1,112,microtubule motor activity,MF,DNAH17
6410,GO:0019058,0.552813732397308,0.71976312568325,2,291,viral life cycle,BP,TOP2A;MOG
9589,GO:0035051,0.553162064030101,0.809493836426425,1,119,cardiocyte differentiation,BP,GREM1
7966,GO:0031625,0.553372952085712,0.719245871466337,2,292,ubiquitin protein ligase binding,MF,GPR37;BOK
7320,GO:0030326,0.553431180663045,0.809249573149446,1,122,embryonic limb morphogenesis,BP,GREM1
9616,GO:0035113,0.553431180663045,0.809249573149446,1,122,embryonic appendage morphogenesis,BP,GREM1
12608,GO:0046683,0.553714546440849,0.808995159634982,1,125,response to organophosphorus,BP,LPAR1
14513,GO:0060048,0.554390303899201,0.808503631422488,1,120,cardiac muscle contraction,BP,RYR2
9298,GO:0034332,0.554391857028909,0.808492422626618,1,121,adherens junction organization,BP,GREM1
17219,GO:0090066,0.554427069819952,0.673351488283434,3,449,regulation of anatomical structure size,BP,MAG;DOCK5;CNTN2
3684,GO:0007224,0.554519581332035,0.808361355607874,1,124,smoothened signaling pathway,BP,HHIP
4554,GO:0009628,0.55584731380417,0.599264323784574,7,1099,response to abiotic stimulus,BP,CAMK2A;MAG;FGF1;HSPA2;PPP1R1B;LPAR1;RYR2
7128,GO:0030036,0.557037807262026,0.642972383995696,4,598,actin cytoskeleton organization,BP,PACSIN1;ERMN;MYBPC1;LPAR1
3885,GO:0008083,0.557324285688153,0.806029692945659,1,133,growth factor activity,MF,FGF1
11653,GO:0044430,0.557367392347016,0.581308180422339,9,1393,cytoskeletal part,CC,NEFM;SEPT4;HSPA2;TOP2A;AK5;MOBP;TPPP;DNAH17;MYBPC1
2142,GO:0004672,0.557439872941047,0.642578695692695,4,597,protein kinase activity,MF,CAMK2A;EPHB6;FGF1;CDK18
18970,GO:1901568,0.557578194587228,0.805833214240118,1,132,fatty acid derivative metabolic process,BP,PTGDS
13728,GO:0051147,0.559294376387749,0.804489010212355,1,127,regulation of muscle cell differentiation,BP,GREM1
7510,GO:0030808,0.559762388232345,0.804100331841501,1,128,regulation of nucleotide biosynthetic process,BP,GRM3
18729,GO:1900371,0.559762388232345,0.804100331841501,1,128,regulation of purine nucleotide biosynthetic process,BP,GRM3
3637,GO:0007167,0.560099617105455,0.606206329829333,6,929,enzyme linked receptor protein signaling pathway,BP,LRP2;EPHB6;FGF1;HHIP;GREM1;RYR2
7026,GO:0022402,0.560184455881838,0.585906115862471,8,1259,cell cycle process,BP,CAMK2A;SEPT4;TPD52L1;PACSIN1;HSPA2;TOP2A;MKI67;GJC2
11186,GO:0043296,0.561259504571372,0.802919897617553,1,124,apical junction complex,CC,CLDN11
14540,GO:0060078,0.561613251923687,0.802621904044726,1,125,regulation of postsynaptic membrane potential,BP,SLC17A7
469,GO:0001501,0.561689101945587,0.666336453214606,3,450,skeletal system development,BP,HAPLN2;HHIP;GREM1
16205,GO:0071236,0.561862010708486,0.802391091458173,1,128,cellular response to antibiotic,BP,GPR37
8090,GO:0031901,0.562629335597594,0.801763935212656,1,128,early endosome membrane,CC,BOK
13785,GO:0051235,0.563082153002797,0.710244130973189,2,287,maintenance of location,BP,SLC17A7;RYR2
7400,GO:0030518,0.564646260370589,0.800109040323643,1,128,intracellular steroid hormone receptor signaling pathway,BP,PADI2
3086,GO:0006333,0.565536030433211,0.799331950818628,1,133,chromatin assembly or disassembly,BP,PADI2
2727,GO:0005740,0.565988954207162,0.634078966944645,4,655,mitochondrial envelope,CC,SOX10;NRGN;BOK;AIFM3
2519,GO:0005261,0.566042449947681,0.707459087494401,2,288,cation channel activity,MF,SLC24A2;RYR2
6216,GO:0017111,0.56604637522972,0.614654127375649,5,769,nucleoside-triphosphatase activity,MF,SEPT4;HSPA2;TOP2A;CARNS1;DNAH17
2990,GO:0006163,0.566059933457324,0.662045537674253,3,471,purine nucleotide metabolic process,BP,GDA;AK5;GRM3
3308,GO:0006626,0.566735757291982,0.798323755987909,1,135,protein targeting to mitochondrion,BP,MYBPC1
11660,GO:0044440,0.567146389256688,0.660992996602017,3,464,endosomal part,CC,LRP2;TF;BOK
12489,GO:0046467,0.568017730841521,0.797269002370074,1,134,membrane lipid biosynthetic process,BP,FA2H
19693,GO:1903364,0.569958218228771,0.795678638062306,1,131,positive regulation of cellular protein catabolic process,BP,LRP2
9576,GO:0035023,0.569978900415558,0.795717142356396,1,125,regulation of Rho protein signal transduction,BP,LPAR1
8787,GO:0032993,0.571145827905034,0.79463411420529,1,137,protein-DNA complex,CC,ST18
14137,GO:0051897,0.57202108898687,0.793950918087451,1,131,positive regulation of protein kinase B signaling,BP,FGF1
14506,GO:0060041,0.57210887041899,0.793904597869527,1,128,retina development in camera-type eye,BP,SLC17A7
1873,GO:0004252,0.572164390614212,0.793771188183166,1,138,serine-type endopeptidase activity,MF,KLK6
4823,GO:0010594,0.572268888951352,0.793751714960386,1,130,regulation of endothelial cell migration,BP,FGF1
14469,GO:0055123,0.57300699081102,0.793130719523005,1,130,digestive system development,BP,SOX10
7031,GO:0022408,0.574119634698764,0.792148263781106,1,135,negative regulation of cell-cell adhesion,BP,MBP
4391,GO:0009165,0.574683918777201,0.69919362304432,2,307,nucleotide biosynthetic process,BP,AK5;GRM3
3200,GO:0006497,0.575063698380641,0.791341114723721,1,136,protein lipidation,BP,HHATL
11678,GO:0044464,0.575175182795134,0.563429952699625,89,14059,cell part,CC,HHATL;CD22;CLDN11;BCAS1;CAMK2A;PPP2R2C;LRP2;FOLH1;TF;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;SLC17A7;MAG;ADAP1;EPHB6;PTGDS;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;FBXO2;PADI2;CDK18;GDA;NECAB1;PLP1;PACSIN1;MYRF;HSPA2;TOP2A;PPP1R1B;RAPGEF5;ERMN;ENPP2;MOG;CXCL14;DOCK5;ST18;SLC39A12;MKI67;NKX6-2;CNDP1;CNTNAP4;AK5;NRGN;SLC24A2;SLC5A11;S100A1;PAQR6;VSNL1;SERPINI1;ETNPPL;HHIP;GREM1;PPP1R14A;KLK6;MOBP;LGI3;GJB1;GPR37;TPPP;MAL;RCAN2;CARNS1;BOK;S1PR5;GPR62;HS3ST4;AIFM3;CNTN2;SV2B;CCK;DNAH17;NKAIN2;MYBPC1;OPALIN;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;TMEM235;FXYD1
7485,GO:0030695,0.575183095337897,0.698755530002815,2,293,GTPase regulator activity,MF,ADAP1;RASAL1
5719,GO:0016125,0.575367524547472,0.791100600183681,1,134,sterol metabolic process,BP,FGF1
7587,GO:0030902,0.576264869928532,0.790365380934237,1,131,hindbrain development,BP,LPAR1
8498,GO:0032555,0.576358389183035,0.550396364286179,11,1724,purine ribonucleotide binding,MF,CAMK2A;EPHB6;SEPT4;CDK18;HSPA2;TOP2A;IQCA1;MKI67;AK5;CARNS1;DNAH17
4151,GO:0008509,0.576735063373519,0.697239080835058,2,302,anion transmembrane transporter activity,MF,SLC17A7;FXYD1
4359,GO:0009132,0.576829954741093,0.789858173733495,1,134,nucleoside diphosphate metabolic process,BP,AK5
11630,GO:0044389,0.577048744176954,0.696928913143746,2,305,ubiquitin-like protein ligase binding,MF,GPR37;BOK
8699,GO:0032870,0.578043567424405,0.62203477862142,4,630,cellular response to hormone stimulus,BP,CAMK2A;SOX10;PADI2;PAQR6
3956,GO:0008201,0.578333238829694,0.788558635279281,1,136,heparin binding,MF,FGF1
11492,GO:0044089,0.578351552247356,0.64992716344754,3,464,positive regulation of cellular component biogenesis,BP,TPPP;CCK;LPAR1
6322,GO:0018210,0.579189472967716,0.787860696652247,1,132,peptidyl-threonine modification,BP,CAMK2A
7952,GO:0031589,0.579198389719291,0.694885503866314,2,295,cell-substrate adhesion,BP,DOCK5;GREM1
19038,GO:1901701,0.57946334852463,0.586619656209072,6,959,cellular response to oxygen-containing compound,BP,CAMK2A;SOX10;VSNL1;GPR37;LPAR1;RYR2
557,GO:0001655,0.58023127257709,0.693886820881035,2,295,urogenital system development,BP,FGF1;GREM1
13247,GO:0048813,0.58102795966596,0.786309225288854,1,129,dendrite morphogenesis,BP,CAMK2A
18883,GO:1901293,0.581372124711266,0.692735808022907,2,311,nucleoside phosphate biosynthetic process,BP,AK5;GRM3
4354,GO:0009127,0.58207777562896,0.785332355364707,1,137,purine nucleoside monophosphate biosynthetic process,BP,AK5
4394,GO:0009168,0.58207777562896,0.785332355364707,1,137,purine ribonucleoside monophosphate biosynthetic process,BP,AK5
2554,GO:0005342,0.582400034003846,0.785053860425142,1,137,organic acid transmembrane transporter activity,MF,SLC17A7
12722,GO:0046943,0.582400034003846,0.785053860425142,1,137,carboxylic acid transmembrane transporter activity,MF,SLC17A7
475,GO:0001508,0.582584518080648,0.784966003585178,1,129,action potential,BP,RYR2
14763,GO:0060402,0.582787539964433,0.7847624605264,1,132,calcium ion transport into cytosol,BP,RYR2
6718,GO:0019953,0.583062633908431,0.616943225901058,4,641,sexual reproduction,BP,CLDN11;SEPT4;HSPA2;PPP1R1B
6700,GO:0019901,0.583305784531136,0.616711845852282,4,625,protein kinase binding,MF,MAG;EPHB6;TOP2A;RYR2
8702,GO:0032874,0.585058310137215,0.782755665352674,1,136,positive regulation of stress-activated MAPK cascade,BP,TPD52L1
13233,GO:0048771,0.585150627542883,0.782675253310199,1,136,tissue remodeling,BP,GREM1
8496,GO:0032553,0.585682572481642,0.540813034990244,11,1736,ribonucleotide binding,MF,CAMK2A;EPHB6;SEPT4;CDK18;HSPA2;TOP2A;IQCA1;MKI67;AK5;CARNS1;DNAH17
17832,GO:0097529,0.586149976907021,0.781745849852383,1,143,myeloid leukocyte migration,BP,GREM1
10601,GO:0042158,0.586311425803024,0.781628753532774,1,140,lipoprotein biosynthetic process,BP,HHATL
6197,GO:0017076,0.586943585031592,0.539511285654226,11,1738,purine nucleotide binding,MF,CAMK2A;EPHB6;SEPT4;CDK18;HSPA2;TOP2A;IQCA1;MKI67;AK5;CARNS1;DNAH17
15728,GO:0070304,0.587669501222164,0.780464658260555,1,137,positive regulation of stress-activated protein kinase signaling cascade,BP,TPD52L1
3333,GO:0006661,0.58827092698607,0.779945265995594,1,136,phosphatidylinositol biosynthetic process,BP,FGF1
5805,GO:0016301,0.588439758497877,0.59191513423133,5,785,kinase activity,MF,CAMK2A;EPHB6;FGF1;CDK18;AK5
18172,GO:0099003,0.588595596018329,0.779668642485606,1,135,vesicle-mediated transport in synapse,BP,PACSIN1
4946,GO:0010770,0.589495767186764,0.778894026725381,1,133,positive regulation of cell morphogenesis involved in differentiation,BP,DOCK5
2669,GO:0005623,0.589954679200042,0.548720178303321,89,14077,cell,CC,HHATL;CD22;CLDN11;BCAS1;CAMK2A;PPP2R2C;LRP2;FOLH1;TF;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;SLC17A7;MAG;ADAP1;EPHB6;PTGDS;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;FBXO2;PADI2;CDK18;GDA;NECAB1;PLP1;PACSIN1;MYRF;HSPA2;TOP2A;PPP1R1B;RAPGEF5;ERMN;ENPP2;MOG;CXCL14;DOCK5;ST18;SLC39A12;MKI67;NKX6-2;CNDP1;CNTNAP4;AK5;NRGN;SLC24A2;SLC5A11;S100A1;PAQR6;VSNL1;SERPINI1;ETNPPL;HHIP;GREM1;PPP1R14A;KLK6;MOBP;LGI3;GJB1;GPR37;TPPP;MAL;RCAN2;CARNS1;BOK;S1PR5;GPR62;HS3ST4;AIFM3;CNTN2;SV2B;CCK;DNAH17;NKAIN2;MYBPC1;OPALIN;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;TMEM235;FXYD1
13834,GO:0051302,0.590791815502702,0.777705180808523,1,138,regulation of cell division,BP,FGF1
4576,GO:0009719,0.591279475142943,0.546671644524933,9,1450,response to endogenous stimulus,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;PAQR6;HHIP;GREM1;RYR2
2751,GO:0005769,0.591895392373053,0.682435548061942,2,308,early endosome,CC,TF;BOK
16991,GO:0072594,0.59369192592839,0.634426366086666,3,493,establishment of protein localization to organelle,BP,PEX5L;MYBPC1;RYR2
16270,GO:0071347,0.594925164484864,0.773961541169293,1,146,cellular response to interleukin-1,BP,ST18
19469,GO:1902903,0.595182793078388,0.679173391700921,2,308,regulation of supramolecular fiber organization,BP,SLC39A12;LPAR1
13638,GO:0051017,0.595203073843785,0.773769414016819,1,139,actin filament bundle assembly,BP,LPAR1
15368,GO:0061572,0.595203073843785,0.773769414016819,1,139,actin filament bundle organization,BP,LPAR1
4369,GO:0009142,0.595994605819107,0.773026468115141,1,143,nucleoside triphosphate biosynthetic process,BP,AK5
1631,GO:0003774,0.596145143366063,0.773026538243174,1,128,motor activity,MF,DNAH17
16269,GO:0071346,0.596336027547858,0.772696087552801,1,146,cellular response to interferon-gamma,BP,CAMK2A
773,GO:0001959,0.596337960174817,0.772718071463276,1,143,regulation of cytokine-mediated signaling pathway,BP,PADI2
13777,GO:0051224,0.596461321474247,0.772599178749561,1,144,negative regulation of protein transport,BP,VSNL1
14397,GO:0055002,0.59654277318096,0.77260243559714,1,135,striated muscle cell development,BP,MYBPC1
395,GO:0001047,0.597158676742426,0.772013037812288,1,139,core promoter binding,MF,ST18
13745,GO:0051172,0.59723138921831,0.520127590731565,13,2109,negative regulation of nitrogen compound metabolic process,BP,HHATL;SOX10;PPP1R16B;PPP1R1B;NKX6-2;S100A1;SERPINI1;GREM1;PPP1R14A;SPOCK3;ZNF536;GRM3;FXYD1
15534,GO:0062013,0.597358060704827,0.771800108833506,1,143,positive regulation of small molecule metabolic process,BP,FGF1
3706,GO:0007269,0.597629608829918,0.77158866761998,1,139,neurotransmitter secretion,BP,CAMK2A
18314,GO:0099643,0.597629608829918,0.77158866761998,1,139,signal release from synapse,BP,CAMK2A
1380,GO:0003018,0.597780416827486,0.771411234700783,1,144,vascular process in circulatory system,BP,DOCK5
2748,GO:0005766,0.599851396763853,0.769513801757202,1,147,primary lysosome,CC,PADI2
10811,GO:0042582,0.599851396763853,0.769513801757202,1,147,azurophil granule,CC,PADI2
3084,GO:0006323,0.600125424028146,0.769305037498404,1,142,DNA packaging,BP,TOP2A
13435,GO:0050707,0.60046278737339,0.768966324664151,1,146,regulation of cytokine secretion,BP,MBP
21859,GO:2001257,0.60062060667089,0.768863457117519,1,141,regulation of cation channel activity,BP,S100A1
16355,GO:0071466,0.600723715336548,0.768729072185571,1,146,cellular response to xenobiotic stimulus,BP,RYR2
18469,GO:0120032,0.600874899268125,0.768632170309649,1,141,regulation of plasma membrane bounded cell projection assembly,BP,PPP1R16B
5177,GO:0014074,0.602518753318346,0.767133127633901,1,141,response to purine-containing compound,BP,RYR2
9441,GO:0034614,0.603324243472011,0.766347328989068,1,147,cellular response to reactive oxygen species,BP,GPR37
4622,GO:0009888,0.603398568984428,0.527761554634266,10,1618,tissue development,BP,LRP2;SOX10;PPP1R16B;FA2H;FGF1;HAPLN2;HHIP;GREM1;KLK6;RYR2
10864,GO:0042692,0.603517591276297,0.670812031498144,2,308,muscle cell differentiation,BP,GREM1;MYBPC1
7067,GO:0022839,0.60367691502374,0.670642373172864,2,311,ion gated channel activity,MF,SLC17A7;RYR2
12899,GO:0048015,0.604580619401249,0.765243295440508,1,141,phosphatidylinositol-mediated signaling,BP,PPP1R16B
21190,GO:2000045,0.604643745582667,0.765152162910653,1,145,regulation of G1/S transition of mitotic cell cycle,BP,GJC2
13133,GO:0048609,0.604793202196624,0.594538781795896,4,657,multicellular organismal reproductive process,BP,CLDN11;SEPT4;HSPA2;PPP1R1B
15551,GO:0070011,0.605021716420066,0.622774478605083,3,494,peptidase activity, acting on L-amino acid peptides,MF,FOLH1;CNDP1;KLK6
21841,GO:2001236,0.605375884975574,0.764470332914015,1,146,regulation of extrinsic apoptotic signaling pathway,BP,MAL
16938,GO:0072521,0.60551059996325,0.622260233468195,3,499,purine-containing compound metabolic process,BP,GDA;AK5;GRM3
3639,GO:0007169,0.605826349169412,0.593466745765132,4,648,transmembrane receptor protein tyrosine kinase signaling pathway,BP,EPHB6;FGF1;HHIP;GREM1
14831,GO:0060491,0.606099989303044,0.763826971805869,1,143,regulation of cell projection assembly,BP,PPP1R16B
20482,GO:1904950,0.606717421008004,0.76321634876385,1,148,negative regulation of establishment of protein localization,BP,VSNL1
7224,GO:0030198,0.607834913620015,0.666423590736038,2,310,extracellular matrix organization,BP,HAPLN2;GREM1
7065,GO:0022836,0.608585451210441,0.665646741064638,2,314,gated channel activity,MF,SLC17A7;RYR2
2854,GO:0005929,0.608981555031882,0.618668012470592,3,485,cilium,CC,SEPT4;HHIP;DNAH17
14762,GO:0060401,0.609077383046018,0.761075840719056,1,142,cytosolic calcium ion transport,BP,RYR2
7161,GO:0030111,0.610913432356484,0.663248831662771,2,320,regulation of Wnt signaling pathway,BP,SOX10;GREM1
9613,GO:0035107,0.611309352467456,0.758992368016992,1,142,appendage morphogenesis,BP,GREM1
9614,GO:0035108,0.611309352467456,0.758992368016992,1,142,limb morphogenesis,BP,GREM1
3337,GO:0006665,0.611697836305004,0.758563562762218,1,150,sphingolipid metabolic process,BP,FA2H
4383,GO:0009156,0.61198725787177,0.758299849833505,1,149,ribonucleoside monophosphate biosynthetic process,BP,AK5
12901,GO:0048017,0.612240499374057,0.758102472216738,1,144,inositol lipid-mediated signaling,BP,PPP1R16B
6105,GO:0016874,0.612726189271139,0.757598103023298,1,150,ligase activity,MF,CARNS1
7229,GO:0030203,0.613589700981426,0.756808918208264,1,147,glycosaminoglycan metabolic process,BP,SPOCK3
8470,GO:0032504,0.613793374389461,0.585068955346814,4,665,multicellular organism reproduction,BP,CLDN11;SEPT4;HSPA2;PPP1R1B
15000,GO:0060759,0.613933655032401,0.756461002125939,1,150,regulation of response to cytokine stimulus,BP,PADI2
8750,GO:0032940,0.616124089991116,0.528076946574673,8,1334,secretion by cell,BP,CAMK2A;TF;SLC17A7;PADI2;VSNL1;LGI3;CCK;MBP
2144,GO:0004674,0.616434692760575,0.610862005467757,3,475,protein serine/threonine kinase activity,MF,CAMK2A;EPHB6;CDK18
12694,GO:0046890,0.616708386782494,0.753825916391767,1,151,regulation of lipid biosynthetic process,BP,FGF1
2818,GO:0005875,0.617076364194788,0.753558341469698,1,141,microtubule associated complex,CC,DNAH17
6703,GO:0019904,0.618406322409961,0.580182674331819,4,657,protein domain specific binding,MF,LRP2;HSPA2;BOK;LPAR1
9821,GO:0035567,0.618436136788132,0.752187538456252,1,150,non-canonical Wnt signaling pathway,BP,CAMK2A
10808,GO:0042578,0.618508621879287,0.655398326699253,2,323,phosphoric ester hydrolase activity,MF,PPP2R2C;ENPP2
7464,GO:0030666,0.620622017644711,0.750078200237696,1,152,endocytic vesicle membrane,CC,CAMK2A
13405,GO:0050673,0.621237547892443,0.652547780983843,2,325,epithelial cell proliferation,BP,PPP1R16B;FGF1
18261,GO:0099531,0.621576795129539,0.749183179190724,1,149,presynaptic process involved in chemical synaptic transmission,BP,CAMK2A
8914,GO:0033209,0.624190824420521,0.746566705630539,1,161,tumor necrosis factor-mediated signaling pathway,BP,ST18
5305,GO:0015079,0.624543299411168,0.746282636236137,1,153,potassium ion transmembrane transporter activity,MF,SLC24A2
83,GO:0000166,0.624998576535737,0.494967510863421,12,1956,nucleotide binding,MF,CAMK2A;EPHB6;SEPT4;CDK18;HSPA2;TOP2A;IQCA1;MKI67;AK5;CARNS1;AIFM3;DNAH17
3601,GO:0007088,0.625389553084604,0.745475339332091,1,151,regulation of mitotic nuclear division,BP,MKI67
8822,GO:0033043,0.625625048324034,0.526994944023022,7,1159,regulation of organelle organization,BP,PADI2;TOP2A;SLC39A12;MKI67;BOK;MYBPC1;LPAR1
18878,GO:1901265,0.62563976136337,0.494284899231195,12,1957,nucleoside phosphate binding,MF,CAMK2A;EPHB6;SEPT4;CDK18;HSPA2;TOP2A;IQCA1;MKI67;AK5;CARNS1;AIFM3;DNAH17
4855,GO:0010639,0.625777907106907,0.647776175449258,2,327,negative regulation of organelle organization,BP,TOP2A;BOK
111,GO:0000226,0.626335311152025,0.600309855444179,3,491,microtubule cytoskeleton organization,BP,SLC39A12;TPPP;CNTN2
6077,GO:0016829,0.627711108157649,0.74314101889628,1,160,lyase activity,MF,ETNPPL
3589,GO:0007059,0.628037406997341,0.645386375860911,2,328,chromosome segregation,BP,TOP2A;MKI67
2756,GO:0005775,0.630140704400249,0.740766913019719,1,158,vacuolar lumen,CC,PADI2
947,GO:0002244,0.630584585526532,0.740321592084659,1,159,hematopoietic progenitor cell differentiation,BP,TOP2A
6970,GO:0021915,0.63062621062879,0.740349195108031,1,150,neural tube development,BP,LRP2
19432,GO:1902806,0.632191093731765,0.738753720342,1,156,regulation of cell cycle G1/S phase transition,BP,GJC2
3604,GO:0007093,0.632563857004103,0.738376337682195,1,157,mitotic cell cycle checkpoint,BP,TOP2A
4392,GO:0009166,0.632596591526062,0.738351309288725,1,156,nucleotide catabolic process,BP,GDA
11427,GO:0043902,0.632963398633618,0.73797204045125,1,158,positive regulation of multi-organism process,BP,TOP2A
14642,GO:0060249,0.633602332424849,0.639442741987012,2,336,anatomical structure homeostasis,BP,TF;SLC17A7
5175,GO:0014070,0.633752592131806,0.54400300183581,5,847,response to organic cyclic compound,BP,SOX10;PADI2;PPP1R1B;PAQR6;RYR2
10820,GO:0042592,0.634148529622526,0.501354689516944,9,1514,homeostatic process,BP,TF;SLC17A7;SLC39A12;SLC24A2;VSNL1;BOK;CCK;LPAR1;RYR2
19778,GO:1903531,0.634158377864726,0.736774991788693,1,159,negative regulation of secretion by cell,BP,VSNL1
5476,GO:0015631,0.634331343619569,0.638699404161652,2,322,tubulin binding,MF,NEFM;TPPP
4351,GO:0009124,0.634823846043157,0.736110741620436,1,159,nucleoside monophosphate biosynthetic process,BP,AK5
7939,GO:0031570,0.63484686169764,0.736102502137075,1,157,DNA integrity checkpoint,BP,TOP2A
11072,GO:0043123,0.63528652447345,0.735640947603251,1,160,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,LPAR1
14396,GO:0055001,0.63530607642482,0.73569822946693,1,150,muscle cell development,BP,MYBPC1
3978,GO:0008236,0.635941155610447,0.734964241399103,1,163,serine-type peptidase activity,MF,KLK6
11749,GO:0044772,0.637119830913399,0.588624746806445,3,515,mitotic cell cycle phase transition,BP,CAMK2A;TPD52L1;GJC2
9303,GO:0034341,0.637811454977178,0.733078029413062,1,164,response to interferon-gamma,BP,CAMK2A
3362,GO:0006694,0.638387433803804,0.732518458456074,1,161,steroid biosynthetic process,BP,FGF1
3783,GO:0007507,0.638796755962683,0.586826695478668,3,493,heart development,BP,LRP2;GREM1;RYR2
2909,GO:0006022,0.638942726116945,0.731979742773862,1,158,aminoglycan metabolic process,BP,SPOCK3
12428,GO:0046328,0.640105790302204,0.730810231204488,1,157,regulation of JNK cascade,BP,TPD52L1
7693,GO:0031099,0.640323147569535,0.73056027298996,1,161,regeneration,BP,KLK6
3091,GO:0006338,0.640500078287295,0.730395378070917,1,159,chromatin remodeling,BP,PADI2
11673,GO:0044455,0.641390142108949,0.729408372139441,1,171,mitochondrial membrane part,CC,SOX10
13499,GO:0050796,0.642063931562778,0.728805051973354,1,159,regulation of insulin secretion,BP,VSNL1
937,GO:0002221,0.642253301997647,0.728597335495661,1,161,pattern recognition receptor signaling pathway,BP,S100A1
14893,GO:0060589,0.64262478773882,0.629711950040667,2,334,nucleoside-triphosphatase regulator activity,MF,ADAP1;RASAL1
8486,GO:0032535,0.642801914140248,0.629516550541629,2,335,regulation of cellular component size,BP,MAG;CNTN2
6696,GO:0019897,0.643337410059493,0.727497562436505,1,160,extrinsic component of plasma membrane,CC,TF
15873,GO:0070555,0.644113527440288,0.726660341358776,1,166,response to interleukin-1,BP,ST18
6253,GO:0017171,0.645193539427335,0.72554487329137,1,167,serine hydrolase activity,MF,KLK6
18468,GO:0120031,0.645475519086899,0.579471871188834,3,509,plasma membrane bounded cell projection assembly,BP,PPP1R16B;SEPT4;LPAR1
18882,GO:1901292,0.64632625317871,0.724413670466615,1,162,nucleoside phosphate catabolic process,BP,GDA
7792,GO:0031301,0.646869604366384,0.723817833971108,1,167,integral component of organelle membrane,CC,SLC17A7
601,GO:0001726,0.647308379168227,0.723437008903788,1,157,ruffle,CC,PACSIN1
4058,GO:0008361,0.647951769068512,0.722771260489234,1,157,regulation of cell size,BP,MAG
18754,GO:1900542,0.65097843815594,0.719571334213241,1,164,regulation of purine nucleotide metabolic process,BP,GRM3
8649,GO:0032787,0.651247303741342,0.573043585995663,3,532,monocarboxylic acid metabolic process,BP,FA2H;PTGDS;PLP1
11668,GO:0044450,0.651250370799888,0.719316529462024,1,160,microtubule organizing center part,CC,TOP2A
7761,GO:0031256,0.651329963147377,0.719248555398861,1,158,leading edge membrane,CC,PACSIN1
3818,GO:0007601,0.651477879777878,0.719049339072207,1,164,visual perception,BP,SLC24A2
18824,GO:1901136,0.651677666604376,0.718819241132085,1,167,carbohydrate derivative catabolic process,BP,FBXO2
13503,GO:0050803,0.652739012595542,0.717757498284829,1,160,regulation of synapse structure or activity,BP,SLC17A7
7489,GO:0030705,0.653144648448699,0.717339173897827,1,159,cytoskeleton-dependent intracellular transport,BP,MOBP
4587,GO:0009749,0.653856117436232,0.716546706901698,1,165,response to glucose,BP,VSNL1
4845,GO:0010628,0.654378108994064,0.473162887496555,10,1691,positive regulation of gene expression,BP,SOX10;FGF1;PADI2;PLP1;MYRF;TOP2A;ST18;GREM1;CNTN2;GJC2
16245,GO:0071310,0.654899146019148,0.455253215225731,14,2366,cellular response to organic substance,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;HSPA2;ST18;PAQR6;VSNL1;HHIP;GREM1;BOK;LPAR1;RYR2
13396,GO:0050663,0.655428177948933,0.71486026467347,1,169,cytokine secretion,BP,MBP
11652,GO:0044429,0.656705434182579,0.518709445339696,5,910,mitochondrial part,CC,SOX10;NRGN;ETNPPL;BOK;AIFM3
3712,GO:0007276,0.657489821349363,0.566064737716782,3,528,gamete generation,BP,CLDN11;SEPT4;HSPA2
13604,GO:0050953,0.658442041606395,0.711674133255151,1,167,sensory perception of light stimulus,BP,SLC24A2
10600,GO:0042157,0.658761172415922,0.711319856384675,1,169,lipoprotein metabolic process,BP,HHATL
13772,GO:0051216,0.659753428039885,0.710280587291305,1,166,cartilage development,BP,GREM1
15842,GO:0070507,0.66021549590658,0.709807693146046,1,163,regulation of microtubule cytoskeleton organization,BP,SLC39A12
15829,GO:0070482,0.660398059344553,0.609989576405217,2,354,response to oxygen levels,BP,LPAR1;RYR2
17007,GO:0072655,0.660597184417517,0.709322203193562,1,174,establishment of protein localization to mitochondrion,BP,MYBPC1
3743,GO:0007369,0.660829965466423,0.709134217032656,1,165,gastrulation,BP,MBP
2407,GO:0005057,0.661987644606477,0.707904605428244,1,163,signal transducer activity, downstream of receptor,MF,EPHB6
4586,GO:0009746,0.662445633624606,0.707368167395354,1,169,response to hexose,BP,VSNL1
7282,GO:0030278,0.662994506449636,0.7067830286529,1,168,regulation of ossification,BP,GREM1
7124,GO:0030031,0.663236881903707,0.5595815084818,3,523,cell projection assembly,BP,PPP1R16B;SEPT4;LPAR1
2177,GO:0004721,0.663279385599408,0.706482423989617,1,167,phosphoprotein phosphatase activity,MF,PPP2R2C
2982,GO:0006140,0.663476631350021,0.706248297034354,1,170,regulation of nucleotide metabolic process,BP,GRM3
8770,GO:0032970,0.664989524933917,0.604815478207856,2,347,regulation of actin filament-based process,BP,LPAR1;RYR2
13212,GO:0048736,0.665500793479462,0.70408950121662,1,165,appendage development,BP,GREM1
14599,GO:0060173,0.665500793479462,0.70408950121662,1,165,limb development,BP,GREM1
4632,GO:0009898,0.666315790622944,0.703166987057485,1,170,cytoplasmic side of plasma membrane,CC,RASAL1
13256,GO:0048839,0.666960832932776,0.70247757618076,1,168,inner ear development,BP,CXCL14
15894,GO:0070585,0.667163289612898,0.702195959661094,1,177,protein localization to mitochondrion,BP,MYBPC1
19010,GO:1901654,0.667822110376199,0.701501931552994,1,173,response to ketone,BP,SOX10
726,GO:0001894,0.66949637738949,0.699665849676197,1,173,tissue homeostasis,BP,TF
14079,GO:0051783,0.670429812419258,0.6986521563716,1,171,regulation of nuclear division,BP,MKI67
14719,GO:0060348,0.671527650386048,0.697454529956241,1,169,bone development,BP,GREM1
6699,GO:0019900,0.672621916618882,0.520311018483297,4,700,kinase binding,MF,MAG;EPHB6;TOP2A;RYR2
9284,GO:0034284,0.673186613637776,0.695582150056155,1,174,response to monosaccharide,BP,VSNL1
13495,GO:0050792,0.673762896325737,0.694915440254484,1,178,regulation of viral process,BP,TOP2A
10743,GO:0042445,0.674210901585418,0.694404116043364,1,180,hormone metabolic process,BP,KLK6
8691,GO:0032838,0.674546495050701,0.694103894319913,1,169,plasma membrane bounded cell projection cytoplasm,CC,DNAH17
11747,GO:0044770,0.675086815167821,0.54598605912468,3,545,cell cycle phase transition,BP,CAMK2A;TPD52L1;GJC2
1195,GO:0002683,0.675938615505415,0.592200829599313,2,368,negative regulation of immune system process,BP,PADI2;GREM1
6232,GO:0017137,0.6763026337224,0.692134729044456,1,170,Rab GTPase binding,MF,MOBP
14136,GO:0051896,0.676857373741383,0.691485241245529,1,174,regulation of protein kinase B signaling,BP,FGF1
18060,GO:0098802,0.67731551817168,0.690970986585461,1,174,plasma membrane receptor complex,CC,TF
13663,GO:0051048,0.677916071754479,0.690262912647925,1,179,negative regulation of secretion,BP,VSNL1
13532,GO:0050852,0.678081988307896,0.69005109757984,1,183,T cell receptor signaling pathway,BP,MOG
7791,GO:0031300,0.678318279952556,0.689791189388223,1,182,intrinsic component of organelle membrane,CC,SLC17A7
11041,GO:0043062,0.680182852286626,0.587286725984986,2,356,extracellular structure organization,BP,HAPLN2;GREM1
19471,GO:1902905,0.68099863778088,0.686786293491858,1,178,positive regulation of supramolecular fiber organization,BP,LPAR1
6175,GO:0017038,0.681899222880742,0.685756569523406,1,179,protein import,BP,PEX5L
3996,GO:0008270,0.684180956911955,0.506959872036518,4,719,zinc ion binding,MF,GDA;ENPP2;ST18;HHIP
7893,GO:0031461,0.68489720553217,0.682325379298843,1,180,cullin-RING ubiquitin ligase complex,CC,FBXO2
4634,GO:0009913,0.685098886914249,0.682093964681945,1,180,epidermal cell differentiation,BP,FA2H
17404,GO:0090316,0.685180224323409,0.682007085519941,1,179,positive regulation of intracellular protein transport,BP,MYBPC1
18531,GO:0140097,0.685562910229944,0.681554620041228,1,181,catalytic activity, acting on DNA,MF,TOP2A
11547,GO:0044242,0.688302008213886,0.678363481916905,1,186,cellular lipid catabolic process,BP,ENPP2
3561,GO:0007017,0.688754467606782,0.501633828697934,4,708,microtubule-based process,BP,SLC39A12;TPPP;CNTN2;DNAH17
11337,GO:0043547,0.68977601902127,0.575949282829055,2,363,positive regulation of GTPase activity,BP,ADAP1;RASAL1
2711,GO:0005694,0.692153301712382,0.478292648150484,5,900,chromosome,CC,SOX10;PADI2;HSPA2;TOP2A;MKI67
18094,GO:0098858,0.692621192593995,0.673389477456515,1,177,actin-based cell projection,CC,ERMN
15929,GO:0070663,0.692627949502207,0.673305302483758,1,189,regulation of leukocyte proliferation,BP,GREM1
7807,GO:0031324,0.693243542746864,0.416389522509487,13,2250,negative regulation of cellular metabolic process,BP,HHATL;SOX10;PPP1R16B;PPP1R1B;NKX6-2;S100A1;SERPINI1;GREM1;PPP1R14A;SPOCK3;ZNF536;GRM3;FXYD1
13436,GO:0050708,0.693948354042409,0.570934222560758,2,374,regulation of protein secretion,BP,VSNL1;MBP
17367,GO:0090276,0.693985787697361,0.6717413734823,1,184,regulation of peptide hormone secretion,BP,VSNL1
18245,GO:0099513,0.694225492478311,0.523531750620445,3,545,polymeric cytoskeletal fiber,CC,NEFM;TPPP;DNAH17
13686,GO:0051090,0.697663040749779,0.566446331518219,2,379,regulation of DNA binding transcription factor activity,BP,CAMK2A;GREM1
11568,GO:0044282,0.698192125636815,0.565782758801713,2,390,small molecule catabolic process,BP,ASPA;CARNS1
3292,GO:0006605,0.701227788703508,0.56208795115375,2,394,protein targeting,BP,PEX5L;MYBPC1
7149,GO:0030073,0.701372799289039,0.662947678286653,1,186,insulin secretion,BP,VSNL1
403,GO:0001076,0.701549000540761,0.662748673520017,1,184,transcription factor activity, RNA polymerase II transcription factor binding,MF,SOX10
12700,GO:0046903,0.701812912100881,0.433232580698373,8,1439,secretion,BP,CAMK2A;TF;SLC17A7;PADI2;VSNL1;LGI3;CCK;MBP
3694,GO:0007254,0.70279729613706,0.661227128059272,1,187,JNK cascade,BP,TPD52L1
14036,GO:0051701,0.702800083590881,0.661205407186673,1,190,interaction with host,BP,MOG
6040,GO:0016773,0.703168954127755,0.484583740789669,4,721,phosphotransferase activity, alcohol group as acceptor,MF,CAMK2A;EPHB6;FGF1;CDK18
5475,GO:0015630,0.703798207211153,0.450519156926638,6,1074,microtubule cytoskeleton,CC,SEPT4;HSPA2;TOP2A;AK5;TPPP;DNAH17
5581,GO:0015850,0.703873427672176,0.659909109084217,1,190,organic hydroxy compound transport,BP,SLC5A11
2031,GO:0004518,0.704742178101086,0.658839181938593,1,193,nuclease activity,MF,ENPP2
2778,GO:0005802,0.705112396969938,0.658414013730512,1,189,trans-Golgi network,CC,BOK
16607,GO:0071897,0.706856693330897,0.656279571648731,1,191,DNA biosynthetic process,BP,GREM1
17948,GO:0098562,0.70725358827012,0.655795206100226,1,191,cytoplasmic side of membrane,CC,RASAL1
750,GO:0001933,0.709396834030624,0.552071811339627,2,387,negative regulation of protein phosphorylation,BP,PPP1R1B;GREM1
21839,GO:2001234,0.710585143659767,0.651672799782964,1,197,negative regulation of apoptotic signaling pathway,BP,BOK
551,GO:0001649,0.711290648568625,0.650837620128722,1,191,osteoblast differentiation,BP,GREM1
4621,GO:0009887,0.713781896607814,0.452726903500832,5,913,animal organ morphogenesis,BP,LRP2;FGF1;HHIP;GREM1;RYR2
8700,GO:0032872,0.71385360597704,0.647648827653561,1,193,regulation of stress-activated MAPK cascade,BP,TPD52L1
18823,GO:1901135,0.713940556242784,0.438534800172797,6,1121,carbohydrate derivative metabolic process,BP,FBXO2;NECAB1;AK5;HS3ST4;SPOCK3;GRM3
4584,GO:0009743,0.714556284871091,0.646761994388113,1,195,response to carbohydrate,BP,VSNL1
3703,GO:0007266,0.715628244182635,0.645460186089542,1,189,Rho protein signal transduction,BP,LPAR1
15726,GO:0070302,0.715661119726114,0.645388607061174,1,194,regulation of stress-activated protein kinase signaling cascade,BP,TPD52L1
8711,GO:0032886,0.715695069974041,0.645370409942955,1,190,regulation of microtubule-based process,BP,SLC39A12
4347,GO:0009117,0.715704678112844,0.497444145249092,3,591,nucleotide metabolic process,BP,GDA;AK5;GRM3
9355,GO:0034404,0.71588378135011,0.645086832340734,1,198,nucleobase-containing small molecule biosynthetic process,BP,GDA
367,GO:0000982,0.717108521085029,0.542446917861046,2,390,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NKX6-2;ZNF536
9005,GO:0033500,0.717879622690225,0.642588361616696,1,197,carbohydrate homeostasis,BP,VSNL1
10821,GO:0042593,0.717879622690225,0.642588361616696,1,197,glucose homeostasis,BP,VSNL1
11358,GO:0043583,0.717909592145088,0.642568274968542,1,194,ear development,BP,CXCL14
15768,GO:0070374,0.718027649234587,0.642396310624835,1,198,positive regulation of ERK1 and ERK2 cascade,BP,EPHB6
2817,GO:0005874,0.718029565378635,0.541309786686331,2,380,microtubule,CC,TPPP;DNAH17
11428,GO:0043903,0.718706643219805,0.641518288266269,1,202,regulation of symbiosis, encompassing mutualism through parasitism,BP,TOP2A
1595,GO:0003674,0.72045655804983,0.417317042393093,90,14390,molecular_function,MF,CD22;CLDN11;CAMK2A;PPP2R2C;LRP2;FOLH1;TF;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;SLC17A7;MAG;ADAP1;EPHB6;PTGDS;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;FBXO2;PADI2;CDK18;GDA;NECAB1;PLP1;PACSIN1;MYRF;HSPA2;EVI2A;TOP2A;PPP1R1B;IQCA1;HAPLN2;RAPGEF5;ERMN;ENPP2;MOG;CXCL14;DOCK5;ST18;SLC39A12;MKI67;NKX6-2;CNDP1;AK5;NRGN;SLC24A2;SLC5A11;S100A1;PAQR6;VSNL1;SERPINI1;ETNPPL;TMEM144;HHIP;GREM1;PPP1R14A;KLK6;MOBP;LGI3;GJB1;GPR37;TPPP;MAL;RCAN2;CARNS1;BOK;TMEM125;S1PR5;GPR62;HS3ST4;AIFM3;CNTN2;SV2B;MPPED1;CCK;DNAH17;MYBPC1;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;FXYD1
5818,GO:0016323,0.72062842728279,0.639133903626423,1,194,basolateral plasma membrane,CC,TF
3320,GO:0006643,0.721702050006108,0.637713254315698,1,204,membrane lipid metabolic process,BP,FA2H
12158,GO:0045732,0.722174183867065,0.637145922949883,1,198,positive regulation of protein catabolic process,BP,LRP2
13934,GO:0051495,0.722395521419752,0.636858173533539,1,199,positive regulation of cytoskeleton organization,BP,LPAR1
17688,GO:0097237,0.722834363214701,0.636270600749091,1,204,cellular response to toxic substance,BP,GPR37
3400,GO:0006753,0.722933310707078,0.488468536373705,3,598,nucleoside phosphate metabolic process,BP,GDA;AK5;GRM3
4155,GO:0008514,0.723564396943123,0.635354635249501,1,201,organic anion transmembrane transporter activity,MF,SLC17A7
13669,GO:0051054,0.723687070792122,0.6351977399658,1,201,positive regulation of DNA metabolic process,BP,GREM1
150,GO:0000302,0.725393783885149,0.632981708892375,1,206,response to reactive oxygen species,BP,GPR37
14713,GO:0060341,0.725404588401095,0.457577641664449,4,761,regulation of cellular localization,BP,CAMK2A;VSNL1;MYBPC1;RYR2
19126,GO:1901991,0.727171055881876,0.630691301375149,1,206,negative regulation of mitotic cell cycle phase transition,BP,GJC2
3630,GO:0007160,0.727361665111906,0.63051368537474,1,194,cell-matrix adhesion,BP,GREM1
1274,GO:0002791,0.727776047861139,0.528875007990333,2,400,regulation of peptide secretion,BP,VSNL1;MBP
16345,GO:0071453,0.728766660694589,0.628630540956373,1,205,cellular response to oxygen levels,BP,LPAR1
18967,GO:1901565,0.728930080191804,0.420582375879781,6,1130,organonitrogen compound catabolic process,BP,LRP2;ASPA;FBXO2;GDA;ENPP2;CARNS1
12504,GO:0046488,0.730307408974457,0.626648794293651,1,201,phosphatidylinositol metabolic process,BP,FGF1
4854,GO:0010638,0.730692934324002,0.478732818094028,3,588,positive regulation of organelle organization,BP,BOK;MYBPC1;LPAR1
13210,GO:0048732,0.731491427551182,0.524090670399668,2,398,gland development,BP,SOX10;FA2H
7104,GO:0023061,0.732057516370253,0.523351862865137,2,401,signal release,BP,CAMK2A;VSNL1
11071,GO:0043122,0.733975357912606,0.621803469350554,1,208,regulation of I-kappaB kinase/NF-kappaB signaling,BP,LPAR1
6039,GO:0016772,0.734725938675301,0.427277420777922,5,936,transferase activity, transferring phosphorus-containing groups,MF,CAMK2A;EPHB6;FGF1;CDK18;AK5
2730,GO:0005743,0.738538207036578,0.514838136815306,2,436,mitochondrial inner membrane,CC,BOK;AIFM3
9446,GO:0034622,0.739400201782518,0.421487219146594,5,969,cellular protein-containing complex assembly,BP,SEPT4;SLC39A12;GREM1;TPPP;MYBPC1
11293,GO:0043491,0.739818671799718,0.614046083223704,1,207,protein kinase B signaling,BP,FGF1
11495,GO:0044092,0.740187794773044,0.420511917589979,5,967,negative regulation of molecular function,BP,PPP1R1B;SERPINI1;PPP1R14A;SPOCK3;GRM3
11726,GO:0044703,0.741209840936312,0.437851596732501,4,787,multi-organism reproductive process,BP,CLDN11;SEPT4;HSPA2;PPP1R1B
36,GO:0000075,0.741670028183563,0.61153766406954,1,211,cell cycle checkpoint,BP,TOP2A
13531,GO:0050851,0.747377246630768,0.603735751933665,1,221,antigen receptor-mediated signaling pathway,BP,MOG
19123,GO:1901988,0.748679570002557,0.601958730757294,1,219,negative regulation of cell cycle phase transition,BP,GJC2
11333,GO:0043543,0.749055585311931,0.601461809503393,1,215,protein acylation,BP,HHATL
4671,GO:0010033,0.750003094727655,0.342574094264787,16,2868,response to organic substance,BP,CAMK2A;LRP2;SOX10;FGF1;FBXO2;PADI2;HSPA2;PPP1R1B;ST18;PAQR6;VSNL1;HHIP;GREM1;BOK;LPAR1;RYR2
10680,GO:0042326,0.751071457280631,0.498205585538956,2,420,negative regulation of phosphorylation,BP,PPP1R1B;GREM1
2752,GO:0005770,0.751483499270887,0.598088546339476,1,219,late endosome,CC,TF
15543,GO:0065008,0.751671085719616,0.334487840034692,19,3342,regulation of biological quality,BP,CAMK2A;TF;SLC17A7;MAG;PPP1R1B;ERMN;DOCK5;SLC39A12;NRGN;SLC24A2;VSNL1;KLK6;BOK;CNTN2;CCK;MBP;LPAR1;RYR2;FXYD1
3174,GO:0006457,0.752480338787263,0.596675793280772,1,225,protein folding,BP,HSPA2
15533,GO:0062012,0.753815825393206,0.494490281856616,2,425,regulation of small molecule metabolic process,BP,FGF1;GRM3
2671,GO:0005635,0.755162655898832,0.492672884126224,2,420,nuclear envelope,CC,PTGDS;BOK
13776,GO:0051223,0.756364848096745,0.445538666029903,3,614,regulation of protein transport,BP,VSNL1;MYBPC1;MBP
3735,GO:0007346,0.756683233778444,0.445117112707802,3,615,regulation of mitotic cell cycle,BP,TOP2A;MKI67;GJC2
362,GO:0000977,0.756908140433484,0.444820927531031,3,614,RNA polymerase II regulatory region sequence-specific DNA binding,MF,SOX10;NKX6-2;ZNF536
19691,GO:1903362,0.757250302184859,0.590023349555489,1,220,regulation of cellular protein catabolic process,BP,LRP2
4665,GO:0010008,0.757294844910856,0.489757838615467,2,427,endosome membrane,CC,TF;BOK
5630,GO:0015931,0.75803727246032,0.588907811423922,1,221,nucleobase-containing compound transport,BP,GJB1
15320,GO:0061448,0.759890010528276,0.586288055558487,1,220,connective tissue development,BP,GREM1
383,GO:0001012,0.759964990206593,0.440766867954995,3,617,RNA polymerase II regulatory region DNA binding,MF,SOX10;NKX6-2;ZNF536
16153,GO:0071103,0.760624332101784,0.585238781894779,1,221,DNA conformation change,BP,TOP2A
5932,GO:0016570,0.76127221744381,0.484323947891192,2,419,histone modification,BP,PADI2;PPP1R1B
13991,GO:0051606,0.761646616811853,0.58376645456437,1,224,detection of stimulus,BP,RYR2
7148,GO:0030072,0.761805269170478,0.583549648487986,1,222,peptide hormone secretion,BP,VSNL1
17011,GO:0072659,0.762711568165134,0.582263140005083,1,220,protein localization to plasma membrane,BP,PACSIN1
3632,GO:0007162,0.762902265275712,0.581979904234657,1,222,negative regulation of cell adhesion,BP,MBP
8371,GO:0032388,0.765646671837764,0.578020513096069,1,224,positive regulation of intracellular transport,BP,MYBPC1
3104,GO:0006357,0.765654847937669,0.340114295465177,11,2033,regulation of transcription by RNA polymerase II,BP,LRP2;SOX10;FGF1;MYRF;TOP2A;ST18;NKX6-2;S100A1;GREM1;ZNF536;RYR2
12238,GO:0045893,0.766475452573196,0.364014553955999,7,1339,positive regulation of transcription, DNA-templated,BP,SOX10;FGF1;PADI2;MYRF;TOP2A;ST18;GREM1
19760,GO:1903508,0.766475452573196,0.364014553955999,7,1339,positive regulation of nucleic acid-templated transcription,BP,SOX10;FGF1;PADI2;MYRF;TOP2A;ST18;GREM1
3480,GO:0006887,0.766610097860671,0.405172511873526,4,817,exocytosis,BP,TF;PADI2;VSNL1;LGI3
4544,GO:0009605,0.766715811089426,0.343522316056233,10,1879,response to external stimulus,BP,MAG;FGF1;PADI2;ENPP2;CXCL14;GREM1;CNTN2;CCK;LPAR1;RYR2
11905,GO:0045165,0.766934098927411,0.576151731535017,1,225,cell fate commitment,BP,NKX6-2
19389,GO:1902680,0.767127381807239,0.363198612520472,7,1340,positive regulation of RNA biosynthetic process,BP,SOX10;FGF1;PADI2;MYRF;TOP2A;ST18;GREM1
310,GO:0000819,0.768265021146264,0.574227130489528,1,223,sister chromatid segregation,BP,TOP2A
5931,GO:0016569,0.770277046632025,0.47180290841318,2,427,covalent chromatin modification,BP,PADI2;PPP1R1B
15927,GO:0070661,0.7704960389404,0.570910659179376,1,235,leukocyte proliferation,BP,GREM1
12317,GO:0046034,0.771418227139617,0.569552275214894,1,236,ATP metabolic process,BP,AK5
9153,GO:0033993,0.772735225367558,0.397098423628645,4,828,response to lipid,BP,SOX10;PADI2;PAQR6;LPAR1
4968,GO:0010817,0.773488203713272,0.467256690421329,2,443,regulation of hormone levels,BP,VSNL1;KLK6
3080,GO:0006310,0.775781889903978,0.563112807872083,1,232,DNA recombination,BP,TOP2A
11530,GO:0044212,0.776640628668047,0.391921237047322,4,817,transcription regulatory region DNA binding,MF,SOX10;ST18;NKX6-2;ZNF536
399,GO:0001067,0.777520395171027,0.390748376250716,4,818,regulatory region nucleic acid binding,MF,SOX10;ST18;NKX6-2;ZNF536
11801,GO:0044877,0.777559282530848,0.390701655720606,4,810,protein-containing complex binding,MF,TF;FGF1;ERMN;MYBPC1
3583,GO:0007049,0.778191672284263,0.334868520403788,9,1712,cell cycle,BP,CAMK2A;PPP2R2C;SEPT4;TPD52L1;PACSIN1;HSPA2;TOP2A;MKI67;GJC2
3180,GO:0006469,0.778734720482645,0.558676381816206,1,236,negative regulation of protein kinase activity,BP,PPP1R1B
12687,GO:0046883,0.778878442844844,0.558464837283829,1,235,regulation of hormone secretion,BP,VSNL1
1252,GO:0002757,0.778894222865468,0.459565909664331,2,451,immune response-activating signal transduction,BP,MOG;S100A1
4377,GO:0009150,0.779851520751667,0.458192115670477,2,454,purine ribonucleotide metabolic process,BP,AK5;GRM3
7982,GO:0031647,0.779974073963378,0.556810179136705,1,236,regulation of protein stability,BP,TF
42,GO:0000086,0.780124243445115,0.556579097303211,1,237,G2/M transition of mitotic cell cycle,BP,TPD52L1
17238,GO:0090087,0.78182487244095,0.411128838590467,3,642,regulation of peptide transport,BP,VSNL1;MYBPC1;MBP
366,GO:0000981,0.782148649007132,0.366924491332556,5,1013,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,SOX10;MYRF;ST18;NKX6-2;ZNF536
11053,GO:0043087,0.783476621169032,0.453012431001197,2,436,regulation of GTPase activity,BP,ADAP1;RASAL1
3690,GO:0007249,0.78424467866457,0.550303268080173,1,241,I-kappaB kinase/NF-kappaB signaling,BP,LPAR1
18968,GO:1901566,0.784760553943595,0.326664309682649,9,1765,organonitrogen compound biosynthetic process,BP,HHATL;FOLH1;FA2H;ASPA;NECAB1;AK5;GPR37;CARNS1;GRM3
18455,GO:0110053,0.784811344043371,0.549458612065528,1,236,regulation of actin filament organization,BP,LPAR1
6055,GO:0016791,0.785067642310811,0.549061547436586,1,237,phosphatase activity,MF,PPP2R2C
2806,GO:0005856,0.785117904699701,0.320891186838659,10,1863,cytoskeleton,CC,NEFM;SEPT4;HSPA2;TOP2A;ERMN;AK5;MOBP;TPPP;DNAH17;MYBPC1
16279,GO:0071356,0.786613074073509,0.546632481416749,1,250,cellular response to tumor necrosis factor,BP,ST18
8882,GO:0033157,0.78828563771555,0.544093081369305,1,240,regulation of intracellular protein transport,BP,MYBPC1
11934,GO:0045211,0.788499971626388,0.543793056005125,1,233,postsynaptic membrane,CC,GRM3
284,GO:0000785,0.788796795907068,0.445264063148736,2,452,chromatin,CC,SOX10;PADI2
8127,GO:0031967,0.790711093213166,0.35558070290325,5,1054,organelle envelope,CC,SOX10;PTGDS;NRGN;BOK;AIFM3
8131,GO:0031975,0.790711093213166,0.35558070290325,5,1054,envelope,CC,SOX10;PTGDS;NRGN;BOK;AIFM3
14011,GO:0051650,0.791319795687107,0.539380303117531,1,239,establishment of vesicle localization,BP,MOBP
13885,GO:0051403,0.791806300016142,0.538602267488169,1,243,stress-activated MAPK cascade,BP,TPD52L1
11363,GO:0043588,0.792487598451638,0.5375440501582,1,241,skin development,BP,FA2H
17970,GO:0098609,0.79263065929983,0.396046308889692,3,650,cell-cell adhesion,BP,CLDN11;MAG;MBP
19334,GO:1902532,0.793533094082904,0.438303448965945,2,458,negative regulation of intracellular signal transduction,BP,RASAL1;LPAR1
1253,GO:0002758,0.793635024170785,0.535712161596392,1,248,innate immune response-activating signal transduction,BP,S100A1
15664,GO:0070201,0.794127548108779,0.393928821715042,3,656,regulation of establishment of protein localization,BP,VSNL1;MYBPC1;MBP
6681,GO:0019866,0.794626332768016,0.436646727036824,2,486,organelle inner membrane,CC,BOK;AIFM3
4463,GO:0009259,0.794823909122725,0.436379245337663,2,469,ribonucleotide metabolic process,BP,AK5;GRM3
14445,GO:0055086,0.795145066196765,0.392474192302492,3,674,nucleobase-containing small molecule metabolic process,BP,GDA;AK5;GRM3
6053,GO:0016788,0.795941669260541,0.39135591401966,3,662,hydrolase activity, acting on ester bonds,MF,PPP2R2C;ASPA;ENPP2
3758,GO:0007411,0.797526373367915,0.529605338720284,1,236,axon guidance,BP,CNTN2
9081,GO:0033673,0.797822726627034,0.529072273693767,1,250,negative regulation of kinase activity,BP,PPP1R1B
2772,GO:0005794,0.799432974416831,0.321930486570971,7,1391,Golgi apparatus,CC,LRP2;PTGDS;MYRF;CXCL14;BOK;HS3ST4;OPALIN
11781,GO:0044839,0.799956688421376,0.525651226299559,1,252,cell cycle G2/M phase transition,BP,TPD52L1
17806,GO:0097485,0.800162598822718,0.525380805906783,1,238,neuron projection guidance,BP,CNTN2
6474,GO:0019221,0.803182561442754,0.380998911779457,3,687,cytokine-mediated signaling pathway,BP,CAMK2A;PADI2;ST18
12277,GO:0045944,0.803812785581086,0.33797677506316,5,1037,positive regulation of transcription by RNA polymerase II,BP,SOX10;FGF1;TOP2A;ST18;GREM1
9434,GO:0034599,0.80462198624151,0.518085700712813,1,258,cellular response to oxidative stress,BP,GPR37
6234,GO:0017144,0.806099788686396,0.376792016171903,3,690,drug metabolic process,BP,AK5;GPR37;CARNS1
21100,GO:1990778,0.806709447861936,0.514702986706208,1,251,protein localization to cell periphery,BP,PACSIN1
19037,GO:1901700,0.807218374582375,0.311723528179418,7,1422,response to oxygen-containing compound,BP,CAMK2A;SOX10;PPP1R1B;VSNL1;GPR37;LPAR1;RYR2
14009,GO:0051648,0.807585289895667,0.513265192622526,1,251,vesicle localization,BP,MOBP
6606,GO:0019693,0.80794492139535,0.416652948985062,2,483,ribose phosphate metabolic process,BP,AK5;GRM3
4424,GO:0009205,0.808137171033311,0.512306172515913,1,264,purine ribonucleoside triphosphate metabolic process,BP,AK5
7810,GO:0031327,0.808166966386736,0.310476605952763,7,1410,negative regulation of cellular biosynthetic process,BP,HHATL;SOX10;NKX6-2;S100A1;GREM1;ZNF536;GRM3
1259,GO:0002764,0.808679789441515,0.415534549978551,2,481,immune response-regulating signaling pathway,BP,MOG;S100A1
12237,GO:0045892,0.809050917725629,0.330832195162902,5,1050,negative regulation of transcription, DNA-templated,BP,SOX10;NKX6-2;S100A1;GREM1;ZNF536
16864,GO:0072331,0.809466243097568,0.510131745986146,1,259,signal transduction by p53 class mediator,BP,BOK
5474,GO:0015629,0.809924473266664,0.413664177927055,2,459,actin cytoskeleton,CC,MOBP;MYBPC1
9439,GO:0034612,0.809986785544077,0.509236367481979,1,268,response to tumor necrosis factor,BP,ST18
4716,GO:0010243,0.810139936351185,0.346059400749612,4,863,response to organonitrogen compound,BP,CAMK2A;FBXO2;PPP1R1B;RYR2
18505,GO:0140014,0.81015252755157,0.509023413534047,1,252,mitotic nuclear division,BP,MKI67
2721,GO:0005730,0.810631697717135,0.345359726951764,4,877,nucleolus,CC,FGF1;TOP2A;MKI67;KLK6
13799,GO:0051254,0.811260697626487,0.306389453343615,7,1409,positive regulation of RNA metabolic process,BP,SOX10;FGF1;PADI2;MYRF;TOP2A;ST18;GREM1
4480,GO:0009306,0.812534777973983,0.409626964719258,2,477,protein secretion,BP,VSNL1;MBP
17393,GO:0090305,0.813187166934529,0.503918121350916,1,265,nucleic acid phosphodiester bond hydrolysis,BP,ENPP2
15766,GO:0070372,0.813938461736604,0.502670383550735,1,262,regulation of ERK1 and ERK2 cascade,BP,EPHB6
4418,GO:0009199,0.815362581516847,0.500245808128201,1,270,ribonucleoside triphosphate metabolic process,BP,AK5
935,GO:0002218,0.815816312519801,0.49949872583061,1,265,activation of innate immune response,BP,S100A1
4371,GO:0009144,0.816231667000389,0.49877520174529,1,271,purine nucleoside triphosphate metabolic process,BP,AK5
3085,GO:0006325,0.816725586882781,0.361286984164317,3,676,chromatin organization,BP,PADI2;PPP1R1B;MKI67
18825,GO:1901137,0.816970444033562,0.360915895996196,3,688,carbohydrate derivative biosynthetic process,BP,NECAB1;AK5;GRM3
1695,GO:0003924,0.817547359390896,0.496542832458015,1,272,GTPase activity,MF,SEPT4
4624,GO:0009890,0.81902371139404,0.296052350218258,7,1430,negative regulation of biosynthetic process,BP,HHATL;SOX10;NKX6-2;S100A1;GREM1;ZNF536;GRM3
13932,GO:0051493,0.819234587955343,0.399224705343736,2,475,regulation of cytoskeleton organization,BP,SLC39A12;LPAR1
3546,GO:0006996,0.81949410189815,0.253770136352549,19,3478,organelle organization,BP,CAMK2A;NEFM;SLC17A7;SEPT4;PEX5L;PADI2;PACSIN1;HSPA2;TOP2A;PPP1R1B;ERMN;SLC39A12;MKI67;TPPP;BOK;CNTN2;CCK;MYBPC1;LPAR1
361,GO:0000976,0.821145804671209,0.354729150563942,3,685,transcription regulatory region sequence-specific DNA binding,MF,SOX10;NKX6-2;ZNF536
5673,GO:0016042,0.821216828520424,0.49027227646123,1,273,lipid catabolic process,BP,ENPP2
3766,GO:0007423,0.822886613917084,0.393475587503146,2,480,sensory organ development,BP,SLC17A7;CXCL14
2767,GO:0005788,0.823153214038524,0.486956303872534,1,267,endoplasmic reticulum lumen,CC,TF
4578,GO:0009725,0.82334663272822,0.327255721232456,4,888,response to hormone,BP,CAMK2A;SOX10;PADI2;PAQR6
10514,GO:0040029,0.823762428627336,0.485905530706631,1,266,regulation of gene expression, epigenetic,BP,PADI2
7692,GO:0031098,0.824653687255241,0.484347947170825,1,269,stress-activated protein kinase signaling cascade,BP,TPD52L1
13113,GO:0048562,0.825844671726977,0.482277859446274,1,268,embryonic organ morphogenesis,BP,RYR2
4393,GO:0009167,0.826712400051762,0.48072286934355,1,279,purine ribonucleoside monophosphate metabolic process,BP,AK5
13857,GO:0051348,0.826855717331864,0.480485834214662,1,275,negative regulation of transferase activity,BP,PPP1R1B
4353,GO:0009126,0.827713181133384,0.478965454676631,1,280,purine nucleoside monophosphate metabolic process,BP,AK5
4517,GO:0009416,0.830622691799673,0.473849812851573,1,275,response to light stimulus,BP,PPP1R1B
19759,GO:1903507,0.832126352543944,0.298658441701419,5,1087,negative regulation of nucleic acid-templated transcription,BP,SOX10;NKX6-2;S100A1;GREM1;ZNF536
13508,GO:0050808,0.832680041285981,0.470226358515905,1,265,synapse organization,BP,CNTN2
12683,GO:0046879,0.832732152347597,0.470089876976783,1,277,hormone secretion,BP,VSNL1
15765,GO:0070371,0.832754608546005,0.470046329713468,1,278,ERK1 and ERK2 cascade,BP,EPHB6
954,GO:0002253,0.833181466622765,0.376974910256916,2,509,activation of immune response,BP,MOG;S100A1
19388,GO:1902679,0.83321113451194,0.297116131181257,5,1089,negative regulation of RNA biosynthetic process,BP,SOX10;NKX6-2;S100A1;GREM1;ZNF536
1600,GO:0003682,0.834731376228387,0.374478708230155,2,495,chromatin binding,MF,SOX10;TOP2A
4828,GO:0010605,0.834975182219231,0.249719187470475,12,2356,negative regulation of macromolecule metabolic process,BP,HHATL;SOX10;PPP1R16B;PPP1R1B;NKX6-2;S100A1;SERPINI1;GREM1;PPP1R14A;SPOCK3;ZNF536;FXYD1
5960,GO:0016604,0.835316881364097,0.33331572976649,3,704,nuclear body,CC,PPP1R16B;RAPGEF5;MKI67
2939,GO:0006066,0.836227217670542,0.463792011411024,1,283,alcohol metabolic process,BP,FGF1
15538,GO:0065003,0.836366049587908,0.265654551409782,8,1656,protein-containing complex assembly,BP,SEPT4;SLC39A12;GREM1;GJB1;TPPP;BOK;CCK;MYBPC1
13281,GO:0048871,0.836493471518202,0.46331741915743,1,281,multicellular organismal homeostasis,BP,TF
13814,GO:0051276,0.83684584631663,0.291931192921477,5,1087,chromosome organization,BP,PADI2;HSPA2;TOP2A;PPP1R1B;MKI67
4177,GO:0008544,0.836850008701124,0.462675628031665,1,280,epidermis development,BP,FA2H
11008,GO:0043010,0.837142284325887,0.462163457121149,1,275,camera-type eye development,BP,SLC17A7
4368,GO:0009141,0.837764886005306,0.460980494746825,1,291,nucleoside triphosphate metabolic process,BP,AK5
18066,GO:0098813,0.838248419367305,0.460140905124425,1,279,nuclear chromosome segregation,BP,TOP2A
1273,GO:0002790,0.838717388615445,0.367950144817564,2,508,peptide secretion,BP,VSNL1;MBP
4387,GO:0009161,0.83922192409253,0.458327325841408,1,291,ribonucleoside monophosphate metabolic process,BP,AK5
16321,GO:0071417,0.839270808122375,0.367052580806313,2,499,cellular response to organonitrogen compound,BP,CAMK2A;RYR2
21232,GO:2000113,0.8413955234859,0.274192269683602,6,1285,negative regulation of cellular macromolecule biosynthetic process,BP,HHATL;SOX10;NKX6-2;S100A1;GREM1;ZNF536
16291,GO:0071375,0.841588817995357,0.454014808245338,1,283,cellular response to peptide hormone stimulus,BP,CAMK2A
12606,GO:0046677,0.841831415248381,0.453545328215995,1,290,response to antibiotic,BP,GPR37
16187,GO:0071214,0.842290400807431,0.452705580621048,1,288,cellular response to abiotic stimulus,BP,MAG
18403,GO:0104004,0.842290400807431,0.452705580621048,1,288,cellular response to environmental stimulus,BP,MAG
12269,GO:0045934,0.842371551555047,0.272815488874259,6,1290,negative regulation of nucleobase-containing compound metabolic process,BP,SOX10;NKX6-2;S100A1;GREM1;ZNF536;GRM3
4635,GO:0009914,0.842976862390079,0.451440790176593,1,287,hormone transport,BP,VSNL1
100,GO:0000209,0.84541941586309,0.446894566776408,1,290,protein polyubiquitination,BP,FBXO2
112,GO:0000228,0.846352375800688,0.355286649056089,2,513,nuclear chromosome,CC,HSPA2;TOP2A
16379,GO:0071496,0.846575845783431,0.444726804820947,1,292,cellular response to external stimulus,BP,MAG
4626,GO:0009892,0.846725984217999,0.231540947655896,13,2559,negative regulation of metabolic process,BP,HHATL;SOX10;PPP1R16B;PPP1R1B;NKX6-2;S100A1;SERPINI1;GREM1;PPP1R14A;SPOCK3;ZNF536;GRM3;FXYD1
21119,GO:1990837,0.847157480364801,0.314933432911661,3,721,sequence-specific double-stranded DNA binding,MF,SOX10;NKX6-2;ZNF536
3111,GO:0006366,0.847548151680982,0.23663973773029,11,2202,transcription by RNA polymerase II,BP,LRP2;SOX10;FGF1;MYRF;TOP2A;ST18;NKX6-2;S100A1;GREM1;ZNF536;RYR2
13805,GO:0051260,0.847996769351087,0.442049592180275,1,295,protein homooligomerization,BP,SEPT4
4777,GO:0010506,0.85008250413447,0.438115300651401,1,293,regulation of autophagy,BP,BOK
4350,GO:0009123,0.853257639759212,0.432021180498072,1,306,nucleoside monophosphate metabolic process,BP,AK5
586,GO:0001701,0.853558327515414,0.431483099871211,1,293,in utero embryonic development,BP,SOX10
11657,GO:0044437,0.854430937307777,0.341595602605705,2,533,vacuolar part,CC,LRP2;PADI2
5075,GO:0010948,0.855650564427785,0.427417581553308,1,304,negative regulation of cell cycle process,BP,GJC2
2789,GO:0005829,0.85623146624806,0.201759222746813,25,4614,cytosol,CC,CAMK2A;PPP2R2C;ADAP1;EPHB6;ASPA;RASAL1;FGF1;PEX5L;FBXO2;PADI2;GDA;NECAB1;PACSIN1;MYRF;HSPA2;PPP1R1B;DOCK5;CNDP1;AK5;VSNL1;PPP1R14A;TPPP;CARNS1;AIFM3;MYBPC1
11007,GO:0043009,0.860836060724326,0.330555068680439,2,528,chordate embryonic development,BP,LRP2;SOX10
3562,GO:0007018,0.861177347104678,0.416653289119947,1,292,microtubule-based movement,BP,DNAH17
11864,GO:0045089,0.861204395087987,0.416549217370777,1,309,positive regulation of innate immune response,BP,S100A1
11555,GO:0044260,0.861444312031152,0.188605203395086,42,7383,cellular macromolecule metabolic process,BP,HHATL;CAMK2A;PPP2R2C;LRP2;FOLH1;TF;SOX10;PPP1R16B;EPHB6;SEPT4;RASAL1;TPD52L1;FGF1;FBXO2;PADI2;CDK18;NECAB1;MYRF;HSPA2;TOP2A;PPP1R1B;ENPP2;ST18;NKX6-2;CNDP1;S100A1;SERPINI1;GREM1;PPP1R14A;GPR37;RCAN2;BOK;HS3ST4;CNTN2;CCK;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GJC2;FXYD1
2785,GO:0005819,0.863289015704727,0.412428942147024,1,305,spindle,CC,HSPA2
1614,GO:0003713,0.86444224907332,0.410126560041311,1,306,transcription coactivator activity,MF,SOX10
8758,GO:0032956,0.866079367653504,0.406845115022716,1,306,regulation of actin cytoskeleton organization,BP,LPAR1
59,GO:0000122,0.866241555039036,0.284282330910274,3,752,negative regulation of transcription by RNA polymerase II,BP,NKX6-2;S100A1;ZNF536
1053,GO:0002429,0.868408966562306,0.4020995609541,1,321,immune response-activating cell surface receptor signaling pathway,BP,MOG
18530,GO:0140096,0.868813923723148,0.211614848734662,10,2058,catalytic activity, acting on a protein,MF,CAMK2A;PPP2R2C;FOLH1;EPHB6;FGF1;FBXO2;CDK18;MYRF;CNDP1;KLK6
4336,GO:0009101,0.868852246581289,0.401223834932142,1,312,glycoprotein biosynthetic process,BP,NECAB1
4801,GO:0010558,0.871029970685529,0.231412555556787,6,1346,negative regulation of macromolecule biosynthetic process,BP,HHATL;SOX10;NKX6-2;S100A1;GREM1;ZNF536
666,GO:0001817,0.87231446122274,0.310229711243792,2,563,regulation of cytokine production,BP,MOG;MBP
13798,GO:0051253,0.872943655002306,0.238570091681211,5,1163,negative regulation of RNA metabolic process,BP,SOX10;NKX6-2;S100A1;GREM1;ZNF536
7814,GO:0031331,0.872991429459588,0.392741487424637,1,314,positive regulation of cellular catabolic process,BP,LRP2
19035,GO:1901698,0.873045479058205,0.252246784154913,4,965,response to nitrogen compound,BP,CAMK2A;FBXO2;PPP1R1B;RYR2
4600,GO:0009792,0.873361795791356,0.308363193419736,2,546,embryo development ending in birth or egg hatching,BP,LRP2;SOX10
567,GO:0001666,0.874794703428593,0.38897953780104,1,324,response to hypoxia,BP,RYR2
8977,GO:0033365,0.875649080800525,0.2686613657579,3,780,protein localization to organelle,BP,PEX5L;MYBPC1;RYR2
3422,GO:0006790,0.877395398738452,0.383523236485749,1,333,sulfur compound metabolic process,BP,SPOCK3
6469,GO:0019216,0.87746213395197,0.383405448614158,1,324,regulation of lipid metabolic process,BP,FGF1
556,GO:0001654,0.878937954824841,0.380309186850679,1,319,eye development,BP,SLC17A7
19009,GO:1901653,0.879243057799167,0.379651157822109,1,324,cellular response to peptide,BP,CAMK2A
1863,GO:0004175,0.879882066332701,0.378270450373527,1,335,endopeptidase activity,MF,KLK6
19936,GO:1903829,0.879957969016,0.378131532636786,1,326,positive regulation of cellular protein localization,BP,MYBPC1
7043,GO:0022607,0.879983851661587,0.187360783652921,13,2631,cellular component assembly,BP,PPP1R16B;NEFM;SEPT4;HSPA2;HAPLN2;SLC39A12;GREM1;GJB1;TPPP;BOK;CCK;MYBPC1;LPAR1
2619,GO:0005525,0.880281488104698,0.377417904353626,1,337,GTP binding,MF,SEPT4
12188,GO:0045786,0.88064071821538,0.295085076407913,2,571,negative regulation of cell cycle,BP,TOP2A;GJC2
10217,GO:0036293,0.881795339644521,0.374204308151929,1,332,response to decreased oxygen levels,BP,RYR2
8493,GO:0032550,0.882507781868827,0.372660540626869,1,340,purine ribonucleoside binding,MF,SEPT4
7030,GO:0022407,0.882591702176831,0.372487650636694,1,337,regulation of cell-cell adhesion,BP,MBP
11650,GO:0044427,0.883274119105097,0.25574479720531,3,786,chromosomal part,CC,SOX10;PADI2;HSPA2
11425,GO:0043900,0.88343541895994,0.370668605904959,1,340,regulation of multi-organism process,BP,TOP2A
1638,GO:0003824,0.883873445327189,0.164989895306062,28,5217,catalytic activity,MF,CAMK2A;PPP2R2C;FOLH1;FA2H;EPHB6;PTGDS;ASPA;SEPT4;FGF1;FBXO2;PADI2;CDK18;GDA;MYRF;HSPA2;TOP2A;ENPP2;CNDP1;AK5;ETNPPL;HHIP;KLK6;LGI3;CARNS1;HS3ST4;AIFM3;MPPED1;DNAH17
10614,GO:0042176,0.884309115627131,0.368802176759485,1,333,regulation of protein catabolic process,BP,LRP2
715,GO:0001883,0.884670823812839,0.36799727228128,1,343,purine nucleoside binding,MF,SEPT4
8492,GO:0032549,0.885700652410962,0.365763669171655,1,344,ribonucleoside binding,MF,SEPT4
4800,GO:0010557,0.886067324724892,0.201668047603661,7,1569,positive regulation of macromolecule biosynthetic process,BP,SOX10;FGF1;PADI2;MYRF;TOP2A;ST18;GREM1
2747,GO:0005765,0.887581710310564,0.361675020128316,1,339,lysosomal membrane,CC,LRP2
18090,GO:0098852,0.887581710310564,0.361675020128316,1,339,lytic vacuole membrane,CC,LRP2
3385,GO:0006732,0.889355077239434,0.357760061067551,1,348,coenzyme metabolic process,BP,FOLH1
714,GO:0001882,0.890655847984164,0.354878487757338,1,351,nucleoside binding,MF,SEPT4
9019,GO:0033554,0.890903702037942,0.188912884898273,8,1785,cellular response to stress,BP,CAMK2A;TPD52L1;FGF1;FBXO2;HSPA2;TOP2A;GPR37;BOK
1262,GO:0002768,0.89168611728792,0.352590185322512,1,351,immune response-regulating cell surface receptor signaling pathway,BP,MOG
1604,GO:0003690,0.892136409566991,0.240410469846778,3,799,double-stranded DNA binding,MF,SOX10;NKX6-2;ZNF536
8504,GO:0032561,0.892952240774972,0.349757976266712,1,354,guanyl ribonucleotide binding,MF,SEPT4
6394,GO:0019001,0.893639473937947,0.348215707326308,1,355,guanyl nucleotide binding,MF,SEPT4
14658,GO:0060271,0.893682202753574,0.348150484613092,1,341,cilium assembly,BP,SEPT4
11545,GO:0044238,0.894215269974716,0.147963487681702,53,9272,primary metabolic process,BP,HHATL;CAMK2A;PPP2R2C;LRP2;FOLH1;TF;SOX10;CPNE6;PPP1R16B;FA2H;EPHB6;PTGDS;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;FBXO2;PADI2;CDK18;GDA;NECAB1;PLP1;MYRF;HSPA2;TOP2A;PPP1R1B;ENPP2;ST18;NKX6-2;CNDP1;AK5;S100A1;SERPINI1;ETNPPL;GREM1;PPP1R14A;KLK6;GPR37;RCAN2;CARNS1;BOK;HS3ST4;CNTN2;CCK;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;FXYD1
471,GO:0001503,0.89465567519032,0.345953898648025,1,344,ossification,BP,GREM1
12187,GO:0045785,0.895488517469248,0.344053559764711,1,353,positive regulation of cell adhesion,BP,DOCK5
12270,GO:0045935,0.897949843551091,0.183804664487725,7,1600,positive regulation of nucleobase-containing compound metabolic process,BP,SOX10;FGF1;PADI2;MYRF;TOP2A;ST18;GREM1
19036,GO:1901699,0.899381116617816,0.259569765989878,2,589,cellular response to nitrogen compound,BP,CAMK2A;RYR2
668,GO:0001819,0.899628509167885,0.334585015381721,1,362,positive regulation of cytokine production,BP,MBP
17100,GO:0080134,0.900243348816936,0.195662541648179,5,1237,regulation of response to stress,BP,CAMK2A;TPD52L1;S100A1;GPR37;BOK
11754,GO:0044782,0.900953536099067,0.331544825315808,1,352,cilium organization,BP,SEPT4
12620,GO:0046700,0.90102263538325,0.25633601418065,2,616,heterocycle catabolic process,BP,GDA;CARNS1
11560,GO:0044270,0.901972694838163,0.254467682352292,2,618,cellular nitrogen compound catabolic process,BP,GDA;CARNS1
11350,GO:0043565,0.902125923621831,0.204593078596678,4,1030,sequence-specific DNA binding,MF,SOX10;MYRF;NKX6-2;ZNF536
6318,GO:0018205,0.902285116988125,0.328440201542896,1,357,peptidyl-lysine modification,BP,TOP2A
11863,GO:0045088,0.902670760058977,0.327526521809688,1,364,regulation of innate immune response,BP,S100A1
5962,GO:0016607,0.903113584336686,0.326497676199504,1,361,nuclear speck,CC,PPP1R16B
13667,GO:0051052,0.903201889584687,0.32629511619672,1,359,regulation of DNA metabolic process,BP,GREM1
665,GO:0001816,0.905563851524186,0.247354927009101,2,621,cytokine production,BP,MOG;MBP
6553,GO:0019439,0.909062631537975,0.240333893579619,2,633,aromatic compound catabolic process,BP,GDA;CARNS1
8369,GO:0032386,0.909938839776326,0.310261903647262,1,371,regulation of intracellular transport,BP,MYBPC1
5889,GO:0016491,0.910216297962802,0.237993774607827,2,646,oxidoreductase activity,MF,FA2H;AIFM3
19125,GO:1901990,0.910363763168829,0.309226025184923,1,376,regulation of mitotic cell cycle phase transition,BP,GJC2
4630,GO:0009896,0.910529771394741,0.308841294622914,1,367,positive regulation of catabolic process,BP,LRP2
5679,GO:0016050,0.910852884901565,0.308051076932731,1,371,vesicle organization,BP,SLC17A7
8419,GO:0032446,0.911309649628921,0.20593175352971,3,845,protein modification by small protein conjugation,BP,SEPT4;FBXO2;TOP2A
11917,GO:0045184,0.911682634649656,0.157763530507732,8,1847,establishment of protein localization,BP,LRP2;TF;PEX5L;VSNL1;CNTN2;MYBPC1;MBP;RYR2
1194,GO:0002682,0.912276310793642,0.175908759130664,5,1285,regulation of immune system process,BP,PADI2;MOG;CXCL14;S100A1;GREM1
13486,GO:0050778,0.91230895418541,0.233747493271272,2,637,positive regulation of immune response,BP,MOG;S100A1
2610,GO:0005515,0.912497061106849,0.125620346575876,59,10245,protein binding,MF,CD22;CLDN11;CAMK2A;PPP2R2C;LRP2;TF;SOX10;CPNE6;PPP1R16B;NEFM;MAG;ADAP1;EPHB6;PTGDS;ASPA;SEPT4;TPD52L1;FGF1;PEX5L;FBXO2;PADI2;CDK18;GDA;PLP1;PACSIN1;HSPA2;TOP2A;PPP1R1B;RAPGEF5;ERMN;ENPP2;MOG;CXCL14;DOCK5;MKI67;NRGN;SLC24A2;SLC5A11;S100A1;VSNL1;ETNPPL;HHIP;GREM1;KLK6;MOBP;GJB1;GPR37;TPPP;MAL;BOK;CNTN2;SV2B;CCK;DNAH17;MYBPC1;MBP;LPAR1;RYR2;FXYD1
2598,GO:0005488,0.912511406387711,0.134186096996982,76,12745,binding,MF,CD22;CLDN11;CAMK2A;PPP2R2C;LRP2;FOLH1;TF;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;MAG;ADAP1;EPHB6;PTGDS;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;FBXO2;PADI2;CDK18;GDA;NECAB1;PLP1;PACSIN1;MYRF;HSPA2;TOP2A;PPP1R1B;IQCA1;HAPLN2;RAPGEF5;ERMN;ENPP2;MOG;CXCL14;DOCK5;ST18;MKI67;NKX6-2;CNDP1;AK5;NRGN;SLC24A2;SLC5A11;S100A1;PAQR6;VSNL1;ETNPPL;HHIP;GREM1;KLK6;MOBP;GJB1;GPR37;TPPP;MAL;RCAN2;CARNS1;BOK;AIFM3;CNTN2;SV2B;CCK;DNAH17;MYBPC1;SPOCK3;MBP;LPAR1;ZNF536;RYR2;FXYD1
162,GO:0000323,0.913073371992399,0.232188951425131,2,633,lytic vacuole,CC,LRP2;PADI2
2746,GO:0005764,0.913073371992399,0.232188951425131,2,633,lysosome,CC,LRP2;PADI2
16513,GO:0071702,0.914043104599027,0.144298137392571,11,2410,organic substance transport,BP,LRP2;TF;SLC17A7;PEX5L;SLC5A11;VSNL1;TMEM144;GJB1;CCK;MYBPC1;MBP
3537,GO:0006979,0.915611145472946,0.296352015248653,1,390,response to oxidative stress,BP,GPR37
11094,GO:0043161,0.915870366723625,0.295713898228524,1,387,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,FBXO2
7758,GO:0031252,0.915905738476962,0.295662127071187,1,367,cell leading edge,CC,PACSIN1
7811,GO:0031328,0.916846978379706,0.154506517782803,7,1662,positive regulation of cellular biosynthetic process,BP,SOX10;FGF1;PADI2;MYRF;TOP2A;ST18;GREM1
11269,GO:0043434,0.918129171816469,0.290077784810438,1,385,response to peptide hormone,BP,CAMK2A
3524,GO:0006955,0.918609668120264,0.151707143249676,7,1710,immune response,BP,CAMK2A;PADI2;ENPP2;MOG;CXCL14;S100A1;MBP
16515,GO:0071705,0.919024095009012,0.142704410931906,9,2063,nitrogen compound transport,BP,LRP2;TF;SLC17A7;PEX5L;VSNL1;GJB1;CCK;MYBPC1;MBP
18913,GO:1901361,0.919530890735674,0.218807017877621,2,657,organic cyclic compound catabolic process,BP,GDA;CARNS1
2755,GO:0005774,0.919781136270428,0.285901443250976,1,392,vacuolar membrane,CC,LRP2
7831,GO:0031349,0.92015235022005,0.284952741245148,1,397,positive regulation of defense response,BP,S100A1
8708,GO:0032880,0.920971460623625,0.187802303867266,3,867,regulation of protein localization,BP,VSNL1;MYBPC1;MBP
1196,GO:0002684,0.921221899692144,0.187317186726688,3,888,positive regulation of immune system process,BP,MOG;CXCL14;S100A1
3894,GO:0008104,0.921492899088822,0.133313913459681,11,2423,protein localization,BP,LRP2;TF;SEPT4;PEX5L;PACSIN1;VSNL1;MAL;CNTN2;MYBPC1;MBP;RYR2
4625,GO:0009891,0.922990116039129,0.144718560866689,7,1684,positive regulation of biosynthetic process,BP,SOX10;FGF1;PADI2;MYRF;TOP2A;ST18;GREM1
19122,GO:1901987,0.923349723591608,0.276773003621724,1,400,regulation of cell cycle phase transition,BP,GJC2
2741,GO:0005759,0.924669881679727,0.27332851550661,1,420,mitochondrial matrix,CC,ETNPPL
4487,GO:0009314,0.925662131439331,0.270773136432075,1,402,response to radiation,BP,PPP1R1B
13118,GO:0048568,0.925852229837613,0.270283154869309,1,398,embryonic organ development,BP,RYR2
19317,GO:1902494,0.927687390797123,0.149728136408003,5,1318,catalytic complex,CC,PPP2R2C;FBXO2;GPR37;DNAH17;FXYD1
2782,GO:0005815,0.929845060840123,0.196758235683871,2,659,microtubule organizing center,CC,TOP2A;AK5
4807,GO:0010564,0.931670233687929,0.192753393183592,2,670,regulation of cell cycle process,BP,MKI67;GJC2
7995,GO:0031667,0.93301066293136,0.251188513162587,1,422,response to nutrient levels,BP,CCK
11553,GO:0044257,0.933163036228392,0.189456791385799,2,676,cellular protein catabolic process,BP,LRP2;FBXO2
11438,GO:0043933,0.934312052497985,0.122271328158125,8,1936,protein-containing complex subunit organization,BP,SEPT4;SLC39A12;GREM1;GJB1;TPPP;BOK;CCK;MYBPC1
68,GO:0000139,0.936675580883237,0.181618787167155,2,685,Golgi membrane,CC,BOK;HS3ST4
3429,GO:0006807,0.937244429486837,0.0918931430327431,49,8864,nitrogen compound metabolic process,BP,HHATL;CAMK2A;PPP2R2C;LRP2;FOLH1;TF;SOX10;PPP1R16B;FA2H;EPHB6;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;FBXO2;PADI2;CDK18;GDA;NECAB1;MYRF;HSPA2;TOP2A;PPP1R1B;ENPP2;ST18;NKX6-2;CNDP1;AK5;S100A1;SERPINI1;GREM1;PPP1R14A;KLK6;GPR37;RCAN2;CARNS1;BOK;HS3ST4;CNTN2;CCK;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;FXYD1
14015,GO:0051656,0.937407720499388,0.239097609580926,1,423,establishment of organelle localization,BP,MOBP
2268,GO:0004842,0.937688577645371,0.238316238727143,1,422,ubiquitin-protein transferase activity,MF,FBXO2
14010,GO:0051649,0.938807315003421,0.114990380004254,8,1941,establishment of localization in cell,BP,CAMK2A;SLC17A7;PEX5L;PACSIN1;VSNL1;MOBP;MYBPC1;RYR2
4774,GO:0010498,0.939168172373288,0.234153289702979,1,436,proteasomal protein catabolic process,BP,FBXO2
16268,GO:0071345,0.941009736871453,0.148250529605978,3,952,cellular response to cytokine stimulus,BP,CAMK2A;PADI2;ST18
11489,GO:0044085,0.941933102833658,0.0989294468532962,13,2889,cellular component biogenesis,BP,PPP1R16B;NEFM;SEPT4;HSPA2;HAPLN2;SLC39A12;GREM1;GJB1;TPPP;BOK;CCK;MYBPC1;LPAR1
4659,GO:0009991,0.94409041659065,0.220077880963513,1,450,response to extracellular stimulus,BP,CCK
11833,GO:0045055,0.944277543935549,0.164219341299646,2,715,regulated exocytosis,BP,TF;PADI2
19008,GO:1901652,0.945250841816994,0.216704927156505,1,446,response to peptide,BP,CAMK2A
11201,GO:0043312,0.94626206612892,0.213723406805608,1,462,neutrophil degranulation,BP,PADI2
2754,GO:0005773,0.946398924791982,0.159251262388023,2,723,vacuole,CC,LRP2;PADI2
6641,GO:0019787,0.946595065655287,0.212760880579564,1,446,ubiquitin-like protein transferase activity,MF,FBXO2
970,GO:0002283,0.947245758299714,0.210818532413513,1,465,neutrophil activation involved in immune response,BP,PADI2
3500,GO:0006914,0.947650402034682,0.209627998835427,1,457,autophagy,BP,BOK
15516,GO:0061919,0.947650402034682,0.209627998835427,1,457,process utilizing autophagic mechanism,BP,BOK
16514,GO:0071704,0.948252647555213,0.0772674035098855,53,9561,organic substance metabolic process,BP,HHATL;CAMK2A;PPP2R2C;LRP2;FOLH1;TF;SOX10;CPNE6;PPP1R16B;FA2H;EPHB6;PTGDS;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;FBXO2;PADI2;CDK18;GDA;NECAB1;PLP1;MYRF;HSPA2;TOP2A;PPP1R1B;ENPP2;ST18;NKX6-2;CNDP1;AK5;S100A1;SERPINI1;ETNPPL;GREM1;PPP1R14A;KLK6;GPR37;RCAN2;CARNS1;BOK;HS3ST4;CNTN2;CCK;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;FXYD1
5667,GO:0016032,0.948435029760317,0.154431046825361,2,736,viral process,BP,TOP2A;MOG
14003,GO:0051641,0.948494135308202,0.0920073239136804,11,2548,cellular localization,BP,CAMK2A;SLC17A7;SEPT4;PEX5L;PACSIN1;VSNL1;MOBP;MAL;CNTN2;MYBPC1;RYR2
10550,GO:0042060,0.949850545508438,0.203048451483435,1,460,wound healing,BP,KLK6
10581,GO:0042119,0.949863287001998,0.202996757056157,1,473,neutrophil activation,BP,PADI2
1069,GO:0002446,0.950480900775337,0.201131001483331,1,475,neutrophil mediated immunity,BP,PADI2
11862,GO:0045087,0.95080648895322,0.148753954242877,2,750,innate immune response,BP,CAMK2A;S100A1
13525,GO:0050839,0.951158965175599,0.199090891153408,1,460,cell adhesion molecule binding,MF,FGF1
10201,GO:0036230,0.951411467411709,0.198304976731494,1,478,granulocyte activation,BP,PADI2
11544,GO:0044237,0.95183741339344,0.0722866852393979,52,9434,cellular metabolic process,BP,HHATL;CAMK2A;PPP2R2C;LRP2;FOLH1;TF;SOX10;CPNE6;PPP1R16B;FA2H;EPHB6;PTGDS;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;FBXO2;PADI2;CDK18;GDA;NECAB1;PLP1;MYRF;HSPA2;TOP2A;PPP1R1B;ENPP2;ST18;NKX6-2;CNDP1;AK5;S100A1;SERPINI1;ETNPPL;GREM1;PPP1R14A;GPR37;RCAN2;CARNS1;BOK;HS3ST4;CNTN2;CCK;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;FXYD1
3533,GO:0006974,0.953555824528214,0.142090916490397,2,745,cellular response to DNA damage stimulus,BP,TOP2A;BOK
1609,GO:0003700,0.953839380913109,0.102451665435438,5,1412,DNA binding transcription factor activity,MF,SOX10;MYRF;ST18;NKX6-2;ZNF536
20942,GO:1990234,0.953941690960987,0.141147840821953,2,744,transferase complex,CC,FBXO2;GPR37
19934,GO:1903827,0.955195853960907,0.186633916521616,1,476,regulation of cellular protein localization,BP,MYBPC1
11141,GO:0043228,0.955226256258171,0.0746647596395902,17,3670,non-membrane-bounded organelle,CC,SOX10;NEFM;SEPT4;FGF1;PADI2;HSPA2;TOP2A;ERMN;MKI67;AK5;S100A1;KLK6;MOBP;TPPP;DNAH17;MYBPC1;RYR2
11145,GO:0043232,0.955226256258171,0.0746647596395902,17,3670,intracellular non-membrane-bounded organelle,CC,SOX10;NEFM;SEPT4;FGF1;PADI2;HSPA2;TOP2A;ERMN;MKI67;AK5;S100A1;KLK6;MOBP;TPPP;DNAH17;MYBPC1;RYR2
11672,GO:0044454,0.955963044403381,0.184223729173944,1,481,nuclear chromosome part,CC,HSPA2
11100,GO:0043170,0.957891477440651,0.0637738429607493,44,8205,macromolecule metabolic process,BP,HHATL;CAMK2A;PPP2R2C;LRP2;FOLH1;TF;SOX10;PPP1R16B;EPHB6;SEPT4;RASAL1;TPD52L1;FGF1;FBXO2;PADI2;CDK18;NECAB1;PLP1;MYRF;HSPA2;TOP2A;PPP1R1B;ENPP2;ST18;NKX6-2;CNDP1;S100A1;SERPINI1;GREM1;PPP1R14A;KLK6;GPR37;RCAN2;BOK;HS3ST4;CNTN2;CCK;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GJC2;FXYD1
9440,GO:0034613,0.958493226812794,0.088627027566709,6,1648,cellular protein localization,BP,SEPT4;PEX5L;PACSIN1;CNTN2;MYBPC1;RYR2
5930,GO:0016567,0.958725735289725,0.129269559555326,2,763,protein ubiquitination,BP,SEPT4;FBXO2
7812,GO:0031329,0.959150751061517,0.128198725650656,2,763,regulation of cellular catabolic process,BP,LRP2;BOK
16059,GO:0070925,0.959152088031789,0.128198990426669,2,753,organelle assembly,BP,SEPT4;MYBPC1
11188,GO:0043299,0.959369167855207,0.173354336064669,1,505,leukocyte degranulation,BP,PADI2
9185,GO:0034097,0.959858683485939,0.10802333633795,3,1031,response to cytokine,BP,CAMK2A;PADI2;ST18
1031,GO:0002376,0.959942342064151,0.0752260889398333,10,2481,immune system process,BP,CAMK2A;MAG;PADI2;TOP2A;ENPP2;MOG;CXCL14;S100A1;GREM1;MBP
15960,GO:0070727,0.960149793834106,0.0855606490111494,6,1658,cellular macromolecule localization,BP,SEPT4;PEX5L;PACSIN1;CNTN2;MYBPC1;RYR2
18049,GO:0098791,0.960454373748339,0.12489476408171,2,769,Golgi subcompartment,CC,BOK;HS3ST4
13756,GO:0051186,0.960636819179168,0.169236992216393,1,513,cofactor metabolic process,BP,FOLH1
15922,GO:0070647,0.961257373392713,0.104895570349445,3,1011,protein modification by small protein conjugation or removal,BP,SEPT4;FBXO2;TOP2A
963,GO:0002275,0.961378448648238,0.166812548519557,1,513,myeloid cell activation involved in immune response,BP,PADI2
11635,GO:0044403,0.96141578354316,0.122435527099386,2,790,symbiont process,BP,TOP2A;MOG
1067,GO:0002444,0.962063954466933,0.16455628158874,1,516,myeloid leukocyte mediated immunity,BP,PADI2
11669,GO:0044451,0.965348387097785,0.0955910828459884,3,1032,nucleoplasm part,CC,PPP1R16B;RAPGEF5;MKI67
11551,GO:0044249,0.965434934914856,0.0549145827477548,28,5703,cellular biosynthetic process,BP,HHATL;CAMK2A;LRP2;FOLH1;SOX10;CPNE6;FA2H;PTGDS;ASPA;FGF1;PADI2;GDA;NECAB1;PLP1;MYRF;TOP2A;PPP1R1B;ST18;NKX6-2;AK5;S100A1;ETNPPL;GREM1;GPR37;CARNS1;ZNF536;RYR2;GRM3
11644,GO:0044419,0.965922039016526,0.110729411024308,2,814,interspecies interaction between organisms,BP,TOP2A;MOG
17009,GO:0072657,0.96630575027014,0.150306596709437,1,530,protein localization to membrane,BP,PACSIN1
7199,GO:0030163,0.967454471814757,0.10667117322234,2,806,protein catabolic process,BP,LRP2;FBXO2
3521,GO:0006952,0.968317118790764,0.0799144809448958,4,1317,defense response,BP,CAMK2A;PLP1;S100A1;CCK
1613,GO:0003712,0.968906907841089,0.141306130108512,1,531,transcription cofactor activity,MF,SOX10
13484,GO:0050776,0.969536794497709,0.101073218384206,2,836,regulation of immune response,BP,MOG;S100A1
8817,GO:0033036,0.969913711210086,0.0570204017529442,11,2703,macromolecule localization,BP,LRP2;TF;SEPT4;PEX5L;PACSIN1;VSNL1;MAL;CNTN2;MYBPC1;MBP;RYR2
3210,GO:0006511,0.970152161524944,0.136914296662,1,539,ubiquitin-dependent protein catabolic process,BP,FBXO2
6716,GO:0019941,0.971983378154278,0.130359526793693,1,549,modification-dependent protein catabolic process,BP,FBXO2
5288,GO:0015031,0.972332226863124,0.0623041385852498,6,1754,protein transport,BP,LRP2;TF;PEX5L;VSNL1;MYBPC1;MBP
8786,GO:0032991,0.972412555992513,0.0464478257613518,21,4556,protein-containing complex,CC,PPP2R2C;LRP2;TF;EPHB6;SEPT4;PEX5L;FBXO2;HSPA2;TOP2A;ST18;S100A1;GJB1;GPR37;GPR62;CNTN2;DNAH17;MYBPC1;MBP;RYR2;GJC2;FXYD1
18975,GO:1901576,0.972458928768763,0.0445751735658594,28,5780,organic substance biosynthetic process,BP,HHATL;CAMK2A;LRP2;FOLH1;SOX10;CPNE6;FA2H;PTGDS;ASPA;FGF1;PADI2;GDA;NECAB1;PLP1;MYRF;TOP2A;PPP1R1B;ST18;NKX6-2;AK5;S100A1;ETNPPL;GREM1;GPR37;CARNS1;ZNF536;RYR2;GRM3
11389,GO:0043632,0.973564279629128,0.124601938187071,1,558,modification-dependent macromolecule catabolic process,BP,FBXO2
14055,GO:0051726,0.973762742360791,0.07570465204445,3,1091,regulation of cell cycle,BP,TOP2A;MKI67;GJC2
14464,GO:0055114,0.974188226992743,0.0882499785249097,2,874,oxidation-reduction process,BP,FA2H;AIFM3
6552,GO:0019438,0.97460793921483,0.0441930259599346,18,4053,aromatic compound biosynthetic process,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;GDA;MYRF;TOP2A;PPP1R1B;ST18;NKX6-2;AK5;S100A1;GREM1;GPR37;ZNF536;RYR2;GRM3
4548,GO:0009611,0.974621100010757,0.120699744950672,1,563,response to wounding,BP,KLK6
9470,GO:0034655,0.974770440807323,0.120137272802786,1,578,nucleobase-containing compound catabolic process,BP,GDA
4628,GO:0009894,0.975803995622269,0.0836858436641802,2,855,regulation of catabolic process,BP,LRP2;BOK
5572,GO:0015833,0.976047872655846,0.0549184857924365,6,1788,peptide transport,BP,LRP2;TF;PEX5L;VSNL1;MYBPC1;MBP
11654,GO:0044431,0.976266447234164,0.0823656110873554,2,858,Golgi apparatus part,CC,BOK;HS3ST4
3523,GO:0006954,0.976328100424792,0.114290574020035,1,591,inflammatory response,BP,PLP1
962,GO:0002274,0.976515396013718,0.113582278337944,1,589,myeloid leukocyte activation,BP,PADI2
4305,GO:0009058,0.976991241960457,0.0377751010583423,28,5840,biosynthetic process,BP,HHATL;CAMK2A;LRP2;FOLH1;SOX10;CPNE6;FA2H;PTGDS;ASPA;FGF1;PADI2;GDA;NECAB1;PLP1;MYRF;TOP2A;PPP1R1B;ST18;NKX6-2;AK5;S100A1;ETNPPL;GREM1;GPR37;CARNS1;ZNF536;RYR2;GRM3
3925,GO:0008152,0.977716434731066,0.0356814255750859,54,10000,metabolic process,BP,HHATL;CAMK2A;PPP2R2C;LRP2;FOLH1;TF;SOX10;CPNE6;PPP1R16B;FA2H;EPHB6;PTGDS;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;FBXO2;PADI2;CDK18;GDA;NECAB1;PLP1;MYRF;HSPA2;TOP2A;PPP1R1B;ENPP2;ST18;NKX6-2;CNDP1;AK5;S100A1;SERPINI1;ETNPPL;GREM1;PPP1R14A;KLK6;GPR37;RCAN2;CARNS1;BOK;HS3ST4;AIFM3;CNTN2;CCK;SPOCK3;MBP;LPAR1;ZNF536;RYR2;GRM3;GJC2;FXYD1
10955,GO:0042886,0.978118394347316,0.0507306292355909,6,1809,amide transport,BP,LRP2;TF;PEX5L;VSNL1;MYBPC1;MBP
6022,GO:0016740,0.978704235850802,0.0454586644496944,8,2206,transferase activity,MF,CAMK2A;EPHB6;FGF1;FBXO2;CDK18;AK5;ETNPPL;HS3ST4
3040,GO:0006259,0.980230920566728,0.0708055530521503,2,898,DNA metabolic process,BP,TOP2A;GREM1
11550,GO:0044248,0.980820231530854,0.0430661968737847,7,2061,cellular catabolic process,BP,LRP2;ASPA;FBXO2;GDA;ENPP2;CARNS1;BOK
371,GO:0000989,0.980953249341181,0.0962893309217239,1,603,transcription factor activity, transcription factor binding,MF,SOX10
370,GO:0000988,0.98145324612167,0.0942771932813193,1,607,transcription factor activity, protein binding,MF,SOX10
7829,GO:0031347,0.981968544711958,0.0921833137971801,1,626,regulation of defense response,BP,S100A1
1023,GO:0002366,0.982170919362893,0.0913582483281152,1,630,leukocyte activation involved in immune response,BP,PADI2
14002,GO:0051640,0.982498138064256,0.090027400765058,1,614,organelle localization,BP,MOBP
4846,GO:0010629,0.982529280177542,0.0442283712206127,5,1637,negative regulation of gene expression,BP,SOX10;NKX6-2;S100A1;GREM1;ZNF536
958,GO:0002263,0.982599203531802,0.0896063146929014,1,633,cell activation involved in immune response,BP,PADI2
9469,GO:0034654,0.982910935523664,0.0311110902622733,17,3989,nucleobase-containing compound biosynthetic process,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;GDA;MYRF;TOP2A;PPP1R1B;ST18;NKX6-2;AK5;S100A1;GREM1;ZNF536;RYR2;GRM3
18914,GO:1901362,0.98298473678122,0.0306495897882366,18,4175,organic cyclic compound biosynthetic process,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;GDA;MYRF;TOP2A;PPP1R1B;ST18;NKX6-2;AK5;S100A1;GREM1;GPR37;ZNF536;RYR2;GRM3
13989,GO:0051603,0.983237768569422,0.0869775427379142,1,627,proteolysis involved in cellular protein catabolic process,BP,FBXO2
18974,GO:1901575,0.984370721223224,0.037710748932076,6,1894,organic substance catabolic process,BP,LRP2;ASPA;FBXO2;GDA;ENPP2;CARNS1
4303,GO:0009056,0.98443580329447,0.0343658462213803,8,2313,catabolic process,BP,LRP2;ASPA;FBXO2;GDA;ENPP2;KLK6;CARNS1;BOK
11368,GO:0043603,0.984558515647322,0.0576201996319656,2,965,cellular amide metabolic process,BP,FOLH1;CARNS1
11033,GO:0043043,0.985634861972855,0.0768539611775462,1,672,peptide biosynthetic process,BP,CARNS1
6298,GO:0018130,0.98594303268377,0.0260135514225763,17,4046,heterocycle biosynthetic process,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;GDA;MYRF;TOP2A;PPP1R1B;ST18;NKX6-2;AK5;S100A1;GREM1;ZNF536;RYR2;GRM3
3520,GO:0006950,0.986151071534623,0.0272061567992516,13,3332,response to stress,BP,CAMK2A;TPD52L1;FGF1;FBXO2;PLP1;HSPA2;TOP2A;S100A1;KLK6;GPR37;BOK;CCK;RYR2
3098,GO:0006351,0.986589889123463,0.0259707477990697,14,3495,transcription, DNA-templated,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;MYRF;TOP2A;PPP1R1B;ST18;NKX6-2;S100A1;GREM1;ZNF536;RYR2
17881,GO:0097659,0.987254908827269,0.0247918423412396,14,3509,nucleic acid-templated transcription,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;MYRF;TOP2A;PPP1R1B;ST18;NKX6-2;S100A1;GREM1;ZNF536;RYR2
1066,GO:0002443,0.987533718758151,0.068549649268777,1,688,leukocyte mediated immunity,BP,PADI2
8638,GO:0032774,0.987838219280729,0.0237527923114583,14,3522,RNA biosynthetic process,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;MYRF;TOP2A;PPP1R1B;ST18;NKX6-2;S100A1;GREM1;ZNF536;RYR2
3102,GO:0006355,0.98855379743995,0.0228671083417104,13,3344,regulation of transcription, DNA-templated,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;MYRF;TOP2A;ST18;NKX6-2;S100A1;GREM1;ZNF536;RYR2
3479,GO:0006886,0.988662528093009,0.0444307996648179,2,1002,intracellular protein transport,BP,PEX5L;MYBPC1
19758,GO:1903506,0.989348562203059,0.0214124427744462,13,3363,regulation of nucleic acid-templated transcription,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;MYRF;TOP2A;ST18;NKX6-2;S100A1;GREM1;ZNF536;RYR2
21782,GO:2001141,0.989541313888829,0.0210580640632057,13,3368,regulation of RNA biosynthetic process,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;MYRF;TOP2A;ST18;NKX6-2;S100A1;GREM1;ZNF536;RYR2
11648,GO:0044424,0.990062206292443,0.0182019446696567,71,12617,intracellular part,CC,HHATL;BCAS1;CAMK2A;PPP2R2C;LRP2;FOLH1;TF;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;SLC17A7;MAG;ADAP1;EPHB6;PTGDS;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;FBXO2;PADI2;CDK18;GDA;NECAB1;PACSIN1;MYRF;HSPA2;TOP2A;PPP1R1B;RAPGEF5;ERMN;CXCL14;DOCK5;ST18;SLC39A12;MKI67;NKX6-2;CNDP1;AK5;NRGN;S100A1;VSNL1;SERPINI1;ETNPPL;HHIP;PPP1R14A;KLK6;MOBP;LGI3;GJB1;GPR37;TPPP;MAL;RCAN2;CARNS1;BOK;HS3ST4;AIFM3;SV2B;DNAH17;MYBPC1;OPALIN;MBP;LPAR1;ZNF536;RYR2;TMEM235
21231,GO:2000112,0.990125436790692,0.0193206178094882,15,3756,regulation of cellular macromolecule biosynthetic process,BP,HHATL;CAMK2A;LRP2;SOX10;FGF1;PADI2;NECAB1;MYRF;TOP2A;ST18;NKX6-2;S100A1;GREM1;ZNF536;RYR2
11558,GO:0044265,0.990419249049768,0.0385230237920293,2,1025,cellular macromolecule catabolic process,BP,LRP2;FBXO2
18537,GO:0140110,0.990526788178616,0.0257971770750847,5,1754,transcription regulator activity,MF,SOX10;MYRF;ST18;NKX6-2;ZNF536
7809,GO:0031326,0.99119527016341,0.0171402378159362,16,3977,regulation of cellular biosynthetic process,BP,HHATL;CAMK2A;LRP2;SOX10;FGF1;PADI2;NECAB1;MYRF;TOP2A;ST18;NKX6-2;S100A1;GREM1;ZNF536;RYR2;GRM3
11369,GO:0043604,0.991349759780531,0.0508881366786845,1,750,amide biosynthetic process,BP,CARNS1
14039,GO:0051704,0.991888610686576,0.021041010832752,6,2043,multi-organism process,BP,CLDN11;SEPT4;HSPA2;TOP2A;PPP1R1B;MOG
7151,GO:0030097,0.99230322139939,0.0462296325654335,1,747,hemopoiesis,BP,TOP2A
4799,GO:0010556,0.992730977111702,0.0145778984683262,15,3837,regulation of macromolecule biosynthetic process,BP,HHATL;CAMK2A;LRP2;SOX10;FGF1;PADI2;NECAB1;MYRF;TOP2A;ST18;NKX6-2;S100A1;GREM1;ZNF536;RYR2
1597,GO:0003677,0.99276630247692,0.0180104409789805,7,2247,DNA binding,MF,SOX10;MYRF;TOP2A;ST18;MKI67;NKX6-2;ZNF536
2668,GO:0005622,0.992953853913765,0.0133944070753002,72,12823,intracellular,CC,HHATL;BCAS1;CAMK2A;PPP2R2C;LRP2;FOLH1;TF;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;SLC17A7;MAG;ADAP1;EPHB6;PTGDS;ASPA;SEPT4;RASAL1;TPD52L1;FGF1;PEX5L;FBXO2;PADI2;CDK18;GDA;NECAB1;PACSIN1;MYRF;HSPA2;TOP2A;PPP1R1B;RAPGEF5;ERMN;CXCL14;DOCK5;ST18;SLC39A12;MKI67;NKX6-2;CNDP1;AK5;NRGN;S100A1;VSNL1;SERPINI1;ETNPPL;HHIP;PPP1R14A;KLK6;MOBP;LGI3;GJB1;GPR37;TPPP;MAL;RCAN2;CARNS1;BOK;GPR62;HS3ST4;AIFM3;SV2B;DNAH17;MYBPC1;OPALIN;MBP;LPAR1;ZNF536;RYR2;TMEM235
4623,GO:0009889,0.993019100351475,0.0138393790139089,16,4038,regulation of biosynthetic process,BP,HHATL;CAMK2A;LRP2;SOX10;FGF1;PADI2;NECAB1;MYRF;TOP2A;ST18;NKX6-2;S100A1;GREM1;ZNF536;RYR2;GRM3
3215,GO:0006518,0.993980222009392,0.0377163970055271,1,805,peptide metabolic process,BP,CARNS1
13098,GO:0048534,0.994008770109122,0.0375701888450836,1,785,hematopoietic or lymphoid organ development,BP,TOP2A
13797,GO:0051252,0.995366184426185,0.0099744271024106,13,3566,regulation of RNA metabolic process,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;MYRF;TOP2A;ST18;NKX6-2;S100A1;GREM1;ZNF536;RYR2
1110,GO:0002520,0.995417490764304,0.0300368814141837,1,824,immune system development,BP,TOP2A
4764,GO:0010468,0.995576441065986,0.00907681964503303,16,4149,regulation of gene expression,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;PLP1;MYRF;TOP2A;ST18;NKX6-2;S100A1;GREM1;CNTN2;ZNF536;RYR2;GJC2
17637,GO:0097159,0.995843479232453,0.00794997188003544,23,5427,organic cyclic compound binding,MF,CAMK2A;SOX10;FA2H;EPHB6;SEPT4;CDK18;MYRF;HSPA2;TOP2A;IQCA1;ENPP2;ST18;MKI67;NKX6-2;AK5;PAQR6;ETNPPL;RCAN2;CARNS1;AIFM3;DNAH17;ZNF536;RYR2
11561,GO:0044271,0.996352548453431,0.00738936505889004,18,4604,cellular nitrogen compound biosynthetic process,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;GDA;MYRF;TOP2A;PPP1R1B;ST18;NKX6-2;AK5;S100A1;GREM1;CARNS1;ZNF536;RYR2;GRM3
11647,GO:0044422,0.996672984256639,0.00603937590459942,40,8352,organelle part,CC,HHATL;CAMK2A;LRP2;TF;SOX10;PPP1R16B;FA2H;NEFM;SLC17A7;PTGDS;SEPT4;FGF1;PEX5L;FBXO2;PADI2;NECAB1;PACSIN1;MYRF;HSPA2;TOP2A;RAPGEF5;MKI67;AK5;NRGN;S100A1;SERPINI1;ETNPPL;HHIP;KLK6;MOBP;GJB1;GPR37;TPPP;BOK;HS3ST4;AIFM3;SV2B;DNAH17;MYBPC1;RYR2
6472,GO:0019219,0.99693212050018,0.00668319658462941,14,3857,regulation of nucleobase-containing compound metabolic process,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;MYRF;TOP2A;ST18;NKX6-2;S100A1;GREM1;ZNF536;RYR2;GRM3
11140,GO:0043227,0.997003666673038,0.00558349535277031,58,11108,membrane-bounded organelle,CC,HHATL;CD22;CLDN11;BCAS1;CAMK2A;LRP2;FOLH1;TF;SOX10;CPNE6;PPP1R16B;FA2H;SLC17A7;ADAP1;PTGDS;ASPA;SEPT4;FGF1;PEX5L;FBXO2;PADI2;CDK18;GDA;NECAB1;PACSIN1;MYRF;HSPA2;TOP2A;PPP1R1B;RAPGEF5;ERMN;CXCL14;ST18;SLC39A12;MKI67;NKX6-2;NRGN;S100A1;SERPINI1;ETNPPL;HHIP;KLK6;MOBP;LGI3;GJB1;GPR37;TPPP;MAL;BOK;HS3ST4;AIFM3;SV2B;OPALIN;MBP;LPAR1;ZNF536;RYR2;TMEM235
4304,GO:0009057,0.997258239449421,0.0130946874961623,2,1231,macromolecule catabolic process,BP,LRP2;FBXO2
11139,GO:0043226,0.998160390649526,0.00362025767402475,63,11884,organelle,CC,HHATL;CD22;CLDN11;BCAS1;CAMK2A;LRP2;FOLH1;TF;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;SLC17A7;ADAP1;PTGDS;ASPA;SEPT4;FGF1;PEX5L;FBXO2;PADI2;CDK18;GDA;NECAB1;PACSIN1;MYRF;HSPA2;TOP2A;PPP1R1B;RAPGEF5;ERMN;CXCL14;ST18;SLC39A12;MKI67;NKX6-2;AK5;NRGN;S100A1;SERPINI1;ETNPPL;HHIP;KLK6;MOBP;LGI3;GJB1;GPR37;TPPP;MAL;BOK;HS3ST4;AIFM3;SV2B;DNAH17;MYBPC1;OPALIN;MBP;LPAR1;ZNF536;RYR2;GRM3;TMEM235
953,GO:0002252,0.998496415447339,0.0116417328772832,1,1003,immune effector process,BP,PADI2
12702,GO:0046907,0.998526624846608,0.00613649848906062,3,1616,intracellular transport,BP,PEX5L;MOBP;MYBPC1
18915,GO:1901363,0.998730397607003,0.00266679143531378,21,5362,heterocyclic compound binding,MF,CAMK2A;SOX10;FA2H;EPHB6;SEPT4;CDK18;MYRF;HSPA2;TOP2A;IQCA1;ENPP2;ST18;MKI67;NKX6-2;AK5;ETNPPL;RCAN2;CARNS1;AIFM3;DNAH17;ZNF536
11651,GO:0044428,0.998866923955273,0.00264710642399564,14,4097,nuclear part,CC,CAMK2A;SOX10;PPP1R16B;PTGDS;SEPT4;FGF1;NECAB1;MYRF;HSPA2;TOP2A;RAPGEF5;MKI67;KLK6;BOK
2670,GO:0005634,0.998906510587382,0.00221176443842234,27,6483,nucleus,CC,CAMK2A;SOX10;PPP1R16B;ADAP1;PTGDS;ASPA;SEPT4;FGF1;PADI2;CDK18;NECAB1;MYRF;HSPA2;TOP2A;PPP1R1B;RAPGEF5;ST18;MKI67;NKX6-2;NRGN;S100A1;HHIP;KLK6;TPPP;BOK;MBP;ZNF536
11664,GO:0044446,0.998920624833765,0.00210324279907499,37,8154,intracellular organelle part,CC,HHATL;CAMK2A;LRP2;TF;SOX10;PPP1R16B;FA2H;NEFM;SLC17A7;PTGDS;SEPT4;FGF1;PEX5L;PADI2;NECAB1;PACSIN1;MYRF;HSPA2;TOP2A;RAPGEF5;MKI67;AK5;NRGN;SERPINI1;ETNPPL;KLK6;MOBP;GJB1;GPR37;TPPP;BOK;HS3ST4;AIFM3;SV2B;DNAH17;MYBPC1;RYR2
11976,GO:0045321,0.999076840962027,0.00763185028353076,1,1074,leukocyte activation,BP,PADI2
3381,GO:0006725,0.999102985342533,0.00192429571901046,21,5492,cellular aromatic compound metabolic process,BP,CAMK2A;LRP2;FOLH1;SOX10;FGF1;PADI2;GDA;MYRF;TOP2A;PPP1R1B;ENPP2;ST18;NKX6-2;AK5;S100A1;GREM1;GPR37;CARNS1;ZNF536;RYR2;GRM3
4763,GO:0010467,0.999173419306568,0.00184569972243657,18,4942,gene expression,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;PLP1;MYRF;TOP2A;PPP1R1B;ST18;NKX6-2;S100A1;GREM1;KLK6;CNTN2;ZNF536;RYR2;GJC2
8132,GO:0031981,0.999207103329908,0.00198530730660027,12,3776,nuclear lumen,CC,CAMK2A;SOX10;PPP1R16B;SEPT4;FGF1;NECAB1;MYRF;HSPA2;TOP2A;RAPGEF5;MKI67;KLK6
8130,GO:0031974,0.999217410347871,0.00177832970166761,17,4779,membrane-enclosed lumen,CC,CAMK2A;LRP2;TF;SOX10;PPP1R16B;SEPT4;FGF1;PADI2;NECAB1;MYRF;HSPA2;TOP2A;RAPGEF5;MKI67;SERPINI1;ETNPPL;KLK6
11146,GO:0043233,0.999217410347871,0.00177832970166761,17,4779,organelle lumen,CC,CAMK2A;LRP2;TF;SOX10;PPP1R16B;SEPT4;FGF1;PADI2;NECAB1;MYRF;HSPA2;TOP2A;RAPGEF5;MKI67;SERPINI1;ETNPPL;KLK6
15553,GO:0070013,0.999217410347871,0.00177832970166761,17,4779,intracellular organelle lumen,CC,CAMK2A;LRP2;TF;SOX10;PPP1R16B;SEPT4;FGF1;PADI2;NECAB1;MYRF;HSPA2;TOP2A;RAPGEF5;MKI67;SERPINI1;ETNPPL;KLK6
11142,GO:0043229,0.999350260284061,0.00132090028779432,56,11114,intracellular organelle,CC,HHATL;CAMK2A;LRP2;TF;SOX10;CPNE6;PPP1R16B;FA2H;NEFM;SLC17A7;ADAP1;PTGDS;ASPA;SEPT4;FGF1;PEX5L;FBXO2;PADI2;CDK18;NECAB1;PACSIN1;MYRF;HSPA2;TOP2A;PPP1R1B;RAPGEF5;ERMN;CXCL14;ST18;MKI67;NKX6-2;AK5;NRGN;S100A1;SERPINI1;ETNPPL;HHIP;KLK6;MOBP;LGI3;GJB1;GPR37;TPPP;MAL;BOK;HS3ST4;AIFM3;SV2B;DNAH17;MYBPC1;OPALIN;MBP;LPAR1;ZNF536;RYR2;TMEM235
2680,GO:0005654,0.999519784550325,0.00137086427978605,9,3247,nucleoplasm,CC,CAMK2A;SOX10;PPP1R16B;SEPT4;NECAB1;MYRF;TOP2A;RAPGEF5;MKI67
9462,GO:0034645,0.999524566379457,0.0011316545213507,16,4682,cellular macromolecule biosynthetic process,BP,HHATL;CAMK2A;LRP2;SOX10;FGF1;PADI2;NECAB1;MYRF;TOP2A;PPP1R1B;ST18;NKX6-2;S100A1;GREM1;ZNF536;RYR2
12500,GO:0046483,0.999529411193125,0.00105987969860949,20,5453,heterocycle metabolic process,BP,CAMK2A;LRP2;FOLH1;SOX10;FGF1;PADI2;GDA;MYRF;TOP2A;PPP1R1B;ENPP2;ST18;NKX6-2;AK5;S100A1;GREM1;CARNS1;ZNF536;RYR2;GRM3
1618,GO:0003723,0.999552743380351,0.00262521136334603,2,1533,RNA binding,MF,TOP2A;MKI67
18912,GO:1901360,0.999585945548267,0.000929066420306702,21,5667,organic cyclic compound metabolic process,BP,CAMK2A;LRP2;FOLH1;SOX10;FGF1;PADI2;GDA;MYRF;TOP2A;PPP1R1B;ENPP2;ST18;NKX6-2;AK5;S100A1;GREM1;GPR37;CARNS1;ZNF536;RYR2;GRM3
5689,GO:0016070,0.999591435764034,0.0010192726108825,14,4325,RNA metabolic process,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;MYRF;TOP2A;PPP1R1B;ST18;NKX6-2;S100A1;GREM1;ZNF536;RYR2
633,GO:0001775,0.99963607928055,0.00337544758956478,1,1208,cell activation,BP,PADI2
4306,GO:0009059,0.999718261725211,0.000691785751624935,16,4792,macromolecule biosynthetic process,BP,HHATL;CAMK2A;LRP2;SOX10;FGF1;PADI2;NECAB1;MYRF;TOP2A;PPP1R1B;ST18;NKX6-2;S100A1;GREM1;ZNF536;RYR2
11144,GO:0043231,0.999841842222308,0.000339025611319793,44,9668,intracellular membrane-bounded organelle,CC,HHATL;CAMK2A;LRP2;TF;SOX10;PPP1R16B;FA2H;ADAP1;PTGDS;ASPA;SEPT4;FGF1;PEX5L;FBXO2;PADI2;CDK18;NECAB1;MYRF;HSPA2;TOP2A;PPP1R1B;RAPGEF5;CXCL14;ST18;MKI67;NKX6-2;NRGN;S100A1;ETNPPL;HHIP;KLK6;MOBP;GJB1;GPR37;TPPP;MAL;BOK;HS3ST4;AIFM3;OPALIN;MBP;ZNF536;RYR2;TMEM235
2981,GO:0006139,0.999845183739504,0.000380863972152781,18,5311,nucleobase-containing compound metabolic process,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;GDA;MYRF;TOP2A;PPP1R1B;ENPP2;ST18;NKX6-2;AK5;S100A1;GREM1;ZNF536;RYR2;GRM3
17392,GO:0090304,0.999878447084602,0.000319018203273389,15,4768,nucleic acid metabolic process,BP,CAMK2A;LRP2;SOX10;FGF1;PADI2;MYRF;TOP2A;PPP1R1B;ENPP2;ST18;NKX6-2;S100A1;GREM1;ZNF536;RYR2
9459,GO:0034641,0.99988547635308,0.000275485199755608,21,5944,cellular nitrogen compound metabolic process,BP,CAMK2A;LRP2;FOLH1;SOX10;FGF1;PADI2;GDA;MYRF;TOP2A;PPP1R1B;ENPP2;ST18;NKX6-2;AK5;S100A1;GREM1;GPR37;CARNS1;ZNF536;RYR2;GRM3
1596,GO:0003676,0.999939110914861,0.000198792972487336,9,3641,nucleic acid binding,MF,SOX10;MYRF;TOP2A;ENPP2;ST18;MKI67;NKX6-2;RCAN2;ZNF536
2148,GO:0004679,0.99999999999999,0.954880512469289,0,7,AMP-activated protein kinase activity,MF,
5538,GO:0015780,0.99999999999999,0.922348245265418,0,13,nucleotide-sugar transmembrane transport,BP,
10017,GO:0035872,0.99999999999999,0.799894815902806,0,35,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
4810,GO:0010569,0.999999999999991,0.838088208378659,0,27,regulation of double-strand break repair via homologous recombination,BP,
17413,GO:0090330,0.999999999999991,0.890526662173958,0,18,regulation of platelet aggregation,BP,
8570,GO:0032663,0.999999999999995,0.733260569647989,0,49,regulation of interleukin-2 production,BP,
20904,GO:1990090,0.999999999999998,0.723096884797589,0,49,cellular response to nerve growth factor stimulus,BP,
19057,GO:1901798,0.999999999999998,0.879298678739469,0,20,positive regulation of signal transduction by p53 class mediator,BP,
8269,GO:0032230,0.999999999999999,0.926343598254107,0,12,positive regulation of synaptic transmission, GABAergic,BP,
6297,GO:0018126,0.999999999999999,0.869657001114041,0,22,protein hydroxylation,BP,
12420,GO:0046320,0.999999999999999,0.829779859909456,0,28,regulation of fatty acid oxidation,BP,
15998,GO:0070830,0.999999999999999,0.732902036956591,0,48,bicellular tight junction assembly,BP,
2879,GO:0005978,1,0.747544921209058,0,44,glycogen biosynthetic process,BP,
4457,GO:0009250,1,0.747544921209058,0,44,glucan biosynthetic process,BP,
6328,GO:0018230,1,0.870796448731544,0,22,peptidyl-L-cysteine S-palmitoylation,BP,
6329,GO:0018231,1,0.870796448731544,0,22,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
1,GO:0000002,1,0.847547648290067,0,26,mitochondrial genome maintenance,BP,
3,GO:0000009,1,0.993960832641712,0,1,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.98783794320482,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000011,1,0.993846081630578,0,1,vacuole inheritance,BP,
6,GO:0000012,1,0.950649781903234,0,8,single strand break repair,BP,
7,GO:0000014,1,0.955553351716814,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
8,GO:0000015,1,0.976335284824185,0,4,phosphopyruvate hydratase complex,CC,
9,GO:0000018,1,0.653685125341639,0,66,regulation of DNA recombination,BP,
10,GO:0000019,1,0.974942891464489,0,4,regulation of mitotic recombination,BP,
11,GO:0000022,1,0.938221591105411,0,10,mitotic spindle elongation,BP,
12,GO:0000023,1,0.979835476831731,0,3,maltose metabolic process,BP,
13,GO:0000026,1,0.980741570130125,0,3,alpha-1,2-mannosyltransferase activity,MF,
14,GO:0000027,1,0.85380427242846,0,26,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.907898933222679,0,17,ribosomal small subunit assembly,BP,
16,GO:0000030,1,0.867400819688957,0,23,mannosyltransferase activity,MF,
17,GO:0000032,1,0.994134543005102,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.982273373855464,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.982785526171937,0,3,acyl binding,MF,
20,GO:0000036,1,0.988946073143875,0,2,acyl carrier activity,MF,
21,GO:0000038,1,0.830082506897208,0,30,very long-chain fatty acid metabolic process,BP,
23,GO:0000045,1,0.567320022218755,0,88,autophagosome assembly,BP,
24,GO:0000048,1,0.987925278367236,0,2,peptidyltransferase activity,MF,
25,GO:0000049,1,0.709536568109223,0,55,tRNA binding,MF,
26,GO:0000050,1,0.928597369577418,0,12,urea cycle,BP,
27,GO:0000052,1,0.948556353719051,0,8,citrulline metabolic process,BP,
28,GO:0000053,1,0.994119382169084,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.924895797475852,0,13,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.953033241434684,0,8,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.958908213749674,0,7,ribosomal small subunit export from nucleus,BP,
32,GO:0000060,1,0.75905533357036,0,43,protein import into nucleus, translocation,BP,
33,GO:0000062,1,0.896649057382372,0,18,fatty-acyl-CoA binding,MF,
34,GO:0000064,1,0.961457195606334,0,6,L-ornithine transmembrane transporter activity,MF,
35,GO:0000070,1,0.388525803720352,0,143,mitotic sister chromatid segregation,BP,
37,GO:0000076,1,0.905466792758491,0,16,DNA replication checkpoint,BP,
38,GO:0000077,1,0.389458390136761,0,147,DNA damage checkpoint,BP,
39,GO:0000079,1,0.593219814062151,0,83,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
41,GO:0000083,1,0.838860813176221,0,28,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
43,GO:0000095,1,0.994003495911578,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
44,GO:0000096,1,0.792751223434157,0,37,sulfur amino acid metabolic process,BP,
45,GO:0000097,1,0.905017261315117,0,16,sulfur amino acid biosynthetic process,BP,
46,GO:0000098,1,0.939969021536103,0,10,sulfur amino acid catabolic process,BP,
47,GO:0000099,1,0.960904247311449,0,6,sulfur amino acid transmembrane transporter activity,MF,
48,GO:0000101,1,0.96879122895038,0,5,sulfur amino acid transport,BP,
49,GO:0000103,1,0.981850573421197,0,3,sulfate assimilation,BP,
50,GO:0000104,1,0.976592183178525,0,4,succinate dehydrogenase activity,MF,
51,GO:0000105,1,0.987649844784581,0,2,histidine biosynthetic process,BP,
52,GO:0000109,1,0.93927033413087,0,10,nucleotide-excision repair complex,CC,
53,GO:0000110,1,0.980703269509068,0,3,nucleotide-excision repair factor 1 complex,CC,
54,GO:0000111,1,0.993605064014263,0,1,nucleotide-excision repair factor 2 complex,CC,
55,GO:0000117,1,0.986844064126777,0,2,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
56,GO:0000118,1,0.668658094666222,0,60,histone deacetylase complex,CC,
57,GO:0000120,1,0.970000871080582,0,5,RNA polymerase I transcription factor complex,CC,
58,GO:0000121,1,0.99374355674937,0,1,glycerol-1-phosphatase activity,MF,
60,GO:0000123,1,0.619307395327378,0,75,histone acetyltransferase complex,CC,
61,GO:0000124,1,0.935252034132617,0,11,SAGA complex,CC,
62,GO:0000125,1,0.978818425521357,0,3,PCAF complex,CC,
63,GO:0000126,1,0.985095875743259,0,2,transcription factor TFIIIB complex,CC,
64,GO:0000127,1,0.962362778875166,0,6,transcription factor TFIIIC complex,CC,
65,GO:0000132,1,0.877940429921294,0,20,establishment of mitotic spindle orientation,BP,
66,GO:0000137,1,0.898341936281275,0,17,Golgi cis cisterna,CC,
67,GO:0000138,1,0.958397763256606,0,7,Golgi trans cisterna,CC,
69,GO:0000145,1,0.890421039689643,0,18,exocyst,CC,
70,GO:0000146,1,0.868371884806876,0,19,microfilament motor activity,MF,
71,GO:0000147,1,0.967991995816364,0,5,actin cortical patch assembly,BP,
72,GO:0000149,1,0.455151837887996,0,122,SNARE binding,MF,
73,GO:0000150,1,0.9526802553458,0,8,recombinase activity,MF,
75,GO:0000152,1,0.788287281901228,0,38,nuclear ubiquitin ligase complex,CC,
76,GO:0000153,1,0.932831910940551,0,11,cytoplasmic ubiquitin ligase complex,CC,
77,GO:0000154,1,0.829186172896694,0,31,rRNA modification,BP,
78,GO:0000155,1,0.960688558775109,0,6,phosphorelay sensor kinase activity,MF,
80,GO:0000160,1,0.95451727184206,0,7,phosphorelay signal transduction system,BP,
81,GO:0000164,1,0.932573035565478,0,11,protein phosphatase type 1 complex,CC,
84,GO:0000170,1,0.994241679979329,0,1,sphingosine hydroxylase activity,MF,
85,GO:0000171,1,0.987266827297526,0,2,ribonuclease MRP activity,MF,
86,GO:0000172,1,0.964246749862843,0,6,ribonuclease MRP complex,CC,
87,GO:0000173,1,0.994170207352916,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
88,GO:0000175,1,0.826824180548478,0,30,3'-5'-exoribonuclease activity,MF,
89,GO:0000176,1,0.925844356380308,0,13,nuclear exosome (RNase complex),CC,
90,GO:0000177,1,0.911711768676592,0,15,cytoplasmic exosome (RNase complex),CC,
91,GO:0000178,1,0.873100745330616,0,22,exosome (RNase complex),CC,
92,GO:0000179,1,0.976310434434507,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
93,GO:0000182,1,0.934154961816576,0,10,rDNA binding,MF,
94,GO:0000183,1,0.894868141132004,0,18,chromatin silencing at rDNA,BP,
95,GO:0000184,1,0.499506501214143,0,117,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
96,GO:0000185,1,0.890676236431814,0,18,activation of MAPKKK activity,BP,
97,GO:0000186,1,0.703965727240662,0,53,activation of MAPKK activity,BP,
99,GO:0000188,1,0.861642986376507,0,24,inactivation of MAPK activity,BP,
101,GO:0000210,1,0.993641883094542,0,1,NAD+ diphosphatase activity,MF,
102,GO:0000212,1,0.933765568754229,0,10,meiotic spindle organization,BP,
103,GO:0000213,1,0.976400197450824,0,4,tRNA-intron endonuclease activity,MF,
104,GO:0000214,1,0.976459202046405,0,4,tRNA-intron endonuclease complex,CC,
105,GO:0000215,1,0.988236641893816,0,2,tRNA 2'-phosphotransferase activity,MF,
106,GO:0000217,1,0.859309630266659,0,24,DNA secondary structure binding,MF,
107,GO:0000220,1,0.963127434101121,0,6,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
108,GO:0000221,1,0.980896517053489,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
109,GO:0000224,1,0.993914188121798,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
110,GO:0000225,1,0.994313874661918,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
113,GO:0000229,1,0.988547187363909,0,2,cytoplasmic chromosome,CC,
114,GO:0000235,1,0.948288682672877,0,8,astral microtubule,CC,
115,GO:0000242,1,0.872374348292521,0,20,pericentriolar material,CC,
116,GO:0000243,1,0.953527298940924,0,8,commitment complex,CC,
117,GO:0000244,1,0.926458854314889,0,12,spliceosomal tri-snRNP complex assembly,BP,
118,GO:0000245,1,0.700327000984893,0,57,spliceosomal complex assembly,BP,
119,GO:0000246,1,0.993412940945061,0,1,delta24(24-1) sterol reductase activity,MF,
120,GO:0000247,1,0.994313297101646,0,1,C-8 sterol isomerase activity,MF,
121,GO:0000248,1,0.987261808256179,0,2,C-5 sterol desaturase activity,MF,
122,GO:0000250,1,0.993421968695501,0,1,lanosterol synthase activity,MF,
123,GO:0000252,1,0.994184790690414,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
124,GO:0000253,1,0.982908967408821,0,3,3-keto sterol reductase activity,MF,
125,GO:0000254,1,0.982050114966748,0,3,C-4 methylsterol oxidase activity,MF,
126,GO:0000255,1,0.974450204520212,0,4,allantoin metabolic process,BP,
127,GO:0000256,1,0.994228396196207,0,1,allantoin catabolic process,BP,
128,GO:0000257,1,0.994252942319835,0,1,nitrilase activity,MF,
129,GO:0000262,1,0.994186234583758,0,1,mitochondrial chromosome,CC,
130,GO:0000266,1,0.799720038694937,0,34,mitochondrial fission,BP,
132,GO:0000270,1,0.988764567890541,0,2,peptidoglycan metabolic process,BP,
133,GO:0000271,1,0.636575315400858,0,69,polysaccharide biosynthetic process,BP,
134,GO:0000272,1,0.843456107372456,0,26,polysaccharide catabolic process,BP,
138,GO:0000285,1,0.974857869355211,0,4,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
140,GO:0000288,1,0.621157326119303,0,74,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
141,GO:0000289,1,0.787550829891976,0,36,nuclear-transcribed mRNA poly(A) tail shortening,BP,
142,GO:0000290,1,0.95035218103007,0,8,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
143,GO:0000291,1,0.810529135762729,0,34,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
144,GO:0000293,1,0.981197458227849,0,3,ferric-chelate reductase activity,MF,
145,GO:0000294,1,0.987009483892421,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
146,GO:0000295,1,0.93461097885464,0,11,adenine nucleotide transmembrane transporter activity,MF,
147,GO:0000296,1,0.993985618449105,0,1,spermine transport,BP,
148,GO:0000298,1,0.975772150142065,0,4,endopolyphosphatase activity,MF,
149,GO:0000301,1,0.97579796432291,0,4,retrograde transport, vesicle recycling within Golgi,BP,
151,GO:0000303,1,0.848392442345845,0,27,response to superoxide,BP,
152,GO:0000305,1,0.832721215395724,0,30,response to oxygen radical,BP,
153,GO:0000306,1,0.974444798170541,0,4,extrinsic component of vacuolar membrane,CC,
154,GO:0000307,1,0.782343304188142,0,39,cyclin-dependent protein kinase holoenzyme complex,CC,
155,GO:0000308,1,0.986773952050607,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
156,GO:0000309,1,0.980841132222427,0,3,nicotinamide-nucleotide adenylyltransferase activity,MF,
157,GO:0000313,1,0.621632731445786,0,82,organellar ribosome,CC,
158,GO:0000314,1,0.855863243408862,0,27,organellar small ribosomal subunit,CC,
159,GO:0000315,1,0.748100485588092,0,50,organellar large ribosomal subunit,CC,
160,GO:0000320,1,0.986866838048769,0,2,re-entry into mitotic cell cycle,BP,
161,GO:0000322,1,0.981477033601269,0,3,storage vacuole,CC,
163,GO:0000333,1,0.986413296453599,0,2,telomerase catalytic core complex,CC,
164,GO:0000334,1,0.994274889465416,0,1,3-hydroxyanthranilate 3,4-dioxygenase activity,MF,
165,GO:0000338,1,0.94202201327621,0,10,protein deneddylation,BP,
166,GO:0000339,1,0.908588250223127,0,15,RNA cap binding,MF,
167,GO:0000340,1,0.955181614300409,0,7,RNA 7-methylguanosine cap binding,MF,
168,GO:0000346,1,0.923030802563037,0,13,transcription export complex,CC,
169,GO:0000347,1,0.964227148744223,0,6,THO complex,CC,
170,GO:0000349,1,0.987881691102729,0,2,generation of catalytic spliceosome for first transesterification step,BP,
171,GO:0000350,1,0.982424845126447,0,3,generation of catalytic spliceosome for second transesterification step,BP,
172,GO:0000354,1,0.986308032442367,0,2,cis assembly of pre-catalytic spliceosome,BP,
173,GO:0000375,1,0.137898372402913,0,315,RNA splicing, via transesterification reactions,BP,
174,GO:0000377,1,0.140459663593198,0,312,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,
175,GO:0000379,1,0.982213727119443,0,3,tRNA-type intron splice site recognition and cleavage,BP,
176,GO:0000380,1,0.707636982467578,0,54,alternative mRNA splicing, via spliceosome,BP,
177,GO:0000381,1,0.763580356721958,0,42,regulation of alternative mRNA splicing, via spliceosome,BP,
178,GO:0000384,1,0.988376638905651,0,2,first spliceosomal transesterification activity,MF,
179,GO:0000386,1,0.980434301625864,0,3,second spliceosomal transesterification activity,MF,
180,GO:0000387,1,0.79341190352786,0,38,spliceosomal snRNP assembly,BP,
181,GO:0000389,1,0.963305434664435,0,6,mRNA 3'-splice site recognition,BP,
182,GO:0000390,1,0.988146317954305,0,2,spliceosomal complex disassembly,BP,
183,GO:0000393,1,0.970517375352307,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
184,GO:0000394,1,0.902912441000932,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
185,GO:0000395,1,0.963879632932577,0,6,mRNA 5'-splice site recognition,BP,
186,GO:0000398,1,0.140459663593198,0,312,mRNA splicing, via spliceosome,BP,
187,GO:0000400,1,0.904903934136421,0,16,four-way junction DNA binding,MF,
188,GO:0000403,1,0.960863310299735,0,6,Y-form DNA binding,MF,
189,GO:0000404,1,0.980778276855085,0,3,heteroduplex DNA loop binding,MF,
190,GO:0000405,1,0.955418648493658,0,7,bubble DNA binding,MF,
191,GO:0000406,1,0.987091497977493,0,2,double-strand/single-strand DNA junction binding,MF,
192,GO:0000407,1,0.808194355131755,0,33,phagophore assembly site,CC,
193,GO:0000408,1,0.970749076829502,0,5,EKC/KEOPS complex,CC,
194,GO:0000409,1,0.992657906656058,0,1,regulation of transcription by galactose,BP,
195,GO:0000411,1,0.992657906656058,0,1,positive regulation of transcription by galactose,BP,
196,GO:0000412,1,0.993813675960111,0,1,histone peptidyl-prolyl isomerization,BP,
197,GO:0000413,1,0.827794528804205,0,31,protein peptidyl-prolyl isomerization,BP,
198,GO:0000414,1,0.971472423364937,0,4,regulation of histone H3-K36 methylation,BP,
199,GO:0000415,1,0.99281275448821,0,1,negative regulation of histone H3-K36 methylation,BP,
200,GO:0000416,1,0.993573949775186,0,1,positive regulation of histone H3-K36 methylation,BP,
201,GO:0000417,1,0.993486524943835,0,1,HIR complex,CC,
202,GO:0000421,1,0.824662870802336,0,31,autophagosome membrane,CC,
203,GO:0000422,1,0.599744490647202,0,80,autophagy of mitochondrion,BP,
204,GO:0000423,1,0.888845330479646,0,18,mitophagy,BP,
205,GO:0000428,1,0.432655017768633,0,132,DNA-directed RNA polymerase complex,CC,
206,GO:0000429,1,0.975151815969548,0,4,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
207,GO:0000430,1,0.982365741424335,0,3,regulation of transcription from RNA polymerase II promoter by glucose,BP,
208,GO:0000431,1,0.992657906656058,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
209,GO:0000432,1,0.982365741424335,0,3,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
210,GO:0000435,1,0.992657906656058,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
211,GO:0000436,1,0.975151815969548,0,4,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
212,GO:0000438,1,0.982541276602222,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
213,GO:0000439,1,0.951550982974367,0,8,core TFIIH complex,CC,
214,GO:0000444,1,0.973356144844024,0,4,MIS12/MIND type complex,CC,
215,GO:0000445,1,0.964227148744223,0,6,THO complex part of transcription export complex,CC,
216,GO:0000447,1,0.945920223813485,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
217,GO:0000448,1,0.992713152022946,0,1,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
218,GO:0000451,1,0.993164549103775,0,1,rRNA 2'-O-methylation,BP,
219,GO:0000453,1,0.993164549103775,0,1,enzyme-directed rRNA 2'-O-methylation,BP,
220,GO:0000454,1,0.983042428434957,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
221,GO:0000455,1,0.988205827791675,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
222,GO:0000459,1,0.959036634913225,0,7,exonucleolytic trimming involved in rRNA processing,BP,
223,GO:0000460,1,0.820426944223979,0,32,maturation of 5.8S rRNA,BP,
224,GO:0000461,1,0.98888661607507,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000462,1,0.796751171172812,0,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000463,1,0.947068638890448,0,9,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000466,1,0.877661218867772,0,21,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
228,GO:0000467,1,0.959036634913225,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
229,GO:0000469,1,0.856214595980083,0,25,cleavage involved in rRNA processing,BP,
230,GO:0000470,1,0.874457860867549,0,22,maturation of LSU-rRNA,BP,
231,GO:0000472,1,0.979963588449347,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
232,GO:0000478,1,0.913991966675375,0,14,endonucleolytic cleavage involved in rRNA processing,BP,
233,GO:0000479,1,0.919568425947485,0,13,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
234,GO:0000480,1,0.961996074557215,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
235,GO:0000481,1,0.993605920287258,0,1,maturation of 5S rRNA,BP,
236,GO:0000491,1,0.952411422032996,0,8,small nucleolar ribonucleoprotein complex assembly,BP,
237,GO:0000492,1,0.963988439887679,0,6,box C/D snoRNP assembly,BP,
238,GO:0000493,1,0.987994969407036,0,2,box H/ACA snoRNP assembly,BP,
239,GO:0000494,1,0.994309542961473,0,1,box C/D snoRNA 3'-end processing,BP,
240,GO:0000495,1,0.993902537562302,0,1,box H/ACA snoRNA 3'-end processing,BP,
241,GO:0000502,1,0.689409988867809,0,62,proteasome complex,CC,
242,GO:0000506,1,0.948179879736382,0,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
243,GO:0000578,1,0.817933690610451,0,31,embryonic axis specification,BP,
244,GO:0000700,1,0.976231215908649,0,4,mismatch base pair DNA N-glycosylase activity,MF,
245,GO:0000701,1,0.988408504528783,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
246,GO:0000702,1,0.971472643288241,0,5,oxidized base lesion DNA N-glycosylase activity,MF,
247,GO:0000703,1,0.988564702705144,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
248,GO:0000706,1,0.981140961059186,0,3,meiotic DNA double-strand break processing,BP,
249,GO:0000707,1,0.952565388135813,0,8,meiotic DNA recombinase assembly,BP,
250,GO:0000710,1,0.974391825158147,0,4,meiotic mismatch repair,BP,
251,GO:0000711,1,0.994237203921849,0,1,meiotic DNA repair synthesis,BP,
253,GO:0000715,1,0.869562266987326,0,23,nucleotide-excision repair, DNA damage recognition,BP,
254,GO:0000717,1,0.872892003341147,0,22,nucleotide-excision repair, DNA duplex unwinding,BP,
255,GO:0000718,1,0.994148115699068,0,1,nucleotide-excision repair, DNA damage removal,BP,
256,GO:0000720,1,0.981616739661013,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
257,GO:0000722,1,0.910782612976377,0,14,telomere maintenance via recombination,BP,
258,GO:0000723,1,0.395236701896393,0,144,telomere maintenance,BP,
259,GO:0000724,1,0.510557076602751,0,104,double-strand break repair via homologous recombination,BP,
260,GO:0000725,1,0.50739358898514,0,105,recombinational repair,BP,
261,GO:0000726,1,0.660231238804609,0,64,non-recombinational repair,BP,
262,GO:0000727,1,0.969970967684613,0,5,double-strand break repair via break-induced replication,BP,
263,GO:0000729,1,0.86708595874192,0,22,DNA double-strand break processing,BP,
264,GO:0000730,1,0.940897153013361,0,10,DNA recombinase assembly,BP,
265,GO:0000731,1,0.645556318339189,0,68,DNA synthesis involved in DNA repair,BP,
266,GO:0000732,1,0.847743085750644,0,25,strand displacement,BP,
267,GO:0000733,1,0.944607073074187,0,9,DNA strand renaturation,BP,
268,GO:0000737,1,0.849761227672661,0,26,DNA catabolic process, endonucleolytic,BP,
269,GO:0000738,1,0.975492594749969,0,4,DNA catabolic process, exonucleolytic,BP,
270,GO:0000741,1,0.994142340087971,0,1,karyogamy,BP,
271,GO:0000768,1,0.783534899605686,0,37,syncytium formation by plasma membrane fusion,BP,
272,GO:0000773,1,0.994360079731816,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
273,GO:0000774,1,0.93464665192521,0,11,adenyl-nucleotide exchange factor activity,MF,
274,GO:0000775,1,0.310175743270984,0,181,chromosome, centromeric region,CC,
275,GO:0000776,1,0.448229171522899,0,125,kinetochore,CC,
276,GO:0000777,1,0.543922113231285,0,96,condensed chromosome kinetochore,CC,
277,GO:0000778,1,0.929569002809855,0,12,condensed nuclear chromosome kinetochore,CC,
278,GO:0000779,1,0.506507421766286,0,107,condensed chromosome, centromeric region,CC,
279,GO:0000780,1,0.882972551162037,0,20,condensed nuclear chromosome, centromeric region,CC,
280,GO:0000781,1,0.418879378174655,0,135,chromosome, telomeric region,CC,
281,GO:0000782,1,0.934138979232835,0,11,telomere cap complex,CC,
282,GO:0000783,1,0.934138979232835,0,11,nuclear telomere cap complex,CC,
283,GO:0000784,1,0.509727917104915,0,105,nuclear chromosome, telomeric region,CC,
285,GO:0000786,1,0.759769160198567,0,47,nucleosome,CC,
286,GO:0000788,1,0.921896511070568,0,14,nuclear nucleosome,CC,
287,GO:0000789,1,0.994328313690731,0,1,cytoplasmic chromatin,CC,
288,GO:0000790,1,0.137419539652263,0,306,nuclear chromatin,CC,
289,GO:0000791,1,0.830309522571609,0,30,euchromatin,CC,
290,GO:0000792,1,0.644935774172278,0,68,heterochromatin,CC,
294,GO:0000796,1,0.953456741216163,0,7,condensin complex,CC,
295,GO:0000797,1,0.993256987689864,0,1,condensin core heterodimer,CC,
296,GO:0000798,1,0.968937060547803,0,5,nuclear cohesin complex,CC,
297,GO:0000799,1,0.97976972518785,0,3,nuclear condensin complex,CC,
298,GO:0000800,1,0.91836176434922,0,13,lateral element,CC,
299,GO:0000801,1,0.964064722050991,0,6,central element,CC,
300,GO:0000803,1,0.850733184361783,0,25,sex chromosome,CC,
301,GO:0000805,1,0.953943849604476,0,7,X chromosome,CC,
302,GO:0000806,1,0.987207329744033,0,2,Y chromosome,CC,
303,GO:0000808,1,0.945840694287015,0,9,origin recognition complex,CC,
304,GO:0000811,1,0.981657869544867,0,3,GINS complex,CC,
305,GO:0000812,1,0.936404062446758,0,10,Swr1 complex,CC,
306,GO:0000813,1,0.940802971621714,0,10,ESCRT I complex,CC,
307,GO:0000814,1,0.982104369509718,0,3,ESCRT II complex,CC,
308,GO:0000815,1,0.929705187613166,0,12,ESCRT III complex,CC,
309,GO:0000818,1,0.987958083533894,0,2,nuclear MIS12/MIND complex,CC,
311,GO:0000820,1,0.968035215057128,0,5,regulation of glutamine family amino acid metabolic process,BP,
312,GO:0000821,1,0.986139007822842,0,2,regulation of arginine metabolic process,BP,
313,GO:0000822,1,0.978247120328859,0,3,inositol hexakisphosphate binding,MF,
314,GO:0000823,1,0.99412876740614,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
315,GO:0000824,1,0.99412876740614,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
316,GO:0000825,1,0.99412876740614,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
317,GO:0000827,1,0.968080035825713,0,5,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
318,GO:0000828,1,0.968080035825713,0,5,inositol hexakisphosphate kinase activity,MF,
319,GO:0000829,1,0.968080035825713,0,5,inositol heptakisphosphate kinase activity,MF,
320,GO:0000831,1,0.993850386749094,0,1,inositol hexakisphosphate 6-kinase activity,MF,
321,GO:0000832,1,0.968080035825713,0,5,inositol hexakisphosphate 5-kinase activity,MF,
322,GO:0000835,1,0.96152969226819,0,6,ER ubiquitin ligase complex,CC,
323,GO:0000836,1,0.968003142230218,0,5,Hrd1p ubiquitin ligase complex,CC,
324,GO:0000839,1,0.980817938423669,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
325,GO:0000900,1,0.917971710761711,0,13,translation repressor activity, mRNA regulatory element binding,MF,
329,GO:0000912,1,0.961020689544952,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
330,GO:0000915,1,0.961020689544952,0,6,actomyosin contractile ring assembly,BP,
331,GO:0000916,1,0.994017052414068,0,1,actomyosin contractile ring contraction,BP,
332,GO:0000917,1,0.994112884832124,0,1,division septum assembly,BP,
333,GO:0000920,1,0.901833238767814,0,17,cell separation after cytokinesis,BP,
335,GO:0000922,1,0.398465124214628,0,142,spindle pole,CC,
336,GO:0000923,1,0.968166465667852,0,5,equatorial microtubule organizing center,CC,
337,GO:0000928,1,0.993846081630578,0,1,gamma-tubulin small complex, spindle pole body,CC,
338,GO:0000930,1,0.882677872225753,0,19,gamma-tubulin complex,CC,
339,GO:0000931,1,0.95457854252708,0,7,gamma-tubulin large complex,CC,
340,GO:0000932,1,0.600403291111344,0,79,P-body,CC,
341,GO:0000938,1,0.974161637553897,0,4,GARP complex,CC,
342,GO:0000939,1,0.982193990380693,0,3,condensed chromosome inner kinetochore,CC,
343,GO:0000940,1,0.919080325287001,0,13,condensed chromosome outer kinetochore,CC,
344,GO:0000941,1,0.993995998098017,0,1,condensed nuclear chromosome inner kinetochore,CC,
345,GO:0000942,1,0.975929656531998,0,4,condensed nuclear chromosome outer kinetochore,CC,
346,GO:0000956,1,0.290810829489336,0,200,nuclear-transcribed mRNA catabolic process,BP,
347,GO:0000957,1,0.967749445829303,0,5,mitochondrial RNA catabolic process,BP,
348,GO:0000958,1,0.980873845681375,0,3,mitochondrial mRNA catabolic process,BP,
349,GO:0000959,1,0.772674347832878,0,41,mitochondrial RNA metabolic process,BP,
350,GO:0000960,1,0.974083830787668,0,4,regulation of mitochondrial RNA catabolic process,BP,
351,GO:0000961,1,0.986622304457524,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
352,GO:0000962,1,0.987293251088477,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
353,GO:0000963,1,0.906494663078707,0,16,mitochondrial RNA processing,BP,
354,GO:0000964,1,0.975657857393279,0,4,mitochondrial RNA 5'-end processing,BP,
355,GO:0000965,1,0.969828006319926,0,5,mitochondrial RNA 3'-end processing,BP,
356,GO:0000966,1,0.878705324485247,0,21,RNA 5'-end processing,BP,
357,GO:0000967,1,0.979963588449347,0,3,rRNA 5'-end processing,BP,
358,GO:0000972,1,0.956821887005131,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
359,GO:0000973,1,0.981149831212258,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
360,GO:0000974,1,0.92314414282834,0,13,Prp19 complex,CC,
364,GO:0000979,1,0.793800654791914,0,36,RNA polymerase II core promoter sequence-specific DNA binding,MF,
368,GO:0000983,1,0.871227132833486,0,21,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,
372,GO:0000990,1,0.947309289165604,0,8,transcription factor activity, core RNA polymerase binding,MF,
373,GO:0000991,1,0.987214223206637,0,2,transcription factor activity, core RNA polymerase II binding,MF,
374,GO:0000992,1,0.98657960984329,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
375,GO:0000993,1,0.836981960050135,0,28,RNA polymerase II core binding,MF,
376,GO:0000994,1,0.994133387882948,0,1,RNA polymerase III core binding,MF,
377,GO:0000995,1,0.971729943068242,0,4,transcription factor activity, core RNA polymerase III binding,MF,
378,GO:0001002,1,0.98657960984329,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
379,GO:0001003,1,0.98657960984329,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
380,GO:0001007,1,0.972003243813424,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
381,GO:0001010,1,0.882883805207178,0,19,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,
382,GO:0001011,1,0.992242901896754,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
384,GO:0001013,1,0.949192885640882,0,8,RNA polymerase I regulatory region DNA binding,MF,
385,GO:0001016,1,0.954909880801275,0,7,RNA polymerase III regulatory region DNA binding,MF,
386,GO:0001018,1,0.987870489931933,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
387,GO:0001025,1,0.976473497518715,0,3,RNA polymerase III transcription factor binding,MF,
388,GO:0001026,1,0.985095875743259,0,2,TFIIIB-type transcription factor activity,MF,
389,GO:0001030,1,0.965984796021468,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
390,GO:0001031,1,0.965984796021468,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
391,GO:0001032,1,0.973326777474259,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
392,GO:0001034,1,0.994125735233454,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
393,GO:0001042,1,0.967021522955793,0,5,RNA polymerase I core binding,MF,
394,GO:0001046,1,0.572687191072211,0,85,core promoter sequence-specific DNA binding,MF,
396,GO:0001054,1,0.935191923622271,0,11,RNA polymerase I activity,MF,
397,GO:0001055,1,0.936056842299272,0,11,RNA polymerase II activity,MF,
398,GO:0001056,1,0.913257616348108,0,15,RNA polymerase III activity,MF,
400,GO:0001069,1,0.986496211797865,0,2,regulatory region RNA binding,MF,
401,GO:0001074,1,0.993899517803582,0,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,
402,GO:0001075,1,0.953826640566532,0,7,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
404,GO:0001077,1,0.186157710809317,0,259,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,
406,GO:0001079,1,0.994026284253939,0,1,nitrogen catabolite regulation of transcription from RNA polymerase II promoter,BP,
407,GO:0001080,1,0.994026284253939,0,1,nitrogen catabolite activation of transcription from RNA polymerase II promoter,BP,
408,GO:0001083,1,0.959449446001659,0,6,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
409,GO:0001084,1,0.993899517803582,0,1,transcription factor activity, TFIID-class binding,MF,
410,GO:0001085,1,0.408475480866194,0,138,RNA polymerase II transcription factor binding,MF,
411,GO:0001087,1,0.992242901896754,0,1,transcription factor activity, TFIIB-class binding,MF,
412,GO:0001091,1,0.901038844797806,0,16,RNA polymerase II basal transcription factor binding,MF,
413,GO:0001093,1,0.97933128618559,0,3,TFIIB-class transcription factor binding,MF,
414,GO:0001094,1,0.944171569395667,0,9,TFIID-class transcription factor binding,MF,
415,GO:0001096,1,0.993588508692189,0,1,TFIIF-class transcription factor binding,MF,
416,GO:0001097,1,0.980779212529277,0,3,TFIIH-class transcription factor binding,MF,
417,GO:0001098,1,0.759986440823063,0,43,basal transcription machinery binding,MF,
418,GO:0001099,1,0.759986440823063,0,43,basal RNA polymerase II transcription machinery binding,MF,
419,GO:0001100,1,0.993846081630578,0,1,negative regulation of exit from mitosis,BP,
420,GO:0001101,1,0.138085971603841,0,309,response to acid chemical,BP,
421,GO:0001102,1,0.737183186378905,0,47,RNA polymerase II activating transcription factor binding,MF,
422,GO:0001103,1,0.816245095541645,0,32,RNA polymerase II repressing transcription factor binding,MF,
423,GO:0001104,1,0.515164577500916,0,101,RNA polymerase II transcription cofactor activity,MF,
424,GO:0001105,1,0.750286601302908,0,43,RNA polymerase II transcription coactivator activity,MF,
425,GO:0001106,1,0.836694063152327,0,28,RNA polymerase II transcription corepressor activity,MF,
426,GO:0001112,1,0.993772442794469,0,1,DNA-templated transcriptional open complex formation,BP,
427,GO:0001113,1,0.993772442794469,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
428,GO:0001120,1,0.993772442794469,0,1,protein-DNA complex remodeling,BP,
429,GO:0001128,1,0.994258140324978,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
430,GO:0001129,1,0.972889508713941,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
431,GO:0001132,1,0.972889508713941,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
432,GO:0001133,1,0.888397296137758,0,18,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,
433,GO:0001134,1,0.832062550509961,0,28,transcription factor activity, transcription factor recruiting,MF,
434,GO:0001135,1,0.955902909865354,0,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
435,GO:0001147,1,0.985163829078294,0,2,transcription termination site sequence-specific DNA binding,MF,
436,GO:0001156,1,0.976473497518715,0,3,TFIIIC-class transcription factor binding,MF,
438,GO:0001160,1,0.985163829078294,0,2,transcription termination site DNA binding,MF,
439,GO:0001161,1,0.925605448927075,0,12,intronic transcription regulatory region sequence-specific DNA binding,MF,
440,GO:0001162,1,0.937175081795188,0,10,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
441,GO:0001163,1,0.949192885640882,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
442,GO:0001164,1,0.949192885640882,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
443,GO:0001165,1,0.993328000752223,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
444,GO:0001172,1,0.98628679046022,0,2,transcription, RNA-templated,BP,
445,GO:0001179,1,0.994109419647035,0,1,RNA polymerase I transcription factor binding,MF,
446,GO:0001181,1,0.993565384694919,0,1,transcription factor activity, core RNA polymerase I binding,MF,
447,GO:0001188,1,0.949192885640882,0,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,
449,GO:0001191,1,0.745958907482422,0,46,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,
450,GO:0001192,1,0.994395022734774,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
451,GO:0001193,1,0.994395022734774,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
452,GO:0001205,1,0.825440242624258,0,30,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
453,GO:0001206,1,0.933465206762154,0,10,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
454,GO:0001221,1,0.767124189934672,0,40,transcription cofactor binding,MF,
455,GO:0001222,1,0.913626643657527,0,14,transcription corepressor binding,MF,
456,GO:0001223,1,0.87279496328329,0,20,transcription coactivator binding,MF,
457,GO:0001224,1,0.979084429595131,0,3,RNA polymerase II transcription cofactor binding,MF,
458,GO:0001225,1,0.985294000877118,0,2,RNA polymerase II transcription coactivator binding,MF,
459,GO:0001226,1,0.993698697076839,0,1,RNA polymerase II transcription corepressor binding,MF,
461,GO:0001228,1,0.0832251978627608,0,383,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,
462,GO:0001300,1,0.987516626935901,0,2,chronological cell aging,BP,
463,GO:0001302,1,0.962773299641244,0,6,replicative cell aging,BP,
464,GO:0001306,1,0.994351416238837,0,1,age-dependent response to oxidative stress,BP,
465,GO:0001315,1,0.994351416238837,0,1,age-dependent response to reactive oxygen species,BP,
466,GO:0001325,1,0.913942584654445,0,14,formation of extrachromosomal circular DNA,BP,
467,GO:0001401,1,0.987868432880732,0,2,mitochondrial sorting and assembly machinery complex,CC,
468,GO:0001405,1,0.969972428959031,0,5,presequence translocase-associated import motor,CC,
470,GO:0001502,1,0.896110727657599,0,17,cartilage condensation,BP,
472,GO:0001504,1,0.824016216145621,0,30,neurotransmitter uptake,BP,
474,GO:0001507,1,0.987716832418492,0,2,acetylcholine catabolic process in synaptic cleft,BP,
476,GO:0001510,1,0.702526244548026,0,57,RNA methylation,BP,
477,GO:0001512,1,0.994317340024882,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
478,GO:0001514,1,0.9496885420506,0,8,selenocysteine incorporation,BP,
479,GO:0001515,1,0.976771328152746,0,4,opioid peptide activity,MF,
481,GO:0001517,1,0.96126373141137,0,6,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
482,GO:0001518,1,0.902645293140804,0,14,voltage-gated sodium channel complex,CC,
483,GO:0001519,1,0.993573236050278,0,1,peptide amidation,BP,
484,GO:0001520,1,0.981002854351586,0,3,outer dense fiber,CC,
485,GO:0001522,1,0.898262275421928,0,18,pseudouridine synthesis,BP,
488,GO:0001527,1,0.933553791908281,0,10,microfibril,CC,
489,GO:0001530,1,0.869946684283563,0,23,lipopolysaccharide binding,MF,
490,GO:0001532,1,0.993705266271688,0,1,interleukin-21 receptor activity,MF,
491,GO:0001533,1,0.830611162100538,0,29,cornified envelope,CC,
492,GO:0001534,1,0.9753300855549,0,4,radial spoke,CC,
493,GO:0001536,1,0.98136980662948,0,3,radial spoke stalk,CC,
494,GO:0001537,1,0.969529089743075,0,5,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
497,GO:0001541,1,0.732419907609653,0,49,ovarian follicle development,BP,
498,GO:0001542,1,0.939749419842839,0,9,ovulation from ovarian follicle,BP,
499,GO:0001543,1,0.992470644937486,0,1,ovarian follicle rupture,BP,
500,GO:0001544,1,0.992536945992545,0,1,initiation of primordial ovarian follicle growth,BP,
501,GO:0001545,1,0.993480089415774,0,1,primary ovarian follicle growth,BP,
502,GO:0001546,1,0.982315038542347,0,3,preantral ovarian follicle growth,BP,
503,GO:0001547,1,0.960598399332876,0,6,antral ovarian follicle growth,BP,
504,GO:0001550,1,0.986409668350338,0,2,ovarian cumulus expansion,BP,
505,GO:0001552,1,0.994086319994597,0,1,ovarian follicle atresia,BP,
506,GO:0001553,1,0.942694549914969,0,9,luteinization,BP,
507,GO:0001554,1,0.966893021577095,0,5,luteolysis,BP,
508,GO:0001555,1,0.981827310630472,0,3,oocyte growth,BP,
509,GO:0001556,1,0.881195444620062,0,20,oocyte maturation,BP,
511,GO:0001560,1,0.979012011640562,0,3,regulation of cell growth by extracellular stimulus,BP,
512,GO:0001561,1,0.952365626365474,0,8,fatty acid alpha-oxidation,BP,
513,GO:0001562,1,0.884492371540986,0,20,response to protozoan,BP,
514,GO:0001567,1,0.994250632095755,0,1,cholesterol 25-hydroxylase activity,MF,
516,GO:0001569,1,0.819693936200601,0,31,branching involved in blood vessel morphogenesis,BP,
517,GO:0001570,1,0.618058614671344,0,73,vasculogenesis,BP,
518,GO:0001572,1,0.993261591024723,0,1,lactosylceramide biosynthetic process,BP,
519,GO:0001573,1,0.897223296242246,0,17,ganglioside metabolic process,BP,
520,GO:0001574,1,0.938034191184947,0,10,ganglioside biosynthetic process,BP,
521,GO:0001575,1,0.988175261085998,0,2,globoside metabolic process,BP,
522,GO:0001576,1,0.994043597612783,0,1,globoside biosynthetic process,BP,
524,GO:0001579,1,0.987456983164581,0,2,medium-chain fatty acid transport,BP,
525,GO:0001580,1,0.884755314039409,0,21,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
526,GO:0001581,1,0.99376386013477,0,1,detection of chemical stimulus involved in sensory perception of sour taste,BP,
527,GO:0001582,1,0.993908146519457,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
528,GO:0001587,1,0.993280287549729,0,1,Gq/11-coupled serotonin receptor activity,MF,
529,GO:0001588,1,0.976415586233986,0,4,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
530,GO:0001591,1,0.982119099676241,0,3,dopamine neurotransmitter receptor activity, coupled via Gi/Go,MF,
531,GO:0001595,1,0.9827014831814,0,3,angiotensin receptor activity,MF,
532,GO:0001596,1,0.993975241200142,0,1,angiotensin type I receptor activity,MF,
533,GO:0001601,1,0.981682711936108,0,3,peptide YY receptor activity,MF,
534,GO:0001602,1,0.970778211646326,0,5,pancreatic polypeptide receptor activity,MF,
535,GO:0001604,1,0.988558962652802,0,2,urotensin II receptor activity,MF,
536,GO:0001605,1,0.981995670165577,0,3,adrenomedullin receptor activity,MF,
537,GO:0001607,1,0.987792298734974,0,2,neuromedin U receptor activity,MF,
538,GO:0001608,1,0.924783717236172,0,13,G-protein coupled nucleotide receptor activity,MF,
539,GO:0001609,1,0.964419352384815,0,6,G-protein coupled adenosine receptor activity,MF,
540,GO:0001614,1,0.886538482556481,0,20,purinergic nucleotide receptor activity,MF,
542,GO:0001621,1,0.994217855801954,0,1,ADP receptor activity,MF,
543,GO:0001626,1,0.993702124387731,0,1,nociceptin receptor activity,MF,
544,GO:0001631,1,0.964672295607315,0,6,cysteinyl leukotriene receptor activity,MF,
545,GO:0001632,1,0.987886857142645,0,2,leukotriene B4 receptor activity,MF,
546,GO:0001635,1,0.981573704133142,0,3,calcitonin gene-related peptide receptor activity,MF,
547,GO:0001637,1,0.864193443280671,0,24,G-protein coupled chemoattractant receptor activity,MF,
550,GO:0001642,1,0.980050509894882,0,3,group III metabotropic glutamate receptor activity,MF,
552,GO:0001650,1,0.444082121807214,0,127,fibrillar center,CC,
553,GO:0001651,1,0.994309542961473,0,1,dense fibrillar component,CC,
554,GO:0001652,1,0.970190341765636,0,5,granular component,CC,
562,GO:0001660,1,0.939047618792416,0,10,fever generation,BP,
563,GO:0001661,1,0.968253787602947,0,5,conditioned taste aversion,BP,
566,GO:0001665,1,0.964672789847073,0,6,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
570,GO:0001671,1,0.853202975284199,0,26,ATPase activator activity,MF,
573,GO:0001674,1,0.987997881656247,0,2,female germ cell nucleus,CC,
574,GO:0001675,1,0.947522249687275,0,8,acrosome assembly,BP,
577,GO:0001680,1,0.993989654703031,0,1,tRNA 3'-terminal CCA addition,BP,
578,GO:0001681,1,0.993826575278686,0,1,sialate O-acetylesterase activity,MF,
579,GO:0001682,1,0.930798644256052,0,12,tRNA 5'-leader removal,BP,
580,GO:0001692,1,0.982506283494928,0,3,histamine metabolic process,BP,
581,GO:0001694,1,0.993950749826968,0,1,histamine biosynthetic process,BP,
582,GO:0001695,1,0.994385781568125,0,1,histamine catabolic process,BP,
583,GO:0001696,1,0.906372960101451,0,16,gastric acid secretion,BP,
584,GO:0001697,1,0.993833027703883,0,1,histamine-induced gastric acid secretion,BP,
585,GO:0001698,1,0.98836530948354,0,2,gastrin-induced gastric acid secretion,BP,
587,GO:0001702,1,0.844701863281532,0,25,gastrulation with mouth forming second,BP,
588,GO:0001704,1,0.486066514977412,0,110,formation of primary germ layer,BP,
589,GO:0001705,1,0.98716975966866,0,2,ectoderm formation,BP,
590,GO:0001706,1,0.706421284513548,0,53,endoderm formation,BP,
591,GO:0001707,1,0.670237307558112,0,62,mesoderm formation,BP,
593,GO:0001709,1,0.789202185176454,0,37,cell fate determination,BP,
594,GO:0001710,1,0.900930788115436,0,17,mesodermal cell fate commitment,BP,
595,GO:0001711,1,0.911133004926534,0,15,endodermal cell fate commitment,BP,
596,GO:0001712,1,0.98716975966866,0,2,ectodermal cell fate commitment,BP,
597,GO:0001714,1,0.953344238701548,0,8,endodermal cell fate specification,BP,
598,GO:0001715,1,0.9935396833748,0,1,ectodermal cell fate specification,BP,
599,GO:0001716,1,0.994053266085172,0,1,L-amino-acid oxidase activity,MF,
600,GO:0001725,1,0.707310969853465,0,52,stress fiber,CC,
602,GO:0001727,1,0.967928724707926,0,5,lipid kinase activity,MF,
603,GO:0001729,1,0.987207112499283,0,2,ceramide kinase activity,MF,
604,GO:0001730,1,0.974949402522372,0,4,2'-5'-oligoadenylate synthetase activity,MF,
605,GO:0001731,1,0.949804925271376,0,8,formation of translation preinitiation complex,BP,
606,GO:0001732,1,0.987238142727551,0,2,formation of cytoplasmic translation initiation complex,BP,
607,GO:0001733,1,0.976177311658591,0,4,galactosylceramide sulfotransferase activity,MF,
608,GO:0001735,1,0.987052003584542,0,2,prenylcysteine oxidase activity,MF,
609,GO:0001736,1,0.475845308465278,0,117,establishment of planar polarity,BP,
610,GO:0001738,1,0.429974685192886,0,132,morphogenesis of a polarized epithelium,BP,
611,GO:0001739,1,0.969599110872807,0,5,sex chromatin,CC,
612,GO:0001740,1,0.980370603623215,0,3,Barr body,CC,
613,GO:0001741,1,0.927744821125224,0,12,XY body,CC,
614,GO:0001743,1,0.980229804726314,0,3,optic placode formation,BP,
615,GO:0001750,1,0.649579912561329,0,66,photoreceptor outer segment,CC,
616,GO:0001754,1,0.779985476283308,0,38,eye photoreceptor cell differentiation,BP,
618,GO:0001756,1,0.685506443707724,0,57,somitogenesis,BP,
619,GO:0001757,1,0.969497195407156,0,5,somite specification,BP,
620,GO:0001758,1,0.958833700474269,0,7,retinal dehydrogenase activity,MF,
624,GO:0001765,1,0.946399749152346,0,9,membrane raft assembly,BP,
626,GO:0001767,1,0.936281250895237,0,10,establishment of lymphocyte polarity,BP,
627,GO:0001768,1,0.943261119300468,0,9,establishment of T cell polarity,BP,
628,GO:0001770,1,0.992604670466661,0,1,establishment of natural killer cell polarity,BP,
629,GO:0001771,1,0.921052083132163,0,13,immunological synapse formation,BP,
630,GO:0001772,1,0.817382471659179,0,32,immunological synapse,CC,
631,GO:0001773,1,0.86434275605403,0,24,myeloid dendritic cell activation,BP,
632,GO:0001774,1,0.850227640296324,0,25,microglial cell activation,BP,
634,GO:0001776,1,0.602318183793759,0,80,leukocyte homeostasis,BP,
635,GO:0001777,1,0.982512874539862,0,3,T cell homeostatic proliferation,BP,
636,GO:0001778,1,0.966304382505283,0,5,plasma membrane repair,BP,
637,GO:0001779,1,0.897731956795426,0,17,natural killer cell differentiation,BP,
638,GO:0001780,1,0.914587066386558,0,14,neutrophil homeostasis,BP,
639,GO:0001781,1,0.956731316522383,0,7,neutrophil apoptotic process,BP,
640,GO:0001782,1,0.83506478737557,0,28,B cell homeostasis,BP,
641,GO:0001783,1,0.870924112232321,0,22,B cell apoptotic process,BP,
642,GO:0001784,1,0.79291216426719,0,35,phosphotyrosine residue binding,MF,
643,GO:0001785,1,0.987683204432912,0,2,prostaglandin J receptor activity,MF,
645,GO:0001787,1,0.957669298540077,0,7,natural killer cell proliferation,BP,
646,GO:0001788,1,0.994183202407459,0,1,antibody-dependent cellular cytotoxicity,BP,
647,GO:0001791,1,0.994147249357845,0,1,IgM binding,MF,
648,GO:0001792,1,0.993416093757989,0,1,polymeric immunoglobulin receptor activity,MF,
649,GO:0001794,1,0.981937377983331,0,3,type IIa hypersensitivity,BP,
650,GO:0001796,1,0.981937377983331,0,3,regulation of type IIa hypersensitivity,BP,
651,GO:0001797,1,0.994183202407459,0,1,negative regulation of type IIa hypersensitivity,BP,
652,GO:0001798,1,0.987683256307399,0,2,positive regulation of type IIa hypersensitivity,BP,
653,GO:0001802,1,0.988398752696063,0,2,type III hypersensitivity,BP,
654,GO:0001803,1,0.988398752696063,0,2,regulation of type III hypersensitivity,BP,
655,GO:0001805,1,0.988398752696063,0,2,positive regulation of type III hypersensitivity,BP,
656,GO:0001806,1,0.982170467564805,0,3,type IV hypersensitivity,BP,
657,GO:0001807,1,0.988336161015103,0,2,regulation of type IV hypersensitivity,BP,
658,GO:0001808,1,0.994057162669787,0,1,negative regulation of type IV hypersensitivity,BP,
659,GO:0001809,1,0.994245145314426,0,1,positive regulation of type IV hypersensitivity,BP,
660,GO:0001810,1,0.982648754194492,0,3,regulation of type I hypersensitivity,BP,
661,GO:0001811,1,0.994183202407459,0,1,negative regulation of type I hypersensitivity,BP,
662,GO:0001812,1,0.988398752696063,0,2,positive regulation of type I hypersensitivity,BP,
663,GO:0001813,1,0.994183202407459,0,1,regulation of antibody-dependent cellular cytotoxicity,BP,
664,GO:0001814,1,0.994183202407459,0,1,negative regulation of antibody-dependent cellular cytotoxicity,BP,
667,GO:0001818,1,0.262808613585549,0,213,negative regulation of cytokine production,BP,
669,GO:0001820,1,0.940909851720083,0,10,serotonin secretion,BP,
670,GO:0001821,1,0.947630039967174,0,9,histamine secretion,BP,
673,GO:0001824,1,0.709795506466495,0,54,blastocyst development,BP,
674,GO:0001825,1,0.853077779967591,0,25,blastocyst formation,BP,
675,GO:0001826,1,0.960134952040535,0,6,inner cell mass cell differentiation,BP,
676,GO:0001827,1,0.98637714104741,0,2,inner cell mass cell fate commitment,BP,
677,GO:0001828,1,0.980427941115657,0,3,inner cell mass cellular morphogenesis,BP,
678,GO:0001829,1,0.926913783900075,0,12,trophectodermal cell differentiation,BP,
679,GO:0001831,1,0.98677871975175,0,2,trophectodermal cellular morphogenesis,BP,
680,GO:0001832,1,0.900162122859166,0,16,blastocyst growth,BP,
681,GO:0001833,1,0.930828493442225,0,11,inner cell mass cell proliferation,BP,
682,GO:0001834,1,0.986447045703861,0,2,trophectodermal cell proliferation,BP,
683,GO:0001835,1,0.99370983661046,0,1,blastocyst hatching,BP,
687,GO:0001839,1,0.962482450240115,0,6,neural plate morphogenesis,BP,
688,GO:0001840,1,0.942289009433155,0,9,neural plate development,BP,
690,GO:0001842,1,0.95656042433999,0,7,neural fold formation,BP,
692,GO:0001844,1,0.821770035309608,0,32,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
693,GO:0001845,1,0.926741806000308,0,12,phagolysosome assembly,BP,
694,GO:0001846,1,0.923488429185966,0,12,opsonin binding,MF,
695,GO:0001847,1,0.974211392685629,0,4,opsonin receptor activity,MF,
696,GO:0001848,1,0.905785147741537,0,15,complement binding,MF,
697,GO:0001849,1,0.96134427082621,0,6,complement component C1q binding,MF,
698,GO:0001850,1,0.994118949009227,0,1,complement component C3a binding,MF,
699,GO:0001851,1,0.973413653506803,0,4,complement component C3b binding,MF,
700,GO:0001855,1,0.986192067122519,0,2,complement component C4b binding,MF,
701,GO:0001856,1,0.993971782678703,0,1,complement component C5a binding,MF,
702,GO:0001861,1,0.991956535396447,0,1,complement component C4b receptor activity,MF,
703,GO:0001865,1,0.949852415664639,0,8,NK T cell differentiation,BP,
704,GO:0001866,1,0.970321347908768,0,5,NK T cell proliferation,BP,
705,GO:0001867,1,0.947002172968373,0,9,complement activation, lectin pathway,BP,
706,GO:0001868,1,0.987439290668901,0,2,regulation of complement activation, lectin pathway,BP,
707,GO:0001869,1,0.987439290668901,0,2,negative regulation of complement activation, lectin pathway,BP,
709,GO:0001872,1,0.994088052350844,0,1,(1->3)-beta-D-glucan binding,MF,
710,GO:0001875,1,0.968884383813533,0,5,lipopolysaccharide receptor activity,MF,
711,GO:0001878,1,0.976377096764655,0,4,response to yeast,BP,
712,GO:0001880,1,0.980422280397789,0,3,Mullerian duct regression,BP,
713,GO:0001881,1,0.824665118104059,0,30,receptor recycling,BP,
716,GO:0001884,1,0.986983443193889,0,2,pyrimidine nucleoside binding,MF,
718,GO:0001886,1,0.935424978916453,0,10,endothelial cell morphogenesis,BP,
719,GO:0001887,1,0.969419588440969,0,5,selenium compound metabolic process,BP,
720,GO:0001888,1,0.986732864514326,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
721,GO:0001889,1,0.428954569695763,0,131,liver development,BP,
722,GO:0001890,1,0.416196507988644,0,136,placenta development,BP,
723,GO:0001891,1,0.875585540483073,0,21,phagocytic cup,CC,
724,GO:0001892,1,0.59139661577457,0,81,embryonic placenta development,BP,
725,GO:0001893,1,0.824012351307299,0,30,maternal placenta development,BP,
728,GO:0001897,1,0.987900628381654,0,2,cytolysis by symbiont of host cells,BP,
729,GO:0001905,1,0.979346471832678,0,3,activation of membrane attack complex,BP,
730,GO:0001906,1,0.520340540483818,0,108,cell killing,BP,
731,GO:0001907,1,0.970055687044502,0,5,killing by symbiont of host cells,BP,
732,GO:0001909,1,0.622912733511201,0,77,leukocyte mediated cytotoxicity,BP,
733,GO:0001910,1,0.72706809693585,0,52,regulation of leukocyte mediated cytotoxicity,BP,
734,GO:0001911,1,0.918075506129818,0,14,negative regulation of leukocyte mediated cytotoxicity,BP,
735,GO:0001912,1,0.821411392576274,0,32,positive regulation of leukocyte mediated cytotoxicity,BP,
736,GO:0001913,1,0.84805683626756,0,27,T cell mediated cytotoxicity,BP,
737,GO:0001914,1,0.885773009753571,0,20,regulation of T cell mediated cytotoxicity,BP,
738,GO:0001915,1,0.963278319762894,0,6,negative regulation of T cell mediated cytotoxicity,BP,
739,GO:0001916,1,0.930384700160712,0,12,positive regulation of T cell mediated cytotoxicity,BP,
740,GO:0001917,1,0.789714464663827,0,36,photoreceptor inner segment,CC,
741,GO:0001919,1,0.869199791151899,0,22,regulation of receptor recycling,BP,
742,GO:0001920,1,0.975423803423714,0,4,negative regulation of receptor recycling,BP,
743,GO:0001921,1,0.919494899489238,0,13,positive regulation of receptor recycling,BP,
744,GO:0001922,1,0.980024888389021,0,3,B-1 B cell homeostasis,BP,
745,GO:0001923,1,0.981073225423105,0,3,B-1 B cell differentiation,BP,
746,GO:0001927,1,0.980664795797792,0,3,exocyst assembly,BP,
747,GO:0001928,1,0.993994844690258,0,1,regulation of exocyst assembly,BP,
748,GO:0001931,1,0.920853898020393,0,13,uropod,CC,
754,GO:0001937,1,0.811981169061761,0,32,negative regulation of endothelial cell proliferation,BP,
756,GO:0001939,1,0.961988621752135,0,6,female pronucleus,CC,
757,GO:0001940,1,0.966098639486768,0,5,male pronucleus,CC,
758,GO:0001941,1,0.793811548856679,0,35,postsynaptic membrane organization,BP,
759,GO:0001942,1,0.590293742116865,0,81,hair follicle development,BP,
761,GO:0001945,1,0.85031874960274,0,24,lymph vessel development,BP,
762,GO:0001946,1,0.90434204723479,0,15,lymphangiogenesis,BP,
763,GO:0001947,1,0.701202278161754,0,55,heart looping,BP,
765,GO:0001951,1,0.974641156223071,0,4,intestinal D-glucose absorption,BP,
767,GO:0001953,1,0.813850400484605,0,31,negative regulation of cell-matrix adhesion,BP,
768,GO:0001954,1,0.742160882839678,0,45,positive regulation of cell-matrix adhesion,BP,
769,GO:0001955,1,0.94947504609609,0,8,blood vessel maturation,BP,
770,GO:0001956,1,0.91818522818309,0,13,positive regulation of neurotransmitter secretion,BP,
771,GO:0001957,1,0.961469262343814,0,6,intramembranous ossification,BP,
772,GO:0001958,1,0.850914839783598,0,25,endochondral ossification,BP,
775,GO:0001961,1,0.757051373072947,0,44,positive regulation of cytokine-mediated signaling pathway,BP,
777,GO:0001964,1,0.852012853125734,0,24,startle response,BP,
779,GO:0001966,1,0.994254097431965,0,1,thigmotaxis,BP,
780,GO:0001967,1,0.931384811390173,0,11,suckling behavior,BP,
781,GO:0001968,1,0.84924169343882,0,25,fibronectin binding,MF,
782,GO:0001969,1,0.979346471832678,0,3,regulation of activation of membrane attack complex,BP,
783,GO:0001970,1,0.986809957170163,0,2,positive regulation of activation of membrane attack complex,BP,
784,GO:0001971,1,0.992437775278252,0,1,negative regulation of activation of membrane attack complex,BP,
785,GO:0001972,1,0.926007857761402,0,12,retinoic acid binding,MF,
787,GO:0001974,1,0.773853607532577,0,39,blood vessel remodeling,BP,
789,GO:0001976,1,0.932478501831043,0,11,neurological system process involved in regulation of systemic arterial blood pressure,BP,
790,GO:0001977,1,0.928745998434159,0,12,renal system process involved in regulation of blood volume,BP,
791,GO:0001978,1,0.994016619707629,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
792,GO:0001979,1,0.994156057153343,0,1,regulation of systemic arterial blood pressure by chemoreceptor signaling,BP,
793,GO:0001980,1,0.994403686358589,0,1,regulation of systemic arterial blood pressure by ischemic conditions,BP,
794,GO:0001983,1,0.994016619707629,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
795,GO:0001985,1,0.994016619707629,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
796,GO:0001990,1,0.830342254309502,0,30,regulation of systemic arterial blood pressure by hormone,BP,
797,GO:0001991,1,0.916362319479847,0,14,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
798,GO:0001992,1,0.975218273585079,0,4,regulation of systemic arterial blood pressure by vasopressin,BP,
799,GO:0001993,1,0.945410397679745,0,9,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
800,GO:0001994,1,0.976069561321128,0,4,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
801,GO:0001996,1,0.974517039481992,0,4,positive regulation of heart rate by epinephrine-norepinephrine,BP,
802,GO:0001997,1,0.987876053054139,0,2,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
803,GO:0001998,1,0.994092672072738,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
804,GO:0001999,1,0.975121799209625,0,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
805,GO:0002001,1,0.975121799209625,0,4,renin secretion into blood stream,BP,
806,GO:0002002,1,0.939756413069313,0,10,regulation of angiotensin levels in blood,BP,
807,GO:0002003,1,0.939756413069313,0,10,angiotensin maturation,BP,
808,GO:0002007,1,0.994156057153343,0,1,detection of hypoxic conditions in blood by chemoreceptor signaling,BP,
810,GO:0002011,1,0.71442776334769,0,50,morphogenesis of an epithelial sheet,BP,
811,GO:0002016,1,0.963894749435159,0,6,regulation of blood volume by renin-angiotensin,BP,
812,GO:0002017,1,0.994103933209592,0,1,regulation of blood volume by renal aldosterone,BP,
813,GO:0002018,1,0.987913998852626,0,2,renin-angiotensin regulation of aldosterone production,BP,
814,GO:0002019,1,0.98213446842911,0,3,regulation of renal output by angiotensin,BP,
816,GO:0002021,1,0.886179978741673,0,19,response to dietary excess,BP,
817,GO:0002023,1,0.994051101396599,0,1,reduction of food intake in response to dietary excess,BP,
818,GO:0002024,1,0.951371207623219,0,8,diet induced thermogenesis,BP,
819,GO:0002025,1,0.981875490746082,0,3,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
823,GO:0002029,1,0.907623412145182,0,16,desensitization of G-protein coupled receptor protein signaling pathway,BP,
824,GO:0002030,1,0.993809091244327,0,1,inhibitory G-protein coupled receptor phosphorylation,BP,
825,GO:0002031,1,0.924240639759017,0,13,G-protein coupled receptor internalization,BP,
826,GO:0002032,1,0.98819003814264,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
827,GO:0002034,1,0.976176183055261,0,4,regulation of blood vessel diameter by renin-angiotensin,BP,
828,GO:0002035,1,0.981359938727205,0,3,brain renin-angiotensin system,BP,
829,GO:0002036,1,0.967981506086942,0,5,regulation of L-glutamate import across plasma membrane,BP,
830,GO:0002037,1,0.994033497602527,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
831,GO:0002038,1,0.993992826293789,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
832,GO:0002039,1,0.6406112442874,0,68,p53 binding,MF,
834,GO:0002041,1,0.993985330159028,0,1,intussusceptive angiogenesis,BP,
837,GO:0002046,1,0.994365277838471,0,1,opsin binding,MF,
838,GO:0002051,1,0.972163867497916,0,4,osteoblast fate commitment,BP,
840,GO:0002053,1,0.840529815781312,0,27,positive regulation of mesenchymal cell proliferation,BP,
841,GO:0002054,1,0.976461127520115,0,4,nucleobase binding,MF,
842,GO:0002055,1,0.994433720502016,0,1,adenine binding,MF,
843,GO:0002058,1,0.994032631957673,0,1,uracil binding,MF,
844,GO:0002059,1,0.994032631957673,0,1,thymine binding,MF,
845,GO:0002060,1,0.982324080946183,0,3,purine nucleobase binding,MF,
846,GO:0002061,1,0.994032631957673,0,1,pyrimidine nucleobase binding,MF,
848,GO:0002063,1,0.857253825965799,0,23,chondrocyte development,BP,
850,GO:0002065,1,0.529444548123348,0,99,columnar/cuboidal epithelial cell differentiation,BP,
851,GO:0002066,1,0.718628813470439,0,51,columnar/cuboidal epithelial cell development,BP,
852,GO:0002067,1,0.75951246829613,0,43,glandular epithelial cell differentiation,BP,
853,GO:0002068,1,0.861296696107908,0,23,glandular epithelial cell development,BP,
854,GO:0002069,1,0.964557236053612,0,6,columnar/cuboidal epithelial cell maturation,BP,
855,GO:0002070,1,0.908231202102097,0,15,epithelial cell maturation,BP,
856,GO:0002071,1,0.98810554370951,0,2,glandular epithelial cell maturation,BP,
857,GO:0002072,1,0.946105859050995,0,8,optic cup morphogenesis involved in camera-type eye development,BP,
858,GO:0002074,1,0.967039474662932,0,5,extraocular skeletal muscle development,BP,
859,GO:0002076,1,0.89498104411508,0,17,osteoblast development,BP,
860,GO:0002077,1,0.994251498429764,0,1,acrosome matrix dispersal,BP,
861,GO:0002079,1,0.974587464243955,0,4,inner acrosomal membrane,CC,
862,GO:0002080,1,0.893637130107366,0,18,acrosomal membrane,CC,
863,GO:0002081,1,0.986204517399257,0,2,outer acrosomal membrane,CC,
864,GO:0002082,1,0.910962395948563,0,15,regulation of oxidative phosphorylation,BP,
865,GO:0002083,1,0.994172950755259,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
866,GO:0002084,1,0.946256738386094,0,9,protein depalmitoylation,BP,
867,GO:0002085,1,0.974172174276753,0,4,inhibition of neuroepithelial cell differentiation,BP,
868,GO:0002086,1,0.98808976191159,0,2,diaphragm contraction,BP,
869,GO:0002087,1,0.925655615606338,0,12,regulation of respiratory gaseous exchange by neurological system process,BP,
870,GO:0002088,1,0.677273141971773,0,59,lens development in camera-type eye,BP,
871,GO:0002089,1,0.896800653933175,0,16,lens morphogenesis in camera-type eye,BP,
873,GO:0002091,1,0.944593877389437,0,9,negative regulation of receptor internalization,BP,
875,GO:0002093,1,0.924800924720455,0,12,auditory receptor cell morphogenesis,BP,
876,GO:0002094,1,0.98790529581443,0,2,polyprenyltransferase activity,MF,
877,GO:0002097,1,0.906210943641993,0,16,tRNA wobble base modification,BP,
878,GO:0002098,1,0.929723647222585,0,12,tRNA wobble uridine modification,BP,
879,GO:0002100,1,0.992847291976754,0,1,tRNA wobble adenosine to inosine editing,BP,
880,GO:0002101,1,0.981752070890757,0,3,tRNA wobble cytosine modification,BP,
881,GO:0002102,1,0.811539170197862,0,32,podosome,CC,
882,GO:0002113,1,0.993986771627898,0,1,interleukin-33 binding,MF,
883,GO:0002114,1,0.987575554751741,0,2,interleukin-33 receptor activity,MF,
884,GO:0002115,1,0.902807459531572,0,16,store-operated calcium entry,BP,
885,GO:0002116,1,0.923508302820486,0,11,semaphorin receptor complex,CC,
886,GO:0002118,1,0.957446679605493,0,7,aggressive behavior,BP,
887,GO:0002121,1,0.987432037025897,0,2,inter-male aggressive behavior,BP,
888,GO:0002125,1,0.987606666958036,0,2,maternal aggressive behavior,BP,
889,GO:0002127,1,0.994232150308785,0,1,tRNA wobble base cytosine methylation,BP,
890,GO:0002133,1,0.983797473999402,0,2,polycystin complex,CC,
891,GO:0002134,1,0.986983443193889,0,2,UTP binding,MF,
892,GO:0002135,1,0.993912174119494,0,1,CTP binding,MF,
893,GO:0002138,1,0.952602093224056,0,8,retinoic acid biosynthetic process,BP,
894,GO:0002139,1,0.971724058568092,0,4,stereocilia coupling link,CC,
895,GO:0002140,1,0.992520445296379,0,1,stereocilia tip link,CC,
896,GO:0002141,1,0.979048480449792,0,3,stereocilia ankle link,CC,
897,GO:0002142,1,0.979048480449792,0,3,stereocilia ankle link complex,CC,
898,GO:0002143,1,0.976420724665154,0,4,tRNA wobble position uridine thiolation,BP,
899,GO:0002144,1,0.994039268855938,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
900,GO:0002148,1,0.993718121396218,0,1,hypochlorous acid metabolic process,BP,
901,GO:0002149,1,0.993718121396218,0,1,hypochlorous acid biosynthetic process,BP,
902,GO:0002151,1,0.95812004270731,0,6,G-quadruplex RNA binding,MF,
903,GO:0002152,1,0.993660008707575,0,1,bile acid conjugation,BP,
904,GO:0002153,1,0.993948013537591,0,1,steroid receptor RNA activator RNA binding,MF,
905,GO:0002154,1,0.965884388494043,0,5,thyroid hormone mediated signaling pathway,BP,
906,GO:0002155,1,0.98074687628425,0,3,regulation of thyroid hormone mediated signaling pathway,BP,
908,GO:0002159,1,0.973281004805321,0,4,desmosome assembly,BP,
909,GO:0002161,1,0.932630456843573,0,11,aminoacyl-tRNA editing activity,MF,
910,GO:0002162,1,0.944863048973531,0,8,dystroglycan binding,MF,
911,GO:0002169,1,0.987536761121932,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
912,GO:0002174,1,0.993799924379055,0,1,mammary stem cell proliferation,BP,
913,GO:0002175,1,0.97228003223353,0,4,protein localization to paranode region of axon,BP,
914,GO:0002176,1,0.965185718099865,0,6,male germ cell proliferation,BP,
915,GO:0002177,1,0.958918681230596,0,7,manchette,CC,
916,GO:0002178,1,0.933988299095875,0,11,palmitoyltransferase complex,CC,
917,GO:0002181,1,0.603063716612644,0,84,cytoplasmic translation,BP,
918,GO:0002182,1,0.938611920769311,0,10,cytoplasmic translational elongation,BP,
919,GO:0002183,1,0.891877702324173,0,18,cytoplasmic translational initiation,BP,
920,GO:0002184,1,0.986457446140707,0,2,cytoplasmic translational termination,BP,
921,GO:0002188,1,0.978878498640993,0,3,translation reinitiation,BP,
922,GO:0002189,1,0.993914331984212,0,1,ribose phosphate diphosphokinase complex,CC,
923,GO:0002190,1,0.970919667585302,0,5,cap-independent translational initiation,BP,
924,GO:0002191,1,0.981432230184042,0,3,cap-dependent translational initiation,BP,
925,GO:0002192,1,0.988604321952196,0,2,IRES-dependent translational initiation of linear mRNA,BP,
926,GO:0002193,1,0.979070059023723,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
927,GO:0002194,1,0.993761857850181,0,1,hepatocyte cell migration,BP,
928,GO:0002196,1,0.994098591296477,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
929,GO:0002199,1,0.952825904001932,0,8,zona pellucida receptor complex,CC,
930,GO:0002200,1,0.690215094397931,0,57,somatic diversification of immune receptors,BP,
931,GO:0002204,1,0.780511387858908,0,39,somatic recombination of immunoglobulin genes involved in immune response,BP,
932,GO:0002208,1,0.780511387858908,0,39,somatic diversification of immunoglobulins involved in immune response,BP,
934,GO:0002215,1,0.988076202002409,0,2,defense response to nematode,BP,
936,GO:0002220,1,0.50255335291784,0,110,innate immune response activating cell surface receptor signaling pathway,BP,
938,GO:0002223,1,0.511524410369026,0,107,stimulatory C-type lectin receptor signaling pathway,BP,
940,GO:0002225,1,0.988358549130909,0,2,positive regulation of antimicrobial peptide production,BP,
941,GO:0002227,1,0.917910539171537,0,15,innate immune response in mucosa,BP,
942,GO:0002228,1,0.724709883577084,0,52,natural killer cell mediated immunity,BP,
943,GO:0002230,1,0.875135542679765,0,21,positive regulation of defense response to virus by host,BP,
944,GO:0002232,1,0.988207836945286,0,2,leukocyte chemotaxis involved in inflammatory response,BP,
945,GO:0002237,1,0.135236093267937,0,318,response to molecule of bacterial origin,BP,
946,GO:0002238,1,0.987129284663403,0,2,response to molecule of fungal origin,BP,
948,GO:0002246,1,0.963868252774715,0,6,wound healing involved in inflammatory response,BP,
949,GO:0002248,1,0.969493837581315,0,5,connective tissue replacement involved in inflammatory response wound healing,BP,
950,GO:0002249,1,0.968648963722723,0,5,lymphocyte anergy,BP,
951,GO:0002250,1,0.14079677748148,0,311,adaptive immune response,BP,
952,GO:0002251,1,0.874395007641823,0,23,organ or tissue specific immune response,BP,
955,GO:0002254,1,0.982171798696256,0,3,kinin cascade,BP,
956,GO:0002260,1,0.684198620543215,0,60,lymphocyte homeostasis,BP,
957,GO:0002262,1,0.42854674863049,0,133,myeloid cell homeostasis,BP,
959,GO:0002265,1,0.977025058041003,0,3,astrocyte activation involved in immune response,BP,
960,GO:0002266,1,0.98215961669386,0,3,follicular dendritic cell activation,BP,
961,GO:0002268,1,0.987906782192349,0,2,follicular dendritic cell differentiation,BP,
964,GO:0002276,1,0.987517978759006,0,2,basophil activation involved in immune response,BP,
965,GO:0002277,1,0.98145081778298,0,3,myeloid dendritic cell activation involved in immune response,BP,
966,GO:0002278,1,0.976223803839749,0,4,eosinophil activation involved in immune response,BP,
967,GO:0002279,1,0.767821333459796,0,42,mast cell activation involved in immune response,BP,
968,GO:0002281,1,0.944967789868947,0,9,macrophage activation involved in immune response,BP,
969,GO:0002282,1,0.987651216198642,0,2,microglial cell activation involved in immune response,BP,
971,GO:0002285,1,0.431079343570753,0,132,lymphocyte activation involved in immune response,BP,
972,GO:0002286,1,0.630256081557224,0,73,T cell activation involved in immune response,BP,
973,GO:0002287,1,0.728046642266821,0,50,alpha-beta T cell activation involved in immune response,BP,
974,GO:0002290,1,0.993820554697066,0,1,gamma-delta T cell activation involved in immune response,BP,
975,GO:0002291,1,0.952246105644615,0,8,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
976,GO:0002292,1,0.705294860673465,0,55,T cell differentiation involved in immune response,BP,
977,GO:0002293,1,0.728046642266821,0,50,alpha-beta T cell differentiation involved in immune response,BP,
978,GO:0002294,1,0.732560618704146,0,49,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,
979,GO:0002295,1,0.921845204825509,0,13,T-helper cell lineage commitment,BP,
980,GO:0002296,1,0.98621059383235,0,2,T-helper 1 cell lineage commitment,BP,
981,GO:0002298,1,0.994163998595989,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
982,GO:0002299,1,0.994195908663481,0,1,alpha-beta intraepithelial T cell differentiation,BP,
983,GO:0002300,1,0.994195908663481,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
984,GO:0002302,1,0.993857563688757,0,1,CD8-positive, alpha-beta T cell differentiation involved in immune response,BP,
985,GO:0002304,1,0.994195908663481,0,1,gamma-delta intraepithelial T cell differentiation,BP,
986,GO:0002305,1,0.994195908663481,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
987,GO:0002309,1,0.976404047242557,0,4,T cell proliferation involved in immune response,BP,
988,GO:0002312,1,0.677548241021907,0,61,B cell activation involved in immune response,BP,
989,GO:0002313,1,0.897301715131498,0,17,mature B cell differentiation involved in immune response,BP,
990,GO:0002314,1,0.98185385552384,0,3,germinal center B cell differentiation,BP,
991,GO:0002315,1,0.940981535154954,0,9,marginal zone B cell differentiation,BP,
992,GO:0002316,1,0.987640339348012,0,2,follicular B cell differentiation,BP,
993,GO:0002317,1,0.982846409063063,0,3,plasma cell differentiation,BP,
994,GO:0002318,1,0.968474039468908,0,5,myeloid progenitor cell differentiation,BP,
995,GO:0002320,1,0.887577322713775,0,18,lymphoid progenitor cell differentiation,BP,
996,GO:0002322,1,0.967817486019101,0,5,B cell proliferation involved in immune response,BP,
997,GO:0002323,1,0.951490192426996,0,8,natural killer cell activation involved in immune response,BP,
998,GO:0002325,1,0.988574604547387,0,2,natural killer cell differentiation involved in immune response,BP,
999,GO:0002326,1,0.977848433885803,0,3,B cell lineage commitment,BP,
1000,GO:0002327,1,0.950487749450213,0,7,immature B cell differentiation,BP,
1001,GO:0002328,1,0.932425796445995,0,10,pro-B cell differentiation,BP,
1002,GO:0002329,1,0.970804491562881,0,4,pre-B cell differentiation,BP,
1003,GO:0002331,1,0.984254937279861,0,2,pre-B cell allelic exclusion,BP,
1004,GO:0002332,1,0.993025076771582,0,1,transitional stage B cell differentiation,BP,
1005,GO:0002333,1,0.993025076771582,0,1,transitional one stage B cell differentiation,BP,
1006,GO:0002335,1,0.874441118473151,0,21,mature B cell differentiation,BP,
1007,GO:0002337,1,0.987789050811642,0,2,B-1a B cell differentiation,BP,
1008,GO:0002339,1,0.982418599925335,0,3,B cell selection,BP,
1009,GO:0002343,1,0.993889166795477,0,1,peripheral B cell selection,BP,
1010,GO:0002344,1,0.993889166795477,0,1,B cell affinity maturation,BP,
1011,GO:0002347,1,0.901444119770974,0,17,response to tumor cell,BP,
1012,GO:0002349,1,0.964924262429177,0,6,histamine production involved in inflammatory response,BP,
1013,GO:0002351,1,0.981607207522266,0,3,serotonin production involved in inflammatory response,BP,
1014,GO:0002352,1,0.988459625416189,0,2,B cell negative selection,BP,
1015,GO:0002353,1,0.982171798696256,0,3,plasma kallikrein-kinin cascade,BP,
1016,GO:0002355,1,0.993946717473058,0,1,detection of tumor cell,BP,
1017,GO:0002357,1,0.981726278237013,0,3,defense response to tumor cell,BP,
1018,GO:0002358,1,0.994412927591184,0,1,B cell homeostatic proliferation,BP,
1019,GO:0002360,1,0.873640873055583,0,21,T cell lineage commitment,BP,
1020,GO:0002361,1,0.976191340930238,0,4,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
1021,GO:0002362,1,0.993972647282024,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment,BP,
1022,GO:0002363,1,0.904976758154282,0,16,alpha-beta T cell lineage commitment,BP,
1024,GO:0002367,1,0.623262874133707,0,76,cytokine production involved in immune response,BP,
1025,GO:0002368,1,0.987903715660093,0,2,B cell cytokine production,BP,
1026,GO:0002369,1,0.831272309059473,0,30,T cell cytokine production,BP,
1027,GO:0002370,1,0.987288490897293,0,2,natural killer cell cytokine production,BP,
1028,GO:0002371,1,0.961387592136404,0,6,dendritic cell cytokine production,BP,
1029,GO:0002373,1,0.994375962862754,0,1,plasmacytoid dendritic cell cytokine production,BP,
1030,GO:0002374,1,0.904202342007968,0,16,cytokine secretion involved in immune response,BP,
1032,GO:0002377,1,0.58217487251567,0,86,immunoglobulin production,BP,
1033,GO:0002378,1,0.980530387506774,0,3,immunoglobulin biosynthetic process,BP,
1034,GO:0002380,1,0.993352985658983,0,1,immunoglobulin secretion involved in immune response,BP,
1035,GO:0002381,1,0.757190521489003,0,44,immunoglobulin production involved in immunoglobulin mediated immune response,BP,
1036,GO:0002384,1,0.987800146366472,0,2,hepatic immune response,BP,
1037,GO:0002385,1,0.885207781729205,0,21,mucosal immune response,BP,
1038,GO:0002386,1,0.987545973829922,0,2,immune response in mucosal-associated lymphoid tissue,BP,
1039,GO:0002396,1,0.971599108828564,0,5,MHC protein complex assembly,BP,
1040,GO:0002397,1,0.994093827025902,0,1,MHC class I protein complex assembly,BP,
1041,GO:0002399,1,0.977372987825636,0,4,MHC class II protein complex assembly,BP,
1042,GO:0002407,1,0.872627412442658,0,22,dendritic cell chemotaxis,BP,
1043,GO:0002408,1,0.976144084291262,0,4,myeloid dendritic cell chemotaxis,BP,
1044,GO:0002414,1,0.981756106596797,0,3,immunoglobulin transcytosis in epithelial cells,BP,
1045,GO:0002415,1,0.987545973829922,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
1046,GO:0002416,1,0.994137863984607,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
1047,GO:0002418,1,0.91785787055058,0,14,immune response to tumor cell,BP,
1048,GO:0002420,1,0.94628081901483,0,9,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1049,GO:0002423,1,0.94628081901483,0,9,natural killer cell mediated immune response to tumor cell,BP,
1050,GO:0002424,1,0.987676349262986,0,2,T cell mediated immune response to tumor cell,BP,
1051,GO:0002426,1,0.994294526425336,0,1,immunoglobulin production in mucosal tissue,BP,
1052,GO:0002428,1,0.982118664281912,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
1054,GO:0002430,1,0.951176601164223,0,8,complement receptor mediated signaling pathway,BP,
1055,GO:0002431,1,0.620652341729406,0,75,Fc receptor mediated stimulatory signaling pathway,BP,
1056,GO:0002432,1,0.99337680715555,0,1,granuloma formation,BP,
1057,GO:0002433,1,0.640079201589985,0,70,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,
1058,GO:0002434,1,0.988143303712721,0,2,immune complex clearance,BP,
1059,GO:0002436,1,0.988143303712721,0,2,immune complex clearance by monocytes and macrophages,BP,
1060,GO:0002437,1,0.787129697096855,0,39,inflammatory response to antigenic stimulus,BP,
1061,GO:0002438,1,0.89115743012281,0,19,acute inflammatory response to antigenic stimulus,BP,
1062,GO:0002439,1,0.976766615444577,0,4,chronic inflammatory response to antigenic stimulus,BP,
1063,GO:0002440,1,0.382433319665849,0,153,production of molecular mediator of immune response,BP,
1064,GO:0002441,1,0.964924262429177,0,6,histamine secretion involved in inflammatory response,BP,
1065,GO:0002442,1,0.981607207522266,0,3,serotonin secretion involved in inflammatory response,BP,
1068,GO:0002445,1,0.981937377983331,0,3,type II hypersensitivity,BP,
1070,GO:0002447,1,0.976223803839749,0,4,eosinophil mediated immunity,BP,
1071,GO:0002448,1,0.758285889273498,0,44,mast cell mediated immunity,BP,
1072,GO:0002449,1,0.297038216614502,0,194,lymphocyte mediated immunity,BP,
1073,GO:0002450,1,0.994183202407459,0,1,B cell antigen processing and presentation,BP,
1074,GO:0002455,1,0.796272113518171,0,37,humoral immune response mediated by circulating immunoglobulin,BP,
1075,GO:0002456,1,0.63197588316823,0,74,T cell mediated immunity,BP,
1076,GO:0002457,1,0.969138668994953,0,5,T cell antigen processing and presentation,BP,
1077,GO:0002458,1,0.988044467122821,0,2,peripheral T cell tolerance induction,BP,
1078,GO:0002460,1,0.284104606772365,0,200,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1079,GO:0002461,1,0.982092148109004,0,3,tolerance induction dependent upon immune response,BP,
1080,GO:0002465,1,0.988044467122821,0,2,peripheral tolerance induction,BP,
1081,GO:0002467,1,0.907998473827536,0,15,germinal center formation,BP,
1082,GO:0002468,1,0.945867814460228,0,9,dendritic cell antigen processing and presentation,BP,
1083,GO:0002474,1,0.586963609589525,0,88,antigen processing and presentation of peptide antigen via MHC class I,BP,
1084,GO:0002475,1,0.951321575214351,0,8,antigen processing and presentation via MHC class Ib,BP,
1085,GO:0002476,1,0.98768756387482,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
1086,GO:0002477,1,0.99436239000041,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1087,GO:0002478,1,0.365290928710392,0,163,antigen processing and presentation of exogenous peptide antigen,BP,
1088,GO:0002479,1,0.663182323301019,0,69,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,
1089,GO:0002480,1,0.953924648917109,0,8,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1090,GO:0002481,1,0.99436239000041,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1091,GO:0002483,1,0.9507898826699,0,8,antigen processing and presentation of endogenous peptide antigen,BP,
1092,GO:0002488,1,0.99348795489116,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1093,GO:0002489,1,0.99348795489116,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1094,GO:0002495,1,0.545783015703483,0,96,antigen processing and presentation of peptide antigen via MHC class II,BP,
1095,GO:0002501,1,0.977152677638647,0,4,peptide antigen assembly with MHC protein complex,BP,
1096,GO:0002502,1,0.994093827025902,0,1,peptide antigen assembly with MHC class I protein complex,BP,
1097,GO:0002503,1,0.982959220684001,0,3,peptide antigen assembly with MHC class II protein complex,BP,
1098,GO:0002504,1,0.541925998605667,0,97,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1099,GO:0002505,1,0.988635919174598,0,2,antigen processing and presentation of polysaccharide antigen via MHC class II,BP,
1100,GO:0002506,1,0.988635919174598,0,2,polysaccharide assembly with MHC class II protein complex,BP,
1101,GO:0002507,1,0.865700662079298,0,23,tolerance induction,BP,
1102,GO:0002508,1,0.987958336107814,0,2,central tolerance induction,BP,
1103,GO:0002509,1,0.994036238886231,0,1,central tolerance induction to self antigen,BP,
1104,GO:0002510,1,0.993886004761557,0,1,central B cell tolerance induction,BP,
1105,GO:0002513,1,0.969464196206374,0,5,tolerance induction to self antigen,BP,
1106,GO:0002514,1,0.987231535774917,0,2,B cell tolerance induction,BP,
1107,GO:0002517,1,0.927856659093748,0,12,T cell tolerance induction,BP,
1108,GO:0002518,1,0.994300013232335,0,1,lymphocyte chemotaxis across high endothelial venule,BP,
1109,GO:0002519,1,0.988175189720938,0,2,natural killer cell tolerance induction,BP,
1111,GO:0002521,1,0.0644415219796843,0,424,leukocyte differentiation,BP,
1112,GO:0002522,1,0.988009936092799,0,2,leukocyte migration involved in immune response,BP,
1113,GO:0002523,1,0.935556249171158,0,11,leukocyte migration involved in inflammatory response,BP,
1114,GO:0002524,1,0.952797048014319,0,8,hypersensitivity,BP,
1115,GO:0002525,1,0.98206119009848,0,3,acute inflammatory response to non-antigenic stimulus,BP,
1116,GO:0002526,1,0.458007476372592,0,126,acute inflammatory response,BP,
1117,GO:0002528,1,0.986175435801805,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
1118,GO:0002532,1,0.745368123500402,0,47,production of molecular mediator involved in inflammatory response,BP,
1119,GO:0002534,1,0.827732396427387,0,30,cytokine production involved in inflammatory response,BP,
1120,GO:0002536,1,0.982619512055953,0,3,respiratory burst involved in inflammatory response,BP,
1121,GO:0002537,1,0.985540671027678,0,2,nitric oxide production involved in inflammatory response,BP,
1122,GO:0002538,1,0.987681190352434,0,2,arachidonic acid metabolite production involved in inflammatory response,BP,
1123,GO:0002540,1,0.987681190352434,0,2,leukotriene production involved in inflammatory response,BP,
1124,GO:0002541,1,0.982122220810905,0,3,activation of plasma proteins involved in acute inflammatory response,BP,
1125,GO:0002542,1,0.988083315489992,0,2,Factor XII activation,BP,
1126,GO:0002543,1,0.987278439247867,0,2,activation of blood coagulation via clotting cascade,BP,
1127,GO:0002544,1,0.900852525481888,0,17,chronic inflammatory response,BP,
1128,GO:0002545,1,0.9941033556982,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1130,GO:0002551,1,0.939574582021365,0,10,mast cell chemotaxis,BP,
1131,GO:0002553,1,0.964924262429177,0,6,histamine secretion by mast cell,BP,
1132,GO:0002554,1,0.981607207522266,0,3,serotonin secretion by platelet,BP,
1133,GO:0002560,1,0.993441878684404,0,1,basophil mediated immunity,BP,
1134,GO:0002561,1,0.993441878684404,0,1,basophil degranulation,BP,
1135,GO:0002562,1,0.718159373497868,0,51,somatic diversification of immune receptors via germline recombination within a single locus,BP,
1136,GO:0002566,1,0.926060409090156,0,12,somatic diversification of immune receptors via somatic mutation,BP,
1137,GO:0002568,1,0.96460546264309,0,5,somatic diversification of T cell receptor genes,BP,
1138,GO:0002572,1,0.987305510487941,0,2,pro-T cell differentiation,BP,
1139,GO:0002573,1,0.333955668204399,0,171,myeloid leukocyte differentiation,BP,
1141,GO:0002577,1,0.902056279498127,0,17,regulation of antigen processing and presentation,BP,
1142,GO:0002578,1,0.95783582727842,0,7,negative regulation of antigen processing and presentation,BP,
1143,GO:0002579,1,0.947366363470424,0,9,positive regulation of antigen processing and presentation,BP,
1144,GO:0002580,1,0.96996589105168,0,5,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1145,GO:0002581,1,0.980991023886655,0,3,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1146,GO:0002582,1,0.988763418874101,0,2,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1147,GO:0002583,1,0.965339223449153,0,6,regulation of antigen processing and presentation of peptide antigen,BP,
1148,GO:0002584,1,0.97631230630057,0,4,negative regulation of antigen processing and presentation of peptide antigen,BP,
1149,GO:0002585,1,0.988763418874101,0,2,positive regulation of antigen processing and presentation of peptide antigen,BP,
1150,GO:0002586,1,0.97682835421081,0,4,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1151,GO:0002587,1,0.987930686094445,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1152,GO:0002588,1,0.988763418874101,0,2,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1153,GO:0002589,1,0.98824113031288,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1154,GO:0002590,1,0.98824113031288,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1155,GO:0002604,1,0.945867814460228,0,9,regulation of dendritic cell antigen processing and presentation,BP,
1156,GO:0002605,1,0.987200067625262,0,2,negative regulation of dendritic cell antigen processing and presentation,BP,
1157,GO:0002606,1,0.958137225278821,0,7,positive regulation of dendritic cell antigen processing and presentation,BP,
1158,GO:0002622,1,0.994183202407459,0,1,regulation of B cell antigen processing and presentation,BP,
1159,GO:0002625,1,0.988236249910978,0,2,regulation of T cell antigen processing and presentation,BP,
1160,GO:0002626,1,0.994084876381684,0,1,negative regulation of T cell antigen processing and presentation,BP,
1161,GO:0002634,1,0.943312696653757,0,9,regulation of germinal center formation,BP,
1162,GO:0002635,1,0.985405780036641,0,2,negative regulation of germinal center formation,BP,
1163,GO:0002636,1,0.982984341234964,0,3,positive regulation of germinal center formation,BP,
1164,GO:0002637,1,0.722773964437868,0,52,regulation of immunoglobulin production,BP,
1165,GO:0002638,1,0.937621930022833,0,10,negative regulation of immunoglobulin production,BP,
1166,GO:0002639,1,0.810380551938704,0,34,positive regulation of immunoglobulin production,BP,
1167,GO:0002640,1,0.993846081630578,0,1,regulation of immunoglobulin biosynthetic process,BP,
1168,GO:0002642,1,0.993846081630578,0,1,positive regulation of immunoglobulin biosynthetic process,BP,
1169,GO:0002643,1,0.903540734167346,0,16,regulation of tolerance induction,BP,
1170,GO:0002644,1,0.994037248861168,0,1,negative regulation of tolerance induction,BP,
1171,GO:0002645,1,0.944056924754087,0,9,positive regulation of tolerance induction,BP,
1172,GO:0002646,1,0.993886004761557,0,1,regulation of central tolerance induction,BP,
1173,GO:0002648,1,0.993886004761557,0,1,positive regulation of central tolerance induction,BP,
1174,GO:0002649,1,0.993305012898809,0,1,regulation of tolerance induction to self antigen,BP,
1175,GO:0002651,1,0.993305012898809,0,1,positive regulation of tolerance induction to self antigen,BP,
1176,GO:0002652,1,0.987984979409531,0,2,regulation of tolerance induction dependent upon immune response,BP,
1177,GO:0002654,1,0.993972647282024,0,1,positive regulation of tolerance induction dependent upon immune response,BP,
1178,GO:0002658,1,0.993972647282024,0,1,regulation of peripheral tolerance induction,BP,
1179,GO:0002660,1,0.993972647282024,0,1,positive regulation of peripheral tolerance induction,BP,
1180,GO:0002661,1,0.987231535774917,0,2,regulation of B cell tolerance induction,BP,
1181,GO:0002663,1,0.987231535774917,0,2,positive regulation of B cell tolerance induction,BP,
1182,GO:0002664,1,0.939174426540354,0,10,regulation of T cell tolerance induction,BP,
1183,GO:0002666,1,0.957270845767005,0,7,positive regulation of T cell tolerance induction,BP,
1184,GO:0002667,1,0.968648963722723,0,5,regulation of T cell anergy,BP,
1185,GO:0002669,1,0.98110526604554,0,3,positive regulation of T cell anergy,BP,
1186,GO:0002673,1,0.635267845693189,0,73,regulation of acute inflammatory response,BP,
1187,GO:0002674,1,0.94445189177565,0,9,negative regulation of acute inflammatory response,BP,
1188,GO:0002675,1,0.858385638454136,0,25,positive regulation of acute inflammatory response,BP,
1189,GO:0002676,1,0.952585413753907,0,8,regulation of chronic inflammatory response,BP,
1190,GO:0002677,1,0.975117249334066,0,4,negative regulation of chronic inflammatory response,BP,
1191,GO:0002678,1,0.976899077390265,0,4,positive regulation of chronic inflammatory response,BP,
1192,GO:0002679,1,0.957241522385816,0,7,respiratory burst involved in defense response,BP,
1193,GO:0002681,1,0.96460546264309,0,5,somatic recombination of T cell receptor gene segments,BP,
1203,GO:0002691,1,0.87102766233574,0,22,regulation of cellular extravasation,BP,
1204,GO:0002692,1,0.950531525390479,0,8,negative regulation of cellular extravasation,BP,
1205,GO:0002693,1,0.927216513502781,0,12,positive regulation of cellular extravasation,BP,
1206,GO:0002694,1,0.0647121902984524,0,431,regulation of leukocyte activation,BP,
1207,GO:0002695,1,0.419614459386616,0,138,negative regulation of leukocyte activation,BP,
1208,GO:0002696,1,0.177458807533159,0,275,positive regulation of leukocyte activation,BP,
1209,GO:0002697,1,0.14931355825209,0,301,regulation of immune effector process,BP,
1210,GO:0002698,1,0.556746838832241,0,93,negative regulation of immune effector process,BP,
1211,GO:0002699,1,0.372520783720608,0,158,positive regulation of immune effector process,BP,
1212,GO:0002700,1,0.521432002298108,0,104,regulation of production of molecular mediator of immune response,BP,
1213,GO:0002701,1,0.828064497849291,0,30,negative regulation of production of molecular mediator of immune response,BP,
1214,GO:0002702,1,0.655327249685548,0,68,positive regulation of production of molecular mediator of immune response,BP,
1215,GO:0002703,1,0.386939236737066,0,152,regulation of leukocyte mediated immunity,BP,
1216,GO:0002704,1,0.775922269124785,0,41,negative regulation of leukocyte mediated immunity,BP,
1217,GO:0002705,1,0.57093165558541,0,90,positive regulation of leukocyte mediated immunity,BP,
1218,GO:0002706,1,0.504624408997803,0,110,regulation of lymphocyte mediated immunity,BP,
1219,GO:0002707,1,0.82637570750637,0,31,negative regulation of lymphocyte mediated immunity,BP,
1220,GO:0002708,1,0.642769331976562,0,71,positive regulation of lymphocyte mediated immunity,BP,
1221,GO:0002709,1,0.745496593755707,0,48,regulation of T cell mediated immunity,BP,
1222,GO:0002710,1,0.913169669982543,0,15,negative regulation of T cell mediated immunity,BP,
1223,GO:0002711,1,0.836637877908146,0,29,positive regulation of T cell mediated immunity,BP,
1224,GO:0002712,1,0.772704697914414,0,41,regulation of B cell mediated immunity,BP,
1225,GO:0002713,1,0.94465788828146,0,9,negative regulation of B cell mediated immunity,BP,
1226,GO:0002714,1,0.83941959568833,0,28,positive regulation of B cell mediated immunity,BP,
1227,GO:0002715,1,0.815354071415862,0,33,regulation of natural killer cell mediated immunity,BP,
1228,GO:0002716,1,0.934926798684226,0,11,negative regulation of natural killer cell mediated immunity,BP,
1229,GO:0002717,1,0.877611928321355,0,21,positive regulation of natural killer cell mediated immunity,BP,
1230,GO:0002718,1,0.688174054200611,0,60,regulation of cytokine production involved in immune response,BP,
1231,GO:0002719,1,0.877929421677697,0,21,negative regulation of cytokine production involved in immune response,BP,
1232,GO:0002720,1,0.804060211766439,0,35,positive regulation of cytokine production involved in immune response,BP,
1233,GO:0002721,1,0.993889166795477,0,1,regulation of B cell cytokine production,BP,
1234,GO:0002724,1,0.878452892354815,0,21,regulation of T cell cytokine production,BP,
1235,GO:0002725,1,0.964764742743293,0,6,negative regulation of T cell cytokine production,BP,
1236,GO:0002726,1,0.916395146058729,0,14,positive regulation of T cell cytokine production,BP,
1237,GO:0002727,1,0.987288490897293,0,2,regulation of natural killer cell cytokine production,BP,
1238,GO:0002728,1,0.993362602124708,0,1,negative regulation of natural killer cell cytokine production,BP,
1239,GO:0002729,1,0.99388571732223,0,1,positive regulation of natural killer cell cytokine production,BP,
1240,GO:0002730,1,0.968014970759386,0,5,regulation of dendritic cell cytokine production,BP,
1241,GO:0002731,1,0.987493394992295,0,2,negative regulation of dendritic cell cytokine production,BP,
1242,GO:0002732,1,0.993354995264372,0,1,positive regulation of dendritic cell cytokine production,BP,
1243,GO:0002736,1,0.994375962862754,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1244,GO:0002737,1,0.994375962862754,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1245,GO:0002739,1,0.922141015002273,0,13,regulation of cytokine secretion involved in immune response,BP,
1246,GO:0002740,1,0.970304278353655,0,5,negative regulation of cytokine secretion involved in immune response,BP,
1247,GO:0002741,1,0.956394576315587,0,7,positive regulation of cytokine secretion involved in immune response,BP,
1248,GO:0002752,1,0.98836601763812,0,2,cell surface pattern recognition receptor signaling pathway,BP,
1249,GO:0002753,1,0.714970951927055,0,52,cytoplasmic pattern recognition receptor signaling pathway,BP,
1250,GO:0002755,1,0.800775696672949,0,35,MyD88-dependent toll-like receptor signaling pathway,BP,
1251,GO:0002756,1,0.829691291973771,0,30,MyD88-independent toll-like receptor signaling pathway,BP,
1254,GO:0002759,1,0.976243397541425,0,4,regulation of antimicrobial humoral response,BP,
1255,GO:0002760,1,0.988358549130909,0,2,positive regulation of antimicrobial humoral response,BP,
1256,GO:0002761,1,0.536065677171913,0,97,regulation of myeloid leukocyte differentiation,BP,
1257,GO:0002762,1,0.766746624740377,0,41,negative regulation of myeloid leukocyte differentiation,BP,
1258,GO:0002763,1,0.766303682933534,0,42,positive regulation of myeloid leukocyte differentiation,BP,
1260,GO:0002765,1,0.958588211054819,0,7,immune response-inhibiting signal transduction,BP,
1261,GO:0002767,1,0.964321134088404,0,6,immune response-inhibiting cell surface receptor signaling pathway,BP,
1263,GO:0002769,1,0.988243739452958,0,2,natural killer cell inhibitory signaling pathway,BP,
1264,GO:0002774,1,0.981499016078299,0,3,Fc receptor mediated inhibitory signaling pathway,BP,
1265,GO:0002775,1,0.976504063052325,0,4,antimicrobial peptide production,BP,
1266,GO:0002777,1,0.994380583425736,0,1,antimicrobial peptide biosynthetic process,BP,
1267,GO:0002778,1,0.976504063052325,0,4,antibacterial peptide production,BP,
1268,GO:0002780,1,0.994380583425736,0,1,antibacterial peptide biosynthetic process,BP,
1269,GO:0002784,1,0.982023481346631,0,3,regulation of antimicrobial peptide production,BP,
1270,GO:0002785,1,0.993591077729755,0,1,negative regulation of antimicrobial peptide production,BP,
1271,GO:0002786,1,0.982023481346631,0,3,regulation of antibacterial peptide production,BP,
1272,GO:0002787,1,0.993591077729755,0,1,negative regulation of antibacterial peptide production,BP,
1277,GO:0002803,1,0.988358549130909,0,2,positive regulation of antibacterial peptide production,BP,
1278,GO:0002812,1,0.994380583425736,0,1,biosynthetic process of antibacterial peptides active against Gram-negative bacteria,BP,
1279,GO:0002818,1,0.994396899850736,0,1,intracellular defense response,BP,
1280,GO:0002819,1,0.473260718704758,0,120,regulation of adaptive immune response,BP,
1281,GO:0002820,1,0.807992131388075,0,34,negative regulation of adaptive immune response,BP,
1282,GO:0002821,1,0.636126169268502,0,73,positive regulation of adaptive immune response,BP,
1283,GO:0002822,1,0.50666179891125,0,109,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1284,GO:0002823,1,0.822939983748962,0,31,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1285,GO:0002824,1,0.652548102184376,0,69,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1286,GO:0002825,1,0.890587980934954,0,19,regulation of T-helper 1 type immune response,BP,
1287,GO:0002826,1,0.957601096674357,0,7,negative regulation of T-helper 1 type immune response,BP,
1288,GO:0002827,1,0.930001798989319,0,12,positive regulation of T-helper 1 type immune response,BP,
1289,GO:0002828,1,0.847232003333639,0,27,regulation of type 2 immune response,BP,
1290,GO:0002829,1,0.934202454120269,0,11,negative regulation of type 2 immune response,BP,
1291,GO:0002830,1,0.912371156178333,0,15,positive regulation of type 2 immune response,BP,
1292,GO:0002831,1,0.501534379421798,0,109,regulation of response to biotic stimulus,BP,
1293,GO:0002832,1,0.787853272042103,0,38,negative regulation of response to biotic stimulus,BP,
1294,GO:0002833,1,0.806322833988564,0,34,positive regulation of response to biotic stimulus,BP,
1295,GO:0002834,1,0.934612651515463,0,11,regulation of response to tumor cell,BP,
1296,GO:0002835,1,0.987660727194719,0,2,negative regulation of response to tumor cell,BP,
1297,GO:0002836,1,0.952336188718391,0,8,positive regulation of response to tumor cell,BP,
1298,GO:0002837,1,0.934612651515463,0,11,regulation of immune response to tumor cell,BP,
1299,GO:0002838,1,0.987660727194719,0,2,negative regulation of immune response to tumor cell,BP,
1300,GO:0002839,1,0.952336188718391,0,8,positive regulation of immune response to tumor cell,BP,
1301,GO:0002840,1,0.987676349262986,0,2,regulation of T cell mediated immune response to tumor cell,BP,
1302,GO:0002842,1,0.993978123519157,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
1303,GO:0002849,1,0.993972647282024,0,1,regulation of peripheral T cell tolerance induction,BP,
1304,GO:0002851,1,0.993972647282024,0,1,positive regulation of peripheral T cell tolerance induction,BP,
1305,GO:0002855,1,0.94628081901483,0,9,regulation of natural killer cell mediated immune response to tumor cell,BP,
1306,GO:0002856,1,0.987660727194719,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1307,GO:0002857,1,0.958108311783298,0,7,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1308,GO:0002858,1,0.94628081901483,0,9,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1309,GO:0002859,1,0.987660727194719,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1310,GO:0002860,1,0.958108311783298,0,7,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1311,GO:0002861,1,0.891813511971246,0,19,regulation of inflammatory response to antigenic stimulus,BP,
1312,GO:0002862,1,0.948032276990736,0,9,negative regulation of inflammatory response to antigenic stimulus,BP,
1313,GO:0002863,1,0.940730852030093,0,10,positive regulation of inflammatory response to antigenic stimulus,BP,
1314,GO:0002864,1,0.935210060978713,0,11,regulation of acute inflammatory response to antigenic stimulus,BP,
1315,GO:0002865,1,0.976300031565431,0,4,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1316,GO:0002866,1,0.957922643156763,0,7,positive regulation of acute inflammatory response to antigenic stimulus,BP,
1317,GO:0002870,1,0.968648963722723,0,5,T cell anergy,BP,
1318,GO:0002874,1,0.982678436383876,0,3,regulation of chronic inflammatory response to antigenic stimulus,BP,
1319,GO:0002875,1,0.994176416104045,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1320,GO:0002876,1,0.988435354265919,0,2,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1321,GO:0002877,1,0.98206119009848,0,3,regulation of acute inflammatory response to non-antigenic stimulus,BP,
1322,GO:0002878,1,0.993732837701607,0,1,negative regulation of acute inflammatory response to non-antigenic stimulus,BP,
1323,GO:0002879,1,0.988255492212567,0,2,positive regulation of acute inflammatory response to non-antigenic stimulus,BP,
1324,GO:0002880,1,0.9941033556982,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1325,GO:0002882,1,0.9941033556982,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1326,GO:0002883,1,0.958780205809404,0,7,regulation of hypersensitivity,BP,
1327,GO:0002884,1,0.988274582512028,0,2,negative regulation of hypersensitivity,BP,
1328,GO:0002885,1,0.97015922567644,0,5,positive regulation of hypersensitivity,BP,
1329,GO:0002886,1,0.765519009150141,0,43,regulation of myeloid leukocyte mediated immunity,BP,
1330,GO:0002887,1,0.939905495161809,0,10,negative regulation of myeloid leukocyte mediated immunity,BP,
1331,GO:0002888,1,0.878224864355664,0,21,positive regulation of myeloid leukocyte mediated immunity,BP,
1332,GO:0002889,1,0.772704697914414,0,41,regulation of immunoglobulin mediated immune response,BP,
1333,GO:0002890,1,0.94465788828146,0,9,negative regulation of immunoglobulin mediated immune response,BP,
1334,GO:0002891,1,0.83941959568833,0,28,positive regulation of immunoglobulin mediated immune response,BP,
1335,GO:0002892,1,0.981937377983331,0,3,regulation of type II hypersensitivity,BP,
1336,GO:0002893,1,0.994183202407459,0,1,negative regulation of type II hypersensitivity,BP,
1337,GO:0002894,1,0.987683256307399,0,2,positive regulation of type II hypersensitivity,BP,
1338,GO:0002895,1,0.993886004761557,0,1,regulation of central B cell tolerance induction,BP,
1339,GO:0002897,1,0.993886004761557,0,1,positive regulation of central B cell tolerance induction,BP,
1340,GO:0002901,1,0.976908952741856,0,4,mature B cell apoptotic process,BP,
1341,GO:0002902,1,0.898922025375018,0,17,regulation of B cell apoptotic process,BP,
1342,GO:0002903,1,0.933841980217084,0,11,negative regulation of B cell apoptotic process,BP,
1343,GO:0002904,1,0.981454660434609,0,3,positive regulation of B cell apoptotic process,BP,
1344,GO:0002905,1,0.976908952741856,0,4,regulation of mature B cell apoptotic process,BP,
1345,GO:0002906,1,0.976908952741856,0,4,negative regulation of mature B cell apoptotic process,BP,
1346,GO:0002911,1,0.968648963722723,0,5,regulation of lymphocyte anergy,BP,
1347,GO:0002913,1,0.98110526604554,0,3,positive regulation of lymphocyte anergy,BP,
1348,GO:0002920,1,0.72532513506387,0,52,regulation of humoral immune response,BP,
1349,GO:0002921,1,0.937104414115319,0,10,negative regulation of humoral immune response,BP,
1350,GO:0002922,1,0.930696295558187,0,12,positive regulation of humoral immune response,BP,
1351,GO:0002923,1,0.946099042156221,0,9,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1352,GO:0002924,1,0.968421346533305,0,5,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1353,GO:0002925,1,0.9769572624616,0,4,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1354,GO:0002930,1,0.987281704867182,0,2,trabecular meshwork development,BP,
1356,GO:0002933,1,0.982241070881442,0,3,lipid hydroxylation,BP,
1357,GO:0002934,1,0.940783856384822,0,9,desmosome organization,BP,
1358,GO:0002940,1,0.987897572110781,0,2,tRNA N2-guanine methylation,BP,
1359,GO:0002943,1,0.976301011811534,0,4,tRNA dihydrouridine synthesis,BP,
1360,GO:0002944,1,0.986295704890163,0,2,cyclin K-CDK12 complex,CC,
1361,GO:0002945,1,0.986696559224203,0,2,cyclin K-CDK13 complex,CC,
1362,GO:0002946,1,0.994232150308785,0,1,tRNA C5-cytosine methylation,BP,
1363,GO:0002947,1,0.993459916345722,0,1,tumor necrosis factor receptor superfamily complex,CC,
1364,GO:0002949,1,0.982395510224373,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1365,GO:0002950,1,0.980778878721603,0,3,ceramide phosphoethanolamine synthase activity,MF,
1366,GO:0002951,1,0.987925278367236,0,2,leukotriene-C(4) hydrolase,MF,
1371,GO:0003009,1,0.788140736832676,0,38,skeletal muscle contraction,BP,
1372,GO:0003010,1,0.968271366666979,0,5,voluntary skeletal muscle contraction,BP,
1373,GO:0003011,1,0.981368212518739,0,3,involuntary skeletal muscle contraction,BP,
1376,GO:0003014,1,0.541061525153882,0,96,renal system process,BP,
1378,GO:0003016,1,0.831136145638376,0,29,respiratory system process,BP,
1379,GO:0003017,1,0.992003276564077,0,1,lymph circulation,BP,
1381,GO:0003025,1,0.979510896649516,0,3,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1382,GO:0003026,1,0.993846081630578,0,1,regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,BP,
1383,GO:0003027,1,0.994156057153343,0,1,regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling,BP,
1384,GO:0003029,1,0.994156057153343,0,1,detection of hypoxic conditions in blood by carotid body chemoreceptor signaling,BP,
1385,GO:0003032,1,0.987761389727227,0,2,detection of oxygen,BP,
1386,GO:0003044,1,0.780497143321831,0,40,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
1387,GO:0003050,1,0.993221297647808,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1388,GO:0003051,1,0.981359938727205,0,3,angiotensin-mediated drinking behavior,BP,
1390,GO:0003057,1,0.970294846392001,0,5,regulation of the force of heart contraction by chemical signal,BP,
1391,GO:0003058,1,0.99428875084381,0,1,hormonal regulation of the force of heart contraction,BP,
1392,GO:0003062,1,0.961480114797509,0,6,regulation of heart rate by chemical signal,BP,
1393,GO:0003064,1,0.987877572985125,0,2,regulation of heart rate by hormone,BP,
1394,GO:0003065,1,0.994129922523121,0,1,positive regulation of heart rate by epinephrine,BP,
1395,GO:0003068,1,0.994351416238837,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1396,GO:0003069,1,0.994351416238837,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1397,GO:0003070,1,0.994351416238837,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
1398,GO:0003071,1,0.895313491304906,0,18,renal system process involved in regulation of systemic arterial blood pressure,BP,
1399,GO:0003072,1,0.976176183055261,0,4,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1400,GO:0003073,1,0.626652125160238,0,74,regulation of systemic arterial blood pressure,BP,
1401,GO:0003081,1,0.889366706224523,0,19,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1402,GO:0003083,1,0.99444816014447,0,1,negative regulation of renal output by angiotensin,BP,
1403,GO:0003084,1,0.944713432570887,0,9,positive regulation of systemic arterial blood pressure,BP,
1404,GO:0003085,1,0.92202106074074,0,13,negative regulation of systemic arterial blood pressure,BP,
1405,GO:0003091,1,0.825288488361176,0,29,renal water homeostasis,BP,
1406,GO:0003093,1,0.939762751822792,0,10,regulation of glomerular filtration,BP,
1407,GO:0003094,1,0.908763721611469,0,15,glomerular filtration,BP,
1408,GO:0003095,1,0.994146383016471,0,1,pressure natriuresis,BP,
1409,GO:0003096,1,0.968554829670335,0,5,renal sodium ion transport,BP,
1410,GO:0003097,1,0.969772803085678,0,5,renal water transport,BP,
1411,GO:0003099,1,0.982233346147778,0,3,positive regulation of the force of heart contraction by chemical signal,BP,
1412,GO:0003100,1,0.963973547169357,0,6,regulation of systemic arterial blood pressure by endothelin,BP,
1413,GO:0003104,1,0.975526839870522,0,4,positive regulation of glomerular filtration,BP,
1414,GO:0003105,1,0.976013414147523,0,4,negative regulation of glomerular filtration,BP,
1415,GO:0003106,1,0.99444816014447,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1416,GO:0003127,1,0.985280241502179,0,2,detection of nodal flow,BP,
1418,GO:0003129,1,0.976517528862048,0,4,heart induction,BP,
1419,GO:0003130,1,0.987907578350312,0,2,BMP signaling pathway involved in heart induction,BP,
1420,GO:0003131,1,0.993830733292028,0,1,mesodermal-endodermal cell signaling,BP,
1421,GO:0003133,1,0.987907578350312,0,2,endodermal-mesodermal cell signaling,BP,
1422,GO:0003134,1,0.987907578350312,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
1423,GO:0003137,1,0.994312719541451,0,1,Notch signaling pathway involved in heart induction,BP,
1424,GO:0003138,1,0.992833564463319,0,1,primary heart field specification,BP,
1426,GO:0003140,1,0.951099205807985,0,8,determination of left/right asymmetry in lateral mesoderm,BP,
1427,GO:0003142,1,0.993969477158945,0,1,cardiogenic plate morphogenesis,BP,
1429,GO:0003147,1,0.994344774242044,0,1,neural crest cell migration involved in heart formation,BP,
1431,GO:0003149,1,0.944402092878964,0,9,membranous septum morphogenesis,BP,
1432,GO:0003150,1,0.967675114959188,0,5,muscular septum morphogenesis,BP,
1435,GO:0003157,1,0.930783845055393,0,11,endocardium development,BP,
1438,GO:0003160,1,0.962597807024427,0,6,endocardium morphogenesis,BP,
1439,GO:0003161,1,0.92485633120041,0,12,cardiac conduction system development,BP,
1440,GO:0003162,1,0.979194406108021,0,3,atrioventricular node development,BP,
1441,GO:0003163,1,0.980787502770568,0,3,sinoatrial node development,BP,
1442,GO:0003164,1,0.968635797713457,0,5,His-Purkinje system development,BP,
1443,GO:0003165,1,0.987150929232623,0,2,Purkinje myocyte development,BP,
1444,GO:0003166,1,0.975448093922074,0,4,bundle of His development,BP,
1445,GO:0003167,1,0.99327928100203,0,1,atrioventricular bundle cell differentiation,BP,
1446,GO:0003168,1,0.994092094599453,0,1,Purkinje myocyte differentiation,BP,
1447,GO:0003169,1,0.985641565378483,0,2,coronary vein morphogenesis,BP,
1448,GO:0003170,1,0.774735128403806,0,38,heart valve development,BP,
1449,GO:0003171,1,0.857746317808494,0,23,atrioventricular valve development,BP,
1450,GO:0003172,1,0.992833564463319,0,1,sinoatrial valve development,BP,
1451,GO:0003174,1,0.933262415290239,0,10,mitral valve development,BP,
1452,GO:0003175,1,0.96049443612052,0,6,tricuspid valve development,BP,
1453,GO:0003176,1,0.962985351636126,0,6,aortic valve development,BP,
1454,GO:0003177,1,0.929019210658091,0,11,pulmonary valve development,BP,
1455,GO:0003179,1,0.794604180824147,0,34,heart valve morphogenesis,BP,
1456,GO:0003180,1,0.962985351636126,0,6,aortic valve morphogenesis,BP,
1457,GO:0003181,1,0.867985061087207,0,21,atrioventricular valve morphogenesis,BP,
1458,GO:0003183,1,0.933262415290239,0,10,mitral valve morphogenesis,BP,
1459,GO:0003184,1,0.929019210658091,0,11,pulmonary valve morphogenesis,BP,
1460,GO:0003185,1,0.992833564463319,0,1,sinoatrial valve morphogenesis,BP,
1461,GO:0003186,1,0.966114425126468,0,5,tricuspid valve morphogenesis,BP,
1462,GO:0003188,1,0.923331361332046,0,12,heart valve formation,BP,
1463,GO:0003190,1,0.952239356933655,0,7,atrioventricular valve formation,BP,
1464,GO:0003192,1,0.977377778128664,0,3,mitral valve formation,BP,
1465,GO:0003193,1,0.994184935079751,0,1,pulmonary valve formation,BP,
1466,GO:0003195,1,0.987625617029542,0,2,tricuspid valve formation,BP,
1467,GO:0003197,1,0.774721885619437,0,39,endocardial cushion development,BP,
1468,GO:0003198,1,0.901894640382667,0,16,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
1469,GO:0003199,1,0.975681832985443,0,4,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1470,GO:0003203,1,0.828684646300582,0,29,endocardial cushion morphogenesis,BP,
1473,GO:0003207,1,0.930428816796007,0,11,cardiac chamber formation,BP,
1475,GO:0003209,1,0.829880202109295,0,28,cardiac atrium morphogenesis,BP,
1476,GO:0003210,1,0.994312719541451,0,1,cardiac atrium formation,BP,
1477,GO:0003211,1,0.941837299431247,0,9,cardiac ventricle formation,BP,
1478,GO:0003213,1,0.984981442772086,0,2,cardiac right atrium morphogenesis,BP,
1480,GO:0003215,1,0.888594470374253,0,18,cardiac right ventricle morphogenesis,BP,
1481,GO:0003218,1,0.993595930235619,0,1,cardiac left ventricle formation,BP,
1482,GO:0003219,1,0.980209963610355,0,3,cardiac right ventricle formation,BP,
1484,GO:0003221,1,0.97921605149973,0,3,right ventricular cardiac muscle tissue morphogenesis,BP,
1485,GO:0003222,1,0.896900699961302,0,16,ventricular trabecula myocardium morphogenesis,BP,
1487,GO:0003226,1,0.991623218798635,0,1,right ventricular compact myocardium morphogenesis,BP,
1488,GO:0003228,1,0.962932742117156,0,6,atrial cardiac muscle tissue development,BP,
1490,GO:0003230,1,0.806900508685247,0,32,cardiac atrium development,BP,
1492,GO:0003235,1,0.994312719541451,0,1,sinus venosus development,BP,
1493,GO:0003236,1,0.994312719541451,0,1,sinus venosus morphogenesis,BP,
1494,GO:0003241,1,0.974456741677439,0,4,growth involved in heart morphogenesis,BP,
1495,GO:0003245,1,0.987977907762982,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1496,GO:0003247,1,0.994173817092608,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1497,GO:0003249,1,0.983342503615803,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1498,GO:0003250,1,0.983342503615803,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1499,GO:0003251,1,0.992116744038807,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1500,GO:0003252,1,0.991156750373185,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1501,GO:0003253,1,0.958018279400201,0,7,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1505,GO:0003259,1,0.994312719541451,0,1,cardioblast anterior-lateral migration,BP,
1506,GO:0003260,1,0.994312719541451,0,1,cardioblast migration,BP,
1507,GO:0003263,1,0.94629295209077,0,9,cardioblast proliferation,BP,
1508,GO:0003264,1,0.938678583619001,0,10,regulation of cardioblast proliferation,BP,
1509,GO:0003266,1,0.944476012794636,0,9,regulation of secondary heart field cardioblast proliferation,BP,
1510,GO:0003270,1,0.991957987154061,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1511,GO:0003272,1,0.872339983559357,0,21,endocardial cushion formation,BP,
1512,GO:0003273,1,0.971583114088008,0,4,cell migration involved in endocardial cushion formation,BP,
1513,GO:0003274,1,0.980378249455785,0,3,endocardial cushion fusion,BP,
1514,GO:0003275,1,0.981089145464345,0,3,apoptotic process involved in outflow tract morphogenesis,BP,
1515,GO:0003278,1,0.963570993188583,0,6,apoptotic process involved in heart morphogenesis,BP,
1518,GO:0003283,1,0.885874908053386,0,18,atrial septum development,BP,
1519,GO:0003284,1,0.974107628271968,0,4,septum primum development,BP,
1520,GO:0003285,1,0.987793578264209,0,2,septum secundum development,BP,
1521,GO:0003289,1,0.974107628271968,0,4,atrial septum primum morphogenesis,BP,
1522,GO:0003290,1,0.993664433437819,0,1,atrial septum secundum morphogenesis,BP,
1523,GO:0003292,1,0.987133994460643,0,2,cardiac septum cell differentiation,BP,
1524,GO:0003294,1,0.993745557971144,0,1,atrial ventricular junction remodeling,BP,
1525,GO:0003298,1,0.895533165053157,0,17,physiological muscle hypertrophy,BP,
1526,GO:0003299,1,0.863477230147477,0,22,muscle hypertrophy in response to stress,BP,
1528,GO:0003301,1,0.895533165053157,0,17,physiological cardiac muscle hypertrophy,BP,
1529,GO:0003306,1,0.950924617707894,0,8,Wnt signaling pathway involved in heart development,BP,
1530,GO:0003307,1,0.970465011316302,0,5,regulation of Wnt signaling pathway involved in heart development,BP,
1531,GO:0003308,1,0.976357911662342,0,4,negative regulation of Wnt signaling pathway involved in heart development,BP,
1532,GO:0003309,1,0.861353731754117,0,23,type B pancreatic cell differentiation,BP,
1533,GO:0003310,1,0.962879200135029,0,6,pancreatic A cell differentiation,BP,
1534,GO:0003312,1,0.987973097599251,0,2,pancreatic PP cell differentiation,BP,
1535,GO:0003318,1,0.994312719541451,0,1,cell migration to the midline involved in heart development,BP,
1536,GO:0003321,1,0.956918522299218,0,7,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1537,GO:0003322,1,0.992661378052887,0,1,pancreatic A cell development,BP,
1538,GO:0003323,1,0.884102248744925,0,19,type B pancreatic cell development,BP,
1539,GO:0003326,1,0.987973097599251,0,2,pancreatic A cell fate commitment,BP,
1540,GO:0003327,1,0.994048215237947,0,1,type B pancreatic cell fate commitment,BP,
1541,GO:0003329,1,0.987973097599251,0,2,pancreatic PP cell fate commitment,BP,
1542,GO:0003330,1,0.987785618907818,0,2,regulation of extracellular matrix constituent secretion,BP,
1543,GO:0003331,1,0.987785618907818,0,2,positive regulation of extracellular matrix constituent secretion,BP,
1545,GO:0003334,1,0.935131602799525,0,10,keratinocyte development,BP,
1546,GO:0003335,1,0.994263627109958,0,1,corneocyte development,BP,
1549,GO:0003339,1,0.951885328090769,0,8,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1550,GO:0003340,1,0.981771091472595,0,3,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1552,GO:0003342,1,0.987904654091096,0,2,proepicardium development,BP,
1553,GO:0003343,1,0.987904654091096,0,2,septum transversum development,BP,
1554,GO:0003344,1,0.939469914109276,0,9,pericardium morphogenesis,BP,
1555,GO:0003345,1,0.993532399308676,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1556,GO:0003348,1,0.960605725902902,0,6,cardiac endothelial cell differentiation,BP,
1557,GO:0003350,1,0.981364411036333,0,3,pulmonary myocardium development,BP,
1558,GO:0003351,1,0.888325377531922,0,19,epithelial cilium movement,BP,
1559,GO:0003352,1,0.919158037985485,0,13,regulation of cilium movement,BP,
1560,GO:0003353,1,0.993780312371482,0,1,positive regulation of cilium movement,BP,
1561,GO:0003356,1,0.936152888320887,0,10,regulation of cilium beat frequency,BP,
1562,GO:0003357,1,0.961878968525542,0,6,noradrenergic neuron differentiation,BP,
1563,GO:0003358,1,0.987802245816286,0,2,noradrenergic neuron development,BP,
1564,GO:0003359,1,0.993932607884681,0,1,noradrenergic neuron fate commitment,BP,
1565,GO:0003360,1,0.959779342130756,0,6,brainstem development,BP,
1566,GO:0003365,1,0.978129454295937,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
1567,GO:0003366,1,0.986780037226099,0,2,cell-matrix adhesion involved in ameboidal cell migration,BP,
1568,GO:0003373,1,0.954327101699323,0,7,dynamin family protein polymerization involved in membrane fission,BP,
1569,GO:0003374,1,0.954327101699323,0,7,dynamin family protein polymerization involved in mitochondrial fission,BP,
1571,GO:0003382,1,0.835353607577458,0,27,epithelial cell morphogenesis,BP,
1572,GO:0003383,1,0.978860170774759,0,3,apical constriction,BP,
1573,GO:0003400,1,0.994020802673904,0,1,regulation of COPII vesicle coating,BP,
1575,GO:0003402,1,0.960908405907544,0,6,planar cell polarity pathway involved in axis elongation,BP,
1576,GO:0003404,1,0.987653155307165,0,2,optic vesicle morphogenesis,BP,
1577,GO:0003406,1,0.967662805166836,0,5,retinal pigment epithelium development,BP,
1579,GO:0003408,1,0.979157682620093,0,3,optic cup formation involved in camera-type eye development,BP,
1580,GO:0003409,1,0.993695555550103,0,1,optic cup structural organization,BP,
1581,GO:0003413,1,0.937340508783466,0,10,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
1582,GO:0003414,1,0.993544253270467,0,1,chondrocyte morphogenesis involved in endochondral bone morphogenesis,BP,
1583,GO:0003415,1,0.974356338067097,0,4,chondrocyte hypertrophy,BP,
1584,GO:0003416,1,0.868588789166922,0,22,endochondral bone growth,BP,
1585,GO:0003417,1,0.910729154759931,0,15,growth plate cartilage development,BP,
1586,GO:0003418,1,0.962834500783098,0,6,growth plate cartilage chondrocyte differentiation,BP,
1587,GO:0003419,1,0.976751615253667,0,4,growth plate cartilage chondrocyte proliferation,BP,
1588,GO:0003420,1,0.987747801951093,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1589,GO:0003421,1,0.993531399454735,0,1,growth plate cartilage axis specification,BP,
1590,GO:0003422,1,0.98711698904061,0,2,growth plate cartilage morphogenesis,BP,
1591,GO:0003429,1,0.993544253270467,0,1,growth plate cartilage chondrocyte morphogenesis,BP,
1592,GO:0003430,1,0.987175063802964,0,2,growth plate cartilage chondrocyte growth,BP,
1593,GO:0003431,1,0.974416687862468,0,4,growth plate cartilage chondrocyte development,BP,
1594,GO:0003433,1,0.962324428582338,0,6,chondrocyte development involved in endochondral bone morphogenesis,BP,
1598,GO:0003678,1,0.742815455274872,0,45,DNA helicase activity,MF,
1599,GO:0003680,1,0.939928825621506,0,10,AT DNA binding,MF,
1601,GO:0003684,1,0.65445880930711,0,66,damaged DNA binding,MF,
1602,GO:0003688,1,0.916228585917733,0,14,DNA replication origin binding,MF,
1603,GO:0003689,1,0.952312045521723,0,8,DNA clamp loader activity,MF,
1605,GO:0003691,1,0.945417225059471,0,9,double-stranded telomeric DNA binding,MF,
1606,GO:0003692,1,0.994016042770872,0,1,left-handed Z-DNA binding,MF,
1607,GO:0003696,1,0.956371684686627,0,7,satellite DNA binding,MF,
1608,GO:0003697,1,0.544927948118899,0,96,single-stranded DNA binding,MF,
1612,GO:0003708,1,0.956434787203858,0,7,retinoic acid receptor activity,MF,
1615,GO:0003714,1,0.257488394984486,0,210,transcription corepressor activity,MF,
1616,GO:0003720,1,0.949675278537298,0,8,telomerase activity,MF,
1617,GO:0003721,1,0.993494245950117,0,1,telomerase RNA reverse transcriptase activity,MF,
1619,GO:0003724,1,0.659125019454751,0,65,RNA helicase activity,MF,
1620,GO:0003725,1,0.653041183645458,0,66,double-stranded RNA binding,MF,
1621,GO:0003726,1,0.980135220018231,0,3,double-stranded RNA adenosine deaminase activity,MF,
1622,GO:0003727,1,0.613888186788769,0,77,single-stranded RNA binding,MF,
1623,GO:0003729,1,0.29662649223094,0,190,mRNA binding,MF,
1624,GO:0003730,1,0.664705474648405,0,63,mRNA 3'-UTR binding,MF,
1625,GO:0003735,1,0.416120161244433,0,153,structural constituent of ribosome,MF,
1626,GO:0003743,1,0.733011756714598,0,50,translation initiation factor activity,MF,
1627,GO:0003746,1,0.894046428976367,0,18,translation elongation factor activity,MF,
1628,GO:0003747,1,0.962341687840941,0,6,translation release factor activity,MF,
1629,GO:0003755,1,0.827794528804205,0,31,peptidyl-prolyl cis-trans isomerase activity,MF,
1630,GO:0003756,1,0.898467851082269,0,17,protein disulfide isomerase activity,MF,
1634,GO:0003785,1,0.854879519321372,0,25,actin monomer binding,MF,
1635,GO:0003796,1,0.983102265303619,0,3,lysozyme activity,MF,
1636,GO:0003810,1,0.963427483080443,0,6,protein-glutamine gamma-glutamyltransferase activity,MF,
1637,GO:0003823,1,0.755232518187036,0,46,antigen binding,MF,
1639,GO:0003826,1,0.988055471821024,0,2,alpha-ketoacid dehydrogenase activity,MF,
1640,GO:0003827,1,0.987665950335084,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1641,GO:0003828,1,0.958907234024446,0,6,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
1642,GO:0003829,1,0.986740064126185,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1643,GO:0003830,1,0.993202291599497,0,1,beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
1644,GO:0003831,1,0.950637175615283,0,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1645,GO:0003834,1,0.993846081630578,0,1,beta-carotene 15,15'-monooxygenase activity,MF,
1646,GO:0003835,1,0.986156340923299,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1647,GO:0003836,1,0.962785542152003,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1648,GO:0003837,1,0.994048792461045,0,1,beta-ureidopropionase activity,MF,
1649,GO:0003839,1,0.976854341579933,0,4,gamma-glutamylcyclotransferase activity,MF,
1650,GO:0003841,1,0.894312884875363,0,17,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
1651,GO:0003842,1,0.99370983661046,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1652,GO:0003844,1,0.99375013260469,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1653,GO:0003845,1,0.988377066809539,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1654,GO:0003846,1,0.987553424899859,0,2,2-acylglycerol O-acyltransferase activity,MF,
1655,GO:0003847,1,0.970834152312629,0,5,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1656,GO:0003854,1,0.982152313957258,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
1657,GO:0003857,1,0.947382940390998,0,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,
1658,GO:0003858,1,0.987510911978534,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1659,GO:0003860,1,0.994089640363377,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1660,GO:0003863,1,0.988055471821024,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1661,GO:0003865,1,0.987909189366315,0,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1662,GO:0003867,1,0.993232525385339,0,1,4-aminobutyrate transaminase activity,MF,
1663,GO:0003868,1,0.98832696982206,0,2,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1664,GO:0003870,1,0.988068137020174,0,2,5-aminolevulinate synthase activity,MF,
1665,GO:0003872,1,0.981454193655725,0,3,6-phosphofructokinase activity,MF,
1666,GO:0003873,1,0.974532167641154,0,4,6-phosphofructo-2-kinase activity,MF,
1667,GO:0003874,1,0.994377406787888,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
1668,GO:0003875,1,0.987823365931129,0,2,ADP-ribosylarginine hydrolase activity,MF,
1669,GO:0003876,1,0.987008302041934,0,2,AMP deaminase activity,MF,
1670,GO:0003877,1,0.994037393144533,0,1,ATP adenylyltransferase activity,MF,
1671,GO:0003878,1,0.993393014434816,0,1,ATP citrate synthase activity,MF,
1672,GO:0003880,1,0.981457495384058,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
1673,GO:0003881,1,0.99410566575366,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1674,GO:0003882,1,0.993939230031619,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1675,GO:0003883,1,0.987396436806412,0,2,CTP synthase activity,MF,
1676,GO:0003884,1,0.988397312447333,0,2,D-amino-acid oxidase activity,MF,
1677,GO:0003886,1,0.980145114738575,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1678,GO:0003887,1,0.838756829752111,0,27,DNA-directed DNA polymerase activity,MF,
1679,GO:0003896,1,0.982161478978253,0,3,DNA primase activity,MF,
1680,GO:0003899,1,0.778078021166257,0,41,DNA-directed 5'-3' RNA polymerase activity,MF,
1681,GO:0003905,1,0.994333222971011,0,1,alkylbase DNA N-glycosylase activity,MF,
1682,GO:0003906,1,0.92550017511131,0,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
1683,GO:0003908,1,0.994281531373096,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1684,GO:0003909,1,0.957296333532002,0,7,DNA ligase activity,MF,
1685,GO:0003910,1,0.963041746819306,0,6,DNA ligase (ATP) activity,MF,
1686,GO:0003912,1,0.994057018348589,0,1,DNA nucleotidylexotransferase activity,MF,
1688,GO:0003917,1,0.975101770818465,0,4,DNA topoisomerase type I activity,MF,
1690,GO:0003919,1,0.994077225514179,0,1,FMN adenylyltransferase activity,MF,
1691,GO:0003920,1,0.988345917261754,0,2,GMP reductase activity,MF,
1692,GO:0003921,1,0.993935199004699,0,1,GMP synthase activity,MF,
1693,GO:0003922,1,0.993935199004699,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1694,GO:0003923,1,0.969668161943458,0,5,GPI-anchor transamidase activity,MF,
1696,GO:0003933,1,0.99408271099283,0,1,GTP cyclohydrolase activity,MF,
1697,GO:0003934,1,0.99408271099283,0,1,GTP cyclohydrolase I activity,MF,
1698,GO:0003937,1,0.994041000326921,0,1,IMP cyclohydrolase activity,MF,
1699,GO:0003938,1,0.988113893529617,0,2,IMP dehydrogenase activity,MF,
1700,GO:0003939,1,0.993916777748947,0,1,L-iditol 2-dehydrogenase activity,MF,
1701,GO:0003940,1,0.994013302402746,0,1,L-iduronidase activity,MF,
1702,GO:0003941,1,0.982458972100245,0,3,L-serine ammonia-lyase activity,MF,
1703,GO:0003943,1,0.987462129965756,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1704,GO:0003944,1,0.994009552647593,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1705,GO:0003945,1,0.975765437962813,0,4,N-acetyllactosamine synthase activity,MF,
1706,GO:0003947,1,0.993777021201298,0,1,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity,MF,
1707,GO:0003948,1,0.994043597612783,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1708,GO:0003950,1,0.884560518375945,0,19,NAD+ ADP-ribosyltransferase activity,MF,
1709,GO:0003951,1,0.900210720842872,0,16,NAD+ kinase activity,MF,
1710,GO:0003952,1,0.993941245723192,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1711,GO:0003953,1,0.988467082645206,0,2,NAD+ nucleosidase activity,MF,
1712,GO:0003954,1,0.796033537651485,0,40,NADH dehydrogenase activity,MF,
1713,GO:0003955,1,0.982005871850719,0,3,NAD(P)H dehydrogenase (quinone) activity,MF,
1714,GO:0003956,1,0.982725681949953,0,3,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1715,GO:0003957,1,0.993301851113816,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1716,GO:0003958,1,0.961454164767613,0,6,NADPH-hemoprotein reductase activity,MF,
1717,GO:0003960,1,0.976669825548892,0,4,NADPH:quinone reductase activity,MF,
1718,GO:0003962,1,0.994143062039743,0,1,cystathionine gamma-synthase activity,MF,
1719,GO:0003963,1,0.9879018728422,0,2,RNA-3'-phosphate cyclase activity,MF,
1720,GO:0003964,1,0.949675278537298,0,8,RNA-directed DNA polymerase activity,MF,
1721,GO:0003968,1,0.98628679046022,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1722,GO:0003972,1,0.993846081630578,0,1,RNA ligase (ATP) activity,MF,
1723,GO:0003973,1,0.987075060165156,0,2,(S)-2-hydroxy-acid oxidase activity,MF,
1724,GO:0003974,1,0.994181036566574,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1725,GO:0003975,1,0.994027438334075,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1726,GO:0003976,1,0.981454756431754,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1727,GO:0003977,1,0.987687944726327,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1728,GO:0003978,1,0.994181036566574,0,1,UDP-glucose 4-epimerase activity,MF,
1729,GO:0003979,1,0.993725550369305,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1730,GO:0003980,1,0.984779802189474,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1731,GO:0003983,1,0.994027726857486,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1732,GO:0003985,1,0.982101252484398,0,3,acetyl-CoA C-acetyltransferase activity,MF,
1733,GO:0003986,1,0.977083978010017,0,4,acetyl-CoA hydrolase activity,MF,
1734,GO:0003987,1,0.981030976433072,0,3,acetate-CoA ligase activity,MF,
1735,GO:0003988,1,0.964737733138745,0,6,acetyl-CoA C-acyltransferase activity,MF,
1736,GO:0003989,1,0.991966407135333,0,1,acetyl-CoA carboxylase activity,MF,
1737,GO:0003990,1,0.987880065634892,0,2,acetylcholinesterase activity,MF,
1738,GO:0003991,1,0.994048215237947,0,1,acetylglutamate kinase activity,MF,
1739,GO:0003993,1,0.964994249114809,0,6,acid phosphatase activity,MF,
1740,GO:0003994,1,0.987512261123157,0,2,aconitate hydratase activity,MF,
1741,GO:0003995,1,0.909883866160492,0,15,acyl-CoA dehydrogenase activity,MF,
1742,GO:0003996,1,0.970252708571746,0,5,acyl-CoA ligase activity,MF,
1743,GO:0003997,1,0.96872238260985,0,5,acyl-CoA oxidase activity,MF,
1744,GO:0003998,1,0.988787250344013,0,2,acylphosphatase activity,MF,
1745,GO:0003999,1,0.994433720502016,0,1,adenine phosphoribosyltransferase activity,MF,
1746,GO:0004000,1,0.943862268465316,0,9,adenosine deaminase activity,MF,
1747,GO:0004001,1,0.994053410399819,0,1,adenosine kinase activity,MF,
1748,GO:0004003,1,0.81126522119985,0,32,ATP-dependent DNA helicase activity,MF,
1749,GO:0004004,1,0.663276328256736,0,64,ATP-dependent RNA helicase activity,MF,
1750,GO:0004008,1,0.985071660032544,0,2,copper-exporting ATPase activity,MF,
1751,GO:0004012,1,0.865602970620009,0,20,phospholipid-translocating ATPase activity,MF,
1752,GO:0004013,1,0.980785445302038,0,3,adenosylhomocysteinase activity,MF,
1753,GO:0004014,1,0.993705980361278,0,1,adenosylmethionine decarboxylase activity,MF,
1754,GO:0004016,1,0.913639317051243,0,13,adenylate cyclase activity,MF,
1756,GO:0004018,1,0.994219444080734,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1757,GO:0004019,1,0.988015043771503,0,2,adenylosuccinate synthase activity,MF,
1758,GO:0004020,1,0.987487375112157,0,2,adenylylsulfate kinase activity,MF,
1759,GO:0004021,1,0.987656863030922,0,2,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1760,GO:0004022,1,0.970398506680503,0,5,alcohol dehydrogenase (NAD) activity,MF,
1761,GO:0004024,1,0.987982637311471,0,2,alcohol dehydrogenase activity, zinc-dependent,MF,
1762,GO:0004027,1,0.994292504971264,0,1,alcohol sulfotransferase activity,MF,
1763,GO:0004028,1,0.957615220408922,0,7,3-chloroallyl aldehyde dehydrogenase activity,MF,
1764,GO:0004029,1,0.909757168535534,0,15,aldehyde dehydrogenase (NAD) activity,MF,
1765,GO:0004030,1,0.963747929080102,0,6,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1766,GO:0004031,1,0.99322014595224,0,1,aldehyde oxidase activity,MF,
1767,GO:0004032,1,0.938180517357804,0,11,alditol:NADP+ 1-oxidoreductase activity,MF,
1768,GO:0004033,1,0.862830086876259,0,25,aldo-keto reductase (NADP) activity,MF,
1769,GO:0004034,1,0.99392972909963,0,1,aldose 1-epimerase activity,MF,
1770,GO:0004035,1,0.987757108285829,0,2,alkaline phosphatase activity,MF,
1771,GO:0004037,1,0.994228396196207,0,1,allantoicase activity,MF,
1772,GO:0004040,1,0.981861033022146,0,3,amidase activity,MF,
1773,GO:0004042,1,0.994048215237947,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1774,GO:0004043,1,0.99362047663938,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1775,GO:0004044,1,0.993567668800607,0,1,amidophosphoribosyltransferase activity,MF,
1776,GO:0004045,1,0.977052699410662,0,4,aminoacyl-tRNA hydrolase activity,MF,
1778,GO:0004047,1,0.988294681251337,0,2,aminomethyltransferase activity,MF,
1779,GO:0004051,1,0.993908146519457,0,1,arachidonate 5-lipoxygenase activity,MF,
1780,GO:0004052,1,0.981866610241294,0,3,arachidonate 12-lipoxygenase activity,MF,
1781,GO:0004053,1,0.98833673163923,0,2,arginase activity,MF,
1782,GO:0004055,1,0.994119382169084,0,1,argininosuccinate synthase activity,MF,
1783,GO:0004056,1,0.994071307272016,0,1,argininosuccinate lyase activity,MF,
1784,GO:0004057,1,0.994007245236631,0,1,arginyltransferase activity,MF,
1785,GO:0004058,1,0.994063368708284,0,1,aromatic-L-amino-acid decarboxylase activity,MF,
1786,GO:0004059,1,0.994222620638038,0,1,aralkylamine N-acetyltransferase activity,MF,
1787,GO:0004060,1,0.982654599078553,0,3,arylamine N-acetyltransferase activity,MF,
1788,GO:0004061,1,0.994156779103132,0,1,arylformamidase activity,MF,
1789,GO:0004062,1,0.948417988816714,0,9,aryl sulfotransferase activity,MF,
1790,GO:0004063,1,0.988475689732004,0,2,aryldialkylphosphatase activity,MF,
1791,GO:0004064,1,0.965412316349843,0,6,arylesterase activity,MF,
1792,GO:0004065,1,0.932370462455621,0,11,arylsulfatase activity,MF,
1793,GO:0004066,1,0.987944318337479,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1794,GO:0004067,1,0.988105898771939,0,2,asparaginase activity,MF,
1795,GO:0004069,1,0.988006515182358,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1796,GO:0004070,1,0.985631899033193,0,2,aspartate carbamoyltransferase activity,MF,
1797,GO:0004074,1,0.988766290262565,0,2,biliverdin reductase activity,MF,
1798,GO:0004075,1,0.985926422253399,0,2,biotin carboxylase activity,MF,
1799,GO:0004077,1,0.992915769695244,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1800,GO:0004078,1,0.992915769695244,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1801,GO:0004079,1,0.992915769695244,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1802,GO:0004080,1,0.992915769695244,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1803,GO:0004081,1,0.988246518363279,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1804,GO:0004082,1,0.976999672609092,0,4,bisphosphoglycerate mutase activity,MF,
1805,GO:0004084,1,0.986486934967653,0,2,branched-chain-amino-acid transaminase activity,MF,
1806,GO:0004085,1,0.994092094599453,0,1,butyryl-CoA dehydrogenase activity,MF,
1807,GO:0004087,1,0.985631899033193,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1808,GO:0004088,1,0.985631899033193,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1809,GO:0004089,1,0.924676747449923,0,13,carbonate dehydratase activity,MF,
1810,GO:0004090,1,0.971780478879132,0,5,carbonyl reductase (NADPH) activity,MF,
1811,GO:0004092,1,0.993832310674607,0,1,carnitine O-acetyltransferase activity,MF,
1812,GO:0004095,1,0.975209509182766,0,4,carnitine O-palmitoyltransferase activity,MF,
1813,GO:0004096,1,0.976354349173592,0,4,catalase activity,MF,
1814,GO:0004098,1,0.994097003190941,0,1,cerebroside-sulfatase activity,MF,
1815,GO:0004102,1,0.993934335275727,0,1,choline O-acetyltransferase activity,MF,
1816,GO:0004103,1,0.988079229738918,0,2,choline kinase activity,MF,
1817,GO:0004104,1,0.981822813900181,0,3,cholinesterase activity,MF,
1818,GO:0004105,1,0.987296071975679,0,2,choline-phosphate cytidylyltransferase activity,MF,
1819,GO:0004108,1,0.993786752715365,0,1,citrate (Si)-synthase activity,MF,
1820,GO:0004109,1,0.98782618642141,0,2,coproporphyrinogen oxidase activity,MF,
1821,GO:0004111,1,0.969669277449165,0,5,creatine kinase activity,MF,
1822,GO:0004112,1,0.858070706708192,0,23,cyclic-nucleotide phosphodiesterase activity,MF,
1823,GO:0004113,1,0.993145236951435,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1824,GO:0004114,1,0.864002043277327,0,22,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1825,GO:0004115,1,0.902992812510884,0,15,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1826,GO:0004117,1,0.981674174554037,0,3,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
1827,GO:0004118,1,0.97818494552839,0,3,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1828,GO:0004119,1,0.986395166566416,0,2,cGMP-inhibited cyclic-nucleotide phosphodiesterase activity,MF,
1829,GO:0004122,1,0.993895779497771,0,1,cystathionine beta-synthase activity,MF,
1830,GO:0004123,1,0.994143062039743,0,1,cystathionine gamma-lyase activity,MF,
1831,GO:0004126,1,0.942414219895841,0,10,cytidine deaminase activity,MF,
1832,GO:0004127,1,0.975558017303813,0,4,cytidylate kinase activity,MF,
1833,GO:0004128,1,0.958440682917149,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1834,GO:0004129,1,0.882236375382519,0,22,cytochrome-c oxidase activity,MF,
1835,GO:0004132,1,0.994060482124383,0,1,dCMP deaminase activity,MF,
1836,GO:0004133,1,0.992570521872392,0,1,glycogen debranching enzyme activity,MF,
1837,GO:0004134,1,0.992570521872392,0,1,4-alpha-glucanotransferase activity,MF,
1838,GO:0004135,1,0.992570521872392,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1839,GO:0004137,1,0.987129842498076,0,2,deoxycytidine kinase activity,MF,
1840,GO:0004138,1,0.994354881633389,0,1,deoxyguanosine kinase activity,MF,
1841,GO:0004139,1,0.994148115699068,0,1,deoxyribose-phosphate aldolase activity,MF,
1842,GO:0004140,1,0.988075581297913,0,2,dephospho-CoA kinase activity,MF,
1843,GO:0004142,1,0.98164650281007,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1844,GO:0004143,1,0.934688120800026,0,10,diacylglycerol kinase activity,MF,
1845,GO:0004144,1,0.987553424899859,0,2,diacylglycerol O-acyltransferase activity,MF,
1846,GO:0004145,1,0.982816324863439,0,3,diamine N-acetyltransferase activity,MF,
1847,GO:0004146,1,0.987892991089006,0,2,dihydrofolate reductase activity,MF,
1848,GO:0004148,1,0.993613912060388,0,1,dihydrolipoyl dehydrogenase activity,MF,
1849,GO:0004149,1,0.99382399483331,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1850,GO:0004151,1,0.985631899033193,0,2,dihydroorotase activity,MF,
1851,GO:0004152,1,0.994049369688487,0,1,dihydroorotate dehydrogenase activity,MF,
1852,GO:0004155,1,0.994170062963291,0,1,6,7-dihydropteridine reductase activity,MF,
1853,GO:0004157,1,0.987410608113399,0,2,dihydropyrimidinase activity,MF,
1854,GO:0004161,1,0.988088458790598,0,2,dimethylallyltranstransferase activity,MF,
1855,GO:0004163,1,0.994127034734214,0,1,diphosphomevalonate decarboxylase activity,MF,
1856,GO:0004164,1,0.994129344964415,0,1,diphthine synthase activity,MF,
1857,GO:0004165,1,0.981329599530252,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1858,GO:0004167,1,0.983011087205847,0,3,dopachrome isomerase activity,MF,
1859,GO:0004168,1,0.994011860158488,0,1,dolichol kinase activity,MF,
1860,GO:0004169,1,0.970423286361027,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1861,GO:0004170,1,0.994105954512412,0,1,dUTP diphosphatase activity,MF,
1862,GO:0004174,1,0.987716558645507,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
1864,GO:0004176,1,0.974854511144788,0,4,ATP-dependent peptidase activity,MF,
1865,GO:0004177,1,0.763159603543427,0,43,aminopeptidase activity,MF,
1868,GO:0004185,1,0.944140342534182,0,9,serine-type carboxypeptidase activity,MF,
1869,GO:0004190,1,0.894910405277995,0,18,aspartic-type endopeptidase activity,MF,
1870,GO:0004197,1,0.592874289424006,0,82,cysteine-type endopeptidase activity,MF,
1871,GO:0004198,1,0.883740050848082,0,20,calcium-dependent cysteine-type endopeptidase activity,MF,
1872,GO:0004222,1,0.539932813924893,0,95,metalloendopeptidase activity,MF,
1874,GO:0004298,1,0.902439516817834,0,18,threonine-type endopeptidase activity,MF,
1875,GO:0004300,1,0.952926925834239,0,8,enoyl-CoA hydratase activity,MF,
1876,GO:0004301,1,0.959088940048783,0,7,epoxide hydrolase activity,MF,
1877,GO:0004303,1,0.948694805918906,0,9,estradiol 17-beta-dehydrogenase activity,MF,
1878,GO:0004304,1,0.988239410216833,0,2,estrone sulfotransferase activity,MF,
1879,GO:0004305,1,0.975654504441592,0,4,ethanolamine kinase activity,MF,
1880,GO:0004306,1,0.994110285938819,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1881,GO:0004307,1,0.98836949594655,0,2,ethanolaminephosphotransferase activity,MF,
1882,GO:0004308,1,0.970151232082645,0,5,exo-alpha-sialidase activity,MF,
1883,GO:0004309,1,0.972390987546153,0,4,exopolyphosphatase activity,MF,
1884,GO:0004310,1,0.994038114565935,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1885,GO:0004311,1,0.981766263820685,0,3,farnesyltranstransferase activity,MF,
1886,GO:0004312,1,0.938912627750174,0,10,fatty acid synthase activity,MF,
1887,GO:0004313,1,0.99219824858548,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1888,GO:0004314,1,0.986328089543399,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
1889,GO:0004315,1,0.986520789922215,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1890,GO:0004316,1,0.99219824858548,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1891,GO:0004317,1,0.99219824858548,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1892,GO:0004319,1,0.99219824858548,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1893,GO:0004320,1,0.986382673615573,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
1894,GO:0004321,1,0.976113612512652,0,4,fatty-acyl-CoA synthase activity,MF,
1895,GO:0004322,1,0.966916462011695,0,5,ferroxidase activity,MF,
1896,GO:0004324,1,0.994098735670444,0,1,ferredoxin-NADP+ reductase activity,MF,
1897,GO:0004325,1,0.992551997993139,0,1,ferrochelatase activity,MF,
1898,GO:0004326,1,0.993927714100447,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1899,GO:0004329,1,0.987291732594318,0,2,formate-tetrahydrofolate ligase activity,MF,
1900,GO:0004331,1,0.974532167641154,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1901,GO:0004332,1,0.982420406250002,0,3,fructose-bisphosphate aldolase activity,MF,
1902,GO:0004333,1,0.994129344964415,0,1,fumarate hydratase activity,MF,
1903,GO:0004334,1,0.994226374750918,0,1,fumarylacetoacetase activity,MF,
1904,GO:0004335,1,0.988022003464994,0,2,galactokinase activity,MF,
1905,GO:0004336,1,0.9938073721994,0,1,galactosylceramidase activity,MF,
1906,GO:0004337,1,0.988088458790598,0,2,geranyltranstransferase activity,MF,
1907,GO:0004339,1,0.992768380925218,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1908,GO:0004340,1,0.967811459914676,0,5,glucokinase activity,MF,
1909,GO:0004341,1,0.99409021782693,0,1,gluconolactonase activity,MF,
1910,GO:0004342,1,0.988112025908512,0,2,glucosamine-6-phosphate deaminase activity,MF,
1911,GO:0004343,1,0.993516542002203,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1912,GO:0004344,1,0.992018951213871,0,1,glucose dehydrogenase activity,MF,
1913,GO:0004345,1,0.986037643311559,0,2,glucose-6-phosphate dehydrogenase activity,MF,
1914,GO:0004346,1,0.981813867016624,0,3,glucose-6-phosphatase activity,MF,
1915,GO:0004347,1,0.994043886205896,0,1,glucose-6-phosphate isomerase activity,MF,
1916,GO:0004348,1,0.981827071422737,0,3,glucosylceramidase activity,MF,
1917,GO:0004349,1,0.99364673542535,0,1,glutamate 5-kinase activity,MF,
1918,GO:0004350,1,0.99364673542535,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1919,GO:0004351,1,0.981356645841115,0,3,glutamate decarboxylase activity,MF,
1920,GO:0004352,1,0.987655601299123,0,2,glutamate dehydrogenase (NAD+) activity,MF,
1921,GO:0004353,1,0.987655601299123,0,2,glutamate dehydrogenase [NAD(P)+] activity,MF,
1922,GO:0004356,1,0.986523926751495,0,2,glutamate-ammonia ligase activity,MF,
1923,GO:0004357,1,0.987373498339495,0,2,glutamate-cysteine ligase activity,MF,
1924,GO:0004359,1,0.981338996865281,0,3,glutaminase activity,MF,
1925,GO:0004360,1,0.985974654604041,0,2,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1926,GO:0004361,1,0.994152447402909,0,1,glutaryl-CoA dehydrogenase activity,MF,
1927,GO:0004362,1,0.993991384634879,0,1,glutathione-disulfide reductase activity,MF,
1928,GO:0004363,1,0.994096136957908,0,1,glutathione synthase activity,MF,
1929,GO:0004364,1,0.870310526173611,0,24,glutathione transferase activity,MF,
1930,GO:0004365,1,0.994267381227237,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1931,GO:0004366,1,0.980630961020104,0,3,glycerol-3-phosphate O-acyltransferase activity,MF,
1932,GO:0004367,1,0.987377312369366,0,2,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1933,GO:0004368,1,0.986801508541513,0,2,glycerol-3-phosphate dehydrogenase activity,MF,
1934,GO:0004370,1,0.98529624882253,0,2,glycerol kinase activity,MF,
1935,GO:0004372,1,0.987972684251583,0,2,glycine hydroxymethyltransferase activity,MF,
1936,GO:0004373,1,0.987435024513305,0,2,glycogen (starch) synthase activity,MF,
1937,GO:0004375,1,0.993545395687408,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1938,GO:0004376,1,0.975917182628778,0,4,glycolipid mannosyltransferase activity,MF,
1939,GO:0004377,1,0.993915051306502,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1940,GO:0004378,1,0.993808518215935,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1941,GO:0004379,1,0.986492078345893,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1942,GO:0004380,1,0.994190277483898,0,1,glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity,MF,
1943,GO:0004381,1,0.994190277483898,0,1,fucosylgalactoside 3-alpha-galactosyltransferase activity,MF,
1944,GO:0004382,1,0.987734982953498,0,2,guanosine-diphosphatase activity,MF,
1945,GO:0004383,1,0.919950443987844,0,12,guanylate cyclase activity,MF,
1946,GO:0004385,1,0.916256552687515,0,13,guanylate kinase activity,MF,
1947,GO:0004386,1,0.385642489269865,0,143,helicase activity,MF,
1948,GO:0004392,1,0.988376639351477,0,2,heme oxygenase (decyclizing) activity,MF,
1949,GO:0004394,1,0.99344789233645,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1950,GO:0004395,1,0.994281242594407,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1951,GO:0004396,1,0.967811459914676,0,5,hexokinase activity,MF,
1952,GO:0004397,1,0.993737267885456,0,1,histidine ammonia-lyase activity,MF,
1953,GO:0004398,1,0.993950749826968,0,1,histidine decarboxylase activity,MF,
1954,GO:0004402,1,0.720216654045873,0,50,histone acetyltransferase activity,MF,
1955,GO:0004407,1,0.755691663820579,0,43,histone deacetylase activity,MF,
1956,GO:0004408,1,0.993986195034811,0,1,holocytochrome-c synthase activity,MF,
1957,GO:0004411,1,0.994090073460822,0,1,homogentisate 1,2-dioxygenase activity,MF,
1958,GO:0004415,1,0.963693727974725,0,6,hyalurononglucosaminidase activity,MF,
1959,GO:0004416,1,0.988015219804929,0,2,hydroxyacylglutathione hydrolase activity,MF,
1960,GO:0004418,1,0.994222620638038,0,1,hydroxymethylbilane synthase activity,MF,
1961,GO:0004419,1,0.988167288157019,0,2,hydroxymethylglutaryl-CoA lyase activity,MF,
1962,GO:0004420,1,0.99334839189276,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1963,GO:0004421,1,0.987633127588846,0,2,hydroxymethylglutaryl-CoA synthase activity,MF,
1964,GO:0004422,1,0.988360845850408,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
1965,GO:0004423,1,0.992974692000358,0,1,iduronate-2-sulfatase activity,MF,
1966,GO:0004427,1,0.982729249295816,0,3,inorganic diphosphatase activity,MF,
1967,GO:0004430,1,0.974180809595037,0,4,1-phosphatidylinositol 4-kinase activity,MF,
1968,GO:0004435,1,0.853423204432087,0,24,phosphatidylinositol phospholipase C activity,MF,
1969,GO:0004438,1,0.902794223686985,0,15,phosphatidylinositol-3-phosphatase activity,MF,
1970,GO:0004439,1,0.94831520361831,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1971,GO:0004441,1,0.994042876135048,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1972,GO:0004445,1,0.968831950225843,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
1973,GO:0004446,1,0.993825428377467,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1974,GO:0004447,1,0.993793337731036,0,1,iodide peroxidase activity,MF,
1975,GO:0004448,1,0.970730971265884,0,5,isocitrate dehydrogenase activity,MF,
1976,GO:0004449,1,0.982370276480196,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1977,GO:0004450,1,0.988153953026735,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
1978,GO:0004452,1,0.994030612164709,0,1,isopentenyl-diphosphate delta-isomerase activity,MF,
1979,GO:0004454,1,0.993948733593664,0,1,ketohexokinase activity,MF,
1980,GO:0004457,1,0.965019380585072,0,6,lactate dehydrogenase activity,MF,
1981,GO:0004458,1,0.987993286083739,0,2,D-lactate dehydrogenase (cytochrome) activity,MF,
1982,GO:0004459,1,0.976749735054801,0,4,L-lactate dehydrogenase activity,MF,
1983,GO:0004461,1,0.982022921215546,0,3,lactose synthase activity,MF,
1984,GO:0004462,1,0.994056296746289,0,1,lactoylglutathione lyase activity,MF,
1985,GO:0004463,1,0.994047926628026,0,1,leukotriene-A4 hydrolase activity,MF,
1986,GO:0004464,1,0.977905444044594,0,4,leukotriene-C4 synthase activity,MF,
1987,GO:0004465,1,0.963717332392656,0,6,lipoprotein lipase activity,MF,
1988,GO:0004466,1,0.970106904185953,0,5,long-chain-acyl-CoA dehydrogenase activity,MF,
1989,GO:0004467,1,0.927071144214239,0,12,long-chain fatty acid-CoA ligase activity,MF,
1990,GO:0004468,1,0.973165101071294,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1991,GO:0004470,1,0.975519992727266,0,4,malic enzyme activity,MF,
1992,GO:0004471,1,0.981133646193599,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1993,GO:0004473,1,0.981133646193599,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
1994,GO:0004474,1,0.99298595432303,0,1,malate synthase activity,MF,
1995,GO:0004475,1,0.994183346796829,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
1996,GO:0004476,1,0.994134543005102,0,1,mannose-6-phosphate isomerase activity,MF,
1997,GO:0004477,1,0.975444703409275,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1998,GO:0004478,1,0.987536844844276,0,2,methionine adenosyltransferase activity,MF,
1999,GO:0004479,1,0.993853544336592,0,1,methionyl-tRNA formyltransferase activity,MF,
2000,GO:0004482,1,0.992859718104023,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
2001,GO:0004483,1,0.987729649828399,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
2002,GO:0004484,1,0.993360162349683,0,1,mRNA guanylyltransferase activity,MF,
2003,GO:0004485,1,0.987536761121932,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
2004,GO:0004486,1,0.993646449990823,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
2005,GO:0004487,1,0.981723943240257,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
2006,GO:0004488,1,0.975444703409275,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
2007,GO:0004489,1,0.992585860572098,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
2008,GO:0004490,1,0.994187389698263,0,1,methylglutaconyl-CoA hydratase activity,MF,
2009,GO:0004491,1,0.994015898537603,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
2010,GO:0004492,1,0.994035806044459,0,1,methylmalonyl-CoA decarboxylase activity,MF,
2011,GO:0004493,1,0.994396177882901,0,1,methylmalonyl-CoA epimerase activity,MF,
2012,GO:0004494,1,0.99379219239543,0,1,methylmalonyl-CoA mutase activity,MF,
2013,GO:0004496,1,0.994048070932843,0,1,mevalonate kinase activity,MF,
2014,GO:0004497,1,0.622244719197906,0,76,monooxygenase activity,MF,
2015,GO:0004498,1,0.993927714100447,0,1,calcidiol 1-monooxygenase activity,MF,
2016,GO:0004499,1,0.969559955791125,0,5,N,N-dimethylaniline monooxygenase activity,MF,
2017,GO:0004500,1,0.987654759371155,0,2,dopamine beta-monooxygenase activity,MF,
2018,GO:0004502,1,0.993202003579622,0,1,kynurenine 3-monooxygenase activity,MF,
2019,GO:0004504,1,0.993573236050278,0,1,peptidylglycine monooxygenase activity,MF,
2020,GO:0004505,1,0.982292633010662,0,3,phenylalanine 4-monooxygenase activity,MF,
2021,GO:0004506,1,0.993783603918764,0,1,squalene monooxygenase activity,MF,
2022,GO:0004509,1,0.994061203761653,0,1,steroid 21-monooxygenase activity,MF,
2023,GO:0004510,1,0.98812009879941,0,2,tryptophan 5-monooxygenase activity,MF,
2024,GO:0004511,1,0.994096425701739,0,1,tyrosine 3-monooxygenase activity,MF,
2025,GO:0004512,1,0.993993402969726,0,1,inositol-3-phosphate synthase activity,MF,
2026,GO:0004513,1,0.993979853004044,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
2027,GO:0004514,1,0.981488223253251,0,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
2028,GO:0004515,1,0.973998495197658,0,4,nicotinate-nucleotide adenylyltransferase activity,MF,
2029,GO:0004516,1,0.993846081630578,0,1,nicotinate phosphoribosyltransferase activity,MF,
2030,GO:0004517,1,0.980085923398937,0,3,nitric-oxide synthase activity,MF,
2032,GO:0004519,1,0.479891195905424,0,118,endonuclease activity,MF,
2033,GO:0004520,1,0.74669363587633,0,47,endodeoxyribonuclease activity,MF,
2034,GO:0004521,1,0.731935205098521,0,51,endoribonuclease activity,MF,
2035,GO:0004522,1,0.983116254985224,0,3,ribonuclease A activity,MF,
2036,GO:0004523,1,0.965134285112369,0,6,RNA-DNA hybrid ribonuclease activity,MF,
2037,GO:0004525,1,0.973305887587926,0,4,ribonuclease III activity,MF,
2038,GO:0004526,1,0.936258740553555,0,11,ribonuclease P activity,MF,
2041,GO:0004529,1,0.888465386003188,0,19,exodeoxyribonuclease activity,MF,
2042,GO:0004530,1,0.985486539150655,0,2,deoxyribonuclease I activity,MF,
2043,GO:0004531,1,0.988419412738136,0,2,deoxyribonuclease II activity,MF,
2044,GO:0004532,1,0.80376864150729,0,34,exoribonuclease activity,MF,
2045,GO:0004534,1,0.977612457888381,0,3,5'-3' exoribonuclease activity,MF,
2046,GO:0004535,1,0.923530411103542,0,12,poly(A)-specific ribonuclease activity,MF,
2047,GO:0004536,1,0.667727736895748,0,65,deoxyribonuclease activity,MF,
2048,GO:0004540,1,0.556815712297927,0,94,ribonuclease activity,MF,
2049,GO:0004549,1,0.908244766970273,0,16,tRNA-specific ribonuclease activity,MF,
2052,GO:0004553,1,0.620111483967844,0,76,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,
2053,GO:0004556,1,0.988226809616709,0,2,alpha-amylase activity,MF,
2054,GO:0004557,1,0.987846811890892,0,2,alpha-galactosidase activity,MF,
2055,GO:0004558,1,0.979835476831731,0,3,alpha-1,4-glucosidase activity,MF,
2056,GO:0004559,1,0.917307131850818,0,13,alpha-mannosidase activity,MF,
2057,GO:0004560,1,0.988111986393287,0,2,alpha-L-fucosidase activity,MF,
2058,GO:0004561,1,0.99384435980605,0,1,alpha-N-acetylglucosaminidase activity,MF,
2059,GO:0004563,1,0.969208956187194,0,5,beta-N-acetylhexosaminidase activity,MF,
2060,GO:0004565,1,0.96391070337826,0,6,beta-galactosidase activity,MF,
2061,GO:0004566,1,0.981441065137155,0,3,beta-glucuronidase activity,MF,
2062,GO:0004567,1,0.993689558529205,0,1,beta-mannosidase activity,MF,
2063,GO:0004568,1,0.964268692097139,0,6,chitinase activity,MF,
2064,GO:0004569,1,0.993331447853925,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
2065,GO:0004571,1,0.954727196923829,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
2066,GO:0004572,1,0.986053627951228,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
2067,GO:0004573,1,0.993858855765715,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
2068,GO:0004574,1,0.993608774512361,0,1,oligo-1,6-glucosidase activity,MF,
2069,GO:0004576,1,0.942020427182489,0,10,oligosaccharyl transferase activity,MF,
2070,GO:0004577,1,0.988144655784933,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
2071,GO:0004578,1,0.993513112654976,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
2072,GO:0004579,1,0.947415303243939,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
2073,GO:0004581,1,0.994308821011737,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
2074,GO:0004582,1,0.983156657113198,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
2075,GO:0004583,1,0.973573498580394,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
2076,GO:0004584,1,0.993964578366847,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
2077,GO:0004585,1,0.994170062963291,0,1,ornithine carbamoyltransferase activity,MF,
2078,GO:0004586,1,0.981425738539516,0,3,ornithine decarboxylase activity,MF,
2079,GO:0004587,1,0.994074338526026,0,1,ornithine-oxo-acid transaminase activity,MF,
2080,GO:0004588,1,0.993879969184172,0,1,orotate phosphoribosyltransferase activity,MF,
2081,GO:0004590,1,0.993879969184172,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
2082,GO:0004591,1,0.974670824542323,0,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
2083,GO:0004594,1,0.975783314216921,0,4,pantothenate kinase activity,MF,
2084,GO:0004595,1,0.993983312180625,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
2085,GO:0004596,1,0.933528892460238,0,11,peptide alpha-N-acetyltransferase activity,MF,
2086,GO:0004597,1,0.993600925319944,0,1,peptide-aspartate beta-dioxygenase activity,MF,
2087,GO:0004598,1,0.993573236050278,0,1,peptidylamidoglycolate lyase activity,MF,
2088,GO:0004601,1,0.794934019297015,0,38,peroxidase activity,MF,
2089,GO:0004602,1,0.911915878420637,0,16,glutathione peroxidase activity,MF,
2090,GO:0004603,1,0.994313297101646,0,1,phenylethanolamine N-methyltransferase activity,MF,
2091,GO:0004605,1,0.981168749388315,0,3,phosphatidate cytidylyltransferase activity,MF,
2092,GO:0004607,1,0.99425554132222,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
2093,GO:0004608,1,0.994360079731816,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
2094,GO:0004609,1,0.987940464133842,0,2,phosphatidylserine decarboxylase activity,MF,
2095,GO:0004610,1,0.994069286485525,0,1,phosphoacetylglucosamine mutase activity,MF,
2096,GO:0004611,1,0.987986796739416,0,2,phosphoenolpyruvate carboxykinase activity,MF,
2097,GO:0004613,1,0.987986796739416,0,2,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
2098,GO:0004614,1,0.96800192182035,0,5,phosphoglucomutase activity,MF,
2099,GO:0004615,1,0.98828513369589,0,2,phosphomannomutase activity,MF,
2100,GO:0004616,1,0.981840295385268,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
2101,GO:0004617,1,0.994063224376902,0,1,phosphoglycerate dehydrogenase activity,MF,
2102,GO:0004618,1,0.993946141459451,0,1,phosphoglycerate kinase activity,MF,
2103,GO:0004619,1,0.976999672609092,0,4,phosphoglycerate mutase activity,MF,
2105,GO:0004621,1,0.993985762594839,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2107,GO:0004623,1,0.853099502276399,0,26,phospholipase A2 activity,MF,
2108,GO:0004629,1,0.837787620222784,0,27,phospholipase C activity,MF,
2109,GO:0004630,1,0.963506303466603,0,6,phospholipase D activity,MF,
2110,GO:0004631,1,0.994272001680887,0,1,phosphomevalonate kinase activity,MF,
2111,GO:0004632,1,0.994281964541159,0,1,phosphopantothenate--cysteine ligase activity,MF,
2112,GO:0004633,1,0.99400609156919,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
2113,GO:0004634,1,0.976335284824185,0,4,phosphopyruvate hydratase activity,MF,
2114,GO:0004637,1,0.993654014170088,0,1,phosphoribosylamine-glycine ligase activity,MF,
2115,GO:0004638,1,0.993683276510387,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
2116,GO:0004639,1,0.993683276510387,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
2117,GO:0004641,1,0.993654014170088,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
2118,GO:0004642,1,0.993091596746235,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
2119,GO:0004643,1,0.994041000326921,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
2120,GO:0004644,1,0.993654014170088,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
2121,GO:0004645,1,0.962760166098552,0,6,phosphorylase activity,MF,
2122,GO:0004647,1,0.982379468079639,0,3,phosphoserine phosphatase activity,MF,
2123,GO:0004648,1,0.994034507535972,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
2124,GO:0004649,1,0.98761694924284,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
2125,GO:0004651,1,0.987571124476374,0,2,polynucleotide 5'-phosphatase activity,MF,
2126,GO:0004652,1,0.942128875245361,0,9,polynucleotide adenylyltransferase activity,MF,
2127,GO:0004653,1,0.886148425561813,0,19,polypeptide N-acetylgalactosaminyltransferase activity,MF,
2128,GO:0004654,1,0.993323404174089,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
2129,GO:0004655,1,0.993727550689085,0,1,porphobilinogen synthase activity,MF,
2130,GO:0004656,1,0.975930990913954,0,4,procollagen-proline 4-dioxygenase activity,MF,
2131,GO:0004657,1,0.99400609156919,0,1,proline dehydrogenase activity,MF,
2132,GO:0004658,1,0.988089027376711,0,2,propionyl-CoA carboxylase activity,MF,
2133,GO:0004659,1,0.909915079583307,0,15,prenyltransferase activity,MF,
2134,GO:0004660,1,0.98805117248067,0,2,protein farnesyltransferase activity,MF,
2135,GO:0004661,1,0.97011664623531,0,5,protein geranylgeranyltransferase activity,MF,
2136,GO:0004662,1,0.988078277786257,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2137,GO:0004663,1,0.976112428189576,0,4,Rab geranylgeranyltransferase activity,MF,
2138,GO:0004666,1,0.986594708375329,0,2,prostaglandin-endoperoxide synthase activity,MF,
2141,GO:0004671,1,0.993262741790684,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
2143,GO:0004673,1,0.955341134821214,0,7,protein histidine kinase activity,MF,
2145,GO:0004675,1,0.90010375149417,0,15,transmembrane receptor protein serine/threonine kinase activity,MF,
2146,GO:0004676,1,0.992616244844643,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
2147,GO:0004677,1,0.976186573132847,0,3,DNA-dependent protein kinase activity,MF,
2150,GO:0004686,1,0.992508575477803,0,1,elongation factor-2 kinase activity,MF,
2151,GO:0004687,1,0.971927560093092,0,4,myosin light chain kinase activity,MF,
2152,GO:0004689,1,0.967209846662748,0,5,phosphorylase kinase activity,MF,
2153,GO:0004690,1,0.946771272806505,0,8,cyclic nucleotide-dependent protein kinase activity,MF,
2154,GO:0004691,1,0.958982786942328,0,6,cAMP-dependent protein kinase activity,MF,
2155,GO:0004692,1,0.987271584770677,0,2,cGMP-dependent protein kinase activity,MF,
2157,GO:0004694,1,0.973842717414366,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
2158,GO:0004697,1,0.90543002234078,0,15,protein kinase C activity,MF,
2159,GO:0004698,1,0.979102923951925,0,3,calcium-dependent protein kinase C activity,MF,
2160,GO:0004699,1,0.98065795498629,0,3,calcium-independent protein kinase C activity,MF,
2162,GO:0004703,1,0.975960631538525,0,4,G-protein coupled receptor kinase activity,MF,
2163,GO:0004704,1,0.968602223793478,0,5,NF-kappaB-inducing kinase activity,MF,
2164,GO:0004705,1,0.98125853008178,0,3,JUN kinase activity,MF,
2165,GO:0004706,1,0.980434375878332,0,3,JUN kinase kinase kinase activity,MF,
2166,GO:0004707,1,0.916097308077161,0,14,MAP kinase activity,MF,
2167,GO:0004708,1,0.909006161867085,0,15,MAP kinase kinase activity,MF,
2169,GO:0004711,1,0.953350291294976,0,7,ribosomal protein S6 kinase activity,MF,
2170,GO:0004712,1,0.768117076264991,0,41,protein serine/threonine/tyrosine kinase activity,MF,
2173,GO:0004715,1,0.731525645719327,0,49,non-membrane spanning protein tyrosine kinase activity,MF,
2174,GO:0004716,1,0.938667958871727,0,9,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,
2175,GO:0004719,1,0.981238155475439,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
2176,GO:0004720,1,0.962800556020501,0,6,protein-lysine 6-oxidase activity,MF,
2179,GO:0004723,1,0.954792419041351,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
2180,GO:0004725,1,0.539666534613448,0,94,protein tyrosine phosphatase activity,MF,
2181,GO:0004726,1,0.95073585187942,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2182,GO:0004727,1,0.988360276708575,0,2,prenylated protein tyrosine phosphatase activity,MF,
2183,GO:0004728,1,0.993898942647536,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
2184,GO:0004729,1,0.994142773259051,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
2185,GO:0004730,1,0.994165442493504,0,1,pseudouridylate synthase activity,MF,
2186,GO:0004731,1,0.987221795421793,0,2,purine-nucleoside phosphorylase activity,MF,
2187,GO:0004733,1,0.993648448042033,0,1,pyridoxamine-phosphate oxidase activity,MF,
2188,GO:0004735,1,0.988292805102191,0,2,pyrroline-5-carboxylate reductase activity,MF,
2189,GO:0004736,1,0.993489956716039,0,1,pyruvate carboxylase activity,MF,
2190,GO:0004738,1,0.96914641911392,0,5,pyruvate dehydrogenase activity,MF,
2191,GO:0004739,1,0.987912164065725,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2192,GO:0004740,1,0.973701065877331,0,4,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
2193,GO:0004741,1,0.979453947490632,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2194,GO:0004742,1,0.993394878532363,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2195,GO:0004743,1,0.987654753327518,0,2,pyruvate kinase activity,MF,
2196,GO:0004744,1,0.993891466686588,0,1,retinal isomerase activity,MF,
2197,GO:0004745,1,0.930663568909812,0,12,retinol dehydrogenase activity,MF,
2198,GO:0004747,1,0.994300590791246,0,1,ribokinase activity,MF,
2199,GO:0004748,1,0.980759034698322,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2200,GO:0004749,1,0.976214556382024,0,4,ribose phosphate diphosphokinase activity,MF,
2201,GO:0004750,1,0.99398302390549,0,1,ribulose-phosphate 3-epimerase activity,MF,
2202,GO:0004751,1,0.994116350061604,0,1,ribose-5-phosphate isomerase activity,MF,
2203,GO:0004753,1,0.992952742782819,0,1,saccharopine dehydrogenase activity,MF,
2204,GO:0004756,1,0.987926048497719,0,2,selenide, water dikinase activity,MF,
2205,GO:0004757,1,0.994226085973012,0,1,sepiapterin reductase activity,MF,
2206,GO:0004758,1,0.96830143041574,0,5,serine C-palmitoyltransferase activity,MF,
2207,GO:0004760,1,0.994183924354294,0,1,serine-pyruvate transaminase activity,MF,
2208,GO:0004766,1,0.994278354807957,0,1,spermidine synthase activity,MF,
2209,GO:0004767,1,0.969079045166816,0,5,sphingomyelin phosphodiesterase activity,MF,
2210,GO:0004768,1,0.980832396335761,0,3,stearoyl-CoA 9-desaturase activity,MF,
2211,GO:0004769,1,0.994313297101646,0,1,steroid delta-isomerase activity,MF,
2212,GO:0004771,1,0.951123418479383,0,8,sterol esterase activity,MF,
2213,GO:0004772,1,0.993666431762045,0,1,sterol O-acyltransferase activity,MF,
2214,GO:0004773,1,0.992810586647109,0,1,steryl-sulfatase activity,MF,
2215,GO:0004774,1,0.982316220214134,0,3,succinate-CoA ligase activity,MF,
2216,GO:0004775,1,0.988279626508485,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
2217,GO:0004776,1,0.988226016012563,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
2218,GO:0004777,1,0.993164260904423,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2219,GO:0004778,1,0.994176704883032,0,1,succinyl-CoA hydrolase activity,MF,
2220,GO:0004779,1,0.987487375112157,0,2,sulfate adenylyltransferase activity,MF,
2221,GO:0004781,1,0.987487375112157,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2222,GO:0004782,1,0.993865891603955,0,1,sulfinoalanine decarboxylase activity,MF,
2223,GO:0004784,1,0.971529840577745,0,5,superoxide dismutase activity,MF,
2224,GO:0004788,1,0.993965442815809,0,1,thiamine diphosphokinase activity,MF,
2225,GO:0004790,1,0.993908721857596,0,1,thioether S-methyltransferase activity,MF,
2226,GO:0004791,1,0.953358543130843,0,8,thioredoxin-disulfide reductase activity,MF,
2227,GO:0004792,1,0.982582389593877,0,3,thiosulfate sulfurtransferase activity,MF,
2228,GO:0004793,1,0.987972684251583,0,2,threonine aldolase activity,MF,
2229,GO:0004794,1,0.988458755126334,0,2,L-threonine ammonia-lyase activity,MF,
2230,GO:0004795,1,0.994036094605325,0,1,threonine synthase activity,MF,
2231,GO:0004796,1,0.994036816012919,0,1,thromboxane-A synthase activity,MF,
2232,GO:0004797,1,0.987418623742583,0,2,thymidine kinase activity,MF,
2233,GO:0004798,1,0.988138766958563,0,2,thymidylate kinase activity,MF,
2234,GO:0004799,1,0.99418912236975,0,1,thymidylate synthase activity,MF,
2235,GO:0004800,1,0.986892845084097,0,2,thyroxine 5'-deiodinase activity,MF,
2236,GO:0004801,1,0.994287306949133,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2237,GO:0004802,1,0.987958198107271,0,2,transketolase activity,MF,
2238,GO:0004803,1,0.993485094935434,0,1,transposase activity,MF,
2239,GO:0004806,1,0.894335423129278,0,18,triglyceride lipase activity,MF,
2240,GO:0004807,1,0.994225219639293,0,1,triose-phosphate isomerase activity,MF,
2241,GO:0004809,1,0.982050173802125,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2242,GO:0004810,1,0.993989654703031,0,1,tRNA adenylyltransferase activity,MF,
2243,GO:0004812,1,0.761616297733401,0,44,aminoacyl-tRNA ligase activity,MF,
2244,GO:0004813,1,0.981162215065408,0,3,alanine-tRNA ligase activity,MF,
2245,GO:0004814,1,0.982244255020542,0,3,arginine-tRNA ligase activity,MF,
2246,GO:0004815,1,0.987689642389277,0,2,aspartate-tRNA ligase activity,MF,
2247,GO:0004816,1,0.987843694057463,0,2,asparagine-tRNA ligase activity,MF,
2248,GO:0004817,1,0.98802363068898,0,2,cysteine-tRNA ligase activity,MF,
2249,GO:0004818,1,0.986759576640946,0,2,glutamate-tRNA ligase activity,MF,
2250,GO:0004819,1,0.987225229956847,0,2,glutamine-tRNA ligase activity,MF,
2251,GO:0004820,1,0.988072296337391,0,2,glycine-tRNA ligase activity,MF,
2252,GO:0004821,1,0.988039252998985,0,2,histidine-tRNA ligase activity,MF,
2253,GO:0004822,1,0.987019994625188,0,2,isoleucine-tRNA ligase activity,MF,
2254,GO:0004823,1,0.986721526598797,0,2,leucine-tRNA ligase activity,MF,
2255,GO:0004824,1,0.994037393144533,0,1,lysine-tRNA ligase activity,MF,
2256,GO:0004825,1,0.987649038901729,0,2,methionine-tRNA ligase activity,MF,
2257,GO:0004826,1,0.970233053518078,0,5,phenylalanine-tRNA ligase activity,MF,
2258,GO:0004827,1,0.981600485394515,0,3,proline-tRNA ligase activity,MF,
2259,GO:0004828,1,0.988180712921334,0,2,serine-tRNA ligase activity,MF,
2260,GO:0004829,1,0.981586502148511,0,3,threonine-tRNA ligase activity,MF,
2261,GO:0004830,1,0.987740789119075,0,2,tryptophan-tRNA ligase activity,MF,
2262,GO:0004831,1,0.987806242429374,0,2,tyrosine-tRNA ligase activity,MF,
2263,GO:0004832,1,0.980380396011027,0,3,valine-tRNA ligase activity,MF,
2264,GO:0004833,1,0.98838238210664,0,2,tryptophan 2,3-dioxygenase activity,MF,
2265,GO:0004835,1,0.993162531681221,0,1,tubulin-tyrosine ligase activity,MF,
2266,GO:0004838,1,0.993849238640097,0,1,L-tyrosine:2-oxoglutarate aminotransferase activity,MF,
2267,GO:0004839,1,0.967658672934351,0,5,ubiquitin activating enzyme activity,MF,
2269,GO:0004843,1,0.627181060558044,0,70,thiol-dependent ubiquitin-specific protease activity,MF,
2270,GO:0004844,1,0.970754169880059,0,5,uracil DNA N-glycosylase activity,MF,
2271,GO:0004849,1,0.970520494120048,0,5,uridine kinase activity,MF,
2272,GO:0004850,1,0.988109364005533,0,2,uridine phosphorylase activity,MF,
2273,GO:0004852,1,0.994254674988056,0,1,uroporphyrinogen-III synthase activity,MF,
2274,GO:0004853,1,0.994246011648254,0,1,uroporphyrinogen decarboxylase activity,MF,
2275,GO:0004854,1,0.986260343357986,0,2,xanthine dehydrogenase activity,MF,
2276,GO:0004855,1,0.992993173329028,0,1,xanthine oxidase activity,MF,
2277,GO:0004856,1,0.993582514073817,0,1,xylulokinase activity,MF,
2279,GO:0004859,1,0.954342104716363,0,8,phospholipase inhibitor activity,MF,
2281,GO:0004861,1,0.929679351311015,0,12,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,
2287,GO:0004869,1,0.77119351505112,0,42,cysteine-type endopeptidase inhibitor activity,MF,
2289,GO:0004873,1,0.988481151662973,0,2,asialoglycoprotein receptor activity,MF,
2290,GO:0004874,1,0.986162876778807,0,2,aryl hydrocarbon receptor activity,MF,
2291,GO:0004875,1,0.956934410403596,0,7,complement receptor activity,MF,
2292,GO:0004876,1,0.994083144067623,0,1,complement component C3a receptor activity,MF,
2293,GO:0004877,1,0.991956535396447,0,1,complement component C3b receptor activity,MF,
2294,GO:0004878,1,0.987854585120266,0,2,complement component C5a receptor activity,MF,
2295,GO:0004879,1,0.740640374074475,0,46,nuclear receptor activity,MF,
2296,GO:0004882,1,0.987510688201038,0,2,androgen receptor activity,MF,
2297,GO:0004883,1,0.992742069735397,0,1,glucocorticoid receptor activity,MF,
2298,GO:0004886,1,0.981280443651624,0,3,9-cis retinoic acid receptor activity,MF,
2299,GO:0004887,1,0.962036484546447,0,6,thyroid hormone receptor activity,MF,
2301,GO:0004890,1,0.895362052776356,0,17,GABA-A receptor activity,MF,
2302,GO:0004896,1,0.597040707371758,0,82,cytokine receptor activity,MF,
2303,GO:0004897,1,0.973230991764247,0,4,ciliary neurotrophic factor receptor activity,MF,
2304,GO:0004900,1,0.994112307298028,0,1,erythropoietin receptor activity,MF,
2305,GO:0004904,1,0.969386233555439,0,5,interferon receptor activity,MF,
2306,GO:0004905,1,0.987171120361711,0,2,type I interferon receptor activity,MF,
2307,GO:0004906,1,0.988074702503813,0,2,interferon-gamma receptor activity,MF,
2308,GO:0004908,1,0.957293088117889,0,7,interleukin-1 receptor activity,MF,
2309,GO:0004909,1,0.987351860625535,0,2,interleukin-1, Type I, activating receptor activity,MF,
2310,GO:0004910,1,0.988052962857824,0,2,interleukin-1, Type II, blocking receptor activity,MF,
2311,GO:0004911,1,0.981517932086866,0,3,interleukin-2 receptor activity,MF,
2312,GO:0004912,1,0.99325123291743,0,1,interleukin-3 receptor activity,MF,
2313,GO:0004913,1,0.988194746362778,0,2,interleukin-4 receptor activity,MF,
2314,GO:0004914,1,0.98735383020944,0,2,interleukin-5 receptor activity,MF,
2315,GO:0004915,1,0.987223668718134,0,2,interleukin-6 receptor activity,MF,
2316,GO:0004917,1,0.988362282960877,0,2,interleukin-7 receptor activity,MF,
2317,GO:0004918,1,0.987816926764533,0,2,interleukin-8 receptor activity,MF,
2318,GO:0004920,1,0.969004519953712,0,5,interleukin-10 receptor activity,MF,
2319,GO:0004921,1,0.99372526461683,0,1,interleukin-11 receptor activity,MF,
2320,GO:0004923,1,0.985483160612502,0,2,leukemia inhibitory factor receptor activity,MF,
2321,GO:0004924,1,0.979172244669431,0,3,oncostatin-M receptor activity,MF,
2322,GO:0004925,1,0.991239523004151,0,1,prolactin receptor activity,MF,
2324,GO:0004931,1,0.958676442175763,0,7,extracellularly ATP-gated cation channel activity,MF,
2325,GO:0004935,1,0.940974163732623,0,10,adrenergic receptor activity,MF,
2326,GO:0004936,1,0.969874668397817,0,5,alpha-adrenergic receptor activity,MF,
2327,GO:0004937,1,0.981999703261013,0,3,alpha1-adrenergic receptor activity,MF,
2328,GO:0004938,1,0.987654985047108,0,2,alpha2-adrenergic receptor activity,MF,
2329,GO:0004939,1,0.981875490746082,0,3,beta-adrenergic receptor activity,MF,
2330,GO:0004940,1,0.993822848063476,0,1,beta1-adrenergic receptor activity,MF,
2331,GO:0004941,1,0.994058605895241,0,1,beta2-adrenergic receptor activity,MF,
2332,GO:0004945,1,0.9827014831814,0,3,angiotensin type II receptor activity,MF,
2333,GO:0004946,1,0.994239369756067,0,1,bombesin receptor activity,MF,
2334,GO:0004947,1,0.987753085311121,0,2,bradykinin receptor activity,MF,
2335,GO:0004948,1,0.986855823415704,0,2,calcitonin receptor activity,MF,
2336,GO:0004949,1,0.980778938394391,0,3,cannabinoid receptor activity,MF,
2337,GO:0004950,1,0.864193443280671,0,24,chemokine receptor activity,MF,
2338,GO:0004951,1,0.988230527011774,0,2,cholecystokinin receptor activity,MF,
2339,GO:0004952,1,0.958952180268424,0,7,dopamine neurotransmitter receptor activity,MF,
2340,GO:0004953,1,0.901606260123362,0,17,icosanoid receptor activity,MF,
2341,GO:0004954,1,0.934647596351398,0,11,prostanoid receptor activity,MF,
2342,GO:0004955,1,0.940300907411535,0,10,prostaglandin receptor activity,MF,
2343,GO:0004956,1,0.987683204432912,0,2,prostaglandin D receptor activity,MF,
2344,GO:0004957,1,0.964097415342326,0,6,prostaglandin E receptor activity,MF,
2345,GO:0004958,1,0.986983775315111,0,2,prostaglandin F receptor activity,MF,
2346,GO:0004960,1,0.993991528798771,0,1,thromboxane receptor activity,MF,
2347,GO:0004961,1,0.993991528798771,0,1,thromboxane A2 receptor activity,MF,
2348,GO:0004962,1,0.987002697720711,0,2,endothelin receptor activity,MF,
2349,GO:0004965,1,0.979944465255217,0,3,G-protein coupled GABA receptor activity,MF,
2350,GO:0004966,1,0.942674161434025,0,10,galanin receptor activity,MF,
2351,GO:0004967,1,0.987945124184597,0,2,glucagon receptor activity,MF,
2352,GO:0004968,1,0.99342555048578,0,1,gonadotropin-releasing hormone receptor activity,MF,
2353,GO:0004969,1,0.96934931213902,0,5,histamine receptor activity,MF,
2354,GO:0004970,1,0.876295080332572,0,19,ionotropic glutamate receptor activity,MF,
2355,GO:0004971,1,0.972789775971176,0,4,AMPA glutamate receptor activity,MF,
2356,GO:0004972,1,0.950293607367549,0,7,NMDA glutamate receptor activity,MF,
2357,GO:0004974,1,0.964672295607315,0,6,leukotriene receptor activity,MF,
2358,GO:0004977,1,0.976666612114224,0,4,melanocortin receptor activity,MF,
2359,GO:0004979,1,0.994108264596255,0,1,beta-endorphin receptor activity,MF,
2360,GO:0004980,1,0.988023088523704,0,2,melanocyte-stimulating hormone receptor activity,MF,
2361,GO:0004982,1,0.982373950436146,0,3,N-formyl peptide receptor activity,MF,
2362,GO:0004983,1,0.946787264109511,0,9,neuropeptide Y receptor activity,MF,
2363,GO:0004984,1,0.900842903927938,0,18,olfactory receptor activity,MF,
2364,GO:0004985,1,0.953004187402522,0,8,opioid receptor activity,MF,
2365,GO:0004990,1,0.993393731406682,0,1,oxytocin receptor activity,MF,
2366,GO:0004991,1,0.987929891509674,0,2,parathyroid hormone receptor activity,MF,
2367,GO:0004992,1,0.980789067296153,0,3,platelet activating factor receptor activity,MF,
2368,GO:0004993,1,0.924284439314344,0,13,G-protein coupled serotonin receptor activity,MF,
2369,GO:0004994,1,0.975814769306675,0,4,somatostatin receptor activity,MF,
2370,GO:0004995,1,0.981907940496552,0,3,tachykinin receptor activity,MF,
2371,GO:0004996,1,0.987856417987663,0,2,thyroid-stimulating hormone receptor activity,MF,
2372,GO:0004998,1,0.987012802291555,0,2,transferrin receptor activity,MF,
2373,GO:0004999,1,0.981631012442526,0,3,vasoactive intestinal polypeptide receptor activity,MF,
2374,GO:0005000,1,0.963397396954325,0,6,vasopressin receptor activity,MF,
2375,GO:0005001,1,0.893836699442799,0,16,transmembrane receptor protein tyrosine phosphatase activity,MF,
2377,GO:0005004,1,0.953658372563048,0,7,GPI-linked ephrin receptor activity,MF,
2379,GO:0005006,1,0.987803604096368,0,2,epidermal growth factor-activated receptor activity,MF,
2380,GO:0005007,1,0.96784361935141,0,5,fibroblast growth factor-activated receptor activity,MF,
2381,GO:0005008,1,0.992728478973141,0,1,hepatocyte growth factor-activated receptor activity,MF,
2382,GO:0005009,1,0.992035059953626,0,1,insulin-activated receptor activity,MF,
2383,GO:0005010,1,0.970229227273519,0,4,insulin-like growth factor-activated receptor activity,MF,
2384,GO:0005011,1,0.986808947025488,0,2,macrophage colony-stimulating factor receptor activity,MF,
2385,GO:0005017,1,0.980092084551298,0,3,platelet-derived growth factor-activated receptor activity,MF,
2386,GO:0005018,1,0.992749587600448,0,1,platelet-derived growth factor alpha-receptor activity,MF,
2387,GO:0005019,1,0.987250994862952,0,2,platelet-derived growth factor beta-receptor activity,MF,
2388,GO:0005020,1,0.993155902566615,0,1,stem cell factor receptor activity,MF,
2389,GO:0005021,1,0.953585682722036,0,7,vascular endothelial growth factor-activated receptor activity,MF,
2390,GO:0005024,1,0.946811023004981,0,8,transforming growth factor beta-activated receptor activity,MF,
2391,GO:0005025,1,0.973363540290972,0,4,transforming growth factor beta receptor activity, type I,MF,
2392,GO:0005026,1,0.993305012898809,0,1,transforming growth factor beta receptor activity, type II,MF,
2393,GO:0005030,1,0.973189123398203,0,4,neurotrophin receptor activity,MF,
2394,GO:0005031,1,0.864346916117913,0,24,tumor necrosis factor-activated receptor activity,MF,
2395,GO:0005034,1,0.993736553306438,0,1,osmosensor activity,MF,
2396,GO:0005035,1,0.864346916117913,0,24,death receptor activity,MF,
2398,GO:0005042,1,0.95909791883148,0,6,netrin receptor activity,MF,
2400,GO:0005046,1,0.988090909875098,0,2,KDEL sequence binding,MF,
2403,GO:0005049,1,0.946506590000735,0,8,nuclear export signal receptor activity,MF,
2405,GO:0005053,1,0.994217711412972,0,1,peroxisome matrix targeting signal-2 binding,MF,
2406,GO:0005055,1,0.9882995532057,0,2,laminin receptor activity,MF,
2408,GO:0005068,1,0.929274716715934,0,11,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
2409,GO:0005070,1,0.695363427393031,0,57,SH3/SH2 adaptor activity,MF,
2410,GO:0005072,1,0.933489776031398,0,10,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2411,GO:0005078,1,0.951071671826584,0,7,MAP-kinase scaffold activity,MF,
2414,GO:0005086,1,0.871541232760457,0,20,ARF guanyl-nucleotide exchange factor activity,MF,
2415,GO:0005087,1,0.976486034167733,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2417,GO:0005089,1,0.585746602446567,0,77,Rho guanyl-nucleotide exchange factor activity,MF,
2418,GO:0005090,1,0.994020802673904,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2419,GO:0005092,1,0.917095946673127,0,14,GDP-dissociation inhibitor activity,MF,
2420,GO:0005093,1,0.987934296274941,0,2,Rab GDP-dissociation inhibitor activity,MF,
2421,GO:0005094,1,0.982876691065706,0,3,Rho GDP-dissociation inhibitor activity,MF,
2422,GO:0005095,1,0.913840708721388,0,14,GTPase inhibitor activity,MF,
2426,GO:0005105,1,0.982594565856624,0,3,type 1 fibroblast growth factor receptor binding,MF,
2427,GO:0005109,1,0.812158919867493,0,33,frizzled binding,MF,
2428,GO:0005111,1,0.983065998415102,0,3,type 2 fibroblast growth factor receptor binding,MF,
2429,GO:0005112,1,0.865431424396444,0,21,Notch binding,MF,
2430,GO:0005113,1,0.956650545463499,0,7,patched binding,MF,
2431,GO:0005114,1,0.95526918880259,0,7,type II transforming growth factor beta receptor binding,MF,
2432,GO:0005115,1,0.992967472159764,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2433,GO:0005119,1,0.979680371603425,0,3,smoothened binding,MF,
2434,GO:0005123,1,0.905247577148003,0,16,death receptor binding,MF,
2435,GO:0005124,1,0.976546078028947,0,4,scavenger receptor binding,MF,
2438,GO:0005127,1,0.968192486302813,0,5,ciliary neurotrophic factor receptor binding,MF,
2439,GO:0005128,1,0.988003496930389,0,2,erythropoietin receptor binding,MF,
2440,GO:0005130,1,0.994208759294191,0,1,granulocyte colony-stimulating factor receptor binding,MF,
2441,GO:0005131,1,0.973992669748937,0,4,growth hormone receptor binding,MF,
2442,GO:0005134,1,0.981855504155539,0,3,interleukin-2 receptor binding,MF,
2443,GO:0005135,1,0.993704409376543,0,1,interleukin-3 receptor binding,MF,
2444,GO:0005136,1,0.987921000324447,0,2,interleukin-4 receptor binding,MF,
2445,GO:0005137,1,0.994021091165497,0,1,interleukin-5 receptor binding,MF,
2446,GO:0005138,1,0.957494249501811,0,7,interleukin-6 receptor binding,MF,
2447,GO:0005139,1,0.98800454668421,0,2,interleukin-7 receptor binding,MF,
2448,GO:0005141,1,0.994176416104045,0,1,interleukin-10 receptor binding,MF,
2449,GO:0005142,1,0.993967171770242,0,1,interleukin-11 receptor binding,MF,
2450,GO:0005143,1,0.981539307566724,0,3,interleukin-12 receptor binding,MF,
2451,GO:0005144,1,0.994276910915076,0,1,interleukin-13 receptor binding,MF,
2452,GO:0005146,1,0.9877247060135,0,2,leukemia inhibitory factor receptor binding,MF,
2453,GO:0005147,1,0.994109708410621,0,1,oncostatin-M receptor binding,MF,
2454,GO:0005148,1,0.994302756637626,0,1,prolactin receptor binding,MF,
2455,GO:0005149,1,0.933331305538289,0,11,interleukin-1 receptor binding,MF,
2456,GO:0005150,1,0.987778412831056,0,2,interleukin-1, Type I receptor binding,MF,
2457,GO:0005151,1,0.987281018884667,0,2,interleukin-1, Type II receptor binding,MF,
2458,GO:0005152,1,0.986852915748231,0,2,interleukin-1 receptor antagonist activity,MF,
2459,GO:0005153,1,0.987630022704206,0,2,interleukin-8 receptor binding,MF,
2460,GO:0005154,1,0.826705701344831,0,29,epidermal growth factor receptor binding,MF,
2461,GO:0005157,1,0.982391294072799,0,3,macrophage colony-stimulating factor receptor binding,MF,
2462,GO:0005158,1,0.862987992262762,0,21,insulin receptor binding,MF,
2463,GO:0005159,1,0.9178960931004,0,13,insulin-like growth factor receptor binding,MF,
2464,GO:0005160,1,0.75267943283609,0,45,transforming growth factor beta receptor binding,MF,
2465,GO:0005161,1,0.911399397231457,0,14,platelet-derived growth factor receptor binding,MF,
2466,GO:0005163,1,0.994344485459851,0,1,nerve growth factor receptor binding,MF,
2467,GO:0005164,1,0.84007545855176,0,29,tumor necrosis factor receptor binding,MF,
2468,GO:0005165,1,0.931848574633213,0,11,neurotrophin receptor binding,MF,
2469,GO:0005166,1,0.982629816515712,0,3,neurotrophin p75 receptor binding,MF,
2470,GO:0005167,1,0.948344690373853,0,8,neurotrophin TRK receptor binding,MF,
2471,GO:0005168,1,0.959977494192563,0,6,neurotrophin TRKA receptor binding,MF,
2472,GO:0005169,1,0.981082465883955,0,3,neurotrophin TRKB receptor binding,MF,
2473,GO:0005170,1,0.993112653583123,0,1,neurotrophin TRKC receptor binding,MF,
2474,GO:0005171,1,0.988157749583447,0,2,hepatocyte growth factor receptor binding,MF,
2476,GO:0005173,1,0.979216367615556,0,3,stem cell factor receptor binding,MF,
2477,GO:0005174,1,0.988140724145709,0,2,CD40 receptor binding,MF,
2478,GO:0005175,1,0.994453069647029,0,1,CD27 receptor binding,MF,
2479,GO:0005176,1,0.981761447519335,0,3,ErbB-2 class receptor binding,MF,
2482,GO:0005183,1,0.988715148653879,0,2,gonadotropin hormone-releasing hormone activity,MF,
2485,GO:0005199,1,0.993676138497648,0,1,structural constituent of cell wall,MF,
2488,GO:0005212,1,0.928046842239124,0,13,structural constituent of eye lens,MF,
2493,GO:0005220,1,0.97495568925959,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2494,GO:0005221,1,0.943413739628956,0,9,intracellular cyclic nucleotide activated cation channel activity,MF,
2495,GO:0005222,1,0.949252460399839,0,8,intracellular cAMP activated cation channel activity,MF,
2496,GO:0005223,1,0.963193890540987,0,6,intracellular cGMP activated cation channel activity,MF,
2497,GO:0005225,1,0.936060423845579,0,10,volume-sensitive anion channel activity,MF,
2498,GO:0005227,1,0.842624421622772,0,27,calcium activated cation channel activity,MF,
2499,GO:0005228,1,0.98625557215708,0,2,intracellular sodium activated potassium channel activity,MF,
2500,GO:0005229,1,0.890350252164242,0,18,intracellular calcium activated chloride channel activity,MF,
2504,GO:0005237,1,0.906581132883541,0,15,inhibitory extracellular ligand-gated ion channel activity,MF,
2505,GO:0005242,1,0.881766079783031,0,20,inward rectifier potassium channel activity,MF,
2507,GO:0005244,1,0.297017109867985,0,184,voltage-gated ion channel activity,MF,
2508,GO:0005245,1,0.755713327743373,0,41,voltage-gated calcium channel activity,MF,
2510,GO:0005247,1,0.936268332903124,0,10,voltage-gated chloride channel activity,MF,
2511,GO:0005248,1,0.847039398378842,0,23,voltage-gated sodium channel activity,MF,
2512,GO:0005249,1,0.576592918009649,0,86,voltage-gated potassium channel activity,MF,
2513,GO:0005250,1,0.974473228882107,0,4,A-type (transient outward) potassium channel activity,MF,
2514,GO:0005251,1,0.84691814248956,0,26,delayed rectifier potassium channel activity,MF,
2515,GO:0005252,1,0.993503108743952,0,1,open rectifier potassium channel activity,MF,
2518,GO:0005260,1,0.992876766536991,0,1,intracellularly ATP-gated chloride channel activity,MF,
2521,GO:0005267,1,0.469492689761968,0,119,potassium channel activity,MF,
2522,GO:0005272,1,0.738402174739143,0,44,sodium channel activity,MF,
2523,GO:0005275,1,0.987888879707127,0,2,amine transmembrane transporter activity,MF,
2524,GO:0005277,1,0.982089029898322,0,3,acetylcholine transmembrane transporter activity,MF,
2525,GO:0005280,1,0.975017067948326,0,4,amino acid:proton symporter activity,MF,
2526,GO:0005283,1,0.89525230928363,0,17,amino acid:sodium symporter activity,MF,
2527,GO:0005287,1,0.986474744014679,0,2,high-affinity basic amino acid transmembrane transporter activity,MF,
2528,GO:0005289,1,0.986474744014679,0,2,high-affinity arginine transmembrane transporter activity,MF,
2529,GO:0005290,1,0.98173284538646,0,3,L-histidine transmembrane transporter activity,MF,
2530,GO:0005292,1,0.986474744014679,0,2,high-affinity lysine transmembrane transporter activity,MF,
2531,GO:0005294,1,0.991861567052743,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2532,GO:0005295,1,0.987575389963902,0,2,neutral amino acid:sodium symporter activity,MF,
2533,GO:0005298,1,0.987004030471515,0,2,proline:sodium symporter activity,MF,
2534,GO:0005302,1,0.993737267885456,0,1,L-tyrosine transmembrane transporter activity,MF,
2535,GO:0005308,1,0.986985429935042,0,2,creatine transmembrane transporter activity,MF,
2536,GO:0005309,1,0.993626470370175,0,1,creatine:sodium symporter activity,MF,
2539,GO:0005314,1,0.955134430610005,0,7,high-affinity glutamate transmembrane transporter activity,MF,
2541,GO:0005316,1,0.993699268281269,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2542,GO:0005319,1,0.467634169409332,0,117,lipid transporter activity,MF,
2543,GO:0005324,1,0.969883328869237,0,5,long-chain fatty acid transporter activity,MF,
2545,GO:0005328,1,0.860646046345152,0,23,neurotransmitter:sodium symporter activity,MF,
2546,GO:0005329,1,0.962194667595445,0,6,dopamine transmembrane transporter activity,MF,
2547,GO:0005330,1,0.980656369199688,0,3,dopamine:sodium symporter activity,MF,
2548,GO:0005332,1,0.975368297168954,0,4,gamma-aminobutyric acid:sodium symporter activity,MF,
2549,GO:0005333,1,0.981821340100679,0,3,norepinephrine transmembrane transporter activity,MF,
2550,GO:0005334,1,0.993678708107879,0,1,norepinephrine:sodium symporter activity,MF,
2551,GO:0005335,1,0.99334092589851,0,1,serotonin:sodium symporter activity,MF,
2552,GO:0005337,1,0.964308642301412,0,6,nucleoside transmembrane transporter activity,MF,
2553,GO:0005338,1,0.927928053554908,0,12,nucleotide-sugar transmembrane transporter activity,MF,
2555,GO:0005343,1,0.844638601513819,0,26,organic acid:sodium symporter activity,MF,
2556,GO:0005344,1,0.927913387313833,0,13,oxygen carrier activity,MF,
2557,GO:0005345,1,0.969837659913872,0,5,purine nucleobase transmembrane transporter activity,MF,
2558,GO:0005346,1,0.93461097885464,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2559,GO:0005347,1,0.951628898489568,0,8,ATP transmembrane transporter activity,MF,
2560,GO:0005350,1,0.981945869249294,0,3,pyrimidine nucleobase transmembrane transporter activity,MF,
2561,GO:0005351,1,0.937994322026052,0,10,carbohydrate:proton symporter activity,MF,
2562,GO:0005353,1,0.993976682335154,0,1,fructose transmembrane transporter activity,MF,
2564,GO:0005362,1,0.987736328081977,0,2,low-affinity glucose:sodium symporter activity,MF,
2565,GO:0005365,1,0.98399691161375,0,2,myo-inositol transmembrane transporter activity,MF,
2566,GO:0005366,1,0.99262955449153,0,1,myo-inositol:proton symporter activity,MF,
2567,GO:0005367,1,0.991303911039852,0,1,myo-inositol:sodium symporter activity,MF,
2568,GO:0005368,1,0.992772428467949,0,1,taurine transmembrane transporter activity,MF,
2569,GO:0005369,1,0.992772428467949,0,1,taurine:sodium symporter activity,MF,
2570,GO:0005372,1,0.935072330884481,0,11,water transmembrane transporter activity,MF,
2571,GO:0005375,1,0.961017330396246,0,6,copper ion transmembrane transporter activity,MF,
2573,GO:0005384,1,0.962241679367007,0,6,manganese ion transmembrane transporter activity,MF,
2575,GO:0005388,1,0.90687828235599,0,14,calcium-transporting ATPase activity,MF,
2576,GO:0005391,1,0.92780351011453,0,12,sodium:potassium-exchanging ATPase activity,MF,
2577,GO:0005395,1,0.992524787725497,0,1,eye pigment precursor transporter activity,MF,
2580,GO:0005415,1,0.988097223280593,0,2,nucleoside:sodium symporter activity,MF,
2581,GO:0005416,1,0.88353934966632,0,19,amino acid:cation symporter activity,MF,
2582,GO:0005427,1,0.993578374751637,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2583,GO:0005432,1,0.961705237082753,0,6,calcium:sodium antiporter activity,MF,
2585,GO:0005451,1,0.919399599689835,0,13,monovalent cation:proton antiporter activity,MF,
2586,GO:0005452,1,0.846019479093124,0,26,inorganic anion exchanger activity,MF,
2587,GO:0005456,1,0.994122991853505,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2588,GO:0005457,1,0.986450387599968,0,2,GDP-fucose transmembrane transporter activity,MF,
2589,GO:0005459,1,0.98848516560721,0,2,UDP-galactose transmembrane transporter activity,MF,
2590,GO:0005461,1,0.992785437825441,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2591,GO:0005462,1,0.986752339139541,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2592,GO:0005464,1,0.992683651306792,0,1,UDP-xylose transmembrane transporter activity,MF,
2593,GO:0005471,1,0.987671446834755,0,2,ATP:ADP antiporter activity,MF,
2594,GO:0005476,1,0.981943780838403,0,3,carnitine:acyl carnitine antiporter activity,MF,
2595,GO:0005477,1,0.993627326619152,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2596,GO:0005483,1,0.981337108311181,0,3,soluble NSF attachment protein activity,MF,
2597,GO:0005484,1,0.800816100215475,0,36,SNAP receptor activity,MF,
2600,GO:0005497,1,0.976740252769389,0,4,androgen binding,MF,
2601,GO:0005499,1,0.974705466474765,0,4,vitamin D binding,MF,
2603,GO:0005502,1,0.975469712779498,0,4,11-cis retinal binding,MF,
2604,GO:0005503,1,0.987412764821512,0,2,all-trans retinal binding,MF,
2607,GO:0005507,1,0.738895498608422,0,49,copper ion binding,MF,
2612,GO:0005518,1,0.679591345213676,0,59,collagen binding,MF,
2613,GO:0005519,1,0.993502251146751,0,1,cytoskeletal regulatory protein binding,MF,
2614,GO:0005520,1,0.830014720906044,0,29,insulin-like growth factor binding,MF,
2615,GO:0005521,1,0.905002980716506,0,15,lamin binding,MF,
2616,GO:0005522,1,0.931937375632046,0,10,profilin binding,MF,
2617,GO:0005523,1,0.921746364005347,0,13,tropomyosin binding,MF,
2620,GO:0005527,1,0.924445909543,0,13,macrolide binding,MF,
2621,GO:0005528,1,0.924445909543,0,13,FK506 binding,MF,
2622,GO:0005534,1,0.969997811307201,0,5,galactose binding,MF,
2623,GO:0005536,1,0.932568294592274,0,11,glucose binding,MF,
2624,GO:0005537,1,0.916626019527607,0,14,mannose binding,MF,
2627,GO:0005542,1,0.941781625558232,0,10,folic acid binding,MF,
2629,GO:0005544,1,0.734789671269049,0,48,calcium-dependent phospholipid binding,MF,
2630,GO:0005545,1,0.904695997629952,0,15,1-phosphatidylinositol binding,MF,
2631,GO:0005546,1,0.681965472582314,0,60,phosphatidylinositol-4,5-bisphosphate binding,MF,
2633,GO:0005548,1,0.706386652080353,0,52,phospholipid transporter activity,MF,
2634,GO:0005549,1,0.977441105031966,0,4,odorant binding,MF,
2637,GO:0005577,1,0.95577464756127,0,7,fibrinogen complex,CC,
2639,GO:0005579,1,0.974269448728968,0,4,membrane attack complex,CC,
2640,GO:0005581,1,0.597143579474232,0,78,collagen trimer,CC,
2641,GO:0005582,1,0.993119575150979,0,1,collagen type XV trimer,CC,
2642,GO:0005583,1,0.919287999879712,0,12,fibrillar collagen trimer,CC,
2643,GO:0005584,1,0.986054110745171,0,2,collagen type I trimer,CC,
2644,GO:0005585,1,0.993199987400036,0,1,collagen type II trimer,CC,
2645,GO:0005586,1,0.99305437415975,0,1,collagen type III trimer,CC,
2646,GO:0005587,1,0.955960704951643,0,6,collagen type IV trimer,CC,
2647,GO:0005588,1,0.977851289963905,0,3,collagen type V trimer,CC,
2648,GO:0005589,1,0.979883074645499,0,3,collagen type VI trimer,CC,
2649,GO:0005590,1,0.991969891159241,0,1,collagen type VII trimer,CC,
2650,GO:0005591,1,0.993888735587382,0,1,collagen type VIII trimer,CC,
2651,GO:0005592,1,0.985472665578371,0,2,collagen type XI trimer,CC,
2652,GO:0005593,1,0.959677923288829,0,6,FACIT collagen trimer,CC,
2653,GO:0005594,1,0.981512592161377,0,3,collagen type IX trimer,CC,
2654,GO:0005595,1,0.991794596932801,0,1,collagen type XII trimer,CC,
2655,GO:0005596,1,0.992777343221931,0,1,collagen type XIV trimer,CC,
2656,GO:0005597,1,0.993021468188549,0,1,collagen type XVI trimer,CC,
2657,GO:0005598,1,0.993888735587382,0,1,short-chain collagen trimer,CC,
2658,GO:0005600,1,0.993764432238996,0,1,collagen type XIII trimer,CC,
2659,GO:0005602,1,0.988708570030597,0,2,complement component C1 complex,CC,
2660,GO:0005604,1,0.539278994307694,0,88,basement membrane,CC,
2661,GO:0005605,1,0.865619724336121,0,20,basal lamina,CC,
2662,GO:0005606,1,0.977380947744453,0,3,laminin-1 complex,CC,
2663,GO:0005607,1,0.986188162271303,0,2,laminin-2 complex,CC,
2664,GO:0005608,1,0.984911071866426,0,2,laminin-3 complex,CC,
2665,GO:0005610,1,0.977304286422058,0,3,laminin-5 complex,CC,
2666,GO:0005614,1,0.923477639849052,0,12,interstitial matrix,CC,
2672,GO:0005637,1,0.725544916731348,0,50,nuclear inner membrane,CC,
2673,GO:0005638,1,0.97525506591226,0,4,lamin filament,CC,
2674,GO:0005639,1,0.916372339995868,0,14,integral component of nuclear inner membrane,CC,
2676,GO:0005641,1,0.948046190851461,0,8,nuclear envelope lumen,CC,
2677,GO:0005642,1,0.965990936580014,0,5,annulate lamellae,CC,
2678,GO:0005643,1,0.606624875737412,0,76,nuclear pore,CC,
2679,GO:0005652,1,0.943721262577904,0,9,nuclear lamina,CC,
2681,GO:0005655,1,0.95376665597749,0,8,nucleolar ribonuclease P complex,CC,
2682,GO:0005656,1,0.982240164304097,0,3,nuclear pre-replicative complex,CC,
2683,GO:0005657,1,0.655874159249981,0,67,replication fork,CC,
2684,GO:0005658,1,0.96320338582066,0,6,alpha DNA polymerase:primase complex,CC,
2685,GO:0005662,1,0.916122753814293,0,14,DNA replication factor A complex,CC,
2686,GO:0005663,1,0.964534613189009,0,6,DNA replication factor C complex,CC,
2687,GO:0005664,1,0.945840694287015,0,9,nuclear origin of replication recognition complex,CC,
2688,GO:0005665,1,0.894760457979142,0,18,DNA-directed RNA polymerase II, core complex,CC,
2689,GO:0005666,1,0.902329445612135,0,17,DNA-directed RNA polymerase III complex,CC,
2690,GO:0005667,1,0.127900731050071,0,319,transcription factor complex,CC,
2691,GO:0005668,1,0.988294598511859,0,2,RNA polymerase transcription factor SL1 complex,CC,
2692,GO:0005669,1,0.799649805483301,0,36,transcription factor TFIID complex,CC,
2693,GO:0005671,1,0.919881360951244,0,13,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2694,GO:0005672,1,0.971280342951394,0,5,transcription factor TFIIA complex,CC,
2695,GO:0005673,1,0.988010874472462,0,2,transcription factor TFIIE complex,CC,
2696,GO:0005674,1,0.988169910485939,0,2,transcription factor TFIIF complex,CC,
2697,GO:0005675,1,0.930080356746805,0,12,holo TFIIH complex,CC,
2698,GO:0005677,1,0.947415912268866,0,8,chromatin silencing complex,CC,
2699,GO:0005680,1,0.879082272088914,0,21,anaphase-promoting complex,CC,
2700,GO:0005681,1,0.324859427792953,0,180,spliceosomal complex,CC,
2701,GO:0005682,1,0.86650117656308,0,22,U5 snRNP,CC,
2702,GO:0005683,1,0.960664716880913,0,7,U7 snRNP,CC,
2703,GO:0005684,1,0.703598330799066,0,57,U2-type spliceosomal complex,CC,
2704,GO:0005685,1,0.884707337998434,0,20,U1 snRNP,CC,
2705,GO:0005686,1,0.885764207799433,0,20,U2 snRNP,CC,
2706,GO:0005687,1,0.935306296191986,0,11,U4 snRNP,CC,
2707,GO:0005688,1,0.954659512531735,0,8,U6 snRNP,CC,
2708,GO:0005689,1,0.856309310123996,0,26,U12-type spliceosomal complex,CC,
2709,GO:0005690,1,0.994013879311082,0,1,U4atac snRNP,CC,
2710,GO:0005691,1,0.99338598736905,0,1,U6atac snRNP,CC,
2712,GO:0005697,1,0.869340600671581,0,22,telomerase holoenzyme complex,CC,
2713,GO:0005712,1,0.986359931841997,0,2,chiasma,CC,
2714,GO:0005713,1,0.993934047371008,0,1,recombination nodule,CC,
2715,GO:0005715,1,0.993934047371008,0,1,late recombination nodule,CC,
2716,GO:0005719,1,0.867395983349928,0,23,nuclear euchromatin,CC,
2717,GO:0005720,1,0.819234491960797,0,31,nuclear heterochromatin,CC,
2718,GO:0005721,1,0.881643203401723,0,19,pericentric heterochromatin,CC,
2719,GO:0005724,1,0.994173817092608,0,1,nuclear telomeric heterochromatin,CC,
2720,GO:0005726,1,0.97346982753712,0,4,perichromatin fibrils,CC,
2722,GO:0005731,1,0.994150714721825,0,1,nucleolus organizer region,CC,
2723,GO:0005732,1,0.889054279317279,0,20,small nucleolar ribonucleoprotein complex,CC,
2724,GO:0005736,1,0.928995624337007,0,12,DNA-directed RNA polymerase I complex,CC,
2729,GO:0005742,1,0.954012831211248,0,8,mitochondrial outer membrane translocase complex,CC,
2731,GO:0005744,1,0.93609040359971,0,11,mitochondrial inner membrane presequence translocase complex,CC,
2732,GO:0005745,1,0.987694217772477,0,2,m-AAA complex,CC,
2733,GO:0005746,1,0.644767948083634,0,76,mitochondrial respiratory chain,CC,
2734,GO:0005747,1,0.782228700207297,0,43,mitochondrial respiratory chain complex I,CC,
2735,GO:0005749,1,0.976592183178525,0,4,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2736,GO:0005750,1,0.936799567899081,0,11,mitochondrial respiratory chain complex III,CC,
2737,GO:0005751,1,0.929771842510743,0,13,mitochondrial respiratory chain complex IV,CC,
2738,GO:0005753,1,0.994012725500462,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
2739,GO:0005757,1,0.976623119375593,0,4,mitochondrial permeability transition pore complex,CC,
2740,GO:0005758,1,0.661518967985983,0,69,mitochondrial intermembrane space,CC,
2742,GO:0005760,1,0.986780502195506,0,2,gamma DNA polymerase complex,CC,
2743,GO:0005761,1,0.621632731445786,0,82,mitochondrial ribosome,CC,
2744,GO:0005762,1,0.748100485588092,0,50,mitochondrial large ribosomal subunit,CC,
2745,GO:0005763,1,0.855863243408862,0,27,mitochondrial small ribosomal subunit,CC,
2749,GO:0005767,1,0.923104016539805,0,13,secondary lysosome,CC,
2753,GO:0005771,1,0.805872288190148,0,35,multivesicular body,CC,
2757,GO:0005776,1,0.573506282459851,0,87,autophagosome,CC,
2760,GO:0005779,1,0.901700331408055,0,17,integral component of peroxisomal membrane,CC,
2761,GO:0005782,1,0.778328084822164,0,41,peroxisomal matrix,CC,
2763,GO:0005784,1,0.977338638365363,0,4,Sec61 translocon complex,CC,
2765,GO:0005786,1,0.964875233713692,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2766,GO:0005787,1,0.970543741926678,0,5,signal peptidase complex,CC,
2771,GO:0005793,1,0.486414227503167,0,113,endoplasmic reticulum-Golgi intermediate compartment,CC,
2773,GO:0005795,1,0.432334747067113,0,130,Golgi stack,CC,
2774,GO:0005796,1,0.607814785855547,0,77,Golgi lumen,CC,
2775,GO:0005797,1,0.951832039834609,0,8,Golgi medial cisterna,CC,
2779,GO:0005811,1,0.637817010273496,0,71,lipid droplet,CC,
2780,GO:0005813,1,0.0470095155134991,0,466,centrosome,CC,
2783,GO:0005816,1,0.962206487086862,0,6,spindle pole body,CC,
2784,GO:0005818,1,0.948288682672877,0,8,aster,CC,
2786,GO:0005826,1,0.966962381982345,0,5,actomyosin contractile ring,CC,
2787,GO:0005827,1,0.967970928906855,0,5,polar microtubule,CC,
2788,GO:0005828,1,0.9520964775296,0,7,kinetochore microtubule,CC,
2790,GO:0005832,1,0.933888928056542,0,11,chaperonin-containing T-complex,CC,
2791,GO:0005833,1,0.940198995239356,0,11,hemoglobin complex,CC,
2792,GO:0005834,1,0.815704368048404,0,33,heterotrimeric G-protein complex,CC,
2793,GO:0005838,1,0.883353399522253,0,21,proteasome regulatory particle,CC,
2794,GO:0005839,1,0.894923908845998,0,19,proteasome core complex,CC,
2795,GO:0005840,1,0.259914107284923,0,228,ribosome,CC,
2796,GO:0005844,1,0.653975080234285,0,69,polysome,CC,
2797,GO:0005845,1,0.932494131864146,0,11,mRNA cap binding complex,CC,
2798,GO:0005846,1,0.98717893768208,0,2,nuclear cap binding complex,CC,
2799,GO:0005847,1,0.903250629856347,0,16,mRNA cleavage and polyadenylation specificity factor complex,CC,
2800,GO:0005849,1,0.891610603034146,0,18,mRNA cleavage factor complex,CC,
2801,GO:0005850,1,0.974761722889743,0,4,eukaryotic translation initiation factor 2 complex,CC,
2802,GO:0005851,1,0.964366649113402,0,6,eukaryotic translation initiation factor 2B complex,CC,
2803,GO:0005852,1,0.901992664282374,0,17,eukaryotic translation initiation factor 3 complex,CC,
2804,GO:0005853,1,0.97658188071025,0,4,eukaryotic translation elongation factor 1 complex,CC,
2805,GO:0005854,1,0.987644615313021,0,2,nascent polypeptide-associated complex,CC,
2809,GO:0005861,1,0.954509970350722,0,8,troponin complex,CC,
2810,GO:0005862,1,0.975878261476582,0,4,muscle thin filament tropomyosin,CC,
2811,GO:0005863,1,0.980132026902085,0,3,striated muscle myosin thick filament,CC,
2813,GO:0005868,1,0.866901494179405,0,22,cytoplasmic dynein complex,CC,
2814,GO:0005869,1,0.952570753590982,0,8,dynactin complex,CC,
2815,GO:0005871,1,0.71314708913826,0,50,kinesin complex,CC,
2816,GO:0005873,1,0.986186219795657,0,2,plus-end kinesin complex,CC,
2819,GO:0005876,1,0.689120387260195,0,57,spindle microtubule,CC,
2820,GO:0005879,1,0.973302285110698,0,4,axonemal microtubule,CC,
2821,GO:0005880,1,0.994225652806153,0,1,nuclear microtubule,CC,
2822,GO:0005881,1,0.70416605956163,0,54,cytoplasmic microtubule,CC,
2825,GO:0005884,1,0.528046447636311,0,98,actin filament,CC,
2826,GO:0005885,1,0.937197975131584,0,11,Arp2/3 protein complex,CC,
2829,GO:0005889,1,0.987271596114889,0,2,potassium:proton exchanging ATPase complex,CC,
2832,GO:0005892,1,0.904765342131156,0,16,acetylcholine-gated channel complex,CC,
2833,GO:0005895,1,0.994021091165497,0,1,interleukin-5 receptor complex,CC,
2834,GO:0005896,1,0.981601187763268,0,3,interleukin-6 receptor complex,CC,
2835,GO:0005898,1,0.993492816263887,0,1,interleukin-13 receptor complex,CC,
2836,GO:0005899,1,0.977262676756571,0,3,insulin receptor complex,CC,
2837,GO:0005900,1,0.987362105893421,0,2,oncostatin-M receptor complex,CC,
2839,GO:0005902,1,0.617845542431484,0,74,microvillus,CC,
2843,GO:0005912,1,0.034690087922631,0,509,adherens junction,CC,
2844,GO:0005913,1,0.503273766585734,0,105,cell-cell adherens junction,CC,
2845,GO:0005914,1,0.993683562044706,0,1,spot adherens junction,CC,
2846,GO:0005915,1,0.95478877195454,0,7,zonula adherens,CC,
2847,GO:0005916,1,0.935916133431184,0,10,fascia adherens,CC,
2851,GO:0005924,1,0.0814127898833827,0,384,cell-substrate adherens junction,CC,
2852,GO:0005925,1,0.0829638808245168,0,381,focal adhesion,CC,
2853,GO:0005927,1,0.981768710754732,0,3,muscle tendon junction,CC,
2858,GO:0005942,1,0.885733870408738,0,18,phosphatidylinositol 3-kinase complex,CC,
2859,GO:0005943,1,0.986595037240293,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
2860,GO:0005944,1,0.9865051906716,0,2,phosphatidylinositol 3-kinase complex, class IB,CC,
2861,GO:0005945,1,0.987491348789311,0,2,6-phosphofructokinase complex,CC,
2862,GO:0005947,1,0.968242343169763,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2863,GO:0005952,1,0.957567570587426,0,7,cAMP-dependent protein kinase complex,CC,
2864,GO:0005953,1,0.988078277786257,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2865,GO:0005954,1,0.993931744222802,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
2866,GO:0005955,1,0.972818860021864,0,4,calcineurin complex,CC,
2867,GO:0005956,1,0.988214896271931,0,2,protein kinase CK2 complex,CC,
2868,GO:0005958,1,0.978528457961108,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2869,GO:0005960,1,0.987794455677767,0,2,glycine cleavage complex,CC,
2870,GO:0005964,1,0.967209846662748,0,5,phosphorylase kinase complex,CC,
2871,GO:0005965,1,0.98805117248067,0,2,protein farnesyltransferase complex,CC,
2872,GO:0005967,1,0.980831186970894,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
2873,GO:0005968,1,0.97457068451403,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2874,GO:0005969,1,0.992334205745111,0,1,serine-pyruvate aminotransferase complex,CC,
2875,GO:0005971,1,0.980759034698322,0,3,ribonucleoside-diphosphate reductase complex,CC,
2876,GO:0005975,1,0.0299682601142941,0,544,carbohydrate metabolic process,BP,
2877,GO:0005976,1,0.524773355335814,0,99,polysaccharide metabolic process,BP,
2878,GO:0005977,1,0.64053583281296,0,68,glycogen metabolic process,BP,
2880,GO:0005979,1,0.853669014745965,0,23,regulation of glycogen biosynthetic process,BP,
2881,GO:0005980,1,0.860201697955309,0,23,glycogen catabolic process,BP,
2882,GO:0005981,1,0.974679688276395,0,4,regulation of glycogen catabolic process,BP,
2883,GO:0005982,1,0.992768380925218,0,1,starch metabolic process,BP,
2884,GO:0005983,1,0.992768380925218,0,1,starch catabolic process,BP,
2885,GO:0005984,1,0.944573400944347,0,9,disaccharide metabolic process,BP,
2886,GO:0005985,1,0.987847571556824,0,2,sucrose metabolic process,BP,
2887,GO:0005986,1,0.994202117396691,0,1,sucrose biosynthetic process,BP,
2888,GO:0005988,1,0.981577551973637,0,3,lactose metabolic process,BP,
2889,GO:0005989,1,0.981577551973637,0,3,lactose biosynthetic process,BP,
2890,GO:0005991,1,0.993793910417337,0,1,trehalose metabolic process,BP,
2891,GO:0005996,1,0.222814217557277,0,235,monosaccharide metabolic process,BP,
2892,GO:0005997,1,0.976521467978787,0,4,xylulose metabolic process,BP,
2893,GO:0005998,1,0.993582514073817,0,1,xylulose catabolic process,BP,
2894,GO:0005999,1,0.988358560357844,0,2,xylulose biosynthetic process,BP,
2895,GO:0006000,1,0.923480437108523,0,13,fructose metabolic process,BP,
2896,GO:0006001,1,0.975866358616636,0,4,fructose catabolic process,BP,
2897,GO:0006002,1,0.950962455604862,0,8,fructose 6-phosphate metabolic process,BP,
2898,GO:0006003,1,0.974532167641154,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2899,GO:0006004,1,0.913086093520666,0,14,fucose metabolic process,BP,
2900,GO:0006006,1,0.331860180369239,0,172,glucose metabolic process,BP,
2901,GO:0006007,1,0.840634486540209,0,28,glucose catabolic process,BP,
2902,GO:0006011,1,0.961379789552954,0,6,UDP-glucose metabolic process,BP,
2903,GO:0006012,1,0.915541693171248,0,14,galactose metabolic process,BP,
2904,GO:0006013,1,0.950331221161966,0,8,mannose metabolic process,BP,
2905,GO:0006014,1,0.982813316298557,0,3,D-ribose metabolic process,BP,
2906,GO:0006015,1,0.981884148045966,0,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2907,GO:0006020,1,0.928451177350495,0,11,inositol metabolic process,BP,
2908,GO:0006021,1,0.974680678581563,0,4,inositol biosynthetic process,BP,
2910,GO:0006023,1,0.498279328094577,0,107,aminoglycan biosynthetic process,BP,
2911,GO:0006024,1,0.510713911042103,0,103,glycosaminoglycan biosynthetic process,BP,
2912,GO:0006026,1,0.679731096557822,0,60,aminoglycan catabolic process,BP,
2913,GO:0006027,1,0.70501044245619,0,54,glycosaminoglycan catabolic process,BP,
2915,GO:0006030,1,0.964268692097139,0,6,chitin metabolic process,BP,
2916,GO:0006032,1,0.964268692097139,0,6,chitin catabolic process,BP,
2917,GO:0006040,1,0.797721043757159,0,36,amino sugar metabolic process,BP,
2918,GO:0006041,1,0.975881559200363,0,4,glucosamine metabolic process,BP,
2919,GO:0006043,1,0.988112025908512,0,2,glucosamine catabolic process,BP,
2920,GO:0006044,1,0.909166827109067,0,15,N-acetylglucosamine metabolic process,BP,
2921,GO:0006045,1,0.986720870031848,0,2,N-acetylglucosamine biosynthetic process,BP,
2922,GO:0006046,1,0.982298040977064,0,3,N-acetylglucosamine catabolic process,BP,
2923,GO:0006047,1,0.910658296112777,0,15,UDP-N-acetylglucosamine metabolic process,BP,
2924,GO:0006048,1,0.933823369723422,0,11,UDP-N-acetylglucosamine biosynthetic process,BP,
2925,GO:0006049,1,0.993804220928322,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2926,GO:0006050,1,0.9884452610511,0,2,mannosamine metabolic process,BP,
2927,GO:0006051,1,0.9884452610511,0,2,N-acetylmannosamine metabolic process,BP,
2928,GO:0006054,1,0.933765434449758,0,11,N-acetylneuraminate metabolic process,BP,
2929,GO:0006055,1,0.99428875084381,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2930,GO:0006056,1,0.994134543005102,0,1,mannoprotein metabolic process,BP,
2931,GO:0006057,1,0.994134543005102,0,1,mannoprotein biosynthetic process,BP,
2932,GO:0006059,1,0.982513527122729,0,3,hexitol metabolic process,BP,
2933,GO:0006060,1,0.988193131373814,0,2,sorbitol metabolic process,BP,
2934,GO:0006061,1,0.994241679979329,0,1,sorbitol biosynthetic process,BP,
2935,GO:0006062,1,0.993916777748947,0,1,sorbitol catabolic process,BP,
2936,GO:0006063,1,0.952342270226255,0,8,uronic acid metabolic process,BP,
2937,GO:0006064,1,0.970686647241458,0,5,glucuronate catabolic process,BP,
2938,GO:0006065,1,0.980663004846773,0,3,UDP-glucuronate biosynthetic process,BP,
2940,GO:0006067,1,0.908172162764321,0,16,ethanol metabolic process,BP,
2941,GO:0006068,1,0.942527586066819,0,10,ethanol catabolic process,BP,
2942,GO:0006069,1,0.951778158681349,0,8,ethanol oxidation,BP,
2943,GO:0006071,1,0.926740277847719,0,12,glycerol metabolic process,BP,
2944,GO:0006072,1,0.947271630430093,0,8,glycerol-3-phosphate metabolic process,BP,
2945,GO:0006073,1,0.635882705379593,0,69,cellular glucan metabolic process,BP,
2946,GO:0006081,1,0.653769758164786,0,69,cellular aldehyde metabolic process,BP,
2948,GO:0006083,1,0.980433901178663,0,3,acetate metabolic process,BP,
2949,GO:0006084,1,0.804600753926547,0,34,acetyl-CoA metabolic process,BP,
2950,GO:0006085,1,0.884544464509648,0,19,acetyl-CoA biosynthetic process,BP,
2951,GO:0006086,1,0.912901251192213,0,14,acetyl-CoA biosynthetic process from pyruvate,BP,
2952,GO:0006089,1,0.933975664020086,0,11,lactate metabolic process,BP,
2953,GO:0006090,1,0.444464764960981,0,126,pyruvate metabolic process,BP,
2954,GO:0006091,1,0.0657299603397395,0,433,generation of precursor metabolites and energy,BP,
2955,GO:0006094,1,0.659906917717735,0,67,gluconeogenesis,BP,
2956,GO:0006096,1,0.550881955914381,0,92,glycolytic process,BP,
2957,GO:0006097,1,0.988153953026735,0,2,glyoxylate cycle,BP,
2958,GO:0006098,1,0.902318988445268,0,17,pentose-phosphate shunt,BP,
2959,GO:0006099,1,0.837505761344464,0,29,tricarboxylic acid cycle,BP,
2960,GO:0006101,1,0.815382334325935,0,33,citrate metabolic process,BP,
2961,GO:0006102,1,0.970707683316869,0,5,isocitrate metabolic process,BP,
2962,GO:0006103,1,0.89331811922583,0,18,2-oxoglutarate metabolic process,BP,
2963,GO:0006104,1,0.964162132002673,0,6,succinyl-CoA metabolic process,BP,
2964,GO:0006105,1,0.933546461361898,0,11,succinate metabolic process,BP,
2965,GO:0006106,1,0.982205557373088,0,3,fumarate metabolic process,BP,
2966,GO:0006107,1,0.928518987848401,0,12,oxaloacetate metabolic process,BP,
2967,GO:0006108,1,0.958418184577395,0,7,malate metabolic process,BP,
2968,GO:0006109,1,0.362115954587401,0,155,regulation of carbohydrate metabolic process,BP,
2969,GO:0006110,1,0.668194409899997,0,61,regulation of glycolytic process,BP,
2970,GO:0006111,1,0.8458442263687,0,26,regulation of gluconeogenesis,BP,
2971,GO:0006112,1,0.593741665650329,0,80,energy reserve metabolic process,BP,
2972,GO:0006114,1,0.969755147783596,0,5,glycerol biosynthetic process,BP,
2973,GO:0006116,1,0.975016952557714,0,4,NADH oxidation,BP,
2974,GO:0006117,1,0.993902537562302,0,1,acetaldehyde metabolic process,BP,
2975,GO:0006119,1,0.560749348039464,0,98,oxidative phosphorylation,BP,
2976,GO:0006120,1,0.777242510356183,0,44,mitochondrial electron transport, NADH to ubiquinone,BP,
2977,GO:0006121,1,0.976575162126717,0,4,mitochondrial electron transport, succinate to ubiquinone,BP,
2978,GO:0006122,1,0.92377676270615,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2979,GO:0006123,1,0.911412883239582,0,16,mitochondrial electron transport, cytochrome c to oxygen,BP,
2980,GO:0006127,1,0.986801508541513,0,2,glycerophosphate shuttle,BP,
2986,GO:0006148,1,0.993949885713262,0,1,inosine catabolic process,BP,
2987,GO:0006152,1,0.964124225355907,0,6,purine nucleoside catabolic process,BP,
2988,GO:0006154,1,0.988142653413691,0,2,adenosine catabolic process,BP,
2989,GO:0006157,1,0.994202694953115,0,1,deoxyadenosine catabolic process,BP,
2993,GO:0006166,1,0.970398411171209,0,5,purine ribonucleoside salvage,BP,
2994,GO:0006167,1,0.965112981508499,0,6,AMP biosynthetic process,BP,
2995,GO:0006168,1,0.98285869723903,0,3,adenine salvage,BP,
2996,GO:0006169,1,0.994053410399819,0,1,adenosine salvage,BP,
3000,GO:0006174,1,0.993846081630578,0,1,dADP phosphorylation,BP,
3001,GO:0006175,1,0.994053410399819,0,1,dATP biosynthetic process,BP,
3002,GO:0006177,1,0.97068730551242,0,5,GMP biosynthetic process,BP,
3003,GO:0006178,1,0.988360845850408,0,2,guanine salvage,BP,
3004,GO:0006182,1,0.819392329849324,0,31,cGMP biosynthetic process,BP,
3005,GO:0006183,1,0.943700172232207,0,10,GTP biosynthetic process,BP,
3006,GO:0006185,1,0.994360946082344,0,1,dGDP biosynthetic process,BP,
3007,GO:0006186,1,0.993846081630578,0,1,dGDP phosphorylation,BP,
3008,GO:0006188,1,0.939258929162659,0,10,IMP biosynthetic process,BP,
3009,GO:0006189,1,0.962839357023392,0,6,'de novo' IMP biosynthetic process,BP,
3010,GO:0006193,1,0.994329035643356,0,1,ITP catabolic process,BP,
3012,GO:0006196,1,0.986919165861427,0,2,AMP catabolic process,BP,
3013,GO:0006198,1,0.891287368288198,0,17,cAMP catabolic process,BP,
3014,GO:0006203,1,0.982332735499951,0,3,dGTP catabolic process,BP,
3015,GO:0006206,1,0.893332618254197,0,18,pyrimidine nucleobase metabolic process,BP,
3016,GO:0006207,1,0.960119861925208,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
3017,GO:0006208,1,0.981903210339295,0,3,pyrimidine nucleobase catabolic process,BP,
3018,GO:0006210,1,0.981903210339295,0,3,thymine catabolic process,BP,
3019,GO:0006211,1,0.975478339590862,0,3,5-methylcytosine catabolic process,BP,
3020,GO:0006212,1,0.987815133867722,0,2,uracil catabolic process,BP,
3021,GO:0006213,1,0.772216358188921,0,43,pyrimidine nucleoside metabolic process,BP,
3022,GO:0006214,1,0.993745557971144,0,1,thymidine catabolic process,BP,
3023,GO:0006216,1,0.953710393298115,0,8,cytidine catabolic process,BP,
3024,GO:0006218,1,0.99412385818235,0,1,uridine catabolic process,BP,
3027,GO:0006222,1,0.940405837511897,0,10,UMP biosynthetic process,BP,
3028,GO:0006226,1,0.982449232123657,0,3,dUMP biosynthetic process,BP,
3029,GO:0006227,1,0.988138766958563,0,2,dUDP biosynthetic process,BP,
3030,GO:0006228,1,0.947976187505267,0,9,UTP biosynthetic process,BP,
3031,GO:0006231,1,0.982291012174994,0,3,dTMP biosynthetic process,BP,
3032,GO:0006233,1,0.988138766958563,0,2,dTDP biosynthetic process,BP,
3033,GO:0006235,1,0.976761976502778,0,4,dTTP biosynthetic process,BP,
3034,GO:0006238,1,0.994287018170238,0,1,CMP salvage,BP,
3035,GO:0006241,1,0.926535925998902,0,13,CTP biosynthetic process,BP,
3036,GO:0006244,1,0.925885467219173,0,13,pyrimidine nucleotide catabolic process,BP,
3037,GO:0006253,1,0.994324559538955,0,1,dCTP catabolic process,BP,
3038,GO:0006256,1,0.993801070054312,0,1,UDP catabolic process,BP,
3039,GO:0006258,1,0.98831034652811,0,2,UDP-glucose catabolic process,BP,
3041,GO:0006260,1,0.169801092578358,0,275,DNA replication,BP,
3042,GO:0006261,1,0.40852703247572,0,141,DNA-dependent DNA replication,BP,
3043,GO:0006264,1,0.938330752416966,0,10,mitochondrial DNA replication,BP,
3046,GO:0006267,1,0.982240164304097,0,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
3047,GO:0006268,1,0.957441692998755,0,7,DNA unwinding involved in DNA replication,BP,
3048,GO:0006269,1,0.969186513158399,0,5,DNA replication, synthesis of RNA primer,BP,
3049,GO:0006270,1,0.770065426425344,0,42,DNA replication initiation,BP,
3050,GO:0006271,1,0.883021674201138,0,20,DNA strand elongation involved in DNA replication,BP,
3051,GO:0006272,1,0.979844303451921,0,3,leading strand elongation,BP,
3052,GO:0006273,1,0.933479777058167,0,11,lagging strand elongation,BP,
3053,GO:0006275,1,0.49668219589984,0,108,regulation of DNA replication,BP,
3054,GO:0006278,1,0.64844217005588,0,67,RNA-dependent DNA biosynthetic process,BP,
3055,GO:0006281,1,0.046442445357067,0,475,DNA repair,BP,
3056,GO:0006282,1,0.565115356319554,0,89,regulation of DNA repair,BP,
3057,GO:0006283,1,0.638144698292308,0,73,transcription-coupled nucleotide-excision repair,BP,
3058,GO:0006284,1,0.771876307212655,0,41,base-excision repair,BP,
3059,GO:0006285,1,0.942434519941662,0,10,base-excision repair, AP site formation,BP,
3060,GO:0006286,1,0.98852967583744,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
3061,GO:0006287,1,0.967978464101994,0,5,base-excision repair, gap-filling,BP,
3062,GO:0006288,1,0.98209281598569,0,3,base-excision repair, DNA ligation,BP,
3063,GO:0006289,1,0.498636132253389,0,112,nucleotide-excision repair,BP,
3064,GO:0006290,1,0.955600586695493,0,7,pyrimidine dimer repair,BP,
3065,GO:0006293,1,0.876077774021954,0,21,nucleotide-excision repair, preincision complex stabilization,BP,
3066,GO:0006294,1,0.836743228771261,0,29,nucleotide-excision repair, preincision complex assembly,BP,
3067,GO:0006295,1,0.876077774021954,0,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,
3068,GO:0006296,1,0.795576485450819,0,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,
3069,GO:0006297,1,0.867832272201473,0,23,nucleotide-excision repair, DNA gap filling,BP,
3070,GO:0006298,1,0.827115283623254,0,30,mismatch repair,BP,
3071,GO:0006301,1,0.738698206033619,0,48,postreplication repair,BP,
3072,GO:0006302,1,0.295233147546651,0,189,double-strand break repair,BP,
3073,GO:0006303,1,0.685240715991199,0,58,double-strand break repair via nonhomologous end joining,BP,
3074,GO:0006304,1,0.551323530578335,0,93,DNA modification,BP,
3075,GO:0006305,1,0.703845370092534,0,54,DNA alkylation,BP,
3076,GO:0006306,1,0.703845370092534,0,54,DNA methylation,BP,
3077,GO:0006307,1,0.940715675661612,0,10,DNA dealkylation involved in DNA repair,BP,
3078,GO:0006308,1,0.801857529102069,0,35,DNA catabolic process,BP,
3079,GO:0006309,1,0.881434665064813,0,20,apoptotic DNA fragmentation,BP,
3081,GO:0006311,1,0.975201294233609,0,4,meiotic gene conversion,BP,
3082,GO:0006312,1,0.860840587162937,0,23,mitotic recombination,BP,
3083,GO:0006313,1,0.993485094935434,0,1,transposition, DNA-mediated,BP,
3087,GO:0006334,1,0.572930833070231,0,91,nucleosome assembly,BP,
3088,GO:0006335,1,0.919765335101954,0,14,DNA replication-dependent nucleosome assembly,BP,
3089,GO:0006336,1,0.781278599637269,0,40,DNA replication-independent nucleosome assembly,BP,
3090,GO:0006337,1,0.895190074312251,0,17,nucleosome disassembly,BP,
3092,GO:0006342,1,0.621056570148007,0,75,chromatin silencing,BP,
3093,GO:0006343,1,0.99354068307125,0,1,establishment of chromatin silencing,BP,
3094,GO:0006344,1,0.972702206692436,0,4,maintenance of chromatin silencing,BP,
3095,GO:0006346,1,0.913187771778472,0,14,methylation-dependent chromatin silencing,BP,
3096,GO:0006348,1,0.950852297932634,0,8,chromatin silencing at telomere,BP,
3097,GO:0006349,1,0.899505133114291,0,16,regulation of gene expression by genetic imprinting,BP,
3099,GO:0006352,1,0.235477400542041,0,225,DNA-templated transcription, initiation,BP,
3100,GO:0006353,1,0.515025124797005,0,107,DNA-templated transcription, termination,BP,
3103,GO:0006356,1,0.822203533841174,0,30,regulation of transcription by RNA polymerase I,BP,
3105,GO:0006359,1,0.839097235448739,0,27,regulation of transcription by RNA polymerase III,BP,
3106,GO:0006360,1,0.685933872044533,0,59,transcription by RNA polymerase I,BP,
3107,GO:0006361,1,0.805226318723847,0,35,transcription initiation from RNA polymerase I promoter,BP,
3108,GO:0006362,1,0.831038928318112,0,30,transcription elongation from RNA polymerase I promoter,BP,
3109,GO:0006363,1,0.831933530644077,0,30,termination of RNA polymerase I transcription,BP,
3110,GO:0006364,1,0.220441665948407,0,249,rRNA processing,BP,
3112,GO:0006367,1,0.320896315772338,0,177,transcription initiation from RNA polymerase II promoter,BP,
3114,GO:0006369,1,0.655499714416553,0,68,termination of RNA polymerase II transcription,BP,
3115,GO:0006370,1,0.826771907393232,0,31,7-methylguanosine mRNA capping,BP,
3116,GO:0006376,1,0.841952330356069,0,27,mRNA splice site selection,BP,
3117,GO:0006378,1,0.773814908610409,0,40,mRNA polyadenylation,BP,
3118,GO:0006379,1,0.844781473510113,0,27,mRNA cleavage,BP,
3119,GO:0006382,1,0.966287196131438,0,5,adenosine to inosine editing,BP,
3120,GO:0006383,1,0.716070668059131,0,53,transcription by RNA polymerase III,BP,
3121,GO:0006384,1,0.953772013685241,0,7,transcription initiation from RNA polymerase III promoter,BP,
3122,GO:0006386,1,0.994417548221172,0,1,termination of RNA polymerase III transcription,BP,
3123,GO:0006388,1,0.920120520539388,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
3124,GO:0006390,1,0.919977713343647,0,13,mitochondrial transcription,BP,
3125,GO:0006391,1,0.981877027744806,0,3,transcription initiation from mitochondrial promoter,BP,
3126,GO:0006393,1,0.987729649828399,0,2,termination of mitochondrial transcription,BP,
3127,GO:0006396,1,0.00327952134812113,0,893,RNA processing,BP,
3128,GO:0006397,1,0.0544742999444044,0,457,mRNA processing,BP,
3129,GO:0006398,1,0.968970102722671,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
3130,GO:0006399,1,0.328371495812476,0,181,tRNA metabolic process,BP,
3131,GO:0006400,1,0.638566002102054,0,73,tRNA modification,BP,
3132,GO:0006401,1,0.103475666012168,0,362,RNA catabolic process,BP,
3133,GO:0006402,1,0.124285579287459,0,333,mRNA catabolic process,BP,
3134,GO:0006403,1,0.249055776893056,0,216,RNA localization,BP,
3135,GO:0006404,1,0.980452940406847,0,3,RNA import into nucleus,BP,
3136,GO:0006405,1,0.422136074821313,0,135,RNA export from nucleus,BP,
3137,GO:0006406,1,0.513245220169102,0,104,mRNA export from nucleus,BP,
3138,GO:0006407,1,0.980855294587806,0,3,rRNA export from nucleus,BP,
3139,GO:0006408,1,0.988219182411416,0,2,snRNA export from nucleus,BP,
3140,GO:0006409,1,0.815697194269152,0,31,tRNA export from nucleus,BP,
3141,GO:0006412,1,0.0163662010296904,0,652,translation,BP,
3142,GO:0006413,1,0.314790964758362,0,191,translational initiation,BP,
3143,GO:0006414,1,0.469558760928674,0,126,translational elongation,BP,
3144,GO:0006415,1,0.557023650667811,0,99,translational termination,BP,
3145,GO:0006417,1,0.0817459886997668,0,387,regulation of translation,BP,
3146,GO:0006418,1,0.739763076525727,0,49,tRNA aminoacylation for protein translation,BP,
3147,GO:0006419,1,0.981162215065408,0,3,alanyl-tRNA aminoacylation,BP,
3148,GO:0006420,1,0.982244255020542,0,3,arginyl-tRNA aminoacylation,BP,
3149,GO:0006421,1,0.981598468700525,0,3,asparaginyl-tRNA aminoacylation,BP,
3150,GO:0006422,1,0.993973223694307,0,1,aspartyl-tRNA aminoacylation,BP,
3151,GO:0006423,1,0.98802363068898,0,2,cysteinyl-tRNA aminoacylation,BP,
3152,GO:0006424,1,0.986759576640946,0,2,glutamyl-tRNA aminoacylation,BP,
3153,GO:0006425,1,0.987225229956847,0,2,glutaminyl-tRNA aminoacylation,BP,
3154,GO:0006426,1,0.988072296337391,0,2,glycyl-tRNA aminoacylation,BP,
3155,GO:0006427,1,0.988039252998985,0,2,histidyl-tRNA aminoacylation,BP,
3156,GO:0006428,1,0.987019994625188,0,2,isoleucyl-tRNA aminoacylation,BP,
3157,GO:0006429,1,0.986721526598797,0,2,leucyl-tRNA aminoacylation,BP,
3158,GO:0006430,1,0.994037393144533,0,1,lysyl-tRNA aminoacylation,BP,
3159,GO:0006431,1,0.987649038901729,0,2,methionyl-tRNA aminoacylation,BP,
3160,GO:0006432,1,0.970233053518078,0,5,phenylalanyl-tRNA aminoacylation,BP,
3161,GO:0006433,1,0.981600485394515,0,3,prolyl-tRNA aminoacylation,BP,
3162,GO:0006434,1,0.988180712921334,0,2,seryl-tRNA aminoacylation,BP,
3163,GO:0006435,1,0.981586502148511,0,3,threonyl-tRNA aminoacylation,BP,
3164,GO:0006436,1,0.987740789119075,0,2,tryptophanyl-tRNA aminoacylation,BP,
3165,GO:0006437,1,0.987806242429374,0,2,tyrosyl-tRNA aminoacylation,BP,
3166,GO:0006438,1,0.980380396011027,0,3,valyl-tRNA aminoacylation,BP,
3167,GO:0006446,1,0.626296542234763,0,74,regulation of translational initiation,BP,
3168,GO:0006447,1,0.980707388914564,0,3,regulation of translational initiation by iron,BP,
3169,GO:0006448,1,0.891997491434718,0,18,regulation of translational elongation,BP,
3170,GO:0006449,1,0.950287963007593,0,8,regulation of translational termination,BP,
3171,GO:0006450,1,0.895922442367279,0,18,regulation of translational fidelity,BP,
3172,GO:0006451,1,0.9496885420506,0,8,translational readthrough,BP,
3173,GO:0006452,1,0.980987326899285,0,3,translational frameshifting,BP,
3176,GO:0006463,1,0.993569096334577,0,1,steroid hormone receptor complex assembly,BP,
3178,GO:0006465,1,0.885926002354254,0,20,signal peptide processing,BP,
3182,GO:0006471,1,0.848246749867095,0,26,protein ADP-ribosylation,BP,
3183,GO:0006473,1,0.326415531233097,0,174,protein acetylation,BP,
3184,GO:0006474,1,0.900874747150163,0,16,N-terminal protein amino acid acetylation,BP,
3185,GO:0006475,1,0.389109698399779,0,146,internal protein amino acid acetylation,BP,
3186,GO:0006476,1,0.536503102514273,0,95,protein deacetylation,BP,
3187,GO:0006477,1,0.962027803148529,0,6,protein sulfation,BP,
3188,GO:0006478,1,0.988173678354216,0,2,peptidyl-tyrosine sulfation,BP,
3189,GO:0006479,1,0.345946882217205,0,163,protein methylation,BP,
3190,GO:0006480,1,0.988256590117764,0,2,N-terminal protein amino acid methylation,BP,
3191,GO:0006481,1,0.981457495384058,0,3,C-terminal protein methylation,BP,
3192,GO:0006482,1,0.81999938061161,0,29,protein demethylation,BP,
3193,GO:0006486,1,0.217795879829085,0,236,protein glycosylation,BP,
3194,GO:0006487,1,0.573593536064864,0,89,protein N-linked glycosylation,BP,
3195,GO:0006488,1,0.882171262115558,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
3196,GO:0006489,1,0.957817901991301,0,7,dolichyl diphosphate biosynthetic process,BP,
3197,GO:0006490,1,0.87679644344133,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
3198,GO:0006491,1,0.886353505007487,0,18,N-glycan processing,BP,
3199,GO:0006493,1,0.518104117578276,0,101,protein O-linked glycosylation,BP,
3202,GO:0006499,1,0.97293433042808,0,4,N-terminal protein myristoylation,BP,
3204,GO:0006501,1,0.69925223018652,0,57,C-terminal protein lipidation,BP,
3205,GO:0006505,1,0.817071208151461,0,33,GPI anchor metabolic process,BP,
3206,GO:0006506,1,0.826790296460796,0,31,GPI anchor biosynthetic process,BP,
3207,GO:0006507,1,0.993985762594839,0,1,GPI anchor release,BP,
3209,GO:0006509,1,0.774263168761269,0,40,membrane protein ectodomain proteolysis,BP,
3211,GO:0006513,1,0.662764882174455,0,63,protein monoubiquitination,BP,
3212,GO:0006515,1,0.851427841766968,0,25,protein quality control for misfolded or incompletely synthesized proteins,BP,
3214,GO:0006517,1,0.802145978767908,0,34,protein deglycosylation,BP,
3217,GO:0006521,1,0.720999341572027,0,55,regulation of cellular amino acid metabolic process,BP,
3218,GO:0006522,1,0.97620048226098,0,4,alanine metabolic process,BP,
3219,GO:0006524,1,0.97620048226098,0,4,alanine catabolic process,BP,
3220,GO:0006525,1,0.881768845363437,0,20,arginine metabolic process,BP,
3221,GO:0006526,1,0.962579288747637,0,6,arginine biosynthetic process,BP,
3222,GO:0006527,1,0.932541890130664,0,11,arginine catabolic process,BP,
3223,GO:0006528,1,0.970605648840643,0,5,asparagine metabolic process,BP,
3224,GO:0006529,1,0.987944318337479,0,2,asparagine biosynthetic process,BP,
3225,GO:0006530,1,0.988105898771939,0,2,asparagine catabolic process,BP,
3227,GO:0006532,1,0.988006515182358,0,2,aspartate biosynthetic process,BP,
3229,GO:0006534,1,0.922794191484279,0,13,cysteine metabolic process,BP,
3230,GO:0006535,1,0.993895779497771,0,1,cysteine biosynthetic process from serine,BP,
3231,GO:0006536,1,0.825121554829889,0,31,glutamate metabolic process,BP,
3232,GO:0006537,1,0.968884436295888,0,5,glutamate biosynthetic process,BP,
3233,GO:0006538,1,0.945446516730916,0,9,glutamate catabolic process,BP,
3234,GO:0006539,1,0.994097580682139,0,1,glutamate catabolic process via 2-oxoglutarate,BP,
3235,GO:0006540,1,0.981132194076262,0,3,glutamate decarboxylation to succinate,BP,
3236,GO:0006541,1,0.861625916933899,0,23,glutamine metabolic process,BP,
3237,GO:0006542,1,0.986523926751495,0,2,glutamine biosynthetic process,BP,
3238,GO:0006543,1,0.980970108682079,0,3,glutamine catabolic process,BP,
3239,GO:0006544,1,0.940824686216676,0,10,glycine metabolic process,BP,
3240,GO:0006545,1,0.982225852607524,0,3,glycine biosynthetic process,BP,
3241,GO:0006546,1,0.981914865995692,0,3,glycine catabolic process,BP,
3244,GO:0006549,1,0.968582131911548,0,5,isoleucine metabolic process,BP,
3245,GO:0006550,1,0.988242444445787,0,2,isoleucine catabolic process,BP,
3246,GO:0006551,1,0.950662797657169,0,8,leucine metabolic process,BP,
3247,GO:0006552,1,0.963690086435708,0,6,leucine catabolic process,BP,
3248,GO:0006553,1,0.922032675299126,0,13,lysine metabolic process,BP,
3249,GO:0006554,1,0.927769619255766,0,12,lysine catabolic process,BP,
3250,GO:0006555,1,0.881335652020205,0,20,methionine metabolic process,BP,
3251,GO:0006556,1,0.981654924886293,0,3,S-adenosylmethionine biosynthetic process,BP,
3252,GO:0006557,1,0.993705980361278,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3253,GO:0006558,1,0.942527961727752,0,10,L-phenylalanine metabolic process,BP,
3254,GO:0006559,1,0.942527961727752,0,10,L-phenylalanine catabolic process,BP,
3255,GO:0006560,1,0.958625313101864,0,7,proline metabolic process,BP,
3256,GO:0006561,1,0.976193014438616,0,4,proline biosynthetic process,BP,
3257,GO:0006562,1,0.982008250768385,0,3,proline catabolic process,BP,
3258,GO:0006563,1,0.936330383923158,0,11,L-serine metabolic process,BP,
3259,GO:0006564,1,0.964763581598855,0,6,L-serine biosynthetic process,BP,
3260,GO:0006565,1,0.976466686506697,0,4,L-serine catabolic process,BP,
3261,GO:0006566,1,0.976852692032042,0,4,threonine metabolic process,BP,
3262,GO:0006567,1,0.982714548907815,0,3,threonine catabolic process,BP,
3263,GO:0006568,1,0.945884162449649,0,9,tryptophan metabolic process,BP,
3264,GO:0006569,1,0.958938004693819,0,7,tryptophan catabolic process,BP,
3265,GO:0006570,1,0.953738379284569,0,8,tyrosine metabolic process,BP,
3266,GO:0006572,1,0.965228589730966,0,6,tyrosine catabolic process,BP,
3267,GO:0006573,1,0.944036111824317,0,9,valine metabolic process,BP,
3268,GO:0006574,1,0.976400616307806,0,4,valine catabolic process,BP,
3270,GO:0006576,1,0.75028718869071,0,47,cellular biogenic amine metabolic process,BP,
3271,GO:0006577,1,0.900012581770506,0,17,amino-acid betaine metabolic process,BP,
3272,GO:0006578,1,0.957674104035778,0,7,amino-acid betaine biosynthetic process,BP,
3273,GO:0006579,1,0.981717790162583,0,3,amino-acid betaine catabolic process,BP,
3274,GO:0006580,1,0.993869194827968,0,1,ethanolamine metabolic process,BP,
3275,GO:0006581,1,0.987716832418492,0,2,acetylcholine catabolic process,BP,
3276,GO:0006582,1,0.90023977868888,0,16,melanin metabolic process,BP,
3277,GO:0006583,1,0.993968468535158,0,1,melanin biosynthetic process from tyrosine,BP,
3279,GO:0006585,1,0.994096425701739,0,1,dopamine biosynthetic process from tyrosine,BP,
3280,GO:0006586,1,0.923716654723659,0,13,indolalkylamine metabolic process,BP,
3281,GO:0006589,1,0.987654759371155,0,2,octopamine biosynthetic process,BP,
3282,GO:0006590,1,0.918540571272184,0,13,thyroid hormone generation,BP,
3283,GO:0006591,1,0.946997174718228,0,9,ornithine metabolic process,BP,
3284,GO:0006592,1,0.99364673542535,0,1,ornithine biosynthetic process,BP,
3285,GO:0006593,1,0.994170062963291,0,1,ornithine catabolic process,BP,
3286,GO:0006595,1,0.909531345869251,0,16,polyamine metabolic process,BP,
3287,GO:0006596,1,0.925464817185024,0,13,polyamine biosynthetic process,BP,
3288,GO:0006597,1,0.987900311611612,0,2,spermine biosynthetic process,BP,
3289,GO:0006598,1,0.965721798460478,0,6,polyamine catabolic process,BP,
3290,GO:0006600,1,0.940226387071673,0,10,creatine metabolic process,BP,
3291,GO:0006601,1,0.988290209019686,0,2,creatine biosynthetic process,BP,
3293,GO:0006606,1,0.435362227870573,0,128,protein import into nucleus,BP,
3294,GO:0006607,1,0.871408290082249,0,20,NLS-bearing protein import into nucleus,BP,
3295,GO:0006610,1,0.948022085682013,0,8,ribosomal protein import into nucleus,BP,
3296,GO:0006611,1,0.329491069526465,0,173,protein export from nucleus,BP,
3297,GO:0006612,1,0.344813347135506,0,177,protein targeting to membrane,BP,
3298,GO:0006613,1,0.578901694923987,0,95,cotranslational protein targeting to membrane,BP,
3299,GO:0006614,1,0.598719827265767,0,90,SRP-dependent cotranslational protein targeting to membrane,BP,
3300,GO:0006616,1,0.965380025345871,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3301,GO:0006617,1,0.988423610618996,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3302,GO:0006620,1,0.956173895110274,0,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3303,GO:0006621,1,0.940181606682409,0,10,protein retention in ER lumen,BP,
3304,GO:0006622,1,0.882073245892925,0,19,protein targeting to lysosome,BP,
3305,GO:0006623,1,0.809719134634029,0,31,protein targeting to vacuole,BP,
3306,GO:0006624,1,0.988494777011294,0,2,vacuolar protein processing,BP,
3309,GO:0006627,1,0.951623205337637,0,8,protein processing involved in protein targeting to mitochondrion,BP,
3313,GO:0006635,1,0.644548915949517,0,70,fatty acid beta-oxidation,BP,
3315,GO:0006637,1,0.565353622906496,0,91,acyl-CoA metabolic process,BP,
3316,GO:0006638,1,0.564285118558487,0,90,neutral lipid metabolic process,BP,
3317,GO:0006639,1,0.567864234731353,0,89,acylglycerol metabolic process,BP,
3318,GO:0006641,1,0.6227961911359,0,75,triglyceride metabolic process,BP,
3319,GO:0006642,1,0.971463008263326,0,4,triglyceride mobilization,BP,
3323,GO:0006649,1,0.98631180140304,0,2,phospholipid transfer to membrane,BP,
3325,GO:0006651,1,0.986965584174884,0,2,diacylglycerol biosynthetic process,BP,
3326,GO:0006654,1,0.80705194102879,0,33,phosphatidic acid biosynthetic process,BP,
3327,GO:0006655,1,0.939736695822909,0,10,phosphatidylglycerol biosynthetic process,BP,
3328,GO:0006656,1,0.815321638971853,0,33,phosphatidylcholine biosynthetic process,BP,
3329,GO:0006657,1,0.957616429366473,0,7,CDP-choline pathway,BP,
3330,GO:0006658,1,0.86205023668961,0,24,phosphatidylserine metabolic process,BP,
3331,GO:0006659,1,0.975714074141797,0,4,phosphatidylserine biosynthetic process,BP,
3332,GO:0006660,1,0.99413223276175,0,1,phosphatidylserine catabolic process,BP,
3334,GO:0006662,1,0.929038388418245,0,12,glycerol ether metabolic process,BP,
3335,GO:0006663,1,0.975416399698968,0,4,platelet activating factor biosynthetic process,BP,
3336,GO:0006664,1,0.478424001243379,0,118,glycolipid metabolic process,BP,
3338,GO:0006666,1,0.993150714099861,0,1,3-keto-sphinganine metabolic process,BP,
3339,GO:0006667,1,0.981027051370399,0,3,sphinganine metabolic process,BP,
3340,GO:0006668,1,0.987525351793317,0,2,sphinganine-1-phosphate metabolic process,BP,
3341,GO:0006669,1,0.993791906069198,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3342,GO:0006670,1,0.934179625987224,0,11,sphingosine metabolic process,BP,
3343,GO:0006671,1,0.993383405662179,0,1,phytosphingosine metabolic process,BP,
3344,GO:0006672,1,0.590107334759021,0,84,ceramide metabolic process,BP,
3345,GO:0006677,1,0.894959933417463,0,18,glycosylceramide metabolic process,BP,
3346,GO:0006678,1,0.956823640571113,0,7,glucosylceramide metabolic process,BP,
3347,GO:0006679,1,0.987391540958619,0,2,glucosylceramide biosynthetic process,BP,
3348,GO:0006680,1,0.981512230845539,0,3,glucosylceramide catabolic process,BP,
3349,GO:0006681,1,0.951776882788481,0,8,galactosylceramide metabolic process,BP,
3350,GO:0006682,1,0.970032415617911,0,5,galactosylceramide biosynthetic process,BP,
3351,GO:0006683,1,0.9938073721994,0,1,galactosylceramide catabolic process,BP,
3352,GO:0006684,1,0.921293482564166,0,13,sphingomyelin metabolic process,BP,
3353,GO:0006685,1,0.968768110431737,0,5,sphingomyelin catabolic process,BP,
3354,GO:0006686,1,0.962281579333492,0,6,sphingomyelin biosynthetic process,BP,
3355,GO:0006687,1,0.650008256775036,0,68,glycosphingolipid metabolic process,BP,
3356,GO:0006688,1,0.869213292190487,0,22,glycosphingolipid biosynthetic process,BP,
3357,GO:0006689,1,0.969948190773218,0,5,ganglioside catabolic process,BP,
3359,GO:0006691,1,0.885745203832735,0,20,leukotriene metabolic process,BP,
3364,GO:0006696,1,0.988102520242584,0,2,ergosterol biosynthetic process,BP,
3365,GO:0006699,1,0.819751660220648,0,32,bile acid biosynthetic process,BP,
3366,GO:0006700,1,0.882747987267454,0,20,C21-steroid hormone biosynthetic process,BP,
3367,GO:0006701,1,0.96833778236092,0,5,progesterone biosynthetic process,BP,
3368,GO:0006702,1,0.956900665173447,0,7,androgen biosynthetic process,BP,
3369,GO:0006703,1,0.942078102650158,0,10,estrogen biosynthetic process,BP,
3370,GO:0006704,1,0.921628438610198,0,13,glucocorticoid biosynthetic process,BP,
3371,GO:0006705,1,0.949970937428906,0,8,mineralocorticoid biosynthetic process,BP,
3372,GO:0006706,1,0.884711258009705,0,20,steroid catabolic process,BP,
3373,GO:0006707,1,0.946145412454657,0,9,cholesterol catabolic process,BP,
3374,GO:0006710,1,0.976083382453465,0,4,androgen catabolic process,BP,
3375,GO:0006711,1,0.99413223276175,0,1,estrogen catabolic process,BP,
3376,GO:0006713,1,0.99413021130263,0,1,glucocorticoid catabolic process,BP,
3377,GO:0006714,1,0.988510436109051,0,2,sesquiterpenoid metabolic process,BP,
3380,GO:0006722,1,0.99395204603589,0,1,triterpenoid metabolic process,BP,
3382,GO:0006726,1,0.98126895710978,0,3,eye pigment biosynthetic process,BP,
3383,GO:0006729,1,0.959409760868636,0,7,tetrahydrobiopterin biosynthetic process,BP,
3384,GO:0006730,1,0.815135347260241,0,33,one-carbon metabolic process,BP,
3386,GO:0006733,1,0.335513780306106,0,172,oxidoreduction coenzyme metabolic process,BP,
3387,GO:0006734,1,0.805313693487113,0,35,NADH metabolic process,BP,
3388,GO:0006735,1,0.862450127022646,0,24,NADH regeneration,BP,
3389,GO:0006738,1,0.993949885713262,0,1,nicotinamide riboside catabolic process,BP,
3390,GO:0006739,1,0.817562977845668,0,33,NADP metabolic process,BP,
3391,GO:0006740,1,0.981361799567107,0,3,NADPH regeneration,BP,
3392,GO:0006741,1,0.975607539018377,0,4,NADP biosynthetic process,BP,
3393,GO:0006742,1,0.982449198422608,0,3,NADP catabolic process,BP,
3394,GO:0006743,1,0.914140642107537,0,15,ubiquinone metabolic process,BP,
3395,GO:0006744,1,0.920267073405664,0,14,ubiquinone biosynthetic process,BP,
3396,GO:0006747,1,0.994077225514179,0,1,FAD biosynthetic process,BP,
3397,GO:0006749,1,0.760391115950319,0,46,glutathione metabolic process,BP,
3398,GO:0006750,1,0.918396590177224,0,14,glutathione biosynthetic process,BP,
3399,GO:0006751,1,0.970614679419533,0,5,glutathione catabolic process,BP,
3401,GO:0006754,1,0.478612956678236,0,115,ATP biosynthetic process,BP,
3402,GO:0006756,1,0.993846081630578,0,1,AMP phosphorylation,BP,
3403,GO:0006757,1,0.547471248178978,0,93,ATP generation from ADP,BP,
3406,GO:0006767,1,0.586818332559345,0,84,water-soluble vitamin metabolic process,BP,
3407,GO:0006768,1,0.937750809901528,0,10,biotin metabolic process,BP,
3408,GO:0006771,1,0.956975289324316,0,7,riboflavin metabolic process,BP,
3409,GO:0006772,1,0.976110504437744,0,4,thiamine metabolic process,BP,
3411,GO:0006776,1,0.957626061778814,0,7,vitamin A metabolic process,BP,
3412,GO:0006777,1,0.963423613916695,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3413,GO:0006778,1,0.824553520652708,0,31,porphyrin-containing compound metabolic process,BP,
3414,GO:0006779,1,0.865020868133,0,23,porphyrin-containing compound biosynthetic process,BP,
3415,GO:0006780,1,0.988309194574336,0,2,uroporphyrinogen III biosynthetic process,BP,
3416,GO:0006781,1,0.994020514183732,0,1,succinyl-CoA pathway,BP,
3417,GO:0006782,1,0.953457389590727,0,8,protoporphyrinogen IX biosynthetic process,BP,
3418,GO:0006783,1,0.887865037532796,0,19,heme biosynthetic process,BP,
3419,GO:0006784,1,0.9864376874449,0,2,heme a biosynthetic process,BP,
3420,GO:0006787,1,0.977272184932079,0,4,porphyrin-containing compound catabolic process,BP,
3421,GO:0006788,1,0.988376639351477,0,2,heme oxidation,BP,
3425,GO:0006797,1,0.966385179851048,0,5,polyphosphate metabolic process,BP,
3426,GO:0006798,1,0.972390987546153,0,4,polyphosphate catabolic process,BP,
3427,GO:0006801,1,0.706113488016156,0,56,superoxide metabolic process,BP,
3428,GO:0006805,1,0.564859667384507,0,93,xenobiotic metabolic process,BP,
3430,GO:0006808,1,0.982085792774054,0,3,regulation of nitrogen utilization,BP,
3431,GO:0006809,1,0.689462039773304,0,58,nitric oxide biosynthetic process,BP,
3441,GO:0006824,1,0.975962499746256,0,4,cobalt ion transport,BP,
3442,GO:0006825,1,0.880199736028967,0,20,copper ion transport,BP,
3444,GO:0006828,1,0.937181695463881,0,10,manganese ion transport,BP,
3446,GO:0006833,1,0.911413026470875,0,15,water transport,BP,
3449,GO:0006837,1,0.911520493780924,0,15,serotonin transport,BP,
3451,GO:0006842,1,0.975068553183937,0,4,tricarboxylic acid transport,BP,
3452,GO:0006843,1,0.994183924354294,0,1,mitochondrial citrate transmembrane transport,BP,
3453,GO:0006844,1,0.988105173172474,0,2,acyl carnitine transport,BP,
3454,GO:0006848,1,0.975668784417214,0,4,pyruvate transport,BP,
3455,GO:0006850,1,0.987729649828399,0,2,mitochondrial pyruvate transmembrane transport,BP,
3456,GO:0006851,1,0.872196330845863,0,22,mitochondrial calcium ion transmembrane transport,BP,
3457,GO:0006853,1,0.941603712492689,0,9,carnitine shuttle,BP,
3459,GO:0006857,1,0.950141067703617,0,8,oligopeptide transport,BP,
3460,GO:0006858,1,0.982083420750924,0,3,extracellular transport,BP,
3462,GO:0006863,1,0.964242458141798,0,6,purine nucleobase transport,BP,
3463,GO:0006864,1,0.987569214767059,0,2,pyrimidine nucleotide transport,BP,
3465,GO:0006867,1,0.987817370384368,0,2,asparagine transport,BP,
3466,GO:0006868,1,0.962764026173822,0,6,glutamine transport,BP,
3467,GO:0006869,1,0.153971797180656,0,287,lipid transport,BP,
3471,GO:0006876,1,0.993535684404757,0,1,cellular cadmium ion homeostasis,BP,
3472,GO:0006878,1,0.921589828891698,0,13,cellular copper ion homeostasis,BP,
3474,GO:0006880,1,0.982854705789887,0,3,intracellular sequestering of iron ion,BP,
3476,GO:0006883,1,0.896116871497509,0,17,cellular sodium ion homeostasis,BP,
3477,GO:0006884,1,0.86548692294674,0,22,cell volume homeostasis,BP,
3478,GO:0006885,1,0.542435262341028,0,96,regulation of pH,BP,
3481,GO:0006888,1,0.30059224402175,0,186,ER to Golgi vesicle-mediated transport,BP,
3482,GO:0006890,1,0.603309061900896,0,79,retrograde vesicle-mediated transport, Golgi to ER,BP,
3483,GO:0006891,1,0.811755358161382,0,33,intra-Golgi vesicle-mediated transport,BP,
3484,GO:0006892,1,0.543047489311535,0,92,post-Golgi vesicle-mediated transport,BP,
3485,GO:0006893,1,0.735364825701697,0,47,Golgi to plasma membrane transport,BP,
3486,GO:0006895,1,0.875619226725469,0,19,Golgi to endosome transport,BP,
3487,GO:0006896,1,0.914358933635505,0,14,Golgi to vacuole transport,BP,
3490,GO:0006900,1,0.549134410191561,0,93,vesicle budding from membrane,BP,
3491,GO:0006901,1,0.654809989696442,0,66,vesicle coating,BP,
3492,GO:0006903,1,0.578765561258565,0,85,vesicle targeting,BP,
3493,GO:0006904,1,0.738716917665729,0,48,vesicle docking involved in exocytosis,BP,
3494,GO:0006906,1,0.384366506408156,0,149,vesicle fusion,BP,
3495,GO:0006907,1,0.892989288409382,0,18,pinocytosis,BP,
3496,GO:0006909,1,0.248337495977671,0,219,phagocytosis,BP,
3497,GO:0006910,1,0.916148551947428,0,14,phagocytosis, recognition,BP,
3498,GO:0006911,1,0.756678245913799,0,44,phagocytosis, engulfment,BP,
3499,GO:0006913,1,0.122802451763059,0,324,nucleocytoplasmic transport,BP,
3504,GO:0006924,1,0.946201014946677,0,9,activation-induced cell death of T cells,BP,
3505,GO:0006925,1,0.898848909011116,0,17,inflammatory cell apoptotic process,BP,
3507,GO:0006929,1,0.847501230801163,0,25,substrate-dependent cell migration,BP,
3508,GO:0006930,1,0.949609040241594,0,8,substrate-dependent cell migration, cell extension,BP,
3509,GO:0006931,1,0.973585505833853,0,4,substrate-dependent cell migration, cell attachment to substrate,BP,
3510,GO:0006933,1,0.981466112506151,0,3,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
3518,GO:0006948,1,0.993750704474997,0,1,induction by virus of host cell-cell fusion,BP,
3519,GO:0006949,1,0.778579960026902,0,38,syncytium formation,BP,
3522,GO:0006953,1,0.801854443421354,0,36,acute-phase response,BP,
3525,GO:0006956,1,0.738502778732015,0,49,complement activation,BP,
3526,GO:0006957,1,0.937653529110509,0,10,complement activation, alternative pathway,BP,
3527,GO:0006958,1,0.849857196671747,0,26,complement activation, classical pathway,BP,
3528,GO:0006959,1,0.38081877705583,0,160,humoral immune response,BP,
3529,GO:0006968,1,0.741104031706084,0,49,cellular defense response,BP,
3530,GO:0006970,1,0.655992237191764,0,66,response to osmotic stress,BP,
3531,GO:0006971,1,0.940586054662005,0,9,hypotonic response,BP,
3532,GO:0006972,1,0.881626574430259,0,20,hyperosmotic response,BP,
3534,GO:0006975,1,0.949630795121009,0,8,DNA damage induced protein phosphorylation,BP,
3535,GO:0006977,1,0.684835321337447,0,60,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,
3536,GO:0006978,1,0.883020922067199,0,19,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
3538,GO:0006982,1,0.988553782459485,0,2,response to lipid hydroperoxide,BP,
3539,GO:0006983,1,0.937247897719143,0,10,ER overload response,BP,
3542,GO:0006987,1,0.951043237250272,0,8,activation of signaling protein activity involved in unfolded protein response,BP,
3543,GO:0006990,1,0.98047624847659,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3544,GO:0006991,1,0.93822784732983,0,10,response to sterol depletion,BP,
3545,GO:0006995,1,0.936609815980278,0,11,cellular response to nitrogen starvation,BP,
3547,GO:0006997,1,0.421385472439215,0,132,nucleus organization,BP,
3548,GO:0006998,1,0.593617406918451,0,81,nuclear envelope organization,BP,
3549,GO:0006999,1,0.904999010245843,0,15,nuclear pore organization,BP,
3550,GO:0007000,1,0.956458113887769,0,7,nucleolus organization,BP,
3551,GO:0007004,1,0.657966719395632,0,65,telomere maintenance via telomerase,BP,
3554,GO:0007007,1,0.875758623005917,0,22,inner mitochondrial membrane organization,BP,
3555,GO:0007008,1,0.99367214148164,0,1,outer mitochondrial membrane organization,BP,
3558,GO:0007014,1,0.993577518319972,0,1,actin ubiquitination,BP,
3560,GO:0007016,1,0.92905942987422,0,10,cytoskeletal anchoring at plasma membrane,BP,
3563,GO:0007019,1,0.77606871627345,0,38,microtubule depolymerization,BP,
3564,GO:0007020,1,0.846835747532561,0,25,microtubule nucleation,BP,
3565,GO:0007021,1,0.959633104149772,0,7,tubulin complex assembly,BP,
3566,GO:0007023,1,0.976281873921131,0,4,post-chaperonin tubulin folding pathway,BP,
3567,GO:0007026,1,0.863316342562387,0,22,negative regulation of microtubule depolymerization,BP,
3568,GO:0007028,1,0.939487971277354,0,9,cytoplasm organization,BP,
3569,GO:0007029,1,0.744502070301144,0,46,endoplasmic reticulum organization,BP,
3570,GO:0007030,1,0.429199355586461,0,128,Golgi organization,BP,
3572,GO:0007032,1,0.644458952157306,0,69,endosome organization,BP,
3573,GO:0007033,1,0.37311134031626,0,153,vacuole organization,BP,
3574,GO:0007034,1,0.44628690970322,0,123,vacuolar transport,BP,
3575,GO:0007035,1,0.870229487642525,0,22,vacuolar acidification,BP,
3577,GO:0007040,1,0.689100818179942,0,58,lysosome organization,BP,
3578,GO:0007041,1,0.541961454328942,0,93,lysosomal transport,BP,
3579,GO:0007042,1,0.953930548042886,0,8,lysosomal lumen acidification,BP,
3584,GO:0007050,1,0.221989537070912,0,235,cell cycle arrest,BP,
3585,GO:0007051,1,0.341859825249528,0,163,spindle organization,BP,
3586,GO:0007052,1,0.499427872219295,0,106,mitotic spindle organization,BP,
3587,GO:0007056,1,0.988056635240022,0,2,spindle assembly involved in female meiosis,BP,
3588,GO:0007057,1,0.988056635240022,0,2,spindle assembly involved in female meiosis I,BP,
3590,GO:0007060,1,0.975602321730552,0,4,male meiosis chromosome segregation,BP,
3591,GO:0007062,1,0.451321942483699,0,123,sister chromatid cohesion,BP,
3592,GO:0007063,1,0.881027038729015,0,19,regulation of sister chromatid cohesion,BP,
3593,GO:0007064,1,0.878730959610873,0,19,mitotic sister chromatid cohesion,BP,
3594,GO:0007066,1,0.99437654043272,0,1,female meiosis sister chromatid cohesion,BP,
3595,GO:0007072,1,0.994150714721825,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3596,GO:0007076,1,0.878558808418632,0,16,mitotic chromosome condensation,BP,
3597,GO:0007077,1,0.760536580025049,0,42,mitotic nuclear envelope disassembly,BP,
3598,GO:0007079,1,0.979491774059471,0,3,mitotic chromosome movement towards spindle pole,BP,
3599,GO:0007080,1,0.760910507154142,0,44,mitotic metaphase plate congression,BP,
3600,GO:0007084,1,0.941378746825557,0,10,mitotic nuclear envelope reassembly,BP,
3602,GO:0007089,1,0.974438592590972,0,4,traversing start control point of mitotic cell cycle,BP,
3603,GO:0007091,1,0.719044188435558,0,51,metaphase/anaphase transition of mitotic cell cycle,BP,
3605,GO:0007094,1,0.818703462188556,0,31,mitotic spindle assembly checkpoint,BP,
3606,GO:0007095,1,0.882642049287989,0,19,mitotic G2 DNA damage checkpoint,BP,
3607,GO:0007096,1,0.905350137643309,0,16,regulation of exit from mitosis,BP,
3608,GO:0007097,1,0.874442133070092,0,19,nuclear migration,BP,
3609,GO:0007098,1,0.474485578240134,0,114,centrosome cycle,BP,
3610,GO:0007099,1,0.828179990373691,0,29,centriole replication,BP,
3611,GO:0007100,1,0.907288584789528,0,15,mitotic centrosome separation,BP,
3612,GO:0007113,1,0.982467883482362,0,3,endomitotic cell cycle,BP,
3614,GO:0007129,1,0.808405206683309,0,34,synapsis,BP,
3615,GO:0007130,1,0.903404141509318,0,16,synaptonemal complex assembly,BP,
3617,GO:0007135,1,0.952102398012106,0,8,meiosis II,BP,
3620,GO:0007143,1,0.862443362025759,0,23,female meiotic nuclear division,BP,
3621,GO:0007144,1,0.957100187692175,0,7,female meiosis I,BP,
3622,GO:0007146,1,0.993846081630578,0,1,meiotic recombination nodule assembly,BP,
3623,GO:0007147,1,0.993601638893225,0,1,female meiosis II,BP,
3626,GO:0007156,1,0.515960089620749,0,95,homophilic cell adhesion via plasma membrane adhesion molecules,BP,
3627,GO:0007157,1,0.755775944872911,0,43,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
3628,GO:0007158,1,0.897987308683129,0,16,neuron cell-cell adhesion,BP,
3629,GO:0007159,1,0.160787501567486,0,290,leukocyte cell-cell adhesion,BP,
3631,GO:0007161,1,0.970454704326829,0,4,calcium-independent cell-matrix adhesion,BP,
3633,GO:0007163,1,0.272283342224281,0,196,establishment or maintenance of cell polarity,BP,
3634,GO:0007164,1,0.475845308465278,0,117,establishment of tissue polarity,BP,
3638,GO:0007168,1,0.970376896745355,0,5,receptor guanylyl cyclase signaling pathway,BP,
3641,GO:0007172,1,0.950863821063302,0,8,signal complex assembly,BP,
3642,GO:0007173,1,0.462002129118171,0,119,epidermal growth factor receptor signaling pathway,BP,
3643,GO:0007174,1,0.994002053936623,0,1,epidermal growth factor catabolic process,BP,
3644,GO:0007175,1,0.913582083085817,0,14,negative regulation of epidermal growth factor-activated receptor activity,BP,
3645,GO:0007176,1,0.84136014130557,0,27,regulation of epidermal growth factor-activated receptor activity,BP,
3647,GO:0007179,1,0.344746495067391,0,162,transforming growth factor beta receptor signaling pathway,BP,
3648,GO:0007181,1,0.980950231713322,0,3,transforming growth factor beta receptor complex assembly,BP,
3649,GO:0007182,1,0.959429593999688,0,6,common-partner SMAD protein phosphorylation,BP,
3650,GO:0007183,1,0.911156094761721,0,14,SMAD protein complex assembly,BP,
3651,GO:0007185,1,0.957044907471817,0,6,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3655,GO:0007189,1,0.592519559659913,0,82,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
3656,GO:0007190,1,0.819492394112078,0,31,activation of adenylate cyclase activity,BP,
3657,GO:0007191,1,0.945625688220568,0,9,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3660,GO:0007195,1,0.962276141835652,0,6,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3662,GO:0007197,1,0.963560278872773,0,6,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
3663,GO:0007198,1,0.976464601523609,0,4,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3664,GO:0007199,1,0.99390239375709,0,1,G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,BP,
3669,GO:0007206,1,0.985855888609836,0,2,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3670,GO:0007207,1,0.9641801737559,0,6,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
3671,GO:0007208,1,0.987048566522371,0,2,phospholipase C-activating serotonin receptor signaling pathway,BP,
3672,GO:0007210,1,0.924284439314344,0,13,serotonin receptor signaling pathway,BP,
3673,GO:0007212,1,0.787439132103318,0,38,dopamine receptor signaling pathway,BP,
3674,GO:0007213,1,0.905015238496288,0,16,G-protein coupled acetylcholine receptor signaling pathway,BP,
3675,GO:0007214,1,0.859958419060531,0,23,gamma-aminobutyric acid signaling pathway,BP,
3678,GO:0007217,1,0.95961043321596,0,7,tachykinin receptor signaling pathway,BP,
3679,GO:0007218,1,0.583536718222175,0,89,neuropeptide signaling pathway,BP,
3680,GO:0007219,1,0.330019369795087,0,172,Notch signaling pathway,BP,
3681,GO:0007220,1,0.895490222420352,0,17,Notch receptor processing,BP,
3682,GO:0007221,1,0.880535135908916,0,18,positive regulation of transcription of Notch receptor target,BP,
3685,GO:0007225,1,0.9932820130094,0,1,patched ligand maturation,BP,
3686,GO:0007227,1,0.974737720105221,0,4,signal transduction downstream of smoothened,BP,
3687,GO:0007228,1,0.981106084060973,0,3,positive regulation of hh target transcription factor activity,BP,
3689,GO:0007231,1,0.982114069841449,0,3,osmosensory signaling pathway,BP,
3691,GO:0007250,1,0.893542758352624,0,18,activation of NF-kappaB-inducing kinase activity,BP,
3692,GO:0007252,1,0.913591810527702,0,14,I-kappaB phosphorylation,BP,
3693,GO:0007253,1,0.958944738752023,0,7,cytoplasmic sequestering of NF-kappaB,BP,
3695,GO:0007256,1,0.958978018361481,0,6,activation of JNKK activity,BP,
3696,GO:0007257,1,0.81180653438698,0,32,activation of JUN kinase activity,BP,
3697,GO:0007258,1,0.975139771268908,0,4,JUN phosphorylation,BP,
3698,GO:0007259,1,0.448881841896087,0,126,JAK-STAT cascade,BP,
3699,GO:0007260,1,0.696156781525162,0,58,tyrosine phosphorylation of STAT protein,BP,
3700,GO:0007263,1,0.876353260709843,0,21,nitric oxide mediated signal transduction,BP,
3707,GO:0007270,1,0.944715392450204,0,8,neuron-neuron synaptic transmission,BP,
3708,GO:0007271,1,0.819014236706933,0,32,synaptic transmission, cholinergic,BP,
3710,GO:0007274,1,0.847524398732781,0,26,neuromuscular synaptic transmission,BP,
3715,GO:0007284,1,0.986852722988662,0,2,spermatogonial cell division,BP,
3717,GO:0007288,1,0.937528403948595,0,10,sperm axoneme assembly,BP,
3718,GO:0007289,1,0.911197219859965,0,14,spermatid nucleus differentiation,BP,
3719,GO:0007290,1,0.993273528885892,0,1,spermatid nucleus elongation,BP,
3720,GO:0007291,1,0.994364122702931,0,1,sperm individualization,BP,
3721,GO:0007292,1,0.508554309314704,0,105,female gamete generation,BP,
3722,GO:0007296,1,0.972094409969501,0,4,vitellogenesis,BP,
3723,GO:0007308,1,0.987573589309452,0,2,oocyte construction,BP,
3724,GO:0007309,1,0.987573589309452,0,2,oocyte axis specification,BP,
3725,GO:0007314,1,0.987573589309452,0,2,oocyte anterior/posterior axis specification,BP,
3726,GO:0007315,1,0.987573589309452,0,2,pole plasm assembly,BP,
3727,GO:0007320,1,0.939366023213564,0,10,insemination,BP,
3728,GO:0007338,1,0.521557422371745,0,105,single fertilization,BP,
3729,GO:0007339,1,0.859752576443195,0,25,binding of sperm to zona pellucida,BP,
3730,GO:0007340,1,0.844580440946824,0,27,acrosome reaction,BP,
3731,GO:0007341,1,0.965160879493604,0,6,penetration of zona pellucida,BP,
3732,GO:0007342,1,0.948713860088744,0,9,fusion of sperm to egg plasma membrane involved in single fertilization,BP,
3733,GO:0007343,1,0.986714154338984,0,2,egg activation,BP,
3734,GO:0007344,1,0.994142340087971,0,1,pronuclear fusion,BP,
3736,GO:0007349,1,0.994364122702931,0,1,cellularization,BP,
3737,GO:0007350,1,0.908013893078315,0,15,blastoderm segmentation,BP,
3738,GO:0007351,1,0.92589663800834,0,12,tripartite regional subdivision,BP,
3739,GO:0007352,1,0.9800118856499,0,3,zygotic specification of dorsal/ventral axis,BP,
3740,GO:0007354,1,0.976102183421374,0,4,zygotic determination of anterior/posterior axis, embryo,BP,
3741,GO:0007356,1,0.982296705127271,0,3,thorax and anterior abdomen determination,BP,
3742,GO:0007368,1,0.493067127627205,0,109,determination of left/right symmetry,BP,
3744,GO:0007371,1,0.993569667341445,0,1,ventral midline determination,BP,
3745,GO:0007379,1,0.911515172110243,0,15,segment specification,BP,
3746,GO:0007386,1,0.967954902564825,0,5,compartment pattern specification,BP,
3747,GO:0007387,1,0.99386431195544,0,1,anterior compartment pattern formation,BP,
3748,GO:0007388,1,0.99386431195544,0,1,posterior compartment specification,BP,
3750,GO:0007398,1,0.890230508632268,0,18,ectoderm development,BP,
3752,GO:0007400,1,0.993932607884681,0,1,neuroblast fate determination,BP,
3753,GO:0007402,1,0.98838300115242,0,2,ganglion mother cell fate determination,BP,
3754,GO:0007403,1,0.993659865977184,0,1,glial cell fate determination,BP,
3756,GO:0007406,1,0.966563312579078,0,5,negative regulation of neuroblast proliferation,BP,
3759,GO:0007412,1,0.987877067950411,0,2,axon target recognition,BP,
3761,GO:0007416,1,0.434498784729436,0,123,synapse assembly,BP,
3763,GO:0007418,1,0.974349009914471,0,4,ventral midline development,BP,
3767,GO:0007431,1,0.780246273251446,0,38,salivary gland development,BP,
3768,GO:0007435,1,0.800721170978036,0,34,salivary gland morphogenesis,BP,
3769,GO:0007439,1,0.987737489069704,0,2,ectodermal digestive tract development,BP,
3770,GO:0007440,1,0.932185553883819,0,10,foregut morphogenesis,BP,
3771,GO:0007442,1,0.954394979862015,0,7,hindgut morphogenesis,BP,
3772,GO:0007468,1,0.988004935007755,0,2,regulation of rhodopsin gene expression,BP,
3773,GO:0007492,1,0.606435158752665,0,76,endoderm development,BP,
3774,GO:0007493,1,0.987647328060856,0,2,endodermal cell fate determination,BP,
3775,GO:0007494,1,0.931690796243336,0,11,midgut development,BP,
3776,GO:0007495,1,0.993728693770675,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3777,GO:0007497,1,0.986696020374953,0,2,posterior midgut development,BP,
3778,GO:0007498,1,0.487351412590425,0,112,mesoderm development,BP,
3779,GO:0007499,1,0.993312916362224,0,1,ectoderm and mesoderm interaction,BP,
3780,GO:0007500,1,0.987969305394592,0,2,mesodermal cell fate determination,BP,
3781,GO:0007501,1,0.923005730241491,0,13,mesodermal cell fate specification,BP,
3782,GO:0007506,1,0.987461268967665,0,2,gonadal mesoderm development,BP,
3784,GO:0007509,1,0.992758839937726,0,1,mesoderm migration involved in gastrulation,BP,
3785,GO:0007512,1,0.924881552623233,0,12,adult heart development,BP,
3787,GO:0007518,1,0.988123976050329,0,2,myoblast fate determination,BP,
3788,GO:0007519,1,0.379950187827403,0,150,skeletal muscle tissue development,BP,
3789,GO:0007520,1,0.828367023743668,0,29,myoblast fusion,BP,
3790,GO:0007521,1,0.986551445076734,0,2,muscle cell fate determination,BP,
3791,GO:0007522,1,0.992927613452405,0,1,visceral muscle development,BP,
3792,GO:0007525,1,0.980927458440063,0,2,somatic muscle development,BP,
3793,GO:0007528,1,0.729744842659709,0,46,neuromuscular junction development,BP,
3794,GO:0007529,1,0.987012645850805,0,2,establishment of synaptic specificity at neuromuscular junction,BP,
3795,GO:0007530,1,0.875740821845624,0,21,sex determination,BP,
3796,GO:0007538,1,0.986647160925582,0,2,primary sex determination,BP,
3797,GO:0007542,1,0.986647160925582,0,2,primary sex determination, germ-line,BP,
3799,GO:0007549,1,0.920613201597134,0,12,dosage compensation,BP,
3800,GO:0007565,1,0.35806592193462,0,160,female pregnancy,BP,
3801,GO:0007566,1,0.761443628010105,0,43,embryo implantation,BP,
3802,GO:0007567,1,0.903566350355299,0,16,parturition,BP,
3803,GO:0007568,1,0.17960214895422,0,267,aging,BP,
3804,GO:0007569,1,0.538957746098998,0,96,cell aging,BP,
3805,GO:0007571,1,0.994351416238837,0,1,age-dependent general metabolic decline,BP,
3806,GO:0007576,1,0.993911886415832,0,1,nucleolar fragmentation,BP,
3807,GO:0007584,1,0.292766295378049,0,194,response to nutrient,BP,
3808,GO:0007585,1,0.68167841728047,0,60,respiratory gaseous exchange,BP,
3809,GO:0007586,1,0.558956201733203,0,93,digestion,BP,
3810,GO:0007588,1,0.729552417974822,0,50,excretion,BP,
3811,GO:0007589,1,0.605667727499591,0,78,body fluid secretion,BP,
3812,GO:0007595,1,0.772167054595539,0,39,lactation,BP,
3813,GO:0007596,1,0.152895953541158,0,293,blood coagulation,BP,
3814,GO:0007597,1,0.911533488753887,0,15,blood coagulation, intrinsic pathway,BP,
3815,GO:0007598,1,0.9760565304365,0,4,blood coagulation, extrinsic pathway,BP,
3816,GO:0007599,1,0.148234228087528,0,298,hemostasis,BP,
3819,GO:0007602,1,0.775753583956958,0,41,phototransduction,BP,
3820,GO:0007603,1,0.849586439643849,0,26,phototransduction, visible light,BP,
3822,GO:0007606,1,0.588537815366335,0,87,sensory perception of chemical stimulus,BP,
3823,GO:0007608,1,0.787020289282017,0,39,sensory perception of smell,BP,
3828,GO:0007614,1,0.945404436668505,0,9,short-term memory,BP,
3832,GO:0007619,1,0.980663332866443,0,3,courtship behavior,BP,
3833,GO:0007620,1,0.904260599860312,0,16,copulation,BP,
3837,GO:0007624,1,0.993454191178716,0,1,ultradian rhythm,BP,
3843,GO:0007634,1,0.993942109626935,0,1,optokinetic behavior,BP,
3844,GO:0007635,1,0.910514857340026,0,14,chemosensory behavior,BP,
3845,GO:0007638,1,0.911868584734097,0,13,mechanosensory behavior,BP,
3847,GO:0008013,1,0.586508915937083,0,79,beta-catenin binding,MF,
3851,GO:0008020,1,0.953429342662113,0,8,G-protein coupled photoreceptor activity,MF,
3854,GO:0008023,1,0.729506497427183,0,48,transcription elongation factor complex,CC,
3855,GO:0008024,1,0.948566285478258,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3856,GO:0008026,1,0.55559468303946,0,91,ATP-dependent helicase activity,MF,
3857,GO:0008028,1,0.73610309982655,0,49,monocarboxylic acid transmembrane transporter activity,MF,
3858,GO:0008033,1,0.485252000245467,0,118,tRNA processing,BP,
3859,GO:0008035,1,0.958589137763282,0,7,high-density lipoprotein particle binding,MF,
3862,GO:0008043,1,0.98872034188743,0,2,intracellular ferritin complex,CC,
3863,GO:0008045,1,0.868475622545687,0,21,motor neuron axon guidance,BP,
3864,GO:0008046,1,0.953204110367469,0,7,axon guidance receptor activity,MF,
3866,GO:0008048,1,0.982499366991836,0,3,calcium sensitive guanylate cyclase activator activity,MF,
3867,GO:0008049,1,0.994095848214574,0,1,male courtship behavior,BP,
3868,GO:0008050,1,0.986488516992125,0,2,female courtship behavior,BP,
3869,GO:0008052,1,0.99435979094836,0,1,sensory organ boundary specification,BP,
3870,GO:0008053,1,0.879445277241992,0,21,mitochondrial fusion,BP,
3871,GO:0008057,1,0.992501047887261,0,1,eye pigment granule organization,BP,
3872,GO:0008061,1,0.958217988370612,0,7,chitin binding,MF,
3873,GO:0008063,1,0.962656769540084,0,6,Toll signaling pathway,BP,
3874,GO:0008064,1,0.343691964257518,0,166,regulation of actin polymerization or depolymerization,BP,
3878,GO:0008073,1,0.982903096730348,0,3,ornithine decarboxylase inhibitor activity,MF,
3879,GO:0008074,1,0.919950443987844,0,12,guanylate cyclase complex, soluble,CC,
3881,GO:0008078,1,0.981529671992607,0,3,mesodermal cell migration,BP,
3882,GO:0008079,1,0.962341687840941,0,6,translation termination factor activity,MF,
3883,GO:0008080,1,0.609378913018141,0,77,N-acetyltransferase activity,MF,
3886,GO:0008088,1,0.701498718934657,0,54,axo-dendritic transport,BP,
3887,GO:0008089,1,0.788889731183647,0,37,anterograde axonal transport,BP,
3888,GO:0008090,1,0.947370543270168,0,8,retrograde axonal transport,BP,
3889,GO:0008091,1,0.940651625831486,0,8,spectrin,CC,
3891,GO:0008093,1,0.924584975790785,0,12,cytoskeletal adaptor activity,MF,
3893,GO:0008097,1,0.942348696112358,0,10,5S rRNA binding,MF,
3895,GO:0008106,1,0.894410170813287,0,19,alcohol dehydrogenase (NADP+) activity,MF,
3896,GO:0008107,1,0.993426410060018,0,1,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3897,GO:0008108,1,0.994260450549984,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
3898,GO:0008109,1,0.987047157926474,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3899,GO:0008111,1,0.99407664811051,0,1,alpha-methylacyl-CoA racemase activity,MF,
3900,GO:0008112,1,0.994191721376386,0,1,nicotinamide N-methyltransferase activity,MF,
3901,GO:0008113,1,0.988512735560387,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
3902,GO:0008115,1,0.993949597679924,0,1,sarcosine oxidase activity,MF,
3903,GO:0008116,1,0.993034169904537,0,1,prostaglandin-I synthase activity,MF,
3904,GO:0008117,1,0.992984799249966,0,1,sphinganine-1-phosphate aldolase activity,MF,
3905,GO:0008118,1,0.994004505318388,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3906,GO:0008119,1,0.993710122269861,0,1,thiopurine S-methyltransferase activity,MF,
3907,GO:0008120,1,0.994175260987969,0,1,ceramide glucosyltransferase activity,MF,
3908,GO:0008121,1,0.959871902835923,0,7,ubiquinol-cytochrome-c reductase activity,MF,
3909,GO:0008124,1,0.988351182388082,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
3910,GO:0008126,1,0.993826575278686,0,1,acetylesterase activity,MF,
3911,GO:0008127,1,0.994271712902477,0,1,quercetin 2,3-dioxygenase activity,MF,
3912,GO:0008131,1,0.968928439777405,0,5,primary amine oxidase activity,MF,
3914,GO:0008135,1,0.588913697372009,0,84,translation factor activity, RNA binding,MF,
3915,GO:0008137,1,0.805532400710213,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3916,GO:0008138,1,0.777923588526731,0,40,protein tyrosine/serine/threonine phosphatase activity,MF,
3917,GO:0008139,1,0.863501315081192,0,22,nuclear localization sequence binding,MF,
3918,GO:0008140,1,0.950606818739803,0,8,cAMP response element binding protein binding,MF,
3919,GO:0008142,1,0.966609066281054,0,5,oxysterol binding,MF,
3920,GO:0008143,1,0.90212195374917,0,16,poly(A) binding,MF,
3923,GO:0008147,1,0.988979389912869,0,2,structural constituent of bone,MF,
3926,GO:0008154,1,0.299993569411473,0,187,actin polymerization or depolymerization,BP,
3927,GO:0008156,1,0.811899151059701,0,32,negative regulation of DNA replication,BP,
3928,GO:0008157,1,0.884951468066513,0,19,protein phosphatase 1 binding,MF,
3929,GO:0008158,1,0.980376663796754,0,3,hedgehog receptor activity,MF,
3930,GO:0008160,1,0.993891754186493,0,1,protein tyrosine phosphatase activator activity,MF,
3931,GO:0008168,1,0.316211105017449,0,182,methyltransferase activity,MF,
3932,GO:0008169,1,0.981630191968568,0,3,C-methyltransferase activity,MF,
3933,GO:0008170,1,0.596061011879621,0,81,N-methyltransferase activity,MF,
3934,GO:0008171,1,0.894428900230992,0,18,O-methyltransferase activity,MF,
3935,GO:0008172,1,0.962091428275448,0,6,S-methyltransferase activity,MF,
3936,GO:0008173,1,0.728023879866342,0,51,RNA methyltransferase activity,MF,
3937,GO:0008174,1,0.945540787931938,0,9,mRNA methyltransferase activity,MF,
3938,GO:0008175,1,0.843997612144061,0,27,tRNA methyltransferase activity,MF,
3939,GO:0008176,1,0.988448698727984,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3940,GO:0008177,1,0.976592183178525,0,4,succinate dehydrogenase (ubiquinone) activity,MF,
3941,GO:0008179,1,0.9174839400639,0,13,adenylate cyclase binding,MF,
3942,GO:0008180,1,0.812006831549292,0,33,COP9 signalosome,CC,
3943,GO:0008184,1,0.981050247571959,0,3,glycogen phosphorylase activity,MF,
3944,GO:0008186,1,0.658954965260951,0,65,RNA-dependent ATPase activity,MF,
3945,GO:0008187,1,0.863708415349455,0,23,poly-pyrimidine tract binding,MF,
3946,GO:0008188,1,0.756419103594007,0,46,neuropeptide receptor activity,MF,
3947,GO:0008190,1,0.937590997966019,0,10,eukaryotic initiation factor 4E binding,MF,
3949,GO:0008192,1,0.981210950431915,0,3,RNA guanylyltransferase activity,MF,
3950,GO:0008193,1,0.987770406365454,0,2,tRNA guanylyltransferase activity,MF,
3951,GO:0008194,1,0.474046899985619,0,118,UDP-glycosyltransferase activity,MF,
3952,GO:0008195,1,0.979481175048533,0,3,phosphatidate phosphatase activity,MF,
3955,GO:0008200,1,0.820036014281966,0,31,ion channel inhibitor activity,MF,
3959,GO:0008204,1,0.988102520242584,0,2,ergosterol metabolic process,BP,
3960,GO:0008206,1,0.764549534706686,0,43,bile acid metabolic process,BP,
3961,GO:0008207,1,0.836614459094279,0,29,C21-steroid hormone metabolic process,BP,
3962,GO:0008209,1,0.876402098200319,0,21,androgen metabolic process,BP,
3963,GO:0008210,1,0.895543837957326,0,18,estrogen metabolic process,BP,
3964,GO:0008211,1,0.883702209394323,0,20,glucocorticoid metabolic process,BP,
3965,GO:0008212,1,0.949970937428906,0,8,mineralocorticoid metabolic process,BP,
3966,GO:0008213,1,0.345946882217205,0,163,protein alkylation,BP,
3967,GO:0008214,1,0.81999938061161,0,29,protein dealkylation,BP,
3968,GO:0008215,1,0.95950029004945,0,7,spermine metabolic process,BP,
3969,GO:0008216,1,0.954113843304839,0,8,spermidine metabolic process,BP,
3970,GO:0008217,1,0.389945945817074,0,149,regulation of blood pressure,BP,
3971,GO:0008218,1,0.993643024809225,0,1,bioluminescence,BP,
3973,GO:0008227,1,0.822517898436917,0,32,G-protein coupled amine receptor activity,MF,
3974,GO:0008228,1,0.955828206186392,0,7,opsonization,BP,
3976,GO:0008234,1,0.357916326929946,0,158,cysteine-type peptidase activity,MF,
3981,GO:0008239,1,0.934876304420898,0,11,dipeptidyl-peptidase activity,MF,
3982,GO:0008240,1,0.98071478112017,0,3,tripeptidyl-peptidase activity,MF,
3983,GO:0008241,1,0.993677708805389,0,1,peptidyl-dipeptidase activity,MF,
3984,GO:0008242,1,0.945091710496709,0,9,omega peptidase activity,MF,
3985,GO:0008250,1,0.931243552069087,0,12,oligosaccharyltransferase complex,CC,
3986,GO:0008251,1,0.986748915659866,0,2,tRNA-specific adenosine deaminase activity,MF,
3987,GO:0008252,1,0.915317297658438,0,14,nucleotidase activity,MF,
3988,GO:0008253,1,0.927808713870644,0,12,5'-nucleotidase activity,MF,
3989,GO:0008254,1,0.992566469930407,0,1,3'-nucleotidase activity,MF,
3990,GO:0008260,1,0.987777440187234,0,2,3-oxoacid CoA-transferase activity,MF,
3991,GO:0008263,1,0.98768136020929,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
3992,GO:0008265,1,0.993857276569899,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
3993,GO:0008266,1,0.88661242086282,0,19,poly(U) RNA binding,MF,
3994,GO:0008267,1,0.992334495528965,0,1,poly-glutamine tract binding,MF,
3995,GO:0008269,1,0.988143855150809,0,2,JAK pathway signal transduction adaptor activity,MF,
3997,GO:0008271,1,0.937020027475712,0,10,secondary active sulfate transmembrane transporter activity,MF,
3998,GO:0008272,1,0.925604714610452,0,12,sulfate transport,BP,
4000,GO:0008274,1,0.95457854252708,0,7,gamma-tubulin ring complex,CC,
4001,GO:0008275,1,0.97449111524129,0,4,gamma-tubulin small complex,CC,
4002,GO:0008276,1,0.609714009501079,0,77,protein methyltransferase activity,MF,
4004,GO:0008278,1,0.935665739649501,0,10,cohesin complex,CC,
4005,GO:0008281,1,0.986545222727523,0,2,sulfonylurea receptor activity,MF,
4006,GO:0008282,1,0.974465142320852,0,4,inward rectifying potassium channel,CC,
4010,GO:0008286,1,0.464307480405364,0,118,insulin receptor signaling pathway,BP,
4013,GO:0008290,1,0.957568644799931,0,7,F-actin capping protein complex,CC,
4014,GO:0008291,1,0.981674053719668,0,3,acetylcholine metabolic process,BP,
4015,GO:0008292,1,0.99388284309816,0,1,acetylcholine biosynthetic process,BP,
4016,GO:0008294,1,0.984551869779806,0,2,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
4017,GO:0008295,1,0.976363438823358,0,4,spermidine biosynthetic process,BP,
4018,GO:0008296,1,0.94031139771567,0,10,3'-5'-exodeoxyribonuclease activity,MF,
4019,GO:0008297,1,0.956655996911226,0,7,single-stranded DNA exodeoxyribonuclease activity,MF,
4020,GO:0008298,1,0.929452484227181,0,12,intracellular mRNA localization,BP,
4021,GO:0008299,1,0.847129228913992,0,27,isoprenoid biosynthetic process,BP,
4022,GO:0008300,1,0.958705657553815,0,7,isoprenoid catabolic process,BP,
4024,GO:0008305,1,0.80740098432301,0,32,integrin complex,CC,
4027,GO:0008308,1,0.90379609748565,0,16,voltage-gated anion channel activity,MF,
4028,GO:0008309,1,0.976228120134141,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
4029,GO:0008310,1,0.968663127538548,0,5,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4030,GO:0008311,1,0.988326109369637,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4031,GO:0008312,1,0.959095601297674,0,7,7S RNA binding,MF,
4032,GO:0008318,1,0.956169894902067,0,7,protein prenyltransferase activity,MF,
4033,GO:0008320,1,0.926332301250766,0,13,protein transmembrane transporter activity,MF,
4034,GO:0008321,1,0.980030746794007,0,3,Ral guanyl-nucleotide exchange factor activity,MF,
4036,GO:0008327,1,0.908447715148707,0,15,methyl-CpG binding,MF,
4037,GO:0008328,1,0.722094406065579,0,49,ionotropic glutamate receptor complex,CC,
4038,GO:0008329,1,0.91664907622441,0,14,signaling pattern recognition receptor activity,MF,
4039,GO:0008330,1,0.976234985038593,0,4,protein tyrosine/threonine phosphatase activity,MF,
4040,GO:0008331,1,0.915734731601133,0,12,high voltage-gated calcium channel activity,MF,
4041,GO:0008332,1,0.970947536903871,0,4,low voltage-gated calcium channel activity,MF,
4042,GO:0008333,1,0.713584782579723,0,52,endosome to lysosome transport,BP,
4043,GO:0008334,1,0.856725844422654,0,24,histone mRNA metabolic process,BP,
4044,GO:0008336,1,0.994101045669862,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4045,GO:0008340,1,0.92614585086439,0,11,determination of adult lifespan,BP,
4046,GO:0008343,1,0.952836585071167,0,8,adult feeding behavior,BP,
4048,GO:0008347,1,0.781538633268186,0,38,glial cell migration,BP,
4049,GO:0008348,1,0.993591077729755,0,1,negative regulation of antimicrobial humoral response,BP,
4050,GO:0008349,1,0.929175044207206,0,11,MAP kinase kinase kinase kinase activity,MF,
4051,GO:0008352,1,0.993878819706179,0,1,katanin complex,CC,
4052,GO:0008353,1,0.905764824938999,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
4053,GO:0008354,1,0.955984868362959,0,7,germ cell migration,BP,
4054,GO:0008355,1,0.986838060429587,0,2,olfactory learning,BP,
4055,GO:0008356,1,0.889536201264818,0,18,asymmetric cell division,BP,
4056,GO:0008358,1,0.987573589309452,0,2,maternal determination of anterior/posterior axis, embryo,BP,
4060,GO:0008373,1,0.878223384081066,0,20,sialyltransferase activity,MF,
4061,GO:0008374,1,0.788376456762044,0,37,O-acyltransferase activity,MF,
4062,GO:0008375,1,0.715352735820686,0,53,acetylglucosaminyltransferase activity,MF,
4063,GO:0008376,1,0.757631276344862,0,44,acetylgalactosaminyltransferase activity,MF,
4064,GO:0008378,1,0.825428365949118,0,31,galactosyltransferase activity,MF,
4065,GO:0008379,1,0.972017781375938,0,5,thioredoxin peroxidase activity,MF,
4066,GO:0008380,1,0.076002511591316,0,406,RNA splicing,BP,
4067,GO:0008381,1,0.945483550325229,0,9,mechanosensitive ion channel activity,MF,
4068,GO:0008384,1,0.987183630447055,0,2,IkappaB kinase activity,MF,
4069,GO:0008385,1,0.944511053613508,0,9,IkappaB kinase complex,CC,
4070,GO:0008386,1,0.994077514217126,0,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,
4071,GO:0008387,1,0.993988789761408,0,1,steroid 7-alpha-hydroxylase activity,MF,
4072,GO:0008389,1,0.988312040650627,0,2,coumarin 7-hydroxylase activity,MF,
4073,GO:0008391,1,0.953645985405628,0,8,arachidonic acid monooxygenase activity,MF,
4074,GO:0008392,1,0.953645985405628,0,8,arachidonic acid epoxygenase activity,MF,
4075,GO:0008395,1,0.875316947047596,0,22,steroid hydroxylase activity,MF,
4076,GO:0008396,1,0.98797982911699,0,2,oxysterol 7-alpha-hydroxylase activity,MF,
4077,GO:0008397,1,0.993511683677316,0,1,sterol 12-alpha-hydroxylase activity,MF,
4078,GO:0008398,1,0.993760141704562,0,1,sterol 14-demethylase activity,MF,
4079,GO:0008401,1,0.981365649928012,0,3,retinoic acid 4-hydroxylase activity,MF,
4080,GO:0008403,1,0.993731980302676,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
4081,GO:0008404,1,0.994109708410621,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
4082,GO:0008405,1,0.994109708410621,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
4084,GO:0008408,1,0.737541387325648,0,48,3'-5' exonuclease activity,MF,
4085,GO:0008409,1,0.899949106787451,0,16,5'-3' exonuclease activity,MF,
4086,GO:0008410,1,0.975924327066627,0,4,CoA-transferase activity,MF,
4087,GO:0008413,1,0.988537119594294,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
4088,GO:0008417,1,0.92459799955966,0,12,fucosyltransferase activity,MF,
4089,GO:0008418,1,0.994325137100556,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
4090,GO:0008419,1,0.99388140610219,0,1,RNA lariat debranching enzyme activity,MF,
4091,GO:0008420,1,0.951327047716432,0,8,CTD phosphatase activity,MF,
4092,GO:0008422,1,0.975233415200311,0,4,beta-glucosidase activity,MF,
4093,GO:0008424,1,0.993698697076839,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
4094,GO:0008425,1,0.994281242594407,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
4095,GO:0008426,1,0.982329855085161,0,3,protein kinase C inhibitor activity,MF,
4096,GO:0008427,1,0.982688360568304,0,3,calcium-dependent protein kinase inhibitor activity,MF,
4097,GO:0008428,1,0.981411968341563,0,3,ribonuclease inhibitor activity,MF,
4098,GO:0008429,1,0.944601852828214,0,9,phosphatidylethanolamine binding,MF,
4099,GO:0008430,1,0.974665742753372,0,4,selenium binding,MF,
4100,GO:0008431,1,0.98769173406734,0,2,vitamin E binding,MF,
4101,GO:0008432,1,0.94919870757924,0,8,JUN kinase binding,MF,
4102,GO:0008434,1,0.993290208061306,0,1,calcitriol receptor activity,MF,
4103,GO:0008437,1,0.99406784309163,0,1,thyrotropin-releasing hormone activity,MF,
4104,GO:0008440,1,0.968631091672897,0,5,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
4105,GO:0008441,1,0.986546866612125,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
4106,GO:0008442,1,0.994075348963234,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
4107,GO:0008443,1,0.956453968441998,0,7,phosphofructokinase activity,MF,
4108,GO:0008444,1,0.994013302402746,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
4109,GO:0008445,1,0.99417930389345,0,1,D-aspartate oxidase activity,MF,
4110,GO:0008446,1,0.994162554698133,0,1,GDP-mannose 4,6-dehydratase activity,MF,
4111,GO:0008448,1,0.994116783218119,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
4112,GO:0008449,1,0.979754491042685,0,3,N-acetylglucosamine-6-sulfatase activity,MF,
4113,GO:0008452,1,0.993846081630578,0,1,RNA ligase activity,MF,
4115,GO:0008454,1,0.980983665928768,0,3,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
4116,GO:0008455,1,0.993865891603955,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
4117,GO:0008456,1,0.99357337879569,0,1,alpha-N-acetylgalactosaminidase activity,MF,
4118,GO:0008457,1,0.993461919915322,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
4119,GO:0008458,1,0.99370955095265,0,1,carnitine O-octanoyltransferase activity,MF,
4120,GO:0008459,1,0.986664541007495,0,2,chondroitin 6-sulfotransferase activity,MF,
4121,GO:0008460,1,0.994095848214574,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
4122,GO:0008465,1,0.994289039622776,0,1,glycerate dehydrogenase activity,MF,
4123,GO:0008466,1,0.987841901444646,0,2,glycogenin glucosyltransferase activity,MF,
4125,GO:0008469,1,0.946816399078739,0,9,histone-arginine N-methyltransferase activity,MF,
4126,GO:0008470,1,0.993316364694155,0,1,isovaleryl-CoA dehydrogenase activity,MF,
4127,GO:0008474,1,0.940707763359972,0,10,palmitoyl-(protein) hydrolase activity,MF,
4128,GO:0008475,1,0.981163422797705,0,3,procollagen-lysine 5-dioxygenase activity,MF,
4129,GO:0008476,1,0.988173678354216,0,2,protein-tyrosine sulfotransferase activity,MF,
4130,GO:0008478,1,0.992519576798508,0,1,pyridoxal kinase activity,MF,
4131,GO:0008479,1,0.97685911148126,0,4,queuine tRNA-ribosyltransferase activity,MF,
4132,GO:0008480,1,0.993692556969627,0,1,sarcosine dehydrogenase activity,MF,
4133,GO:0008481,1,0.98793637601544,0,2,sphinganine kinase activity,MF,
4134,GO:0008482,1,0.993972935487167,0,1,sulfite oxidase activity,MF,
4136,GO:0008484,1,0.901766610304901,0,16,sulfuric ester hydrolase activity,MF,
4137,GO:0008486,1,0.975772150142065,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
4138,GO:0008488,1,0.993732694800541,0,1,gamma-glutamyl carboxylase activity,MF,
4139,GO:0008489,1,0.993809521024471,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
4140,GO:0008493,1,0.994108697739627,0,1,tetracycline transmembrane transporter activity,MF,
4141,GO:0008494,1,0.933572618027814,0,11,translation activator activity,MF,
4142,GO:0008495,1,0.9937816003229,0,1,protoheme IX farnesyltransferase activity,MF,
4143,GO:0008496,1,0.9934226850833,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
4144,GO:0008499,1,0.928479621911532,0,12,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
4145,GO:0008502,1,0.976378787227812,0,4,melatonin receptor activity,MF,
4146,GO:0008503,1,0.936722642135727,0,10,benzodiazepine receptor activity,MF,
4147,GO:0008504,1,0.944716967868803,0,9,monoamine transmembrane transporter activity,MF,
4148,GO:0008506,1,0.98146129146013,0,3,sucrose:proton symporter activity,MF,
4149,GO:0008507,1,0.993614482895545,0,1,sodium:iodide symporter activity,MF,
4150,GO:0008508,1,0.976820051432138,0,4,bile acid:sodium symporter activity,MF,
4152,GO:0008510,1,0.939878107402299,0,9,sodium:bicarbonate symporter activity,MF,
4153,GO:0008511,1,0.986001355832601,0,2,sodium:potassium:chloride symporter activity,MF,
4154,GO:0008513,1,0.982151697091242,0,3,secondary active organic cation transmembrane transporter activity,MF,
4156,GO:0008515,1,0.98146129146013,0,3,sucrose transmembrane transporter activity,MF,
4157,GO:0008517,1,0.963219557459404,0,6,folic acid transmembrane transporter activity,MF,
4158,GO:0008518,1,0.993827722238844,0,1,reduced folate carrier activity,MF,
4159,GO:0008519,1,0.840209114234356,0,28,ammonium transmembrane transporter activity,MF,
4160,GO:0008520,1,0.99264141663663,0,1,L-ascorbate:sodium symporter activity,MF,
4161,GO:0008521,1,0.993879107070959,0,1,acetyl-CoA transmembrane transporter activity,MF,
4162,GO:0008523,1,0.993694556007345,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
4163,GO:0008525,1,0.947839272733836,0,8,phosphatidylcholine transporter activity,MF,
4164,GO:0008526,1,0.94901921540425,0,8,phosphatidylinositol transporter activity,MF,
4165,GO:0008527,1,0.921634188510827,0,14,taste receptor activity,MF,
4167,GO:0008531,1,0.993865891603955,0,1,riboflavin kinase activity,MF,
4168,GO:0008532,1,0.952138161574665,0,8,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
4169,GO:0008534,1,0.977147548688277,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
4170,GO:0008535,1,0.863855595609632,0,24,respiratory chain complex IV assembly,BP,
4171,GO:0008536,1,0.801844253149869,0,33,Ran GTPase binding,MF,
4172,GO:0008537,1,0.982565466680791,0,3,proteasome activator complex,CC,
4173,GO:0008540,1,0.931147506710333,0,12,proteasome regulatory particle, base subcomplex,CC,
4174,GO:0008541,1,0.959780807690223,0,7,proteasome regulatory particle, lid subcomplex,CC,
4178,GO:0008545,1,0.987282086276543,0,2,JUN kinase kinase activity,MF,
4179,GO:0008553,1,0.921057456781857,0,13,proton-exporting ATPase activity, phosphorylative mechanism,MF,
4180,GO:0008554,1,0.993267056919744,0,1,sodium-exporting ATPase activity, phosphorylative mechanism,MF,
4181,GO:0008555,1,0.99310025090384,0,1,chloride-transporting ATPase activity,MF,
4182,GO:0008556,1,0.92780351011453,0,12,potassium-transporting ATPase activity,MF,
4183,GO:0008559,1,0.960198394178163,0,6,xenobiotic transmembrane transporting ATPase activity,MF,
4185,GO:0008568,1,0.937784323730437,0,10,microtubule-severing ATPase activity,MF,
4187,GO:0008574,1,0.819144062932383,0,30,ATP-dependent microtubule motor activity, plus-end-directed,MF,
4188,GO:0008579,1,0.99312678444135,0,1,JUN kinase phosphatase activity,MF,
4189,GO:0008582,1,0.967390902969863,0,5,regulation of synaptic growth at neuromuscular junction,BP,
4191,GO:0008585,1,0.571900066294087,0,86,female gonad development,BP,
4193,GO:0008591,1,0.994126168400043,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
4194,GO:0008592,1,0.993713264629147,0,1,regulation of Toll signaling pathway,BP,
4195,GO:0008593,1,0.559435746351167,0,90,regulation of Notch signaling pathway,BP,
4196,GO:0008594,1,0.987009076228158,0,2,photoreceptor cell morphogenesis,BP,
4197,GO:0008595,1,0.92589663800834,0,12,anterior/posterior axis specification, embryo,BP,
4199,GO:0008603,1,0.958031712897415,0,7,cAMP-dependent protein kinase regulator activity,MF,
4200,GO:0008607,1,0.981760514317476,0,3,phosphorylase kinase regulator activity,MF,
4201,GO:0008608,1,0.827164103136308,0,30,attachment of spindle microtubules to kinetochore,BP,
4202,GO:0008609,1,0.992434444552799,0,1,alkylglycerone-phosphate synthase activity,MF,
4204,GO:0008611,1,0.968304572427629,0,5,ether lipid biosynthetic process,BP,
4205,GO:0008612,1,0.975946024012505,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
4206,GO:0008614,1,0.987720461373441,0,2,pyridoxine metabolic process,BP,
4207,GO:0008615,1,0.987720461373441,0,2,pyridoxine biosynthetic process,BP,
4208,GO:0008616,1,0.98249922809034,0,3,queuosine biosynthetic process,BP,
4209,GO:0008617,1,0.994354881633389,0,1,guanosine metabolic process,BP,
4210,GO:0008622,1,0.96927578101518,0,5,epsilon DNA polymerase complex,CC,
4211,GO:0008623,1,0.986912546995264,0,2,CHRAC,CC,
4213,GO:0008626,1,0.964690563017795,0,6,granzyme-mediated apoptotic signaling pathway,BP,
4214,GO:0008627,1,0.94980348916842,0,8,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
4215,GO:0008628,1,0.982689932109085,0,3,hormone-mediated apoptotic signaling pathway,BP,
4217,GO:0008631,1,0.770393115395468,0,42,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
4220,GO:0008641,1,0.938741316727842,0,10,ubiquitin-like modifier activating enzyme activity,MF,
4223,GO:0008649,1,0.912571251532008,0,15,rRNA methyltransferase activity,MF,
4224,GO:0008650,1,0.99361790789639,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
4227,GO:0008655,1,0.930693842231555,0,12,pyrimidine-containing compound salvage,BP,
4228,GO:0008656,1,0.914994247702362,0,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
4229,GO:0008670,1,0.988505842636756,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
4230,GO:0008689,1,0.994281242594407,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4231,GO:0008700,1,0.993846081630578,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
4232,GO:0008705,1,0.991591223513368,0,1,methionine synthase activity,MF,
4233,GO:0008709,1,0.994372353053026,0,1,cholate 7-alpha-dehydrogenase activity,MF,
4234,GO:0008721,1,0.993930880583482,0,1,D-serine ammonia-lyase activity,MF,
4235,GO:0008725,1,0.994333222971011,0,1,DNA-3-methyladenine glycosylase activity,MF,
4236,GO:0008732,1,0.987972684251583,0,2,L-allo-threonine aldolase activity,MF,
4237,GO:0008745,1,0.994372497445327,0,1,N-acetylmuramoyl-L-alanine amidase activity,MF,
4238,GO:0008746,1,0.987673506587506,0,2,NAD(P)+ transhydrogenase activity,MF,
4239,GO:0008747,1,0.994196630609363,0,1,N-acetylneuraminate lyase activity,MF,
4240,GO:0008750,1,0.993301851113816,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
4241,GO:0008753,1,0.993652158771642,0,1,NADPH dehydrogenase (quinone) activity,MF,
4242,GO:0008757,1,0.432756548766772,0,132,S-adenosylmethionine-dependent methyltransferase activity,MF,
4243,GO:0008761,1,0.993122170575948,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4244,GO:0008768,1,0.994397333031549,0,1,UDP-sugar diphosphatase activity,MF,
4245,GO:0008775,1,0.99411981532945,0,1,acetate CoA-transferase activity,MF,
4246,GO:0008781,1,0.988465354465586,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
4247,GO:0008783,1,0.994012148604285,0,1,agmatinase activity,MF,
4248,GO:0008785,1,0.994194897939155,0,1,alkyl hydroperoxide reductase activity,MF,
4249,GO:0008792,1,0.993846081630578,0,1,arginine decarboxylase activity,MF,
4250,GO:0008794,1,0.994384048852904,0,1,arsenate reductase (glutaredoxin) activity,MF,
4251,GO:0008796,1,0.988246518363279,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
4252,GO:0008798,1,0.986999053762705,0,2,beta-aspartyl-peptidase activity,MF,
4253,GO:0008802,1,0.99362047663938,0,1,betaine-aldehyde dehydrogenase activity,MF,
4254,GO:0008803,1,0.99436152364949,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
4255,GO:0008808,1,0.99355267808908,0,1,cardiolipin synthase activity,MF,
4256,GO:0008812,1,0.99359735741612,0,1,choline dehydrogenase activity,MF,
4257,GO:0008817,1,0.99345590883462,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
4258,GO:0008821,1,0.952006701784963,0,8,crossover junction endodeoxyribonuclease activity,MF,
4259,GO:0008823,1,0.968124596979458,0,5,cupric reductase activity,MF,
4260,GO:0008829,1,0.994120970426215,0,1,dCTP deaminase activity,MF,
4261,GO:0008832,1,0.993724407370571,0,1,dGTPase activity,MF,
4262,GO:0008841,1,0.993927714100447,0,1,dihydrofolate synthase activity,MF,
4263,GO:0008843,1,0.993978988252915,0,1,endochitinase activity,MF,
4264,GO:0008852,1,0.993829442790293,0,1,exodeoxyribonuclease I activity,MF,
4265,GO:0008853,1,0.976027436914803,0,4,exodeoxyribonuclease III activity,MF,
4266,GO:0008859,1,0.994371053522594,0,1,exoribonuclease II activity,MF,
4267,GO:0008865,1,0.967811459914676,0,5,fructokinase activity,MF,
4268,GO:0008887,1,0.993713550307928,0,1,glycerate kinase activity,MF,
4269,GO:0008889,1,0.968515104761994,0,5,glycerophosphodiester phosphodiesterase activity,MF,
4270,GO:0008890,1,0.994189411148297,0,1,glycine C-acetyltransferase activity,MF,
4271,GO:0008891,1,0.994141762526464,0,1,glycolate oxidase activity,MF,
4273,GO:0008893,1,0.994345929371049,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
4274,GO:0008894,1,0.99385698945447,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
4275,GO:0008897,1,0.993821128017126,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
4276,GO:0008900,1,0.981563290476552,0,3,potassium:proton exchanging ATPase activity,MF,
4277,GO:0008903,1,0.994326581004905,0,1,hydroxypyruvate isomerase activity,MF,
4278,GO:0008905,1,0.994183346796829,0,1,mannose-phosphate guanylyltransferase activity,MF,
4279,GO:0008934,1,0.974431993046586,0,4,inositol monophosphate 1-phosphatase activity,MF,
4280,GO:0008940,1,0.981228828040481,0,3,nitrate reductase activity,MF,
4281,GO:0008941,1,0.988041845899609,0,2,nitric oxide dioxygenase activity,MF,
4282,GO:0008948,1,0.975404371757706,0,4,oxaloacetate decarboxylase activity,MF,
4283,GO:0008955,1,0.993508825572082,0,1,peptidoglycan glycosyltransferase activity,MF,
4284,GO:0008962,1,0.988004758266017,0,2,phosphatidylglycerophosphatase activity,MF,
4285,GO:0008963,1,0.994027438334075,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4286,GO:0008967,1,0.987843547416533,0,2,phosphoglycolate phosphatase activity,MF,
4287,GO:0008970,1,0.946636721679609,0,9,phosphatidylcholine 1-acylhydrolase activity,MF,
4288,GO:0008973,1,0.993710979257611,0,1,phosphopentomutase activity,MF,
4289,GO:0008988,1,0.987729649828399,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
4290,GO:0008995,1,0.993898942647536,0,1,ribonuclease E activity,MF,
4291,GO:0009000,1,0.993934911092572,0,1,selenocysteine lyase activity,MF,
4292,GO:0009007,1,0.993588223240604,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4293,GO:0009008,1,0.968288875584845,0,5,DNA-methyltransferase activity,MF,
4294,GO:0009013,1,0.993164260904423,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4295,GO:0009019,1,0.974903811323712,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4296,GO:0009020,1,0.994081123065024,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4297,GO:0009032,1,0.99416717517006,0,1,thymidine phosphorylase activity,MF,
4298,GO:0009041,1,0.982034142509011,0,3,uridylate kinase activity,MF,
4299,GO:0009048,1,0.931667391832476,0,10,dosage compensation by inactivation of X chromosome,BP,
4300,GO:0009051,1,0.982507244058715,0,3,pentose-phosphate shunt, oxidative branch,BP,
4301,GO:0009052,1,0.970320813528222,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4302,GO:0009055,1,0.547771798120525,0,101,electron transfer activity,MF,
4307,GO:0009060,1,0.639242532331332,0,74,aerobic respiration,BP,
4308,GO:0009061,1,0.99395478262682,0,1,anaerobic respiration,BP,
4309,GO:0009062,1,0.521034022447613,0,104,fatty acid catabolic process,BP,
4311,GO:0009064,1,0.649127634903374,0,69,glutamine family amino acid metabolic process,BP,
4312,GO:0009065,1,0.839133849056141,0,28,glutamine family amino acid catabolic process,BP,
4314,GO:0009067,1,0.870870717105931,0,22,aspartate family amino acid biosynthetic process,BP,
4316,GO:0009069,1,0.802410341105539,0,36,serine family amino acid metabolic process,BP,
4317,GO:0009070,1,0.913492327200131,0,15,serine family amino acid biosynthetic process,BP,
4318,GO:0009071,1,0.936538254129745,0,11,serine family amino acid catabolic process,BP,
4319,GO:0009072,1,0.865275132984991,0,24,aromatic amino acid family metabolic process,BP,
4320,GO:0009074,1,0.898490547746595,0,18,aromatic amino acid family catabolic process,BP,
4321,GO:0009078,1,0.97620048226098,0,4,pyruvate family amino acid metabolic process,BP,
4322,GO:0009080,1,0.97620048226098,0,4,pyruvate family amino acid catabolic process,BP,
4323,GO:0009081,1,0.858336196090806,0,24,branched-chain amino acid metabolic process,BP,
4324,GO:0009082,1,0.986486934967653,0,2,branched-chain amino acid biosynthetic process,BP,
4325,GO:0009083,1,0.875780439652239,0,21,branched-chain amino acid catabolic process,BP,
4326,GO:0009084,1,0.898117929565676,0,17,glutamine family amino acid biosynthetic process,BP,
4327,GO:0009085,1,0.986816973595944,0,2,lysine biosynthetic process,BP,
4328,GO:0009086,1,0.92706249354346,0,12,methionine biosynthetic process,BP,
4329,GO:0009087,1,0.993665289857805,0,1,methionine catabolic process,BP,
4330,GO:0009088,1,0.994036094605325,0,1,threonine biosynthetic process,BP,
4331,GO:0009092,1,0.976120858834261,0,4,homoserine metabolic process,BP,
4332,GO:0009093,1,0.982364627580649,0,3,cysteine catabolic process,BP,
4333,GO:0009098,1,0.986486934967653,0,2,leucine biosynthetic process,BP,
4334,GO:0009099,1,0.986486934967653,0,2,valine biosynthetic process,BP,
4337,GO:0009106,1,0.987813797454652,0,2,lipoate metabolic process,BP,
4338,GO:0009107,1,0.994162987867528,0,1,lipoate biosynthetic process,BP,
4339,GO:0009108,1,0.245459285879132,0,221,coenzyme biosynthetic process,BP,
4340,GO:0009109,1,0.917773168693579,0,14,coenzyme catabolic process,BP,
4341,GO:0009110,1,0.877237051796189,0,21,vitamin biosynthetic process,BP,
4342,GO:0009111,1,0.940868945322718,0,10,vitamin catabolic process,BP,
4344,GO:0009113,1,0.923716103436197,0,13,purine nucleobase biosynthetic process,BP,
4345,GO:0009115,1,0.986260343357986,0,2,xanthine catabolic process,BP,
4346,GO:0009116,1,0.495445389815552,0,113,nucleoside metabolic process,BP,
4348,GO:0009119,1,0.556172656069829,0,94,ribonucleoside metabolic process,BP,
4349,GO:0009120,1,0.964365580615424,0,6,deoxyribonucleoside metabolic process,BP,
4352,GO:0009125,1,0.935200902680962,0,11,nucleoside monophosphate catabolic process,BP,
4355,GO:0009128,1,0.946498635823615,0,9,purine nucleoside monophosphate catabolic process,BP,
4356,GO:0009129,1,0.90763373565376,0,16,pyrimidine nucleoside monophosphate metabolic process,BP,
4357,GO:0009130,1,0.912943925506067,0,15,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4358,GO:0009131,1,0.994188833591182,0,1,pyrimidine nucleoside monophosphate catabolic process,BP,
4361,GO:0009134,1,0.963660293122992,0,6,nucleoside diphosphate catabolic process,BP,
4364,GO:0009137,1,0.981281697804671,0,3,purine nucleoside diphosphate catabolic process,BP,
4365,GO:0009138,1,0.982012620217351,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
4366,GO:0009139,1,0.988138766958563,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4367,GO:0009140,1,0.993801070054312,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4370,GO:0009143,1,0.928604498582232,0,12,nucleoside triphosphate catabolic process,BP,
4372,GO:0009145,1,0.448763008543074,0,126,purine nucleoside triphosphate biosynthetic process,BP,
4373,GO:0009146,1,0.964212259968264,0,6,purine nucleoside triphosphate catabolic process,BP,
4374,GO:0009147,1,0.882463988013147,0,21,pyrimidine nucleoside triphosphate metabolic process,BP,
4375,GO:0009148,1,0.898274839341516,0,18,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4376,GO:0009149,1,0.988463625774805,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4381,GO:0009154,1,0.81724688451598,0,31,purine ribonucleotide catabolic process,BP,
4382,GO:0009155,1,0.969713190896687,0,5,purine deoxyribonucleotide catabolic process,BP,
4384,GO:0009157,1,0.947362142477538,0,9,deoxyribonucleoside monophosphate biosynthetic process,BP,
4385,GO:0009158,1,0.951901608149652,0,8,ribonucleoside monophosphate catabolic process,BP,
4386,GO:0009159,1,0.988070313786006,0,2,deoxyribonucleoside monophosphate catabolic process,BP,
4388,GO:0009162,1,0.930772193890443,0,12,deoxyribonucleoside monophosphate metabolic process,BP,
4389,GO:0009163,1,0.781261293245755,0,41,nucleoside biosynthetic process,BP,
4390,GO:0009164,1,0.85040398829359,0,27,nucleoside catabolic process,BP,
4395,GO:0009169,1,0.951901608149652,0,8,purine ribonucleoside monophosphate catabolic process,BP,
4396,GO:0009170,1,0.994360946082344,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4397,GO:0009173,1,0.940405837511897,0,10,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4398,GO:0009174,1,0.940405837511897,0,10,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4399,GO:0009176,1,0.965172576208512,0,6,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4400,GO:0009177,1,0.9708158498904,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4401,GO:0009178,1,0.994188833591182,0,1,pyrimidine deoxyribonucleoside monophosphate catabolic process,BP,
4404,GO:0009181,1,0.981281697804671,0,3,purine ribonucleoside diphosphate catabolic process,BP,
4413,GO:0009191,1,0.969635625203592,0,5,ribonucleoside diphosphate catabolic process,BP,
4414,GO:0009193,1,0.993801070054312,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4415,GO:0009195,1,0.993801070054312,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4416,GO:0009196,1,0.988138766958563,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4417,GO:0009197,1,0.988138766958563,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4419,GO:0009200,1,0.90832582006036,0,16,deoxyribonucleoside triphosphate metabolic process,BP,
4420,GO:0009201,1,0.434612591773359,0,131,ribonucleoside triphosphate biosynthetic process,BP,
4421,GO:0009202,1,0.964975230529264,0,6,deoxyribonucleoside triphosphate biosynthetic process,BP,
4422,GO:0009203,1,0.994329035643356,0,1,ribonucleoside triphosphate catabolic process,BP,
4423,GO:0009204,1,0.958522724118568,0,7,deoxyribonucleoside triphosphate catabolic process,BP,
4425,GO:0009206,1,0.451469526167198,0,125,purine ribonucleoside triphosphate biosynthetic process,BP,
4426,GO:0009207,1,0.994329035643356,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4427,GO:0009208,1,0.914034878342074,0,15,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4428,GO:0009209,1,0.919664081436177,0,14,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4429,GO:0009211,1,0.965490995055665,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4430,GO:0009212,1,0.976761976502778,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4431,GO:0009213,1,0.988463625774805,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4432,GO:0009214,1,0.873511100005872,0,20,cyclic nucleotide catabolic process,BP,
4433,GO:0009215,1,0.947225778387548,0,9,purine deoxyribonucleoside triphosphate metabolic process,BP,
4434,GO:0009216,1,0.987935715575278,0,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4435,GO:0009217,1,0.969713190896687,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4437,GO:0009219,1,0.893860821190703,0,19,pyrimidine deoxyribonucleotide metabolic process,BP,
4439,GO:0009221,1,0.95379431680887,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4440,GO:0009222,1,0.993801070054312,0,1,pyrimidine ribonucleotide catabolic process,BP,
4441,GO:0009223,1,0.931664954208366,0,12,pyrimidine deoxyribonucleotide catabolic process,BP,
4442,GO:0009224,1,0.994287018170238,0,1,CMP biosynthetic process,BP,
4443,GO:0009225,1,0.798490964908239,0,36,nucleotide-sugar metabolic process,BP,
4444,GO:0009226,1,0.868147380148067,0,23,nucleotide-sugar biosynthetic process,BP,
4445,GO:0009227,1,0.982186261248502,0,3,nucleotide-sugar catabolic process,BP,
4446,GO:0009229,1,0.993965442815809,0,1,thiamine diphosphate biosynthetic process,BP,
4447,GO:0009231,1,0.993865891603955,0,1,riboflavin biosynthetic process,BP,
4448,GO:0009233,1,0.987362532938191,0,2,menaquinone metabolic process,BP,
4449,GO:0009234,1,0.993595930235619,0,1,menaquinone biosynthetic process,BP,
4450,GO:0009235,1,0.884878263333966,0,19,cobalamin metabolic process,BP,
4451,GO:0009236,1,0.980346552774308,0,3,cobalamin biosynthetic process,BP,
4452,GO:0009237,1,0.993803361559966,0,1,siderophore metabolic process,BP,
4453,GO:0009240,1,0.976682294816776,0,4,isopentenyl diphosphate biosynthetic process,BP,
4454,GO:0009245,1,0.988946073143875,0,2,lipid A biosynthetic process,BP,
4455,GO:0009247,1,0.672224977907787,0,64,glycolipid biosynthetic process,BP,
4456,GO:0009249,1,0.955358988440895,0,8,protein lipoylation,BP,
4458,GO:0009251,1,0.853971519960281,0,24,glucan catabolic process,BP,
4459,GO:0009253,1,0.988764567890541,0,2,peptidoglycan catabolic process,BP,
4460,GO:0009256,1,0.967851807799139,0,5,10-formyltetrahydrofolate metabolic process,BP,
4461,GO:0009257,1,0.987291732594318,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4462,GO:0009258,1,0.986264900716323,0,2,10-formyltetrahydrofolate catabolic process,BP,
4465,GO:0009261,1,0.81217041731369,0,32,ribonucleotide catabolic process,BP,
4468,GO:0009264,1,0.898135487816669,0,18,deoxyribonucleotide catabolic process,BP,
4471,GO:0009267,1,0.435853951767774,0,130,cellular response to starvation,BP,
4472,GO:0009268,1,0.799908139325295,0,36,response to pH,BP,
4473,GO:0009295,1,0.77275710480015,0,41,nucleoid,CC,
4474,GO:0009298,1,0.976771876269959,0,4,GDP-mannose biosynthetic process,BP,
4475,GO:0009299,1,0.851671213563134,0,25,mRNA transcription,BP,
4476,GO:0009301,1,0.662157035075264,0,66,snRNA transcription,BP,
4477,GO:0009303,1,0.843767765602449,0,27,rRNA transcription,BP,
4478,GO:0009304,1,0.956204067733131,0,7,tRNA transcription,BP,
4479,GO:0009305,1,0.992915769695244,0,1,protein biotinylation,BP,
4482,GO:0009309,1,0.882136556478044,0,21,amine biosynthetic process,BP,
4483,GO:0009310,1,0.879299499794427,0,21,amine catabolic process,BP,
4484,GO:0009311,1,0.631398810232469,0,73,oligosaccharide metabolic process,BP,
4485,GO:0009312,1,0.789410754802007,0,38,oligosaccharide biosynthetic process,BP,
4486,GO:0009313,1,0.934066430429088,0,11,oligosaccharide catabolic process,BP,
4488,GO:0009328,1,0.975978481927053,0,4,phenylalanine-tRNA ligase complex,CC,
4490,GO:0009331,1,0.980406988235644,0,3,glycerol-3-phosphate dehydrogenase complex,CC,
4491,GO:0009346,1,0.993393014434816,0,1,citrate lyase complex,CC,
4492,GO:0009353,1,0.994263915888173,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4493,GO:0009360,1,0.993867614970942,0,1,DNA polymerase III complex,CC,
4494,GO:0009368,1,0.98831385603826,0,2,endopeptidase Clp complex,CC,
4495,GO:0009372,1,0.993701267540879,0,1,quorum sensing,BP,
4496,GO:0009374,1,0.966664927371373,0,5,biotin binding,MF,
4497,GO:0009378,1,0.967463494556768,0,5,four-way junction helicase activity,MF,
4498,GO:0009383,1,0.987276925075891,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4499,GO:0009384,1,0.993122170575948,0,1,N-acylmannosamine kinase activity,MF,
4500,GO:0009386,1,0.988203601766993,0,2,translational attenuation,BP,
4503,GO:0009396,1,0.946507999283532,0,9,folic acid-containing compound biosynthetic process,BP,
4504,GO:0009397,1,0.974153860812295,0,4,folic acid-containing compound catabolic process,BP,
4505,GO:0009398,1,0.993865891603955,0,1,FMN biosynthetic process,BP,
4506,GO:0009400,1,0.993825715097266,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4507,GO:0009403,1,0.974945808050987,0,4,toxin biosynthetic process,BP,
4508,GO:0009404,1,0.884315098889833,0,20,toxin metabolic process,BP,
4509,GO:0009405,1,0.986070013228274,0,2,pathogenesis,BP,
4510,GO:0009407,1,0.971247635342701,0,5,toxin catabolic process,BP,
4514,GO:0009411,1,0.438458837796587,0,129,response to UV,BP,
4515,GO:0009414,1,0.958102115984223,0,7,response to water deprivation,BP,
4516,GO:0009415,1,0.926172160203464,0,12,response to water,BP,
4518,GO:0009435,1,0.747047027526074,0,47,NAD biosynthetic process,BP,
4519,GO:0009436,1,0.988065434455525,0,2,glyoxylate catabolic process,BP,
4520,GO:0009437,1,0.922985509703762,0,13,carnitine metabolic process,BP,
4521,GO:0009438,1,0.970800577767362,0,5,methylglyoxal metabolic process,BP,
4522,GO:0009439,1,0.988575472934903,0,2,cyanate metabolic process,BP,
4523,GO:0009440,1,0.988575472934903,0,2,cyanate catabolic process,BP,
4524,GO:0009441,1,0.981191753105941,0,3,glycolate metabolic process,BP,
4525,GO:0009443,1,0.992519576798508,0,1,pyridoxal 5'-phosphate salvage,BP,
4526,GO:0009444,1,0.993119430958074,0,1,pyruvate oxidation,BP,
4527,GO:0009445,1,0.958906756434872,0,7,putrescine metabolic process,BP,
4528,GO:0009446,1,0.969846206932228,0,5,putrescine biosynthetic process,BP,
4529,GO:0009447,1,0.982945933636704,0,3,putrescine catabolic process,BP,
4530,GO:0009448,1,0.974204404767162,0,4,gamma-aminobutyric acid metabolic process,BP,
4531,GO:0009449,1,0.980910970238233,0,3,gamma-aminobutyric acid biosynthetic process,BP,
4532,GO:0009450,1,0.986442578322871,0,2,gamma-aminobutyric acid catabolic process,BP,
4533,GO:0009451,1,0.448513388142626,0,130,RNA modification,BP,
4534,GO:0009452,1,0.821455597141531,0,32,7-methylguanosine RNA capping,BP,
4535,GO:0009566,1,0.433841104380488,0,133,fertilization,BP,
4536,GO:0009581,1,0.497543195546053,0,105,detection of external stimulus,BP,
4537,GO:0009582,1,0.488248293739483,0,108,detection of abiotic stimulus,BP,
4538,GO:0009583,1,0.717226279622213,0,53,detection of light stimulus,BP,
4539,GO:0009584,1,0.762886833638269,0,43,detection of visible light,BP,
4540,GO:0009590,1,0.994054276293114,0,1,detection of gravity,BP,
4542,GO:0009595,1,0.884966560401156,0,19,detection of biotic stimulus,BP,
4543,GO:0009597,1,0.969194978488642,0,5,detection of virus,BP,
4545,GO:0009607,1,0.00981277614591692,0,726,response to biotic stimulus,BP,
4546,GO:0009608,1,0.987839184228186,0,2,response to symbiont,BP,
4547,GO:0009609,1,0.987839184228186,0,2,response to symbiotic bacterium,BP,
4550,GO:0009615,1,0.184456174168985,0,267,response to virus,BP,
4551,GO:0009617,1,0.0660907647105129,0,432,response to bacterium,BP,
4552,GO:0009620,1,0.807734560376828,0,36,response to fungus,BP,
4553,GO:0009624,1,0.993893766769423,0,1,response to nematode,BP,
4555,GO:0009629,1,0.941387693487473,0,10,response to gravity,BP,
4556,GO:0009631,1,0.993176940438187,0,1,cold acclimation,BP,
4557,GO:0009635,1,0.935713410455614,0,11,response to herbicide,BP,
4559,GO:0009637,1,0.987202376119001,0,2,response to blue light,BP,
4560,GO:0009642,1,0.932460202041077,0,11,response to light intensity,BP,
4561,GO:0009644,1,0.987215779608153,0,2,response to high light intensity,BP,
4562,GO:0009645,1,0.993643024809225,0,1,response to low light intensity stimulus,BP,
4563,GO:0009646,1,0.993697840280528,0,1,response to absence of light,BP,
4564,GO:0009648,1,0.858891415521492,0,24,photoperiodism,BP,
4565,GO:0009649,1,0.848352604928271,0,26,entrainment of circadian clock,BP,
4566,GO:0009650,1,0.92290029947122,0,13,UV protection,BP,
4567,GO:0009651,1,0.882367197138363,0,20,response to salt stress,BP,
4569,GO:0009669,1,0.98146129146013,0,3,sucrose:cation symporter activity,MF,
4570,GO:0009673,1,0.993591648620705,0,1,low-affinity phosphate transmembrane transporter activity,MF,
4571,GO:0009674,1,0.986001355832601,0,2,potassium:sodium symporter activity,MF,
4572,GO:0009692,1,0.993893766769423,0,1,ethylene metabolic process,BP,
4573,GO:0009698,1,0.965183539217527,0,6,phenylpropanoid metabolic process,BP,
4577,GO:0009720,1,0.993785750786921,0,1,detection of hormone stimulus,BP,
4579,GO:0009726,1,0.979156541209127,0,3,detection of endogenous stimulus,BP,
4580,GO:0009730,1,0.976298374042888,0,4,detection of carbohydrate stimulus,BP,
4581,GO:0009732,1,0.976298374042888,0,4,detection of hexose stimulus,BP,
4582,GO:0009737,1,0.993394304974037,0,1,response to abscisic acid,BP,
4583,GO:0009738,1,0.993394304974037,0,1,abscisic acid-activated signaling pathway,BP,
4585,GO:0009744,1,0.974445773805484,0,4,response to sucrose,BP,
4588,GO:0009750,1,0.951063879957682,0,8,response to fructose,BP,
4589,GO:0009753,1,0.977252045272567,0,4,response to jasmonic acid,BP,
4591,GO:0009756,1,0.957977270476771,0,7,carbohydrate mediated signaling,BP,
4592,GO:0009757,1,0.969884719784543,0,5,hexose mediated signaling,BP,
4593,GO:0009758,1,0.992116453925477,0,1,carbohydrate utilization,BP,
4594,GO:0009785,1,0.987202376119001,0,2,blue light signaling pathway,BP,
4595,GO:0009786,1,0.972899276025671,0,4,regulation of asymmetric cell division,BP,
4596,GO:0009787,1,0.993394304974037,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4597,GO:0009789,1,0.993394304974037,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4599,GO:0009791,1,0.564669853415982,0,84,post-embryonic development,BP,
4601,GO:0009794,1,0.97553527018937,0,4,regulation of mitotic cell cycle, embryonic,BP,
4602,GO:0009798,1,0.592742245184486,0,81,axis specification,BP,
4604,GO:0009804,1,0.965183539217527,0,6,coumarin metabolic process,BP,
4605,GO:0009810,1,0.994009264215723,0,1,stilbene metabolic process,BP,
4606,GO:0009812,1,0.963954389326901,0,6,flavonoid metabolic process,BP,
4607,GO:0009814,1,0.994011283271499,0,1,defense response, incompatible interaction,BP,
4608,GO:0009817,1,0.994011283271499,0,1,defense response to fungus, incompatible interaction,BP,
4609,GO:0009820,1,0.970785939597292,0,5,alkaloid metabolic process,BP,
4610,GO:0009822,1,0.988374630039465,0,2,alkaloid catabolic process,BP,
4611,GO:0009826,1,0.986913922220438,0,2,unidimensional cell growth,BP,
4612,GO:0009838,1,0.970603793695696,0,5,abscission,BP,
4613,GO:0009841,1,0.993965730969657,0,1,mitochondrial endopeptidase Clp complex,CC,
4614,GO:0009850,1,0.988455302081744,0,2,auxin metabolic process,BP,
4615,GO:0009852,1,0.988455302081744,0,2,auxin catabolic process,BP,
4617,GO:0009880,1,0.69332548907455,0,56,embryonic pattern specification,BP,
4618,GO:0009881,1,0.941221810316315,0,10,photoreceptor activity,MF,
4619,GO:0009882,1,0.987202376119001,0,2,blue light photoreceptor activity,MF,
4620,GO:0009886,1,0.928418599143171,0,11,post-embryonic animal morphogenesis,BP,
4629,GO:0009895,1,0.205947053057578,0,243,negative regulation of catabolic process,BP,
4633,GO:0009912,1,0.968030161640181,0,5,auditory receptor cell fate commitment,BP,
4636,GO:0009918,1,0.993880400251359,0,1,sterol delta7 reductase activity,MF,
4637,GO:0009922,1,0.963060796982218,0,6,fatty acid elongase activity,MF,
4640,GO:0009946,1,0.982532619732154,0,3,proximal/distal axis specification,BP,
4641,GO:0009948,1,0.760866838490349,0,43,anterior/posterior axis specification,BP,
4642,GO:0009949,1,0.994192298933327,0,1,polarity specification of anterior/posterior axis,BP,
4643,GO:0009950,1,0.892595063117366,0,17,dorsal/ventral axis specification,BP,
4644,GO:0009952,1,0.302681099536696,0,184,anterior/posterior pattern specification,BP,
4647,GO:0009955,1,0.99401041795257,0,1,adaxial/abaxial pattern specification,BP,
4648,GO:0009956,1,0.993521256909049,0,1,radial pattern formation,BP,
4649,GO:0009957,1,0.979969729316357,0,3,epidermal cell fate specification,BP,
4653,GO:0009972,1,0.953710393298115,0,8,cytidine deamination,BP,
4654,GO:0009975,1,0.897352245863318,0,16,cyclase activity,MF,
4655,GO:0009982,1,0.924222971271569,0,13,pseudouridine synthase activity,MF,
4658,GO:0009988,1,0.722887665239582,0,53,cell-cell recognition,BP,
4660,GO:0009992,1,0.994017485123824,0,1,cellular water homeostasis,BP,
4661,GO:0009994,1,0.761355284012919,0,43,oocyte differentiation,BP,
4662,GO:0009996,1,0.970374406784898,0,5,negative regulation of cell fate specification,BP,
4666,GO:0010009,1,0.969777578918687,0,5,cytoplasmic side of endosome membrane,CC,
4667,GO:0010015,1,0.994422168860593,0,1,root morphogenesis,BP,
4668,GO:0010021,1,0.993737553720693,0,1,amylopectin biosynthetic process,BP,
4669,GO:0010025,1,0.98720890042454,0,2,wax biosynthetic process,BP,
4670,GO:0010032,1,0.966162621887397,0,5,meiotic chromosome condensation,BP,
4672,GO:0010034,1,0.993627612035653,0,1,response to acetate,BP,
4674,GO:0010037,1,0.99375456484417,0,1,response to carbon dioxide,BP,
4677,GO:0010040,1,0.975971146760067,0,4,response to iron(II) ion,BP,
4678,GO:0010041,1,0.968855471944628,0,5,response to iron(III) ion,BP,
4679,GO:0010042,1,0.901778677767138,0,16,response to manganese ion,BP,
4680,GO:0010043,1,0.742378783444269,0,49,response to zinc ion,BP,
4681,GO:0010044,1,0.969929731433367,0,5,response to aluminum ion,BP,
4682,GO:0010045,1,0.992464274173605,0,1,response to nickel cation,BP,
4683,GO:0010046,1,0.963601579754347,0,6,response to mycotoxin,BP,
4684,GO:0010053,1,0.994422168860593,0,1,root epidermal cell differentiation,BP,
4685,GO:0010054,1,0.994422168860593,0,1,trichoblast differentiation,BP,
4686,GO:0010070,1,0.993949597679924,0,1,zygote asymmetric cell division,BP,
4687,GO:0010085,1,0.99404504058974,0,1,polarity specification of proximal/distal axis,BP,
4689,GO:0010106,1,0.994084876381684,0,1,cellular response to iron ion starvation,BP,
4690,GO:0010107,1,0.772422162600347,0,40,potassium ion import,BP,
4691,GO:0010121,1,0.994074338526026,0,1,arginine catabolic process to proline via ornithine,BP,
4692,GO:0010124,1,0.988455302081744,0,2,phenylacetate catabolic process,BP,
4693,GO:0010133,1,0.987753248392844,0,2,proline catabolic process to glutamate,BP,
4694,GO:0010138,1,0.970850799659427,0,5,pyrimidine ribonucleotide salvage,BP,
4695,GO:0010139,1,0.994180170230059,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4696,GO:0010142,1,0.987633127588846,0,2,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
4697,GO:0010155,1,0.913653217588713,0,15,regulation of proton transport,BP,
4698,GO:0010157,1,0.992389836139498,0,1,response to chlorate,BP,
4699,GO:0010159,1,0.981237394784732,0,3,specification of animal organ position,BP,
4700,GO:0010160,1,0.99435979094836,0,1,formation of animal organ boundary,BP,
4701,GO:0010164,1,0.994180170230059,0,1,response to cesium ion,BP,
4702,GO:0010165,1,0.795347344153636,0,35,response to X-ray,BP,
4703,GO:0010166,1,0.98720890042454,0,2,wax metabolic process,BP,
4704,GO:0010171,1,0.733418349660276,0,47,body morphogenesis,BP,
4705,GO:0010172,1,0.927326383488246,0,11,embryonic body morphogenesis,BP,
4706,GO:0010181,1,0.932660456516823,0,11,FMN binding,MF,
4707,GO:0010182,1,0.969884719784543,0,5,sugar mediated signaling pathway,BP,
4708,GO:0010189,1,0.994162410308334,0,1,vitamin E biosynthetic process,BP,
4709,GO:0010193,1,0.976109908460312,0,4,response to ozone,BP,
4710,GO:0010212,1,0.402200339413354,0,142,response to ionizing radiation,BP,
4711,GO:0010216,1,0.967504874241613,0,5,maintenance of DNA methylation,BP,
4712,GO:0010224,1,0.900319556277798,0,17,response to UV-B,BP,
4713,GO:0010225,1,0.917062239159369,0,13,response to UV-C,BP,
4714,GO:0010226,1,0.870057517969341,0,22,response to lithium ion,BP,
4715,GO:0010232,1,0.993745557971144,0,1,vascular transport,BP,
4717,GO:0010248,1,0.923203814038964,0,13,establishment or maintenance of transmembrane electrochemical gradient,BP,
4718,GO:0010255,1,0.969884719784543,0,5,glucose mediated signaling pathway,BP,
4720,GO:0010257,1,0.727584431866457,0,55,NADH dehydrogenase complex assembly,BP,
4721,GO:0010259,1,0.845632211705253,0,25,multicellular organism aging,BP,
4722,GO:0010265,1,0.962429671727865,0,6,SCF complex assembly,BP,
4723,GO:0010266,1,0.980801982313464,0,3,response to vitamin B1,BP,
4724,GO:0010269,1,0.967181271334441,0,5,response to selenium ion,BP,
4725,GO:0010273,1,0.938992621508128,0,11,detoxification of copper ion,BP,
4726,GO:0010286,1,0.970805429596937,0,5,heat acclimation,BP,
4727,GO:0010288,1,0.875462531862449,0,21,response to lead ion,BP,
4728,GO:0010309,1,0.994163421036889,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4729,GO:0010310,1,0.918518114491612,0,14,regulation of hydrogen peroxide metabolic process,BP,
4730,GO:0010314,1,0.935845522903083,0,10,phosphatidylinositol-5-phosphate binding,MF,
4731,GO:0010324,1,0.679448278759555,0,61,membrane invagination,BP,
4732,GO:0010332,1,0.711887516000077,0,52,response to gamma radiation,BP,
4733,GO:0010335,1,0.993353559842376,0,1,response to non-ionic osmotic stress,BP,
4734,GO:0010340,1,0.963040057977828,0,6,carboxyl-O-methyltransferase activity,MF,
4735,GO:0010348,1,0.993846081630578,0,1,lithium:proton antiporter activity,MF,
4736,GO:0010359,1,0.942159190412002,0,9,regulation of anion channel activity,BP,
4737,GO:0010360,1,0.98110343612079,0,3,negative regulation of anion channel activity,BP,
4738,GO:0010369,1,0.912892711345858,0,14,chromocenter,CC,
4739,GO:0010370,1,0.987646429216819,0,2,perinucleolar chromocenter,CC,
4740,GO:0010385,1,0.968693822931621,0,5,double-stranded methylated DNA binding,MF,
4741,GO:0010387,1,0.987867763538962,0,2,COP9 signalosome assembly,BP,
4742,GO:0010389,1,0.306029655460219,0,186,regulation of G2/M transition of mitotic cell cycle,BP,
4743,GO:0010390,1,0.839141978628623,0,27,histone monoubiquitination,BP,
4744,GO:0010412,1,0.993689558529205,0,1,mannan metabolic process,BP,
4745,GO:0010420,1,0.994281242594407,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4746,GO:0010421,1,0.927796866473745,0,12,hydrogen peroxide-mediated programmed cell death,BP,
4747,GO:0010428,1,0.992948699216184,0,1,methyl-CpNpG binding,MF,
4748,GO:0010430,1,0.993292651914914,0,1,fatty acid omega-oxidation,BP,
4749,GO:0010446,1,0.98761128446765,0,2,response to alkaline pH,BP,
4750,GO:0010447,1,0.888713163532925,0,19,response to acidic pH,BP,
4751,GO:0010452,1,0.938545521827729,0,9,histone H3-K36 methylation,BP,
4755,GO:0010457,1,0.927037450030651,0,11,centriole-centriole cohesion,BP,
4756,GO:0010458,1,0.843793934926433,0,27,exit from mitosis,BP,
4757,GO:0010459,1,0.947524897173642,0,9,negative regulation of heart rate,BP,
4759,GO:0010463,1,0.740718852940348,0,46,mesenchymal cell proliferation,BP,
4760,GO:0010464,1,0.798290784325312,0,35,regulation of mesenchymal cell proliferation,BP,
4761,GO:0010465,1,0.986548976861476,0,2,nerve growth factor receptor activity,MF,
4767,GO:0010477,1,0.993710693593427,0,1,response to sulfur dioxide,BP,
4768,GO:0010481,1,0.98761910387172,0,2,epidermal cell division,BP,
4769,GO:0010482,1,0.98761910387172,0,2,regulation of epidermal cell division,BP,
4770,GO:0010484,1,0.972387683484159,0,4,H3 histone acetyltransferase activity,MF,
4771,GO:0010485,1,0.888824933447488,0,18,H4 histone acetyltransferase activity,MF,
4772,GO:0010494,1,0.75734868696659,0,42,cytoplasmic stress granule,CC,
4773,GO:0010496,1,0.99406870912543,0,1,intercellular transport,BP,
4775,GO:0010499,1,0.883399639899306,0,21,proteasomal ubiquitin-independent protein catabolic process,BP,
4776,GO:0010501,1,0.757696765334796,0,44,RNA secondary structure unwinding,BP,
4778,GO:0010507,1,0.647466917257786,0,67,negative regulation of autophagy,BP,
4779,GO:0010508,1,0.524691960582136,0,98,positive regulation of autophagy,BP,
4780,GO:0010509,1,0.99305437415975,0,1,polyamine homeostasis,BP,
4781,GO:0010510,1,0.924251200537664,0,12,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4782,GO:0010511,1,0.95777651791619,0,7,regulation of phosphatidylinositol biosynthetic process,BP,
4783,GO:0010512,1,0.987701003265702,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
4784,GO:0010513,1,0.969706658909016,0,5,positive regulation of phosphatidylinositol biosynthetic process,BP,
4787,GO:0010519,1,0.968768608877564,0,5,negative regulation of phospholipase activity,BP,
4788,GO:0010520,1,0.981323773311521,0,3,regulation of reciprocal meiotic recombination,BP,
4789,GO:0010521,1,0.981800855224234,0,3,telomerase inhibitor activity,MF,
4791,GO:0010523,1,0.899715390421661,0,17,negative regulation of calcium ion transport into cytosol,BP,
4792,GO:0010524,1,0.734785131240595,0,49,positive regulation of calcium ion transport into cytosol,BP,
4793,GO:0010528,1,0.899126386455611,0,17,regulation of transposition,BP,
4794,GO:0010529,1,0.899126386455611,0,17,negative regulation of transposition,BP,
4795,GO:0010533,1,0.976848390755235,0,4,regulation of activation of Janus kinase activity,BP,
4796,GO:0010536,1,0.988283023583339,0,2,positive regulation of activation of Janus kinase activity,BP,
4797,GO:0010543,1,0.825555948452046,0,30,regulation of platelet activation,BP,
4798,GO:0010544,1,0.897511637442028,0,17,negative regulation of platelet activation,BP,
4803,GO:0010560,1,0.884564199003095,0,19,positive regulation of glycoprotein biosynthetic process,BP,
4804,GO:0010561,1,0.93982791554506,0,10,negative regulation of glycoprotein biosynthetic process,BP,
4808,GO:0010565,1,0.396721778007829,0,147,regulation of cellular ketone metabolic process,BP,
4809,GO:0010566,1,0.921951055964133,0,13,regulation of ketone biosynthetic process,BP,
4811,GO:0010571,1,0.959005431160444,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
4812,GO:0010572,1,0.968678841898405,0,5,positive regulation of platelet activation,BP,
4813,GO:0010573,1,0.818748001280529,0,31,vascular endothelial growth factor production,BP,
4814,GO:0010574,1,0.824558351064198,0,30,regulation of vascular endothelial growth factor production,BP,
4815,GO:0010575,1,0.849133360705549,0,25,positive regulation of vascular endothelial growth factor production,BP,
4816,GO:0010578,1,0.993906995876712,0,1,regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,BP,
4817,GO:0010585,1,0.994090362193189,0,1,glutamine secretion,BP,
4818,GO:0010586,1,0.868304168454912,0,22,miRNA metabolic process,BP,
4819,GO:0010587,1,0.967279438273962,0,5,miRNA catabolic process,BP,
4820,GO:0010591,1,0.838633034316072,0,27,regulation of lamellipodium assembly,BP,
4821,GO:0010592,1,0.90599774302115,0,15,positive regulation of lamellipodium assembly,BP,
4822,GO:0010593,1,0.986088624942768,0,2,negative regulation of lamellipodium assembly,BP,
4825,GO:0010596,1,0.760726326691761,0,42,negative regulation of endothelial cell migration,BP,
4826,GO:0010603,1,0.946600785785873,0,8,regulation of cytoplasmic mRNA processing body assembly,BP,
4829,GO:0010606,1,0.964900555539582,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4830,GO:0010607,1,0.994080545641901,0,1,negative regulation of cytoplasmic mRNA processing body assembly,BP,
4831,GO:0010608,1,0.0376949183990974,0,509,posttranscriptional regulation of gene expression,BP,
4832,GO:0010609,1,0.987860575439678,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4833,GO:0010610,1,0.992177223136307,0,1,regulation of mRNA stability involved in response to stress,BP,
4834,GO:0010611,1,0.74801434144286,0,44,regulation of cardiac muscle hypertrophy,BP,
4835,GO:0010612,1,0.947569323493861,0,8,regulation of cardiac muscle adaptation,BP,
4836,GO:0010613,1,0.84278693593969,0,26,positive regulation of cardiac muscle hypertrophy,BP,
4837,GO:0010614,1,0.901272978272705,0,16,negative regulation of cardiac muscle hypertrophy,BP,
4838,GO:0010615,1,0.987004793562329,0,2,positive regulation of cardiac muscle adaptation,BP,
4839,GO:0010616,1,0.960050534531224,0,6,negative regulation of cardiac muscle adaptation,BP,
4840,GO:0010621,1,0.982447750753614,0,3,negative regulation of transcription by transcription factor localization,BP,
4841,GO:0010623,1,0.925402317214719,0,12,programmed cell death involved in cell development,BP,
4843,GO:0010625,1,0.993938798113062,0,1,positive regulation of Schwann cell proliferation,BP,
4849,GO:0010633,1,0.690634510150509,0,57,negative regulation of epithelial cell migration,BP,
4851,GO:0010635,1,0.951073121359365,0,8,regulation of mitochondrial fusion,BP,
4852,GO:0010636,1,0.986758373359351,0,2,positive regulation of mitochondrial fusion,BP,
4853,GO:0010637,1,0.969793610458854,0,5,negative regulation of mitochondrial fusion,BP,
4856,GO:0010640,1,0.864636197928001,0,22,regulation of platelet-derived growth factor receptor signaling pathway,BP,
4857,GO:0010641,1,0.967534707901818,0,5,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4858,GO:0010642,1,0.899546811335532,0,16,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,
4859,GO:0010643,1,0.987562954363753,0,2,cell communication by chemical coupling,BP,
4861,GO:0010645,1,0.993745557971144,0,1,regulation of cell communication by chemical coupling,BP,
4865,GO:0010649,1,0.924006851839077,0,12,regulation of cell communication by electrical coupling,BP,
4866,GO:0010650,1,0.985180111500027,0,2,positive regulation of cell communication by electrical coupling,BP,
4867,GO:0010652,1,0.993745557971144,0,1,positive regulation of cell communication by chemical coupling,BP,
4868,GO:0010656,1,0.815938617623115,0,32,negative regulation of muscle cell apoptotic process,BP,
4876,GO:0010664,1,0.870248430270434,0,22,negative regulation of striated muscle cell apoptotic process,BP,
4879,GO:0010667,1,0.88724815714293,0,19,negative regulation of cardiac muscle cell apoptotic process,BP,
4880,GO:0010668,1,0.961487004428653,0,6,ectodermal cell differentiation,BP,
4881,GO:0010669,1,0.880573529854973,0,20,epithelial structure maintenance,BP,
4882,GO:0010675,1,0.507121413427911,0,104,regulation of cellular carbohydrate metabolic process,BP,
4883,GO:0010676,1,0.747323887390568,0,44,positive regulation of cellular carbohydrate metabolic process,BP,
4884,GO:0010677,1,0.829447603337472,0,29,negative regulation of cellular carbohydrate metabolic process,BP,
4885,GO:0010692,1,0.939407417814382,0,9,regulation of alkaline phosphatase activity,BP,
4886,GO:0010693,1,0.980785099007268,0,3,negative regulation of alkaline phosphatase activity,BP,
4887,GO:0010694,1,0.957819845465699,0,6,positive regulation of alkaline phosphatase activity,BP,
4888,GO:0010698,1,0.988129076732996,0,2,acetyltransferase activator activity,MF,
4889,GO:0010700,1,0.97022297470496,0,5,negative regulation of norepinephrine secretion,BP,
4890,GO:0010701,1,0.98111743530644,0,3,positive regulation of norepinephrine secretion,BP,
4891,GO:0010705,1,0.987217009148944,0,2,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4892,GO:0010710,1,0.981934201594494,0,3,regulation of collagen catabolic process,BP,
4893,GO:0010711,1,0.994423612812389,0,1,negative regulation of collagen catabolic process,BP,
4894,GO:0010712,1,0.824884576030259,0,31,regulation of collagen metabolic process,BP,
4895,GO:0010713,1,0.952713704804896,0,8,negative regulation of collagen metabolic process,BP,
4896,GO:0010714,1,0.882105881305162,0,20,positive regulation of collagen metabolic process,BP,
4897,GO:0010715,1,0.916295541886152,0,13,regulation of extracellular matrix disassembly,BP,
4898,GO:0010716,1,0.976009365384193,0,4,negative regulation of extracellular matrix disassembly,BP,
4900,GO:0010718,1,0.748091942099686,0,44,positive regulation of epithelial to mesenchymal transition,BP,
4901,GO:0010719,1,0.85209634365825,0,26,negative regulation of epithelial to mesenchymal transition,BP,
4904,GO:0010722,1,0.992582677171849,0,1,regulation of ferrochelatase activity,BP,
4905,GO:0010724,1,0.975291659296081,0,4,regulation of definitive erythrocyte differentiation,BP,
4906,GO:0010725,1,0.987930637840669,0,2,regulation of primitive erythrocyte differentiation,BP,
4907,GO:0010726,1,0.987832025265977,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
4908,GO:0010727,1,0.957729476809614,0,7,negative regulation of hydrogen peroxide metabolic process,BP,
4909,GO:0010728,1,0.974933831455555,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
4910,GO:0010729,1,0.994061781075666,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
4911,GO:0010730,1,0.980758944248642,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
4915,GO:0010735,1,0.974609249784267,0,4,positive regulation of transcription via serum response element binding,BP,
4916,GO:0010736,1,0.987535291897666,0,2,serum response element binding,MF,
4917,GO:0010737,1,0.821115031190456,0,26,protein kinase A signaling,BP,
4918,GO:0010738,1,0.884402147026623,0,18,regulation of protein kinase A signaling,BP,
4919,GO:0010739,1,0.96298598599934,0,6,positive regulation of protein kinase A signaling,BP,
4920,GO:0010742,1,0.826690403120039,0,29,macrophage derived foam cell differentiation,BP,
4921,GO:0010743,1,0.84908360604053,0,25,regulation of macrophage derived foam cell differentiation,BP,
4922,GO:0010744,1,0.914728623043434,0,14,positive regulation of macrophage derived foam cell differentiation,BP,
4923,GO:0010745,1,0.928298379176741,0,11,negative regulation of macrophage derived foam cell differentiation,BP,
4924,GO:0010746,1,0.972838695841112,0,4,regulation of plasma membrane long-chain fatty acid transport,BP,
4925,GO:0010748,1,0.972838695841112,0,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,
4926,GO:0010749,1,0.967295696777476,0,5,regulation of nitric oxide mediated signal transduction,BP,
4927,GO:0010750,1,0.987308916871302,0,2,positive regulation of nitric oxide mediated signal transduction,BP,
4928,GO:0010751,1,0.97973213997106,0,3,negative regulation of nitric oxide mediated signal transduction,BP,
4929,GO:0010752,1,0.986418079180627,0,2,regulation of cGMP-mediated signaling,BP,
4930,GO:0010754,1,0.992976424716485,0,1,negative regulation of cGMP-mediated signaling,BP,
4931,GO:0010755,1,0.940989412855581,0,10,regulation of plasminogen activation,BP,
4932,GO:0010756,1,0.970810854734008,0,5,positive regulation of plasminogen activation,BP,
4933,GO:0010757,1,0.969291067706878,0,5,negative regulation of plasminogen activation,BP,
4934,GO:0010758,1,0.893894614983919,0,18,regulation of macrophage chemotaxis,BP,
4935,GO:0010759,1,0.939495653102009,0,10,positive regulation of macrophage chemotaxis,BP,
4936,GO:0010760,1,0.969947270372683,0,5,negative regulation of macrophage chemotaxis,BP,
4937,GO:0010761,1,0.779605616433595,0,38,fibroblast migration,BP,
4938,GO:0010762,1,0.836339717697252,0,28,regulation of fibroblast migration,BP,
4939,GO:0010763,1,0.931281047167798,0,11,positive regulation of fibroblast migration,BP,
4940,GO:0010764,1,0.951268438374098,0,8,negative regulation of fibroblast migration,BP,
4942,GO:0010766,1,0.911120993578263,0,14,negative regulation of sodium ion transport,BP,
4943,GO:0010767,1,0.979250986103454,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4944,GO:0010768,1,0.985289827157373,0,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4948,GO:0010789,1,0.993846081630578,0,1,meiotic sister chromatid cohesion involved in meiosis I,BP,
4949,GO:0010792,1,0.969367504376257,0,5,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4950,GO:0010793,1,0.967108200480064,0,5,regulation of mRNA export from nucleus,BP,
4951,GO:0010795,1,0.994281242594407,0,1,regulation of ubiquinone biosynthetic process,BP,
4952,GO:0010796,1,0.982484018747401,0,3,regulation of multivesicular body size,BP,
4953,GO:0010797,1,0.994296259100739,0,1,regulation of multivesicular body size involved in endosome transport,BP,
4954,GO:0010799,1,0.778126285514603,0,39,regulation of peptidyl-threonine phosphorylation,BP,
4955,GO:0010800,1,0.835295501970216,0,28,positive regulation of peptidyl-threonine phosphorylation,BP,
4956,GO:0010801,1,0.914712211950115,0,14,negative regulation of peptidyl-threonine phosphorylation,BP,
4957,GO:0010803,1,0.716204954117375,0,54,regulation of tumor necrosis factor-mediated signaling pathway,BP,
4958,GO:0010804,1,0.903528447720523,0,17,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
4959,GO:0010807,1,0.961955360586574,0,6,regulation of synaptic vesicle priming,BP,
4960,GO:0010808,1,0.992803938441872,0,1,positive regulation of synaptic vesicle priming,BP,
4963,GO:0010812,1,0.713543215611316,0,51,negative regulation of cell-substrate adhesion,BP,
4964,GO:0010813,1,0.987431559556798,0,2,neuropeptide catabolic process,BP,
4965,GO:0010814,1,0.993171465498053,0,1,substance P catabolic process,BP,
4966,GO:0010815,1,0.974713670743001,0,4,bradykinin catabolic process,BP,
4967,GO:0010816,1,0.993171465498053,0,1,calcitonin catabolic process,BP,
4969,GO:0010818,1,0.886098725221826,0,20,T cell chemotaxis,BP,
4970,GO:0010819,1,0.940933100682023,0,10,regulation of T cell chemotaxis,BP,
4971,GO:0010820,1,0.946322225690084,0,9,positive regulation of T cell chemotaxis,BP,
4975,GO:0010824,1,0.776571011649266,0,39,regulation of centrosome duplication,BP,
4976,GO:0010825,1,0.961637854941464,0,6,positive regulation of centrosome duplication,BP,
4977,GO:0010826,1,0.925229547263659,0,12,negative regulation of centrosome duplication,BP,
4978,GO:0010827,1,0.645274195626883,0,67,regulation of glucose transmembrane transport,BP,
4979,GO:0010828,1,0.766018973745849,0,40,positive regulation of glucose transmembrane transport,BP,
4980,GO:0010829,1,0.90475474841043,0,16,negative regulation of glucose transmembrane transport,BP,
4981,GO:0010830,1,0.747034616614001,0,46,regulation of myotube differentiation,BP,
4982,GO:0010831,1,0.854519772290214,0,25,positive regulation of myotube differentiation,BP,
4983,GO:0010832,1,0.91368905456365,0,14,negative regulation of myotube differentiation,BP,
4984,GO:0010833,1,0.617095963360503,0,75,telomere maintenance via telomere lengthening,BP,
4985,GO:0010835,1,0.963262030392657,0,6,regulation of protein ADP-ribosylation,BP,
4986,GO:0010836,1,0.982353497743385,0,3,negative regulation of protein ADP-ribosylation,BP,
4987,GO:0010837,1,0.847603655729663,0,25,regulation of keratinocyte proliferation,BP,
4988,GO:0010838,1,0.956001218735439,0,7,positive regulation of keratinocyte proliferation,BP,
4989,GO:0010839,1,0.927556538708307,0,11,negative regulation of keratinocyte proliferation,BP,
4990,GO:0010840,1,0.97615672773593,0,4,regulation of circadian sleep/wake cycle, wakefulness,BP,
4991,GO:0010841,1,0.981929171907266,0,3,positive regulation of circadian sleep/wake cycle, wakefulness,BP,
4992,GO:0010842,1,0.876982184400417,0,19,retina layer formation,BP,
4993,GO:0010845,1,0.987509352990765,0,2,positive regulation of reciprocal meiotic recombination,BP,
4994,GO:0010847,1,0.972912384736939,0,4,regulation of chromatin assembly,BP,
4996,GO:0010849,1,0.994012725500462,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
4997,GO:0010851,1,0.970300689685504,0,5,cyclase regulator activity,MF,
4998,GO:0010853,1,0.976710267802471,0,4,cyclase activator activity,MF,
4999,GO:0010854,1,0.993439157866199,0,1,adenylate cyclase regulator activity,MF,
5000,GO:0010855,1,0.993439157866199,0,1,adenylate cyclase inhibitor activity,MF,
5001,GO:0010856,1,0.99370012509836,0,1,adenylate cyclase activator activity,MF,
5003,GO:0010858,1,0.982688360568304,0,3,calcium-dependent protein kinase regulator activity,MF,
5004,GO:0010859,1,0.993387708407071,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
5005,GO:0010862,1,0.756412581294639,0,44,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,
5007,GO:0010866,1,0.910446927980317,0,15,regulation of triglyceride biosynthetic process,BP,
5008,GO:0010867,1,0.934148918530716,0,11,positive regulation of triglyceride biosynthetic process,BP,
5009,GO:0010868,1,0.986904722776914,0,2,negative regulation of triglyceride biosynthetic process,BP,
5010,GO:0010869,1,0.883831815833117,0,19,regulation of receptor biosynthetic process,BP,
5011,GO:0010870,1,0.934163991221507,0,11,positive regulation of receptor biosynthetic process,BP,
5012,GO:0010871,1,0.966063907307637,0,5,negative regulation of receptor biosynthetic process,BP,
5013,GO:0010872,1,0.953668087579423,0,8,regulation of cholesterol esterification,BP,
5014,GO:0010873,1,0.965578201103942,0,6,positive regulation of cholesterol esterification,BP,
5015,GO:0010874,1,0.886819933605809,0,18,regulation of cholesterol efflux,BP,
5016,GO:0010875,1,0.915016378086096,0,13,positive regulation of cholesterol efflux,BP,
5017,GO:0010876,1,0.127082018863598,0,317,lipid localization,BP,
5018,GO:0010877,1,0.988333335226323,0,2,lipid transport involved in lipid storage,BP,
5019,GO:0010878,1,0.904394458396016,0,15,cholesterol storage,BP,
5020,GO:0010879,1,0.993992826293789,0,1,cholesterol transport involved in cholesterol storage,BP,
5024,GO:0010883,1,0.772053131488643,0,40,regulation of lipid storage,BP,
5025,GO:0010884,1,0.879517791999176,0,20,positive regulation of lipid storage,BP,
5026,GO:0010885,1,0.915670090370297,0,13,regulation of cholesterol storage,BP,
5027,GO:0010886,1,0.953648382873302,0,7,positive regulation of cholesterol storage,BP,
5028,GO:0010887,1,0.960194680047159,0,6,negative regulation of cholesterol storage,BP,
5029,GO:0010888,1,0.90051308501375,0,16,negative regulation of lipid storage,BP,
5030,GO:0010889,1,0.926487289695128,0,12,regulation of sequestering of triglyceride,BP,
5031,GO:0010890,1,0.959061435459215,0,7,positive regulation of sequestering of triglyceride,BP,
5032,GO:0010891,1,0.966049628694779,0,5,negative regulation of sequestering of triglyceride,BP,
5035,GO:0010896,1,0.952410689415522,0,8,regulation of triglyceride catabolic process,BP,
5036,GO:0010897,1,0.981145824206181,0,3,negative regulation of triglyceride catabolic process,BP,
5037,GO:0010898,1,0.970718282574044,0,5,positive regulation of triglyceride catabolic process,BP,
5038,GO:0010899,1,0.981627918769943,0,3,regulation of phosphatidylcholine catabolic process,BP,
5039,GO:0010900,1,0.994514006385232,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
5040,GO:0010901,1,0.988858189133867,0,2,regulation of very-low-density lipoprotein particle remodeling,BP,
5041,GO:0010902,1,0.994439207553949,0,1,positive regulation of very-low-density lipoprotein particle remodeling,BP,
5042,GO:0010903,1,0.994388091856786,0,1,negative regulation of very-low-density lipoprotein particle remodeling,BP,
5043,GO:0010904,1,0.994015898537603,0,1,regulation of UDP-glucose catabolic process,BP,
5044,GO:0010905,1,0.994015898537603,0,1,negative regulation of UDP-glucose catabolic process,BP,
5045,GO:0010906,1,0.58625596003472,0,81,regulation of glucose metabolic process,BP,
5046,GO:0010907,1,0.827824974479716,0,28,positive regulation of glucose metabolic process,BP,
5047,GO:0010908,1,0.981125239851471,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5048,GO:0010909,1,0.981125239851471,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5049,GO:0010911,1,0.954899036261437,0,7,regulation of isomerase activity,BP,
5050,GO:0010912,1,0.954899036261437,0,7,positive regulation of isomerase activity,BP,
5051,GO:0010915,1,0.983239328270516,0,3,regulation of very-low-density lipoprotein particle clearance,BP,
5052,GO:0010916,1,0.983239328270516,0,3,negative regulation of very-low-density lipoprotein particle clearance,BP,
5053,GO:0010917,1,0.952337814792573,0,8,negative regulation of mitochondrial membrane potential,BP,
5054,GO:0010918,1,0.951811833325677,0,8,positive regulation of mitochondrial membrane potential,BP,
5055,GO:0010919,1,0.927778912587122,0,12,regulation of inositol phosphate biosynthetic process,BP,
5056,GO:0010920,1,0.993823134750506,0,1,negative regulation of inositol phosphate biosynthetic process,BP,
5058,GO:0010922,1,0.828014223952852,0,28,positive regulation of phosphatase activity,BP,
5060,GO:0010924,1,0.993823134750506,0,1,regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5061,GO:0010925,1,0.993823134750506,0,1,positive regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5063,GO:0010931,1,0.992269572932972,0,1,macrophage tolerance induction,BP,
5064,GO:0010932,1,0.992269572932972,0,1,regulation of macrophage tolerance induction,BP,
5065,GO:0010933,1,0.992269572932972,0,1,positive regulation of macrophage tolerance induction,BP,
5066,GO:0010934,1,0.91442426140464,0,14,macrophage cytokine production,BP,
5067,GO:0010935,1,0.926005909669612,0,12,regulation of macrophage cytokine production,BP,
5068,GO:0010936,1,0.967877141203759,0,5,negative regulation of macrophage cytokine production,BP,
5069,GO:0010938,1,0.993593932162934,0,1,cytoplasmic microtubule depolymerization,BP,
5071,GO:0010940,1,0.965513714759515,0,6,positive regulation of necrotic cell death,BP,
5074,GO:0010944,1,0.950857991392062,0,8,negative regulation of transcription by competitive promoter binding,BP,
5076,GO:0010949,1,0.993875658902209,0,1,negative regulation of intestinal phytosterol absorption,BP,
5081,GO:0010955,1,0.795219030400652,0,35,negative regulation of protein processing,BP,
5082,GO:0010956,1,0.981377239416376,0,3,negative regulation of calcidiol 1-monooxygenase activity,BP,
5083,GO:0010957,1,0.969829529512963,0,5,negative regulation of vitamin D biosynthetic process,BP,
5084,GO:0010958,1,0.962077181592514,0,6,regulation of amino acid import across plasma membrane,BP,
5086,GO:0010960,1,0.932777274939974,0,10,magnesium ion homeostasis,BP,
5087,GO:0010961,1,0.973164021763595,0,4,cellular magnesium ion homeostasis,BP,
5088,GO:0010962,1,0.853669014745965,0,23,regulation of glucan biosynthetic process,BP,
5089,GO:0010963,1,0.988165338738831,0,2,regulation of L-arginine import,BP,
5090,GO:0010965,1,0.715033743698888,0,52,regulation of mitotic sister chromatid separation,BP,
5091,GO:0010966,1,0.973055972256682,0,4,regulation of phosphate transport,BP,
5092,GO:0010967,1,0.994156779103132,0,1,regulation of polyamine biosynthetic process,BP,
5093,GO:0010968,1,0.963177893947922,0,6,regulation of microtubule nucleation,BP,
5094,GO:0010970,1,0.405874385389924,0,137,transport along microtubule,BP,
5095,GO:0010971,1,0.875327792457522,0,21,positive regulation of G2/M transition of mitotic cell cycle,BP,
5096,GO:0010972,1,0.590920134943417,0,86,negative regulation of G2/M transition of mitotic cell cycle,BP,
5100,GO:0010979,1,0.987258252839684,0,2,regulation of vitamin D 24-hydroxylase activity,BP,
5101,GO:0010980,1,0.987258252839684,0,2,positive regulation of vitamin D 24-hydroxylase activity,BP,
5102,GO:0010982,1,0.987479491739976,0,2,regulation of high-density lipoprotein particle clearance,BP,
5103,GO:0010983,1,0.987479491739976,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
5104,GO:0010984,1,0.912629390659806,0,15,regulation of lipoprotein particle clearance,BP,
5105,GO:0010985,1,0.958392183550599,0,7,negative regulation of lipoprotein particle clearance,BP,
5106,GO:0010986,1,0.974979614205694,0,4,positive regulation of lipoprotein particle clearance,BP,
5107,GO:0010988,1,0.946480986155033,0,9,regulation of low-density lipoprotein particle clearance,BP,
5108,GO:0010989,1,0.974733606211134,0,4,negative regulation of low-density lipoprotein particle clearance,BP,
5109,GO:0010990,1,0.961626450857974,0,6,regulation of SMAD protein complex assembly,BP,
5110,GO:0010991,1,0.967924510301913,0,5,negative regulation of SMAD protein complex assembly,BP,
5111,GO:0010992,1,0.956658895346764,0,7,ubiquitin recycling,BP,
5112,GO:0010994,1,0.969837003917815,0,5,free ubiquitin chain polymerization,BP,
5113,GO:0010996,1,0.868953062727854,0,21,response to auditory stimulus,BP,
5114,GO:0010997,1,0.968661667159879,0,5,anaphase-promoting complex binding,MF,
5115,GO:0010998,1,0.937462245583046,0,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
5116,GO:0010999,1,0.993360879946457,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
5120,GO:0012507,1,0.698942212031672,0,57,ER to Golgi transport vesicle membrane,CC,
5124,GO:0014004,1,0.981152584574431,0,3,microglia differentiation,BP,
5125,GO:0014005,1,0.981152584574431,0,3,microglia development,BP,
5128,GO:0014011,1,0.993846081630578,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5129,GO:0014012,1,0.969800516111849,0,5,peripheral nervous system axon regeneration,BP,
5133,GO:0014016,1,0.981902663222249,0,3,neuroblast differentiation,BP,
5134,GO:0014017,1,0.993932607884681,0,1,neuroblast fate commitment,BP,
5136,GO:0014022,1,0.98080626286396,0,3,neural plate elongation,BP,
5137,GO:0014028,1,0.987266647523898,0,2,notochord formation,BP,
5138,GO:0014029,1,0.931509742304822,0,11,neural crest formation,BP,
5142,GO:0014034,1,0.981301093171557,0,3,neural crest cell fate commitment,BP,
5143,GO:0014036,1,0.987858576441013,0,2,neural crest cell fate specification,BP,
5145,GO:0014038,1,0.9798607716028,0,3,regulation of Schwann cell differentiation,BP,
5146,GO:0014040,1,0.985635136917322,0,2,positive regulation of Schwann cell differentiation,BP,
5147,GO:0014041,1,0.940673512832259,0,9,regulation of neuron maturation,BP,
5148,GO:0014042,1,0.971999700500359,0,4,positive regulation of neuron maturation,BP,
5149,GO:0014043,1,0.981166621882047,0,3,negative regulation of neuron maturation,BP,
5151,GO:0014045,1,0.975305525568676,0,4,establishment of endothelial blood-brain barrier,BP,
5152,GO:0014046,1,0.870811622586337,0,22,dopamine secretion,BP,
5156,GO:0014050,1,0.969694074979569,0,5,negative regulation of glutamate secretion,BP,
5157,GO:0014051,1,0.940407927880056,0,9,gamma-aminobutyric acid secretion,BP,
5158,GO:0014052,1,0.961842203548846,0,6,regulation of gamma-aminobutyric acid secretion,BP,
5159,GO:0014053,1,0.993232525385339,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
5160,GO:0014054,1,0.974856848779329,0,4,positive regulation of gamma-aminobutyric acid secretion,BP,
5161,GO:0014055,1,0.981841430143099,0,3,acetylcholine secretion, neurotransmission,BP,
5162,GO:0014056,1,0.981841430143099,0,3,regulation of acetylcholine secretion, neurotransmission,BP,
5163,GO:0014057,1,0.98789279838202,0,2,positive regulation of acetylcholine secretion, neurotransmission,BP,
5164,GO:0014059,1,0.870811622586337,0,22,regulation of dopamine secretion,BP,
5165,GO:0014060,1,0.976486506048906,0,4,regulation of epinephrine secretion,BP,
5166,GO:0014061,1,0.929101518170282,0,12,regulation of norepinephrine secretion,BP,
5167,GO:0014062,1,0.958547771799539,0,7,regulation of serotonin secretion,BP,
5168,GO:0014063,1,0.976113639285429,0,4,negative regulation of serotonin secretion,BP,
5169,GO:0014064,1,0.99334092589851,0,1,positive regulation of serotonin secretion,BP,
5172,GO:0014067,1,0.938040756651758,0,10,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
5173,GO:0014068,1,0.674792720526031,0,60,positive regulation of phosphatidylinositol 3-kinase signaling,BP,
5181,GO:0014705,1,0.993425837012921,0,1,C zone,CC,
5183,GO:0014707,1,0.98804864541545,0,2,branchiomeric skeletal muscle development,BP,
5184,GO:0014717,1,0.987992517826003,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5185,GO:0014718,1,0.987992517826003,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5186,GO:0014719,1,0.968242157371836,0,5,skeletal muscle satellite cell activation,BP,
5187,GO:0014721,1,0.968271366666979,0,5,twitch skeletal muscle contraction,BP,
5188,GO:0014722,1,0.963525603153294,0,6,regulation of skeletal muscle contraction by calcium ion signaling,BP,
5189,GO:0014724,1,0.986576130597596,0,2,regulation of twitch skeletal muscle contraction,BP,
5190,GO:0014728,1,0.992901902858012,0,1,regulation of the force of skeletal muscle contraction,BP,
5191,GO:0014731,1,0.948501642307447,0,7,spectrin-associated cytoskeleton,CC,
5192,GO:0014732,1,0.95709193988995,0,7,skeletal muscle atrophy,BP,
5193,GO:0014733,1,0.928292861207829,0,11,regulation of skeletal muscle adaptation,BP,
5194,GO:0014734,1,0.979169699355653,0,3,skeletal muscle hypertrophy,BP,
5195,GO:0014735,1,0.980632512578493,0,3,regulation of muscle atrophy,BP,
5196,GO:0014736,1,0.986409373472634,0,2,negative regulation of muscle atrophy,BP,
5197,GO:0014737,1,0.994144361552652,0,1,positive regulation of muscle atrophy,BP,
5198,GO:0014738,1,0.982303383993707,0,3,regulation of muscle hyperplasia,BP,
5199,GO:0014739,1,0.994462599894402,0,1,positive regulation of muscle hyperplasia,BP,
5200,GO:0014740,1,0.987773767675085,0,2,negative regulation of muscle hyperplasia,BP,
5201,GO:0014741,1,0.889300354260281,0,18,negative regulation of muscle hypertrophy,BP,
5202,GO:0014742,1,0.84278693593969,0,26,positive regulation of muscle hypertrophy,BP,
5203,GO:0014743,1,0.738058838831826,0,46,regulation of muscle hypertrophy,BP,
5204,GO:0014744,1,0.968095398968196,0,5,positive regulation of muscle adaptation,BP,
5205,GO:0014745,1,0.928721901071921,0,11,negative regulation of muscle adaptation,BP,
5206,GO:0014802,1,0.972845428568229,0,4,terminal cisterna,CC,
5207,GO:0014804,1,0.994080256931388,0,1,terminal cisterna lumen,CC,
5208,GO:0014805,1,0.976995292176624,0,4,smooth muscle adaptation,BP,
5209,GO:0014806,1,0.988169252115423,0,2,smooth muscle hyperplasia,BP,
5210,GO:0014807,1,0.956449183415816,0,7,regulation of somitogenesis,BP,
5212,GO:0014809,1,0.969519556356579,0,5,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5213,GO:0014810,1,0.994421013699845,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5215,GO:0014813,1,0.993993691310324,0,1,skeletal muscle satellite cell commitment,BP,
5216,GO:0014816,1,0.953519342209639,0,7,skeletal muscle satellite cell differentiation,BP,
5217,GO:0014819,1,0.932370441032454,0,11,regulation of skeletal muscle contraction,BP,
5218,GO:0014820,1,0.945462678479563,0,9,tonic smooth muscle contraction,BP,
5219,GO:0014821,1,0.896188055855529,0,18,phasic smooth muscle contraction,BP,
5220,GO:0014822,1,0.993908434187134,0,1,detection of wounding,BP,
5222,GO:0014824,1,0.958001236819103,0,7,artery smooth muscle contraction,BP,
5223,GO:0014825,1,0.994411772435139,0,1,stomach fundus smooth muscle contraction,BP,
5224,GO:0014826,1,0.975860798680491,0,4,vein smooth muscle contraction,BP,
5225,GO:0014827,1,0.963995723883119,0,6,intestine smooth muscle contraction,BP,
5226,GO:0014828,1,0.993155902566615,0,1,distal stomach smooth muscle contraction,BP,
5228,GO:0014831,1,0.93367596901466,0,11,gastro-intestinal system smooth muscle contraction,BP,
5229,GO:0014832,1,0.956699421940082,0,7,urinary bladder smooth muscle contraction,BP,
5230,GO:0014834,1,0.97438076557377,0,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
5231,GO:0014835,1,0.987435239459231,0,2,myoblast differentiation involved in skeletal muscle regeneration,BP,
5232,GO:0014839,1,0.988386972218935,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
5233,GO:0014841,1,0.918466070775524,0,13,skeletal muscle satellite cell proliferation,BP,
5234,GO:0014842,1,0.925479788984828,0,12,regulation of skeletal muscle satellite cell proliferation,BP,
5235,GO:0014843,1,0.992697245356871,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
5236,GO:0014846,1,0.986493146353481,0,2,esophagus smooth muscle contraction,BP,
5237,GO:0014847,1,0.994411772435139,0,1,proximal stomach smooth muscle contraction,BP,
5238,GO:0014848,1,0.956699421940082,0,7,urinary tract smooth muscle contraction,BP,
5240,GO:0014852,1,0.993819551421369,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
5241,GO:0014853,1,0.993819551421369,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5242,GO:0014854,1,0.917206584641403,0,13,response to inactivity,BP,
5243,GO:0014855,1,0.680694589530166,0,59,striated muscle cell proliferation,BP,
5244,GO:0014856,1,0.913127275598253,0,14,skeletal muscle cell proliferation,BP,
5245,GO:0014857,1,0.920100641228712,0,13,regulation of skeletal muscle cell proliferation,BP,
5246,GO:0014858,1,0.980656466169827,0,3,positive regulation of skeletal muscle cell proliferation,BP,
5247,GO:0014859,1,0.980943029710008,0,3,negative regulation of skeletal muscle cell proliferation,BP,
5248,GO:0014861,1,0.993099097068624,0,1,regulation of skeletal muscle contraction via regulation of action potential,BP,
5249,GO:0014862,1,0.992901902858012,0,1,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,
5250,GO:0014866,1,0.902986840716513,0,12,skeletal myofibril assembly,BP,
5251,GO:0014870,1,0.933894359865357,0,10,response to muscle inactivity,BP,
5252,GO:0014873,1,0.988082098373211,0,2,response to muscle activity involved in regulation of muscle adaptation,BP,
5253,GO:0014874,1,0.910179422574307,0,14,response to stimulus involved in regulation of muscle adaptation,BP,
5254,GO:0014876,1,0.994248033093942,0,1,response to injury involved in regulation of muscle adaptation,BP,
5255,GO:0014877,1,0.939680738871775,0,9,response to muscle inactivity involved in regulation of muscle adaptation,BP,
5256,GO:0014878,1,0.974467017880615,0,4,response to electrical stimulus involved in regulation of muscle adaptation,BP,
5257,GO:0014883,1,0.960808035422656,0,6,transition between fast and slow fiber,BP,
5258,GO:0014886,1,0.993706123180338,0,1,transition between slow and fast fiber,BP,
5259,GO:0014887,1,0.863477230147477,0,22,cardiac muscle adaptation,BP,
5260,GO:0014888,1,0.765301461961015,0,41,striated muscle adaptation,BP,
5261,GO:0014889,1,0.927028762508009,0,12,muscle atrophy,BP,
5262,GO:0014891,1,0.951210302401769,0,8,striated muscle atrophy,BP,
5263,GO:0014894,1,0.939680738871775,0,9,response to denervation involved in regulation of muscle adaptation,BP,
5264,GO:0014895,1,0.99444816014447,0,1,smooth muscle hypertrophy,BP,
5267,GO:0014898,1,0.863477230147477,0,22,cardiac muscle hypertrophy in response to stress,BP,
5268,GO:0014900,1,0.976604231842257,0,4,muscle hyperplasia,BP,
5269,GO:0014901,1,0.987992517826003,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
5270,GO:0014902,1,0.559951345496369,0,89,myotube differentiation,BP,
5271,GO:0014904,1,0.818787254278373,0,31,myotube cell development,BP,
5272,GO:0014908,1,0.987007578098848,0,2,myotube differentiation involved in skeletal muscle regeneration,BP,
5276,GO:0014912,1,0.871142160073431,0,21,negative regulation of smooth muscle cell migration,BP,
5277,GO:0014916,1,0.978340778553377,0,3,regulation of lung blood pressure,BP,
5278,GO:0015002,1,0.882236375382519,0,22,heme-copper terminal oxidase activity,MF,
5279,GO:0015012,1,0.847282954038234,0,25,heparan sulfate proteoglycan biosynthetic process,BP,
5280,GO:0015014,1,0.960144164409965,0,6,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
5281,GO:0015015,1,0.961260417819848,0,6,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
5282,GO:0015016,1,0.972720908124007,0,4,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
5283,GO:0015018,1,0.98204277972818,0,3,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
5284,GO:0015019,1,0.993143795523594,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
5285,GO:0015020,1,0.916079783818318,0,14,glucuronosyltransferase activity,MF,
5286,GO:0015026,1,0.794137979535942,0,36,coreceptor activity,MF,
5287,GO:0015030,1,0.718965743488518,0,53,Cajal body,CC,
5289,GO:0015035,1,0.887131764836457,0,20,protein disulfide oxidoreductase activity,MF,
5290,GO:0015036,1,0.805690608336976,0,36,disulfide oxidoreductase activity,MF,
5291,GO:0015037,1,0.926265025430731,0,13,peptide disulfide oxidoreductase activity,MF,
5292,GO:0015038,1,0.971590677518848,0,5,glutathione disulfide oxidoreductase activity,MF,
5293,GO:0015039,1,0.994098735670444,0,1,NADPH-adrenodoxin reductase activity,MF,
5294,GO:0015052,1,0.993884567595617,0,1,beta3-adrenergic receptor activity,MF,
5295,GO:0015054,1,0.994034940369317,0,1,gastrin receptor activity,MF,
5296,GO:0015056,1,0.988098155355054,0,2,corticotrophin-releasing factor receptor activity,MF,
5297,GO:0015057,1,0.969201917400571,0,5,thrombin-activated receptor activity,MF,
5298,GO:0015065,1,0.982319656696343,0,3,uridine nucleotide receptor activity,MF,
5299,GO:0015067,1,0.993899805385953,0,1,amidinotransferase activity,MF,
5300,GO:0015068,1,0.993899805385953,0,1,glycine amidinotransferase activity,MF,
5301,GO:0015074,1,0.937211800651924,0,10,DNA integration,BP,
5304,GO:0015078,1,0.545812216230966,0,98,proton transmembrane transporter activity,MF,
5308,GO:0015086,1,0.993446460613398,0,1,cadmium ion transmembrane transporter activity,MF,
5309,GO:0015087,1,0.993446460613398,0,1,cobalt ion transmembrane transporter activity,MF,
5311,GO:0015093,1,0.980549423470157,0,3,ferrous iron transmembrane transporter activity,MF,
5312,GO:0015094,1,0.993446460613398,0,1,lead ion transmembrane transporter activity,MF,
5313,GO:0015095,1,0.902129296921491,0,16,magnesium ion transmembrane transporter activity,MF,
5314,GO:0015098,1,0.994098591296477,0,1,molybdate ion transmembrane transporter activity,MF,
5315,GO:0015101,1,0.857448490304365,0,25,organic cation transmembrane transporter activity,MF,
5317,GO:0015105,1,0.994276333357988,0,1,arsenite transmembrane transporter activity,MF,
5318,GO:0015106,1,0.868927804134904,0,21,bicarbonate transmembrane transporter activity,MF,
5320,GO:0015111,1,0.980401470552596,0,3,iodide transmembrane transporter activity,MF,
5321,GO:0015112,1,0.993881118712334,0,1,nitrate transmembrane transporter activity,MF,
5323,GO:0015116,1,0.931488929121959,0,11,sulfate transmembrane transporter activity,MF,
5324,GO:0015117,1,0.994101045669862,0,1,thiosulfate transmembrane transporter activity,MF,
5325,GO:0015119,1,0.981349159630943,0,3,hexose phosphate transmembrane transporter activity,MF,
5326,GO:0015125,1,0.921788594972717,0,13,bile acid transmembrane transporter activity,MF,
5327,GO:0015126,1,0.993267056919744,0,1,canalicular bile acid transmembrane transporter activity,MF,
5328,GO:0015127,1,0.993186448387138,0,1,bilirubin transmembrane transporter activity,MF,
5329,GO:0015129,1,0.968486520683206,0,5,lactate transmembrane transporter activity,MF,
5330,GO:0015130,1,0.993455479429119,0,1,mevalonate transmembrane transporter activity,MF,
5331,GO:0015131,1,0.994101045669862,0,1,oxaloacetate transmembrane transporter activity,MF,
5332,GO:0015132,1,0.99343013463261,0,1,prostaglandin transmembrane transporter activity,MF,
5333,GO:0015136,1,0.993690415212532,0,1,sialic acid transmembrane transporter activity,MF,
5334,GO:0015137,1,0.975068553183937,0,4,citrate transmembrane transporter activity,MF,
5335,GO:0015139,1,0.993820554697066,0,1,alpha-ketoglutarate transmembrane transporter activity,MF,
5336,GO:0015140,1,0.988268115005349,0,2,malate transmembrane transporter activity,MF,
5337,GO:0015141,1,0.981413182994906,0,3,succinate transmembrane transporter activity,MF,
5338,GO:0015142,1,0.975068553183937,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5339,GO:0015143,1,0.970535001036518,0,5,urate transmembrane transporter activity,MF,
5343,GO:0015152,1,0.994038403136624,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
5344,GO:0015154,1,0.98146129146013,0,3,disaccharide transmembrane transporter activity,MF,
5345,GO:0015157,1,0.98146129146013,0,3,oligosaccharide transmembrane transporter activity,MF,
5346,GO:0015165,1,0.939580965824463,0,10,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5348,GO:0015168,1,0.970512227416547,0,5,glycerol transmembrane transporter activity,MF,
5351,GO:0015173,1,0.981597296868001,0,3,aromatic amino acid transmembrane transporter activity,MF,
5352,GO:0015174,1,0.932741352328467,0,11,basic amino acid transmembrane transporter activity,MF,
5353,GO:0015175,1,0.831571860470466,0,29,neutral amino acid transmembrane transporter activity,MF,
5355,GO:0015180,1,0.968507637318252,0,5,L-alanine transmembrane transporter activity,MF,
5356,GO:0015181,1,0.961643876944568,0,6,arginine transmembrane transporter activity,MF,
5357,GO:0015182,1,0.987817370384368,0,2,L-asparagine transmembrane transporter activity,MF,
5358,GO:0015183,1,0.975438486754185,0,4,L-aspartate transmembrane transporter activity,MF,
5359,GO:0015184,1,0.981099360483175,0,3,L-cystine transmembrane transporter activity,MF,
5360,GO:0015185,1,0.96942134016794,0,5,gamma-aminobutyric acid transmembrane transporter activity,MF,
5361,GO:0015186,1,0.968908734677981,0,5,L-glutamine transmembrane transporter activity,MF,
5362,GO:0015187,1,0.96310211748809,0,6,glycine transmembrane transporter activity,MF,
5363,GO:0015189,1,0.961643876944568,0,6,L-lysine transmembrane transporter activity,MF,
5364,GO:0015190,1,0.993844646767904,0,1,L-leucine transmembrane transporter activity,MF,
5365,GO:0015191,1,0.993844646767904,0,1,L-methionine transmembrane transporter activity,MF,
5366,GO:0015193,1,0.967422943221909,0,5,L-proline transmembrane transporter activity,MF,
5367,GO:0015194,1,0.946847795149549,0,9,L-serine transmembrane transporter activity,MF,
5368,GO:0015195,1,0.99340878453303,0,1,L-threonine transmembrane transporter activity,MF,
5369,GO:0015196,1,0.993934047371008,0,1,L-tryptophan transmembrane transporter activity,MF,
5370,GO:0015203,1,0.988276251451287,0,2,polyamine transmembrane transporter activity,MF,
5371,GO:0015204,1,0.963778160050491,0,6,urea transmembrane transporter activity,MF,
5372,GO:0015205,1,0.962698806878736,0,6,nucleobase transmembrane transporter activity,MF,
5373,GO:0015207,1,0.987671446834755,0,2,adenine transmembrane transporter activity,MF,
5374,GO:0015215,1,0.905790279593859,0,16,nucleotide transmembrane transporter activity,MF,
5375,GO:0015216,1,0.928366934968387,0,12,purine nucleotide transmembrane transporter activity,MF,
5376,GO:0015217,1,0.945832350121611,0,9,ADP transmembrane transporter activity,MF,
5377,GO:0015218,1,0.987569214767059,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5378,GO:0015220,1,0.963058777137663,0,6,choline transmembrane transporter activity,MF,
5379,GO:0015222,1,0.981377109830865,0,3,serotonin transmembrane transporter activity,MF,
5380,GO:0015226,1,0.964167816410599,0,6,carnitine transmembrane transporter activity,MF,
5381,GO:0015227,1,0.988105173172474,0,2,acyl carnitine transmembrane transporter activity,MF,
5382,GO:0015228,1,0.981758589806163,0,3,coenzyme A transmembrane transporter activity,MF,
5383,GO:0015229,1,0.99264141663663,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5384,GO:0015230,1,0.987804290661449,0,2,FAD transmembrane transporter activity,MF,
5385,GO:0015232,1,0.950197454488449,0,8,heme transporter activity,MF,
5386,GO:0015234,1,0.981449429074335,0,3,thiamine transmembrane transporter activity,MF,
5388,GO:0015245,1,0.951683898704592,0,8,fatty acid transmembrane transporter activity,MF,
5389,GO:0015247,1,0.979829383555238,0,3,aminophospholipid transmembrane transporter activity,MF,
5390,GO:0015248,1,0.851706794414827,0,25,sterol transporter activity,MF,
5391,GO:0015250,1,0.94122439858064,0,10,water channel activity,MF,
5392,GO:0015252,1,0.981903856330004,0,3,proton channel activity,MF,
5393,GO:0015254,1,0.976516918497761,0,4,glycerol channel activity,MF,
5394,GO:0015265,1,0.981486870095881,0,3,urea channel activity,MF,
5396,GO:0015269,1,0.899202755254359,0,17,calcium-activated potassium channel activity,MF,
5397,GO:0015271,1,0.906839071449081,0,15,outward rectifier potassium channel activity,MF,
5398,GO:0015272,1,0.968596752574512,0,5,ATP-activated inward rectifier potassium channel activity,MF,
5399,GO:0015275,1,0.980887139896602,0,3,stretch-activated, cation-selective, calcium channel activity,MF,
5401,GO:0015277,1,0.966844478036096,0,5,kainate selective glutamate receptor activity,MF,
5403,GO:0015279,1,0.941312565337488,0,9,store-operated calcium channel activity,MF,
5404,GO:0015280,1,0.950257670593204,0,8,ligand-gated sodium channel activity,MF,
5405,GO:0015288,1,0.964891206042546,0,6,porin activity,MF,
5407,GO:0015292,1,0.993846081630578,0,1,uniporter activity,MF,
5410,GO:0015295,1,0.875615581139521,0,21,solute:proton symporter activity,MF,
5411,GO:0015296,1,0.934501669186275,0,10,anion:cation symporter activity,MF,
5414,GO:0015299,1,0.890812926759065,0,18,solute:proton antiporter activity,MF,
5415,GO:0015301,1,0.834057841858865,0,28,anion:anion antiporter activity,MF,
5416,GO:0015307,1,0.981986296729471,0,3,drug:proton antiporter activity,MF,
5417,GO:0015315,1,0.981349159630943,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5418,GO:0015317,1,0.994160822020254,0,1,phosphate:proton symporter activity,MF,
5422,GO:0015322,1,0.993578374751637,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5423,GO:0015327,1,0.991861567052743,0,1,cystine:glutamate antiporter activity,MF,
5424,GO:0015328,1,0.991861567052743,0,1,cystine secondary active transmembrane transporter activity,MF,
5425,GO:0015333,1,0.981086464837127,0,3,peptide:proton symporter activity,MF,
5426,GO:0015343,1,0.993846081630578,0,1,siderophore transmembrane transporter activity,MF,
5427,GO:0015347,1,0.858998745672227,0,24,sodium-independent organic anion transmembrane transporter activity,MF,
5428,GO:0015349,1,0.974979609789725,0,4,thyroid hormone transmembrane transporter activity,MF,
5429,GO:0015350,1,0.986651205286064,0,2,methotrexate transmembrane transporter activity,MF,
5430,GO:0015355,1,0.934168344285181,0,11,secondary active monocarboxylate transmembrane transporter activity,MF,
5431,GO:0015362,1,0.993477657882324,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5432,GO:0015367,1,0.994132810322219,0,1,oxoglutarate:malate antiporter activity,MF,
5434,GO:0015369,1,0.9930737087104,0,1,calcium:proton antiporter activity,MF,
5436,GO:0015373,1,0.973639203423286,0,4,anion:sodium symporter activity,MF,
5437,GO:0015375,1,0.987575389963902,0,2,glycine:sodium symporter activity,MF,
5438,GO:0015377,1,0.946371896542013,0,8,cation:chloride symporter activity,MF,
5439,GO:0015378,1,0.986001355832601,0,2,sodium:chloride symporter activity,MF,
5440,GO:0015379,1,0.946371896542013,0,8,potassium:chloride symporter activity,MF,
5441,GO:0015382,1,0.993810523874367,0,1,sodium:sulfate symporter activity,MF,
5442,GO:0015385,1,0.925234658067391,0,12,sodium:proton antiporter activity,MF,
5443,GO:0015386,1,0.936736362000239,0,10,potassium:proton antiporter activity,MF,
5444,GO:0015389,1,0.988097223280593,0,2,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5445,GO:0015390,1,0.994004937927393,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5446,GO:0015391,1,0.988097223280593,0,2,nucleobase:cation symporter activity,MF,
5447,GO:0015399,1,0.505510320490475,0,103,primary active transmembrane transporter activity,MF,
5448,GO:0015405,1,0.505510320490475,0,103,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,
5449,GO:0015410,1,0.980954667722041,0,3,manganese-transporting ATPase activity,MF,
5450,GO:0015420,1,0.992802204087989,0,1,cobalamin-transporting ATPase activity,MF,
5451,GO:0015421,1,0.993628468285784,0,1,oligopeptide-transporting ATPase activity,MF,
5452,GO:0015431,1,0.992802204087989,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5453,GO:0015432,1,0.986936713742306,0,2,bile acid-exporting ATPase activity,MF,
5454,GO:0015433,1,0.987166568795366,0,2,peptide antigen-transporting ATPase activity,MF,
5455,GO:0015439,1,0.993785607657234,0,1,heme-transporting ATPase activity,MF,
5456,GO:0015440,1,0.974787379284378,0,4,peptide-transporting ATPase activity,MF,
5457,GO:0015450,1,0.965535330811324,0,6,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5458,GO:0015459,1,0.746329883142597,0,46,potassium channel regulator activity,MF,
5459,GO:0015464,1,0.888568992868984,0,19,acetylcholine receptor activity,MF,
5460,GO:0015467,1,0.938109519204791,0,10,G-protein activated inward rectifier potassium channel activity,MF,
5461,GO:0015485,1,0.789384548064524,0,37,cholesterol binding,MF,
5462,GO:0015489,1,0.988276251451287,0,2,putrescine transmembrane transporter activity,MF,
5464,GO:0015495,1,0.993904407095087,0,1,gamma-aminobutyric acid:proton symporter activity,MF,
5465,GO:0015499,1,0.993880400251359,0,1,formate transmembrane transporter activity,MF,
5466,GO:0015501,1,0.955134430610005,0,7,glutamate:sodium symporter activity,MF,
5467,GO:0015526,1,0.981349159630943,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5468,GO:0015538,1,0.993690415212532,0,1,sialic acid:proton symporter activity,MF,
5469,GO:0015556,1,0.951684454146745,0,8,C4-dicarboxylate transmembrane transporter activity,MF,
5470,GO:0015562,1,0.974294836432319,0,4,efflux transmembrane transporter activity,MF,
5471,GO:0015578,1,0.993938078260922,0,1,mannose transmembrane transporter activity,MF,
5472,GO:0015605,1,0.865593921764614,0,23,organophosphate ester transmembrane transporter activity,MF,
5473,GO:0015616,1,0.971408221659526,0,4,DNA translocase activity,MF,
5477,GO:0015633,1,0.994041866078383,0,1,zinc-transporting ATPase activity,MF,
5478,GO:0015636,1,0.993979564751744,0,1,short-chain fatty acid transmembrane transporter activity,MF,
5479,GO:0015643,1,0.946109716393056,0,9,toxic substance binding,MF,
5480,GO:0015645,1,0.899462098904536,0,17,fatty acid ligase activity,MF,
5481,GO:0015651,1,0.940299507180491,0,10,quaternary ammonium group transmembrane transporter activity,MF,
5482,GO:0015658,1,0.993844646767904,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5483,GO:0015660,1,0.993880400251359,0,1,formate efflux transmembrane transporter activity,MF,
5484,GO:0015662,1,0.77885046779949,0,38,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,
5485,GO:0015665,1,0.988238062880966,0,2,alcohol transmembrane transporter activity,MF,
5486,GO:0015669,1,0.905918963531267,0,17,gas transport,BP,
5487,GO:0015670,1,0.982243837703955,0,3,carbon dioxide transport,BP,
5488,GO:0015671,1,0.922309040047056,0,14,oxygen transport,BP,
5490,GO:0015677,1,0.947249041776055,0,8,copper ion import,BP,
5491,GO:0015679,1,0.985520415788485,0,2,plasma membrane copper ion transport,BP,
5492,GO:0015680,1,0.981785018156809,0,3,intracellular copper ion transport,BP,
5494,GO:0015684,1,0.980549423470157,0,3,ferrous iron transport,BP,
5495,GO:0015688,1,0.982376431763838,0,3,iron chelate transport,BP,
5496,GO:0015689,1,0.994098591296477,0,1,molybdate ion transport,BP,
5497,GO:0015691,1,0.974997012189113,0,4,cadmium ion transport,BP,
5498,GO:0015692,1,0.993446460613398,0,1,lead ion transport,BP,
5499,GO:0015693,1,0.895897268285737,0,17,magnesium ion transport,BP,
5500,GO:0015694,1,0.993186448387138,0,1,mercury ion transport,BP,
5501,GO:0015695,1,0.784193111183285,0,39,organic cation transport,BP,
5502,GO:0015696,1,0.58490614215259,0,86,ammonium transport,BP,
5503,GO:0015697,1,0.921954177867254,0,13,quaternary ammonium group transport,BP,
5505,GO:0015700,1,0.994276333357988,0,1,arsenite transport,BP,
5506,GO:0015701,1,0.771206920953102,0,41,bicarbonate transport,BP,
5507,GO:0015705,1,0.965080486417185,0,5,iodide transport,BP,
5508,GO:0015706,1,0.993881118712334,0,1,nitrate transport,BP,
5509,GO:0015707,1,0.993535684404757,0,1,nitrite transport,BP,
5510,GO:0015709,1,0.994101045669862,0,1,thiosulfate transport,BP,
5512,GO:0015712,1,0.963868785440872,0,6,hexose phosphate transport,BP,
5513,GO:0015718,1,0.426154704507929,0,134,monocarboxylic acid transport,BP,
5514,GO:0015721,1,0.853586629898134,0,25,bile acid and bile salt transport,BP,
5515,GO:0015722,1,0.974108513001036,0,4,canalicular bile acid transport,BP,
5516,GO:0015723,1,0.993186448387138,0,1,bilirubin transport,BP,
5517,GO:0015724,1,0.993880400251359,0,1,formate transport,BP,
5518,GO:0015727,1,0.962099133172879,0,6,lactate transport,BP,
5519,GO:0015728,1,0.993455479429119,0,1,mevalonate transport,BP,
5520,GO:0015729,1,0.994101045669862,0,1,oxaloacetate transport,BP,
5521,GO:0015732,1,0.921894376355665,0,13,prostaglandin transport,BP,
5522,GO:0015734,1,0.992772428467949,0,1,taurine transport,BP,
5523,GO:0015739,1,0.993690415212532,0,1,sialic acid transport,BP,
5524,GO:0015740,1,0.924275471804773,0,12,C4-dicarboxylate transport,BP,
5525,GO:0015742,1,0.982096396598651,0,3,alpha-ketoglutarate transport,BP,
5526,GO:0015743,1,0.994101045669862,0,1,malate transport,BP,
5527,GO:0015744,1,0.981413182994906,0,3,succinate transport,BP,
5528,GO:0015746,1,0.975068553183937,0,4,citrate transport,BP,
5529,GO:0015747,1,0.964619168706188,0,6,urate transport,BP,
5532,GO:0015755,1,0.993976682335154,0,1,fructose transmembrane transport,BP,
5533,GO:0015760,1,0.963868785440872,0,6,glucose-6-phosphate transport,BP,
5534,GO:0015761,1,0.993938078260922,0,1,mannose transmembrane transport,BP,
5535,GO:0015766,1,0.98146129146013,0,3,disaccharide transport,BP,
5536,GO:0015770,1,0.98146129146013,0,3,sucrose transport,BP,
5537,GO:0015772,1,0.98146129146013,0,3,oligosaccharide transport,BP,
5539,GO:0015782,1,0.994122991853505,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
5540,GO:0015783,1,0.986450387599968,0,2,GDP-fucose transmembrane transport,BP,
5541,GO:0015786,1,0.993991384634879,0,1,UDP-glucose transmembrane transport,BP,
5542,GO:0015787,1,0.992785437825441,0,1,UDP-glucuronic acid transmembrane transport,BP,
5543,GO:0015790,1,0.992683651306792,0,1,UDP-xylose transmembrane transport,BP,
5545,GO:0015793,1,0.970512227416547,0,5,glycerol transport,BP,
5546,GO:0015797,1,0.993880400251359,0,1,mannitol transport,BP,
5549,GO:0015801,1,0.969485759738502,0,5,aromatic amino acid transport,BP,
5550,GO:0015802,1,0.92753276418801,0,12,basic amino acid transport,BP,
5551,GO:0015803,1,0.974283064934546,0,4,branched-chain amino acid transport,BP,
5552,GO:0015804,1,0.811201561433488,0,33,neutral amino acid transport,BP,
5553,GO:0015805,1,0.994003495911578,0,1,S-adenosyl-L-methionine transport,BP,
5555,GO:0015808,1,0.968507637318252,0,5,L-alanine transport,BP,
5556,GO:0015809,1,0.950386668491802,0,8,arginine transport,BP,
5557,GO:0015810,1,0.981480998069897,0,3,aspartate transmembrane transport,BP,
5558,GO:0015811,1,0.981099360483175,0,3,L-cystine transport,BP,
5559,GO:0015812,1,0.917740638223077,0,13,gamma-aminobutyric acid transport,BP,
5561,GO:0015816,1,0.949566383904244,0,8,glycine transport,BP,
5562,GO:0015817,1,0.987813947748991,0,2,histidine transport,BP,
5563,GO:0015819,1,0.994101623174299,0,1,lysine transport,BP,
5564,GO:0015820,1,0.980318491795613,0,3,leucine transport,BP,
5565,GO:0015821,1,0.993844646767904,0,1,methionine transport,BP,
5566,GO:0015822,1,0.961318742383418,0,6,ornithine transport,BP,
5567,GO:0015824,1,0.954110199932193,0,7,proline transport,BP,
5568,GO:0015825,1,0.946847795149549,0,9,L-serine transport,BP,
5569,GO:0015826,1,0.99340878453303,0,1,threonine transport,BP,
5570,GO:0015827,1,0.981671845461029,0,3,tryptophan transport,BP,
5571,GO:0015828,1,0.993737267885456,0,1,tyrosine transport,BP,
5574,GO:0015838,1,0.94536157806363,0,9,amino-acid betaine transport,BP,
5575,GO:0015840,1,0.963888624368976,0,6,urea transport,BP,
5576,GO:0015842,1,0.976292026213194,0,4,aminergic neurotransmitter loading into synaptic vesicle,BP,
5577,GO:0015844,1,0.674636411845127,0,63,monoamine transport,BP,
5578,GO:0015846,1,0.958303973821764,0,7,polyamine transport,BP,
5579,GO:0015847,1,0.988276251451287,0,2,putrescine transport,BP,
5582,GO:0015851,1,0.957144373216066,0,7,nucleobase transport,BP,
5583,GO:0015853,1,0.981974414906417,0,3,adenine transport,BP,
5584,GO:0015855,1,0.981945869249294,0,3,pyrimidine nucleobase transport,BP,
5585,GO:0015858,1,0.958354183446653,0,7,nucleoside transport,BP,
5586,GO:0015860,1,0.994004937927393,0,1,purine nucleoside transmembrane transport,BP,
5587,GO:0015862,1,0.993973800114585,0,1,uridine transport,BP,
5588,GO:0015864,1,0.9880144989146,0,2,pyrimidine nucleoside transport,BP,
5590,GO:0015866,1,0.945832350121611,0,9,ADP transport,BP,
5591,GO:0015867,1,0.939775716364953,0,10,ATP transport,BP,
5593,GO:0015870,1,0.975834232016878,0,4,acetylcholine transport,BP,
5594,GO:0015871,1,0.955388871576836,0,7,choline transport,BP,
5595,GO:0015872,1,0.803550662567705,0,35,dopamine transport,BP,
5596,GO:0015874,1,0.900248878389518,0,17,norepinephrine transport,BP,
5597,GO:0015876,1,0.993879107070959,0,1,acetyl-CoA transport,BP,
5598,GO:0015878,1,0.993694556007345,0,1,biotin transport,BP,
5599,GO:0015879,1,0.958416309941877,0,7,carnitine transport,BP,
5600,GO:0015880,1,0.981758589806163,0,3,coenzyme A transport,BP,
5601,GO:0015881,1,0.986985429935042,0,2,creatine transmembrane transport,BP,
5602,GO:0015882,1,0.99264141663663,0,1,L-ascorbic acid transmembrane transport,BP,
5604,GO:0015886,1,0.950197454488449,0,8,heme transport,BP,
5605,GO:0015887,1,0.993694556007345,0,1,pantothenate transmembrane transport,BP,
5606,GO:0015888,1,0.981093863315954,0,3,thiamine transport,BP,
5607,GO:0015889,1,0.961375568456306,0,6,cobalamin transport,BP,
5608,GO:0015891,1,0.982376431763838,0,3,siderophore transport,BP,
5610,GO:0015904,1,0.994108697739627,0,1,tetracycline transport,BP,
5611,GO:0015908,1,0.633059497838496,0,72,fatty acid transport,BP,
5612,GO:0015909,1,0.725256736674577,0,51,long-chain fatty acid transport,BP,
5613,GO:0015910,1,0.987610989252548,0,2,peroxisomal long-chain fatty acid import,BP,
5614,GO:0015911,1,0.966963596443776,0,5,plasma membrane long-chain fatty acid transport,BP,
5615,GO:0015912,1,0.993979564751744,0,1,short-chain fatty acid transport,BP,
5616,GO:0015913,1,0.993979564751744,0,1,short-chain fatty acid import,BP,
5617,GO:0015914,1,0.681948761475843,0,58,phospholipid transport,BP,
5618,GO:0015916,1,0.993879107070959,0,1,fatty-acyl-CoA transport,BP,
5619,GO:0015917,1,0.972510527164027,0,4,aminophospholipid transport,BP,
5620,GO:0015918,1,0.619504632254755,0,74,sterol transport,BP,
5622,GO:0015920,1,0.98802539727005,0,2,lipopolysaccharide transport,BP,
5623,GO:0015922,1,0.99417930389345,0,1,aspartate oxidase activity,MF,
5624,GO:0015923,1,0.911513435037803,0,14,mannosidase activity,MF,
5625,GO:0015924,1,0.941405966494927,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5626,GO:0015925,1,0.952191746276747,0,8,galactosidase activity,MF,
5627,GO:0015926,1,0.936523665879906,0,10,glucosidase activity,MF,
5628,GO:0015928,1,0.988111986393287,0,2,fucosidase activity,MF,
5629,GO:0015929,1,0.923065733452601,0,13,hexosaminidase activity,MF,
5631,GO:0015932,1,0.799642916480416,0,36,nucleobase-containing compound transmembrane transporter activity,MF,
5632,GO:0015934,1,0.520348215661255,0,113,large ribosomal subunit,CC,
5633,GO:0015935,1,0.670657081385513,0,69,small ribosomal subunit,CC,
5634,GO:0015936,1,0.912284215184052,0,15,coenzyme A metabolic process,BP,
5635,GO:0015937,1,0.941696884661032,0,10,coenzyme A biosynthetic process,BP,
5636,GO:0015938,1,0.994354881633389,0,1,coenzyme A catabolic process,BP,
5637,GO:0015939,1,0.950971079677937,0,8,pantothenate metabolic process,BP,
5638,GO:0015942,1,0.96408157331692,0,6,formate metabolic process,BP,
5640,GO:0015950,1,0.988345917261754,0,2,purine nucleotide interconversion,BP,
5641,GO:0015951,1,0.988345917261754,0,2,purine ribonucleotide interconversion,BP,
5642,GO:0015959,1,0.957794441282192,0,7,diadenosine polyphosphate metabolic process,BP,
5643,GO:0015960,1,0.981580484052497,0,3,diadenosine polyphosphate biosynthetic process,BP,
5644,GO:0015961,1,0.975772150142065,0,4,diadenosine polyphosphate catabolic process,BP,
5645,GO:0015965,1,0.981580484052497,0,3,diadenosine tetraphosphate metabolic process,BP,
5646,GO:0015966,1,0.981580484052497,0,3,diadenosine tetraphosphate biosynthetic process,BP,
5647,GO:0015980,1,0.218896225273225,0,244,energy derivation by oxidation of organic compounds,BP,
5648,GO:0015985,1,0.946340938187894,0,9,energy coupled proton transport, down electrochemical gradient,BP,
5649,GO:0015986,1,0.946340938187894,0,9,ATP synthesis coupled proton transport,BP,
5650,GO:0015988,1,0.841442509283612,0,28,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5651,GO:0015990,1,0.99441928095983,0,1,electron transport coupled proton transport,BP,
5652,GO:0015991,1,0.846172799057977,0,27,ATP hydrolysis coupled proton transport,BP,
5653,GO:0016004,1,0.945376996748526,0,9,phospholipase activator activity,MF,
5654,GO:0016005,1,0.987160032987494,0,2,phospholipase A2 activator activity,MF,
5655,GO:0016010,1,0.876128245572299,0,20,dystrophin-associated glycoprotein complex,CC,
5656,GO:0016011,1,0.9557339363657,0,7,dystroglycan complex,CC,
5657,GO:0016012,1,0.962467054790336,0,6,sarcoglycan complex,CC,
5658,GO:0016013,1,0.974921672179931,0,4,syntrophin complex,CC,
5660,GO:0016018,1,0.940240699674056,0,10,cyclosporin A binding,MF,
5661,GO:0016019,1,0.98859283985546,0,2,peptidoglycan receptor activity,MF,
5664,GO:0016024,1,0.92969503256083,0,11,CDP-diacylglycerol biosynthetic process,BP,
5665,GO:0016028,1,0.993598784585451,0,1,rhabdomere,CC,
5666,GO:0016031,1,0.99367214148164,0,1,tRNA import into mitochondrion,BP,
5668,GO:0016034,1,0.994260450549984,0,1,maleylacetoacetate isomerase activity,MF,
5669,GO:0016035,1,0.98591550151646,0,2,zeta DNA polymerase complex,CC,
5670,GO:0016036,1,0.993991528798771,0,1,cellular response to phosphate starvation,BP,
5671,GO:0016037,1,0.993848377595178,0,1,light absorption,BP,
5672,GO:0016038,1,0.993848377595178,0,1,absorption of visible light,BP,
5675,GO:0016045,1,0.936305148386047,0,10,detection of bacterium,BP,
5676,GO:0016046,1,0.993022334258447,0,1,detection of fungus,BP,
5677,GO:0016048,1,0.892057892166077,0,18,detection of temperature stimulus,BP,
5680,GO:0016051,1,0.275882252668322,0,203,carbohydrate biosynthetic process,BP,
5681,GO:0016052,1,0.349987883084002,0,163,carbohydrate catabolic process,BP,
5685,GO:0016056,1,0.866194863615913,0,23,rhodopsin mediated signaling pathway,BP,
5686,GO:0016062,1,0.993906132924117,0,1,adaptation of rhodopsin mediated signaling,BP,
5687,GO:0016064,1,0.570281278800473,0,90,immunoglobulin mediated immune response,BP,
5688,GO:0016068,1,0.982648754194492,0,3,type I hypersensitivity,BP,
5690,GO:0016071,1,0.00711183772372108,0,774,mRNA metabolic process,BP,
5691,GO:0016072,1,0.18132847865199,0,279,rRNA metabolic process,BP,
5692,GO:0016073,1,0.5951521563067,0,84,snRNA metabolic process,BP,
5693,GO:0016074,1,0.931786970876643,0,12,snoRNA metabolic process,BP,
5694,GO:0016075,1,0.905541069128113,0,16,rRNA catabolic process,BP,
5695,GO:0016077,1,0.992912447527943,0,1,snoRNA catabolic process,BP,
5696,GO:0016078,1,0.964877377026701,0,6,tRNA catabolic process,BP,
5697,GO:0016079,1,0.568353055839469,0,86,synaptic vesicle exocytosis,BP,
5698,GO:0016080,1,0.973174979620945,0,4,synaptic vesicle targeting,BP,
5699,GO:0016081,1,0.94078034215313,0,9,synaptic vesicle docking,BP,
5700,GO:0016082,1,0.904011362955684,0,15,synaptic vesicle priming,BP,
5701,GO:0016093,1,0.952879378917798,0,8,polyprenol metabolic process,BP,
5702,GO:0016094,1,0.980960910000741,0,3,polyprenol biosynthetic process,BP,
5703,GO:0016095,1,0.982459157930554,0,3,polyprenol catabolic process,BP,
5704,GO:0016098,1,0.988386976143421,0,2,monoterpenoid metabolic process,BP,
5706,GO:0016102,1,0.946736960538984,0,9,diterpenoid biosynthetic process,BP,
5707,GO:0016103,1,0.98189371607573,0,3,diterpenoid catabolic process,BP,
5708,GO:0016107,1,0.988510436109051,0,2,sesquiterpenoid catabolic process,BP,
5709,GO:0016108,1,0.98167179353668,0,3,tetraterpenoid metabolic process,BP,
5710,GO:0016109,1,0.993891466686588,0,1,tetraterpenoid biosynthetic process,BP,
5711,GO:0016114,1,0.918229048964088,0,14,terpenoid biosynthetic process,BP,
5712,GO:0016115,1,0.970610092955153,0,5,terpenoid catabolic process,BP,
5713,GO:0016116,1,0.98167179353668,0,3,carotenoid metabolic process,BP,
5714,GO:0016117,1,0.993891466686588,0,1,carotenoid biosynthetic process,BP,
5715,GO:0016119,1,0.987705987927284,0,2,carotene metabolic process,BP,
5716,GO:0016121,1,0.993822274700288,0,1,carotene catabolic process,BP,
5717,GO:0016122,1,0.987751095433012,0,2,xanthophyll metabolic process,BP,
5718,GO:0016123,1,0.993891466686588,0,1,xanthophyll biosynthetic process,BP,
5721,GO:0016127,1,0.946145412454657,0,9,sterol catabolic process,BP,
5722,GO:0016128,1,0.982054991795429,0,3,phytosteroid metabolic process,BP,
5723,GO:0016129,1,0.982054991795429,0,3,phytosteroid biosynthetic process,BP,
5724,GO:0016131,1,0.993880400251359,0,1,brassinosteroid metabolic process,BP,
5725,GO:0016132,1,0.993880400251359,0,1,brassinosteroid biosynthetic process,BP,
5726,GO:0016137,1,0.903591856365692,0,17,glycoside metabolic process,BP,
5727,GO:0016139,1,0.952495258074097,0,8,glycoside catabolic process,BP,
5728,GO:0016149,1,0.993584226851973,0,1,translation release factor activity, codon specific,MF,
5729,GO:0016150,1,0.99417930389345,0,1,translation release factor activity, codon nonspecific,MF,
5731,GO:0016153,1,0.993675710237039,0,1,urocanate hydratase activity,MF,
5732,GO:0016154,1,0.99416717517006,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
5733,GO:0016155,1,0.986264900716323,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
5734,GO:0016160,1,0.981079469337183,0,3,amylase activity,MF,
5735,GO:0016165,1,0.987888821737539,0,2,linoleate 13S-lipoxygenase activity,MF,
5736,GO:0016167,1,0.98581341015804,0,2,glial cell-derived neurotrophic factor receptor activity,MF,
5737,GO:0016174,1,0.961075606248574,0,6,NAD(P)H oxidase activity,MF,
5738,GO:0016175,1,0.95189893982761,0,8,superoxide-generating NADPH oxidase activity,MF,
5739,GO:0016176,1,0.949654949417828,0,8,superoxide-generating NADPH oxidase activator activity,MF,
5740,GO:0016180,1,0.86679696007091,0,23,snRNA processing,BP,
5741,GO:0016182,1,0.993258713991078,0,1,synaptic vesicle budding from endosome,BP,
5742,GO:0016185,1,0.979885114389886,0,3,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
5744,GO:0016189,1,0.992334205745111,0,1,synaptic vesicle to endosome fusion,BP,
5745,GO:0016191,1,0.967164312800418,0,5,synaptic vesicle uncoating,BP,
5747,GO:0016197,1,0.304181008850069,0,183,endosomal transport,BP,
5748,GO:0016198,1,0.960891224558334,0,6,axon choice point recognition,BP,
5749,GO:0016199,1,0.972709943933119,0,4,axon midline choice point recognition,BP,
5751,GO:0016206,1,0.987794468998477,0,2,catechol O-methyltransferase activity,MF,
5752,GO:0016208,1,0.941222426775747,0,10,AMP binding,MF,
5753,GO:0016209,1,0.652168406018814,0,71,antioxidant activity,MF,
5754,GO:0016211,1,0.986523926751495,0,2,ammonia ligase activity,MF,
5755,GO:0016212,1,0.987979417740989,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5756,GO:0016213,1,0.993736982052292,0,1,linoleoyl-CoA desaturase activity,MF,
5757,GO:0016215,1,0.980832396335761,0,3,acyl-CoA desaturase activity,MF,
5758,GO:0016222,1,0.987761666278198,0,2,procollagen-proline 4-dioxygenase complex,CC,
5759,GO:0016226,1,0.886970800338555,0,20,iron-sulfur cluster assembly,BP,
5760,GO:0016229,1,0.863232719310228,0,25,steroid dehydrogenase activity,MF,
5761,GO:0016230,1,0.987902246497398,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5762,GO:0016231,1,0.993170600990028,0,1,beta-N-acetylglucosaminidase activity,MF,
5763,GO:0016232,1,0.993834318414939,0,1,HNK-1 sulfotransferase activity,MF,
5766,GO:0016235,1,0.765921445957759,0,41,aggresome,CC,
5767,GO:0016236,1,0.167981331220594,0,279,macroautophagy,BP,
5768,GO:0016237,1,0.993215826877262,0,1,lysosomal microautophagy,BP,
5769,GO:0016239,1,0.681089890768182,0,58,positive regulation of macroautophagy,BP,
5770,GO:0016240,1,0.974600882487177,0,4,autophagosome membrane docking,BP,
5771,GO:0016241,1,0.366443987549001,0,156,regulation of macroautophagy,BP,
5772,GO:0016242,1,0.838438729740704,0,27,negative regulation of macroautophagy,BP,
5773,GO:0016243,1,0.993494531880438,0,1,regulation of autophagosome size,BP,
5774,GO:0016246,1,0.907559533786889,0,15,RNA interference,BP,
5776,GO:0016248,1,0.814727738495937,0,32,channel inhibitor activity,MF,
5777,GO:0016250,1,0.993847803582838,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5778,GO:0016254,1,0.907636196857343,0,16,preassembly of GPI anchor in ER membrane,BP,
5779,GO:0016255,1,0.955808904654934,0,7,attachment of GPI anchor to protein,BP,
5780,GO:0016256,1,0.987352544194065,0,2,N-glycan processing to lysosome,BP,
5781,GO:0016259,1,0.975239622467668,0,4,selenocysteine metabolic process,BP,
5782,GO:0016260,1,0.987926048497719,0,2,selenocysteine biosynthetic process,BP,
5783,GO:0016262,1,0.981140299681618,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5784,GO:0016263,1,0.988247015119595,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5786,GO:0016266,1,0.721085380678249,0,50,O-glycan processing,BP,
5787,GO:0016267,1,0.988247015119595,0,2,O-glycan processing, core 1,BP,
5788,GO:0016272,1,0.961017488303994,0,7,prefoldin complex,CC,
5789,GO:0016273,1,0.929583821292243,0,12,arginine N-methyltransferase activity,MF,
5790,GO:0016274,1,0.929583821292243,0,12,protein-arginine N-methyltransferase activity,MF,
5791,GO:0016277,1,0.993952766171747,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5792,GO:0016278,1,0.71567928178529,0,51,lysine N-methyltransferase activity,MF,
5793,GO:0016279,1,0.720125702771737,0,50,protein-lysine N-methyltransferase activity,MF,
5794,GO:0016281,1,0.944280563062996,0,9,eukaryotic translation initiation factor 4F complex,CC,
5795,GO:0016282,1,0.993354421101832,0,1,eukaryotic 43S preinitiation complex,CC,
5796,GO:0016286,1,0.976088911219193,0,4,small conductance calcium-activated potassium channel activity,MF,
5797,GO:0016287,1,0.993870487511782,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5798,GO:0016289,1,0.903329314852969,0,17,CoA hydrolase activity,MF,
5799,GO:0016290,1,0.947764989924968,0,9,palmitoyl-CoA hydrolase activity,MF,
5800,GO:0016295,1,0.986382673615573,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5801,GO:0016296,1,0.986382673615573,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5802,GO:0016297,1,0.986382673615573,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
5804,GO:0016300,1,0.981174417480907,0,3,tRNA (uracil) methyltransferase activity,MF,
5807,GO:0016307,1,0.9052056314101,0,15,phosphatidylinositol phosphate kinase activity,MF,
5808,GO:0016308,1,0.961980463478748,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5809,GO:0016309,1,0.987328786054458,0,2,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5812,GO:0016312,1,0.974197816381333,0,4,inositol bisphosphate phosphatase activity,MF,
5813,GO:0016314,1,0.980545135891048,0,3,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5814,GO:0016316,1,0.986232922701696,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5815,GO:0016320,1,0.986615479665642,0,2,endoplasmic reticulum membrane fusion,BP,
5816,GO:0016321,1,0.975792394116636,0,4,female meiosis chromosome segregation,BP,
5817,GO:0016322,1,0.938545187177614,0,10,neuron remodeling,BP,
5820,GO:0016327,1,0.905237706982748,0,16,apicolateral plasma membrane,CC,
5823,GO:0016332,1,0.993521399777171,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5824,GO:0016333,1,0.993798635555643,0,1,morphogenesis of follicular epithelium,BP,
5825,GO:0016334,1,0.993798635555643,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5827,GO:0016339,1,0.807890964211062,0,33,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
5828,GO:0016340,1,0.985608862485841,0,2,calcium-dependent cell-matrix adhesion,BP,
5829,GO:0016342,1,0.832921143462175,0,28,catenin complex,CC,
5830,GO:0016344,1,0.980301952783034,0,3,meiotic chromosome movement towards spindle pole,BP,
5832,GO:0016361,1,0.973760471115717,0,4,activin receptor activity, type I,MF,
5833,GO:0016362,1,0.982593085487067,0,2,activin receptor activity, type II,MF,
5834,GO:0016363,1,0.511740390350539,0,103,nuclear matrix,CC,
5835,GO:0016401,1,0.974743832631324,0,4,palmitoyl-CoA oxidase activity,MF,
5836,GO:0016402,1,0.987838501739655,0,2,pristanoyl-CoA oxidase activity,MF,
5837,GO:0016403,1,0.98779437437371,0,2,dimethylargininase activity,MF,
5838,GO:0016404,1,0.987251395338121,0,2,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5839,GO:0016405,1,0.871532942887322,0,22,CoA-ligase activity,MF,
5840,GO:0016406,1,0.963094582221654,0,6,carnitine O-acyltransferase activity,MF,
5841,GO:0016407,1,0.546457832322274,0,94,acetyltransferase activity,MF,
5842,GO:0016408,1,0.901284085790541,0,17,C-acyltransferase activity,MF,
5843,GO:0016409,1,0.786160423284369,0,38,palmitoyltransferase activity,MF,
5844,GO:0016410,1,0.555020271985816,0,92,N-acyltransferase activity,MF,
5845,GO:0016411,1,0.872486995910582,0,21,acylglycerol O-acyltransferase activity,MF,
5846,GO:0016413,1,0.956679902821227,0,7,O-acetyltransferase activity,MF,
5847,GO:0016414,1,0.99370955095265,0,1,O-octanoyltransferase activity,MF,
5848,GO:0016415,1,0.988115366768236,0,2,octanoyltransferase activity,MF,
5849,GO:0016416,1,0.968617103472042,0,5,O-palmitoyltransferase activity,MF,
5850,GO:0016417,1,0.821518233448384,0,31,S-acyltransferase activity,MF,
5851,GO:0016418,1,0.985644136937601,0,2,S-acetyltransferase activity,MF,
5852,GO:0016419,1,0.986328089543399,0,2,S-malonyltransferase activity,MF,
5853,GO:0016420,1,0.986328089543399,0,2,malonyltransferase activity,MF,
5854,GO:0016421,1,0.967931826953439,0,5,CoA carboxylase activity,MF,
5855,GO:0016422,1,0.98207126903365,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5856,GO:0016423,1,0.922661098790024,0,13,tRNA (guanine) methyltransferase activity,MF,
5857,GO:0016426,1,0.981784796005287,0,3,tRNA (adenine) methyltransferase activity,MF,
5858,GO:0016427,1,0.949944660873912,0,8,tRNA (cytosine) methyltransferase activity,MF,
5859,GO:0016428,1,0.974748351175882,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5860,GO:0016429,1,0.981784796005287,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
5861,GO:0016433,1,0.964588489559434,0,6,rRNA (adenine) methyltransferase activity,MF,
5862,GO:0016434,1,0.981200511960268,0,3,rRNA (cytosine) methyltransferase activity,MF,
5863,GO:0016435,1,0.981377840136614,0,3,rRNA (guanine) methyltransferase activity,MF,
5864,GO:0016436,1,0.987428555240694,0,2,rRNA (uridine) methyltransferase activity,MF,
5865,GO:0016441,1,0.455666613547362,0,121,posttranscriptional gene silencing,BP,
5866,GO:0016442,1,0.928377994734002,0,11,RISC complex,CC,
5867,GO:0016444,1,0.718159373497868,0,51,somatic cell DNA recombination,BP,
5868,GO:0016445,1,0.734457068160594,0,48,somatic diversification of immunoglobulins,BP,
5869,GO:0016446,1,0.932815805456027,0,11,somatic hypermutation of immunoglobulin genes,BP,
5870,GO:0016447,1,0.75862800772887,0,43,somatic recombination of immunoglobulin gene segments,BP,
5871,GO:0016453,1,0.976393616678178,0,4,C-acetyltransferase activity,MF,
5872,GO:0016454,1,0.96830143041574,0,5,C-palmitoyltransferase activity,MF,
5873,GO:0016458,1,0.252386323802088,0,212,gene silencing,BP,
5876,GO:0016461,1,0.932076821484758,0,10,unconventional myosin complex,CC,
5878,GO:0016469,1,0.844282645349793,0,28,proton-transporting two-sector ATPase complex,CC,
5879,GO:0016471,1,0.911891243244029,0,15,vacuolar proton-transporting V-type ATPase complex,CC,
5880,GO:0016476,1,0.980892678855863,0,3,regulation of embryonic cell shape,BP,
5882,GO:0016479,1,0.974095879272657,0,4,negative regulation of transcription by RNA polymerase I,BP,
5883,GO:0016480,1,0.982529134653667,0,3,negative regulation of transcription by RNA polymerase III,BP,
5884,GO:0016482,1,0.406996572399639,0,136,cytosolic transport,BP,
5886,GO:0016486,1,0.843503030083405,0,27,peptide hormone processing,BP,
5887,GO:0016487,1,0.988510436109051,0,2,farnesol metabolic process,BP,
5888,GO:0016488,1,0.988510436109051,0,2,farnesol catabolic process,BP,
5890,GO:0016492,1,0.987679493407597,0,2,G-protein coupled neurotensin receptor activity,MF,
5891,GO:0016493,1,0.941206880242385,0,10,C-C chemokine receptor activity,MF,
5892,GO:0016494,1,0.952908282706614,0,8,C-X-C chemokine receptor activity,MF,
5893,GO:0016495,1,0.993730122665948,0,1,C-X3-C chemokine receptor activity,MF,
5894,GO:0016496,1,0.993708979641733,0,1,substance P receptor activity,MF,
5895,GO:0016497,1,0.993949309648881,0,1,substance K receptor activity,MF,
5896,GO:0016499,1,0.988224770296822,0,2,orexin receptor activity,MF,
5897,GO:0016500,1,0.937219200926969,0,10,protein-hormone receptor activity,MF,
5898,GO:0016501,1,0.987881228980663,0,2,prostacyclin receptor activity,MF,
5899,GO:0016502,1,0.886538482556481,0,20,nucleotide receptor activity,MF,
5900,GO:0016503,1,0.994268825118805,0,1,pheromone receptor activity,MF,
5903,GO:0016507,1,0.993767006835621,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5904,GO:0016508,1,0.981275326593145,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5905,GO:0016509,1,0.981802549179903,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5906,GO:0016514,1,0.906714157386994,0,15,SWI/SNF complex,CC,
5907,GO:0016517,1,0.994073183752291,0,1,interleukin-12 receptor activity,MF,
5908,GO:0016519,1,0.994059760493024,0,1,gastric inhibitory peptide receptor activity,MF,
5909,GO:0016520,1,0.987613748314389,0,2,growth hormone-releasing hormone receptor activity,MF,
5910,GO:0016521,1,0.993732837701607,0,1,pituitary adenylate cyclase activating polypeptide activity,MF,
5911,GO:0016525,1,0.569828179812883,0,86,negative regulation of angiogenesis,BP,
5915,GO:0016531,1,0.970305880386896,0,5,copper chaperone activity,MF,
5916,GO:0016532,1,0.981039310107192,0,3,superoxide dismutase copper chaperone activity,MF,
5917,GO:0016533,1,0.981895127655133,0,3,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
5918,GO:0016534,1,0.98750995322072,0,2,cyclin-dependent protein kinase 5 activator activity,MF,
5919,GO:0016538,1,0.838539442820032,0,29,cyclin-dependent protein serine/threonine kinase regulator activity,MF,
5920,GO:0016539,1,0.994192298933327,0,1,intein-mediated protein splicing,BP,
5922,GO:0016553,1,0.915411305615921,0,14,base conversion or substitution editing,BP,
5923,GO:0016554,1,0.94736703171455,0,9,cytidine to uridine editing,BP,
5924,GO:0016556,1,0.913021961164746,0,15,mRNA modification,BP,
5925,GO:0016557,1,0.982375849906112,0,3,peroxisome membrane biogenesis,BP,
5927,GO:0016559,1,0.947335540666237,0,9,peroxisome fission,BP,
5929,GO:0016561,1,0.987763760040097,0,2,protein import into peroxisome matrix, translocation,BP,
5933,GO:0016571,1,0.447150994036221,0,122,histone methylation,BP,
5935,GO:0016573,1,0.411447990341373,0,137,histone acetylation,BP,
5936,GO:0016574,1,0.75330653059815,0,43,histone ubiquitination,BP,
5937,GO:0016575,1,0.581566029985051,0,83,histone deacetylation,BP,
5938,GO:0016576,1,0.962286434301926,0,6,histone dephosphorylation,BP,
5939,GO:0016577,1,0.829956780193071,0,27,histone demethylation,BP,
5940,GO:0016578,1,0.866748007202284,0,22,histone deubiquitination,BP,
5941,GO:0016579,1,0.198143592815558,0,249,protein deubiquitination,BP,
5942,GO:0016580,1,0.923205758388454,0,12,Sin3 complex,CC,
5943,GO:0016581,1,0.890435330880617,0,17,NuRD complex,CC,
5944,GO:0016584,1,0.958323017163259,0,7,nucleosome positioning,BP,
5945,GO:0016586,1,0.985876305925355,0,2,RSC-type complex,CC,
5946,GO:0016589,1,0.953753023873259,0,7,NURF complex,CC,
5947,GO:0016590,1,0.992924002632181,0,1,ACF complex,CC,
5948,GO:0016591,1,0.506556472721167,0,107,DNA-directed RNA polymerase II, holoenzyme,CC,
5949,GO:0016592,1,0.79223259347088,0,36,mediator complex,CC,
5950,GO:0016593,1,0.949119131737232,0,8,Cdc73/Paf1 complex,CC,
5951,GO:0016594,1,0.909617238398032,0,15,glycine binding,MF,
5952,GO:0016595,1,0.937011893622084,0,10,glutamate binding,MF,
5953,GO:0016596,1,0.993846081630578,0,1,thienylcyclohexylpiperidine binding,MF,
5954,GO:0016597,1,0.69398668100939,0,58,amino acid binding,MF,
5955,GO:0016598,1,0.988159357928193,0,2,protein arginylation,BP,
5956,GO:0016600,1,0.940876395577178,0,9,flotillin complex,CC,
5957,GO:0016601,1,0.786188529810607,0,37,Rac protein signal transduction,BP,
5958,GO:0016602,1,0.975112545169452,0,4,CCAAT-binding factor complex,CC,
5959,GO:0016603,1,0.988211446190987,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5961,GO:0016605,1,0.541743692183979,0,94,PML body,CC,
5963,GO:0016608,1,0.988988006052657,0,2,growth hormone-releasing hormone activity,MF,
5964,GO:0016614,1,0.48613201272139,0,118,oxidoreductase activity, acting on CH-OH group of donors,MF,
5965,GO:0016615,1,0.958354415448622,0,7,malate dehydrogenase activity,MF,
5966,GO:0016616,1,0.532600278722883,0,104,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
5967,GO:0016618,1,0.982007778896684,0,3,hydroxypyruvate reductase activity,MF,
5968,GO:0016620,1,0.818866373833054,0,32,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
5969,GO:0016623,1,0.987401223712343,0,2,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
5970,GO:0016624,1,0.951380463046376,0,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
5971,GO:0016627,1,0.717025972343158,0,54,oxidoreductase activity, acting on the CH-CH group of donors,MF,
5972,GO:0016628,1,0.864225908829871,0,24,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,
5973,GO:0016634,1,0.951318093128983,0,8,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
5974,GO:0016635,1,0.970779442957883,0,5,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
5975,GO:0016638,1,0.878190355588788,0,21,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,
5976,GO:0016639,1,0.981976060029684,0,3,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
5977,GO:0016641,1,0.905242555113226,0,16,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,
5978,GO:0016642,1,0.993545395687408,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
5979,GO:0016645,1,0.860991581541337,0,24,oxidoreductase activity, acting on the CH-NH group of donors,MF,
5980,GO:0016646,1,0.904161140860361,0,16,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,
5981,GO:0016647,1,0.982259310357197,0,3,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
5982,GO:0016649,1,0.987716558645507,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
5983,GO:0016651,1,0.557394985929641,0,98,oxidoreductase activity, acting on NAD(P)H,MF,
5984,GO:0016652,1,0.987673506587506,0,2,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
5985,GO:0016653,1,0.920263842246592,0,13,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
5986,GO:0016655,1,0.742070531425781,0,52,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
5987,GO:0016657,1,0.988345917261754,0,2,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
5988,GO:0016661,1,0.969694675184117,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
5989,GO:0016662,1,0.993895779497771,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
5990,GO:0016667,1,0.724902438794835,0,53,oxidoreductase activity, acting on a sulfur group of donors,MF,
5991,GO:0016668,1,0.924890529703248,0,13,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
5992,GO:0016670,1,0.950595807219788,0,8,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5993,GO:0016671,1,0.936316054993184,0,11,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
5994,GO:0016672,1,0.988668072217978,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
5995,GO:0016675,1,0.876867771055673,0,23,oxidoreductase activity, acting on a heme group of donors,MF,
5996,GO:0016676,1,0.882236375382519,0,22,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
5997,GO:0016679,1,0.954008257666854,0,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5998,GO:0016681,1,0.959871902835923,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5999,GO:0016684,1,0.775934554939983,0,42,oxidoreductase activity, acting on peroxide as acceptor,MF,
6000,GO:0016701,1,0.859666901850105,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
6001,GO:0016702,1,0.859666901850105,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
6002,GO:0016705,1,0.438718340610571,0,130,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,
6003,GO:0016706,1,0.766253854559362,0,41,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,
6004,GO:0016708,1,0.988041845899609,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
6005,GO:0016709,1,0.798593697734153,0,36,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,
6006,GO:0016711,1,0.993893766769423,0,1,flavonoid 3'-monooxygenase activity,MF,
6007,GO:0016712,1,0.890785440449121,0,19,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
6008,GO:0016713,1,0.988258213344568,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,
6009,GO:0016714,1,0.958949096399812,0,7,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
6010,GO:0016715,1,0.97491134516589,0,4,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
6011,GO:0016717,1,0.968335913407712,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
6012,GO:0016721,1,0.971529840577745,0,5,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
6013,GO:0016722,1,0.901561206484993,0,16,oxidoreductase activity, oxidizing metal ions,MF,
6014,GO:0016723,1,0.938094023920295,0,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,
6015,GO:0016724,1,0.966916462011695,0,5,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
6016,GO:0016725,1,0.955769596681994,0,7,oxidoreductase activity, acting on CH or CH2 groups,MF,
6017,GO:0016726,1,0.986260343357986,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
6018,GO:0016727,1,0.992993173329028,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
6019,GO:0016728,1,0.980759034698322,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
6020,GO:0016730,1,0.994098735670444,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
6021,GO:0016731,1,0.994098735670444,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
6023,GO:0016741,1,0.292562824686076,0,194,transferase activity, transferring one-carbon groups,MF,
6024,GO:0016742,1,0.950878983116888,0,8,hydroxymethyl-, formyl- and related transferase activity,MF,
6025,GO:0016743,1,0.979884881043568,0,3,carboxyl- or carbamoyltransferase activity,MF,
6026,GO:0016744,1,0.982313600070513,0,3,transferase activity, transferring aldehyde or ketonic groups,MF,
6027,GO:0016746,1,0.246616305045023,0,220,transferase activity, transferring acyl groups,MF,
6028,GO:0016747,1,0.292045064462635,0,193,transferase activity, transferring acyl groups other than amino-acyl groups,MF,
6029,GO:0016748,1,0.981965077714607,0,3,succinyltransferase activity,MF,
6030,GO:0016749,1,0.988068137020174,0,2,N-succinyltransferase activity,MF,
6031,GO:0016751,1,0.99382399483331,0,1,S-succinyltransferase activity,MF,
6032,GO:0016755,1,0.929200494318267,0,12,transferase activity, transferring amino-acyl groups,MF,
6033,GO:0016757,1,0.217885892989547,0,240,transferase activity, transferring glycosyl groups,MF,
6034,GO:0016758,1,0.330059563936039,0,175,transferase activity, transferring hexosyl groups,MF,
6035,GO:0016763,1,0.75750145261133,0,44,transferase activity, transferring pentosyl groups,MF,
6036,GO:0016765,1,0.722285084378503,0,54,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
6037,GO:0016768,1,0.994157934222616,0,1,spermine synthase activity,MF,
6041,GO:0016774,1,0.981752037151149,0,3,phosphotransferase activity, carboxyl group as acceptor,MF,
6042,GO:0016775,1,0.926351641342999,0,12,phosphotransferase activity, nitrogenous group as acceptor,MF,
6044,GO:0016778,1,0.970322090441238,0,5,diphosphotransferase activity,MF,
6045,GO:0016779,1,0.433935461096886,0,132,nucleotidyltransferase activity,MF,
6046,GO:0016780,1,0.893644983510956,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
6047,GO:0016781,1,0.987926048497719,0,2,phosphotransferase activity, paired acceptors,MF,
6049,GO:0016783,1,0.931974401955544,0,12,sulfurtransferase activity,MF,
6050,GO:0016784,1,0.994221032359422,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6051,GO:0016785,1,0.993021468188549,0,1,transferase activity, transferring selenium-containing groups,MF,
6054,GO:0016790,1,0.823329278996263,0,32,thiolester hydrolase activity,MF,
6056,GO:0016793,1,0.993724407370571,0,1,triphosphoric monoester hydrolase activity,MF,
6057,GO:0016794,1,0.994345929371049,0,1,diphosphoric monoester hydrolase activity,MF,
6058,GO:0016796,1,0.726649185289063,0,50,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6059,GO:0016798,1,0.533933384248381,0,101,hydrolase activity, acting on glycosyl bonds,MF,
6060,GO:0016799,1,0.87595351885427,0,22,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
6061,GO:0016801,1,0.917887534012878,0,14,hydrolase activity, acting on ether bonds,MF,
6062,GO:0016802,1,0.980785445302038,0,3,trialkylsulfonium hydrolase activity,MF,
6063,GO:0016803,1,0.935882140874717,0,11,ether hydrolase activity,MF,
6065,GO:0016807,1,0.993846081630578,0,1,cysteine-type carboxypeptidase activity,MF,
6068,GO:0016812,1,0.954975405398027,0,7,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
6071,GO:0016815,1,0.994252942319835,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6074,GO:0016822,1,0.982705270803483,0,3,hydrolase activity, acting on acid carbon-carbon bonds,MF,
6075,GO:0016823,1,0.982705270803483,0,3,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
6076,GO:0016826,1,0.993847803582838,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
6078,GO:0016830,1,0.749293364845598,0,47,carbon-carbon lyase activity,MF,
6079,GO:0016831,1,0.821268129638152,0,32,carboxy-lyase activity,MF,
6080,GO:0016832,1,0.952250311769439,0,8,aldehyde-lyase activity,MF,
6081,GO:0016833,1,0.963410096774399,0,6,oxo-acid-lyase activity,MF,
6083,GO:0016836,1,0.747030583684624,0,48,hydro-lyase activity,MF,
6085,GO:0016840,1,0.925237093595977,0,13,carbon-nitrogen lyase activity,MF,
6086,GO:0016841,1,0.970541864556187,0,5,ammonia-lyase activity,MF,
6087,GO:0016842,1,0.959239620984957,0,7,amidine-lyase activity,MF,
6088,GO:0016843,1,0.993846081630578,0,1,amine-lyase activity,MF,
6089,GO:0016844,1,0.993846081630578,0,1,strictosidine synthase activity,MF,
6090,GO:0016846,1,0.949320299354514,0,9,carbon-sulfur lyase activity,MF,
6091,GO:0016849,1,0.897170469281413,0,16,phosphorus-oxygen lyase activity,MF,
6093,GO:0016854,1,0.905786980719983,0,16,racemase and epimerase activity,MF,
6094,GO:0016855,1,0.993930880583482,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
6095,GO:0016857,1,0.932649614786668,0,11,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
6096,GO:0016859,1,0.81799670676132,0,33,cis-trans isomerase activity,MF,
6098,GO:0016861,1,0.953633225337684,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
6099,GO:0016862,1,0.988976805027349,0,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
6100,GO:0016863,1,0.942638973309302,0,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
6101,GO:0016864,1,0.898467851082269,0,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
6102,GO:0016866,1,0.84766045723447,0,27,intramolecular transferase activity,MF,
6103,GO:0016868,1,0.934644875898385,0,11,intramolecular transferase activity, phosphotransferases,MF,
6104,GO:0016872,1,0.993993402969726,0,1,intramolecular lyase activity,MF,
6106,GO:0016875,1,0.761616297733401,0,44,ligase activity, forming carbon-oxygen bonds,MF,
6107,GO:0016877,1,0.798436336549764,0,36,ligase activity, forming carbon-sulfur bonds,MF,
6108,GO:0016878,1,0.850628123584113,0,26,acid-thiol ligase activity,MF,
6110,GO:0016880,1,0.980452101144769,0,3,acid-ammonia (or amide) ligase activity,MF,
6112,GO:0016882,1,0.988081375344286,0,2,cyclo-ligase activity,MF,
6113,GO:0016884,1,0.938069201110508,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
6114,GO:0016885,1,0.955884453094983,0,7,ligase activity, forming carbon-carbon bonds,MF,
6115,GO:0016886,1,0.939886585550067,0,10,ligase activity, forming phosphoric ester bonds,MF,
6117,GO:0016888,1,0.937576625307033,0,10,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6118,GO:0016889,1,0.88655017870842,0,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
6119,GO:0016890,1,0.987626713560162,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
6120,GO:0016891,1,0.847070732928831,0,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
6121,GO:0016892,1,0.954423571273485,0,8,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
6122,GO:0016893,1,0.81062683516341,0,34,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6123,GO:0016894,1,0.846095826775845,0,28,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
6124,GO:0016895,1,0.888465386003188,0,19,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6125,GO:0016896,1,0.813454248186227,0,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
6126,GO:0016898,1,0.987993286083739,0,2,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
6127,GO:0016899,1,0.980719811864407,0,3,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
6128,GO:0016900,1,0.988723932762689,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
6129,GO:0016901,1,0.986801508541513,0,2,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
6130,GO:0016903,1,0.773751528042749,0,41,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,
6131,GO:0016907,1,0.963560278872773,0,6,G-protein coupled acetylcholine receptor activity,MF,
6132,GO:0016909,1,0.98125853008178,0,3,SAP kinase activity,MF,
6133,GO:0016917,1,0.877385032409593,0,20,GABA receptor activity,MF,
6134,GO:0016918,1,0.925875144940012,0,13,retinal binding,MF,
6135,GO:0016920,1,0.992606985399686,0,1,pyroglutamyl-peptidase activity,MF,
6136,GO:0016922,1,0.867240993893849,0,21,ligand-dependent nuclear receptor binding,MF,
6138,GO:0016926,1,0.955064787458161,0,7,protein desumoylation,BP,
6139,GO:0016929,1,0.960674685655404,0,6,SUMO-specific protease activity,MF,
6140,GO:0016933,1,0.969696818676095,0,5,extracellularly glycine-gated ion channel activity,MF,
6141,GO:0016934,1,0.969696818676095,0,5,extracellularly glycine-gated chloride channel activity,MF,
6142,GO:0016935,1,0.987412663957013,0,2,glycine-gated chloride channel complex,CC,
6143,GO:0016936,1,0.977126740201195,0,4,galactoside binding,MF,
6144,GO:0016938,1,0.993795199006858,0,1,kinesin I complex,CC,
6145,GO:0016939,1,0.979650816481859,0,3,kinesin II complex,CC,
6146,GO:0016941,1,0.981095134715626,0,3,natriuretic peptide receptor activity,MF,
6147,GO:0016942,1,0.968122281082553,0,5,insulin-like growth factor binding protein complex,CC,
6148,GO:0016964,1,0.990311716646201,0,1,alpha-2 macroglobulin receptor activity,MF,
6149,GO:0016971,1,0.981207544619007,0,3,flavin-linked sulfhydryl oxidase activity,MF,
6150,GO:0016972,1,0.97461227557652,0,4,thiol oxidase activity,MF,
6151,GO:0016973,1,0.928142132778253,0,12,poly(A)+ mRNA export from nucleus,BP,
6152,GO:0016979,1,0.994238792200268,0,1,lipoate-protein ligase activity,MF,
6153,GO:0016990,1,0.993989654703031,0,1,arginine deiminase activity,MF,
6154,GO:0016992,1,0.994162987867528,0,1,lipoate synthase activity,MF,
6155,GO:0016997,1,0.970151232082645,0,5,alpha-sialidase activity,MF,
6156,GO:0016998,1,0.976897380052782,0,4,cell wall macromolecule catabolic process,BP,
6157,GO:0016999,1,0.467813814464101,0,124,antibiotic metabolic process,BP,
6158,GO:0017000,1,0.908619390849038,0,15,antibiotic biosynthetic process,BP,
6159,GO:0017001,1,0.772800227265864,0,43,antibiotic catabolic process,BP,
6160,GO:0017002,1,0.950236403178315,0,7,activin-activated receptor activity,MF,
6161,GO:0017003,1,0.993986195034811,0,1,protein-heme linkage,BP,
6162,GO:0017004,1,0.812208428534467,0,34,cytochrome complex assembly,BP,
6163,GO:0017005,1,0.99359735741612,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6164,GO:0017006,1,0.993986195034811,0,1,protein-tetrapyrrole linkage,BP,
6165,GO:0017014,1,0.918442608960887,0,13,protein nitrosylation,BP,
6166,GO:0017015,1,0.523360136875176,0,98,regulation of transforming growth factor beta receptor signaling pathway,BP,
6168,GO:0017017,1,0.934450054966721,0,11,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,
6169,GO:0017018,1,0.972264212502811,0,4,myosin phosphatase activity,MF,
6170,GO:0017020,1,0.993819551421369,0,1,myosin phosphatase regulator activity,MF,
6172,GO:0017024,1,0.994388669429253,0,1,myosin I binding,MF,
6173,GO:0017025,1,0.854843073808932,0,25,TBP-class protein binding,MF,
6176,GO:0017040,1,0.969904738530126,0,5,N-acylsphingosine amidohydrolase activity,MF,
6177,GO:0017042,1,0.9941603888507,0,1,glycosylceramidase activity,MF,
6178,GO:0017045,1,0.994278354807957,0,1,corticotropin-releasing hormone activity,MF,
6179,GO:0017046,1,0.794452279965023,0,36,peptide hormone binding,MF,
6180,GO:0017048,1,0.328030769041136,0,164,Rho GTPase binding,MF,
6181,GO:0017049,1,0.879930236655173,0,20,GTP-Rho binding,MF,
6182,GO:0017050,1,0.98793637601544,0,2,D-erythro-sphingosine kinase activity,MF,
6183,GO:0017053,1,0.577877952341218,0,82,transcriptional repressor complex,CC,
6184,GO:0017055,1,0.987646428241603,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
6185,GO:0017056,1,0.859478108346149,0,23,structural constituent of nuclear pore,MF,
6186,GO:0017057,1,0.986412413784478,0,2,6-phosphogluconolactonase activity,MF,
6187,GO:0017059,1,0.951288488973353,0,8,serine C-palmitoyltransferase complex,CC,
6188,GO:0017060,1,0.981951690099636,0,3,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
6189,GO:0017061,1,0.993231373931652,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
6190,GO:0017062,1,0.945752020481638,0,9,respiratory chain complex III assembly,BP,
6191,GO:0017064,1,0.988138669575988,0,2,fatty acid amide hydrolase activity,MF,
6192,GO:0017065,1,0.994193742825538,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
6193,GO:0017069,1,0.791840341403046,0,38,snRNA binding,MF,
6194,GO:0017070,1,0.934760806681072,0,11,U6 snRNA binding,MF,
6195,GO:0017071,1,0.993594074883222,0,1,intracellular cyclic nucleotide activated cation channel complex,CC,
6196,GO:0017075,1,0.863523737509471,0,22,syntaxin-1 binding,MF,
6198,GO:0017077,1,0.988179069746776,0,2,oxidative phosphorylation uncoupler activity,MF,
6200,GO:0017081,1,0.902839650083398,0,16,chloride channel regulator activity,MF,
6201,GO:0017082,1,0.993846081630578,0,1,mineralocorticoid receptor activity,MF,
6202,GO:0017084,1,0.99364673542535,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
6203,GO:0017085,1,0.904276983110027,0,16,response to insecticide,BP,
6204,GO:0017087,1,0.993517113533191,0,1,mitochondrial processing peptidase complex,CC,
6205,GO:0017089,1,0.988076753056812,0,2,glycolipid transporter activity,MF,
6206,GO:0017090,1,0.993799351560667,0,1,meprin A complex,CC,
6207,GO:0017091,1,0.859761917421457,0,24,AU-rich element binding,MF,
6208,GO:0017095,1,0.979403583125061,0,3,heparan sulfate 6-O-sulfotransferase activity,MF,
6209,GO:0017098,1,0.987908826398135,0,2,sulfonylurea receptor binding,MF,
6210,GO:0017099,1,0.976035979827541,0,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,
6211,GO:0017101,1,0.92839370554658,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
6212,GO:0017102,1,0.987684557085716,0,2,methionyl glutamyl tRNA synthetase complex,CC,
6213,GO:0017108,1,0.969290199232844,0,5,5'-flap endonuclease activity,MF,
6214,GO:0017109,1,0.987373498339495,0,2,glutamate-cysteine ligase complex,CC,
6215,GO:0017110,1,0.920527896766423,0,13,nucleoside-diphosphatase activity,MF,
6217,GO:0017112,1,0.716340549047532,0,51,Rab guanyl-nucleotide exchange factor activity,MF,
6218,GO:0017113,1,0.993745557971144,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6219,GO:0017116,1,0.980989605200311,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
6220,GO:0017119,1,0.921270739949326,0,13,Golgi transport complex,CC,
6221,GO:0017121,1,0.938725531938546,0,10,phospholipid scrambling,BP,
6223,GO:0017125,1,0.993281006499041,0,1,deoxycytidyl transferase activity,MF,
6224,GO:0017126,1,0.99311250937715,0,1,nucleologenesis,BP,
6225,GO:0017127,1,0.908509830669553,0,15,cholesterol transporter activity,MF,
6226,GO:0017128,1,0.950323583703514,0,8,phospholipid scramblase activity,MF,
6227,GO:0017129,1,0.987752189272352,0,2,triglyceride binding,MF,
6228,GO:0017130,1,0.992681481951384,0,1,poly(C) RNA binding,MF,
6229,GO:0017133,1,0.993967171770242,0,1,mitochondrial electron transfer flavoprotein complex,CC,
6230,GO:0017134,1,0.871756068940202,0,21,fibroblast growth factor binding,MF,
6231,GO:0017136,1,0.902595678398503,0,16,NAD-dependent histone deacetylase activity,MF,
6233,GO:0017143,1,0.987806871352148,0,2,insecticide metabolic process,BP,
6235,GO:0017145,1,0.784825904515608,0,37,stem cell division,BP,
6236,GO:0017146,1,0.925006418985532,0,11,NMDA selective glutamate receptor complex,CC,
6237,GO:0017147,1,0.818730942310706,0,31,Wnt-protein binding,MF,
6238,GO:0017148,1,0.25969371430585,0,206,negative regulation of translation,BP,
6239,GO:0017150,1,0.976301011811534,0,4,tRNA dihydrouridine synthase activity,MF,
6240,GO:0017151,1,0.949783523976523,0,8,DEAD/H-box RNA helicase binding,MF,
6241,GO:0017153,1,0.94293896221178,0,9,sodium:dicarboxylate symporter activity,MF,
6242,GO:0017154,1,0.923508302820486,0,11,semaphorin receptor activity,MF,
6243,GO:0017156,1,0.48615894457118,0,110,calcium ion regulated exocytosis,BP,
6245,GO:0017158,1,0.62104070879764,0,73,regulation of calcium ion-dependent exocytosis,BP,
6246,GO:0017159,1,0.981870412347572,0,3,pantetheine hydrolase activity,MF,
6247,GO:0017160,1,0.899944298970345,0,16,Ral GTPase binding,MF,
6248,GO:0017161,1,0.986232922701696,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
6249,GO:0017162,1,0.942528615365343,0,9,aryl hydrocarbon receptor binding,MF,
6250,GO:0017166,1,0.932008477433588,0,10,vinculin binding,MF,
6251,GO:0017168,1,0.993486524943835,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
6252,GO:0017169,1,0.958670592757632,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
6254,GO:0017172,1,0.994181325345393,0,1,cysteine dioxygenase activity,MF,
6255,GO:0017174,1,0.994338421038792,0,1,glycine N-methyltransferase activity,MF,
6256,GO:0017176,1,0.959621353250907,0,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
6257,GO:0017177,1,0.993522828433545,0,1,glucosidase II complex,CC,
6258,GO:0017178,1,0.993846081630578,0,1,diphthine-ammonia ligase activity,MF,
6259,GO:0017182,1,0.951894490938893,0,8,peptidyl-diphthamide metabolic process,BP,
6260,GO:0017183,1,0.951894490938893,0,8,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
6261,GO:0017185,1,0.951133585480482,0,8,peptidyl-lysine hydroxylation,BP,
6262,GO:0017186,1,0.988211446190987,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
6263,GO:0017187,1,0.953581303860631,0,8,peptidyl-glutamic acid carboxylation,BP,
6264,GO:0017188,1,0.992958519151001,0,1,aspartate N-acetyltransferase activity,MF,
6265,GO:0017196,1,0.962275324956417,0,6,N-terminal peptidyl-methionine acetylation,BP,
6266,GO:0017198,1,0.988633615391754,0,2,N-terminal peptidyl-serine acetylation,BP,
6267,GO:0018002,1,0.988633615391754,0,2,N-terminal peptidyl-glutamic acid acetylation,BP,
6268,GO:0018008,1,0.986492078345893,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6269,GO:0018009,1,0.994030035092705,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
6270,GO:0018011,1,0.993846081630578,0,1,N-terminal peptidyl-alanine methylation,BP,
6271,GO:0018012,1,0.993846081630578,0,1,N-terminal peptidyl-alanine trimethylation,BP,
6272,GO:0018013,1,0.993846081630578,0,1,N-terminal peptidyl-glycine methylation,BP,
6273,GO:0018016,1,0.993846081630578,0,1,N-terminal peptidyl-proline dimethylation,BP,
6274,GO:0018022,1,0.501957238134527,0,104,peptidyl-lysine methylation,BP,
6275,GO:0018023,1,0.794905807498453,0,35,peptidyl-lysine trimethylation,BP,
6276,GO:0018024,1,0.76183174514577,0,41,histone-lysine N-methyltransferase activity,MF,
6277,GO:0018025,1,0.993846081630578,0,1,calmodulin-lysine N-methyltransferase activity,MF,
6278,GO:0018026,1,0.9493792291207,0,8,peptidyl-lysine monomethylation,BP,
6279,GO:0018027,1,0.906713069116756,0,15,peptidyl-lysine dimethylation,BP,
6280,GO:0018032,1,0.993573236050278,0,1,protein amidation,BP,
6281,GO:0018057,1,0.974965300239248,0,4,peptidyl-lysine oxidation,BP,
6282,GO:0018063,1,0.993986195034811,0,1,cytochrome c-heme linkage,BP,
6283,GO:0018065,1,0.933211964831011,0,12,protein-cofactor linkage,BP,
6284,GO:0018076,1,0.970654388356743,0,4,N-terminal peptidyl-lysine acetylation,BP,
6285,GO:0018094,1,0.987715993976727,0,2,protein polyglycylation,BP,
6286,GO:0018095,1,0.944783100426354,0,9,protein polyglutamylation,BP,
6288,GO:0018103,1,0.967425082156821,0,5,protein C-linked glycosylation,BP,
6290,GO:0018106,1,0.994436030837879,0,1,peptidyl-histidine phosphorylation,BP,
6293,GO:0018114,1,0.993930880583482,0,1,threonine racemase activity,MF,
6294,GO:0018117,1,0.994170640521777,0,1,protein adenylylation,BP,
6295,GO:0018119,1,0.918442608960887,0,13,peptidyl-cysteine S-nitrosylation,BP,
6296,GO:0018125,1,0.982077714538145,0,3,peptidyl-cysteine methylation,BP,
6299,GO:0018146,1,0.847051321444077,0,26,keratan sulfate biosynthetic process,BP,
6301,GO:0018153,1,0.987877002322719,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
6302,GO:0018158,1,0.929573143112637,0,12,protein oxidation,BP,
6303,GO:0018160,1,0.994222620638038,0,1,peptidyl-pyrromethane cofactor linkage,BP,
6304,GO:0018166,1,0.993162531681221,0,1,C-terminal protein-tyrosinylation,BP,
6305,GO:0018171,1,0.976272451633224,0,4,peptidyl-cysteine oxidation,BP,
6306,GO:0018175,1,0.994170640521777,0,1,protein nucleotidylation,BP,
6307,GO:0018192,1,0.993938366199964,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
6309,GO:0018194,1,0.993846081630578,0,1,peptidyl-alanine modification,BP,
6311,GO:0018196,1,0.76492979509026,0,43,peptidyl-asparagine modification,BP,
6312,GO:0018197,1,0.979886347430565,0,3,peptidyl-aspartic acid modification,BP,
6313,GO:0018198,1,0.753027279663164,0,45,peptidyl-cysteine modification,BP,
6314,GO:0018199,1,0.976229919623826,0,4,peptidyl-glutamine modification,BP,
6316,GO:0018201,1,0.980420446770725,0,3,peptidyl-glycine modification,BP,
6317,GO:0018202,1,0.939640005723358,0,10,peptidyl-histidine modification,BP,
6319,GO:0018206,1,0.933764938447808,0,11,peptidyl-methionine modification,BP,
6320,GO:0018208,1,0.757884453029318,0,45,peptidyl-proline modification,BP,
6323,GO:0018211,1,0.967425082156821,0,5,peptidyl-tryptophan modification,BP,
6325,GO:0018214,1,0.953581303860631,0,8,protein carboxylation,BP,
6326,GO:0018216,1,0.912306835320199,0,15,peptidyl-arginine methylation,BP,
6327,GO:0018217,1,0.993494531880438,0,1,peptidyl-aspartic acid phosphorylation,BP,
6330,GO:0018242,1,0.880688430472327,0,20,protein O-linked glycosylation via serine,BP,
6331,GO:0018243,1,0.886148425561813,0,19,protein O-linked glycosylation via threonine,BP,
6332,GO:0018262,1,0.987877002322719,0,2,isopeptide cross-linking,BP,
6333,GO:0018271,1,0.992915769695244,0,1,biotin-protein ligase activity,MF,
6334,GO:0018272,1,0.994143062039743,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
6335,GO:0018277,1,0.993964578366847,0,1,protein deamination,BP,
6336,GO:0018279,1,0.77060398616294,0,42,protein N-linked glycosylation via asparagine,BP,
6337,GO:0018282,1,0.986586992373551,0,2,metal incorporation into metallo-sulfur cluster,BP,
6338,GO:0018283,1,0.986586992373551,0,2,iron incorporation into metallo-sulfur cluster,BP,
6339,GO:0018293,1,0.994298569335304,0,1,protein-FAD linkage,BP,
6340,GO:0018298,1,0.95260756066949,0,8,protein-chromophore linkage,BP,
6341,GO:0018307,1,0.988349509145167,0,2,enzyme active site formation,BP,
6342,GO:0018312,1,0.98763800273613,0,2,peptidyl-serine ADP-ribosylation,BP,
6343,GO:0018315,1,0.993419246286832,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
6344,GO:0018317,1,0.967425082156821,0,5,protein C-linked glycosylation via tryptophan,BP,
6345,GO:0018322,1,0.993162531681221,0,1,protein tyrosinylation,BP,
6346,GO:0018323,1,0.994377406787888,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
6347,GO:0018335,1,0.974830413617183,0,4,protein succinylation,BP,
6348,GO:0018342,1,0.943334490151673,0,9,protein prenylation,BP,
6349,GO:0018343,1,0.98805117248067,0,2,protein farnesylation,BP,
6350,GO:0018344,1,0.957095933658458,0,7,protein geranylgeranylation,BP,
6352,GO:0018350,1,0.993956799190961,0,1,protein esterification,BP,
6353,GO:0018352,1,0.988140625495804,0,2,protein-pyridoxal-5-phosphate linkage,BP,
6354,GO:0018364,1,0.988820850611195,0,2,peptidyl-glutamine methylation,BP,
6355,GO:0018377,1,0.97293433042808,0,4,protein myristoylation,BP,
6356,GO:0018393,1,0.403861371483357,0,140,internal peptidyl-lysine acetylation,BP,
6357,GO:0018394,1,0.386350360104541,0,147,peptidyl-lysine acetylation,BP,
6358,GO:0018395,1,0.993603636886392,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6359,GO:0018400,1,0.992731949049883,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
6360,GO:0018401,1,0.968621601801301,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
6361,GO:0018406,1,0.967425082156821,0,5,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
6363,GO:0018423,1,0.988115494092223,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
6364,GO:0018444,1,0.980127681363691,0,3,translation release factor complex,CC,
6365,GO:0018455,1,0.994277488472205,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
6366,GO:0018467,1,0.993883417918289,0,1,formaldehyde dehydrogenase activity,MF,
6367,GO:0018478,1,0.994015898537603,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
6368,GO:0018479,1,0.988206409739126,0,2,benzaldehyde dehydrogenase (NAD+) activity,MF,
6369,GO:0018549,1,0.994152736183038,0,1,methanethiol oxidase activity,MF,
6370,GO:0018585,1,0.994022389395235,0,1,fluorene oxygenase activity,MF,
6371,GO:0018636,1,0.982853866524095,0,3,phenanthrene 9,10-monooxygenase activity,MF,
6372,GO:0018685,1,0.994146383016471,0,1,alkane 1-monooxygenase activity,MF,
6373,GO:0018733,1,0.994302323468291,0,1,3,4-dihydrocoumarin hydrolase activity,MF,
6374,GO:0018738,1,0.99430145712971,0,1,S-formylglutathione hydrolase activity,MF,
6375,GO:0018773,1,0.994161688359258,0,1,acetylpyruvate hydrolase activity,MF,
6376,GO:0018812,1,0.975608343238402,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
6377,GO:0018872,1,0.993933759468776,0,1,arsonoacetate metabolic process,BP,
6378,GO:0018874,1,0.994052255889866,0,1,benzoate metabolic process,BP,
6379,GO:0018879,1,0.987934714245259,0,2,biphenyl metabolic process,BP,
6380,GO:0018885,1,0.994164287375524,0,1,carbon tetrachloride metabolic process,BP,
6381,GO:0018894,1,0.987806871352148,0,2,dibenzo-p-dioxin metabolic process,BP,
6382,GO:0018904,1,0.907145835056856,0,16,ether metabolic process,BP,
6383,GO:0018910,1,0.994164287375524,0,1,benzene metabolic process,BP,
6384,GO:0018916,1,0.976506263964714,0,4,nitrobenzene metabolic process,BP,
6385,GO:0018917,1,0.994022389395235,0,1,fluorene metabolic process,BP,
6386,GO:0018931,1,0.994241679979329,0,1,naphthalene metabolic process,BP,
6388,GO:0018963,1,0.988008301731293,0,2,phthalate metabolic process,BP,
6389,GO:0018964,1,0.993416380363284,0,1,propylene metabolic process,BP,
6390,GO:0018969,1,0.993811096950118,0,1,thiocyanate metabolic process,BP,
6391,GO:0018992,1,0.986647160925582,0,2,germ-line sex determination,BP,
6392,GO:0018993,1,0.987614433557442,0,2,somatic sex determination,BP,
6395,GO:0019002,1,0.987322033197545,0,2,GMP binding,MF,
6396,GO:0019003,1,0.698235851948256,0,58,GDP binding,MF,
6398,GO:0019008,1,0.987722032527295,0,2,molybdopterin synthase complex,CC,
6399,GO:0019034,1,0.986667099428371,0,2,viral replication complex,CC,
6401,GO:0019042,1,0.932603864088248,0,11,viral latency,BP,
6402,GO:0019043,1,0.946758892859294,0,9,establishment of viral latency,BP,
6403,GO:0019045,1,0.98505724079859,0,2,latent virus replication,BP,
6404,GO:0019046,1,0.98505724079859,0,2,release from viral latency,BP,
6405,GO:0019048,1,0.810136610780384,0,32,modulation by virus of host morphology or physiology,BP,
6406,GO:0019049,1,0.974221269171982,0,4,evasion or tolerance of host defenses by virus,BP,
6407,GO:0019050,1,0.982222607219231,0,3,suppression by virus of host apoptotic process,BP,
6408,GO:0019054,1,0.873974977372668,0,21,modulation by virus of host process,BP,
6409,GO:0019056,1,0.993817688310509,0,1,modulation by virus of host transcription,BP,
6411,GO:0019060,1,0.988589664605642,0,2,intracellular transport of viral protein in host cell,BP,
6412,GO:0019061,1,0.993989943020525,0,1,uncoating of virus,BP,
6413,GO:0019062,1,0.956591951235956,0,7,virion attachment to host cell,BP,
6414,GO:0019064,1,0.963981574373282,0,6,fusion of virus membrane with host plasma membrane,BP,
6415,GO:0019065,1,0.980986286182899,0,3,receptor-mediated endocytosis of virus by host cell,BP,
6416,GO:0019068,1,0.796757898566875,0,37,virion assembly,BP,
6417,GO:0019072,1,0.986388509631132,0,2,viral genome packaging,BP,
6418,GO:0019074,1,0.986388509631132,0,2,viral RNA genome packaging,BP,
6419,GO:0019075,1,0.987729649828399,0,2,virus maturation,BP,
6420,GO:0019076,1,0.811327720342484,0,33,viral release from host cell,BP,
6422,GO:0019080,1,0.326082429558267,0,184,viral gene expression,BP,
6423,GO:0019081,1,0.914637647149409,0,14,viral translation,BP,
6424,GO:0019082,1,0.993441305898967,0,1,viral protein processing,BP,
6425,GO:0019083,1,0.356806734481624,0,170,viral transcription,BP,
6426,GO:0019085,1,0.987074059109332,0,2,early viral transcription,BP,
6427,GO:0019086,1,0.975568957286261,0,4,late viral transcription,BP,
6428,GO:0019087,1,0.980360540485777,0,3,transformation of host cell by virus,BP,
6429,GO:0019088,1,0.99418912236975,0,1,immortalization of host cell by virus,BP,
6430,GO:0019089,1,0.992805094668721,0,1,transmission of virus,BP,
6432,GO:0019100,1,0.986647160925582,0,2,male germ-line sex determination,BP,
6433,GO:0019101,1,0.993806799211177,0,1,female somatic sex determination,BP,
6434,GO:0019102,1,0.993769438593287,0,1,male somatic sex determination,BP,
6435,GO:0019103,1,0.964311454832776,0,6,pyrimidine nucleotide binding,MF,
6436,GO:0019104,1,0.915461977321518,0,15,DNA N-glycosylase activity,MF,
6437,GO:0019107,1,0.986492078345893,0,2,myristoyltransferase activity,MF,
6438,GO:0019115,1,0.994074771569389,0,1,benzaldehyde dehydrogenase activity,MF,
6439,GO:0019118,1,0.994252942319835,0,1,phenanthrene-epoxide hydrolase activity,MF,
6440,GO:0019119,1,0.994252942319835,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6441,GO:0019135,1,0.994102056303801,0,1,deoxyhypusine monooxygenase activity,MF,
6442,GO:0019136,1,0.975848454509824,0,4,deoxynucleoside kinase activity,MF,
6443,GO:0019144,1,0.988534412433592,0,2,ADP-sugar diphosphatase activity,MF,
6444,GO:0019145,1,0.993923396668192,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6445,GO:0019150,1,0.994052111577287,0,1,D-ribulokinase activity,MF,
6446,GO:0019153,1,0.994185368247776,0,1,protein-disulfide reductase (glutathione) activity,MF,
6447,GO:0019158,1,0.967811459914676,0,5,mannokinase activity,MF,
6448,GO:0019166,1,0.982358297029498,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
6449,GO:0019171,1,0.99219824858548,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6450,GO:0019184,1,0.906871375070182,0,16,nonribosomal peptide biosynthetic process,BP,
6451,GO:0019185,1,0.987224398114972,0,2,snRNA-activating protein complex,CC,
6452,GO:0019187,1,0.993513112654976,0,1,beta-1,4-mannosyltransferase activity,MF,
6453,GO:0019198,1,0.893836699442799,0,16,transmembrane receptor protein phosphatase activity,MF,
6455,GO:0019200,1,0.870729144972792,0,22,carbohydrate kinase activity,MF,
6457,GO:0019202,1,0.987531518019218,0,2,amino acid kinase activity,MF,
6458,GO:0019203,1,0.951254637781236,0,8,carbohydrate phosphatase activity,MF,
6465,GO:0019211,1,0.938691841625574,0,10,phosphatase activator activity,MF,
6467,GO:0019213,1,0.700751346992155,0,55,deacetylase activity,MF,
6468,GO:0019215,1,0.918835885787776,0,13,intermediate filament binding,MF,
6470,GO:0019217,1,0.622158411187127,0,73,regulation of fatty acid metabolic process,BP,
6476,GO:0019226,1,0.637787283226881,0,67,transmission of nerve impulse,BP,
6477,GO:0019227,1,0.961202657736114,0,6,neuronal action potential propagation,BP,
6478,GO:0019228,1,0.791148064716485,0,34,neuronal action potential,BP,
6480,GO:0019230,1,0.97342981796389,0,4,proprioception,BP,
6482,GO:0019236,1,0.976707075620969,0,4,response to pheromone,BP,
6483,GO:0019237,1,0.962024589951464,0,6,centromeric DNA binding,MF,
6484,GO:0019238,1,0.963891172567254,0,6,cyclohydrolase activity,MF,
6486,GO:0019240,1,0.965964484406949,0,5,citrulline biosynthetic process,BP,
6487,GO:0019242,1,0.994043886205896,0,1,methylglyoxal biosynthetic process,BP,
6488,GO:0019243,1,0.988015219804929,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6489,GO:0019244,1,0.99428326404548,0,1,lactate biosynthetic process from pyruvate,BP,
6490,GO:0019249,1,0.981589548395504,0,3,lactate biosynthetic process,BP,
6491,GO:0019254,1,0.981762350486407,0,3,carnitine metabolic process, CoA-linked,BP,
6492,GO:0019255,1,0.988132073749267,0,2,glucose 1-phosphate metabolic process,BP,
6493,GO:0019262,1,0.965309337078832,0,6,N-acetylneuraminate catabolic process,BP,
6494,GO:0019264,1,0.987972684251583,0,2,glycine biosynthetic process from serine,BP,
6495,GO:0019265,1,0.994183924354294,0,1,glycine biosynthetic process, by transamination of glyoxylate,BP,
6496,GO:0019276,1,0.987367661368307,0,2,UDP-N-acetylgalactosamine metabolic process,BP,
6497,GO:0019285,1,0.987258265738285,0,2,glycine betaine biosynthetic process from choline,BP,
6498,GO:0019287,1,0.982548559337057,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6499,GO:0019290,1,0.993803361559966,0,1,siderophore biosynthetic process,BP,
6500,GO:0019303,1,0.988630750681736,0,2,D-ribose catabolic process,BP,
6501,GO:0019317,1,0.947617573234456,0,8,fucose catabolic process,BP,
6502,GO:0019318,1,0.260141298808608,0,210,hexose metabolic process,BP,
6503,GO:0019319,1,0.647695208807354,0,70,hexose biosynthetic process,BP,
6504,GO:0019320,1,0.745052682924011,0,47,hexose catabolic process,BP,
6505,GO:0019321,1,0.92022951036403,0,14,pentose metabolic process,BP,
6506,GO:0019322,1,0.97658760272407,0,4,pentose biosynthetic process,BP,
6507,GO:0019323,1,0.970840630275041,0,5,pentose catabolic process,BP,
6508,GO:0019336,1,0.945842323887404,0,9,phenol-containing compound catabolic process,BP,
6509,GO:0019341,1,0.993893766769423,0,1,dibenzo-p-dioxin catabolic process,BP,
6510,GO:0019343,1,0.988074230793688,0,2,cysteine biosynthetic process via cystathionine,BP,
6511,GO:0019344,1,0.982109346194734,0,3,cysteine biosynthetic process,BP,
6512,GO:0019346,1,0.976120858834261,0,4,transsulfuration,BP,
6513,GO:0019348,1,0.970076240969274,0,5,dolichol metabolic process,BP,
6514,GO:0019353,1,0.993865029965055,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
6515,GO:0019355,1,0.980841132222427,0,3,nicotinamide nucleotide biosynthetic process from aspartate,BP,
6516,GO:0019357,1,0.993846081630578,0,1,nicotinate nucleotide biosynthetic process,BP,
6517,GO:0019358,1,0.993846081630578,0,1,nicotinate nucleotide salvage,BP,
6518,GO:0019359,1,0.465136133458694,0,119,nicotinamide nucleotide biosynthetic process,BP,
6519,GO:0019362,1,0.367365211966496,0,157,pyridine nucleotide metabolic process,BP,
6520,GO:0019363,1,0.465136133458694,0,119,pyridine nucleotide biosynthetic process,BP,
6521,GO:0019364,1,0.982449198422608,0,3,pyridine nucleotide catabolic process,BP,
6522,GO:0019365,1,0.993846081630578,0,1,pyridine nucleotide salvage,BP,
6523,GO:0019367,1,0.963060796982218,0,6,fatty acid elongation, saturated fatty acid,BP,
6524,GO:0019368,1,0.963060796982218,0,6,fatty acid elongation, unsaturated fatty acid,BP,
6526,GO:0019370,1,0.936630415902763,0,11,leukotriene biosynthetic process,BP,
6528,GO:0019372,1,0.908652408745103,0,16,lipoxygenase pathway,BP,
6529,GO:0019373,1,0.935695717804863,0,11,epoxygenase P450 pathway,BP,
6530,GO:0019374,1,0.951776882788481,0,8,galactolipid metabolic process,BP,
6531,GO:0019375,1,0.970032415617911,0,5,galactolipid biosynthetic process,BP,
6532,GO:0019376,1,0.9938073721994,0,1,galactolipid catabolic process,BP,
6533,GO:0019377,1,0.923599550122133,0,13,glycolipid catabolic process,BP,
6534,GO:0019388,1,0.94542232412437,0,9,galactose catabolic process,BP,
6535,GO:0019389,1,0.993884280171658,0,1,glucuronoside metabolic process,BP,
6536,GO:0019391,1,0.993884280171658,0,1,glucuronoside catabolic process,BP,
6537,GO:0019395,1,0.549794369524908,0,95,fatty acid oxidation,BP,
6538,GO:0019400,1,0.910522379848939,0,15,alditol metabolic process,BP,
6539,GO:0019401,1,0.9641692413341,0,6,alditol biosynthetic process,BP,
6540,GO:0019402,1,0.994253231097859,0,1,galactitol metabolic process,BP,
6541,GO:0019405,1,0.966770753719636,0,5,alditol catabolic process,BP,
6542,GO:0019406,1,0.994241679979329,0,1,hexitol biosynthetic process,BP,
6543,GO:0019407,1,0.993916777748947,0,1,hexitol catabolic process,BP,
6544,GO:0019408,1,0.9871849563263,0,2,dolichol biosynthetic process,BP,
6545,GO:0019413,1,0.987182911052961,0,2,acetate biosynthetic process,BP,
6546,GO:0019417,1,0.987187461524035,0,2,sulfur oxidation,BP,
6547,GO:0019418,1,0.977117809031929,0,4,sulfide oxidation,BP,
6548,GO:0019427,1,0.987182911052961,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6549,GO:0019430,1,0.874955201274841,0,22,removal of superoxide radicals,BP,
6550,GO:0019432,1,0.836953988180895,0,28,triglyceride biosynthetic process,BP,
6551,GO:0019433,1,0.851058279370374,0,26,triglyceride catabolic process,BP,
6554,GO:0019441,1,0.964461688830162,0,6,tryptophan catabolic process to kynurenine,BP,
6555,GO:0019442,1,0.9884069298022,0,2,tryptophan catabolic process to acetyl-CoA,BP,
6556,GO:0019448,1,0.982364627580649,0,3,L-cysteine catabolic process,BP,
6557,GO:0019464,1,0.981914865995692,0,3,glycine decarboxylation via glycine cleavage system,BP,
6558,GO:0019470,1,0.975722830869706,0,4,4-hydroxyproline catabolic process,BP,
6559,GO:0019471,1,0.939784695514771,0,10,4-hydroxyproline metabolic process,BP,
6560,GO:0019474,1,0.974966529228788,0,4,L-lysine catabolic process to acetyl-CoA,BP,
6561,GO:0019477,1,0.974966529228788,0,4,L-lysine catabolic process,BP,
6562,GO:0019478,1,0.988397312447333,0,2,D-amino acid catabolic process,BP,
6563,GO:0019482,1,0.975668862352755,0,4,beta-alanine metabolic process,BP,
6564,GO:0019483,1,0.987831194315074,0,2,beta-alanine biosynthetic process,BP,
6565,GO:0019493,1,0.994074338526026,0,1,arginine catabolic process to proline,BP,
6566,GO:0019509,1,0.969860072790003,0,5,L-methionine salvage from methylthioadenosine,BP,
6567,GO:0019510,1,0.993985041870798,0,1,S-adenosylhomocysteine catabolic process,BP,
6568,GO:0019511,1,0.921377132351472,0,13,peptidyl-proline hydroxylation,BP,
6569,GO:0019516,1,0.988216730854825,0,2,lactate oxidation,BP,
6570,GO:0019518,1,0.994189411148297,0,1,L-threonine catabolic process to glycine,BP,
6571,GO:0019519,1,0.993916777748947,0,1,pentitol metabolic process,BP,
6572,GO:0019520,1,0.987967563795862,0,2,aldonic acid metabolic process,BP,
6573,GO:0019521,1,0.987967563795862,0,2,D-gluconate metabolic process,BP,
6574,GO:0019527,1,0.993916777748947,0,1,pentitol catabolic process,BP,
6575,GO:0019530,1,0.962283571125112,0,6,taurine metabolic process,BP,
6576,GO:0019531,1,0.942859326701371,0,9,oxalate transmembrane transporter activity,MF,
6577,GO:0019532,1,0.937372301096663,0,10,oxalate transport,BP,
6578,GO:0019534,1,0.966737162816043,0,5,toxin transmembrane transporter activity,MF,
6580,GO:0019541,1,0.975322130101139,0,4,propionate metabolic process,BP,
6581,GO:0019542,1,0.987182911052961,0,2,propionate biosynthetic process,BP,
6582,GO:0019543,1,0.987986796739416,0,2,propionate catabolic process,BP,
6583,GO:0019544,1,0.994074338526026,0,1,arginine catabolic process to glutamate,BP,
6584,GO:0019546,1,0.993989654703031,0,1,arginine deiminase pathway,BP,
6585,GO:0019547,1,0.98833673163923,0,2,arginine catabolic process to ornithine,BP,
6586,GO:0019550,1,0.988006515182358,0,2,glutamate catabolic process to aspartate,BP,
6587,GO:0019551,1,0.988006515182358,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6588,GO:0019556,1,0.975761716964562,0,4,histidine catabolic process to glutamate and formamide,BP,
6589,GO:0019557,1,0.975761716964562,0,4,histidine catabolic process to glutamate and formate,BP,
6590,GO:0019563,1,0.972689507021009,0,4,glycerol catabolic process,BP,
6591,GO:0019566,1,0.987729649828399,0,2,arabinose metabolic process,BP,
6592,GO:0019585,1,0.952342270226255,0,8,glucuronate metabolic process,BP,
6593,GO:0019605,1,0.988179132599072,0,2,butyrate metabolic process,BP,
6594,GO:0019614,1,0.951515271538319,0,8,catechol-containing compound catabolic process,BP,
6595,GO:0019626,1,0.952239186016697,0,8,short-chain fatty acid catabolic process,BP,
6596,GO:0019627,1,0.92304600938283,0,13,urea metabolic process,BP,
6598,GO:0019640,1,0.970686647241458,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6599,GO:0019646,1,0.911412883239582,0,16,aerobic electron transport chain,BP,
6600,GO:0019673,1,0.960039827525513,0,7,GDP-mannose metabolic process,BP,
6601,GO:0019674,1,0.672730507898096,0,64,NAD metabolic process,BP,
6602,GO:0019676,1,0.98745679863795,0,2,ammonia assimilation cycle,BP,
6603,GO:0019677,1,0.988008761762562,0,2,NAD catabolic process,BP,
6604,GO:0019682,1,0.880520162987096,0,21,glyceraldehyde-3-phosphate metabolic process,BP,
6607,GO:0019694,1,0.962283571125112,0,6,alkanesulfonate metabolic process,BP,
6608,GO:0019695,1,0.944649011416677,0,9,choline metabolic process,BP,
6609,GO:0019706,1,0.843694893832896,0,27,protein-cysteine S-palmitoyltransferase activity,MF,
6610,GO:0019707,1,0.843694893832896,0,27,protein-cysteine S-acyltransferase activity,MF,
6611,GO:0019720,1,0.963423613916695,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6613,GO:0019724,1,0.566801824050778,0,91,B cell mediated immunity,BP,
6615,GO:0019730,1,0.693300457860426,0,63,antimicrobial humoral response,BP,
6616,GO:0019731,1,0.860046960893955,0,26,antibacterial humoral response,BP,
6617,GO:0019732,1,0.976888744511089,0,4,antifungal humoral response,BP,
6618,GO:0019740,1,0.968848707737097,0,5,nitrogen utilization,BP,
6619,GO:0019742,1,0.99395204603589,0,1,pentacyclic triterpenoid metabolic process,BP,
6620,GO:0019747,1,0.988712588699833,0,2,regulation of isoprenoid metabolic process,BP,
6621,GO:0019748,1,0.7061432715802,0,56,secondary metabolic process,BP,
6622,GO:0019751,1,0.523365700145778,0,101,polyol metabolic process,BP,
6624,GO:0019755,1,0.946767291973876,0,9,one-carbon compound transport,BP,
6625,GO:0019763,1,0.970917065877218,0,5,immunoglobulin receptor activity,MF,
6626,GO:0019767,1,0.994476173363802,0,1,IgE receptor activity,MF,
6627,GO:0019770,1,0.988354819138182,0,2,IgG receptor activity,MF,
6628,GO:0019772,1,0.994183202407459,0,1,low-affinity IgG receptor activity,MF,
6629,GO:0019773,1,0.960949112921,0,7,proteasome core complex, alpha-subunit complex,CC,
6630,GO:0019774,1,0.950301299993192,0,9,proteasome core complex, beta-subunit complex,CC,
6631,GO:0019776,1,0.981480878637359,0,3,Atg8 ligase activity,MF,
6632,GO:0019777,1,0.988286871862859,0,2,Atg12 transferase activity,MF,
6633,GO:0019778,1,0.993215826877262,0,1,Atg12 activating enzyme activity,MF,
6634,GO:0019779,1,0.993215826877262,0,1,Atg8 activating enzyme activity,MF,
6635,GO:0019780,1,0.992783414207864,0,1,FAT10 activating enzyme activity,MF,
6636,GO:0019781,1,0.988191626634631,0,2,NEDD8 activating enzyme activity,MF,
6637,GO:0019782,1,0.993686988544381,0,1,ISG15 activating enzyme activity,MF,
6638,GO:0019783,1,0.52042063499841,0,98,ubiquitin-like protein-specific protease activity,MF,
6639,GO:0019784,1,0.959122342434677,0,7,NEDD8-specific protease activity,MF,
6640,GO:0019785,1,0.987570636113297,0,2,ISG15-specific protease activity,MF,
6642,GO:0019788,1,0.96424721100002,0,6,NEDD8 transferase activity,MF,
6643,GO:0019789,1,0.902811213768768,0,16,SUMO transferase activity,MF,
6644,GO:0019797,1,0.981650478584491,0,3,procollagen-proline 3-dioxygenase activity,MF,
6645,GO:0019798,1,0.958018711512459,0,7,procollagen-proline dioxygenase activity,MF,
6646,GO:0019799,1,0.993846081630578,0,1,tubulin N-acetyltransferase activity,MF,
6648,GO:0019805,1,0.981804445691555,0,3,quinolinate biosynthetic process,BP,
6650,GO:0019808,1,0.970019026716629,0,5,polyamine binding,MF,
6651,GO:0019809,1,0.982816324863439,0,3,spermidine binding,MF,
6652,GO:0019810,1,0.993705980361278,0,1,putrescine binding,MF,
6653,GO:0019811,1,0.99334092589851,0,1,cocaine binding,MF,
6654,GO:0019814,1,0.970385748467483,0,5,immunoglobulin complex,CC,
6655,GO:0019815,1,0.981890583576116,0,3,B cell receptor complex,CC,
6656,GO:0019825,1,0.820369145859745,0,33,oxygen binding,MF,
6657,GO:0019826,1,0.980207033183986,0,3,oxygen sensor activity,MF,
6658,GO:0019827,1,0.377454480350268,0,148,stem cell population maintenance,BP,
6659,GO:0019828,1,0.981881894979359,0,3,aspartic-type endopeptidase inhibitor activity,MF,
6660,GO:0019829,1,0.714143043432297,0,52,cation-transporting ATPase activity,MF,
6661,GO:0019834,1,0.982692424445364,0,3,phospholipase A2 inhibitor activity,MF,
6662,GO:0019835,1,0.835854099784643,0,30,cytolysis,BP,
6663,GO:0019836,1,0.987900628381654,0,2,hemolysis by symbiont of host erythrocytes,BP,
6664,GO:0019838,1,0.430741203992353,0,128,growth factor binding,MF,
6666,GO:0019841,1,0.936843316951592,0,11,retinol binding,MF,
6668,GO:0019843,1,0.720553893852525,0,55,rRNA binding,MF,
6669,GO:0019852,1,0.940118435996186,0,10,L-ascorbic acid metabolic process,BP,
6670,GO:0019853,1,0.988345055973308,0,2,L-ascorbic acid biosynthetic process,BP,
6671,GO:0019855,1,0.946022270533495,0,9,calcium channel inhibitor activity,MF,
6672,GO:0019856,1,0.960119861925208,0,6,pyrimidine nucleobase biosynthetic process,BP,
6673,GO:0019857,1,0.975478339590862,0,3,5-methylcytosine metabolic process,BP,
6674,GO:0019858,1,0.98798591513664,0,2,cytosine metabolic process,BP,
6675,GO:0019859,1,0.981903210339295,0,3,thymine metabolic process,BP,
6676,GO:0019860,1,0.982074344679521,0,3,uracil metabolic process,BP,
6677,GO:0019862,1,0.994194031603953,0,1,IgA binding,MF,
6678,GO:0019863,1,0.977398238784211,0,4,IgE binding,MF,
6679,GO:0019864,1,0.948544379611514,0,9,IgG binding,MF,
6680,GO:0019865,1,0.908386997288112,0,16,immunoglobulin binding,MF,
6683,GO:0019869,1,0.942444879415247,0,9,chloride channel inhibitor activity,MF,
6684,GO:0019870,1,0.960023702169711,0,6,potassium channel inhibitor activity,MF,
6685,GO:0019871,1,0.961108365832526,0,6,sodium channel inhibitor activity,MF,
6686,GO:0019878,1,0.986816973595944,0,2,lysine biosynthetic process via aminoadipic acid,BP,
6687,GO:0019882,1,0.277096325404193,0,207,antigen processing and presentation,BP,
6688,GO:0019883,1,0.933333308975039,0,11,antigen processing and presentation of endogenous antigen,BP,
6689,GO:0019884,1,0.353721850686258,0,168,antigen processing and presentation of exogenous antigen,BP,
6690,GO:0019885,1,0.956375761293555,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6691,GO:0019886,1,0.555893095980293,0,93,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,
6694,GO:0019894,1,0.782890983685534,0,37,kinesin binding,MF,
6695,GO:0019896,1,0.93043530663086,0,11,axonal transport of mitochondrion,BP,
6701,GO:0019902,1,0.336785891654076,0,166,phosphatase binding,MF,
6702,GO:0019903,1,0.467352611257313,0,117,protein phosphatase binding,MF,
6704,GO:0019905,1,0.564073382007128,0,88,syntaxin binding,MF,
6705,GO:0019907,1,0.956954725096787,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6706,GO:0019908,1,0.902470120261225,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6708,GO:0019912,1,0.988020662830137,0,2,cyclin-dependent protein kinase activating kinase activity,MF,
6709,GO:0019915,1,0.683966341791572,0,59,lipid storage,BP,
6710,GO:0019918,1,0.975807807542643,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6711,GO:0019919,1,0.952589523272424,0,8,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6714,GO:0019934,1,0.93816105935286,0,10,cGMP-mediated signaling,BP,
6717,GO:0019948,1,0.987846767790183,0,2,SUMO activating enzyme activity,MF,
6720,GO:0019956,1,0.85518441708413,0,25,chemokine binding,MF,
6721,GO:0019957,1,0.940854038764863,0,10,C-C chemokine binding,MF,
6722,GO:0019958,1,0.963239972097529,0,6,C-X-C chemokine binding,MF,
6723,GO:0019959,1,0.981197569179989,0,3,interleukin-8 binding,MF,
6724,GO:0019960,1,0.966521783120859,0,5,C-X3-C chemokine binding,MF,
6725,GO:0019961,1,0.986584366521857,0,2,interferon binding,MF,
6726,GO:0019962,1,0.992892079878959,0,1,type I interferon binding,MF,
6727,GO:0019964,1,0.993647591731625,0,1,interferon-gamma binding,MF,
6728,GO:0019966,1,0.95653751552844,0,7,interleukin-1 binding,MF,
6729,GO:0019969,1,0.993575519951012,0,1,interleukin-10 binding,MF,
6730,GO:0019970,1,0.99372526461683,0,1,interleukin-11 binding,MF,
6731,GO:0019972,1,0.994231572753009,0,1,interleukin-12 binding,MF,
6732,GO:0019975,1,0.994231572753009,0,1,interleukin-17 binding,MF,
6733,GO:0019976,1,0.981517932086866,0,3,interleukin-2 binding,MF,
6734,GO:0019981,1,0.987223668718134,0,2,interleukin-6 binding,MF,
6735,GO:0019985,1,0.786715577112111,0,38,translesion synthesis,BP,
6736,GO:0019988,1,0.993853544336592,0,1,charged-tRNA amino acid modification,BP,
6737,GO:0019992,1,0.922038590832373,0,12,diacylglycerol binding,MF,
6738,GO:0020003,1,0.982312537767073,0,3,symbiont-containing vacuole,CC,
6739,GO:0020005,1,0.988395767164406,0,2,symbiont-containing vacuole membrane,CC,
6740,GO:0020012,1,0.987054758386881,0,2,evasion or tolerance of host immune response,BP,
6741,GO:0020016,1,0.980719632458502,0,3,ciliary pocket,CC,
6742,GO:0020018,1,0.980719632458502,0,3,ciliary pocket membrane,CC,
6743,GO:0020021,1,0.99418912236975,0,1,immortalization of host cell,BP,
6744,GO:0020027,1,0.918759544950062,0,14,hemoglobin metabolic process,BP,
6746,GO:0021501,1,0.994044463395542,0,1,prechordal plate formation,BP,
6747,GO:0021502,1,0.9811200412838,0,3,neural fold elevation formation,BP,
6748,GO:0021503,1,0.992210282806647,0,1,neural fold bending,BP,
6749,GO:0021508,1,0.992696088455201,0,1,floor plate formation,BP,
6750,GO:0021509,1,0.994071884646952,0,1,roof plate formation,BP,
6753,GO:0021512,1,0.99342239852996,0,1,spinal cord anterior/posterior patterning,BP,
6757,GO:0021516,1,0.888376236773446,0,19,dorsal spinal cord development,BP,
6759,GO:0021519,1,0.994276910915076,0,1,spinal cord association neuron specification,BP,
6763,GO:0021523,1,0.969332056840317,0,5,somatic motor neuron differentiation,BP,
6764,GO:0021524,1,0.982281013440309,0,3,visceral motor neuron differentiation,BP,
6765,GO:0021526,1,0.988100446921117,0,2,medial motor column neuron differentiation,BP,
6766,GO:0021527,1,0.933435907564633,0,11,spinal cord association neuron differentiation,BP,
6767,GO:0021528,1,0.993846081630578,0,1,commissural neuron differentiation in spinal cord,BP,
6768,GO:0021529,1,0.982018020005835,0,3,spinal cord oligodendrocyte cell differentiation,BP,
6769,GO:0021530,1,0.982018020005835,0,3,spinal cord oligodendrocyte cell fate specification,BP,
6770,GO:0021532,1,0.792822971129178,0,36,neural tube patterning,BP,
6771,GO:0021533,1,0.890908163951279,0,17,cell differentiation in hindbrain,BP,
6772,GO:0021534,1,0.931480416560827,0,11,cell proliferation in hindbrain,BP,
6773,GO:0021535,1,0.91578719267065,0,13,cell migration in hindbrain,BP,
6774,GO:0021536,1,0.638966019572975,0,70,diencephalon development,BP,
6776,GO:0021538,1,0.979975028009356,0,3,epithalamus development,BP,
6777,GO:0021539,1,0.988225676581988,0,2,subthalamus development,BP,
6778,GO:0021540,1,0.96765482043558,0,5,corpus callosum morphogenesis,BP,
6779,GO:0021541,1,0.993431423813083,0,1,ammon gyrus development,BP,
6780,GO:0021542,1,0.908002710015289,0,15,dentate gyrus development,BP,
6781,GO:0021543,1,0.356735338990748,0,155,pallium development,BP,
6782,GO:0021544,1,0.86064319789873,0,23,subpallium development,BP,
6784,GO:0021546,1,0.969920366716274,0,5,rhombomere development,BP,
6785,GO:0021547,1,0.994044463395542,0,1,midbrain-hindbrain boundary initiation,BP,
6786,GO:0021548,1,0.944575098979938,0,9,pons development,BP,
6788,GO:0021550,1,0.993932607884681,0,1,medulla oblongata development,BP,
6789,GO:0021551,1,0.991202075423326,0,1,central nervous system morphogenesis,BP,
6790,GO:0021553,1,0.978806848584299,0,3,olfactory nerve development,BP,
6792,GO:0021555,1,0.981728512611719,0,3,midbrain-hindbrain boundary morphogenesis,BP,
6793,GO:0021557,1,0.982185818566523,0,3,oculomotor nerve development,BP,
6794,GO:0021558,1,0.988417983523352,0,2,trochlear nerve development,BP,
6795,GO:0021559,1,0.93849606554215,0,10,trigeminal nerve development,BP,
6796,GO:0021560,1,0.987660425866534,0,2,abducens nerve development,BP,
6797,GO:0021561,1,0.943499318877639,0,9,facial nerve development,BP,
6798,GO:0021562,1,0.961707225788517,0,6,vestibulocochlear nerve development,BP,
6799,GO:0021563,1,0.966913718830358,0,5,glossopharyngeal nerve development,BP,
6800,GO:0021564,1,0.979516325067434,0,3,vagus nerve development,BP,
6801,GO:0021566,1,0.993224752587359,0,1,hypoglossal nerve development,BP,
6802,GO:0021568,1,0.994262183218973,0,1,rhombomere 2 development,BP,
6803,GO:0021569,1,0.988043059130199,0,2,rhombomere 3 development,BP,
6804,GO:0021570,1,0.994185657026448,0,1,rhombomere 4 development,BP,
6805,GO:0021571,1,0.987540913290853,0,2,rhombomere 5 development,BP,
6806,GO:0021572,1,0.993680421227072,0,1,rhombomere 6 development,BP,
6807,GO:0021575,1,0.780870946998023,0,37,hindbrain morphogenesis,BP,
6808,GO:0021577,1,0.987442990518734,0,2,hindbrain structural organization,BP,
6809,GO:0021578,1,0.96154658346538,0,6,hindbrain maturation,BP,
6810,GO:0021586,1,0.98100773223916,0,3,pons maturation,BP,
6811,GO:0021587,1,0.795558986131955,0,34,cerebellum morphogenesis,BP,
6812,GO:0021589,1,0.987442990518734,0,2,cerebellum structural organization,BP,
6813,GO:0021590,1,0.980165926303364,0,3,cerebellum maturation,BP,
6814,GO:0021591,1,0.853522944603149,0,24,ventricular system development,BP,
6815,GO:0021592,1,0.993127937862553,0,1,fourth ventricle development,BP,
6816,GO:0021593,1,0.993821844687351,0,1,rhombomere morphogenesis,BP,
6817,GO:0021594,1,0.993821844687351,0,1,rhombomere formation,BP,
6818,GO:0021598,1,0.987660425866534,0,2,abducens nerve morphogenesis,BP,
6819,GO:0021599,1,0.987660425866534,0,2,abducens nerve formation,BP,
6820,GO:0021602,1,0.851243917161756,0,25,cranial nerve morphogenesis,BP,
6821,GO:0021603,1,0.956992699390333,0,7,cranial nerve formation,BP,
6822,GO:0021604,1,0.943880413242507,0,9,cranial nerve structural organization,BP,
6823,GO:0021610,1,0.943499318877639,0,9,facial nerve morphogenesis,BP,
6824,GO:0021612,1,0.955798099062274,0,7,facial nerve structural organization,BP,
6825,GO:0021615,1,0.975195189978838,0,4,glossopharyngeal nerve morphogenesis,BP,
6826,GO:0021618,1,0.993224752587359,0,1,hypoglossal nerve morphogenesis,BP,
6827,GO:0021622,1,0.987889086156016,0,2,oculomotor nerve morphogenesis,BP,
6828,GO:0021623,1,0.987889086156016,0,2,oculomotor nerve formation,BP,
6829,GO:0021626,1,0.96154658346538,0,6,central nervous system maturation,BP,
6830,GO:0021631,1,0.959997493585292,0,6,optic nerve morphogenesis,BP,
6831,GO:0021633,1,0.987536883034208,0,2,optic nerve structural organization,BP,
6832,GO:0021634,1,0.99346392336041,0,1,optic nerve formation,BP,
6833,GO:0021636,1,0.967368763302044,0,5,trigeminal nerve morphogenesis,BP,
6834,GO:0021637,1,0.967368763302044,0,5,trigeminal nerve structural organization,BP,
6835,GO:0021639,1,0.994157067883032,0,1,trochlear nerve morphogenesis,BP,
6836,GO:0021642,1,0.994157067883032,0,1,trochlear nerve formation,BP,
6837,GO:0021644,1,0.987904623438278,0,2,vagus nerve morphogenesis,BP,
6838,GO:0021648,1,0.97487873780892,0,4,vestibulocochlear nerve morphogenesis,BP,
6839,GO:0021649,1,0.993929441234976,0,1,vestibulocochlear nerve structural organization,BP,
6840,GO:0021650,1,0.980834121410568,0,3,vestibulocochlear nerve formation,BP,
6841,GO:0021658,1,0.993821844687351,0,1,rhombomere 3 morphogenesis,BP,
6842,GO:0021660,1,0.993821844687351,0,1,rhombomere 3 formation,BP,
6843,GO:0021664,1,0.993821844687351,0,1,rhombomere 5 morphogenesis,BP,
6844,GO:0021666,1,0.993821844687351,0,1,rhombomere 5 formation,BP,
6845,GO:0021670,1,0.936306500371588,0,10,lateral ventricle development,BP,
6847,GO:0021678,1,0.982140647561956,0,3,third ventricle development,BP,
6848,GO:0021679,1,0.987496064137174,0,2,cerebellar molecular layer development,BP,
6849,GO:0021680,1,0.866308186261736,0,21,cerebellar Purkinje cell layer development,BP,
6850,GO:0021681,1,0.918946842215851,0,13,cerebellar granular layer development,BP,
6851,GO:0021682,1,0.99300703279648,0,1,nerve maturation,BP,
6852,GO:0021683,1,0.942416399883348,0,9,cerebellar granular layer morphogenesis,BP,
6853,GO:0021684,1,0.955239700136592,0,7,cerebellar granular layer formation,BP,
6854,GO:0021685,1,0.992543893219924,0,1,cerebellar granular layer structural organization,BP,
6855,GO:0021686,1,0.994172373196962,0,1,cerebellar granular layer maturation,BP,
6856,GO:0021687,1,0.987496064137174,0,2,cerebellar molecular layer morphogenesis,BP,
6857,GO:0021688,1,0.993691843042761,0,1,cerebellar molecular layer formation,BP,
6858,GO:0021691,1,0.985912284560423,0,2,cerebellar Purkinje cell layer maturation,BP,
6859,GO:0021692,1,0.924129026379601,0,11,cerebellar Purkinje cell layer morphogenesis,BP,
6860,GO:0021693,1,0.986282294111393,0,2,cerebellar Purkinje cell layer structural organization,BP,
6861,GO:0021694,1,0.94419807733678,0,8,cerebellar Purkinje cell layer formation,BP,
6862,GO:0021695,1,0.747636470743435,0,44,cerebellar cortex development,BP,
6863,GO:0021696,1,0.828151495530721,0,28,cerebellar cortex morphogenesis,BP,
6864,GO:0021697,1,0.879318989626882,0,19,cerebellar cortex formation,BP,
6865,GO:0021698,1,0.986282294111393,0,2,cerebellar cortex structural organization,BP,
6866,GO:0021699,1,0.980165926303364,0,3,cerebellar cortex maturation,BP,
6868,GO:0021702,1,0.94419807733678,0,8,cerebellar Purkinje cell differentiation,BP,
6869,GO:0021703,1,0.994157067883032,0,1,locus ceruleus development,BP,
6870,GO:0021707,1,0.955239700136592,0,7,cerebellar granule cell differentiation,BP,
6871,GO:0021718,1,0.98750995322072,0,2,superior olivary nucleus development,BP,
6872,GO:0021722,1,0.98750995322072,0,2,superior olivary nucleus maturation,BP,
6873,GO:0021730,1,0.9860768475881,0,2,trigeminal sensory nucleus development,BP,
6874,GO:0021740,1,0.9860768475881,0,2,principal sensory nucleus of trigeminal nerve development,BP,
6875,GO:0021747,1,0.980140021446365,0,3,cochlear nucleus development,BP,
6876,GO:0021750,1,0.993932607884681,0,1,vestibular nucleus development,BP,
6877,GO:0021756,1,0.893388380004411,0,17,striatum development,BP,
6878,GO:0021757,1,0.99359735741612,0,1,caudate nucleus development,BP,
6879,GO:0021758,1,0.99359735741612,0,1,putamen development,BP,
6880,GO:0021759,1,0.97495409303437,0,4,globus pallidus development,BP,
6881,GO:0021761,1,0.533469932082198,0,96,limbic system development,BP,
6883,GO:0021763,1,0.994001477158181,0,1,subthalamic nucleus development,BP,
6884,GO:0021764,1,0.971579800845874,0,4,amygdala development,BP,
6885,GO:0021766,1,0.623404124724713,0,72,hippocampus development,BP,
6886,GO:0021767,1,0.992000954286328,0,1,mammillary body development,BP,
6887,GO:0021768,1,0.993638457983371,0,1,nucleus accumbens development,BP,
6888,GO:0021769,1,0.974687788935964,0,4,orbitofrontal cortex development,BP,
6889,GO:0021771,1,0.993002124395044,0,1,lateral geniculate nucleus development,BP,
6890,GO:0021772,1,0.813337943976523,0,31,olfactory bulb development,BP,
6891,GO:0021773,1,0.979175254981533,0,3,striatal medium spiny neuron differentiation,BP,
6892,GO:0021775,1,0.978365826242795,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6893,GO:0021776,1,0.978365826242795,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6894,GO:0021778,1,0.967074843212665,0,5,oligodendrocyte cell fate specification,BP,
6895,GO:0021779,1,0.967074843212665,0,5,oligodendrocyte cell fate commitment,BP,
6896,GO:0021780,1,0.967074843212665,0,5,glial cell fate specification,BP,
6897,GO:0021781,1,0.92558510979213,0,12,glial cell fate commitment,BP,
6899,GO:0021783,1,0.913477255065831,0,14,preganglionic parasympathetic fiber development,BP,
6900,GO:0021784,1,0.988151132221063,0,2,postganglionic parasympathetic fiber development,BP,
6901,GO:0021785,1,0.951331822630945,0,7,branchiomotor neuron axon guidance,BP,
6902,GO:0021793,1,0.993665289857805,0,1,chemorepulsion of branchiomotor axon,BP,
6903,GO:0021794,1,0.91901164631642,0,13,thalamus development,BP,
6904,GO:0021795,1,0.778382784127444,0,38,cerebral cortex cell migration,BP,
6905,GO:0021796,1,0.962144635202246,0,6,cerebral cortex regionalization,BP,
6906,GO:0021797,1,0.981759009302692,0,3,forebrain anterior/posterior pattern specification,BP,
6907,GO:0021798,1,0.955587936006451,0,7,forebrain dorsal/ventral pattern formation,BP,
6908,GO:0021799,1,0.852461922495218,0,24,cerebral cortex radially oriented cell migration,BP,
6909,GO:0021800,1,0.945779213218163,0,8,cerebral cortex tangential migration,BP,
6910,GO:0021801,1,0.891904994604385,0,17,cerebral cortex radial glia guided migration,BP,
6911,GO:0021812,1,0.986897691784468,0,2,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6912,GO:0021813,1,0.993898655073879,0,1,cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,BP,
6913,GO:0021814,1,0.96603117601479,0,5,cell motility involved in cerebral cortex radial glia guided migration,BP,
6914,GO:0021815,1,0.978336623962461,0,3,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6915,GO:0021817,1,0.978336623962461,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6916,GO:0021819,1,0.929421884425279,0,11,layer formation in cerebral cortex,BP,
6917,GO:0021822,1,0.994028736699939,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
6918,GO:0021823,1,0.985769688884372,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6919,GO:0021824,1,0.986988539177487,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6920,GO:0021825,1,0.972941522209375,0,4,substrate-dependent cerebral cortex tangential migration,BP,
6922,GO:0021827,1,0.985769688884372,0,2,postnatal olfactory bulb interneuron migration,BP,
6923,GO:0021828,1,0.986988539177487,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6925,GO:0021831,1,0.993818261559461,0,1,embryonic olfactory bulb interneuron precursor migration,BP,
6926,GO:0021836,1,0.985769688884372,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6927,GO:0021840,1,0.987581413528884,0,2,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6928,GO:0021842,1,0.987581413528884,0,2,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6930,GO:0021846,1,0.838239313067863,0,26,cell proliferation in forebrain,BP,
6931,GO:0021847,1,0.980585666651877,0,3,ventricular zone neuroblast division,BP,
6932,GO:0021849,1,0.987282231604293,0,2,neuroblast division in subventricular zone,BP,
6934,GO:0021854,1,0.894993939886615,0,18,hypothalamus development,BP,
6935,GO:0021855,1,0.98106727691095,0,3,hypothalamus cell migration,BP,
6936,GO:0021856,1,0.986988539177487,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
6937,GO:0021859,1,0.946429115799237,0,8,pyramidal neuron differentiation,BP,
6938,GO:0021860,1,0.953541987455751,0,7,pyramidal neuron development,BP,
6939,GO:0021861,1,0.957412839951486,0,7,forebrain radial glial cell differentiation,BP,
6940,GO:0021869,1,0.961778081461918,0,6,forebrain ventricular zone progenitor cell division,BP,
6941,GO:0021870,1,0.992894391215572,0,1,Cajal-Retzius cell differentiation,BP,
6942,GO:0021871,1,0.874399323948392,0,21,forebrain regionalization,BP,
6944,GO:0021873,1,0.953768039066598,0,7,forebrain neuroblast division,BP,
6945,GO:0021877,1,0.937011313988872,0,10,forebrain neuron fate commitment,BP,
6947,GO:0021881,1,0.993667430938724,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
6948,GO:0021882,1,0.988007472762109,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6951,GO:0021886,1,0.981428672084498,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6952,GO:0021888,1,0.981428672084498,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
6953,GO:0021889,1,0.922650238817496,0,12,olfactory bulb interneuron differentiation,BP,
6954,GO:0021891,1,0.953660055018743,0,7,olfactory bulb interneuron development,BP,
6956,GO:0021893,1,0.988007472762109,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
6959,GO:0021896,1,0.984225101769502,0,2,forebrain astrocyte differentiation,BP,
6960,GO:0021897,1,0.984225101769502,0,2,forebrain astrocyte development,BP,
6961,GO:0021898,1,0.981750079197124,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
6962,GO:0021902,1,0.960205402725843,0,6,commitment of neuronal cell to specific neuron type in forebrain,BP,
6963,GO:0021903,1,0.93800155078439,0,10,rostrocaudal neural tube patterning,BP,
6964,GO:0021904,1,0.867833645319707,0,22,dorsal/ventral neural tube patterning,BP,
6965,GO:0021905,1,0.992661378052887,0,1,forebrain-midbrain boundary formation,BP,
6966,GO:0021910,1,0.948216492995468,0,8,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6969,GO:0021914,1,0.969246736308969,0,5,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6971,GO:0021917,1,0.992661378052887,0,1,somatic motor neuron fate commitment,BP,
6972,GO:0021918,1,0.992661378052887,0,1,regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment,BP,
6973,GO:0021919,1,0.993627041202741,0,1,BMP signaling pathway involved in spinal cord dorsal/ventral patterning,BP,
6974,GO:0021920,1,0.994276910915076,0,1,regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification,BP,
6975,GO:0021924,1,0.937133393527352,0,10,cell proliferation in external granule layer,BP,
6976,GO:0021930,1,0.937133393527352,0,10,cerebellar granule cell precursor proliferation,BP,
6977,GO:0021932,1,0.942349362641673,0,9,hindbrain radial glia guided cell migration,BP,
6978,GO:0021933,1,0.994172373196962,0,1,radial glia guided migration of cerebellar granule cell,BP,
6979,GO:0021934,1,0.984419828538411,0,2,hindbrain tangential cell migration,BP,
6980,GO:0021935,1,0.984419828538411,0,2,cerebellar granule cell precursor tangential migration,BP,
6981,GO:0021936,1,0.94425312684468,0,9,regulation of cerebellar granule cell precursor proliferation,BP,
6982,GO:0021937,1,0.968545266760871,0,5,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6983,GO:0021938,1,0.974349009914471,0,4,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6984,GO:0021940,1,0.956161107813793,0,7,positive regulation of cerebellar granule cell precursor proliferation,BP,
6985,GO:0021941,1,0.987551712117236,0,2,negative regulation of cerebellar granule cell precursor proliferation,BP,
6986,GO:0021942,1,0.973851833513861,0,4,radial glia guided migration of Purkinje cell,BP,
6987,GO:0021943,1,0.973334068876709,0,4,formation of radial glial scaffolds,BP,
6988,GO:0021952,1,0.85446577452558,0,23,central nervous system projection neuron axonogenesis,BP,
6991,GO:0021955,1,0.82766134261814,0,28,central nervous system neuron axonogenesis,BP,
6992,GO:0021956,1,0.99406986384896,0,1,central nervous system interneuron axonogenesis,BP,
6993,GO:0021957,1,0.959591652165633,0,6,corticospinal tract morphogenesis,BP,
6994,GO:0021960,1,0.966971391186515,0,5,anterior commissure morphogenesis,BP,
6995,GO:0021965,1,0.977778495033719,0,3,spinal cord ventral commissure morphogenesis,BP,
6996,GO:0021966,1,0.987530026183172,0,2,corticospinal neuron axon guidance,BP,
6997,GO:0021972,1,0.993214099152136,0,1,corticospinal neuron axon guidance through spinal cord,BP,
6998,GO:0021978,1,0.928219467224962,0,12,telencephalon regionalization,BP,
6999,GO:0021979,1,0.962773734068226,0,6,hypothalamus cell differentiation,BP,
7000,GO:0021983,1,0.772797569051821,0,41,pituitary gland development,BP,
7001,GO:0021984,1,0.929498806422595,0,12,adenohypophysis development,BP,
7002,GO:0021985,1,0.98738688185437,0,2,neurohypophysis development,BP,
7003,GO:0021986,1,0.979975028009356,0,3,habenula development,BP,
7004,GO:0021987,1,0.502484312134785,0,103,cerebral cortex development,BP,
7005,GO:0021988,1,0.808190204096003,0,32,olfactory lobe development,BP,
7006,GO:0021993,1,0.993127937862553,0,1,initiation of neural tube closure,BP,
7007,GO:0021997,1,0.985275235151329,0,2,neural plate axis specification,BP,
7008,GO:0021998,1,0.993603636886392,0,1,neural plate mediolateral regionalization,BP,
7009,GO:0021999,1,0.961669464715341,0,6,neural plate anterior/posterior regionalization,BP,
7010,GO:0022007,1,0.98080626286396,0,3,convergent extension involved in neural plate elongation,BP,
7012,GO:0022009,1,0.975305525568676,0,4,central nervous system vasculogenesis,BP,
7015,GO:0022012,1,0.992277399595933,0,1,subpallium cell proliferation in forebrain,BP,
7016,GO:0022013,1,0.992177223136307,0,1,pallium cell proliferation in forebrain,BP,
7017,GO:0022018,1,0.992277399595933,0,1,lateral ganglionic eminence cell proliferation,BP,
7018,GO:0022027,1,0.955538060775178,0,6,interkinetic nuclear migration,BP,
7019,GO:0022028,1,0.959033035732812,0,6,tangential migration from the subventricular zone to the olfactory bulb,BP,
7021,GO:0022030,1,0.891904994604385,0,17,telencephalon glial cell migration,BP,
7024,GO:0022400,1,0.882347222600465,0,20,regulation of rhodopsin mediated signaling pathway,BP,
7025,GO:0022401,1,0.907623412145182,0,16,negative adaptation of signaling pathway,BP,
7027,GO:0022404,1,0.582464602202644,0,83,molting cycle process,BP,
7028,GO:0022405,1,0.582464602202644,0,83,hair cycle process,BP,
7029,GO:0022406,1,0.314139441048312,0,179,membrane docking,BP,
7032,GO:0022409,1,0.24292533242995,0,225,positive regulation of cell-cell adhesion,BP,
7037,GO:0022417,1,0.959920101163858,0,7,protein maturation by protein folding,BP,
7038,GO:0022600,1,0.6237334712236,0,75,digestive system process,BP,
7039,GO:0022602,1,0.774957553193055,0,39,ovulation cycle process,BP,
7042,GO:0022605,1,0.963541636355327,0,6,mammalian oogenesis stage,BP,
7045,GO:0022612,1,0.481435170478717,0,111,gland morphogenesis,BP,
7046,GO:0022613,1,0.063193280342735,0,442,ribonucleoprotein complex biogenesis,BP,
7047,GO:0022614,1,0.967887887277007,0,5,membrane to membrane docking,BP,
7048,GO:0022615,1,0.976485476308829,0,4,protein to membrane docking,BP,
7049,GO:0022616,1,0.847915844872277,0,26,DNA strand elongation,BP,
7050,GO:0022617,1,0.587957035354221,0,81,extracellular matrix disassembly,BP,
7051,GO:0022618,1,0.292237633366369,0,195,ribonucleoprotein complex assembly,BP,
7052,GO:0022622,1,0.994422168860593,0,1,root system development,BP,
7053,GO:0022624,1,0.867933201556573,0,24,proteasome accessory complex,CC,
7054,GO:0022625,1,0.70039389918941,0,62,cytosolic large ribosomal subunit,CC,
7055,GO:0022626,1,0.516018801994532,0,114,cytosolic ribosome,CC,
7056,GO:0022627,1,0.770438637197184,0,45,cytosolic small ribosomal subunit,CC,
7060,GO:0022824,1,0.71592244160024,0,51,transmitter-gated ion channel activity,MF,
7062,GO:0022832,1,0.297017109867985,0,184,voltage-gated channel activity,MF,
7064,GO:0022835,1,0.71592244160024,0,51,transmitter-gated channel activity,MF,
7068,GO:0022840,1,0.905417695642441,0,16,leak channel activity,MF,
7069,GO:0022841,1,0.917785740998759,0,14,potassium ion leak channel activity,MF,
7070,GO:0022842,1,0.905417695642441,0,16,narrow pore channel activity,MF,
7071,GO:0022843,1,0.413648713875545,0,134,voltage-gated cation channel activity,MF,
7072,GO:0022848,1,0.916991669124958,0,14,acetylcholine-gated cation-selective channel activity,MF,
7073,GO:0022849,1,0.963935872637458,0,5,glutamate-gated calcium ion channel activity,MF,
7074,GO:0022850,1,0.976426231220386,0,4,serotonin-gated cation-selective channel activity,MF,
7075,GO:0022851,1,0.929755638579697,0,11,GABA-gated chloride ion channel activity,MF,
7076,GO:0022852,1,0.987335561485915,0,2,glycine-gated chloride ion channel activity,MF,
7077,GO:0022853,1,0.709385091740385,0,53,active ion transmembrane transporter activity,MF,
7079,GO:0022858,1,0.968507637318252,0,5,alanine transmembrane transporter activity,MF,
7080,GO:0022884,1,0.914057796419486,0,15,macromolecule transmembrane transporter activity,MF,
7081,GO:0022889,1,0.946847795149549,0,9,serine transmembrane transporter activity,MF,
7083,GO:0022894,1,0.993999458486108,0,1,Intermediate conductance calcium-activated potassium channel activity,MF,
7085,GO:0022900,1,0.390166355217016,0,158,electron transport chain,BP,
7086,GO:0022904,1,0.564326878849995,0,97,respiratory electron transport chain,BP,
7088,GO:0023016,1,0.979600821330451,0,3,signal transduction by trans-phosphorylation,BP,
7089,GO:0023019,1,0.893187792448475,0,18,signal transduction involved in regulation of gene expression,BP,
7090,GO:0023021,1,0.981879076658352,0,3,termination of signal transduction,BP,
7091,GO:0023023,1,0.887434791409912,0,20,MHC protein complex binding,MF,
7092,GO:0023024,1,0.982342447209426,0,3,MHC class I protein complex binding,MF,
7093,GO:0023025,1,0.987773168425605,0,2,MHC class Ib protein complex binding,MF,
7094,GO:0023026,1,0.908852025604746,0,16,MHC class II protein complex binding,MF,
7095,GO:0023029,1,0.969201590236453,0,5,MHC class Ib protein binding,MF,
7096,GO:0023030,1,0.987773168425605,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
7097,GO:0023035,1,0.951463339475768,0,8,CD40 signaling pathway,BP,
7098,GO:0023041,1,0.962240037690935,0,6,neuronal signal transduction,BP,
7103,GO:0023058,1,0.902087017842324,0,17,adaptation of signaling pathway,BP,
7106,GO:0030002,1,0.935693027335884,0,10,cellular anion homeostasis,BP,
7108,GO:0030004,1,0.503384870708463,0,107,cellular monovalent inorganic cation homeostasis,BP,
7109,GO:0030007,1,0.913812462955907,0,14,cellular potassium ion homeostasis,BP,
7110,GO:0030008,1,0.918461049501565,0,14,TRAPP complex,CC,
7111,GO:0030010,1,0.452371413127411,0,119,establishment of cell polarity,BP,
7112,GO:0030011,1,0.892727443714474,0,17,maintenance of cell polarity,BP,
7113,GO:0030014,1,0.906524298859955,0,15,CCR4-NOT complex,CC,
7114,GO:0030015,1,0.968534876437096,0,5,CCR4-NOT core complex,CC,
7118,GO:0030020,1,0.959943592892167,0,6,extracellular matrix structural constituent conferring tensile strength,MF,
7119,GO:0030021,1,0.993758711651685,0,1,extracellular matrix structural constituent conferring compression resistance,MF,
7120,GO:0030023,1,0.963094949667885,0,5,extracellular matrix constituent conferring elasticity,MF,
7121,GO:0030027,1,0.306313658710712,0,177,lamellipodium,CC,
7125,GO:0030032,1,0.706726320765713,0,53,lamellipodium assembly,BP,
7126,GO:0030033,1,0.899566344052129,0,16,microvillus assembly,BP,
7127,GO:0030035,1,0.973676269685115,0,4,microspike assembly,BP,
7129,GO:0030037,1,0.993216114826184,0,1,actin filament reorganization involved in cell cycle,BP,
7131,GO:0030041,1,0.356255308721768,0,161,actin filament polymerization,BP,
7132,GO:0030042,1,0.731877342513099,0,47,actin filament depolymerization,BP,
7133,GO:0030043,1,0.976204892403415,0,4,actin filament fragmentation,BP,
7134,GO:0030046,1,0.967498112416761,0,5,parallel actin filament bundle assembly,BP,
7135,GO:0030047,1,0.980750905783226,0,3,actin modification,BP,
7140,GO:0030055,1,0.0796329487079442,0,387,cell-substrate junction,CC,
7141,GO:0030056,1,0.95953628763088,0,5,hemidesmosome,CC,
7142,GO:0030057,1,0.861571217465227,0,22,desmosome,CC,
7143,GO:0030060,1,0.976787205033874,0,4,L-malate dehydrogenase activity,MF,
7144,GO:0030061,1,0.968855057458637,0,5,mitochondrial crista,CC,
7145,GO:0030062,1,0.962398626883278,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
7146,GO:0030070,1,0.973815579350892,0,4,insulin processing,BP,
7147,GO:0030071,1,0.733894358005536,0,48,regulation of mitotic metaphase/anaphase transition,BP,
7150,GO:0030091,1,0.959345632395121,0,7,protein repair,BP,
7152,GO:0030098,1,0.15872250274709,0,286,lymphocyte differentiation,BP,
7153,GO:0030099,1,0.107163750463591,0,346,myeloid cell differentiation,BP,
7155,GO:0030101,1,0.737785986731488,0,49,natural killer cell activation,BP,
7156,GO:0030103,1,0.988247260722335,0,2,vasopressin secretion,BP,
7157,GO:0030104,1,0.694413275864695,0,56,water homeostasis,BP,
7158,GO:0030107,1,0.993820554697066,0,1,HLA-A specific inhibitory MHC class I receptor activity,MF,
7159,GO:0030108,1,0.994221032359422,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7160,GO:0030109,1,0.987953665037254,0,2,HLA-B specific inhibitory MHC class I receptor activity,MF,
7162,GO:0030117,1,0.540426231583489,0,96,membrane coat,CC,
7163,GO:0030118,1,0.731379744819947,0,48,clathrin coat,CC,
7164,GO:0030119,1,0.748185638458355,0,45,AP-type membrane coat adaptor complex,CC,
7165,GO:0030120,1,0.708099474539458,0,54,vesicle coat,CC,
7166,GO:0030121,1,0.962588918666763,0,6,AP-1 adaptor complex,CC,
7167,GO:0030122,1,0.912575223353042,0,14,AP-2 adaptor complex,CC,
7168,GO:0030123,1,0.937151454574095,0,10,AP-3 adaptor complex,CC,
7169,GO:0030124,1,0.975197102428627,0,4,AP-4 adaptor complex,CC,
7170,GO:0030125,1,0.8446371546192,0,26,clathrin vesicle coat,CC,
7171,GO:0030126,1,0.911439896843246,0,15,COPI vesicle coat,CC,
7172,GO:0030127,1,0.914151724521271,0,14,COPII vesicle coat,CC,
7173,GO:0030128,1,0.906459333277604,0,15,clathrin coat of endocytic vesicle,CC,
7174,GO:0030130,1,0.925724121843198,0,12,clathrin coat of trans-Golgi network vesicle,CC,
7175,GO:0030131,1,0.828894566297741,0,29,clathrin adaptor complex,CC,
7176,GO:0030132,1,0.883033470849495,0,19,clathrin coat of coated pit,CC,
7178,GO:0030134,1,0.591812257695207,0,83,COPII-coated ER to Golgi transport vesicle,CC,
7185,GO:0030144,1,0.981443216692609,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
7188,GO:0030149,1,0.873220418457082,0,22,sphingolipid catabolic process,BP,
7189,GO:0030150,1,0.903265869147632,0,17,protein import into mitochondrial matrix,BP,
7190,GO:0030151,1,0.975743885672935,0,4,molybdenum ion binding,MF,
7193,GO:0030156,1,0.994434009293863,0,1,benzodiazepine receptor binding,MF,
7194,GO:0030157,1,0.920333302854966,0,13,pancreatic juice secretion,BP,
7195,GO:0030158,1,0.97955546063479,0,3,protein xylosyltransferase activity,MF,
7196,GO:0030159,1,0.852565522367712,0,24,receptor signaling complex scaffold activity,MF,
7197,GO:0030160,1,0.971579339796306,0,4,GKAP/Homer scaffold activity,MF,
7201,GO:0030166,1,0.671606933284381,0,60,proteoglycan biosynthetic process,BP,
7202,GO:0030167,1,0.975021218327001,0,4,proteoglycan catabolic process,BP,
7203,GO:0030168,1,0.383342028331074,0,149,platelet activation,BP,
7204,GO:0030169,1,0.917699299478571,0,13,low-density lipoprotein particle binding,MF,
7206,GO:0030171,1,0.994148260089254,0,1,voltage-gated proton channel activity,MF,
7207,GO:0030172,1,0.983118121749577,0,3,troponin C binding,MF,
7208,GO:0030173,1,0.768328541225804,0,42,integral component of Golgi membrane,CC,
7209,GO:0030174,1,0.963679407149284,0,6,regulation of DNA-dependent DNA replication initiation,BP,
7211,GO:0030176,1,0.42671620786005,0,137,integral component of endoplasmic reticulum membrane,CC,
7212,GO:0030177,1,0.357482952920922,0,160,positive regulation of Wnt signaling pathway,BP,
7215,GO:0030183,1,0.536508795851244,0,96,B cell differentiation,BP,
7216,GO:0030184,1,0.993852396074305,0,1,nitric oxide transmembrane transporter activity,MF,
7217,GO:0030185,1,0.982462557508773,0,3,nitric oxide transport,BP,
7218,GO:0030186,1,0.994222620638038,0,1,melatonin metabolic process,BP,
7219,GO:0030187,1,0.994222620638038,0,1,melatonin biosynthetic process,BP,
7220,GO:0030193,1,0.646298227064168,0,70,regulation of blood coagulation,BP,
7221,GO:0030194,1,0.866523658191851,0,23,positive regulation of blood coagulation,BP,
7222,GO:0030195,1,0.761688687970724,0,44,negative regulation of blood coagulation,BP,
7223,GO:0030197,1,0.987262948957878,0,2,extracellular matrix constituent, lubricant activity,MF,
7226,GO:0030200,1,0.981681519692839,0,3,heparan sulfate proteoglycan catabolic process,BP,
7228,GO:0030202,1,0.947400793012014,0,8,heparin metabolic process,BP,
7231,GO:0030205,1,0.917429489812792,0,13,dermatan sulfate metabolic process,BP,
7232,GO:0030206,1,0.847632088888202,0,25,chondroitin sulfate biosynthetic process,BP,
7233,GO:0030207,1,0.91338197130479,0,14,chondroitin sulfate catabolic process,BP,
7234,GO:0030208,1,0.922959477745228,0,12,dermatan sulfate biosynthetic process,BP,
7235,GO:0030209,1,0.994013302402746,0,1,dermatan sulfate catabolic process,BP,
7236,GO:0030210,1,0.947400793012014,0,8,heparin biosynthetic process,BP,
7237,GO:0030212,1,0.806893546385057,0,34,hyaluronan metabolic process,BP,
7238,GO:0030213,1,0.920645156675726,0,13,hyaluronan biosynthetic process,BP,
7239,GO:0030214,1,0.9162103582287,0,14,hyaluronan catabolic process,BP,
7240,GO:0030215,1,0.873905803350941,0,20,semaphorin receptor binding,MF,
7241,GO:0030216,1,0.427389970596203,0,133,keratinocyte differentiation,BP,
7242,GO:0030217,1,0.270393121548578,0,204,T cell differentiation,BP,
7243,GO:0030218,1,0.523482633818392,0,101,erythrocyte differentiation,BP,
7244,GO:0030219,1,0.638817359403955,0,70,megakaryocyte differentiation,BP,
7245,GO:0030220,1,0.889094909714342,0,18,platelet formation,BP,
7246,GO:0030221,1,0.987467505203899,0,2,basophil differentiation,BP,
7247,GO:0030222,1,0.981609284043378,0,3,eosinophil differentiation,BP,
7248,GO:0030223,1,0.963503109810067,0,6,neutrophil differentiation,BP,
7249,GO:0030224,1,0.824719506455888,0,30,monocyte differentiation,BP,
7250,GO:0030225,1,0.79388366863164,0,37,macrophage differentiation,BP,
7251,GO:0030226,1,0.974823821847567,0,3,apolipoprotein receptor activity,MF,
7253,GO:0030229,1,0.974264675459786,0,4,very-low-density lipoprotein particle receptor activity,MF,
7254,GO:0030233,1,0.994172084417801,0,1,deoxynucleotide transmembrane transporter activity,MF,
7256,GO:0030235,1,0.955461631828985,0,7,nitric-oxide synthase regulator activity,MF,
7257,GO:0030237,1,0.987370187229894,0,2,female sex determination,BP,
7258,GO:0030238,1,0.914063373903593,0,14,male sex determination,BP,
7260,GO:0030240,1,0.915104051192773,0,10,skeletal muscle thin filament assembly,BP,
7261,GO:0030241,1,0.931429401602008,0,7,skeletal muscle myosin thick filament assembly,BP,
7262,GO:0030242,1,0.967481273755939,0,5,autophagy of peroxisome,BP,
7265,GO:0030249,1,0.976710267802471,0,4,guanylate cyclase regulator activity,MF,
7266,GO:0030250,1,0.976710267802471,0,4,guanylate cyclase activator activity,MF,
7267,GO:0030252,1,0.913876615328188,0,14,growth hormone secretion,BP,
7269,GO:0030259,1,0.958068521721767,0,7,lipid glycosylation,BP,
7274,GO:0030264,1,0.993846081630578,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
7275,GO:0030267,1,0.982007778896684,0,3,glyoxylate reductase (NADP) activity,MF,
7276,GO:0030272,1,0.994392134866724,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
7277,GO:0030273,1,0.993948445569514,0,1,melanin-concentrating hormone receptor activity,MF,
7278,GO:0030274,1,0.961856284699199,0,6,LIM domain binding,MF,
7279,GO:0030275,1,0.908122641835515,0,15,LRR domain binding,MF,
7280,GO:0030276,1,0.637097133908145,0,69,clathrin binding,MF,
7281,GO:0030277,1,0.914906166458876,0,14,maintenance of gastrointestinal epithelium,BP,
7284,GO:0030280,1,0.964320766305087,0,6,structural constituent of epidermis,MF,
7286,GO:0030283,1,0.994372353053026,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
7287,GO:0030284,1,0.968348505595806,0,5,estrogen receptor activity,MF,
7290,GO:0030289,1,0.982102078362299,0,3,protein phosphatase 4 complex,CC,
7291,GO:0030290,1,0.993615909981128,0,1,sphingolipid activator protein activity,MF,
7293,GO:0030292,1,0.981214115239359,0,3,protein tyrosine kinase inhibitor activity,MF,
7294,GO:0030294,1,0.994009120000379,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
7298,GO:0030299,1,0.951557006716134,0,8,intestinal cholesterol absorption,BP,
7299,GO:0030300,1,0.982031362508953,0,3,regulation of intestinal cholesterol absorption,BP,
7300,GO:0030301,1,0.648903214852844,0,67,cholesterol transport,BP,
7301,GO:0030302,1,0.994172084417801,0,1,deoxynucleotide transport,BP,
7302,GO:0030305,1,0.987594721488231,0,2,heparanase activity,MF,
7303,GO:0030306,1,0.946914529602499,0,8,ADP-ribosylation factor binding,MF,
7306,GO:0030309,1,0.951989510226181,0,8,poly-N-acetyllactosamine metabolic process,BP,
7307,GO:0030311,1,0.958036411655065,0,7,poly-N-acetyllactosamine biosynthetic process,BP,
7308,GO:0030312,1,0.993998016627916,0,1,external encapsulating structure,CC,
7309,GO:0030314,1,0.952265280308653,0,7,junctional membrane complex,CC,
7311,GO:0030316,1,0.604979117359748,0,77,osteoclast differentiation,BP,
7312,GO:0030317,1,0.677686379199025,0,61,flagellated sperm motility,BP,
7314,GO:0030320,1,0.935693027335884,0,10,cellular monovalent inorganic anion homeostasis,BP,
7315,GO:0030321,1,0.969094040595474,0,5,transepithelial chloride transport,BP,
7316,GO:0030322,1,0.917661463024665,0,14,stabilization of membrane potential,BP,
7319,GO:0030325,1,0.884743412826301,0,19,adrenal gland development,BP,
7321,GO:0030327,1,0.980868695282244,0,3,prenylated protein catabolic process,BP,
7322,GO:0030328,1,0.987052003584542,0,2,prenylcysteine catabolic process,BP,
7323,GO:0030329,1,0.987052003584542,0,2,prenylcysteine metabolic process,BP,
7324,GO:0030330,1,0.502893670041151,0,107,DNA damage response, signal transduction by p53 class mediator,BP,
7326,GO:0030332,1,0.825937028519033,0,30,cyclin binding,MF,
7330,GO:0030337,1,0.98814163797345,0,2,DNA polymerase processivity factor activity,MF,
7331,GO:0030342,1,0.993731980302676,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
7332,GO:0030343,1,0.994180170230059,0,1,vitamin D3 25-hydroxylase activity,MF,
7333,GO:0030345,1,0.993758711651685,0,1,structural constituent of tooth enamel,MF,
7334,GO:0030346,1,0.955412942952215,0,7,protein phosphatase 2B binding,MF,
7335,GO:0030348,1,0.980950931550453,0,3,syntaxin-3 binding,MF,
7336,GO:0030350,1,0.986475881520577,0,2,iron-responsive element binding,MF,
7337,GO:0030351,1,0.993825428377467,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
7338,GO:0030366,1,0.988439087029103,0,2,molybdopterin synthase activity,MF,
7339,GO:0030368,1,0.949806889494165,0,8,interleukin-17 receptor activity,MF,
7340,GO:0030369,1,0.98701689813002,0,2,ICAM-3 receptor activity,MF,
7341,GO:0030371,1,0.854568770591859,0,24,translation repressor activity,MF,
7342,GO:0030372,1,0.993266193924789,0,1,high molecular weight B cell growth factor receptor binding,MF,
7343,GO:0030374,1,0.638188218750962,0,68,ligand-dependent nuclear receptor transcription coactivator activity,MF,
7344,GO:0030375,1,0.972588858990913,0,4,thyroid hormone receptor coactivator activity,MF,
7345,GO:0030377,1,0.994231283975121,0,1,urokinase plasminogen activator receptor activity,MF,
7346,GO:0030378,1,0.993930880583482,0,1,serine racemase activity,MF,
7347,GO:0030379,1,0.992621742422653,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
7349,GO:0030387,1,0.994232727864556,0,1,fructosamine-3-kinase activity,MF,
7350,GO:0030388,1,0.970599551448161,0,5,fructose 1,6-bisphosphate metabolic process,BP,
7351,GO:0030389,1,0.988714304721683,0,2,fructosamine metabolic process,BP,
7352,GO:0030393,1,0.994232727864556,0,1,fructoselysine metabolic process,BP,
7353,GO:0030395,1,0.988662888529485,0,2,lactose binding,MF,
7354,GO:0030397,1,0.741218906504129,0,46,membrane disassembly,BP,
7355,GO:0030407,1,0.994098446922635,0,1,formimidoyltransferase activity,MF,
7356,GO:0030409,1,0.994098446922635,0,1,glutamate formimidoyltransferase activity,MF,
7357,GO:0030412,1,0.994098446922635,0,1,formimidoyltetrahydrofolate cyclodeaminase activity,MF,
7359,GO:0030421,1,0.994388091856786,0,1,defecation,BP,
7360,GO:0030422,1,0.944318324073396,0,9,production of siRNA involved in RNA interference,BP,
7361,GO:0030423,1,0.973629701007479,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
7364,GO:0030426,1,0.377991631729793,0,146,growth cone,CC,
7365,GO:0030427,1,0.363773333762234,0,151,site of polarized growth,CC,
7366,GO:0030429,1,0.994217567023989,0,1,kynureninase activity,MF,
7367,GO:0030430,1,0.963811607259417,0,6,host cell cytoplasm,CC,
7369,GO:0030432,1,0.952693671016078,0,8,peristalsis,BP,
7371,GO:0030449,1,0.793397388658005,0,37,regulation of complement activation,BP,
7372,GO:0030450,1,0.986004056279632,0,2,regulation of complement activation, classical pathway,BP,
7373,GO:0030451,1,0.991956535396447,0,1,regulation of complement activation, alternative pathway,BP,
7374,GO:0030473,1,0.965358638927642,0,5,nuclear migration along microtubule,BP,
7375,GO:0030474,1,0.993846081630578,0,1,spindle pole body duplication,BP,
7376,GO:0030478,1,0.974355783276927,0,4,actin cap,CC,
7377,GO:0030479,1,0.954393319045921,0,7,actin cortical patch,CC,
7378,GO:0030485,1,0.987558086917161,0,2,smooth muscle contractile fiber,CC,
7379,GO:0030488,1,0.824988227654916,0,31,tRNA methylation,BP,
7380,GO:0030490,1,0.730676742569428,0,51,maturation of SSU-rRNA,BP,
7381,GO:0030492,1,0.97770193308214,0,4,hemoglobin binding,MF,
7382,GO:0030496,1,0.353199467483151,0,160,midbody,CC,
7383,GO:0030497,1,0.934210763854124,0,11,fatty acid elongation,BP,
7385,GO:0030501,1,0.800643065696159,0,34,positive regulation of bone mineralization,BP,
7387,GO:0030504,1,0.992280008412294,0,1,inorganic diphosphate transmembrane transporter activity,MF,
7388,GO:0030505,1,0.984835489311039,0,2,inorganic diphosphate transport,BP,
7389,GO:0030506,1,0.880930241073192,0,17,ankyrin binding,MF,
7390,GO:0030507,1,0.843089984419193,0,25,spectrin binding,MF,
7393,GO:0030511,1,0.849267702074832,0,25,positive regulation of transforming growth factor beta receptor signaling pathway,BP,
7394,GO:0030512,1,0.646686214737363,0,66,negative regulation of transforming growth factor beta receptor signaling pathway,BP,
7395,GO:0030513,1,0.813435043314544,0,31,positive regulation of BMP signaling pathway,BP,
7397,GO:0030515,1,0.836757254996292,0,29,snoRNA binding,MF,
7402,GO:0030521,1,0.671422437016089,0,61,androgen receptor signaling pathway,BP,
7404,GO:0030523,1,0.993394878532363,0,1,dihydrolipoamide S-acyltransferase activity,MF,
7405,GO:0030526,1,0.99325123291743,0,1,granulocyte macrophage colony-stimulating factor receptor complex,CC,
7406,GO:0030532,1,0.652979591389511,0,68,small nuclear ribonucleoprotein complex,CC,
7408,GO:0030538,1,0.981871568765248,0,3,embryonic genitalia morphogenesis,BP,
7409,GO:0030539,1,0.885857786275179,0,19,male genitalia development,BP,
7414,GO:0030547,1,0.889867709882446,0,19,receptor inhibitor activity,MF,
7415,GO:0030548,1,0.958687190838,0,7,acetylcholine receptor regulator activity,MF,
7416,GO:0030549,1,0.994314885392528,0,1,acetylcholine receptor activator activity,MF,
7417,GO:0030550,1,0.975479922464147,0,4,acetylcholine receptor inhibitor activity,MF,
7418,GO:0030551,1,0.794961289705328,0,35,cyclic nucleotide binding,MF,
7419,GO:0030552,1,0.853192487157275,0,24,cAMP binding,MF,
7420,GO:0030553,1,0.91830974779276,0,13,cGMP binding,MF,
7422,GO:0030572,1,0.99355267808908,0,1,phosphatidyltransferase activity,MF,
7423,GO:0030573,1,0.988096808864991,0,2,bile acid catabolic process,BP,
7425,GO:0030575,1,0.926561512294431,0,11,nuclear body organization,BP,
7426,GO:0030576,1,0.981524216299582,0,3,Cajal body organization,BP,
7427,GO:0030578,1,0.971738633335975,0,4,PML body organization,BP,
7428,GO:0030579,1,0.968299344141102,0,5,ubiquitin-dependent SMAD protein catabolic process,BP,
7429,GO:0030580,1,0.994281242594407,0,1,quinone cofactor methyltransferase activity,MF,
7430,GO:0030581,1,0.988589664605642,0,2,symbiont intracellular protein transport in host,BP,
7431,GO:0030586,1,0.993697840280528,0,1,[methionine synthase] reductase activity,MF,
7432,GO:0030593,1,0.657726228897348,0,69,neutrophil chemotaxis,BP,
7433,GO:0030594,1,0.565270024461549,0,89,neurotransmitter receptor activity,MF,
7435,GO:0030611,1,0.994384048852904,0,1,arsenate reductase activity,MF,
7436,GO:0030613,1,0.983115116217181,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
7437,GO:0030614,1,0.983115116217181,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
7438,GO:0030616,1,0.992116744038807,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
7439,GO:0030617,1,0.987612888114951,0,2,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
7440,GO:0030618,1,0.964557755412245,0,5,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
7441,GO:0030619,1,0.957138557031481,0,7,U1 snRNA binding,MF,
7442,GO:0030620,1,0.964325658004451,0,6,U2 snRNA binding,MF,
7443,GO:0030621,1,0.96858526113856,0,5,U4 snRNA binding,MF,
7444,GO:0030622,1,0.987140675600827,0,2,U4atac snRNA binding,MF,
7445,GO:0030623,1,0.992535209145496,0,1,U5 snRNA binding,MF,
7446,GO:0030624,1,0.99338598736905,0,1,U6atac snRNA binding,MF,
7447,GO:0030626,1,0.987682418041001,0,2,U12 snRNA binding,MF,
7448,GO:0030627,1,0.988154020095861,0,2,pre-mRNA 5'-splice site binding,MF,
7449,GO:0030628,1,0.964706775491912,0,6,pre-mRNA 3'-splice site binding,MF,
7450,GO:0030629,1,0.993846081630578,0,1,U6 snRNA 3'-end binding,MF,
7451,GO:0030638,1,0.954319008446093,0,8,polyketide metabolic process,BP,
7452,GO:0030641,1,0.566627346105938,0,89,regulation of cellular pH,BP,
7453,GO:0030643,1,0.960019390238771,0,6,cellular phosphate ion homeostasis,BP,
7454,GO:0030644,1,0.974670962229741,0,4,cellular chloride ion homeostasis,BP,
7455,GO:0030647,1,0.954319008446093,0,8,aminoglycoside antibiotic metabolic process,BP,
7456,GO:0030653,1,0.993186448387138,0,1,beta-lactam antibiotic metabolic process,BP,
7457,GO:0030656,1,0.934714774384471,0,11,regulation of vitamin metabolic process,BP,
7462,GO:0030663,1,0.8955314052589,0,18,COPI-coated vesicle membrane,CC,
7465,GO:0030667,1,0.162140158531115,0,282,secretory granule membrane,CC,
7466,GO:0030669,1,0.769529226527895,0,41,clathrin-coated endocytic vesicle membrane,CC,
7467,GO:0030670,1,0.653327965814456,0,68,phagocytic vesicle membrane,CC,
7469,GO:0030673,1,0.893856511934486,0,16,axolemma,CC,
7470,GO:0030674,1,0.346775081976264,0,163,protein binding, bridging,MF,
7471,GO:0030676,1,0.898029652224201,0,16,Rac guanyl-nucleotide exchange factor activity,MF,
7472,GO:0030677,1,0.925252888418377,0,13,ribonuclease P complex,CC,
7473,GO:0030678,1,0.982216919629131,0,3,mitochondrial ribonuclease P complex,CC,
7474,GO:0030681,1,0.942014943139477,0,10,multimeric ribonuclease P complex,CC,
7475,GO:0030682,1,0.987054758386881,0,2,evasion or tolerance of host defense response,BP,
7476,GO:0030683,1,0.987054758386881,0,2,evasion or tolerance by virus of host immune response,BP,
7477,GO:0030684,1,0.636142117887678,0,72,preribosome,CC,
7478,GO:0030686,1,0.826979349852959,0,30,90S preribosome,CC,
7479,GO:0030687,1,0.859834205555651,0,24,preribosome, large subunit precursor,CC,
7480,GO:0030688,1,0.926719537698001,0,12,preribosome, small subunit precursor,CC,
7481,GO:0030689,1,0.98191812241838,0,3,Noc complex,CC,
7482,GO:0030690,1,0.993835178930527,0,1,Noc1p-Noc2p complex,CC,
7483,GO:0030691,1,0.993835178930527,0,1,Noc2p-Noc3p complex,CC,
7484,GO:0030692,1,0.988009773537511,0,2,Noc4p-Nop14p complex,CC,
7486,GO:0030696,1,0.993735124187004,0,1,tRNA (m5U54) methyltransferase activity,MF,
7487,GO:0030697,1,0.993735124187004,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7488,GO:0030702,1,0.993486524943835,0,1,chromatin silencing at centromere,BP,
7490,GO:0030718,1,0.987777261949421,0,2,germ-line stem cell population maintenance,BP,
7491,GO:0030719,1,0.987573589309452,0,2,P granule organization,BP,
7492,GO:0030728,1,0.883467382923427,0,19,ovulation,BP,
7493,GO:0030729,1,0.993685846359545,0,1,acetoacetate-CoA ligase activity,MF,
7494,GO:0030730,1,0.908867673950032,0,15,sequestering of triglyceride,BP,
7495,GO:0030731,1,0.994356325548811,0,1,guanidinoacetate N-methyltransferase activity,MF,
7497,GO:0030748,1,0.993908721857596,0,1,amine N-methyltransferase activity,MF,
7498,GO:0030760,1,0.994191721376386,0,1,pyridine N-methyltransferase activity,MF,
7499,GO:0030791,1,0.993933759468776,0,1,arsenite methyltransferase activity,MF,
7500,GO:0030792,1,0.993933759468776,0,1,methylarsonite methyltransferase activity,MF,
7503,GO:0030801,1,0.768632055631434,0,43,positive regulation of cyclic nucleotide metabolic process,BP,
7506,GO:0030804,1,0.822147783325309,0,32,positive regulation of cyclic nucleotide biosynthetic process,BP,
7507,GO:0030805,1,0.979474346741688,0,3,regulation of cyclic nucleotide catabolic process,BP,
7508,GO:0030806,1,0.986459919149878,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7509,GO:0030807,1,0.992919525115996,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7512,GO:0030810,1,0.702448956141071,0,56,positive regulation of nucleotide biosynthetic process,BP,
7513,GO:0030811,1,0.654423344664124,0,64,regulation of nucleotide catabolic process,BP,
7514,GO:0030812,1,0.92332767341879,0,12,negative regulation of nucleotide catabolic process,BP,
7515,GO:0030813,1,0.892312612496694,0,17,positive regulation of nucleotide catabolic process,BP,
7518,GO:0030816,1,0.853458009051891,0,26,positive regulation of cAMP metabolic process,BP,
7521,GO:0030819,1,0.901013365574947,0,17,positive regulation of cAMP biosynthetic process,BP,
7522,GO:0030820,1,0.979474346741688,0,3,regulation of cAMP catabolic process,BP,
7523,GO:0030821,1,0.986459919149878,0,2,negative regulation of cAMP catabolic process,BP,
7524,GO:0030822,1,0.992919525115996,0,1,positive regulation of cAMP catabolic process,BP,
7525,GO:0030823,1,0.871325675446718,0,22,regulation of cGMP metabolic process,BP,
7526,GO:0030824,1,0.994241391201421,0,1,negative regulation of cGMP metabolic process,BP,
7527,GO:0030825,1,0.900761555292499,0,17,positive regulation of cGMP metabolic process,BP,
7528,GO:0030826,1,0.901301110237775,0,17,regulation of cGMP biosynthetic process,BP,
7529,GO:0030827,1,0.994241391201421,0,1,negative regulation of cGMP biosynthetic process,BP,
7530,GO:0030828,1,0.912559049511889,0,15,positive regulation of cGMP biosynthetic process,BP,
7531,GO:0030832,1,0.33915793616542,0,167,regulation of actin filament length,BP,
7532,GO:0030833,1,0.389928179966607,0,147,regulation of actin filament polymerization,BP,
7533,GO:0030834,1,0.747164190751524,0,44,regulation of actin filament depolymerization,BP,
7534,GO:0030835,1,0.796710081896732,0,34,negative regulation of actin filament depolymerization,BP,
7535,GO:0030836,1,0.937907171776507,0,10,positive regulation of actin filament depolymerization,BP,
7536,GO:0030837,1,0.7179617365168,0,51,negative regulation of actin filament polymerization,BP,
7537,GO:0030838,1,0.574917958788257,0,88,positive regulation of actin filament polymerization,BP,
7538,GO:0030842,1,0.993048890532864,0,1,regulation of intermediate filament depolymerization,BP,
7539,GO:0030844,1,0.993048890532864,0,1,positive regulation of intermediate filament depolymerization,BP,
7540,GO:0030845,1,0.993823134750506,0,1,phospholipase C-inhibiting G-protein coupled receptor signaling pathway,BP,
7541,GO:0030846,1,0.991459989512687,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7542,GO:0030849,1,0.98735196959284,0,2,autosome,CC,
7543,GO:0030850,1,0.73434568599267,0,47,prostate gland development,BP,
7544,GO:0030851,1,0.85021105638484,0,26,granulocyte differentiation,BP,
7545,GO:0030852,1,0.921767094328288,0,13,regulation of granulocyte differentiation,BP,
7546,GO:0030853,1,0.956280673553573,0,7,negative regulation of granulocyte differentiation,BP,
7547,GO:0030854,1,0.957755396129349,0,7,positive regulation of granulocyte differentiation,BP,
7549,GO:0030856,1,0.458612510189943,0,120,regulation of epithelial cell differentiation,BP,
7550,GO:0030857,1,0.80881122643213,0,33,negative regulation of epithelial cell differentiation,BP,
7551,GO:0030858,1,0.725213632377247,0,50,positive regulation of epithelial cell differentiation,BP,
7552,GO:0030859,1,0.88904702213276,0,18,polarized epithelial cell differentiation,BP,
7553,GO:0030860,1,0.9870173879482,0,2,regulation of polarized epithelial cell differentiation,BP,
7554,GO:0030862,1,0.993049612079565,0,1,positive regulation of polarized epithelial cell differentiation,BP,
7557,GO:0030865,1,0.726882167265304,0,49,cortical cytoskeleton organization,BP,
7558,GO:0030866,1,0.77473129170142,0,39,cortical actin cytoskeleton organization,BP,
7560,GO:0030868,1,0.969535852957121,0,5,smooth endoplasmic reticulum membrane,CC,
7561,GO:0030870,1,0.967870642967339,0,5,Mre11 complex,CC,
7562,GO:0030874,1,0.994150714721825,0,1,nucleolar chromatin,CC,
7563,GO:0030877,1,0.922369635093732,0,12,beta-catenin destruction complex,CC,
7564,GO:0030878,1,0.854120299457466,0,25,thyroid gland development,BP,
7565,GO:0030879,1,0.43792552667388,0,125,mammary gland development,BP,
7566,GO:0030880,1,0.427084047435777,0,134,RNA polymerase complex,CC,
7567,GO:0030881,1,0.958820433739743,0,7,beta-2-microglobulin binding,MF,
7568,GO:0030882,1,0.98161142346582,0,3,lipid antigen binding,MF,
7569,GO:0030883,1,0.98161142346582,0,3,endogenous lipid antigen binding,MF,
7570,GO:0030884,1,0.98161142346582,0,3,exogenous lipid antigen binding,MF,
7571,GO:0030885,1,0.971284785784249,0,5,regulation of myeloid dendritic cell activation,BP,
7572,GO:0030886,1,0.982502823562801,0,3,negative regulation of myeloid dendritic cell activation,BP,
7573,GO:0030887,1,0.99420500517857,0,1,positive regulation of myeloid dendritic cell activation,BP,
7574,GO:0030888,1,0.706033802697489,0,55,regulation of B cell proliferation,BP,
7575,GO:0030889,1,0.902114017025442,0,16,negative regulation of B cell proliferation,BP,
7576,GO:0030890,1,0.798205507123497,0,36,positive regulation of B cell proliferation,BP,
7577,GO:0030891,1,0.975742157254515,0,4,VCB complex,CC,
7578,GO:0030893,1,0.960892427602117,0,6,meiotic cohesin complex,CC,
7579,GO:0030894,1,0.851290906623919,0,26,replisome,CC,
7580,GO:0030895,1,0.988011139530324,0,2,apolipoprotein B mRNA editing enzyme complex,CC,
7581,GO:0030896,1,0.969770299497289,0,5,checkpoint clamp complex,CC,
7582,GO:0030897,1,0.910324454090715,0,14,HOPS complex,CC,
7583,GO:0030898,1,0.917586534780496,0,12,actin-dependent ATPase activity,MF,
7584,GO:0030899,1,0.983070721925123,0,3,calcium-dependent ATPase activity,MF,
7588,GO:0030903,1,0.901285675950557,0,16,notochord development,BP,
7589,GO:0030904,1,0.873308481367722,0,21,retromer complex,CC,
7590,GO:0030905,1,0.97441870278156,0,4,retromer, tubulation complex,CC,
7591,GO:0030906,1,0.975728205527288,0,4,retromer, cargo-selective complex,CC,
7592,GO:0030908,1,0.994192298933327,0,1,protein splicing,BP,
7593,GO:0030910,1,0.974407120654792,0,4,olfactory placode formation,BP,
7594,GO:0030911,1,0.949077353909014,0,8,TPR domain binding,MF,
7595,GO:0030913,1,0.953404562857886,0,7,paranodal junction assembly,BP,
7596,GO:0030914,1,0.932183040286511,0,11,STAGA complex,CC,
7597,GO:0030915,1,0.963730379015821,0,6,Smc5-Smc6 complex,CC,
7598,GO:0030916,1,0.951622335903631,0,8,otic vesicle formation,BP,
7599,GO:0030917,1,0.95636110173327,0,7,midbrain-hindbrain boundary development,BP,
7600,GO:0030920,1,0.988633615391754,0,2,peptidyl-serine acetylation,BP,
7601,GO:0030934,1,0.97672267136921,0,3,anchoring collagen complex,CC,
7602,GO:0030935,1,0.993888735587382,0,1,sheet-forming collagen trimer,CC,
7603,GO:0030936,1,0.993764432238996,0,1,transmembrane collagen trimer,CC,
7604,GO:0030942,1,0.982342184139367,0,3,endoplasmic reticulum signal peptide binding,MF,
7605,GO:0030943,1,0.981819889963799,0,3,mitochondrion targeting sequence binding,MF,
7606,GO:0030947,1,0.835746373781981,0,28,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7607,GO:0030948,1,0.943836151619687,0,9,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7608,GO:0030949,1,0.909327734616119,0,15,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7609,GO:0030950,1,0.915381829535973,0,14,establishment or maintenance of actin cytoskeleton polarity,BP,
7610,GO:0030951,1,0.974379752964252,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7611,GO:0030952,1,0.891908625372529,0,18,establishment or maintenance of cytoskeleton polarity,BP,
7612,GO:0030953,1,0.953506422142805,0,7,astral microtubule organization,BP,
7614,GO:0030956,1,0.981944238142415,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7615,GO:0030957,1,0.93961792411549,0,10,Tat protein binding,MF,
7616,GO:0030961,1,0.993846081630578,0,1,peptidyl-arginine hydroxylation,BP,
7617,GO:0030964,1,0.782228700207297,0,43,NADH dehydrogenase complex,CC,
7619,GO:0030969,1,0.98131375204058,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
7620,GO:0030970,1,0.848946752990287,0,26,retrograde protein transport, ER to cytosol,BP,
7621,GO:0030971,1,0.698379546446454,0,55,receptor tyrosine kinase binding,MF,
7622,GO:0030974,1,0.988090216031518,0,2,thiamine pyrophosphate transmembrane transport,BP,
7623,GO:0030975,1,0.993965442815809,0,1,thiamine binding,MF,
7624,GO:0030976,1,0.968601806305891,0,5,thiamine pyrophosphate binding,MF,
7625,GO:0030977,1,0.994123569405883,0,1,taurine binding,MF,
7626,GO:0030981,1,0.978965825575465,0,3,cortical microtubule cytoskeleton,CC,
7627,GO:0030983,1,0.920911675648322,0,13,mismatched DNA binding,MF,
7628,GO:0030984,1,0.988191435894259,0,2,kininogen binding,MF,
7629,GO:0030990,1,0.821372178953309,0,31,intraciliary transport particle,CC,
7630,GO:0030991,1,0.948240541557471,0,8,intraciliary transport particle A,CC,
7631,GO:0030992,1,0.883045241554357,0,20,intraciliary transport particle B,CC,
7632,GO:0030997,1,0.980061924847246,0,3,regulation of centriole-centriole cohesion,BP,
7634,GO:0031001,1,0.993846081630578,0,1,response to brefeldin A,BP,
7635,GO:0031005,1,0.930723933676021,0,11,filamin binding,MF,
7636,GO:0031010,1,0.928301681222466,0,11,ISWI-type complex,CC,
7637,GO:0031011,1,0.91303894272081,0,15,Ino80 complex,CC,
7639,GO:0031013,1,0.971291013464209,0,5,troponin I binding,MF,
7640,GO:0031014,1,0.97782534663785,0,4,troponin T binding,MF,
7642,GO:0031017,1,0.968825982680867,0,5,exocrine pancreas development,BP,
7644,GO:0031021,1,0.981962472072809,0,3,interphase microtubule organizing center,CC,
7645,GO:0031022,1,0.984665691497769,0,2,nuclear migration along microfilament,BP,
7646,GO:0031023,1,0.446595550384939,0,123,microtubule organizing center organization,BP,
7650,GO:0031038,1,0.994038114565935,0,1,myosin II filament organization,BP,
7651,GO:0031045,1,0.918897193993164,0,13,dense core granule,CC,
7652,GO:0031047,1,0.403559486880183,0,140,gene silencing by RNA,BP,
7653,GO:0031048,1,0.987234991968563,0,2,chromatin silencing by small RNA,BP,
7654,GO:0031049,1,0.993830733292028,0,1,programmed DNA elimination,BP,
7655,GO:0031050,1,0.754371474849154,0,43,dsRNA fragmentation,BP,
7656,GO:0031052,1,0.993830733292028,0,1,chromosome breakage,BP,
7657,GO:0031053,1,0.936152052348559,0,10,primary miRNA processing,BP,
7658,GO:0031054,1,0.919058660215006,0,13,pre-miRNA processing,BP,
7659,GO:0031055,1,0.824610526818399,0,32,chromatin remodeling at centromere,BP,
7660,GO:0031056,1,0.421524103480324,0,132,regulation of histone modification,BP,
7661,GO:0031057,1,0.784722522091793,0,37,negative regulation of histone modification,BP,
7662,GO:0031058,1,0.592074931765811,0,81,positive regulation of histone modification,BP,
7663,GO:0031060,1,0.685308109309232,0,57,regulation of histone methylation,BP,
7664,GO:0031061,1,0.893633819859766,0,17,negative regulation of histone methylation,BP,
7665,GO:0031062,1,0.805377945852464,0,33,positive regulation of histone methylation,BP,
7666,GO:0031063,1,0.849962472491003,0,25,regulation of histone deacetylation,BP,
7667,GO:0031064,1,0.973213012514027,0,4,negative regulation of histone deacetylation,BP,
7668,GO:0031065,1,0.89473978839313,0,17,positive regulation of histone deacetylation,BP,
7669,GO:0031069,1,0.857860341487619,0,24,hair follicle morphogenesis,BP,
7670,GO:0031071,1,0.993959968294987,0,1,cysteine desulfurase activity,MF,
7672,GO:0031074,1,0.980948403242504,0,3,nucleocytoplasmic transport complex,CC,
7673,GO:0031076,1,0.778913850573982,0,37,embryonic camera-type eye development,BP,
7674,GO:0031077,1,0.956155056844869,0,7,post-embryonic camera-type eye development,BP,
7675,GO:0031078,1,0.930398058266878,0,11,histone deacetylase activity (H3-K14 specific),MF,
7676,GO:0031080,1,0.937289005323586,0,10,nuclear pore outer ring,CC,
7677,GO:0031081,1,0.987327624599677,0,2,nuclear pore distribution,BP,
7678,GO:0031082,1,0.889859063916247,0,19,BLOC complex,CC,
7679,GO:0031083,1,0.919092234192432,0,14,BLOC-1 complex,CC,
7680,GO:0031084,1,0.980656030787019,0,3,BLOC-2 complex,CC,
7681,GO:0031085,1,0.987321549840704,0,2,BLOC-3 complex,CC,
7682,GO:0031086,1,0.957547434860103,0,7,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7683,GO:0031087,1,0.963546658564463,0,6,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7684,GO:0031088,1,0.961520510535645,0,6,platelet dense granule membrane,CC,
7685,GO:0031089,1,0.936017593428688,0,11,platelet dense granule lumen,CC,
7687,GO:0031091,1,0.587504515737616,0,84,platelet alpha granule,CC,
7688,GO:0031092,1,0.900143364602298,0,16,platelet alpha granule membrane,CC,
7689,GO:0031093,1,0.674015269746612,0,63,platelet alpha granule lumen,CC,
7690,GO:0031094,1,0.92450958427653,0,11,platelet dense tubular network,CC,
7691,GO:0031095,1,0.936154884849137,0,9,platelet dense tubular network membrane,CC,
7694,GO:0031100,1,0.638616376154158,0,71,animal organ regeneration,BP,
7695,GO:0031102,1,0.729266384800555,0,49,neuron projection regeneration,BP,
7696,GO:0031103,1,0.772174035079174,0,40,axon regeneration,BP,
7697,GO:0031104,1,0.993469789872251,0,1,dendrite regeneration,BP,
7702,GO:0031111,1,0.810678566697504,0,32,negative regulation of microtubule polymerization or depolymerization,BP,
7703,GO:0031112,1,0.836869699665592,0,27,positive regulation of microtubule polymerization or depolymerization,BP,
7705,GO:0031114,1,0.837921723731574,0,26,regulation of microtubule depolymerization,BP,
7706,GO:0031115,1,0.933894905808409,0,11,negative regulation of microtubule polymerization,BP,
7707,GO:0031116,1,0.852092063138613,0,24,positive regulation of microtubule polymerization,BP,
7708,GO:0031117,1,0.982164202400249,0,3,positive regulation of microtubule depolymerization,BP,
7709,GO:0031118,1,0.954607786609135,0,8,rRNA pseudouridine synthesis,BP,
7710,GO:0031119,1,0.959129996942234,0,7,tRNA pseudouridine synthesis,BP,
7711,GO:0031120,1,0.977259363581245,0,4,snRNA pseudouridine synthesis,BP,
7712,GO:0031122,1,0.706050236990791,0,52,cytoplasmic microtubule organization,BP,
7713,GO:0031123,1,0.470638159960165,0,120,RNA 3'-end processing,BP,
7714,GO:0031124,1,0.574615894624472,0,88,mRNA 3'-end processing,BP,
7715,GO:0031125,1,0.932245699233852,0,12,rRNA 3'-end processing,BP,
7716,GO:0031126,1,0.960138498665575,0,7,snoRNA 3'-end processing,BP,
7717,GO:0031127,1,0.993426410060018,0,1,alpha-(1,2)-fucosyltransferase activity,MF,
7719,GO:0031129,1,0.993152443633547,0,1,inductive cell-cell signaling,BP,
7721,GO:0031134,1,0.981347879551438,0,3,sister chromatid biorientation,BP,
7722,GO:0031143,1,0.915164159829089,0,14,pseudopodium,CC,
7723,GO:0031145,1,0.631697031889245,0,77,anaphase-promoting complex-dependent catabolic process,BP,
7725,GO:0031151,1,0.992498731644909,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7726,GO:0031161,1,0.993739840477931,0,1,phosphatidylinositol catabolic process,BP,
7727,GO:0031163,1,0.886970800338555,0,20,metallo-sulfur cluster assembly,BP,
7728,GO:0031166,1,0.980891272617253,0,3,integral component of vacuolar membrane,CC,
7729,GO:0031167,1,0.896261790112571,0,18,rRNA methylation,BP,
7731,GO:0031177,1,0.981229690078724,0,3,phosphopantetheine binding,MF,
7732,GO:0031179,1,0.993573236050278,0,1,peptide modification,BP,
7733,GO:0031201,1,0.738539153716341,0,49,SNARE complex,CC,
7734,GO:0031204,1,0.9807154278605,0,3,posttranslational protein targeting to membrane, translocation,BP,
7735,GO:0031205,1,0.980527241345033,0,3,endoplasmic reticulum Sec complex,CC,
7736,GO:0031208,1,0.986640531630367,0,2,POZ domain binding,MF,
7737,GO:0031209,1,0.94817763470652,0,8,SCAR complex,CC,
7738,GO:0031210,1,0.897993459361095,0,17,phosphatidylcholine binding,MF,
7739,GO:0031211,1,0.951288488973353,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7740,GO:0031213,1,0.986744565921698,0,2,RSF complex,CC,
7742,GO:0031223,1,0.92511813935569,0,11,auditory behavior,BP,
7746,GO:0031227,1,0.415770974220141,0,141,intrinsic component of endoplasmic reticulum membrane,CC,
7747,GO:0031228,1,0.74953667469045,0,46,intrinsic component of Golgi membrane,CC,
7748,GO:0031229,1,0.916372339995868,0,14,intrinsic component of nuclear inner membrane,CC,
7749,GO:0031231,1,0.901700331408055,0,17,intrinsic component of peroxisomal membrane,CC,
7751,GO:0031233,1,0.893570178509853,0,18,intrinsic component of external side of plasma membrane,CC,
7752,GO:0031234,1,0.512457740064687,0,105,extrinsic component of cytoplasmic side of plasma membrane,CC,
7754,GO:0031247,1,0.987945786342409,0,2,actin rod assembly,BP,
7755,GO:0031248,1,0.579981600202194,0,85,protein acetyltransferase complex,CC,
7756,GO:0031249,1,0.993947293495943,0,1,denatured protein binding,MF,
7757,GO:0031251,1,0.986187141591124,0,2,PAN complex,CC,
7760,GO:0031254,1,0.920853898020393,0,13,cell trailing edge,CC,
7762,GO:0031257,1,0.993846081630578,0,1,cell trailing edge membrane,CC,
7763,GO:0031258,1,0.863020268709626,0,22,lamellipodium membrane,CC,
7764,GO:0031259,1,0.993846081630578,0,1,uropod membrane,CC,
7765,GO:0031261,1,0.969849832144262,0,5,DNA replication preinitiation complex,CC,
7766,GO:0031262,1,0.977021826798648,0,4,Ndc80 complex,CC,
7767,GO:0031264,1,0.945814970852028,0,9,death-inducing signaling complex,CC,
7768,GO:0031265,1,0.963391149204892,0,6,CD95 death-inducing signaling complex,CC,
7770,GO:0031268,1,0.92141648825525,0,13,pseudopodium organization,BP,
7771,GO:0031269,1,0.92141648825525,0,13,pseudopodium assembly,BP,
7772,GO:0031271,1,0.993846081630578,0,1,lateral pseudopodium assembly,BP,
7773,GO:0031272,1,0.92141648825525,0,13,regulation of pseudopodium assembly,BP,
7774,GO:0031274,1,0.927126341921182,0,12,positive regulation of pseudopodium assembly,BP,
7775,GO:0031275,1,0.993846081630578,0,1,regulation of lateral pseudopodium assembly,BP,
7778,GO:0031281,1,0.904008303059413,0,16,positive regulation of cyclase activity,BP,
7779,GO:0031282,1,0.946125541792197,0,9,regulation of guanylate cyclase activity,BP,
7780,GO:0031283,1,0.994241391201421,0,1,negative regulation of guanylate cyclase activity,BP,
7781,GO:0031284,1,0.951608248857913,0,8,positive regulation of guanylate cyclase activity,BP,
7782,GO:0031289,1,0.993768151168476,0,1,actin phosphorylation,BP,
7783,GO:0031290,1,0.880041947451641,0,19,retinal ganglion cell axon guidance,BP,
7784,GO:0031291,1,0.981721995565537,0,3,Ran protein signal transduction,BP,
7785,GO:0031293,1,0.857006307681858,0,24,membrane protein intracellular domain proteolysis,BP,
7786,GO:0031294,1,0.658762847142754,0,68,lymphocyte costimulation,BP,
7787,GO:0031295,1,0.662552653662103,0,67,T cell costimulation,BP,
7788,GO:0031296,1,0.983084427488203,0,3,B cell costimulation,BP,
7789,GO:0031297,1,0.839148437348807,0,27,replication fork processing,BP,
7790,GO:0031298,1,0.945051048779056,0,9,replication fork protection complex,CC,
7793,GO:0031302,1,0.993171465498053,0,1,intrinsic component of endosome membrane,CC,
7794,GO:0031304,1,0.809001998705339,0,35,intrinsic component of mitochondrial inner membrane,CC,
7795,GO:0031305,1,0.809001998705339,0,35,integral component of mitochondrial inner membrane,CC,
7796,GO:0031306,1,0.867222030882873,0,23,intrinsic component of mitochondrial outer membrane,CC,
7797,GO:0031307,1,0.873062939568695,0,22,integral component of mitochondrial outer membrane,CC,
7798,GO:0031308,1,0.993846081630578,0,1,intrinsic component of nuclear outer membrane,CC,
7799,GO:0031309,1,0.993846081630578,0,1,integral component of nuclear outer membrane,CC,
7800,GO:0031310,1,0.980891272617253,0,3,intrinsic component of vacuolar membrane,CC,
7802,GO:0031313,1,0.950383666833748,0,8,extrinsic component of endosome membrane,CC,
7803,GO:0031314,1,0.968592530796158,0,5,extrinsic component of mitochondrial inner membrane,CC,
7805,GO:0031320,1,0.993916777748947,0,1,hexitol dehydrogenase activity,MF,
7813,GO:0031330,1,0.259625801608675,0,208,negative regulation of cellular catabolic process,BP,
7815,GO:0031332,1,0.928377994734002,0,11,RNAi effector complex,CC,
7816,GO:0031333,1,0.464570023648575,0,119,negative regulation of protein complex assembly,BP,
7818,GO:0031335,1,0.987952210536008,0,2,regulation of sulfur amino acid metabolic process,BP,
7819,GO:0031337,1,0.993991528798771,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7820,GO:0031338,1,0.691140334630425,0,57,regulation of vesicle fusion,BP,
7821,GO:0031339,1,0.961656060261316,0,6,negative regulation of vesicle fusion,BP,
7822,GO:0031340,1,0.956751470193389,0,7,positive regulation of vesicle fusion,BP,
7823,GO:0031341,1,0.693120003305649,0,60,regulation of cell killing,BP,
7824,GO:0031342,1,0.907254474630648,0,16,negative regulation of cell killing,BP,
7825,GO:0031343,1,0.792459251561371,0,38,positive regulation of cell killing,BP,
7830,GO:0031348,1,0.385550768619834,0,151,negative regulation of defense response,BP,
7832,GO:0031362,1,0.915347975744994,0,14,anchored component of external side of plasma membrane,CC,
7834,GO:0031369,1,0.834193382348914,0,29,translation initiation factor binding,MF,
7835,GO:0031370,1,0.993280575130787,0,1,eukaryotic initiation factor 4G binding,MF,
7836,GO:0031371,1,0.952248465259698,0,8,ubiquitin conjugating enzyme complex,CC,
7837,GO:0031372,1,0.988153539344705,0,2,UBC13-MMS2 complex,CC,
7838,GO:0031379,1,0.987232670850143,0,2,RNA-directed RNA polymerase complex,CC,
7839,GO:0031380,1,0.993697840280528,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7840,GO:0031386,1,0.910498802192005,0,16,protein tag,MF,
7841,GO:0031389,1,0.993810810410542,0,1,Rad17 RFC-like complex,CC,
7842,GO:0031390,1,0.95257897133056,0,8,Ctf18 RFC-like complex,CC,
7843,GO:0031392,1,0.968727996538374,0,5,regulation of prostaglandin biosynthetic process,BP,
7844,GO:0031393,1,0.987326798979397,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7845,GO:0031394,1,0.981164894098947,0,3,positive regulation of prostaglandin biosynthetic process,BP,
7847,GO:0031397,1,0.678751604821968,0,61,negative regulation of protein ubiquitination,BP,
7853,GO:0031403,1,0.986233756525499,0,2,lithium ion binding,MF,
7854,GO:0031404,1,0.945485057108221,0,9,chloride ion binding,MF,
7855,GO:0031405,1,0.991522852838188,0,1,lipoic acid binding,MF,
7857,GO:0031407,1,0.993963713936849,0,1,oxylipin metabolic process,BP,
7859,GO:0031414,1,0.93680014134443,0,10,N-terminal protein acetyltransferase complex,CC,
7860,GO:0031415,1,0.96974984922789,0,5,NatA complex,CC,
7861,GO:0031416,1,0.98734616498335,0,2,NatB complex,CC,
7862,GO:0031417,1,0.978416390075076,0,3,NatC complex,CC,
7863,GO:0031418,1,0.883287218614379,0,20,L-ascorbic acid binding,MF,
7864,GO:0031419,1,0.941928464571006,0,9,cobalamin binding,MF,
7866,GO:0031424,1,0.647321608183566,0,70,keratinization,BP,
7867,GO:0031427,1,0.974952822583925,0,4,response to methotrexate,BP,
7868,GO:0031428,1,0.976846431094041,0,4,box C/D snoRNP complex,CC,
7869,GO:0031429,1,0.971705618001626,0,5,box H/ACA snoRNP complex,CC,
7871,GO:0031431,1,0.987395688652454,0,2,Dbf4-dependent protein kinase complex,CC,
7873,GO:0031433,1,0.940931929325976,0,6,telethonin binding,MF,
7875,GO:0031435,1,0.907732736122541,0,15,mitogen-activated protein kinase kinase kinase binding,MF,
7876,GO:0031436,1,0.986534920104241,0,2,BRCA1-BARD1 complex,CC,
7877,GO:0031437,1,0.981204525104721,0,3,regulation of mRNA cleavage,BP,
7878,GO:0031438,1,0.993760427722582,0,1,negative regulation of mRNA cleavage,BP,
7879,GO:0031439,1,0.987366063913567,0,2,positive regulation of mRNA cleavage,BP,
7880,GO:0031440,1,0.869171443349677,0,22,regulation of mRNA 3'-end processing,BP,
7881,GO:0031441,1,0.944405884660342,0,9,negative regulation of mRNA 3'-end processing,BP,
7882,GO:0031442,1,0.943969219435541,0,9,positive regulation of mRNA 3'-end processing,BP,
7883,GO:0031443,1,0.986340428353529,0,2,fast-twitch skeletal muscle fiber contraction,BP,
7884,GO:0031444,1,0.98168325155853,0,3,slow-twitch skeletal muscle fiber contraction,BP,
7885,GO:0031445,1,0.98605488023304,0,2,regulation of heterochromatin assembly,BP,
7886,GO:0031446,1,0.993629467245593,0,1,regulation of fast-twitch skeletal muscle fiber contraction,BP,
7887,GO:0031448,1,0.993629467245593,0,1,positive regulation of fast-twitch skeletal muscle fiber contraction,BP,
7888,GO:0031449,1,0.992901902858012,0,1,regulation of slow-twitch skeletal muscle fiber contraction,BP,
7889,GO:0031453,1,0.98605488023304,0,2,positive regulation of heterochromatin assembly,BP,
7890,GO:0031455,1,0.987258265738285,0,2,glycine betaine metabolic process,BP,
7891,GO:0031456,1,0.987258265738285,0,2,glycine betaine biosynthetic process,BP,
7892,GO:0031460,1,0.993239433575035,0,1,glycine betaine transport,BP,
7894,GO:0031462,1,0.914339939273729,0,14,Cul2-RING ubiquitin ligase complex,CC,
7895,GO:0031463,1,0.651646703006382,0,66,Cul3-RING ubiquitin ligase complex,CC,
7896,GO:0031464,1,0.928132738872388,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7897,GO:0031465,1,0.968895270434902,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
7898,GO:0031466,1,0.963626503737659,0,6,Cul5-RING ubiquitin ligase complex,CC,
7899,GO:0031467,1,0.969364151022574,0,5,Cul7-RING ubiquitin ligase complex,CC,
7900,GO:0031468,1,0.895566031117249,0,18,nuclear envelope reassembly,BP,
7901,GO:0031475,1,0.994207892959886,0,1,myosin V complex,CC,
7902,GO:0031477,1,0.992520445296379,0,1,myosin VII complex,CC,
7903,GO:0031489,1,0.905246992426084,0,16,myosin V binding,MF,
7904,GO:0031490,1,0.55586857867308,0,91,chromatin DNA binding,MF,
7905,GO:0031491,1,0.705785622234841,0,55,nucleosome binding,MF,
7906,GO:0031492,1,0.819705598525258,0,32,nucleosomal DNA binding,MF,
7907,GO:0031493,1,0.988034723299409,0,2,nucleosomal histone binding,MF,
7908,GO:0031497,1,0.513132592738793,0,108,chromatin assembly,BP,
7910,GO:0031501,1,0.977221866086861,0,4,mannosyltransferase complex,CC,
7911,GO:0031503,1,0.222012710796856,0,233,protein-containing complex localization,BP,
7912,GO:0031506,1,0.994134543005102,0,1,cell wall glycoprotein biosynthetic process,BP,
7913,GO:0031507,1,0.942715609350773,0,9,heterochromatin assembly,BP,
7914,GO:0031508,1,0.988094892655603,0,2,pericentric heterochromatin assembly,BP,
7915,GO:0031509,1,0.994173817092608,0,1,telomeric heterochromatin assembly,BP,
7916,GO:0031510,1,0.982144027337344,0,3,SUMO activating enzyme complex,CC,
7918,GO:0031515,1,0.981914966864661,0,3,tRNA (m1A) methyltransferase complex,CC,
7919,GO:0031519,1,0.741028067065316,0,46,PcG protein complex,CC,
7920,GO:0031523,1,0.986093837858597,0,2,Myb complex,CC,
7922,GO:0031527,1,0.889573639854529,0,17,filopodium membrane,CC,
7923,GO:0031528,1,0.873595847437829,0,21,microvillus membrane,CC,
7924,GO:0031529,1,0.75922760631612,0,44,ruffle organization,BP,
7925,GO:0031530,1,0.988715148653879,0,2,gonadotropin-releasing hormone receptor binding,MF,
7926,GO:0031531,1,0.994263915888173,0,1,thyrotropin-releasing hormone receptor binding,MF,
7927,GO:0031532,1,0.523950019980922,0,100,actin cytoskeleton reorganization,BP,
7928,GO:0031533,1,0.992859718104023,0,1,mRNA cap methyltransferase complex,CC,
7929,GO:0031536,1,0.97677136962597,0,4,positive regulation of exit from mitosis,BP,
7930,GO:0031543,1,0.928127929052052,0,12,peptidyl-proline dioxygenase activity,MF,
7931,GO:0031544,1,0.975537446790572,0,4,peptidyl-proline 3-dioxygenase activity,MF,
7932,GO:0031545,1,0.951413623973415,0,8,peptidyl-proline 4-dioxygenase activity,MF,
7933,GO:0031547,1,0.965637759345348,0,5,brain-derived neurotrophic factor receptor signaling pathway,BP,
7934,GO:0031548,1,0.986631220484297,0,2,regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7935,GO:0031549,1,0.993095635465579,0,1,negative regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7936,GO:0031550,1,0.993491100563466,0,1,positive regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7937,GO:0031554,1,0.991459989512687,0,1,regulation of DNA-templated transcription, termination,BP,
7938,GO:0031559,1,0.993421968695501,0,1,oxidosqualene cyclase activity,MF,
7940,GO:0031571,1,0.644018151939658,0,69,mitotic G1 DNA damage checkpoint,BP,
7941,GO:0031572,1,0.811077431480524,0,32,G2 DNA damage checkpoint,BP,
7942,GO:0031573,1,0.917674557470485,0,14,intra-S DNA damage checkpoint,BP,
7943,GO:0031577,1,0.803889587499724,0,34,spindle checkpoint,BP,
7946,GO:0031581,1,0.925699366799614,0,11,hemidesmosome assembly,BP,
7947,GO:0031583,1,0.994041144618094,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
7948,GO:0031584,1,0.969356574881168,0,5,activation of phospholipase D activity,BP,
7949,GO:0031585,1,0.968926221677145,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7950,GO:0031587,1,0.977614260916493,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7951,GO:0031588,1,0.942744441363456,0,9,nucleotide-activated protein kinase complex,CC,
7953,GO:0031590,1,0.987690606713151,0,2,wybutosine metabolic process,BP,
7954,GO:0031591,1,0.987690606713151,0,2,wybutosine biosynthetic process,BP,
7955,GO:0031592,1,0.99235709730824,0,1,centrosomal corona,CC,
7956,GO:0031593,1,0.798498736847539,0,35,polyubiquitin modification-dependent protein binding,MF,
7957,GO:0031594,1,0.690535259324788,0,56,neuromuscular junction,CC,
7958,GO:0031595,1,0.953987867917779,0,8,nuclear proteasome complex,CC,
7959,GO:0031597,1,0.930186610814654,0,12,cytosolic proteasome complex,CC,
7960,GO:0031616,1,0.940766384971446,0,10,spindle pole centrosome,CC,
7961,GO:0031618,1,0.939987775631623,0,9,nuclear pericentric heterochromatin,CC,
7962,GO:0031620,1,0.956750919967758,0,7,regulation of fever generation,BP,
7963,GO:0031622,1,0.963095935440936,0,6,positive regulation of fever generation,BP,
7965,GO:0031624,1,0.802765657493347,0,33,ubiquitin conjugating enzyme binding,MF,
7967,GO:0031626,1,0.993150425839933,0,1,beta-endorphin binding,MF,
7968,GO:0031627,1,0.981323653287523,0,3,telomeric loop formation,BP,
7969,GO:0031628,1,0.951119017363336,0,8,opioid receptor binding,MF,
7970,GO:0031629,1,0.905896954576785,0,16,synaptic vesicle fusion to presynaptic active zone membrane,BP,
7971,GO:0031630,1,0.981473671646561,0,3,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
7972,GO:0031635,1,0.987368809340864,0,2,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7973,GO:0031638,1,0.774996026289399,0,41,zymogen activation,BP,
7974,GO:0031639,1,0.884904736905396,0,20,plasminogen activation,BP,
7975,GO:0031640,1,0.80662240564324,0,37,killing of cells of other organism,BP,
7977,GO:0031642,1,0.961392542474957,0,6,negative regulation of myelination,BP,
7980,GO:0031645,1,0.926680890948523,0,12,negative regulation of neurological system process,BP,
7983,GO:0031648,1,0.760283974813514,0,42,protein destabilization,BP,
7984,GO:0031649,1,0.8932515534639,0,18,heat generation,BP,
7985,GO:0031650,1,0.926912904388359,0,12,regulation of heat generation,BP,
7986,GO:0031651,1,0.993449037670222,0,1,negative regulation of heat generation,BP,
7987,GO:0031652,1,0.939218744698411,0,10,positive regulation of heat generation,BP,
7988,GO:0031657,1,0.911991919300316,0,14,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7989,GO:0031658,1,0.955685890774847,0,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7990,GO:0031659,1,0.954300637553657,0,7,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7991,GO:0031663,1,0.735936520106319,0,49,lipopolysaccharide-mediated signaling pathway,BP,
7992,GO:0031664,1,0.876187406222926,0,21,regulation of lipopolysaccharide-mediated signaling pathway,BP,
7993,GO:0031665,1,0.93981323747752,0,10,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
7994,GO:0031666,1,0.950514569803939,0,8,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
7996,GO:0031668,1,0.23739161760803,0,224,cellular response to extracellular stimulus,BP,
7997,GO:0031669,1,0.283745168275158,0,196,cellular response to nutrient levels,BP,
7998,GO:0031670,1,0.685398161498029,0,59,cellular response to nutrient,BP,
8000,GO:0031673,1,0.989503369401351,0,1,H zone,CC,
8002,GO:0031681,1,0.946055435044998,0,9,G-protein beta-subunit binding,MF,
8003,GO:0031682,1,0.993770583016034,0,1,G-protein gamma-subunit binding,MF,
8004,GO:0031683,1,0.893287143977812,0,18,G-protein beta/gamma-subunit complex binding,MF,
8005,GO:0031685,1,0.981524494021129,0,3,adenosine receptor binding,MF,
8006,GO:0031686,1,0.993752420141711,0,1,A1 adenosine receptor binding,MF,
8007,GO:0031687,1,0.994181325345393,0,1,A2A adenosine receptor binding,MF,
8008,GO:0031690,1,0.891455897672873,0,18,adrenergic receptor binding,MF,
8009,GO:0031691,1,0.988142561927884,0,2,alpha-1A adrenergic receptor binding,MF,
8010,GO:0031692,1,0.981752427597201,0,3,alpha-1B adrenergic receptor binding,MF,
8011,GO:0031694,1,0.976374163377265,0,4,alpha-2A adrenergic receptor binding,MF,
8012,GO:0031695,1,0.99393678256535,0,1,alpha-2B adrenergic receptor binding,MF,
8013,GO:0031696,1,0.98750956038478,0,2,alpha-2C adrenergic receptor binding,MF,
8014,GO:0031697,1,0.973078169956492,0,4,beta-1 adrenergic receptor binding,MF,
8015,GO:0031698,1,0.973540325506137,0,4,beta-2 adrenergic receptor binding,MF,
8016,GO:0031699,1,0.987373261005695,0,2,beta-3 adrenergic receptor binding,MF,
8017,GO:0031700,1,0.994228684974104,0,1,adrenomedullin receptor binding,MF,
8018,GO:0031701,1,0.93177159250248,0,11,angiotensin receptor binding,MF,
8019,GO:0031702,1,0.937389452584222,0,10,type 1 angiotensin receptor binding,MF,
8020,GO:0031703,1,0.99390239375709,0,1,type 2 angiotensin receptor binding,MF,
8021,GO:0031704,1,0.993718692812986,0,1,apelin receptor binding,MF,
8022,GO:0031705,1,0.982331237893996,0,3,bombesin receptor binding,MF,
8023,GO:0031707,1,0.994041144618094,0,1,endothelin A receptor binding,MF,
8024,GO:0031708,1,0.982331237893996,0,3,endothelin B receptor binding,MF,
8025,GO:0031711,1,0.987690653927802,0,2,bradykinin receptor binding,MF,
8026,GO:0031714,1,0.99316973647014,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
8027,GO:0031715,1,0.99316973647014,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
8028,GO:0031717,1,0.994172373196962,0,1,cannabinoid receptor binding,MF,
8029,GO:0031718,1,0.994172373196962,0,1,type 1 cannabinoid receptor binding,MF,
8030,GO:0031720,1,0.983511252333941,0,3,haptoglobin binding,MF,
8031,GO:0031724,1,0.994300013232335,0,1,CXCR5 chemokine receptor binding,MF,
8032,GO:0031726,1,0.994415237905012,0,1,CCR1 chemokine receptor binding,MF,
8033,GO:0031727,1,0.982870295712112,0,3,CCR2 chemokine receptor binding,MF,
8034,GO:0031728,1,0.989033388191181,0,2,CCR3 chemokine receptor binding,MF,
8035,GO:0031730,1,0.974732573542261,0,4,CCR5 chemokine receptor binding,MF,
8036,GO:0031731,1,0.988948800300425,0,2,CCR6 chemokine receptor binding,MF,
8037,GO:0031732,1,0.988875133518266,0,2,CCR7 chemokine receptor binding,MF,
8038,GO:0031735,1,0.983233632503721,0,3,CCR10 chemokine receptor binding,MF,
8039,GO:0031737,1,0.993704695006763,0,1,CX3C chemokine receptor binding,MF,
8040,GO:0031739,1,0.994034940369317,0,1,cholecystokinin receptor binding,MF,
8041,GO:0031741,1,0.994034940369317,0,1,type B gastrin/cholecystokinin receptor binding,MF,
8047,GO:0031753,1,0.993841203462039,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
8048,GO:0031755,1,0.993841203462039,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
8049,GO:0031762,1,0.988142561927884,0,2,follicle-stimulating hormone receptor binding,MF,
8050,GO:0031763,1,0.994422168860593,0,1,galanin receptor binding,MF,
8051,GO:0031764,1,0.994422168860593,0,1,type 1 galanin receptor binding,MF,
8052,GO:0031765,1,0.994422168860593,0,1,type 2 galanin receptor binding,MF,
8053,GO:0031766,1,0.994422168860593,0,1,type 3 galanin receptor binding,MF,
8054,GO:0031768,1,0.994440940310254,0,1,ghrelin receptor binding,MF,
8055,GO:0031770,1,0.994516894440089,0,1,growth hormone-releasing hormone receptor binding,MF,
8056,GO:0031773,1,0.994441517896023,0,1,kisspeptin receptor binding,MF,
8057,GO:0031775,1,0.992270732458831,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
8058,GO:0031779,1,0.977373409433207,0,4,melanocortin receptor binding,MF,
8059,GO:0031780,1,0.988454749036563,0,2,corticotropin hormone receptor binding,MF,
8060,GO:0031781,1,0.977373409433207,0,4,type 3 melanocortin receptor binding,MF,
8061,GO:0031782,1,0.977373409433207,0,4,type 4 melanocortin receptor binding,MF,
8062,GO:0031783,1,0.988454749036563,0,2,type 5 melanocortin receptor binding,MF,
8063,GO:0031798,1,0.992442409233327,0,1,type 1 metabotropic glutamate receptor binding,MF,
8064,GO:0031802,1,0.968827559622334,0,5,type 5 metabotropic glutamate receptor binding,MF,
8065,GO:0031811,1,0.993525257047037,0,1,G-protein coupled nucleotide receptor binding,MF,
8066,GO:0031812,1,0.993525257047037,0,1,P2Y1 nucleotide receptor binding,MF,
8067,GO:0031821,1,0.957078685906868,0,7,G-protein coupled serotonin receptor binding,MF,
8068,GO:0031826,1,0.982407441622494,0,3,type 2A serotonin receptor binding,MF,
8069,GO:0031834,1,0.994318350756186,0,1,neurokinin receptor binding,MF,
8070,GO:0031835,1,0.994318350756186,0,1,substance P receptor binding,MF,
8071,GO:0031838,1,0.977863254611699,0,4,haptoglobin-hemoglobin complex,CC,
8072,GO:0031839,1,0.994411772435139,0,1,type 1 neuromedin U receptor binding,MF,
8073,GO:0031840,1,0.994411772435139,0,1,type 2 neuromedin U receptor binding,MF,
8074,GO:0031841,1,0.994485414935947,0,1,neuropeptide Y receptor binding,MF,
8075,GO:0031848,1,0.938417443897057,0,10,protection from non-homologous end joining at telomere,BP,
8076,GO:0031849,1,0.975992421633788,0,4,olfactory receptor binding,MF,
8077,GO:0031852,1,0.973765077475093,0,4,mu-type opioid receptor binding,MF,
8078,GO:0031858,1,0.993732837701607,0,1,pituitary adenylate cyclase-activating polypeptide receptor binding,MF,
8079,GO:0031859,1,0.994096714446092,0,1,platelet activating factor receptor binding,MF,
8080,GO:0031860,1,0.980008106154229,0,3,telomeric 3' overhang formation,BP,
8081,GO:0031862,1,0.986485511318564,0,2,prostanoid receptor binding,MF,
8082,GO:0031867,1,0.993542253986565,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
8083,GO:0031870,1,0.992897858165778,0,1,thromboxane A2 receptor binding,MF,
8084,GO:0031871,1,0.980925687439211,0,3,proteinase activated receptor binding,MF,
8085,GO:0031877,1,0.99272934649843,0,1,somatostatin receptor binding,MF,
8086,GO:0031883,1,0.994040134586067,0,1,taste receptor binding,MF,
8087,GO:0031893,1,0.987502425073664,0,2,vasopressin receptor binding,MF,
8088,GO:0031894,1,0.993452759729804,0,1,V1A vasopressin receptor binding,MF,
8089,GO:0031896,1,0.994010850610291,0,1,V2 vasopressin receptor binding,MF,
8091,GO:0031902,1,0.492501232216463,0,114,late endosome membrane,CC,
8094,GO:0031905,1,0.981860567906426,0,3,early endosome lumen,CC,
8095,GO:0031906,1,0.966042411797498,0,6,late endosome lumen,CC,
8096,GO:0031907,1,0.778328084822164,0,41,microbody lumen,CC,
8097,GO:0031914,1,0.973623268941351,0,4,negative regulation of synaptic plasticity,BP,
8098,GO:0031915,1,0.942967901886239,0,9,positive regulation of synaptic plasticity,BP,
8099,GO:0031929,1,0.52405149659568,0,99,TOR signaling,BP,
8100,GO:0031930,1,0.994224642083472,0,1,mitochondria-nucleus signaling pathway,BP,
8101,GO:0031931,1,0.954273845939031,0,7,TORC1 complex,CC,
8102,GO:0031932,1,0.91999661859327,0,13,TORC2 complex,CC,
8103,GO:0031933,1,0.979743988419884,0,3,telomeric heterochromatin,CC,
8104,GO:0031935,1,0.880846768643131,0,19,regulation of chromatin silencing,BP,
8105,GO:0031936,1,0.946372303654003,0,8,negative regulation of chromatin silencing,BP,
8106,GO:0031937,1,0.948549861038142,0,8,positive regulation of chromatin silencing,BP,
8107,GO:0031938,1,0.988299408732025,0,2,regulation of chromatin silencing at telomere,BP,
8108,GO:0031940,1,0.994173817092608,0,1,positive regulation of chromatin silencing at telomere,BP,
8109,GO:0031941,1,0.791637980278942,0,36,filamentous actin,CC,
8110,GO:0031943,1,0.945559907540014,0,9,regulation of glucocorticoid metabolic process,BP,
8111,GO:0031944,1,0.969155487620109,0,5,negative regulation of glucocorticoid metabolic process,BP,
8112,GO:0031945,1,0.993523685605848,0,1,positive regulation of glucocorticoid metabolic process,BP,
8113,GO:0031946,1,0.956431601753587,0,7,regulation of glucocorticoid biosynthetic process,BP,
8114,GO:0031947,1,0.969155487620109,0,5,negative regulation of glucocorticoid biosynthetic process,BP,
8115,GO:0031948,1,0.993523685605848,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
8117,GO:0031953,1,0.938197104607749,0,10,negative regulation of protein autophosphorylation,BP,
8119,GO:0031956,1,0.956189150112812,0,7,medium-chain fatty acid-CoA ligase activity,MF,
8120,GO:0031957,1,0.945488048632987,0,9,very long-chain fatty acid-CoA ligase activity,MF,
8121,GO:0031958,1,0.893428257607088,0,17,corticosteroid receptor signaling pathway,BP,
8122,GO:0031959,1,0.987009288913982,0,2,mineralocorticoid receptor signaling pathway,BP,
8123,GO:0031960,1,0.395851171232617,0,147,response to corticosteroid,BP,
8124,GO:0031962,1,0.992946821815491,0,1,mineralocorticoid receptor binding,MF,
8129,GO:0031970,1,0.627009129490777,0,77,organelle envelope lumen,CC,
8136,GO:0031985,1,0.530301866401225,0,99,Golgi cisterna,CC,
8138,GO:0031989,1,0.994239369756067,0,1,bombesin receptor signaling pathway,BP,
8139,GO:0031990,1,0.985858767283349,0,2,mRNA export from nucleus in response to heat stress,BP,
8140,GO:0031994,1,0.915694622507047,0,13,insulin-like growth factor I binding,MF,
8141,GO:0031995,1,0.948740153967581,0,8,insulin-like growth factor II binding,MF,
8142,GO:0031996,1,0.933707041182466,0,11,thioesterase binding,MF,
8143,GO:0031997,1,0.98180172140023,0,3,N-terminal myristoylation domain binding,MF,
8144,GO:0031998,1,0.896131750320369,0,16,regulation of fatty acid beta-oxidation,BP,
8145,GO:0031999,1,0.972977039229089,0,4,negative regulation of fatty acid beta-oxidation,BP,
8146,GO:0032000,1,0.940499163571756,0,9,positive regulation of fatty acid beta-oxidation,BP,
8147,GO:0032002,1,0.987969572555115,0,2,interleukin-28 receptor complex,CC,
8148,GO:0032006,1,0.585967507460587,0,82,regulation of TOR signaling,BP,
8149,GO:0032007,1,0.780709889713515,0,38,negative regulation of TOR signaling,BP,
8150,GO:0032008,1,0.809110763453794,0,33,positive regulation of TOR signaling,BP,
8151,GO:0032009,1,0.948625652026627,0,8,early phagosome,CC,
8152,GO:0032010,1,0.970424697804968,0,5,phagolysosome,CC,
8155,GO:0032020,1,0.964945977303985,0,6,ISG15-protein conjugation,BP,
8156,GO:0032021,1,0.975608343238402,0,4,NELF complex,CC,
8157,GO:0032023,1,0.993988789761408,0,1,trypsinogen activation,BP,
8159,GO:0032025,1,0.945411590604297,0,9,response to cobalt ion,BP,
8160,GO:0032026,1,0.89647037048791,0,16,response to magnesium ion,BP,
8161,GO:0032027,1,0.968526874306143,0,5,myosin light chain binding,MF,
8162,GO:0032028,1,0.994038403136624,0,1,myosin head/neck binding,MF,
8163,GO:0032029,1,0.991241854145486,0,1,myosin tail binding,MF,
8164,GO:0032036,1,0.944813093776448,0,9,myosin heavy chain binding,MF,
8165,GO:0032038,1,0.988801039379852,0,2,myosin II heavy chain binding,MF,
8166,GO:0032039,1,0.904168542800088,0,15,integrator complex,CC,
8167,GO:0032040,1,0.818684190514486,0,32,small-subunit processome,CC,
8168,GO:0032041,1,0.930398058266878,0,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
8169,GO:0032042,1,0.902884040856857,0,16,mitochondrial DNA metabolic process,BP,
8170,GO:0032044,1,0.987827154906811,0,2,DSIF complex,CC,
8171,GO:0032045,1,0.917570381152647,0,13,guanyl-nucleotide exchange factor complex,CC,
8172,GO:0032048,1,0.916265074457316,0,14,cardiolipin metabolic process,BP,
8173,GO:0032049,1,0.951884080286118,0,8,cardiolipin biosynthetic process,BP,
8174,GO:0032050,1,0.953052566286645,0,7,clathrin heavy chain binding,MF,
8175,GO:0032051,1,0.965981554579657,0,5,clathrin light chain binding,MF,
8176,GO:0032052,1,0.942943741612206,0,10,bile acid binding,MF,
8177,GO:0032053,1,0.986611957452031,0,2,ciliary basal body organization,BP,
8178,GO:0032055,1,0.962369332054819,0,6,negative regulation of translation in response to stress,BP,
8179,GO:0032056,1,0.962291610308372,0,6,positive regulation of translation in response to stress,BP,
8180,GO:0032057,1,0.974208189747679,0,4,negative regulation of translational initiation in response to stress,BP,
8181,GO:0032058,1,0.973871800779538,0,4,positive regulation of translational initiation in response to stress,BP,
8182,GO:0032059,1,0.949916410875308,0,8,bleb,CC,
8184,GO:0032069,1,0.830622161934341,0,30,regulation of nuclease activity,BP,
8185,GO:0032070,1,0.94114625560356,0,10,regulation of deoxyribonuclease activity,BP,
8186,GO:0032071,1,0.952429503972502,0,8,regulation of endodeoxyribonuclease activity,BP,
8187,GO:0032072,1,0.993660436899797,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
8188,GO:0032074,1,0.957930885607552,0,7,negative regulation of nuclease activity,BP,
8189,GO:0032075,1,0.906183131940759,0,16,positive regulation of nuclease activity,BP,
8190,GO:0032076,1,0.988286060279591,0,2,negative regulation of deoxyribonuclease activity,BP,
8191,GO:0032077,1,0.970196543082896,0,5,positive regulation of deoxyribonuclease activity,BP,
8192,GO:0032078,1,0.994388380642999,0,1,negative regulation of endodeoxyribonuclease activity,BP,
8193,GO:0032079,1,0.975798442463798,0,4,positive regulation of endodeoxyribonuclease activity,BP,
8194,GO:0032088,1,0.606185340232378,0,79,negative regulation of NF-kappaB transcription factor activity,BP,
8195,GO:0032089,1,0.98699175084616,0,2,NACHT domain binding,MF,
8196,GO:0032090,1,0.988053663020139,0,2,Pyrin domain binding,MF,
8197,GO:0032091,1,0.560950457735434,0,91,negative regulation of protein binding,BP,
8198,GO:0032092,1,0.57712460180653,0,84,positive regulation of protein binding,BP,
8199,GO:0032093,1,0.993846081630578,0,1,SAM domain binding,MF,
8203,GO:0032097,1,0.983129369789275,0,3,positive regulation of response to food,BP,
8206,GO:0032100,1,0.983129369789275,0,3,positive regulation of appetite,BP,
8212,GO:0032106,1,0.971324647167952,0,5,positive regulation of response to extracellular stimulus,BP,
8215,GO:0032109,1,0.971324647167952,0,5,positive regulation of response to nutrient levels,BP,
8216,GO:0032116,1,0.985612665301958,0,2,SMC loading complex,CC,
8217,GO:0032119,1,0.933910335675813,0,11,sequestering of zinc ion,BP,
8218,GO:0032127,1,0.987248533472056,0,2,dense core granule membrane,CC,
8219,GO:0032129,1,0.987751751576033,0,2,histone deacetylase activity (H3-K9 specific),MF,
8220,GO:0032133,1,0.970826692142718,0,5,chromosome passenger complex,CC,
8221,GO:0032135,1,0.962731218306974,0,6,DNA insertion or deletion binding,MF,
8222,GO:0032137,1,0.981191810273648,0,3,guanine/thymine mispair binding,MF,
8223,GO:0032138,1,0.974524107522909,0,4,single base insertion or deletion binding,MF,
8224,GO:0032139,1,0.981425430857716,0,3,dinucleotide insertion or deletion binding,MF,
8225,GO:0032142,1,0.980578703574331,0,3,single guanine insertion binding,MF,
8226,GO:0032143,1,0.987180788278317,0,2,single thymine insertion binding,MF,
8227,GO:0032144,1,0.993232525385339,0,1,4-aminobutyrate transaminase complex,CC,
8228,GO:0032145,1,0.993232525385339,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8232,GO:0032154,1,0.712366227500861,0,52,cleavage furrow,CC,
8233,GO:0032155,1,0.671819432875676,0,61,cell division site part,CC,
8236,GO:0032173,1,0.993781457214331,0,1,septin collar,CC,
8237,GO:0032181,1,0.987091497977493,0,2,dinucleotide repeat insertion binding,MF,
8239,GO:0032183,1,0.909477175398309,0,14,SUMO binding,MF,
8240,GO:0032184,1,0.966706360094116,0,5,SUMO polymer binding,MF,
8242,GO:0032190,1,0.98255733500946,0,3,acrosin binding,MF,
8243,GO:0032194,1,0.993595930235619,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
8244,GO:0032196,1,0.887587055098891,0,19,transposition,BP,
8245,GO:0032200,1,0.383260848549054,0,149,telomere organization,BP,
8246,GO:0032201,1,0.845766958443314,0,27,telomere maintenance via semi-conservative replication,BP,
8247,GO:0032202,1,0.975913827475072,0,4,telomere assembly,BP,
8248,GO:0032203,1,0.994110430321073,0,1,telomere formation via telomerase,BP,
8249,GO:0032204,1,0.608661069771549,0,76,regulation of telomere maintenance,BP,
8250,GO:0032205,1,0.79625456727988,0,34,negative regulation of telomere maintenance,BP,
8251,GO:0032206,1,0.730925565308957,0,49,positive regulation of telomere maintenance,BP,
8252,GO:0032207,1,0.993810523874367,0,1,regulation of telomere maintenance via recombination,BP,
8253,GO:0032208,1,0.993810523874367,0,1,negative regulation of telomere maintenance via recombination,BP,
8254,GO:0032210,1,0.714169774832716,0,52,regulation of telomere maintenance via telomerase,BP,
8255,GO:0032211,1,0.882288816088677,0,19,negative regulation of telomere maintenance via telomerase,BP,
8256,GO:0032212,1,0.805962339729274,0,34,positive regulation of telomere maintenance via telomerase,BP,
8257,GO:0032213,1,0.987648861234141,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
8258,GO:0032214,1,0.987648861234141,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
8259,GO:0032217,1,0.976058140115995,0,4,riboflavin transmembrane transporter activity,MF,
8260,GO:0032218,1,0.981650478584491,0,3,riboflavin transport,BP,
8261,GO:0032222,1,0.95632656457379,0,7,regulation of synaptic transmission, cholinergic,BP,
8262,GO:0032223,1,0.993902249952584,0,1,negative regulation of synaptic transmission, cholinergic,BP,
8263,GO:0032224,1,0.968127611964946,0,5,positive regulation of synaptic transmission, cholinergic,BP,
8265,GO:0032226,1,0.958189175579763,0,7,positive regulation of synaptic transmission, dopaminergic,BP,
8266,GO:0032227,1,0.980553971657452,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
8268,GO:0032229,1,0.96381038092827,0,6,negative regulation of synaptic transmission, GABAergic,BP,
8271,GO:0032232,1,0.863404639810775,0,22,negative regulation of actin filament bundle assembly,BP,
8273,GO:0032237,1,0.974155344428127,0,4,activation of store-operated calcium channel activity,BP,
8274,GO:0032239,1,0.89205875844357,0,17,regulation of nucleobase-containing compound transport,BP,
8275,GO:0032240,1,0.984896382526277,0,2,negative regulation of nucleobase-containing compound transport,BP,
8276,GO:0032241,1,0.949074269682129,0,8,positive regulation of nucleobase-containing compound transport,BP,
8277,GO:0032242,1,0.993827435493265,0,1,regulation of nucleoside transport,BP,
8278,GO:0032244,1,0.993827435493265,0,1,positive regulation of nucleoside transport,BP,
8279,GO:0032252,1,0.971577725226254,0,4,secretory granule localization,BP,
8280,GO:0032253,1,0.993846081630578,0,1,dense core granule localization,BP,
8281,GO:0032258,1,0.987908467919477,0,2,protein localization by the Cvt pathway,BP,
8282,GO:0032259,1,0.14045521569462,0,306,methylation,BP,
8283,GO:0032261,1,0.958724452121853,0,7,purine nucleotide salvage,BP,
8284,GO:0032262,1,0.96519891153028,0,6,pyrimidine nucleotide salvage,BP,
8285,GO:0032263,1,0.988360845850408,0,2,GMP salvage,BP,
8286,GO:0032264,1,0.975518835869651,0,4,IMP salvage,BP,
8287,GO:0032266,1,0.805189643426255,0,33,phosphatidylinositol-3-phosphate binding,MF,
8292,GO:0032272,1,0.666449642010585,0,63,negative regulation of protein polymerization,BP,
8294,GO:0032274,1,0.914481087347867,0,14,gonadotropin secretion,BP,
8295,GO:0032275,1,0.937235290694942,0,10,luteinizing hormone secretion,BP,
8296,GO:0032276,1,0.93916740504158,0,10,regulation of gonadotropin secretion,BP,
8297,GO:0032277,1,0.96397663626488,0,6,negative regulation of gonadotropin secretion,BP,
8298,GO:0032278,1,0.956817356572753,0,7,positive regulation of gonadotropin secretion,BP,
8300,GO:0032280,1,0.94790076582423,0,8,symmetric synapse,CC,
8301,GO:0032281,1,0.843309708539378,0,27,AMPA glutamate receptor complex,CC,
8304,GO:0032288,1,0.871273608405951,0,20,myelin assembly,BP,
8305,GO:0032289,1,0.981648413749457,0,3,central nervous system myelin formation,BP,
8306,GO:0032290,1,0.968386339252591,0,4,peripheral nervous system myelin formation,BP,
8309,GO:0032296,1,0.973305887587926,0,4,double-stranded RNA-specific ribonuclease activity,MF,
8310,GO:0032298,1,0.993999314298386,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
8311,GO:0032299,1,0.982454772053717,0,3,ribonuclease H2 complex,CC,
8312,GO:0032300,1,0.942634757370249,0,9,mismatch repair complex,CC,
8313,GO:0032301,1,0.987180788278317,0,2,MutSalpha complex,CC,
8314,GO:0032302,1,0.987091497977493,0,2,MutSbeta complex,CC,
8315,GO:0032303,1,0.934028559862864,0,11,regulation of icosanoid secretion,BP,
8316,GO:0032304,1,0.993197107021168,0,1,negative regulation of icosanoid secretion,BP,
8317,GO:0032305,1,0.94042842881141,0,10,positive regulation of icosanoid secretion,BP,
8318,GO:0032306,1,0.959119899040341,0,7,regulation of prostaglandin secretion,BP,
8319,GO:0032308,1,0.959119899040341,0,7,positive regulation of prostaglandin secretion,BP,
8320,GO:0032309,1,0.840650036562355,0,28,icosanoid secretion,BP,
8321,GO:0032310,1,0.940483292859284,0,10,prostaglandin secretion,BP,
8322,GO:0032311,1,0.98849664086734,0,2,angiogenin-PRI complex,CC,
8323,GO:0032324,1,0.957804923536054,0,7,molybdopterin cofactor biosynthetic process,BP,
8324,GO:0032328,1,0.949378265721331,0,8,alanine transport,BP,
8325,GO:0032329,1,0.941070263087131,0,10,serine transport,BP,
8328,GO:0032332,1,0.883132376993819,0,19,positive regulation of chondrocyte differentiation,BP,
8329,GO:0032341,1,0.955648962266948,0,7,aldosterone metabolic process,BP,
8330,GO:0032342,1,0.955648962266948,0,7,aldosterone biosynthetic process,BP,
8331,GO:0032344,1,0.96305713910476,0,6,regulation of aldosterone metabolic process,BP,
8332,GO:0032345,1,0.975433615847637,0,4,negative regulation of aldosterone metabolic process,BP,
8333,GO:0032346,1,0.987315020333662,0,2,positive regulation of aldosterone metabolic process,BP,
8334,GO:0032347,1,0.96305713910476,0,6,regulation of aldosterone biosynthetic process,BP,
8335,GO:0032348,1,0.975433615847637,0,4,negative regulation of aldosterone biosynthetic process,BP,
8336,GO:0032349,1,0.987315020333662,0,2,positive regulation of aldosterone biosynthetic process,BP,
8337,GO:0032350,1,0.822559893819016,0,31,regulation of hormone metabolic process,BP,
8338,GO:0032351,1,0.934230492082845,0,11,negative regulation of hormone metabolic process,BP,
8339,GO:0032352,1,0.926799794926915,0,12,positive regulation of hormone metabolic process,BP,
8340,GO:0032353,1,0.93959636434139,0,10,negative regulation of hormone biosynthetic process,BP,
8341,GO:0032354,1,0.910495040858995,0,14,response to follicle-stimulating hormone,BP,
8342,GO:0032355,1,0.485534724258494,0,115,response to estradiol,BP,
8343,GO:0032356,1,0.938858549967847,0,10,oxidized DNA binding,MF,
8344,GO:0032357,1,0.944494426835322,0,9,oxidized purine DNA binding,MF,
8345,GO:0032358,1,0.994404263934584,0,1,oxidized pyrimidine DNA binding,MF,
8346,GO:0032361,1,0.99406870912543,0,1,pyridoxal phosphate catabolic process,BP,
8347,GO:0032364,1,0.962661085163675,0,6,oxygen homeostasis,BP,
8348,GO:0032365,1,0.826507103154215,0,29,intracellular lipid transport,BP,
8349,GO:0032366,1,0.889225379161065,0,18,intracellular sterol transport,BP,
8350,GO:0032367,1,0.889225379161065,0,18,intracellular cholesterol transport,BP,
8351,GO:0032368,1,0.59018890397662,0,82,regulation of lipid transport,BP,
8352,GO:0032369,1,0.883983551873881,0,19,negative regulation of lipid transport,BP,
8353,GO:0032370,1,0.74101121312293,0,47,positive regulation of lipid transport,BP,
8354,GO:0032371,1,0.798360063237125,0,35,regulation of sterol transport,BP,
8355,GO:0032372,1,0.951767960697814,0,8,negative regulation of sterol transport,BP,
8356,GO:0032373,1,0.887117928999026,0,18,positive regulation of sterol transport,BP,
8357,GO:0032374,1,0.798360063237125,0,35,regulation of cholesterol transport,BP,
8358,GO:0032375,1,0.951767960697814,0,8,negative regulation of cholesterol transport,BP,
8359,GO:0032376,1,0.887117928999026,0,18,positive regulation of cholesterol transport,BP,
8360,GO:0032377,1,0.956415647122953,0,7,regulation of intracellular lipid transport,BP,
8361,GO:0032378,1,0.993597928285159,0,1,negative regulation of intracellular lipid transport,BP,
8362,GO:0032379,1,0.982314247433009,0,3,positive regulation of intracellular lipid transport,BP,
8363,GO:0032380,1,0.956415647122953,0,7,regulation of intracellular sterol transport,BP,
8364,GO:0032381,1,0.993597928285159,0,1,negative regulation of intracellular sterol transport,BP,
8365,GO:0032382,1,0.982314247433009,0,3,positive regulation of intracellular sterol transport,BP,
8366,GO:0032383,1,0.956415647122953,0,7,regulation of intracellular cholesterol transport,BP,
8367,GO:0032384,1,0.993597928285159,0,1,negative regulation of intracellular cholesterol transport,BP,
8368,GO:0032385,1,0.982314247433009,0,3,positive regulation of intracellular cholesterol transport,BP,
8370,GO:0032387,1,0.704434754165189,0,56,negative regulation of intracellular transport,BP,
8372,GO:0032389,1,0.974652363201777,0,4,MutLalpha complex,CC,
8373,GO:0032391,1,0.81035287440382,0,32,photoreceptor connecting cilium,CC,
8375,GO:0032393,1,0.95942301927864,0,7,MHC class I receptor activity,MF,
8376,GO:0032394,1,0.994191143819417,0,1,MHC class Ib receptor activity,MF,
8377,GO:0032395,1,0.948845736297969,0,9,MHC class II receptor activity,MF,
8378,GO:0032396,1,0.981828795737391,0,3,inhibitory MHC class I receptor activity,MF,
8379,GO:0032397,1,0.994221032359422,0,1,activating MHC class I receptor activity,MF,
8380,GO:0032398,1,0.994161977138893,0,1,MHC class Ib protein complex,CC,
8381,GO:0032400,1,0.849461775678513,0,26,melanosome localization,BP,
8382,GO:0032401,1,0.859960118022201,0,24,establishment of melanosome localization,BP,
8383,GO:0032402,1,0.866467184415124,0,23,melanosome transport,BP,
8384,GO:0032404,1,0.950783518551668,0,8,mismatch repair complex binding,MF,
8385,GO:0032405,1,0.968233494403961,0,5,MutLalpha complex binding,MF,
8386,GO:0032407,1,0.968696392029676,0,5,MutSalpha complex binding,MF,
8388,GO:0032410,1,0.653141002346442,0,67,negative regulation of transporter activity,BP,
8391,GO:0032413,1,0.683167088003936,0,60,negative regulation of ion transmembrane transporter activity,BP,
8393,GO:0032415,1,0.970395887009726,0,5,regulation of sodium:proton antiporter activity,BP,
8394,GO:0032416,1,0.994068131768718,0,1,negative regulation of sodium:proton antiporter activity,BP,
8395,GO:0032417,1,0.976187925685938,0,4,positive regulation of sodium:proton antiporter activity,BP,
8396,GO:0032418,1,0.6768288957998,0,62,lysosome localization,BP,
8397,GO:0032419,1,0.994002053936623,0,1,extrinsic component of lysosome membrane,CC,
8398,GO:0032420,1,0.773724789238672,0,39,stereocilium,CC,
8399,GO:0032421,1,0.750159190480526,0,44,stereocilium bundle,CC,
8400,GO:0032422,1,0.974179324284971,0,4,purine-rich negative regulatory element binding,MF,
8401,GO:0032423,1,0.980951096136767,0,3,regulation of mismatch repair,BP,
8402,GO:0032425,1,0.987440981930493,0,2,positive regulation of mismatch repair,BP,
8403,GO:0032426,1,0.908648733564125,0,15,stereocilium tip,CC,
8404,GO:0032427,1,0.987401426221672,0,2,GBD domain binding,MF,
8405,GO:0032428,1,0.993615909981128,0,1,beta-N-acetylgalactosaminidase activity,MF,
8406,GO:0032429,1,0.94845049204196,0,8,regulation of phospholipase A2 activity,BP,
8407,GO:0032430,1,0.969883535997777,0,5,positive regulation of phospholipase A2 activity,BP,
8408,GO:0032431,1,0.982425933634722,0,3,activation of phospholipase A2 activity,BP,
8409,GO:0032432,1,0.690120478775383,0,56,actin filament bundle,CC,
8410,GO:0032433,1,0.896398398247483,0,16,filopodium tip,CC,
8411,GO:0032434,1,0.487346230809445,0,113,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8412,GO:0032435,1,0.842975036820999,0,27,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8413,GO:0032436,1,0.608870685618718,0,78,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8414,GO:0032437,1,0.966080075802338,0,5,cuticular plate,CC,
8415,GO:0032438,1,0.846922885759483,0,26,melanosome organization,BP,
8416,GO:0032440,1,0.994285285497053,0,1,2-alkenal reductase [NAD(P)] activity,MF,
8417,GO:0032444,1,0.97792661150897,0,3,activin responsive factor complex,CC,
8418,GO:0032445,1,0.993976682335154,0,1,fructose import,BP,
8420,GO:0032447,1,0.993938366199964,0,1,protein urmylation,BP,
8421,GO:0032448,1,0.994190277483898,0,1,DNA hairpin binding,MF,
8422,GO:0032449,1,0.968562602658029,0,5,CBM complex,CC,
8423,GO:0032450,1,0.979835476831731,0,3,maltose alpha-glucosidase activity,MF,
8424,GO:0032451,1,0.795069818242827,0,34,demethylase activity,MF,
8425,GO:0032452,1,0.84020043575613,0,25,histone demethylase activity,MF,
8426,GO:0032453,1,0.95816428570297,0,6,histone demethylase activity (H3-K4 specific),MF,
8427,GO:0032454,1,0.921361549855816,0,12,histone demethylase activity (H3-K9 specific),MF,
8428,GO:0032455,1,0.975385701479041,0,4,nerve growth factor processing,BP,
8429,GO:0032456,1,0.80095876925982,0,34,endocytic recycling,BP,
8430,GO:0032458,1,0.993531685129323,0,1,slow endocytic recycling,BP,
8432,GO:0032460,1,0.913544409672271,0,14,negative regulation of protein oligomerization,BP,
8434,GO:0032462,1,0.901143826514168,0,17,regulation of protein homooligomerization,BP,
8435,GO:0032463,1,0.940450128164852,0,10,negative regulation of protein homooligomerization,BP,
8436,GO:0032464,1,0.957766768281699,0,7,positive regulation of protein homooligomerization,BP,
8437,GO:0032465,1,0.61839887632246,0,73,regulation of cytokinesis,BP,
8438,GO:0032466,1,0.957021886118983,0,7,negative regulation of cytokinesis,BP,
8439,GO:0032467,1,0.828324879983429,0,29,positive regulation of cytokinesis,BP,
8440,GO:0032468,1,0.993638743407555,0,1,Golgi calcium ion homeostasis,BP,
8441,GO:0032469,1,0.873480724547487,0,21,endoplasmic reticulum calcium ion homeostasis,BP,
8442,GO:0032470,1,0.985948940620491,0,2,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
8443,GO:0032471,1,0.951963946847555,0,8,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
8444,GO:0032472,1,0.987755127790769,0,2,Golgi calcium ion transport,BP,
8445,GO:0032473,1,0.991973955775138,0,1,cytoplasmic side of mitochondrial outer membrane,CC,
8446,GO:0032474,1,0.980816545928251,0,3,otolith morphogenesis,BP,
8447,GO:0032475,1,0.99388284309816,0,1,otolith formation,BP,
8448,GO:0032479,1,0.479935911876914,0,115,regulation of type I interferon production,BP,
8449,GO:0032480,1,0.750705686510122,0,45,negative regulation of type I interferon production,BP,
8450,GO:0032481,1,0.642776941012696,0,69,positive regulation of type I interferon production,BP,
8451,GO:0032482,1,0.65752426161611,0,68,Rab protein signal transduction,BP,
8452,GO:0032483,1,0.973620745129919,0,4,regulation of Rab protein signal transduction,BP,
8453,GO:0032484,1,0.97962781379743,0,3,Ral protein signal transduction,BP,
8454,GO:0032485,1,0.97962781379743,0,3,regulation of Ral protein signal transduction,BP,
8455,GO:0032486,1,0.916837970793128,0,13,Rap protein signal transduction,BP,
8456,GO:0032487,1,0.979631247404593,0,3,regulation of Rap protein signal transduction,BP,
8457,GO:0032488,1,0.914293017106052,0,14,Cdc42 protein signal transduction,BP,
8458,GO:0032489,1,0.962209707260267,0,6,regulation of Cdc42 protein signal transduction,BP,
8459,GO:0032490,1,0.925047120568208,0,12,detection of molecule of bacterial origin,BP,
8460,GO:0032493,1,0.949611511009557,0,8,response to bacterial lipoprotein,BP,
8461,GO:0032494,1,0.939083030101841,0,10,response to peptidoglycan,BP,
8462,GO:0032495,1,0.912291992143559,0,14,response to muramyl dipeptide,BP,
8463,GO:0032496,1,0.15032264987157,0,302,response to lipopolysaccharide,BP,
8464,GO:0032497,1,0.9759317654596,0,4,detection of lipopolysaccharide,BP,
8465,GO:0032498,1,0.993354995264372,0,1,detection of muramyl dipeptide,BP,
8466,GO:0032499,1,0.987735532891669,0,2,detection of peptidoglycan,BP,
8467,GO:0032500,1,0.993354995264372,0,1,muramyl dipeptide binding,MF,
8471,GO:0032506,1,0.861700423587558,0,23,cytokinetic process,BP,
8472,GO:0032507,1,0.621500324079194,0,72,maintenance of protein location in cell,BP,
8474,GO:0032509,1,0.87549321580866,0,21,endosome transport via multivesicular body sorting pathway,BP,
8475,GO:0032510,1,0.960438697672458,0,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,
8476,GO:0032511,1,0.952760077739619,0,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
8478,GO:0032516,1,0.897971336018669,0,16,positive regulation of phosphoprotein phosphatase activity,BP,
8479,GO:0032525,1,0.944391932804931,0,9,somite rostral/caudal axis specification,BP,
8480,GO:0032526,1,0.539611745438858,0,97,response to retinoic acid,BP,
8481,GO:0032527,1,0.778591180721311,0,39,protein exit from endoplasmic reticulum,BP,
8482,GO:0032528,1,0.859722557022073,0,23,microvillus organization,BP,
8483,GO:0032530,1,0.925434973769143,0,12,regulation of microvillus organization,BP,
8484,GO:0032532,1,0.963194489429804,0,6,regulation of microvillus length,BP,
8485,GO:0032534,1,0.960812322368078,0,6,regulation of microvillus assembly,BP,
8488,GO:0032541,1,0.969628741295228,0,5,cortical endoplasmic reticulum,CC,
8489,GO:0032542,1,0.987588083644011,0,2,sulfiredoxin activity,MF,
8490,GO:0032543,1,0.470521250806397,0,127,mitochondrial translation,BP,
8491,GO:0032545,1,0.987776186337744,0,2,CURI complex,CC,
8494,GO:0032551,1,0.986983443193889,0,2,pyrimidine ribonucleoside binding,MF,
8495,GO:0032552,1,0.964737269423579,0,6,deoxyribonucleotide binding,MF,
8497,GO:0032554,1,0.975999542012548,0,4,purine deoxyribonucleotide binding,MF,
8499,GO:0032556,1,0.988463625774805,0,2,pyrimidine deoxyribonucleotide binding,MF,
8500,GO:0032557,1,0.981088122640482,0,3,pyrimidine ribonucleotide binding,MF,
8501,GO:0032558,1,0.982164333959039,0,3,adenyl deoxyribonucleotide binding,MF,
8503,GO:0032560,1,0.993724407370571,0,1,guanyl deoxyribonucleotide binding,MF,
8505,GO:0032564,1,0.982164333959039,0,3,dATP binding,MF,
8506,GO:0032567,1,0.993724407370571,0,1,dGTP binding,MF,
8508,GO:0032571,1,0.976102074322086,0,4,response to vitamin K,BP,
8509,GO:0032574,1,0.993506253102954,0,1,5'-3' RNA helicase activity,MF,
8510,GO:0032575,1,0.993506253102954,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
8511,GO:0032580,1,0.607476786406133,0,78,Golgi cisterna membrane,CC,
8512,GO:0032581,1,0.99411389551973,0,1,ER-dependent peroxisome organization,BP,
8513,GO:0032584,1,0.963245685944663,0,6,growth cone membrane,CC,
8514,GO:0032585,1,0.946476899763631,0,9,multivesicular body membrane,CC,
8517,GO:0032589,1,0.700786436797418,0,53,neuron projection membrane,CC,
8518,GO:0032590,1,0.786616479595198,0,37,dendrite membrane,CC,
8519,GO:0032591,1,0.916876689311696,0,13,dendritic spine membrane,CC,
8520,GO:0032592,1,0.672023901801843,0,65,integral component of mitochondrial membrane,CC,
8521,GO:0032593,1,0.954665045326307,0,7,insulin-responsive compartment,CC,
8522,GO:0032594,1,0.850708542852763,0,26,protein transport within lipid bilayer,BP,
8523,GO:0032596,1,0.969023772159668,0,5,protein transport into membrane raft,BP,
8524,GO:0032601,1,0.994276910915076,0,1,connective tissue growth factor production,BP,
8526,GO:0032603,1,0.994383471281417,0,1,fractalkine production,BP,
8527,GO:0032604,1,0.928226177693007,0,12,granulocyte macrophage colony-stimulating factor production,BP,
8528,GO:0032605,1,0.993724407370571,0,1,hepatocyte growth factor production,BP,
8529,GO:0032606,1,0.477145417761689,0,116,type I interferon production,BP,
8530,GO:0032607,1,0.844405404612926,0,26,interferon-alpha production,BP,
8531,GO:0032608,1,0.741198037173767,0,47,interferon-beta production,BP,
8532,GO:0032609,1,0.570202212502294,0,91,interferon-gamma production,BP,
8533,GO:0032610,1,0.959610124002246,0,7,interleukin-1 alpha production,BP,
8534,GO:0032611,1,0.691925610797283,0,59,interleukin-1 beta production,BP,
8535,GO:0032612,1,0.639643680774076,0,72,interleukin-1 production,BP,
8536,GO:0032613,1,0.772730106404494,0,42,interleukin-10 production,BP,
8537,GO:0032615,1,0.736170418103749,0,49,interleukin-12 production,BP,
8538,GO:0032616,1,0.899700188171411,0,17,interleukin-13 production,BP,
8539,GO:0032618,1,0.9883272570364,0,2,interleukin-15 production,BP,
8540,GO:0032620,1,0.884990368860158,0,20,interleukin-17 production,BP,
8541,GO:0032621,1,0.950134664552532,0,8,interleukin-18 production,BP,
8542,GO:0032623,1,0.701863775189425,0,56,interleukin-2 production,BP,
8543,GO:0032625,1,0.993620333931535,0,1,interleukin-21 production,BP,
8544,GO:0032627,1,0.968912082990165,0,5,interleukin-23 production,BP,
8545,GO:0032632,1,0.980833414292401,0,3,interleukin-3 production,BP,
8546,GO:0032633,1,0.824715220393325,0,31,interleukin-4 production,BP,
8547,GO:0032634,1,0.909551247936479,0,15,interleukin-5 production,BP,
8549,GO:0032637,1,0.683762910641479,0,61,interleukin-8 production,BP,
8550,GO:0032639,1,0.987971972327246,0,2,TRAIL production,BP,
8551,GO:0032640,1,0.501362628436701,0,110,tumor necrosis factor production,BP,
8552,GO:0032641,1,0.987653819040612,0,2,lymphotoxin A production,BP,
8554,GO:0032643,1,0.994276910915076,0,1,regulation of connective tissue growth factor production,BP,
8555,GO:0032644,1,0.994383471281417,0,1,regulation of fractalkine production,BP,
8556,GO:0032645,1,0.933694676779304,0,11,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8557,GO:0032646,1,0.993724407370571,0,1,regulation of hepatocyte growth factor production,BP,
8558,GO:0032647,1,0.849314977306052,0,25,regulation of interferon-alpha production,BP,
8559,GO:0032648,1,0.750358195217806,0,45,regulation of interferon-beta production,BP,
8560,GO:0032649,1,0.611383271603926,0,80,regulation of interferon-gamma production,BP,
8561,GO:0032650,1,0.964946439552187,0,6,regulation of interleukin-1 alpha production,BP,
8562,GO:0032651,1,0.729028399978257,0,51,regulation of interleukin-1 beta production,BP,
8563,GO:0032652,1,0.67773269286618,0,63,regulation of interleukin-1 production,BP,
8564,GO:0032653,1,0.78238083931675,0,40,regulation of interleukin-10 production,BP,
8565,GO:0032655,1,0.745486567842517,0,47,regulation of interleukin-12 production,BP,
8566,GO:0032656,1,0.904848679552613,0,16,regulation of interleukin-13 production,BP,
8567,GO:0032658,1,0.994131655201584,0,1,regulation of interleukin-15 production,BP,
8568,GO:0032660,1,0.901051795899263,0,17,regulation of interleukin-17 production,BP,
8569,GO:0032661,1,0.962701080748562,0,6,regulation of interleukin-18 production,BP,
8571,GO:0032667,1,0.968912082990165,0,5,regulation of interleukin-23 production,BP,
8572,GO:0032672,1,0.987215924713825,0,2,regulation of interleukin-3 production,BP,
8573,GO:0032673,1,0.857492033503038,0,25,regulation of interleukin-4 production,BP,
8574,GO:0032674,1,0.909551247936479,0,15,regulation of interleukin-5 production,BP,
8576,GO:0032677,1,0.709984997592534,0,55,regulation of interleukin-8 production,BP,
8577,GO:0032679,1,0.987971972327246,0,2,regulation of TRAIL production,BP,
8578,GO:0032680,1,0.510801173249038,0,107,regulation of tumor necrosis factor production,BP,
8579,GO:0032681,1,0.993863163183324,0,1,regulation of lymphotoxin A production,BP,
8580,GO:0032682,1,0.908246866017576,0,16,negative regulation of chemokine production,BP,
8581,GO:0032685,1,0.993705551906401,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8582,GO:0032686,1,0.993724407370571,0,1,negative regulation of hepatocyte growth factor production,BP,
8583,GO:0032687,1,0.962645919073864,0,6,negative regulation of interferon-alpha production,BP,
8584,GO:0032688,1,0.916268069687461,0,14,negative regulation of interferon-beta production,BP,
8585,GO:0032689,1,0.852917191886667,0,26,negative regulation of interferon-gamma production,BP,
8586,GO:0032690,1,0.994233305420335,0,1,negative regulation of interleukin-1 alpha production,BP,
8587,GO:0032691,1,0.912962736240212,0,15,negative regulation of interleukin-1 beta production,BP,
8588,GO:0032692,1,0.88030120609607,0,21,negative regulation of interleukin-1 production,BP,
8589,GO:0032693,1,0.91861517981682,0,14,negative regulation of interleukin-10 production,BP,
8590,GO:0032695,1,0.902938601658366,0,16,negative regulation of interleukin-12 production,BP,
8591,GO:0032696,1,0.981428071956726,0,3,negative regulation of interleukin-13 production,BP,
8592,GO:0032700,1,0.945829919972994,0,9,negative regulation of interleukin-17 production,BP,
8593,GO:0032701,1,0.987918252355566,0,2,negative regulation of interleukin-18 production,BP,
8594,GO:0032703,1,0.888420216436993,0,19,negative regulation of interleukin-2 production,BP,
8595,GO:0032707,1,0.98702659584649,0,2,negative regulation of interleukin-23 production,BP,
8596,GO:0032712,1,0.993976394104219,0,1,negative regulation of interleukin-3 production,BP,
8597,GO:0032713,1,0.969247027285734,0,5,negative regulation of interleukin-4 production,BP,
8598,GO:0032714,1,0.981327233771474,0,3,negative regulation of interleukin-5 production,BP,
8599,GO:0032715,1,0.812995199371129,0,33,negative regulation of interleukin-6 production,BP,
8600,GO:0032717,1,0.905591616977767,0,16,negative regulation of interleukin-8 production,BP,
8601,GO:0032720,1,0.768164722047113,0,43,negative regulation of tumor necrosis factor production,BP,
8603,GO:0032723,1,0.994276910915076,0,1,positive regulation of connective tissue growth factor production,BP,
8604,GO:0032724,1,0.994383471281417,0,1,positive regulation of fractalkine production,BP,
8605,GO:0032725,1,0.939612769352665,0,10,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8606,GO:0032727,1,0.882314359081575,0,19,positive regulation of interferon-alpha production,BP,
8607,GO:0032728,1,0.829945821921887,0,29,positive regulation of interferon-beta production,BP,
8608,GO:0032729,1,0.711616138814588,0,55,positive regulation of interferon-gamma production,BP,
8609,GO:0032730,1,0.970544979694411,0,5,positive regulation of interleukin-1 alpha production,BP,
8610,GO:0032731,1,0.817985581666231,0,32,positive regulation of interleukin-1 beta production,BP,
8611,GO:0032732,1,0.788335961883092,0,38,positive regulation of interleukin-1 production,BP,
8612,GO:0032733,1,0.842071811892902,0,28,positive regulation of interleukin-10 production,BP,
8613,GO:0032735,1,0.836978524582146,0,29,positive regulation of interleukin-12 production,BP,
8614,GO:0032736,1,0.921985801338976,0,13,positive regulation of interleukin-13 production,BP,
8615,GO:0032738,1,0.994131655201584,0,1,positive regulation of interleukin-15 production,BP,
8616,GO:0032740,1,0.946975414264248,0,9,positive regulation of interleukin-17 production,BP,
8617,GO:0032741,1,0.980643834776741,0,3,positive regulation of interleukin-18 production,BP,
8618,GO:0032743,1,0.830473643402849,0,29,positive regulation of interleukin-2 production,BP,
8619,GO:0032747,1,0.987564813291629,0,2,positive regulation of interleukin-23 production,BP,
8620,GO:0032752,1,0.993198979283753,0,1,positive regulation of interleukin-3 production,BP,
8621,GO:0032753,1,0.879394477587293,0,21,positive regulation of interleukin-4 production,BP,
8622,GO:0032754,1,0.932411531267602,0,11,positive regulation of interleukin-5 production,BP,
8624,GO:0032757,1,0.779531861532825,0,40,positive regulation of interleukin-8 production,BP,
8625,GO:0032759,1,0.987971972327246,0,2,positive regulation of TRAIL production,BP,
8626,GO:0032760,1,0.666892563184025,0,64,positive regulation of tumor necrosis factor production,BP,
8627,GO:0032761,1,0.993863163183324,0,1,positive regulation of lymphotoxin A production,BP,
8628,GO:0032762,1,0.957186986662067,0,7,mast cell cytokine production,BP,
8629,GO:0032763,1,0.969549955461453,0,5,regulation of mast cell cytokine production,BP,
8630,GO:0032764,1,0.987864850286866,0,2,negative regulation of mast cell cytokine production,BP,
8631,GO:0032765,1,0.981462409685865,0,3,positive regulation of mast cell cytokine production,BP,
8632,GO:0032767,1,0.980397483056935,0,3,copper-dependent protein binding,MF,
8634,GO:0032769,1,0.938403332318947,0,10,negative regulation of monooxygenase activity,BP,
8636,GO:0032771,1,0.993413800831215,0,1,regulation of monophenol monooxygenase activity,BP,
8637,GO:0032773,1,0.993413800831215,0,1,positive regulation of monophenol monooxygenase activity,BP,
8639,GO:0032775,1,0.993588223240604,0,1,DNA methylation on adenine,BP,
8640,GO:0032776,1,0.980145114738575,0,3,DNA methylation on cytosine,BP,
8641,GO:0032777,1,0.975778049451161,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8642,GO:0032780,1,0.924041482687298,0,13,negative regulation of ATPase activity,BP,
8644,GO:0032782,1,0.975707571749537,0,4,bile acid secretion,BP,
8645,GO:0032783,1,0.955374837107862,0,6,ELL-EAF complex,CC,
8646,GO:0032784,1,0.772427989170771,0,41,regulation of DNA-templated transcription, elongation,BP,
8647,GO:0032785,1,0.921312751423965,0,13,negative regulation of DNA-templated transcription, elongation,BP,
8648,GO:0032786,1,0.864992080512242,0,23,positive regulation of DNA-templated transcription, elongation,BP,
8650,GO:0032788,1,0.994176704883032,0,1,saturated monocarboxylic acid metabolic process,BP,
8651,GO:0032789,1,0.994176704883032,0,1,unsaturated monocarboxylic acid metabolic process,BP,
8652,GO:0032790,1,0.950462956945492,0,8,ribosome disassembly,BP,
8653,GO:0032792,1,0.969095638176998,0,5,negative regulation of CREB transcription factor activity,BP,
8654,GO:0032793,1,0.911526837766548,0,14,positive regulation of CREB transcription factor activity,BP,
8655,GO:0032794,1,0.909642339086193,0,14,GTPase activating protein binding,MF,
8656,GO:0032795,1,0.981807091658156,0,3,heterotrimeric G-protein binding,MF,
8657,GO:0032796,1,0.986695929561186,0,2,uropod organization,BP,
8658,GO:0032797,1,0.928654829868718,0,12,SMN complex,CC,
8659,GO:0032798,1,0.987729649828399,0,2,Swi5-Sfr1 complex,CC,
8660,GO:0032799,1,0.874584057172254,0,21,low-density lipoprotein receptor particle metabolic process,BP,
8661,GO:0032800,1,0.862675017355026,0,23,receptor biosynthetic process,BP,
8662,GO:0032801,1,0.811169745376964,0,32,receptor catabolic process,BP,
8663,GO:0032802,1,0.920825607938487,0,13,low-density lipoprotein particle receptor catabolic process,BP,
8664,GO:0032803,1,0.969652256824046,0,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,
8665,GO:0032804,1,0.987653091009395,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
8666,GO:0032805,1,0.987940662836011,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8667,GO:0032806,1,0.859177181824681,0,24,carboxy-terminal domain protein kinase complex,CC,
8668,GO:0032807,1,0.975581765792015,0,4,DNA ligase IV complex,CC,
8670,GO:0032809,1,0.862808261979341,0,23,neuronal cell body membrane,CC,
8671,GO:0032810,1,0.987453289617825,0,2,sterol response element binding,MF,
8672,GO:0032811,1,0.98200325907406,0,3,negative regulation of epinephrine secretion,BP,
8673,GO:0032812,1,0.994383182495716,0,1,positive regulation of epinephrine secretion,BP,
8674,GO:0032813,1,0.769851182729485,0,43,tumor necrosis factor receptor superfamily binding,MF,
8675,GO:0032814,1,0.872640240736843,0,22,regulation of natural killer cell activation,BP,
8676,GO:0032815,1,0.970833275079536,0,5,negative regulation of natural killer cell activation,BP,
8677,GO:0032816,1,0.921882331103035,0,13,positive regulation of natural killer cell activation,BP,
8678,GO:0032817,1,0.963980025931632,0,6,regulation of natural killer cell proliferation,BP,
8679,GO:0032819,1,0.976206441521366,0,4,positive regulation of natural killer cell proliferation,BP,
8680,GO:0032823,1,0.939094816166453,0,10,regulation of natural killer cell differentiation,BP,
8681,GO:0032824,1,0.994372497445327,0,1,negative regulation of natural killer cell differentiation,BP,
8682,GO:0032825,1,0.956429758272773,0,7,positive regulation of natural killer cell differentiation,BP,
8683,GO:0032826,1,0.988574604547387,0,2,regulation of natural killer cell differentiation involved in immune response,BP,
8684,GO:0032827,1,0.994372497445327,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
8685,GO:0032829,1,0.988171464544701,0,2,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8686,GO:0032831,1,0.988171464544701,0,2,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8687,GO:0032832,1,0.994163998595989,0,1,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8688,GO:0032834,1,0.994163998595989,0,1,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8689,GO:0032835,1,0.697977902927518,0,54,glomerulus development,BP,
8690,GO:0032836,1,0.933109479055421,0,10,glomerular basement membrane development,BP,
8692,GO:0032839,1,0.839258047677686,0,27,dendrite cytoplasm,CC,
8693,GO:0032841,1,0.993605064014263,0,1,calcitonin binding,MF,
8694,GO:0032847,1,0.975559710719182,0,4,regulation of cellular pH reduction,BP,
8695,GO:0032848,1,0.993539826189683,0,1,negative regulation of cellular pH reduction,BP,
8696,GO:0032849,1,0.981904160673618,0,3,positive regulation of cellular pH reduction,BP,
8697,GO:0032868,1,0.213639426954322,0,238,response to insulin,BP,
8698,GO:0032869,1,0.295734614356489,0,187,cellular response to insulin stimulus,BP,
8701,GO:0032873,1,0.779028635971294,0,39,negative regulation of stress-activated MAPK cascade,BP,
8703,GO:0032875,1,0.952997007220937,0,7,regulation of DNA endoreduplication,BP,
8704,GO:0032876,1,0.972035068409683,0,4,negative regulation of DNA endoreduplication,BP,
8705,GO:0032877,1,0.98661339413189,0,2,positive regulation of DNA endoreduplication,BP,
8706,GO:0032878,1,0.868009932042367,0,21,regulation of establishment or maintenance of cell polarity,BP,
8709,GO:0032881,1,0.800663453661234,0,33,regulation of polysaccharide metabolic process,BP,
8710,GO:0032885,1,0.815136120319787,0,30,regulation of polysaccharide biosynthetic process,BP,
8712,GO:0032887,1,0.992572258392098,0,1,regulation of spindle elongation,BP,
8713,GO:0032888,1,0.992572258392098,0,1,regulation of mitotic spindle elongation,BP,
8714,GO:0032889,1,0.993917641006514,0,1,regulation of vacuole fusion, non-autophagic,BP,
8716,GO:0032891,1,0.9079671754914,0,15,negative regulation of organic acid transport,BP,
8718,GO:0032897,1,0.881448448313734,0,20,negative regulation of viral transcription,BP,
8719,GO:0032898,1,0.97473217766883,0,4,neurotrophin production,BP,
8720,GO:0032899,1,0.987394950649639,0,2,regulation of neurotrophin production,BP,
8721,GO:0032900,1,0.993827435493265,0,1,negative regulation of neurotrophin production,BP,
8722,GO:0032901,1,0.993527971230643,0,1,positive regulation of neurotrophin production,BP,
8723,GO:0032902,1,0.987177223717029,0,2,nerve growth factor production,BP,
8724,GO:0032905,1,0.938697485235521,0,10,transforming growth factor beta1 production,BP,
8725,GO:0032906,1,0.948094109067726,0,8,transforming growth factor beta2 production,BP,
8726,GO:0032907,1,0.984835063030753,0,2,transforming growth factor beta3 production,BP,
8727,GO:0032908,1,0.938697485235521,0,10,regulation of transforming growth factor beta1 production,BP,
8728,GO:0032909,1,0.948094109067726,0,8,regulation of transforming growth factor beta2 production,BP,
8729,GO:0032910,1,0.984835063030753,0,2,regulation of transforming growth factor beta3 production,BP,
8730,GO:0032911,1,0.974415776643963,0,4,negative regulation of transforming growth factor beta1 production,BP,
8731,GO:0032912,1,0.98709515028775,0,2,negative regulation of transforming growth factor beta2 production,BP,
8732,GO:0032914,1,0.963353405220702,0,6,positive regulation of transforming growth factor beta1 production,BP,
8733,GO:0032915,1,0.988160770065939,0,2,positive regulation of transforming growth factor beta2 production,BP,
8734,GO:0032916,1,0.984835063030753,0,2,positive regulation of transforming growth factor beta3 production,BP,
8735,GO:0032917,1,0.982816324863439,0,3,polyamine acetylation,BP,
8736,GO:0032918,1,0.982816324863439,0,3,spermidine acetylation,BP,
8737,GO:0032919,1,0.994368454463406,0,1,spermine acetylation,BP,
8738,GO:0032920,1,0.994368454463406,0,1,putrescine acetylation,BP,
8739,GO:0032922,1,0.715035903781297,0,50,circadian regulation of gene expression,BP,
8740,GO:0032924,1,0.787007208470261,0,37,activin receptor signaling pathway,BP,
8741,GO:0032925,1,0.863141465127307,0,23,regulation of activin receptor signaling pathway,BP,
8742,GO:0032926,1,0.944582657277905,0,9,negative regulation of activin receptor signaling pathway,BP,
8743,GO:0032927,1,0.946928069440435,0,8,positive regulation of activin receptor signaling pathway,BP,
8744,GO:0032928,1,0.90675491648285,0,16,regulation of superoxide anion generation,BP,
8745,GO:0032929,1,0.988525079665824,0,2,negative regulation of superoxide anion generation,BP,
8746,GO:0032930,1,0.923576314788908,0,13,positive regulation of superoxide anion generation,BP,
8747,GO:0032933,1,0.950583930990898,0,8,SREBP signaling pathway,BP,
8748,GO:0032934,1,0.767905371461481,0,41,sterol binding,MF,
8749,GO:0032937,1,0.98128643085046,0,3,SREBP-SCAP-Insig complex,CC,
8751,GO:0032941,1,0.813782339295942,0,33,secretion by tissue,BP,
8752,GO:0032943,1,0.246079453862317,0,224,mononuclear cell proliferation,BP,
8753,GO:0032944,1,0.319158261563995,0,183,regulation of mononuclear cell proliferation,BP,
8754,GO:0032945,1,0.668433819015215,0,64,negative regulation of mononuclear cell proliferation,BP,
8755,GO:0032946,1,0.482516548149218,0,118,positive regulation of mononuclear cell proliferation,BP,
8757,GO:0032954,1,0.98655810998527,0,2,regulation of cytokinetic process,BP,
8759,GO:0032957,1,0.94900499868273,0,8,inositol trisphosphate metabolic process,BP,
8760,GO:0032958,1,0.857843227228167,0,24,inositol phosphate biosynthetic process,BP,
8761,GO:0032959,1,0.96187436299531,0,6,inositol trisphosphate biosynthetic process,BP,
8762,GO:0032960,1,0.974628400159587,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
8763,GO:0032962,1,0.981109158019202,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
8765,GO:0032964,1,0.80092212994878,0,35,collagen biosynthetic process,BP,
8766,GO:0032965,1,0.845062678786772,0,27,regulation of collagen biosynthetic process,BP,
8767,GO:0032966,1,0.958058541241852,0,7,negative regulation of collagen biosynthetic process,BP,
8768,GO:0032967,1,0.882105881305162,0,20,positive regulation of collagen biosynthetic process,BP,
8769,GO:0032968,1,0.91471129802161,0,14,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8771,GO:0032971,1,0.976240944251191,0,4,regulation of muscle filament sliding,BP,
8772,GO:0032972,1,0.988795580414443,0,2,regulation of muscle filament sliding speed,BP,
8773,GO:0032976,1,0.994412927591184,0,1,release of matrix enzymes from mitochondria,BP,
8774,GO:0032977,1,0.993345807666878,0,1,membrane insertase activity,MF,
8775,GO:0032978,1,0.993345807666878,0,1,protein insertion into membrane from inner side,BP,
8776,GO:0032979,1,0.993345807666878,0,1,protein insertion into mitochondrial membrane from inner side,BP,
8777,GO:0032980,1,0.993949021620118,0,1,keratinocyte activation,BP,
8778,GO:0032981,1,0.727584431866457,0,55,mitochondrial respiratory chain complex I assembly,BP,
8780,GO:0032983,1,0.966844478036096,0,5,kainate selective glutamate receptor complex,CC,
8781,GO:0032984,1,0.152925642154907,0,295,protein-containing complex disassembly,BP,
8782,GO:0032986,1,0.884864150562996,0,19,protein-DNA complex disassembly,BP,
8783,GO:0032988,1,0.921328926705543,0,13,ribonucleoprotein complex disassembly,BP,
8788,GO:0032994,1,0.807720021016852,0,34,protein-lipid complex,CC,
8789,GO:0032996,1,0.994107687073044,0,1,Bcl3-Bcl10 complex,CC,
8790,GO:0032997,1,0.988661168060893,0,2,Fc receptor complex,CC,
8791,GO:0032998,1,0.988661168060893,0,2,Fc-epsilon receptor I complex,CC,
8792,GO:0033002,1,0.340894292877804,0,167,muscle cell proliferation,BP,
8793,GO:0033003,1,0.805225484081369,0,35,regulation of mast cell activation,BP,
8794,GO:0033004,1,0.935184698447908,0,11,negative regulation of mast cell activation,BP,
8795,GO:0033005,1,0.911549552065945,0,15,positive regulation of mast cell activation,BP,
8796,GO:0033006,1,0.846700331873375,0,27,regulation of mast cell activation involved in immune response,BP,
8797,GO:0033007,1,0.958856078823924,0,7,negative regulation of mast cell activation involved in immune response,BP,
8798,GO:0033008,1,0.92917355480223,0,12,positive regulation of mast cell activation involved in immune response,BP,
8799,GO:0033010,1,0.953498738995971,0,7,paranodal junction,CC,
8800,GO:0033011,1,0.98810112817009,0,2,perinuclear theca,CC,
8801,GO:0033013,1,0.729453559230322,0,50,tetrapyrrole metabolic process,BP,
8802,GO:0033014,1,0.847995302942754,0,26,tetrapyrrole biosynthetic process,BP,
8803,GO:0033015,1,0.977272184932079,0,4,tetrapyrrole catabolic process,BP,
8805,GO:0033018,1,0.957244328884936,0,7,sarcoplasmic reticulum lumen,CC,
8806,GO:0033023,1,0.981307573599482,0,3,mast cell homeostasis,BP,
8807,GO:0033024,1,0.981307573599482,0,3,mast cell apoptotic process,BP,
8808,GO:0033025,1,0.981307573599482,0,3,regulation of mast cell apoptotic process,BP,
8809,GO:0033026,1,0.987609130153754,0,2,negative regulation of mast cell apoptotic process,BP,
8810,GO:0033028,1,0.839371891806644,0,28,myeloid cell apoptotic process,BP,
8811,GO:0033029,1,0.962212785865962,0,6,regulation of neutrophil apoptotic process,BP,
8812,GO:0033030,1,0.986765783542429,0,2,negative regulation of neutrophil apoptotic process,BP,
8813,GO:0033031,1,0.975121044577518,0,4,positive regulation of neutrophil apoptotic process,BP,
8814,GO:0033032,1,0.859989826700923,0,24,regulation of myeloid cell apoptotic process,BP,
8815,GO:0033033,1,0.922494883919825,0,13,negative regulation of myeloid cell apoptotic process,BP,
8816,GO:0033034,1,0.956402966043116,0,7,positive regulation of myeloid cell apoptotic process,BP,
8818,GO:0033037,1,0.99299274019862,0,1,polysaccharide localization,BP,
8819,GO:0033038,1,0.944537928152351,0,10,bitter taste receptor activity,MF,
8820,GO:0033040,1,0.99376386013477,0,1,sour taste receptor activity,MF,
8821,GO:0033041,1,0.993908146519457,0,1,sweet taste receptor activity,MF,
8824,GO:0033045,1,0.633271986383453,0,70,regulation of sister chromatid segregation,BP,
8825,GO:0033046,1,0.785176444299836,0,37,negative regulation of sister chromatid segregation,BP,
8826,GO:0033047,1,0.670185859826338,0,61,regulation of mitotic sister chromatid segregation,BP,
8827,GO:0033048,1,0.790938052099751,0,36,negative regulation of mitotic sister chromatid segregation,BP,
8828,GO:0033058,1,0.977887109117434,0,3,directional locomotion,BP,
8829,GO:0033059,1,0.716901409480829,0,52,cellular pigmentation,BP,
8830,GO:0033061,1,0.946700479150528,0,9,DNA recombinase mediator complex,CC,
8831,GO:0033063,1,0.958466257762706,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8832,GO:0033065,1,0.988305154609843,0,2,Rad51C-XRCC3 complex,CC,
8833,GO:0033076,1,0.982451514614669,0,3,isoquinoline alkaloid metabolic process,BP,
8834,GO:0033077,1,0.680062315219186,0,60,T cell differentiation in thymus,BP,
8835,GO:0033078,1,0.981667068081733,0,3,extrathymic T cell differentiation,BP,
8836,GO:0033079,1,0.957925922114799,0,7,immature T cell proliferation,BP,
8837,GO:0033080,1,0.969478967378933,0,5,immature T cell proliferation in thymus,BP,
8838,GO:0033081,1,0.88189188344378,0,20,regulation of T cell differentiation in thymus,BP,
8839,GO:0033082,1,0.987441068832231,0,2,regulation of extrathymic T cell differentiation,BP,
8840,GO:0033083,1,0.964172524322562,0,6,regulation of immature T cell proliferation,BP,
8841,GO:0033084,1,0.975800130716389,0,4,regulation of immature T cell proliferation in thymus,BP,
8842,GO:0033085,1,0.964290720803285,0,6,negative regulation of T cell differentiation in thymus,BP,
8843,GO:0033087,1,0.981679048324303,0,3,negative regulation of immature T cell proliferation,BP,
8844,GO:0033088,1,0.98745397938298,0,2,negative regulation of immature T cell proliferation in thymus,BP,
8845,GO:0033089,1,0.944910247603364,0,9,positive regulation of T cell differentiation in thymus,BP,
8846,GO:0033091,1,0.982170089473103,0,3,positive regulation of immature T cell proliferation,BP,
8847,GO:0033092,1,0.988199596026091,0,2,positive regulation of immature T cell proliferation in thymus,BP,
8848,GO:0033093,1,0.966954117177271,0,5,Weibel-Palade body,CC,
8850,GO:0033108,1,0.598858735182047,0,87,mitochondrial respiratory chain complex assembly,BP,
8851,GO:0033116,1,0.676123098697543,0,62,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,
8852,GO:0033119,1,0.862444835296225,0,24,negative regulation of RNA splicing,BP,
8853,GO:0033120,1,0.82477309224821,0,30,positive regulation of RNA splicing,BP,
8854,GO:0033121,1,0.979474346741688,0,3,regulation of purine nucleotide catabolic process,BP,
8855,GO:0033122,1,0.986459919149878,0,2,negative regulation of purine nucleotide catabolic process,BP,
8856,GO:0033123,1,0.992919525115996,0,1,positive regulation of purine nucleotide catabolic process,BP,
8857,GO:0033127,1,0.921396508866958,0,13,regulation of histone phosphorylation,BP,
8858,GO:0033128,1,0.982251369884051,0,3,negative regulation of histone phosphorylation,BP,
8859,GO:0033129,1,0.949744033917488,0,8,positive regulation of histone phosphorylation,BP,
8860,GO:0033130,1,0.937152646373949,0,10,acetylcholine receptor binding,MF,
8861,GO:0033131,1,0.944385165853776,0,9,regulation of glucokinase activity,BP,
8862,GO:0033132,1,0.97605762101554,0,4,negative regulation of glucokinase activity,BP,
8863,GO:0033133,1,0.967558522795073,0,5,positive regulation of glucokinase activity,BP,
8864,GO:0033135,1,0.507013535963511,0,106,regulation of peptidyl-serine phosphorylation,BP,
8865,GO:0033137,1,0.864472440614589,0,23,negative regulation of peptidyl-serine phosphorylation,BP,
8866,GO:0033138,1,0.613971711440292,0,77,positive regulation of peptidyl-serine phosphorylation,BP,
8867,GO:0033139,1,0.974880030683059,0,4,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8868,GO:0033140,1,0.994108842120936,0,1,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8869,GO:0033141,1,0.980658392393109,0,3,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8870,GO:0033142,1,0.994014167767511,0,1,progesterone receptor binding,MF,
8871,GO:0033143,1,0.638733129610816,0,70,regulation of intracellular steroid hormone receptor signaling pathway,BP,
8872,GO:0033144,1,0.825445632973745,0,30,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8873,GO:0033145,1,0.909373587926948,0,15,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8874,GO:0033146,1,0.798024172022429,0,35,regulation of intracellular estrogen receptor signaling pathway,BP,
8875,GO:0033147,1,0.9253313521657,0,12,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8876,GO:0033148,1,0.943669082368519,0,9,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8877,GO:0033149,1,0.986288117398926,0,2,FFAT motif binding,MF,
8878,GO:0033150,1,0.994087474896291,0,1,cytoskeletal calyx,CC,
8879,GO:0033151,1,0.920462417114173,0,12,V(D)J recombination,BP,
8880,GO:0033152,1,0.972196186592298,0,4,immunoglobulin V(D)J recombination,BP,
8881,GO:0033153,1,0.96460546264309,0,5,T cell receptor V(D)J recombination,BP,
8883,GO:0033158,1,0.885551443195996,0,18,regulation of protein import into nucleus, translocation,BP,
8884,GO:0033159,1,0.981111484433224,0,3,negative regulation of protein import into nucleus, translocation,BP,
8885,GO:0033160,1,0.924494443813156,0,11,positive regulation of protein import into nucleus, translocation,BP,
8886,GO:0033162,1,0.93629067215714,0,11,melanosome membrane,CC,
8887,GO:0033165,1,0.987703510943629,0,2,interphotoreceptor matrix,CC,
8888,GO:0033167,1,0.991682396568226,0,1,ARC complex,CC,
8889,GO:0033168,1,0.991682396568226,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8890,GO:0033169,1,0.915741419658856,0,13,histone H3-K9 demethylation,BP,
8891,GO:0033170,1,0.952312045521723,0,8,protein-DNA loading ATPase activity,MF,
8893,GO:0033176,1,0.864369278089426,0,24,proton-transporting V-type ATPase complex,CC,
8894,GO:0033177,1,0.935171674473664,0,11,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8895,GO:0033178,1,0.935185556448706,0,11,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8896,GO:0033179,1,0.9405888176524,0,10,proton-transporting V-type ATPase, V0 domain,CC,
8897,GO:0033180,1,0.946196237224614,0,9,proton-transporting V-type ATPase, V1 domain,CC,
8898,GO:0033181,1,0.988160290478469,0,2,plasma membrane proton-transporting V-type ATPase complex,CC,
8899,GO:0033182,1,0.936499482576271,0,10,regulation of histone ubiquitination,BP,
8900,GO:0033183,1,0.978810918667109,0,3,negative regulation of histone ubiquitination,BP,
8901,GO:0033184,1,0.968428182033117,0,5,positive regulation of histone ubiquitination,BP,
8902,GO:0033185,1,0.983156657113198,0,3,dolichol-phosphate-mannose synthase complex,CC,
8903,GO:0033186,1,0.980155779231198,0,3,CAF-1 complex,CC,
8904,GO:0033188,1,0.980778878721603,0,3,sphingomyelin synthase activity,MF,
8905,GO:0033189,1,0.912089818957187,0,15,response to vitamin A,BP,
8906,GO:0033192,1,0.966984768948177,0,5,calmodulin-dependent protein phosphatase activity,MF,
8907,GO:0033193,1,0.993208627667738,0,1,Lsd1/2 complex,CC,
8908,GO:0033194,1,0.905447180920995,0,16,response to hydroperoxide,BP,
8909,GO:0033197,1,0.928559097041105,0,12,response to vitamin E,BP,
8910,GO:0033198,1,0.826602617672857,0,30,response to ATP,BP,
8911,GO:0033202,1,0.91303894272081,0,15,DNA helicase complex,CC,
8912,GO:0033204,1,0.993929873032904,0,1,ribonuclease P RNA binding,MF,
8913,GO:0033206,1,0.967400698904522,0,5,meiotic cytokinesis,BP,
8915,GO:0033210,1,0.945362769488336,0,9,leptin-mediated signaling pathway,BP,
8916,GO:0033211,1,0.969404681985708,0,5,adiponectin-activated signaling pathway,BP,
8917,GO:0033212,1,0.993961985134131,0,1,iron assimilation,BP,
8918,GO:0033214,1,0.993961985134131,0,1,iron assimilation by chelation and transport,BP,
8919,GO:0033216,1,0.962061956735995,0,6,ferric iron import,BP,
8921,GO:0033220,1,0.974787379284378,0,4,amide-transporting ATPase activity,MF,
8922,GO:0033227,1,0.968754598288691,0,5,dsRNA transport,BP,
8923,GO:0033229,1,0.99357337879569,0,1,cysteine transmembrane transporter activity,MF,
8924,GO:0033231,1,0.993498820562144,0,1,carbohydrate export,BP,
8925,GO:0033233,1,0.876804707456433,0,21,regulation of protein sumoylation,BP,
8926,GO:0033234,1,0.939524474752182,0,10,negative regulation of protein sumoylation,BP,
8927,GO:0033235,1,0.933343822753981,0,11,positive regulation of protein sumoylation,BP,
8929,GO:0033239,1,0.966743963821348,0,5,negative regulation of cellular amine metabolic process,BP,
8931,GO:0033241,1,0.992100351952376,0,1,regulation of cellular amine catabolic process,BP,
8932,GO:0033242,1,0.992100351952376,0,1,negative regulation of cellular amine catabolic process,BP,
8933,GO:0033256,1,0.958086803172319,0,7,I-kappaB/NF-kappaB complex,CC,
8934,GO:0033257,1,0.987906782192349,0,2,Bcl3/NF-kappaB2 complex,CC,
8935,GO:0033260,1,0.734736329615515,0,49,nuclear DNA replication,BP,
8936,GO:0033262,1,0.924507403980866,0,12,regulation of nuclear cell cycle DNA replication,BP,
8937,GO:0033263,1,0.973998879348411,0,4,CORVET complex,CC,
8938,GO:0033265,1,0.987847208764165,0,2,choline binding,MF,
8943,GO:0033273,1,0.589469453427071,0,84,response to vitamin,BP,
8944,GO:0033274,1,0.992585860572098,0,1,response to vitamin B2,BP,
8946,GO:0033276,1,0.920172271064751,0,13,transcription factor TFTC complex,CC,
8947,GO:0033277,1,0.986873449518945,0,2,abortive mitotic cell cycle,BP,
8948,GO:0033278,1,0.968077121315949,0,5,cell proliferation in midbrain,BP,
8949,GO:0033280,1,0.809711273645091,0,33,response to vitamin D,BP,
8950,GO:0033283,1,0.986936713742306,0,2,organic acid-transporting ATPase activity,MF,
8951,GO:0033284,1,0.986936713742306,0,2,carboxylic acid-transporting ATPase activity,MF,
8952,GO:0033285,1,0.986936713742306,0,2,monocarboxylic acid-transporting ATPase activity,MF,
8953,GO:0033290,1,0.993448178673619,0,1,eukaryotic 48S preinitiation complex,CC,
8954,GO:0033291,1,0.994539277062001,0,1,eukaryotic 80S initiation complex,CC,
8955,GO:0033292,1,0.984635981435917,0,2,T-tubule organization,BP,
8957,GO:0033299,1,0.969592447919513,0,5,secretion of lysosomal enzymes,BP,
8958,GO:0033300,1,0.98087771177236,0,3,dehydroascorbic acid transmembrane transporter activity,MF,
8959,GO:0033301,1,0.993575662693004,0,1,cell cycle comprising mitosis without cytokinesis,BP,
8960,GO:0033306,1,0.987704752253838,0,2,phytol metabolic process,BP,
8961,GO:0033313,1,0.969186211053612,0,5,meiotic cell cycle checkpoint,BP,
8962,GO:0033314,1,0.951429469076023,0,8,mitotic DNA replication checkpoint,BP,
8963,GO:0033316,1,0.993772585859067,0,1,meiotic spindle assembly checkpoint,BP,
8964,GO:0033319,1,0.994042443251876,0,1,UDP-D-xylose metabolic process,BP,
8965,GO:0033320,1,0.994042443251876,0,1,UDP-D-xylose biosynthetic process,BP,
8966,GO:0033326,1,0.987125102063183,0,2,cerebrospinal fluid secretion,BP,
8967,GO:0033327,1,0.938595675185043,0,10,Leydig cell differentiation,BP,
8968,GO:0033328,1,0.993605492151102,0,1,peroxisome membrane targeting sequence binding,MF,
8969,GO:0033341,1,0.986336591451002,0,2,regulation of collagen binding,BP,
8970,GO:0033342,1,0.993917928764395,0,1,negative regulation of collagen binding,BP,
8971,GO:0033343,1,0.992372743118404,0,1,positive regulation of collagen binding,BP,
8972,GO:0033344,1,0.810298778351189,0,32,cholesterol efflux,BP,
8973,GO:0033345,1,0.993959536128931,0,1,asparagine catabolic process via L-aspartate,BP,
8974,GO:0033353,1,0.974603158852164,0,4,S-adenosylmethionine cycle,BP,
8975,GO:0033363,1,0.847233011343387,0,25,secretory granule organization,BP,
8976,GO:0033364,1,0.985072777971243,0,2,mast cell secretory granule organization,BP,
8978,GO:0033366,1,0.994285863054733,0,1,protein localization to secretory granule,BP,
8979,GO:0033367,1,0.994285863054733,0,1,protein localization to mast cell secretory granule,BP,
8980,GO:0033368,1,0.994285863054733,0,1,protease localization to mast cell secretory granule,BP,
8981,GO:0033370,1,0.994285863054733,0,1,maintenance of protein location in mast cell secretory granule,BP,
8982,GO:0033371,1,0.994285863054733,0,1,T cell secretory granule organization,BP,
8983,GO:0033373,1,0.994285863054733,0,1,maintenance of protease location in mast cell secretory granule,BP,
8984,GO:0033374,1,0.994285863054733,0,1,protein localization to T cell secretory granule,BP,
8985,GO:0033375,1,0.994285863054733,0,1,protease localization to T cell secretory granule,BP,
8986,GO:0033377,1,0.994285863054733,0,1,maintenance of protein location in T cell secretory granule,BP,
8987,GO:0033379,1,0.994285863054733,0,1,maintenance of protease location in T cell secretory granule,BP,
8988,GO:0033380,1,0.994285863054733,0,1,granzyme B localization to T cell secretory granule,BP,
8989,GO:0033382,1,0.994285863054733,0,1,maintenance of granzyme B location in T cell secretory granule,BP,
8990,GO:0033383,1,0.988088458790598,0,2,geranyl diphosphate metabolic process,BP,
8991,GO:0033384,1,0.988088458790598,0,2,geranyl diphosphate biosynthetic process,BP,
8992,GO:0033385,1,0.993835752626004,0,1,geranylgeranyl diphosphate metabolic process,BP,
8993,GO:0033386,1,0.993835752626004,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
8994,GO:0033387,1,0.981425738539516,0,3,putrescine biosynthetic process from ornithine,BP,
8995,GO:0033388,1,0.994012148604285,0,1,putrescine biosynthetic process from arginine,BP,
8996,GO:0033391,1,0.93053762285155,0,11,chromatoid body,CC,
8997,GO:0033396,1,0.994048792461045,0,1,beta-alanine biosynthetic process via 3-ureidopropionate,BP,
8998,GO:0033477,1,0.994071018585764,0,1,S-methylmethionine metabolic process,BP,
8999,GO:0033483,1,0.945012725204917,0,9,gas homeostasis,BP,
9000,GO:0033484,1,0.981674162822662,0,3,nitric oxide homeostasis,BP,
9001,GO:0033488,1,0.993760141704562,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
9002,GO:0033489,1,0.97567529747159,0,4,cholesterol biosynthetic process via desmosterol,BP,
9003,GO:0033490,1,0.97567529747159,0,4,cholesterol biosynthetic process via lathosterol,BP,
9004,GO:0033499,1,0.988224666675857,0,2,galactose catabolic process via UDP-galactose,BP,
9006,GO:0033503,1,0.975182670027009,0,4,HULC complex,CC,
9007,GO:0033504,1,0.967122197792904,0,5,floor plate development,BP,
9008,GO:0033505,1,0.986784182737936,0,2,floor plate morphogenesis,BP,
9009,GO:0033512,1,0.980902548727055,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
9010,GO:0033514,1,0.993949597679924,0,1,L-lysine catabolic process to acetyl-CoA via L-pipecolate,BP,
9011,GO:0033522,1,0.853828850692768,0,24,histone H2A ubiquitination,BP,
9012,GO:0033523,1,0.925844552090577,0,12,histone H2B ubiquitination,BP,
9013,GO:0033526,1,0.993865029965055,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
9014,GO:0033539,1,0.916685791839574,0,14,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
9015,GO:0033540,1,0.916934937018245,0,14,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
9016,GO:0033549,1,0.928336331404634,0,12,MAP kinase phosphatase activity,MF,
9017,GO:0033552,1,0.993899517803582,0,1,response to vitamin B3,BP,
9018,GO:0033553,1,0.973883404091506,0,4,rDNA heterochromatin,CC,
9021,GO:0033557,1,0.987729649828399,0,2,Slx1-Slx4 complex,CC,
9022,GO:0033558,1,0.75094633156636,0,44,protein deacetylase activity,MF,
9024,GO:0033560,1,0.993519399581866,0,1,folate reductase activity,MF,
9025,GO:0033561,1,0.892122030798721,0,18,regulation of water loss via skin,BP,
9026,GO:0033563,1,0.978542807292206,0,3,dorsal/ventral axon guidance,BP,
9027,GO:0033564,1,0.959666473891986,0,6,anterior/posterior axon guidance,BP,
9028,GO:0033565,1,0.980720027560519,0,3,ESCRT-0 complex,CC,
9029,GO:0033566,1,0.98783139017797,0,2,gamma-tubulin complex localization,BP,
9030,GO:0033567,1,0.969976676605488,0,5,DNA replication, Okazaki fragment processing,BP,
9031,GO:0033570,1,0.987012802291555,0,2,transferrin transmembrane transporter activity,MF,
9033,GO:0033574,1,0.773968216399601,0,41,response to testosterone,BP,
9034,GO:0033577,1,0.987760862201641,0,2,protein glycosylation in endoplasmic reticulum,BP,
9035,GO:0033578,1,0.968531327185356,0,5,protein glycosylation in Golgi,BP,
9036,GO:0033588,1,0.969889756425281,0,5,Elongator holoenzyme complex,CC,
9037,GO:0033590,1,0.982104625591562,0,3,response to cobalamin,BP,
9038,GO:0033591,1,0.968525138822067,0,5,response to L-ascorbic acid,BP,
9039,GO:0033592,1,0.968143404390682,0,5,RNA strand annealing activity,MF,
9040,GO:0033593,1,0.991351679107575,0,1,BRCA2-MAGE-D1 complex,CC,
9041,GO:0033594,1,0.976352998267335,0,4,response to hydroxyisoflavone,BP,
9042,GO:0033595,1,0.987779656814456,0,2,response to genistein,BP,
9043,GO:0033596,1,0.985249334745785,0,2,TSC1-TSC2 complex,CC,
9044,GO:0033597,1,0.994024985939764,0,1,mitotic checkpoint complex,CC,
9045,GO:0033598,1,0.843001784336153,0,26,mammary gland epithelial cell proliferation,BP,
9046,GO:0033599,1,0.893643030337444,0,17,regulation of mammary gland epithelial cell proliferation,BP,
9047,GO:0033600,1,0.972142653918631,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
9048,GO:0033601,1,0.946788014568825,0,8,positive regulation of mammary gland epithelial cell proliferation,BP,
9049,GO:0033602,1,0.98021723789413,0,3,negative regulation of dopamine secretion,BP,
9050,GO:0033603,1,0.962828763576788,0,6,positive regulation of dopamine secretion,BP,
9051,GO:0033604,1,0.939190818202351,0,10,negative regulation of catecholamine secretion,BP,
9052,GO:0033605,1,0.939332170884041,0,10,positive regulation of catecholamine secretion,BP,
9053,GO:0033608,1,0.993846081630578,0,1,formyl-CoA transferase activity,MF,
9054,GO:0033609,1,0.993846081630578,0,1,oxalate metabolic process,BP,
9055,GO:0033612,1,0.887490842670057,0,19,receptor serine/threonine kinase binding,MF,
9056,GO:0033613,1,0.63152406701183,0,70,activating transcription factor binding,MF,
9057,GO:0033615,1,0.98179063728582,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
9058,GO:0033617,1,0.886213769572721,0,20,mitochondrial respiratory chain complex IV assembly,BP,
9059,GO:0033619,1,0.67238924777275,0,62,membrane protein proteolysis,BP,
9060,GO:0033622,1,0.883927553155481,0,19,integrin activation,BP,
9061,GO:0033623,1,0.938077542928189,0,10,regulation of integrin activation,BP,
9062,GO:0033624,1,0.98625452008957,0,2,negative regulation of integrin activation,BP,
9063,GO:0033625,1,0.969405020960803,0,5,positive regulation of integrin activation,BP,
9064,GO:0033626,1,0.993578374751637,0,1,positive regulation of integrin activation by cell surface receptor linked signal transduction,BP,
9065,GO:0033627,1,0.715160340587247,0,52,cell adhesion mediated by integrin,BP,
9066,GO:0033628,1,0.792174630719354,0,37,regulation of cell adhesion mediated by integrin,BP,
9067,GO:0033629,1,0.949256728159853,0,8,negative regulation of cell adhesion mediated by integrin,BP,
9068,GO:0033630,1,0.90469992005787,0,16,positive regulation of cell adhesion mediated by integrin,BP,
9069,GO:0033631,1,0.931951068240412,0,11,cell-cell adhesion mediated by integrin,BP,
9070,GO:0033632,1,0.956780303986499,0,7,regulation of cell-cell adhesion mediated by integrin,BP,
9071,GO:0033633,1,0.99325152067185,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
9072,GO:0033634,1,0.981201879854415,0,3,positive regulation of cell-cell adhesion mediated by integrin,BP,
9073,GO:0033643,1,0.927055787516509,0,12,host cell part,CC,
9074,GO:0033644,1,0.993441878684404,0,1,host cell membrane,CC,
9075,GO:0033646,1,0.945232550628121,0,9,host intracellular part,CC,
9076,GO:0033647,1,0.968795756694098,0,5,host intracellular organelle,CC,
9077,GO:0033648,1,0.968795756694098,0,5,host intracellular membrane-bounded organelle,CC,
9078,GO:0033650,1,0.994140607403246,0,1,host cell mitochondrion,CC,
9079,GO:0033655,1,0.963811607259417,0,6,host cell cytoplasm part,CC,
9080,GO:0033668,1,0.975792273875669,0,4,negative regulation by symbiont of host apoptotic process,BP,
9083,GO:0033676,1,0.994240524867684,0,1,double-stranded DNA-dependent ATPase activity,MF,
9084,GO:0033677,1,0.98117269880866,0,3,DNA/RNA helicase activity,MF,
9085,GO:0033678,1,0.993877957630742,0,1,5'-3' DNA/RNA helicase activity,MF,
9086,GO:0033679,1,0.993316508368644,0,1,3'-5' DNA/RNA helicase activity,MF,
9087,GO:0033680,1,0.987234967779859,0,2,ATP-dependent DNA/RNA helicase activity,MF,
9088,GO:0033681,1,0.993316508368644,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
9089,GO:0033682,1,0.993877957630742,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
9090,GO:0033683,1,0.785988277122144,0,39,nucleotide-excision repair, DNA incision,BP,
9091,GO:0033684,1,0.956304503797683,0,7,regulation of luteinizing hormone secretion,BP,
9092,GO:0033685,1,0.98156171043753,0,3,negative regulation of luteinizing hormone secretion,BP,
9093,GO:0033686,1,0.97427316884609,0,4,positive regulation of luteinizing hormone secretion,BP,
9097,GO:0033690,1,0.932929242617902,0,11,positive regulation of osteoblast proliferation,BP,
9099,GO:0033692,1,0.670487773085839,0,61,cellular polysaccharide biosynthetic process,BP,
9101,GO:0033695,1,0.994090362193189,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
9102,GO:0033699,1,0.994063224376902,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
9103,GO:0033700,1,0.949049093365696,0,8,phospholipid efflux,BP,
9104,GO:0033735,1,0.994373652584019,0,1,aspartate dehydrogenase activity,MF,
9105,GO:0033737,1,0.993923396668192,0,1,1-pyrroline dehydrogenase activity,MF,
9106,GO:0033743,1,0.97586556764138,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
9107,GO:0033745,1,0.981499150980783,0,3,L-methionine-(R)-S-oxide reductase activity,MF,
9108,GO:0033746,1,0.993603636886392,0,1,histone demethylase activity (H3-R2 specific),MF,
9109,GO:0033749,1,0.993603636886392,0,1,histone demethylase activity (H4-R3 specific),MF,
9110,GO:0033750,1,0.924895797475852,0,13,ribosome localization,BP,
9111,GO:0033754,1,0.99419287649023,0,1,indoleamine 2,3-dioxygenase activity,MF,
9112,GO:0033762,1,0.739503281509295,0,47,response to glucagon,BP,
9113,GO:0033764,1,0.879119909260551,0,22,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
9114,GO:0033765,1,0.987909189366315,0,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
9115,GO:0033768,1,0.993796774035418,0,1,SUMO-targeted ubiquitin ligase complex,CC,
9116,GO:0033778,1,0.993511683677316,0,1,7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity,MF,
9117,GO:0033781,1,0.994044463395542,0,1,cholesterol 24-hydroxylase activity,MF,
9118,GO:0033787,1,0.993825428377467,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
9119,GO:0033791,1,0.993977547039697,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity,MF,
9120,GO:0033798,1,0.994041000326921,0,1,thyroxine 5-deiodinase activity,MF,
9121,GO:0033814,1,0.99423648197711,0,1,propanoyl-CoA C-acyltransferase activity,MF,
9122,GO:0033819,1,0.99437076473813,0,1,lipoyl(octanoyl) transferase activity,MF,
9123,GO:0033823,1,0.993784462646258,0,1,procollagen glucosyltransferase activity,MF,
9124,GO:0033829,1,0.982289876827216,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
9125,GO:0033842,1,0.987339949356537,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
9126,GO:0033857,1,0.986192583735348,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
9127,GO:0033858,1,0.99373312350525,0,1,N-acetylgalactosamine kinase activity,MF,
9128,GO:0033860,1,0.959521031219061,0,7,regulation of NAD(P)H oxidase activity,BP,
9129,GO:0033861,1,0.988273387918008,0,2,negative regulation of NAD(P)H oxidase activity,BP,
9130,GO:0033862,1,0.993785321400087,0,1,UMP kinase activity,MF,
9131,GO:0033864,1,0.970909927170153,0,5,positive regulation of NAD(P)H oxidase activity,BP,
9132,GO:0033865,1,0.791144549631167,0,38,nucleoside bisphosphate metabolic process,BP,
9133,GO:0033866,1,0.906031208561677,0,16,nucleoside bisphosphate biosynthetic process,BP,
9134,GO:0033867,1,0.994171795638613,0,1,Fas-activated serine/threonine kinase activity,MF,
9135,GO:0033869,1,0.994354881633389,0,1,nucleoside bisphosphate catabolic process,BP,
9136,GO:0033871,1,0.994084587661038,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
9137,GO:0033872,1,0.988014885362323,0,2,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
9138,GO:0033875,1,0.791144549631167,0,38,ribonucleoside bisphosphate metabolic process,BP,
9139,GO:0033878,1,0.993550250716522,0,1,hormone-sensitive lipase activity,MF,
9140,GO:0033882,1,0.994312430761374,0,1,choloyl-CoA hydrolase activity,MF,
9141,GO:0033883,1,0.988424867128497,0,2,pyridoxal phosphatase activity,MF,
9142,GO:0033885,1,0.994009264215723,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
9143,GO:0033897,1,0.994285863054733,0,1,ribonuclease T2 activity,MF,
9144,GO:0033906,1,0.988130508623699,0,2,hyaluronoglucuronidase activity,MF,
9145,GO:0033919,1,0.993522828433545,0,1,glucan 1,3-alpha-glucosidase activity,MF,
9146,GO:0033925,1,0.993353559842376,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
9147,GO:0033961,1,0.994141906916851,0,1,cis-stilbene-oxide hydrolase activity,MF,
9148,GO:0033962,1,0.883163381255754,0,18,cytoplasmic mRNA processing body assembly,BP,
9149,GO:0033967,1,0.994309542961473,0,1,box C/D snoRNA metabolic process,BP,
9150,GO:0033979,1,0.993902537562302,0,1,box H/ACA snoRNA metabolic process,BP,
9151,GO:0033981,1,0.994461155914366,0,1,D-dopachrome decarboxylase activity,MF,
9152,GO:0033989,1,0.993870200243014,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9154,GO:0034014,1,0.993985762594839,0,1,response to triglyceride,BP,
9155,GO:0034030,1,0.906031208561677,0,16,ribonucleoside bisphosphate biosynthetic process,BP,
9156,GO:0034031,1,0.994354881633389,0,1,ribonucleoside bisphosphate catabolic process,BP,
9157,GO:0034032,1,0.791144549631167,0,38,purine nucleoside bisphosphate metabolic process,BP,
9158,GO:0034033,1,0.906031208561677,0,16,purine nucleoside bisphosphate biosynthetic process,BP,
9159,GO:0034034,1,0.994354881633389,0,1,purine nucleoside bisphosphate catabolic process,BP,
9160,GO:0034035,1,0.86732860117177,0,23,purine ribonucleoside bisphosphate metabolic process,BP,
9161,GO:0034036,1,0.962148932286986,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
9162,GO:0034038,1,0.99430405614583,0,1,deoxyhypusine synthase activity,MF,
9163,GO:0034039,1,0.988242851761779,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
9164,GO:0034040,1,0.960929897823356,0,6,lipid-transporting ATPase activity,MF,
9165,GO:0034041,1,0.981350150748496,0,3,sterol-transporting ATPase activity,MF,
9166,GO:0034045,1,0.899892296236788,0,16,phagophore assembly site membrane,CC,
9167,GO:0034046,1,0.953488465025446,0,7,poly(G) binding,MF,
9168,GO:0034056,1,0.974259484152899,0,4,estrogen response element binding,MF,
9169,GO:0034057,1,0.987444674636159,0,2,RNA strand-exchange activity,MF,
9170,GO:0034058,1,0.935477978597669,0,10,endosomal vesicle fusion,BP,
9171,GO:0034059,1,0.980006059427734,0,3,response to anoxia,BP,
9172,GO:0034061,1,0.796472757599188,0,35,DNA polymerase activity,MF,
9173,GO:0034062,1,0.768344896138074,0,43,5'-3' RNA polymerase activity,MF,
9174,GO:0034063,1,0.91590332640042,0,13,stress granule assembly,BP,
9175,GO:0034066,1,0.988152401188568,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
9176,GO:0034067,1,0.86396432916614,0,21,protein localization to Golgi apparatus,BP,
9177,GO:0034080,1,0.834564354241345,0,30,CENP-A containing nucleosome assembly,BP,
9178,GO:0034085,1,0.961092122716456,0,6,establishment of sister chromatid cohesion,BP,
9179,GO:0034086,1,0.933851614588168,0,10,maintenance of sister chromatid cohesion,BP,
9180,GO:0034087,1,0.98538551348997,0,2,establishment of mitotic sister chromatid cohesion,BP,
9181,GO:0034088,1,0.933851614588168,0,10,maintenance of mitotic sister chromatid cohesion,BP,
9182,GO:0034091,1,0.959684362491328,0,6,regulation of maintenance of sister chromatid cohesion,BP,
9183,GO:0034092,1,0.977850128358061,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
9184,GO:0034093,1,0.98142695488817,0,3,positive regulation of maintenance of sister chromatid cohesion,BP,
9186,GO:0034098,1,0.943734659606847,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
9187,GO:0034101,1,0.498887889709572,0,109,erythrocyte homeostasis,BP,
9190,GO:0034105,1,0.868223733201421,0,22,positive regulation of tissue remodeling,BP,
9191,GO:0034109,1,0.647677190413682,0,67,homotypic cell-cell adhesion,BP,
9192,GO:0034110,1,0.861904321731318,0,23,regulation of homotypic cell-cell adhesion,BP,
9193,GO:0034111,1,0.914870716259518,0,14,negative regulation of homotypic cell-cell adhesion,BP,
9194,GO:0034112,1,0.974219330091408,0,4,positive regulation of homotypic cell-cell adhesion,BP,
9198,GO:0034116,1,0.940343578923092,0,10,positive regulation of heterotypic cell-cell adhesion,BP,
9199,GO:0034117,1,0.994486570136063,0,1,erythrocyte aggregation,BP,
9200,GO:0034118,1,0.994486570136063,0,1,regulation of erythrocyte aggregation,BP,
9201,GO:0034120,1,0.994486570136063,0,1,positive regulation of erythrocyte aggregation,BP,
9202,GO:0034121,1,0.695423193118403,0,57,regulation of toll-like receptor signaling pathway,BP,
9203,GO:0034122,1,0.80784212333156,0,33,negative regulation of toll-like receptor signaling pathway,BP,
9204,GO:0034123,1,0.883571679432849,0,20,positive regulation of toll-like receptor signaling pathway,BP,
9205,GO:0034124,1,0.976151739485731,0,4,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9206,GO:0034125,1,0.988274143970183,0,2,negative regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9207,GO:0034127,1,0.950892827050331,0,8,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9208,GO:0034128,1,0.956562133056858,0,7,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9209,GO:0034130,1,0.993825141661333,0,1,toll-like receptor 1 signaling pathway,BP,
9210,GO:0034134,1,0.927406070936791,0,12,toll-like receptor 2 signaling pathway,BP,
9211,GO:0034135,1,0.957113565764919,0,7,regulation of toll-like receptor 2 signaling pathway,BP,
9212,GO:0034136,1,0.980221902641159,0,3,negative regulation of toll-like receptor 2 signaling pathway,BP,
9213,GO:0034137,1,0.976430151102063,0,4,positive regulation of toll-like receptor 2 signaling pathway,BP,
9214,GO:0034138,1,0.888452762931375,0,19,toll-like receptor 3 signaling pathway,BP,
9215,GO:0034139,1,0.944820733679483,0,9,regulation of toll-like receptor 3 signaling pathway,BP,
9216,GO:0034140,1,0.980770364166791,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
9217,GO:0034141,1,0.957393255299167,0,7,positive regulation of toll-like receptor 3 signaling pathway,BP,
9218,GO:0034142,1,0.839830585988897,0,28,toll-like receptor 4 signaling pathway,BP,
9219,GO:0034143,1,0.910895956570956,0,15,regulation of toll-like receptor 4 signaling pathway,BP,
9220,GO:0034144,1,0.962913515318137,0,6,negative regulation of toll-like receptor 4 signaling pathway,BP,
9221,GO:0034145,1,0.945999255128278,0,9,positive regulation of toll-like receptor 4 signaling pathway,BP,
9222,GO:0034146,1,0.986834636280934,0,2,toll-like receptor 5 signaling pathway,BP,
9223,GO:0034147,1,0.99337221620826,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
9224,GO:0034148,1,0.99337221620826,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
9225,GO:0034150,1,0.992956208625693,0,1,toll-like receptor 6 signaling pathway,BP,
9226,GO:0034154,1,0.957065599606652,0,7,toll-like receptor 7 signaling pathway,BP,
9227,GO:0034155,1,0.981945697374102,0,3,regulation of toll-like receptor 7 signaling pathway,BP,
9228,GO:0034156,1,0.994153024963152,0,1,negative regulation of toll-like receptor 7 signaling pathway,BP,
9229,GO:0034157,1,0.987721607180406,0,2,positive regulation of toll-like receptor 7 signaling pathway,BP,
9230,GO:0034158,1,0.993435577506204,0,1,toll-like receptor 8 signaling pathway,BP,
9231,GO:0034162,1,0.880263278771263,0,20,toll-like receptor 9 signaling pathway,BP,
9232,GO:0034163,1,0.962094924775734,0,6,regulation of toll-like receptor 9 signaling pathway,BP,
9233,GO:0034164,1,0.986927326873284,0,2,negative regulation of toll-like receptor 9 signaling pathway,BP,
9234,GO:0034165,1,0.987335411784029,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
9235,GO:0034166,1,0.993692985329558,0,1,toll-like receptor 10 signaling pathway,BP,
9236,GO:0034182,1,0.959684362491328,0,6,regulation of maintenance of mitotic sister chromatid cohesion,BP,
9237,GO:0034183,1,0.977850128358061,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
9238,GO:0034184,1,0.98142695488817,0,3,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
9239,GO:0034185,1,0.894938982847789,0,16,apolipoprotein binding,MF,
9240,GO:0034186,1,0.973987727240653,0,4,apolipoprotein A-I binding,MF,
9241,GO:0034188,1,0.984362124985117,0,2,apolipoprotein A-I receptor activity,MF,
9242,GO:0034189,1,0.987246496006566,0,2,very-low-density lipoprotein particle binding,MF,
9243,GO:0034190,1,0.968609203678752,0,5,apolipoprotein receptor binding,MF,
9244,GO:0034191,1,0.974851892394868,0,4,apolipoprotein A-I receptor binding,MF,
9245,GO:0034196,1,0.976175711300865,0,4,acylglycerol transport,BP,
9246,GO:0034197,1,0.976175711300865,0,4,triglyceride transport,BP,
9247,GO:0034198,1,0.768178271983409,0,42,cellular response to amino acid starvation,BP,
9248,GO:0034199,1,0.897968353578107,0,16,activation of protein kinase A activity,BP,
9249,GO:0034201,1,0.968883391582481,0,5,response to oleic acid,BP,
9250,GO:0034203,1,0.993178957399573,0,1,glycolipid translocation,BP,
9251,GO:0034204,1,0.843514188989239,0,24,lipid translocation,BP,
9252,GO:0034205,1,0.86028968155613,0,23,amyloid-beta formation,BP,
9253,GO:0034211,1,0.991973955775138,0,1,GTP-dependent protein kinase activity,MF,
9254,GO:0034212,1,0.676294810409663,0,60,peptide N-acetyltransferase activity,MF,
9255,GO:0034213,1,0.994199807170744,0,1,quinolinate catabolic process,BP,
9256,GO:0034214,1,0.949927051899807,0,8,protein hexamerization,BP,
9259,GO:0034224,1,0.993997584078746,0,1,cellular response to zinc ion starvation,BP,
9260,GO:0034227,1,0.97075606137572,0,5,tRNA thio-modification,BP,
9261,GO:0034230,1,0.993281150287577,0,1,enkephalin processing,BP,
9262,GO:0034231,1,0.993281150287577,0,1,islet amyloid polypeptide processing,BP,
9263,GO:0034235,1,0.963975690230445,0,6,GPI anchor binding,MF,
9266,GO:0034238,1,0.993499392348228,0,1,macrophage fusion,BP,
9267,GO:0034239,1,0.993499392348228,0,1,regulation of macrophage fusion,BP,
9268,GO:0034241,1,0.993499392348228,0,1,positive regulation of macrophage fusion,BP,
9269,GO:0034242,1,0.98142323994433,0,3,negative regulation of syncytium formation by plasma membrane fusion,BP,
9270,GO:0034243,1,0.852916132430068,0,25,regulation of transcription elongation from RNA polymerase II promoter,BP,
9271,GO:0034244,1,0.933299963554073,0,11,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
9272,GO:0034245,1,0.993548537220894,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
9273,GO:0034247,1,0.994274023129977,0,1,snoRNA splicing,BP,
9274,GO:0034248,1,0.0618888334469431,0,430,regulation of cellular amide metabolic process,BP,
9275,GO:0034249,1,0.234024492294991,0,222,negative regulation of cellular amide metabolic process,BP,
9276,GO:0034250,1,0.436818585932663,0,131,positive regulation of cellular amide metabolic process,BP,
9277,GO:0034255,1,0.994026284253939,0,1,regulation of urea metabolic process,BP,
9278,GO:0034260,1,0.751028315977149,0,44,negative regulation of GTPase activity,BP,
9279,GO:0034271,1,0.981095905635727,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
9280,GO:0034272,1,0.981095905635727,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
9281,GO:0034274,1,0.980514516962372,0,3,Atg12-Atg5-Atg16 complex,CC,
9282,GO:0034275,1,0.99419287649023,0,1,kynurenic acid metabolic process,BP,
9283,GO:0034276,1,0.99419287649023,0,1,kynurenic acid biosynthetic process,BP,
9285,GO:0034285,1,0.974445773805484,0,4,response to disaccharide,BP,
9286,GO:0034287,1,0.976298374042888,0,4,detection of monosaccharide stimulus,BP,
9287,GO:0034308,1,0.731185207730314,0,51,primary alcohol metabolic process,BP,
9288,GO:0034309,1,0.994377406787888,0,1,primary alcohol biosynthetic process,BP,
9289,GO:0034310,1,0.926229841979713,0,13,primary alcohol catabolic process,BP,
9290,GO:0034311,1,0.891068659941788,0,19,diol metabolic process,BP,
9291,GO:0034312,1,0.907103217593978,0,16,diol biosynthetic process,BP,
9292,GO:0034314,1,0.823932949822687,0,31,Arp2/3 complex-mediated actin nucleation,BP,
9293,GO:0034315,1,0.910121760481596,0,15,regulation of Arp2/3 complex-mediated actin nucleation,BP,
9294,GO:0034316,1,0.969767489815726,0,5,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
9297,GO:0034331,1,0.932727937707043,0,11,cell junction maintenance,BP,
9300,GO:0034334,1,0.974076420157858,0,4,adherens junction maintenance,BP,
9301,GO:0034338,1,0.974418590074483,0,4,short-chain carboxylesterase activity,MF,
9302,GO:0034340,1,0.625305162743267,0,75,response to type I interferon,BP,
9304,GO:0034342,1,0.987915350502032,0,2,response to type III interferon,BP,
9305,GO:0034343,1,0.980827086857816,0,3,type III interferon production,BP,
9306,GO:0034344,1,0.980827086857816,0,3,regulation of type III interferon production,BP,
9307,GO:0034346,1,0.993770439960859,0,1,positive regulation of type III interferon production,BP,
9308,GO:0034349,1,0.91388626913404,0,14,glial cell apoptotic process,BP,
9309,GO:0034350,1,0.949982350327197,0,8,regulation of glial cell apoptotic process,BP,
9310,GO:0034351,1,0.949982350327197,0,8,negative regulation of glial cell apoptotic process,BP,
9311,GO:0034353,1,0.993846081630578,0,1,RNA pyrophosphohydrolase activity,MF,
9312,GO:0034354,1,0.994274889465416,0,1,'de novo' NAD biosynthetic process from tryptophan,BP,
9313,GO:0034355,1,0.993846081630578,0,1,NAD salvage,BP,
9314,GO:0034356,1,0.927028574405546,0,12,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,
9315,GO:0034358,1,0.817667711285204,0,32,plasma lipoprotein particle,CC,
9316,GO:0034359,1,0.990553328559098,0,1,mature chylomicron,CC,
9317,GO:0034360,1,0.990553328559098,0,1,chylomicron remnant,CC,
9318,GO:0034361,1,0.911511982053286,0,15,very-low-density lipoprotein particle,CC,
9319,GO:0034362,1,0.925311471219178,0,12,low-density lipoprotein particle,CC,
9320,GO:0034363,1,0.973937812961919,0,4,intermediate-density lipoprotein particle,CC,
9321,GO:0034364,1,0.882755864695947,0,21,high-density lipoprotein particle,CC,
9322,GO:0034365,1,0.983215642208803,0,3,discoidal high-density lipoprotein particle,CC,
9323,GO:0034366,1,0.965995719302137,0,6,spherical high-density lipoprotein particle,CC,
9324,GO:0034367,1,0.866112035024553,0,23,protein-containing complex remodeling,BP,
9325,GO:0034368,1,0.871547242244522,0,22,protein-lipid complex remodeling,BP,
9326,GO:0034369,1,0.871547242244522,0,22,plasma lipoprotein particle remodeling,BP,
9327,GO:0034370,1,0.950911057640473,0,8,triglyceride-rich lipoprotein particle remodeling,BP,
9328,GO:0034371,1,0.967670883431375,0,5,chylomicron remodeling,BP,
9329,GO:0034372,1,0.959983465325074,0,7,very-low-density lipoprotein particle remodeling,BP,
9330,GO:0034373,1,0.994182769239322,0,1,intermediate-density lipoprotein particle remodeling,BP,
9331,GO:0034374,1,0.932010197397731,0,11,low-density lipoprotein particle remodeling,BP,
9332,GO:0034375,1,0.919218508635229,0,14,high-density lipoprotein particle remodeling,BP,
9333,GO:0034377,1,0.868426729090419,0,22,plasma lipoprotein particle assembly,BP,
9334,GO:0034378,1,0.954954811416314,0,7,chylomicron assembly,BP,
9335,GO:0034379,1,0.943100609789028,0,9,very-low-density lipoprotein particle assembly,BP,
9336,GO:0034380,1,0.932533130883595,0,11,high-density lipoprotein particle assembly,BP,
9337,GO:0034381,1,0.743438598365704,0,47,plasma lipoprotein particle clearance,BP,
9338,GO:0034382,1,0.95586247276694,0,7,chylomicron remnant clearance,BP,
9339,GO:0034383,1,0.82582621525587,0,30,low-density lipoprotein particle clearance,BP,
9340,GO:0034384,1,0.938768341108541,0,10,high-density lipoprotein particle clearance,BP,
9341,GO:0034385,1,0.911511982053286,0,15,triglyceride-rich plasma lipoprotein particle,CC,
9342,GO:0034386,1,0.993232525385339,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
9343,GO:0034388,1,0.962602007545573,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
9344,GO:0034389,1,0.899840677802573,0,17,lipid particle organization,BP,
9345,GO:0034390,1,0.896636502502135,0,17,smooth muscle cell apoptotic process,BP,
9346,GO:0034391,1,0.896636502502135,0,17,regulation of smooth muscle cell apoptotic process,BP,
9347,GO:0034392,1,0.967158481256539,0,5,negative regulation of smooth muscle cell apoptotic process,BP,
9348,GO:0034393,1,0.93876931089399,0,10,positive regulation of smooth muscle cell apoptotic process,BP,
9349,GO:0034394,1,0.71722995891326,0,51,protein localization to cell surface,BP,
9350,GO:0034395,1,0.987915369578445,0,2,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
9351,GO:0034397,1,0.930518671503302,0,11,telomere localization,BP,
9352,GO:0034398,1,0.962300326947037,0,6,telomere tethering at nuclear periphery,BP,
9353,GO:0034399,1,0.432875246825142,0,128,nuclear periphery,CC,
9354,GO:0034402,1,0.986953356298486,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
9356,GO:0034405,1,0.807239819671503,0,33,response to fluid shear stress,BP,
9357,GO:0034414,1,0.987588615648171,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
9358,GO:0034416,1,0.993825428377467,0,1,bisphosphoglycerate phosphatase activity,MF,
9359,GO:0034417,1,0.993825428377467,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
9360,GO:0034418,1,0.988009650645627,0,2,urate biosynthetic process,BP,
9361,GO:0034421,1,0.981138438232625,0,3,post-translational protein acetylation,BP,
9362,GO:0034423,1,0.993886579649392,0,1,autophagosome lumen,CC,
9363,GO:0034427,1,0.942566746058709,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
9364,GO:0034431,1,0.975772150142065,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
9365,GO:0034432,1,0.975772150142065,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
9366,GO:0034433,1,0.94217847471122,0,10,steroid esterification,BP,
9367,GO:0034434,1,0.94217847471122,0,10,sterol esterification,BP,
9368,GO:0034435,1,0.94217847471122,0,10,cholesterol esterification,BP,
9369,GO:0034436,1,0.981864224530968,0,3,glycoprotein transport,BP,
9370,GO:0034437,1,0.987433130054848,0,2,glycoprotein transporter activity,MF,
9371,GO:0034439,1,0.98801630975614,0,2,lipoprotein lipid oxidation,BP,
9372,GO:0034440,1,0.543422562912673,0,97,lipid oxidation,BP,
9373,GO:0034441,1,0.988586653902986,0,2,plasma lipoprotein particle oxidation,BP,
9374,GO:0034442,1,0.98801630975614,0,2,regulation of lipoprotein oxidation,BP,
9375,GO:0034443,1,0.994320516609717,0,1,negative regulation of lipoprotein oxidation,BP,
9376,GO:0034444,1,0.994427078300591,0,1,regulation of plasma lipoprotein oxidation,BP,
9377,GO:0034445,1,0.994427078300591,0,1,negative regulation of plasma lipoprotein oxidation,BP,
9379,GO:0034447,1,0.950996899212232,0,8,very-low-density lipoprotein particle clearance,BP,
9380,GO:0034448,1,0.970136433602677,0,5,EGO complex,CC,
9381,GO:0034450,1,0.918636261102261,0,13,ubiquitin-ubiquitin ligase activity,MF,
9382,GO:0034451,1,0.835576366577416,0,27,centriolar satellite,CC,
9383,GO:0034452,1,0.931235752703422,0,10,dynactin binding,MF,
9384,GO:0034453,1,0.858613529916989,0,22,microtubule anchoring,BP,
9385,GO:0034454,1,0.938091988677024,0,9,microtubule anchoring at centrosome,BP,
9386,GO:0034455,1,0.986658751076619,0,2,t-UTP complex,CC,
9387,GO:0034456,1,0.987776186337744,0,2,UTP-C complex,CC,
9388,GO:0034457,1,0.982661337864756,0,3,Mpp10 complex,CC,
9389,GO:0034458,1,0.98728639672069,0,2,3'-5' RNA helicase activity,MF,
9390,GO:0034459,1,0.993316508368644,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
9391,GO:0034462,1,0.993997151533403,0,1,small-subunit processome assembly,BP,
9392,GO:0034463,1,0.994539277062001,0,1,90S preribosome assembly,BP,
9393,GO:0034464,1,0.945849035859209,0,9,BBSome,CC,
9394,GO:0034465,1,0.975215243581598,0,4,response to carbon monoxide,BP,
9395,GO:0034466,1,0.993848090587249,0,1,chromaffin granule lumen,CC,
9396,GO:0034470,1,0.0906969633211379,0,389,ncRNA processing,BP,
9397,GO:0034471,1,0.890374653248207,0,19,ncRNA 5'-end processing,BP,
9398,GO:0034472,1,0.911210449283413,0,15,snRNA 3'-end processing,BP,
9399,GO:0034473,1,0.982830595171892,0,3,U1 snRNA 3'-end processing,BP,
9400,GO:0034474,1,0.992626371836323,0,1,U2 snRNA 3'-end processing,BP,
9401,GO:0034475,1,0.95487515990154,0,8,U4 snRNA 3'-end processing,BP,
9402,GO:0034476,1,0.982830595171892,0,3,U5 snRNA 3'-end processing,BP,
9403,GO:0034477,1,0.993846081630578,0,1,U6 snRNA 3'-end processing,BP,
9404,GO:0034481,1,0.96240395261735,0,6,chondroitin sulfotransferase activity,MF,
9406,GO:0034485,1,0.974499519446269,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
9407,GO:0034497,1,0.919384172124951,0,13,protein localization to phagophore assembly site,BP,
9408,GO:0034498,1,0.949515231745931,0,8,early endosome to Golgi transport,BP,
9409,GO:0034499,1,0.985956399586434,0,2,late endosome to Golgi transport,BP,
9410,GO:0034501,1,0.906682148149084,0,16,protein localization to kinetochore,BP,
9411,GO:0034502,1,0.639652146331069,0,70,protein localization to chromosome,BP,
9412,GO:0034504,1,0.230480241181903,0,226,protein localization to nucleus,BP,
9413,GO:0034505,1,0.905430391010297,0,15,tooth mineralization,BP,
9414,GO:0034506,1,0.99348795489116,0,1,chromosome, centromeric core domain,CC,
9415,GO:0034508,1,0.77958867672056,0,40,centromere complex assembly,BP,
9416,GO:0034511,1,0.968384170199545,0,5,U3 snoRNA binding,MF,
9417,GO:0034513,1,0.971705618001626,0,5,box H/ACA snoRNA binding,MF,
9418,GO:0034515,1,0.987548931339192,0,2,proteasome storage granule,CC,
9419,GO:0034516,1,0.994217567023989,0,1,response to vitamin B6,BP,
9420,GO:0034518,1,0.932494131864146,0,11,RNA cap binding complex,CC,
9421,GO:0034545,1,0.994161688359258,0,1,fumarylpyruvate hydrolase activity,MF,
9422,GO:0034551,1,0.945752020481638,0,9,mitochondrial respiratory chain complex III assembly,BP,
9423,GO:0034552,1,0.988651712642329,0,2,respiratory chain complex II assembly,BP,
9424,GO:0034553,1,0.988651712642329,0,2,mitochondrial respiratory chain complex II assembly,BP,
9425,GO:0034584,1,0.987304079274475,0,2,piRNA binding,MF,
9426,GO:0034587,1,0.915486475082543,0,14,piRNA metabolic process,BP,
9427,GO:0034589,1,0.99340878453303,0,1,hydroxyproline transport,BP,
9428,GO:0034590,1,0.99340878453303,0,1,L-hydroxyproline transmembrane transporter activity,MF,
9429,GO:0034593,1,0.845761092979474,0,25,phosphatidylinositol bisphosphate phosphatase activity,MF,
9430,GO:0034594,1,0.962030475025728,0,6,phosphatidylinositol trisphosphate phosphatase activity,MF,
9431,GO:0034595,1,0.917360958408924,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
9432,GO:0034596,1,0.946974087539751,0,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,
9433,GO:0034597,1,0.986232922701696,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
9435,GO:0034602,1,0.993408067860926,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
9436,GO:0034603,1,0.96914641911392,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
9437,GO:0034604,1,0.96914641911392,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
9442,GO:0034616,1,0.914308115468825,0,14,response to laminar fluid shear stress,BP,
9443,GO:0034617,1,0.974298729021557,0,4,tetrahydrobiopterin binding,MF,
9444,GO:0034618,1,0.962608362247183,0,6,arginine binding,MF,
9447,GO:0034625,1,0.963060796982218,0,6,fatty acid elongation, monounsaturated fatty acid,BP,
9448,GO:0034626,1,0.963060796982218,0,6,fatty acid elongation, polyunsaturated fatty acid,BP,
9449,GO:0034627,1,0.97522460260343,0,4,'de novo' NAD biosynthetic process,BP,
9450,GO:0034628,1,0.980841132222427,0,3,'de novo' NAD biosynthetic process from aspartate,BP,
9451,GO:0034629,1,0.865575586024821,0,23,cellular protein-containing complex localization,BP,
9452,GO:0034632,1,0.988238062880966,0,2,retinol transmembrane transporter activity,MF,
9453,GO:0034633,1,0.988238062880966,0,2,retinol transport,BP,
9454,GO:0034634,1,0.992802204087989,0,1,glutathione transmembrane transporter activity,MF,
9455,GO:0034635,1,0.986912599467702,0,2,glutathione transport,BP,
9456,GO:0034637,1,0.614668138614796,0,75,cellular carbohydrate biosynthetic process,BP,
9458,GO:0034640,1,0.993716692884511,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
9460,GO:0034643,1,0.881398365748399,0,19,establishment of mitochondrion localization, microtubule-mediated,BP,
9461,GO:0034644,1,0.62077110938125,0,74,cellular response to UV,BP,
9463,GO:0034647,1,0.984361752583971,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
9464,GO:0034648,1,0.971882937123658,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
9465,GO:0034649,1,0.993527971230643,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
9466,GO:0034650,1,0.949563299616496,0,8,cortisol metabolic process,BP,
9467,GO:0034651,1,0.955223233279174,0,7,cortisol biosynthetic process,BP,
9468,GO:0034653,1,0.98189371607573,0,3,retinoic acid catabolic process,BP,
9471,GO:0034656,1,0.768173963875048,0,43,nucleobase-containing small molecule catabolic process,BP,
9472,GO:0034657,1,0.974974373317581,0,4,GID complex,CC,
9473,GO:0034660,1,0.0331586208748563,0,546,ncRNA metabolic process,BP,
9474,GO:0034661,1,0.857190407938308,0,24,ncRNA catabolic process,BP,
9475,GO:0034663,1,0.945913774147356,0,9,endoplasmic reticulum chaperone complex,CC,
9476,GO:0034665,1,0.986867054686713,0,2,integrin alpha1-beta1 complex,CC,
9477,GO:0034666,1,0.979834117590891,0,3,integrin alpha2-beta1 complex,CC,
9478,GO:0034667,1,0.986822296935796,0,2,integrin alpha3-beta1 complex,CC,
9479,GO:0034668,1,0.99351511314133,0,1,integrin alpha4-beta1 complex,CC,
9480,GO:0034669,1,0.986780037226099,0,2,integrin alpha4-beta7 complex,CC,
9481,GO:0034670,1,0.991831208149266,0,1,chemotaxis to arachidonic acid,BP,
9482,GO:0034673,1,0.980299549606392,0,3,inhibin-betaglycan-ActRII complex,CC,
9483,GO:0034676,1,0.992988120061458,0,1,integrin alpha6-beta4 complex,CC,
9484,GO:0034677,1,0.993563100523778,0,1,integrin alpha7-beta1 complex,CC,
9485,GO:0034678,1,0.980713806295616,0,3,integrin alpha8-beta1 complex,CC,
9486,GO:0034679,1,0.993500821774813,0,1,integrin alpha9-beta1 complex,CC,
9487,GO:0034680,1,0.986759747345649,0,2,integrin alpha10-beta1 complex,CC,
9488,GO:0034681,1,0.986807846290552,0,2,integrin alpha11-beta1 complex,CC,
9489,GO:0034683,1,0.985932983086805,0,2,integrin alphav-beta3 complex,CC,
9490,GO:0034684,1,0.986365679719604,0,2,integrin alphav-beta5 complex,CC,
9491,GO:0034685,1,0.986642837021249,0,2,integrin alphav-beta6 complex,CC,
9492,GO:0034686,1,0.984819309355658,0,2,integrin alphav-beta8 complex,CC,
9493,GO:0034687,1,0.98701689813002,0,2,integrin alphaL-beta2 complex,CC,
9494,GO:0034688,1,0.987114320630936,0,2,integrin alphaM-beta2 complex,CC,
9495,GO:0034693,1,0.993935774836339,0,1,U11/U12 snRNP,CC,
9496,GO:0034694,1,0.828934426082426,0,29,response to prostaglandin,BP,
9497,GO:0034695,1,0.869429813847381,0,22,response to prostaglandin E,BP,
9498,GO:0034696,1,0.987975787839416,0,2,response to prostaglandin F,BP,
9499,GO:0034698,1,0.849804514668932,0,25,response to gonadotropin,BP,
9500,GO:0034699,1,0.980636389307738,0,3,response to luteinizing hormone,BP,
9505,GO:0034706,1,0.850778210350688,0,23,sodium channel complex,CC,
9506,GO:0034707,1,0.759696847540983,0,43,chloride channel complex,CC,
9507,GO:0034708,1,0.568066663451548,0,88,methyltransferase complex,CC,
9508,GO:0034709,1,0.933189864279225,0,12,methylosome,CC,
9509,GO:0034711,1,0.969239572408347,0,5,inhibin binding,MF,
9510,GO:0034713,1,0.943451066427663,0,9,type I transforming growth factor beta receptor binding,MF,
9511,GO:0034714,1,0.981012020404823,0,3,type III transforming growth factor beta receptor binding,MF,
9512,GO:0034715,1,0.966196350668616,0,6,pICln-Sm protein complex,CC,
9513,GO:0034718,1,0.993085826812568,0,1,SMN-Gemin2 complex,CC,
9514,GO:0034719,1,0.90387170944139,0,17,SMN-Sm protein complex,CC,
9515,GO:0034720,1,0.95816428570297,0,6,histone H3-K4 demethylation,BP,
9516,GO:0034721,1,0.984361752583971,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
9517,GO:0034722,1,0.994215978745102,0,1,gamma-glutamyl-peptidase activity,MF,
9518,GO:0034723,1,0.919765335101954,0,14,DNA replication-dependent nucleosome organization,BP,
9519,GO:0034724,1,0.776026023260951,0,41,DNA replication-independent nucleosome organization,BP,
9520,GO:0034727,1,0.993215826877262,0,1,piecemeal microautophagy of the nucleus,BP,
9521,GO:0034728,1,0.482247327669829,0,117,nucleosome organization,BP,
9522,GO:0034729,1,0.980330488222373,0,3,histone H3-K79 methylation,BP,
9523,GO:0034736,1,0.993666431762045,0,1,cholesterol O-acyltransferase activity,MF,
9524,GO:0034739,1,0.988269552140773,0,2,histone deacetylase activity (H4-K16 specific),MF,
9525,GO:0034750,1,0.986850700796228,0,2,Scrib-APC-beta-catenin complex,CC,
9526,GO:0034751,1,0.981167926878497,0,3,aryl hydrocarbon receptor complex,CC,
9527,GO:0034752,1,0.992847291976754,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
9528,GO:0034753,1,0.992847291976754,0,1,nuclear aryl hydrocarbon receptor complex,CC,
9529,GO:0034754,1,0.570955368248332,0,91,cellular hormone metabolic process,BP,
9530,GO:0034755,1,0.902757676435581,0,16,iron ion transmembrane transport,BP,
9532,GO:0034757,1,0.986762627190251,0,2,negative regulation of iron ion transport,BP,
9533,GO:0034759,1,0.986762627190251,0,2,regulation of iron ion transmembrane transport,BP,
9534,GO:0034760,1,0.986762627190251,0,2,negative regulation of iron ion transmembrane transport,BP,
9536,GO:0034763,1,0.529138913685543,0,100,negative regulation of transmembrane transport,BP,
9539,GO:0034766,1,0.599646568174957,0,80,negative regulation of ion transmembrane transport,BP,
9541,GO:0034769,1,0.987551622055976,0,2,basement membrane disassembly,BP,
9542,GO:0034770,1,0.957170209827665,0,6,histone H4-K20 methylation,BP,
9543,GO:0034773,1,0.973072969376687,0,4,histone H4-K20 trimethylation,BP,
9545,GO:0034775,1,0.992802204087989,0,1,glutathione transmembrane transport,BP,
9546,GO:0034776,1,0.942474963729825,0,9,response to histamine,BP,
9547,GO:0034777,1,0.994001332964613,0,1,recycling endosome lumen,CC,
9548,GO:0034875,1,0.994090362193189,0,1,caffeine oxidase activity,MF,
9549,GO:0034899,1,0.994046050690459,0,1,trimethylamine monooxygenase activity,MF,
9550,GO:0034959,1,0.993171465498053,0,1,endothelin maturation,BP,
9551,GO:0034963,1,0.994309542961473,0,1,box C/D snoRNA processing,BP,
9552,GO:0034964,1,0.993902537562302,0,1,box H/ACA snoRNA processing,BP,
9553,GO:0034968,1,0.527822525047154,0,96,histone lysine methylation,BP,
9554,GO:0034969,1,0.929222401161561,0,12,histone arginine methylation,BP,
9555,GO:0034970,1,0.987711212420599,0,2,histone H3-R2 methylation,BP,
9556,GO:0034971,1,0.987850914938419,0,2,histone H3-R17 methylation,BP,
9557,GO:0034975,1,0.922015576329309,0,13,protein folding in endoplasmic reticulum,BP,
9559,GO:0034979,1,0.89693810068514,0,17,NAD-dependent protein deacetylase activity,MF,
9560,GO:0034982,1,0.928667163535887,0,12,mitochondrial protein processing,BP,
9561,GO:0034983,1,0.955563778933351,0,7,peptidyl-lysine deacetylation,BP,
9563,GO:0034987,1,0.962965740642497,0,6,immunoglobulin receptor binding,MF,
9564,GO:0034988,1,0.986172025601911,0,2,Fc-gamma receptor I complex binding,MF,
9565,GO:0034991,1,0.975214068552587,0,4,nuclear meiotic cohesin complex,CC,
9566,GO:0034992,1,0.950233169707479,0,7,microtubule organizing center attachment site,CC,
9567,GO:0034993,1,0.950233169707479,0,7,meiotic nuclear membrane microtubule tethering complex,CC,
9568,GO:0034998,1,0.993846081630578,0,1,oligosaccharyltransferase I complex,CC,
9570,GO:0035005,1,0.952410843013374,0,7,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
9571,GO:0035014,1,0.948868743531998,0,8,phosphatidylinositol 3-kinase regulator activity,MF,
9572,GO:0035019,1,0.650676984662418,0,67,somatic stem cell population maintenance,BP,
9573,GO:0035020,1,0.898384400282259,0,16,regulation of Rac protein signal transduction,BP,
9574,GO:0035021,1,0.972312672942148,0,4,negative regulation of Rac protein signal transduction,BP,
9575,GO:0035022,1,0.973974383868235,0,4,positive regulation of Rac protein signal transduction,BP,
9577,GO:0035024,1,0.887658247315101,0,18,negative regulation of Rho protein signal transduction,BP,
9579,GO:0035026,1,0.987054375021569,0,2,leading edge cell differentiation,BP,
9580,GO:0035032,1,0.9632433454978,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
9581,GO:0035033,1,0.981821272549522,0,3,histone deacetylase regulator activity,MF,
9582,GO:0035034,1,0.987812113247653,0,2,histone acetyltransferase regulator activity,MF,
9583,GO:0035035,1,0.826751757776419,0,29,histone acetyltransferase binding,MF,
9584,GO:0035036,1,0.799834160973908,0,37,sperm-egg recognition,BP,
9585,GO:0035037,1,0.993346669094013,0,1,sperm entry,BP,
9586,GO:0035038,1,0.987777736415818,0,2,female pronucleus assembly,BP,
9587,GO:0035039,1,0.993978411761806,0,1,male pronucleus assembly,BP,
9590,GO:0035054,1,0.98153495582536,0,3,embryonic heart tube anterior/posterior pattern specification,BP,
9591,GO:0035061,1,0.972928666129227,0,4,interchromatin granule,CC,
9592,GO:0035063,1,0.984339127843022,0,2,nuclear speck organization,BP,
9593,GO:0035064,1,0.691693631944205,0,56,methylated histone binding,MF,
9594,GO:0035065,1,0.718199952079271,0,52,regulation of histone acetylation,BP,
9595,GO:0035066,1,0.837346049094933,0,28,positive regulation of histone acetylation,BP,
9596,GO:0035067,1,0.897735435706314,0,17,negative regulation of histone acetylation,BP,
9597,GO:0035068,1,0.941483435771134,0,9,micro-ribonucleoprotein complex,CC,
9598,GO:0035082,1,0.710050420066341,0,52,axoneme assembly,BP,
9599,GO:0035087,1,0.974148884235594,0,4,siRNA loading onto RISC involved in RNA interference,BP,
9600,GO:0035088,1,0.747462631959439,0,45,establishment or maintenance of apical/basal cell polarity,BP,
9601,GO:0035089,1,0.896031804838434,0,17,establishment of apical/basal cell polarity,BP,
9602,GO:0035090,1,0.926623407339829,0,12,maintenance of apical/basal cell polarity,BP,
9604,GO:0035092,1,0.960113811815823,0,6,sperm chromatin condensation,BP,
9605,GO:0035093,1,0.972113797631453,0,4,spermatogenesis, exchange of chromosomal proteins,BP,
9606,GO:0035094,1,0.765145856594488,0,42,response to nicotine,BP,
9607,GO:0035095,1,0.95443584530073,0,7,behavioral response to nicotine,BP,
9608,GO:0035097,1,0.639517380918162,0,68,histone methyltransferase complex,CC,
9609,GO:0035098,1,0.90112501929793,0,16,ESC/E(Z) complex,CC,
9610,GO:0035101,1,0.981104907457731,0,3,FACT complex,CC,
9611,GO:0035102,1,0.930988195839945,0,11,PRC1 complex,CC,
9612,GO:0035106,1,0.981449129000774,0,3,operant conditioning,BP,
9615,GO:0035112,1,0.929976644580116,0,11,genitalia morphogenesis,BP,
9617,GO:0035115,1,0.815195962714399,0,32,embryonic forelimb morphogenesis,BP,
9618,GO:0035116,1,0.835941440597774,0,28,embryonic hindlimb morphogenesis,BP,
9619,GO:0035120,1,0.991425784812328,0,1,post-embryonic appendage morphogenesis,BP,
9620,GO:0035127,1,0.991425784812328,0,1,post-embryonic limb morphogenesis,BP,
9621,GO:0035128,1,0.991425784812328,0,1,post-embryonic forelimb morphogenesis,BP,
9622,GO:0035136,1,0.770503831030975,0,40,forelimb morphogenesis,BP,
9623,GO:0035137,1,0.79137551825879,0,36,hindlimb morphogenesis,BP,
9624,GO:0035145,1,0.887605212943897,0,19,exon-exon junction complex,CC,
9627,GO:0035162,1,0.876598659870421,0,20,embryonic hemopoiesis,BP,
9628,GO:0035166,1,0.980899388180945,0,3,post-embryonic hemopoiesis,BP,
9629,GO:0035173,1,0.9016708481836,0,16,histone kinase activity,MF,
9630,GO:0035174,1,0.956649915133935,0,7,histone serine kinase activity,MF,
9631,GO:0035175,1,0.994153024963152,0,1,histone kinase activity (H3-S10 specific),MF,
9632,GO:0035176,1,0.719407856937309,0,49,social behavior,BP,
9633,GO:0035184,1,0.967441390117022,0,5,histone threonine kinase activity,MF,
9634,GO:0035188,1,0.99370983661046,0,1,hatching,BP,
9635,GO:0035189,1,0.981267120685687,0,3,Rb-E2F complex,CC,
9636,GO:0035194,1,0.459198246595286,0,120,posttranscriptional gene silencing by RNA,BP,
9637,GO:0035195,1,0.477025670983833,0,114,gene silencing by miRNA,BP,
9638,GO:0035196,1,0.768895471369184,0,40,production of miRNAs involved in gene silencing by miRNA,BP,
9639,GO:0035197,1,0.935495235184737,0,10,siRNA binding,MF,
9640,GO:0035198,1,0.869459826707706,0,22,miRNA binding,MF,
9641,GO:0035226,1,0.99375985568903,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9642,GO:0035227,1,0.99375985568903,0,1,regulation of glutamate-cysteine ligase activity,BP,
9643,GO:0035229,1,0.99375985568903,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9644,GO:0035234,1,0.953825266728549,0,7,ectopic germ cell programmed cell death,BP,
9645,GO:0035235,1,0.836784045635805,0,26,ionotropic glutamate receptor signaling pathway,BP,
9646,GO:0035238,1,0.993846081630578,0,1,vitamin A biosynthetic process,BP,
9648,GO:0035240,1,0.952425545858558,0,8,dopamine binding,MF,
9649,GO:0035241,1,0.97587346421368,0,4,protein-arginine omega-N monomethyltransferase activity,MF,
9650,GO:0035242,1,0.952589523272424,0,8,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9651,GO:0035243,1,0.975807807542643,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
9652,GO:0035246,1,0.929583821292243,0,12,peptidyl-arginine N-methylation,BP,
9653,GO:0035247,1,0.940986527312265,0,10,peptidyl-arginine omega-N-methylation,BP,
9654,GO:0035248,1,0.993819121459416,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9656,GO:0035250,1,0.846115562728924,0,27,UDP-galactosyltransferase activity,MF,
9657,GO:0035251,1,0.943696790434503,0,9,UDP-glucosyltransferase activity,MF,
9658,GO:0035252,1,0.960620789619279,0,6,UDP-xylosyltransferase activity,MF,
9659,GO:0035253,1,0.929429329637765,0,11,ciliary rootlet,CC,
9661,GO:0035255,1,0.834762642447736,0,27,ionotropic glutamate receptor binding,MF,
9662,GO:0035256,1,0.951224264129378,0,8,G-protein coupled glutamate receptor binding,MF,
9665,GO:0035259,1,0.912543730435231,0,14,glucocorticoid receptor binding,MF,
9666,GO:0035261,1,0.983516461757089,0,2,external genitalia morphogenesis,BP,
9667,GO:0035262,1,0.986147292903037,0,2,gonad morphogenesis,BP,
9668,GO:0035264,1,0.41791306604232,0,132,multicellular organism growth,BP,
9669,GO:0035265,1,0.392884846695174,0,142,organ growth,BP,
9670,GO:0035267,1,0.892226151250371,0,18,NuA4 histone acetyltransferase complex,CC,
9671,GO:0035268,1,0.896786095765983,0,17,protein mannosylation,BP,
9672,GO:0035269,1,0.928176605192169,0,12,protein O-linked mannosylation,BP,
9675,GO:0035276,1,0.987171891273677,0,2,ethanol binding,MF,
9676,GO:0035278,1,0.915095174835725,0,13,miRNA mediated inhibition of translation,BP,
9677,GO:0035279,1,0.987497050694203,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9678,GO:0035280,1,0.954941838469397,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9679,GO:0035281,1,0.987472749819839,0,2,pre-miRNA export from nucleus,BP,
9680,GO:0035282,1,0.581893611541364,0,83,segmentation,BP,
9681,GO:0035283,1,0.987540913290853,0,2,central nervous system segmentation,BP,
9682,GO:0035284,1,0.987540913290853,0,2,brain segmentation,BP,
9683,GO:0035290,1,0.98070104487238,0,3,trunk segmentation,BP,
9686,GO:0035299,1,0.993378815519592,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9693,GO:0035312,1,0.962743683083295,0,6,5'-3' exodeoxyribonuclease activity,MF,
9694,GO:0035313,1,0.907962836182984,0,14,wound healing, spreading of epidermal cells,BP,
9695,GO:0035315,1,0.790206642674361,0,36,hair cell differentiation,BP,
9696,GO:0035325,1,0.940085944980049,0,10,Toll-like receptor binding,MF,
9699,GO:0035329,1,0.769147132012953,0,38,hippo signaling,BP,
9700,GO:0035330,1,0.925896860886497,0,11,regulation of hippo signaling,BP,
9701,GO:0035331,1,0.945735657551113,0,8,negative regulation of hippo signaling,BP,
9702,GO:0035332,1,0.984678649327143,0,2,positive regulation of hippo signaling,BP,
9703,GO:0035333,1,0.919291337348138,0,13,Notch receptor processing, ligand-dependent,BP,
9704,GO:0035335,1,0.543000053467683,0,93,peptidyl-tyrosine dephosphorylation,BP,
9705,GO:0035336,1,0.871419815289347,0,22,long-chain fatty-acyl-CoA metabolic process,BP,
9706,GO:0035337,1,0.803059981359922,0,35,fatty-acyl-CoA metabolic process,BP,
9707,GO:0035338,1,0.9045031842182,0,16,long-chain fatty-acyl-CoA biosynthetic process,BP,
9708,GO:0035339,1,0.976642432720451,0,4,SPOTS complex,CC,
9709,GO:0035349,1,0.981758589806163,0,3,coenzyme A transmembrane transport,BP,
9710,GO:0035350,1,0.987804290661449,0,2,FAD transmembrane transport,BP,
9711,GO:0035352,1,0.993992826293789,0,1,NAD transmembrane transport,BP,
9712,GO:0035354,1,0.987531704359857,0,2,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9713,GO:0035355,1,0.992956208625693,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9714,GO:0035356,1,0.958148876111678,0,7,cellular triglyceride homeostasis,BP,
9715,GO:0035357,1,0.878731484964463,0,20,peroxisome proliferator activated receptor signaling pathway,BP,
9716,GO:0035358,1,0.926546802557084,0,12,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9717,GO:0035359,1,0.981700441150612,0,3,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9718,GO:0035360,1,0.955828251204672,0,7,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9719,GO:0035363,1,0.975585768672402,0,4,histone locus body,CC,
9720,GO:0035368,1,0.974727491140729,0,4,selenocysteine insertion sequence binding,MF,
9721,GO:0035370,1,0.987924868890894,0,2,UBC13-UEV1A complex,CC,
9722,GO:0035371,1,0.880747336408949,0,18,microtubule plus-end,CC,
9723,GO:0035372,1,0.917387723583412,0,13,protein localization to microtubule,BP,
9724,GO:0035373,1,0.978004980504721,0,3,chondroitin sulfate proteoglycan binding,MF,
9725,GO:0035374,1,0.961122364269439,0,6,chondroitin sulfate binding,MF,
9726,GO:0035375,1,0.992427782925699,0,1,zymogen binding,MF,
9727,GO:0035376,1,0.958302513141543,0,7,sterol import,BP,
9728,GO:0035377,1,0.986772509640733,0,2,transepithelial water transport,BP,
9729,GO:0035378,1,0.993852396074305,0,1,carbon dioxide transmembrane transport,BP,
9730,GO:0035379,1,0.993852396074305,0,1,carbon dioxide transmembrane transporter activity,MF,
9731,GO:0035381,1,0.951844635689405,0,8,ATP-gated ion channel activity,MF,
9732,GO:0035383,1,0.565353622906496,0,91,thioester metabolic process,BP,
9733,GO:0035384,1,0.745077153356495,0,46,thioester biosynthetic process,BP,
9734,GO:0035385,1,0.952604931395911,0,7,Roundabout signaling pathway,BP,
9735,GO:0035397,1,0.993750704474997,0,1,helper T cell enhancement of adaptive immune response,BP,
9736,GO:0035400,1,0.993121305444278,0,1,histone tyrosine kinase activity,MF,
9737,GO:0035401,1,0.993121305444278,0,1,histone kinase activity (H3-Y41 specific),MF,
9738,GO:0035402,1,0.987682853544012,0,2,histone kinase activity (H3-T11 specific),MF,
9739,GO:0035403,1,0.985270396075216,0,2,histone kinase activity (H3-T6 specific),MF,
9741,GO:0035405,1,0.967441390117022,0,5,histone-threonine phosphorylation,BP,
9742,GO:0035406,1,0.993121305444278,0,1,histone-tyrosine phosphorylation,BP,
9743,GO:0035407,1,0.987682853544012,0,2,histone H3-T11 phosphorylation,BP,
9744,GO:0035408,1,0.985270396075216,0,2,histone H3-T6 phosphorylation,BP,
9745,GO:0035409,1,0.993121305444278,0,1,histone H3-Y41 phosphorylation,BP,
9746,GO:0035410,1,0.994292793750381,0,1,dihydrotestosterone 17-beta-dehydrogenase activity,MF,
9747,GO:0035418,1,0.786138294122881,0,35,protein localization to synapse,BP,
9748,GO:0035425,1,0.987283475582531,0,2,autocrine signaling,BP,
9749,GO:0035426,1,0.967578981039651,0,5,extracellular matrix-cell signaling,BP,
9750,GO:0035434,1,0.961017330396246,0,6,copper ion transmembrane transport,BP,
9751,GO:0035435,1,0.942243395229203,0,9,phosphate ion transmembrane transport,BP,
9752,GO:0035437,1,0.922134102064583,0,13,maintenance of protein localization in endoplasmic reticulum,BP,
9753,GO:0035438,1,0.994158800562055,0,1,cyclic-di-GMP binding,MF,
9754,GO:0035441,1,0.978953574349899,0,3,cell migration involved in vasculogenesis,BP,
9755,GO:0035442,1,0.988080898559558,0,2,dipeptide transmembrane transport,BP,
9756,GO:0035443,1,0.992802204087989,0,1,tripeptide transmembrane transport,BP,
9757,GO:0035445,1,0.993748417049011,0,1,borate transmembrane transport,BP,
9758,GO:0035455,1,0.881550518278734,0,20,response to interferon-alpha,BP,
9759,GO:0035456,1,0.88621898419046,0,20,response to interferon-beta,BP,
9760,GO:0035457,1,0.93657130293068,0,10,cellular response to interferon-alpha,BP,
9761,GO:0035458,1,0.922931648396933,0,13,cellular response to interferon-beta,BP,
9762,GO:0035459,1,0.878848012629642,0,20,cargo loading into vesicle,BP,
9764,GO:0035469,1,0.967816317725211,0,5,determination of pancreatic left/right asymmetry,BP,
9765,GO:0035470,1,0.988322232566251,0,2,positive regulation of vascular wound healing,BP,
9766,GO:0035473,1,0.972319560621976,0,4,lipase binding,MF,
9767,GO:0035480,1,0.994312719541451,0,1,regulation of Notch signaling pathway involved in heart induction,BP,
9768,GO:0035481,1,0.994312719541451,0,1,positive regulation of Notch signaling pathway involved in heart induction,BP,
9769,GO:0035482,1,0.97767736084379,0,4,gastric motility,BP,
9770,GO:0035483,1,0.983414421742385,0,3,gastric emptying,BP,
9771,GO:0035485,1,0.994114473057151,0,1,adenine/guanine mispair binding,MF,
9772,GO:0035490,1,0.993735267096645,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9773,GO:0035491,1,0.993735267096645,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
9774,GO:0035493,1,0.909905517644876,0,15,SNARE complex assembly,BP,
9775,GO:0035494,1,0.981598848502456,0,3,SNARE complex disassembly,BP,
9776,GO:0035497,1,0.919997193445836,0,13,cAMP response element binding,MF,
9779,GO:0035500,1,0.98743257450915,0,2,MH2 domain binding,MF,
9780,GO:0035501,1,0.993830733292028,0,1,MH1 domain binding,MF,
9781,GO:0035502,1,0.96928268327681,0,5,metanephric part of ureteric bud development,BP,
9782,GO:0035504,1,0.994213668521084,0,1,regulation of myosin light chain kinase activity,BP,
9783,GO:0035505,1,0.994213668521084,0,1,positive regulation of myosin light chain kinase activity,BP,
9784,GO:0035507,1,0.953388212362493,0,7,regulation of myosin-light-chain-phosphatase activity,BP,
9785,GO:0035508,1,0.993035324535872,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9786,GO:0035509,1,0.967157190796927,0,5,negative regulation of myosin-light-chain-phosphatase activity,BP,
9787,GO:0035510,1,0.83416993438467,0,28,DNA dealkylation,BP,
9788,GO:0035511,1,0.96995310965725,0,5,oxidative DNA demethylation,BP,
9789,GO:0035513,1,0.97539080470457,0,4,oxidative RNA demethylation,BP,
9790,GO:0035514,1,0.982085019600461,0,3,DNA demethylase activity,MF,
9791,GO:0035515,1,0.97539080470457,0,4,oxidative RNA demethylase activity,MF,
9792,GO:0035516,1,0.9934115077548,0,1,oxidative DNA demethylase activity,MF,
9793,GO:0035517,1,0.972401008183392,0,4,PR-DUB complex,CC,
9794,GO:0035518,1,0.901576579554648,0,16,histone H2A monoubiquitination,BP,
9795,GO:0035519,1,0.97595202096963,0,4,protein K29-linked ubiquitination,BP,
9796,GO:0035520,1,0.941484684602539,0,9,monoubiquitinated protein deubiquitination,BP,
9797,GO:0035521,1,0.975008449879882,0,4,monoubiquitinated histone deubiquitination,BP,
9798,GO:0035522,1,0.975008449879882,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9799,GO:0035523,1,0.978579561835061,0,3,protein K29-linked deubiquitination,BP,
9800,GO:0035524,1,0.967422943221909,0,5,proline transmembrane transport,BP,
9801,GO:0035525,1,0.993902537562302,0,1,NF-kappaB p50/p65 complex,CC,
9802,GO:0035526,1,0.986726297323225,0,2,retrograde transport, plasma membrane to Golgi,BP,
9803,GO:0035529,1,0.957697280919187,0,7,NADH pyrophosphatase activity,MF,
9804,GO:0035538,1,0.993707694215025,0,1,carbohydrate response element binding,MF,
9805,GO:0035539,1,0.988537119594294,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9806,GO:0035542,1,0.944011449467373,0,9,regulation of SNARE complex assembly,BP,
9807,GO:0035544,1,0.980702013697259,0,3,negative regulation of SNARE complex assembly,BP,
9808,GO:0035545,1,0.993514541583525,0,1,determination of left/right asymmetry in nervous system,BP,
9809,GO:0035546,1,0.965790916821188,0,5,interferon-beta secretion,BP,
9810,GO:0035547,1,0.965790916821188,0,5,regulation of interferon-beta secretion,BP,
9811,GO:0035548,1,0.993820554697066,0,1,negative regulation of interferon-beta secretion,BP,
9812,GO:0035549,1,0.971797835759568,0,4,positive regulation of interferon-beta secretion,BP,
9813,GO:0035552,1,0.981616681878399,0,3,oxidative single-stranded DNA demethylation,BP,
9814,GO:0035553,1,0.981377981918969,0,3,oxidative single-stranded RNA demethylation,BP,
9816,GO:0035561,1,0.874518001580116,0,21,regulation of chromatin binding,BP,
9817,GO:0035562,1,0.954606659830903,0,7,negative regulation of chromatin binding,BP,
9818,GO:0035563,1,0.921991414706807,0,13,positive regulation of chromatin binding,BP,
9819,GO:0035564,1,0.985489806953763,0,2,regulation of kidney size,BP,
9820,GO:0035566,1,0.99346392336041,0,1,regulation of metanephros size,BP,
9822,GO:0035568,1,0.993846081630578,0,1,N-terminal peptidyl-proline methylation,BP,
9823,GO:0035570,1,0.993846081630578,0,1,N-terminal peptidyl-serine methylation,BP,
9824,GO:0035572,1,0.993846081630578,0,1,N-terminal peptidyl-serine dimethylation,BP,
9825,GO:0035573,1,0.993846081630578,0,1,N-terminal peptidyl-serine trimethylation,BP,
9826,GO:0035574,1,0.986788351458374,0,2,histone H4-K20 demethylation,BP,
9827,GO:0035575,1,0.986788351458374,0,2,histone demethylase activity (H4-K20 specific),MF,
9828,GO:0035577,1,0.700506898141115,0,56,azurophil granule membrane,CC,
9830,GO:0035579,1,0.568258358140958,0,88,specific granule membrane,CC,
9831,GO:0035580,1,0.697267015368614,0,59,specific granule lumen,CC,
9832,GO:0035581,1,0.946862611594908,0,8,sequestering of extracellular ligand from receptor,BP,
9833,GO:0035582,1,0.974008593690616,0,4,sequestering of BMP in extracellular matrix,BP,
9834,GO:0035583,1,0.976128454584545,0,3,sequestering of TGFbeta in extracellular matrix,BP,
9836,GO:0035585,1,0.984622804241699,0,2,calcium-mediated signaling using extracellular calcium source,BP,
9837,GO:0035586,1,0.870513754722846,0,23,purinergic receptor activity,MF,
9840,GO:0035589,1,0.924783717236172,0,13,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
9841,GO:0035590,1,0.880565218332085,0,21,purinergic nucleotide receptor signaling pathway,BP,
9842,GO:0035591,1,0.594279053404836,0,80,signaling adaptor activity,MF,
9844,GO:0035596,1,0.987800643230655,0,2,methylthiotransferase activity,MF,
9845,GO:0035597,1,0.994062069734077,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9846,GO:0035598,1,0.993701553155067,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9847,GO:0035600,1,0.987800643230655,0,2,tRNA methylthiolation,BP,
9848,GO:0035601,1,0.504427535988585,0,105,protein deacylation,BP,
9849,GO:0035602,1,0.993467929875384,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9850,GO:0035603,1,0.993467929875384,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9851,GO:0035604,1,0.993467929875384,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9852,GO:0035605,1,0.994267381227237,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9853,GO:0035606,1,0.988779780732849,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9854,GO:0035607,1,0.986536815047316,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9857,GO:0035610,1,0.974687757537841,0,4,protein side chain deglutamylation,BP,
9858,GO:0035611,1,0.993826431912824,0,1,protein branching point deglutamylation,BP,
9859,GO:0035612,1,0.943911477249671,0,8,AP-2 adaptor complex binding,MF,
9860,GO:0035613,1,0.906542734320199,0,15,RNA stem-loop binding,MF,
9861,GO:0035614,1,0.982360609244002,0,3,snRNA stem-loop binding,MF,
9862,GO:0035615,1,0.931256909423984,0,11,clathrin adaptor activity,MF,
9863,GO:0035616,1,0.980259458291406,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9864,GO:0035617,1,0.980993834921085,0,3,stress granule disassembly,BP,
9865,GO:0035620,1,0.974581980408949,0,4,ceramide transporter activity,MF,
9866,GO:0035621,1,0.987206600449502,0,2,ER to Golgi ceramide transport,BP,
9867,GO:0035622,1,0.993517685056616,0,1,intrahepatic bile duct development,BP,
9868,GO:0035623,1,0.993712693276495,0,1,renal glucose absorption,BP,
9869,GO:0035624,1,0.973834679632922,0,4,receptor transactivation,BP,
9870,GO:0035625,1,0.981353138877024,0,3,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
9871,GO:0035627,1,0.955270874614133,0,7,ceramide transport,BP,
9873,GO:0035631,1,0.933878375013902,0,11,CD40 receptor complex,CC,
9875,GO:0035634,1,0.981302622664106,0,3,response to stilbenoid,BP,
9876,GO:0035635,1,0.888457444282209,0,18,entry of bacterium into host cell,BP,
9878,GO:0035638,1,0.9932820130094,0,1,signal maturation,BP,
9880,GO:0035640,1,0.860348483053782,0,23,exploration behavior,BP,
9881,GO:0035641,1,0.917859293741798,0,13,locomotory exploration behavior,BP,
9882,GO:0035642,1,0.993787897820967,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9883,GO:0035643,1,0.994156201543309,0,1,L-DOPA receptor activity,MF,
9884,GO:0035644,1,0.993779453769308,0,1,phosphoanandamide dephosphorylation,BP,
9885,GO:0035645,1,0.993414374076963,0,1,enteric smooth muscle cell differentiation,BP,
9886,GO:0035646,1,0.939431298074293,0,10,endosome to melanosome transport,BP,
9887,GO:0035650,1,0.976090337489105,0,4,AP-1 adaptor complex binding,MF,
9888,GO:0035651,1,0.982089379100731,0,3,AP-3 adaptor complex binding,MF,
9889,GO:0035655,1,0.952401909290102,0,8,interleukin-18-mediated signaling pathway,BP,
9890,GO:0035658,1,0.981723269076498,0,3,Mon1-Ccz1 complex,CC,
9891,GO:0035659,1,0.994152158622771,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
9892,GO:0035662,1,0.98323617211875,0,3,Toll-like receptor 4 binding,MF,
9893,GO:0035663,1,0.981032596441423,0,3,Toll-like receptor 2 binding,MF,
9894,GO:0035664,1,0.994131655201584,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9895,GO:0035665,1,0.994131655201584,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9896,GO:0035666,1,0.846850475500694,0,27,TRIF-dependent toll-like receptor signaling pathway,BP,
9897,GO:0035668,1,0.986884714976823,0,2,TRAM-dependent toll-like receptor signaling pathway,BP,
9898,GO:0035669,1,0.986884714976823,0,2,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9899,GO:0035671,1,0.982270289623317,0,3,enone reductase activity,MF,
9900,GO:0035672,1,0.961738940574813,0,6,oligopeptide transmembrane transport,BP,
9901,GO:0035673,1,0.973343500387961,0,4,oligopeptide transmembrane transporter activity,MF,
9902,GO:0035674,1,0.98793948923895,0,2,tricarboxylic acid transmembrane transport,BP,
9903,GO:0035675,1,0.99388284309816,0,1,neuromast hair cell development,BP,
9904,GO:0035684,1,0.994432276543402,0,1,helper T cell extravasation,BP,
9905,GO:0035686,1,0.976100001683118,0,4,sperm fibrous sheath,CC,
9907,GO:0035691,1,0.98770344884277,0,2,macrophage migration inhibitory factor signaling pathway,BP,
9908,GO:0035692,1,0.987518269363152,0,2,macrophage migration inhibitory factor receptor complex,CC,
9909,GO:0035693,1,0.994267670005535,0,1,NOS2-CD74 complex,CC,
9910,GO:0035694,1,0.974994529421692,0,4,mitochondrial protein catabolic process,BP,
9911,GO:0035695,1,0.993408067860926,0,1,mitophagy by induced vacuole formation,BP,
9912,GO:0035696,1,0.980247324441006,0,3,monocyte extravasation,BP,
9913,GO:0035697,1,0.982233825199852,0,3,CD8-positive, alpha-beta T cell extravasation,BP,
9914,GO:0035698,1,0.98823797167635,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9915,GO:0035700,1,0.988092927622623,0,2,astrocyte chemotaxis,BP,
9916,GO:0035701,1,0.96124719724576,0,6,hematopoietic stem cell migration,BP,
9917,GO:0035704,1,0.99392512357135,0,1,helper T cell chemotaxis,BP,
9918,GO:0035705,1,0.99392512357135,0,1,T-helper 17 cell chemotaxis,BP,
9919,GO:0035708,1,0.993641597666767,0,1,interleukin-4-dependent isotype switching to IgE isotypes,BP,
9920,GO:0035709,1,0.987689713496103,0,2,memory T cell activation,BP,
9921,GO:0035710,1,0.659088536228764,0,66,CD4-positive, alpha-beta T cell activation,BP,
9922,GO:0035711,1,0.98799076653363,0,2,T-helper 1 cell activation,BP,
9923,GO:0035712,1,0.987384779548782,0,2,T-helper 2 cell activation,BP,
9924,GO:0035713,1,0.993641597666767,0,1,response to nitrogen dioxide,BP,
9925,GO:0035715,1,0.99392512357135,0,1,chemokine (C-C motif) ligand 2 binding,MF,
9926,GO:0035716,1,0.99392512357135,0,1,chemokine (C-C motif) ligand 12 binding,MF,
9927,GO:0035717,1,0.98783732406047,0,2,chemokine (C-C motif) ligand 7 binding,MF,
9928,GO:0035718,1,0.988517329486134,0,2,macrophage migration inhibitory factor binding,MF,
9929,GO:0035720,1,0.980660320737364,0,3,intraciliary anterograde transport,BP,
9930,GO:0035721,1,0.922641595397828,0,12,intraciliary retrograde transport,BP,
9931,GO:0035722,1,0.763938009941193,0,44,interleukin-12-mediated signaling pathway,BP,
9932,GO:0035723,1,0.919055109142577,0,13,interleukin-15-mediated signaling pathway,BP,
9933,GO:0035724,1,0.992692183858825,0,1,CD24 biosynthetic process,BP,
9935,GO:0035726,1,0.956727385106317,0,7,common myeloid progenitor cell proliferation,BP,
9937,GO:0035728,1,0.900930382369838,0,16,response to hepatocyte growth factor,BP,
9938,GO:0035729,1,0.913358544013586,0,14,cellular response to hepatocyte growth factor stimulus,BP,
9939,GO:0035730,1,0.994369898384902,0,1,S-nitrosoglutathione binding,MF,
9940,GO:0035731,1,0.994369898384902,0,1,dinitrosyl-iron complex binding,MF,
9941,GO:0035732,1,0.994369898384902,0,1,nitric oxide storage,BP,
9942,GO:0035733,1,0.956329325066846,0,7,hepatic stellate cell activation,BP,
9943,GO:0035735,1,0.771158830116595,0,40,intraciliary transport involved in cilium assembly,BP,
9944,GO:0035739,1,0.963779343740637,0,6,CD4-positive, alpha-beta T cell proliferation,BP,
9945,GO:0035740,1,0.982184050375767,0,3,CD8-positive, alpha-beta T cell proliferation,BP,
9946,GO:0035743,1,0.918882768214169,0,14,CD4-positive, alpha-beta T cell cytokine production,BP,
9947,GO:0035744,1,0.976918040250464,0,4,T-helper 1 cell cytokine production,BP,
9948,GO:0035745,1,0.941054595437858,0,10,T-helper 2 cell cytokine production,BP,
9949,GO:0035746,1,0.994294526425336,0,1,granzyme A production,BP,
9951,GO:0035748,1,0.96152657356209,0,6,myelin sheath abaxonal region,CC,
9953,GO:0035750,1,0.993103423866075,0,1,protein localization to myelin sheath abaxonal region,BP,
9954,GO:0035751,1,0.929429160152046,0,12,regulation of lysosomal lumen pH,BP,
9955,GO:0035752,1,0.994096858818453,0,1,lysosomal lumen pH elevation,BP,
9956,GO:0035754,1,0.952237264127136,0,8,B cell chemotaxis,BP,
9957,GO:0035755,1,0.993904407095087,0,1,cardiolipin hydrolase activity,MF,
9958,GO:0035757,1,0.994020514183732,0,1,chemokine (C-C motif) ligand 19 binding,MF,
9959,GO:0035758,1,0.994020514183732,0,1,chemokine (C-C motif) ligand 21 binding,MF,
9960,GO:0035759,1,0.988291086942074,0,2,mesangial cell-matrix adhesion,BP,
9964,GO:0035770,1,0.295952494670726,0,189,ribonucleoprotein granule,CC,
9965,GO:0035771,1,0.956285525021521,0,7,interleukin-4-mediated signaling pathway,BP,
9966,GO:0035772,1,0.994138585936954,0,1,interleukin-13-mediated signaling pathway,BP,
9969,GO:0035782,1,0.994294526425336,0,1,mature natural killer cell chemotaxis,BP,
9970,GO:0035783,1,0.993641597666767,0,1,CD4-positive, alpha-beta T cell costimulation,BP,
9971,GO:0035787,1,0.974024036710743,0,4,cell migration involved in kidney development,BP,
9972,GO:0035788,1,0.980784331747529,0,3,cell migration involved in metanephros development,BP,
9973,GO:0035789,1,0.980784331747529,0,3,metanephric mesenchymal cell migration,BP,
9974,GO:0035790,1,0.986336203604174,0,2,platelet-derived growth factor receptor-alpha signaling pathway,BP,
9975,GO:0035791,1,0.914659544529189,0,13,platelet-derived growth factor receptor-beta signaling pathway,BP,
9976,GO:0035793,1,0.980784331747529,0,3,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
9978,GO:0035795,1,0.969950517604621,0,5,negative regulation of mitochondrial membrane permeability,BP,
9979,GO:0035799,1,0.974413347989509,0,4,ureter maturation,BP,
9980,GO:0035800,1,0.987817682492947,0,2,deubiquitinase activator activity,MF,
9981,GO:0035801,1,0.987946946060339,0,2,adrenal cortex development,BP,
9982,GO:0035802,1,0.987946946060339,0,2,adrenal cortex formation,BP,
9983,GO:0035803,1,0.988509864650833,0,2,egg coat formation,BP,
9984,GO:0035805,1,0.993998016627916,0,1,egg coat,CC,
9985,GO:0035809,1,0.894293483886699,0,18,regulation of urine volume,BP,
9986,GO:0035810,1,0.927451970521499,0,12,positive regulation of urine volume,BP,
9987,GO:0035811,1,0.981454767537625,0,3,negative regulation of urine volume,BP,
9988,GO:0035812,1,0.905798204784879,0,16,renal sodium excretion,BP,
9989,GO:0035813,1,0.905798204784879,0,16,regulation of renal sodium excretion,BP,
9990,GO:0035814,1,0.970504450411494,0,5,negative regulation of renal sodium excretion,BP,
9991,GO:0035815,1,0.945420185920087,0,9,positive regulation of renal sodium excretion,BP,
9992,GO:0035821,1,0.476547649505424,0,119,modification of morphology or physiology of other organism,BP,
9993,GO:0035822,1,0.968167231771716,0,5,gene conversion,BP,
9995,GO:0035838,1,0.979544041049993,0,3,growing cell tip,CC,
9996,GO:0035841,1,0.986011349277537,0,2,new growing cell tip,CC,
9997,GO:0035844,1,0.97482345227204,0,4,cloaca development,BP,
9998,GO:0035845,1,0.942326938301538,0,9,photoreceptor cell outer segment organization,BP,
10000,GO:0035851,1,0.993789901870996,0,1,Krueppel-associated box domain binding,MF,
10001,GO:0035853,1,0.99335700476731,0,1,chromosome passenger complex localization to spindle midzone,BP,
10002,GO:0035854,1,0.987930637840669,0,2,eosinophil fate commitment,BP,
10003,GO:0035855,1,0.904839457930468,0,15,megakaryocyte development,BP,
10004,GO:0035859,1,0.922475171313938,0,13,Seh1-associated complex,CC,
10005,GO:0035860,1,0.96642837199664,0,5,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
10006,GO:0035861,1,0.823134497942794,0,30,site of double-strand break,CC,
10007,GO:0035862,1,0.992912447527943,0,1,dITP metabolic process,BP,
10008,GO:0035863,1,0.992912447527943,0,1,dITP catabolic process,BP,
10009,GO:0035864,1,0.937785903290458,0,10,response to potassium ion,BP,
10010,GO:0035865,1,0.962095969759019,0,6,cellular response to potassium ion,BP,
10011,GO:0035866,1,0.978157786384436,0,3,alphav-beta3 integrin-PKCalpha complex,CC,
10012,GO:0035867,1,0.970170264207535,0,4,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
10013,GO:0035868,1,0.979681698255772,0,3,alphav-beta3 integrin-HMGB1 complex,CC,
10014,GO:0035869,1,0.688552891193574,0,58,ciliary transition zone,CC,
10015,GO:0035870,1,0.987281268878669,0,2,dITP diphosphatase activity,MF,
10016,GO:0035871,1,0.945792255056085,0,8,protein K11-linked deubiquitination,BP,
10018,GO:0035873,1,0.962099133172879,0,6,lactate transmembrane transport,BP,
10019,GO:0035877,1,0.975421664251018,0,4,death effector domain binding,MF,
10020,GO:0035878,1,0.950539116840474,0,8,nail development,BP,
10021,GO:0035879,1,0.981041587846428,0,3,plasma membrane lactate transport,BP,
10022,GO:0035880,1,0.981772241506844,0,3,embryonic nail plate morphogenesis,BP,
10023,GO:0035881,1,0.957198854798299,0,7,amacrine cell differentiation,BP,
10024,GO:0035883,1,0.851132368205229,0,25,enteroendocrine cell differentiation,BP,
10025,GO:0035886,1,0.886442938772384,0,19,vascular smooth muscle cell differentiation,BP,
10026,GO:0035887,1,0.994143062039743,0,1,aortic smooth muscle cell differentiation,BP,
10027,GO:0035890,1,0.811327720342484,0,33,exit from host,BP,
10028,GO:0035891,1,0.811327720342484,0,33,exit from host cell,BP,
10029,GO:0035897,1,0.963956412270529,0,6,proteolysis in other organism,BP,
10030,GO:0035898,1,0.981006381390799,0,3,parathyroid hormone secretion,BP,
10031,GO:0035900,1,0.963561873072681,0,6,response to isolation stress,BP,
10032,GO:0035902,1,0.886873739558418,0,19,response to immobilization stress,BP,
10034,GO:0035905,1,0.974741209170618,0,4,ascending aorta development,BP,
10035,GO:0035907,1,0.944777797653321,0,9,dorsal aorta development,BP,
10036,GO:0035909,1,0.817283547489113,0,30,aorta morphogenesis,BP,
10037,GO:0035910,1,0.974741209170618,0,4,ascending aorta morphogenesis,BP,
10038,GO:0035912,1,0.950768423072381,0,8,dorsal aorta morphogenesis,BP,
10039,GO:0035914,1,0.673905933343252,0,61,skeletal muscle cell differentiation,BP,
10040,GO:0035915,1,0.983162059682052,0,3,pore formation in membrane of other organism,BP,
10041,GO:0035921,1,0.994041577493381,0,1,desmosome disassembly,BP,
10042,GO:0035922,1,0.994184935079751,0,1,foramen ovale closure,BP,
10043,GO:0035924,1,0.765671990300348,0,41,cellular response to vascular endothelial growth factor stimulus,BP,
10044,GO:0035925,1,0.925579670554705,0,12,mRNA 3'-UTR AU-rich region binding,MF,
10046,GO:0035927,1,0.975901031618571,0,4,RNA import into mitochondrion,BP,
10047,GO:0035928,1,0.982116869238957,0,3,rRNA import into mitochondrion,BP,
10048,GO:0035929,1,0.895786801485839,0,18,steroid hormone secretion,BP,
10049,GO:0035930,1,0.924278043025218,0,13,corticosteroid hormone secretion,BP,
10050,GO:0035931,1,0.975714548322954,0,4,mineralocorticoid secretion,BP,
10051,GO:0035932,1,0.975714548322954,0,4,aldosterone secretion,BP,
10052,GO:0035933,1,0.947296120054295,0,9,glucocorticoid secretion,BP,
10053,GO:0035934,1,0.976983472711008,0,4,corticosterone secretion,BP,
10054,GO:0035935,1,0.993702410006232,0,1,androgen secretion,BP,
10055,GO:0035936,1,0.986399214905425,0,2,testosterone secretion,BP,
10056,GO:0035938,1,0.980482951755732,0,3,estradiol secretion,BP,
10057,GO:0035939,1,0.981437686283588,0,3,microsatellite binding,MF,
10058,GO:0035945,1,0.99392972909963,0,1,mitochondrial ncRNA surveillance,BP,
10059,GO:0035946,1,0.99392972909963,0,1,mitochondrial mRNA surveillance,BP,
10060,GO:0035947,1,0.96800743593267,0,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,
10061,GO:0035948,1,0.98087146901558,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
10062,GO:0035962,1,0.981663885160152,0,3,response to interleukin-13,BP,
10063,GO:0035963,1,0.981663885160152,0,3,cellular response to interleukin-13,BP,
10064,GO:0035964,1,0.962812301878706,0,6,COPI-coated vesicle budding,BP,
10065,GO:0035965,1,0.969289813517113,0,5,cardiolipin acyl-chain remodeling,BP,
10068,GO:0035970,1,0.903862703578963,0,16,peptidyl-threonine dephosphorylation,BP,
10069,GO:0035971,1,0.994294526425336,0,1,peptidyl-histidine dephosphorylation,BP,
10070,GO:0035973,1,0.953863544431879,0,7,aggrephagy,BP,
10071,GO:0035976,1,0.970678082913974,0,5,transcription factor AP-1 complex,CC,
10072,GO:0035977,1,0.973815253730134,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
10073,GO:0035978,1,0.993830733292028,0,1,histone H2A-S139 phosphorylation,BP,
10074,GO:0035981,1,0.987585547108245,0,2,tongue muscle cell differentiation,BP,
10075,GO:0035983,1,0.974582976705836,0,4,response to trichostatin A,BP,
10076,GO:0035984,1,0.974582976705836,0,4,cellular response to trichostatin A,BP,
10077,GO:0035985,1,0.976544865496988,0,4,senescence-associated heterochromatin focus,CC,
10078,GO:0035986,1,0.982323576812728,0,3,senescence-associated heterochromatin focus assembly,BP,
10079,GO:0035987,1,0.743195602731535,0,45,endodermal cell differentiation,BP,
10080,GO:0035988,1,0.91387957082075,0,14,chondrocyte proliferation,BP,
10081,GO:0035989,1,0.967626772944064,0,5,tendon development,BP,
10082,GO:0035990,1,0.982562682322513,0,3,tendon cell differentiation,BP,
10083,GO:0035992,1,0.982562682322513,0,3,tendon formation,BP,
10084,GO:0035993,1,0.988168263593334,0,2,deltoid tuberosity development,BP,
10086,GO:0035995,1,0.959012706934895,0,3,detection of muscle stretch,BP,
10087,GO:0035998,1,0.99408271099283,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
10088,GO:0035999,1,0.945758195346818,0,9,tetrahydrofolate interconversion,BP,
10089,GO:0036002,1,0.800875869482017,0,35,pre-mRNA binding,MF,
10090,GO:0036003,1,0.854916229191842,0,25,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,
10091,GO:0036004,1,0.994290772296812,0,1,GAF domain binding,MF,
10092,GO:0036005,1,0.951063398734954,0,8,response to macrophage colony-stimulating factor,BP,
10093,GO:0036006,1,0.951063398734954,0,8,cellular response to macrophage colony-stimulating factor stimulus,BP,
10094,GO:0036009,1,0.994309542961473,0,1,protein-glutamine N-methyltransferase activity,MF,
10095,GO:0036010,1,0.887321669860182,0,18,protein localization to endosome,BP,
10096,GO:0036015,1,0.974636622913573,0,4,response to interleukin-3,BP,
10097,GO:0036016,1,0.974636622913573,0,4,cellular response to interleukin-3,BP,
10098,GO:0036017,1,0.959997718640829,0,7,response to erythropoietin,BP,
10099,GO:0036018,1,0.965284571931472,0,6,cellular response to erythropoietin,BP,
10100,GO:0036019,1,0.884113675638764,0,19,endolysosome,CC,
10101,GO:0036020,1,0.912028009865363,0,14,endolysosome membrane,CC,
10102,GO:0036021,1,0.969421422295291,0,5,endolysosome lumen,CC,
10103,GO:0036022,1,0.981987916480935,0,3,limb joint morphogenesis,BP,
10104,GO:0036023,1,0.981987916480935,0,3,embryonic skeletal limb joint morphogenesis,BP,
10105,GO:0036024,1,0.993978988252915,0,1,protein C inhibitor-TMPRSS7 complex,CC,
10106,GO:0036025,1,0.993978988252915,0,1,protein C inhibitor-TMPRSS11E complex,CC,
10107,GO:0036026,1,0.993978988252915,0,1,protein C inhibitor-PLAT complex,CC,
10108,GO:0036027,1,0.993978988252915,0,1,protein C inhibitor-PLAU complex,CC,
10109,GO:0036028,1,0.993978988252915,0,1,protein C inhibitor-thrombin complex,CC,
10110,GO:0036029,1,0.993978988252915,0,1,protein C inhibitor-KLK3 complex,CC,
10111,GO:0036030,1,0.993978988252915,0,1,protein C inhibitor-plasma kallikrein complex,CC,
10112,GO:0036033,1,0.969652756676053,0,4,mediator complex binding,MF,
10113,GO:0036034,1,0.987879695135121,0,2,mediator complex assembly,BP,
10114,GO:0036035,1,0.893934579696792,0,17,osteoclast development,BP,
10115,GO:0036037,1,0.92277587778988,0,13,CD8-positive, alpha-beta T cell activation,BP,
10116,GO:0036038,1,0.922587486047053,0,13,MKS complex,CC,
10117,GO:0036041,1,0.948843153634119,0,9,long-chain fatty acid binding,MF,
10118,GO:0036042,1,0.976912138024794,0,4,long-chain fatty acyl-CoA binding,MF,
10119,GO:0036046,1,0.993738411238908,0,1,protein demalonylation,BP,
10120,GO:0036047,1,0.993738411238908,0,1,peptidyl-lysine demalonylation,BP,
10121,GO:0036048,1,0.993738411238908,0,1,protein desuccinylation,BP,
10122,GO:0036049,1,0.993738411238908,0,1,peptidyl-lysine desuccinylation,BP,
10123,GO:0036053,1,0.993862875998648,0,1,glomerular endothelium fenestra,CC,
10124,GO:0036054,1,0.993738411238908,0,1,protein-malonyllysine demalonylase activity,MF,
10125,GO:0036055,1,0.993738411238908,0,1,protein-succinyllysine desuccinylase activity,MF,
10126,GO:0036056,1,0.952763424082398,0,7,filtration diaphragm,CC,
10127,GO:0036057,1,0.952763424082398,0,7,slit diaphragm,CC,
10128,GO:0036058,1,0.993487239925093,0,1,filtration diaphragm assembly,BP,
10129,GO:0036060,1,0.993487239925093,0,1,slit diaphragm assembly,BP,
10130,GO:0036064,1,0.518734951124175,0,101,ciliary basal body,CC,
10131,GO:0036065,1,0.849756266288263,0,25,fucosylation,BP,
10132,GO:0036066,1,0.913221016343994,0,14,protein O-linked fucosylation,BP,
10133,GO:0036071,1,0.993698697076839,0,1,N-glycan fucosylation,BP,
10134,GO:0036072,1,0.961469262343814,0,6,direct ossification,BP,
10135,GO:0036075,1,0.850914839783598,0,25,replacement ossification,BP,
10136,GO:0036080,1,0.986450387599968,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
10137,GO:0036085,1,0.993721264275222,0,1,GDP-fucose import into Golgi lumen,BP,
10138,GO:0036088,1,0.99418450191171,0,1,D-serine catabolic process,BP,
10139,GO:0036089,1,0.95631081627178,0,7,cleavage furrow formation,BP,
10140,GO:0036090,1,0.988163633358361,0,2,cleavage furrow ingression,BP,
10141,GO:0036091,1,0.968174065421884,0,5,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
10143,GO:0036093,1,0.965185718099865,0,6,germ cell proliferation,BP,
10145,GO:0036100,1,0.987965436982747,0,2,leukotriene catabolic process,BP,
10146,GO:0036101,1,0.987965436982747,0,2,leukotriene B4 catabolic process,BP,
10147,GO:0036102,1,0.987965436982747,0,2,leukotriene B4 metabolic process,BP,
10148,GO:0036105,1,0.993605492151102,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
10149,GO:0036109,1,0.92726829577206,0,12,alpha-linolenic acid metabolic process,BP,
10150,GO:0036111,1,0.993870200243014,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10151,GO:0036112,1,0.981972932360972,0,3,medium-chain fatty-acyl-CoA metabolic process,BP,
10152,GO:0036114,1,0.994204860789484,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
10153,GO:0036115,1,0.994204860789484,0,1,fatty-acyl-CoA catabolic process,BP,
10154,GO:0036116,1,0.994204860789484,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
10155,GO:0036117,1,0.987980630728529,0,2,hyaluranon cable,CC,
10156,GO:0036118,1,0.981544651972138,0,3,hyaluranon cable assembly,BP,
10157,GO:0036119,1,0.869600716756392,0,21,response to platelet-derived growth factor,BP,
10158,GO:0036120,1,0.875040683182795,0,20,cellular response to platelet-derived growth factor stimulus,BP,
10160,GO:0036123,1,0.963816460618528,0,6,histone H3-K9 dimethylation,BP,
10161,GO:0036124,1,0.910557678020301,0,14,histone H3-K9 trimethylation,BP,
10162,GO:0036125,1,0.993767006835621,0,1,fatty acid beta-oxidation multienzyme complex,CC,
10165,GO:0036130,1,0.994292793750381,0,1,prostaglandin H2 endoperoxidase reductase activity,MF,
10166,GO:0036131,1,0.994292793750381,0,1,prostaglandin D2 11-ketoreductase activity,MF,
10167,GO:0036132,1,0.981377175489927,0,3,13-prostaglandin reductase activity,MF,
10168,GO:0036134,1,0.994036816012919,0,1,12-hydroxyheptadecatrienoic acid synthase activity,MF,
10169,GO:0036135,1,0.986458408758536,0,2,Schwann cell migration,BP,
10170,GO:0036137,1,0.987979417740989,0,2,kynurenine aminotransferase activity,MF,
10171,GO:0036138,1,0.992656170933357,0,1,peptidyl-histidine hydroxylation,BP,
10172,GO:0036139,1,0.992656170933357,0,1,peptidyl-histidine dioxygenase activity,MF,
10173,GO:0036140,1,0.992656170933357,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
10174,GO:0036143,1,0.994401664843668,0,1,kringle domain binding,MF,
10175,GO:0036145,1,0.994132521541948,0,1,dendritic cell homeostasis,BP,
10176,GO:0036146,1,0.969406679959394,0,5,cellular response to mycotoxin,BP,
10177,GO:0036148,1,0.920757182305162,0,13,phosphatidylglycerol acyl-chain remodeling,BP,
10178,GO:0036149,1,0.940775299246437,0,10,phosphatidylinositol acyl-chain remodeling,BP,
10179,GO:0036150,1,0.910505776730593,0,15,phosphatidylserine acyl-chain remodeling,BP,
10180,GO:0036151,1,0.877925625291527,0,21,phosphatidylcholine acyl-chain remodeling,BP,
10181,GO:0036152,1,0.885144755747226,0,20,phosphatidylethanolamine acyl-chain remodeling,BP,
10182,GO:0036153,1,0.993836326336171,0,1,triglyceride acyl-chain remodeling,BP,
10183,GO:0036155,1,0.969162680759478,0,5,acylglycerol acyl-chain remodeling,BP,
10184,GO:0036156,1,0.96542883025919,0,4,inner dynein arm,CC,
10185,GO:0036157,1,0.939346129682509,0,9,outer dynein arm,CC,
10186,GO:0036158,1,0.899862717541402,0,16,outer dynein arm assembly,BP,
10187,GO:0036159,1,0.908255316911804,0,14,inner dynein arm assembly,BP,
10188,GO:0036164,1,0.994329468815,0,1,cell-abiotic substrate adhesion,BP,
10189,GO:0036166,1,0.973328641295632,0,4,phenotypic switching,BP,
10190,GO:0036179,1,0.993851534914036,0,1,osteoclast maturation,BP,
10191,GO:0036194,1,0.982700703733308,0,3,muscle cell projection,CC,
10192,GO:0036195,1,0.982700703733308,0,3,muscle cell projection membrane,CC,
10194,GO:0036213,1,0.994017052414068,0,1,contractile ring contraction,BP,
10195,GO:0036215,1,0.986989582376367,0,2,response to stem cell factor,BP,
10196,GO:0036216,1,0.986989582376367,0,2,cellular response to stem cell factor stimulus,BP,
10197,GO:0036219,1,0.994440940310254,0,1,GTP diphosphatase activity,MF,
10198,GO:0036220,1,0.994329035643356,0,1,ITP diphosphatase activity,MF,
10199,GO:0036222,1,0.994329035643356,0,1,XTP diphosphatase activity,MF,
10200,GO:0036228,1,0.987412744208165,0,2,protein localization to nuclear inner membrane,BP,
10202,GO:0036245,1,0.987511153402131,0,2,cellular response to menadione,BP,
10203,GO:0036250,1,0.994090073460822,0,1,peroxisome transport along microtubule,BP,
10204,GO:0036255,1,0.993545395687408,0,1,response to methylamine,BP,
10205,GO:0036257,1,0.826915694383226,0,31,multivesicular body organization,BP,
10206,GO:0036258,1,0.832052241514454,0,30,multivesicular body assembly,BP,
10207,GO:0036260,1,0.821455597141531,0,32,RNA capping,BP,
10208,GO:0036261,1,0.993582228608314,0,1,7-methylguanosine cap hypermethylation,BP,
10209,GO:0036265,1,0.975971965839632,0,4,RNA (guanine-N7)-methylation,BP,
10210,GO:0036266,1,0.993910591783376,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
10211,GO:0036269,1,0.987084157300877,0,2,swimming behavior,BP,
10213,GO:0036284,1,0.986698505445546,0,2,tubulobulbar complex,CC,
10214,GO:0036289,1,0.954231413211376,0,7,peptidyl-serine autophosphorylation,BP,
10215,GO:0036290,1,0.993489670748233,0,1,protein trans-autophosphorylation,BP,
10216,GO:0036292,1,0.987856219211072,0,2,DNA rewinding,BP,
10218,GO:0036294,1,0.298334638671631,0,190,cellular response to decreased oxygen levels,BP,
10219,GO:0036295,1,0.921371842815244,0,13,cellular response to increased oxygen levels,BP,
10220,GO:0036296,1,0.843977502393171,0,27,response to increased oxygen levels,BP,
10221,GO:0036297,1,0.756579984257371,0,44,interstrand cross-link repair,BP,
10222,GO:0036301,1,0.969617936366426,0,5,macrophage colony-stimulating factor production,BP,
10223,GO:0036302,1,0.952578029331672,0,7,atrioventricular canal development,BP,
10224,GO:0036303,1,0.884561019207731,0,18,lymph vessel morphogenesis,BP,
10225,GO:0036304,1,0.987895731112923,0,2,umbilical cord morphogenesis,BP,
10226,GO:0036306,1,0.994184935079751,0,1,embryonic heart tube elongation,BP,
10227,GO:0036309,1,0.980552018230186,0,2,protein localization to M-band,BP,
10228,GO:0036310,1,0.950408021507081,0,8,annealing helicase activity,MF,
10229,GO:0036312,1,0.944744863006161,0,8,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
10230,GO:0036313,1,0.993944413474727,0,1,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
10231,GO:0036314,1,0.854194592682162,0,23,response to sterol,BP,
10232,GO:0036315,1,0.902089761506395,0,15,cellular response to sterol,BP,
10233,GO:0036316,1,0.993863593966619,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
10234,GO:0036317,1,0.993846081630578,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
10235,GO:0036323,1,0.993283019497895,0,1,vascular endothelial growth factor receptor-1 signaling pathway,BP,
10236,GO:0036324,1,0.987713003430361,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
10237,GO:0036326,1,0.993283019497895,0,1,VEGF-A-activated receptor activity,MF,
10238,GO:0036327,1,0.993283019497895,0,1,VEGF-B-activated receptor activity,MF,
10239,GO:0036328,1,0.993149993447709,0,1,VEGF-C-activated receptor activity,MF,
10240,GO:0036332,1,0.993283019497895,0,1,placental growth factor-activated receptor activity,MF,
10241,GO:0036333,1,0.993886723373256,0,1,hepatocyte homeostasis,BP,
10242,GO:0036335,1,0.993134569678585,0,1,intestinal stem cell homeostasis,BP,
10243,GO:0036336,1,0.849860324285487,0,26,dendritic cell migration,BP,
10244,GO:0036337,1,0.974158251695004,0,4,Fas signaling pathway,BP,
10245,GO:0036342,1,0.906426766696026,0,15,post-anal tail morphogenesis,BP,
10246,GO:0036343,1,0.976500341240076,0,4,psychomotor behavior,BP,
10247,GO:0036344,1,0.883864851470796,0,19,platelet morphogenesis,BP,
10248,GO:0036345,1,0.988003208117032,0,2,platelet maturation,BP,
10249,GO:0036351,1,0.993978123519157,0,1,histone H2A-K13 ubiquitination,BP,
10250,GO:0036352,1,0.993978123519157,0,1,histone H2A-K15 ubiquitination,BP,
10251,GO:0036353,1,0.955602834744918,0,7,histone H2A-K119 monoubiquitination,BP,
10252,GO:0036361,1,0.993930880583482,0,1,racemase activity, acting on amino acids and derivatives,MF,
10253,GO:0036363,1,0.987281523152657,0,2,transforming growth factor beta activation,BP,
10254,GO:0036367,1,0.993906132924117,0,1,light adaption,BP,
10255,GO:0036369,1,0.985011333250881,0,2,transcription factor catabolic process,BP,
10256,GO:0036371,1,0.99230638444094,0,1,protein localization to T-tubule,BP,
10257,GO:0036372,1,0.994365277838471,0,1,opsin transport,BP,
10258,GO:0036374,1,0.981880669410057,0,3,glutathione hydrolase activity,MF,
10260,GO:0036378,1,0.98814286537436,0,2,calcitriol biosynthetic process from calciol,BP,
10262,GO:0036387,1,0.982240164304097,0,3,pre-replicative complex,CC,
10263,GO:0036388,1,0.982240164304097,0,3,pre-replicative complex assembly,BP,
10264,GO:0036392,1,0.993577518319972,0,1,chemokine (C-C motif) ligand 20 production,BP,
10265,GO:0036393,1,0.993811096950118,0,1,thiocyanate peroxidase activity,MF,
10266,GO:0036396,1,0.982370046278418,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
10267,GO:0036398,1,0.987682005706877,0,2,TCR signalosome,CC,
10268,GO:0036399,1,0.993701267540879,0,1,TCR signalosome assembly,BP,
10269,GO:0036402,1,0.965767115019756,0,6,proteasome-activating ATPase activity,MF,
10270,GO:0036403,1,0.993888591852874,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
10271,GO:0036404,1,0.991682396568226,0,1,conversion of ds siRNA to ss siRNA,BP,
10274,GO:0036435,1,0.987843506141336,0,2,K48-linked polyubiquitin modification-dependent protein binding,MF,
10275,GO:0036438,1,0.975106257960998,0,4,maintenance of lens transparency,BP,
10276,GO:0036440,1,0.993786752715365,0,1,citrate synthase activity,MF,
10277,GO:0036442,1,0.845597606371253,0,27,proton-exporting ATPase activity,MF,
10278,GO:0036444,1,0.950569840675522,0,8,calcium import into the mitochondrion,BP,
10279,GO:0036445,1,0.916952551776982,0,13,neuronal stem cell division,BP,
10280,GO:0036446,1,0.98025677322259,0,3,myofibroblast differentiation,BP,
10281,GO:0036449,1,0.95047910774444,0,7,microtubule minus-end,CC,
10282,GO:0036451,1,0.987729649828399,0,2,cap mRNA methylation,BP,
10283,GO:0036452,1,0.842370274215271,0,28,ESCRT complex,CC,
10284,GO:0036454,1,0.968122281082553,0,5,growth factor complex,CC,
10285,GO:0036455,1,0.994322393683573,0,1,iron-sulfur transferase activity,MF,
10286,GO:0036458,1,0.994013302402746,0,1,hepatocyte growth factor binding,MF,
10287,GO:0036459,1,0.554792579327023,0,88,thiol-dependent ubiquitinyl hydrolase activity,MF,
10288,GO:0036461,1,0.988573320878318,0,2,BLOC-2 complex binding,MF,
10289,GO:0036462,1,0.957444298566558,0,7,TRAIL-activated apoptotic signaling pathway,BP,
10290,GO:0036464,1,0.313794652267144,0,180,cytoplasmic ribonucleoprotein granule,CC,
10292,GO:0036466,1,0.98664207885235,0,2,synaptic vesicle recycling via endosome,BP,
10293,GO:0036468,1,0.994063368708284,0,1,L-dopa decarboxylase activity,MF,
10294,GO:0036470,1,0.994377406787888,0,1,tyrosine 3-monooxygenase activator activity,MF,
10295,GO:0036471,1,0.994377406787888,0,1,cellular response to glyoxal,BP,
10298,GO:0036475,1,0.872936912903368,0,21,neuron death in response to oxidative stress,BP,
10299,GO:0036476,1,0.9757723243876,0,4,neuron death in response to hydrogen peroxide,BP,
10301,GO:0036478,1,0.994377406787888,0,1,L-dopa decarboxylase activator activity,MF,
10302,GO:0036479,1,0.991973955775138,0,1,peroxidase inhibitor activity,MF,
10303,GO:0036480,1,0.956916449604132,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
10304,GO:0036481,1,0.964652239258775,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10305,GO:0036482,1,0.988290008317986,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10306,GO:0036483,1,0.993335181890393,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
10307,GO:0036484,1,0.98070104487238,0,3,trunk neural crest cell migration,BP,
10308,GO:0036486,1,0.98070104487238,0,3,ventral trunk neural crest cell migration,BP,
10309,GO:0036487,1,0.992100351952376,0,1,nitric-oxide synthase inhibitor activity,MF,
10310,GO:0036488,1,0.988534828622545,0,2,CHOP-C/EBP complex,CC,
10311,GO:0036490,1,0.949354627632043,0,8,regulation of translation in response to endoplasmic reticulum stress,BP,
10312,GO:0036491,1,0.955432194753704,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10313,GO:0036492,1,0.96124073175761,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
10314,GO:0036493,1,0.981233875852498,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
10315,GO:0036494,1,0.993039654295679,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10316,GO:0036496,1,0.988215982722692,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
10317,GO:0036497,1,0.993959680183743,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
10318,GO:0036498,1,0.652647115026927,0,67,IRE1-mediated unfolded protein response,BP,
10320,GO:0036500,1,0.939779291389742,0,10,ATF6-mediated unfolded protein response,BP,
10321,GO:0036501,1,0.993383979390311,0,1,UFD1-NPL4 complex,CC,
10322,GO:0036502,1,0.993743270869338,0,1,Derlin-1-VIMP complex,CC,
10325,GO:0036506,1,0.980373554522884,0,3,maintenance of unfolded protein,BP,
10326,GO:0036507,1,0.85569814238746,0,24,protein demannosylation,BP,
10327,GO:0036508,1,0.85569814238746,0,24,protein alpha-1,2-demannosylation,BP,
10328,GO:0036509,1,0.987985011245759,0,2,trimming of terminal mannose on B branch,BP,
10329,GO:0036510,1,0.980944214425177,0,3,trimming of terminal mannose on C branch,BP,
10330,GO:0036511,1,0.987985011245759,0,2,trimming of first mannose on A branch,BP,
10331,GO:0036512,1,0.987985011245759,0,2,trimming of second mannose on A branch,BP,
10332,GO:0036513,1,0.932717226683627,0,11,Derlin-1 retrotranslocation complex,CC,
10333,GO:0036514,1,0.96506875238382,0,5,dopaminergic neuron axon guidance,BP,
10334,GO:0036515,1,0.971094047970494,0,4,serotonergic neuron axon guidance,BP,
10335,GO:0036517,1,0.992967472159764,0,1,chemoattraction of serotonergic neuron axon,BP,
10336,GO:0036518,1,0.986807855021205,0,2,chemorepulsion of dopaminergic neuron axon,BP,
10337,GO:0036524,1,0.994377406787888,0,1,protein deglycase activity,MF,
10338,GO:0036525,1,0.994377406787888,0,1,protein deglycation,BP,
10339,GO:0036526,1,0.994377406787888,0,1,peptidyl-cysteine deglycation,BP,
10340,GO:0036527,1,0.994377406787888,0,1,peptidyl-arginine deglycation,BP,
10341,GO:0036528,1,0.994377406787888,0,1,peptidyl-lysine deglycation,BP,
10342,GO:0036529,1,0.994377406787888,0,1,protein deglycation, glyoxal removal,BP,
10343,GO:0036530,1,0.994377406787888,0,1,protein deglycation, methylglyoxal removal,BP,
10344,GO:0036531,1,0.994377406787888,0,1,glutathione deglycation,BP,
10345,GO:0038001,1,0.978703617508966,0,3,paracrine signaling,BP,
10346,GO:0038002,1,0.993105298739487,0,1,endocrine signaling,BP,
10347,GO:0038003,1,0.941051499856872,0,10,opioid receptor signaling pathway,BP,
10348,GO:0038007,1,0.952727097813545,0,7,netrin-activated signaling pathway,BP,
10349,GO:0038016,1,0.987661872878805,0,2,insulin receptor internalization,BP,
10350,GO:0038018,1,0.986146100259169,0,2,Wnt receptor catabolic process,BP,
10351,GO:0038021,1,0.993420679160135,0,1,leptin receptor activity,MF,
10354,GO:0038025,1,0.987081045099304,0,2,reelin receptor activity,MF,
10355,GO:0038026,1,0.971979160387807,0,4,reelin-mediated signaling pathway,BP,
10356,GO:0038027,1,0.964777993300421,0,5,apolipoprotein A-I-mediated signaling pathway,BP,
10357,GO:0038028,1,0.974624408690069,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
10358,GO:0038030,1,0.955740071659125,0,7,non-canonical Wnt signaling pathway via MAPK cascade,BP,
10359,GO:0038031,1,0.961972565294168,0,6,non-canonical Wnt signaling pathway via JNK cascade,BP,
10360,GO:0038033,1,0.968606607965778,0,5,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
10363,GO:0038037,1,0.950022509231632,0,8,G-protein coupled receptor dimeric complex,CC,
10364,GO:0038038,1,0.992659931645416,0,1,G-protein coupled receptor homodimeric complex,CC,
10365,GO:0038039,1,0.986414959022327,0,2,G-protein coupled receptor heterodimeric complex,CC,
10366,GO:0038042,1,0.957550855123014,0,7,dimeric G-protein coupled receptor signaling pathway,BP,
10367,GO:0038043,1,0.98735383020944,0,2,interleukin-5-mediated signaling pathway,BP,
10368,GO:0038044,1,0.966267575562864,0,5,transforming growth factor-beta secretion,BP,
10369,GO:0038046,1,0.99413512056647,0,1,enkephalin receptor activity,MF,
10370,GO:0038047,1,0.994108264596255,0,1,morphine receptor activity,MF,
10371,GO:0038048,1,0.993221009726206,0,1,dynorphin receptor activity,MF,
10372,GO:0038049,1,0.984143160445616,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
10373,GO:0038051,1,0.992742069735397,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
10374,GO:0038052,1,0.986801290186264,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
10375,GO:0038060,1,0.993683276510387,0,1,nitric oxide-cGMP-mediated signaling pathway,BP,
10376,GO:0038061,1,0.486645463460387,0,117,NIK/NF-kappaB signaling,BP,
10377,GO:0038062,1,0.987305214973206,0,2,protein tyrosine kinase collagen receptor activity,MF,
10378,GO:0038063,1,0.93853948758785,0,9,collagen-activated tyrosine kinase receptor signaling pathway,BP,
10379,GO:0038064,1,0.97311136001403,0,4,collagen receptor activity,MF,
10380,GO:0038065,1,0.925039785610291,0,11,collagen-activated signaling pathway,BP,
10381,GO:0038066,1,0.790579694185253,0,37,p38MAPK cascade,BP,
10383,GO:0038084,1,0.847084616400193,0,25,vascular endothelial growth factor signaling pathway,BP,
10384,GO:0038085,1,0.967208745362228,0,5,vascular endothelial growth factor binding,MF,
10385,GO:0038086,1,0.979520327902172,0,3,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
10386,GO:0038089,1,0.954758770084922,0,7,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
10387,GO:0038091,1,0.979520327902172,0,3,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
10388,GO:0038092,1,0.909591949201607,0,15,nodal signaling pathway,BP,
10389,GO:0038093,1,0.326990667274322,0,178,Fc receptor signaling pathway,BP,
10390,GO:0038094,1,0.625243582592232,0,74,Fc-gamma receptor signaling pathway,BP,
10391,GO:0038095,1,0.479221621459072,0,118,Fc-epsilon receptor signaling pathway,BP,
10392,GO:0038096,1,0.640079201589985,0,70,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
10393,GO:0038097,1,0.993119430958074,0,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,
10394,GO:0038098,1,0.987542328799678,0,2,sequestering of BMP from receptor via BMP binding,BP,
10395,GO:0038100,1,0.980695320035971,0,3,nodal binding,MF,
10396,GO:0038101,1,0.994147538138271,0,1,sequestering of nodal from receptor via nodal binding,BP,
10397,GO:0038107,1,0.957257425097043,0,7,nodal signaling pathway involved in determination of left/right asymmetry,BP,
10398,GO:0038108,1,0.975538089203094,0,4,negative regulation of appetite by leptin-mediated signaling pathway,BP,
10399,GO:0038109,1,0.986989582376367,0,2,Kit signaling pathway,BP,
10400,GO:0038110,1,0.930936280527093,0,11,interleukin-2-mediated signaling pathway,BP,
10401,GO:0038111,1,0.889729450932625,0,18,interleukin-7-mediated signaling pathway,BP,
10402,GO:0038112,1,0.987816926764533,0,2,interleukin-8-mediated signaling pathway,BP,
10403,GO:0038113,1,0.980594983959447,0,3,interleukin-9-mediated signaling pathway,BP,
10404,GO:0038114,1,0.955711324922345,0,7,interleukin-21-mediated signaling pathway,BP,
10405,GO:0038115,1,0.994020514183732,0,1,chemokine (C-C motif) ligand 19 signaling pathway,BP,
10406,GO:0038116,1,0.994020514183732,0,1,chemokine (C-C motif) ligand 21 signaling pathway,BP,
10407,GO:0038117,1,0.994020514183732,0,1,C-C motif chemokine 19 receptor activity,MF,
10408,GO:0038118,1,0.994343330331289,0,1,C-C chemokine receptor CCR7 signaling pathway,BP,
10409,GO:0038121,1,0.994020514183732,0,1,C-C motif chemokine 21 receptor activity,MF,
10410,GO:0038123,1,0.981791404785368,0,3,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10411,GO:0038124,1,0.975093724850932,0,4,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10412,GO:0038127,1,0.397636110505358,0,141,ERBB signaling pathway,BP,
10413,GO:0038128,1,0.782081123576108,0,38,ERBB2 signaling pathway,BP,
10414,GO:0038129,1,0.982065561473907,0,3,ERBB3 signaling pathway,BP,
10415,GO:0038131,1,0.987829650075993,0,2,neuregulin receptor activity,MF,
10416,GO:0038132,1,0.966031519136055,0,5,neuregulin binding,MF,
10417,GO:0038133,1,0.994057451312921,0,1,ERBB2-ERBB3 signaling pathway,BP,
10418,GO:0038145,1,0.969451028382177,0,5,macrophage colony-stimulating factor signaling pathway,BP,
10419,GO:0038154,1,0.99372526461683,0,1,interleukin-11-mediated signaling pathway,BP,
10420,GO:0038155,1,0.956739641604941,0,7,interleukin-23-mediated signaling pathway,BP,
10421,GO:0038156,1,0.99325123291743,0,1,interleukin-3-mediated signaling pathway,BP,
10422,GO:0038158,1,0.987852604046366,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
10423,GO:0038161,1,0.985138970277316,0,2,prolactin signaling pathway,BP,
10424,GO:0038162,1,0.981643508327594,0,3,erythropoietin-mediated signaling pathway,BP,
10425,GO:0038163,1,0.982190892093991,0,3,thrombopoietin-mediated signaling pathway,BP,
10426,GO:0038164,1,0.993595644798119,0,1,thrombopoietin receptor activity,MF,
10427,GO:0038165,1,0.973403399488399,0,4,oncostatin-M-mediated signaling pathway,BP,
10429,GO:0038167,1,0.99310501030028,0,1,epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity,BP,
10430,GO:0038168,1,0.99310501030028,0,1,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade,BP,
10431,GO:0038169,1,0.975814769306675,0,4,somatostatin receptor signaling pathway,BP,
10432,GO:0038170,1,0.975814769306675,0,4,somatostatin signaling pathway,BP,
10433,GO:0038171,1,0.955696141984499,0,7,cannabinoid signaling pathway,BP,
10434,GO:0038172,1,0.981533915487104,0,3,interleukin-33-mediated signaling pathway,BP,
10435,GO:0038178,1,0.987854585120266,0,2,complement component C5a signaling pathway,BP,
10436,GO:0038179,1,0.797591155584501,0,35,neurotrophin signaling pathway,BP,
10437,GO:0038180,1,0.924709408747944,0,12,nerve growth factor signaling pathway,BP,
10438,GO:0038181,1,0.98164453957434,0,3,bile acid receptor activity,MF,
10439,GO:0038182,1,0.994215978745102,0,1,G-protein coupled bile acid receptor activity,MF,
10440,GO:0038183,1,0.98164453957434,0,3,bile acid signaling pathway,BP,
10441,GO:0038184,1,0.994215978745102,0,1,cell surface bile acid receptor signaling pathway,BP,
10442,GO:0038185,1,0.994026284253939,0,1,intracellular bile acid receptor signaling pathway,BP,
10443,GO:0038186,1,0.993290208061306,0,1,lithocholic acid receptor activity,MF,
10444,GO:0038187,1,0.91664907622441,0,14,pattern recognition receptor activity,MF,
10445,GO:0038188,1,0.988230527011774,0,2,cholecystokinin signaling pathway,BP,
10446,GO:0038189,1,0.974846252783141,0,4,neuropilin signaling pathway,BP,
10447,GO:0038190,1,0.987600593383178,0,2,VEGF-activated neuropilin signaling pathway,BP,
10448,GO:0038191,1,0.87904607873625,0,19,neuropilin binding,MF,
10449,GO:0038192,1,0.994059760493024,0,1,gastric inhibitory peptide signaling pathway,BP,
10450,GO:0038193,1,0.993991528798771,0,1,thromboxane A2 signaling pathway,BP,
10451,GO:0038194,1,0.987856417987663,0,2,thyroid-stimulating hormone signaling pathway,BP,
10452,GO:0038195,1,0.994231283975121,0,1,urokinase plasminogen activator signaling pathway,BP,
10453,GO:0038201,1,0.90128805921298,0,16,TOR complex,CC,
10454,GO:0038202,1,0.813171552353678,0,32,TORC1 signaling,BP,
10455,GO:0038203,1,0.957460855254059,0,7,TORC2 signaling,BP,
10456,GO:0039003,1,0.987038592633319,0,2,pronephric field specification,BP,
10457,GO:0039007,1,0.993049612079565,0,1,pronephric nephron morphogenesis,BP,
10458,GO:0039008,1,0.993049612079565,0,1,pronephric nephron tubule morphogenesis,BP,
10459,GO:0039017,1,0.987038592633319,0,2,pattern specification involved in pronephros development,BP,
10460,GO:0039019,1,0.986691869817489,0,2,pronephric nephron development,BP,
10461,GO:0039020,1,0.993049612079565,0,1,pronephric nephron tubule development,BP,
10462,GO:0039022,1,0.993049612079565,0,1,pronephric duct development,BP,
10463,GO:0039023,1,0.993049612079565,0,1,pronephric duct morphogenesis,BP,
10464,GO:0039502,1,0.993147831445154,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
10465,GO:0039503,1,0.993147831445154,0,1,suppression by virus of host innate immune response,BP,
10466,GO:0039506,1,0.987039644151015,0,2,modulation by virus of host molecular function,BP,
10467,GO:0039507,1,0.987039644151015,0,2,suppression by virus of host molecular function,BP,
10468,GO:0039513,1,0.993850099716597,0,1,suppression by virus of host catalytic activity,BP,
10469,GO:0039514,1,0.993147831445154,0,1,suppression by virus of host JAK-STAT cascade,BP,
10470,GO:0039516,1,0.993850099716597,0,1,modulation by virus of host catalytic activity,BP,
10471,GO:0039519,1,0.986313977354232,0,2,modulation by virus of host autophagy,BP,
10472,GO:0039520,1,0.9930514880772,0,1,induction by virus of host autophagy,BP,
10473,GO:0039521,1,0.993215826877262,0,1,suppression by virus of host autophagy,BP,
10474,GO:0039526,1,0.982222607219231,0,3,modulation by virus of host apoptotic process,BP,
10475,GO:0039528,1,0.877280251221816,0,20,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,
10476,GO:0039529,1,0.904613484508564,0,15,RIG-I signaling pathway,BP,
10477,GO:0039530,1,0.949664002911151,0,8,MDA-5 signaling pathway,BP,
10478,GO:0039531,1,0.905242156625923,0,15,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10479,GO:0039532,1,0.944250325349174,0,9,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10480,GO:0039533,1,0.967055452435467,0,5,regulation of MDA-5 signaling pathway,BP,
10481,GO:0039534,1,0.981794684033038,0,3,negative regulation of MDA-5 signaling pathway,BP,
10482,GO:0039535,1,0.916644553421946,0,13,regulation of RIG-I signaling pathway,BP,
10483,GO:0039536,1,0.956138918074534,0,7,negative regulation of RIG-I signaling pathway,BP,
10484,GO:0039552,1,0.993064474786422,0,1,RIG-I binding,MF,
10485,GO:0039562,1,0.993147831445154,0,1,suppression by virus of host STAT activity,BP,
10486,GO:0039563,1,0.993147831445154,0,1,suppression by virus of host STAT1 activity,BP,
10487,GO:0039564,1,0.993147831445154,0,1,suppression by virus of host STAT2 activity,BP,
10488,GO:0039650,1,0.993850099716597,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
10489,GO:0039656,1,0.981817475083039,0,3,modulation by virus of host gene expression,BP,
10490,GO:0039663,1,0.963981574373282,0,6,membrane fusion involved in viral entry into host cell,BP,
10491,GO:0039689,1,0.981520331813157,0,3,negative stranded viral RNA replication,BP,
10494,GO:0039695,1,0.993316508368644,0,1,DNA-templated viral transcription,BP,
10495,GO:0039702,1,0.880190658853341,0,21,viral budding via host ESCRT complex,BP,
10496,GO:0039706,1,0.932633950871632,0,11,co-receptor binding,MF,
10497,GO:0039713,1,0.993655726867109,0,1,viral factory,CC,
10498,GO:0039714,1,0.993655726867109,0,1,cytoplasmic viral factory,CC,
10499,GO:0040001,1,0.853985529354183,0,24,establishment of mitotic spindle localization,BP,
10502,GO:0040009,1,0.965194918903499,0,5,regulation of growth rate,BP,
10503,GO:0040010,1,0.994440940310254,0,1,positive regulation of growth rate,BP,
10507,GO:0040014,1,0.672193952310734,0,61,regulation of multicellular organism growth,BP,
10508,GO:0040015,1,0.930679290487451,0,11,negative regulation of multicellular organism growth,BP,
10511,GO:0040018,1,0.828098605910891,0,29,positive regulation of multicellular organism growth,BP,
10512,GO:0040019,1,0.827604101671269,0,29,positive regulation of embryonic development,BP,
10513,GO:0040020,1,0.849544852804391,0,26,regulation of meiotic nuclear division,BP,
10515,GO:0040030,1,0.988069100563081,0,2,regulation of molecular function, epigenetic,BP,
10516,GO:0040031,1,0.965273615891845,0,6,snRNA modification,BP,
10517,GO:0040032,1,0.994100323791854,0,1,post-embryonic body morphogenesis,BP,
10518,GO:0040033,1,0.915095174835725,0,13,negative regulation of translation, ncRNA-mediated,BP,
10519,GO:0040034,1,0.926124443077436,0,12,regulation of development, heterochronic,BP,
10521,GO:0040037,1,0.919306906565004,0,13,negative regulation of fibroblast growth factor receptor signaling pathway,BP,
10522,GO:0040038,1,0.979730415588547,0,3,polar body extrusion after meiotic divisions,BP,
10523,GO:0040040,1,0.992899880523067,0,1,thermosensory behavior,BP,
10524,GO:0042000,1,0.993949453664117,0,1,translocation of peptides or proteins into host,BP,
10525,GO:0042007,1,0.994237059532894,0,1,interleukin-18 binding,MF,
10526,GO:0042008,1,0.99363189329802,0,1,interleukin-18 receptor activity,MF,
10527,GO:0042011,1,0.993750704474997,0,1,interleukin-16 binding,MF,
10528,GO:0042012,1,0.993750704474997,0,1,interleukin-16 receptor activity,MF,
10529,GO:0042015,1,0.981595437675575,0,3,interleukin-20 binding,MF,
10530,GO:0042019,1,0.994073183752291,0,1,interleukin-23 binding,MF,
10531,GO:0042020,1,0.994073183752291,0,1,interleukin-23 receptor activity,MF,
10532,GO:0042022,1,0.994073183752291,0,1,interleukin-12 receptor complex,CC,
10533,GO:0042023,1,0.947129468915671,0,8,DNA endoreduplication,BP,
10534,GO:0042025,1,0.980730531990208,0,3,host cell nucleus,CC,
10536,GO:0042030,1,0.980016761438931,0,3,ATPase inhibitor activity,MF,
10537,GO:0042033,1,0.930752004936079,0,12,chemokine biosynthetic process,BP,
10538,GO:0042035,1,0.575985327960116,0,88,regulation of cytokine biosynthetic process,BP,
10539,GO:0042036,1,0.842448005429831,0,28,negative regulation of cytokine biosynthetic process,BP,
10540,GO:0042040,1,0.993419246286832,0,1,metal incorporation into metallo-molybdopterin complex,BP,
10541,GO:0042043,1,0.917766590055739,0,13,neurexin family protein binding,MF,
10542,GO:0042044,1,0.875772587169939,0,21,fluid transport,BP,
10543,GO:0042045,1,0.954183828007088,0,7,epithelial fluid transport,BP,
10544,GO:0042048,1,0.95186365961217,0,7,olfactory behavior,BP,
10546,GO:0042054,1,0.708171267417194,0,53,histone methyltransferase activity,MF,
10547,GO:0042056,1,0.875633229687262,0,22,chemoattractant activity,MF,
10548,GO:0042058,1,0.612746658678807,0,77,regulation of epidermal growth factor receptor signaling pathway,BP,
10549,GO:0042059,1,0.769929970268961,0,41,negative regulation of epidermal growth factor receptor signaling pathway,BP,
10553,GO:0042073,1,0.723619646500827,0,50,intraciliary transport,BP,
10554,GO:0042074,1,0.918366490925585,0,13,cell migration involved in gastrulation,BP,
10555,GO:0042078,1,0.981874611229399,0,3,germ-line stem cell division,BP,
10556,GO:0042083,1,0.99418912236975,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
10557,GO:0042084,1,0.991591223513368,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
10558,GO:0042088,1,0.800682162466845,0,36,T-helper 1 type immune response,BP,
10559,GO:0042089,1,0.551728885491594,0,95,cytokine biosynthetic process,BP,
10560,GO:0042090,1,0.956152761178744,0,7,interleukin-12 biosynthetic process,BP,
10561,GO:0042091,1,0.980950922922827,0,3,interleukin-10 biosynthetic process,BP,
10562,GO:0042092,1,0.817264626808093,0,33,type 2 immune response,BP,
10563,GO:0042093,1,0.736874402773485,0,48,T-helper cell differentiation,BP,
10564,GO:0042094,1,0.884013384891829,0,20,interleukin-2 biosynthetic process,BP,
10565,GO:0042095,1,0.912181472017694,0,15,interferon-gamma biosynthetic process,BP,
10566,GO:0042097,1,0.980814861957243,0,3,interleukin-4 biosynthetic process,BP,
10567,GO:0042098,1,0.373391279947045,0,158,T cell proliferation,BP,
10568,GO:0042100,1,0.651572589955068,0,68,B cell proliferation,BP,
10569,GO:0042101,1,0.890583533633588,0,19,T cell receptor complex,CC,
10570,GO:0042102,1,0.596726157031628,0,84,positive regulation of T cell proliferation,BP,
10571,GO:0042104,1,0.889678199923329,0,19,positive regulation of activated T cell proliferation,BP,
10572,GO:0042105,1,0.971414273455489,0,5,alpha-beta T cell receptor complex,CC,
10573,GO:0042107,1,0.548438478901531,0,96,cytokine metabolic process,BP,
10574,GO:0042108,1,0.721516536413095,0,52,positive regulation of cytokine biosynthetic process,BP,
10575,GO:0042109,1,0.987653819040612,0,2,lymphotoxin A biosynthetic process,BP,
10576,GO:0042110,1,0.0764326523355881,0,403,T cell activation,BP,
10577,GO:0042113,1,0.282526824674343,0,197,B cell activation,BP,
10578,GO:0042116,1,0.679345222330782,0,60,macrophage activation,BP,
10579,GO:0042117,1,0.958262677133337,0,7,monocyte activation,BP,
10580,GO:0042118,1,0.943344768945023,0,9,endothelial cell activation,BP,
10582,GO:0042126,1,0.975807965019155,0,4,nitrate metabolic process,BP,
10584,GO:0042128,1,0.993972935487167,0,1,nitrate assimilation,BP,
10585,GO:0042129,1,0.438040388483678,0,133,regulation of T cell proliferation,BP,
10586,GO:0042130,1,0.726647988066846,0,51,negative regulation of T cell proliferation,BP,
10587,GO:0042131,1,0.993917209374713,0,1,thiamine phosphate phosphatase activity,MF,
10588,GO:0042132,1,0.994202117396691,0,1,fructose 1,6-bisphosphate 1-phosphatase activity,MF,
10589,GO:0042133,1,0.456105906900968,0,123,neurotransmitter metabolic process,BP,
10590,GO:0042134,1,0.988451565781663,0,2,rRNA primary transcript binding,MF,
10591,GO:0042135,1,0.87639844483236,0,21,neurotransmitter catabolic process,BP,
10592,GO:0042136,1,0.586523589031846,0,84,neurotransmitter biosynthetic process,BP,
10594,GO:0042138,1,0.981754535354321,0,3,meiotic DNA double-strand break formation,BP,
10595,GO:0042140,1,0.993846081630578,0,1,late meiotic recombination nodule assembly,BP,
10596,GO:0042144,1,0.987202069040316,0,2,vacuole fusion, non-autophagic,BP,
10597,GO:0042147,1,0.624925384091585,0,72,retrograde transport, endosome to Golgi,BP,
10598,GO:0042148,1,0.951740077816261,0,8,strand invasion,BP,
10599,GO:0042149,1,0.79031460352068,0,37,cellular response to glucose starvation,BP,
10602,GO:0042159,1,0.912129717018118,0,14,lipoprotein catabolic process,BP,
10603,GO:0042160,1,0.98801630975614,0,2,lipoprotein modification,BP,
10604,GO:0042161,1,0.98801630975614,0,2,lipoprotein oxidation,BP,
10605,GO:0042162,1,0.791891024360773,0,36,telomeric DNA binding,MF,
10606,GO:0042163,1,0.994231572753009,0,1,interleukin-12 beta subunit binding,MF,
10607,GO:0042165,1,0.737256718264696,0,49,neurotransmitter binding,MF,
10608,GO:0042166,1,0.905419179680933,0,16,acetylcholine binding,MF,
10609,GO:0042167,1,0.977272184932079,0,4,heme catabolic process,BP,
10610,GO:0042168,1,0.857248340284633,0,25,heme metabolic process,BP,
10611,GO:0042169,1,0.810336828402933,0,32,SH2 domain binding,MF,
10612,GO:0042171,1,0.888794365141949,0,18,lysophosphatidic acid acyltransferase activity,MF,
10615,GO:0042177,1,0.5087665871166,0,105,negative regulation of protein catabolic process,BP,
10616,GO:0042178,1,0.942138032298302,0,10,xenobiotic catabolic process,BP,
10617,GO:0042180,1,0.287966903867049,0,199,cellular ketone metabolic process,BP,
10618,GO:0042181,1,0.8163325388384,0,33,ketone biosynthetic process,BP,
10619,GO:0042182,1,0.964403784468815,0,6,ketone catabolic process,BP,
10620,GO:0042197,1,0.994164287375524,0,1,halogenated hydrocarbon metabolic process,BP,
10621,GO:0042214,1,0.981874258107603,0,3,terpene metabolic process,BP,
10622,GO:0042219,1,0.883307445549407,0,20,cellular modified amino acid catabolic process,BP,
10625,GO:0042222,1,0.982631790416677,0,3,interleukin-1 biosynthetic process,BP,
10626,GO:0042223,1,0.993198979283753,0,1,interleukin-3 biosynthetic process,BP,
10627,GO:0042226,1,0.91644283833423,0,14,interleukin-6 biosynthetic process,BP,
10628,GO:0042228,1,0.938921455326627,0,10,interleukin-8 biosynthetic process,BP,
10629,GO:0042231,1,0.987472176332129,0,2,interleukin-13 biosynthetic process,BP,
10630,GO:0042241,1,0.993713264629147,0,1,interleukin-18 biosynthetic process,BP,
10631,GO:0042245,1,0.987351668119277,0,2,RNA repair,BP,
10633,GO:0042247,1,0.993798635555643,0,1,establishment of planar polarity of follicular epithelium,BP,
10634,GO:0042249,1,0.893819118569651,0,17,establishment of planar polarity of embryonic epithelium,BP,
10635,GO:0042253,1,0.981480147714928,0,3,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
10636,GO:0042254,1,0.151013126980472,0,309,ribosome biogenesis,BP,
10637,GO:0042255,1,0.728545623061058,0,53,ribosome assembly,BP,
10638,GO:0042256,1,0.969660449252001,0,5,mature ribosome assembly,BP,
10639,GO:0042262,1,0.97143736058749,0,5,DNA protection,BP,
10640,GO:0042264,1,0.986303613928665,0,2,peptidyl-aspartic acid hydroxylation,BP,
10641,GO:0042265,1,0.992656170933357,0,1,peptidyl-asparagine hydroxylation,BP,
10642,GO:0042267,1,0.742948020517254,0,48,natural killer cell mediated cytotoxicity,BP,
10643,GO:0042268,1,0.942324044993413,0,10,regulation of cytolysis,BP,
10644,GO:0042269,1,0.825847883420965,0,31,regulation of natural killer cell mediated cytotoxicity,BP,
10645,GO:0042270,1,0.987654279916724,0,2,protection from natural killer cell mediated cytotoxicity,BP,
10646,GO:0042271,1,0.980874084846747,0,3,susceptibility to natural killer cell mediated cytotoxicity,BP,
10647,GO:0042272,1,0.978921863632114,0,3,nuclear RNA export factor complex,CC,
10648,GO:0042273,1,0.6711948356476,0,66,ribosomal large subunit biogenesis,BP,
10649,GO:0042274,1,0.666099064220108,0,67,ribosomal small subunit biogenesis,BP,
10650,GO:0042275,1,0.994207604181777,0,1,error-free postreplication DNA repair,BP,
10651,GO:0042276,1,0.88816037147367,0,19,error-prone translesion synthesis,BP,
10653,GO:0042278,1,0.631754370103882,0,73,purine nucleoside metabolic process,BP,
10654,GO:0042281,1,0.987861493565313,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10655,GO:0042282,1,0.99334839189276,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
10656,GO:0042284,1,0.98838697211612,0,2,sphingolipid delta-4 desaturase activity,MF,
10657,GO:0042285,1,0.960620789619279,0,6,xylosyltransferase activity,MF,
10658,GO:0042287,1,0.847070513482102,0,27,MHC protein binding,MF,
10659,GO:0042288,1,0.907115645177992,0,16,MHC class I protein binding,MF,
10660,GO:0042289,1,0.964108479748149,0,6,MHC class II protein binding,MF,
10661,GO:0042292,1,0.993938366199964,0,1,URM1 activating enzyme activity,MF,
10662,GO:0042296,1,0.976492700481853,0,4,ISG15 transferase activity,MF,
10663,GO:0042297,1,0.948436169942827,0,7,vocal learning,BP,
10664,GO:0042301,1,0.933975276720581,0,11,phosphate ion binding,MF,
10666,GO:0042304,1,0.806821331827932,0,34,regulation of fatty acid biosynthetic process,BP,
10667,GO:0042306,1,0.736599704236052,0,47,regulation of protein import into nucleus,BP,
10668,GO:0042307,1,0.817633623126725,0,30,positive regulation of protein import into nucleus,BP,
10669,GO:0042308,1,0.939951173252032,0,10,negative regulation of protein import into nucleus,BP,
10670,GO:0042309,1,0.993848090587249,0,1,homoiothermy,BP,
10672,GO:0042311,1,0.840150831267965,0,28,vasodilation,BP,
10673,GO:0042313,1,0.994041144618094,0,1,protein kinase C deactivation,BP,
10674,GO:0042316,1,0.993186448387138,0,1,penicillin metabolic process,BP,
10675,GO:0042320,1,0.970889412450325,0,5,regulation of circadian sleep/wake cycle, REM sleep,BP,
10676,GO:0042321,1,0.970968850428305,0,5,negative regulation of circadian sleep/wake cycle, sleep,BP,
10677,GO:0042322,1,0.988750779094263,0,2,negative regulation of circadian sleep/wake cycle, REM sleep,BP,
10678,GO:0042323,1,0.988065551576397,0,2,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
10682,GO:0042328,1,0.972795187828978,0,4,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
10684,GO:0042335,1,0.979986109523773,0,3,cuticle development,BP,
10685,GO:0042339,1,0.821144942720957,0,31,keratan sulfate metabolic process,BP,
10686,GO:0042340,1,0.931921888007897,0,11,keratan sulfate catabolic process,BP,
10687,GO:0042350,1,0.982040228894939,0,3,GDP-L-fucose biosynthetic process,BP,
10688,GO:0042351,1,0.98844870459532,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
10689,GO:0042352,1,0.99351739929584,0,1,GDP-L-fucose salvage,BP,
10690,GO:0042354,1,0.947617573234456,0,8,L-fucose metabolic process,BP,
10691,GO:0042355,1,0.947617573234456,0,8,L-fucose catabolic process,BP,
10692,GO:0042356,1,0.994252942319835,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
10693,GO:0042357,1,0.988128993916733,0,2,thiamine diphosphate metabolic process,BP,
10695,GO:0042360,1,0.982300310831386,0,3,vitamin E metabolic process,BP,
10696,GO:0042361,1,0.993726836278559,0,1,menaquinone catabolic process,BP,
10697,GO:0042362,1,0.929291976261745,0,12,fat-soluble vitamin biosynthetic process,BP,
10698,GO:0042363,1,0.963725916833701,0,6,fat-soluble vitamin catabolic process,BP,
10699,GO:0042364,1,0.944025037786322,0,9,water-soluble vitamin biosynthetic process,BP,
10700,GO:0042365,1,0.981862815923222,0,3,water-soluble vitamin catabolic process,BP,
10701,GO:0042368,1,0.946609607071212,0,9,vitamin D biosynthetic process,BP,
10702,GO:0042369,1,0.987697369546547,0,2,vitamin D catabolic process,BP,
10703,GO:0042371,1,0.993595930235619,0,1,vitamin K biosynthetic process,BP,
10704,GO:0042373,1,0.970649838868113,0,5,vitamin K metabolic process,BP,
10705,GO:0042374,1,0.988088933403491,0,2,phylloquinone metabolic process,BP,
10706,GO:0042376,1,0.988088933403491,0,2,phylloquinone catabolic process,BP,
10707,GO:0042377,1,0.993726836278559,0,1,vitamin K catabolic process,BP,
10709,GO:0042382,1,0.962275872701386,0,6,paraspeckles,CC,
10712,GO:0042392,1,0.988030861436468,0,2,sphingosine-1-phosphate phosphatase activity,MF,
10713,GO:0042393,1,0.327801405481917,0,170,histone binding,MF,
10715,GO:0042401,1,0.887196524213256,0,20,cellular biogenic amine biosynthetic process,BP,
10716,GO:0042402,1,0.886309623806037,0,20,cellular biogenic amine catabolic process,BP,
10717,GO:0042403,1,0.895205325614896,0,17,thyroid hormone metabolic process,BP,
10718,GO:0042404,1,0.994041000326921,0,1,thyroid hormone catabolic process,BP,
10719,GO:0042405,1,0.924203182942561,0,11,nuclear inclusion body,CC,
10720,GO:0042406,1,0.976091146211536,0,4,extrinsic component of endoplasmic reticulum membrane,CC,
10721,GO:0042407,1,0.913357635631276,0,15,cristae formation,BP,
10722,GO:0042412,1,0.98808254714732,0,2,taurine biosynthetic process,BP,
10723,GO:0042413,1,0.993926850567635,0,1,carnitine catabolic process,BP,
10724,GO:0042414,1,0.980727589978332,0,3,epinephrine metabolic process,BP,
10725,GO:0042415,1,0.938352013054065,0,10,norepinephrine metabolic process,BP,
10728,GO:0042418,1,0.988442953879447,0,2,epinephrine biosynthetic process,BP,
10729,GO:0042420,1,0.957487015977891,0,7,dopamine catabolic process,BP,
10730,GO:0042421,1,0.963824012200492,0,6,norepinephrine biosynthetic process,BP,
10732,GO:0042424,1,0.951515271538319,0,8,catecholamine catabolic process,BP,
10733,GO:0042426,1,0.962521345187414,0,6,choline catabolic process,BP,
10734,GO:0042427,1,0.9822532805186,0,3,serotonin biosynthetic process,BP,
10735,GO:0042428,1,0.934618256313721,0,10,serotonin metabolic process,BP,
10736,GO:0042430,1,0.885814997954089,0,19,indole-containing compound metabolic process,BP,
10737,GO:0042435,1,0.976577396181416,0,4,indole-containing compound biosynthetic process,BP,
10738,GO:0042436,1,0.958938004693819,0,7,indole-containing compound catabolic process,BP,
10739,GO:0042438,1,0.906099209850422,0,15,melanin biosynthetic process,BP,
10740,GO:0042439,1,0.963138166109675,0,6,ethanolamine-containing compound metabolic process,BP,
10741,GO:0042440,1,0.694271525260394,0,58,pigment metabolic process,BP,
10742,GO:0042441,1,0.98126895710978,0,3,eye pigment metabolic process,BP,
10744,GO:0042446,1,0.65834309988499,0,67,hormone biosynthetic process,BP,
10745,GO:0042447,1,0.917569603904852,0,14,hormone catabolic process,BP,
10746,GO:0042448,1,0.923172836588437,0,13,progesterone metabolic process,BP,
10747,GO:0042450,1,0.988275583337683,0,2,arginine biosynthetic process via ornithine,BP,
10748,GO:0042451,1,0.882872988971305,0,21,purine nucleoside biosynthetic process,BP,
10749,GO:0042454,1,0.908399979795717,0,16,ribonucleoside catabolic process,BP,
10750,GO:0042455,1,0.80533635602543,0,36,ribonucleoside biosynthetic process,BP,
10751,GO:0042461,1,0.779574685596392,0,38,photoreceptor cell development,BP,
10752,GO:0042462,1,0.833734186971725,0,28,eye photoreceptor cell development,BP,
10753,GO:0042470,1,0.529485742910512,0,101,melanosome,CC,
10754,GO:0042471,1,0.498310674535067,0,108,ear morphogenesis,BP,
10755,GO:0042472,1,0.561009790699914,0,89,inner ear morphogenesis,BP,
10756,GO:0042473,1,0.945175744728777,0,9,outer ear morphogenesis,BP,
10757,GO:0042474,1,0.89043215837616,0,19,middle ear morphogenesis,BP,
10758,GO:0042475,1,0.627797043800202,0,71,odontogenesis of dentin-containing tooth,BP,
10759,GO:0042476,1,0.504551075184844,0,105,odontogenesis,BP,
10760,GO:0042481,1,0.88386131424908,0,20,regulation of odontogenesis,BP,
10761,GO:0042482,1,0.958212227441971,0,7,positive regulation of odontogenesis,BP,
10762,GO:0042483,1,0.974695756857142,0,4,negative regulation of odontogenesis,BP,
10763,GO:0042487,1,0.946214526586169,0,9,regulation of odontogenesis of dentin-containing tooth,BP,
10764,GO:0042488,1,0.993945565455181,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
10765,GO:0042489,1,0.987746120690339,0,2,negative regulation of odontogenesis of dentin-containing tooth,BP,
10766,GO:0042490,1,0.705350773404557,0,53,mechanoreceptor differentiation,BP,
10767,GO:0042491,1,0.827614873427089,0,29,inner ear auditory receptor cell differentiation,BP,
10768,GO:0042492,1,0.961392208170295,0,6,gamma-delta T cell differentiation,BP,
10770,GO:0042494,1,0.966560665766302,0,5,detection of bacterial lipoprotein,BP,
10771,GO:0042495,1,0.987531704359857,0,2,detection of triacyl bacterial lipopeptide,BP,
10772,GO:0042496,1,0.986668218104898,0,2,detection of diacyl bacterial lipopeptide,BP,
10773,GO:0042497,1,0.993667859160363,0,1,triacyl lipopeptide binding,MF,
10774,GO:0042500,1,0.962877165614746,0,6,aspartic endopeptidase activity, intramembrane cleaving,MF,
10775,GO:0042501,1,0.956931018341729,0,7,serine phosphorylation of STAT protein,BP,
10776,GO:0042509,1,0.70542130543612,0,56,regulation of tyrosine phosphorylation of STAT protein,BP,
10777,GO:0042531,1,0.741206804862911,0,48,positive regulation of tyrosine phosphorylation of STAT protein,BP,
10778,GO:0042532,1,0.938618418631072,0,10,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10779,GO:0042533,1,0.893615153321768,0,18,tumor necrosis factor biosynthetic process,BP,
10780,GO:0042534,1,0.893615153321768,0,18,regulation of tumor necrosis factor biosynthetic process,BP,
10781,GO:0042535,1,0.932321077453782,0,11,positive regulation of tumor necrosis factor biosynthetic process,BP,
10782,GO:0042536,1,0.970638157631006,0,5,negative regulation of tumor necrosis factor biosynthetic process,BP,
10783,GO:0042537,1,0.89800827720102,0,18,benzene-containing compound metabolic process,BP,
10784,GO:0042538,1,0.957740796008718,0,7,hyperosmotic salinity response,BP,
10785,GO:0042539,1,0.986270282982521,0,2,hypotonic salinity response,BP,
10786,GO:0042541,1,0.946772630708199,0,9,hemoglobin biosynthetic process,BP,
10788,GO:0042543,1,0.994489169339282,0,1,protein N-linked glycosylation via arginine,BP,
10789,GO:0042546,1,0.994134543005102,0,1,cell wall biogenesis,BP,
10792,GO:0042554,1,0.857154520903977,0,25,superoxide anion generation,BP,
10793,GO:0042555,1,0.933469884837476,0,11,MCM complex,CC,
10795,GO:0042559,1,0.919441810345821,0,14,pteridine-containing compound biosynthetic process,BP,
10796,GO:0042560,1,0.974153860812295,0,4,pteridine-containing compound catabolic process,BP,
10797,GO:0042562,1,0.592844172726314,0,83,hormone binding,MF,
10798,GO:0042564,1,0.993393731406682,0,1,NLS-dependent protein nuclear import complex,CC,
10799,GO:0042565,1,0.987472749819839,0,2,RNA nuclear export complex,CC,
10800,GO:0042567,1,0.973606967115204,0,4,insulin-like growth factor ternary complex,CC,
10801,GO:0042568,1,0.994368165679189,0,1,insulin-like growth factor binary complex,CC,
10802,GO:0042571,1,0.988285149329887,0,2,immunoglobulin complex, circulating,CC,
10803,GO:0042572,1,0.84699703743005,0,27,retinol metabolic process,BP,
10804,GO:0042573,1,0.90091217540623,0,17,retinoic acid metabolic process,BP,
10805,GO:0042574,1,0.922069016979541,0,13,retinal metabolic process,BP,
10806,GO:0042575,1,0.902295499012667,0,16,DNA polymerase complex,CC,
10807,GO:0042577,1,0.987765204966236,0,2,lipid phosphatase activity,MF,
10810,GO:0042581,1,0.378797931168639,0,154,specific granule,CC,
10812,GO:0042583,1,0.948957851906614,0,8,chromaffin granule,CC,
10813,GO:0042584,1,0.960567565596851,0,6,chromaffin granule membrane,CC,
10814,GO:0042585,1,0.994001188771455,0,1,germinal vesicle,CC,
10815,GO:0042586,1,0.994313297101646,0,1,peptide deformylase activity,MF,
10816,GO:0042587,1,0.967730590195617,0,5,glycogen granule,CC,
10817,GO:0042588,1,0.926633995684297,0,12,zymogen granule,CC,
10818,GO:0042589,1,0.938438561224947,0,10,zymogen granule membrane,CC,
10819,GO:0042590,1,0.651405560919418,0,72,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,
10822,GO:0042594,1,0.354347741245313,0,162,response to starvation,BP,
10823,GO:0042595,1,0.987959491315713,0,2,behavioral response to starvation,BP,
10825,GO:0042599,1,0.905862444660661,0,16,lamellar body,CC,
10826,GO:0042602,1,0.994399643330413,0,1,riboflavin reductase (NADPH) activity,MF,
10827,GO:0042605,1,0.880780913348655,0,21,peptide antigen binding,MF,
10828,GO:0042608,1,0.958309691158316,0,7,T cell receptor binding,MF,
10829,GO:0042609,1,0.957302625857969,0,7,CD4 receptor binding,MF,
10830,GO:0042610,1,0.988118154475035,0,2,CD8 receptor binding,MF,
10831,GO:0042611,1,0.880361935260212,0,22,MHC protein complex,CC,
10832,GO:0042612,1,0.954783871581009,0,8,MHC class I protein complex,CC,
10833,GO:0042613,1,0.922088987551154,0,14,MHC class II protein complex,CC,
10834,GO:0042622,1,0.91963828351109,0,13,photoreceptor outer segment membrane,CC,
10836,GO:0042624,1,0.99444816014447,0,1,ATPase activity, uncoupled,MF,
10837,GO:0042625,1,0.709385091740385,0,53,ATPase coupled ion transmembrane transporter activity,MF,
10838,GO:0042626,1,0.523676109791822,0,97,ATPase activity, coupled to transmembrane movement of substances,MF,
10839,GO:0042627,1,0.945277066667587,0,9,chylomicron,CC,
10840,GO:0042628,1,0.993993835481293,0,1,mating plug formation,BP,
10841,GO:0042629,1,0.875477118940481,0,21,mast cell granule,CC,
10842,GO:0042631,1,0.98711103664641,0,2,cellular response to water deprivation,BP,
10843,GO:0042632,1,0.715233375477166,0,53,cholesterol homeostasis,BP,
10846,GO:0042635,1,0.928072003419151,0,12,positive regulation of hair cycle,BP,
10847,GO:0042636,1,0.974057724048756,0,4,negative regulation of hair cycle,BP,
10848,GO:0042637,1,0.97522899682106,0,4,catagen,BP,
10849,GO:0042640,1,0.96779111146716,0,5,anagen,BP,
10850,GO:0042641,1,0.649457519952751,0,64,actomyosin,CC,
10851,GO:0042643,1,0.987421110663228,0,2,actomyosin, actin portion,CC,
10852,GO:0042645,1,0.77275710480015,0,41,mitochondrial nucleoid,CC,
10853,GO:0042658,1,0.994267670005535,0,1,MHC class II protein binding, via antigen binding groove,MF,
10854,GO:0042659,1,0.932261573024671,0,11,regulation of cell fate specification,BP,
10855,GO:0042660,1,0.992697245356871,0,1,positive regulation of cell fate specification,BP,
10856,GO:0042661,1,0.963664834774403,0,6,regulation of mesodermal cell fate specification,BP,
10857,GO:0042662,1,0.976685619555293,0,4,negative regulation of mesodermal cell fate specification,BP,
10858,GO:0042663,1,0.982438955584245,0,3,regulation of endodermal cell fate specification,BP,
10859,GO:0042664,1,0.994312719541451,0,1,negative regulation of endodermal cell fate specification,BP,
10860,GO:0042665,1,0.9935396833748,0,1,regulation of ectodermal cell fate specification,BP,
10861,GO:0042666,1,0.9935396833748,0,1,negative regulation of ectodermal cell fate specification,BP,
10862,GO:0042668,1,0.988530824920682,0,2,auditory receptor cell fate determination,BP,
10863,GO:0042670,1,0.950833669040464,0,8,retinal cone cell differentiation,BP,
10865,GO:0042693,1,0.928885944035516,0,12,muscle cell fate commitment,BP,
10866,GO:0042695,1,0.968204254086112,0,5,thelarche,BP,
10867,GO:0042698,1,0.680366190592943,0,60,ovulation cycle,BP,
10868,GO:0042699,1,0.988142561927884,0,2,follicle-stimulating hormone signaling pathway,BP,
10869,GO:0042700,1,0.993315933667812,0,1,luteinizing hormone signaling pathway,BP,
10870,GO:0042701,1,0.9753428495149,0,4,progesterone secretion,BP,
10871,GO:0042704,1,0.986923215580246,0,2,uterine wall breakdown,BP,
10872,GO:0042709,1,0.993966595443765,0,1,succinate-CoA ligase complex,CC,
10873,GO:0042710,1,0.993961985134131,0,1,biofilm formation,BP,
10874,GO:0042711,1,0.925974373869035,0,12,maternal behavior,BP,
10875,GO:0042713,1,0.967461016372262,0,5,sperm ejaculation,BP,
10876,GO:0042719,1,0.971413041289544,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10877,GO:0042720,1,0.988656585627452,0,2,mitochondrial inner membrane peptidase complex,CC,
10878,GO:0042721,1,0.97093902700834,0,5,mitochondrial inner membrane protein insertion complex,CC,
10879,GO:0042723,1,0.957998669524778,0,7,thiamine-containing compound metabolic process,BP,
10880,GO:0042726,1,0.950783596474767,0,8,flavin-containing compound metabolic process,BP,
10881,GO:0042727,1,0.987979079437266,0,2,flavin-containing compound biosynthetic process,BP,
10882,GO:0042728,1,0.993532827811427,0,1,flavin-containing compound catabolic process,BP,
10883,GO:0042730,1,0.879486921268389,0,21,fibrinolysis,BP,
10884,GO:0042731,1,0.974814430453491,0,4,PH domain binding,MF,
10885,GO:0042732,1,0.982426159238553,0,3,D-xylose metabolic process,BP,
10886,GO:0042733,1,0.675558293950125,0,60,embryonic digit morphogenesis,BP,
10888,GO:0042737,1,0.496439462696486,0,115,drug catabolic process,BP,
10889,GO:0042738,1,0.911917702302805,0,15,exogenous drug catabolic process,BP,
10890,GO:0042742,1,0.392252122417228,0,153,defense response to bacterium,BP,
10891,GO:0042743,1,0.78438464402789,0,40,hydrogen peroxide metabolic process,BP,
10892,GO:0042744,1,0.880279382197701,0,21,hydrogen peroxide catabolic process,BP,
10894,GO:0042746,1,0.97615672773593,0,4,circadian sleep/wake cycle, wakefulness,BP,
10895,GO:0042747,1,0.953793309060133,0,8,circadian sleep/wake cycle, REM sleep,BP,
10896,GO:0042748,1,0.950593072663146,0,8,circadian sleep/wake cycle, non-REM sleep,BP,
10899,GO:0042753,1,0.903898743868823,0,16,positive regulation of circadian rhythm,BP,
10900,GO:0042754,1,0.921514871525909,0,13,negative regulation of circadian rhythm,BP,
10902,GO:0042756,1,0.952492907529377,0,8,drinking behavior,BP,
10903,GO:0042758,1,0.95235249562713,0,8,long-chain fatty acid catabolic process,BP,
10905,GO:0042760,1,0.957146729459575,0,7,very long-chain fatty acid catabolic process,BP,
10906,GO:0042761,1,0.928447532556865,0,12,very long-chain fatty acid biosynthetic process,BP,
10907,GO:0042762,1,0.894984401545787,0,17,regulation of sulfur metabolic process,BP,
10908,GO:0042765,1,0.969668161943458,0,5,GPI-anchor transamidase complex,CC,
10909,GO:0042766,1,0.992262180790202,0,1,nucleosome mobilization,BP,
10910,GO:0042769,1,0.796451646939277,0,37,DNA damage response, detection of DNA damage,BP,
10911,GO:0042770,1,0.4416969799983,0,127,signal transduction in response to DNA damage,BP,
10912,GO:0042771,1,0.767259532151162,0,42,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
10913,GO:0042772,1,0.877997295065445,0,20,DNA damage response, signal transduction resulting in transcription,BP,
10914,GO:0042773,1,0.623771473216068,0,81,ATP synthesis coupled electron transport,BP,
10915,GO:0042774,1,0.993846081630578,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10916,GO:0042775,1,0.627652346145425,0,80,mitochondrial ATP synthesis coupled electron transport,BP,
10917,GO:0042776,1,0.977510965378525,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
10918,GO:0042779,1,0.987588615648171,0,2,tRNA 3'-trailer cleavage,BP,
10919,GO:0042780,1,0.958442083036803,0,7,tRNA 3'-end processing,BP,
10920,GO:0042781,1,0.987588615648171,0,2,3'-tRNA processing endoribonuclease activity,MF,
10921,GO:0042788,1,0.837847538219293,0,30,polysomal ribosome,CC,
10922,GO:0042789,1,0.885058157341963,0,19,mRNA transcription by RNA polymerase II,BP,
10923,GO:0042790,1,0.926826392212634,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10924,GO:0042791,1,0.962362778875166,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10925,GO:0042795,1,0.662157035075264,0,66,snRNA transcription by RNA polymerase II,BP,
10926,GO:0042796,1,0.963118949205034,0,6,snRNA transcription by RNA polymerase III,BP,
10927,GO:0042797,1,0.962362778875166,0,6,tRNA transcription by RNA polymerase III,BP,
10928,GO:0042799,1,0.991001900003745,0,1,histone methyltransferase activity (H4-K20 specific),MF,
10929,GO:0042800,1,0.901496091354426,0,16,histone methyltransferase activity (H3-K4 specific),MF,
10933,GO:0042806,1,0.97611057895831,0,4,fucose binding,MF,
10934,GO:0042809,1,0.9050899670054,0,15,vitamin D receptor binding,MF,
10935,GO:0042813,1,0.865255196367253,0,22,Wnt-activated receptor activity,MF,
10936,GO:0042816,1,0.967906358154979,0,5,vitamin B6 metabolic process,BP,
10937,GO:0042819,1,0.980330966567053,0,3,vitamin B6 biosynthetic process,BP,
10938,GO:0042820,1,0.99406870912543,0,1,vitamin B6 catabolic process,BP,
10939,GO:0042822,1,0.980364701422964,0,3,pyridoxal phosphate metabolic process,BP,
10940,GO:0042823,1,0.986215055882738,0,2,pyridoxal phosphate biosynthetic process,BP,
10941,GO:0042824,1,0.975244002866901,0,4,MHC class I peptide loading complex,CC,
10942,GO:0042825,1,0.981039319600945,0,3,TAP complex,CC,
10944,GO:0042827,1,0.894036295049526,0,18,platelet dense granule,CC,
10945,GO:0042832,1,0.889931930411608,0,19,defense response to protozoan,BP,
10946,GO:0042834,1,0.946003793927492,0,9,peptidoglycan binding,MF,
10947,GO:0042835,1,0.986815461140313,0,2,BRE binding,MF,
10948,GO:0042839,1,0.994221032359422,0,1,D-glucuronate metabolic process,BP,
10949,GO:0042840,1,0.994221032359422,0,1,D-glucuronate catabolic process,BP,
10950,GO:0042843,1,0.994334089315175,0,1,D-xylose catabolic process,BP,
10951,GO:0042851,1,0.981911849818124,0,3,L-alanine metabolic process,BP,
10952,GO:0042853,1,0.981911849818124,0,3,L-alanine catabolic process,BP,
10953,GO:0042866,1,0.537777424444443,0,96,pyruvate biosynthetic process,BP,
10954,GO:0042883,1,0.99357337879569,0,1,cysteine transport,BP,
10956,GO:0042887,1,0.801200093109405,0,36,amide transmembrane transporter activity,MF,
10957,GO:0042891,1,0.950797258229185,0,8,antibiotic transport,BP,
10958,GO:0042895,1,0.963388905989706,0,6,antibiotic transmembrane transporter activity,MF,
10959,GO:0042903,1,0.987583652583397,0,2,tubulin deacetylase activity,MF,
10960,GO:0042904,1,0.975869767377888,0,4,9-cis-retinoic acid biosynthetic process,BP,
10961,GO:0042905,1,0.975869767377888,0,4,9-cis-retinoic acid metabolic process,BP,
10962,GO:0042908,1,0.940893651213317,0,9,xenobiotic transport,BP,
10963,GO:0042910,1,0.947141132952327,0,8,xenobiotic transmembrane transporter activity,MF,
10964,GO:0042921,1,0.905199317545657,0,15,glucocorticoid receptor signaling pathway,BP,
10965,GO:0042922,1,0.994411772435139,0,1,neuromedin U receptor binding,MF,
10966,GO:0042923,1,0.891499684289412,0,19,neuropeptide binding,MF,
10967,GO:0042924,1,0.987792298734974,0,2,neuromedin U binding,MF,
10968,GO:0042930,1,0.993846081630578,0,1,enterobactin transport,BP,
10969,GO:0042931,1,0.993846081630578,0,1,enterobactin transmembrane transporter activity,MF,
10970,GO:0042937,1,0.992802204087989,0,1,tripeptide transmembrane transporter activity,MF,
10971,GO:0042938,1,0.988080898559558,0,2,dipeptide transport,BP,
10972,GO:0042939,1,0.986912599467702,0,2,tripeptide transport,BP,
10973,GO:0042940,1,0.96044571740977,0,6,D-amino acid transport,BP,
10974,GO:0042941,1,0.994083144067623,0,1,D-alanine transport,BP,
10975,GO:0042942,1,0.988020392641891,0,2,D-serine transport,BP,
10976,GO:0042946,1,0.993846081630578,0,1,glucoside transport,BP,
10977,GO:0042947,1,0.993846081630578,0,1,glucoside transmembrane transporter activity,MF,
10980,GO:0042974,1,0.854928096395848,0,24,retinoic acid receptor binding,MF,
10981,GO:0042975,1,0.928177202967589,0,11,peroxisome proliferator activated receptor binding,MF,
10982,GO:0042976,1,0.94301913634063,0,9,activation of Janus kinase activity,BP,
10983,GO:0042978,1,0.978651214493449,0,3,ornithine decarboxylase activator activity,MF,
10984,GO:0042979,1,0.961915656069858,0,6,ornithine decarboxylase regulator activity,MF,
10989,GO:0042985,1,0.969196618462757,0,5,negative regulation of amyloid precursor protein biosynthetic process,BP,
10990,GO:0042986,1,0.987786957394233,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
10991,GO:0042987,1,0.812506991449887,0,32,amyloid precursor protein catabolic process,BP,
10992,GO:0042988,1,0.993154317244616,0,1,X11-like protein binding,MF,
10993,GO:0042989,1,0.943555249299679,0,10,sequestering of actin monomers,BP,
10994,GO:0042994,1,0.892740383980178,0,18,cytoplasmic sequestering of transcription factor,BP,
10996,GO:0042996,1,0.962603731995491,0,6,regulation of Golgi to plasma membrane protein transport,BP,
10997,GO:0042997,1,0.975311637049141,0,4,negative regulation of Golgi to plasma membrane protein transport,BP,
10998,GO:0042998,1,0.98697371733672,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
10999,GO:0042999,1,0.993326133453127,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
11000,GO:0043000,1,0.987593661930464,0,2,Golgi to plasma membrane CFTR protein transport,BP,
11001,GO:0043001,1,0.817054590878727,0,31,Golgi to plasma membrane protein transport,BP,
11002,GO:0043002,1,0.993326133453127,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
11003,GO:0043004,1,0.993326133453127,0,1,cytoplasmic sequestering of CFTR protein,BP,
11005,GO:0043006,1,0.987994262127697,0,2,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
11006,GO:0043008,1,0.951914989126179,0,8,ATP-dependent protein binding,MF,
11009,GO:0043011,1,0.912554166765018,0,15,myeloid dendritic cell differentiation,BP,
11010,GO:0043012,1,0.993898079935285,0,1,regulation of fusion of sperm to egg plasma membrane,BP,
11011,GO:0043014,1,0.840652752603056,0,27,alpha-tubulin binding,MF,
11012,GO:0043015,1,0.846264836144887,0,26,gamma-tubulin binding,MF,
11013,GO:0043016,1,0.993863163183324,0,1,regulation of lymphotoxin A biosynthetic process,BP,
11014,GO:0043017,1,0.993863163183324,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
11015,GO:0043020,1,0.94745455052066,0,9,NADPH oxidase complex,CC,
11017,GO:0043022,1,0.740833552972085,0,47,ribosome binding,MF,
11018,GO:0043023,1,0.933867006904474,0,11,ribosomal large subunit binding,MF,
11019,GO:0043024,1,0.915378200971974,0,14,ribosomal small subunit binding,MF,
11021,GO:0043027,1,0.864999084209832,0,23,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,
11022,GO:0043028,1,0.786452251336407,0,38,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,
11023,GO:0043029,1,0.792804761908053,0,37,T cell homeostasis,BP,
11024,GO:0043030,1,0.792160276630902,0,36,regulation of macrophage activation,BP,
11025,GO:0043031,1,0.952758979478027,0,8,negative regulation of macrophage activation,BP,
11026,GO:0043032,1,0.874764620500835,0,21,positive regulation of macrophage activation,BP,
11027,GO:0043033,1,0.992570521872392,0,1,isoamylase complex,CC,
11028,GO:0043034,1,0.871496128557864,0,19,costamere,CC,
11029,GO:0043035,1,0.993555105371205,0,1,chromatin insulator sequence binding,MF,
11030,GO:0043038,1,0.721715306870782,0,53,amino acid activation,BP,
11031,GO:0043039,1,0.726365305823319,0,52,tRNA aminoacylation,BP,
11032,GO:0043041,1,0.99361904956048,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
11034,GO:0043044,1,0.675052534637808,0,62,ATP-dependent chromatin remodeling,BP,
11035,GO:0043045,1,0.960658423537353,0,6,DNA methylation involved in embryo development,BP,
11036,GO:0043046,1,0.898375668232097,0,17,DNA methylation involved in gamete generation,BP,
11037,GO:0043047,1,0.933113450265079,0,11,single-stranded telomeric DNA binding,MF,
11038,GO:0043048,1,0.994011860158488,0,1,dolichyl monophosphate biosynthetic process,BP,
11039,GO:0043049,1,0.993761857850181,0,1,otic placode formation,BP,
11040,GO:0043060,1,0.993934047371008,0,1,meiotic metaphase I plate congression,BP,
11042,GO:0043063,1,0.993239289663792,0,1,intercellular bridge organization,BP,
11049,GO:0043083,1,0.941107221061528,0,9,synaptic cleft,CC,
11050,GO:0043084,1,0.955202635891825,0,7,penile erection,BP,
11055,GO:0043094,1,0.813388340275473,0,34,cellular metabolic compound salvage,BP,
11056,GO:0043095,1,0.994441517896023,0,1,regulation of GTP cyclohydrolase I activity,BP,
11057,GO:0043096,1,0.971202555815802,0,5,purine nucleobase salvage,BP,
11058,GO:0043097,1,0.936145711498355,0,11,pyrimidine nucleoside salvage,BP,
11059,GO:0043101,1,0.918825889649555,0,14,purine-containing compound salvage,BP,
11060,GO:0043102,1,0.958248428186903,0,7,amino acid salvage,BP,
11061,GO:0043103,1,0.982447925374247,0,3,hypoxanthine salvage,BP,
11062,GO:0043105,1,0.994441517896023,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
11063,GO:0043111,1,0.987477316962678,0,2,replication fork arrest,BP,
11065,GO:0043113,1,0.723007676339612,0,49,receptor clustering,BP,
11066,GO:0043114,1,0.825183353339827,0,30,regulation of vascular permeability,BP,
11067,GO:0043116,1,0.93226635618152,0,11,negative regulation of vascular permeability,BP,
11068,GO:0043117,1,0.940442703052759,0,10,positive regulation of vascular permeability,BP,
11069,GO:0043120,1,0.970123121873232,0,5,tumor necrosis factor binding,MF,
11070,GO:0043121,1,0.93601837404019,0,10,neurotrophin binding,MF,
11073,GO:0043124,1,0.774814394643224,0,39,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
11074,GO:0043125,1,0.974771771536007,0,4,ErbB-3 class receptor binding,MF,
11075,GO:0043126,1,0.994213668521084,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11076,GO:0043128,1,0.994213668521084,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11077,GO:0043129,1,0.950311649406955,0,8,surfactant homeostasis,BP,
11079,GO:0043131,1,0.993164260904423,0,1,erythrocyte enucleation,BP,
11080,GO:0043132,1,0.987770743632168,0,2,NAD transport,BP,
11081,GO:0043136,1,0.99374355674937,0,1,glycerol-3-phosphatase activity,MF,
11082,GO:0043137,1,0.976077417398999,0,4,DNA replication, removal of RNA primer,BP,
11083,GO:0043138,1,0.925532286072473,0,12,3'-5' DNA helicase activity,MF,
11084,GO:0043139,1,0.957586125936206,0,7,5'-3' DNA helicase activity,MF,
11085,GO:0043140,1,0.954314542369221,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
11086,GO:0043141,1,0.969776161433067,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
11087,GO:0043142,1,0.920624815436964,0,13,single-stranded DNA-dependent ATPase activity,MF,
11088,GO:0043144,1,0.954638490466221,0,8,snoRNA processing,BP,
11090,GO:0043152,1,0.975491765084066,0,4,induction of bacterial agglutination,BP,
11091,GO:0043153,1,0.874908238870795,0,21,entrainment of circadian clock by photoperiod,BP,
11092,GO:0043154,1,0.582209534445303,0,86,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
11093,GO:0043159,1,0.987901748478835,0,2,acrosomal matrix,CC,
11095,GO:0043162,1,0.893417560988825,0,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11096,GO:0043163,1,0.987752767983103,0,2,cell envelope organization,BP,
11101,GO:0043171,1,0.852849495345904,0,25,peptide catabolic process,BP,
11102,GO:0043173,1,0.913679904675151,0,15,nucleotide salvage,BP,
11103,GO:0043174,1,0.9084159164754,0,16,nucleoside salvage,BP,
11104,GO:0043175,1,0.799609746200241,0,35,RNA polymerase core enzyme binding,MF,
11105,GO:0043176,1,0.934877080306907,0,11,amine binding,MF,
11108,GO:0043179,1,0.994041144618094,0,1,rhythmic excitation,BP,
11109,GO:0043181,1,0.993608774512361,0,1,vacuolar sequestering,BP,
11110,GO:0043183,1,0.987992360404529,0,2,vascular endothelial growth factor receptor 1 binding,MF,
11112,GO:0043185,1,0.99404590638951,0,1,vascular endothelial growth factor receptor 3 binding,MF,
11113,GO:0043186,1,0.915207777149309,0,14,P granule,CC,
11114,GO:0043189,1,0.892226151250371,0,18,H4/H2A histone acetyltransferase complex,CC,
11115,GO:0043190,1,0.954381695060968,0,7,ATP-binding cassette (ABC) transporter complex,CC,
11118,GO:0043196,1,0.958101811956399,0,7,varicosity,CC,
11121,GO:0043199,1,0.974363966113696,0,4,sulfate binding,MF,
11122,GO:0043200,1,0.508534708522985,0,105,response to amino acid,BP,
11123,GO:0043201,1,0.921085739985163,0,12,response to leucine,BP,
11124,GO:0043202,1,0.572908498738572,0,87,lysosomal lumen,CC,
11127,GO:0043207,1,0.012447612811825,0,690,response to external biotic stimulus,BP,
11130,GO:0043210,1,0.994123569405883,0,1,alkanesulfonate binding,MF,
11131,GO:0043215,1,0.993498820562144,0,1,daunorubicin transport,BP,
11134,GO:0043219,1,0.974873330981648,0,4,lateral loop,CC,
11136,GO:0043221,1,0.993534256127888,0,1,SMC family protein binding,MF,
11137,GO:0043224,1,0.988715588042792,0,2,nuclear SCF ubiquitin ligase complex,CC,
11138,GO:0043225,1,0.922169155931896,0,12,ATPase-coupled anion transmembrane transporter activity,MF,
11148,GO:0043236,1,0.843586851313534,0,26,laminin binding,MF,
11149,GO:0043237,1,0.967399878377698,0,5,laminin-1 binding,MF,
11150,GO:0043240,1,0.944728143799077,0,9,Fanconi anaemia nuclear complex,CC,
11151,GO:0043242,1,0.661241486917746,0,62,negative regulation of protein complex disassembly,BP,
11152,GO:0043243,1,0.814681956005569,0,31,positive regulation of protein complex disassembly,BP,
11153,GO:0043244,1,0.518222827809972,0,98,regulation of protein complex disassembly,BP,
11154,GO:0043247,1,0.919545231183857,0,13,telomere maintenance in response to DNA damage,BP,
11155,GO:0043248,1,0.932389370113015,0,12,proteasome assembly,BP,
11156,GO:0043249,1,0.922886466882078,0,13,erythrocyte maturation,BP,
11157,GO:0043250,1,0.994212802187016,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
11158,GO:0043251,1,0.994212802187016,0,1,sodium-dependent organic anion transport,BP,
11159,GO:0043252,1,0.843174176795115,0,27,sodium-independent organic anion transport,BP,
11161,GO:0043255,1,0.643214131643004,0,67,regulation of carbohydrate biosynthetic process,BP,
11162,GO:0043256,1,0.942005611386465,0,8,laminin complex,CC,
11163,GO:0043257,1,0.992956497442959,0,1,laminin-8 complex,CC,
11164,GO:0043259,1,0.976827987791197,0,3,laminin-10 complex,CC,
11165,GO:0043260,1,0.976839638509734,0,3,laminin-11 complex,CC,
11166,GO:0043262,1,0.98170292904489,0,3,adenosine-diphosphatase activity,MF,
11167,GO:0043265,1,0.993741269770033,0,1,ectoplasm,CC,
11168,GO:0043266,1,0.582439218494327,0,83,regulation of potassium ion transport,BP,
11169,GO:0043267,1,0.851078431549968,0,25,negative regulation of potassium ion transport,BP,
11170,GO:0043268,1,0.772698385186742,0,39,positive regulation of potassium ion transport,BP,
11173,GO:0043271,1,0.468327166175626,0,119,negative regulation of ion transport,BP,
11174,GO:0043273,1,0.993091885232637,0,1,CTPase activity,MF,
11175,GO:0043274,1,0.919167159528583,0,13,phospholipase binding,MF,
11176,GO:0043276,1,0.827826682780388,0,29,anoikis,BP,
11177,GO:0043277,1,0.767827439311657,0,41,apoptotic cell clearance,BP,
11182,GO:0043291,1,0.983057644561897,0,2,RAVE complex,CC,
11184,GO:0043293,1,0.986789620473928,0,2,apoptosome,CC,
11185,GO:0043295,1,0.936528854758263,0,11,glutathione binding,MF,
11187,GO:0043297,1,0.69093235155096,0,57,apical junction assembly,BP,
11189,GO:0043300,1,0.774006782974635,0,41,regulation of leukocyte degranulation,BP,
11190,GO:0043301,1,0.933929992543825,0,11,negative regulation of leukocyte degranulation,BP,
11191,GO:0043302,1,0.882907106824708,0,20,positive regulation of leukocyte degranulation,BP,
11192,GO:0043303,1,0.767821333459796,0,42,mast cell degranulation,BP,
11193,GO:0043304,1,0.846700331873375,0,27,regulation of mast cell degranulation,BP,
11194,GO:0043305,1,0.96484840609904,0,6,negative regulation of mast cell degranulation,BP,
11195,GO:0043306,1,0.92917355480223,0,12,positive regulation of mast cell degranulation,BP,
11196,GO:0043307,1,0.970463975556238,0,5,eosinophil activation,BP,
11197,GO:0043308,1,0.976223803839749,0,4,eosinophil degranulation,BP,
11198,GO:0043309,1,0.982093329575353,0,3,regulation of eosinophil degranulation,BP,
11199,GO:0043310,1,0.99392512357135,0,1,negative regulation of eosinophil degranulation,BP,
11200,GO:0043311,1,0.988096626000539,0,2,positive regulation of eosinophil degranulation,BP,
11202,GO:0043313,1,0.948687649217964,0,8,regulation of neutrophil degranulation,BP,
11203,GO:0043314,1,0.985848273233504,0,2,negative regulation of neutrophil degranulation,BP,
11204,GO:0043315,1,0.974732315530952,0,4,positive regulation of neutrophil degranulation,BP,
11205,GO:0043316,1,0.981778435565868,0,3,cytotoxic T cell degranulation,BP,
11206,GO:0043317,1,0.987866234775996,0,2,regulation of cytotoxic T cell degranulation,BP,
11207,GO:0043318,1,0.987866234775996,0,2,negative regulation of cytotoxic T cell degranulation,BP,
11208,GO:0043320,1,0.968379638333666,0,5,natural killer cell degranulation,BP,
11209,GO:0043321,1,0.98662841238285,0,2,regulation of natural killer cell degranulation,BP,
11210,GO:0043323,1,0.98662841238285,0,2,positive regulation of natural killer cell degranulation,BP,
11211,GO:0043324,1,0.98126895710978,0,3,pigment metabolic process involved in developmental pigmentation,BP,
11212,GO:0043325,1,0.878215340209448,0,20,phosphatidylinositol-3,4-bisphosphate binding,MF,
11213,GO:0043328,1,0.976560247580771,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11214,GO:0043330,1,0.838138577961245,0,28,response to exogenous dsRNA,BP,
11215,GO:0043331,1,0.604586633944171,0,78,response to dsRNA,BP,
11216,GO:0043335,1,0.987880933539332,0,2,protein unfolding,BP,
11217,GO:0043337,1,0.99355267808908,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
11218,GO:0043353,1,0.948887673233899,0,8,enucleate erythrocyte differentiation,BP,
11219,GO:0043354,1,0.993164260904423,0,1,enucleate erythrocyte maturation,BP,
11220,GO:0043363,1,0.993846081630578,0,1,nucleate erythrocyte differentiation,BP,
11221,GO:0043366,1,0.981491329985333,0,3,beta selection,BP,
11222,GO:0043367,1,0.69221619176334,0,58,CD4-positive, alpha-beta T cell differentiation,BP,
11223,GO:0043368,1,0.836629946840684,0,28,positive T cell selection,BP,
11224,GO:0043369,1,0.892391639613783,0,18,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
11225,GO:0043370,1,0.818341215572528,0,32,regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11226,GO:0043371,1,0.913640550720359,0,14,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11227,GO:0043372,1,0.879684238094757,0,21,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11228,GO:0043373,1,0.916284315774275,0,14,CD4-positive, alpha-beta T cell lineage commitment,BP,
11229,GO:0043374,1,0.944929666641676,0,9,CD8-positive, alpha-beta T cell differentiation,BP,
11230,GO:0043375,1,0.993539826189683,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
11231,GO:0043376,1,0.987166620851531,0,2,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11232,GO:0043378,1,0.993519399581866,0,1,positive regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11233,GO:0043379,1,0.962164190772142,0,6,memory T cell differentiation,BP,
11234,GO:0043380,1,0.969770722957554,0,5,regulation of memory T cell differentiation,BP,
11235,GO:0043382,1,0.975990256159779,0,4,positive regulation of memory T cell differentiation,BP,
11236,GO:0043383,1,0.932881222410029,0,11,negative T cell selection,BP,
11237,GO:0043385,1,0.993856415233832,0,1,mycotoxin metabolic process,BP,
11238,GO:0043387,1,0.993856415233832,0,1,mycotoxin catabolic process,BP,
11239,GO:0043388,1,0.723829327484899,0,51,positive regulation of DNA binding,BP,
11240,GO:0043392,1,0.722759013900446,0,51,negative regulation of DNA binding,BP,
11241,GO:0043393,1,0.281855333185658,0,196,regulation of protein binding,BP,
11242,GO:0043394,1,0.79069807560087,0,35,proteoglycan binding,MF,
11243,GO:0043395,1,0.879688910987271,0,19,heparan sulfate proteoglycan binding,MF,
11244,GO:0043396,1,0.987040761087342,0,2,corticotropin-releasing hormone secretion,BP,
11245,GO:0043397,1,0.987040761087342,0,2,regulation of corticotropin-releasing hormone secretion,BP,
11246,GO:0043398,1,0.981149054249401,0,3,HLH domain binding,MF,
11247,GO:0043400,1,0.970179142121313,0,5,cortisol secretion,BP,
11249,GO:0043402,1,0.977547694567326,0,3,glucocorticoid mediated signaling pathway,BP,
11250,GO:0043403,1,0.844630935382022,0,27,skeletal muscle tissue regeneration,BP,
11253,GO:0043407,1,0.655154409792395,0,67,negative regulation of MAP kinase activity,BP,
11255,GO:0043409,1,0.399174427999917,0,143,negative regulation of MAPK cascade,BP,
11258,GO:0043413,1,0.217795879829085,0,236,macromolecule glycosylation,BP,
11259,GO:0043414,1,0.195621792209831,0,253,macromolecule methylation,BP,
11260,GO:0043415,1,0.96939943025385,0,5,positive regulation of skeletal muscle tissue regeneration,BP,
11261,GO:0043416,1,0.96939943025385,0,5,regulation of skeletal muscle tissue regeneration,BP,
11262,GO:0043418,1,0.981652813005447,0,3,homocysteine catabolic process,BP,
11263,GO:0043420,1,0.994217567023989,0,1,anthranilate metabolic process,BP,
11264,GO:0043422,1,0.925826809468668,0,12,protein kinase B binding,MF,
11265,GO:0043423,1,0.993395738852918,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
11266,GO:0043425,1,0.855305067608713,0,24,bHLH transcription factor binding,MF,
11267,GO:0043426,1,0.96731848069044,0,5,MRF binding,MF,
11268,GO:0043433,1,0.382775891258743,0,150,negative regulation of DNA binding transcription factor activity,BP,
11270,GO:0043435,1,0.969094589760264,0,5,response to corticotropin-releasing hormone,BP,
11272,GO:0043438,1,0.99381654185483,0,1,acetoacetic acid metabolic process,BP,
11273,GO:0043449,1,0.987349940620179,0,2,cellular alkene metabolic process,BP,
11274,GO:0043455,1,0.930853831745466,0,11,regulation of secondary metabolic process,BP,
11275,GO:0043456,1,0.976999672609092,0,4,regulation of pentose-phosphate shunt,BP,
11276,GO:0043457,1,0.874959369485004,0,21,regulation of cellular respiration,BP,
11277,GO:0043461,1,0.976093011963927,0,4,proton-transporting ATP synthase complex assembly,BP,
11279,GO:0043467,1,0.491652932703969,0,108,regulation of generation of precursor metabolites and energy,BP,
11280,GO:0043470,1,0.636077085116182,0,69,regulation of carbohydrate catabolic process,BP,
11281,GO:0043471,1,0.946554700928825,0,9,regulation of cellular carbohydrate catabolic process,BP,
11283,GO:0043474,1,0.98126895710978,0,3,pigment metabolic process involved in pigmentation,BP,
11284,GO:0043476,1,0.924417389828234,0,12,pigment accumulation,BP,
11285,GO:0043482,1,0.924417389828234,0,12,cellular pigment accumulation,BP,
11286,GO:0043484,1,0.484981880134607,0,112,regulation of RNA splicing,BP,
11287,GO:0043485,1,0.939431298074293,0,10,endosome to pigment granule transport,BP,
11288,GO:0043486,1,0.782202198005801,0,40,histone exchange,BP,
11289,GO:0043487,1,0.369032009059537,0,157,regulation of RNA stability,BP,
11290,GO:0043488,1,0.38890217628375,0,149,regulation of mRNA stability,BP,
11291,GO:0043489,1,0.792315321273802,0,36,RNA stabilization,BP,
11292,GO:0043490,1,0.987257930720202,0,2,malate-aspartate shuttle,BP,
11294,GO:0043492,1,0.477017875712684,0,110,ATPase activity, coupled to movement of substances,MF,
11295,GO:0043495,1,0.936410850458805,0,10,protein membrane anchor,MF,
11296,GO:0043496,1,0.875881332930351,0,21,regulation of protein homodimerization activity,BP,
11297,GO:0043497,1,0.939499437867892,0,10,regulation of protein heterodimerization activity,BP,
11298,GO:0043500,1,0.58056417484446,0,84,muscle adaptation,BP,
11299,GO:0043501,1,0.872867269509093,0,21,skeletal muscle adaptation,BP,
11300,GO:0043502,1,0.637236662473926,0,68,regulation of muscle adaptation,BP,
11301,GO:0043503,1,0.9883757766551,0,2,skeletal muscle fiber adaptation,BP,
11302,GO:0043504,1,0.980836384037931,0,3,mitochondrial DNA repair,BP,
11303,GO:0043506,1,0.605093517850194,0,77,regulation of JUN kinase activity,BP,
11304,GO:0043507,1,0.655695441165329,0,64,positive regulation of JUN kinase activity,BP,
11305,GO:0043508,1,0.922120279297063,0,13,negative regulation of JUN kinase activity,BP,
11306,GO:0043509,1,0.994019937207677,0,1,activin A complex,CC,
11307,GO:0043511,1,0.988290822635306,0,2,inhibin complex,CC,
11308,GO:0043512,1,0.988290822635306,0,2,inhibin A complex,CC,
11309,GO:0043513,1,0.994236770754998,0,1,inhibin B complex,CC,
11310,GO:0043514,1,0.994231572753009,0,1,interleukin-12 complex,CC,
11311,GO:0043515,1,0.966903512799896,0,5,kinetochore binding,MF,
11312,GO:0043516,1,0.831822012892737,0,29,regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11313,GO:0043517,1,0.913036283739224,0,14,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11314,GO:0043518,1,0.91648780169276,0,14,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11315,GO:0043519,1,0.994038114565935,0,1,regulation of myosin II filament organization,BP,
11316,GO:0043522,1,0.945513316527323,0,9,leucine zipper domain binding,MF,
11319,GO:0043525,1,0.745179555177221,0,46,positive regulation of neuron apoptotic process,BP,
11320,GO:0043527,1,0.97057047002168,0,5,tRNA methyltransferase complex,CC,
11321,GO:0043531,1,0.806380274434244,0,33,ADP binding,MF,
11322,GO:0043532,1,0.992707946355192,0,1,angiostatin binding,MF,
11325,GO:0043535,1,0.602422597435301,0,78,regulation of blood vessel endothelial cell migration,BP,
11326,GO:0043536,1,0.732958806681701,0,48,positive regulation of blood vessel endothelial cell migration,BP,
11327,GO:0043537,1,0.828260651719519,0,29,negative regulation of blood vessel endothelial cell migration,BP,
11328,GO:0043538,1,0.993768151168476,0,1,regulation of actin phosphorylation,BP,
11329,GO:0043539,1,0.818843780936834,0,32,protein serine/threonine kinase activator activity,MF,
11330,GO:0043540,1,0.994143783991404,0,1,6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex,CC,
11331,GO:0043541,1,0.987383584714716,0,2,UDP-N-acetylglucosamine transferase complex,CC,
11334,GO:0043544,1,0.993613912060388,0,1,lipoamide binding,MF,
11335,GO:0043545,1,0.957804923536054,0,7,molybdopterin cofactor metabolic process,BP,
11336,GO:0043546,1,0.961909887743695,0,6,molybdopterin cofactor binding,MF,
11338,GO:0043548,1,0.832481111981269,0,27,phosphatidylinositol 3-kinase binding,MF,
11340,GO:0043550,1,0.737389566670994,0,47,regulation of lipid kinase activity,BP,
11341,GO:0043551,1,0.770579182317406,0,40,regulation of phosphatidylinositol 3-kinase activity,BP,
11342,GO:0043552,1,0.822627814735558,0,30,positive regulation of phosphatidylinositol 3-kinase activity,BP,
11343,GO:0043553,1,0.987341094909699,0,2,negative regulation of phosphatidylinositol 3-kinase activity,BP,
11344,GO:0043555,1,0.891335073762963,0,18,regulation of translation in response to stress,BP,
11345,GO:0043558,1,0.914945843683484,0,14,regulation of translational initiation in response to stress,BP,
11346,GO:0043559,1,0.963767049068568,0,5,insulin binding,MF,
11347,GO:0043560,1,0.927190086004761,0,11,insulin receptor substrate binding,MF,
11348,GO:0043562,1,0.936609815980278,0,11,cellular response to nitrogen levels,BP,
11349,GO:0043564,1,0.987720826092851,0,2,Ku70:Ku80 complex,CC,
11351,GO:0043567,1,0.890622558637231,0,18,regulation of insulin-like growth factor receptor signaling pathway,BP,
11352,GO:0043568,1,0.941964910974194,0,9,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
11353,GO:0043569,1,0.955131423314955,0,7,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
11354,GO:0043570,1,0.967800429630411,0,5,maintenance of DNA repeat elements,BP,
11356,GO:0043576,1,0.866683209725155,0,22,regulation of respiratory gaseous exchange,BP,
11357,GO:0043578,1,0.976333108185311,0,3,nuclear matrix organization,BP,
11359,GO:0043584,1,0.899287316639524,0,16,nose development,BP,
11360,GO:0043585,1,0.979250375736816,0,3,nose morphogenesis,BP,
11361,GO:0043586,1,0.882400357553628,0,19,tongue development,BP,
11362,GO:0043587,1,0.949792789949299,0,8,tongue morphogenesis,BP,
11364,GO:0043589,1,0.946948108461385,0,8,skin morphogenesis,BP,
11365,GO:0043596,1,0.772628186974533,0,41,nuclear replication fork,CC,
11366,GO:0043601,1,0.861372466317901,0,24,nuclear replisome,CC,
11367,GO:0043602,1,0.993922533251768,0,1,nitrate catabolic process,BP,
11370,GO:0043605,1,0.982501348504966,0,3,cellular amide catabolic process,BP,
11371,GO:0043606,1,0.975761716964562,0,4,formamide metabolic process,BP,
11372,GO:0043610,1,0.992116453925477,0,1,regulation of carbohydrate utilization,BP,
11373,GO:0043614,1,0.986609224642804,0,2,multi-eIF complex,CC,
11374,GO:0043615,1,0.958034409260269,0,7,astrocyte cell migration,BP,
11375,GO:0043616,1,0.799251441659272,0,34,keratinocyte proliferation,BP,
11376,GO:0043618,1,0.512566649739899,0,108,regulation of transcription from RNA polymerase II promoter in response to stress,BP,
11377,GO:0043619,1,0.931080394659694,0,11,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
11378,GO:0043620,1,0.495559166679395,0,113,regulation of DNA-templated transcription in response to stress,BP,
11380,GO:0043622,1,0.973966770420518,0,4,cortical microtubule organization,BP,
11381,GO:0043624,1,0.286118822472362,0,199,cellular protein complex disassembly,BP,
11382,GO:0043625,1,0.976050601814606,0,4,delta DNA polymerase complex,CC,
11383,GO:0043626,1,0.994260594939061,0,1,PCNA complex,CC,
11384,GO:0043627,1,0.648320040505275,0,69,response to estrogen,BP,
11385,GO:0043628,1,0.842554963209941,0,28,ncRNA 3'-end processing,BP,
11386,GO:0043629,1,0.992327975285565,0,1,ncRNA polyadenylation,BP,
11387,GO:0043630,1,0.992327975285565,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
11388,GO:0043631,1,0.763010483077903,0,42,RNA polyadenylation,BP,
11390,GO:0043633,1,0.951599630113071,0,8,polyadenylation-dependent RNA catabolic process,BP,
11391,GO:0043634,1,0.957998591203804,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
11392,GO:0043647,1,0.668987732523612,0,62,inositol phosphate metabolic process,BP,
11395,GO:0043650,1,0.927883639213347,0,12,dicarboxylic acid biosynthetic process,BP,
11396,GO:0043651,1,0.911408281648336,0,15,linoleic acid metabolic process,BP,
11397,GO:0043652,1,0.932970678754194,0,11,engulfment of apoptotic cell,BP,
11398,GO:0043653,1,0.94486745147703,0,9,mitochondrial fragmentation involved in apoptotic process,BP,
11399,GO:0043654,1,0.96237208481663,0,6,recognition of apoptotic cell,BP,
11400,GO:0043656,1,0.945232550628121,0,9,intracellular region of host,CC,
11404,GO:0043682,1,0.985071660032544,0,2,copper-transporting ATPase activity,MF,
11405,GO:0043686,1,0.982181354989545,0,3,co-translational protein modification,BP,
11407,GO:0043691,1,0.921778375083649,0,13,reverse cholesterol transport,BP,
11408,GO:0043696,1,0.954311495219781,0,7,dedifferentiation,BP,
11409,GO:0043697,1,0.954311495219781,0,7,cell dedifferentiation,BP,
11410,GO:0043733,1,0.994333222971011,0,1,DNA-3-methylbase glycosylase activity,MF,
11411,GO:0043734,1,0.976093572665499,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
11412,GO:0043739,1,0.993710693593427,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
11413,GO:0043754,1,0.991522852838188,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
11414,GO:0043783,1,0.993967171770242,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11415,GO:0043795,1,0.994241679979329,0,1,glyceraldehyde oxidoreductase activity,MF,
11416,GO:0043812,1,0.980058182978643,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
11417,GO:0043813,1,0.965615724840644,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
11418,GO:0043843,1,0.993908146519457,0,1,ADP-specific glucokinase activity,MF,
11419,GO:0043849,1,0.993804937091189,0,1,Ras palmitoyltransferase activity,MF,
11420,GO:0043855,1,0.943413739628956,0,9,cyclic nucleotide-gated ion channel activity,MF,
11421,GO:0043865,1,0.993844646767904,0,1,methionine transmembrane transporter activity,MF,
11422,GO:0043874,1,0.994065245036766,0,1,acireductone synthase activity,MF,
11423,GO:0043890,1,0.993962273262593,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
11424,GO:0043891,1,0.994267381227237,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
11426,GO:0043901,1,0.406528406251235,0,144,negative regulation of multi-organism process,BP,
11429,GO:0043914,1,0.993517113533191,0,1,NADPH:sulfur oxidoreductase activity,MF,
11430,GO:0043916,1,0.994333222971011,0,1,DNA-7-methylguanine glycosylase activity,MF,
11431,GO:0043921,1,0.856963820408511,0,24,modulation by host of viral transcription,BP,
11432,GO:0043922,1,0.945267192356269,0,9,negative regulation by host of viral transcription,BP,
11433,GO:0043923,1,0.895152604027873,0,17,positive regulation by host of viral transcription,BP,
11435,GO:0043928,1,0.820332102357513,0,32,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
11437,GO:0043932,1,0.976208029785431,0,4,ossification involved in bone remodeling,BP,
11439,GO:0043946,1,0.994142484478339,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
11440,GO:0043947,1,0.994142484478339,0,1,positive regulation by host of symbiont catalytic activity,BP,
11444,GO:0043954,1,0.795538423000042,0,35,cellular component maintenance,BP,
11445,GO:0043966,1,0.700648116061288,0,56,histone H3 acetylation,BP,
11446,GO:0043967,1,0.669532886463473,0,62,histone H4 acetylation,BP,
11447,GO:0043968,1,0.908601949013895,0,15,histone H2A acetylation,BP,
11448,GO:0043969,1,0.992113842885886,0,1,histone H2B acetylation,BP,
11449,GO:0043970,1,0.919621586325047,0,13,histone H3-K9 acetylation,BP,
11450,GO:0043972,1,0.993287764076323,0,1,histone H3-K23 acetylation,BP,
11451,GO:0043973,1,0.994010273734103,0,1,histone H3-K4 acetylation,BP,
11452,GO:0043974,1,0.980215526092823,0,3,histone H3-K27 acetylation,BP,
11453,GO:0043981,1,0.909162869857483,0,15,histone H4-K5 acetylation,BP,
11454,GO:0043982,1,0.909162869857483,0,15,histone H4-K8 acetylation,BP,
11455,GO:0043983,1,0.958149939883768,0,7,histone H4-K12 acetylation,BP,
11456,GO:0043984,1,0.889474094749932,0,18,histone H4-K16 acetylation,BP,
11457,GO:0043985,1,0.963853864977683,0,6,histone H4-R3 methylation,BP,
11459,GO:0043988,1,0.981894459682488,0,3,histone H3-S28 phosphorylation,BP,
11460,GO:0043990,1,0.993754421859856,0,1,histone H2A-S1 phosphorylation,BP,
11461,GO:0043994,1,0.993287764076323,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
11462,GO:0043995,1,0.937150942842496,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
11463,GO:0043996,1,0.937150942842496,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
11464,GO:0043997,1,0.993745843868824,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
11465,GO:0043998,1,0.993685275274045,0,1,H2A histone acetyltransferase activity,MF,
11466,GO:0044003,1,0.771147456018122,0,40,modification by symbiont of host morphology or physiology,BP,
11467,GO:0044004,1,0.970055687044502,0,5,disruption by symbiont of host cell,BP,
11468,GO:0044007,1,0.992805094668721,0,1,dissemination or transmission of symbiont from host,BP,
11469,GO:0044010,1,0.993961985134131,0,1,single-species biofilm formation,BP,
11470,GO:0044020,1,0.976228856076286,0,4,histone methyltransferase activity (H4-R3 specific),MF,
11471,GO:0044026,1,0.987833935980051,0,2,DNA hypermethylation,BP,
11472,GO:0044027,1,0.994240669256645,0,1,hypermethylation of CpG island,BP,
11473,GO:0044028,1,0.987151461965049,0,2,DNA hypomethylation,BP,
11474,GO:0044029,1,0.987151461965049,0,2,hypomethylation of CpG island,BP,
11475,GO:0044030,1,0.907538657424945,0,15,regulation of DNA methylation,BP,
11476,GO:0044033,1,0.958338266301781,0,7,multi-organism metabolic process,BP,
11477,GO:0044035,1,0.994173961482157,0,1,multi-organism catabolic process,BP,
11478,GO:0044036,1,0.971166066974514,0,5,cell wall macromolecule metabolic process,BP,
11479,GO:0044038,1,0.994134543005102,0,1,cell wall macromolecule biosynthetic process,BP,
11480,GO:0044042,1,0.635882705379593,0,69,glucan metabolic process,BP,
11481,GO:0044053,1,0.993949453664117,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
11483,GO:0044058,1,0.820334318447718,0,32,regulation of digestive system process,BP,
11484,GO:0044060,1,0.779626519509846,0,40,regulation of endocrine process,BP,
11485,GO:0044062,1,0.888494547066783,0,19,regulation of excretion,BP,
11486,GO:0044065,1,0.90856412476302,0,15,regulation of respiratory system process,BP,
11487,GO:0044068,1,0.851499482698677,0,25,modulation by symbiont of host cellular process,BP,
11491,GO:0044088,1,0.777917586457075,0,39,regulation of vacuole organization,BP,
11493,GO:0044090,1,0.929861178765802,0,11,positive regulation of vacuole organization,BP,
11494,GO:0044091,1,0.808862013630162,0,32,membrane biogenesis,BP,
11497,GO:0044094,1,0.980730531990208,0,3,host cell nuclear part,CC,
11498,GO:0044105,1,0.99440686302825,0,1,L-xylulose reductase (NAD+) activity,MF,
11500,GO:0044107,1,0.976385032548613,0,4,cellular alcohol metabolic process,BP,
11501,GO:0044108,1,0.976385032548613,0,4,cellular alcohol biosynthetic process,BP,
11502,GO:0044110,1,0.920128689047359,0,14,growth involved in symbiotic interaction,BP,
11503,GO:0044111,1,0.987020549022876,0,2,development involved in symbiotic interaction,BP,
11504,GO:0044115,1,0.994173961482157,0,1,development of symbiont involved in interaction with host,BP,
11505,GO:0044116,1,0.920128689047359,0,14,growth of symbiont involved in interaction with host,BP,
11506,GO:0044117,1,0.925276425044209,0,13,growth of symbiont in host,BP,
11507,GO:0044126,1,0.93051675128012,0,12,regulation of growth of symbiont in host,BP,
11508,GO:0044128,1,0.993182414893304,0,1,positive regulation of growth of symbiont in host,BP,
11509,GO:0044130,1,0.936908438917435,0,11,negative regulation of growth of symbiont in host,BP,
11510,GO:0044133,1,0.994440940310254,0,1,growth of symbiont on or near host,BP,
11511,GO:0044139,1,0.994440940310254,0,1,modulation of growth of symbiont on or near host,BP,
11512,GO:0044140,1,0.994440940310254,0,1,negative regulation of growth of symbiont on or near host surface,BP,
11513,GO:0044144,1,0.925340158695554,0,13,modulation of growth of symbiont involved in interaction with host,BP,
11514,GO:0044145,1,0.994173961482157,0,1,modulation of development of symbiont involved in interaction with host,BP,
11515,GO:0044146,1,0.931696651628914,0,12,negative regulation of growth of symbiont involved in interaction with host,BP,
11516,GO:0044147,1,0.994173961482157,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
11517,GO:0044148,1,0.993182414893304,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
11518,GO:0044154,1,0.951516272851277,0,8,histone H3-K14 acetylation,BP,
11519,GO:0044179,1,0.987900628381654,0,2,hemolysis in other organism,BP,
11521,GO:0044190,1,0.994140607403246,0,1,host cell mitochondrial envelope,CC,
11522,GO:0044194,1,0.970578355940303,0,5,cytolytic granule,CC,
11523,GO:0044205,1,0.980642718291626,0,3,'de novo' UMP biosynthetic process,BP,
11524,GO:0044206,1,0.970850799659427,0,5,UMP salvage,BP,
11525,GO:0044207,1,0.993448178673619,0,1,translation initiation ternary complex,CC,
11526,GO:0044208,1,0.982303066535225,0,3,'de novo' AMP biosynthetic process,BP,
11527,GO:0044209,1,0.988519895240721,0,2,AMP salvage,BP,
11528,GO:0044210,1,0.987396436806412,0,2,'de novo' CTP biosynthetic process,BP,
11529,GO:0044211,1,0.982535865026045,0,3,CTP salvage,BP,
11531,GO:0044213,1,0.925605448927075,0,12,intronic transcription regulatory region DNA binding,MF,
11532,GO:0044214,1,0.965663374187015,0,5,spanning component of plasma membrane,CC,
11536,GO:0044218,1,0.969539579562712,0,5,other organism cell membrane,CC,
11537,GO:0044220,1,0.993254973595417,0,1,host cell perinuclear region of cytoplasm,CC,
11538,GO:0044221,1,0.993441878684404,0,1,host cell synapse,CC,
11540,GO:0044228,1,0.993284601078409,0,1,host cell surface,CC,
11541,GO:0044231,1,0.993441878684404,0,1,host cell presynaptic membrane,CC,
11542,GO:0044232,1,0.885515242297077,0,19,organelle membrane contact site,CC,
11543,GO:0044233,1,0.920952037322088,0,13,ER-mitochondrion membrane contact site,CC,
11546,GO:0044241,1,0.945671757686326,0,9,lipid digestion,BP,
11548,GO:0044245,1,0.981042749820101,0,3,polysaccharide digestion,BP,
11549,GO:0044247,1,0.848573923411857,0,25,cellular polysaccharide catabolic process,BP,
11554,GO:0044258,1,0.993956799190961,0,1,intestinal lipid catabolic process,BP,
11556,GO:0044262,1,0.228969547016145,0,227,cellular carbohydrate metabolic process,BP,
11557,GO:0044264,1,0.563018647220393,0,88,cellular polysaccharide metabolic process,BP,
11562,GO:0044272,1,0.345045518174562,0,167,sulfur compound biosynthetic process,BP,
11563,GO:0044273,1,0.762903898425147,0,43,sulfur compound catabolic process,BP,
11564,GO:0044275,1,0.777624968178577,0,39,cellular carbohydrate catabolic process,BP,
11565,GO:0044278,1,0.994412638802119,0,1,cell wall disruption in other organism,BP,
11566,GO:0044279,1,0.969539579562712,0,5,other organism membrane,CC,
11570,GO:0044284,1,0.994387225498306,0,1,mitochondrial crista junction,CC,
11572,GO:0044292,1,0.938070991951245,0,10,dendrite terminus,CC,
11573,GO:0044294,1,0.96079056465673,0,6,dendritic growth cone,CC,
11574,GO:0044295,1,0.870260144834068,0,21,axonal growth cone,CC,
11576,GO:0044298,1,0.862808261979341,0,23,cell body membrane,CC,
11577,GO:0044299,1,0.992769826486379,0,1,C-fiber,CC,
11579,GO:0044301,1,0.987609726798416,0,2,climbing fiber,CC,
11580,GO:0044302,1,0.972074744511865,0,4,dentate gyrus mossy fiber,CC,
11582,GO:0044305,1,0.970882551156726,0,4,calyx of Held,CC,
11584,GO:0044307,1,0.991034862753636,0,1,dendritic branch,CC,
11585,GO:0044308,1,0.97877849567861,0,3,axonal spine,CC,
11587,GO:0044313,1,0.978846506237921,0,3,protein K6-linked deubiquitination,BP,
11588,GO:0044314,1,0.976798603594355,0,4,protein K27-linked ubiquitination,BP,
11589,GO:0044316,1,0.987519116553796,0,2,cone cell pedicle,CC,
11590,GO:0044317,1,0.994250632095755,0,1,rod spherule,CC,
11591,GO:0044319,1,0.837247943753454,0,27,wound healing, spreading of cells,BP,
11592,GO:0044320,1,0.909522016322306,0,15,cellular response to leptin stimulus,BP,
11593,GO:0044321,1,0.887132037216934,0,19,response to leptin,BP,
11594,GO:0044322,1,0.83489128640618,0,28,endoplasmic reticulum quality control compartment,CC,
11596,GO:0044324,1,0.994384626424525,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
11598,GO:0044326,1,0.973080291536002,0,4,dendritic spine neck,CC,
11600,GO:0044331,1,0.811641848019127,0,33,cell-cell adhesion mediated by cadherin,BP,
11601,GO:0044332,1,0.951605711925849,0,7,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
11602,GO:0044333,1,0.994104221965913,0,1,Wnt signaling pathway involved in digestive tract morphogenesis,BP,
11603,GO:0044334,1,0.98720119157577,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
11604,GO:0044335,1,0.991732545770068,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
11605,GO:0044336,1,0.980934156237558,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
11606,GO:0044338,1,0.987649807380574,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
11607,GO:0044339,1,0.974346402397102,0,4,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
11608,GO:0044340,1,0.967177426748437,0,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
11610,GO:0044342,1,0.904673686444376,0,16,type B pancreatic cell proliferation,BP,
11611,GO:0044343,1,0.993362745636125,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
11613,GO:0044345,1,0.993362745636125,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
11614,GO:0044346,1,0.889470992891526,0,18,fibroblast apoptotic process,BP,
11615,GO:0044349,1,0.994148115699068,0,1,DNA excision,BP,
11616,GO:0044351,1,0.95636264253963,0,7,macropinocytosis,BP,
11617,GO:0044352,1,0.97423970472166,0,4,pinosome,CC,
11618,GO:0044354,1,0.97423970472166,0,4,macropinosome,CC,
11619,GO:0044355,1,0.994229840085675,0,1,clearance of foreign intracellular DNA,BP,
11620,GO:0044356,1,0.994229840085675,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
11621,GO:0044359,1,0.951837727730582,0,8,modulation of molecular function in other organism,BP,
11622,GO:0044362,1,0.958754355545553,0,7,negative regulation of molecular function in other organism,BP,
11623,GO:0044364,1,0.80662240564324,0,37,disruption of cells of other organism,BP,
11624,GO:0044375,1,0.982932376339028,0,3,regulation of peroxisome size,BP,
11625,GO:0044378,1,0.987137824124889,0,2,non-sequence-specific DNA binding, bending,MF,
11626,GO:0044380,1,0.718423571515787,0,49,protein localization to cytoskeleton,BP,
11627,GO:0044381,1,0.870382427489793,0,21,glucose import in response to insulin stimulus,BP,
11628,GO:0044387,1,0.950327045186199,0,8,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,
11629,GO:0044388,1,0.971052751269369,0,5,small protein activating enzyme binding,MF,
11631,GO:0044390,1,0.77467771132551,0,39,ubiquitin-like protein conjugating enzyme binding,MF,
11632,GO:0044391,1,0.350142685501953,0,181,ribosomal subunit,CC,
11633,GO:0044393,1,0.981246410028513,0,3,microspike,CC,
11634,GO:0044396,1,0.967991995816364,0,5,actin cortical patch organization,BP,
11636,GO:0044406,1,0.933671778139189,0,11,adhesion of symbiont to host,BP,
11637,GO:0044407,1,0.993961985134131,0,1,single-species biofilm formation in or on host organism,BP,
11639,GO:0044413,1,0.974221269171982,0,4,avoidance of host defenses,BP,
11640,GO:0044414,1,0.993147831445154,0,1,suppression of host defenses,BP,
11641,GO:0044415,1,0.974221269171982,0,4,evasion or tolerance of host defenses,BP,
11642,GO:0044416,1,0.994011283271499,0,1,induction by symbiont of host defense response,BP,
11643,GO:0044417,1,0.946626021861483,0,9,translocation of molecules into host,BP,
11645,GO:0044420,1,0.450530501777591,0,114,extracellular matrix component,CC,
11663,GO:0044445,1,0.252768333610629,0,227,cytosolic part,CC,
11670,GO:0044452,1,0.341145687185634,0,170,nucleolar part,CC,
11671,GO:0044453,1,0.910728046436161,0,15,nuclear membrane part,CC,
11675,GO:0044458,1,0.884674214212455,0,20,motile cilium assembly,BP,
11679,GO:0044467,1,0.987780023564917,0,2,glial cell-derived neurotrophic factor secretion,BP,
11680,GO:0044495,1,0.994411772435139,0,1,modulation of blood pressure in other organism,BP,
11681,GO:0044497,1,0.994411772435139,0,1,positive regulation of blood pressure in other organism,BP,
11682,GO:0044501,1,0.986892388881614,0,2,modulation of signal transduction in other organism,BP,
11683,GO:0044508,1,0.993744414402594,0,1,glucagon-like peptide 1 receptor activity,MF,
11684,GO:0044524,1,0.994143062039743,0,1,protein sulfhydration,BP,
11685,GO:0044528,1,0.975547470656143,0,4,regulation of mitochondrial mRNA stability,BP,
11686,GO:0044530,1,0.980049190435436,0,3,supraspliceosomal complex,CC,
11687,GO:0044531,1,0.963628949564839,0,6,modulation of programmed cell death in other organism,BP,
11688,GO:0044532,1,0.963628949564839,0,6,modulation of apoptotic process in other organism,BP,
11689,GO:0044533,1,0.981938725725604,0,3,positive regulation of apoptotic process in other organism,BP,
11690,GO:0044537,1,0.994131943981625,0,1,regulation of circulating fibrinogen levels,BP,
11691,GO:0044539,1,0.957727934059848,0,7,long-chain fatty acid import,BP,
11692,GO:0044540,1,0.994143062039743,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
11693,GO:0044545,1,0.969862112834188,0,5,NSL complex,CC,
11694,GO:0044546,1,0.925162724738855,0,12,NLRP3 inflammasome complex assembly,BP,
11695,GO:0044547,1,0.968925496812741,0,5,DNA topoisomerase binding,MF,
11697,GO:0044549,1,0.994441517896023,0,1,GTP cyclohydrolase binding,MF,
11698,GO:0044550,1,0.866747237054048,0,22,secondary metabolite biosynthetic process,BP,
11699,GO:0044557,1,0.957023235343877,0,7,relaxation of smooth muscle,BP,
11700,GO:0044558,1,0.993205747724528,0,1,uterine smooth muscle relaxation,BP,
11701,GO:0044565,1,0.988046665652911,0,2,dendritic cell proliferation,BP,
11702,GO:0044571,1,0.977153057013829,0,4,[2Fe-2S] cluster assembly,BP,
11703,GO:0044594,1,0.993870200243014,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
11704,GO:0044595,1,0.994281242594407,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
11705,GO:0044596,1,0.994281242594407,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
11706,GO:0044597,1,0.954319008446093,0,8,daunorubicin metabolic process,BP,
11707,GO:0044598,1,0.954319008446093,0,8,doxorubicin metabolic process,BP,
11708,GO:0044599,1,0.993846081630578,0,1,AP-5 adaptor complex,CC,
11709,GO:0044601,1,0.994170640521777,0,1,protein denucleotidylation,BP,
11710,GO:0044602,1,0.994170640521777,0,1,protein deadenylylation,BP,
11711,GO:0044603,1,0.994170640521777,0,1,protein adenylylhydrolase activity,MF,
11712,GO:0044609,1,0.987912482667627,0,2,DBIRD complex,CC,
11713,GO:0044610,1,0.993992826293789,0,1,FMN transmembrane transporter activity,MF,
11714,GO:0044611,1,0.979384366618598,0,3,nuclear pore inner ring,CC,
11715,GO:0044613,1,0.933160252697674,0,11,nuclear pore central transport channel,CC,
11716,GO:0044614,1,0.972293121611456,0,4,nuclear pore cytoplasmic filaments,CC,
11717,GO:0044615,1,0.944302039945218,0,8,nuclear pore nuclear basket,CC,
11718,GO:0044620,1,0.988946073143875,0,2,ACP phosphopantetheine attachment site binding,MF,
11719,GO:0044648,1,0.993846081630578,0,1,histone H3-K4 dimethylation,BP,
11720,GO:0044650,1,0.94514213963538,0,9,adhesion of symbiont to host cell,BP,
11721,GO:0044651,1,0.994276044579464,0,1,adhesion of symbiont to host epithelial cell,BP,
11722,GO:0044657,1,0.989040856318623,0,2,pore formation in membrane of other organism during symbiotic interaction,BP,
11723,GO:0044665,1,0.834779038647911,0,28,MLL1/2 complex,CC,
11724,GO:0044666,1,0.937623825979052,0,10,MLL3/4 complex,CC,
11725,GO:0044691,1,0.978439787973542,0,3,tooth eruption,BP,
11727,GO:0044706,1,0.301551293862698,0,187,multi-multicellular organism process,BP,
11728,GO:0044713,1,0.994440940310254,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
11729,GO:0044714,1,0.994440940310254,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
11730,GO:0044715,1,0.99429799177658,0,1,8-oxo-dGDP phosphatase activity,MF,
11731,GO:0044721,1,0.994090073460822,0,1,protein import into peroxisome matrix, substrate release,BP,
11732,GO:0044722,1,0.993531399454735,0,1,renal phosphate excretion,BP,
11733,GO:0044725,1,0.991475125065925,0,1,chromatin reprogramming in the zygote,BP,
11734,GO:0044727,1,0.991475125065925,0,1,DNA demethylation of male pronucleus,BP,
11735,GO:0044728,1,0.618037432051486,0,74,DNA methylation or demethylation,BP,
11736,GO:0044729,1,0.987562672026938,0,2,hemi-methylated DNA-binding,MF,
11737,GO:0044730,1,0.994173961482157,0,1,bone sialoprotein binding,MF,
11738,GO:0044732,1,0.993846081630578,0,1,mitotic spindle pole body,CC,
11739,GO:0044736,1,0.981650478584491,0,3,acid-sensing ion channel activity,MF,
11741,GO:0044752,1,0.981423757373389,0,3,response to human chorionic gonadotropin,BP,
11742,GO:0044753,1,0.985832516619102,0,2,amphisome,CC,
11743,GO:0044754,1,0.951057083449983,0,8,autolysosome,CC,
11744,GO:0044764,1,0.810404312442268,0,33,multi-organism cellular process,BP,
11745,GO:0044766,1,0.644692197159731,0,69,multi-organism transport,BP,
11746,GO:0044769,1,0.88482885507593,0,20,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
11748,GO:0044771,1,0.987595362660233,0,2,meiotic cell cycle phase transition,BP,
11750,GO:0044773,1,0.528442653582465,0,100,mitotic DNA damage checkpoint,BP,
11752,GO:0044778,1,0.98798103729189,0,2,meiotic DNA integrity checkpoint,BP,
11753,GO:0044779,1,0.993772585859067,0,1,meiotic spindle checkpoint,BP,
11755,GO:0044783,1,0.639917043410749,0,70,G1 DNA damage checkpoint,BP,
11756,GO:0044784,1,0.719044188435558,0,51,metaphase/anaphase transition of cell cycle,BP,
11757,GO:0044785,1,0.993772585859067,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
11758,GO:0044786,1,0.695771346006422,0,57,cell cycle DNA replication,BP,
11759,GO:0044788,1,0.880311199684771,0,20,modulation by host of viral process,BP,
11760,GO:0044789,1,0.967469451277749,0,5,modulation by host of viral release from host cell,BP,
11761,GO:0044791,1,0.967469451277749,0,5,positive regulation by host of viral release from host cell,BP,
11762,GO:0044793,1,0.962209625816048,0,6,negative regulation by host of viral process,BP,
11763,GO:0044794,1,0.91993883077485,0,13,positive regulation by host of viral process,BP,
11764,GO:0044795,1,0.994313008321541,0,1,trans-Golgi network to recycling endosome transport,BP,
11765,GO:0044796,1,0.994260594939061,0,1,DNA polymerase processivity factor complex,CC,
11766,GO:0044798,1,0.321730588223837,0,176,nuclear transcription factor complex,CC,
11767,GO:0044800,1,0.963981574373282,0,6,multi-organism membrane fusion,BP,
11768,GO:0044803,1,0.957457085116887,0,7,multi-organism membrane organization,BP,
11769,GO:0044804,1,0.88556108223048,0,19,autophagy of nucleus,BP,
11770,GO:0044805,1,0.980241286738626,0,3,late nucleophagy,BP,
11771,GO:0044806,1,0.954877609920247,0,7,G-quadruplex DNA unwinding,BP,
11772,GO:0044815,1,0.724310076492627,0,54,DNA packaging complex,CC,
11773,GO:0044818,1,0.844888050140783,0,26,mitotic G2/M transition checkpoint,BP,
11774,GO:0044819,1,0.644018151939658,0,69,mitotic G1/S transition checkpoint,BP,
11775,GO:0044821,1,0.96894982769558,0,5,meiotic telomere tethering at nuclear periphery,BP,
11776,GO:0044827,1,0.924677384726016,0,12,modulation by host of viral genome replication,BP,
11777,GO:0044828,1,0.973815397684057,0,4,negative regulation by host of viral genome replication,BP,
11778,GO:0044829,1,0.954763957846419,0,7,positive regulation by host of viral genome replication,BP,
11779,GO:0044830,1,0.987237891285313,0,2,modulation by host of viral RNA genome replication,BP,
11780,GO:0044837,1,0.955268626782912,0,7,actomyosin contractile ring organization,BP,
11783,GO:0044848,1,0.943810044280161,0,9,biological phase,BP,
11784,GO:0044849,1,0.916926942244375,0,14,estrous cycle,BP,
11785,GO:0044851,1,0.943810044280161,0,9,hair cycle phase,BP,
11787,GO:0044854,1,0.975969853569328,0,4,plasma membrane raft assembly,BP,
11788,GO:0044855,1,0.993857420128899,0,1,plasma membrane raft distribution,BP,
11789,GO:0044856,1,0.993857420128899,0,1,plasma membrane raft localization,BP,
11790,GO:0044857,1,0.975969853569328,0,4,plasma membrane raft organization,BP,
11791,GO:0044858,1,0.993857420128899,0,1,plasma membrane raft polarization,BP,
11792,GO:0044860,1,0.975064001238324,0,4,protein localization to plasma membrane raft,BP,
11793,GO:0044861,1,0.987109721477858,0,2,protein transport into plasma membrane raft,BP,
11794,GO:0044866,1,0.994088052350844,0,1,modulation by host of viral exo-alpha-sialidase activity,BP,
11795,GO:0044867,1,0.994088052350844,0,1,modulation by host of viral catalytic activity,BP,
11796,GO:0044868,1,0.986919158675131,0,2,modulation by host of viral molecular function,BP,
11797,GO:0044869,1,0.994088052350844,0,1,negative regulation by host of viral exo-alpha-sialidase activity,BP,
11798,GO:0044870,1,0.994088052350844,0,1,modulation by host of viral glycoprotein metabolic process,BP,
11799,GO:0044871,1,0.994088052350844,0,1,negative regulation by host of viral glycoprotein metabolic process,BP,
11802,GO:0044878,1,0.976615251560875,0,4,mitotic cytokinesis checkpoint,BP,
11803,GO:0045002,1,0.96364057918784,0,6,double-strand break repair via single-strand annealing,BP,
11804,GO:0045003,1,0.940897153013361,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11805,GO:0045004,1,0.986071169988202,0,2,DNA replication proofreading,BP,
11806,GO:0045005,1,0.807415917883975,0,33,DNA-dependent DNA replication maintenance of fidelity,BP,
11807,GO:0045006,1,0.93174155142192,0,12,DNA deamination,BP,
11808,GO:0045007,1,0.982642025499772,0,3,depurination,BP,
11809,GO:0045008,1,0.953422590457228,0,8,depyrimidination,BP,
11810,GO:0045009,1,0.93629067215714,0,11,chitosome,CC,
11811,GO:0045010,1,0.751558952961754,0,45,actin nucleation,BP,
11812,GO:0045016,1,0.993682419914046,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11814,GO:0045019,1,0.926760939860914,0,12,negative regulation of nitric oxide biosynthetic process,BP,
11815,GO:0045022,1,0.786020657625785,0,37,early endosome to late endosome transport,BP,
11816,GO:0045023,1,0.758721324668369,0,42,G0 to G1 transition,BP,
11817,GO:0045025,1,0.987293251088477,0,2,mitochondrial degradosome,CC,
11818,GO:0045026,1,0.842956169948609,0,28,plasma membrane fusion,BP,
11819,GO:0045027,1,0.994040134586067,0,1,DNA end binding,MF,
11820,GO:0045028,1,0.924783717236172,0,13,G-protein coupled purinergic nucleotide receptor activity,MF,
11821,GO:0045029,1,0.988076216300154,0,2,UDP-activated nucleotide receptor activity,MF,
11822,GO:0045030,1,0.994174683429863,0,1,UTP-activated nucleotide receptor activity,MF,
11823,GO:0045031,1,0.987866703641688,0,2,ATP-activated adenosine receptor activity,MF,
11824,GO:0045032,1,0.993752420141711,0,1,ADP-activated adenosine receptor activity,MF,
11825,GO:0045039,1,0.965817689692685,0,6,protein import into mitochondrial inner membrane,BP,
11826,GO:0045040,1,0.965092986759155,0,6,protein import into mitochondrial outer membrane,BP,
11827,GO:0045041,1,0.988221546546149,0,2,protein import into mitochondrial intermembrane space,BP,
11828,GO:0045046,1,0.963008138682353,0,6,protein import into peroxisome membrane,BP,
11829,GO:0045047,1,0.562863374805092,0,100,protein targeting to ER,BP,
11830,GO:0045048,1,0.969078263371837,0,5,protein insertion into ER membrane,BP,
11831,GO:0045053,1,0.958601365109752,0,5,protein retention in Golgi apparatus,BP,
11832,GO:0045054,1,0.975982112734357,0,4,constitutive secretory pathway,BP,
11834,GO:0045056,1,0.906296720107732,0,15,transcytosis,BP,
11835,GO:0045058,1,0.764940567741257,0,42,T cell selection,BP,
11836,GO:0045059,1,0.945369111119081,0,9,positive thymic T cell selection,BP,
11837,GO:0045060,1,0.938956162968532,0,10,negative thymic T cell selection,BP,
11838,GO:0045061,1,0.892020148393029,0,18,thymic T cell selection,BP,
11839,GO:0045062,1,0.994153313743245,0,1,extrathymic T cell selection,BP,
11840,GO:0045063,1,0.898727913845961,0,17,T-helper 1 cell differentiation,BP,
11841,GO:0045064,1,0.917675438505238,0,14,T-helper 2 cell differentiation,BP,
11842,GO:0045065,1,0.98170682823211,0,3,cytotoxic T cell differentiation,BP,
11843,GO:0045066,1,0.849318138929165,0,26,regulatory T cell differentiation,BP,
11846,GO:0045071,1,0.736933678110566,0,49,negative regulation of viral genome replication,BP,
11847,GO:0045072,1,0.917400651009788,0,14,regulation of interferon-gamma biosynthetic process,BP,
11848,GO:0045073,1,0.936076339574726,0,11,regulation of chemokine biosynthetic process,BP,
11849,GO:0045074,1,0.980950922922827,0,3,regulation of interleukin-10 biosynthetic process,BP,
11850,GO:0045075,1,0.956152761178744,0,7,regulation of interleukin-12 biosynthetic process,BP,
11851,GO:0045076,1,0.9001826770643,0,17,regulation of interleukin-2 biosynthetic process,BP,
11852,GO:0045077,1,0.976261954962743,0,4,negative regulation of interferon-gamma biosynthetic process,BP,
11853,GO:0045078,1,0.939721801147776,0,10,positive regulation of interferon-gamma biosynthetic process,BP,
11854,GO:0045079,1,0.982946076827207,0,3,negative regulation of chemokine biosynthetic process,BP,
11855,GO:0045080,1,0.95232525348211,0,8,positive regulation of chemokine biosynthetic process,BP,
11856,GO:0045081,1,0.993604921301833,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
11857,GO:0045082,1,0.987265385829565,0,2,positive regulation of interleukin-10 biosynthetic process,BP,
11858,GO:0045083,1,0.99346692829367,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
11859,GO:0045084,1,0.969240575557329,0,5,positive regulation of interleukin-12 biosynthetic process,BP,
11860,GO:0045085,1,0.976668594310144,0,4,negative regulation of interleukin-2 biosynthetic process,BP,
11861,GO:0045086,1,0.927201950857388,0,12,positive regulation of interleukin-2 biosynthetic process,BP,
11866,GO:0045092,1,0.993609059933458,0,1,interleukin-18 receptor complex,CC,
11867,GO:0045095,1,0.874706892400004,0,22,keratin filament,CC,
11868,GO:0045098,1,0.982336917171575,0,3,type III intermediate filament,CC,
11871,GO:0045105,1,0.993048890532864,0,1,intermediate filament polymerization or depolymerization,BP,
11872,GO:0045106,1,0.993048890532864,0,1,intermediate filament depolymerization,BP,
11873,GO:0045108,1,0.993048890532864,0,1,regulation of intermediate filament polymerization or depolymerization,BP,
11877,GO:0045112,1,0.968132078694442,0,5,integrin biosynthetic process,BP,
11878,GO:0045113,1,0.97574707998328,0,4,regulation of integrin biosynthetic process,BP,
11879,GO:0045116,1,0.917611175098673,0,14,protein neddylation,BP,
11880,GO:0045117,1,0.890121842577755,0,19,azole transport,BP,
11881,GO:0045120,1,0.923253090798936,0,12,pronucleus,CC,
11883,GO:0045123,1,0.738753784741203,0,48,cellular extravasation,BP,
11884,GO:0045124,1,0.81765046854946,0,31,regulation of bone resorption,BP,
11886,GO:0045127,1,0.994191432597904,0,1,N-acetylglucosamine kinase activity,MF,
11887,GO:0045128,1,0.993736982052292,0,1,negative regulation of reciprocal meiotic recombination,BP,
11888,GO:0045130,1,0.993862732407554,0,1,keratan sulfotransferase activity,MF,
11889,GO:0045131,1,0.99378646644639,0,1,pre-mRNA branch point binding,MF,
11891,GO:0045134,1,0.975580126684621,0,4,uridine-diphosphatase activity,MF,
11892,GO:0045136,1,0.944096596042825,0,9,development of secondary sexual characteristics,BP,
11894,GO:0045141,1,0.936950771303253,0,10,meiotic telomere clustering,BP,
11895,GO:0045142,1,0.986871401065333,0,2,triplex DNA binding,MF,
11896,GO:0045143,1,0.746855197595087,0,46,homologous chromosome segregation,BP,
11897,GO:0045144,1,0.958236200562803,0,7,meiotic sister chromatid segregation,BP,
11898,GO:0045145,1,0.987608432790512,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
11899,GO:0045153,1,0.994297125438604,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
11900,GO:0045155,1,0.987399890722841,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
11901,GO:0045159,1,0.964358327423251,0,6,myosin II binding,MF,
11903,GO:0045162,1,0.95215180816068,0,7,clustering of voltage-gated sodium channels,BP,
11906,GO:0045167,1,0.994152158622771,0,1,asymmetric protein localization involved in cell fate determination,BP,
11907,GO:0045168,1,0.987955417097345,0,2,cell-cell signaling involved in cell fate commitment,BP,
11908,GO:0045171,1,0.711100498160467,0,54,intercellular bridge,CC,
11909,GO:0045174,1,0.988668072217978,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
11913,GO:0045179,1,0.956965734821136,0,7,apical cortex,CC,
11914,GO:0045180,1,0.964595426563594,0,5,basal cortex,CC,
11915,GO:0045182,1,0.725035809555666,0,50,translation regulator activity,MF,
11916,GO:0045183,1,0.993846081630578,0,1,translation factor activity, non-nucleic acid binding,MF,
11918,GO:0045185,1,0.510125369704033,0,102,maintenance of protein location,BP,
11919,GO:0045186,1,0.992485412697891,0,1,zonula adherens assembly,BP,
11921,GO:0045188,1,0.95812559123961,0,7,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11922,GO:0045190,1,0.780511387858908,0,39,isotype switching,BP,
11924,GO:0045196,1,0.980293864561736,0,3,establishment or maintenance of neuroblast polarity,BP,
11925,GO:0045197,1,0.761808288563581,0,42,establishment or maintenance of epithelial cell apical/basal polarity,BP,
11926,GO:0045198,1,0.919625779680369,0,13,establishment of epithelial cell apical/basal polarity,BP,
11927,GO:0045199,1,0.926623407339829,0,12,maintenance of epithelial cell apical/basal polarity,BP,
11928,GO:0045200,1,0.980293864561736,0,3,establishment of neuroblast polarity,BP,
11930,GO:0045204,1,0.980282376578391,0,3,MAPK export from nucleus,BP,
11931,GO:0045208,1,0.993619334976343,0,1,MAPK phosphatase export from nucleus,BP,
11932,GO:0045209,1,0.993619334976343,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
11933,GO:0045210,1,0.986073902133961,0,2,FasL biosynthetic process,BP,
11935,GO:0045212,1,0.993902249952584,0,1,neurotransmitter receptor biosynthetic process,BP,
11936,GO:0045213,1,0.982151700231489,0,3,neurotransmitter receptor metabolic process,BP,
11939,GO:0045217,1,0.939266330706288,0,10,cell-cell junction maintenance,BP,
11940,GO:0045218,1,0.980901633292297,0,3,zonula adherens maintenance,BP,
11941,GO:0045219,1,0.993078902384903,0,1,regulation of FasL biosynthetic process,BP,
11942,GO:0045221,1,0.993078902384903,0,1,negative regulation of FasL biosynthetic process,BP,
11943,GO:0045222,1,0.994312430761374,0,1,CD4 biosynthetic process,BP,
11944,GO:0045223,1,0.994312430761374,0,1,regulation of CD4 biosynthetic process,BP,
11945,GO:0045225,1,0.994312430761374,0,1,negative regulation of CD4 biosynthetic process,BP,
11946,GO:0045226,1,0.981730161746108,0,3,extracellular polysaccharide biosynthetic process,BP,
11947,GO:0045229,1,0.987752767983103,0,2,external encapsulating structure organization,BP,
11948,GO:0045234,1,0.994131077641733,0,1,protein palmitoleylation,BP,
11949,GO:0045236,1,0.909686292879434,0,16,CXCR chemokine receptor binding,MF,
11950,GO:0045239,1,0.920335886962172,0,13,tricarboxylic acid cycle enzyme complex,CC,
11951,GO:0045240,1,0.931398629721092,0,11,dihydrolipoyl dehydrogenase complex,CC,
11952,GO:0045244,1,0.993966595443765,0,1,succinate-CoA ligase complex (GDP-forming),CC,
11953,GO:0045251,1,0.993967171770242,0,1,electron transfer flavoprotein complex,CC,
11954,GO:0045252,1,0.956440065142945,0,7,oxoglutarate dehydrogenase complex,CC,
11955,GO:0045254,1,0.956886331352174,0,7,pyruvate dehydrogenase complex,CC,
11956,GO:0045257,1,0.976592183178525,0,4,succinate dehydrogenase complex (ubiquinone),CC,
11957,GO:0045259,1,0.98829111579682,0,2,proton-transporting ATP synthase complex,CC,
11958,GO:0045263,1,0.994244278980629,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
11959,GO:0045271,1,0.782228700207297,0,43,respiratory chain complex I,CC,
11960,GO:0045272,1,0.982556886135024,0,3,plasma membrane respiratory chain complex I,CC,
11961,GO:0045273,1,0.976592183178525,0,4,respiratory chain complex II,CC,
11962,GO:0045274,1,0.99395478262682,0,1,plasma membrane respiratory chain complex II,CC,
11963,GO:0045275,1,0.936799567899081,0,11,respiratory chain complex III,CC,
11964,GO:0045277,1,0.924668948058649,0,14,respiratory chain complex IV,CC,
11965,GO:0045281,1,0.976592183178525,0,4,succinate dehydrogenase complex,CC,
11966,GO:0045282,1,0.99395478262682,0,1,plasma membrane succinate dehydrogenase complex,CC,
11967,GO:0045283,1,0.976592183178525,0,4,fumarate reductase complex,CC,
11968,GO:0045292,1,0.899832629030667,0,17,mRNA cis splicing, via spliceosome,BP,
11969,GO:0045293,1,0.982370046278418,0,3,mRNA editing complex,CC,
11970,GO:0045294,1,0.929244836736487,0,11,alpha-catenin binding,MF,
11971,GO:0045295,1,0.923342759736508,0,11,gamma-catenin binding,MF,
11972,GO:0045296,1,0.133995255858553,0,309,cadherin binding,MF,
11973,GO:0045297,1,0.993993835481293,0,1,post-mating behavior,BP,
11974,GO:0045298,1,0.967603420965984,0,5,tubulin complex,CC,
11975,GO:0045309,1,0.748540922959686,0,44,protein phosphorylated amino acid binding,MF,
11977,GO:0045322,1,0.981288091143417,0,3,unmethylated CpG binding,MF,
11978,GO:0045323,1,0.981506059271991,0,3,interleukin-1 receptor complex,CC,
11979,GO:0045324,1,0.93465119722389,0,11,late endosome to vacuole transport,BP,
11980,GO:0045329,1,0.970037882249514,0,5,carnitine biosynthetic process,BP,
11981,GO:0045332,1,0.849317041284884,0,23,phospholipid translocation,BP,
11982,GO:0045333,1,0.375156333902932,0,162,cellular respiration,BP,
11984,GO:0045335,1,0.471307464673893,0,119,phagocytic vesicle,CC,
11985,GO:0045337,1,0.975867409470919,0,4,farnesyl diphosphate biosynthetic process,BP,
11986,GO:0045338,1,0.970047953185026,0,5,farnesyl diphosphate metabolic process,BP,
11987,GO:0045340,1,0.994377406787888,0,1,mercury ion binding,MF,
11988,GO:0045341,1,0.96750334077673,0,5,MHC class I biosynthetic process,BP,
11989,GO:0045342,1,0.933283378472878,0,11,MHC class II biosynthetic process,BP,
11990,GO:0045343,1,0.96750334077673,0,5,regulation of MHC class I biosynthetic process,BP,
11991,GO:0045345,1,0.96750334077673,0,5,positive regulation of MHC class I biosynthetic process,BP,
11992,GO:0045346,1,0.939359559983441,0,10,regulation of MHC class II biosynthetic process,BP,
11993,GO:0045347,1,0.96965215646918,0,5,negative regulation of MHC class II biosynthetic process,BP,
11994,GO:0045348,1,0.963125456589895,0,6,positive regulation of MHC class II biosynthetic process,BP,
11995,GO:0045349,1,0.962927461076119,0,6,interferon-alpha biosynthetic process,BP,
11996,GO:0045350,1,0.944431131726186,0,9,interferon-beta biosynthetic process,BP,
11997,GO:0045351,1,0.933362110178752,0,11,type I interferon biosynthetic process,BP,
11998,GO:0045352,1,0.99413223276175,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11999,GO:0045353,1,0.99413223276175,0,1,interleukin-1 Type II receptor antagonist activity,MF,
12000,GO:0045354,1,0.962927461076119,0,6,regulation of interferon-alpha biosynthetic process,BP,
12001,GO:0045355,1,0.988428607789006,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
12002,GO:0045356,1,0.974203339996529,0,4,positive regulation of interferon-alpha biosynthetic process,BP,
12003,GO:0045357,1,0.944431131726186,0,9,regulation of interferon-beta biosynthetic process,BP,
12004,GO:0045358,1,0.988432340430841,0,2,negative regulation of interferon-beta biosynthetic process,BP,
12005,GO:0045359,1,0.955489011257347,0,7,positive regulation of interferon-beta biosynthetic process,BP,
12006,GO:0045360,1,0.982631790416677,0,3,regulation of interleukin-1 biosynthetic process,BP,
12007,GO:0045362,1,0.982631790416677,0,3,positive regulation of interleukin-1 biosynthetic process,BP,
12008,GO:0045366,1,0.993117556425263,0,1,regulation of interleukin-13 biosynthetic process,BP,
12009,GO:0045368,1,0.993117556425263,0,1,positive regulation of interleukin-13 biosynthetic process,BP,
12010,GO:0045381,1,0.993713264629147,0,1,regulation of interleukin-18 biosynthetic process,BP,
12011,GO:0045399,1,0.993198979283753,0,1,regulation of interleukin-3 biosynthetic process,BP,
12012,GO:0045401,1,0.993198979283753,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
12013,GO:0045402,1,0.980814861957243,0,3,regulation of interleukin-4 biosynthetic process,BP,
12014,GO:0045403,1,0.99371155059077,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
12015,GO:0045404,1,0.987022527907857,0,2,positive regulation of interleukin-4 biosynthetic process,BP,
12016,GO:0045408,1,0.922208896907182,0,13,regulation of interleukin-6 biosynthetic process,BP,
12017,GO:0045409,1,0.975517219454012,0,4,negative regulation of interleukin-6 biosynthetic process,BP,
12018,GO:0045410,1,0.956633719707056,0,7,positive regulation of interleukin-6 biosynthetic process,BP,
12019,GO:0045414,1,0.945209233519627,0,9,regulation of interleukin-8 biosynthetic process,BP,
12020,GO:0045415,1,0.976462184490762,0,4,negative regulation of interleukin-8 biosynthetic process,BP,
12021,GO:0045416,1,0.962559941328155,0,6,positive regulation of interleukin-8 biosynthetic process,BP,
12022,GO:0045423,1,0.987091621025035,0,2,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12023,GO:0045425,1,0.987091621025035,0,2,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12024,GO:0045428,1,0.74141600574483,0,47,regulation of nitric oxide biosynthetic process,BP,
12025,GO:0045429,1,0.800146485118251,0,35,positive regulation of nitric oxide biosynthetic process,BP,
12026,GO:0045444,1,0.289127584312854,0,193,fat cell differentiation,BP,
12029,GO:0045448,1,0.97553527018937,0,4,mitotic cell cycle, embryonic,BP,
12030,GO:0045453,1,0.730848013658247,0,49,bone resorption,BP,
12031,GO:0045454,1,0.680605138501501,0,63,cell redox homeostasis,BP,
12032,GO:0045471,1,0.480742987456346,0,116,response to ethanol,BP,
12033,GO:0045472,1,0.937045685996627,0,10,response to ether,BP,
12034,GO:0045475,1,0.934632756915586,0,10,locomotor rhythm,BP,
12035,GO:0045485,1,0.993375372544306,0,1,omega-6 fatty acid desaturase activity,MF,
12036,GO:0045494,1,0.815692858426134,0,31,photoreceptor cell maintenance,BP,
12037,GO:0045495,1,0.915207777149309,0,14,pole plasm,CC,
12038,GO:0045499,1,0.869843661508688,0,21,chemorepellent activity,MF,
12040,GO:0045504,1,0.915645088910265,0,14,dynein heavy chain binding,MF,
12042,GO:0045509,1,0.987469911995011,0,2,interleukin-27 receptor activity,MF,
12043,GO:0045513,1,0.994231572753009,0,1,interleukin-27 binding,MF,
12044,GO:0045519,1,0.994346506935695,0,1,interleukin-23 receptor binding,MF,
12045,GO:0045523,1,0.988697944951371,0,2,interleukin-27 receptor binding,MF,
12047,GO:0045541,1,0.970279252863665,0,5,negative regulation of cholesterol biosynthetic process,BP,
12049,GO:0045545,1,0.959992481754874,0,6,syndecan binding,MF,
12050,GO:0045550,1,0.988510436109051,0,2,geranylgeranyl reductase activity,MF,
12051,GO:0045553,1,0.993774016542511,0,1,TRAIL biosynthetic process,BP,
12052,GO:0045554,1,0.993774016542511,0,1,regulation of TRAIL biosynthetic process,BP,
12053,GO:0045556,1,0.993774016542511,0,1,positive regulation of TRAIL biosynthetic process,BP,
12054,GO:0045569,1,0.97571346878709,0,4,TRAIL binding,MF,
12055,GO:0045575,1,0.987517978759006,0,2,basophil activation,BP,
12056,GO:0045576,1,0.7223271710583,0,52,mast cell activation,BP,
12057,GO:0045577,1,0.841823364935913,0,27,regulation of B cell differentiation,BP,
12058,GO:0045578,1,0.96986278635604,0,5,negative regulation of B cell differentiation,BP,
12059,GO:0045579,1,0.920798007415465,0,13,positive regulation of B cell differentiation,BP,
12060,GO:0045580,1,0.49177020784185,0,112,regulation of T cell differentiation,BP,
12061,GO:0045581,1,0.836309553876389,0,28,negative regulation of T cell differentiation,BP,
12062,GO:0045582,1,0.669529496234866,0,64,positive regulation of T cell differentiation,BP,
12063,GO:0045583,1,0.987809438754761,0,2,regulation of cytotoxic T cell differentiation,BP,
12064,GO:0045585,1,0.987809438754761,0,2,positive regulation of cytotoxic T cell differentiation,BP,
12065,GO:0045586,1,0.973631610321334,0,4,regulation of gamma-delta T cell differentiation,BP,
12066,GO:0045588,1,0.980029496270157,0,3,positive regulation of gamma-delta T cell differentiation,BP,
12067,GO:0045589,1,0.859756145054589,0,24,regulation of regulatory T cell differentiation,BP,
12068,GO:0045590,1,0.981470132232641,0,3,negative regulation of regulatory T cell differentiation,BP,
12069,GO:0045591,1,0.941408210815362,0,10,positive regulation of regulatory T cell differentiation,BP,
12073,GO:0045598,1,0.49069288454934,0,111,regulation of fat cell differentiation,BP,
12074,GO:0045599,1,0.757299631492751,0,43,negative regulation of fat cell differentiation,BP,
12075,GO:0045600,1,0.710294806574451,0,54,positive regulation of fat cell differentiation,BP,
12076,GO:0045601,1,0.821578845096755,0,30,regulation of endothelial cell differentiation,BP,
12077,GO:0045602,1,0.947062005165994,0,8,negative regulation of endothelial cell differentiation,BP,
12078,GO:0045603,1,0.907747117232427,0,15,positive regulation of endothelial cell differentiation,BP,
12079,GO:0045604,1,0.735395580667366,0,48,regulation of epidermal cell differentiation,BP,
12080,GO:0045605,1,0.94468691934974,0,9,negative regulation of epidermal cell differentiation,BP,
12081,GO:0045606,1,0.878059139693991,0,20,positive regulation of epidermal cell differentiation,BP,
12082,GO:0045607,1,0.95658549352845,0,7,regulation of inner ear auditory receptor cell differentiation,BP,
12083,GO:0045608,1,0.98000928890351,0,3,negative regulation of inner ear auditory receptor cell differentiation,BP,
12084,GO:0045616,1,0.81697294701875,0,31,regulation of keratinocyte differentiation,BP,
12085,GO:0045617,1,0.975462365020793,0,4,negative regulation of keratinocyte differentiation,BP,
12086,GO:0045618,1,0.91189316874272,0,14,positive regulation of keratinocyte differentiation,BP,
12087,GO:0045619,1,0.420187721821125,0,137,regulation of lymphocyte differentiation,BP,
12088,GO:0045620,1,0.801702371475246,0,35,negative regulation of lymphocyte differentiation,BP,
12089,GO:0045621,1,0.624479643177144,0,75,positive regulation of lymphocyte differentiation,BP,
12090,GO:0045622,1,0.849420499456754,0,26,regulation of T-helper cell differentiation,BP,
12091,GO:0045623,1,0.919474597561168,0,13,negative regulation of T-helper cell differentiation,BP,
12092,GO:0045624,1,0.907082141162149,0,16,positive regulation of T-helper cell differentiation,BP,
12093,GO:0045625,1,0.940458175547796,0,10,regulation of T-helper 1 cell differentiation,BP,
12094,GO:0045626,1,0.980800323760906,0,3,negative regulation of T-helper 1 cell differentiation,BP,
12095,GO:0045627,1,0.964330791673919,0,6,positive regulation of T-helper 1 cell differentiation,BP,
12096,GO:0045628,1,0.934173426857424,0,11,regulation of T-helper 2 cell differentiation,BP,
12097,GO:0045629,1,0.975449848642058,0,4,negative regulation of T-helper 2 cell differentiation,BP,
12098,GO:0045630,1,0.957695236942847,0,7,positive regulation of T-helper 2 cell differentiation,BP,
12099,GO:0045631,1,0.95658549352845,0,7,regulation of mechanoreceptor differentiation,BP,
12100,GO:0045632,1,0.974393228355949,0,4,negative regulation of mechanoreceptor differentiation,BP,
12101,GO:0045634,1,0.953313315304795,0,7,regulation of melanocyte differentiation,BP,
12102,GO:0045636,1,0.964659908395148,0,5,positive regulation of melanocyte differentiation,BP,
12103,GO:0045637,1,0.274065687315799,0,201,regulation of myeloid cell differentiation,BP,
12104,GO:0045638,1,0.629467115486568,0,73,negative regulation of myeloid cell differentiation,BP,
12105,GO:0045639,1,0.62373989702328,0,74,positive regulation of myeloid cell differentiation,BP,
12106,GO:0045643,1,0.99360220975019,0,1,regulation of eosinophil differentiation,BP,
12107,GO:0045645,1,0.99360220975019,0,1,positive regulation of eosinophil differentiation,BP,
12108,GO:0045646,1,0.763565189767763,0,42,regulation of erythrocyte differentiation,BP,
12109,GO:0045647,1,0.950650724712584,0,8,negative regulation of erythrocyte differentiation,BP,
12110,GO:0045648,1,0.840195742944496,0,27,positive regulation of erythrocyte differentiation,BP,
12111,GO:0045649,1,0.888443375968939,0,19,regulation of macrophage differentiation,BP,
12112,GO:0045650,1,0.964317737725649,0,6,negative regulation of macrophage differentiation,BP,
12113,GO:0045651,1,0.921346094272061,0,13,positive regulation of macrophage differentiation,BP,
12114,GO:0045652,1,0.710184387163365,0,54,regulation of megakaryocyte differentiation,BP,
12115,GO:0045653,1,0.955305042355057,0,8,negative regulation of megakaryocyte differentiation,BP,
12116,GO:0045654,1,0.964613790738309,0,6,positive regulation of megakaryocyte differentiation,BP,
12117,GO:0045655,1,0.902768577291875,0,16,regulation of monocyte differentiation,BP,
12118,GO:0045656,1,0.96044255795184,0,6,negative regulation of monocyte differentiation,BP,
12119,GO:0045657,1,0.951653760771805,0,8,positive regulation of monocyte differentiation,BP,
12120,GO:0045658,1,0.981045104032909,0,3,regulation of neutrophil differentiation,BP,
12121,GO:0045659,1,0.986896611151665,0,2,negative regulation of neutrophil differentiation,BP,
12122,GO:0045660,1,0.994071595959074,0,1,positive regulation of neutrophil differentiation,BP,
12125,GO:0045663,1,0.894955289293479,0,17,positive regulation of myoblast differentiation,BP,
12131,GO:0045669,1,0.694781003183683,0,56,positive regulation of osteoblast differentiation,BP,
12132,GO:0045670,1,0.708498434506085,0,53,regulation of osteoclast differentiation,BP,
12133,GO:0045671,1,0.853583762685122,0,24,negative regulation of osteoclast differentiation,BP,
12134,GO:0045672,1,0.897288297488021,0,17,positive regulation of osteoclast differentiation,BP,
12135,GO:0045682,1,0.647644747776065,0,68,regulation of epidermis development,BP,
12136,GO:0045683,1,0.926043223036826,0,12,negative regulation of epidermis development,BP,
12137,GO:0045684,1,0.816117202761388,0,32,positive regulation of epidermis development,BP,
12141,GO:0045703,1,0.994292793750381,0,1,ketoreductase activity,MF,
12142,GO:0045713,1,0.943590824741022,0,9,low-density lipoprotein particle receptor biosynthetic process,BP,
12143,GO:0045714,1,0.949184077992814,0,8,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12144,GO:0045715,1,0.985932983086805,0,2,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12145,GO:0045716,1,0.97611625347043,0,4,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12146,GO:0045717,1,0.921705557442383,0,13,negative regulation of fatty acid biosynthetic process,BP,
12147,GO:0045719,1,0.966623743999206,0,5,negative regulation of glycogen biosynthetic process,BP,
12148,GO:0045720,1,0.987929249990823,0,2,negative regulation of integrin biosynthetic process,BP,
12149,GO:0045721,1,0.945199094594429,0,9,negative regulation of gluconeogenesis,BP,
12150,GO:0045722,1,0.941166404646608,0,9,positive regulation of gluconeogenesis,BP,
12151,GO:0045723,1,0.922721782631215,0,13,positive regulation of fatty acid biosynthetic process,BP,
12152,GO:0045724,1,0.887744087438398,0,18,positive regulation of cilium assembly,BP,
12153,GO:0045725,1,0.913095818920249,0,13,positive regulation of glycogen biosynthetic process,BP,
12154,GO:0045726,1,0.986963684193059,0,2,positive regulation of integrin biosynthetic process,BP,
12155,GO:0045727,1,0.493130960706062,0,112,positive regulation of translation,BP,
12156,GO:0045728,1,0.994023399149167,0,1,respiratory burst after phagocytosis,BP,
12157,GO:0045730,1,0.867304470009104,0,23,respiratory burst,BP,
12159,GO:0045736,1,0.823630899775908,0,30,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12160,GO:0045737,1,0.81862090916981,0,32,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12161,GO:0045738,1,0.865490440248235,0,22,negative regulation of DNA repair,BP,
12162,GO:0045739,1,0.766805348242883,0,42,positive regulation of DNA repair,BP,
12163,GO:0045740,1,0.721586768493025,0,51,positive regulation of DNA replication,BP,
12164,GO:0045741,1,0.938454424063751,0,10,positive regulation of epidermal growth factor-activated receptor activity,BP,
12165,GO:0045742,1,0.815566928898931,0,32,positive regulation of epidermal growth factor receptor signaling pathway,BP,
12166,GO:0045743,1,0.9680592416628,0,5,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
12167,GO:0045744,1,0.779434575705771,0,40,negative regulation of G-protein coupled receptor protein signaling pathway,BP,
12169,GO:0045746,1,0.783616758409114,0,39,negative regulation of Notch signaling pathway,BP,
12170,GO:0045747,1,0.74809199189885,0,44,positive regulation of Notch signaling pathway,BP,
12171,GO:0045751,1,0.993713264629147,0,1,negative regulation of Toll signaling pathway,BP,
12172,GO:0045759,1,0.962792414385106,0,6,negative regulation of action potential,BP,
12173,GO:0045760,1,0.93556583276736,0,10,positive regulation of action potential,BP,
12175,GO:0045762,1,0.967566205679165,0,5,positive regulation of adenylate cyclase activity,BP,
12176,GO:0045763,1,0.985350369726558,0,2,negative regulation of cellular amino acid metabolic process,BP,
12177,GO:0045764,1,0.982497239903984,0,3,positive regulation of cellular amino acid metabolic process,BP,
12180,GO:0045769,1,0.991496662166757,0,1,negative regulation of asymmetric cell division,BP,
12181,GO:0045773,1,0.776091350111564,0,37,positive regulation of axon extension,BP,
12182,GO:0045776,1,0.797144975452064,0,36,negative regulation of blood pressure,BP,
12183,GO:0045777,1,0.824592637170663,0,31,positive regulation of blood pressure,BP,
12184,GO:0045778,1,0.60304045309301,0,78,positive regulation of ossification,BP,
12185,GO:0045779,1,0.945191237003114,0,9,negative regulation of bone resorption,BP,
12186,GO:0045780,1,0.918040284428818,0,13,positive regulation of bone resorption,BP,
12189,GO:0045787,1,0.112614230282336,0,337,positive regulation of cell cycle,BP,
12190,GO:0045792,1,0.942480307200302,0,9,negative regulation of cell size,BP,
12191,GO:0045793,1,0.937537622690655,0,10,positive regulation of cell size,BP,
12192,GO:0045794,1,0.966382997053814,0,5,negative regulation of cell volume,BP,
12193,GO:0045795,1,0.992665717207799,0,1,positive regulation of cell volume,BP,
12194,GO:0045796,1,0.993875658902209,0,1,negative regulation of intestinal cholesterol absorption,BP,
12195,GO:0045799,1,0.979357258445525,0,3,positive regulation of chromatin assembly or disassembly,BP,
12198,GO:0045813,1,0.994126168400043,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
12199,GO:0045814,1,0.56306643280484,0,90,negative regulation of gene expression, epigenetic,BP,
12201,GO:0045819,1,0.993514827363392,0,1,positive regulation of glycogen catabolic process,BP,
12202,GO:0045820,1,0.936009816320934,0,10,negative regulation of glycolytic process,BP,
12203,GO:0045821,1,0.898682624307635,0,16,positive regulation of glycolytic process,BP,
12204,GO:0045822,1,0.884589487562689,0,19,negative regulation of heart contraction,BP,
12206,GO:0045824,1,0.780502358318058,0,39,negative regulation of innate immune response,BP,
12207,GO:0045827,1,0.994292793750381,0,1,negative regulation of isoprenoid metabolic process,BP,
12208,GO:0045829,1,0.975469588916674,0,4,negative regulation of isotype switching,BP,
12209,GO:0045830,1,0.885788198923874,0,19,positive regulation of isotype switching,BP,
12210,GO:0045833,1,0.661866953710527,0,66,negative regulation of lipid metabolic process,BP,
12212,GO:0045835,1,0.94525176642777,0,9,negative regulation of meiotic nuclear division,BP,
12213,GO:0045836,1,0.932834341881555,0,11,positive regulation of meiotic nuclear division,BP,
12214,GO:0045837,1,0.946812150824435,0,9,negative regulation of membrane potential,BP,
12215,GO:0045838,1,0.932737282956809,0,11,positive regulation of membrane potential,BP,
12216,GO:0045839,1,0.743860779095347,0,46,negative regulation of mitotic nuclear division,BP,
12217,GO:0045840,1,0.74497905074082,0,45,positive regulation of mitotic nuclear division,BP,
12218,GO:0045841,1,0.813424457877003,0,32,negative regulation of mitotic metaphase/anaphase transition,BP,
12219,GO:0045842,1,0.950061769814463,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
12220,GO:0045843,1,0.764727946490491,0,42,negative regulation of striated muscle tissue development,BP,
12222,GO:0045848,1,0.994026284253939,0,1,positive regulation of nitrogen utilization,BP,
12223,GO:0045851,1,0.743002490456531,0,48,pH reduction,BP,
12224,GO:0045852,1,0.97463580442428,0,4,pH elevation,BP,
12229,GO:0045869,1,0.947028456495725,0,9,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12231,GO:0045872,1,0.99407765856888,0,1,positive regulation of rhodopsin gene expression,BP,
12232,GO:0045875,1,0.970742295006085,0,4,negative regulation of sister chromatid cohesion,BP,
12233,GO:0045876,1,0.949024619262283,0,8,positive regulation of sister chromatid cohesion,BP,
12235,GO:0045880,1,0.82271285541115,0,30,positive regulation of smoothened signaling pathway,BP,
12236,GO:0045887,1,0.992529998507841,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
12239,GO:0045898,1,0.915168174638921,0,14,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12240,GO:0045899,1,0.93287521847868,0,11,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12241,GO:0045900,1,0.974589832650491,0,4,negative regulation of translational elongation,BP,
12242,GO:0045901,1,0.974890457952938,0,4,positive regulation of translational elongation,BP,
12243,GO:0045903,1,0.98289124623533,0,3,positive regulation of translational fidelity,BP,
12244,GO:0045905,1,0.980987326899285,0,3,positive regulation of translational termination,BP,
12246,GO:0045907,1,0.845130336071147,0,27,positive regulation of vasoconstriction,BP,
12247,GO:0045910,1,0.860652583826378,0,23,negative regulation of DNA recombination,BP,
12248,GO:0045911,1,0.862981161429219,0,23,positive regulation of DNA recombination,BP,
12250,GO:0045913,1,0.677237215039745,0,59,positive regulation of carbohydrate metabolic process,BP,
12251,GO:0045914,1,0.981119780014937,0,3,negative regulation of catecholamine metabolic process,BP,
12253,GO:0045916,1,0.960281195987931,0,6,negative regulation of complement activation,BP,
12254,GO:0045917,1,0.981005693363459,0,3,positive regulation of complement activation,BP,
12255,GO:0045918,1,0.982407463527497,0,3,negative regulation of cytolysis,BP,
12256,GO:0045919,1,0.95920602539294,0,7,positive regulation of cytolysis,BP,
12257,GO:0045920,1,0.843173332323647,0,27,negative regulation of exocytosis,BP,
12259,GO:0045922,1,0.886257364706717,0,19,negative regulation of fatty acid metabolic process,BP,
12260,GO:0045923,1,0.833271692363576,0,28,positive regulation of fatty acid metabolic process,BP,
12262,GO:0045925,1,0.993948013537591,0,1,positive regulation of female receptivity,BP,
12266,GO:0045931,1,0.428512672899514,0,130,positive regulation of mitotic cell cycle,BP,
12268,GO:0045933,1,0.760056926551591,0,44,positive regulation of muscle contraction,BP,
12273,GO:0045938,1,0.965530609543821,0,6,positive regulation of circadian sleep/wake cycle, sleep,BP,
12276,GO:0045943,1,0.871536667037496,0,21,positive regulation of transcription by RNA polymerase I,BP,
12278,GO:0045945,1,0.92948328654455,0,11,positive regulation of transcription by RNA polymerase III,BP,
12279,GO:0045947,1,0.885374940931759,0,19,negative regulation of translational initiation,BP,
12280,GO:0045948,1,0.846829020465975,0,26,positive regulation of translational initiation,BP,
12281,GO:0045950,1,0.981852913923752,0,3,negative regulation of mitotic recombination,BP,
12282,GO:0045953,1,0.94117762186869,0,10,negative regulation of natural killer cell mediated cytotoxicity,BP,
12283,GO:0045954,1,0.888182932796511,0,19,positive regulation of natural killer cell mediated cytotoxicity,BP,
12284,GO:0045955,1,0.942584031750801,0,9,negative regulation of calcium ion-dependent exocytosis,BP,
12285,GO:0045956,1,0.866322744167694,0,22,positive regulation of calcium ion-dependent exocytosis,BP,
12286,GO:0045957,1,0.991956535396447,0,1,negative regulation of complement activation, alternative pathway,BP,
12287,GO:0045959,1,0.986004056279632,0,2,negative regulation of complement activation, classical pathway,BP,
12288,GO:0045963,1,0.981119780014937,0,3,negative regulation of dopamine metabolic process,BP,
12290,GO:0045967,1,0.983365800709758,0,2,negative regulation of growth rate,BP,
12291,GO:0045974,1,0.915095174835725,0,13,regulation of translation, ncRNA-mediated,BP,
12292,GO:0045976,1,0.987221356623409,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
12293,GO:0045977,1,0.994227529862516,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
12295,GO:0045981,1,0.636741082743025,0,72,positive regulation of nucleotide metabolic process,BP,
12297,GO:0045987,1,0.828194512680439,0,30,positive regulation of smooth muscle contraction,BP,
12298,GO:0045988,1,0.955246440803454,0,7,negative regulation of striated muscle contraction,BP,
12299,GO:0045989,1,0.917782109680787,0,14,positive regulation of striated muscle contraction,BP,
12300,GO:0045990,1,0.968718680678289,0,5,carbon catabolite regulation of transcription,BP,
12301,GO:0045991,1,0.968718680678289,0,5,carbon catabolite activation of transcription,BP,
12302,GO:0045992,1,0.851116068131459,0,25,negative regulation of embryonic development,BP,
12303,GO:0045993,1,0.993360879946457,0,1,negative regulation of translational initiation by iron,BP,
12304,GO:0045994,1,0.987262799613385,0,2,positive regulation of translational initiation by iron,BP,
12306,GO:0046005,1,0.988858183535638,0,2,positive regulation of circadian sleep/wake cycle, REM sleep,BP,
12307,GO:0046006,1,0.820128758992542,0,32,regulation of activated T cell proliferation,BP,
12308,GO:0046007,1,0.932565028633014,0,11,negative regulation of activated T cell proliferation,BP,
12309,GO:0046010,1,0.982399096307245,0,3,positive regulation of circadian sleep/wake cycle, non-REM sleep,BP,
12310,GO:0046013,1,0.988033767399883,0,2,regulation of T cell homeostatic proliferation,BP,
12311,GO:0046015,1,0.970188252835526,0,5,regulation of transcription by glucose,BP,
12312,GO:0046016,1,0.975885500952504,0,4,positive regulation of transcription by glucose,BP,
12313,GO:0046030,1,0.930096593550465,0,11,inositol trisphosphate phosphatase activity,MF,
12315,GO:0046032,1,0.994203705676791,0,1,ADP catabolic process,BP,
12316,GO:0046033,1,0.935033680320281,0,11,AMP metabolic process,BP,
12318,GO:0046035,1,0.994287018170238,0,1,CMP metabolic process,BP,
12319,GO:0046036,1,0.926535925998902,0,13,CTP metabolic process,BP,
12320,GO:0046037,1,0.872373572060597,0,21,GMP metabolic process,BP,
12321,GO:0046038,1,0.994237637088681,0,1,GMP catabolic process,BP,
12322,GO:0046039,1,0.8306458884622,0,30,GTP metabolic process,BP,
12323,GO:0046040,1,0.921600790300217,0,13,IMP metabolic process,BP,
12324,GO:0046041,1,0.988247645849723,0,2,ITP metabolic process,BP,
12325,GO:0046048,1,0.993801070054312,0,1,UDP metabolic process,BP,
12326,GO:0046049,1,0.940405837511897,0,10,UMP metabolic process,BP,
12327,GO:0046051,1,0.942175477870733,0,10,UTP metabolic process,BP,
12328,GO:0046054,1,0.994360946082344,0,1,dGMP metabolic process,BP,
12331,GO:0046060,1,0.97111831417299,0,5,dATP metabolic process,BP,
12332,GO:0046061,1,0.982470291564738,0,3,dATP catabolic process,BP,
12333,GO:0046065,1,0.994324559538955,0,1,dCTP metabolic process,BP,
12334,GO:0046066,1,0.988241377791679,0,2,dGDP metabolic process,BP,
12335,GO:0046068,1,0.760119533090003,0,42,cGMP metabolic process,BP,
12336,GO:0046069,1,0.96084526497178,0,6,cGMP catabolic process,BP,
12337,GO:0046070,1,0.976786344432225,0,4,dGTP metabolic process,BP,
12338,GO:0046072,1,0.988138766958563,0,2,dTDP metabolic process,BP,
12339,GO:0046073,1,0.982291012174994,0,3,dTMP metabolic process,BP,
12340,GO:0046075,1,0.976761976502778,0,4,dTTP metabolic process,BP,
12341,GO:0046077,1,0.988138766958563,0,2,dUDP metabolic process,BP,
12342,GO:0046078,1,0.971061955998666,0,5,dUMP metabolic process,BP,
12343,GO:0046079,1,0.994188833591182,0,1,dUMP catabolic process,BP,
12344,GO:0046080,1,0.994105954512412,0,1,dUTP metabolic process,BP,
12345,GO:0046081,1,0.994105954512412,0,1,dUTP catabolic process,BP,
12346,GO:0046083,1,0.98285869723903,0,3,adenine metabolic process,BP,
12347,GO:0046084,1,0.98285869723903,0,3,adenine biosynthetic process,BP,
12348,GO:0046085,1,0.945973547208826,0,9,adenosine metabolic process,BP,
12349,GO:0046086,1,0.9875708825242,0,2,adenosine biosynthetic process,BP,
12350,GO:0046087,1,0.953710393298115,0,8,cytidine metabolic process,BP,
12351,GO:0046090,1,0.994202694953115,0,1,deoxyadenosine metabolic process,BP,
12352,GO:0046092,1,0.993193794409005,0,1,deoxycytidine metabolic process,BP,
12354,GO:0046099,1,0.988360845850408,0,2,guanine biosynthetic process,BP,
12355,GO:0046100,1,0.970802287355784,0,5,hypoxanthine metabolic process,BP,
12356,GO:0046101,1,0.976575734892632,0,4,hypoxanthine biosynthetic process,BP,
12357,GO:0046102,1,0.982163551660357,0,3,inosine metabolic process,BP,
12358,GO:0046103,1,0.988142653413691,0,2,inosine biosynthetic process,BP,
12359,GO:0046104,1,0.981242075717896,0,3,thymidine metabolic process,BP,
12360,GO:0046108,1,0.988109364005533,0,2,uridine metabolic process,BP,
12361,GO:0046110,1,0.980541886365485,0,3,xanthine metabolic process,BP,
12362,GO:0046111,1,0.994202694953115,0,1,xanthine biosynthetic process,BP,
12363,GO:0046112,1,0.886848937968659,0,19,nucleobase biosynthetic process,BP,
12365,GO:0046116,1,0.98249922809034,0,3,queuosine metabolic process,BP,
12366,GO:0046121,1,0.982201863601205,0,3,deoxyribonucleoside catabolic process,BP,
12367,GO:0046122,1,0.988589970791107,0,2,purine deoxyribonucleoside metabolic process,BP,
12368,GO:0046124,1,0.994202694953115,0,1,purine deoxyribonucleoside catabolic process,BP,
12369,GO:0046125,1,0.981242075717896,0,3,pyrimidine deoxyribonucleoside metabolic process,BP,
12370,GO:0046127,1,0.993745557971144,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
12371,GO:0046128,1,0.643682763542582,0,70,purine ribonucleoside metabolic process,BP,
12372,GO:0046129,1,0.882872988971305,0,21,purine ribonucleoside biosynthetic process,BP,
12373,GO:0046130,1,0.964124225355907,0,6,purine ribonucleoside catabolic process,BP,
12374,GO:0046131,1,0.835285485133078,0,30,pyrimidine ribonucleoside metabolic process,BP,
12375,GO:0046132,1,0.886783821185768,0,20,pyrimidine ribonucleoside biosynthetic process,BP,
12376,GO:0046133,1,0.942223136088875,0,10,pyrimidine ribonucleoside catabolic process,BP,
12377,GO:0046134,1,0.860299601227435,0,25,pyrimidine nucleoside biosynthetic process,BP,
12378,GO:0046135,1,0.887288084710601,0,20,pyrimidine nucleoside catabolic process,BP,
12379,GO:0046136,1,0.988412816122182,0,2,positive regulation of vitamin metabolic process,BP,
12380,GO:0046137,1,0.964292785971033,0,6,negative regulation of vitamin metabolic process,BP,
12381,GO:0046144,1,0.99418450191171,0,1,D-alanine family amino acid metabolic process,BP,
12382,GO:0046146,1,0.959409760868636,0,7,tetrahydrobiopterin metabolic process,BP,
12383,GO:0046148,1,0.729059954749748,0,50,pigment biosynthetic process,BP,
12384,GO:0046149,1,0.977272184932079,0,4,pigment catabolic process,BP,
12385,GO:0046160,1,0.9864376874449,0,2,heme a metabolic process,BP,
12386,GO:0046164,1,0.774524731196488,0,41,alcohol catabolic process,BP,
12388,GO:0046166,1,0.988296839507515,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
12389,GO:0046167,1,0.98529624882253,0,2,glycerol-3-phosphate biosynthetic process,BP,
12390,GO:0046168,1,0.987377312369366,0,2,glycerol-3-phosphate catabolic process,BP,
12391,GO:0046173,1,0.722343355653836,0,52,polyol biosynthetic process,BP,
12392,GO:0046174,1,0.894753093837006,0,17,polyol catabolic process,BP,
12393,GO:0046176,1,0.993846081630578,0,1,aldonic acid catabolic process,BP,
12394,GO:0046177,1,0.993846081630578,0,1,D-gluconate catabolic process,BP,
12395,GO:0046184,1,0.919648314365073,0,13,aldehyde biosynthetic process,BP,
12396,GO:0046185,1,0.941921455297269,0,10,aldehyde catabolic process,BP,
12398,GO:0046203,1,0.988493780027599,0,2,spermidine catabolic process,BP,
12399,GO:0046204,1,0.994368454463406,0,1,nor-spermidine metabolic process,BP,
12400,GO:0046208,1,0.976757631539327,0,4,spermine catabolic process,BP,
12401,GO:0046209,1,0.676109314301733,0,61,nitric oxide metabolic process,BP,
12402,GO:0046210,1,0.993922533251768,0,1,nitric oxide catabolic process,BP,
12403,GO:0046218,1,0.958938004693819,0,7,indolalkylamine catabolic process,BP,
12404,GO:0046219,1,0.976577396181416,0,4,indolalkylamine biosynthetic process,BP,
12405,GO:0046222,1,0.993856415233832,0,1,aflatoxin metabolic process,BP,
12406,GO:0046223,1,0.993856415233832,0,1,aflatoxin catabolic process,BP,
12407,GO:0046226,1,0.988471956754279,0,2,coumarin catabolic process,BP,
12408,GO:0046247,1,0.993822274700288,0,1,terpene catabolic process,BP,
12409,GO:0046271,1,0.988471956754279,0,2,phenylpropanoid catabolic process,BP,
12410,GO:0046272,1,0.994009264215723,0,1,stilbene catabolic process,BP,
12411,GO:0046292,1,0.981571346618266,0,3,formaldehyde metabolic process,BP,
12412,GO:0046293,1,0.993273528885892,0,1,formaldehyde biosynthetic process,BP,
12413,GO:0046294,1,0.988219376908243,0,2,formaldehyde catabolic process,BP,
12414,GO:0046295,1,0.994377406787888,0,1,glycolate biosynthetic process,BP,
12415,GO:0046296,1,0.994141762526464,0,1,glycolate catabolic process,BP,
12416,GO:0046305,1,0.98808254714732,0,2,alkanesulfonate biosynthetic process,BP,
12417,GO:0046316,1,0.993846081630578,0,1,gluconokinase activity,MF,
12418,GO:0046317,1,0.993176940438187,0,1,regulation of glucosylceramide biosynthetic process,BP,
12419,GO:0046318,1,0.993176940438187,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
12421,GO:0046321,1,0.90313401166729,0,15,positive regulation of fatty acid oxidation,BP,
12422,GO:0046322,1,0.949985073045302,0,8,negative regulation of fatty acid oxidation,BP,
12423,GO:0046323,1,0.639215595606547,0,68,glucose import,BP,
12424,GO:0046324,1,0.692217337644246,0,56,regulation of glucose import,BP,
12425,GO:0046325,1,0.927614778334421,0,12,negative regulation of glucose import,BP,
12426,GO:0046326,1,0.78650448884945,0,36,positive regulation of glucose import,BP,
12427,GO:0046327,1,0.987986796739416,0,2,glycerol biosynthetic process from pyruvate,BP,
12429,GO:0046329,1,0.824688996917415,0,30,negative regulation of JNK cascade,BP,
12431,GO:0046331,1,0.987955417097345,0,2,lateral inhibition,BP,
12432,GO:0046332,1,0.607945322624476,0,74,SMAD binding,MF,
12433,GO:0046333,1,0.987654759371155,0,2,octopamine metabolic process,BP,
12435,GO:0046338,1,0.987528197425683,0,2,phosphatidylethanolamine catabolic process,BP,
12436,GO:0046339,1,0.925125622567717,0,12,diacylglycerol metabolic process,BP,
12437,GO:0046340,1,0.980525112949974,0,3,diacylglycerol catabolic process,BP,
12438,GO:0046341,1,0.924211033021224,0,12,CDP-diacylglycerol metabolic process,BP,
12439,GO:0046348,1,0.925034087498899,0,13,amino sugar catabolic process,BP,
12440,GO:0046349,1,0.921414399419075,0,13,amino sugar biosynthetic process,BP,
12441,GO:0046351,1,0.975885403378526,0,4,disaccharide biosynthetic process,BP,
12442,GO:0046355,1,0.993689558529205,0,1,mannan catabolic process,BP,
12443,GO:0046356,1,0.988417415022392,0,2,acetyl-CoA catabolic process,BP,
12444,GO:0046359,1,0.994092094599453,0,1,butyrate catabolic process,BP,
12445,GO:0046360,1,0.994036094605325,0,1,2-oxobutyrate biosynthetic process,BP,
12446,GO:0046361,1,0.994036094605325,0,1,2-oxobutyrate metabolic process,BP,
12447,GO:0046364,1,0.62505883609711,0,76,monosaccharide biosynthetic process,BP,
12448,GO:0046365,1,0.706542836145103,0,56,monosaccharide catabolic process,BP,
12449,GO:0046368,1,0.975850954855776,0,4,GDP-L-fucose metabolic process,BP,
12450,GO:0046370,1,0.988193131373814,0,2,fructose biosynthetic process,BP,
12451,GO:0046373,1,0.987729649828399,0,2,L-arabinose metabolic process,BP,
12452,GO:0046379,1,0.981730161746108,0,3,extracellular polysaccharide metabolic process,BP,
12453,GO:0046380,1,0.993554819813192,0,1,N-acetylneuraminate biosynthetic process,BP,
12454,GO:0046381,1,0.99428875084381,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12456,GO:0046386,1,0.892480917612512,0,19,deoxyribose phosphate catabolic process,BP,
12458,GO:0046391,1,0.981884148045966,0,3,5-phosphoribose 1-diphosphate metabolic process,BP,
12461,GO:0046398,1,0.974296086047636,0,4,UDP-glucuronate metabolic process,BP,
12462,GO:0046403,1,0.994148115699068,0,1,polynucleotide 3'-phosphatase activity,MF,
12463,GO:0046404,1,0.981091167560702,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
12464,GO:0046415,1,0.951905335435117,0,8,urate metabolic process,BP,
12465,GO:0046416,1,0.982397898585643,0,3,D-amino acid metabolic process,BP,
12466,GO:0046425,1,0.49883994453719,0,110,regulation of JAK-STAT cascade,BP,
12467,GO:0046426,1,0.75174810925342,0,45,negative regulation of JAK-STAT cascade,BP,
12468,GO:0046427,1,0.68968099456997,0,59,positive regulation of JAK-STAT cascade,BP,
12470,GO:0046436,1,0.99418450191171,0,1,D-alanine metabolic process,BP,
12471,GO:0046437,1,0.993930880583482,0,1,D-amino acid biosynthetic process,BP,
12472,GO:0046439,1,0.95741119577062,0,7,L-cysteine metabolic process,BP,
12473,GO:0046440,1,0.974966529228788,0,4,L-lysine metabolic process,BP,
12474,GO:0046443,1,0.994077225514179,0,1,FAD metabolic process,BP,
12475,GO:0046444,1,0.993865891603955,0,1,FMN metabolic process,BP,
12476,GO:0046448,1,0.993941245723192,0,1,tropane alkaloid metabolic process,BP,
12477,GO:0046449,1,0.973260818027747,0,4,creatinine metabolic process,BP,
12478,GO:0046452,1,0.982005407260343,0,3,dihydrofolate metabolic process,BP,
12481,GO:0046459,1,0.906230372619211,0,16,short-chain fatty acid metabolic process,BP,
12482,GO:0046460,1,0.826025081708244,0,30,neutral lipid biosynthetic process,BP,
12483,GO:0046461,1,0.818219202109683,0,32,neutral lipid catabolic process,BP,
12484,GO:0046462,1,0.988014057761391,0,2,monoacylglycerol metabolic process,BP,
12485,GO:0046463,1,0.826025081708244,0,30,acylglycerol biosynthetic process,BP,
12486,GO:0046464,1,0.818219202109683,0,32,acylglycerol catabolic process,BP,
12487,GO:0046465,1,0.957817901991301,0,7,dolichyl diphosphate metabolic process,BP,
12488,GO:0046466,1,0.85724296608646,0,25,membrane lipid catabolic process,BP,
12490,GO:0046469,1,0.962926076881716,0,6,platelet activating factor metabolic process,BP,
12492,GO:0046471,1,0.843468743493759,0,27,phosphatidylglycerol metabolic process,BP,
12493,GO:0046473,1,0.80174347662777,0,34,phosphatidic acid metabolic process,BP,
12496,GO:0046476,1,0.957798027175978,0,7,glycosylceramide biosynthetic process,BP,
12497,GO:0046477,1,0.957946294673847,0,7,glycosylceramide catabolic process,BP,
12498,GO:0046478,1,0.993261591024723,0,1,lactosylceramide metabolic process,BP,
12499,GO:0046479,1,0.929145838833122,0,12,glycosphingolipid catabolic process,BP,
12501,GO:0046485,1,0.945161188445034,0,9,ether lipid metabolic process,BP,
12503,GO:0046487,1,0.958824726542884,0,7,glyoxylate metabolic process,BP,
12505,GO:0046490,1,0.976682294816776,0,4,isopentenyl diphosphate metabolic process,BP,
12506,GO:0046491,1,0.994396177882901,0,1,L-methylmalonyl-CoA metabolic process,BP,
12507,GO:0046493,1,0.988946073143875,0,2,lipid A metabolic process,BP,
12508,GO:0046495,1,0.993949885713262,0,1,nicotinamide riboside metabolic process,BP,
12509,GO:0046496,1,0.367365211966496,0,157,nicotinamide nucleotide metabolic process,BP,
12510,GO:0046497,1,0.993846081630578,0,1,nicotinate nucleotide metabolic process,BP,
12511,GO:0046498,1,0.9636339744068,0,6,S-adenosylhomocysteine metabolic process,BP,
12512,GO:0046499,1,0.993705980361278,0,1,S-adenosylmethioninamine metabolic process,BP,
12513,GO:0046500,1,0.92807355821095,0,12,S-adenosylmethionine metabolic process,BP,
12514,GO:0046501,1,0.940066123504347,0,10,protoporphyrinogen IX metabolic process,BP,
12515,GO:0046502,1,0.988309194574336,0,2,uroporphyrinogen III metabolic process,BP,
12517,GO:0046504,1,0.968304572427629,0,5,glycerol ether biosynthetic process,BP,
12518,GO:0046511,1,0.986709614753125,0,2,sphinganine biosynthetic process,BP,
12519,GO:0046512,1,0.945502917359689,0,9,sphingosine biosynthetic process,BP,
12520,GO:0046513,1,0.712616953369637,0,54,ceramide biosynthetic process,BP,
12521,GO:0046514,1,0.918413608341903,0,14,ceramide catabolic process,BP,
12522,GO:0046519,1,0.916464812454392,0,14,sphingoid metabolic process,BP,
12523,GO:0046520,1,0.939389835477796,0,10,sphingoid biosynthetic process,BP,
12524,GO:0046521,1,0.994108264596255,0,1,sphingoid catabolic process,BP,
12525,GO:0046523,1,0.993751133383812,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
12526,GO:0046525,1,0.994148404479436,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
12527,GO:0046526,1,0.993916777748947,0,1,D-xylulose reductase activity,MF,
12528,GO:0046527,1,0.901588594569066,0,16,glucosyltransferase activity,MF,
12529,GO:0046530,1,0.710466511204677,0,52,photoreceptor cell differentiation,BP,
12530,GO:0046532,1,0.961927807237213,0,6,regulation of photoreceptor cell differentiation,BP,
12531,GO:0046533,1,0.961927807237213,0,6,negative regulation of photoreceptor cell differentiation,BP,
12532,GO:0046538,1,0.976999672609092,0,4,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
12533,GO:0046539,1,0.994385781568125,0,1,histamine N-methyltransferase activity,MF,
12534,GO:0046540,1,0.867061889521555,0,23,U4/U6 x U5 tri-snRNP complex,CC,
12535,GO:0046541,1,0.941253278920289,0,10,saliva secretion,BP,
12536,GO:0046543,1,0.955677136779145,0,7,development of secondary female sexual characteristics,BP,
12537,GO:0046544,1,0.993178092995635,0,1,development of secondary male sexual characteristics,BP,
12538,GO:0046545,1,0.557905261490225,0,90,development of primary female sexual characteristics,BP,
12540,GO:0046548,1,0.955454708893956,0,7,retinal rod cell development,BP,
12541,GO:0046549,1,0.950833669040464,0,8,retinal cone cell development,BP,
12542,GO:0046554,1,0.994269402675484,0,1,malate dehydrogenase (NADP+) activity,MF,
12543,GO:0046556,1,0.987729649828399,0,2,alpha-L-arabinofuranosidase activity,MF,
12544,GO:0046570,1,0.994282975266729,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
12545,GO:0046573,1,0.982715684463169,0,3,lactonohydrolase activity,MF,
12546,GO:0046577,1,0.993562386706456,0,1,long-chain-alcohol oxidase activity,MF,
12550,GO:0046581,1,0.960634511490476,0,6,intercellular canaliculus,CC,
12551,GO:0046586,1,0.988198518892016,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
12552,GO:0046587,1,0.993778738287005,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
12553,GO:0046588,1,0.994385203996264,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
12554,GO:0046592,1,0.988239275505747,0,2,polyamine oxidase activity,MF,
12555,GO:0046596,1,0.852839758024718,0,26,regulation of viral entry into host cell,BP,
12556,GO:0046597,1,0.906288186262021,0,16,negative regulation of viral entry into host cell,BP,
12557,GO:0046598,1,0.94721675237538,0,9,positive regulation of viral entry into host cell,BP,
12558,GO:0046599,1,0.895764726017955,0,17,regulation of centriole replication,BP,
12559,GO:0046600,1,0.948500078680021,0,8,negative regulation of centriole replication,BP,
12560,GO:0046601,1,0.981029517462849,0,3,positive regulation of centriole replication,BP,
12561,GO:0046602,1,0.936764476226527,0,10,regulation of mitotic centrosome separation,BP,
12562,GO:0046603,1,0.994232294697729,0,1,negative regulation of mitotic centrosome separation,BP,
12563,GO:0046604,1,0.973478476997275,0,4,positive regulation of mitotic centrosome separation,BP,
12564,GO:0046605,1,0.703927403446549,0,54,regulation of centrosome cycle,BP,
12565,GO:0046606,1,0.914393298158149,0,14,negative regulation of centrosome cycle,BP,
12566,GO:0046607,1,0.936123709874592,0,10,positive regulation of centrosome cycle,BP,
12567,GO:0046618,1,0.969167775863471,0,5,drug export,BP,
12568,GO:0046619,1,0.986477607297271,0,2,optic placode formation involved in camera-type eye formation,BP,
12569,GO:0046620,1,0.5848289053566,0,82,regulation of organ growth,BP,
12570,GO:0046621,1,0.854057380947411,0,24,negative regulation of organ growth,BP,
12571,GO:0046622,1,0.748830474049713,0,44,positive regulation of organ growth,BP,
12572,GO:0046623,1,0.992802204087989,0,1,sphingolipid-translocating ATPase activity,MF,
12573,GO:0046624,1,0.944307326358508,0,9,sphingolipid transporter activity,MF,
12575,GO:0046626,1,0.733635065956343,0,48,regulation of insulin receptor signaling pathway,BP,
12576,GO:0046627,1,0.820592198502067,0,31,negative regulation of insulin receptor signaling pathway,BP,
12577,GO:0046628,1,0.928393428953866,0,11,positive regulation of insulin receptor signaling pathway,BP,
12578,GO:0046629,1,0.932213732136403,0,11,gamma-delta T cell activation,BP,
12579,GO:0046631,1,0.511119616984116,0,106,alpha-beta T cell activation,BP,
12580,GO:0046632,1,0.589347777817457,0,83,alpha-beta T cell differentiation,BP,
12581,GO:0046633,1,0.866708849304024,0,23,alpha-beta T cell proliferation,BP,
12582,GO:0046634,1,0.657307794828304,0,67,regulation of alpha-beta T cell activation,BP,
12583,GO:0046635,1,0.757017219915696,0,45,positive regulation of alpha-beta T cell activation,BP,
12584,GO:0046636,1,0.852711956826784,0,25,negative regulation of alpha-beta T cell activation,BP,
12585,GO:0046637,1,0.743396703597364,0,47,regulation of alpha-beta T cell differentiation,BP,
12586,GO:0046638,1,0.809365071357705,0,34,positive regulation of alpha-beta T cell differentiation,BP,
12587,GO:0046639,1,0.901307999249583,0,16,negative regulation of alpha-beta T cell differentiation,BP,
12588,GO:0046640,1,0.883865262231762,0,20,regulation of alpha-beta T cell proliferation,BP,
12589,GO:0046641,1,0.907188465770973,0,16,positive regulation of alpha-beta T cell proliferation,BP,
12590,GO:0046642,1,0.969284147608036,0,5,negative regulation of alpha-beta T cell proliferation,BP,
12591,GO:0046643,1,0.961181522632558,0,6,regulation of gamma-delta T cell activation,BP,
12592,GO:0046645,1,0.967498429176533,0,5,positive regulation of gamma-delta T cell activation,BP,
12593,GO:0046649,1,0.0259597200242235,0,568,lymphocyte activation,BP,
12594,GO:0046651,1,0.249197905725338,0,222,lymphocyte proliferation,BP,
12595,GO:0046653,1,0.893875127871513,0,18,tetrahydrofolate metabolic process,BP,
12596,GO:0046654,1,0.957666303560741,0,7,tetrahydrofolate biosynthetic process,BP,
12597,GO:0046655,1,0.881347998239228,0,20,folic acid metabolic process,BP,
12598,GO:0046657,1,0.987722019129196,0,2,folic acid catabolic process,BP,
12599,GO:0046658,1,0.789259960413257,0,38,anchored component of plasma membrane,CC,
12602,GO:0046666,1,0.976375100282277,0,4,retinal cell programmed cell death,BP,
12603,GO:0046668,1,0.987679167402451,0,2,regulation of retinal cell programmed cell death,BP,
12604,GO:0046671,1,0.993539826189683,0,1,negative regulation of retinal cell programmed cell death,BP,
12607,GO:0046680,1,0.994043020430024,0,1,response to DDT,BP,
12609,GO:0046684,1,0.97588750128413,0,4,response to pyrethroid,BP,
12610,GO:0046685,1,0.83588517128952,0,29,response to arsenic-containing substance,BP,
12611,GO:0046686,1,0.712488349096357,0,56,response to cadmium ion,BP,
12612,GO:0046687,1,0.994330768330158,0,1,response to chromate,BP,
12613,GO:0046688,1,0.836109814682091,0,30,response to copper ion,BP,
12614,GO:0046689,1,0.952349212468451,0,8,response to mercury ion,BP,
12615,GO:0046690,1,0.993643024809225,0,1,response to tellurium ion,BP,
12616,GO:0046691,1,0.993821701351506,0,1,intracellular canaliculus,CC,
12617,GO:0046695,1,0.982348470549682,0,3,SLIK (SAGA-like) complex,CC,
12618,GO:0046696,1,0.969785109901828,0,5,lipopolysaccharide receptor complex,CC,
12619,GO:0046697,1,0.885284923400952,0,19,decidualization,BP,
12621,GO:0046703,1,0.959871363151761,0,7,natural killer cell lectin-like receptor binding,MF,
12622,GO:0046707,1,0.987156818245337,0,2,IDP metabolic process,BP,
12623,GO:0046709,1,0.987156818245337,0,2,IDP catabolic process,BP,
12624,GO:0046710,1,0.916256552687515,0,13,GDP metabolic process,BP,
12625,GO:0046711,1,0.994360946082344,0,1,GDP biosynthetic process,BP,
12626,GO:0046713,1,0.993748417049011,0,1,borate transport,BP,
12627,GO:0046715,1,0.993748417049011,0,1,active borate transmembrane transporter activity,MF,
12628,GO:0046716,1,0.909422072712764,0,15,muscle cell cellular homeostasis,BP,
12631,GO:0046719,1,0.957208795954534,0,7,regulation by virus of viral protein levels in host cell,BP,
12632,GO:0046724,1,0.988099555489292,0,2,oxalic acid secretion,BP,
12633,GO:0046725,1,0.99361819331252,0,1,negative regulation by virus of viral protein levels in host cell,BP,
12634,GO:0046726,1,0.974481176983055,0,4,positive regulation by virus of viral protein levels in host cell,BP,
12635,GO:0046730,1,0.994011283271499,0,1,induction of host immune response by virus,BP,
12636,GO:0046732,1,0.994011283271499,0,1,active induction of host immune response by virus,BP,
12637,GO:0046745,1,0.993846081630578,0,1,viral capsid secondary envelopment,BP,
12638,GO:0046755,1,0.864126029613858,0,24,viral budding,BP,
12640,GO:0046778,1,0.987925895851358,0,2,modification by virus of host mRNA processing,BP,
12641,GO:0046782,1,0.685515016291685,0,60,regulation of viral transcription,BP,
12642,GO:0046784,1,0.95239137109179,0,8,viral mRNA export from host cell nucleus,BP,
12644,GO:0046786,1,0.993234252518537,0,1,viral replication complex formation and maintenance,BP,
12645,GO:0046789,1,0.993724407370571,0,1,host cell surface receptor binding,MF,
12646,GO:0046790,1,0.966409316708792,0,5,virion binding,MF,
12647,GO:0046794,1,0.697779764998139,0,56,transport of virus,BP,
12648,GO:0046811,1,0.987513122381573,0,2,histone deacetylase inhibitor activity,MF,
12649,GO:0046812,1,0.993724407370571,0,1,host cell surface binding,MF,
12650,GO:0046813,1,0.968819016566895,0,5,receptor-mediated virion attachment to host cell,BP,
12651,GO:0046822,1,0.530518795405792,0,97,regulation of nucleocytoplasmic transport,BP,
12652,GO:0046823,1,0.887016381379943,0,19,negative regulation of nucleocytoplasmic transport,BP,
12653,GO:0046824,1,0.693621759454279,0,55,positive regulation of nucleocytoplasmic transport,BP,
12654,GO:0046825,1,0.77593669985019,0,39,regulation of protein export from nucleus,BP,
12655,GO:0046826,1,0.95819652412157,0,7,negative regulation of protein export from nucleus,BP,
12656,GO:0046827,1,0.876926349040804,0,20,positive regulation of protein export from nucleus,BP,
12657,GO:0046831,1,0.903453165880155,0,15,regulation of RNA export from nucleus,BP,
12658,GO:0046832,1,0.984896382526277,0,2,negative regulation of RNA export from nucleus,BP,
12659,GO:0046833,1,0.954971657172077,0,7,positive regulation of RNA export from nucleus,BP,
12661,GO:0046835,1,0.84840010289464,0,26,carbohydrate phosphorylation,BP,
12662,GO:0046836,1,0.969804250790903,0,5,glycolipid transport,BP,
12663,GO:0046838,1,0.931158337558119,0,11,phosphorylated carbohydrate dephosphorylation,BP,
12664,GO:0046839,1,0.851743896437774,0,24,phospholipid dephosphorylation,BP,
12666,GO:0046848,1,0.994492923751266,0,1,hydroxyapatite binding,MF,
12670,GO:0046852,1,0.918040284428818,0,13,positive regulation of bone remodeling,BP,
12672,GO:0046855,1,0.937014678071803,0,10,inositol phosphate dephosphorylation,BP,
12673,GO:0046856,1,0.856885342735931,0,23,phosphatidylinositol dephosphorylation,BP,
12674,GO:0046864,1,0.988238062880966,0,2,isoprenoid transport,BP,
12675,GO:0046865,1,0.988238062880966,0,2,terpenoid transport,BP,
12679,GO:0046874,1,0.976108726083706,0,4,quinolinate metabolic process,BP,
12680,GO:0046875,1,0.839493123288558,0,27,ephrin receptor binding,MF,
12681,GO:0046877,1,0.964382047767833,0,6,regulation of saliva secretion,BP,
12682,GO:0046878,1,0.981987750555828,0,3,positive regulation of saliva secretion,BP,
12684,GO:0046880,1,0.962167648350802,0,6,regulation of follicle-stimulating hormone secretion,BP,
12685,GO:0046881,1,0.962167648350802,0,6,positive regulation of follicle-stimulating hormone secretion,BP,
12686,GO:0046882,1,0.982087968707722,0,3,negative regulation of follicle-stimulating hormone secretion,BP,
12688,GO:0046884,1,0.955698653750154,0,7,follicle-stimulating hormone secretion,BP,
12689,GO:0046885,1,0.858403850230657,0,24,regulation of hormone biosynthetic process,BP,
12690,GO:0046886,1,0.944321961074986,0,9,positive regulation of hormone biosynthetic process,BP,
12695,GO:0046898,1,0.973894815461997,0,4,response to cycloheximide,BP,
12696,GO:0046899,1,0.987767615668282,0,2,nucleoside triphosphate adenylate kinase activity,MF,
12697,GO:0046900,1,0.988178458642561,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
12698,GO:0046901,1,0.993927714100447,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
12703,GO:0046911,1,0.9943066551631,0,1,metal chelating activity,MF,
12704,GO:0046912,1,0.968169456306269,0,5,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
12708,GO:0046920,1,0.94851216743802,0,8,alpha-(1->3)-fucosyltransferase activity,MF,
12709,GO:0046921,1,0.993698697076839,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
12710,GO:0046922,1,0.987475905635847,0,2,peptide-O-fucosyltransferase activity,MF,
12711,GO:0046923,1,0.970469384284761,0,5,ER retention sequence binding,MF,
12713,GO:0046929,1,0.934381522407651,0,10,negative regulation of neurotransmitter secretion,BP,
12714,GO:0046930,1,0.912108706606665,0,15,pore complex,CC,
12715,GO:0046931,1,0.901607838577799,0,16,pore complex assembly,BP,
12716,GO:0046933,1,0.982897249494981,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
12718,GO:0046935,1,0.96739454633836,0,5,1-phosphatidylinositol-3-kinase regulator activity,MF,
12720,GO:0046940,1,0.970041342958619,0,5,nucleoside monophosphate phosphorylation,BP,
12723,GO:0046946,1,0.981163422797705,0,3,hydroxylysine metabolic process,BP,
12724,GO:0046947,1,0.981163422797705,0,3,hydroxylysine biosynthetic process,BP,
12725,GO:0046949,1,0.843974858435257,0,27,fatty-acyl-CoA biosynthetic process,BP,
12726,GO:0046950,1,0.934742407658309,0,11,cellular ketone body metabolic process,BP,
12727,GO:0046951,1,0.94631527882685,0,9,ketone body biosynthetic process,BP,
12728,GO:0046952,1,0.975661139462546,0,4,ketone body catabolic process,BP,
12729,GO:0046958,1,0.960858952149148,0,6,nonassociative learning,BP,
12730,GO:0046959,1,0.972823556857538,0,4,habituation,BP,
12731,GO:0046960,1,0.987676206228736,0,2,sensitization,BP,
12732,GO:0046961,1,0.88482885507593,0,20,proton-transporting ATPase activity, rotational mechanism,MF,
12733,GO:0046963,1,0.988142684895526,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
12734,GO:0046964,1,0.988142684895526,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
12735,GO:0046965,1,0.906616418898066,0,15,retinoid X receptor binding,MF,
12736,GO:0046966,1,0.835258788627742,0,27,thyroid hormone receptor binding,MF,
12737,GO:0046967,1,0.98732186986591,0,2,cytosol to ER transport,BP,
12738,GO:0046968,1,0.986962004642377,0,2,peptide antigen transport,BP,
12739,GO:0046969,1,0.987751751576033,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
12740,GO:0046970,1,0.994084587661038,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
12741,GO:0046972,1,0.937150942842496,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
12742,GO:0046974,1,0.968020139238011,0,5,histone methyltransferase activity (H3-K9 specific),MF,
12743,GO:0046975,1,0.957419772855593,0,6,histone methyltransferase activity (H3-K36 specific),MF,
12744,GO:0046976,1,0.968695211527836,0,5,histone methyltransferase activity (H3-K27 specific),MF,
12745,GO:0046977,1,0.975422516703803,0,4,TAP binding,MF,
12746,GO:0046978,1,0.975422516703803,0,4,TAP1 binding,MF,
12747,GO:0046979,1,0.981817349009992,0,3,TAP2 binding,MF,
12748,GO:0046980,1,0.99348795489116,0,1,tapasin binding,MF,
12751,GO:0046984,1,0.975631081843815,0,4,regulation of hemoglobin biosynthetic process,BP,
12752,GO:0046985,1,0.98215290731198,0,3,positive regulation of hemoglobin biosynthetic process,BP,
12753,GO:0046986,1,0.993360879946457,0,1,negative regulation of hemoglobin biosynthetic process,BP,
12754,GO:0046996,1,0.993846081630578,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
12755,GO:0046997,1,0.987486541334719,0,2,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,
12756,GO:0047006,1,0.988513597346295,0,2,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
12757,GO:0047012,1,0.994184790690414,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
12758,GO:0047015,1,0.994372353053026,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
12759,GO:0047016,1,0.994015321608265,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
12760,GO:0047017,1,0.988173640634071,0,2,prostaglandin-F synthase activity,MF,
12761,GO:0047020,1,0.994292793750381,0,1,15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,MF,
12762,GO:0047021,1,0.994287884506968,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12763,GO:0047023,1,0.977252045272567,0,4,androsterone dehydrogenase activity,MF,
12764,GO:0047025,1,0.988047676540027,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
12765,GO:0047035,1,0.966017701788953,0,6,testosterone dehydrogenase (NAD+) activity,MF,
12766,GO:0047042,1,0.994247744315977,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12767,GO:0047045,1,0.982995197690625,0,3,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
12768,GO:0047057,1,0.988723932762689,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
12769,GO:0047066,1,0.994375385292897,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
12770,GO:0047086,1,0.977252045272567,0,4,ketosteroid monooxygenase activity,MF,
12771,GO:0047105,1,0.993923396668192,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
12772,GO:0047115,1,0.977284123554934,0,4,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
12773,GO:0047117,1,0.99219824858548,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
12774,GO:0047127,1,0.994250198928768,0,1,thiomorpholine-carboxylate dehydrogenase activity,MF,
12775,GO:0047130,1,0.992952742782819,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
12776,GO:0047131,1,0.992952742782819,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
12777,GO:0047134,1,0.965128789412555,0,6,protein-disulfide reductase activity,MF,
12778,GO:0047144,1,0.943296843599057,0,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
12779,GO:0047150,1,0.988031222255798,0,2,betaine-homocysteine S-methyltransferase activity,MF,
12780,GO:0047159,1,0.993509397209302,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
12781,GO:0047166,1,0.994093538286793,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
12782,GO:0047173,1,0.993241736100263,0,1,phosphatidylcholine-retinol O-acyltransferase activity,MF,
12783,GO:0047179,1,0.988670664749728,0,2,platelet-activating factor acetyltransferase activity,MF,
12784,GO:0047184,1,0.969170834563443,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
12785,GO:0047186,1,0.993527399836446,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
12786,GO:0047191,1,0.993509397209302,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
12787,GO:0047192,1,0.980820133391569,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
12788,GO:0047220,1,0.993842925050413,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
12789,GO:0047223,1,0.993823851483904,0,1,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12790,GO:0047237,1,0.981022812488175,0,3,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12791,GO:0047238,1,0.968256114766206,0,5,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12792,GO:0047256,1,0.993461919915322,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
12793,GO:0047263,1,0.993809521024471,0,1,N-acylsphingosine galactosyltransferase activity,MF,
12794,GO:0047273,1,0.993691271906932,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
12795,GO:0047275,1,0.987685571385018,0,2,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
12796,GO:0047277,1,0.994084010221686,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
12797,GO:0047280,1,0.993328288021607,0,1,nicotinamide phosphoribosyltransferase activity,MF,
12798,GO:0047288,1,0.987547279673095,0,2,monosialoganglioside sialyltransferase activity,MF,
12799,GO:0047290,1,0.994171218080227,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
12800,GO:0047291,1,0.993979853004044,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
12801,GO:0047293,1,0.994172950755259,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
12802,GO:0047298,1,0.993232525385339,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
12803,GO:0047322,1,0.985180014765096,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12804,GO:0047323,1,0.99403118924193,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
12805,GO:0047325,1,0.993708408337088,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
12806,GO:0047326,1,0.99412876740614,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
12807,GO:0047341,1,0.99366015143815,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
12808,GO:0047349,1,0.99307818105914,0,1,D-ribitol-5-phosphate cytidylyltransferase activity,MF,
12809,GO:0047369,1,0.993846081630578,0,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,
12810,GO:0047372,1,0.932636763008446,0,11,acylglycerol lipase activity,MF,
12811,GO:0047374,1,0.981993138503446,0,3,methylumbelliferyl-acetate deacetylase activity,MF,
12812,GO:0047389,1,0.986844252125163,0,2,glycerophosphocholine phosphodiesterase activity,MF,
12813,GO:0047390,1,0.993513684232251,0,1,glycerophosphocholine cholinephosphodiesterase activity,MF,
12815,GO:0047394,1,0.994000467811907,0,1,glycerophosphoinositol inositolphosphodiesterase activity,MF,
12816,GO:0047395,1,0.993799924379055,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12817,GO:0047408,1,0.987794979584285,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
12818,GO:0047409,1,0.987794979584285,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
12819,GO:0047429,1,0.945092007412114,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12820,GO:0047444,1,0.99428875084381,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12821,GO:0047451,1,0.99219824858548,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12822,GO:0047464,1,0.993196530928221,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12823,GO:0047484,1,0.944604327610132,0,9,regulation of response to osmotic stress,BP,
12824,GO:0047485,1,0.507522614574477,0,106,protein N-terminus binding,MF,
12825,GO:0047493,1,0.980778878721603,0,3,ceramide cholinephosphotransferase activity,MF,
12826,GO:0047496,1,0.77816624952409,0,38,vesicle transport along microtubule,BP,
12827,GO:0047497,1,0.881398365748399,0,19,mitochondrion transport along microtubule,BP,
12828,GO:0047498,1,0.957568027973265,0,7,calcium-dependent phospholipase A2 activity,MF,
12829,GO:0047499,1,0.96398096619088,0,6,calcium-independent phospholipase A2 activity,MF,
12830,GO:0047522,1,0.981377175489927,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
12831,GO:0047536,1,0.994004505318388,0,1,2-aminoadipate transaminase activity,MF,
12832,GO:0047545,1,0.992892079878959,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
12833,GO:0047555,1,0.922780124986856,0,12,3',5'-cyclic-GMP phosphodiesterase activity,MF,
12834,GO:0047560,1,0.993150714099861,0,1,3-dehydrosphinganine reductase activity,MF,
12835,GO:0047578,1,0.993938942085317,0,1,4-hydroxyglutamate transaminase activity,MF,
12836,GO:0047598,1,0.993880400251359,0,1,7-dehydrocholesterol reductase activity,MF,
12837,GO:0047617,1,0.913868957276308,0,15,acyl-CoA hydrolase activity,MF,
12838,GO:0047620,1,0.993799924379055,0,1,acylglycerol kinase activity,MF,
12839,GO:0047621,1,0.994161688359258,0,1,acylpyruvate hydrolase activity,MF,
12840,GO:0047623,1,0.987008302041934,0,2,adenosine-phosphate deaminase activity,MF,
12841,GO:0047631,1,0.971400786912015,0,5,ADP-ribose diphosphatase activity,MF,
12842,GO:0047635,1,0.987656863030922,0,2,alanine-oxo-acid transaminase activity,MF,
12843,GO:0047658,1,0.994156779103132,0,1,alpha-amino-acid esterase activity,MF,
12844,GO:0047661,1,0.993930880583482,0,1,amino-acid racemase activity,MF,
12845,GO:0047676,1,0.993154029000181,0,1,arachidonate-CoA ligase activity,MF,
12846,GO:0047685,1,0.994211791463895,0,1,amine sulfotransferase activity,MF,
12847,GO:0047693,1,0.994440940310254,0,1,ATP diphosphatase activity,MF,
12848,GO:0047696,1,0.987736337818134,0,2,beta-adrenergic receptor kinase activity,MF,
12849,GO:0047704,1,0.994072750715385,0,1,bile-salt sulfotransferase activity,MF,
12850,GO:0047708,1,0.988393865608496,0,2,biotinidase activity,MF,
12851,GO:0047710,1,0.987671929854316,0,2,bis(5'-adenosyl)-triphosphatase activity,MF,
12852,GO:0047718,1,0.982823602291949,0,3,indanol dehydrogenase activity,MF,
12853,GO:0047726,1,0.993922533251768,0,1,iron-cytochrome-c reductase activity,MF,
12855,GO:0047734,1,0.993846081630578,0,1,CDP-glycerol diphosphatase activity,MF,
12856,GO:0047743,1,0.99430145712971,0,1,chlordecone reductase activity,MF,
12857,GO:0047747,1,0.993962561393188,0,1,cholate-CoA ligase activity,MF,
12858,GO:0047750,1,0.988710005400097,0,2,cholestenol delta-isomerase activity,MF,
12859,GO:0047751,1,0.987909189366315,0,2,cholestenone 5-alpha-reductase activity,MF,
12860,GO:0047756,1,0.975414839313343,0,4,chondroitin 4-sulfotransferase activity,MF,
12861,GO:0047757,1,0.985512748888318,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
12862,GO:0047760,1,0.969948765063049,0,5,butyrate-CoA ligase activity,MF,
12863,GO:0047777,1,0.99298595432303,0,1,(3S)-citramalyl-CoA lyase activity,MF,
12864,GO:0047787,1,0.994292793750381,0,1,delta4-3-oxosteroid 5beta-reductase activity,MF,
12865,GO:0047800,1,0.993576233658846,0,1,cysteamine dioxygenase activity,MF,
12866,GO:0047801,1,0.994031766324357,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
12867,GO:0047837,1,0.994334089315175,0,1,D-xylose 1-dehydrogenase (NADP+) activity,MF,
12868,GO:0047840,1,0.994324559538955,0,1,dCTP diphosphatase activity,MF,
12869,GO:0047844,1,0.959223155700494,0,7,deoxycytidine deaminase activity,MF,
12870,GO:0047856,1,0.994302323468291,0,1,dihydrocoumarin hydrolase activity,MF,
12871,GO:0047860,1,0.994279509922419,0,1,diiodophenylpyruvate reductase activity,MF,
12872,GO:0047865,1,0.993754993800707,0,1,dimethylglycine dehydrogenase activity,MF,
12873,GO:0047874,1,0.994036671730784,0,1,dolichyldiphosphatase activity,MF,
12874,GO:0047888,1,0.994083721502998,0,1,fatty acid peroxidase activity,MF,
12875,GO:0047894,1,0.982818314630412,0,3,flavonol 3-sulfotransferase activity,MF,
12876,GO:0047915,1,0.994161110799932,0,1,ganglioside galactosyltransferase activity,MF,
12877,GO:0047933,1,0.992193898681344,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12878,GO:0047936,1,0.992018951213871,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
12879,GO:0047939,1,0.994221032359422,0,1,L-glucuronate reductase activity,MF,
12880,GO:0047946,1,0.994049081074231,0,1,glutamine N-acyltransferase activity,MF,
12881,GO:0047961,1,0.988332144534003,0,2,glycine N-acyltransferase activity,MF,
12882,GO:0047963,1,0.993660008707575,0,1,glycine N-choloyltransferase activity,MF,
12883,GO:0047969,1,0.994141762526464,0,1,glyoxylate oxidase activity,MF,
12884,GO:0047977,1,0.987871967818852,0,2,hepoxilin-epoxide hydrolase activity,MF,
12885,GO:0047982,1,0.994143062039743,0,1,homocysteine desulfhydrase activity,MF,
12886,GO:0047988,1,0.994097580682139,0,1,hydroxyacid-oxoacid transhydrogenase activity,MF,
12887,GO:0047992,1,0.993846081630578,0,1,hydroxylysine kinase activity,MF,
12888,GO:0048002,1,0.338657499535762,0,175,antigen processing and presentation of peptide antigen,BP,
12889,GO:0048003,1,0.968647874622299,0,5,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12890,GO:0048006,1,0.993557960885695,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
12891,GO:0048007,1,0.968647874622299,0,5,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
12892,GO:0048008,1,0.72446061007074,0,48,platelet-derived growth factor receptor signaling pathway,BP,
12893,GO:0048009,1,0.810534090093174,0,31,insulin-like growth factor receptor signaling pathway,BP,
12894,GO:0048010,1,0.556755140240014,0,91,vascular endothelial growth factor receptor signaling pathway,BP,
12895,GO:0048011,1,0.857825213317201,0,24,neurotrophin TRK receptor signaling pathway,BP,
12896,GO:0048012,1,0.904098321416843,0,16,hepatocyte growth factor receptor signaling pathway,BP,
12898,GO:0048014,1,0.979938236834248,0,3,Tie signaling pathway,BP,
12903,GO:0048019,1,0.929144163029082,0,12,receptor antagonist activity,MF,
12904,GO:0048020,1,0.884298781470687,0,21,CCR chemokine receptor binding,MF,
12905,GO:0048021,1,0.960029479264055,0,6,regulation of melanin biosynthetic process,BP,
12906,GO:0048022,1,0.985696884740094,0,2,negative regulation of melanin biosynthetic process,BP,
12907,GO:0048023,1,0.973963919489474,0,4,positive regulation of melanin biosynthetic process,BP,
12908,GO:0048024,1,0.620977547810182,0,75,regulation of mRNA splicing, via spliceosome,BP,
12909,GO:0048025,1,0.888653312069055,0,19,negative regulation of mRNA splicing, via spliceosome,BP,
12910,GO:0048026,1,0.905296913721698,0,16,positive regulation of mRNA splicing, via spliceosome,BP,
12911,GO:0048027,1,0.865863496143085,0,23,mRNA 5'-UTR binding,MF,
12912,GO:0048029,1,0.67251115417738,0,64,monosaccharide binding,MF,
12913,GO:0048030,1,0.982892380726624,0,3,disaccharide binding,MF,
12914,GO:0048033,1,0.9937816003229,0,1,heme o metabolic process,BP,
12915,GO:0048034,1,0.9937816003229,0,1,heme O biosynthetic process,BP,
12917,GO:0048038,1,0.920365665067097,0,14,quinone binding,MF,
12918,GO:0048039,1,0.965372615184647,0,6,ubiquinone binding,MF,
12919,GO:0048040,1,0.994042443251876,0,1,UDP-glucuronate decarboxylase activity,MF,
12921,GO:0048048,1,0.791892325944423,0,34,embryonic eye morphogenesis,BP,
12922,GO:0048050,1,0.962722115442867,0,6,post-embryonic eye morphogenesis,BP,
12924,GO:0048069,1,0.956474576448078,0,7,eye pigmentation,BP,
12925,GO:0048070,1,0.905902871747854,0,15,regulation of developmental pigmentation,BP,
12926,GO:0048073,1,0.986843766790804,0,2,regulation of eye pigmentation,BP,
12927,GO:0048075,1,0.993406921155481,0,1,positive regulation of eye pigmentation,BP,
12928,GO:0048087,1,0.941242466261336,0,9,positive regulation of developmental pigmentation,BP,
12930,GO:0048101,1,0.987733801669903,0,2,calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity,MF,
12931,GO:0048102,1,0.956842735033818,0,7,autophagic cell death,BP,
12932,GO:0048103,1,0.863763923153001,0,22,somatic stem cell division,BP,
12933,GO:0048104,1,0.971623021793015,0,4,establishment of body hair or bristle planar orientation,BP,
12934,GO:0048105,1,0.971623021793015,0,4,establishment of body hair planar orientation,BP,
12935,GO:0048133,1,0.981874611229399,0,3,male germ-line stem cell asymmetric division,BP,
12936,GO:0048143,1,0.922265709011295,0,12,astrocyte activation,BP,
12937,GO:0048144,1,0.610741413706664,0,77,fibroblast proliferation,BP,
12938,GO:0048145,1,0.614743849618108,0,76,regulation of fibroblast proliferation,BP,
12939,GO:0048146,1,0.735656277710476,0,48,positive regulation of fibroblast proliferation,BP,
12940,GO:0048147,1,0.843267385151183,0,27,negative regulation of fibroblast proliferation,BP,
12942,GO:0048149,1,0.938237535053019,0,10,behavioral response to ethanol,BP,
12943,GO:0048156,1,0.934262523644383,0,11,tau protein binding,MF,
12944,GO:0048160,1,0.993315933667812,0,1,primary follicle stage,BP,
12945,GO:0048162,1,0.982315038542347,0,3,multi-layer follicle stage,BP,
12946,GO:0048165,1,0.986409668350338,0,2,fused antrum stage,BP,
12949,GO:0048169,1,0.843114128420477,0,26,regulation of long-term neuronal synaptic plasticity,BP,
12950,GO:0048170,1,0.967252258111191,0,5,positive regulation of long-term neuronal synaptic plasticity,BP,
12951,GO:0048172,1,0.904198227988922,0,15,regulation of short-term neuronal synaptic plasticity,BP,
12952,GO:0048174,1,0.993469360651845,0,1,negative regulation of short-term neuronal synaptic plasticity,BP,
12953,GO:0048175,1,0.993724407370571,0,1,hepatocyte growth factor biosynthetic process,BP,
12954,GO:0048176,1,0.993724407370571,0,1,regulation of hepatocyte growth factor biosynthetic process,BP,
12955,GO:0048178,1,0.993724407370571,0,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,
12956,GO:0048179,1,0.980192527491446,0,3,activin receptor complex,CC,
12957,GO:0048180,1,0.994019937207677,0,1,activin complex,CC,
12958,GO:0048185,1,0.924378877426517,0,12,activin binding,MF,
12959,GO:0048188,1,0.922708793303543,0,12,Set1C/COMPASS complex,CC,
12960,GO:0048193,1,0.110899653875937,0,335,Golgi vesicle transport,BP,
12961,GO:0048194,1,0.603299173817897,0,78,Golgi vesicle budding,BP,
12962,GO:0048199,1,0.638458792794211,0,70,vesicle targeting, to, from or within Golgi,BP,
12963,GO:0048200,1,0.962812301878706,0,6,Golgi transport vesicle coating,BP,
12964,GO:0048203,1,0.987946771755858,0,2,vesicle targeting, trans-Golgi to endosome,BP,
12965,GO:0048205,1,0.962812301878706,0,6,COPI coating of Golgi vesicle,BP,
12966,GO:0048207,1,0.671686695580594,0,62,vesicle targeting, rough ER to cis-Golgi,BP,
12967,GO:0048208,1,0.671686695580594,0,62,COPII vesicle coating,BP,
12968,GO:0048209,1,0.987207469792306,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
12969,GO:0048210,1,0.975919672772301,0,4,Golgi vesicle fusion to target membrane,BP,
12970,GO:0048211,1,0.987420840123445,0,2,Golgi vesicle docking,BP,
12971,GO:0048213,1,0.988004264291918,0,2,Golgi vesicle prefusion complex stabilization,BP,
12972,GO:0048227,1,0.950858501743094,0,8,plasma membrane to endosome transport,BP,
12974,GO:0048237,1,0.982498047816161,0,3,rough endoplasmic reticulum lumen,CC,
12975,GO:0048239,1,0.987883444229472,0,2,negative regulation of DNA recombination at telomere,BP,
12977,GO:0048241,1,0.970735296875128,0,5,epinephrine transport,BP,
12978,GO:0048242,1,0.976486506048906,0,4,epinephrine secretion,BP,
12979,GO:0048243,1,0.922719137535643,0,13,norepinephrine secretion,BP,
12980,GO:0048244,1,0.994166020052406,0,1,phytanoyl-CoA dioxygenase activity,MF,
12981,GO:0048245,1,0.937392168686149,0,11,eosinophil chemotaxis,BP,
12982,GO:0048246,1,0.837728955292347,0,29,macrophage chemotaxis,BP,
12984,GO:0048248,1,0.971575320046522,0,5,CXCR3 chemokine receptor binding,MF,
12985,GO:0048250,1,0.988341036853907,0,2,iron import into the mitochondrion,BP,
12986,GO:0048251,1,0.941704335229949,0,9,elastic fiber assembly,BP,
12987,GO:0048254,1,0.975771874394428,0,4,snoRNA localization,BP,
12988,GO:0048255,1,0.812144515272672,0,32,mRNA stabilization,BP,
12989,GO:0048256,1,0.957376784568611,0,7,flap endonuclease activity,MF,
12990,GO:0048257,1,0.987834252975898,0,2,3'-flap endonuclease activity,MF,
12993,GO:0048261,1,0.899187147279523,0,17,negative regulation of receptor-mediated endocytosis,BP,
12996,GO:0048264,1,0.993779024477802,0,1,determination of ventral identity,BP,
12997,GO:0048265,1,0.845352589844606,0,26,response to pain,BP,
12998,GO:0048266,1,0.924974722582192,0,12,behavioral response to pain,BP,
12999,GO:0048268,1,0.899542096983117,0,16,clathrin coat assembly,BP,
13000,GO:0048269,1,0.987913846962623,0,2,methionine adenosyltransferase complex,CC,
13001,GO:0048270,1,0.99404460769367,0,1,methionine adenosyltransferase regulator activity,MF,
13002,GO:0048273,1,0.961817382492281,0,6,mitogen-activated protein kinase p38 binding,MF,
13003,GO:0048278,1,0.645378679370014,0,69,vesicle docking,BP,
13004,GO:0048280,1,0.952005931155719,0,8,vesicle fusion with Golgi apparatus,BP,
13005,GO:0048284,1,0.326968086117889,0,175,organelle fusion,BP,
13007,GO:0048286,1,0.786018492883254,0,36,lung alveolus development,BP,
13008,GO:0048289,1,0.963055807304408,0,6,isotype switching to IgE isotypes,BP,
13009,GO:0048290,1,0.963947894192277,0,6,isotype switching to IgA isotypes,BP,
13010,GO:0048291,1,0.933103716838369,0,11,isotype switching to IgG isotypes,BP,
13011,GO:0048293,1,0.963055807304408,0,6,regulation of isotype switching to IgE isotypes,BP,
13012,GO:0048294,1,0.981328643820148,0,3,negative regulation of isotype switching to IgE isotypes,BP,
13013,GO:0048295,1,0.981383041241981,0,3,positive regulation of isotype switching to IgE isotypes,BP,
13014,GO:0048296,1,0.970077360253536,0,5,regulation of isotype switching to IgA isotypes,BP,
13015,GO:0048297,1,0.994030612164709,0,1,negative regulation of isotype switching to IgA isotypes,BP,
13016,GO:0048298,1,0.975904358074649,0,4,positive regulation of isotype switching to IgA isotypes,BP,
13017,GO:0048302,1,0.938760452578429,0,10,regulation of isotype switching to IgG isotypes,BP,
13018,GO:0048304,1,0.956556354285898,0,7,positive regulation of isotype switching to IgG isotypes,BP,
13019,GO:0048305,1,0.898005186687049,0,18,immunoglobulin secretion,BP,
13021,GO:0048308,1,0.910477983486281,0,15,organelle inheritance,BP,
13022,GO:0048311,1,0.897605444116334,0,16,mitochondrion distribution,BP,
13023,GO:0048312,1,0.947016989206131,0,8,intracellular distribution of mitochondria,BP,
13024,GO:0048313,1,0.916120743077315,0,14,Golgi inheritance,BP,
13025,GO:0048318,1,0.957752479484462,0,7,axial mesoderm development,BP,
13026,GO:0048319,1,0.980596448660412,0,3,axial mesoderm morphogenesis,BP,
13027,GO:0048320,1,0.987749799194104,0,2,axial mesoderm formation,BP,
13028,GO:0048321,1,0.99404504058974,0,1,axial mesodermal cell differentiation,BP,
13029,GO:0048322,1,0.99404504058974,0,1,axial mesodermal cell fate commitment,BP,
13030,GO:0048327,1,0.99404504058974,0,1,axial mesodermal cell fate specification,BP,
13031,GO:0048332,1,0.660508522546562,0,64,mesoderm morphogenesis,BP,
13032,GO:0048333,1,0.825689667031516,0,30,mesodermal cell differentiation,BP,
13033,GO:0048338,1,0.993603636886392,0,1,mesoderm structural organization,BP,
13034,GO:0048339,1,0.894574530134371,0,17,paraxial mesoderm development,BP,
13035,GO:0048340,1,0.942035986784182,0,9,paraxial mesoderm morphogenesis,BP,
13036,GO:0048341,1,0.962903081951835,0,6,paraxial mesoderm formation,BP,
13037,GO:0048342,1,0.99416313225732,0,1,paraxial mesodermal cell differentiation,BP,
13038,GO:0048343,1,0.99416313225732,0,1,paraxial mesodermal cell fate commitment,BP,
13039,GO:0048352,1,0.993603636886392,0,1,paraxial mesoderm structural organization,BP,
13040,GO:0048364,1,0.994422168860593,0,1,root development,BP,
13041,GO:0048365,1,0.672051389724352,0,60,Rac GTPase binding,MF,
13042,GO:0048368,1,0.910166358078746,0,15,lateral mesoderm development,BP,
13043,GO:0048369,1,0.974956652248363,0,4,lateral mesoderm morphogenesis,BP,
13044,GO:0048370,1,0.974956652248363,0,4,lateral mesoderm formation,BP,
13045,GO:0048371,1,0.980660389518606,0,3,lateral mesodermal cell differentiation,BP,
13046,GO:0048372,1,0.986671584868274,0,2,lateral mesodermal cell fate commitment,BP,
13047,GO:0048377,1,0.986671584868274,0,2,lateral mesodermal cell fate specification,BP,
13048,GO:0048378,1,0.986671584868274,0,2,regulation of lateral mesodermal cell fate specification,BP,
13049,GO:0048382,1,0.975986957859813,0,4,mesendoderm development,BP,
13052,GO:0048386,1,0.975209226255747,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
13054,GO:0048388,1,0.981940211754237,0,3,endosomal lumen acidification,BP,
13055,GO:0048389,1,0.988266966649503,0,2,intermediate mesoderm development,BP,
13056,GO:0048390,1,0.994131943981625,0,1,intermediate mesoderm morphogenesis,BP,
13057,GO:0048391,1,0.994131943981625,0,1,intermediate mesoderm formation,BP,
13058,GO:0048392,1,0.994131943981625,0,1,intermediate mesodermal cell differentiation,BP,
13059,GO:0048403,1,0.979362400233235,0,3,brain-derived neurotrophic factor binding,MF,
13060,GO:0048406,1,0.961699701327498,0,6,nerve growth factor binding,MF,
13061,GO:0048407,1,0.926587748365029,0,11,platelet-derived growth factor binding,MF,
13062,GO:0048408,1,0.982185269652632,0,3,epidermal growth factor binding,MF,
13066,GO:0048475,1,0.540426231583489,0,96,coated membrane,CC,
13067,GO:0048476,1,0.970750980959924,0,5,Holliday junction resolvase complex,CC,
13068,GO:0048477,1,0.652755452959087,0,67,oogenesis,BP,
13069,GO:0048478,1,0.954787924181586,0,7,replication fork protection,BP,
13072,GO:0048485,1,0.877055325879116,0,20,sympathetic nervous system development,BP,
13073,GO:0048486,1,0.908403741939033,0,15,parasympathetic nervous system development,BP,
13074,GO:0048487,1,0.797109437840591,0,36,beta-tubulin binding,MF,
13076,GO:0048489,1,0.468791350000688,0,116,synaptic vesicle transport,BP,
13077,GO:0048490,1,0.899841650903061,0,17,anterograde synaptic vesicle transport,BP,
13078,GO:0048495,1,0.965699164347403,0,5,Roundabout binding,MF,
13079,GO:0048496,1,0.971727978091388,0,4,maintenance of animal organ identity,BP,
13080,GO:0048499,1,0.975841227656685,0,4,synaptic vesicle membrane organization,BP,
13081,GO:0048500,1,0.947430434650007,0,9,signal recognition particle,CC,
13082,GO:0048505,1,0.931463993217239,0,11,regulation of timing of cell differentiation,BP,
13090,GO:0048520,1,0.893463777385051,0,18,positive regulation of behavior,BP,
13091,GO:0048521,1,0.925205268745288,0,13,negative regulation of behavior,BP,
13095,GO:0048525,1,0.6057167377511,0,80,negative regulation of viral process,BP,
13096,GO:0048531,1,0.917558994628128,0,14,beta-1,3-galactosyltransferase activity,MF,
13097,GO:0048532,1,0.907578666928471,0,15,anatomical structure arrangement,BP,
13099,GO:0048535,1,0.911041404176533,0,15,lymph node development,BP,
13100,GO:0048536,1,0.809894989610467,0,33,spleen development,BP,
13101,GO:0048537,1,0.963297894420685,0,6,mucosal-associated lymphoid tissue development,BP,
13102,GO:0048538,1,0.75493913091014,0,43,thymus development,BP,
13103,GO:0048539,1,0.956749534358229,0,7,bone marrow development,BP,
13104,GO:0048541,1,0.963297894420685,0,6,Peyer's patch development,BP,
13107,GO:0048548,1,0.944408662771246,0,9,regulation of pinocytosis,BP,
13108,GO:0048549,1,0.97424879072826,0,4,positive regulation of pinocytosis,BP,
13109,GO:0048550,1,0.969379169445882,0,5,negative regulation of pinocytosis,BP,
13110,GO:0048557,1,0.901793157156403,0,16,embryonic digestive tract morphogenesis,BP,
13111,GO:0048560,1,0.988058067929787,0,2,establishment of anatomical structure orientation,BP,
13112,GO:0048561,1,0.99400551474507,0,1,establishment of animal organ orientation,BP,
13114,GO:0048563,1,0.949048887304874,0,8,post-embryonic animal organ morphogenesis,BP,
13116,GO:0048566,1,0.815786848388213,0,32,embryonic digestive tract development,BP,
13117,GO:0048567,1,0.993908434187134,0,1,ectodermal digestive tract morphogenesis,BP,
13119,GO:0048569,1,0.905883861626848,0,15,post-embryonic animal organ development,BP,
13120,GO:0048570,1,0.94887447199305,0,8,notochord morphogenesis,BP,
13126,GO:0048592,1,0.41672984216354,0,132,eye morphogenesis,BP,
13127,GO:0048593,1,0.523766879251031,0,98,camera-type eye morphogenesis,BP,
13128,GO:0048596,1,0.840796451745314,0,25,embryonic camera-type eye morphogenesis,BP,
13129,GO:0048597,1,0.982796775706185,0,3,post-embryonic camera-type eye morphogenesis,BP,
13131,GO:0048599,1,0.784550964632745,0,38,oocyte development,BP,
13134,GO:0048611,1,0.987737489069704,0,2,embryonic ectodermal digestive tract development,BP,
13135,GO:0048613,1,0.993908434187134,0,1,embryonic ectodermal digestive tract morphogenesis,BP,
13136,GO:0048617,1,0.939747787932726,0,9,embryonic foregut morphogenesis,BP,
13137,GO:0048619,1,0.981469779705839,0,3,embryonic hindgut morphogenesis,BP,
13138,GO:0048625,1,0.969092055523854,0,5,myoblast fate commitment,BP,
13139,GO:0048627,1,0.987991807729028,0,2,myoblast development,BP,
13140,GO:0048630,1,0.956040807461152,0,7,skeletal muscle tissue growth,BP,
13141,GO:0048631,1,0.967422082531176,0,5,regulation of skeletal muscle tissue growth,BP,
13142,GO:0048632,1,0.986576996376846,0,2,negative regulation of skeletal muscle tissue growth,BP,
13143,GO:0048633,1,0.980587121943601,0,3,positive regulation of skeletal muscle tissue growth,BP,
13145,GO:0048635,1,0.759821573479262,0,43,negative regulation of muscle organ development,BP,
13150,GO:0048641,1,0.742769506695581,0,46,regulation of skeletal muscle tissue development,BP,
13151,GO:0048642,1,0.920092215931726,0,13,negative regulation of skeletal muscle tissue development,BP,
13152,GO:0048643,1,0.873787352940721,0,21,positive regulation of skeletal muscle tissue development,BP,
13156,GO:0048659,1,0.472462719448143,0,117,smooth muscle cell proliferation,BP,
13157,GO:0048660,1,0.481796404790542,0,114,regulation of smooth muscle cell proliferation,BP,
13158,GO:0048661,1,0.628422640593212,0,72,positive regulation of smooth muscle cell proliferation,BP,
13159,GO:0048662,1,0.784159199312125,0,39,negative regulation of smooth muscle cell proliferation,BP,
13161,GO:0048664,1,0.964850877079566,0,6,neuron fate determination,BP,
13165,GO:0048668,1,0.848894354196991,0,25,collateral sprouting,BP,
13166,GO:0048669,1,0.981096819812074,0,3,collateral sprouting in absence of injury,BP,
13167,GO:0048670,1,0.88455445890086,0,19,regulation of collateral sprouting,BP,
13168,GO:0048671,1,0.946455523055147,0,8,negative regulation of collateral sprouting,BP,
13169,GO:0048672,1,0.934632460775526,0,11,positive regulation of collateral sprouting,BP,
13170,GO:0048673,1,0.994189699926839,0,1,collateral sprouting of intact axon in response to injury,BP,
13171,GO:0048674,1,0.993941533688724,0,1,collateral sprouting of injured axon,BP,
13173,GO:0048677,1,0.980067365789184,0,3,axon extension involved in regeneration,BP,
13174,GO:0048678,1,0.675755659044524,0,62,response to axon injury,BP,
13175,GO:0048679,1,0.868598042262029,0,22,regulation of axon regeneration,BP,
13176,GO:0048680,1,0.958396339528447,0,7,positive regulation of axon regeneration,BP,
13177,GO:0048681,1,0.925194714886677,0,12,negative regulation of axon regeneration,BP,
13178,GO:0048682,1,0.974128444368736,0,4,sprouting of injured axon,BP,
13179,GO:0048683,1,0.994189699926839,0,1,regulation of collateral sprouting of intact axon in response to injury,BP,
13180,GO:0048685,1,0.994189699926839,0,1,negative regulation of collateral sprouting of intact axon in response to injury,BP,
13181,GO:0048686,1,0.981028044685007,0,3,regulation of sprouting of injured axon,BP,
13182,GO:0048687,1,0.987796297369385,0,2,positive regulation of sprouting of injured axon,BP,
13183,GO:0048688,1,0.987131604074488,0,2,negative regulation of sprouting of injured axon,BP,
13184,GO:0048689,1,0.993941533688724,0,1,formation of growth cone in injured axon,BP,
13185,GO:0048690,1,0.987008598616014,0,2,regulation of axon extension involved in regeneration,BP,
13186,GO:0048691,1,0.993817688310509,0,1,positive regulation of axon extension involved in regeneration,BP,
13187,GO:0048692,1,0.993148984521768,0,1,negative regulation of axon extension involved in regeneration,BP,
13188,GO:0048693,1,0.993941533688724,0,1,regulation of collateral sprouting of injured axon,BP,
13189,GO:0048694,1,0.993941533688724,0,1,positive regulation of collateral sprouting of injured axon,BP,
13190,GO:0048696,1,0.994214823633125,0,1,regulation of collateral sprouting in absence of injury,BP,
13191,GO:0048697,1,0.994214823633125,0,1,positive regulation of collateral sprouting in absence of injury,BP,
13193,GO:0048701,1,0.754232409833938,0,43,embryonic cranial skeleton morphogenesis,BP,
13194,GO:0048702,1,0.954684586717452,0,7,embryonic neurocranium morphogenesis,BP,
13195,GO:0048703,1,0.940723611535024,0,9,embryonic viscerocranium morphogenesis,BP,
13196,GO:0048704,1,0.567102540366818,0,88,embryonic skeletal system morphogenesis,BP,
13198,GO:0048706,1,0.475889618627609,0,115,embryonic skeletal system development,BP,
13203,GO:0048712,1,0.931347856210497,0,11,negative regulation of astrocyte differentiation,BP,
13206,GO:0048715,1,0.930492427216131,0,11,negative regulation of oligodendrocyte differentiation,BP,
13208,GO:0048730,1,0.842405740579323,0,27,epidermis morphogenesis,BP,
13214,GO:0048739,1,0.8959359998976,0,13,cardiac muscle fiber development,BP,
13215,GO:0048741,1,0.835006922519283,0,28,skeletal muscle fiber development,BP,
13216,GO:0048742,1,0.94346427179933,0,9,regulation of skeletal muscle fiber development,BP,
13217,GO:0048743,1,0.963125977418023,0,6,positive regulation of skeletal muscle fiber development,BP,
13218,GO:0048745,1,0.881769295633171,0,19,smooth muscle tissue development,BP,
13219,GO:0048747,1,0.695971923314265,0,52,muscle fiber development,BP,
13220,GO:0048749,1,0.993488383863548,0,1,compound eye development,BP,
13221,GO:0048752,1,0.954686459297837,0,7,semicircular canal morphogenesis,BP,
13222,GO:0048753,1,0.841442363726446,0,27,pigment granule organization,BP,
13224,GO:0048755,1,0.941139819573492,0,9,branching morphogenesis of a nerve,BP,
13225,GO:0048757,1,0.939431298074293,0,10,pigment granule maturation,BP,
13228,GO:0048764,1,0.994422168860593,0,1,trichoblast maturation,BP,
13229,GO:0048765,1,0.994422168860593,0,1,root hair cell differentiation,BP,
13230,GO:0048767,1,0.994422168860593,0,1,root hair elongation,BP,
13231,GO:0048769,1,0.951253122988996,0,4,sarcomerogenesis,BP,
13232,GO:0048770,1,0.529485742910512,0,101,pigment granule,CC,
13235,GO:0048787,1,0.967838793979437,0,5,presynaptic active zone membrane,CC,
13236,GO:0048788,1,0.952148858692979,0,6,cytoskeleton of presynaptic active zone,CC,
13237,GO:0048789,1,0.993231949661646,0,1,cytoskeletal matrix organization at active zone,BP,
13238,GO:0048790,1,0.994213379743068,0,1,maintenance of presynaptic active zone structure,BP,
13239,GO:0048791,1,0.785657365964047,0,37,calcium ion-regulated exocytosis of neurotransmitter,BP,
13240,GO:0048792,1,0.993657582313545,0,1,spontaneous exocytosis of neurotransmitter,BP,
13241,GO:0048793,1,0.960736733471416,0,6,pronephros development,BP,
13244,GO:0048807,1,0.982262260178387,0,3,female genitalia morphogenesis,BP,
13245,GO:0048808,1,0.981410078327311,0,3,male genitalia morphogenesis,BP,
13248,GO:0048814,1,0.592553256523271,0,78,regulation of dendrite morphogenesis,BP,
13249,GO:0048817,1,0.986621195471805,0,2,negative regulation of hair follicle maturation,BP,
13250,GO:0048818,1,0.968932091454396,0,5,positive regulation of hair follicle maturation,BP,
13251,GO:0048819,1,0.943810044280161,0,9,regulation of hair follicle maturation,BP,
13252,GO:0048820,1,0.89808073762825,0,16,hair follicle maturation,BP,
13253,GO:0048821,1,0.837742279962941,0,28,erythrocyte development,BP,
13254,GO:0048822,1,0.979629700008998,0,3,enucleate erythrocyte development,BP,
13255,GO:0048823,1,0.993846081630578,0,1,nucleate erythrocyte development,BP,
13257,GO:0048840,1,0.968851016079606,0,5,otolith development,BP,
13258,GO:0048841,1,0.828109724379999,0,27,regulation of axon extension involved in axon guidance,BP,
13259,GO:0048842,1,0.9492243766809,0,7,positive regulation of axon extension involved in axon guidance,BP,
13260,GO:0048843,1,0.879634517570844,0,19,negative regulation of axon extension involved in axon guidance,BP,
13262,GO:0048845,1,0.935575633587436,0,10,venous blood vessel morphogenesis,BP,
13263,GO:0048846,1,0.799500787426491,0,32,axon extension involved in axon guidance,BP,
13264,GO:0048850,1,0.985829828834935,0,2,hypophysis morphogenesis,BP,
13265,GO:0048852,1,0.979935355329798,0,3,diencephalon morphogenesis,BP,
13266,GO:0048853,1,0.918357966583543,0,13,forebrain morphogenesis,BP,
13267,GO:0048854,1,0.790712536550184,0,35,brain morphogenesis,BP,
13268,GO:0048855,1,0.992812320922039,0,1,adenohypophysis morphogenesis,BP,
13272,GO:0048859,1,0.969384640242806,0,5,formation of anatomical boundary,BP,
13273,GO:0048861,1,0.973384271491074,0,4,leukemia inhibitory factor signaling pathway,BP,
13276,GO:0048865,1,0.952594657879198,0,8,stem cell fate commitment,BP,
13277,GO:0048866,1,0.976161152849273,0,4,stem cell fate specification,BP,
13278,GO:0048867,1,0.982385380713844,0,3,stem cell fate determination,BP,
13282,GO:0048872,1,0.236862680786501,0,225,homeostasis of number of cells,BP,
13283,GO:0048873,1,0.842754845163792,0,27,homeostasis of number of cells within a tissue,BP,
13284,GO:0048874,1,0.993701267540879,0,1,homeostasis of number of cells in a free-living population,BP,
13285,GO:0048875,1,0.938497617905539,0,10,chemical homeostasis within a tissue,BP,
13287,GO:0048880,1,0.974558313011498,0,4,sensory system development,BP,
13288,GO:0048882,1,0.99388284309816,0,1,lateral line development,BP,
13289,GO:0048884,1,0.99388284309816,0,1,neuromast development,BP,
13290,GO:0048886,1,0.99388284309816,0,1,neuromast hair cell differentiation,BP,
13291,GO:0048925,1,0.99388284309816,0,1,lateral line system development,BP,
13292,GO:0048934,1,0.916503377768759,0,13,peripheral nervous system neuron differentiation,BP,
13293,GO:0048935,1,0.916503377768759,0,13,peripheral nervous system neuron development,BP,
13294,GO:0048936,1,0.981638451895742,0,3,peripheral nervous system neuron axonogenesis,BP,
13295,GO:0050000,1,0.63540120500244,0,71,chromosome localization,BP,
13296,GO:0050011,1,0.994187389698263,0,1,itaconyl-CoA hydratase activity,MF,
13297,GO:0050023,1,0.994109130883807,0,1,L-fuconate dehydratase activity,MF,
13298,GO:0050031,1,0.993949597679924,0,1,L-pipecolate oxidase activity,MF,
13299,GO:0050038,1,0.99440686302825,0,1,L-xylulose reductase (NADP+) activity,MF,
13300,GO:0050046,1,0.993846081630578,0,1,lathosterol oxidase activity,MF,
13301,GO:0050051,1,0.987965436982747,0,2,leukotriene-B4 20-monooxygenase activity,MF,
13302,GO:0050072,1,0.955606883577272,0,7,m7G(5')pppN diphosphatase activity,MF,
13303,GO:0050080,1,0.994013590856156,0,1,malonyl-CoA decarboxylase activity,MF,
13304,GO:0050104,1,0.994213379743068,0,1,L-gulonate 3-dehydrogenase activity,MF,
13305,GO:0050115,1,0.993241736100263,0,1,myosin-light-chain-phosphatase activity,MF,
13306,GO:0050119,1,0.985874075500823,0,2,N-acetylglucosamine deacetylase activity,MF,
13307,GO:0050121,1,0.99422059919251,0,1,N-acylglucosamine 2-epimerase activity,MF,
13308,GO:0050124,1,0.993554819813192,0,1,N-acylneuraminate-9-phosphatase activity,MF,
13309,GO:0050129,1,0.993724121625502,0,1,N-formylglutamate deformylase activity,MF,
13310,GO:0050135,1,0.988467082645206,0,2,NAD(P)+ nucleosidase activity,MF,
13311,GO:0050136,1,0.805532400710213,0,38,NADH dehydrogenase (quinone) activity,MF,
13312,GO:0050144,1,0.993846081630578,0,1,nucleoside deoxyribosyltransferase activity,MF,
13313,GO:0050145,1,0.970041342958619,0,5,nucleoside phosphate kinase activity,MF,
13314,GO:0050146,1,0.993115105043379,0,1,nucleoside phosphotransferase activity,MF,
13315,GO:0050152,1,0.994278643586554,0,1,omega-amidase activity,MF,
13316,GO:0050178,1,0.988976805027349,0,2,phenylpyruvate tautomerase activity,MF,
13317,GO:0050185,1,0.985727709030456,0,2,phosphatidylinositol deacylase activity,MF,
13318,GO:0050197,1,0.993978411761806,0,1,phytanate-CoA ligase activity,MF,
13319,GO:0050201,1,0.99351739929584,0,1,fucokinase activity,MF,
13320,GO:0050211,1,0.981589608089028,0,3,procollagen galactosyltransferase activity,MF,
13321,GO:0050220,1,0.976994849312761,0,4,prostaglandin-E synthase activity,MF,
13322,GO:0050221,1,0.994287884506968,0,1,prostaglandin-E2 9-reductase activity,MF,
13323,GO:0050252,1,0.987553424899859,0,2,retinol O-fatty-acyltransferase activity,MF,
13324,GO:0050253,1,0.987050521265885,0,2,retinyl-palmitate esterase activity,MF,
13325,GO:0050254,1,0.988079579941712,0,2,rhodopsin kinase activity,MF,
13326,GO:0050262,1,0.987729649828399,0,2,ribosylnicotinamide kinase activity,MF,
13327,GO:0050265,1,0.979943692617803,0,3,RNA uridylyltransferase activity,MF,
13328,GO:0050277,1,0.99354168274972,0,1,sedoheptulokinase activity,MF,
13329,GO:0050290,1,0.993281437863294,0,1,sphingomyelin phosphodiesterase D activity,MF,
13330,GO:0050291,1,0.957939916415213,0,7,sphingosine N-acyltransferase activity,MF,
13331,GO:0050294,1,0.976980951304333,0,4,steroid sulfotransferase activity,MF,
13332,GO:0050308,1,0.951254637781236,0,8,sugar-phosphatase activity,MF,
13333,GO:0050309,1,0.981813867016624,0,3,sugar-terminal-phosphatase activity,MF,
13334,GO:0050313,1,0.994368454463406,0,1,sulfur dioxygenase activity,MF,
13335,GO:0050321,1,0.91918036362892,0,13,tau-protein kinase activity,MF,
13336,GO:0050333,1,0.994128478627179,0,1,thiamin-triphosphatase activity,MF,
13337,GO:0050337,1,0.994478483752097,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
13338,GO:0050346,1,0.993846081630578,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
13339,GO:0050347,1,0.98783794320482,0,2,trans-octaprenyltranstransferase activity,MF,
13340,GO:0050353,1,0.993822274700288,0,1,trimethyllysine dioxygenase activity,MF,
13341,GO:0050355,1,0.993360162349683,0,1,triphosphatase activity,MF,
13342,GO:0050379,1,0.993196530928221,0,1,UDP-glucuronate 5'-epimerase activity,MF,
13343,GO:0050405,1,0.985180014765096,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
13344,GO:0050421,1,0.993895779497771,0,1,nitrite reductase (NO-forming) activity,MF,
13345,GO:0050427,1,0.86732860117177,0,23,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,
13346,GO:0050428,1,0.962148932286986,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
13347,GO:0050429,1,0.992786594168375,0,1,calcium-dependent phospholipase C activity,MF,
13348,GO:0050431,1,0.881140444549236,0,19,transforming growth factor beta binding,MF,
13349,GO:0050432,1,0.783057733875943,0,39,catecholamine secretion,BP,
13350,GO:0050433,1,0.799642877526368,0,36,regulation of catecholamine secretion,BP,
13351,GO:0050434,1,0.772568968059817,0,41,positive regulation of viral transcription,BP,
13352,GO:0050435,1,0.810198006211543,0,32,amyloid-beta metabolic process,BP,
13353,GO:0050436,1,0.986720331428968,0,2,microfibril binding,MF,
13354,GO:0050444,1,0.993697840280528,0,1,aquacobalamin reductase (NADPH) activity,MF,
13356,GO:0050462,1,0.99428875084381,0,1,N-acetylneuraminate synthase activity,MF,
13357,GO:0050473,1,0.98123114599667,0,3,arachidonate 15-lipoxygenase activity,MF,
13358,GO:0050479,1,0.993846081630578,0,1,glyceryl-ether monooxygenase activity,MF,
13359,GO:0050480,1,0.994029169494557,0,1,imidazolonepropionase activity,MF,
13360,GO:0050482,1,0.88897663404256,0,19,arachidonic acid secretion,BP,
13361,GO:0050497,1,0.987800643230655,0,2,transferase activity, transferring alkylthio groups,MF,
13362,GO:0050501,1,0.975910535494811,0,4,hyaluronan synthase activity,MF,
13363,GO:0050508,1,0.980865135998604,0,3,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
13364,GO:0050509,1,0.987292441437179,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
13365,GO:0050510,1,0.97451530760419,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
13366,GO:0050512,1,0.994043597612783,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
13367,GO:0050528,1,0.993956223018718,0,1,acyloxyacyl hydrolase activity,MF,
13368,GO:0050542,1,0.965941305021048,0,6,icosanoid binding,MF,
13369,GO:0050543,1,0.966126827942131,0,6,icosatetraenoic acid binding,MF,
13370,GO:0050544,1,0.97163729995164,0,5,arachidonic acid binding,MF,
13371,GO:0050560,1,0.993678708107879,0,1,aspartate-tRNA(Asn) ligase activity,MF,
13372,GO:0050561,1,0.993519113832321,0,1,glutamate-tRNA(Gln) ligase activity,MF,
13373,GO:0050567,1,0.981944238142415,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
13374,GO:0050571,1,0.994181902902985,0,1,1,5-anhydro-D-fructose reductase activity,MF,
13375,GO:0050577,1,0.994252942319835,0,1,GDP-L-fucose synthase activity,MF,
13376,GO:0050610,1,0.988668072217978,0,2,methylarsonate reductase activity,MF,
13377,GO:0050613,1,0.987780289515868,0,2,delta14-sterol reductase activity,MF,
13378,GO:0050614,1,0.993412940945061,0,1,delta24-sterol reductase activity,MF,
13379,GO:0050632,1,0.99423648197711,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
13380,GO:0050646,1,0.994139452279732,0,1,5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13381,GO:0050647,1,0.994139452279732,0,1,5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13382,GO:0050648,1,0.994139452279732,0,1,5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13383,GO:0050650,1,0.822577888118669,0,30,chondroitin sulfate proteoglycan biosynthetic process,BP,
13384,GO:0050651,1,0.905805441158456,0,15,dermatan sulfate proteoglycan biosynthetic process,BP,
13385,GO:0050652,1,0.993574806237928,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13386,GO:0050653,1,0.987124916061862,0,2,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13388,GO:0050655,1,0.900377196850508,0,16,dermatan sulfate proteoglycan metabolic process,BP,
13389,GO:0050656,1,0.961922629153224,0,6,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
13390,GO:0050657,1,0.312779809486459,0,180,nucleic acid transport,BP,
13391,GO:0050658,1,0.312779809486459,0,180,RNA transport,BP,
13392,GO:0050659,1,0.986340195167282,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
13394,GO:0050661,1,0.759077477264574,0,44,NADP binding,MF,
13397,GO:0050664,1,0.920925483286875,0,13,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
13398,GO:0050665,1,0.93268006536245,0,11,hydrogen peroxide biosynthetic process,BP,
13399,GO:0050666,1,0.987952210536008,0,2,regulation of homocysteine metabolic process,BP,
13400,GO:0050667,1,0.91580684282609,0,14,homocysteine metabolic process,BP,
13401,GO:0050668,1,0.993991528798771,0,1,positive regulation of homocysteine metabolic process,BP,
13402,GO:0050670,1,0.321125095025183,0,182,regulation of lymphocyte proliferation,BP,
13403,GO:0050671,1,0.48547753284828,0,117,positive regulation of lymphocyte proliferation,BP,
13404,GO:0050672,1,0.668433819015215,0,64,negative regulation of lymphocyte proliferation,BP,
13406,GO:0050674,1,0.994466354247885,0,1,urothelial cell proliferation,BP,
13407,GO:0050675,1,0.994466354247885,0,1,regulation of urothelial cell proliferation,BP,
13408,GO:0050677,1,0.994466354247885,0,1,positive regulation of urothelial cell proliferation,BP,
13411,GO:0050680,1,0.487355962796811,0,110,negative regulation of epithelial cell proliferation,BP,
13412,GO:0050681,1,0.765955394707885,0,41,androgen receptor binding,MF,
13413,GO:0050682,1,0.978867499847848,0,3,AF-2 domain binding,MF,
13414,GO:0050683,1,0.993463637161612,0,1,AF-1 domain binding,MF,
13415,GO:0050684,1,0.490398800537377,0,112,regulation of mRNA processing,BP,
13416,GO:0050685,1,0.855257043079501,0,25,positive regulation of mRNA processing,BP,
13417,GO:0050686,1,0.833945996025994,0,29,negative regulation of mRNA processing,BP,
13418,GO:0050687,1,0.876535895759897,0,21,negative regulation of defense response to virus,BP,
13419,GO:0050688,1,0.690712722783967,0,58,regulation of defense response to virus,BP,
13420,GO:0050689,1,0.97073380508279,0,5,negative regulation of defense response to virus by host,BP,
13421,GO:0050690,1,0.833744602472444,0,29,regulation of defense response to virus by virus,BP,
13422,GO:0050691,1,0.817582470413932,0,32,regulation of defense response to virus by host,BP,
13423,GO:0050692,1,0.98104872908299,0,3,DBD domain binding,MF,
13424,GO:0050693,1,0.962335154767599,0,6,LBD domain binding,MF,
13425,GO:0050694,1,0.976177311658591,0,4,galactose 3-O-sulfotransferase activity,MF,
13426,GO:0050698,1,0.987643180499662,0,2,proteoglycan sulfotransferase activity,MF,
13427,GO:0050699,1,0.827674577301845,0,30,WW domain binding,MF,
13428,GO:0050700,1,0.926101037837837,0,12,CARD domain binding,MF,
13429,GO:0050701,1,0.760310498739092,0,44,interleukin-1 secretion,BP,
13430,GO:0050702,1,0.78300542975305,0,39,interleukin-1 beta secretion,BP,
13431,GO:0050703,1,0.970971398314362,0,5,interleukin-1 alpha secretion,BP,
13432,GO:0050704,1,0.796241969540151,0,37,regulation of interleukin-1 secretion,BP,
13433,GO:0050705,1,0.976370242330603,0,4,regulation of interleukin-1 alpha secretion,BP,
13434,GO:0050706,1,0.815455829658976,0,33,regulation of interleukin-1 beta secretion,BP,
13438,GO:0050710,1,0.736645363128857,0,49,negative regulation of cytokine secretion,BP,
13439,GO:0050711,1,0.935240402112071,0,11,negative regulation of interleukin-1 secretion,BP,
13440,GO:0050712,1,0.994233305420335,0,1,negative regulation of interleukin-1 alpha secretion,BP,
13441,GO:0050713,1,0.952413401444979,0,8,negative regulation of interleukin-1 beta secretion,BP,
13444,GO:0050716,1,0.850228642214364,0,26,positive regulation of interleukin-1 secretion,BP,
13445,GO:0050717,1,0.982034379849413,0,3,positive regulation of interleukin-1 alpha secretion,BP,
13446,GO:0050718,1,0.860434510707144,0,24,positive regulation of interleukin-1 beta secretion,BP,
13447,GO:0050719,1,0.994404408328597,0,1,interleukin-1 alpha biosynthetic process,BP,
13448,GO:0050720,1,0.988161810915886,0,2,interleukin-1 beta biosynthetic process,BP,
13449,GO:0050721,1,0.994404408328597,0,1,regulation of interleukin-1 alpha biosynthetic process,BP,
13450,GO:0050722,1,0.988161810915886,0,2,regulation of interleukin-1 beta biosynthetic process,BP,
13451,GO:0050725,1,0.988161810915886,0,2,positive regulation of interleukin-1 beta biosynthetic process,BP,
13452,GO:0050726,1,0.994404408328597,0,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,
13453,GO:0050727,1,0.167194121459572,0,284,regulation of inflammatory response,BP,
13454,GO:0050728,1,0.534559845487548,0,100,negative regulation of inflammatory response,BP,
13455,GO:0050729,1,0.541493059156359,0,99,positive regulation of inflammatory response,BP,
13458,GO:0050732,1,0.757214904122689,0,44,negative regulation of peptidyl-tyrosine phosphorylation,BP,
13459,GO:0050733,1,0.968428944180801,0,5,RS domain binding,MF,
13461,GO:0050747,1,0.968705547115965,0,5,positive regulation of lipoprotein metabolic process,BP,
13463,GO:0050750,1,0.887473227326489,0,18,low-density lipoprotein particle receptor binding,MF,
13464,GO:0050751,1,0.994383471281417,0,1,fractalkine biosynthetic process,BP,
13465,GO:0050752,1,0.994383471281417,0,1,regulation of fractalkine biosynthetic process,BP,
13466,GO:0050754,1,0.994383471281417,0,1,positive regulation of fractalkine biosynthetic process,BP,
13467,GO:0050755,1,0.930752004936079,0,12,chemokine metabolic process,BP,
13468,GO:0050756,1,0.994383471281417,0,1,fractalkine metabolic process,BP,
13469,GO:0050757,1,0.9882424762092,0,2,thymidylate synthase biosynthetic process,BP,
13470,GO:0050758,1,0.9882424762092,0,2,regulation of thymidylate synthase biosynthetic process,BP,
13471,GO:0050760,1,0.99388499873734,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
13472,GO:0050764,1,0.651629490624915,0,68,regulation of phagocytosis,BP,
13473,GO:0050765,1,0.92329904030457,0,13,negative regulation of phagocytosis,BP,
13474,GO:0050766,1,0.733732663514947,0,49,positive regulation of phagocytosis,BP,
13480,GO:0050772,1,0.594638354202038,0,77,positive regulation of axonogenesis,BP,
13482,GO:0050774,1,0.90629858078402,0,15,negative regulation of dendrite morphogenesis,BP,
13483,GO:0050775,1,0.806200750157769,0,32,positive regulation of dendrite morphogenesis,BP,
13485,GO:0050777,1,0.475979998343705,0,118,negative regulation of immune response,BP,
13487,GO:0050779,1,0.851298548841386,0,24,RNA destabilization,BP,
13489,GO:0050783,1,0.993941245723192,0,1,cocaine metabolic process,BP,
13490,GO:0050785,1,0.994259584215574,0,1,advanced glycation end-product receptor activity,MF,
13491,GO:0050786,1,0.944862237238356,0,10,RAGE receptor binding,MF,
13492,GO:0050787,1,0.987601776433629,0,2,detoxification of mercury ion,BP,
13500,GO:0050798,1,0.798960092452128,0,36,activated T cell proliferation,BP,
13507,GO:0050807,1,0.370596554283899,0,150,regulation of synapse organization,BP,
13510,GO:0050811,1,0.913186611111845,0,14,GABA receptor binding,MF,
13511,GO:0050812,1,0.918454654099202,0,13,regulation of acyl-CoA biosynthetic process,BP,
13512,GO:0050815,1,0.962850275836189,0,6,phosphoserine residue binding,MF,
13513,GO:0050816,1,0.980856160534767,0,3,phosphothreonine residue binding,MF,
13514,GO:0050817,1,0.150837968944866,0,295,coagulation,BP,
13515,GO:0050818,1,0.630322543474307,0,74,regulation of coagulation,BP,
13516,GO:0050819,1,0.748224132387391,0,47,negative regulation of coagulation,BP,
13517,GO:0050820,1,0.860357506766256,0,24,positive regulation of coagulation,BP,
13518,GO:0050821,1,0.390843452593473,0,147,protein stabilization,BP,
13519,GO:0050822,1,0.993637601712559,0,1,peptide stabilization,BP,
13520,GO:0050823,1,0.993637601712559,0,1,peptide antigen stabilization,BP,
13521,GO:0050829,1,0.75623805972574,0,47,defense response to Gram-negative bacterium,BP,
13522,GO:0050830,1,0.730508503228837,0,53,defense response to Gram-positive bacterium,BP,
13523,GO:0050832,1,0.860586830879182,0,26,defense response to fungus,BP,
13524,GO:0050833,1,0.975668784417214,0,4,pyruvate transmembrane transporter activity,MF,
13526,GO:0050840,1,0.730165408428624,0,48,extracellular matrix binding,MF,
13527,GO:0050847,1,0.945103994403831,0,8,progesterone receptor signaling pathway,BP,
13529,GO:0050849,1,0.897592980501318,0,17,negative regulation of calcium-mediated signaling,BP,
13530,GO:0050850,1,0.811731136743191,0,33,positive regulation of calcium-mediated signaling,BP,
13533,GO:0050853,1,0.719778787497865,0,52,B cell receptor signaling pathway,BP,
13534,GO:0050854,1,0.719816504804474,0,52,regulation of antigen receptor-mediated signaling pathway,BP,
13535,GO:0050855,1,0.880735250362319,0,20,regulation of B cell receptor signaling pathway,BP,
13536,GO:0050856,1,0.803073424057618,0,35,regulation of T cell receptor signaling pathway,BP,
13537,GO:0050857,1,0.881439986483501,0,20,positive regulation of antigen receptor-mediated signaling pathway,BP,
13538,GO:0050858,1,0.873707374735679,0,22,negative regulation of antigen receptor-mediated signaling pathway,BP,
13539,GO:0050859,1,0.969820317701465,0,5,negative regulation of B cell receptor signaling pathway,BP,
13540,GO:0050860,1,0.895509867154097,0,18,negative regulation of T cell receptor signaling pathway,BP,
13541,GO:0050861,1,0.955762272400432,0,7,positive regulation of B cell receptor signaling pathway,BP,
13542,GO:0050862,1,0.928594452283336,0,12,positive regulation of T cell receptor signaling pathway,BP,
13543,GO:0050863,1,0.168539214856822,0,283,regulation of T cell activation,BP,
13544,GO:0050864,1,0.511210981330709,0,106,regulation of B cell activation,BP,
13545,GO:0050865,1,0.0520852888608527,0,464,regulation of cell activation,BP,
13546,GO:0050866,1,0.373970569409669,0,156,negative regulation of cell activation,BP,
13547,GO:0050867,1,0.166406880957921,0,285,positive regulation of cell activation,BP,
13548,GO:0050868,1,0.578078025205414,0,87,negative regulation of T cell activation,BP,
13549,GO:0050869,1,0.822395787689708,0,31,negative regulation of B cell activation,BP,
13550,GO:0050870,1,0.311387765985829,0,187,positive regulation of T cell activation,BP,
13551,GO:0050871,1,0.652110010672848,0,68,positive regulation of B cell activation,BP,
13552,GO:0050872,1,0.926074061876512,0,12,white fat cell differentiation,BP,
13553,GO:0050873,1,0.812105156170332,0,33,brown fat cell differentiation,BP,
13555,GO:0050878,1,0.0634951113276656,0,426,regulation of body fluid levels,BP,
13556,GO:0050879,1,0.738229259722617,0,47,multicellular organismal movement,BP,
13558,GO:0050881,1,0.738229259722617,0,47,musculoskeletal movement,BP,
13559,GO:0050882,1,0.956012665225375,0,6,voluntary musculoskeletal movement,BP,
13560,GO:0050883,1,0.993932607884681,0,1,musculoskeletal movement, spinal reflex action,BP,
13561,GO:0050884,1,0.912494058215815,0,14,neuromuscular process controlling posture,BP,
13563,GO:0050886,1,0.63654697121669,0,72,endocrine process,BP,
13565,GO:0050891,1,0.712641300254096,0,52,multicellular organismal water homeostasis,BP,
13566,GO:0050892,1,0.848527520984849,0,26,intestinal absorption,BP,
13567,GO:0050893,1,0.974930203975654,0,4,sensory processing,BP,
13568,GO:0050894,1,0.99272934649843,0,1,determination of affect,BP,
13570,GO:0050897,1,0.992912447527943,0,1,cobalt ion binding,MF,
13572,GO:0050901,1,0.860412694553994,0,24,leukocyte tethering or rolling,BP,
13573,GO:0050902,1,0.987659094113074,0,2,leukocyte adhesive activation,BP,
13574,GO:0050904,1,0.986727668248043,0,2,diapedesis,BP,
13576,GO:0050906,1,0.585322369893307,0,87,detection of stimulus involved in sensory perception,BP,
13577,GO:0050907,1,0.777117387848329,0,43,detection of chemical stimulus involved in sensory perception,BP,
13578,GO:0050908,1,0.913532393135057,0,14,detection of light stimulus involved in visual perception,BP,
13579,GO:0050909,1,0.766778011372083,0,44,sensory perception of taste,BP,
13580,GO:0050910,1,0.932558080664095,0,11,detection of mechanical stimulus involved in sensory perception of sound,BP,
13581,GO:0050911,1,0.900842903927938,0,18,detection of chemical stimulus involved in sensory perception of smell,BP,
13582,GO:0050912,1,0.873867810639936,0,23,detection of chemical stimulus involved in sensory perception of taste,BP,
13583,GO:0050913,1,0.861188253045297,0,25,sensory perception of bitter taste,BP,
13584,GO:0050915,1,0.975527615353572,0,4,sensory perception of sour taste,BP,
13585,GO:0050916,1,0.973997606926162,0,4,sensory perception of sweet taste,BP,
13586,GO:0050917,1,0.967915609653382,0,5,sensory perception of umami taste,BP,
13587,GO:0050918,1,0.723661322173041,0,51,positive chemotaxis,BP,
13588,GO:0050919,1,0.783148167336508,0,36,negative chemotaxis,BP,
13592,GO:0050923,1,0.97261513392402,0,4,regulation of negative chemotaxis,BP,
13593,GO:0050924,1,0.993214099152136,0,1,positive regulation of negative chemotaxis,BP,
13594,GO:0050925,1,0.985505541328693,0,2,negative regulation of negative chemotaxis,BP,
13595,GO:0050926,1,0.854417546955995,0,25,regulation of positive chemotaxis,BP,
13596,GO:0050927,1,0.860335146314259,0,24,positive regulation of positive chemotaxis,BP,
13597,GO:0050928,1,0.993132263029185,0,1,negative regulation of positive chemotaxis,BP,
13598,GO:0050929,1,0.993214099152136,0,1,induction of negative chemotaxis,BP,
13599,GO:0050930,1,0.924591882401308,0,13,induction of positive chemotaxis,BP,
13601,GO:0050932,1,0.94161015444826,0,9,regulation of pigment cell differentiation,BP,
13602,GO:0050942,1,0.952818874772258,0,7,positive regulation of pigment cell differentiation,BP,
13603,GO:0050951,1,0.885038443615362,0,19,sensory perception of temperature stimulus,BP,
13606,GO:0050955,1,0.986525874559681,0,2,thermoception,BP,
13607,GO:0050957,1,0.960338697378808,0,6,equilibrioception,BP,
13608,GO:0050960,1,0.993456624497855,0,1,detection of temperature stimulus involved in thermoception,BP,
13609,GO:0050961,1,0.916297932668298,0,14,detection of temperature stimulus involved in sensory perception,BP,
13610,GO:0050962,1,0.913532393135057,0,14,detection of light stimulus involved in sensory perception,BP,
13611,GO:0050965,1,0.916297932668298,0,14,detection of temperature stimulus involved in sensory perception of pain,BP,
13612,GO:0050966,1,0.947835314710249,0,8,detection of mechanical stimulus involved in sensory perception of pain,BP,
13613,GO:0050968,1,0.987342565229736,0,2,detection of chemical stimulus involved in sensory perception of pain,BP,
13614,GO:0050974,1,0.862661416361823,0,23,detection of mechanical stimulus involved in sensory perception,BP,
13615,GO:0050975,1,0.980807096149278,0,3,sensory perception of touch,BP,
13616,GO:0050976,1,0.986516481021072,0,2,detection of mechanical stimulus involved in sensory perception of touch,BP,
13617,GO:0050982,1,0.759007973153931,0,38,detection of mechanical stimulus,BP,
13618,GO:0050992,1,0.994030612164709,0,1,dimethylallyl diphosphate biosynthetic process,BP,
13619,GO:0050993,1,0.994030612164709,0,1,dimethylallyl diphosphate metabolic process,BP,
13620,GO:0050994,1,0.758267555378876,0,43,regulation of lipid catabolic process,BP,
13621,GO:0050995,1,0.896804663783753,0,17,negative regulation of lipid catabolic process,BP,
13622,GO:0050996,1,0.895789951788505,0,17,positive regulation of lipid catabolic process,BP,
13623,GO:0050997,1,0.897993459361095,0,17,quaternary ammonium group binding,MF,
13624,GO:0050998,1,0.922381260044458,0,12,nitric-oxide synthase binding,MF,
13627,GO:0051001,1,0.962251223163686,0,6,negative regulation of nitric-oxide synthase activity,BP,
13628,GO:0051004,1,0.911977093099699,0,15,regulation of lipoprotein lipase activity,BP,
13629,GO:0051005,1,0.981363862040698,0,3,negative regulation of lipoprotein lipase activity,BP,
13630,GO:0051006,1,0.959099374211815,0,7,positive regulation of lipoprotein lipase activity,BP,
13631,GO:0051010,1,0.90910798395779,0,13,microtubule plus-end binding,MF,
13632,GO:0051011,1,0.93763474069895,0,9,microtubule minus-end binding,MF,
13633,GO:0051012,1,0.987353695349839,0,2,microtubule sliding,BP,
13634,GO:0051013,1,0.956063547854455,0,7,microtubule severing,BP,
13635,GO:0051014,1,0.950641892908473,0,8,actin filament severing,BP,
13637,GO:0051016,1,0.915973266951631,0,14,barbed-end actin filament capping,BP,
13640,GO:0051019,1,0.844365420168905,0,26,mitogen-activated protein kinase binding,MF,
13642,GO:0051021,1,0.969490520148627,0,5,GDP-dissociation inhibitor binding,MF,
13643,GO:0051022,1,0.975134700648009,0,4,Rho GDP-dissociation inhibitor binding,MF,
13644,GO:0051023,1,0.914807109849287,0,15,regulation of immunoglobulin secretion,BP,
13645,GO:0051024,1,0.94833653194471,0,9,positive regulation of immunoglobulin secretion,BP,
13646,GO:0051025,1,0.987681337751598,0,2,negative regulation of immunoglobulin secretion,BP,
13647,GO:0051026,1,0.963515615479564,0,6,chiasma assembly,BP,
13648,GO:0051028,1,0.408182135160726,0,138,mRNA transport,BP,
13649,GO:0051029,1,0.963311101290786,0,6,rRNA transport,BP,
13650,GO:0051030,1,0.976879212094863,0,4,snRNA transport,BP,
13651,GO:0051031,1,0.810524872261282,0,32,tRNA transport,BP,
13652,GO:0051032,1,0.986759625697182,0,2,nucleic acid transmembrane transporter activity,MF,
13653,GO:0051033,1,0.986759625697182,0,2,RNA transmembrane transporter activity,MF,
13654,GO:0051036,1,0.96989689808193,0,5,regulation of endosome size,BP,
13655,GO:0051040,1,0.98748297730513,0,2,regulation of calcium-independent cell-cell adhesion,BP,
13656,GO:0051041,1,0.993704695006763,0,1,positive regulation of calcium-independent cell-cell adhesion,BP,
13657,GO:0051042,1,0.993739268775992,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
13658,GO:0051043,1,0.87528887671555,0,21,regulation of membrane protein ectodomain proteolysis,BP,
13659,GO:0051044,1,0.921827578803008,0,13,positive regulation of membrane protein ectodomain proteolysis,BP,
13660,GO:0051045,1,0.949555592211201,0,8,negative regulation of membrane protein ectodomain proteolysis,BP,
13668,GO:0051053,1,0.46445892148676,0,117,negative regulation of DNA metabolic process,BP,
13670,GO:0051055,1,0.760620302137554,0,44,negative regulation of lipid biosynthetic process,BP,
13674,GO:0051059,1,0.839713321810677,0,28,NF-kappaB binding,MF,
13675,GO:0051066,1,0.988286921246038,0,2,dihydrobiopterin metabolic process,BP,
13676,GO:0051068,1,0.993613912060388,0,1,dihydrolipoamide metabolic process,BP,
13677,GO:0051081,1,0.741218906504129,0,46,nuclear envelope disassembly,BP,
13679,GO:0051083,1,0.9881861789473,0,2,'de novo' cotranslational protein folding,BP,
13682,GO:0051086,1,0.994079390804092,0,1,chaperone mediated protein folding independent of cofactor,BP,
13684,GO:0051088,1,0.980756758631436,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
13685,GO:0051089,1,0.993513684232251,0,1,constitutive protein ectodomain proteolysis,BP,
13691,GO:0051095,1,0.94515418735372,0,9,regulation of helicase activity,BP,
13692,GO:0051096,1,0.96281577334458,0,6,positive regulation of helicase activity,BP,
13693,GO:0051097,1,0.981663345802532,0,3,negative regulation of helicase activity,BP,
13694,GO:0051098,1,0.116752363030326,0,333,regulation of binding,BP,
13695,GO:0051099,1,0.350450762994161,0,163,positive regulation of binding,BP,
13696,GO:0051100,1,0.392543950696263,0,147,negative regulation of binding,BP,
13697,GO:0051101,1,0.496179990775652,0,110,regulation of DNA binding,BP,
13698,GO:0051102,1,0.993480232441356,0,1,DNA ligation involved in DNA recombination,BP,
13699,GO:0051103,1,0.934827647245652,0,11,DNA ligation involved in DNA repair,BP,
13700,GO:0051105,1,0.963570189313431,0,6,regulation of DNA ligation,BP,
13701,GO:0051106,1,0.969572946946461,0,5,positive regulation of DNA ligation,BP,
13702,GO:0051107,1,0.993810810410542,0,1,negative regulation of DNA ligation,BP,
13705,GO:0051120,1,0.98163643928793,0,3,hepoxilin A3 synthase activity,MF,
13706,GO:0051121,1,0.969704399828108,0,5,hepoxilin metabolic process,BP,
13707,GO:0051122,1,0.969704399828108,0,5,hepoxilin biosynthetic process,BP,
13708,GO:0051123,1,0.822780459445743,0,31,RNA polymerase II transcriptional preinitiation complex assembly,BP,
13709,GO:0051124,1,0.93225319487207,0,10,synaptic growth at neuromuscular junction,BP,
13710,GO:0051125,1,0.840950383910502,0,27,regulation of actin nucleation,BP,
13711,GO:0051126,1,0.958184005150111,0,7,negative regulation of actin nucleation,BP,
13712,GO:0051127,1,0.905058017458644,0,15,positive regulation of actin nucleation,BP,
13716,GO:0051131,1,0.895841486644994,0,18,chaperone-mediated protein complex assembly,BP,
13717,GO:0051132,1,0.952877771551716,0,8,NK T cell activation,BP,
13718,GO:0051133,1,0.964800188946912,0,6,regulation of NK T cell activation,BP,
13719,GO:0051134,1,0.994101334421856,0,1,negative regulation of NK T cell activation,BP,
13720,GO:0051135,1,0.970526745118111,0,5,positive regulation of NK T cell activation,BP,
13721,GO:0051136,1,0.962042414226871,0,6,regulation of NK T cell differentiation,BP,
13722,GO:0051138,1,0.974281582555846,0,4,positive regulation of NK T cell differentiation,BP,
13723,GO:0051139,1,0.986653713161094,0,2,metal ion:proton antiporter activity,MF,
13724,GO:0051140,1,0.982459758057413,0,3,regulation of NK T cell proliferation,BP,
13725,GO:0051142,1,0.982459758057413,0,3,positive regulation of NK T cell proliferation,BP,
13726,GO:0051145,1,0.721793196273498,0,51,smooth muscle cell differentiation,BP,
13729,GO:0051148,1,0.77226100818435,0,40,negative regulation of muscle cell differentiation,BP,
13731,GO:0051150,1,0.847179477112027,0,26,regulation of smooth muscle cell differentiation,BP,
13732,GO:0051151,1,0.931793549230323,0,11,negative regulation of smooth muscle cell differentiation,BP,
13733,GO:0051152,1,0.933639325542343,0,11,positive regulation of smooth muscle cell differentiation,BP,
13735,GO:0051154,1,0.834156354868063,0,28,negative regulation of striated muscle cell differentiation,BP,
13737,GO:0051156,1,0.852227508919968,0,26,glucose 6-phosphate metabolic process,BP,
13738,GO:0051160,1,0.993916777748947,0,1,L-xylitol catabolic process,BP,
13739,GO:0051164,1,0.993916777748947,0,1,L-xylitol metabolic process,BP,
13740,GO:0051167,1,0.970686647241458,0,5,xylulose 5-phosphate metabolic process,BP,
13741,GO:0051168,1,0.291840432914234,0,191,nuclear export,BP,
13742,GO:0051169,1,0.120566850339541,0,327,nuclear transport,BP,
13743,GO:0051170,1,0.383049795669119,0,149,import into nucleus,BP,
13748,GO:0051176,1,0.980425543471633,0,3,positive regulation of sulfur metabolic process,BP,
13749,GO:0051177,1,0.964026375128103,0,6,meiotic sister chromatid cohesion,BP,
13753,GO:0051182,1,0.950692589145923,0,8,coenzyme transport,BP,
13754,GO:0051184,1,0.879816495312793,0,20,cofactor transmembrane transporter activity,MF,
13755,GO:0051185,1,0.962756408770091,0,6,coenzyme transmembrane transporter activity,MF,
13757,GO:0051187,1,0.761534095355432,0,45,cofactor catabolic process,BP,
13758,GO:0051188,1,0.175394994284615,0,274,cofactor biosynthetic process,BP,
13759,GO:0051189,1,0.957804923536054,0,7,prosthetic group metabolic process,BP,
13760,GO:0051192,1,0.988946073143875,0,2,prosthetic group binding,MF,
13761,GO:0051193,1,0.543080235652485,0,94,regulation of cofactor metabolic process,BP,
13762,GO:0051194,1,0.882275133547126,0,19,positive regulation of cofactor metabolic process,BP,
13763,GO:0051195,1,0.902545120237554,0,16,negative regulation of cofactor metabolic process,BP,
13764,GO:0051196,1,0.591592713784209,0,80,regulation of coenzyme metabolic process,BP,
13765,GO:0051197,1,0.898682624307635,0,16,positive regulation of coenzyme metabolic process,BP,
13766,GO:0051198,1,0.936009816320934,0,10,negative regulation of coenzyme metabolic process,BP,
13767,GO:0051204,1,0.811587320116834,0,34,protein insertion into mitochondrial membrane,BP,
13768,GO:0051205,1,0.753563094551844,0,46,protein insertion into membrane,BP,
13771,GO:0051213,1,0.578097427857658,0,85,dioxygenase activity,MF,
13773,GO:0051219,1,0.614695923676311,0,74,phosphoprotein binding,MF,
13774,GO:0051220,1,0.856788161689731,0,24,cytoplasmic sequestering of protein,BP,
13778,GO:0051225,1,0.4990289666398,0,106,spindle assembly,BP,
13779,GO:0051228,1,0.993158352534952,0,1,mitotic spindle disassembly,BP,
13780,GO:0051230,1,0.993158352534952,0,1,spindle disassembly,BP,
13781,GO:0051231,1,0.932552106840506,0,11,spindle elongation,BP,
13782,GO:0051232,1,0.993961120761595,0,1,meiotic spindle elongation,BP,
13783,GO:0051233,1,0.817746788229283,0,31,spindle midzone,CC,
13786,GO:0051236,1,0.305710579026692,0,183,establishment of RNA localization,BP,
13787,GO:0051238,1,0.91788708390101,0,14,sequestering of metal ion,BP,
13794,GO:0051249,1,0.0963808495059915,0,370,regulation of lymphocyte activation,BP,
13795,GO:0051250,1,0.478405933021345,0,117,negative regulation of lymphocyte activation,BP,
13796,GO:0051251,1,0.217860187949768,0,243,positive regulation of lymphocyte activation,BP,
13800,GO:0051255,1,0.939420904881686,0,10,spindle midzone assembly,BP,
13801,GO:0051256,1,0.951184665780257,0,8,mitotic spindle midzone assembly,BP,
13802,GO:0051257,1,0.993934047371008,0,1,meiotic spindle midzone assembly,BP,
13806,GO:0051261,1,0.528580796841119,0,96,protein depolymerization,BP,
13807,GO:0051262,1,0.451632428221332,0,125,protein tetramerization,BP,
13808,GO:0051264,1,0.993836326336171,0,1,mono-olein transacylation activity,MF,
13809,GO:0051265,1,0.993836326336171,0,1,diolein transacylation activity,MF,
13810,GO:0051267,1,0.99371155059077,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13816,GO:0051280,1,0.923374880577225,0,13,negative regulation of release of sequestered calcium ion into cytosol,BP,
13817,GO:0051281,1,0.795558276601417,0,36,positive regulation of release of sequestered calcium ion into cytosol,BP,
13821,GO:0051286,1,0.954550023366395,0,7,cell tip,CC,
13822,GO:0051287,1,0.710078324049332,0,56,NAD binding,MF,
13823,GO:0051289,1,0.622131024143743,0,75,protein homotetramerization,BP,
13824,GO:0051290,1,0.840290187004808,0,28,protein heterotetramerization,BP,
13825,GO:0051291,1,0.530785941051223,0,100,protein heterooligomerization,BP,
13826,GO:0051292,1,0.935223765905715,0,10,nuclear pore complex assembly,BP,
13827,GO:0051293,1,0.796379503879149,0,34,establishment of spindle localization,BP,
13828,GO:0051294,1,0.843655284882346,0,26,establishment of spindle orientation,BP,
13829,GO:0051295,1,0.972356399137131,0,4,establishment of meiotic spindle localization,BP,
13830,GO:0051298,1,0.665656377617728,0,62,centrosome duplication,BP,
13831,GO:0051299,1,0.901446307925036,0,16,centrosome separation,BP,
13832,GO:0051300,1,0.993846081630578,0,1,spindle pole body organization,BP,
13835,GO:0051303,1,0.639810525336787,0,70,establishment of chromosome localization,BP,
13837,GO:0051305,1,0.960193660469744,0,6,chromosome movement towards spindle pole,BP,
13838,GO:0051306,1,0.706160837413036,0,54,mitotic sister chromatid separation,BP,
13840,GO:0051308,1,0.993846081630578,0,1,male meiosis chromosome separation,BP,
13841,GO:0051310,1,0.705704911097227,0,55,metaphase plate congression,BP,
13842,GO:0051311,1,0.993934047371008,0,1,meiotic metaphase plate congression,BP,
13843,GO:0051315,1,0.921112277424117,0,13,attachment of mitotic spindle microtubules to kinetochore,BP,
13844,GO:0051316,1,0.987878653022165,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
13849,GO:0051340,1,0.947608511721493,0,9,regulation of ligase activity,BP,
13851,GO:0051342,1,0.951315929986343,0,8,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13852,GO:0051343,1,0.975685228549031,0,4,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13853,GO:0051344,1,0.968954865290489,0,5,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13858,GO:0051349,1,0.908750372906096,0,15,positive regulation of lyase activity,BP,
13860,GO:0051351,1,0.959183815014731,0,7,positive regulation of ligase activity,BP,
13861,GO:0051352,1,0.987937233899787,0,2,negative regulation of ligase activity,BP,
13863,GO:0051354,1,0.882462105567511,0,20,negative regulation of oxidoreductase activity,BP,
13864,GO:0051355,1,0.993550536294562,0,1,proprioception involved in equilibrioception,BP,
13865,GO:0051365,1,0.981611385610539,0,3,cellular response to potassium ion starvation,BP,
13867,GO:0051373,1,0.969773301179422,0,5,FATZ binding,MF,
13868,GO:0051377,1,0.980791159018528,0,3,mannose-ethanolamine phosphotransferase activity,MF,
13869,GO:0051378,1,0.934877080306907,0,11,serotonin binding,MF,
13870,GO:0051379,1,0.958374818912237,0,7,epinephrine binding,MF,
13871,GO:0051380,1,0.969919067007483,0,5,norepinephrine binding,MF,
13872,GO:0051382,1,0.912888597579352,0,14,kinetochore assembly,BP,
13873,GO:0051383,1,0.884059673231718,0,19,kinetochore organization,BP,
13874,GO:0051384,1,0.440653268778685,0,130,response to glucocorticoid,BP,
13875,GO:0051385,1,0.840226217938622,0,28,response to mineralocorticoid,BP,
13876,GO:0051386,1,0.944611631677257,0,9,regulation of neurotrophin TRK receptor signaling pathway,BP,
13877,GO:0051387,1,0.981999668417773,0,3,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
13878,GO:0051388,1,0.974157958034955,0,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
13879,GO:0051389,1,0.984697374583577,0,2,inactivation of MAPKK activity,BP,
13880,GO:0051391,1,0.993508682661501,0,1,tRNA acetylation,BP,
13881,GO:0051392,1,0.993508682661501,0,1,tRNA N-acetyltransferase activity,MF,
13886,GO:0051409,1,0.93871644298895,0,10,response to nitrosative stress,BP,
13887,GO:0051410,1,0.97010133378567,0,5,detoxification of nitrogen compound,BP,
13888,GO:0051412,1,0.904323990314522,0,16,response to corticosterone,BP,
13889,GO:0051413,1,0.993921957653899,0,1,response to cortisone,BP,
13890,GO:0051414,1,0.966815214278847,0,5,response to cortisol,BP,
13891,GO:0051415,1,0.968166465667852,0,5,microtubule nucleation by interphase microtubule organizing center,BP,
13892,GO:0051417,1,0.993846081630578,0,1,microtubule nucleation by spindle pole body,BP,
13893,GO:0051418,1,0.953754341024048,0,7,microtubule nucleation by microtubule organizing center,BP,
13894,GO:0051424,1,0.994115772520527,0,1,corticotropin-releasing hormone binding,MF,
13895,GO:0051425,1,0.97289897747243,0,4,PTB domain binding,MF,
13897,GO:0051428,1,0.902633585303649,0,17,peptide hormone receptor binding,MF,
13898,GO:0051429,1,0.970687454760994,0,5,corticotropin-releasing hormone receptor binding,MF,
13899,GO:0051430,1,0.976333143323903,0,4,corticotropin-releasing hormone receptor 1 binding,MF,
13900,GO:0051431,1,0.983062857527726,0,3,corticotropin-releasing hormone receptor 2 binding,MF,
13901,GO:0051433,1,0.99333891558761,0,1,BH2 domain binding,MF,
13902,GO:0051434,1,0.969955069600084,0,5,BH3 domain binding,MF,
13903,GO:0051438,1,0.725314319625222,0,51,regulation of ubiquitin-protein transferase activity,BP,
13904,GO:0051443,1,0.817940382077457,0,32,positive regulation of ubiquitin-protein transferase activity,BP,
13905,GO:0051444,1,0.917256078065934,0,14,negative regulation of ubiquitin-protein transferase activity,BP,
13906,GO:0051445,1,0.786235428843238,0,38,regulation of meiotic cell cycle,BP,
13907,GO:0051446,1,0.914139849131306,0,14,positive regulation of meiotic cell cycle,BP,
13908,GO:0051447,1,0.916655408707804,0,14,negative regulation of meiotic cell cycle,BP,
13909,GO:0051450,1,0.892746653742045,0,18,myoblast proliferation,BP,
13910,GO:0051451,1,0.931694399172001,0,11,myoblast migration,BP,
13911,GO:0051452,1,0.747471181829687,0,47,intracellular pH reduction,BP,
13912,GO:0051453,1,0.581191070096279,0,85,regulation of intracellular pH,BP,
13913,GO:0051454,1,0.97463580442428,0,4,intracellular pH elevation,BP,
13914,GO:0051455,1,0.993846081630578,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
13915,GO:0051456,1,0.993995998098017,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
13916,GO:0051457,1,0.867141008487092,0,22,maintenance of protein location in nucleus,BP,
13917,GO:0051458,1,0.958909811861671,0,7,corticotropin secretion,BP,
13918,GO:0051459,1,0.96479042857129,0,6,regulation of corticotropin secretion,BP,
13919,GO:0051460,1,0.994115772520527,0,1,negative regulation of corticotropin secretion,BP,
13920,GO:0051461,1,0.970502828595945,0,5,positive regulation of corticotropin secretion,BP,
13921,GO:0051462,1,0.970179142121313,0,5,regulation of cortisol secretion,BP,
13922,GO:0051463,1,0.992835732033628,0,1,negative regulation of cortisol secretion,BP,
13923,GO:0051464,1,0.977181575965124,0,4,positive regulation of cortisol secretion,BP,
13924,GO:0051466,1,0.993718692812986,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13926,GO:0051481,1,0.939736281437766,0,9,negative regulation of cytosolic calcium ion concentration,BP,
13929,GO:0051490,1,0.988029153181071,0,2,negative regulation of filopodium assembly,BP,
13930,GO:0051491,1,0.833331246512175,0,28,positive regulation of filopodium assembly,BP,
13933,GO:0051494,1,0.438464387372797,0,126,negative regulation of cytoskeleton organization,BP,
13936,GO:0051497,1,0.8762440169779,0,20,negative regulation of stress fiber assembly,BP,
13937,GO:0051499,1,0.988133457935278,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13938,GO:0051500,1,0.988133457935278,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
13939,GO:0051503,1,0.922967635577479,0,13,adenine nucleotide transport,BP,
13940,GO:0051525,1,0.967466156673521,0,5,NFAT protein binding,MF,
13943,GO:0051538,1,0.981898420804313,0,3,3 iron, 4 sulfur cluster binding,MF,
13944,GO:0051539,1,0.778808394582276,0,40,4 iron, 4 sulfur cluster binding,MF,
13946,GO:0051541,1,0.97432650202063,0,4,elastin metabolic process,BP,
13947,GO:0051542,1,0.986207983870179,0,2,elastin biosynthetic process,BP,
13948,GO:0051543,1,0.993966019125604,0,1,regulation of elastin biosynthetic process,BP,
13949,GO:0051545,1,0.993966019125604,0,1,negative regulation of elastin biosynthetic process,BP,
13950,GO:0051546,1,0.914266975745005,0,14,keratinocyte migration,BP,
13951,GO:0051547,1,0.943061187743317,0,9,regulation of keratinocyte migration,BP,
13952,GO:0051548,1,0.99305033362119,0,1,negative regulation of keratinocyte migration,BP,
13953,GO:0051549,1,0.949664505105325,0,8,positive regulation of keratinocyte migration,BP,
13954,GO:0051552,1,0.992826483555519,0,1,flavone metabolic process,BP,
13955,GO:0051560,1,0.877255797128633,0,21,mitochondrial calcium ion homeostasis,BP,
13956,GO:0051561,1,0.940866389676141,0,10,positive regulation of mitochondrial calcium ion concentration,BP,
13957,GO:0051562,1,0.982084428032472,0,3,negative regulation of mitochondrial calcium ion concentration,BP,
13958,GO:0051563,1,0.986584679336326,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13959,GO:0051567,1,0.82330919634127,0,29,histone H3-K9 methylation,BP,
13960,GO:0051568,1,0.728870233128593,0,48,histone H3-K4 methylation,BP,
13961,GO:0051569,1,0.855841826495152,0,24,regulation of histone H3-K4 methylation,BP,
13962,GO:0051570,1,0.8742827133869,0,20,regulation of histone H3-K9 methylation,BP,
13963,GO:0051571,1,0.905901294452263,0,15,positive regulation of histone H3-K4 methylation,BP,
13964,GO:0051572,1,0.979636112374443,0,3,negative regulation of histone H3-K4 methylation,BP,
13965,GO:0051573,1,0.936592033616075,0,10,negative regulation of histone H3-K9 methylation,BP,
13966,GO:0051574,1,0.941263953276063,0,9,positive regulation of histone H3-K9 methylation,BP,
13967,GO:0051575,1,0.967933729319685,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
13968,GO:0051580,1,0.910411974603767,0,15,regulation of neurotransmitter uptake,BP,
13969,GO:0051581,1,0.974744032739728,0,4,negative regulation of neurotransmitter uptake,BP,
13970,GO:0051582,1,0.976534445972882,0,4,positive regulation of neurotransmitter uptake,BP,
13971,GO:0051583,1,0.935118036869218,0,11,dopamine uptake involved in synaptic transmission,BP,
13972,GO:0051584,1,0.958966635237723,0,7,regulation of dopamine uptake involved in synaptic transmission,BP,
13973,GO:0051585,1,0.993733409310885,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13974,GO:0051586,1,0.982437181157132,0,3,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13976,GO:0051589,1,0.882967834571074,0,19,negative regulation of neurotransmitter transport,BP,
13977,GO:0051590,1,0.847942812277171,0,26,positive regulation of neurotransmitter transport,BP,
13978,GO:0051591,1,0.553251379256313,0,91,response to cAMP,BP,
13980,GO:0051593,1,0.935166818314418,0,11,response to folic acid,BP,
13981,GO:0051594,1,0.976298374042888,0,4,detection of glucose,BP,
13982,GO:0051595,1,0.981452439003768,0,3,response to methylglyoxal,BP,
13983,GO:0051596,1,0.988015219804929,0,2,methylglyoxal catabolic process,BP,
13984,GO:0051597,1,0.955328249616977,0,7,response to methylmercury,BP,
13985,GO:0051598,1,0.993323260522915,0,1,meiotic recombination checkpoint,BP,
13986,GO:0051599,1,0.966688052588891,0,5,response to hydrostatic pressure,BP,
13987,GO:0051601,1,0.950973020265294,0,8,exocyst localization,BP,
13988,GO:0051602,1,0.782185123723605,0,39,response to electrical stimulus,BP,
13992,GO:0051607,1,0.304723927076666,0,188,defense response to virus,BP,
13993,GO:0051608,1,0.941019103718958,0,10,histamine transport,BP,
13994,GO:0051610,1,0.974064765232405,0,4,serotonin uptake,BP,
13995,GO:0051611,1,0.980595927285987,0,3,regulation of serotonin uptake,BP,
13996,GO:0051612,1,0.980595927285987,0,3,negative regulation of serotonin uptake,BP,
13997,GO:0051615,1,0.993027530544951,0,1,histamine uptake,BP,
13998,GO:0051620,1,0.993733409310885,0,1,norepinephrine uptake,BP,
13999,GO:0051621,1,0.993733409310885,0,1,regulation of norepinephrine uptake,BP,
14000,GO:0051622,1,0.993733409310885,0,1,negative regulation of norepinephrine uptake,BP,
14001,GO:0051639,1,0.949179489461897,0,8,actin filament network formation,BP,
14004,GO:0051642,1,0.857349129267405,0,22,centrosome localization,BP,
14005,GO:0051643,1,0.965179661085184,0,5,endoplasmic reticulum localization,BP,
14006,GO:0051645,1,0.918361201835618,0,13,Golgi localization,BP,
14007,GO:0051646,1,0.773557470665711,0,39,mitochondrion localization,BP,
14008,GO:0051647,1,0.858980286843692,0,22,nucleus localization,BP,
14012,GO:0051651,1,0.559212896659867,0,88,maintenance of location in cell,BP,
14013,GO:0051653,1,0.774454787924149,0,38,spindle localization,BP,
14014,GO:0051654,1,0.881398365748399,0,19,establishment of mitochondrion localization,BP,
14016,GO:0051657,1,0.932468831835886,0,10,maintenance of organelle location,BP,
14017,GO:0051659,1,0.987663039544381,0,2,maintenance of mitochondrion location,BP,
14018,GO:0051660,1,0.973767617191627,0,4,establishment of centrosome localization,BP,
14019,GO:0051661,1,0.963675485112817,0,5,maintenance of centrosome location,BP,
14020,GO:0051664,1,0.987327624599677,0,2,nuclear pore localization,BP,
14022,GO:0051666,1,0.967991995816364,0,5,actin cortical patch localization,BP,
14024,GO:0051673,1,0.960907245798742,0,7,membrane disruption in other organism,BP,
14026,GO:0051683,1,0.957381803282076,0,7,establishment of Golgi localization,BP,
14027,GO:0051684,1,0.979685955462506,0,3,maintenance of Golgi location,BP,
14028,GO:0051685,1,0.993846081630578,0,1,maintenance of ER location,BP,
14029,GO:0051686,1,0.991115060036865,0,1,establishment of ER localization,BP,
14030,GO:0051691,1,0.9941603888507,0,1,cellular oligosaccharide metabolic process,BP,
14031,GO:0051692,1,0.9941603888507,0,1,cellular oligosaccharide catabolic process,BP,
14032,GO:0051693,1,0.813338851562706,0,31,actin filament capping,BP,
14033,GO:0051694,1,0.961602563601277,0,6,pointed-end actin filament capping,BP,
14034,GO:0051695,1,0.993340064348855,0,1,actin filament uncapping,BP,
14035,GO:0051697,1,0.976269435950666,0,4,protein delipidation,BP,
14037,GO:0051702,1,0.670783871148815,0,64,interaction with symbiont,BP,
14038,GO:0051703,1,0.719407856937309,0,49,intraspecies interaction between organisms,BP,
14040,GO:0051705,1,0.658307722287364,0,63,multi-organism behavior,BP,
14041,GO:0051707,1,0.0126015211196364,0,688,response to other organism,BP,
14042,GO:0051708,1,0.988589664605642,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
14043,GO:0051709,1,0.941120914997141,0,10,regulation of killing of cells of other organism,BP,
14044,GO:0051710,1,0.994372497445327,0,1,regulation of cytolysis in other organism,BP,
14045,GO:0051712,1,0.947052081876886,0,9,positive regulation of killing of cells of other organism,BP,
14046,GO:0051714,1,0.994372497445327,0,1,positive regulation of cytolysis in other organism,BP,
14047,GO:0051715,1,0.976951001814315,0,4,cytolysis in other organism,BP,
14049,GO:0051717,1,0.986918238281122,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
14050,GO:0051721,1,0.838900493415998,0,27,protein phosphatase 2A binding,MF,
14051,GO:0051722,1,0.993936350677816,0,1,protein C-terminal methylesterase activity,MF,
14052,GO:0051723,1,0.993936350677816,0,1,protein methylesterase activity,MF,
14053,GO:0051724,1,0.993992826293789,0,1,NAD transmembrane transporter activity,MF,
14054,GO:0051725,1,0.975601924524975,0,4,protein de-ADP-ribosylation,BP,
14056,GO:0051728,1,0.993784462646258,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
14057,GO:0051729,1,0.993784462646258,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
14058,GO:0051731,1,0.973940718270333,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
14059,GO:0051732,1,0.994142340087971,0,1,polyribonucleotide kinase activity,MF,
14060,GO:0051733,1,0.981091167560702,0,3,polydeoxyribonucleotide kinase activity,MF,
14061,GO:0051734,1,0.981091167560702,0,3,ATP-dependent polynucleotide kinase activity,MF,
14062,GO:0051736,1,0.994142340087971,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
14063,GO:0051747,1,0.98859915727395,0,2,cytosine C-5 DNA demethylase activity,MF,
14064,GO:0051748,1,0.994027726857486,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
14065,GO:0051750,1,0.994281242594407,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
14066,GO:0051754,1,0.975236240857248,0,4,meiotic sister chromatid cohesion, centromeric,BP,
14067,GO:0051758,1,0.992794399293455,0,1,homologous chromosome movement towards spindle pole involved in homologous chromosome segregation,BP,
14068,GO:0051764,1,0.93110052753826,0,11,actin crosslink formation,BP,
14069,GO:0051765,1,0.987873740385257,0,2,inositol tetrakisphosphate kinase activity,MF,
14070,GO:0051766,1,0.962534884290799,0,6,inositol trisphosphate kinase activity,MF,
14071,GO:0051767,1,0.896794732348528,0,17,nitric-oxide synthase biosynthetic process,BP,
14072,GO:0051769,1,0.896794732348528,0,17,regulation of nitric-oxide synthase biosynthetic process,BP,
14073,GO:0051770,1,0.912900822183787,0,14,positive regulation of nitric-oxide synthase biosynthetic process,BP,
14074,GO:0051771,1,0.982373496554651,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
14076,GO:0051780,1,0.993455479429119,0,1,behavioral response to nutrient,BP,
14078,GO:0051782,1,0.912424102005162,0,14,negative regulation of cell division,BP,
14080,GO:0051784,1,0.707437016214407,0,54,negative regulation of nuclear division,BP,
14081,GO:0051785,1,0.699001899557312,0,55,positive regulation of nuclear division,BP,
14082,GO:0051786,1,0.993691271906932,0,1,all-trans-retinol 13,14-reductase activity,MF,
14084,GO:0051788,1,0.862428632593336,0,23,response to misfolded protein,BP,
14085,GO:0051790,1,0.975678973555686,0,4,short-chain fatty acid biosynthetic process,BP,
14086,GO:0051791,1,0.940294290366067,0,10,medium-chain fatty acid metabolic process,BP,
14087,GO:0051792,1,0.969210712943678,0,5,medium-chain fatty acid biosynthetic process,BP,
14088,GO:0051793,1,0.968877529645543,0,5,medium-chain fatty acid catabolic process,BP,
14089,GO:0051794,1,0.97522899682106,0,4,regulation of timing of catagen,BP,
14090,GO:0051795,1,0.981695856161166,0,3,positive regulation of timing of catagen,BP,
14091,GO:0051796,1,0.993413800831215,0,1,negative regulation of timing of catagen,BP,
14092,GO:0051797,1,0.891451649057643,0,18,regulation of hair follicle development,BP,
14093,GO:0051798,1,0.934153588708255,0,11,positive regulation of hair follicle development,BP,
14094,GO:0051799,1,0.980276023948042,0,3,negative regulation of hair follicle development,BP,
14095,GO:0051800,1,0.987208018876572,0,2,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
14096,GO:0051801,1,0.987900628381654,0,2,cytolysis in other organism involved in symbiotic interaction,BP,
14097,GO:0051805,1,0.987054758386881,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
14099,GO:0051807,1,0.987054758386881,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
14100,GO:0051808,1,0.993949453664117,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
14101,GO:0051817,1,0.554125877475225,0,93,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,
14102,GO:0051818,1,0.916417227655312,0,15,disruption of cells of other organism involved in symbiotic interaction,BP,
14103,GO:0051821,1,0.992805094668721,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
14104,GO:0051823,1,0.941019143832812,0,9,regulation of synapse structural plasticity,BP,
14106,GO:0051832,1,0.974221269171982,0,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,
14107,GO:0051833,1,0.993147831445154,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
14108,GO:0051834,1,0.974221269171982,0,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
14109,GO:0051835,1,0.973294643745859,0,4,positive regulation of synapse structural plasticity,BP,
14110,GO:0051836,1,0.946626021861483,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
14111,GO:0051851,1,0.688620840200585,0,60,modification by host of symbiont morphology or physiology,BP,
14112,GO:0051852,1,0.939303604091294,0,11,disruption by host of symbiont cells,BP,
14114,GO:0051864,1,0.9473501905702,0,8,histone demethylase activity (H3-K36 specific),MF,
14115,GO:0051865,1,0.703085435920322,0,54,protein autoubiquitination,BP,
14116,GO:0051866,1,0.987946483199746,0,2,general adaptation syndrome,BP,
14117,GO:0051867,1,0.994280809426372,0,1,general adaptation syndrome, behavioral process,BP,
14118,GO:0051870,1,0.982291559571115,0,3,methotrexate binding,MF,
14119,GO:0051873,1,0.949717145931892,0,9,killing by host of symbiont cells,BP,
14120,GO:0051875,1,0.843097637621769,0,27,pigment granule localization,BP,
14121,GO:0051877,1,0.987668763005475,0,2,pigment granule aggregation in cell center,BP,
14122,GO:0051879,1,0.816040726479994,0,32,Hsp90 protein binding,MF,
14123,GO:0051880,1,0.952855340802841,0,7,G-quadruplex DNA binding,MF,
14126,GO:0051883,1,0.926579613850843,0,13,killing of cells in other organism involved in symbiotic interaction,BP,
14127,GO:0051884,1,0.96779111146716,0,5,regulation of timing of anagen,BP,
14128,GO:0051885,1,0.987000684221274,0,2,positive regulation of timing of anagen,BP,
14129,GO:0051886,1,0.993162819888306,0,1,negative regulation of timing of anagen,BP,
14130,GO:0051890,1,0.962171088505108,0,6,regulation of cardioblast differentiation,BP,
14131,GO:0051891,1,0.968543435783466,0,5,positive regulation of cardioblast differentiation,BP,
14132,GO:0051892,1,0.993422828359076,0,1,negative regulation of cardioblast differentiation,BP,
14134,GO:0051894,1,0.856413371582015,0,23,positive regulation of focal adhesion assembly,BP,
14135,GO:0051895,1,0.905787471642066,0,15,negative regulation of focal adhesion assembly,BP,
14138,GO:0051898,1,0.776134471096787,0,39,negative regulation of protein kinase B signaling,BP,
14143,GO:0051903,1,0.993883417918289,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
14144,GO:0051904,1,0.85997694958125,0,24,pigment granule transport,BP,
14145,GO:0051905,1,0.853518130911614,0,25,establishment of pigment granule localization,BP,
14146,GO:0051908,1,0.993724121625502,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
14147,GO:0051916,1,0.993790903951466,0,1,granulocyte colony-stimulating factor binding,MF,
14148,GO:0051917,1,0.940130021521085,0,10,regulation of fibrinolysis,BP,
14149,GO:0051918,1,0.957375254347751,0,7,negative regulation of fibrinolysis,BP,
14150,GO:0051919,1,0.982116241097795,0,3,positive regulation of fibrinolysis,BP,
14151,GO:0051920,1,0.954996585012111,0,8,peroxiredoxin activity,MF,
14152,GO:0051923,1,0.911838330178047,0,15,sulfation,BP,
14154,GO:0051926,1,0.73130521555979,0,50,negative regulation of calcium ion transport,BP,
14159,GO:0051933,1,0.979401526776589,0,3,amino acid neurotransmitter reuptake,BP,
14160,GO:0051934,1,0.935118036869218,0,11,catecholamine uptake involved in synaptic transmission,BP,
14161,GO:0051935,1,0.979401526776589,0,3,glutamate reuptake,BP,
14162,GO:0051937,1,0.722511809145727,0,52,catecholamine transport,BP,
14164,GO:0051939,1,0.993351550164066,0,1,gamma-aminobutyric acid import,BP,
14165,GO:0051940,1,0.958966635237723,0,7,regulation of catecholamine uptake involved in synaptic transmission,BP,
14166,GO:0051941,1,0.985938469379791,0,2,regulation of amino acid uptake involved in synaptic transmission,BP,
14167,GO:0051944,1,0.982437181157132,0,3,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
14168,GO:0051945,1,0.993733409310885,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
14169,GO:0051946,1,0.985938469379791,0,2,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14171,GO:0051953,1,0.882998432783328,0,20,negative regulation of amine transport,BP,
14174,GO:0051956,1,0.939732328769911,0,10,negative regulation of amino acid transport,BP,
14176,GO:0051958,1,0.986651205286064,0,2,methotrexate transport,BP,
14181,GO:0051963,1,0.594955225847601,0,78,regulation of synapse assembly,BP,
14182,GO:0051964,1,0.958747489173296,0,6,negative regulation of synapse assembly,BP,
14183,GO:0051965,1,0.677497557084377,0,59,positive regulation of synapse assembly,BP,
14185,GO:0051967,1,0.937808660107774,0,10,negative regulation of synaptic transmission, glutamatergic,BP,
14186,GO:0051968,1,0.82983929056696,0,28,positive regulation of synaptic transmission, glutamatergic,BP,
14187,GO:0051969,1,0.922002216116703,0,13,regulation of transmission of nerve impulse,BP,
14188,GO:0051970,1,0.981793201105564,0,3,negative regulation of transmission of nerve impulse,BP,
14189,GO:0051971,1,0.968204254434383,0,5,positive regulation of transmission of nerve impulse,BP,
14192,GO:0051974,1,0.946001382652268,0,9,negative regulation of telomerase activity,BP,
14193,GO:0051977,1,0.99401460045499,0,1,lysophospholipid transport,BP,
14194,GO:0051978,1,0.99401460045499,0,1,lysophospholipid transporter activity,MF,
14196,GO:0051984,1,0.854423680385708,0,24,positive regulation of chromosome segregation,BP,
14197,GO:0051985,1,0.785176444299836,0,37,negative regulation of chromosome segregation,BP,
14198,GO:0051987,1,0.968717180748362,0,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,
14199,GO:0051988,1,0.925151441383195,0,12,regulation of attachment of spindle microtubules to kinetochore,BP,
14200,GO:0051990,1,0.987908563004551,0,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
14201,GO:0051996,1,0.994038114565935,0,1,squalene synthase activity,MF,
14202,GO:0051998,1,0.963040057977828,0,6,protein carboxyl O-methyltransferase activity,MF,
14203,GO:0052025,1,0.989040856318623,0,2,modification by symbiont of host cell membrane,BP,
14204,GO:0052026,1,0.993817688310509,0,1,modulation by symbiont of host transcription,BP,
14205,GO:0052027,1,0.986892388881614,0,2,modulation by symbiont of host signal transduction pathway,BP,
14206,GO:0052029,1,0.993147831445154,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
14207,GO:0052031,1,0.987199734375094,0,2,modulation by symbiont of host defense response,BP,
14208,GO:0052037,1,0.993147831445154,0,1,negative regulation by symbiont of host defense response,BP,
14209,GO:0052040,1,0.963628949564839,0,6,modulation by symbiont of host programmed cell death,BP,
14210,GO:0052041,1,0.975792273875669,0,4,negative regulation by symbiont of host programmed cell death,BP,
14211,GO:0052042,1,0.981938725725604,0,3,positive regulation by symbiont of host programmed cell death,BP,
14212,GO:0052043,1,0.989040856318623,0,2,modification by symbiont of host cellular component,BP,
14213,GO:0052047,1,0.986234824820222,0,2,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
14214,GO:0052053,1,0.993850099716597,0,1,negative regulation by symbiont of host catalytic activity,BP,
14215,GO:0052055,1,0.987039644151015,0,2,modulation by symbiont of host molecular function,BP,
14216,GO:0052056,1,0.987039644151015,0,2,negative regulation by symbiont of host molecular function,BP,
14217,GO:0052066,1,0.992646913472096,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
14218,GO:0052097,1,0.993701267540879,0,1,interspecies quorum sensing,BP,
14219,GO:0052106,1,0.993701267540879,0,1,quorum sensing involved in interaction with host,BP,
14220,GO:0052111,1,0.989040856318623,0,2,modification by symbiont of host structure,BP,
14221,GO:0052126,1,0.811327720342484,0,33,movement in host environment,BP,
14222,GO:0052148,1,0.993850099716597,0,1,modulation by symbiont of host catalytic activity,BP,
14223,GO:0052150,1,0.969186697691673,0,5,modulation by symbiont of host apoptotic process,BP,
14224,GO:0052151,1,0.987600984710986,0,2,positive regulation by symbiont of host apoptotic process,BP,
14225,GO:0052167,1,0.993147831445154,0,1,modulation by symbiont of host innate immune response,BP,
14226,GO:0052170,1,0.993147831445154,0,1,negative regulation by symbiont of host innate immune response,BP,
14227,GO:0052173,1,0.968531949944629,0,5,response to defenses of other organism involved in symbiotic interaction,BP,
14228,GO:0052182,1,0.993961697007813,0,1,modification by host of symbiont morphology or physiology via secreted substance,BP,
14229,GO:0052185,1,0.989040856318623,0,2,modification of structure of other organism involved in symbiotic interaction,BP,
14230,GO:0052188,1,0.989040856318623,0,2,modification of cellular component in other organism involved in symbiotic interaction,BP,
14231,GO:0052190,1,0.992646913472096,0,1,modulation by symbiont of host phagocytosis,BP,
14232,GO:0052191,1,0.992646913472096,0,1,positive regulation by symbiont of host phagocytosis,BP,
14233,GO:0052192,1,0.811327720342484,0,33,movement in environment of other organism involved in symbiotic interaction,BP,
14234,GO:0052199,1,0.987974141062693,0,2,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14235,GO:0052200,1,0.968531949944629,0,5,response to host defenses,BP,
14236,GO:0052203,1,0.982186354494352,0,3,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14237,GO:0052204,1,0.958754355545553,0,7,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
14238,GO:0052205,1,0.951837727730582,0,8,modulation of molecular function in other organism involved in symbiotic interaction,BP,
14239,GO:0052212,1,0.993961697007813,0,1,modification of morphology or physiology of other organism via secreted substance involved in symbiotic interaction,BP,
14240,GO:0052213,1,0.993961697007813,0,1,interaction with symbiont via secreted substance involved in symbiotic interaction,BP,
14241,GO:0052214,1,0.994173961482157,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
14242,GO:0052227,1,0.994173961482157,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
14243,GO:0052229,1,0.994173961482157,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
14244,GO:0052231,1,0.992646913472096,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
14245,GO:0052248,1,0.963628949564839,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
14246,GO:0052250,1,0.986892388881614,0,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,
14247,GO:0052251,1,0.994011283271499,0,1,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
14248,GO:0052255,1,0.987199734375094,0,2,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14249,GO:0052261,1,0.993147831445154,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
14250,GO:0052306,1,0.993147831445154,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
14251,GO:0052309,1,0.993147831445154,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
14252,GO:0052312,1,0.851657476944358,0,25,modulation of transcription in other organism involved in symbiotic interaction,BP,
14253,GO:0052314,1,0.988194486075513,0,2,phytoalexin metabolic process,BP,
14254,GO:0052330,1,0.981938725725604,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14255,GO:0052331,1,0.987900628381654,0,2,hemolysis in other organism involved in symbiotic interaction,BP,
14256,GO:0052332,1,0.989040856318623,0,2,modification by organism of membrane in other organism involved in symbiotic interaction,BP,
14257,GO:0052360,1,0.994173961482157,0,1,catabolism by host of symbiont macromolecule,BP,
14258,GO:0052361,1,0.994173961482157,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
14259,GO:0052362,1,0.994173961482157,0,1,catabolism by host of symbiont protein,BP,
14260,GO:0052363,1,0.994173961482157,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14261,GO:0052364,1,0.994173961482157,0,1,catabolism by host of substance in symbiont,BP,
14262,GO:0052370,1,0.992646913472096,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
14263,GO:0052381,1,0.99403118924193,0,1,tRNA dimethylallyltransferase activity,MF,
14264,GO:0052403,1,0.994088052350844,0,1,negative regulation by host of symbiont catalytic activity,BP,
14265,GO:0052405,1,0.971347070928209,0,5,negative regulation by host of symbiont molecular function,BP,
14266,GO:0052416,1,0.994173961482157,0,1,metabolism by host of symbiont macromolecule,BP,
14267,GO:0052417,1,0.994173961482157,0,1,metabolism by host of symbiont protein,BP,
14268,GO:0052418,1,0.994173961482157,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14269,GO:0052419,1,0.994173961482157,0,1,metabolism by host of substance in symbiont,BP,
14270,GO:0052422,1,0.988264814691588,0,2,modulation by host of symbiont catalytic activity,BP,
14271,GO:0052428,1,0.964340526196745,0,6,modulation by host of symbiont molecular function,BP,
14272,GO:0052433,1,0.963628949564839,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14273,GO:0052472,1,0.856963820408511,0,24,modulation by host of symbiont transcription,BP,
14274,GO:0052490,1,0.975792273875669,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14275,GO:0052493,1,0.993147831445154,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
14276,GO:0052501,1,0.981938725725604,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14277,GO:0052509,1,0.994011283271499,0,1,positive regulation by symbiont of host defense response,BP,
14278,GO:0052510,1,0.994011283271499,0,1,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14279,GO:0052522,1,0.992646913472096,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
14282,GO:0052550,1,0.994161688359258,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
14283,GO:0052552,1,0.987199734375094,0,2,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14284,GO:0052553,1,0.987199734375094,0,2,modulation by symbiont of host immune response,BP,
14285,GO:0052561,1,0.993147831445154,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14286,GO:0052562,1,0.993147831445154,0,1,negative regulation by symbiont of host immune response,BP,
14287,GO:0052564,1,0.975413456075505,0,4,response to immune response of other organism involved in symbiotic interaction,BP,
14288,GO:0052567,1,0.994161688359258,0,1,response to defense-related host reactive oxygen species production,BP,
14289,GO:0052572,1,0.975413456075505,0,4,response to host immune response,BP,
14290,GO:0052590,1,0.992941478338514,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
14291,GO:0052591,1,0.992941478338514,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
14292,GO:0052593,1,0.987419217352102,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
14293,GO:0052594,1,0.987419217352102,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
14294,GO:0052595,1,0.987419217352102,0,2,aliphatic-amine oxidase activity,MF,
14295,GO:0052596,1,0.987419217352102,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
14296,GO:0052629,1,0.920765190582961,0,12,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
14297,GO:0052642,1,0.988075874125521,0,2,lysophosphatidic acid phosphatase activity,MF,
14298,GO:0052646,1,0.941701711840193,0,9,alditol phosphate metabolic process,BP,
14299,GO:0052650,1,0.953529211724354,0,8,NADP-retinol dehydrogenase activity,MF,
14300,GO:0052651,1,0.988014057761391,0,2,monoacylglycerol catabolic process,BP,
14302,GO:0052654,1,0.986486934967653,0,2,L-leucine transaminase activity,MF,
14303,GO:0052655,1,0.986486934967653,0,2,L-valine transaminase activity,MF,
14304,GO:0052656,1,0.986486934967653,0,2,L-isoleucine transaminase activity,MF,
14305,GO:0052657,1,0.994237637088681,0,1,guanine phosphoribosyltransferase activity,MF,
14306,GO:0052658,1,0.961275239698005,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
14307,GO:0052659,1,0.942401136447921,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
14308,GO:0052666,1,0.994081123065024,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
14310,GO:0052692,1,0.994236770754998,0,1,raffinose alpha-galactosidase activity,MF,
14311,GO:0052695,1,0.981107332500624,0,3,cellular glucuronidation,BP,
14312,GO:0052717,1,0.992847291976754,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
14313,GO:0052718,1,0.992847291976754,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
14314,GO:0052723,1,0.968080035825713,0,5,inositol hexakisphosphate 1-kinase activity,MF,
14315,GO:0052724,1,0.968080035825713,0,5,inositol hexakisphosphate 3-kinase activity,MF,
14316,GO:0052725,1,0.993708408337088,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
14317,GO:0052726,1,0.993708408337088,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
14318,GO:0052731,1,0.99403825885113,0,1,phosphocholine phosphatase activity,MF,
14319,GO:0052732,1,0.99403825885113,0,1,phosphoethanolamine phosphatase activity,MF,
14320,GO:0052735,1,0.980364130780271,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
14321,GO:0052739,1,0.982578243304182,0,3,phosphatidylserine 1-acylhydrolase activity,MF,
14322,GO:0052740,1,0.988371330383848,0,2,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
14324,GO:0052743,1,0.930065454511294,0,11,inositol tetrakisphosphate phosphatase activity,MF,
14325,GO:0052744,1,0.902794223686985,0,15,phosphatidylinositol monophosphate phosphatase activity,MF,
14326,GO:0052745,1,0.882821393827521,0,19,inositol phosphate phosphatase activity,MF,
14327,GO:0052746,1,0.987128459340479,0,2,inositol phosphorylation,BP,
14328,GO:0052794,1,0.981980586998376,0,3,exo-alpha-(2->3)-sialidase activity,MF,
14329,GO:0052795,1,0.981980586998376,0,3,exo-alpha-(2->6)-sialidase activity,MF,
14330,GO:0052796,1,0.981980586998376,0,3,exo-alpha-(2->8)-sialidase activity,MF,
14331,GO:0052798,1,0.994041000326921,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
14334,GO:0052810,1,0.98748829513573,0,2,1-phosphatidylinositol-5-kinase activity,MF,
14335,GO:0052811,1,0.974429755111127,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
14336,GO:0052812,1,0.980764252585462,0,3,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
14338,GO:0052815,1,0.988008132727028,0,2,medium-chain acyl-CoA hydrolase activity,MF,
14339,GO:0052816,1,0.993660008707575,0,1,long-chain acyl-CoA hydrolase activity,MF,
14340,GO:0052817,1,0.993660008707575,0,1,very long chain acyl-CoA hydrolase activity,MF,
14341,GO:0052821,1,0.994333222971011,0,1,DNA-7-methyladenine glycosylase activity,MF,
14342,GO:0052822,1,0.994333222971011,0,1,DNA-3-methylguanine glycosylase activity,MF,
14343,GO:0052825,1,0.993708408337088,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
14344,GO:0052826,1,0.993825428377467,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
14345,GO:0052827,1,0.987572290604957,0,2,inositol pentakisphosphate phosphatase activity,MF,
14346,GO:0052828,1,0.986232922701696,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
14347,GO:0052829,1,0.994042876135048,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
14348,GO:0052830,1,0.993708408337088,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
14349,GO:0052831,1,0.993708408337088,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
14350,GO:0052832,1,0.974431993046586,0,4,inositol monophosphate 3-phosphatase activity,MF,
14351,GO:0052833,1,0.974431993046586,0,4,inositol monophosphate 4-phosphatase activity,MF,
14352,GO:0052834,1,0.974431993046586,0,4,inositol monophosphate phosphatase activity,MF,
14353,GO:0052835,1,0.993708408337088,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
14354,GO:0052836,1,0.981636444346081,0,3,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
14355,GO:0052839,1,0.981636444346081,0,3,inositol diphosphate tetrakisphosphate kinase activity,MF,
14356,GO:0052840,1,0.975772150142065,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
14357,GO:0052841,1,0.975772150142065,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
14358,GO:0052842,1,0.975772150142065,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
14359,GO:0052843,1,0.975772150142065,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
14360,GO:0052844,1,0.975772150142065,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
14361,GO:0052845,1,0.975772150142065,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
14362,GO:0052846,1,0.975772150142065,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
14363,GO:0052847,1,0.975772150142065,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14364,GO:0052848,1,0.975772150142065,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14365,GO:0052851,1,0.968124596979458,0,5,ferric-chelate reductase (NADPH) activity,MF,
14366,GO:0052852,1,0.994141762526464,0,1,very-long-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14367,GO:0052853,1,0.994141762526464,0,1,long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,MF,
14368,GO:0052854,1,0.994141762526464,0,1,medium-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14369,GO:0052856,1,0.994362678784099,0,1,NADHX epimerase activity,MF,
14370,GO:0052857,1,0.994362678784099,0,1,NADPHX epimerase activity,MF,
14371,GO:0052858,1,0.993617051647556,0,1,peptidyl-lysine acetyltransferase activity,MF,
14372,GO:0052866,1,0.829159831969517,0,28,phosphatidylinositol phosphate phosphatase activity,MF,
14373,GO:0052870,1,0.993783031448323,0,1,tocopherol omega-hydroxylase activity,MF,
14374,GO:0052871,1,0.993783031448323,0,1,alpha-tocopherol omega-hydroxylase activity,MF,
14375,GO:0052884,1,0.993891466686588,0,1,all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity,MF,
14376,GO:0052885,1,0.993891466686588,0,1,all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,MF,
14377,GO:0052890,1,0.994092094599453,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
14378,GO:0052894,1,0.994048070932843,0,1,norspermine:oxygen oxidoreductase activity,MF,
14379,GO:0052895,1,0.994048070932843,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
14380,GO:0052899,1,0.994156779103132,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14381,GO:0052901,1,0.988239275505747,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
14382,GO:0052902,1,0.994156779103132,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
14383,GO:0052903,1,0.994156779103132,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14384,GO:0052904,1,0.994156779103132,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14385,GO:0052905,1,0.981650478584491,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
14386,GO:0052906,1,0.993128514566326,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
14387,GO:0052907,1,0.993846081630578,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
14388,GO:0052909,1,0.993846081630578,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
14389,GO:0052917,1,0.993960832641712,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
14390,GO:0052918,1,0.992835009513031,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14391,GO:0052925,1,0.994208326127047,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
14392,GO:0052926,1,0.992835009513031,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14393,GO:0052927,1,0.993989654703031,0,1,CTP:tRNA cytidylyltransferase activity,MF,
14394,GO:0052928,1,0.993989654703031,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
14395,GO:0052929,1,0.993989654703031,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
14398,GO:0055003,1,0.852989973142328,0,20,cardiac myofibril assembly,BP,
14399,GO:0055005,1,0.981047168344828,0,3,ventricular cardiac myofibril assembly,BP,
14400,GO:0055006,1,0.638708767221675,0,64,cardiac cell development,BP,
14403,GO:0055009,1,0.962932742117156,0,6,atrial cardiac muscle tissue morphogenesis,BP,
14405,GO:0055011,1,0.988282470344621,0,2,atrial cardiac muscle cell differentiation,BP,
14406,GO:0055012,1,0.908756840566307,0,15,ventricular cardiac muscle cell differentiation,BP,
14407,GO:0055013,1,0.661490696143576,0,59,cardiac muscle cell development,BP,
14408,GO:0055014,1,0.988282470344621,0,2,atrial cardiac muscle cell development,BP,
14409,GO:0055015,1,0.9402516669629,0,10,ventricular cardiac muscle cell development,BP,
14410,GO:0055017,1,0.645373890509795,0,67,cardiac muscle tissue growth,BP,
14411,GO:0055018,1,0.994131943981625,0,1,regulation of cardiac muscle fiber development,BP,
14412,GO:0055020,1,0.994131943981625,0,1,positive regulation of cardiac muscle fiber development,BP,
14413,GO:0055021,1,0.735481588558687,0,47,regulation of cardiac muscle tissue growth,BP,
14414,GO:0055022,1,0.903923315503791,0,16,negative regulation of cardiac muscle tissue growth,BP,
14415,GO:0055023,1,0.823979832060301,0,29,positive regulation of cardiac muscle tissue growth,BP,
14418,GO:0055026,1,0.851469028299491,0,25,negative regulation of cardiac muscle tissue development,BP,
14419,GO:0055028,1,0.992572258392098,0,1,cortical microtubule,CC,
14420,GO:0055029,1,0.4354884097387,0,131,nuclear DNA-directed RNA polymerase complex,CC,
14423,GO:0055048,1,0.992572258392098,0,1,anastral spindle assembly,BP,
14424,GO:0055056,1,0.944354497228092,0,9,D-glucose transmembrane transporter activity,MF,
14425,GO:0055057,1,0.916952551776982,0,13,neuroblast division,BP,
14426,GO:0055059,1,0.961418230511824,0,6,asymmetric neuroblast division,BP,
14427,GO:0055062,1,0.941456050432305,0,9,phosphate ion homeostasis,BP,
14428,GO:0055064,1,0.9229518938376,0,12,chloride ion homeostasis,BP,
14430,GO:0055067,1,0.399510825637629,0,143,monovalent inorganic cation homeostasis,BP,
14432,GO:0055070,1,0.904095521152959,0,16,copper ion homeostasis,BP,
14434,GO:0055073,1,0.988050646595348,0,2,cadmium ion homeostasis,BP,
14436,GO:0055075,1,0.837653992977789,0,27,potassium ion homeostasis,BP,
14438,GO:0055077,1,0.987663292743395,0,2,gap junction hemi-channel activity,MF,
14439,GO:0055078,1,0.770097231740803,0,41,sodium ion homeostasis,BP,
14441,GO:0055081,1,0.749849574889157,0,44,anion homeostasis,BP,
14443,GO:0055083,1,0.868875742292492,0,21,monovalent inorganic anion homeostasis,BP,
14446,GO:0055087,1,0.981016463656988,0,3,Ski complex,CC,
14447,GO:0055088,1,0.542380730165241,0,96,lipid homeostasis,BP,
14448,GO:0055089,1,0.925478195310937,0,12,fatty acid homeostasis,BP,
14449,GO:0055090,1,0.856646817567513,0,25,acylglycerol homeostasis,BP,
14450,GO:0055091,1,0.949880974139525,0,8,phospholipid homeostasis,BP,
14451,GO:0055092,1,0.715233375477166,0,53,sterol homeostasis,BP,
14452,GO:0055093,1,0.881338340749452,0,20,response to hyperoxia,BP,
14453,GO:0055094,1,0.862685931233242,0,23,response to lipoprotein particle,BP,
14454,GO:0055095,1,0.98127608787672,0,3,lipoprotein particle mediated signaling,BP,
14455,GO:0055096,1,0.98127608787672,0,3,low-density lipoprotein particle mediated signaling,BP,
14456,GO:0055100,1,0.981197905491054,0,3,adiponectin binding,MF,
14457,GO:0055102,1,0.937421753110152,0,11,lipase inhibitor activity,MF,
14458,GO:0055103,1,0.99371155059077,0,1,ligase regulator activity,MF,
14459,GO:0055105,1,0.96629121067168,0,6,ubiquitin-protein transferase inhibitor activity,MF,
14460,GO:0055106,1,0.908788927121005,0,16,ubiquitin-protein transferase regulator activity,MF,
14461,GO:0055108,1,0.994075637661302,0,1,Golgi to transport vesicle transport,BP,
14462,GO:0055111,1,0.993021756879215,0,1,ingression involved in gastrulation with mouth forming second,BP,
14463,GO:0055113,1,0.991470177029021,0,1,epiboly involved in gastrulation with mouth forming second,BP,
14466,GO:0055118,1,0.961912669309196,0,6,negative regulation of cardiac muscle contraction,BP,
14467,GO:0055119,1,0.894737974631159,0,17,relaxation of cardiac muscle,BP,
14468,GO:0055120,1,0.994344774242044,0,1,striated muscle dense body,CC,
14470,GO:0055129,1,0.976193014438616,0,4,L-proline biosynthetic process,BP,
14471,GO:0055130,1,0.99418450191171,0,1,D-alanine catabolic process,BP,
14472,GO:0055131,1,0.964271613531132,0,6,C3HC4-type RING finger domain binding,MF,
14473,GO:0060001,1,0.992141112001619,0,1,minus-end directed microfilament motor activity,MF,
14474,GO:0060002,1,0.984369455569766,0,2,plus-end directed microfilament motor activity,MF,
14475,GO:0060003,1,0.985071660032544,0,2,copper ion export,BP,
14476,GO:0060004,1,0.889457898472327,0,18,reflex,BP,
14477,GO:0060005,1,0.974261645003081,0,4,vestibular reflex,BP,
14478,GO:0060007,1,0.993445028828441,0,1,linear vestibuloocular reflex,BP,
14479,GO:0060008,1,0.896262552032945,0,17,Sertoli cell differentiation,BP,
14480,GO:0060009,1,0.918663595055143,0,13,Sertoli cell development,BP,
14481,GO:0060010,1,0.993690272431213,0,1,Sertoli cell fate commitment,BP,
14482,GO:0060011,1,0.981287750656849,0,3,Sertoli cell proliferation,BP,
14483,GO:0060012,1,0.957644953037184,0,7,synaptic transmission, glycinergic,BP,
14484,GO:0060013,1,0.948124975930346,0,8,righting reflex,BP,
14485,GO:0060014,1,0.993806799211177,0,1,granulosa cell differentiation,BP,
14486,GO:0060017,1,0.962042126384322,0,6,parathyroid gland development,BP,
14487,GO:0060018,1,0.980619938858775,0,3,astrocyte fate commitment,BP,
14488,GO:0060019,1,0.928457711146462,0,12,radial glial cell differentiation,BP,
14489,GO:0060020,1,0.950688609554228,0,8,Bergmann glial cell differentiation,BP,
14490,GO:0060021,1,0.576153403251732,0,83,roof of mouth development,BP,
14491,GO:0060022,1,0.960737890753111,0,6,hard palate development,BP,
14492,GO:0060023,1,0.966536251597446,0,5,soft palate development,BP,
14493,GO:0060024,1,0.973965427490709,0,4,rhythmic synaptic transmission,BP,
14494,GO:0060025,1,0.980149477003764,0,3,regulation of synaptic activity,BP,
14495,GO:0060026,1,0.907614768983273,0,15,convergent extension,BP,
14496,GO:0060027,1,0.949248308311794,0,8,convergent extension involved in gastrulation,BP,
14497,GO:0060028,1,0.956129654205774,0,7,convergent extension involved in axis elongation,BP,
14498,GO:0060029,1,0.962611929259847,0,6,convergent extension involved in organogenesis,BP,
14499,GO:0060031,1,0.987099259451629,0,2,mediolateral intercalation,BP,
14500,GO:0060032,1,0.986385640412168,0,2,notochord regression,BP,
14501,GO:0060033,1,0.937668481157697,0,10,anatomical structure regression,BP,
14502,GO:0060037,1,0.854834903682217,0,24,pharyngeal system development,BP,
14503,GO:0060038,1,0.740195892300255,0,46,cardiac muscle cell proliferation,BP,
14504,GO:0060039,1,0.876462758932593,0,19,pericardium development,BP,
14505,GO:0060040,1,0.976190823004395,0,4,retinal bipolar neuron differentiation,BP,
14507,GO:0060042,1,0.761491934351175,0,41,retina morphogenesis in camera-type eye,BP,
14508,GO:0060043,1,0.790485242984006,0,36,regulation of cardiac muscle cell proliferation,BP,
14509,GO:0060044,1,0.926689764954838,0,12,negative regulation of cardiac muscle cell proliferation,BP,
14510,GO:0060045,1,0.863762768398498,0,22,positive regulation of cardiac muscle cell proliferation,BP,
14511,GO:0060046,1,0.92872883217055,0,12,regulation of acrosome reaction,BP,
14514,GO:0060049,1,0.919066895696529,0,13,regulation of protein glycosylation,BP,
14515,GO:0060050,1,0.942451838248151,0,9,positive regulation of protein glycosylation,BP,
14516,GO:0060051,1,0.988016210489593,0,2,negative regulation of protein glycosylation,BP,
14517,GO:0060052,1,0.962896921395037,0,6,neurofilament cytoskeleton organization,BP,
14518,GO:0060053,1,0.986666241395604,0,2,neurofilament cytoskeleton,CC,
14519,GO:0060054,1,0.975816740340037,0,4,positive regulation of epithelial cell proliferation involved in wound healing,BP,
14520,GO:0060055,1,0.886734418220415,0,19,angiogenesis involved in wound healing,BP,
14521,GO:0060056,1,0.950686793182966,0,8,mammary gland involution,BP,
14522,GO:0060057,1,0.981258598165644,0,3,apoptotic process involved in mammary gland involution,BP,
14523,GO:0060058,1,0.981258598165644,0,3,positive regulation of apoptotic process involved in mammary gland involution,BP,
14524,GO:0060059,1,0.949454432019693,0,7,embryonic retina morphogenesis in camera-type eye,BP,
14525,GO:0060060,1,0.992591648433673,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
14526,GO:0060061,1,0.987015130301428,0,2,Spemann organizer formation,BP,
14527,GO:0060064,1,0.994214823633125,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
14528,GO:0060065,1,0.879741290482437,0,19,uterus development,BP,
14529,GO:0060066,1,0.987848724563904,0,2,oviduct development,BP,
14530,GO:0060067,1,0.992967472159764,0,1,cervix development,BP,
14533,GO:0060071,1,0.511114054483619,0,106,Wnt signaling pathway, planar cell polarity pathway,BP,
14534,GO:0060072,1,0.986450931187634,0,2,large conductance calcium-activated potassium channel activity,MF,
14535,GO:0060073,1,0.955696214126097,0,7,micturition,BP,
14536,GO:0060074,1,0.890748044198729,0,17,synapse maturation,BP,
14537,GO:0060075,1,0.954437803592223,0,7,regulation of resting membrane potential,BP,
14539,GO:0060077,1,0.907449816610583,0,15,inhibitory synapse,CC,
14542,GO:0060080,1,0.904862477103919,0,15,inhibitory postsynaptic potential,BP,
14543,GO:0060081,1,0.93214363409662,0,11,membrane hyperpolarization,BP,
14544,GO:0060083,1,0.980138379024826,0,3,smooth muscle contraction involved in micturition,BP,
14545,GO:0060084,1,0.980938051695338,0,3,synaptic transmission involved in micturition,BP,
14546,GO:0060086,1,0.98763059738284,0,2,circadian temperature homeostasis,BP,
14547,GO:0060087,1,0.970455516592311,0,5,relaxation of vascular smooth muscle,BP,
14548,GO:0060088,1,0.936675502231897,0,10,auditory receptor cell stereocilium organization,BP,
14550,GO:0060090,1,0.305255977100122,0,182,molecular adaptor activity,MF,
14551,GO:0060091,1,0.957193571406307,0,7,kinocilium,CC,
14552,GO:0060092,1,0.993718692812986,0,1,regulation of synaptic transmission, glycinergic,BP,
14553,GO:0060099,1,0.931849354674024,0,11,regulation of phagocytosis, engulfment,BP,
14554,GO:0060100,1,0.943165803403567,0,9,positive regulation of phagocytosis, engulfment,BP,
14555,GO:0060101,1,0.994101334421856,0,1,negative regulation of phagocytosis, engulfment,BP,
14556,GO:0060112,1,0.988589378532484,0,2,generation of ovulation cycle rhythm,BP,
14557,GO:0060113,1,0.728044534891776,0,48,inner ear receptor cell differentiation,BP,
14558,GO:0060117,1,0.893704075388112,0,17,auditory receptor cell development,BP,
14559,GO:0060119,1,0.788544092983059,0,36,inner ear receptor cell development,BP,
14560,GO:0060120,1,0.968030161640181,0,5,inner ear receptor cell fate commitment,BP,
14561,GO:0060122,1,0.860214354644639,0,23,inner ear receptor cell stereocilium organization,BP,
14562,GO:0060123,1,0.931623354269135,0,11,regulation of growth hormone secretion,BP,
14563,GO:0060124,1,0.95307493089774,0,8,positive regulation of growth hormone secretion,BP,
14564,GO:0060125,1,0.985761867063504,0,2,negative regulation of growth hormone secretion,BP,
14565,GO:0060126,1,0.981885312464987,0,3,somatotropin secreting cell differentiation,BP,
14566,GO:0060127,1,0.994001477158181,0,1,prolactin secreting cell differentiation,BP,
14567,GO:0060128,1,0.988119520061225,0,2,corticotropin hormone secreting cell differentiation,BP,
14568,GO:0060129,1,0.981719369326587,0,3,thyroid-stimulating hormone-secreting cell differentiation,BP,
14569,GO:0060133,1,0.994250920873754,0,1,somatotropin secreting cell development,BP,
14570,GO:0060134,1,0.923925792953636,0,12,prepulse inhibition,BP,
14571,GO:0060135,1,0.693793541425239,0,56,maternal process involved in female pregnancy,BP,
14572,GO:0060136,1,0.962822677708448,0,6,embryonic process involved in female pregnancy,BP,
14573,GO:0060137,1,0.950871082159139,0,8,maternal process involved in parturition,BP,
14574,GO:0060139,1,0.987600984710986,0,2,positive regulation of apoptotic process by virus,BP,
14575,GO:0060142,1,0.895797463766282,0,18,regulation of syncytium formation by plasma membrane fusion,BP,
14576,GO:0060143,1,0.906300577729824,0,16,positive regulation of syncytium formation by plasma membrane fusion,BP,
14577,GO:0060147,1,0.576886491217719,0,86,regulation of posttranscriptional gene silencing,BP,
14578,GO:0060148,1,0.874108610619981,0,21,positive regulation of posttranscriptional gene silencing,BP,
14579,GO:0060149,1,0.911747074239639,0,14,negative regulation of posttranscriptional gene silencing,BP,
14580,GO:0060151,1,0.986773938132841,0,2,peroxisome localization,BP,
14581,GO:0060152,1,0.986773938132841,0,2,microtubule-based peroxisome localization,BP,
14582,GO:0060154,1,0.981611900571838,0,3,cellular process regulating host cell cycle in response to virus,BP,
14583,GO:0060155,1,0.951031638635087,0,8,platelet dense granule organization,BP,
14584,GO:0060156,1,0.993745557971144,0,1,milk ejection reflex,BP,
14585,GO:0060157,1,0.968149715975747,0,5,urinary bladder development,BP,
14586,GO:0060158,1,0.946912999453315,0,9,phospholipase C-activating dopamine receptor signaling pathway,BP,
14587,GO:0060159,1,0.943964640580422,0,9,regulation of dopamine receptor signaling pathway,BP,
14588,GO:0060160,1,0.987752921958557,0,2,negative regulation of dopamine receptor signaling pathway,BP,
14589,GO:0060161,1,0.973598691464195,0,4,positive regulation of dopamine receptor signaling pathway,BP,
14590,GO:0060163,1,0.988264557806141,0,2,subpallium neuron fate commitment,BP,
14591,GO:0060164,1,0.981975325136168,0,3,regulation of timing of neuron differentiation,BP,
14592,GO:0060165,1,0.993932607884681,0,1,regulation of timing of subpallium neuron differentiation,BP,
14593,GO:0060166,1,0.981916731345598,0,3,olfactory pit development,BP,
14596,GO:0060169,1,0.994202694953115,0,1,negative regulation of adenosine receptor signaling pathway,BP,
14598,GO:0060171,1,0.984330202046456,0,2,stereocilium membrane,CC,
14600,GO:0060174,1,0.929091230552238,0,11,limb bud formation,BP,
14601,GO:0060175,1,0.992596857355811,0,1,brain-derived neurotrophic factor-activated receptor activity,MF,
14602,GO:0060177,1,0.993677708805389,0,1,regulation of angiotensin metabolic process,BP,
14603,GO:0060178,1,0.993994844690258,0,1,regulation of exocyst localization,BP,
14604,GO:0060179,1,0.97478474367959,0,4,male mating behavior,BP,
14606,GO:0060183,1,0.993718692812986,0,1,apelin receptor signaling pathway,BP,
14607,GO:0060184,1,0.993784462646258,0,1,cell cycle switching,BP,
14608,GO:0060187,1,0.986455587735227,0,2,cell pole,CC,
14610,GO:0060192,1,0.933925925601344,0,11,negative regulation of lipase activity,BP,
14612,GO:0060197,1,0.98164756866645,0,3,cloacal septation,BP,
14615,GO:0060200,1,0.981538518271268,0,3,clathrin-sculpted acetylcholine transport vesicle,CC,
14616,GO:0060201,1,0.981538518271268,0,3,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
14619,GO:0060211,1,0.927588503277257,0,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14620,GO:0060212,1,0.994120970426215,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14621,GO:0060213,1,0.927588503277257,0,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14622,GO:0060214,1,0.976296726795551,0,4,endocardium formation,BP,
14623,GO:0060215,1,0.950118489756279,0,8,primitive hemopoiesis,BP,
14624,GO:0060216,1,0.872007142054902,0,21,definitive hemopoiesis,BP,
14625,GO:0060217,1,0.993208627667738,0,1,hemangioblast cell differentiation,BP,
14626,GO:0060218,1,0.583565292121653,0,89,hematopoietic stem cell differentiation,BP,
14627,GO:0060219,1,0.907221094518889,0,15,camera-type eye photoreceptor cell differentiation,BP,
14628,GO:0060221,1,0.981599537904369,0,3,retinal rod cell differentiation,BP,
14629,GO:0060228,1,0.983301600160506,0,3,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
14630,GO:0060229,1,0.939984732062639,0,10,lipase activator activity,MF,
14631,GO:0060230,1,0.988770020974228,0,2,lipoprotein lipase activator activity,MF,
14633,GO:0060232,1,0.981759701144332,0,3,delamination,BP,
14634,GO:0060235,1,0.971263354855936,0,4,lens induction in camera-type eye,BP,
14635,GO:0060236,1,0.78705794593686,0,36,regulation of mitotic spindle organization,BP,
14636,GO:0060242,1,0.95032064982338,0,8,contact inhibition,BP,
14637,GO:0060243,1,0.993428129143902,0,1,negative regulation of cell growth involved in contact inhibition,BP,
14638,GO:0060244,1,0.98172193043923,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
14639,GO:0060245,1,0.993569667341445,0,1,detection of cell density,BP,
14640,GO:0060246,1,0.993569667341445,0,1,detection of cell density by contact stimulus,BP,
14641,GO:0060248,1,0.993569667341445,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
14644,GO:0060252,1,0.93115043791322,0,11,positive regulation of glial cell proliferation,BP,
14648,GO:0060259,1,0.897321644485122,0,17,regulation of feeding behavior,BP,
14649,GO:0060260,1,0.842753286123393,0,27,regulation of transcription initiation from RNA polymerase II promoter,BP,
14650,GO:0060261,1,0.881092112116172,0,20,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
14652,GO:0060263,1,0.939651552134948,0,10,regulation of respiratory burst,BP,
14653,GO:0060264,1,0.982619512055953,0,3,regulation of respiratory burst involved in inflammatory response,BP,
14654,GO:0060265,1,0.988552054930486,0,2,positive regulation of respiratory burst involved in inflammatory response,BP,
14655,GO:0060266,1,0.988434662433928,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
14656,GO:0060267,1,0.974864493560311,0,4,positive regulation of respiratory burst,BP,
14657,GO:0060268,1,0.981185346655038,0,3,negative regulation of respiratory burst,BP,
14659,GO:0060272,1,0.928641693778034,0,12,embryonic skeletal joint morphogenesis,BP,
14660,GO:0060278,1,0.981831026236066,0,3,regulation of ovulation,BP,
14661,GO:0060279,1,0.987781492322273,0,2,positive regulation of ovulation,BP,
14662,GO:0060280,1,0.993976682335154,0,1,negative regulation of ovulation,BP,
14663,GO:0060281,1,0.938288273779796,0,10,regulation of oocyte development,BP,
14664,GO:0060282,1,0.974467433762541,0,4,positive regulation of oocyte development,BP,
14665,GO:0060283,1,0.974748816931124,0,4,negative regulation of oocyte development,BP,
14668,GO:0060287,1,0.944921145320978,0,9,epithelial cilium movement involved in determination of left/right asymmetry,BP,
14669,GO:0060290,1,0.962698665614187,0,6,transdifferentiation,BP,
14672,GO:0060293,1,0.915207777149309,0,14,germ plasm,CC,
14673,GO:0060294,1,0.908519436741067,0,16,cilium movement involved in cell motility,BP,
14674,GO:0060295,1,0.969714655511505,0,5,regulation of cilium movement involved in cell motility,BP,
14675,GO:0060296,1,0.969714655511505,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
14676,GO:0060297,1,0.964283441546359,0,5,regulation of sarcomere organization,BP,
14677,GO:0060298,1,0.980272577865099,0,3,positive regulation of sarcomere organization,BP,
14678,GO:0060300,1,0.975871522133809,0,4,regulation of cytokine activity,BP,
14679,GO:0060301,1,0.993929441234976,0,1,positive regulation of cytokine activity,BP,
14680,GO:0060302,1,0.988312040328184,0,2,negative regulation of cytokine activity,BP,
14681,GO:0060304,1,0.95916873943684,0,6,regulation of phosphatidylinositol dephosphorylation,BP,
14682,GO:0060305,1,0.993823134750506,0,1,regulation of cell diameter,BP,
14683,GO:0060306,1,0.823807743141761,0,29,regulation of membrane repolarization,BP,
14684,GO:0060307,1,0.887846968073145,0,18,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
14685,GO:0060309,1,0.994423612812389,0,1,elastin catabolic process,BP,
14686,GO:0060310,1,0.994423612812389,0,1,regulation of elastin catabolic process,BP,
14687,GO:0060311,1,0.994423612812389,0,1,negative regulation of elastin catabolic process,BP,
14688,GO:0060312,1,0.949353766770917,0,8,regulation of blood vessel remodeling,BP,
14689,GO:0060313,1,0.980350004116301,0,3,negative regulation of blood vessel remodeling,BP,
14690,GO:0060314,1,0.851684913226939,0,25,regulation of ryanodine-sensitive calcium-release channel activity,BP,
14691,GO:0060315,1,0.935062865258466,0,11,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
14692,GO:0060316,1,0.950090134840628,0,8,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
14693,GO:0060317,1,0.821156660848357,0,31,cardiac epithelial to mesenchymal transition,BP,
14694,GO:0060318,1,0.968264565742689,0,5,definitive erythrocyte differentiation,BP,
14695,GO:0060319,1,0.975465445154072,0,4,primitive erythrocyte differentiation,BP,
14697,GO:0060323,1,0.800571083675652,0,34,head morphogenesis,BP,
14698,GO:0060324,1,0.739139644270568,0,46,face development,BP,
14699,GO:0060325,1,0.825271083928589,0,29,face morphogenesis,BP,
14701,GO:0060327,1,0.993852970198522,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
14702,GO:0060330,1,0.865754712059527,0,23,regulation of response to interferon-gamma,BP,
14703,GO:0060331,1,0.963715611297855,0,6,negative regulation of response to interferon-gamma,BP,
14704,GO:0060332,1,0.961454347894064,0,6,positive regulation of response to interferon-gamma,BP,
14706,GO:0060334,1,0.865754712059527,0,23,regulation of interferon-gamma-mediated signaling pathway,BP,
14707,GO:0060335,1,0.961454347894064,0,6,positive regulation of interferon-gamma-mediated signaling pathway,BP,
14708,GO:0060336,1,0.963715611297855,0,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,
14709,GO:0060337,1,0.641988894715301,0,71,type I interferon signaling pathway,BP,
14710,GO:0060338,1,0.822796060585316,0,30,regulation of type I interferon-mediated signaling pathway,BP,
14711,GO:0060339,1,0.95537173868864,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
14712,GO:0060340,1,0.935627559289413,0,10,positive regulation of type I interferon-mediated signaling pathway,BP,
14714,GO:0060342,1,0.987987926172894,0,2,photoreceptor inner segment membrane,CC,
14716,GO:0060345,1,0.99367985018319,0,1,spleen trabecula formation,BP,
14718,GO:0060347,1,0.926894637337115,0,12,heart trabecula formation,BP,
14720,GO:0060349,1,0.595423220072489,0,80,bone morphogenesis,BP,
14721,GO:0060350,1,0.733087951481315,0,48,endochondral bone morphogenesis,BP,
14722,GO:0060351,1,0.85810863924191,0,24,cartilage development involved in endochondral bone morphogenesis,BP,
14723,GO:0060352,1,0.958016138729948,0,7,cell adhesion molecule production,BP,
14724,GO:0060353,1,0.970682580486515,0,5,regulation of cell adhesion molecule production,BP,
14725,GO:0060354,1,0.994388091856786,0,1,negative regulation of cell adhesion molecule production,BP,
14726,GO:0060355,1,0.976162058107535,0,4,positive regulation of cell adhesion molecule production,BP,
14728,GO:0060363,1,0.951156082643645,0,8,cranial suture morphogenesis,BP,
14729,GO:0060364,1,0.974276117109514,0,4,frontal suture morphogenesis,BP,
14730,GO:0060366,1,0.992277399595933,0,1,lambdoid suture morphogenesis,BP,
14731,GO:0060367,1,0.992277399595933,0,1,sagittal suture morphogenesis,BP,
14732,GO:0060368,1,0.963144623877621,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14733,GO:0060369,1,0.974873305050584,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14734,GO:0060370,1,0.987372722800771,0,2,susceptibility to T cell mediated cytotoxicity,BP,
14735,GO:0060371,1,0.952797958658801,0,7,regulation of atrial cardiac muscle cell membrane depolarization,BP,
14736,GO:0060372,1,0.95354763169784,0,7,regulation of atrial cardiac muscle cell membrane repolarization,BP,
14737,GO:0060373,1,0.966628892023397,0,5,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
14738,GO:0060374,1,0.9673537978351,0,5,mast cell differentiation,BP,
14739,GO:0060375,1,0.986962452584059,0,2,regulation of mast cell differentiation,BP,
14740,GO:0060377,1,0.99371155059077,0,1,negative regulation of mast cell differentiation,BP,
14741,GO:0060378,1,0.986579812914271,0,2,regulation of brood size,BP,
14743,GO:0060380,1,0.994051101396599,0,1,regulation of single-stranded telomeric DNA binding,BP,
14744,GO:0060381,1,0.994051101396599,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
14745,GO:0060382,1,0.986304315279846,0,2,regulation of DNA strand elongation,BP,
14746,GO:0060383,1,0.993468788348972,0,1,positive regulation of DNA strand elongation,BP,
14747,GO:0060384,1,0.844847420784718,0,25,innervation,BP,
14748,GO:0060385,1,0.968197115640046,0,5,axonogenesis involved in innervation,BP,
14749,GO:0060386,1,0.992998659534131,0,1,synapse assembly involved in innervation,BP,
14751,GO:0060390,1,0.896384369750775,0,17,regulation of SMAD protein signal transduction,BP,
14752,GO:0060391,1,0.918781929748782,0,13,positive regulation of SMAD protein signal transduction,BP,
14753,GO:0060392,1,0.982324955826443,0,3,negative regulation of SMAD protein signal transduction,BP,
14756,GO:0060395,1,0.678235200212932,0,60,SMAD protein signal transduction,BP,
14757,GO:0060396,1,0.881745439956851,0,19,growth hormone receptor signaling pathway,BP,
14758,GO:0060397,1,0.922907326407545,0,12,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
14759,GO:0060398,1,0.974041171577321,0,4,regulation of growth hormone receptor signaling pathway,BP,
14760,GO:0060399,1,0.980600540286622,0,3,positive regulation of growth hormone receptor signaling pathway,BP,
14761,GO:0060400,1,0.993312197924978,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
14764,GO:0060404,1,0.993593932162934,0,1,axonemal microtubule depolymerization,BP,
14765,GO:0060405,1,0.96814674195471,0,5,regulation of penile erection,BP,
14766,GO:0060406,1,0.980684909366665,0,3,positive regulation of penile erection,BP,
14767,GO:0060407,1,0.994202694953115,0,1,negative regulation of penile erection,BP,
14769,GO:0060412,1,0.793313721582621,0,35,ventricular septum morphogenesis,BP,
14770,GO:0060413,1,0.911079359922982,0,14,atrial septum morphogenesis,BP,
14771,GO:0060414,1,0.979421135628912,0,3,aorta smooth muscle tissue morphogenesis,BP,
14773,GO:0060416,1,0.820519263250361,0,30,response to growth hormone,BP,
14774,GO:0060419,1,0.616616003468014,0,74,heart growth,BP,
14775,GO:0060420,1,0.70678510115024,0,53,regulation of heart growth,BP,
14776,GO:0060421,1,0.802428167162802,0,33,positive regulation of heart growth,BP,
14777,GO:0060422,1,0.993984177017301,0,1,peptidyl-dipeptidase inhibitor activity,MF,
14778,GO:0060423,1,0.981590386934468,0,3,foregut regionalization,BP,
14779,GO:0060424,1,0.981590386934468,0,3,lung field specification,BP,
14781,GO:0060426,1,0.969698089955532,0,5,lung vasculature development,BP,
14782,GO:0060428,1,0.804296738204351,0,34,lung epithelium development,BP,
14784,GO:0060430,1,0.955838589221295,0,7,lung saccule development,BP,
14785,GO:0060431,1,0.969619473502697,0,5,primary lung bud formation,BP,
14786,GO:0060432,1,0.994466354247885,0,1,lung pattern specification process,BP,
14787,GO:0060433,1,0.939636687516723,0,10,bronchus development,BP,
14788,GO:0060434,1,0.987253245029153,0,2,bronchus morphogenesis,BP,
14789,GO:0060435,1,0.988760827674431,0,2,bronchiole development,BP,
14790,GO:0060436,1,0.994466354247885,0,1,bronchiole morphogenesis,BP,
14791,GO:0060437,1,0.969140761153182,0,5,lung growth,BP,
14792,GO:0060438,1,0.884967510414452,0,19,trachea development,BP,
14793,GO:0060439,1,0.932281446783758,0,11,trachea morphogenesis,BP,
14794,GO:0060440,1,0.963248921935158,0,6,trachea formation,BP,
14796,GO:0060442,1,0.925213754582353,0,12,branching involved in prostate gland morphogenesis,BP,
14797,GO:0060443,1,0.751136717756077,0,43,mammary gland morphogenesis,BP,
14798,GO:0060444,1,0.861652628105811,0,22,branching involved in mammary gland duct morphogenesis,BP,
14799,GO:0060445,1,0.865096069299349,0,22,branching involved in salivary gland morphogenesis,BP,
14800,GO:0060447,1,0.981226503432724,0,3,bud outgrowth involved in lung branching,BP,
14801,GO:0060448,1,0.978825719264126,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
14802,GO:0060449,1,0.957592169183776,0,7,bud elongation involved in lung branching,BP,
14803,GO:0060452,1,0.934876812539458,0,11,positive regulation of cardiac muscle contraction,BP,
14804,GO:0060453,1,0.940638787126088,0,10,regulation of gastric acid secretion,BP,
14805,GO:0060454,1,0.987199540462744,0,2,positive regulation of gastric acid secretion,BP,
14806,GO:0060455,1,0.971178409243681,0,5,negative regulation of gastric acid secretion,BP,
14807,GO:0060456,1,0.941584301125393,0,10,positive regulation of digestive system process,BP,
14808,GO:0060457,1,0.921892353176134,0,13,negative regulation of digestive system process,BP,
14809,GO:0060458,1,0.98813575210087,0,2,right lung development,BP,
14810,GO:0060459,1,0.982342691663301,0,3,left lung development,BP,
14811,GO:0060460,1,0.988081876236802,0,2,left lung morphogenesis,BP,
14812,GO:0060461,1,0.993908434187134,0,1,right lung morphogenesis,BP,
14813,GO:0060462,1,0.962313417735885,0,6,lung lobe development,BP,
14814,GO:0060463,1,0.962313417735885,0,6,lung lobe morphogenesis,BP,
14815,GO:0060465,1,0.987366897909797,0,2,pharynx development,BP,
14816,GO:0060466,1,0.992692183858825,0,1,activation of meiosis involved in egg activation,BP,
14817,GO:0060467,1,0.988277351917118,0,2,negative regulation of fertilization,BP,
14818,GO:0060474,1,0.988231726684759,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
14819,GO:0060478,1,0.975787483286852,0,4,acrosomal vesicle exocytosis,BP,
14820,GO:0060479,1,0.875161882660818,0,21,lung cell differentiation,BP,
14821,GO:0060480,1,0.982738806661153,0,3,lung goblet cell differentiation,BP,
14822,GO:0060481,1,0.976371187761927,0,4,lobar bronchus epithelium development,BP,
14823,GO:0060482,1,0.970044130317563,0,5,lobar bronchus development,BP,
14824,GO:0060484,1,0.950594167165906,0,8,lung-associated mesenchyme development,BP,
14826,GO:0060486,1,0.97414745958789,0,4,Clara cell differentiation,BP,
14827,GO:0060487,1,0.880753192985798,0,20,lung epithelial cell differentiation,BP,
14828,GO:0060488,1,0.98451610917279,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14829,GO:0060489,1,0.98451610917279,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14830,GO:0060490,1,0.98451610917279,0,2,lateral sprouting involved in lung morphogenesis,BP,
14832,GO:0060492,1,0.981590386934468,0,3,lung induction,BP,
14833,GO:0060495,1,0.994466354247885,0,1,cell-cell signaling involved in lung development,BP,
14834,GO:0060496,1,0.994466354247885,0,1,mesenchymal-epithelial cell signaling involved in lung development,BP,
14835,GO:0060501,1,0.962847623332975,0,6,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
14836,GO:0060502,1,0.937895796513187,0,10,epithelial cell proliferation involved in lung morphogenesis,BP,
14837,GO:0060503,1,0.994131943981625,0,1,bud dilation involved in lung branching,BP,
14838,GO:0060509,1,0.965228078598185,0,5,Type I pneumocyte differentiation,BP,
14839,GO:0060510,1,0.969076679103906,0,5,Type II pneumocyte differentiation,BP,
14840,GO:0060512,1,0.838702545965623,0,27,prostate gland morphogenesis,BP,
14841,GO:0060513,1,0.937930925621964,0,10,prostatic bud formation,BP,
14842,GO:0060514,1,0.993769438593287,0,1,prostate induction,BP,
14843,GO:0060515,1,0.993769438593287,0,1,prostate field specification,BP,
14844,GO:0060516,1,0.987747249444622,0,2,primary prostatic bud elongation,BP,
14845,GO:0060517,1,0.993517685056616,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
14846,GO:0060520,1,0.993769438593287,0,1,activation of prostate induction by androgen receptor signaling pathway,BP,
14847,GO:0060523,1,0.980606197867815,0,3,prostate epithelial cord elongation,BP,
14848,GO:0060525,1,0.928508104577019,0,11,prostate glandular acinus development,BP,
14849,GO:0060526,1,0.960721956247339,0,6,prostate glandular acinus morphogenesis,BP,
14850,GO:0060527,1,0.960721956247339,0,6,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
14851,GO:0060528,1,0.972990875894422,0,4,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
14852,GO:0060529,1,0.986824084058471,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
14853,GO:0060532,1,0.986964632631231,0,2,bronchus cartilage development,BP,
14854,GO:0060534,1,0.948865464933357,0,8,trachea cartilage development,BP,
14855,GO:0060535,1,0.973518546959289,0,4,trachea cartilage morphogenesis,BP,
14856,GO:0060536,1,0.931616221998679,0,11,cartilage morphogenesis,BP,
14858,GO:0060538,1,0.365912289858217,0,156,skeletal muscle organ development,BP,
14859,GO:0060539,1,0.957165336450411,0,7,diaphragm development,BP,
14861,GO:0060542,1,0.992985376787579,0,1,regulation of strand invasion,BP,
14863,GO:0060545,1,0.987662730740671,0,2,positive regulation of necroptotic process,BP,
14867,GO:0060556,1,0.952153745821091,0,8,regulation of vitamin D biosynthetic process,BP,
14868,GO:0060557,1,0.988412816122182,0,2,positive regulation of vitamin D biosynthetic process,BP,
14869,GO:0060558,1,0.963493132385505,0,6,regulation of calcidiol 1-monooxygenase activity,BP,
14870,GO:0060559,1,0.988412816122182,0,2,positive regulation of calcidiol 1-monooxygenase activity,BP,
14872,GO:0060561,1,0.861894914167181,0,23,apoptotic process involved in morphogenesis,BP,
14874,GO:0060563,1,0.724987083568407,0,50,neuroepithelial cell differentiation,BP,
14875,GO:0060566,1,0.991459989512687,0,1,positive regulation of DNA-templated transcription, termination,BP,
14876,GO:0060571,1,0.849193130059627,0,26,morphogenesis of an epithelial fold,BP,
14877,GO:0060572,1,0.89814335905861,0,17,morphogenesis of an epithelial bud,BP,
14879,GO:0060574,1,0.976171102424016,0,4,intestinal epithelial cell maturation,BP,
14880,GO:0060575,1,0.905199568055267,0,16,intestinal epithelial cell differentiation,BP,
14881,GO:0060576,1,0.940973716674842,0,10,intestinal epithelial cell development,BP,
14882,GO:0060577,1,0.98822094002871,0,2,pulmonary vein morphogenesis,BP,
14883,GO:0060578,1,0.994001477158181,0,1,superior vena cava morphogenesis,BP,
14885,GO:0060580,1,0.994048215237947,0,1,ventral spinal cord interneuron fate determination,BP,
14887,GO:0060582,1,0.994048215237947,0,1,cell fate determination involved in pattern specification,BP,
14888,GO:0060584,1,0.981795119885996,0,3,regulation of prostaglandin-endoperoxide synthase activity,BP,
14889,GO:0060585,1,0.981795119885996,0,3,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
14890,GO:0060586,1,0.950277217319841,0,8,multicellular organismal iron ion homeostasis,BP,
14891,GO:0060587,1,0.98801630975614,0,2,regulation of lipoprotein lipid oxidation,BP,
14892,GO:0060588,1,0.994320516609717,0,1,negative regulation of lipoprotein lipid oxidation,BP,
14894,GO:0060590,1,0.776399196455462,0,41,ATPase regulator activity,MF,
14895,GO:0060591,1,0.974575519544881,0,4,chondroblast differentiation,BP,
14896,GO:0060592,1,0.955732804961915,0,7,mammary gland formation,BP,
14897,GO:0060594,1,0.980339427207726,0,3,mammary gland specification,BP,
14898,GO:0060595,1,0.987970063526169,0,2,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
14899,GO:0060596,1,0.980660631297089,0,3,mammary placode formation,BP,
14900,GO:0060598,1,0.99428990595974,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
14901,GO:0060599,1,0.986780283301173,0,2,lateral sprouting involved in mammary gland duct morphogenesis,BP,
14902,GO:0060600,1,0.933753869196443,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
14903,GO:0060601,1,0.91736209069852,0,13,lateral sprouting from an epithelium,BP,
14905,GO:0060603,1,0.816708793151927,0,30,mammary gland duct morphogenesis,BP,
14906,GO:0060605,1,0.968435725112305,0,5,tube lumen cavitation,BP,
14908,GO:0060611,1,0.993945565455181,0,1,mammary gland fat development,BP,
14909,GO:0060612,1,0.79409135645189,0,36,adipose tissue development,BP,
14910,GO:0060613,1,0.955034864749485,0,7,fat pad development,BP,
14911,GO:0060615,1,0.987970063526169,0,2,mammary gland bud formation,BP,
14912,GO:0060620,1,0.993846081630578,0,1,regulation of cholesterol import,BP,
14913,GO:0060623,1,0.987682387624152,0,2,regulation of chromosome condensation,BP,
14915,GO:0060628,1,0.925799016061322,0,12,regulation of ER to Golgi vesicle-mediated transport,BP,
14916,GO:0060629,1,0.993824854948857,0,1,regulation of homologous chromosome segregation,BP,
14917,GO:0060631,1,0.957143827701059,0,7,regulation of meiosis I,BP,
14918,GO:0060632,1,0.864017507817594,0,23,regulation of microtubule-based movement,BP,
14919,GO:0060633,1,0.968821645919248,0,5,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
14920,GO:0060638,1,0.949874459603074,0,8,mesenchymal-epithelial cell signaling,BP,
14921,GO:0060644,1,0.899767083813803,0,16,mammary gland epithelial cell differentiation,BP,
14922,GO:0060648,1,0.982148773568169,0,3,mammary gland bud morphogenesis,BP,
14923,GO:0060661,1,0.988519907778103,0,2,submandibular salivary gland formation,BP,
14924,GO:0060662,1,0.968435725112305,0,5,salivary gland cavitation,BP,
14925,GO:0060664,1,0.970348789345291,0,5,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
14926,GO:0060665,1,0.975300796138625,0,4,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
14927,GO:0060666,1,0.965243416916839,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
14928,GO:0060667,1,0.987970063526169,0,2,branch elongation involved in salivary gland morphogenesis,BP,
14929,GO:0060668,1,0.99360477858932,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
14930,GO:0060669,1,0.864032504097562,0,23,embryonic placenta morphogenesis,BP,
14931,GO:0060670,1,0.939703313843192,0,10,branching involved in labyrinthine layer morphogenesis,BP,
14932,GO:0060671,1,0.987879652526673,0,2,epithelial cell differentiation involved in embryonic placenta development,BP,
14933,GO:0060672,1,0.987879652526673,0,2,epithelial cell morphogenesis involved in placental branching,BP,
14934,GO:0060674,1,0.828180459034957,0,29,placenta blood vessel development,BP,
14938,GO:0060678,1,0.993993691310324,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
14940,GO:0060683,1,0.993846942590791,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
14941,GO:0060684,1,0.958421953179532,0,7,epithelial-mesenchymal cell signaling,BP,
14942,GO:0060685,1,0.962172681868005,0,6,regulation of prostatic bud formation,BP,
14943,GO:0060686,1,0.97386457765651,0,4,negative regulation of prostatic bud formation,BP,
14944,GO:0060687,1,0.955178801569383,0,7,regulation of branching involved in prostate gland morphogenesis,BP,
14946,GO:0060689,1,0.980276772031312,0,3,cell differentiation involved in salivary gland development,BP,
14947,GO:0060690,1,0.994125157678534,0,1,epithelial cell differentiation involved in salivary gland development,BP,
14948,GO:0060691,1,0.994125157678534,0,1,epithelial cell maturation involved in salivary gland development,BP,
14949,GO:0060693,1,0.945162258557078,0,9,regulation of branching involved in salivary gland morphogenesis,BP,
14950,GO:0060694,1,0.994110430321073,0,1,regulation of cholesterol transporter activity,BP,
14951,GO:0060696,1,0.964306470458513,0,6,regulation of phospholipid catabolic process,BP,
14952,GO:0060697,1,0.988314739205984,0,2,positive regulation of phospholipid catabolic process,BP,
14953,GO:0060698,1,0.987238399484703,0,2,endoribonuclease inhibitor activity,MF,
14954,GO:0060699,1,0.975621131403369,0,4,regulation of endoribonuclease activity,BP,
14955,GO:0060700,1,0.945325825552732,0,9,regulation of ribonuclease activity,BP,
14956,GO:0060701,1,0.987238399484703,0,2,negative regulation of ribonuclease activity,BP,
14957,GO:0060702,1,0.987238399484703,0,2,negative regulation of endoribonuclease activity,BP,
14958,GO:0060703,1,0.993863593966619,0,1,deoxyribonuclease inhibitor activity,MF,
14959,GO:0060706,1,0.870447751424486,0,22,cell differentiation involved in embryonic placenta development,BP,
14960,GO:0060707,1,0.932715056860201,0,11,trophoblast giant cell differentiation,BP,
14961,GO:0060708,1,0.98176655346372,0,3,spongiotrophoblast differentiation,BP,
14962,GO:0060709,1,0.993820268042417,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
14963,GO:0060710,1,0.957285703163768,0,7,chorio-allantoic fusion,BP,
14964,GO:0060711,1,0.760526116993679,0,43,labyrinthine layer development,BP,
14965,GO:0060712,1,0.912771332245088,0,14,spongiotrophoblast layer development,BP,
14966,GO:0060713,1,0.887812313166598,0,19,labyrinthine layer morphogenesis,BP,
14967,GO:0060715,1,0.980794824793351,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
14968,GO:0060716,1,0.887511866116758,0,19,labyrinthine layer blood vessel development,BP,
14969,GO:0060717,1,0.954967733810943,0,7,chorion development,BP,
14970,GO:0060718,1,0.966888627850244,0,5,chorionic trophoblast cell differentiation,BP,
14971,GO:0060720,1,0.986743300878636,0,2,spongiotrophoblast cell proliferation,BP,
14972,GO:0060721,1,0.986743300878636,0,2,regulation of spongiotrophoblast cell proliferation,BP,
14973,GO:0060722,1,0.986743300878636,0,2,cell proliferation involved in embryonic placenta development,BP,
14974,GO:0060723,1,0.986743300878636,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
14975,GO:0060729,1,0.968695279886747,0,5,intestinal epithelial structure maintenance,BP,
14976,GO:0060730,1,0.98762824876835,0,2,regulation of intestinal epithelial structure maintenance,BP,
14977,GO:0060731,1,0.993701267540879,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14978,GO:0060732,1,0.939759697951023,0,10,positive regulation of inositol phosphate biosynthetic process,BP,
14979,GO:0060733,1,0.986659712938815,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
14980,GO:0060734,1,0.993307312235963,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
14981,GO:0060735,1,0.994252364763791,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
14982,GO:0060736,1,0.927628306292863,0,11,prostate gland growth,BP,
14983,GO:0060737,1,0.974248333531747,0,4,prostate gland morphogenetic growth,BP,
14984,GO:0060738,1,0.987979782090093,0,2,epithelial-mesenchymal signaling involved in prostate gland development,BP,
14985,GO:0060739,1,0.992451531999952,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
14986,GO:0060740,1,0.843341290422179,0,26,prostate gland epithelium morphogenesis,BP,
14987,GO:0060741,1,0.98233539704044,0,3,prostate gland stromal morphogenesis,BP,
14988,GO:0060742,1,0.930696883417495,0,11,epithelial cell differentiation involved in prostate gland development,BP,
14989,GO:0060743,1,0.981547089770195,0,3,epithelial cell maturation involved in prostate gland development,BP,
14990,GO:0060744,1,0.968204254086112,0,5,mammary gland branching involved in thelarche,BP,
14991,GO:0060745,1,0.957343803164747,0,6,mammary gland branching involved in pregnancy,BP,
14992,GO:0060746,1,0.919681618494465,0,13,parental behavior,BP,
14993,GO:0060748,1,0.978323311127901,0,3,tertiary branching involved in mammary gland duct morphogenesis,BP,
14994,GO:0060749,1,0.894714586301583,0,17,mammary gland alveolus development,BP,
14995,GO:0060750,1,0.972655284796554,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
14996,GO:0060751,1,0.96682868468427,0,5,branch elongation involved in mammary gland duct branching,BP,
14997,GO:0060752,1,0.993875658902209,0,1,intestinal phytosterol absorption,BP,
14998,GO:0060753,1,0.964165197850871,0,6,regulation of mast cell chemotaxis,BP,
14999,GO:0060754,1,0.969769394300043,0,5,positive regulation of mast cell chemotaxis,BP,
15001,GO:0060760,1,0.74215544680916,0,47,positive regulation of response to cytokine stimulus,BP,
15003,GO:0060762,1,0.974913560417801,0,4,regulation of branching involved in mammary gland duct morphogenesis,BP,
15004,GO:0060763,1,0.986792343110092,0,2,mammary duct terminal end bud growth,BP,
15005,GO:0060764,1,0.98746985426231,0,2,cell-cell signaling involved in mammary gland development,BP,
15006,GO:0060765,1,0.852693667529174,0,25,regulation of androgen receptor signaling pathway,BP,
15007,GO:0060766,1,0.932791465453905,0,11,negative regulation of androgen receptor signaling pathway,BP,
15008,GO:0060767,1,0.933059305285387,0,11,epithelial cell proliferation involved in prostate gland development,BP,
15009,GO:0060768,1,0.939151066679494,0,10,regulation of epithelial cell proliferation involved in prostate gland development,BP,
15010,GO:0060769,1,0.981732749143044,0,3,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
15011,GO:0060770,1,0.964392489398649,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
15012,GO:0060775,1,0.987099259451629,0,2,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
15013,GO:0060781,1,0.994192298933327,0,1,mesenchymal cell proliferation involved in prostate gland development,BP,
15014,GO:0060782,1,0.994192298933327,0,1,regulation of mesenchymal cell proliferation involved in prostate gland development,BP,
15015,GO:0060783,1,0.994192298933327,0,1,mesenchymal smoothened signaling pathway involved in prostate gland development,BP,
15016,GO:0060784,1,0.993517685056616,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
15017,GO:0060788,1,0.913836072449358,0,14,ectodermal placode formation,BP,
15018,GO:0060789,1,0.963421752107932,0,6,hair follicle placode formation,BP,
15019,GO:0060795,1,0.824686074693367,0,31,cell fate commitment involved in formation of primary germ layer,BP,
15020,GO:0060796,1,0.988220843740886,0,2,regulation of transcription involved in primary germ layer cell fate commitment,BP,
15021,GO:0060800,1,0.980934012858839,0,3,regulation of cell differentiation involved in embryonic placenta development,BP,
15022,GO:0060802,1,0.99404504058974,0,1,epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification,BP,
15023,GO:0060803,1,0.994216845079056,0,1,BMP signaling pathway involved in mesodermal cell fate specification,BP,
15024,GO:0060804,1,0.993739268775992,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
15025,GO:0060806,1,0.994159378121617,0,1,negative regulation of cell differentiation involved in embryonic placenta development,BP,
15026,GO:0060807,1,0.993969477158945,0,1,regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification,BP,
15027,GO:0060809,1,0.986867794895856,0,2,mesodermal to mesenchymal transition involved in gastrulation,BP,
15028,GO:0060816,1,0.985318097007116,0,2,random inactivation of X chromosome,BP,
15029,GO:0060819,1,0.985660571945567,0,2,inactivation of X chromosome by genetic imprinting,BP,
15030,GO:0060821,1,0.992134730213663,0,1,inactivation of X chromosome by DNA methylation,BP,
15031,GO:0060823,1,0.987183414641345,0,2,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15032,GO:0060825,1,0.988302279164469,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15033,GO:0060827,1,0.993475083113072,0,1,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15035,GO:0060829,1,0.993475083113072,0,1,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15036,GO:0060830,1,0.98133976202872,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
15037,GO:0060831,1,0.917074175203351,0,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
15038,GO:0060836,1,0.946660505783862,0,8,lymphatic endothelial cell differentiation,BP,
15039,GO:0060837,1,0.94408317634889,0,9,blood vessel endothelial cell differentiation,BP,
15040,GO:0060838,1,0.981262016841506,0,3,lymphatic endothelial cell fate commitment,BP,
15041,GO:0060839,1,0.957318719071685,0,7,endothelial cell fate commitment,BP,
15043,GO:0060841,1,0.896124494584305,0,16,venous blood vessel development,BP,
15044,GO:0060842,1,0.962147520785749,0,6,arterial endothelial cell differentiation,BP,
15045,GO:0060843,1,0.991957987154061,0,1,venous endothelial cell differentiation,BP,
15046,GO:0060844,1,0.987695396202993,0,2,arterial endothelial cell fate commitment,BP,
15047,GO:0060846,1,0.981698777846449,0,3,blood vessel endothelial cell fate commitment,BP,
15048,GO:0060847,1,0.981698777846449,0,3,endothelial cell fate specification,BP,
15049,GO:0060849,1,0.987323120291743,0,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
15051,GO:0060853,1,0.993691843042761,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
15052,GO:0060856,1,0.939615940951521,0,10,establishment of blood-brain barrier,BP,
15053,GO:0060857,1,0.993989366387351,0,1,establishment of glial blood-brain barrier,BP,
15054,GO:0060872,1,0.941314741990571,0,9,semicircular canal development,BP,
15055,GO:0060873,1,0.992277399595933,0,1,anterior semicircular canal development,BP,
15056,GO:0060875,1,0.992277399595933,0,1,lateral semicircular canal development,BP,
15057,GO:0060876,1,0.988441645797705,0,2,semicircular canal formation,BP,
15058,GO:0060879,1,0.994466354247885,0,1,semicircular canal fusion,BP,
15059,GO:0060896,1,0.941439602951775,0,9,neural plate pattern specification,BP,
15060,GO:0060897,1,0.955515832003001,0,7,neural plate regionalization,BP,
15061,GO:0060900,1,0.922123679005727,0,12,embryonic camera-type eye formation,BP,
15062,GO:0060901,1,0.993413800831215,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
15063,GO:0060903,1,0.975250199424728,0,4,positive regulation of meiosis I,BP,
15064,GO:0060904,1,0.993505109729269,0,1,regulation of protein folding in endoplasmic reticulum,BP,
15065,GO:0060907,1,0.956753201255418,0,7,positive regulation of macrophage cytokine production,BP,
15066,GO:0060911,1,0.940658812644556,0,10,cardiac cell fate commitment,BP,
15067,GO:0060912,1,0.987852293645464,0,2,cardiac cell fate specification,BP,
15068,GO:0060913,1,0.982251279062633,0,3,cardiac cell fate determination,BP,
15070,GO:0060915,1,0.987970063526169,0,2,mesenchymal cell differentiation involved in lung development,BP,
15071,GO:0060916,1,0.967578600510803,0,5,mesenchymal cell proliferation involved in lung development,BP,
15072,GO:0060920,1,0.968166203441445,0,5,cardiac pacemaker cell differentiation,BP,
15073,GO:0060921,1,0.980787502770568,0,3,sinoatrial node cell differentiation,BP,
15074,GO:0060922,1,0.987133994460643,0,2,atrioventricular node cell differentiation,BP,
15075,GO:0060923,1,0.96359568306441,0,6,cardiac muscle cell fate commitment,BP,
15076,GO:0060926,1,0.973705441342867,0,4,cardiac pacemaker cell development,BP,
15077,GO:0060927,1,0.994092094599453,0,1,cardiac pacemaker cell fate commitment,BP,
15078,GO:0060928,1,0.987133994460643,0,2,atrioventricular node cell development,BP,
15079,GO:0060929,1,0.994092094599453,0,1,atrioventricular node cell fate commitment,BP,
15080,GO:0060931,1,0.986398207921164,0,2,sinoatrial node cell development,BP,
15081,GO:0060932,1,0.987410678339324,0,2,His-Purkinje system cell differentiation,BP,
15082,GO:0060935,1,0.980478429646816,0,3,cardiac fibroblast cell differentiation,BP,
15083,GO:0060936,1,0.980478429646816,0,3,cardiac fibroblast cell development,BP,
15084,GO:0060938,1,0.980478429646816,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
15085,GO:0060939,1,0.980478429646816,0,3,epicardium-derived cardiac fibroblast cell development,BP,
15086,GO:0060940,1,0.987593251164026,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
15087,GO:0060947,1,0.948538228896585,0,8,cardiac vascular smooth muscle cell differentiation,BP,
15088,GO:0060948,1,0.979604555542563,0,3,cardiac vascular smooth muscle cell development,BP,
15089,GO:0060956,1,0.960605725902902,0,6,endocardial cell differentiation,BP,
15090,GO:0060957,1,0.993792908224421,0,1,endocardial cell fate commitment,BP,
15091,GO:0060964,1,0.589029784097306,0,83,regulation of gene silencing by miRNA,BP,
15092,GO:0060965,1,0.924417962424477,0,12,negative regulation of gene silencing by miRNA,BP,
15093,GO:0060966,1,0.576886491217719,0,86,regulation of gene silencing by RNA,BP,
15094,GO:0060967,1,0.911747074239639,0,14,negative regulation of gene silencing by RNA,BP,
15095,GO:0060968,1,0.504717506081147,0,106,regulation of gene silencing,BP,
15096,GO:0060969,1,0.862807324750234,0,22,negative regulation of gene silencing,BP,
15097,GO:0060971,1,0.973465827813713,0,4,embryonic heart tube left/right pattern formation,BP,
15098,GO:0060972,1,0.871095854906466,0,21,left/right pattern formation,BP,
15099,GO:0060973,1,0.895195838883678,0,17,cell migration involved in heart development,BP,
15100,GO:0060974,1,0.988689330056409,0,2,cell migration involved in heart formation,BP,
15101,GO:0060975,1,0.994312719541451,0,1,cardioblast migration to the midline involved in heart field formation,BP,
15104,GO:0060978,1,0.979878625981833,0,3,angiogenesis involved in coronary vascular morphogenesis,BP,
15105,GO:0060979,1,0.971219844297794,0,4,vasculogenesis involved in coronary vascular morphogenesis,BP,
15106,GO:0060980,1,0.993595930235619,0,1,cell migration involved in coronary vasculogenesis,BP,
15107,GO:0060981,1,0.992998082048884,0,1,cell migration involved in coronary angiogenesis,BP,
15109,GO:0060986,1,0.762974864042955,0,43,endocrine hormone secretion,BP,
15110,GO:0060987,1,0.993976682335154,0,1,lipid tube,CC,
15111,GO:0060988,1,0.987450829002557,0,2,lipid tube assembly,BP,
15112,GO:0060992,1,0.930158695195252,0,11,response to fungicide,BP,
15114,GO:0060994,1,0.987749179929164,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
15115,GO:0060995,1,0.986939247105958,0,2,cell-cell signaling involved in kidney development,BP,
15117,GO:0060997,1,0.721169956093881,0,48,dendritic spine morphogenesis,BP,
15120,GO:0061000,1,0.927973576329663,0,11,negative regulation of dendritic spine development,BP,
15121,GO:0061001,1,0.792525968758962,0,34,regulation of dendritic spine morphogenesis,BP,
15122,GO:0061002,1,0.96087248273127,0,6,negative regulation of dendritic spine morphogenesis,BP,
15123,GO:0061003,1,0.889607801791132,0,17,positive regulation of dendritic spine morphogenesis,BP,
15124,GO:0061004,1,0.946749772076664,0,9,pattern specification involved in kidney development,BP,
15126,GO:0061008,1,0.420203534942605,0,134,hepaticobiliary system development,BP,
15127,GO:0061009,1,0.970165445106242,0,5,common bile duct development,BP,
15128,GO:0061010,1,0.979957541884278,0,3,gall bladder development,BP,
15129,GO:0061011,1,0.99413974106064,0,1,hepatic duct development,BP,
15130,GO:0061013,1,0.337352419213261,0,170,regulation of mRNA catabolic process,BP,
15131,GO:0061014,1,0.769575993107111,0,39,positive regulation of mRNA catabolic process,BP,
15132,GO:0061015,1,0.988526223326986,0,2,snRNA import into nucleus,BP,
15133,GO:0061017,1,0.99413974106064,0,1,hepatoblast differentiation,BP,
15135,GO:0061025,1,0.251793376494143,0,216,membrane fusion,BP,
15136,GO:0061026,1,0.991202075423326,0,1,cardiac muscle tissue regeneration,BP,
15137,GO:0061027,1,0.987895731112923,0,2,umbilical cord development,BP,
15139,GO:0061029,1,0.919004776350522,0,13,eyelid development in camera-type eye,BP,
15140,GO:0061030,1,0.981767716226282,0,3,epithelial cell differentiation involved in mammary gland alveolus development,BP,
15141,GO:0061031,1,0.982329073588816,0,3,endodermal digestive tract morphogenesis,BP,
15142,GO:0061032,1,0.987781760136587,0,2,visceral serous pericardium development,BP,
15143,GO:0061033,1,0.988016704116756,0,2,secretion by lung epithelial cell involved in lung growth,BP,
15144,GO:0061034,1,0.986605192760323,0,2,olfactory bulb mitral cell layer development,BP,
15146,GO:0061036,1,0.837202818241741,0,27,positive regulation of cartilage development,BP,
15148,GO:0061038,1,0.958678381049986,0,6,uterus morphogenesis,BP,
15149,GO:0061040,1,0.992116744038807,0,1,female gonad morphogenesis,BP,
15150,GO:0061041,1,0.499020246451866,0,109,regulation of wound healing,BP,
15151,GO:0061042,1,0.945770289983828,0,9,vascular wound healing,BP,
15152,GO:0061043,1,0.975619379036098,0,4,regulation of vascular wound healing,BP,
15153,GO:0061044,1,0.993735267096645,0,1,negative regulation of vascular wound healing,BP,
15154,GO:0061045,1,0.678387336287493,0,61,negative regulation of wound healing,BP,
15155,GO:0061046,1,0.963843944085256,0,6,regulation of branching involved in lung morphogenesis,BP,
15156,GO:0061047,1,0.975829270169346,0,4,positive regulation of branching involved in lung morphogenesis,BP,
15157,GO:0061048,1,0.994165731272958,0,1,negative regulation of branching involved in lung morphogenesis,BP,
15158,GO:0061049,1,0.895533165053157,0,17,cell growth involved in cardiac muscle cell development,BP,
15159,GO:0061050,1,0.930578695063697,0,11,regulation of cell growth involved in cardiac muscle cell development,BP,
15160,GO:0061051,1,0.954009456078012,0,7,positive regulation of cell growth involved in cardiac muscle cell development,BP,
15161,GO:0061052,1,0.975451347960203,0,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,
15162,GO:0061053,1,0.616476287002066,0,73,somite development,BP,
15163,GO:0061054,1,0.987634433705847,0,2,dermatome development,BP,
15164,GO:0061055,1,0.974316441515274,0,4,myotome development,BP,
15165,GO:0061056,1,0.976327621131509,0,4,sclerotome development,BP,
15167,GO:0061072,1,0.940837938661915,0,9,iris morphogenesis,BP,
15168,GO:0061073,1,0.980980433782232,0,3,ciliary body morphogenesis,BP,
15169,GO:0061074,1,0.969674958722612,0,5,regulation of neural retina development,BP,
15170,GO:0061075,1,0.988007472762109,0,2,positive regulation of neural retina development,BP,
15171,GO:0061076,1,0.993742413242347,0,1,negative regulation of neural retina development,BP,
15173,GO:0061078,1,0.994485414935947,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
15174,GO:0061081,1,0.933827807200943,0,11,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
15175,GO:0061082,1,0.870406879833585,0,22,myeloid leukocyte cytokine production,BP,
15176,GO:0061083,1,0.975156698422287,0,4,regulation of protein refolding,BP,
15177,GO:0061084,1,0.975156698422287,0,4,negative regulation of protein refolding,BP,
15178,GO:0061085,1,0.944047653109177,0,9,regulation of histone H3-K27 methylation,BP,
15179,GO:0061086,1,0.97475613980674,0,4,negative regulation of histone H3-K27 methylation,BP,
15180,GO:0061087,1,0.962415648223227,0,6,positive regulation of histone H3-K27 methylation,BP,
15181,GO:0061088,1,0.944264695596987,0,9,regulation of sequestering of zinc ion,BP,
15182,GO:0061090,1,0.993953342290562,0,1,positive regulation of sequestering of zinc ion,BP,
15183,GO:0061091,1,0.979103878199976,0,3,regulation of phospholipid translocation,BP,
15184,GO:0061092,1,0.979103878199976,0,3,positive regulation of phospholipid translocation,BP,
15187,GO:0061099,1,0.858791388038514,0,24,negative regulation of protein tyrosine kinase activity,BP,
15188,GO:0061100,1,0.993932607884681,0,1,lung neuroendocrine cell differentiation,BP,
15189,GO:0061101,1,0.952909908031563,0,8,neuroendocrine cell differentiation,BP,
15190,GO:0061102,1,0.98819480614553,0,2,stomach neuroendocrine cell differentiation,BP,
15191,GO:0061103,1,0.993932607884681,0,1,carotid body glomus cell differentiation,BP,
15192,GO:0061104,1,0.987802245816286,0,2,adrenal chromaffin cell differentiation,BP,
15193,GO:0061105,1,0.994227529862516,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
15194,GO:0061106,1,0.994227529862516,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15195,GO:0061107,1,0.98205110373648,0,3,seminal vesicle development,BP,
15196,GO:0061108,1,0.993993835481293,0,1,seminal vesicle epithelium development,BP,
15197,GO:0061110,1,0.979898180757291,0,3,dense core granule biogenesis,BP,
15198,GO:0061113,1,0.98067201094224,0,3,pancreas morphogenesis,BP,
15199,GO:0061114,1,0.993761857850181,0,1,branching involved in pancreas morphogenesis,BP,
15200,GO:0061115,1,0.994466354247885,0,1,lung proximal/distal axis specification,BP,
15201,GO:0061117,1,0.903923315503791,0,16,negative regulation of heart growth,BP,
15202,GO:0061133,1,0.965430795270294,0,6,endopeptidase activator activity,MF,
15205,GO:0061136,1,0.349220116715728,0,165,regulation of proteasomal protein catabolic process,BP,
15207,GO:0061140,1,0.946562825254498,0,9,lung secretory cell differentiation,BP,
15208,GO:0061141,1,0.980582364203206,0,3,lung ciliated cell differentiation,BP,
15209,GO:0061143,1,0.993825141661333,0,1,alveolar primary septum development,BP,
15210,GO:0061144,1,0.99375156229785,0,1,alveolar secondary septum development,BP,
15211,GO:0061145,1,0.986964632631231,0,2,lung smooth muscle development,BP,
15212,GO:0061146,1,0.981212794874114,0,3,Peyer's patch morphogenesis,BP,
15213,GO:0061149,1,0.994131943981625,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
15214,GO:0061150,1,0.994131943981625,0,1,renal system segmentation,BP,
15215,GO:0061151,1,0.994131943981625,0,1,BMP signaling pathway involved in renal system segmentation,BP,
15216,GO:0061152,1,0.987978818195472,0,2,trachea submucosa development,BP,
15217,GO:0061153,1,0.987978818195472,0,2,trachea gland development,BP,
15219,GO:0061155,1,0.994131943981625,0,1,pulmonary artery endothelial tube morphogenesis,BP,
15221,GO:0061157,1,0.862114694515622,0,22,mRNA destabilization,BP,
15222,GO:0061158,1,0.920960739304844,0,12,3'-UTR-mediated mRNA destabilization,BP,
15223,GO:0061162,1,0.881723736051529,0,19,establishment of monopolar cell polarity,BP,
15225,GO:0061179,1,0.946364821258663,0,9,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15226,GO:0061180,1,0.653574161055556,0,64,mammary gland epithelium development,BP,
15227,GO:0061181,1,0.993428415649494,0,1,regulation of chondrocyte development,BP,
15228,GO:0061183,1,0.987634433705847,0,2,regulation of dermatome development,BP,
15229,GO:0061184,1,0.993523685605848,0,1,positive regulation of dermatome development,BP,
15230,GO:0061185,1,0.994072750715385,0,1,negative regulation of dermatome development,BP,
15231,GO:0061187,1,0.986051487041028,0,2,regulation of chromatin silencing at rDNA,BP,
15232,GO:0061188,1,0.986051487041028,0,2,negative regulation of chromatin silencing at rDNA,BP,
15233,GO:0061189,1,0.994192298933327,0,1,positive regulation of sclerotome development,BP,
15234,GO:0061190,1,0.994192298933327,0,1,regulation of sclerotome development,BP,
15235,GO:0061193,1,0.99435979094836,0,1,taste bud development,BP,
15236,GO:0061196,1,0.961770985883726,0,6,fungiform papilla development,BP,
15237,GO:0061197,1,0.967586792099131,0,5,fungiform papilla morphogenesis,BP,
15238,GO:0061198,1,0.98055757653995,0,3,fungiform papilla formation,BP,
15239,GO:0061200,1,0.952052403600607,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,
15240,GO:0061202,1,0.952052403600607,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,
15241,GO:0061205,1,0.987388412085541,0,2,paramesonephric duct development,BP,
15242,GO:0061209,1,0.975837422759034,0,4,cell proliferation involved in mesonephros development,BP,
15244,GO:0061216,1,0.994131943981625,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
15247,GO:0061227,1,0.988266966649503,0,2,pattern specification involved in mesonephros development,BP,
15248,GO:0061245,1,0.747462631959439,0,45,establishment or maintenance of bipolar cell polarity,BP,
15249,GO:0061289,1,0.986939247105958,0,2,Wnt signaling pathway involved in kidney development,BP,
15250,GO:0061290,1,0.986939247105958,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15251,GO:0061298,1,0.895279209995686,0,16,retina vasculature development in camera-type eye,BP,
15252,GO:0061299,1,0.942052974480504,0,9,retina vasculature morphogenesis in camera-type eye,BP,
15253,GO:0061300,1,0.986772372919284,0,2,cerebellum vasculature development,BP,
15254,GO:0061301,1,0.992521603287303,0,1,cerebellum vasculature morphogenesis,BP,
15255,GO:0061302,1,0.970041036438472,0,5,smooth muscle cell-matrix adhesion,BP,
15256,GO:0061303,1,0.950225092746547,0,8,cornea development in camera-type eye,BP,
15257,GO:0061304,1,0.971906057178938,0,4,retinal blood vessel morphogenesis,BP,
15258,GO:0061307,1,0.934117751782611,0,11,cardiac neural crest cell differentiation involved in heart development,BP,
15259,GO:0061308,1,0.934117751782611,0,11,cardiac neural crest cell development involved in heart development,BP,
15260,GO:0061309,1,0.945736966619707,0,9,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
15261,GO:0061311,1,0.857880014680952,0,24,cell surface receptor signaling pathway involved in heart development,BP,
15262,GO:0061312,1,0.964267660578758,0,6,BMP signaling pathway involved in heart development,BP,
15263,GO:0061314,1,0.941299160489481,0,9,Notch signaling involved in heart development,BP,
15264,GO:0061316,1,0.981861507468858,0,3,canonical Wnt signaling pathway involved in heart development,BP,
15265,GO:0061317,1,0.988127127208535,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
15266,GO:0061318,1,0.905864669501447,0,15,renal filtration cell differentiation,BP,
15267,GO:0061323,1,0.908020472749987,0,15,cell proliferation involved in heart morphogenesis,BP,
15268,GO:0061324,1,0.993659865977184,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
15269,GO:0061325,1,0.97597452328349,0,4,cell proliferation involved in outflow tract morphogenesis,BP,
15273,GO:0061339,1,0.881723736051529,0,19,establishment or maintenance of monopolar cell polarity,BP,
15274,GO:0061341,1,0.986124060893406,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
15275,GO:0061343,1,0.973103016700572,0,4,cell adhesion involved in heart morphogenesis,BP,
15276,GO:0061346,1,0.986124060893406,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
15277,GO:0061347,1,0.992967472159764,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
15278,GO:0061348,1,0.992967472159764,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
15279,GO:0061349,1,0.992967472159764,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
15280,GO:0061350,1,0.992967472159764,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
15282,GO:0061354,1,0.992967472159764,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
15283,GO:0061355,1,0.975113326667024,0,4,Wnt protein secretion,BP,
15284,GO:0061356,1,0.975113326667024,0,4,regulation of Wnt protein secretion,BP,
15285,GO:0061357,1,0.980893626994425,0,3,positive regulation of Wnt protein secretion,BP,
15286,GO:0061358,1,0.994108264596255,0,1,negative regulation of Wnt protein secretion,BP,
15287,GO:0061360,1,0.99346392336041,0,1,optic chiasma development,BP,
15288,GO:0061364,1,0.979394498075325,0,3,apoptotic process involved in luteolysis,BP,
15289,GO:0061365,1,0.959099374211815,0,7,positive regulation of triglyceride lipase activity,BP,
15290,GO:0061366,1,0.981131901946803,0,3,behavioral response to chemical pain,BP,
15291,GO:0061368,1,0.981131901946803,0,3,behavioral response to formalin induced pain,BP,
15292,GO:0061369,1,0.993523685605848,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
15293,GO:0061370,1,0.964260971119551,0,6,testosterone biosynthetic process,BP,
15294,GO:0061371,1,0.687161853952232,0,58,determination of heart left/right asymmetry,BP,
15295,GO:0061373,1,0.992000954286328,0,1,mammillary axonal complex development,BP,
15296,GO:0061377,1,0.894714586301583,0,17,mammary gland lobule development,BP,
15298,GO:0061384,1,0.814430259231337,0,31,heart trabecula morphogenesis,BP,
15299,GO:0061386,1,0.9850500403142,0,2,closure of optic fissure,BP,
15301,GO:0061394,1,0.988241568579295,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15302,GO:0061395,1,0.994150859111933,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15303,GO:0061400,1,0.993846081630578,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
15304,GO:0061402,1,0.987844769337218,0,2,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,BP,
15305,GO:0061408,1,0.981911785400012,0,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
15306,GO:0061418,1,0.634692879033746,0,74,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15307,GO:0061419,1,0.967337203572251,0,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15308,GO:0061428,1,0.974921414374176,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15310,GO:0061433,1,0.994084587661038,0,1,cellular response to caloric restriction,BP,
15311,GO:0061436,1,0.903520940703861,0,16,establishment of skin barrier,BP,
15312,GO:0061437,1,0.861779268977763,0,23,renal system vasculature development,BP,
15313,GO:0061438,1,0.959988188945426,0,6,renal system vasculature morphogenesis,BP,
15314,GO:0061439,1,0.959988188945426,0,6,kidney vasculature morphogenesis,BP,
15315,GO:0061440,1,0.861779268977763,0,23,kidney vasculature development,BP,
15316,GO:0061441,1,0.987160554999904,0,2,renal artery morphogenesis,BP,
15317,GO:0061443,1,0.986754501606269,0,2,endocardial cushion cell differentiation,BP,
15318,GO:0061444,1,0.992918080732535,0,1,endocardial cushion cell development,BP,
15319,GO:0061445,1,0.993792908224421,0,1,endocardial cushion cell fate commitment,BP,
15321,GO:0061450,1,0.940138696423791,0,10,trophoblast cell migration,BP,
15323,GO:0061459,1,0.992466301258203,0,1,L-arginine transmembrane transporter activity,MF,
15324,GO:0061462,1,0.798897699283258,0,35,protein localization to lysosome,BP,
15325,GO:0061469,1,0.95054089401893,0,8,regulation of type B pancreatic cell proliferation,BP,
15326,GO:0061470,1,0.973048232919067,0,4,T follicular helper cell differentiation,BP,
15327,GO:0061474,1,0.993912461825907,0,1,phagolysosome membrane,CC,
15328,GO:0061476,1,0.968005746749974,0,5,response to anticoagulant,BP,
15329,GO:0061478,1,0.921004176131321,0,12,response to platelet aggregation inhibitor,BP,
15330,GO:0061481,1,0.994404263934584,0,1,response to TNF agonist,BP,
15331,GO:0061484,1,0.974364944541496,0,4,hematopoietic stem cell homeostasis,BP,
15332,GO:0061485,1,0.992488018653014,0,1,memory T cell proliferation,BP,
15333,GO:0061495,1,0.993846081630578,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
15334,GO:0061502,1,0.971570822633824,0,4,early endosome to recycling endosome transport,BP,
15336,GO:0061507,1,0.994158800562055,0,1,cyclic-GMP-AMP binding,MF,
15337,GO:0061508,1,0.993846081630578,0,1,CDP phosphorylation,BP,
15338,GO:0061511,1,0.974294111571123,0,4,centriole elongation,BP,
15339,GO:0061512,1,0.804174132828557,0,34,protein localization to cilium,BP,
15340,GO:0061513,1,0.981349159630943,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
15341,GO:0061515,1,0.666557726434934,0,63,myeloid cell development,BP,
15342,GO:0061517,1,0.987746229797272,0,2,macrophage proliferation,BP,
15343,GO:0061518,1,0.987746229797272,0,2,microglial cell proliferation,BP,
15344,GO:0061519,1,0.993611914132385,0,1,macrophage homeostasis,BP,
15345,GO:0061523,1,0.993593932162934,0,1,cilium disassembly,BP,
15346,GO:0061525,1,0.947799882690946,0,8,hindgut development,BP,
15347,GO:0061526,1,0.975834232016878,0,4,acetylcholine secretion,BP,
15348,GO:0061528,1,0.993232525385339,0,1,aspartate secretion,BP,
15349,GO:0061534,1,0.991058779362369,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
15350,GO:0061535,1,0.977963197478451,0,3,glutamate secretion, neurotransmission,BP,
15351,GO:0061536,1,0.993718692812986,0,1,glycine secretion,BP,
15352,GO:0061537,1,0.993718692812986,0,1,glycine secretion, neurotransmission,BP,
15353,GO:0061542,1,0.994281242594407,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
15354,GO:0061547,1,0.987435024513305,0,2,glycogen synthase activity, transferring glucose-1-phosphate,MF,
15355,GO:0061548,1,0.925637527794416,0,12,ganglion development,BP,
15356,GO:0061549,1,0.949751063128262,0,8,sympathetic ganglion development,BP,
15357,GO:0061550,1,0.967757022880022,0,5,cranial ganglion development,BP,
15358,GO:0061551,1,0.973933551085519,0,4,trigeminal ganglion development,BP,
15359,GO:0061552,1,0.993929441234976,0,1,ganglion morphogenesis,BP,
15361,GO:0061565,1,0.993846081630578,0,1,dAMP phosphorylation,BP,
15362,GO:0061566,1,0.993846081630578,0,1,CMP phosphorylation,BP,
15363,GO:0061567,1,0.993846081630578,0,1,dCMP phosphorylation,BP,
15364,GO:0061568,1,0.993846081630578,0,1,GDP phosphorylation,BP,
15365,GO:0061569,1,0.993846081630578,0,1,UDP phosphorylation,BP,
15366,GO:0061570,1,0.993846081630578,0,1,dCDP phosphorylation,BP,
15367,GO:0061571,1,0.993846081630578,0,1,TDP phosphorylation,BP,
15369,GO:0061574,1,0.981431684420046,0,3,ASAP complex,CC,
15370,GO:0061575,1,0.977353373010278,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
15371,GO:0061577,1,0.927553337909493,0,11,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
15372,GO:0061578,1,0.935547147815601,0,10,Lys63-specific deubiquitinase activity,MF,
15373,GO:0061580,1,0.993460775033623,0,1,colon epithelial cell migration,BP,
15374,GO:0061582,1,0.986342881250278,0,2,intestinal epithelial cell migration,BP,
15375,GO:0061588,1,0.967808459041805,0,5,calcium activated phospholipid scrambling,BP,
15376,GO:0061589,1,0.974698631190831,0,4,calcium activated phosphatidylserine scrambling,BP,
15377,GO:0061590,1,0.967808459041805,0,5,calcium activated phosphatidylcholine scrambling,BP,
15378,GO:0061591,1,0.967808459041805,0,5,calcium activated galactosylceramide scrambling,BP,
15379,GO:0061598,1,0.993419246286832,0,1,molybdopterin adenylyltransferase activity,MF,
15380,GO:0061599,1,0.993419246286832,0,1,molybdopterin molybdotransferase activity,MF,
15381,GO:0061604,1,0.993938366199964,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
15382,GO:0061605,1,0.993938366199964,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
15383,GO:0061608,1,0.944228678669135,0,9,nuclear import signal receptor activity,MF,
15384,GO:0061609,1,0.993945277456549,0,1,fructose-1-phosphate aldolase activity,MF,
15385,GO:0061611,1,0.994134543005102,0,1,mannose to fructose-6-phosphate metabolic process,BP,
15386,GO:0061614,1,0.779304720272726,0,38,pri-miRNA transcription by RNA polymerase II,BP,
15387,GO:0061615,1,0.85748635427349,0,25,glycolytic process through fructose-6-phosphate,BP,
15388,GO:0061617,1,0.953330699601507,0,8,MICOS complex,CC,
15389,GO:0061618,1,0.991332893610053,0,1,sublamina densa,CC,
15390,GO:0061620,1,0.85748635427349,0,25,glycolytic process through glucose-6-phosphate,BP,
15391,GO:0061621,1,0.862450127022646,0,24,canonical glycolysis,BP,
15392,GO:0061622,1,0.988009643502487,0,2,glycolytic process through glucose-1-phosphate,BP,
15393,GO:0061623,1,0.994253231097859,0,1,glycolytic process from galactose,BP,
15394,GO:0061624,1,0.975866358616636,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
15395,GO:0061626,1,0.955575332617011,0,7,pharyngeal arch artery morphogenesis,BP,
15396,GO:0061627,1,0.994071018585764,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
15397,GO:0061628,1,0.978424118273194,0,3,H3K27me3 modified histone binding,MF,
15398,GO:0061629,1,0.969130524372376,0,5,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
15399,GO:0061630,1,0.249406304609851,0,212,ubiquitin protein ligase activity,MF,
15400,GO:0061631,1,0.843881609140941,0,27,ubiquitin conjugating enzyme activity,MF,
15401,GO:0061635,1,0.952748517737849,0,8,regulation of protein complex stability,BP,
15403,GO:0061641,1,0.834564354241345,0,30,CENP-A containing chromatin organization,BP,
15404,GO:0061642,1,0.992967472159764,0,1,chemoattraction of axon,BP,
15405,GO:0061643,1,0.980555868937706,0,3,chemorepulsion of axon,BP,
15406,GO:0061645,1,0.954393319045921,0,7,endocytic patch,CC,
15407,GO:0061646,1,0.993224752587359,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
15408,GO:0061647,1,0.767078094480928,0,40,histone H3-K9 modification,BP,
15409,GO:0061649,1,0.980324790913153,0,3,ubiquitin modification-dependent histone binding,MF,
15410,GO:0061650,1,0.839063177009918,0,28,ubiquitin-like protein conjugating enzyme activity,MF,
15411,GO:0061656,1,0.994300013232335,0,1,SUMO conjugating enzyme activity,MF,
15412,GO:0061659,1,0.241693599527603,0,217,ubiquitin-like protein ligase activity,MF,
15413,GO:0061663,1,0.992524498233347,0,1,NEDD8 ligase activity,MF,
15414,GO:0061665,1,0.969504211572204,0,5,SUMO ligase activity,MF,
15415,GO:0061668,1,0.962551255830577,0,6,mitochondrial ribosome assembly,BP,
15416,GO:0061669,1,0.978314599124737,0,3,spontaneous neurotransmitter secretion,BP,
15417,GO:0061670,1,0.994213379743068,0,1,evoked neurotransmitter secretion,BP,
15418,GO:0061673,1,0.968348743808844,0,5,mitotic spindle astral microtubule,CC,
15419,GO:0061676,1,0.96219653128077,0,6,importin-alpha family protein binding,MF,
15420,GO:0061682,1,0.99397091809355,0,1,seminal vesicle morphogenesis,BP,
15421,GO:0061684,1,0.928367509566645,0,12,chaperone-mediated autophagy,BP,
15422,GO:0061685,1,0.993846081630578,0,1,diphthine methylesterase activity,MF,
15423,GO:0061687,1,0.927051749948274,0,13,detoxification of inorganic compound,BP,
15424,GO:0061689,1,0.974493603161925,0,4,tricellular tight junction,CC,
15425,GO:0061690,1,0.994309254181574,0,1,lipoamidase activity,MF,
15426,GO:0061695,1,0.197130804456899,0,251,transferase complex, transferring phosphorus-containing groups,CC,
15427,GO:0061697,1,0.993738411238908,0,1,protein-glutaryllysine deglutarylase activity,MF,
15428,GO:0061698,1,0.993738411238908,0,1,protein deglutarylation,BP,
15429,GO:0061699,1,0.993738411238908,0,1,peptidyl-lysine deglutarylation,BP,
15430,GO:0061700,1,0.945846327583112,0,9,GATOR2 complex,CC,
15431,GO:0061702,1,0.928626171599701,0,12,inflammasome complex,CC,
15432,GO:0061709,1,0.992723707511408,0,1,reticulophagy,BP,
15433,GO:0061711,1,0.988210209702086,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
15434,GO:0061712,1,0.993701553155067,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
15435,GO:0061713,1,0.994344774242044,0,1,anterior neural tube closure,BP,
15436,GO:0061714,1,0.988699667951163,0,2,folic acid receptor activity,MF,
15437,GO:0061718,1,0.862450127022646,0,24,glucose catabolic process to pyruvate,BP,
15438,GO:0061723,1,0.986707162328723,0,2,glycophagy,BP,
15439,GO:0061724,1,0.959779299517937,0,6,lipophagy,BP,
15440,GO:0061726,1,0.599744490647202,0,80,mitochondrion disassembly,BP,
15441,GO:0061727,1,0.988015219804929,0,2,methylglyoxal catabolic process to lactate,BP,
15442,GO:0061731,1,0.980759034698322,0,3,ribonucleoside-diphosphate reductase activity,MF,
15443,GO:0061732,1,0.963618086340514,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
15444,GO:0061733,1,0.710994298371624,0,52,peptide-lysine-N-acetyltransferase activity,MF,
15445,GO:0061734,1,0.964993634883781,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
15446,GO:0061736,1,0.993003712426929,0,1,engulfment of target by autophagosome,BP,
15447,GO:0061737,1,0.970564121374217,0,5,leukotriene signaling pathway,BP,
15448,GO:0061738,1,0.981858595687597,0,3,late endosomal microautophagy,BP,
15449,GO:0061739,1,0.975153445489763,0,4,protein lipidation involved in autophagosome assembly,BP,
15450,GO:0061740,1,0.981473460157768,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
15451,GO:0061741,1,0.987921493326906,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
15452,GO:0061743,1,0.9760011920708,0,4,motor learning,BP,
15453,GO:0061744,1,0.969882709630827,0,5,motor behavior,BP,
15454,GO:0061749,1,0.986371970016311,0,2,forked DNA-dependent helicase activity,MF,
15455,GO:0061750,1,0.993975241200142,0,1,acid sphingomyelin phosphodiesterase activity,MF,
15456,GO:0061752,1,0.987905830433573,0,2,telomeric repeat-containing RNA binding,MF,
15457,GO:0061753,1,0.993003712426929,0,1,substrate localization to autophagosome,BP,
15458,GO:0061756,1,0.84386862858349,0,27,leukocyte adhesion to vascular endothelial cell,BP,
15459,GO:0061757,1,0.988002885362154,0,2,leukocyte adhesion to arterial endothelial cell,BP,
15460,GO:0061760,1,0.988269223677867,0,2,antifungal innate immune response,BP,
15461,GO:0061762,1,0.972682438858466,0,4,CAMKK-AMPK signaling cascade,BP,
15462,GO:0061763,1,0.987771615367676,0,2,multivesicular body-lysosome fusion,BP,
15463,GO:0061767,1,0.992946821815491,0,1,negative regulation of lung blood pressure,BP,
15464,GO:0061768,1,0.993249218590187,0,1,magnesium:sodium antiporter activity,MF,
15465,GO:0061769,1,0.987729649828399,0,2,ribosylnicotinate kinase activity,MF,
15466,GO:0061770,1,0.994023399149167,0,1,translation elongation factor binding,MF,
15467,GO:0061771,1,0.981632970275583,0,3,response to caloric restriction,BP,
15468,GO:0061772,1,0.993662149684397,0,1,drug transport across blood-nerve barrier,BP,
15469,GO:0061778,1,0.890350252164242,0,18,intracellular chloride channel activity,MF,
15470,GO:0061780,1,0.99171612148374,0,1,mitotic cohesin loading,BP,
15471,GO:0061782,1,0.993469360651845,0,1,vesicle fusion with vesicle,BP,
15472,GO:0061783,1,0.977568894598448,0,4,peptidoglycan muralytic activity,MF,
15473,GO:0061789,1,0.977071242003923,0,3,dense core granule priming,BP,
15474,GO:0061792,1,0.980094330214477,0,3,secretory granule maturation,BP,
15475,GO:0061798,1,0.993449037670222,0,1,GTP 3',8'-cyclase activity,MF,
15476,GO:0061799,1,0.993449037670222,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
15477,GO:0061809,1,0.988467082645206,0,2,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
15478,GO:0061811,1,0.994218577746861,0,1,ADP-ribosyl cyclase activity,MF,
15479,GO:0061812,1,0.994218577746861,0,1,cyclic ADP-ribose hydrolase,MF,
15480,GO:0061817,1,0.979865711465565,0,3,endoplasmic reticulum-plasma membrane tethering,BP,
15481,GO:0061819,1,0.980552581237701,0,3,telomeric DNA-containing double minutes formation,BP,
15482,GO:0061820,1,0.9497689674227,0,8,telomeric D-loop disassembly,BP,
15483,GO:0061821,1,0.97360083018687,0,4,telomeric D-loop binding,MF,
15484,GO:0061825,1,0.99351625623385,0,1,podosome core,CC,
15485,GO:0061827,1,0.970111924522752,0,5,sperm head,CC,
15486,GO:0061828,1,0.992442409233327,0,1,apical tubulobulbar complex,CC,
15487,GO:0061829,1,0.992442409233327,0,1,basal tubulobulbar complex,CC,
15488,GO:0061832,1,0.992390415536943,0,1,basal ectoplasmic specialization,CC,
15489,GO:0061833,1,0.987442718804204,0,2,protein localization to tricellular tight junction,BP,
15490,GO:0061842,1,0.847008145591216,0,24,microtubule organizing center localization,BP,
15491,GO:0061844,1,0.823821560906783,0,34,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,
15492,GO:0061845,1,0.993708408337088,0,1,neuron projection branch point,CC,
15493,GO:0061846,1,0.993708408337088,0,1,dendritic spine cytoplasm,CC,
15494,GO:0061847,1,0.993980429514427,0,1,response to cholecystokinin,BP,
15495,GO:0061849,1,0.986371970016311,0,2,telomeric G-quadruplex DNA binding,MF,
15496,GO:0061850,1,0.994391268506931,0,1,growth cone leading edge,CC,
15497,GO:0061851,1,0.993861870878592,0,1,leading edge of lamellipodium,CC,
15498,GO:0061853,1,0.993205747724528,0,1,regulation of neuroblast migration,BP,
15499,GO:0061855,1,0.993205747724528,0,1,negative regulation of neuroblast migration,BP,
15500,GO:0061857,1,0.987418304319572,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
15501,GO:0061880,1,0.994155335203454,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
15502,GO:0061881,1,0.994155335203454,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
15503,GO:0061884,1,0.994058605895241,0,1,regulation of mini excitatory postsynaptic potential,BP,
15504,GO:0061885,1,0.994058605895241,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
15505,GO:0061888,1,0.973882547119002,0,4,regulation of astrocyte activation,BP,
15506,GO:0061889,1,0.993129667960171,0,1,negative regulation of astrocyte activation,BP,
15507,GO:0061890,1,0.980621079949398,0,3,positive regulation of astrocyte activation,BP,
15508,GO:0061896,1,0.993298689102869,0,1,all-trans retinol 3,4-desaturase activity,MF,
15509,GO:0061897,1,0.993298689102869,0,1,all-trans retinal 3,4-desaturase activity,MF,
15510,GO:0061898,1,0.993298689102869,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
15511,GO:0061899,1,0.993298689102869,0,1,11-cis-retinal 3,4-desaturase activity,MF,
15512,GO:0061900,1,0.815638914870423,0,31,glial cell activation,BP,
15513,GO:0061901,1,0.994081700490923,0,1,regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15514,GO:0061903,1,0.994081700490923,0,1,positive regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15515,GO:0061912,1,0.77029894072167,0,40,selective autophagy,BP,
15517,GO:0061920,1,0.992113842885886,0,1,protein propionyltransferase activity,MF,
15518,GO:0061921,1,0.992113842885886,0,1,peptidyl-lysine propionylation,BP,
15519,GO:0061930,1,0.993164260904423,0,1,regulation of erythrocyte enucleation,BP,
15520,GO:0061931,1,0.993164260904423,0,1,positive regulation of erythrocyte enucleation,BP,
15521,GO:0061944,1,0.993399466672945,0,1,negative regulation of protein K48-linked ubiquitination,BP,
15522,GO:0061945,1,0.981304909013995,0,3,regulation of protein K48-linked ubiquitination,BP,
15523,GO:0061951,1,0.777588052917039,0,39,establishment of protein localization to plasma membrane,BP,
15524,GO:0061953,1,0.981784796005287,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
15525,GO:0061971,1,0.733087951481315,0,48,replacement bone morphogenesis,BP,
15526,GO:0061980,1,0.82380160379811,0,30,regulatory RNA binding,MF,
15527,GO:0061981,1,0.994217567023989,0,1,3-hydroxykynureninase activity,MF,
15529,GO:0061983,1,0.952102398012106,0,8,meiosis II cell cycle process,BP,
15530,GO:0061986,1,0.993950173748882,0,1,negative regulation of transcription by glucose,BP,
15531,GO:0061987,1,0.993950173748882,0,1,negative regulation of transcription from RNA polymerase II promoter by glucose,BP,
15532,GO:0062009,1,0.935511107018747,0,10,secondary palate development,BP,
15536,GO:0065001,1,0.974346955963611,0,4,specification of axis polarity,BP,
15539,GO:0065004,1,0.301094901585402,0,192,protein-DNA complex assembly,BP,
15540,GO:0065005,1,0.857513092870198,0,24,protein-lipid complex assembly,BP,
15541,GO:0065006,1,0.988635919174598,0,2,protein-carbohydrate complex assembly,BP,
15545,GO:0065010,1,0.970498574261606,0,5,extracellular membrane-bounded organelle,CC,
15546,GO:0070001,1,0.894910405277995,0,18,aspartic-type peptidase activity,MF,
15547,GO:0070003,1,0.902439516817834,0,18,threonine-type peptidase activity,MF,
15548,GO:0070004,1,0.993846081630578,0,1,cysteine-type exopeptidase activity,MF,
15549,GO:0070006,1,0.88496749296571,0,19,metalloaminopeptidase activity,MF,
15550,GO:0070008,1,0.926090218335784,0,12,serine-type exopeptidase activity,MF,
15552,GO:0070012,1,0.987816887389039,0,2,oligopeptidase activity,MF,
15554,GO:0070016,1,0.93618571306906,0,10,armadillo repeat domain binding,MF,
15555,GO:0070022,1,0.973451418817094,0,4,transforming growth factor beta receptor complex,CC,
15556,GO:0070025,1,0.993895779497771,0,1,carbon monoxide binding,MF,
15557,GO:0070026,1,0.988299696443272,0,2,nitric oxide binding,MF,
15558,GO:0070032,1,0.976355937260996,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,
15559,GO:0070033,1,0.98147230719586,0,3,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,
15560,GO:0070034,1,0.865593503185656,0,22,telomerase RNA binding,MF,
15561,GO:0070035,1,0.55559468303946,0,91,purine NTP-dependent helicase activity,MF,
15562,GO:0070037,1,0.994343619113397,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
15563,GO:0070039,1,0.993164549103775,0,1,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
15564,GO:0070042,1,0.993771298301969,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
15565,GO:0070044,1,0.975925608973903,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
15567,GO:0070051,1,0.980680763575328,0,3,fibrinogen binding,MF,
15568,GO:0070052,1,0.986753543773748,0,2,collagen V binding,MF,
15569,GO:0070053,1,0.981177133488648,0,3,thrombospondin receptor activity,MF,
15570,GO:0070054,1,0.98131375204058,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
15571,GO:0070055,1,0.98131375204058,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
15573,GO:0070060,1,0.992013145935308,0,1,'de novo' actin filament nucleation,BP,
15574,GO:0070061,1,0.969941535191413,0,5,fructose binding,MF,
15576,GO:0070063,1,0.706265684277096,0,54,RNA polymerase binding,MF,
15577,GO:0070064,1,0.886349087747073,0,18,proline-rich region binding,MF,
15578,GO:0070069,1,0.864384633484501,0,25,cytochrome complex,CC,
15579,GO:0070070,1,0.933839089627931,0,10,proton-transporting V-type ATPase complex assembly,BP,
15580,GO:0070071,1,0.911498397938671,0,14,proton-transporting two-sector ATPase complex assembly,BP,
15581,GO:0070072,1,0.933839089627931,0,10,vacuolar proton-transporting V-type ATPase complex assembly,BP,
15582,GO:0070075,1,0.994466354247885,0,1,tear secretion,BP,
15583,GO:0070076,1,0.841647178847894,0,25,histone lysine demethylation,BP,
15584,GO:0070077,1,0.993603636886392,0,1,histone arginine demethylation,BP,
15585,GO:0070078,1,0.993603636886392,0,1,histone H3-R2 demethylation,BP,
15586,GO:0070079,1,0.993603636886392,0,1,histone H4-R3 demethylation,BP,
15587,GO:0070080,1,0.987747078479704,0,2,titin Z domain binding,MF,
15588,GO:0070081,1,0.969788563156995,0,5,clathrin-sculpted monoamine transport vesicle,CC,
15589,GO:0070083,1,0.969788563156995,0,5,clathrin-sculpted monoamine transport vesicle membrane,CC,
15590,GO:0070085,1,0.208435470972846,0,243,glycosylation,BP,
15591,GO:0070086,1,0.975332778188007,0,4,ubiquitin-dependent endocytosis,BP,
15592,GO:0070087,1,0.958232867163116,0,6,chromo shadow domain binding,MF,
15593,GO:0070091,1,0.957980111548576,0,7,glucagon secretion,BP,
15594,GO:0070092,1,0.963468662645146,0,6,regulation of glucagon secretion,BP,
15595,GO:0070093,1,0.98242445700314,0,3,negative regulation of glucagon secretion,BP,
15596,GO:0070094,1,0.993900955744329,0,1,positive regulation of glucagon secretion,BP,
15597,GO:0070095,1,0.981995043296553,0,3,fructose-6-phosphate binding,MF,
15598,GO:0070096,1,0.99367214148164,0,1,mitochondrial outer membrane translocase complex assembly,BP,
15599,GO:0070097,1,0.959179655438365,0,6,delta-catenin binding,MF,
15603,GO:0070101,1,0.981986957216544,0,3,positive regulation of chemokine-mediated signaling pathway,BP,
15605,GO:0070103,1,0.982364754168122,0,3,regulation of interleukin-6-mediated signaling pathway,BP,
15606,GO:0070104,1,0.99415475764347,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
15607,GO:0070105,1,0.988141381444102,0,2,positive regulation of interleukin-6-mediated signaling pathway,BP,
15608,GO:0070106,1,0.932178245235309,0,11,interleukin-27-mediated signaling pathway,BP,
15609,GO:0070110,1,0.981371667275455,0,3,ciliary neurotrophic factor receptor complex,CC,
15610,GO:0070119,1,0.9934577695263,0,1,ciliary neurotrophic factor binding,MF,
15611,GO:0070120,1,0.967488923641372,0,5,ciliary neurotrophic factor-mediated signaling pathway,BP,
15612,GO:0070121,1,0.993049612079565,0,1,Kupffer's vesicle development,BP,
15613,GO:0070122,1,0.968811125920442,0,5,isopeptidase activity,MF,
15614,GO:0070123,1,0.992796711859633,0,1,transforming growth factor beta receptor activity, type III,MF,
15615,GO:0070124,1,0.988231001687528,0,2,mitochondrial translational initiation,BP,
15616,GO:0070125,1,0.61335612704922,0,84,mitochondrial translational elongation,BP,
15617,GO:0070126,1,0.605914061808821,0,86,mitochondrial translational termination,BP,
15618,GO:0070127,1,0.9513725248911,0,8,tRNA aminoacylation for mitochondrial protein translation,BP,
15619,GO:0070129,1,0.895549418470945,0,18,regulation of mitochondrial translation,BP,
15620,GO:0070130,1,0.993846081630578,0,1,negative regulation of mitochondrial translation,BP,
15621,GO:0070131,1,0.935240118094226,0,11,positive regulation of mitochondrial translation,BP,
15622,GO:0070137,1,0.972848929741637,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
15623,GO:0070138,1,0.980654603835254,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
15624,GO:0070139,1,0.972848929741637,0,4,SUMO-specific endopeptidase activity,MF,
15625,GO:0070140,1,0.980654603835254,0,3,SUMO-specific isopeptidase activity,MF,
15626,GO:0070141,1,0.962704941774494,0,6,response to UV-A,BP,
15627,GO:0070142,1,0.967510422810968,0,5,synaptic vesicle budding,BP,
15628,GO:0070143,1,0.993266769256478,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
15629,GO:0070145,1,0.993678708107879,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
15630,GO:0070150,1,0.988072296337391,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
15631,GO:0070159,1,0.993958527760437,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
15633,GO:0070161,1,0.0312487445921486,0,524,anchoring junction,CC,
15634,GO:0070162,1,0.961893220037294,0,6,adiponectin secretion,BP,
15635,GO:0070163,1,0.961893220037294,0,6,regulation of adiponectin secretion,BP,
15636,GO:0070164,1,0.974094589623104,0,4,negative regulation of adiponectin secretion,BP,
15637,GO:0070165,1,0.987477476061357,0,2,positive regulation of adiponectin secretion,BP,
15638,GO:0070166,1,0.941183411482521,0,9,enamel mineralization,BP,
15641,GO:0070169,1,0.795953670966804,0,35,positive regulation of biomineral tissue development,BP,
15642,GO:0070170,1,0.974836002838568,0,4,regulation of tooth mineralization,BP,
15643,GO:0070171,1,0.986789385803358,0,2,negative regulation of tooth mineralization,BP,
15644,GO:0070172,1,0.987888225223026,0,2,positive regulation of tooth mineralization,BP,
15645,GO:0070176,1,0.994127323512544,0,1,DRM complex,CC,
15646,GO:0070178,1,0.988150319272098,0,2,D-serine metabolic process,BP,
15647,GO:0070179,1,0.993930880583482,0,1,D-serine biosynthetic process,BP,
15648,GO:0070180,1,0.994480216545381,0,1,large ribosomal subunit rRNA binding,MF,
15649,GO:0070181,1,0.953682280852904,0,8,small ribosomal subunit rRNA binding,MF,
15650,GO:0070182,1,0.903257565954432,0,16,DNA polymerase binding,MF,
15651,GO:0070183,1,0.993833314522088,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
15652,GO:0070184,1,0.994023399149167,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15653,GO:0070187,1,0.963785382792403,0,6,shelterin complex,CC,
15654,GO:0070189,1,0.958613877714638,0,7,kynurenine metabolic process,BP,
15655,GO:0070191,1,0.987968855137581,0,2,methionine-R-sulfoxide reductase activity,MF,
15656,GO:0070192,1,0.703000301143119,0,55,chromosome organization involved in meiotic cell cycle,BP,
15659,GO:0070195,1,0.993391723850019,0,1,growth hormone receptor complex,CC,
15660,GO:0070197,1,0.96894982769558,0,5,meiotic attachment of telomere to nuclear envelope,BP,
15661,GO:0070198,1,0.838778973220094,0,27,protein localization to chromosome, telomeric region,BP,
15662,GO:0070199,1,0.865750072897228,0,23,establishment of protein localization to chromosome,BP,
15663,GO:0070200,1,0.909786570208951,0,15,establishment of protein localization to telomere,BP,
15665,GO:0070202,1,0.935390513375081,0,11,regulation of establishment of protein localization to chromosome,BP,
15666,GO:0070203,1,0.941186069009164,0,10,regulation of establishment of protein localization to telomere,BP,
15667,GO:0070206,1,0.738049851061423,0,48,protein trimerization,BP,
15668,GO:0070207,1,0.83762724689137,0,28,protein homotrimerization,BP,
15669,GO:0070208,1,0.931911908220209,0,11,protein heterotrimerization,BP,
15670,GO:0070209,1,0.993683562044706,0,1,ASTRA complex,CC,
15671,GO:0070212,1,0.973242332212357,0,4,protein poly-ADP-ribosylation,BP,
15672,GO:0070213,1,0.972537640004194,0,4,protein auto-ADP-ribosylation,BP,
15673,GO:0070221,1,0.977117809031929,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
15674,GO:0070227,1,0.675678712826618,0,63,lymphocyte apoptotic process,BP,
15675,GO:0070228,1,0.742160464346872,0,48,regulation of lymphocyte apoptotic process,BP,
15676,GO:0070229,1,0.844280872621275,0,27,negative regulation of lymphocyte apoptotic process,BP,
15677,GO:0070230,1,0.91813428505816,0,14,positive regulation of lymphocyte apoptotic process,BP,
15678,GO:0070231,1,0.76627086669773,0,43,T cell apoptotic process,BP,
15679,GO:0070232,1,0.835735970481748,0,29,regulation of T cell apoptotic process,BP,
15680,GO:0070233,1,0.898910565161727,0,17,negative regulation of T cell apoptotic process,BP,
15681,GO:0070234,1,0.94139113339953,0,10,positive regulation of T cell apoptotic process,BP,
15682,GO:0070235,1,0.96943342052873,0,5,regulation of activation-induced cell death of T cells,BP,
15683,GO:0070236,1,0.975197393802845,0,4,negative regulation of activation-induced cell death of T cells,BP,
15684,GO:0070238,1,0.994163998595989,0,1,activated T cell autonomous cell death,BP,
15685,GO:0070239,1,0.994163998595989,0,1,regulation of activated T cell autonomous cell death,BP,
15686,GO:0070241,1,0.994163998595989,0,1,positive regulation of activated T cell autonomous cell death,BP,
15687,GO:0070242,1,0.898083828622915,0,17,thymocyte apoptotic process,BP,
15688,GO:0070243,1,0.927597808613422,0,12,regulation of thymocyte apoptotic process,BP,
15689,GO:0070244,1,0.957006734977489,0,7,negative regulation of thymocyte apoptotic process,BP,
15690,GO:0070245,1,0.969283451929209,0,5,positive regulation of thymocyte apoptotic process,BP,
15691,GO:0070246,1,0.994272579237724,0,1,natural killer cell apoptotic process,BP,
15692,GO:0070247,1,0.994272579237724,0,1,regulation of natural killer cell apoptotic process,BP,
15693,GO:0070251,1,0.993978411761806,0,1,pristanate-CoA ligase activity,MF,
15695,GO:0070253,1,0.977285067617556,0,4,somatostatin secretion,BP,
15696,GO:0070254,1,0.940490579582916,0,10,mucus secretion,BP,
15697,GO:0070255,1,0.945758197139954,0,9,regulation of mucus secretion,BP,
15698,GO:0070256,1,0.988065551576397,0,2,negative regulation of mucus secretion,BP,
15699,GO:0070257,1,0.963089804953281,0,6,positive regulation of mucus secretion,BP,
15700,GO:0070259,1,0.987482440815983,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
15701,GO:0070260,1,0.993846081630578,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
15705,GO:0070267,1,0.993613626642583,0,1,oncosis,BP,
15706,GO:0070268,1,0.691990649831243,0,59,cornification,BP,
15707,GO:0070269,1,0.947225881605674,0,9,pyroptosis,BP,
15708,GO:0070273,1,0.867976725103798,0,22,phosphatidylinositol-4-phosphate binding,MF,
15709,GO:0070274,1,0.988306589278807,0,2,RES complex,CC,
15710,GO:0070278,1,0.969706501414991,0,5,extracellular matrix constituent secretion,BP,
15712,GO:0070280,1,0.993545395687408,0,1,pyridoxal binding,MF,
15713,GO:0070283,1,0.994162987867528,0,1,radical SAM enzyme activity,MF,
15714,GO:0070286,1,0.816324025810196,0,30,axonemal dynein complex assembly,BP,
15715,GO:0070287,1,0.993601638893225,0,1,ferritin receptor activity,MF,
15716,GO:0070288,1,0.98872034188743,0,2,ferritin complex,CC,
15717,GO:0070290,1,0.968312328247218,0,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
15718,GO:0070291,1,0.981196755929367,0,3,N-acylethanolamine metabolic process,BP,
15719,GO:0070292,1,0.986947453256196,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
15720,GO:0070293,1,0.911906072924847,0,15,renal absorption,BP,
15721,GO:0070294,1,0.97433599158445,0,4,renal sodium ion absorption,BP,
15722,GO:0070295,1,0.981941988805462,0,3,renal water absorption,BP,
15727,GO:0070303,1,0.779028635971294,0,39,negative regulation of stress-activated protein kinase signaling cascade,BP,
15729,GO:0070305,1,0.959825344998762,0,6,response to cGMP,BP,
15730,GO:0070306,1,0.844609096580553,0,26,lens fiber cell differentiation,BP,
15731,GO:0070307,1,0.932986295975784,0,11,lens fiber cell development,BP,
15732,GO:0070309,1,0.975003436447239,0,4,lens fiber cell morphogenesis,BP,
15733,GO:0070314,1,0.96243275036026,0,6,G1 to G0 transition,BP,
15734,GO:0070315,1,0.987481837260936,0,2,G1 to G0 transition involved in cell differentiation,BP,
15735,GO:0070316,1,0.769532342401568,0,40,regulation of G0 to G1 transition,BP,
15736,GO:0070317,1,0.789636885480103,0,36,negative regulation of G0 to G1 transition,BP,
15737,GO:0070318,1,0.974600008927353,0,4,positive regulation of G0 to G1 transition,BP,
15738,GO:0070320,1,0.993875802566782,0,1,inward rectifier potassium channel inhibitor activity,MF,
15739,GO:0070324,1,0.95756239588191,0,7,thyroid hormone binding,MF,
15740,GO:0070325,1,0.866302344911817,0,21,lipoprotein particle receptor binding,MF,
15741,GO:0070326,1,0.973644386377826,0,4,very-low-density lipoprotein particle receptor binding,MF,
15742,GO:0070327,1,0.957352164231347,0,7,thyroid hormone transport,BP,
15743,GO:0070328,1,0.856646817567513,0,25,triglyceride homeostasis,BP,
15744,GO:0070329,1,0.987926048497719,0,2,tRNA seleno-modification,BP,
15745,GO:0070330,1,0.906592052189135,0,16,aromatase activity,MF,
15746,GO:0070335,1,0.992589043918148,0,1,aspartate binding,MF,
15747,GO:0070336,1,0.986874188326183,0,2,flap-structured DNA binding,MF,
15748,GO:0070337,1,0.992985376787579,0,1,3'-flap-structured DNA binding,MF,
15749,GO:0070339,1,0.963382452026925,0,6,response to bacterial lipopeptide,BP,
15750,GO:0070340,1,0.980574849820674,0,3,detection of bacterial lipopeptide,BP,
15751,GO:0070341,1,0.944879732938898,0,9,fat cell proliferation,BP,
15752,GO:0070343,1,0.982258189735961,0,3,white fat cell proliferation,BP,
15753,GO:0070344,1,0.944879732938898,0,9,regulation of fat cell proliferation,BP,
15754,GO:0070345,1,0.967894588426875,0,5,negative regulation of fat cell proliferation,BP,
15755,GO:0070346,1,0.98270525161939,0,3,positive regulation of fat cell proliferation,BP,
15756,GO:0070350,1,0.982258189735961,0,3,regulation of white fat cell proliferation,BP,
15757,GO:0070352,1,0.988773464319455,0,2,positive regulation of white fat cell proliferation,BP,
15758,GO:0070358,1,0.962091953590773,0,6,actin polymerization-dependent cell motility,BP,
15759,GO:0070365,1,0.92166768114119,0,13,hepatocyte differentiation,BP,
15760,GO:0070366,1,0.988405059833153,0,2,regulation of hepatocyte differentiation,BP,
15761,GO:0070367,1,0.99405889454324,0,1,negative regulation of hepatocyte differentiation,BP,
15762,GO:0070368,1,0.994312719541451,0,1,positive regulation of hepatocyte differentiation,BP,
15763,GO:0070369,1,0.979542372963274,0,3,beta-catenin-TCF7L2 complex,CC,
15764,GO:0070370,1,0.970805429596937,0,5,cellular heat acclimation,BP,
15767,GO:0070373,1,0.690976428378639,0,58,negative regulation of ERK1 and ERK2 cascade,BP,
15769,GO:0070375,1,0.980969774088662,0,3,ERK5 cascade,BP,
15770,GO:0070376,1,0.993811383493096,0,1,regulation of ERK5 cascade,BP,
15771,GO:0070377,1,0.993811383493096,0,1,negative regulation of ERK5 cascade,BP,
15772,GO:0070381,1,0.987259672402034,0,2,endosome to plasma membrane transport vesicle,CC,
15774,GO:0070383,1,0.95328168842046,0,8,DNA cytosine deamination,BP,
15775,GO:0070384,1,0.975674187186663,0,4,Harderian gland development,BP,
15776,GO:0070390,1,0.994152158622771,0,1,transcription export complex 2,CC,
15777,GO:0070391,1,0.935105550525339,0,11,response to lipoteichoic acid,BP,
15778,GO:0070392,1,0.994343330331289,0,1,detection of lipoteichoic acid,BP,
15779,GO:0070401,1,0.988201846573512,0,2,NADP+ binding,MF,
15780,GO:0070402,1,0.922170256920646,0,13,NADPH binding,MF,
15781,GO:0070403,1,0.918505450211205,0,14,NAD+ binding,MF,
15782,GO:0070404,1,0.982613834703891,0,3,NADH binding,MF,
15783,GO:0070405,1,0.693416381577292,0,59,ammonium ion binding,MF,
15784,GO:0070407,1,0.993746415670902,0,1,oxidation-dependent protein catabolic process,BP,
15785,GO:0070408,1,0.992991440799671,0,1,carbamoyl phosphate metabolic process,BP,
15786,GO:0070409,1,0.992991440799671,0,1,carbamoyl phosphate biosynthetic process,BP,
15787,GO:0070410,1,0.919287239104126,0,12,co-SMAD binding,MF,
15788,GO:0070411,1,0.928239273507796,0,11,I-SMAD binding,MF,
15789,GO:0070412,1,0.855335587625238,0,23,R-SMAD binding,MF,
15790,GO:0070413,1,0.993793910417337,0,1,trehalose metabolism in response to stress,BP,
15791,GO:0070417,1,0.954865285948357,0,7,cellular response to cold,BP,
15792,GO:0070418,1,0.993158496647898,0,1,DNA-dependent protein kinase complex,CC,
15793,GO:0070419,1,0.954565383636919,0,7,nonhomologous end joining complex,CC,
15794,GO:0070423,1,0.804687880169557,0,34,nucleotide-binding oligomerization domain containing signaling pathway,BP,
15795,GO:0070424,1,0.94852737760636,0,8,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15796,GO:0070425,1,0.987192480433126,0,2,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15797,GO:0070426,1,0.981009833624715,0,3,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15798,GO:0070427,1,0.97472828903184,0,4,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15799,GO:0070428,1,0.986440328412346,0,2,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15800,GO:0070429,1,0.99337221620826,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15801,GO:0070430,1,0.993022334258447,0,1,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15802,GO:0070431,1,0.933485830466996,0,11,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15803,GO:0070432,1,0.968443088502517,0,5,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15804,GO:0070433,1,0.987192480433126,0,2,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15805,GO:0070434,1,0.981009833624715,0,3,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15806,GO:0070435,1,0.987632629175484,0,2,Shc-EGFR complex,CC,
15807,GO:0070436,1,0.987146827336002,0,2,Grb2-EGFR complex,CC,
15808,GO:0070442,1,0.994248033093942,0,1,integrin alphaIIb-beta3 complex,CC,
15811,GO:0070446,1,0.994084587661038,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
15813,GO:0070458,1,0.982154920126045,0,3,cellular detoxification of nitrogen compound,BP,
15814,GO:0070459,1,0.958399859663808,0,7,prolactin secretion,BP,
15815,GO:0070460,1,0.993532827811427,0,1,thyroid-stimulating hormone secretion,BP,
15816,GO:0070461,1,0.862397259709206,0,23,SAGA-type complex,CC,
15817,GO:0070462,1,0.993593932162934,0,1,plus-end specific microtubule depolymerization,BP,
15818,GO:0070463,1,0.993645879123069,0,1,tubulin-dependent ATPase activity,MF,
15819,GO:0070469,1,0.625240596608919,0,81,respiratory chain,CC,
15820,GO:0070470,1,0.976616052308222,0,4,plasma membrane respiratory chain,CC,
15821,GO:0070471,1,0.951315035680104,0,8,uterine smooth muscle contraction,BP,
15822,GO:0070472,1,0.957153984836701,0,7,regulation of uterine smooth muscle contraction,BP,
15823,GO:0070473,1,0.994083144067623,0,1,negative regulation of uterine smooth muscle contraction,BP,
15824,GO:0070474,1,0.962853243817911,0,6,positive regulation of uterine smooth muscle contraction,BP,
15825,GO:0070475,1,0.958850143817847,0,7,rRNA base methylation,BP,
15826,GO:0070476,1,0.994480216545381,0,1,rRNA (guanine-N7)-methylation,BP,
15827,GO:0070478,1,0.993440733103706,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
15828,GO:0070481,1,0.993805653274634,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
15830,GO:0070483,1,0.993728693770675,0,1,detection of hypoxia,BP,
15831,GO:0070486,1,0.92732392540211,0,12,leukocyte aggregation,BP,
15832,GO:0070487,1,0.968144195660508,0,5,monocyte aggregation,BP,
15833,GO:0070488,1,0.989040856116663,0,2,neutrophil aggregation,BP,
15834,GO:0070489,1,0.987626317473162,0,2,T cell aggregation,BP,
15835,GO:0070491,1,0.672348003333616,0,62,repressing transcription factor binding,MF,
15836,GO:0070492,1,0.941320465916965,0,10,oligosaccharide binding,MF,
15837,GO:0070493,1,0.926027052777465,0,12,thrombin-activated receptor signaling pathway,BP,
15838,GO:0070494,1,0.98076432796543,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
15839,GO:0070495,1,0.98076432796543,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
15841,GO:0070506,1,0.987788445319443,0,2,high-density lipoprotein particle receptor activity,MF,
15843,GO:0070508,1,0.958302513141543,0,7,cholesterol import,BP,
15844,GO:0070509,1,0.648652911946719,0,65,calcium ion import,BP,
15845,GO:0070510,1,0.99259381883555,0,1,regulation of histone H4-K20 methylation,BP,
15846,GO:0070512,1,0.99259381883555,0,1,positive regulation of histone H4-K20 methylation,BP,
15847,GO:0070513,1,0.941683576826101,0,10,death domain binding,MF,
15848,GO:0070522,1,0.974517135037891,0,4,ERCC4-ERCC1 complex,CC,
15849,GO:0070524,1,0.994239514145018,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15850,GO:0070525,1,0.92429834159443,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
15851,GO:0070527,1,0.717146128548116,0,52,platelet aggregation,BP,
15852,GO:0070528,1,0.842686260488503,0,27,protein kinase C signaling,BP,
15853,GO:0070530,1,0.895705628037702,0,17,K63-linked polyubiquitin modification-dependent protein binding,MF,
15854,GO:0070531,1,0.968445161374651,0,5,BRCA1-A complex,CC,
15855,GO:0070534,1,0.763907269885839,0,42,protein K63-linked ubiquitination,BP,
15856,GO:0070535,1,0.966157649087501,0,5,histone H2A K63-linked ubiquitination,BP,
15857,GO:0070536,1,0.85356437251285,0,24,protein K63-linked deubiquitination,BP,
15858,GO:0070537,1,0.981606674811141,0,3,histone H2A K63-linked deubiquitination,BP,
15859,GO:0070538,1,0.988599162579397,0,2,oleic acid binding,MF,
15860,GO:0070539,1,0.993634176653069,0,1,linoleic acid binding,MF,
15861,GO:0070541,1,0.980658236407858,0,3,response to platinum ion,BP,
15862,GO:0070542,1,0.620542098720032,0,75,response to fatty acid,BP,
15863,GO:0070543,1,0.99404850384895,0,1,response to linoleic acid,BP,
15864,GO:0070544,1,0.9473501905702,0,8,histone H3-K36 demethylation,BP,
15865,GO:0070545,1,0.981410008313922,0,3,PeBoW complex,CC,
15866,GO:0070547,1,0.993849238640097,0,1,L-tyrosine aminotransferase activity,MF,
15867,GO:0070548,1,0.985974654604041,0,2,L-glutamine aminotransferase activity,MF,
15868,GO:0070550,1,0.99171612148374,0,1,rDNA condensation,BP,
15869,GO:0070551,1,0.993846081630578,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
15870,GO:0070552,1,0.981771959170605,0,3,BRISC complex,CC,
15871,GO:0070553,1,0.993846081630578,0,1,nicotinic acid receptor activity,MF,
15872,GO:0070554,1,0.987364179650681,0,2,synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex,CC,
15874,GO:0070557,1,0.988305470814427,0,2,PCNA-p21 complex,CC,
15875,GO:0070560,1,0.987706842738166,0,2,protein secretion by platelet,BP,
15876,GO:0070561,1,0.943337775472793,0,9,vitamin D receptor signaling pathway,BP,
15877,GO:0070562,1,0.961608159495196,0,6,regulation of vitamin D receptor signaling pathway,BP,
15878,GO:0070563,1,0.98726620745346,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
15879,GO:0070564,1,0.987994779919543,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
15880,GO:0070566,1,0.84128026103054,0,27,adenylyltransferase activity,MF,
15881,GO:0070567,1,0.945290314300332,0,9,cytidylyltransferase activity,MF,
15882,GO:0070568,1,0.969316386118257,0,5,guanylyltransferase activity,MF,
15883,GO:0070569,1,0.956569594751803,0,7,uridylyltransferase activity,MF,
15884,GO:0070570,1,0.846278893466131,0,26,regulation of neuron projection regeneration,BP,
15885,GO:0070571,1,0.912773184127468,0,14,negative regulation of neuron projection regeneration,BP,
15886,GO:0070572,1,0.952707415578022,0,8,positive regulation of neuron projection regeneration,BP,
15887,GO:0070573,1,0.981791022938858,0,3,metallodipeptidase activity,MF,
15888,GO:0070574,1,0.974997012189113,0,4,cadmium ion transmembrane transport,BP,
15889,GO:0070576,1,0.987663632853376,0,2,vitamin D 24-hydroxylase activity,MF,
15890,GO:0070577,1,0.888329627176642,0,17,lysine-acetylated histone binding,MF,
15891,GO:0070578,1,0.94428704748053,0,9,RISC-loading complex,CC,
15892,GO:0070579,1,0.969526790867665,0,4,methylcytosine dioxygenase activity,MF,
15893,GO:0070584,1,0.877383766817879,0,21,mitochondrion morphogenesis,BP,
15898,GO:0070589,1,0.994134543005102,0,1,cellular component macromolecule biosynthetic process,BP,
15899,GO:0070593,1,0.985844075842457,0,2,dendrite self-avoidance,BP,
15900,GO:0070601,1,0.939470881961259,0,10,centromeric sister chromatid cohesion,BP,
15901,GO:0070602,1,0.975264795167755,0,4,regulation of centromeric sister chromatid cohesion,BP,
15902,GO:0070603,1,0.618371764591702,0,73,SWI/SNF superfamily-type complex,CC,
15903,GO:0070611,1,0.99388571732223,0,1,histone methyltransferase activity (H3-R2 specific),MF,
15904,GO:0070612,1,0.99388571732223,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
15906,GO:0070615,1,0.993471506695919,0,1,nucleosome-dependent ATPase activity,MF,
15907,GO:0070618,1,0.993871062059072,0,1,Grb2-Sos complex,CC,
15908,GO:0070625,1,0.99404590638951,0,1,zymogen granule exocytosis,BP,
15909,GO:0070626,1,0.994219444080734,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
15910,GO:0070627,1,0.993446460613398,0,1,ferrous iron import,BP,
15911,GO:0070628,1,0.876348533975927,0,21,proteasome binding,MF,
15912,GO:0070631,1,0.993846081630578,0,1,spindle pole body localization,BP,
15913,GO:0070632,1,0.993846081630578,0,1,establishment of spindle pole body localization,BP,
15914,GO:0070633,1,0.906992438076299,0,15,transepithelial transport,BP,
15915,GO:0070634,1,0.986794396973264,0,2,transepithelial ammonium transport,BP,
15916,GO:0070637,1,0.993949885713262,0,1,pyridine nucleoside metabolic process,BP,
15917,GO:0070638,1,0.993949885713262,0,1,pyridine nucleoside catabolic process,BP,
15918,GO:0070640,1,0.981248524976817,0,3,vitamin D3 metabolic process,BP,
15919,GO:0070643,1,0.994180170230059,0,1,vitamin D 25-hydroxylase activity,MF,
15920,GO:0070644,1,0.979899623409572,0,3,vitamin D response element binding,MF,
15921,GO:0070646,1,0.180072501268027,0,264,protein modification by small protein removal,BP,
15923,GO:0070649,1,0.979730415588547,0,3,formin-nucleated actin cable assembly,BP,
15924,GO:0070651,1,0.993805653274634,0,1,nonfunctional rRNA decay,BP,
15925,GO:0070652,1,0.95069389434033,0,8,HAUS complex,CC,
15926,GO:0070653,1,0.994388091856786,0,1,high-density lipoprotein particle receptor binding,MF,
15928,GO:0070662,1,0.980145623654388,0,3,mast cell proliferation,BP,
15931,GO:0070665,1,0.473437008897367,0,121,positive regulation of leukocyte proliferation,BP,
15932,GO:0070666,1,0.986900975521474,0,2,regulation of mast cell proliferation,BP,
15933,GO:0070667,1,0.993763145018849,0,1,negative regulation of mast cell proliferation,BP,
15934,GO:0070668,1,0.986900975521474,0,2,positive regulation of mast cell proliferation,BP,
15935,GO:0070669,1,0.919939333806411,0,13,response to interleukin-2,BP,
15936,GO:0070670,1,0.829187254283885,0,30,response to interleukin-4,BP,
15937,GO:0070671,1,0.754533004916797,0,46,response to interleukin-12,BP,
15938,GO:0070672,1,0.912757883065302,0,14,response to interleukin-15,BP,
15939,GO:0070673,1,0.934830276312682,0,11,response to interleukin-18,BP,
15940,GO:0070676,1,0.982472389650096,0,3,intralumenal vesicle formation,BP,
15941,GO:0070678,1,0.993873073076598,0,1,preprotein binding,MF,
15942,GO:0070679,1,0.912347454459474,0,13,inositol 1,4,5 trisphosphate binding,MF,
15943,GO:0070681,1,0.981944238142415,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
15944,GO:0070682,1,0.981960937410308,0,3,proteasome regulatory particle assembly,BP,
15945,GO:0070684,1,0.994319072707266,0,1,seminal clot liquefaction,BP,
15946,GO:0070685,1,0.994037104578111,0,1,macropinocytic cup,CC,
15947,GO:0070694,1,0.993846081630578,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
15948,GO:0070695,1,0.965440604877724,0,5,FHF complex,CC,
15949,GO:0070696,1,0.892752911277059,0,18,transmembrane receptor protein serine/threonine kinase binding,MF,
15950,GO:0070697,1,0.963537652562737,0,6,activin receptor binding,MF,
15951,GO:0070698,1,0.987898885879815,0,2,type I activin receptor binding,MF,
15952,GO:0070699,1,0.986724755940138,0,2,type II activin receptor binding,MF,
15953,GO:0070700,1,0.926563413733977,0,12,BMP receptor binding,MF,
15954,GO:0070704,1,0.987261808256179,0,2,sterol desaturase activity,MF,
15955,GO:0070715,1,0.993701267540879,0,1,sodium-dependent organic cation transport,BP,
15956,GO:0070717,1,0.860754501653679,0,23,poly-purine tract binding,MF,
15957,GO:0070722,1,0.993639314256837,0,1,Tle3-Aes complex,CC,
15958,GO:0070723,1,0.872303182345204,0,20,response to cholesterol,BP,
15959,GO:0070724,1,0.993739268775992,0,1,BMP receptor complex,CC,
15961,GO:0070728,1,0.955566228370475,0,7,leucine binding,MF,
15962,GO:0070733,1,0.994170640521777,0,1,protein adenylyltransferase activity,MF,
15963,GO:0070734,1,0.884806110573037,0,19,histone H3-K27 methylation,BP,
15964,GO:0070735,1,0.987715993976727,0,2,protein-glycine ligase activity,MF,
15965,GO:0070736,1,0.993664718910378,0,1,protein-glycine ligase activity, initiating,MF,
15966,GO:0070739,1,0.956525293138792,0,7,protein-glutamic acid ligase activity,MF,
15967,GO:0070740,1,0.956525293138792,0,7,tubulin-glutamic acid ligase activity,MF,
15969,GO:0070742,1,0.912608413238993,0,14,C2H2 zinc finger domain binding,MF,
15970,GO:0070743,1,0.994346506935695,0,1,interleukin-23 complex,CC,
15971,GO:0070757,1,0.931866244147043,0,11,interleukin-35-mediated signaling pathway,BP,
15972,GO:0070761,1,0.969321789995871,0,5,pre-snoRNP complex,CC,
15973,GO:0070762,1,0.993846081630578,0,1,nuclear pore transmembrane ring,CC,
15974,GO:0070765,1,0.962709021477279,0,6,gamma-secretase complex,CC,
15975,GO:0070772,1,0.993750704474997,0,1,PAS complex,CC,
15976,GO:0070773,1,0.994257273990689,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
15977,GO:0070774,1,0.993383405662179,0,1,phytoceramidase activity,MF,
15978,GO:0070775,1,0.955262994579107,0,7,H3 histone acetyltransferase complex,CC,
15979,GO:0070776,1,0.955262994579107,0,7,MOZ/MORF histone acetyltransferase complex,CC,
15980,GO:0070777,1,0.972094369335478,0,4,D-aspartate transport,BP,
15981,GO:0070778,1,0.962958145873505,0,6,L-aspartate transmembrane transport,BP,
15982,GO:0070779,1,0.972094369335478,0,4,D-aspartate import across plasma membrane,BP,
15983,GO:0070780,1,0.988030861436468,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
15984,GO:0070781,1,0.987126714568564,0,2,response to biotin,BP,
15985,GO:0070782,1,0.994024264666125,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
15986,GO:0070813,1,0.969453938043474,0,5,hydrogen sulfide metabolic process,BP,
15987,GO:0070814,1,0.974945808050987,0,4,hydrogen sulfide biosynthetic process,BP,
15988,GO:0070815,1,0.974886331275429,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
15989,GO:0070816,1,0.909460252395074,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
15990,GO:0070818,1,0.994142773259051,0,1,protoporphyrinogen oxidase activity,MF,
15991,GO:0070820,1,0.376903643960995,0,155,tertiary granule,CC,
15992,GO:0070821,1,0.636720794245041,0,70,tertiary granule membrane,CC,
15993,GO:0070822,1,0.906307103291035,0,15,Sin3-type complex,CC,
15994,GO:0070826,1,0.993446460613398,0,1,paraferritin complex,CC,
15995,GO:0070827,1,0.973029320996688,0,4,chromatin maintenance,BP,
15996,GO:0070828,1,0.905354046456049,0,15,heterochromatin organization,BP,
15997,GO:0070829,1,0.985928023528794,0,2,heterochromatin maintenance,BP,
15999,GO:0070831,1,0.946572402374448,0,8,basement membrane assembly,BP,
16000,GO:0070836,1,0.981746908246082,0,3,caveola assembly,BP,
16001,GO:0070837,1,0.98087771177236,0,3,dehydroascorbic acid transport,BP,
16003,GO:0070839,1,0.987255975808754,0,2,divalent metal ion export,BP,
16004,GO:0070840,1,0.872377851980187,0,20,dynein complex binding,MF,
16006,GO:0070842,1,0.975061320875727,0,4,aggresome assembly,BP,
16007,GO:0070843,1,0.993460775033623,0,1,misfolded protein transport,BP,
16008,GO:0070844,1,0.993460775033623,0,1,polyubiquitinated protein transport,BP,
16009,GO:0070845,1,0.993460775033623,0,1,polyubiquitinated misfolded protein transport,BP,
16010,GO:0070846,1,0.993460775033623,0,1,Hsp90 deacetylation,BP,
16011,GO:0070847,1,0.952551783854298,0,8,core mediator complex,CC,
16013,GO:0070849,1,0.753715399598805,0,43,response to epidermal growth factor,BP,
16015,GO:0070852,1,0.959603374865978,0,6,cell body fiber,CC,
16016,GO:0070853,1,0.985017596224176,0,2,myosin VI binding,MF,
16017,GO:0070856,1,0.992896124698882,0,1,myosin VI light chain binding,MF,
16018,GO:0070857,1,0.95170434263967,0,8,regulation of bile acid biosynthetic process,BP,
16019,GO:0070858,1,0.981745276635778,0,3,negative regulation of bile acid biosynthetic process,BP,
16020,GO:0070859,1,0.98182679015917,0,3,positive regulation of bile acid biosynthetic process,BP,
16021,GO:0070860,1,0.993980717772487,0,1,RNA polymerase I core factor complex,CC,
16022,GO:0070861,1,0.860351779407262,0,23,regulation of protein exit from endoplasmic reticulum,BP,
16023,GO:0070862,1,0.93940657604691,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
16024,GO:0070863,1,0.92860439405384,0,11,positive regulation of protein exit from endoplasmic reticulum,BP,
16025,GO:0070873,1,0.838519279432833,0,26,regulation of glycogen metabolic process,BP,
16026,GO:0070874,1,0.966623743999206,0,5,negative regulation of glycogen metabolic process,BP,
16027,GO:0070875,1,0.907168758659329,0,14,positive regulation of glycogen metabolic process,BP,
16028,GO:0070876,1,0.97512138583163,0,4,SOSS complex,CC,
16029,GO:0070877,1,0.987254107618277,0,2,microprocessor complex,CC,
16030,GO:0070878,1,0.947661547277966,0,8,primary miRNA binding,MF,
16031,GO:0070883,1,0.967877814818948,0,5,pre-miRNA binding,MF,
16033,GO:0070885,1,0.9799384099994,0,3,negative regulation of calcineurin-NFAT signaling cascade,BP,
16034,GO:0070886,1,0.942818326921262,0,9,positive regulation of calcineurin-NFAT signaling cascade,BP,
16036,GO:0070888,1,0.820281354319404,0,31,E-box binding,MF,
16037,GO:0070889,1,0.987887984000659,0,2,platelet alpha granule organization,BP,
16038,GO:0070890,1,0.99264141663663,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
16039,GO:0070891,1,0.976553125918163,0,4,lipoteichoic acid binding,MF,
16040,GO:0070892,1,0.99404850384895,0,1,lipoteichoic acid receptor activity,MF,
16041,GO:0070893,1,0.986978358815608,0,2,transposon integration,BP,
16042,GO:0070894,1,0.986978358815608,0,2,regulation of transposon integration,BP,
16043,GO:0070895,1,0.986978358815608,0,2,negative regulation of transposon integration,BP,
16044,GO:0070897,1,0.76465975546172,0,42,DNA-templated transcriptional preinitiation complex assembly,BP,
16045,GO:0070898,1,0.99143873961278,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
16046,GO:0070899,1,0.993780169269349,0,1,mitochondrial tRNA wobble uridine modification,BP,
16047,GO:0070900,1,0.946863292335647,0,9,mitochondrial tRNA modification,BP,
16048,GO:0070901,1,0.975683760665923,0,4,mitochondrial tRNA methylation,BP,
16049,GO:0070902,1,0.994165442493504,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
16050,GO:0070903,1,0.994078235977714,0,1,mitochondrial tRNA thio-modification,BP,
16051,GO:0070904,1,0.99264141663663,0,1,transepithelial L-ascorbic acid transport,BP,
16052,GO:0070905,1,0.981525848552517,0,3,serine binding,MF,
16053,GO:0070911,1,0.819649792644297,0,32,global genome nucleotide-excision repair,BP,
16054,GO:0070914,1,0.932816890234321,0,11,UV-damage excision repair,BP,
16056,GO:0070918,1,0.754371474849154,0,43,production of small RNA involved in gene silencing by RNA,BP,
16057,GO:0070920,1,0.90749580566076,0,15,regulation of production of small RNA involved in gene silencing by RNA,BP,
16058,GO:0070922,1,0.942997191941652,0,9,small RNA loading onto RISC,BP,
16060,GO:0070926,1,0.993533970467786,0,1,regulation of ATP:ADP antiporter activity,BP,
16061,GO:0070931,1,0.99299764893338,0,1,Golgi-associated vesicle lumen,CC,
16062,GO:0070932,1,0.878435921536067,0,20,histone H3 deacetylation,BP,
16063,GO:0070933,1,0.941855041085846,0,9,histone H4 deacetylation,BP,
16064,GO:0070934,1,0.965548587703699,0,5,CRD-mediated mRNA stabilization,BP,
16065,GO:0070935,1,0.908633077767429,0,15,3'-UTR-mediated mRNA stabilization,BP,
16066,GO:0070936,1,0.730005859814593,0,49,protein K48-linked ubiquitination,BP,
16067,GO:0070937,1,0.959230462051265,0,6,CRD-mediated mRNA stability complex,CC,
16068,GO:0070938,1,0.927727743476437,0,11,contractile ring,CC,
16069,GO:0070939,1,0.980263344053583,0,3,Dsl1/NZR complex,CC,
16070,GO:0070940,1,0.968947494894878,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
16071,GO:0070942,1,0.95425849956841,0,8,neutrophil mediated cytotoxicity,BP,
16072,GO:0070943,1,0.965841731830481,0,6,neutrophil mediated killing of symbiont cell,BP,
16073,GO:0070944,1,0.971450493443327,0,5,neutrophil mediated killing of bacterium,BP,
16074,GO:0070945,1,0.982460937786344,0,3,neutrophil mediated killing of gram-negative bacterium,BP,
16075,GO:0070946,1,0.994380294640332,0,1,neutrophil mediated killing of gram-positive bacterium,BP,
16076,GO:0070947,1,0.988640796188329,0,2,neutrophil mediated killing of fungus,BP,
16077,GO:0070948,1,0.976232499937859,0,4,regulation of neutrophil mediated cytotoxicity,BP,
16078,GO:0070949,1,0.988079692400052,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,
16079,GO:0070950,1,0.99381625524968,0,1,regulation of neutrophil mediated killing of bacterium,BP,
16080,GO:0070951,1,0.99381625524968,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16081,GO:0070953,1,0.994228107418313,0,1,regulation of neutrophil mediated killing of fungus,BP,
16082,GO:0070960,1,0.988079692400052,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
16083,GO:0070961,1,0.988079692400052,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
16084,GO:0070962,1,0.99381625524968,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
16085,GO:0070963,1,0.99381625524968,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16086,GO:0070965,1,0.994228107418313,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
16087,GO:0070966,1,0.98026197354583,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
16088,GO:0070970,1,0.935978421674987,0,10,interleukin-2 secretion,BP,
16089,GO:0070971,1,0.892934060691372,0,17,endoplasmic reticulum exit site,CC,
16091,GO:0070973,1,0.960125373842552,0,6,protein localization to endoplasmic reticulum exit site,BP,
16092,GO:0070974,1,0.993769438593287,0,1,POU domain binding,MF,
16093,GO:0070975,1,0.992522182280074,0,1,FHA domain binding,MF,
16094,GO:0070976,1,0.993864455555704,0,1,TIR domain binding,MF,
16096,GO:0070979,1,0.848840547812256,0,27,protein K11-linked ubiquitination,BP,
16097,GO:0070981,1,0.993974664759957,0,1,L-asparagine biosynthetic process,BP,
16098,GO:0070982,1,0.993974664759957,0,1,L-asparagine metabolic process,BP,
16099,GO:0070984,1,0.993447319654661,0,1,SET domain binding,MF,
16100,GO:0070985,1,0.988488042444436,0,2,TFIIK complex,CC,
16101,GO:0070986,1,0.91678439263005,0,13,left/right axis specification,BP,
16102,GO:0070987,1,0.894282742311979,0,18,error-free translesion synthesis,BP,
16103,GO:0070988,1,0.675746759540195,0,59,demethylation,BP,
16104,GO:0070989,1,0.923725704180992,0,12,oxidative demethylation,BP,
16105,GO:0070990,1,0.96551168132293,0,6,snRNP binding,MF,
16106,GO:0070991,1,0.981525225401941,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
16107,GO:0070992,1,0.98833656086768,0,2,translation initiation complex,CC,
16108,GO:0070993,1,0.986845699151051,0,2,translation preinitiation complex,CC,
16109,GO:0070995,1,0.98104299623407,0,3,NADPH oxidation,BP,
16110,GO:0070996,1,0.982800634060174,0,3,type 1 melanocortin receptor binding,MF,
16112,GO:0071000,1,0.988112137361818,0,2,response to magnetism,BP,
16113,GO:0071001,1,0.98176674611489,0,3,U4/U6 snRNP,CC,
16114,GO:0071004,1,0.898426395340363,0,17,U2-type prespliceosome,CC,
16115,GO:0071005,1,0.994013879311082,0,1,U2-type precatalytic spliceosome,CC,
16116,GO:0071006,1,0.981744965967452,0,3,U2-type catalytic step 1 spliceosome,CC,
16117,GO:0071007,1,0.837106795428371,0,29,U2-type catalytic step 2 spliceosome,CC,
16118,GO:0071008,1,0.975950147983361,0,4,U2-type post-mRNA release spliceosomal complex,CC,
16119,GO:0071010,1,0.871752290203374,0,22,prespliceosome,CC,
16120,GO:0071011,1,0.824947284113324,0,31,precatalytic spliceosome,CC,
16121,GO:0071012,1,0.963584417615966,0,6,catalytic step 1 spliceosome,CC,
16122,GO:0071013,1,0.54317717777679,0,97,catalytic step 2 spliceosome,CC,
16123,GO:0071014,1,0.946604072649989,0,9,post-mRNA release spliceosomal complex,CC,
16124,GO:0071020,1,0.988324673253871,0,2,post-spliceosomal complex,CC,
16125,GO:0071021,1,0.994153313743245,0,1,U2-type post-spliceosomal complex,CC,
16126,GO:0071025,1,0.913118896369247,0,15,RNA surveillance,BP,
16127,GO:0071026,1,0.99392972909963,0,1,cytoplasmic RNA surveillance,BP,
16128,GO:0071027,1,0.924431299296132,0,13,nuclear RNA surveillance,BP,
16129,GO:0071028,1,0.924431299296132,0,13,nuclear mRNA surveillance,BP,
16130,GO:0071029,1,0.965407874501915,0,6,nuclear ncRNA surveillance,BP,
16131,GO:0071030,1,0.988031586729915,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
16132,GO:0071031,1,0.988362452494062,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
16133,GO:0071033,1,0.970819932613307,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
16134,GO:0071034,1,0.97486227160654,0,4,CUT catabolic process,BP,
16135,GO:0071035,1,0.965407874501915,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
16136,GO:0071038,1,0.971390846537812,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
16137,GO:0071042,1,0.976267476477962,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
16138,GO:0071043,1,0.97486227160654,0,4,CUT metabolic process,BP,
16139,GO:0071044,1,0.926710240704943,0,11,histone mRNA catabolic process,BP,
16140,GO:0071045,1,0.994172084417801,0,1,nuclear histone mRNA catabolic process,BP,
16141,GO:0071046,1,0.965407874501915,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
16142,GO:0071047,1,0.976267476477962,0,4,polyadenylation-dependent mRNA catabolic process,BP,
16143,GO:0071048,1,0.988031586729915,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
16144,GO:0071049,1,0.988362452494062,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
16145,GO:0071051,1,0.971561159379085,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
16146,GO:0071062,1,0.980937852083405,0,3,alphav-beta3 integrin-vitronectin complex,CC,
16147,GO:0071065,1,0.987568652863298,0,2,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
16148,GO:0071071,1,0.922736720583594,0,13,regulation of phospholipid biosynthetic process,BP,
16149,GO:0071072,1,0.975030861077516,0,4,negative regulation of phospholipid biosynthetic process,BP,
16150,GO:0071073,1,0.952121233442922,0,8,positive regulation of phospholipid biosynthetic process,BP,
16151,GO:0071074,1,0.994094693246456,0,1,eukaryotic initiation factor eIF2 binding,MF,
16152,GO:0071077,1,0.981758589806163,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
16154,GO:0071104,1,0.975085354099505,0,4,response to interleukin-9,BP,
16155,GO:0071105,1,0.98769110409474,0,2,response to interleukin-11,BP,
16156,GO:0071106,1,0.981758589806163,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
16157,GO:0071107,1,0.948369367680683,0,8,response to parathyroid hormone,BP,
16158,GO:0071108,1,0.846490717405979,0,24,protein K48-linked deubiquitination,BP,
16159,GO:0071109,1,0.984449399127768,0,2,superior temporal gyrus development,BP,
16160,GO:0071110,1,0.992915769695244,0,1,histone biotinylation,BP,
16161,GO:0071133,1,0.993738697082491,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
16162,GO:0071139,1,0.986770067815682,0,2,resolution of recombination intermediates,BP,
16163,GO:0071140,1,0.986770067815682,0,2,resolution of mitotic recombination intermediates,BP,
16164,GO:0071141,1,0.944919336095226,0,8,SMAD protein complex,CC,
16165,GO:0071144,1,0.984636323699849,0,2,heteromeric SMAD protein complex,CC,
16166,GO:0071148,1,0.985103174156314,0,2,TEAD-1-YAP complex,CC,
16167,GO:0071149,1,0.987185686609076,0,2,TEAD-2-YAP complex,CC,
16168,GO:0071156,1,0.511456490231046,0,107,regulation of cell cycle arrest,BP,
16169,GO:0071157,1,0.877799256210024,0,21,negative regulation of cell cycle arrest,BP,
16170,GO:0071158,1,0.588797406898313,0,84,positive regulation of cell cycle arrest,BP,
16171,GO:0071159,1,0.988340574963402,0,2,NF-kappaB complex,CC,
16172,GO:0071163,1,0.982364715377133,0,3,DNA replication preinitiation complex assembly,BP,
16173,GO:0071164,1,0.993582228608314,0,1,RNA trimethylguanosine synthase activity,MF,
16174,GO:0071166,1,0.456475232704055,0,123,ribonucleoprotein complex localization,BP,
16175,GO:0071168,1,0.880650110881586,0,20,protein localization to chromatin,BP,
16176,GO:0071169,1,0.957537645495629,0,7,establishment of protein localization to chromatin,BP,
16177,GO:0071173,1,0.818703462188556,0,31,spindle assembly checkpoint,BP,
16178,GO:0071174,1,0.818703462188556,0,31,mitotic spindle checkpoint,BP,
16179,GO:0071203,1,0.967056877479603,0,5,WASH complex,CC,
16180,GO:0071204,1,0.963175028435021,0,6,histone pre-mRNA 3'end processing complex,CC,
16183,GO:0071207,1,0.987505622649418,0,2,histone pre-mRNA stem-loop binding,MF,
16184,GO:0071208,1,0.977324992573116,0,4,histone pre-mRNA DCP binding,MF,
16185,GO:0071209,1,0.982657401339812,0,3,U7 snRNA binding,MF,
16186,GO:0071211,1,0.974605484046168,0,4,protein targeting to vacuole involved in autophagy,BP,
16188,GO:0071215,1,0.993394304974037,0,1,cellular response to abscisic acid stimulus,BP,
16189,GO:0071216,1,0.313134537557195,0,184,cellular response to biotic stimulus,BP,
16190,GO:0071217,1,0.993498820562144,0,1,cellular response to external biotic stimulus,BP,
16191,GO:0071218,1,0.872993648756464,0,21,cellular response to misfolded protein,BP,
16192,GO:0071219,1,0.354914187977276,0,165,cellular response to molecule of bacterial origin,BP,
16193,GO:0071220,1,0.963382452026925,0,6,cellular response to bacterial lipoprotein,BP,
16194,GO:0071221,1,0.963382452026925,0,6,cellular response to bacterial lipopeptide,BP,
16195,GO:0071222,1,0.373500931957881,0,157,cellular response to lipopolysaccharide,BP,
16196,GO:0071223,1,0.935105550525339,0,11,cellular response to lipoteichoic acid,BP,
16197,GO:0071224,1,0.969293867404013,0,5,cellular response to peptidoglycan,BP,
16198,GO:0071225,1,0.968232291106225,0,5,cellular response to muramyl dipeptide,BP,
16199,GO:0071226,1,0.987129284663403,0,2,cellular response to molecule of fungal origin,BP,
16200,GO:0071228,1,0.994331490283208,0,1,cellular response to tumor cell,BP,
16201,GO:0071229,1,0.296045486018686,0,188,cellular response to acid chemical,BP,
16202,GO:0071230,1,0.671399516729197,0,61,cellular response to amino acid stimulus,BP,
16203,GO:0071231,1,0.988699667951163,0,2,cellular response to folic acid,BP,
16204,GO:0071233,1,0.940054536196044,0,9,cellular response to leucine,BP,
16207,GO:0071242,1,0.713035172380945,0,53,cellular response to ammonium ion,BP,
16208,GO:0071243,1,0.907861433779466,0,16,cellular response to arsenic-containing substance,BP,
16209,GO:0071245,1,0.993598071002145,0,1,cellular response to carbon monoxide,BP,
16210,GO:0071247,1,0.994330768330158,0,1,cellular response to chromate,BP,
16212,GO:0071250,1,0.992826483555519,0,1,cellular response to nitrite,BP,
16213,GO:0071253,1,0.974922202315732,0,4,connexin binding,MF,
16214,GO:0071256,1,0.977338638365363,0,4,translocon complex,CC,
16215,GO:0071257,1,0.926539958493566,0,12,cellular response to electrical stimulus,BP,
16216,GO:0071258,1,0.993455479429119,0,1,cellular response to gravity,BP,
16217,GO:0071259,1,0.988112137361818,0,2,cellular response to magnetism,BP,
16219,GO:0071262,1,0.986659712938815,0,2,regulation of translational initiation in response to starvation,BP,
16220,GO:0071264,1,0.986659712938815,0,2,positive regulation of translational initiation in response to starvation,BP,
16221,GO:0071265,1,0.952633589816061,0,8,L-methionine biosynthetic process,BP,
16222,GO:0071266,1,0.994143062039743,0,1,'de novo' L-methionine biosynthetic process,BP,
16223,GO:0071267,1,0.958248428186903,0,7,L-methionine salvage,BP,
16224,GO:0071268,1,0.993985041870798,0,1,homocysteine biosynthetic process,BP,
16225,GO:0071275,1,0.994025995737292,0,1,cellular response to aluminum ion,BP,
16226,GO:0071276,1,0.82614814935733,0,32,cellular response to cadmium ion,BP,
16228,GO:0071279,1,0.980722472069093,0,3,cellular response to cobalt ion,BP,
16229,GO:0071280,1,0.899578756943427,0,18,cellular response to copper ion,BP,
16231,GO:0071283,1,0.988438652647405,0,2,cellular response to iron(III) ion,BP,
16232,GO:0071284,1,0.973208504324601,0,4,cellular response to lead ion,BP,
16233,GO:0071285,1,0.929307271955067,0,12,cellular response to lithium ion,BP,
16234,GO:0071286,1,0.956305450892195,0,6,cellular response to magnesium ion,BP,
16235,GO:0071287,1,0.943092047535611,0,9,cellular response to manganese ion,BP,
16236,GO:0071288,1,0.993852396074305,0,1,cellular response to mercury ion,BP,
16237,GO:0071294,1,0.903971943963656,0,17,cellular response to zinc ion,BP,
16238,GO:0071295,1,0.835445689790399,0,28,cellular response to vitamin,BP,
16239,GO:0071298,1,0.99366015143815,0,1,cellular response to L-ascorbic acid,BP,
16240,GO:0071300,1,0.663322024423667,0,64,cellular response to retinoic acid,BP,
16241,GO:0071301,1,0.992524498233347,0,1,cellular response to vitamin B1,BP,
16242,GO:0071305,1,0.884810751740855,0,19,cellular response to vitamin D,BP,
16243,GO:0071306,1,0.987080423538075,0,2,cellular response to vitamin E,BP,
16244,GO:0071307,1,0.987677597426441,0,2,cellular response to vitamin K,BP,
16248,GO:0071314,1,0.982336939356819,0,3,cellular response to cocaine,BP,
16249,GO:0071315,1,0.975493443646688,0,4,cellular response to morphine,BP,
16250,GO:0071316,1,0.952691607613799,0,8,cellular response to nicotine,BP,
16251,GO:0071317,1,0.975493443646688,0,4,cellular response to isoquinoline alkaloid,BP,
16253,GO:0071320,1,0.726678319513404,0,48,cellular response to cAMP,BP,
16254,GO:0071321,1,0.959825344998762,0,6,cellular response to cGMP,BP,
16256,GO:0071324,1,0.993207763700228,0,1,cellular response to disaccharide stimulus,BP,
16258,GO:0071329,1,0.993207763700228,0,1,cellular response to sucrose stimulus,BP,
16260,GO:0071332,1,0.969066410487087,0,5,cellular response to fructose stimulus,BP,
16262,GO:0071335,1,0.988519907778103,0,2,hair follicle cell proliferation,BP,
16263,GO:0071336,1,0.988519907778103,0,2,regulation of hair follicle cell proliferation,BP,
16264,GO:0071338,1,0.988519907778103,0,2,positive regulation of hair follicle cell proliferation,BP,
16265,GO:0071339,1,0.834779038647911,0,28,MLL1 complex,CC,
16266,GO:0071340,1,0.933558337303444,0,11,skeletal muscle acetylcholine-gated channel clustering,BP,
16267,GO:0071344,1,0.988489476833479,0,2,diphosphate metabolic process,BP,
16271,GO:0071348,1,0.993271227843075,0,1,cellular response to interleukin-11,BP,
16272,GO:0071349,1,0.763938009941193,0,44,cellular response to interleukin-12,BP,
16273,GO:0071350,1,0.919055109142577,0,13,cellular response to interleukin-15,BP,
16274,GO:0071351,1,0.952401909290102,0,8,cellular response to interleukin-18,BP,
16275,GO:0071352,1,0.925140464634994,0,12,cellular response to interleukin-2,BP,
16276,GO:0071353,1,0.839618268025134,0,28,cellular response to interleukin-4,BP,
16278,GO:0071355,1,0.980594983959447,0,3,cellular response to interleukin-9,BP,
16280,GO:0071357,1,0.641988894715301,0,71,cellular response to type I interferon,BP,
16281,GO:0071359,1,0.668663286033057,0,62,cellular response to dsRNA,BP,
16282,GO:0071360,1,0.920602769627938,0,13,cellular response to exogenous dsRNA,BP,
16283,GO:0071361,1,0.917086602759954,0,13,cellular response to ethanol,BP,
16284,GO:0071362,1,0.967220290750755,0,5,cellular response to ether,BP,
16286,GO:0071364,1,0.774120241356761,0,39,cellular response to epidermal growth factor stimulus,BP,
16287,GO:0071371,1,0.901420100213053,0,16,cellular response to gonadotropin stimulus,BP,
16288,GO:0071372,1,0.936237773961186,0,10,cellular response to follicle-stimulating hormone stimulus,BP,
16289,GO:0071373,1,0.98775234535819,0,2,cellular response to luteinizing hormone stimulus,BP,
16290,GO:0071374,1,0.961062795882614,0,6,cellular response to parathyroid hormone stimulus,BP,
16292,GO:0071376,1,0.969094589760264,0,5,cellular response to corticotropin-releasing hormone stimulus,BP,
16293,GO:0071377,1,0.794104145953793,0,36,cellular response to glucagon stimulus,BP,
16294,GO:0071378,1,0.876338792696807,0,20,cellular response to growth hormone stimulus,BP,
16295,GO:0071379,1,0.869909547062538,0,21,cellular response to prostaglandin stimulus,BP,
16296,GO:0071380,1,0.901404329421088,0,16,cellular response to prostaglandin E stimulus,BP,
16298,GO:0071384,1,0.679903166177494,0,61,cellular response to corticosteroid stimulus,BP,
16299,GO:0071385,1,0.696191322481636,0,57,cellular response to glucocorticoid stimulus,BP,
16300,GO:0071386,1,0.979046566016481,0,3,cellular response to corticosterone stimulus,BP,
16301,GO:0071387,1,0.993150425839933,0,1,cellular response to cortisol stimulus,BP,
16302,GO:0071389,1,0.955977241675948,0,7,cellular response to mineralocorticoid stimulus,BP,
16303,GO:0071391,1,0.925269561695851,0,12,cellular response to estrogen stimulus,BP,
16304,GO:0071392,1,0.811626044211301,0,33,cellular response to estradiol stimulus,BP,
16306,GO:0071394,1,0.944983380728935,0,9,cellular response to testosterone stimulus,BP,
16307,GO:0071395,1,0.977252045272567,0,4,cellular response to jasmonic acid stimulus,BP,
16309,GO:0071397,1,0.921202961557003,0,12,cellular response to cholesterol,BP,
16310,GO:0071398,1,0.726906652672103,0,49,cellular response to fatty acid,BP,
16311,GO:0071400,1,0.986971573757215,0,2,cellular response to oleic acid,BP,
16312,GO:0071401,1,0.993985762594839,0,1,cellular response to triglyceride,BP,
16313,GO:0071402,1,0.851838835681271,0,25,cellular response to lipoprotein particle stimulus,BP,
16314,GO:0071403,1,0.987445185699087,0,2,cellular response to high density lipoprotein particle stimulus,BP,
16315,GO:0071404,1,0.890852294109136,0,18,cellular response to low-density lipoprotein particle stimulus,BP,
16317,GO:0071409,1,0.979837295326879,0,3,cellular response to cycloheximide,BP,
16318,GO:0071412,1,0.993987924836092,0,1,cellular response to genistein,BP,
16319,GO:0071413,1,0.993987924836092,0,1,cellular response to hydroxyisoflavone,BP,
16322,GO:0071418,1,0.994254674988056,0,1,cellular response to amine stimulus,BP,
16323,GO:0071420,1,0.953764213671011,0,7,cellular response to histamine,BP,
16324,GO:0071421,1,0.974578971607085,0,4,manganese ion transmembrane transport,BP,
16325,GO:0071422,1,0.981413182994906,0,3,succinate transmembrane transport,BP,
16326,GO:0071423,1,0.994101045669862,0,1,malate transmembrane transport,BP,
16327,GO:0071424,1,0.993846081630578,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
16328,GO:0071425,1,0.88574527340133,0,19,hematopoietic stem cell proliferation,BP,
16329,GO:0071426,1,0.459246190008685,0,122,ribonucleoprotein complex export from nucleus,BP,
16330,GO:0071427,1,0.513245220169102,0,104,mRNA-containing ribonucleoprotein complex export from nucleus,BP,
16331,GO:0071428,1,0.912424136644709,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
16332,GO:0071431,1,0.815697194269152,0,31,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
16333,GO:0071435,1,0.928178083460055,0,12,potassium ion export,BP,
16334,GO:0071437,1,0.913472844114783,0,14,invadopodium,CC,
16335,GO:0071438,1,0.968761811453109,0,5,invadopodium membrane,CC,
16336,GO:0071439,1,0.942804022440989,0,9,clathrin complex,CC,
16337,GO:0071440,1,0.963264054805414,0,6,regulation of histone H3-K14 acetylation,BP,
16338,GO:0071441,1,0.99354068307125,0,1,negative regulation of histone H3-K14 acetylation,BP,
16339,GO:0071442,1,0.975533384302857,0,4,positive regulation of histone H3-K14 acetylation,BP,
16340,GO:0071444,1,0.994586498412711,0,1,cellular response to pheromone,BP,
16341,GO:0071447,1,0.950714176809581,0,8,cellular response to hydroperoxide,BP,
16342,GO:0071449,1,0.994382604924395,0,1,cellular response to lipid hydroperoxide,BP,
16343,GO:0071450,1,0.86494530312786,0,24,cellular response to oxygen radical,BP,
16344,GO:0071451,1,0.86494530312786,0,24,cellular response to superoxide,BP,
16346,GO:0071454,1,0.992508575477803,0,1,cellular response to anoxia,BP,
16347,GO:0071455,1,0.962121449856317,0,6,cellular response to hyperoxia,BP,
16348,GO:0071456,1,0.313923504773087,0,183,cellular response to hypoxia,BP,
16349,GO:0071458,1,0.968997957873748,0,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
16350,GO:0071459,1,0.884369071182484,0,20,protein localization to chromosome, centromeric region,BP,
16351,GO:0071460,1,0.988609352479308,0,2,cellular response to cell-matrix adhesion,BP,
16352,GO:0071461,1,0.988168235106912,0,2,cellular response to redox state,BP,
16353,GO:0071462,1,0.980388114908629,0,3,cellular response to water stimulus,BP,
16354,GO:0071464,1,0.993190193531548,0,1,cellular response to hydrostatic pressure,BP,
16356,GO:0071467,1,0.889003198564553,0,19,cellular response to pH,BP,
16357,GO:0071468,1,0.944736104811199,0,9,cellular response to acidic pH,BP,
16358,GO:0071469,1,0.98761128446765,0,2,cellular response to alkaline pH,BP,
16359,GO:0071470,1,0.815345394817481,0,32,cellular response to osmotic stress,BP,
16360,GO:0071471,1,0.993353559842376,0,1,cellular response to non-ionic osmotic stress,BP,
16361,GO:0071472,1,0.944396176842573,0,9,cellular response to salt stress,BP,
16362,GO:0071474,1,0.933989629709965,0,11,cellular hyperosmotic response,BP,
16363,GO:0071475,1,0.975646951134427,0,4,cellular hyperosmotic salinity response,BP,
16364,GO:0071476,1,0.954600229174107,0,7,cellular hypotonic response,BP,
16365,GO:0071477,1,0.986270282982521,0,2,cellular hypotonic salinity response,BP,
16366,GO:0071478,1,0.349828439992641,0,164,cellular response to radiation,BP,
16367,GO:0071479,1,0.655185523020296,0,66,cellular response to ionizing radiation,BP,
16368,GO:0071480,1,0.84052983920432,0,27,cellular response to gamma radiation,BP,
16369,GO:0071481,1,0.915818376010818,0,13,cellular response to X-ray,BP,
16370,GO:0071482,1,0.507642821118277,0,106,cellular response to light stimulus,BP,
16371,GO:0071483,1,0.987202376119001,0,2,cellular response to blue light,BP,
16372,GO:0071484,1,0.986871513525179,0,2,cellular response to light intensity,BP,
16373,GO:0071485,1,0.993697840280528,0,1,cellular response to absence of light,BP,
16374,GO:0071486,1,0.993130821335686,0,1,cellular response to high light intensity,BP,
16375,GO:0071492,1,0.981096087036549,0,3,cellular response to UV-A,BP,
16376,GO:0071493,1,0.952533374490195,0,8,cellular response to UV-B,BP,
16377,GO:0071494,1,0.973019773698416,0,4,cellular response to UV-C,BP,
16380,GO:0071498,1,0.89206578819518,0,18,cellular response to fluid shear stress,BP,
16381,GO:0071499,1,0.957901133545857,0,7,cellular response to laminar fluid shear stress,BP,
16382,GO:0071500,1,0.96245640853573,0,6,cellular response to nitrosative stress,BP,
16383,GO:0071501,1,0.944119629949452,0,9,cellular response to sterol depletion,BP,
16384,GO:0071502,1,0.969222816490542,0,5,cellular response to temperature stimulus,BP,
16385,GO:0071503,1,0.974090993513017,0,4,response to heparin,BP,
16386,GO:0071504,1,0.974090993513017,0,4,cellular response to heparin,BP,
16387,GO:0071505,1,0.987598250277676,0,2,response to mycophenolic acid,BP,
16388,GO:0071506,1,0.987598250277676,0,2,cellular response to mycophenolic acid,BP,
16389,GO:0071514,1,0.867083476465549,0,22,genetic imprinting,BP,
16390,GO:0071526,1,0.803581864285936,0,32,semaphorin-plexin signaling pathway,BP,
16391,GO:0071527,1,0.993964002078067,0,1,semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
16392,GO:0071528,1,0.993528828309228,0,1,tRNA re-export from nucleus,BP,
16393,GO:0071529,1,0.993901243341133,0,1,cementum mineralization,BP,
16394,GO:0071532,1,0.9665114708173,0,5,ankyrin repeat binding,MF,
16395,GO:0071535,1,0.975451296812661,0,4,RING-like zinc finger domain binding,MF,
16396,GO:0071538,1,0.993980429514427,0,1,SH2 domain-mediated complex assembly,BP,
16397,GO:0071539,1,0.831640170115777,0,27,protein localization to centrosome,BP,
16398,GO:0071540,1,0.993116402843604,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
16399,GO:0071541,1,0.958777409572524,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
16400,GO:0071542,1,0.81695684131184,0,32,dopaminergic neuron differentiation,BP,
16401,GO:0071543,1,0.975772150142065,0,4,diphosphoinositol polyphosphate metabolic process,BP,
16402,GO:0071544,1,0.994257273990689,0,1,diphosphoinositol polyphosphate catabolic process,BP,
16403,GO:0071545,1,0.925531699693118,0,12,inositol phosphate catabolic process,BP,
16404,GO:0071546,1,0.962376167769355,0,6,pi-body,CC,
16405,GO:0071547,1,0.969251812841693,0,5,piP-body,CC,
16406,GO:0071548,1,0.772879725384759,0,41,response to dexamethasone,BP,
16407,GO:0071549,1,0.818515788223257,0,32,cellular response to dexamethasone stimulus,BP,
16408,GO:0071550,1,0.947223175789004,0,9,death-inducing signaling complex assembly,BP,
16409,GO:0071553,1,0.982319656696343,0,3,G-protein coupled pyrimidinergic nucleotide receptor activity,MF,
16410,GO:0071554,1,0.971166066974514,0,5,cell wall organization or biogenesis,BP,
16411,GO:0071556,1,0.861684018732096,0,25,integral component of lumenal side of endoplasmic reticulum membrane,CC,
16412,GO:0071557,1,0.966126779634201,0,5,histone H3-K27 demethylation,BP,
16413,GO:0071558,1,0.966126779634201,0,5,histone demethylase activity (H3-K27 specific),MF,
16414,GO:0071559,1,0.248063256125811,0,212,response to transforming growth factor beta,BP,
16415,GO:0071560,1,0.25579142953233,0,208,cellular response to transforming growth factor beta stimulus,BP,
16416,GO:0071561,1,0.993193650378136,0,1,nucleus-vacuole junction,CC,
16417,GO:0071564,1,0.92499003560128,0,12,npBAF complex,CC,
16418,GO:0071565,1,0.911959597184759,0,14,nBAF complex,CC,
16419,GO:0071566,1,0.993796487659536,0,1,UFM1 activating enzyme activity,MF,
16420,GO:0071567,1,0.988356204525015,0,2,UFM1 hydrolase activity,MF,
16421,GO:0071568,1,0.988203490780802,0,2,UFM1 transferase activity,MF,
16422,GO:0071569,1,0.964770208787522,0,6,protein ufmylation,BP,
16423,GO:0071573,1,0.993800354001242,0,1,shelterin complex assembly,BP,
16426,GO:0071579,1,0.987925234174469,0,2,regulation of zinc ion transport,BP,
16427,GO:0071580,1,0.994064956368378,0,1,regulation of zinc ion transmembrane transport,BP,
16428,GO:0071581,1,0.994064956368378,0,1,regulation of zinc ion transmembrane import,BP,
16429,GO:0071582,1,0.994064956368378,0,1,negative regulation of zinc ion transport,BP,
16430,GO:0071583,1,0.994064956368378,0,1,negative regulation of zinc ion transmembrane transport,BP,
16431,GO:0071584,1,0.994064956368378,0,1,negative regulation of zinc ion transmembrane import,BP,
16432,GO:0071585,1,0.994064956368378,0,1,detoxification of cadmium ion,BP,
16433,GO:0071586,1,0.987993990029663,0,2,CAAX-box protein processing,BP,
16434,GO:0071593,1,0.974957726796073,0,4,lymphocyte aggregation,BP,
16435,GO:0071595,1,0.987729649828399,0,2,Nem1-Spo7 phosphatase complex,CC,
16436,GO:0071596,1,0.978032143538706,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
16437,GO:0071598,1,0.969565632761652,0,5,neuronal ribonucleoprotein granule,CC,
16438,GO:0071599,1,0.909297117425956,0,15,otic vesicle development,BP,
16439,GO:0071600,1,0.939536572574823,0,10,otic vesicle morphogenesis,BP,
16440,GO:0071602,1,0.993383405662179,0,1,phytosphingosine biosynthetic process,BP,
16441,GO:0071603,1,0.974693153885821,0,4,endothelial cell-cell adhesion,BP,
16442,GO:0071604,1,0.8351731583881,0,28,transforming growth factor beta production,BP,
16443,GO:0071605,1,0.930102005794704,0,12,monocyte chemotactic protein-1 production,BP,
16444,GO:0071606,1,0.994074771569389,0,1,chemokine (C-C motif) ligand 4 production,BP,
16445,GO:0071608,1,0.975442686392555,0,4,macrophage inflammatory protein-1 alpha production,BP,
16446,GO:0071609,1,0.937520481251414,0,10,chemokine (C-C motif) ligand 5 production,BP,
16447,GO:0071610,1,0.993921957653899,0,1,chemokine (C-C motif) ligand 1 production,BP,
16448,GO:0071611,1,0.970132251319138,0,5,granulocyte colony-stimulating factor production,BP,
16449,GO:0071612,1,0.991248847410707,0,1,IP-10 production,BP,
16450,GO:0071613,1,0.988250237897871,0,2,granzyme B production,BP,
16451,GO:0071614,1,0.994109708410621,0,1,linoleic acid epoxygenase activity,MF,
16452,GO:0071616,1,0.745077153356495,0,46,acyl-CoA biosynthetic process,BP,
16453,GO:0071617,1,0.888794365141949,0,18,lysophospholipid acyltransferase activity,MF,
16454,GO:0071619,1,0.993990375500128,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
16455,GO:0071621,1,0.602669455268045,0,83,granulocyte chemotaxis,BP,
16456,GO:0071622,1,0.772279445322091,0,43,regulation of granulocyte chemotaxis,BP,
16457,GO:0071623,1,0.987101517329035,0,2,negative regulation of granulocyte chemotaxis,BP,
16458,GO:0071624,1,0.838073163761814,0,30,positive regulation of granulocyte chemotaxis,BP,
16459,GO:0071625,1,0.887833729453079,0,17,vocalization behavior,BP,
16460,GO:0071626,1,0.994280665037031,0,1,mastication,BP,
16461,GO:0071629,1,0.994172084417801,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
16462,GO:0071630,1,0.979581675864714,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
16463,GO:0071633,1,0.993823708135416,0,1,dihydroceramidase activity,MF,
16464,GO:0071634,1,0.840791853458839,0,27,regulation of transforming growth factor beta production,BP,
16465,GO:0071635,1,0.956593086917601,0,7,negative regulation of transforming growth factor beta production,BP,
16466,GO:0071636,1,0.897952769708264,0,17,positive regulation of transforming growth factor beta production,BP,
16467,GO:0071637,1,0.930102005794704,0,12,regulation of monocyte chemotactic protein-1 production,BP,
16468,GO:0071638,1,0.970034292813037,0,5,negative regulation of monocyte chemotactic protein-1 production,BP,
16469,GO:0071639,1,0.958846666873398,0,7,positive regulation of monocyte chemotactic protein-1 production,BP,
16470,GO:0071640,1,0.975442686392555,0,4,regulation of macrophage inflammatory protein 1 alpha production,BP,
16471,GO:0071641,1,0.987749689535282,0,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
16472,GO:0071642,1,0.987541919930286,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
16473,GO:0071643,1,0.994074771569389,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
16474,GO:0071644,1,0.994074771569389,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
16475,GO:0071649,1,0.94302946860081,0,9,regulation of chemokine (C-C motif) ligand 5 production,BP,
16476,GO:0071650,1,0.9822937166044,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
16477,GO:0071651,1,0.9600351362357,0,6,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
16478,GO:0071652,1,0.993921957653899,0,1,regulation of chemokine (C-C motif) ligand 1 production,BP,
16479,GO:0071654,1,0.993921957653899,0,1,positive regulation of chemokine (C-C motif) ligand 1 production,BP,
16480,GO:0071655,1,0.975845050637909,0,4,regulation of granulocyte colony-stimulating factor production,BP,
16481,GO:0071656,1,0.993976394104219,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
16482,GO:0071657,1,0.981759893233178,0,3,positive regulation of granulocyte colony-stimulating factor production,BP,
16483,GO:0071658,1,0.991248847410707,0,1,regulation of IP-10 production,BP,
16484,GO:0071660,1,0.991248847410707,0,1,positive regulation of IP-10 production,BP,
16485,GO:0071661,1,0.988250237897871,0,2,regulation of granzyme B production,BP,
16486,GO:0071663,1,0.988250237897871,0,2,positive regulation of granzyme B production,BP,
16487,GO:0071664,1,0.973346580437035,0,4,catenin-TCF7L2 complex,CC,
16488,GO:0071665,1,0.993676138497648,0,1,gamma-catenin-TCF7L2 complex,CC,
16491,GO:0071672,1,0.976351007385577,0,4,negative regulation of smooth muscle cell chemotaxis,BP,
16496,GO:0071677,1,0.902381348282505,0,17,positive regulation of mononuclear cell migration,BP,
16497,GO:0071678,1,0.992427203642683,0,1,olfactory bulb axon guidance,BP,
16498,GO:0071679,1,0.947069629421572,0,8,commissural neuron axon guidance,BP,
16499,GO:0071680,1,0.967184150096935,0,5,response to indole-3-methanol,BP,
16500,GO:0071681,1,0.967184150096935,0,5,cellular response to indole-3-methanol,BP,
16501,GO:0071682,1,0.890988515991033,0,19,endocytic vesicle lumen,CC,
16502,GO:0071684,1,0.99370983661046,0,1,organism emergence from protective structure,BP,
16504,GO:0071691,1,0.992648649281165,0,1,cardiac muscle thin filament assembly,BP,
16505,GO:0071692,1,0.95914685013957,0,6,protein localization to extracellular region,BP,
16506,GO:0071694,1,0.95914685013957,0,6,maintenance of protein location in extracellular region,BP,
16508,GO:0071696,1,0.908283488966354,0,15,ectodermal placode development,BP,
16509,GO:0071697,1,0.913836072449358,0,14,ectodermal placode morphogenesis,BP,
16510,GO:0071698,1,0.974407120654792,0,4,olfactory placode development,BP,
16511,GO:0071699,1,0.974407120654792,0,4,olfactory placode morphogenesis,BP,
16512,GO:0071701,1,0.993250657403617,0,1,regulation of MAPK export from nucleus,BP,
16516,GO:0071706,1,0.489133550463592,0,114,tumor necrosis factor superfamily cytokine production,BP,
16517,GO:0071707,1,0.994280665037031,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
16518,GO:0071709,1,0.833876768564549,0,27,membrane assembly,BP,
16519,GO:0071711,1,0.880307294478227,0,19,basement membrane organization,BP,
16520,GO:0071712,1,0.926269245593975,0,12,ER-associated misfolded protein catabolic process,BP,
16521,GO:0071713,1,0.993292651914914,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
16522,GO:0071714,1,0.99343013463261,0,1,icosanoid transmembrane transporter activity,MF,
16523,GO:0071715,1,0.824015504570153,0,31,icosanoid transport,BP,
16524,GO:0071723,1,0.951311673504224,0,8,lipopeptide binding,MF,
16525,GO:0071724,1,0.975093724850932,0,4,response to diacyl bacterial lipopeptide,BP,
16526,GO:0071725,1,0.981791404785368,0,3,response to triacyl bacterial lipopeptide,BP,
16527,GO:0071726,1,0.975093724850932,0,4,cellular response to diacyl bacterial lipopeptide,BP,
16528,GO:0071727,1,0.981791404785368,0,3,cellular response to triacyl bacterial lipopeptide,BP,
16529,GO:0071731,1,0.893195875933067,0,18,response to nitric oxide,BP,
16530,GO:0071732,1,0.910334679303573,0,15,cellular response to nitric oxide,BP,
16531,GO:0071733,1,0.974112383316534,0,4,transcriptional activation by promoter-enhancer looping,BP,
16532,GO:0071763,1,0.962976252184297,0,6,nuclear membrane organization,BP,
16533,GO:0071765,1,0.993433858798392,0,1,nuclear inner membrane organization,BP,
16537,GO:0071782,1,0.893402719739984,0,18,endoplasmic reticulum tubular network,CC,
16538,GO:0071786,1,0.908927570578209,0,15,endoplasmic reticulum tubular network organization,BP,
16539,GO:0071787,1,0.975868902857711,0,4,endoplasmic reticulum tubular network formation,BP,
16540,GO:0071789,1,0.993846081630578,0,1,spindle pole body localization to nuclear envelope,BP,
16541,GO:0071790,1,0.993846081630578,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
16542,GO:0071791,1,0.987542892894811,0,2,chemokine (C-C motif) ligand 5 binding,MF,
16543,GO:0071796,1,0.994274023129977,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
16544,GO:0071797,1,0.975678114491872,0,4,LUBAC complex,CC,
16545,GO:0071798,1,0.968260083957339,0,5,response to prostaglandin D,BP,
16546,GO:0071799,1,0.968260083957339,0,5,cellular response to prostaglandin D stimulus,BP,
16547,GO:0071800,1,0.878413523150785,0,20,podosome assembly,BP,
16548,GO:0071801,1,0.920076778577625,0,13,regulation of podosome assembly,BP,
16549,GO:0071802,1,0.993439873892425,0,1,negative regulation of podosome assembly,BP,
16550,GO:0071803,1,0.943462887195005,0,9,positive regulation of podosome assembly,BP,
16551,GO:0071804,1,0.29826274866789,0,187,cellular potassium ion transport,BP,
16552,GO:0071805,1,0.29826274866789,0,187,potassium ion transmembrane transport,BP,
16554,GO:0071812,1,0.993744700291415,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
16555,GO:0071813,1,0.873481923251494,0,21,lipoprotein particle binding,MF,
16556,GO:0071814,1,0.873481923251494,0,21,protein-lipid complex binding,MF,
16557,GO:0071816,1,0.976291260280959,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
16558,GO:0071817,1,0.970129969185818,0,5,MMXD complex,CC,
16559,GO:0071818,1,0.981979190932213,0,3,BAT3 complex,CC,
16560,GO:0071819,1,0.988125216597025,0,2,DUBm complex,CC,
16561,GO:0071820,1,0.994227529862516,0,1,N-box binding,MF,
16562,GO:0071821,1,0.987008844864126,0,2,FANCM-MHF complex,CC,
16563,GO:0071823,1,0.988635919174598,0,2,protein-carbohydrate complex subunit organization,BP,
16564,GO:0071824,1,0.251853963301201,0,219,protein-DNA complex subunit organization,BP,
16565,GO:0071825,1,0.78032375097762,0,39,protein-lipid complex subunit organization,BP,
16566,GO:0071826,1,0.27118739492688,0,207,ribonucleoprotein complex subunit organization,BP,
16567,GO:0071827,1,0.790264616515523,0,37,plasma lipoprotein particle organization,BP,
16568,GO:0071830,1,0.95586247276694,0,7,triglyceride-rich lipoprotein particle clearance,BP,
16569,GO:0071837,1,0.896520219578567,0,17,HMG box domain binding,MF,
16570,GO:0071838,1,0.962198646585979,0,6,cell proliferation in bone marrow,BP,
16571,GO:0071839,1,0.975979452150517,0,4,apoptotic process in bone marrow,BP,
16573,GO:0071846,1,0.994456823981072,0,1,actin filament debranching,BP,
16574,GO:0071847,1,0.987139414132924,0,2,TNFSF11-mediated signaling pathway,BP,
16575,GO:0071848,1,0.993744700291415,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
16576,GO:0071850,1,0.915998857476259,0,14,mitotic cell cycle arrest,BP,
16577,GO:0071855,1,0.87325593330324,0,23,neuropeptide receptor binding,MF,
16578,GO:0071863,1,0.961995446796745,0,6,regulation of cell proliferation in bone marrow,BP,
16579,GO:0071864,1,0.961995446796745,0,6,positive regulation of cell proliferation in bone marrow,BP,
16580,GO:0071865,1,0.975519267425574,0,4,regulation of apoptotic process in bone marrow,BP,
16581,GO:0071866,1,0.975519267425574,0,4,negative regulation of apoptotic process in bone marrow,BP,
16588,GO:0071873,1,0.980534904537285,0,3,response to norepinephrine,BP,
16589,GO:0071874,1,0.987620513631805,0,2,cellular response to norepinephrine stimulus,BP,
16590,GO:0071875,1,0.870769806277267,0,21,adrenergic receptor signaling pathway,BP,
16591,GO:0071877,1,0.994257273990689,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16592,GO:0071878,1,0.985684884631601,0,2,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16593,GO:0071879,1,0.98018331491122,0,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16594,GO:0071880,1,0.886902573254248,0,18,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16595,GO:0071881,1,0.987828000390216,0,2,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16596,GO:0071882,1,0.993533970467786,0,1,phospholipase C-activating adrenergic receptor signaling pathway,BP,
16597,GO:0071885,1,0.988256590117764,0,2,N-terminal protein N-methyltransferase activity,MF,
16598,GO:0071886,1,0.987048566522371,0,2,1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding,MF,
16599,GO:0071887,1,0.559173320320568,0,93,leukocyte apoptotic process,BP,
16600,GO:0071888,1,0.945095292638865,0,9,macrophage apoptotic process,BP,
16601,GO:0071889,1,0.848515465108631,0,25,14-3-3 protein binding,MF,
16602,GO:0071890,1,0.993145525233373,0,1,bicarbonate binding,MF,
16603,GO:0071893,1,0.994131943981625,0,1,BMP signaling pathway involved in nephric duct formation,BP,
16604,GO:0071894,1,0.987728795234638,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
16605,GO:0071895,1,0.963213118770289,0,6,odontoblast differentiation,BP,
16606,GO:0071896,1,0.971186912321434,0,4,protein localization to adherens junction,BP,
16608,GO:0071898,1,0.98166648091838,0,3,regulation of estrogen receptor binding,BP,
16609,GO:0071899,1,0.98166648091838,0,3,negative regulation of estrogen receptor binding,BP,
16613,GO:0071907,1,0.954072091038789,0,7,determination of digestive tract left/right asymmetry,BP,
16614,GO:0071908,1,0.993095923938043,0,1,determination of intestine left/right asymmetry,BP,
16615,GO:0071909,1,0.993095923938043,0,1,determination of stomach left/right asymmetry,BP,
16616,GO:0071910,1,0.961223483693947,0,6,determination of liver left/right asymmetry,BP,
16617,GO:0071914,1,0.987099388573699,0,2,prominosome,CC,
16618,GO:0071918,1,0.975054840167816,0,4,urea transmembrane transport,BP,
16619,GO:0071920,1,0.987958879566923,0,2,cleavage body,CC,
16620,GO:0071921,1,0.967268235853322,0,5,cohesin loading,BP,
16621,GO:0071922,1,0.973259245307236,0,4,regulation of cohesin loading,BP,
16622,GO:0071926,1,0.974430636199835,0,4,endocannabinoid signaling pathway,BP,
16623,GO:0071929,1,0.987630022704206,0,2,alpha-tubulin acetylation,BP,
16624,GO:0071930,1,0.980259087023563,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16625,GO:0071931,1,0.981984723316426,0,3,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16626,GO:0071933,1,0.949052916475024,0,8,Arp2/3 complex binding,MF,
16627,GO:0071934,1,0.981449429074335,0,3,thiamine transmembrane transport,BP,
16628,GO:0071936,1,0.946897654025362,0,8,coreceptor activity involved in Wnt signaling pathway,MF,
16629,GO:0071938,1,0.993825141661333,0,1,vitamin A transport,BP,
16630,GO:0071939,1,0.993825141661333,0,1,vitamin A import,BP,
16631,GO:0071941,1,0.917478216426844,0,14,nitrogen cycle metabolic process,BP,
16632,GO:0071942,1,0.981511947203364,0,3,XPC complex,CC,
16634,GO:0071947,1,0.980491977381191,0,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
16635,GO:0071949,1,0.85333936911922,0,25,FAD binding,MF,
16636,GO:0071951,1,0.993853544336592,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
16637,GO:0071953,1,0.975786644046687,0,4,elastic fiber,CC,
16638,GO:0071954,1,0.993641597666767,0,1,chemokine (C-C motif) ligand 11 production,BP,
16639,GO:0071955,1,0.985933832127824,0,2,recycling endosome to Golgi transport,BP,
16640,GO:0071960,1,0.994391268506931,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
16641,GO:0071962,1,0.982230597839643,0,3,mitotic sister chromatid cohesion, centromeric,BP,
16642,GO:0071963,1,0.994142628868695,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
16643,GO:0071971,1,0.957303890982845,0,7,extracellular exosome assembly,BP,
16644,GO:0071976,1,0.993696983496525,0,1,cell gliding,BP,
16645,GO:0071985,1,0.836307039007194,0,28,multivesicular body sorting pathway,BP,
16646,GO:0071986,1,0.96369867082195,0,6,Ragulator complex,CC,
16647,GO:0071987,1,0.973726879028963,0,4,WD40-repeat domain binding,MF,
16648,GO:0071988,1,0.992572258392098,0,1,protein localization to spindle pole body,BP,
16649,GO:0071997,1,0.992802204087989,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
16651,GO:0072003,1,0.981337049506878,0,3,kidney rudiment formation,BP,
16652,GO:0072004,1,0.987038592633319,0,2,kidney field specification,BP,
16654,GO:0072007,1,0.95667713669487,0,7,mesangial cell differentiation,BP,
16655,GO:0072008,1,0.962356528951986,0,6,glomerular mesangial cell differentiation,BP,
16657,GO:0072010,1,0.889105509838736,0,18,glomerular epithelium development,BP,
16658,GO:0072011,1,0.988061466351242,0,2,glomerular endothelium development,BP,
16659,GO:0072012,1,0.873003594236471,0,21,glomerulus vasculature development,BP,
16660,GO:0072014,1,0.966410235841683,0,5,proximal tubule development,BP,
16661,GO:0072015,1,0.94014785079122,0,9,glomerular visceral epithelial cell development,BP,
16662,GO:0072016,1,0.993886004761557,0,1,glomerular parietal epithelial cell development,BP,
16663,GO:0072017,1,0.925467995081134,0,11,distal tubule development,BP,
16664,GO:0072019,1,0.994029169494557,0,1,proximal convoluted tubule development,BP,
16665,GO:0072021,1,0.978104518162406,0,3,ascending thin limb development,BP,
16666,GO:0072023,1,0.994214246077107,0,1,thick ascending limb development,BP,
16667,GO:0072024,1,0.994214246077107,0,1,macula densa development,BP,
16668,GO:0072025,1,0.97535403691637,0,4,distal convoluted tubule development,BP,
16669,GO:0072027,1,0.99391447584731,0,1,connecting tubule development,BP,
16671,GO:0072033,1,0.946108030733485,0,8,renal vesicle formation,BP,
16672,GO:0072034,1,0.980931043880555,0,3,renal vesicle induction,BP,
16673,GO:0072036,1,0.993569667341445,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
16674,GO:0072038,1,0.969118087111847,0,5,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
16675,GO:0072039,1,0.980608688386946,0,3,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16676,GO:0072040,1,0.980608688386946,0,3,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16677,GO:0072044,1,0.921722989373461,0,12,collecting duct development,BP,
16678,GO:0072046,1,0.994224353305557,0,1,establishment of planar polarity involved in nephron morphogenesis,BP,
16679,GO:0072047,1,0.970683298440128,0,5,proximal/distal pattern formation involved in nephron development,BP,
16680,GO:0072048,1,0.946749772076664,0,9,renal system pattern specification,BP,
16681,GO:0072049,1,0.969534638391453,0,5,comma-shaped body morphogenesis,BP,
16682,GO:0072050,1,0.956939066317906,0,7,S-shaped body morphogenesis,BP,
16683,GO:0072051,1,0.994214246077107,0,1,juxtaglomerular apparatus development,BP,
16684,GO:0072053,1,0.987221924511899,0,2,renal inner medulla development,BP,
16685,GO:0072054,1,0.987221924511899,0,2,renal outer medulla development,BP,
16686,GO:0072055,1,0.993190193531548,0,1,renal cortex development,BP,
16687,GO:0072059,1,0.993190193531548,0,1,cortical collecting duct development,BP,
16688,GO:0072060,1,0.993521399777171,0,1,outer medullary collecting duct development,BP,
16689,GO:0072061,1,0.981673958641874,0,3,inner medullary collecting duct development,BP,
16690,GO:0072069,1,0.981327071966082,0,3,DCT cell differentiation,BP,
16691,GO:0072070,1,0.936199544697266,0,10,loop of Henle development,BP,
16692,GO:0072071,1,0.98836199433328,0,2,kidney interstitial fibroblast differentiation,BP,
16694,GO:0072074,1,0.891243644231246,0,18,kidney mesenchyme development,BP,
16695,GO:0072075,1,0.912982809812749,0,14,metanephric mesenchyme development,BP,
16696,GO:0072076,1,0.979733083589461,0,3,nephrogenic mesenchyme development,BP,
16701,GO:0072081,1,0.970683298440128,0,5,specification of nephron tubule identity,BP,
16702,GO:0072086,1,0.976444982498537,0,4,specification of loop of Henle identity,BP,
16707,GO:0072092,1,0.976946462854492,0,3,ureteric bud invasion,BP,
16708,GO:0072093,1,0.970662882546528,0,4,metanephric renal vesicle formation,BP,
16709,GO:0072095,1,0.98098343013876,0,3,regulation of branch elongation involved in ureteric bud branching,BP,
16710,GO:0072096,1,0.994131943981625,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
16711,GO:0072097,1,0.994131943981625,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
16712,GO:0072098,1,0.988266966649503,0,2,anterior/posterior pattern specification involved in kidney development,BP,
16713,GO:0072099,1,0.994131943981625,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
16714,GO:0072100,1,0.994131943981625,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
16715,GO:0072101,1,0.994131943981625,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
16716,GO:0072102,1,0.952931949818362,0,7,glomerulus morphogenesis,BP,
16717,GO:0072103,1,0.972477796433719,0,4,glomerulus vasculature morphogenesis,BP,
16718,GO:0072104,1,0.972477796433719,0,4,glomerular capillary formation,BP,
16719,GO:0072106,1,0.975176123072168,0,4,regulation of ureteric bud formation,BP,
16720,GO:0072107,1,0.975176123072168,0,4,positive regulation of ureteric bud formation,BP,
16721,GO:0072108,1,0.975198808240893,0,4,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
16722,GO:0072109,1,0.915028591033663,0,14,glomerular mesangium development,BP,
16723,GO:0072110,1,0.944956931730628,0,9,glomerular mesangial cell proliferation,BP,
16724,GO:0072111,1,0.892947450315226,0,18,cell proliferation involved in kidney development,BP,
16725,GO:0072112,1,0.905864669501447,0,15,glomerular visceral epithelial cell differentiation,BP,
16726,GO:0072114,1,0.993049612079565,0,1,pronephros morphogenesis,BP,
16727,GO:0072124,1,0.95162348102659,0,8,regulation of glomerular mesangial cell proliferation,BP,
16728,GO:0072125,1,0.981512895418046,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
16729,GO:0072126,1,0.969553319446863,0,5,positive regulation of glomerular mesangial cell proliferation,BP,
16730,GO:0072127,1,0.993993691310324,0,1,renal capsule development,BP,
16731,GO:0072128,1,0.993993691310324,0,1,renal capsule morphogenesis,BP,
16732,GO:0072129,1,0.993993691310324,0,1,renal capsule formation,BP,
16733,GO:0072130,1,0.993993691310324,0,1,renal capsule specification,BP,
16734,GO:0072131,1,0.973923946372919,0,4,kidney mesenchyme morphogenesis,BP,
16735,GO:0072132,1,0.748007913276837,0,45,mesenchyme morphogenesis,BP,
16736,GO:0072133,1,0.973923946372919,0,4,metanephric mesenchyme morphogenesis,BP,
16737,GO:0072134,1,0.985654096530848,0,2,nephrogenic mesenchyme morphogenesis,BP,
16738,GO:0072135,1,0.981412061629311,0,3,kidney mesenchymal cell proliferation,BP,
16739,GO:0072136,1,0.981412061629311,0,3,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
16740,GO:0072137,1,0.969085196131463,0,4,condensed mesenchymal cell proliferation,BP,
16741,GO:0072138,1,0.981963765382025,0,3,mesenchymal cell proliferation involved in ureteric bud development,BP,
16742,GO:0072139,1,0.987441500582512,0,2,glomerular parietal epithelial cell differentiation,BP,
16743,GO:0072141,1,0.98836199433328,0,2,renal interstitial fibroblast development,BP,
16744,GO:0072143,1,0.962586944329604,0,6,mesangial cell development,BP,
16745,GO:0072144,1,0.968301060385884,0,5,glomerular mesangial cell development,BP,
16746,GO:0072148,1,0.909628782958019,0,15,epithelial cell fate commitment,BP,
16747,GO:0072156,1,0.9768476994996,0,3,distal tubule morphogenesis,BP,
16748,GO:0072160,1,0.914995020663514,0,13,nephron tubule epithelial cell differentiation,BP,
16749,GO:0072161,1,0.957497358616915,0,7,mesenchymal cell differentiation involved in kidney development,BP,
16750,GO:0072162,1,0.974942933383833,0,4,metanephric mesenchymal cell differentiation,BP,
16753,GO:0072165,1,0.994100756918309,0,1,anterior mesonephric tubule development,BP,
16754,GO:0072166,1,0.987917673017785,0,2,posterior mesonephric tubule development,BP,
16755,GO:0072167,1,0.994100756918309,0,1,specification of mesonephric tubule identity,BP,
16756,GO:0072168,1,0.994100756918309,0,1,specification of anterior mesonephric tubule identity,BP,
16757,GO:0072169,1,0.994100756918309,0,1,specification of posterior mesonephric tubule identity,BP,
16758,GO:0072170,1,0.864038849243994,0,22,metanephric tubule development,BP,
16761,GO:0072173,1,0.930336100477417,0,11,metanephric tubule morphogenesis,BP,
16762,GO:0072174,1,0.96262041288661,0,6,metanephric tubule formation,BP,
16764,GO:0072176,1,0.916828141117227,0,13,nephric duct development,BP,
16765,GO:0072177,1,0.960778597826876,0,6,mesonephric duct development,BP,
16766,GO:0072178,1,0.937482220927026,0,10,nephric duct morphogenesis,BP,
16767,GO:0072179,1,0.975802758587648,0,4,nephric duct formation,BP,
16768,GO:0072180,1,0.982412335879851,0,3,mesonephric duct morphogenesis,BP,
16769,GO:0072181,1,0.994224353305557,0,1,mesonephric duct formation,BP,
16770,GO:0072182,1,0.927915753212272,0,11,regulation of nephron tubule epithelial cell differentiation,BP,
16771,GO:0072183,1,0.987756216162278,0,2,negative regulation of nephron tubule epithelial cell differentiation,BP,
16772,GO:0072184,1,0.994100756918309,0,1,renal vesicle progenitor cell differentiation,BP,
16773,GO:0072185,1,0.988100864873272,0,2,metanephric cap development,BP,
16774,GO:0072186,1,0.988100864873272,0,2,metanephric cap morphogenesis,BP,
16775,GO:0072189,1,0.919797436231862,0,13,ureter development,BP,
16776,GO:0072190,1,0.981859939719569,0,3,ureter urothelium development,BP,
16777,GO:0072191,1,0.975932348296862,0,4,ureter smooth muscle development,BP,
16778,GO:0072192,1,0.994131943981625,0,1,ureter epithelial cell differentiation,BP,
16779,GO:0072193,1,0.975932348296862,0,4,ureter smooth muscle cell differentiation,BP,
16780,GO:0072194,1,0.981595850035315,0,3,kidney smooth muscle tissue development,BP,
16781,GO:0072195,1,0.994192298933327,0,1,kidney smooth muscle cell differentiation,BP,
16782,GO:0072197,1,0.98153167069757,0,3,ureter morphogenesis,BP,
16783,GO:0072198,1,0.982301090138189,0,3,mesenchymal cell proliferation involved in ureter development,BP,
16784,GO:0072199,1,0.982301090138189,0,3,regulation of mesenchymal cell proliferation involved in ureter development,BP,
16785,GO:0072200,1,0.994131943981625,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
16786,GO:0072201,1,0.94987645179471,0,8,negative regulation of mesenchymal cell proliferation,BP,
16788,GO:0072203,1,0.938037553827769,0,10,cell proliferation involved in metanephros development,BP,
16789,GO:0072204,1,0.986939247105958,0,2,cell-cell signaling involved in metanephros development,BP,
16790,GO:0072205,1,0.952572045675112,0,7,metanephric collecting duct development,BP,
16791,GO:0072206,1,0.994214246077107,0,1,metanephric juxtaglomerular apparatus development,BP,
16792,GO:0072207,1,0.852609906543119,0,24,metanephric epithelium development,BP,
16793,GO:0072208,1,0.987330715810397,0,2,metanephric smooth muscle tissue development,BP,
16794,GO:0072209,1,0.987716839140807,0,2,metanephric mesangial cell differentiation,BP,
16796,GO:0072213,1,0.993993691310324,0,1,metanephric capsule development,BP,
16797,GO:0072214,1,0.993190193531548,0,1,metanephric cortex development,BP,
16798,GO:0072215,1,0.878351931231152,0,20,regulation of metanephros development,BP,
16799,GO:0072216,1,0.927020384945181,0,12,positive regulation of metanephros development,BP,
16800,GO:0072217,1,0.957361590829913,0,7,negative regulation of metanephros development,BP,
16801,GO:0072218,1,0.978104518162406,0,3,metanephric ascending thin limb development,BP,
16802,GO:0072219,1,0.993190193531548,0,1,metanephric cortical collecting duct development,BP,
16803,GO:0072221,1,0.97535403691637,0,4,metanephric distal convoluted tubule development,BP,
16804,GO:0072223,1,0.968599127439368,0,5,metanephric glomerular mesangium development,BP,
16805,GO:0072224,1,0.930152550411615,0,11,metanephric glomerulus development,BP,
16806,GO:0072227,1,0.994214246077107,0,1,metanephric macula densa development,BP,
16807,GO:0072229,1,0.994029169494557,0,1,metanephric proximal convoluted tubule development,BP,
16808,GO:0072233,1,0.994214246077107,0,1,metanephric thick ascending limb development,BP,
16809,GO:0072234,1,0.880158786420336,0,19,metanephric nephron tubule development,BP,
16810,GO:0072235,1,0.959546848192764,0,6,metanephric distal tubule development,BP,
16811,GO:0072236,1,0.971766343690288,0,4,metanephric loop of Henle development,BP,
16812,GO:0072237,1,0.984628595944897,0,2,metanephric proximal tubule development,BP,
16813,GO:0072239,1,0.955899285269358,0,7,metanephric glomerulus vasculature development,BP,
16814,GO:0072240,1,0.981327071966082,0,3,metanephric DCT cell differentiation,BP,
16815,GO:0072243,1,0.873961773088328,0,20,metanephric nephron epithelium development,BP,
16816,GO:0072244,1,0.992968338556447,0,1,metanephric glomerular epithelium development,BP,
16817,GO:0072248,1,0.992968338556447,0,1,metanephric glomerular visceral epithelial cell differentiation,BP,
16818,GO:0072249,1,0.992968338556447,0,1,metanephric glomerular visceral epithelial cell development,BP,
16819,GO:0072254,1,0.987716839140807,0,2,metanephric glomerular mesangial cell differentiation,BP,
16820,GO:0072255,1,0.993816398551809,0,1,metanephric glomerular mesangial cell development,BP,
16821,GO:0072257,1,0.951457666087453,0,7,metanephric nephron tubule epithelial cell differentiation,BP,
16822,GO:0072258,1,0.994100756918309,0,1,metanephric interstitial fibroblast differentiation,BP,
16823,GO:0072259,1,0.994100756918309,0,1,metanephric interstitial fibroblast development,BP,
16824,GO:0072262,1,0.98064695939874,0,3,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
16825,GO:0072265,1,0.993993691310324,0,1,metanephric capsule morphogenesis,BP,
16826,GO:0072266,1,0.993993691310324,0,1,metanephric capsule formation,BP,
16827,GO:0072267,1,0.993993691310324,0,1,metanephric capsule specification,BP,
16828,GO:0072268,1,0.976290939988246,0,4,pattern specification involved in metanephros development,BP,
16829,GO:0072272,1,0.988020652445202,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
16831,GO:0072274,1,0.992968338556447,0,1,metanephric glomerular basement membrane development,BP,
16832,GO:0072275,1,0.985797922436337,0,2,metanephric glomerulus morphogenesis,BP,
16833,GO:0072276,1,0.985797922436337,0,2,metanephric glomerulus vasculature morphogenesis,BP,
16834,GO:0072277,1,0.985797922436337,0,2,metanephric glomerular capillary formation,BP,
16835,GO:0072278,1,0.98078565582061,0,3,metanephric comma-shaped body morphogenesis,BP,
16836,GO:0072282,1,0.94767970463569,0,8,metanephric nephron tubule morphogenesis,BP,
16838,GO:0072284,1,0.96804540839944,0,5,metanephric S-shaped body morphogenesis,BP,
16839,GO:0072285,1,0.993569667341445,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
16840,GO:0072286,1,0.99391447584731,0,1,metanephric connecting tubule development,BP,
16841,GO:0072287,1,0.990543534756162,0,1,metanephric distal tubule morphogenesis,BP,
16842,GO:0072289,1,0.974527317033659,0,4,metanephric nephron tubule formation,BP,
16843,GO:0072298,1,0.974471103237826,0,4,regulation of metanephric glomerulus development,BP,
16844,GO:0072299,1,0.993780598577905,0,1,negative regulation of metanephric glomerulus development,BP,
16845,GO:0072300,1,0.980570884465282,0,3,positive regulation of metanephric glomerulus development,BP,
16846,GO:0072301,1,0.987562672026938,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
16847,GO:0072302,1,0.993780598577905,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
16848,GO:0072303,1,0.99374355674937,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
16849,GO:0072304,1,0.987038592633319,0,2,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16850,GO:0072305,1,0.987038592633319,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16851,GO:0072307,1,0.951457666087453,0,7,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16852,GO:0072308,1,0.99361819331252,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16853,GO:0072309,1,0.987038592633319,0,2,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
16854,GO:0072310,1,0.934396181643146,0,10,glomerular epithelial cell development,BP,
16855,GO:0072311,1,0.900320644106102,0,16,glomerular epithelial cell differentiation,BP,
16856,GO:0072312,1,0.992968338556447,0,1,metanephric glomerular epithelial cell differentiation,BP,
16857,GO:0072313,1,0.992968338556447,0,1,metanephric glomerular epithelial cell development,BP,
16858,GO:0072318,1,0.961416893947703,0,6,clathrin coat disassembly,BP,
16859,GO:0072319,1,0.95566248381643,0,7,vesicle uncoating,BP,
16860,GO:0072320,1,0.974736617726046,0,4,volume-sensitive chloride channel activity,MF,
16861,GO:0072321,1,0.942343210128541,0,10,chaperone-mediated protein transport,BP,
16862,GO:0072329,1,0.463809191768342,0,123,monocarboxylic acid catabolic process,BP,
16866,GO:0072334,1,0.98848516560721,0,2,UDP-galactose transmembrane transport,BP,
16868,GO:0072338,1,0.960977458207974,0,6,cellular lactam metabolic process,BP,
16869,GO:0072340,1,0.994156779103132,0,1,cellular lactam catabolic process,BP,
16871,GO:0072343,1,0.988420705612791,0,2,pancreatic stellate cell proliferation,BP,
16872,GO:0072344,1,0.975814886102358,0,4,rescue of stalled ribosome,BP,
16873,GO:0072345,1,0.962438975991533,0,6,NAADP-sensitive calcium-release channel activity,MF,
16875,GO:0072348,1,0.826080146361225,0,30,sulfur compound transport,BP,
16876,GO:0072349,1,0.918441189813804,0,13,modified amino acid transmembrane transporter activity,MF,
16877,GO:0072350,1,0.800820290585245,0,36,tricarboxylic acid metabolic process,BP,
16878,GO:0072354,1,0.994153024963152,0,1,histone kinase activity (H3-T3 specific),MF,
16879,GO:0072355,1,0.994153024963152,0,1,histone H3-T3 phosphorylation,BP,
16880,GO:0072356,1,0.99348795489116,0,1,chromosome passenger complex localization to kinetochore,BP,
16881,GO:0072357,1,0.95539536576284,0,7,PTW/PP1 phosphatase complex,CC,
16884,GO:0072361,1,0.984175421639398,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
16885,GO:0072362,1,0.992354779300768,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
16886,GO:0072363,1,0.991758269572945,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
16887,GO:0072364,1,0.983973423368186,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
16888,GO:0072365,1,0.992151119379947,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
16889,GO:0072366,1,0.991758269572945,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
16890,GO:0072367,1,0.971615503309183,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
16891,GO:0072368,1,0.985809603994776,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
16892,GO:0072369,1,0.985603663109901,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
16893,GO:0072376,1,0.66056119678393,0,67,protein activation cascade,BP,
16894,GO:0072378,1,0.878483848441625,0,21,blood coagulation, fibrin clot formation,BP,
16895,GO:0072379,1,0.981979190932213,0,3,ER membrane insertion complex,CC,
16896,GO:0072382,1,0.990474673266173,0,1,minus-end-directed vesicle transport along microtubule,BP,
16897,GO:0072383,1,0.952248987118401,0,7,plus-end-directed vesicle transport along microtubule,BP,
16898,GO:0072384,1,0.633268180223565,0,69,organelle transport along microtubule,BP,
16899,GO:0072385,1,0.971165111684416,0,4,minus-end-directed organelle transport along microtubule,BP,
16900,GO:0072386,1,0.94556806043516,0,8,plus-end-directed organelle transport along microtubule,BP,
16901,GO:0072387,1,0.987647968420625,0,2,flavin adenine dinucleotide metabolic process,BP,
16902,GO:0072388,1,0.994077225514179,0,1,flavin adenine dinucleotide biosynthetic process,BP,
16903,GO:0072389,1,0.993532827811427,0,1,flavin adenine dinucleotide catabolic process,BP,
16904,GO:0072393,1,0.925661210050936,0,11,microtubule anchoring at microtubule organizing center,BP,
16905,GO:0072395,1,0.62327528641332,0,74,signal transduction involved in cell cycle checkpoint,BP,
16906,GO:0072396,1,0.966661495073256,0,5,response to cell cycle checkpoint signaling,BP,
16907,GO:0072401,1,0.628239949353702,0,73,signal transduction involved in DNA integrity checkpoint,BP,
16908,GO:0072402,1,0.966661495073256,0,5,response to DNA integrity checkpoint signaling,BP,
16909,GO:0072413,1,0.674229246495518,0,62,signal transduction involved in mitotic cell cycle checkpoint,BP,
16910,GO:0072414,1,0.992609300303989,0,1,response to mitotic cell cycle checkpoint signaling,BP,
16911,GO:0072422,1,0.628239949353702,0,73,signal transduction involved in DNA damage checkpoint,BP,
16912,GO:0072423,1,0.966661495073256,0,5,response to DNA damage checkpoint signaling,BP,
16913,GO:0072425,1,0.929687606806292,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
16914,GO:0072428,1,0.994107398311986,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
16915,GO:0072429,1,0.981878489268798,0,3,response to intra-S DNA damage checkpoint signaling,BP,
16916,GO:0072431,1,0.678462148241863,0,61,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,
16917,GO:0072432,1,0.992609300303989,0,1,response to G1 DNA damage checkpoint signaling,BP,
16918,GO:0072434,1,0.985277590439152,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
16919,GO:0072487,1,0.975016943655064,0,4,MSL complex,CC,
16920,GO:0072488,1,0.929003938212275,0,12,ammonium transmembrane transport,BP,
16921,GO:0072492,1,0.994140607403246,0,1,host cell mitochondrial intermembrane space,CC,
16922,GO:0072497,1,0.947503618836596,0,8,mesenchymal stem cell differentiation,BP,
16923,GO:0072498,1,0.917490481690512,0,14,embryonic skeletal joint development,BP,
16924,GO:0072501,1,0.960019390238771,0,6,cellular divalent inorganic anion homeostasis,BP,
16925,GO:0072502,1,0.960019390238771,0,6,cellular trivalent inorganic anion homeostasis,BP,
16927,GO:0072505,1,0.941456050432305,0,9,divalent inorganic anion homeostasis,BP,
16928,GO:0072506,1,0.941456050432305,0,9,trivalent inorganic anion homeostasis,BP,
16934,GO:0072513,1,0.975622566448689,0,4,positive regulation of secondary heart field cardioblast proliferation,BP,
16935,GO:0072517,1,0.993655726867109,0,1,host cell viral assembly compartment,CC,
16936,GO:0072518,1,0.99279642279045,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
16937,GO:0072520,1,0.930315726891566,0,11,seminiferous tubule development,BP,
16941,GO:0072524,1,0.355456007142336,0,162,pyridine-containing compound metabolic process,BP,
16942,GO:0072525,1,0.455916339958402,0,122,pyridine-containing compound biosynthetic process,BP,
16943,GO:0072526,1,0.965078850793861,0,6,pyridine-containing compound catabolic process,BP,
16946,GO:0072529,1,0.810704691247213,0,34,pyrimidine-containing compound catabolic process,BP,
16947,GO:0072530,1,0.95259542792629,0,8,purine-containing compound transmembrane transport,BP,
16948,GO:0072531,1,0.945917596166243,0,9,pyrimidine-containing compound transmembrane transport,BP,
16949,GO:0072534,1,0.98549027206463,0,2,perineuronal net,CC,
16950,GO:0072535,1,0.987738104566535,0,2,tumor necrosis factor (ligand) superfamily member 11 production,BP,
16951,GO:0072536,1,0.994073183752291,0,1,interleukin-23 receptor complex,CC,
16952,GO:0072537,1,0.94441433585908,0,9,fibroblast activation,BP,
16953,GO:0072538,1,0.897943827553306,0,17,T-helper 17 type immune response,BP,
16954,GO:0072539,1,0.903639413154572,0,16,T-helper 17 cell differentiation,BP,
16955,GO:0072540,1,0.940662571507102,0,10,T-helper 17 cell lineage commitment,BP,
16956,GO:0072542,1,0.95742246303656,0,7,protein phosphatase activator activity,MF,
16957,GO:0072544,1,0.994156201543309,0,1,L-DOPA binding,MF,
16958,GO:0072545,1,0.988214172288063,0,2,tyrosine binding,MF,
16959,GO:0072546,1,0.939884919882647,0,10,ER membrane protein complex,CC,
16960,GO:0072553,1,0.961498793644339,0,6,terminal button organization,BP,
16961,GO:0072554,1,0.987674109605389,0,2,blood vessel lumenization,BP,
16962,GO:0072556,1,0.993441878684404,0,1,other organism presynaptic membrane,CC,
16963,GO:0072557,1,0.976772672832349,0,4,IPAF inflammasome complex,CC,
16964,GO:0072558,1,0.976297935307767,0,4,NLRP1 inflammasome complex,CC,
16965,GO:0072559,1,0.952381769926306,0,8,NLRP3 inflammasome complex,CC,
16966,GO:0072560,1,0.98810554370951,0,2,type B pancreatic cell maturation,BP,
16968,GO:0072563,1,0.987961644074819,0,2,endothelial microparticle,CC,
16969,GO:0072564,1,0.988248605346077,0,2,blood microparticle formation,BP,
16970,GO:0072566,1,0.987904591665112,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
16972,GO:0072570,1,0.993712550439358,0,1,ADP-D-ribose binding,MF,
16973,GO:0072572,1,0.994028880964481,0,1,poly-ADP-D-ribose binding,MF,
16974,GO:0072573,1,0.99337221620826,0,1,tolerance induction to lipopolysaccharide,BP,
16975,GO:0072574,1,0.915519763598134,0,14,hepatocyte proliferation,BP,
16976,GO:0072575,1,0.915519763598134,0,14,epithelial cell proliferation involved in liver morphogenesis,BP,
16977,GO:0072576,1,0.908821851692465,0,15,liver morphogenesis,BP,
16978,GO:0072577,1,0.737014509498886,0,47,endothelial cell apoptotic process,BP,
16979,GO:0072578,1,0.933553250534508,0,10,neurotransmitter-gated ion channel clustering,BP,
16980,GO:0072579,1,0.993419246286832,0,1,glycine receptor clustering,BP,
16981,GO:0072583,1,0.77500306997219,0,38,clathrin-dependent endocytosis,BP,
16982,GO:0072584,1,0.944032260502862,0,9,caveolin-mediated endocytosis,BP,
16983,GO:0072586,1,0.993350401730761,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
16984,GO:0072587,1,0.993350401730761,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
16985,GO:0072588,1,0.971705618001626,0,5,box H/ACA RNP complex,CC,
16986,GO:0072589,1,0.977323381437968,0,4,box H/ACA scaRNP complex,CC,
16987,GO:0072590,1,0.984623286238704,0,2,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
16988,GO:0072591,1,0.992968916151883,0,1,citrate-L-glutamate ligase activity,MF,
16989,GO:0072592,1,0.970412784952841,0,5,oxygen metabolic process,BP,
16990,GO:0072593,1,0.254564007769622,0,216,reactive oxygen species metabolic process,BP,
16992,GO:0072595,1,0.774419702594617,0,40,maintenance of protein localization in organelle,BP,
16994,GO:0072602,1,0.962197530161205,0,6,interleukin-4 secretion,BP,
16995,GO:0072603,1,0.963595875654334,0,6,interleukin-5 secretion,BP,
16997,GO:0072606,1,0.851239530337599,0,26,interleukin-8 secretion,BP,
16998,GO:0072608,1,0.953109040796067,0,8,interleukin-10 secretion,BP,
16999,GO:0072610,1,0.946286801981918,0,9,interleukin-12 secretion,BP,
17000,GO:0072611,1,0.958117547467484,0,7,interleukin-13 secretion,BP,
17001,GO:0072615,1,0.988136092263063,0,2,interleukin-17 secretion,BP,
17002,GO:0072616,1,0.993495532618457,0,1,interleukin-18 secretion,BP,
17003,GO:0072619,1,0.993620333931535,0,1,interleukin-21 secretion,BP,
17004,GO:0072641,1,0.953497437839905,0,7,type I interferon secretion,BP,
17005,GO:0072642,1,0.959428672859158,0,6,interferon-alpha secretion,BP,
17006,GO:0072643,1,0.910382809708094,0,15,interferon-gamma secretion,BP,
17008,GO:0072656,1,0.96866912221634,0,5,maintenance of protein location in mitochondrion,BP,
17010,GO:0072658,1,0.991776434087182,0,1,maintenance of protein location in membrane,BP,
17012,GO:0072660,1,0.991776434087182,0,1,maintenance of protein location in plasma membrane,BP,
17015,GO:0072665,1,0.702350672194764,0,54,protein localization to vacuole,BP,
17016,GO:0072666,1,0.75795333979192,0,42,establishment of protein localization to vacuole,BP,
17017,GO:0072669,1,0.959642494875288,0,7,tRNA-splicing ligase complex,CC,
17018,GO:0072671,1,0.993910591783376,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
17019,GO:0072672,1,0.956120165589332,0,7,neutrophil extravasation,BP,
17021,GO:0072674,1,0.970938806326327,0,4,multinuclear osteoclast differentiation,BP,
17022,GO:0072675,1,0.970938806326327,0,4,osteoclast fusion,BP,
17024,GO:0072677,1,0.92014833973355,0,14,eosinophil migration,BP,
17025,GO:0072678,1,0.763611782178966,0,44,T cell migration,BP,
17026,GO:0072679,1,0.970507652234538,0,5,thymocyte migration,BP,
17027,GO:0072680,1,0.993738697082491,0,1,extracellular matrix-dependent thymocyte migration,BP,
17028,GO:0072681,1,0.993738697082491,0,1,fibronectin-dependent thymocyte migration,BP,
17029,GO:0072682,1,0.993663862494985,0,1,eosinophil extravasation,BP,
17030,GO:0072683,1,0.976764020613921,0,4,T cell extravasation,BP,
17031,GO:0072684,1,0.993547680455242,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
17032,GO:0072686,1,0.570447641777691,0,85,mitotic spindle,CC,
17034,GO:0072695,1,0.987883444229472,0,2,regulation of DNA recombination at telomere,BP,
17035,GO:0072697,1,0.930799330320305,0,11,protein localization to cell cortex,BP,
17036,GO:0072698,1,0.747834780294032,0,43,protein localization to microtubule cytoskeleton,BP,
17037,GO:0072702,1,0.993026808852261,0,1,response to methyl methanesulfonate,BP,
17038,GO:0072703,1,0.993026808852261,0,1,cellular response to methyl methanesulfonate,BP,
17039,GO:0072706,1,0.993905126178139,0,1,response to sodium dodecyl sulfate,BP,
17040,GO:0072707,1,0.993905126178139,0,1,cellular response to sodium dodecyl sulfate,BP,
17041,GO:0072708,1,0.969861127755513,0,5,response to sorbitol,BP,
17042,GO:0072709,1,0.981884522429081,0,3,cellular response to sorbitol,BP,
17043,GO:0072710,1,0.947741229940545,0,8,response to hydroxyurea,BP,
17044,GO:0072711,1,0.953612519466437,0,7,cellular response to hydroxyurea,BP,
17045,GO:0072714,1,0.994144361552652,0,1,response to selenite ion,BP,
17046,GO:0072715,1,0.994144361552652,0,1,cellular response to selenite ion,BP,
17047,GO:0072716,1,0.974984992731261,0,4,response to actinomycin D,BP,
17048,GO:0072717,1,0.981023306925236,0,3,cellular response to actinomycin D,BP,
17049,GO:0072718,1,0.943690733242025,0,9,response to cisplatin,BP,
17050,GO:0072719,1,0.962582990629605,0,6,cellular response to cisplatin,BP,
17051,GO:0072720,1,0.987729649828399,0,2,response to dithiothreitol,BP,
17052,GO:0072721,1,0.993846081630578,0,1,cellular response to dithiothreitol,BP,
17053,GO:0072733,1,0.982100287775091,0,3,response to staurosporine,BP,
17054,GO:0072734,1,0.982100287775091,0,3,cellular response to staurosporine,BP,
17055,GO:0072737,1,0.987961151352563,0,2,response to diamide,BP,
17056,GO:0072738,1,0.987961151352563,0,2,cellular response to diamide,BP,
17057,GO:0072739,1,0.987981912689956,0,2,response to anisomycin,BP,
17058,GO:0072740,1,0.994099890666424,0,1,cellular response to anisomycin,BP,
17059,GO:0072741,1,0.980146848871237,0,3,protein localization to cell division site,BP,
17060,GO:0072749,1,0.994124435735787,0,1,cellular response to cytochalasin B,BP,
17061,GO:0072750,1,0.99427575580093,0,1,cellular response to leptomycin B,BP,
17062,GO:0072752,1,0.992746117854566,0,1,cellular response to rapamycin,BP,
17063,GO:0072755,1,0.993563957095796,0,1,cellular response to benomyl,BP,
17064,GO:0072757,1,0.975003770287337,0,4,cellular response to camptothecin,BP,
17065,GO:0075044,1,0.967427352320601,0,5,autophagy of host cells involved in interaction with symbiont,BP,
17066,GO:0075071,1,0.967427352320601,0,5,autophagy involved in symbiotic interaction,BP,
17067,GO:0075109,1,0.993147831445154,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
17068,GO:0075111,1,0.993147831445154,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
17069,GO:0075112,1,0.993147831445154,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
17070,GO:0075114,1,0.993147831445154,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
17071,GO:0075136,1,0.968531949944629,0,5,response to host,BP,
17072,GO:0075341,1,0.993984032876687,0,1,host cell PML body,CC,
17073,GO:0075509,1,0.980986286182899,0,3,endocytosis involved in viral entry into host cell,BP,
17074,GO:0075519,1,0.994446138588212,0,1,microtubule-dependent intracellular transport of viral material,BP,
17075,GO:0075521,1,0.994446138588212,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
17076,GO:0075522,1,0.938100857762722,0,10,IRES-dependent viral translational initiation,BP,
17077,GO:0075525,1,0.96973439717218,0,5,viral translational termination-reinitiation,BP,
17078,GO:0075528,1,0.987199734375094,0,2,modulation by virus of host immune response,BP,
17079,GO:0075606,1,0.994446138588212,0,1,transport of viral material towards nucleus,BP,
17080,GO:0075713,1,0.952403804096109,0,8,establishment of integrated proviral latency,BP,
17081,GO:0075732,1,0.986408588820609,0,2,viral penetration into host nucleus,BP,
17082,GO:0075733,1,0.7113518425445,0,53,intracellular transport of virus,BP,
17083,GO:0080008,1,0.804853418018044,0,34,Cul4-RING E3 ubiquitin ligase complex,CC,
17084,GO:0080009,1,0.941063895141625,0,10,mRNA methylation,BP,
17085,GO:0080019,1,0.98720890042454,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17086,GO:0080023,1,0.987729649828399,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
17087,GO:0080025,1,0.865915076023246,0,22,phosphatidylinositol-3,5-bisphosphate binding,MF,
17088,GO:0080033,1,0.992826483555519,0,1,response to nitrite,BP,
17089,GO:0080048,1,0.993846081630578,0,1,GDP-D-glucose phosphorylase activity,MF,
17090,GO:0080058,1,0.994254097431965,0,1,protein deglutathionylation,BP,
17091,GO:0080084,1,0.965984796021468,0,5,5S rDNA binding,MF,
17093,GO:0080101,1,0.994360079731816,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
17094,GO:0080111,1,0.865580128512614,0,22,DNA demethylation,BP,
17095,GO:0080120,1,0.987993990029663,0,2,CAAX-box protein maturation,BP,
17096,GO:0080121,1,0.987773016977291,0,2,AMP transport,BP,
17097,GO:0080122,1,0.981758589806163,0,3,AMP transmembrane transporter activity,MF,
17098,GO:0080129,1,0.994331490283208,0,1,proteasome core complex assembly,BP,
17102,GO:0080144,1,0.987553023031716,0,2,amino acid homeostasis,BP,
17103,GO:0080146,1,0.994143062039743,0,1,L-cysteine desulfhydrase activity,MF,
17104,GO:0080147,1,0.994422168860593,0,1,root hair cell development,BP,
17105,GO:0080154,1,0.906212186262235,0,16,regulation of fertilization,BP,
17106,GO:0080163,1,0.993955790895329,0,1,regulation of protein serine/threonine phosphatase activity,BP,
17107,GO:0080171,1,0.689100818179942,0,58,lytic vacuole organization,BP,
17108,GO:0080182,1,0.899705533199699,0,16,histone H3-K4 trimethylation,BP,
17109,GO:0080184,1,0.970474622522558,0,5,response to phenylpropanoid,BP,
17110,GO:0085018,1,0.993852396074305,0,1,maintenance of symbiont-containing vacuole by host,BP,
17111,GO:0085020,1,0.957662855525341,0,7,protein K6-linked ubiquitination,BP,
17113,GO:0085032,1,0.993701838770676,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
17119,GO:0086006,1,0.966489019327559,0,5,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
17120,GO:0086007,1,0.963123649515367,0,5,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
17121,GO:0086008,1,0.928222452144613,0,12,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
17122,GO:0086009,1,0.76938634071984,0,40,membrane repolarization,BP,
17123,GO:0086010,1,0.723934408767058,0,45,membrane depolarization during action potential,BP,
17124,GO:0086011,1,0.859273456932545,0,24,membrane repolarization during action potential,BP,
17125,GO:0086012,1,0.868192546150432,0,20,membrane depolarization during cardiac muscle cell action potential,BP,
17126,GO:0086013,1,0.875586358432079,0,21,membrane repolarization during cardiac muscle cell action potential,BP,
17130,GO:0086017,1,0.980081508414905,0,3,Purkinje myocyte action potential,BP,
17133,GO:0086020,1,0.992446319044454,0,1,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
17134,GO:0086021,1,0.992446319044454,0,1,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
17135,GO:0086023,1,0.956782575897573,0,6,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17136,GO:0086024,1,0.992304065815459,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
17139,GO:0086028,1,0.961030184871038,0,6,bundle of His cell to Purkinje myocyte signaling,BP,
17141,GO:0086030,1,0.994056585386465,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,
17143,GO:0086037,1,0.993619620392167,0,1,sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17144,GO:0086038,1,0.993846081630578,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17145,GO:0086039,1,0.992270732458831,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17146,GO:0086040,1,0.993330298851794,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17147,GO:0086041,1,0.992564733356991,0,1,voltage-gated potassium channel activity involved in SA node cell action potential depolarization,MF,
17148,GO:0086042,1,0.953896513745348,0,7,cardiac muscle cell-cardiac muscle cell adhesion,BP,
17149,GO:0086043,1,0.961030184871038,0,6,bundle of His cell action potential,BP,
17150,GO:0086045,1,0.962853337962913,0,5,membrane depolarization during AV node cell action potential,BP,
17151,GO:0086046,1,0.962516277324582,0,5,membrane depolarization during SA node cell action potential,BP,
17152,GO:0086047,1,0.980081508414905,0,3,membrane depolarization during Purkinje myocyte cell action potential,BP,
17153,GO:0086048,1,0.979351596752048,0,3,membrane depolarization during bundle of His cell action potential,BP,
17154,GO:0086050,1,0.993821701351506,0,1,membrane repolarization during bundle of His cell action potential,BP,
17155,GO:0086052,1,0.993821701351506,0,1,membrane repolarization during SA node cell action potential,BP,
17156,GO:0086053,1,0.992446319044454,0,1,AV node cell to bundle of His cell communication by electrical coupling,BP,
17157,GO:0086056,1,0.976802315620108,0,3,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
17158,GO:0086057,1,0.99353711264266,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
17159,GO:0086059,1,0.984935029872536,0,2,voltage-gated calcium channel activity involved SA node cell action potential,MF,
17160,GO:0086060,1,0.992197668603963,0,1,voltage-gated sodium channel activity involved in AV node cell action potential,MF,
17161,GO:0086061,1,0.992197668603963,0,1,voltage-gated sodium channel activity involved in bundle of His cell action potential,MF,
17162,GO:0086062,1,0.986519353581361,0,2,voltage-gated sodium channel activity involved in Purkinje myocyte action potential,MF,
17163,GO:0086063,1,0.992197668603963,0,1,voltage-gated sodium channel activity involved in SA node cell action potential,MF,
17169,GO:0086069,1,0.916524684767026,0,13,bundle of His cell to Purkinje myocyte communication,BP,
17171,GO:0086072,1,0.993933183671745,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
17172,GO:0086073,1,0.959721402714342,0,6,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
17173,GO:0086075,1,0.98623864252122,0,2,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
17174,GO:0086077,1,0.992446319044454,0,1,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
17175,GO:0086080,1,0.933257910512675,0,10,protein binding involved in heterotypic cell-cell adhesion,MF,
17176,GO:0086082,1,0.993933183671745,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
17177,GO:0086083,1,0.965791085099174,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
17178,GO:0086087,1,0.993821701351506,0,1,voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization,MF,
17179,GO:0086089,1,0.975416327488051,0,4,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
17180,GO:0086090,1,0.993821701351506,0,1,voltage-gated potassium channel activity involved in SA node cell action potential repolarization,MF,
17181,GO:0086091,1,0.788778311536901,0,35,regulation of heart rate by cardiac conduction,BP,
17182,GO:0086092,1,0.987521925889443,0,2,regulation of the force of heart contraction by cardiac conduction,BP,
17183,GO:0086096,1,0.994257273990689,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17184,GO:0086097,1,0.987355023197338,0,2,phospholipase C-activating angiotensin-activated signaling pathway,BP,
17185,GO:0086098,1,0.987395416312353,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
17186,GO:0086100,1,0.987002697720711,0,2,endothelin receptor signaling pathway,BP,
17187,GO:0086103,1,0.93389331766231,0,10,G-protein coupled receptor signaling pathway involved in heart process,BP,
17188,GO:0089700,1,0.974120973208772,0,4,protein kinase D signaling,BP,
17189,GO:0089701,1,0.970904205686784,0,5,U2AF,CC,
17190,GO:0089709,1,0.981853593697368,0,3,L-histidine transmembrane transport,BP,
17191,GO:0089717,1,0.933459535075171,0,10,spanning component of membrane,CC,
17192,GO:0089718,1,0.882616776841288,0,19,amino acid import across plasma membrane,BP,
17193,GO:0089720,1,0.948224006627432,0,9,caspase binding,MF,
17194,GO:0090009,1,0.943603275135972,0,9,primitive streak formation,BP,
17195,GO:0090010,1,0.99404504058974,0,1,transforming growth factor beta receptor signaling pathway involved in primitive streak formation,BP,
17197,GO:0090023,1,0.842846247332242,0,29,positive regulation of neutrophil chemotaxis,BP,
17198,GO:0090024,1,0.987101517329035,0,2,negative regulation of neutrophil chemotaxis,BP,
17200,GO:0090026,1,0.92446361668577,0,13,positive regulation of monocyte chemotaxis,BP,
17202,GO:0090030,1,0.944673085803015,0,9,regulation of steroid hormone biosynthetic process,BP,
17203,GO:0090031,1,0.981313866706955,0,3,positive regulation of steroid hormone biosynthetic process,BP,
17204,GO:0090032,1,0.969155487620109,0,5,negative regulation of steroid hormone biosynthetic process,BP,
17205,GO:0090034,1,0.987682346238717,0,2,regulation of chaperone-mediated protein complex assembly,BP,
17206,GO:0090035,1,0.987682346238717,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
17207,GO:0090036,1,0.906622868079233,0,15,regulation of protein kinase C signaling,BP,
17208,GO:0090037,1,0.950626733066218,0,8,positive regulation of protein kinase C signaling,BP,
17209,GO:0090038,1,0.987311328390414,0,2,negative regulation of protein kinase C signaling,BP,
17210,GO:0090042,1,0.942103883523898,0,9,tubulin deacetylation,BP,
17211,GO:0090043,1,0.953954172811557,0,7,regulation of tubulin deacetylation,BP,
17212,GO:0090044,1,0.994183924354294,0,1,positive regulation of tubulin deacetylation,BP,
17213,GO:0090045,1,0.94905825794182,0,8,positive regulation of deacetylase activity,BP,
17214,GO:0090049,1,0.802400257254795,0,34,regulation of cell migration involved in sprouting angiogenesis,BP,
17215,GO:0090050,1,0.890713104551739,0,18,positive regulation of cell migration involved in sprouting angiogenesis,BP,
17216,GO:0090051,1,0.906673998227471,0,15,negative regulation of cell migration involved in sprouting angiogenesis,BP,
17217,GO:0090063,1,0.974450133954879,0,4,positive regulation of microtubule nucleation,BP,
17218,GO:0090065,1,0.993494245950117,0,1,regulation of production of siRNA involved in RNA interference,BP,
17220,GO:0090067,1,0.99334092589851,0,1,regulation of thalamus size,BP,
17221,GO:0090068,1,0.205783690481324,0,244,positive regulation of cell cycle process,BP,
17222,GO:0090069,1,0.919757110757761,0,13,regulation of ribosome biogenesis,BP,
17223,GO:0090070,1,0.950959987988034,0,8,positive regulation of ribosome biogenesis,BP,
17224,GO:0090071,1,0.973889455114701,0,4,negative regulation of ribosome biogenesis,BP,
17225,GO:0090073,1,0.944596459319543,0,9,positive regulation of protein homodimerization activity,BP,
17226,GO:0090074,1,0.967283944708281,0,5,negative regulation of protein homodimerization activity,BP,
17227,GO:0090075,1,0.841747998418503,0,27,relaxation of muscle,BP,
17228,GO:0090076,1,0.986772081225073,0,2,relaxation of skeletal muscle,BP,
17229,GO:0090077,1,0.826690403120039,0,29,foam cell differentiation,BP,
17230,GO:0090079,1,0.856941771569275,0,24,translation regulator activity, nucleic acid binding,MF,
17231,GO:0090080,1,0.980746182021529,0,3,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
17232,GO:0090081,1,0.988471954944112,0,2,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
17233,GO:0090082,1,0.988471954944112,0,2,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
17236,GO:0090085,1,0.93260054549769,0,11,regulation of protein deubiquitination,BP,
17237,GO:0090086,1,0.982838718683118,0,3,negative regulation of protein deubiquitination,BP,
17239,GO:0090088,1,0.988080898559558,0,2,regulation of oligopeptide transport,BP,
17240,GO:0090089,1,0.988080898559558,0,2,regulation of dipeptide transport,BP,
17242,GO:0090091,1,0.966779111262752,0,5,positive regulation of extracellular matrix disassembly,BP,
17244,GO:0090094,1,0.988100864873272,0,2,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
17245,GO:0090095,1,0.993964866514398,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
17246,GO:0090096,1,0.993964866514398,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
17247,GO:0090100,1,0.5363104033439,0,96,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
17249,GO:0090102,1,0.756012472289909,0,43,cochlea development,BP,
17250,GO:0090103,1,0.868821621731689,0,22,cochlea morphogenesis,BP,
17251,GO:0090107,1,0.98006384383226,0,3,regulation of high-density lipoprotein particle assembly,BP,
17252,GO:0090108,1,0.994048792461045,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
17254,GO:0090110,1,0.917924498179866,0,13,cargo loading into COPII-coated vesicle,BP,
17255,GO:0090113,1,0.994020802673904,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
17256,GO:0090114,1,0.640723350475591,0,69,COPII-coated vesicle budding,BP,
17257,GO:0090116,1,0.980145114738575,0,3,C-5 methylation of cytosine,BP,
17258,GO:0090118,1,0.96687518652317,0,5,receptor-mediated endocytosis involved in cholesterol transport,BP,
17259,GO:0090119,1,0.98744700049023,0,2,vesicle-mediated cholesterol transport,BP,
17260,GO:0090122,1,0.994064667700889,0,1,cholesterol ester hydrolysis involved in cholesterol transport,BP,
17261,GO:0090128,1,0.934267856784432,0,10,regulation of synapse maturation,BP,
17262,GO:0090129,1,0.946952697399749,0,8,positive regulation of synapse maturation,BP,
17264,GO:0090131,1,0.970509595501598,0,5,mesenchyme migration,BP,
17266,GO:0090133,1,0.994345207415381,0,1,mesendoderm migration,BP,
17267,GO:0090134,1,0.994345207415381,0,1,cell migration involved in mesendoderm migration,BP,
17268,GO:0090135,1,0.981257052630157,0,3,actin filament branching,BP,
17269,GO:0090136,1,0.907126800046417,0,15,epithelial cell-cell adhesion,BP,
17270,GO:0090138,1,0.993590506836563,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
17271,GO:0090140,1,0.869425920048603,0,21,regulation of mitochondrial fission,BP,
17272,GO:0090141,1,0.913747784947068,0,14,positive regulation of mitochondrial fission,BP,
17273,GO:0090148,1,0.924135339320802,0,12,membrane fission,BP,
17274,GO:0090149,1,0.9873535949668,0,2,mitochondrial membrane fission,BP,
17275,GO:0090150,1,0.173816416951538,0,285,establishment of protein localization to membrane,BP,
17276,GO:0090151,1,0.932092114931394,0,12,establishment of protein localization to mitochondrial membrane,BP,
17277,GO:0090153,1,0.923207599430397,0,13,regulation of sphingolipid biosynthetic process,BP,
17278,GO:0090154,1,0.951693343622865,0,8,positive regulation of sphingolipid biosynthetic process,BP,
17279,GO:0090155,1,0.975731416757807,0,4,negative regulation of sphingolipid biosynthetic process,BP,
17280,GO:0090156,1,0.982435843097562,0,3,cellular sphingolipid homeostasis,BP,
17281,GO:0090158,1,0.96355975779498,0,6,endoplasmic reticulum membrane organization,BP,
17282,GO:0090160,1,0.949720575648591,0,8,Golgi to lysosome transport,BP,
17283,GO:0090161,1,0.929196327339583,0,11,Golgi ribbon formation,BP,
17284,GO:0090162,1,0.831026171025015,0,28,establishment of epithelial cell polarity,BP,
17285,GO:0090164,1,0.98637900466459,0,2,asymmetric Golgi ribbon formation,BP,
17286,GO:0090166,1,0.963174937819225,0,6,Golgi disassembly,BP,
17287,GO:0090168,1,0.974613007646443,0,4,Golgi reassembly,BP,
17288,GO:0090169,1,0.846467711440069,0,25,regulation of spindle assembly,BP,
17289,GO:0090170,1,0.975947474318702,0,4,regulation of Golgi inheritance,BP,
17290,GO:0090171,1,0.993544253270467,0,1,chondrocyte morphogenesis,BP,
17291,GO:0090174,1,0.372080633684835,0,154,organelle membrane fusion,BP,
17292,GO:0090175,1,0.504531028982466,0,108,regulation of establishment of planar polarity,BP,
17293,GO:0090176,1,0.993030417270611,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
17294,GO:0090177,1,0.905522840796402,0,15,establishment of planar polarity involved in neural tube closure,BP,
17295,GO:0090178,1,0.910723105234294,0,14,regulation of establishment of planar polarity involved in neural tube closure,BP,
17296,GO:0090179,1,0.916852335637245,0,13,planar cell polarity pathway involved in neural tube closure,BP,
17298,GO:0090182,1,0.988279322516815,0,2,regulation of secretion of lysosomal enzymes,BP,
17302,GO:0090186,1,0.954870171161544,0,7,regulation of pancreatic juice secretion,BP,
17303,GO:0090187,1,0.988579899228169,0,2,positive regulation of pancreatic juice secretion,BP,
17304,GO:0090188,1,0.965904784519192,0,5,negative regulation of pancreatic juice secretion,BP,
17308,GO:0090192,1,0.933461451524897,0,11,regulation of glomerulus development,BP,
17309,GO:0090193,1,0.951052584135203,0,8,positive regulation of glomerulus development,BP,
17310,GO:0090194,1,0.981512895418046,0,3,negative regulation of glomerulus development,BP,
17314,GO:0090198,1,0.99381625524968,0,1,negative regulation of chemokine secretion,BP,
17315,GO:0090199,1,0.773265004318814,0,42,regulation of release of cytochrome c from mitochondria,BP,
17316,GO:0090200,1,0.844066967167485,0,28,positive regulation of release of cytochrome c from mitochondria,BP,
17317,GO:0090201,1,0.910766125614886,0,15,negative regulation of release of cytochrome c from mitochondria,BP,
17318,GO:0090202,1,0.974112383316534,0,4,gene looping,BP,
17319,GO:0090204,1,0.981297535166256,0,3,protein localization to nuclear pore,BP,
17321,GO:0090206,1,0.970279252863665,0,5,negative regulation of cholesterol metabolic process,BP,
17322,GO:0090207,1,0.855971444552506,0,25,regulation of triglyceride metabolic process,BP,
17323,GO:0090208,1,0.906776687275993,0,16,positive regulation of triglyceride metabolic process,BP,
17324,GO:0090209,1,0.962780323199048,0,6,negative regulation of triglyceride metabolic process,BP,
17325,GO:0090210,1,0.987383372101082,0,2,regulation of establishment of blood-brain barrier,BP,
17326,GO:0090212,1,0.987383372101082,0,2,negative regulation of establishment of blood-brain barrier,BP,
17327,GO:0090214,1,0.986743300878636,0,2,spongiotrophoblast layer developmental growth,BP,
17328,GO:0090218,1,0.813034372076163,0,32,positive regulation of lipid kinase activity,BP,
17329,GO:0090219,1,0.981162486193581,0,3,negative regulation of lipid kinase activity,BP,
17330,GO:0090220,1,0.936950771303253,0,10,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
17331,GO:0090222,1,0.985118875639262,0,2,centrosome-templated microtubule nucleation,BP,
17332,GO:0090224,1,0.771441161910288,0,39,regulation of spindle organization,BP,
17333,GO:0090226,1,0.994407729393441,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
17334,GO:0090230,1,0.973900788022288,0,4,regulation of centromere complex assembly,BP,
17335,GO:0090231,1,0.909271395323491,0,15,regulation of spindle checkpoint,BP,
17336,GO:0090232,1,0.949716145361271,0,8,positive regulation of spindle checkpoint,BP,
17337,GO:0090233,1,0.993873647682063,0,1,negative regulation of spindle checkpoint,BP,
17338,GO:0090234,1,0.980502081833116,0,3,regulation of kinetochore assembly,BP,
17339,GO:0090235,1,0.951356784138199,0,7,regulation of metaphase plate congression,BP,
17340,GO:0090237,1,0.968478371334378,0,5,regulation of arachidonic acid secretion,BP,
17341,GO:0090238,1,0.975111826700892,0,4,positive regulation of arachidonic acid secretion,BP,
17342,GO:0090239,1,0.927891778777412,0,12,regulation of histone H4 acetylation,BP,
17343,GO:0090240,1,0.956996127125199,0,7,positive regulation of histone H4 acetylation,BP,
17344,GO:0090241,1,0.970095873180136,0,5,negative regulation of histone H4 acetylation,BP,
17345,GO:0090244,1,0.973555970546349,0,4,Wnt signaling pathway involved in somitogenesis,BP,
17346,GO:0090245,1,0.971919442880846,0,4,axis elongation involved in somitogenesis,BP,
17347,GO:0090246,1,0.993362745636125,0,1,convergent extension involved in somitogenesis,BP,
17348,GO:0090247,1,0.993898942647536,0,1,cell motility involved in somitogenic axis elongation,BP,
17349,GO:0090249,1,0.993898942647536,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17350,GO:0090251,1,0.991348475501748,0,1,protein localization involved in establishment of planar polarity,BP,
17352,GO:0090258,1,0.979828013309195,0,3,negative regulation of mitochondrial fission,BP,
17353,GO:0090259,1,0.968408704355777,0,5,regulation of retinal ganglion cell axon guidance,BP,
17354,GO:0090260,1,0.986745086162419,0,2,negative regulation of retinal ganglion cell axon guidance,BP,
17355,GO:0090261,1,0.976549750733638,0,4,positive regulation of inclusion body assembly,BP,
17356,GO:0090263,1,0.44837107096368,0,126,positive regulation of canonical Wnt signaling pathway,BP,
17357,GO:0090264,1,0.988143303712721,0,2,regulation of immune complex clearance by monocytes and macrophages,BP,
17358,GO:0090265,1,0.99392512357135,0,1,positive regulation of immune complex clearance by monocytes and macrophages,BP,
17359,GO:0090266,1,0.915042697138284,0,14,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17360,GO:0090267,1,0.955741472078478,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17361,GO:0090269,1,0.960810880510906,0,6,fibroblast growth factor production,BP,
17362,GO:0090270,1,0.960810880510906,0,6,regulation of fibroblast growth factor production,BP,
17363,GO:0090271,1,0.979344412400231,0,3,positive regulation of fibroblast growth factor production,BP,
17364,GO:0090272,1,0.981079563862458,0,3,negative regulation of fibroblast growth factor production,BP,
17365,GO:0090273,1,0.988265665097244,0,2,regulation of somatostatin secretion,BP,
17366,GO:0090274,1,0.988265665097244,0,2,positive regulation of somatostatin secretion,BP,
17370,GO:0090279,1,0.838196655842695,0,28,regulation of calcium ion import,BP,
17371,GO:0090280,1,0.909610425042657,0,15,positive regulation of calcium ion import,BP,
17372,GO:0090281,1,0.971298557139961,0,5,negative regulation of calcium ion import,BP,
17373,GO:0090282,1,0.99377644886179,0,1,positive regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
17374,GO:0090283,1,0.980664570334396,0,3,regulation of protein glycosylation in Golgi,BP,
17375,GO:0090284,1,0.992560102415789,0,1,positive regulation of protein glycosylation in Golgi,BP,
17376,GO:0090285,1,0.988016210489593,0,2,negative regulation of protein glycosylation in Golgi,BP,
17377,GO:0090286,1,0.956119737958216,0,6,cytoskeletal anchoring at nuclear membrane,BP,
17381,GO:0090290,1,0.994346795718048,0,1,positive regulation of osteoclast proliferation,BP,
17383,GO:0090292,1,0.976333108185311,0,3,nuclear matrix anchoring at nuclear membrane,BP,
17384,GO:0090293,1,0.994026284253939,0,1,nitrogen catabolite regulation of transcription,BP,
17385,GO:0090294,1,0.994026284253939,0,1,nitrogen catabolite activation of transcription,BP,
17386,GO:0090296,1,0.975256483476456,0,4,regulation of mitochondrial DNA replication,BP,
17387,GO:0090297,1,0.994277777250779,0,1,positive regulation of mitochondrial DNA replication,BP,
17388,GO:0090298,1,0.980870345584334,0,3,negative regulation of mitochondrial DNA replication,BP,
17389,GO:0090299,1,0.994166597611257,0,1,regulation of neural crest formation,BP,
17390,GO:0090301,1,0.994166597611257,0,1,negative regulation of neural crest formation,BP,
17391,GO:0090303,1,0.766118023503804,0,42,positive regulation of wound healing,BP,
17394,GO:0090306,1,0.973202252765022,0,4,spindle assembly involved in meiosis,BP,
17395,GO:0090307,1,0.668479831242838,0,62,mitotic spindle assembly,BP,
17396,GO:0090308,1,0.953873112702459,0,7,regulation of methylation-dependent chromatin silencing,BP,
17397,GO:0090309,1,0.973879659940984,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
17398,GO:0090310,1,0.985770582773606,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
17399,GO:0090311,1,0.789248071500737,0,36,regulation of protein deacetylation,BP,
17400,GO:0090312,1,0.878333308208874,0,20,positive regulation of protein deacetylation,BP,
17401,GO:0090313,1,0.823518544880073,0,31,regulation of protein targeting to membrane,BP,
17402,GO:0090314,1,0.844296607470336,0,27,positive regulation of protein targeting to membrane,BP,
17403,GO:0090315,1,0.969688810116795,0,5,negative regulation of protein targeting to membrane,BP,
17405,GO:0090317,1,0.798989327762734,0,36,negative regulation of intracellular protein transport,BP,
17406,GO:0090322,1,0.848237115886886,0,27,regulation of superoxide metabolic process,BP,
17407,GO:0090323,1,0.994485414935947,0,1,prostaglandin secretion involved in immune response,BP,
17408,GO:0090324,1,0.969422302994404,0,5,negative regulation of oxidative phosphorylation,BP,
17409,GO:0090325,1,0.981144768499078,0,3,regulation of locomotion involved in locomotory behavior,BP,
17410,GO:0090326,1,0.99369726908984,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
17411,GO:0090327,1,0.993449037670222,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
17412,GO:0090329,1,0.748702155630725,0,45,regulation of DNA-dependent DNA replication,BP,
17414,GO:0090331,1,0.932283569317167,0,11,negative regulation of platelet aggregation,BP,
17415,GO:0090335,1,0.924474285090044,0,12,regulation of brown fat cell differentiation,BP,
17416,GO:0090336,1,0.961904121335523,0,6,positive regulation of brown fat cell differentiation,BP,
17417,GO:0090340,1,0.994048792461045,0,1,positive regulation of secretion of lysosomal enzymes,BP,
17418,GO:0090341,1,0.994196341831012,0,1,negative regulation of secretion of lysosomal enzymes,BP,
17419,GO:0090342,1,0.777601442801812,0,39,regulation of cell aging,BP,
17420,GO:0090343,1,0.941056763363869,0,10,positive regulation of cell aging,BP,
17421,GO:0090344,1,0.870890000731531,0,21,negative regulation of cell aging,BP,
17422,GO:0090345,1,0.988146612655271,0,2,cellular organohalogen metabolic process,BP,
17423,GO:0090346,1,0.988146612655271,0,2,cellular organofluorine metabolic process,BP,
17424,GO:0090347,1,0.99418912236975,0,1,regulation of cellular organohalogen metabolic process,BP,
17425,GO:0090348,1,0.99418912236975,0,1,regulation of cellular organofluorine metabolic process,BP,
17426,GO:0090349,1,0.99418912236975,0,1,negative regulation of cellular organohalogen metabolic process,BP,
17427,GO:0090350,1,0.99418912236975,0,1,negative regulation of cellular organofluorine metabolic process,BP,
17428,GO:0090360,1,0.981555587866481,0,3,platelet-derived growth factor production,BP,
17429,GO:0090361,1,0.981555587866481,0,3,regulation of platelet-derived growth factor production,BP,
17430,GO:0090362,1,0.987431327904083,0,2,positive regulation of platelet-derived growth factor production,BP,
17431,GO:0090365,1,0.994016763942744,0,1,regulation of mRNA modification,BP,
17432,GO:0090367,1,0.994016763942744,0,1,negative regulation of mRNA modification,BP,
17433,GO:0090370,1,0.98095702509261,0,3,negative regulation of cholesterol efflux,BP,
17434,GO:0090381,1,0.988471954944112,0,2,regulation of heart induction,BP,
17435,GO:0090382,1,0.77935333130935,0,40,phagosome maturation,BP,
17436,GO:0090383,1,0.853813611431099,0,26,phagosome acidification,BP,
17437,GO:0090385,1,0.957039668634456,0,7,phagosome-lysosome fusion,BP,
17438,GO:0090386,1,0.985883573084551,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
17439,GO:0090387,1,0.985883573084551,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
17440,GO:0090389,1,0.992442698851743,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
17441,GO:0090394,1,0.935667618697653,0,10,negative regulation of excitatory postsynaptic potential,BP,
17442,GO:0090398,1,0.690826623844194,0,58,cellular senescence,BP,
17443,GO:0090399,1,0.918193331406239,0,13,replicative senescence,BP,
17444,GO:0090400,1,0.950808924097984,0,8,stress-induced premature senescence,BP,
17445,GO:0090402,1,0.987942979508749,0,2,oncogene-induced cell senescence,BP,
17446,GO:0090403,1,0.974952992584644,0,4,oxidative stress-induced premature senescence,BP,
17448,GO:0090409,1,0.993985906741029,0,1,malonyl-CoA synthetase activity,MF,
17449,GO:0090410,1,0.993985906741029,0,1,malonate catabolic process,BP,
17450,GO:0090416,1,0.993906420572166,0,1,nicotinate transmembrane transporter activity,MF,
17451,GO:0090420,1,0.994241679979329,0,1,naphthalene-containing compound metabolic process,BP,
17452,GO:0090422,1,0.988090216031518,0,2,thiamine pyrophosphate transmembrane transporter activity,MF,
17453,GO:0090425,1,0.993761857850181,0,1,acinar cell differentiation,BP,
17454,GO:0090427,1,0.980912401522682,0,3,activation of meiosis,BP,
17455,GO:0090435,1,0.95720901826636,0,7,protein localization to nuclear envelope,BP,
17456,GO:0090461,1,0.993412940945061,0,1,glutamate homeostasis,BP,
17457,GO:0090472,1,0.993441305898967,0,1,dibasic protein processing,BP,
17458,GO:0090480,1,0.980379010019396,0,3,purine nucleotide-sugar transmembrane transport,BP,
17459,GO:0090481,1,0.9339318037953,0,11,pyrimidine nucleotide-sugar transmembrane transport,BP,
17460,GO:0090482,1,0.870736381368591,0,22,vitamin transmembrane transporter activity,MF,
17461,GO:0090493,1,0.935118036869218,0,11,catecholamine uptake,BP,
17462,GO:0090494,1,0.935118036869218,0,11,dopamine uptake,BP,
17463,GO:0090498,1,0.980732943953717,0,3,extrinsic component of Golgi membrane,CC,
17464,GO:0090500,1,0.969536685988954,0,5,endocardial cushion to mesenchymal transition,BP,
17465,GO:0090501,1,0.445619027037894,0,129,RNA phosphodiester bond hydrolysis,BP,
17466,GO:0090502,1,0.68132173042795,0,62,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
17467,GO:0090503,1,0.799127191592893,0,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
17468,GO:0090504,1,0.830093477379592,0,28,epiboly,BP,
17469,GO:0090505,1,0.837247943753454,0,27,epiboly involved in wound healing,BP,
17471,GO:0090521,1,0.974217867212886,0,4,glomerular visceral epithelial cell migration,BP,
17472,GO:0090527,1,0.928150043793287,0,11,actin filament reorganization,BP,
17473,GO:0090529,1,0.994112884832124,0,1,cell septum assembly,BP,
17475,GO:0090534,1,0.994153024963152,0,1,calcium ion-transporting ATPase complex,CC,
17476,GO:0090537,1,0.986538359411323,0,2,CERF complex,CC,
17477,GO:0090541,1,0.98727264351408,0,2,MIT domain binding,MF,
17478,GO:0090543,1,0.84559164363763,0,26,Flemming body,CC,
17479,GO:0090545,1,0.890435330880617,0,17,CHD-type complex,CC,
17480,GO:0090554,1,0.971347949973822,0,4,phosphatidylcholine-translocating ATPase activity,MF,
17481,GO:0090555,1,0.985813674892443,0,2,phosphatidylethanolamine-translocating ATPase activity,MF,
17482,GO:0090556,1,0.984362124985117,0,2,phosphatidylserine-translocating ATPase activity,MF,
17483,GO:0090557,1,0.946789683770365,0,8,establishment of endothelial intestinal barrier,BP,
17484,GO:0090558,1,0.994422168860593,0,1,plant epidermis development,BP,
17486,GO:0090560,1,0.994024120412427,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
17487,GO:0090568,1,0.823089369056777,0,29,nuclear transcriptional repressor complex,CC,
17488,GO:0090571,1,0.975776219297309,0,4,RNA polymerase II transcription repressor complex,CC,
17489,GO:0090575,1,0.389465806277716,0,147,RNA polymerase II transcription factor complex,CC,
17490,GO:0090576,1,0.948014032986505,0,8,RNA polymerase III transcription factor complex,CC,
17491,GO:0090579,1,0.974112383316534,0,4,dsDNA loop formation,BP,
17492,GO:0090594,1,0.957880846884325,0,7,inflammatory response to wounding,BP,
17493,GO:0090596,1,0.222808330035556,0,229,sensory organ morphogenesis,BP,
17494,GO:0090598,1,0.981410078327311,0,3,male anatomical structure morphogenesis,BP,
17495,GO:0090599,1,0.966253120048608,0,5,alpha-glucosidase activity,MF,
17496,GO:0090600,1,0.993522828433545,0,1,alpha-1,3-glucosidase activity,MF,
17497,GO:0090601,1,0.993164260904423,0,1,enucleation,BP,
17498,GO:0090611,1,0.969382933067528,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
17499,GO:0090615,1,0.987454830290657,0,2,mitochondrial mRNA processing,BP,
17500,GO:0090616,1,0.993323404174089,0,1,mitochondrial mRNA 3'-end processing,BP,
17501,GO:0090624,1,0.993846081630578,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
17502,GO:0090625,1,0.993846081630578,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
17503,GO:0090627,1,0.994422168860593,0,1,plant epidermal cell differentiation,BP,
17504,GO:0090630,1,0.594021181357577,0,79,activation of GTPase activity,BP,
17505,GO:0090634,1,0.99420904807227,0,1,microglial cell mediated cytotoxicity,BP,
17506,GO:0090646,1,0.929378350624619,0,12,mitochondrial tRNA processing,BP,
17507,GO:0090647,1,0.955569720925348,0,7,modulation of age-related behavioral decline,BP,
17508,GO:0090648,1,0.992850181848853,0,1,response to environmental enrichment,BP,
17509,GO:0090649,1,0.96550676397936,0,5,response to oxygen-glucose deprivation,BP,
17510,GO:0090650,1,0.96550676397936,0,5,cellular response to oxygen-glucose deprivation,BP,
17511,GO:0090651,1,0.992701872891372,0,1,apical cytoplasm,CC,
17512,GO:0090656,1,0.913942584654445,0,14,t-circle formation,BP,
17513,GO:0090657,1,0.937667426992122,0,10,telomeric loop disassembly,BP,
17515,GO:0090661,1,0.977323381437968,0,4,box H/ACA telomerase RNP complex,CC,
17516,GO:0090662,1,0.835896593714572,0,29,ATP hydrolysis coupled transmembrane transport,BP,
17517,GO:0090663,1,0.988618690084042,0,2,galanin-activated signaling pathway,BP,
17518,GO:0090665,1,0.876128245572299,0,20,glycoprotein complex,CC,
17519,GO:0090666,1,0.976320924667564,0,4,scaRNA localization to Cajal body,BP,
17520,GO:0090667,1,0.992379551540298,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
17521,GO:0090668,1,0.992379551540298,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
17522,GO:0090669,1,0.975635312144051,0,4,telomerase RNA stabilization,BP,
17523,GO:0090670,1,0.890741913742627,0,19,RNA localization to Cajal body,BP,
17524,GO:0090671,1,0.890741913742627,0,19,telomerase RNA localization to Cajal body,BP,
17525,GO:0090672,1,0.890741913742627,0,19,telomerase RNA localization,BP,
17526,GO:0090673,1,0.992531445921699,0,1,endothelial cell-matrix adhesion,BP,
17527,GO:0090675,1,0.993428129143902,0,1,intermicrovillar adhesion,BP,
17528,GO:0090677,1,0.98796187363012,0,2,reversible differentiation,BP,
17529,GO:0090678,1,0.98796187363012,0,2,cell dedifferentiation involved in phenotypic switching,BP,
17530,GO:0090685,1,0.890741913742627,0,19,RNA localization to nucleus,BP,
17531,GO:0090694,1,0.985612665301958,0,2,Scc2-Scc4 cohesin loading complex,CC,
17532,GO:0090713,1,0.962164190772142,0,6,immunological memory process,BP,
17533,GO:0090715,1,0.962164190772142,0,6,immunological memory formation process,BP,
17534,GO:0090722,1,0.974598861661583,0,4,receptor-receptor interaction,MF,
17535,GO:0090723,1,0.914384043497072,0,14,growth cone part,CC,
17536,GO:0090724,1,0.981219946891114,0,3,central region of growth cone,CC,
17537,GO:0090725,1,0.994391268506931,0,1,peripheral region of growth cone,CC,
17538,GO:0090731,1,0.9943066551631,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17539,GO:0090734,1,0.807485238649841,0,33,site of DNA damage,CC,
17540,GO:0090735,1,0.940897153013361,0,10,DNA repair complex assembly,BP,
17541,GO:0090737,1,0.913942584654445,0,14,telomere maintenance via telomere trimming,BP,
17542,GO:0090741,1,0.93629067215714,0,11,pigment granule membrane,CC,
17543,GO:0093001,1,0.993720692826793,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
17544,GO:0095500,1,0.876340871224859,0,21,acetylcholine receptor signaling pathway,BP,
17546,GO:0097003,1,0.987574813381959,0,2,adipokinetic hormone receptor activity,MF,
17547,GO:0097006,1,0.624783228100174,0,74,regulation of plasma lipoprotein particle levels,BP,
17548,GO:0097009,1,0.890698555333032,0,18,energy homeostasis,BP,
17549,GO:0097010,1,0.980671404627864,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
17550,GO:0097011,1,0.951430865306552,0,8,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
17551,GO:0097012,1,0.951430865306552,0,8,response to granulocyte macrophage colony-stimulating factor,BP,
17552,GO:0097013,1,0.98282953127748,0,3,phagocytic vesicle lumen,CC,
17554,GO:0097016,1,0.975403455934429,0,4,L27 domain binding,MF,
17555,GO:0097017,1,0.98781747810692,0,2,renal protein absorption,BP,
17556,GO:0097018,1,0.993923108860103,0,1,renal albumin absorption,BP,
17557,GO:0097020,1,0.99367699502543,0,1,COPII adaptor activity,MF,
17558,GO:0097021,1,0.98150097700104,0,3,lymphocyte migration into lymphoid organs,BP,
17559,GO:0097022,1,0.994020514183732,0,1,lymphocyte migration into lymph node,BP,
17560,GO:0097025,1,0.96871588440752,0,5,MPP7-DLG1-LIN7 complex,CC,
17561,GO:0097026,1,0.975398501292789,0,4,dendritic cell dendrite assembly,BP,
17562,GO:0097027,1,0.958477768948898,0,7,ubiquitin-protein transferase activator activity,MF,
17563,GO:0097028,1,0.798399394186876,0,37,dendritic cell differentiation,BP,
17564,GO:0097029,1,0.976846296542233,0,4,mature conventional dendritic cell differentiation,BP,
17565,GO:0097035,1,0.77828018262986,0,37,regulation of membrane lipid distribution,BP,
17566,GO:0097036,1,0.994231572753009,0,1,regulation of plasma membrane sterol distribution,BP,
17567,GO:0097037,1,0.993657011404137,0,1,heme export,BP,
17568,GO:0097038,1,0.930766726150426,0,11,perinuclear endoplasmic reticulum,CC,
17569,GO:0097039,1,0.967269192002671,0,5,protein linear polyubiquitination,BP,
17570,GO:0097045,1,0.993270508744335,0,1,phosphatidylserine exposure on blood platelet,BP,
17571,GO:0097048,1,0.940240244966909,0,10,dendritic cell apoptotic process,BP,
17572,GO:0097049,1,0.956926215563118,0,7,motor neuron apoptotic process,BP,
17574,GO:0097051,1,0.979450198716648,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
17575,GO:0097052,1,0.982265789658299,0,3,L-kynurenine metabolic process,BP,
17576,GO:0097053,1,0.994217567023989,0,1,L-kynurenine catabolic process,BP,
17577,GO:0097055,1,0.987894705141507,0,2,agmatine biosynthetic process,BP,
17578,GO:0097056,1,0.975546600403498,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
17579,GO:0097057,1,0.988391328226668,0,2,TRAF2-GSTP1 complex,CC,
17580,GO:0097058,1,0.982457216782191,0,3,CRLF-CLCF1 complex,CC,
17581,GO:0097059,1,0.988235247411565,0,2,CNTFR-CLCF1 complex,CC,
17583,GO:0097061,1,0.640201836995189,0,66,dendritic spine organization,BP,
17584,GO:0097062,1,0.89347821302103,0,17,dendritic spine maintenance,BP,
17585,GO:0097064,1,0.790602148113894,0,36,ncRNA export from nucleus,BP,
17586,GO:0097065,1,0.962200580021567,0,6,anterior head development,BP,
17587,GO:0097066,1,0.858353186001424,0,24,response to thyroid hormone,BP,
17588,GO:0097067,1,0.901750410048428,0,16,cellular response to thyroid hormone stimulus,BP,
17589,GO:0097068,1,0.968539249572102,0,5,response to thyroxine,BP,
17590,GO:0097069,1,0.987373498339495,0,2,cellular response to thyroxine stimulus,BP,
17591,GO:0097070,1,0.967677051374778,0,5,ductus arteriosus closure,BP,
17592,GO:0097084,1,0.950591160285705,0,8,vascular smooth muscle cell development,BP,
17593,GO:0097086,1,0.993592790396055,0,1,amniotic stem cell differentiation,BP,
17594,GO:0097089,1,0.988179205129017,0,2,methyl-branched fatty acid metabolic process,BP,
17596,GO:0097091,1,0.940677902640992,0,9,synaptic vesicle clustering,BP,
17597,GO:0097094,1,0.906016601852441,0,15,craniofacial suture morphogenesis,BP,
17598,GO:0097100,1,0.96989345323373,0,5,supercoiled DNA binding,MF,
17599,GO:0097101,1,0.981698777846449,0,3,blood vessel endothelial cell fate specification,BP,
17600,GO:0097102,1,0.987659189904302,0,2,endothelial tip cell fate specification,BP,
17601,GO:0097104,1,0.925898603339398,0,11,postsynaptic membrane assembly,BP,
17602,GO:0097105,1,0.933734099356901,0,10,presynaptic membrane assembly,BP,
17603,GO:0097106,1,0.899534558336963,0,15,postsynaptic density organization,BP,
17604,GO:0097107,1,0.94940432146424,0,7,postsynaptic density assembly,BP,
17606,GO:0097109,1,0.966099049026886,0,5,neuroligin family protein binding,MF,
17607,GO:0097110,1,0.67706500163357,0,59,scaffold protein binding,MF,
17608,GO:0097111,1,0.985511274334247,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
17609,GO:0097112,1,0.987228276161745,0,2,gamma-aminobutyric acid receptor clustering,BP,
17610,GO:0097113,1,0.953952012570219,0,7,AMPA glutamate receptor clustering,BP,
17611,GO:0097114,1,0.97171070420917,0,4,NMDA glutamate receptor clustering,BP,
17612,GO:0097115,1,0.993231949661646,0,1,neurexin clustering involved in presynaptic membrane assembly,BP,
17613,GO:0097116,1,0.978218462519522,0,3,gephyrin clustering involved in postsynaptic density assembly,BP,
17614,GO:0097117,1,0.99258412417868,0,1,guanylate kinase-associated protein clustering,BP,
17615,GO:0097118,1,0.971112758253693,0,4,neuroligin clustering involved in postsynaptic membrane assembly,BP,
17616,GO:0097119,1,0.938688295255408,0,9,postsynaptic density protein 95 clustering,BP,
17617,GO:0097120,1,0.813649564668086,0,32,receptor localization to synapse,BP,
17618,GO:0097123,1,0.988130806002218,0,2,cyclin A1-CDK2 complex,CC,
17619,GO:0097124,1,0.987874818214584,0,2,cyclin A2-CDK2 complex,CC,
17620,GO:0097125,1,0.988219900346818,0,2,cyclin B1-CDK1 complex,CC,
17621,GO:0097129,1,0.981394853007712,0,3,cyclin D2-CDK4 complex,CC,
17622,GO:0097134,1,0.988140995820466,0,2,cyclin E1-CDK2 complex,CC,
17623,GO:0097135,1,0.987894789990517,0,2,cyclin E2-CDK2 complex,CC,
17624,GO:0097136,1,0.963316816857358,0,6,Bcl-2 family protein complex,CC,
17625,GO:0097144,1,0.994412927591184,0,1,BAX complex,CC,
17626,GO:0097145,1,0.994013590856156,0,1,BAK complex,CC,
17627,GO:0097149,1,0.98097058111036,0,3,centralspindlin complex,CC,
17628,GO:0097150,1,0.858389727699896,0,22,neuronal stem cell population maintenance,BP,
17629,GO:0097151,1,0.952543028335866,0,7,positive regulation of inhibitory postsynaptic potential,BP,
17630,GO:0097152,1,0.927582917275962,0,12,mesenchymal cell apoptotic process,BP,
17631,GO:0097153,1,0.924982686349923,0,13,cysteine-type endopeptidase activity involved in apoptotic process,MF,
17633,GO:0097155,1,0.977873072386743,0,3,fasciculation of sensory neuron axon,BP,
17634,GO:0097156,1,0.986287105932783,0,2,fasciculation of motor neuron axon,BP,
17635,GO:0097157,1,0.94880676818308,0,8,pre-mRNA intronic binding,MF,
17636,GO:0097158,1,0.994172373196962,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
17638,GO:0097161,1,0.992816656537859,0,1,DH domain binding,MF,
17639,GO:0097162,1,0.993702410006232,0,1,MADS box domain binding,MF,
17641,GO:0097165,1,0.968710169483558,0,5,nuclear stress granule,CC,
17642,GO:0097166,1,0.986257065450578,0,2,lens epithelial cell proliferation,BP,
17643,GO:0097167,1,0.974544023613879,0,4,circadian regulation of translation,BP,
17644,GO:0097168,1,0.987394593133991,0,2,mesenchymal stem cell proliferation,BP,
17645,GO:0097169,1,0.971819585515123,0,5,AIM2 inflammasome complex,CC,
17646,GO:0097176,1,0.976452743998352,0,4,epoxide metabolic process,BP,
17647,GO:0097177,1,0.98240597393727,0,3,mitochondrial ribosome binding,MF,
17648,GO:0097178,1,0.808789700483156,0,34,ruffle assembly,BP,
17649,GO:0097179,1,0.977122072770043,0,4,protease inhibitor complex,CC,
17650,GO:0097180,1,0.988184945336842,0,2,serine protease inhibitor complex,CC,
17651,GO:0097181,1,0.993978988252915,0,1,protein C inhibitor-coagulation factor V complex,CC,
17652,GO:0097182,1,0.993978988252915,0,1,protein C inhibitor-coagulation factor Xa complex,CC,
17653,GO:0097183,1,0.993978988252915,0,1,protein C inhibitor-coagulation factor XI complex,CC,
17654,GO:0097186,1,0.899447740242405,0,16,amelogenesis,BP,
17655,GO:0097187,1,0.981731516560976,0,3,dentinogenesis,BP,
17661,GO:0097195,1,0.981503121549481,0,3,pilomotor reflex,BP,
17662,GO:0097196,1,0.98796856817166,0,2,Shu complex,CC,
17663,GO:0097197,1,0.957408642995961,0,7,tetraspanin-enriched microdomain,CC,
17664,GO:0097198,1,0.986039149339953,0,2,histone H3-K36 trimethylation,BP,
17665,GO:0097199,1,0.964343336550384,0,6,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
17666,GO:0097200,1,0.935386658149338,0,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
17667,GO:0097201,1,0.928091629574773,0,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,
17668,GO:0097202,1,0.919836505491523,0,13,activation of cysteine-type endopeptidase activity,BP,
17669,GO:0097205,1,0.902592642285692,0,16,renal filtration,BP,
17670,GO:0097208,1,0.963361419709695,0,6,alveolar lamellar body,CC,
17671,GO:0097209,1,0.974320543309089,0,4,epidermal lamellar body,CC,
17672,GO:0097210,1,0.968996537672968,0,5,response to gonadotropin-releasing hormone,BP,
17673,GO:0097211,1,0.968996537672968,0,5,cellular response to gonadotropin-releasing hormone,BP,
17674,GO:0097212,1,0.982655750223209,0,3,lysosomal membrane organization,BP,
17675,GO:0097213,1,0.988512746705713,0,2,regulation of lysosomal membrane permeability,BP,
17676,GO:0097214,1,0.994479638947422,0,1,positive regulation of lysosomal membrane permeability,BP,
17677,GO:0097222,1,0.993323404174089,0,1,mitochondrial mRNA polyadenylation,BP,
17679,GO:0097224,1,0.988281321165575,0,2,sperm connecting piece,CC,
17680,GO:0097225,1,0.907979764543088,0,16,sperm midpiece,CC,
17681,GO:0097226,1,0.99398705992719,0,1,sperm mitochondrial sheath,CC,
17683,GO:0097228,1,0.892556353225596,0,18,sperm principal piece,CC,
17684,GO:0097229,1,0.994262760775351,0,1,sperm end piece,CC,
17685,GO:0097231,1,0.994151292282251,0,1,cell motility in response to calcium ion,BP,
17686,GO:0097232,1,0.986461808504843,0,2,lamellar body membrane,CC,
17687,GO:0097233,1,0.986461808504843,0,2,alveolar lamellar body membrane,CC,
17689,GO:0097238,1,0.988651134718688,0,2,cellular response to methylglyoxal,BP,
17690,GO:0097240,1,0.96894982769558,0,5,chromosome attachment to the nuclear envelope,BP,
17691,GO:0097241,1,0.987945048512317,0,2,hematopoietic stem cell migration to bone marrow,BP,
17692,GO:0097242,1,0.876188287838552,0,19,amyloid-beta clearance,BP,
17693,GO:0097252,1,0.981536728437891,0,3,oligodendrocyte apoptotic process,BP,
17694,GO:0097254,1,0.994036238886231,0,1,renal tubular secretion,BP,
17695,GO:0097255,1,0.965065352024893,0,6,R2TP complex,CC,
17696,GO:0097258,1,0.993783031448323,0,1,20-hydroxy-leukotriene B4 omega oxidase activity,MF,
17697,GO:0097259,1,0.993783031448323,0,1,20-aldehyde-leukotriene B4 20-monooxygenase activity,MF,
17698,GO:0097260,1,0.993871636619337,0,1,eoxin A4 synthase activity,MF,
17699,GO:0097264,1,0.956941989265392,0,7,self proteolysis,BP,
17700,GO:0097267,1,0.974671782798032,0,4,omega-hydroxylase P450 pathway,BP,
17701,GO:0097272,1,0.987197068346661,0,2,ammonia homeostasis,BP,
17702,GO:0097273,1,0.992986531856292,0,1,creatinine homeostasis,BP,
17703,GO:0097274,1,0.986679358363979,0,2,urea homeostasis,BP,
17704,GO:0097275,1,0.992986531856292,0,1,cellular ammonia homeostasis,BP,
17705,GO:0097276,1,0.992986531856292,0,1,cellular creatinine homeostasis,BP,
17706,GO:0097277,1,0.992986531856292,0,1,cellular urea homeostasis,BP,
17707,GO:0097278,1,0.982133593611586,0,3,complement-dependent cytotoxicity,BP,
17708,GO:0097283,1,0.970071803333274,0,5,keratinocyte apoptotic process,BP,
17709,GO:0097284,1,0.926834987311621,0,12,hepatocyte apoptotic process,BP,
17711,GO:0097291,1,0.994068131768718,0,1,renal phosphate ion absorption,BP,
17712,GO:0097296,1,0.92281480927719,0,13,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
17713,GO:0097298,1,0.99351625623385,0,1,regulation of nucleus size,BP,
17715,GO:0097305,1,0.333935281083868,0,171,response to alcohol,BP,
17716,GO:0097306,1,0.703234232031971,0,53,cellular response to alcohol,BP,
17717,GO:0097309,1,0.987729649828399,0,2,cap1 mRNA methylation,BP,
17718,GO:0097310,1,0.993846081630578,0,1,cap2 mRNA methylation,BP,
17720,GO:0097322,1,0.956106697731744,0,7,7SK snRNA binding,MF,
17721,GO:0097323,1,0.987932320834483,0,2,B cell adhesion,BP,
17722,GO:0097324,1,0.985211049073365,0,2,melanocyte migration,BP,
17723,GO:0097325,1,0.986849269293994,0,2,melanocyte proliferation,BP,
17724,GO:0097326,1,0.993155902566615,0,1,melanocyte adhesion,BP,
17725,GO:0097327,1,0.584423894911879,0,84,response to antineoplastic agent,BP,
17726,GO:0097329,1,0.923990147345395,0,12,response to antimetabolite,BP,
17727,GO:0097332,1,0.981431487496444,0,3,response to antipsychotic drug,BP,
17728,GO:0097338,1,0.986990223722682,0,2,response to clozapine,BP,
17729,GO:0097340,1,0.916735042444363,0,13,inhibition of cysteine-type endopeptidase activity,BP,
17730,GO:0097341,1,0.916735042444363,0,13,zymogen inhibition,BP,
17731,GO:0097342,1,0.96300634508971,0,6,ripoptosome,CC,
17732,GO:0097343,1,0.9794116781691,0,3,ripoptosome assembly,BP,
17733,GO:0097344,1,0.987994189018248,0,2,Rix1 complex,CC,
17735,GO:0097346,1,0.864984798219534,0,23,INO80-type complex,CC,
17736,GO:0097350,1,0.96909451660314,0,5,neutrophil clearance,BP,
17737,GO:0097352,1,0.807034509356248,0,34,autophagosome maturation,BP,
17738,GO:0097354,1,0.943334490151673,0,9,prenylation,BP,
17739,GO:0097359,1,0.984779802189474,0,2,UDP-glucosylation,BP,
17741,GO:0097361,1,0.975753727923289,0,4,CIA complex,CC,
17742,GO:0097362,1,0.987552547975749,0,2,MCM8-MCM9 complex,CC,
17743,GO:0097363,1,0.986957680215936,0,2,protein O-GlcNAc transferase activity,MF,
17746,GO:0097368,1,0.974234882435849,0,4,establishment of Sertoli cell barrier,BP,
17747,GO:0097371,1,0.95475312821482,0,7,MDM2/MDM4 family protein binding,MF,
17748,GO:0097372,1,0.994150714721825,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
17749,GO:0097374,1,0.993929441234976,0,1,sensory neuron axon guidance,BP,
17750,GO:0097376,1,0.98825469319021,0,2,interneuron axon guidance,BP,
17751,GO:0097377,1,0.993983600457643,0,1,spinal cord interneuron axon guidance,BP,
17752,GO:0097378,1,0.993983600457643,0,1,dorsal spinal cord interneuron axon guidance,BP,
17753,GO:0097380,1,0.993983600457643,0,1,dorsal spinal cord interneuron anterior axon guidance,BP,
17754,GO:0097381,1,0.908624657917885,0,15,photoreceptor disc membrane,CC,
17755,GO:0097382,1,0.992912447527943,0,1,deoxynucleoside-diphosphatase activity,MF,
17756,GO:0097383,1,0.992912447527943,0,1,dIDP diphosphatase activity,MF,
17757,GO:0097384,1,0.956780423370426,0,7,cellular lipid biosynthetic process,BP,
17758,GO:0097386,1,0.902332934143359,0,16,glial cell projection,CC,
17759,GO:0097393,1,0.991425784812328,0,1,telomeric repeat-containing RNA transcription,BP,
17760,GO:0097394,1,0.991425784812328,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
17761,GO:0097396,1,0.969475634449094,0,5,response to interleukin-17,BP,
17762,GO:0097398,1,0.969475634449094,0,5,cellular response to interleukin-17,BP,
17763,GO:0097400,1,0.969475634449094,0,5,interleukin-17-mediated signaling pathway,BP,
17765,GO:0097402,1,0.987166295672023,0,2,neuroblast migration,BP,
17766,GO:0097403,1,0.993776162696212,0,1,cellular response to raffinose,BP,
17767,GO:0097409,1,0.994081267421243,0,1,glial cytoplasmic inclusion,CC,
17768,GO:0097411,1,0.967505042318928,0,5,hypoxia-inducible factor-1alpha signaling pathway,BP,
17769,GO:0097413,1,0.958181014050278,0,7,Lewy body,CC,
17770,GO:0097414,1,0.994081267421243,0,1,classical Lewy body,CC,
17772,GO:0097421,1,0.81976248108069,0,32,liver regeneration,BP,
17773,GO:0097422,1,0.969136533982881,0,5,tubular endosome,CC,
17774,GO:0097425,1,0.969535852957121,0,5,smooth endoplasmic reticulum part,CC,
17776,GO:0097428,1,0.943612502067359,0,10,protein maturation by iron-sulfur cluster transfer,BP,
17777,GO:0097431,1,0.845313891630612,0,25,mitotic spindle pole,CC,
17778,GO:0097433,1,0.969609784333109,0,5,dense body,CC,
17780,GO:0097440,1,0.903102631739468,0,15,apical dendrite,CC,
17781,GO:0097441,1,0.966284855565168,0,5,basal dendrite,CC,
17782,GO:0097442,1,0.979398417401053,0,3,CA3 pyramidal cell dendrite,CC,
17783,GO:0097443,1,0.961047285428886,0,6,sorting endosome,CC,
17784,GO:0097444,1,0.993169592382351,0,1,spine apparatus,CC,
17786,GO:0097449,1,0.939462106656649,0,10,astrocyte projection,CC,
17787,GO:0097450,1,0.975610934251434,0,4,astrocyte end-foot,CC,
17788,GO:0097451,1,0.987010885118445,0,2,glial limiting end-foot,CC,
17789,GO:0097452,1,0.97471973019628,0,4,GAIT complex,CC,
17791,GO:0097454,1,0.979862860290593,0,3,Schwann cell microvillus,CC,
17792,GO:0097457,1,0.978174466988681,0,3,hippocampal mossy fiber,CC,
17794,GO:0097462,1,0.994081267421243,0,1,Lewy neurite,CC,
17795,GO:0097466,1,0.973815253730134,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
17796,GO:0097468,1,0.927796866473745,0,12,programmed cell death in response to reactive oxygen species,BP,
17797,GO:0097470,1,0.966188527639638,0,5,ribbon synapse,CC,
17799,GO:0097473,1,0.993130821335686,0,1,retinal rod cell apoptotic process,BP,
17800,GO:0097475,1,0.96577890906381,0,5,motor neuron migration,BP,
17801,GO:0097476,1,0.985239595759088,0,2,spinal cord motor neuron migration,BP,
17802,GO:0097477,1,0.985239595759088,0,2,lateral motor column neuron migration,BP,
17803,GO:0097479,1,0.446626664456601,0,123,synaptic vesicle localization,BP,
17804,GO:0097480,1,0.468791350000688,0,116,establishment of synaptic vesicle localization,BP,
17807,GO:0097486,1,0.971648939462666,0,5,multivesicular body lumen,CC,
17808,GO:0097487,1,0.974478688425449,0,4,multivesicular body, internal vesicle,CC,
17809,GO:0097489,1,0.993907283533197,0,1,multivesicular body, internal vesicle lumen,CC,
17810,GO:0097490,1,0.97393254720571,0,4,sympathetic neuron projection extension,BP,
17811,GO:0097491,1,0.97393254720571,0,4,sympathetic neuron projection guidance,BP,
17813,GO:0097494,1,0.974241101616597,0,4,regulation of vesicle size,BP,
17814,GO:0097497,1,0.993736553306438,0,1,blood vessel endothelial cell delamination,BP,
17815,GO:0097498,1,0.987091504497735,0,2,endothelial tube lumen extension,BP,
17816,GO:0097499,1,0.944744910506242,0,9,protein localization to non-motile cilium,BP,
17817,GO:0097500,1,0.974867006118379,0,4,receptor localization to non-motile cilium,BP,
17818,GO:0097501,1,0.927349400807799,0,13,stress response to metal ion,BP,
17819,GO:0097502,1,0.833391637672869,0,29,mannosylation,BP,
17820,GO:0097503,1,0.878223384081066,0,20,sialylation,BP,
17821,GO:0097504,1,0.928019258341794,0,12,Gemini of coiled bodies,CC,
17822,GO:0097505,1,0.992994039585965,0,1,Rad6-Rad18 complex,CC,
17823,GO:0097506,1,0.970754169880059,0,5,deaminated base DNA N-glycosylase activity,MF,
17824,GO:0097510,1,0.99405442060956,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
17825,GO:0097512,1,0.963900889629318,0,6,cardiac myofibril,CC,
17826,GO:0097513,1,0.977757197843405,0,3,myosin II filament,CC,
17827,GO:0097517,1,0.707310969853465,0,52,contractile actin filament bundle,CC,
17828,GO:0097524,1,0.979799329340434,0,3,sperm plasma membrane,CC,
17829,GO:0097525,1,0.684312824779256,0,61,spliceosomal snRNP complex,CC,
17830,GO:0097526,1,0.842785050738992,0,28,spliceosomal tri-snRNP complex,CC,
17831,GO:0097527,1,0.964137283584742,0,6,necroptotic signaling pathway,BP,
17833,GO:0097530,1,0.562739440574081,0,94,granulocyte migration,BP,
17834,GO:0097531,1,0.933160828275376,0,11,mast cell migration,BP,
17835,GO:0097532,1,0.987841420244119,0,2,stress response to acid chemical,BP,
17836,GO:0097533,1,0.987841420244119,0,2,cellular stress response to acid chemical,BP,
17837,GO:0097534,1,0.992427203642683,0,1,lymphoid lineage cell migration,BP,
17838,GO:0097535,1,0.992427203642683,0,1,lymphoid lineage cell migration into thymus,BP,
17839,GO:0097536,1,0.994036238886231,0,1,thymus epithelium morphogenesis,BP,
17840,GO:0097539,1,0.934412807460744,0,10,ciliary transition fiber,CC,
17841,GO:0097541,1,0.993846081630578,0,1,axonemal basal plate,CC,
17842,GO:0097542,1,0.756339942699831,0,43,ciliary tip,CC,
17843,GO:0097543,1,0.986958140173996,0,2,ciliary inversin compartment,CC,
17844,GO:0097546,1,0.841204058363693,0,27,ciliary base,CC,
17845,GO:0097550,1,0.96387708374453,0,6,transcriptional preinitiation complex,CC,
17847,GO:0097573,1,0.994254097431965,0,1,glutathione oxidoreductase activity,MF,
17848,GO:0097574,1,0.986387649144082,0,2,lateral part of cell,CC,
17849,GO:0097575,1,0.986387649144082,0,2,lateral cell cortex,CC,
17850,GO:0097576,1,0.987202069040316,0,2,vacuole fusion,BP,
17851,GO:0097577,1,0.982854705789887,0,3,sequestering of iron ion,BP,
17853,GO:0097598,1,0.986981194834367,0,2,sperm cytoplasmic droplet,CC,
17854,GO:0097602,1,0.898371536037357,0,17,cullin family protein binding,MF,
17855,GO:0097603,1,0.987618542501639,0,2,temperature-gated ion channel activity,MF,
17856,GO:0097604,1,0.99412385818235,0,1,temperature-gated cation channel activity,MF,
17857,GO:0097617,1,0.920115791034118,0,13,annealing activity,MF,
17858,GO:0097621,1,0.99398302390549,0,1,monoamine oxidase activity,MF,
17859,GO:0097623,1,0.957449614144504,0,7,potassium ion export across plasma membrane,BP,
17860,GO:0097625,1,0.992466301258203,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
17861,GO:0097626,1,0.992466301258203,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
17862,GO:0097627,1,0.992466301258203,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
17863,GO:0097629,1,0.968971789734728,0,5,extrinsic component of omegasome membrane,CC,
17864,GO:0097630,1,0.993846081630578,0,1,intrinsic component of omegasome membrane,CC,
17865,GO:0097631,1,0.993846081630578,0,1,integral component of omegasome membrane,CC,
17866,GO:0097632,1,0.987026484210111,0,2,extrinsic component of phagophore assembly site membrane,CC,
17867,GO:0097635,1,0.986491659754631,0,2,extrinsic component of autophagosome membrane,CC,
17868,GO:0097636,1,0.987315053171161,0,2,intrinsic component of autophagosome membrane,CC,
17869,GO:0097637,1,0.987315053171161,0,2,integral component of autophagosome membrane,CC,
17870,GO:0097638,1,0.973168846549835,0,4,L-arginine import across plasma membrane,BP,
17871,GO:0097639,1,0.986414167141898,0,2,L-lysine import across plasma membrane,BP,
17872,GO:0097640,1,0.992466301258203,0,1,L-ornithine import across plasma membrane,BP,
17873,GO:0097642,1,0.964283495969605,0,6,calcitonin family receptor activity,MF,
17874,GO:0097643,1,0.976871905388626,0,4,amylin receptor activity,MF,
17875,GO:0097644,1,0.975838577234847,0,4,calcitonin family binding,MF,
17876,GO:0097646,1,0.964633925862324,0,6,calcitonin family receptor signaling pathway,BP,
17877,GO:0097647,1,0.971232726666201,0,5,amylin receptor signaling pathway,BP,
17878,GO:0097648,1,0.950022509231632,0,8,G-protein coupled receptor complex,CC,
17879,GO:0097651,1,0.973279304772985,0,4,phosphatidylinositol 3-kinase complex, class I,CC,
17880,GO:0097655,1,0.993846081630578,0,1,serpin family protein binding,MF,
17882,GO:0097676,1,0.977640545900753,0,3,histone H3-K36 dimethylation,BP,
17883,GO:0097677,1,0.967420008622085,0,5,STAT family protein binding,MF,
17884,GO:0097679,1,0.988474397765253,0,2,other organism cytoplasm,CC,
17885,GO:0097680,1,0.980790192790317,0,3,double-strand break repair via classical nonhomologous end joining,BP,
17886,GO:0097681,1,0.982910579224803,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
17887,GO:0097682,1,0.994038691708521,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
17888,GO:0097688,1,0.953952012570219,0,7,glutamate receptor clustering,BP,
17889,GO:0097689,1,0.99367985018319,0,1,iron channel activity,MF,
17890,GO:0097692,1,0.992847580966016,0,1,histone H3-K4 monomethylation,BP,
17891,GO:0097694,1,0.977662052290946,0,3,establishment of RNA localization to telomere,BP,
17892,GO:0097695,1,0.977662052290946,0,3,establishment of protein-containing complex localization to telomere,BP,
17893,GO:0097696,1,0.446223343722699,0,127,STAT cascade,BP,
17894,GO:0097698,1,0.994216267523088,0,1,telomere maintenance via base-excision repair,BP,
17895,GO:0097699,1,0.993363606693429,0,1,vascular endothelial cell response to fluid shear stress,BP,
17896,GO:0097707,1,0.994375385292897,0,1,ferroptosis,BP,
17898,GO:0097709,1,0.963004388400388,0,6,connective tissue replacement,BP,
17899,GO:0097711,1,0.534372476541791,0,96,ciliary basal body-plasma membrane docking,BP,
17900,GO:0097712,1,0.993846081630578,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
17903,GO:0097722,1,0.667787196263697,0,63,sperm motility,BP,
17904,GO:0097724,1,0.994118515849893,0,1,sperm flagellum movement,BP,
17905,GO:0097726,1,0.994323260025601,0,1,LEM domain binding,MF,
17907,GO:0097730,1,0.485548622561482,0,111,non-motile cilium,CC,
17908,GO:0097731,1,0.566443727712669,0,87,9+0 non-motile cilium,CC,
17909,GO:0097732,1,0.957193571406307,0,7,9+2 non-motile cilium,CC,
17910,GO:0097733,1,0.566443727712669,0,87,photoreceptor cell cilium,CC,
17911,GO:0097734,1,0.894868100919843,0,18,extracellular exosome biogenesis,BP,
17912,GO:0097742,1,0.974267911925167,0,4,de novo centriole assembly,BP,
17913,GO:0097745,1,0.982216919629131,0,3,mitochondrial tRNA 5'-end processing,BP,
17915,GO:0097747,1,0.768344896138074,0,43,RNA polymerase activity,MF,
17916,GO:0097749,1,0.986713288766013,0,2,membrane tubulation,BP,
17917,GO:0097752,1,0.98164509280772,0,3,regulation of DNA stability,BP,
17918,GO:0097753,1,0.987451294675719,0,2,membrane bending,BP,
17921,GO:0098501,1,0.970527672374997,0,5,polynucleotide dephosphorylation,BP,
17922,GO:0098502,1,0.982744235119214,0,3,DNA dephosphorylation,BP,
17923,GO:0098503,1,0.994148115699068,0,1,DNA 3' dephosphorylation,BP,
17924,GO:0098504,1,0.994148115699068,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
17925,GO:0098505,1,0.939729971186346,0,10,G-rich strand telomeric DNA binding,MF,
17926,GO:0098506,1,0.994148115699068,0,1,polynucleotide 3' dephosphorylation,BP,
17927,GO:0098507,1,0.987571124476374,0,2,polynucleotide 5' dephosphorylation,BP,
17928,GO:0098508,1,0.98794842683712,0,2,endothelial to hematopoietic transition,BP,
17929,GO:0098518,1,0.981791236861713,0,3,polynucleotide phosphatase activity,MF,
17930,GO:0098519,1,0.969127438853008,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
17931,GO:0098528,1,0.968468093412956,0,5,skeletal muscle fiber differentiation,BP,
17932,GO:0098530,1,0.992985376787579,0,1,positive regulation of strand invasion,BP,
17933,GO:0098531,1,0.740640374074475,0,46,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,
17934,GO:0098532,1,0.955972475112709,0,7,histone H3-K27 trimethylation,BP,
17936,GO:0098534,1,0.81338581958778,0,32,centriole assembly,BP,
17937,GO:0098535,1,0.974267911925167,0,4,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
17938,GO:0098536,1,0.974665147375685,0,4,deuterosome,CC,
17939,GO:0098542,1,0.117295160603243,0,343,defense response to other organism,BP,
17940,GO:0098543,1,0.929767552051429,0,11,detection of other organism,BP,
17941,GO:0098547,1,0.993997151533403,0,1,lumenal side of Golgi membrane,CC,
17943,GO:0098553,1,0.861684018732096,0,25,lumenal side of endoplasmic reticulum membrane,CC,
17944,GO:0098554,1,0.924253382420268,0,13,cytoplasmic side of endoplasmic reticulum membrane,CC,
17945,GO:0098556,1,0.972455228313039,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
17946,GO:0098559,1,0.981827183745533,0,3,cytoplasmic side of early endosome membrane,CC,
17947,GO:0098560,1,0.987794624816989,0,2,cytoplasmic side of late endosome membrane,CC,
17950,GO:0098573,1,0.66751598912865,0,66,intrinsic component of mitochondrial membrane,CC,
17951,GO:0098574,1,0.969812505820297,0,5,cytoplasmic side of lysosomal membrane,CC,
17952,GO:0098575,1,0.98809249494494,0,2,lumenal side of lysosomal membrane,CC,
17953,GO:0098576,1,0.975940926558167,0,4,lumenal side of membrane,CC,
17954,GO:0098577,1,0.992681481951384,0,1,inactive sex chromosome,CC,
17955,GO:0098581,1,0.902078902575166,0,16,detection of external biotic stimulus,BP,
17956,GO:0098582,1,0.986577830743163,0,2,innate vocalization behavior,BP,
17957,GO:0098583,1,0.994280665037031,0,1,learned vocalization behavior,BP,
17958,GO:0098586,1,0.773694200921669,0,40,cellular response to virus,BP,
17962,GO:0098592,1,0.981196445333092,0,3,cytoplasmic side of apical plasma membrane,CC,
17963,GO:0098594,1,0.994433431710208,0,1,mucin granule,CC,
17964,GO:0098595,1,0.993998016627916,0,1,perivitelline space,CC,
17965,GO:0098596,1,0.948436169942827,0,7,imitative learning,BP,
17966,GO:0098597,1,0.93995143742626,0,8,observational learning,BP,
17967,GO:0098598,1,0.943008823508211,0,8,learned vocalization behavior or vocal learning,BP,
17968,GO:0098599,1,0.940707763359972,0,10,palmitoyl hydrolase activity,MF,
17969,GO:0098601,1,0.993665289857805,0,1,selenomethionine adenosyltransferase activity,MF,
17971,GO:0098619,1,0.994097869428488,0,1,selenocysteine-tRNA ligase activity,MF,
17972,GO:0098621,1,0.993021468188549,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
17973,GO:0098625,1,0.993552535304992,0,1,methylselenol reductase activity,MF,
17974,GO:0098626,1,0.993552535304992,0,1,methylseleninic acid reductase activity,MF,
17975,GO:0098629,1,0.993846081630578,0,1,trans-Golgi network membrane organization,BP,
17976,GO:0098631,1,0.773523054821702,0,40,cell adhesion mediator activity,MF,
17977,GO:0098632,1,0.820331579121691,0,31,cell-cell adhesion mediator activity,MF,
17978,GO:0098633,1,0.993915626776518,0,1,collagen fibril binding,MF,
17979,GO:0098634,1,0.95422150743355,0,7,cell-matrix adhesion mediator activity,MF,
17980,GO:0098636,1,0.792518992918511,0,35,protein complex involved in cell adhesion,CC,
17981,GO:0098637,1,0.99351511314133,0,1,protein complex involved in cell-matrix adhesion,CC,
17982,GO:0098639,1,0.966017643382561,0,5,collagen binding involved in cell-matrix adhesion,MF,
17983,GO:0098640,1,0.987793182510986,0,2,integrin binding involved in cell-matrix adhesion,MF,
17984,GO:0098641,1,0.891250035223191,0,19,cadherin binding involved in cell-cell adhesion,MF,
17985,GO:0098642,1,0.950115899962778,0,7,network-forming collagen trimer,CC,
17986,GO:0098643,1,0.919287999879712,0,12,banded collagen fibril,CC,
17987,GO:0098644,1,0.866368689520611,0,20,complex of collagen trimers,CC,
17988,GO:0098645,1,0.950115899962778,0,7,collagen network,CC,
17989,GO:0098646,1,0.993888735587382,0,1,collagen sheet,CC,
17990,GO:0098647,1,0.979883074645499,0,3,collagen beaded filament,CC,
17991,GO:0098648,1,0.991969891159241,0,1,collagen anchoring fibril,CC,
17992,GO:0098651,1,0.943575298538982,0,8,basement membrane collagen trimer,CC,
17993,GO:0098652,1,0.991969891159241,0,1,collagen type VII anchoring fibril,CC,
18001,GO:0098664,1,0.924284439314344,0,13,G-protein coupled serotonin receptor signaling pathway,BP,
18002,GO:0098679,1,0.984175421639398,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18003,GO:0098680,1,0.993494245950117,0,1,template-free RNA nucleotidyltransferase,MF,
18004,GO:0098687,1,0.134084232393438,0,310,chromosomal region,CC,
18005,GO:0098693,1,0.754959716564355,0,42,regulation of synaptic vesicle cycle,BP,
18006,GO:0098698,1,0.94940432146424,0,7,postsynaptic specialization assembly,BP,
18008,GO:0098703,1,0.918881554895429,0,13,calcium ion import across plasma membrane,BP,
18009,GO:0098704,1,0.993976682335154,0,1,carbohydrate import across plasma membrane,BP,
18010,GO:0098705,1,0.993273097448867,0,1,copper ion import across plasma membrane,BP,
18011,GO:0098706,1,0.973546223602372,0,4,ferric iron import across plasma membrane,BP,
18012,GO:0098711,1,0.96154471489722,0,6,iron ion import across plasma membrane,BP,
18013,GO:0098712,1,0.929246290953831,0,11,L-glutamate import across plasma membrane,BP,
18014,GO:0098713,1,0.993993114630875,0,1,leucine import across plasma membrane,BP,
18015,GO:0098719,1,0.911325550190184,0,14,sodium ion import across plasma membrane,BP,
18016,GO:0098722,1,0.943985216620943,0,9,asymmetric stem cell division,BP,
18017,GO:0098725,1,0.993846081630578,0,1,symmetric cell division,BP,
18018,GO:0098727,1,0.372303485923157,0,150,maintenance of cell number,BP,
18019,GO:0098728,1,0.981874611229399,0,3,germline stem cell asymmetric division,BP,
18020,GO:0098732,1,0.501450509369199,0,106,macromolecule deacylation,BP,
18021,GO:0098734,1,0.940707763359972,0,10,macromolecule depalmitoylation,BP,
18023,GO:0098736,1,0.992100351952376,0,1,negative regulation of the force of heart contraction,BP,
18026,GO:0098743,1,0.890802130056167,0,18,cell aggregation,BP,
18027,GO:0098745,1,0.994143783991404,0,1,Dcp1-Dcp2 complex,CC,
18028,GO:0098746,1,0.993262166411103,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
18029,GO:0098748,1,0.931256909423984,0,11,endocytic adaptor activity,MF,
18030,GO:0098749,1,0.99331737040542,0,1,cerebellar neuron development,BP,
18031,GO:0098751,1,0.808774669992153,0,32,bone cell development,BP,
18032,GO:0098754,1,0.546993296471077,0,100,detoxification,BP,
18033,GO:0098756,1,0.955711324922345,0,7,response to interleukin-21,BP,
18034,GO:0098757,1,0.955711324922345,0,7,cellular response to interleukin-21,BP,
18035,GO:0098758,1,0.981635935441011,0,3,response to interleukin-8,BP,
18036,GO:0098759,1,0.981635935441011,0,3,cellular response to interleukin-8,BP,
18037,GO:0098760,1,0.884285996164283,0,19,response to interleukin-7,BP,
18038,GO:0098761,1,0.884285996164283,0,19,cellular response to interleukin-7,BP,
18039,GO:0098770,1,0.984902432162435,0,2,FBXO family protein binding,MF,
18042,GO:0098773,1,0.586550057848269,0,82,skin epidermis development,BP,
18043,GO:0098779,1,0.948178089027106,0,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
18044,GO:0098780,1,0.895593721430846,0,17,response to mitochondrial depolarisation,BP,
18045,GO:0098781,1,0.554434432162554,0,94,ncRNA transcription,BP,
18046,GO:0098782,1,0.99412385818235,0,1,mechanosensitived potassium channel activity,MF,
18047,GO:0098787,1,0.914397886123466,0,14,mRNA cleavage involved in mRNA processing,BP,
18048,GO:0098789,1,0.931822587712218,0,11,pre-mRNA cleavage required for polyadenylation,BP,
18050,GO:0098792,1,0.938790859805511,0,10,xenophagy,BP,
18053,GO:0098795,1,0.987497050694203,0,2,mRNA cleavage involved in gene silencing,BP,
18056,GO:0098798,1,0.277764217582153,0,217,mitochondrial protein complex,CC,
18057,GO:0098799,1,0.930722383645259,0,12,outer mitochondrial membrane protein complex,CC,
18058,GO:0098800,1,0.557773637637439,0,100,inner mitochondrial membrane protein complex,CC,
18059,GO:0098801,1,0.84517706858666,0,27,regulation of renal system process,BP,
18061,GO:0098803,1,0.672903972722866,0,69,respiratory chain complex,CC,
18063,GO:0098808,1,0.987963546372208,0,2,mRNA cap binding,MF,
18064,GO:0098809,1,0.993895779497771,0,1,nitrite reductase activity,MF,
18065,GO:0098810,1,0.903725214661744,0,16,neurotransmitter reuptake,BP,
18067,GO:0098814,1,0.966514758992262,0,5,spontaneous synaptic transmission,BP,
18068,GO:0098815,1,0.775774742236494,0,38,modulation of excitatory postsynaptic potential,BP,
18069,GO:0098816,1,0.994058605895241,0,1,mini excitatory postsynaptic potential,BP,
18070,GO:0098821,1,0.965912480970495,0,5,BMP receptor activity,MF,
18071,GO:0098822,1,0.993938366199964,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
18072,GO:0098826,1,0.975847332442755,0,4,endoplasmic reticulum tubular network membrane,CC,
18074,GO:0098828,1,0.952543028335866,0,7,modulation of inhibitory postsynaptic potential,BP,
18075,GO:0098829,1,0.992779366906103,0,1,intestinal folate absorption,BP,
18076,GO:0098830,1,0.993258713991078,0,1,presynaptic endosome,CC,
18077,GO:0098831,1,0.93030648057145,0,9,presynaptic active zone cytoplasmic component,CC,
18078,GO:0098833,1,0.993223025145237,0,1,presynaptic endocytic zone,CC,
18079,GO:0098835,1,0.993223025145237,0,1,presynaptic endocytic zone membrane,CC,
18080,GO:0098837,1,0.981916623266586,0,3,postsynaptic recycling endosome,CC,
18081,GO:0098838,1,0.993827722238844,0,1,reduced folate transmembrane transport,BP,
18082,GO:0098839,1,0.804201785846898,0,32,postsynaptic density membrane,CC,
18083,GO:0098840,1,0.973241482039708,0,4,protein transport along microtubule,BP,
18084,GO:0098842,1,0.987989069292105,0,2,postsynaptic early endosome,CC,
18085,GO:0098843,1,0.961973633149726,0,6,postsynaptic endocytic zone,CC,
18086,GO:0098844,1,0.979885114389886,0,3,postsynaptic endocytic zone membrane,CC,
18087,GO:0098845,1,0.963754906768834,0,6,postsynaptic endosome,CC,
18088,GO:0098847,1,0.922096145512057,0,13,sequence-specific single stranded DNA binding,MF,
18089,GO:0098850,1,0.994084587661038,0,1,extrinsic component of synaptic vesicle membrane,CC,
18091,GO:0098855,1,0.979471773480505,0,3,HCN channel complex,CC,
18092,GO:0098856,1,0.951557006716134,0,8,intestinal lipid absorption,BP,
18096,GO:0098868,1,0.857387219401649,0,24,bone growth,BP,
18097,GO:0098869,1,0.607765388666971,0,82,cellular oxidant detoxification,BP,
18098,GO:0098870,1,0.961202657736114,0,6,action potential propagation,BP,
18099,GO:0098871,1,0.994157645442769,0,1,postsynaptic actin cytoskeleton,CC,
18100,GO:0098875,1,0.993283450843411,0,1,epididymosome,CC,
18101,GO:0098876,1,0.643163158335005,0,68,vesicle-mediated transport to the plasma membrane,BP,
18102,GO:0098877,1,0.939263752656074,0,10,neurotransmitter receptor transport to plasma membrane,BP,
18103,GO:0098878,1,0.713513982862854,0,51,neurotransmitter receptor complex,CC,
18104,GO:0098881,1,0.975380621859883,0,4,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
18105,GO:0098883,1,0.994126168400043,0,1,synapse disassembly,BP,
18106,GO:0098884,1,0.979885114389886,0,3,postsynaptic neurotransmitter receptor internalization,BP,
18107,GO:0098885,1,0.992567048784626,0,1,modification of postsynaptic actin cytoskeleton,BP,
18108,GO:0098886,1,0.987057281691321,0,2,modification of dendritic spine,BP,
18109,GO:0098887,1,0.974924208441423,0,4,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
18110,GO:0098888,1,0.992554603024368,0,1,extrinsic component of presynaptic membrane,CC,
18111,GO:0098889,1,0.975113468258118,0,4,intrinsic component of presynaptic membrane,CC,
18112,GO:0098890,1,0.992554603024368,0,1,extrinsic component of postsynaptic membrane,CC,
18113,GO:0098895,1,0.993440160298641,0,1,postsynaptic endosome membrane,CC,
18116,GO:0098902,1,0.972583636229332,0,4,regulation of membrane depolarization during action potential,BP,
18117,GO:0098903,1,0.948480477989442,0,8,regulation of membrane repolarization during action potential,BP,
18119,GO:0098905,1,0.994407729393441,0,1,regulation of bundle of His cell action potential,BP,
18121,GO:0098908,1,0.975374916157561,0,4,regulation of neuronal action potential,BP,
18122,GO:0098909,1,0.952591307317278,0,7,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
18125,GO:0098912,1,0.976539874892471,0,3,membrane depolarization during atrial cardiac muscle cell action potential,BP,
18126,GO:0098914,1,0.962053599717353,0,6,membrane repolarization during atrial cardiac muscle cell action potential,BP,
18127,GO:0098915,1,0.927394745641044,0,12,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
18129,GO:0098917,1,0.954876216074594,0,7,retrograde trans-synaptic signaling,BP,
18130,GO:0098918,1,0.994124435735787,0,1,structural constituent of synapse,MF,
18131,GO:0098920,1,0.986891167767825,0,2,retrograde trans-synaptic signaling by lipid,BP,
18132,GO:0098921,1,0.986891167767825,0,2,retrograde trans-synaptic signaling by endocannabinoid,BP,
18133,GO:0098923,1,0.992587886344041,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
18134,GO:0098924,1,0.992587886344041,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
18135,GO:0098926,1,0.992642863188016,0,1,postsynaptic signal transduction,BP,
18136,GO:0098927,1,0.76943878449576,0,40,vesicle-mediated transport between endosomal compartments,BP,
18137,GO:0098928,1,0.979341629677536,0,2,presynaptic signal transduction,BP,
18138,GO:0098930,1,0.74540666254752,0,45,axonal transport,BP,
18139,GO:0098935,1,0.965902972220831,0,5,dendritic transport,BP,
18140,GO:0098936,1,0.933475881807497,0,10,intrinsic component of postsynaptic membrane,CC,
18141,GO:0098937,1,0.965902972220831,0,5,anterograde dendritic transport,BP,
18142,GO:0098939,1,0.992765200650824,0,1,dendritic transport of mitochondrion,BP,
18143,GO:0098942,1,0.993231949661646,0,1,retrograde trans-synaptic signaling by trans-synaptic protein complex,BP,
18144,GO:0098943,1,0.958573833361945,0,7,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
18145,GO:0098945,1,0.993387708407071,0,1,intrinsic component of presynaptic active zone membrane,CC,
18146,GO:0098948,1,0.970201720634226,0,4,intrinsic component of postsynaptic specialization membrane,CC,
18147,GO:0098953,1,0.952518631315059,0,8,receptor diffusion trapping,BP,
18148,GO:0098957,1,0.973949120005644,0,4,anterograde axonal transport of mitochondrion,BP,
18149,GO:0098960,1,0.784281360483363,0,37,postsynaptic neurotransmitter receptor activity,MF,
18150,GO:0098961,1,0.992645177646854,0,1,dendritic transport of ribonucleoprotein complex,BP,
18151,GO:0098963,1,0.992645177646854,0,1,dendritic transport of messenger ribonucleoprotein complex,BP,
18152,GO:0098964,1,0.992645177646854,0,1,anterograde dendritic transport of messenger ribonucleoprotein complex,BP,
18153,GO:0098967,1,0.975380621859883,0,4,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
18154,GO:0098968,1,0.993147831445154,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
18155,GO:0098969,1,0.945224664296641,0,9,neurotransmitter receptor transport to postsynaptic membrane,BP,
18156,GO:0098970,1,0.952518631315059,0,8,postsynaptic neurotransmitter receptor diffusion trapping,BP,
18157,GO:0098971,1,0.972943988837861,0,4,anterograde dendritic transport of neurotransmitter receptor complex,BP,
18158,GO:0098972,1,0.992765200650824,0,1,anterograde dendritic transport of mitochondrion,BP,
18159,GO:0098973,1,0.994124435735787,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
18160,GO:0098974,1,0.994124435735787,0,1,postsynaptic actin cytoskeleton organization,BP,
18161,GO:0098976,1,0.945223912099164,0,8,excitatory chemical synaptic transmission,BP,
18162,GO:0098978,1,0.959050379510352,0,6,glutamatergic synapse,CC,
18163,GO:0098982,1,0.967185035270404,0,5,GABA-ergic synapse,CC,
18164,GO:0098983,1,0.973251586276036,0,4,symmetric, GABA-ergic, inhibitory synapse,CC,
18166,GO:0098985,1,0.959050379510352,0,6,asymmetric, glutamatergic, excitatory synapse,CC,
18168,GO:0098989,1,0.986821427660678,0,2,NMDA selective glutamate receptor signaling pathway,BP,
18169,GO:0098992,1,0.993933471569023,0,1,neuronal dense core vesicle,CC,
18170,GO:0098993,1,0.94742004095939,0,9,anchored component of synaptic vesicle membrane,CC,
18171,GO:0098999,1,0.993440160298641,0,1,extrinsic component of postsynaptic endosome membrane,CC,
18173,GO:0099004,1,0.967318953376321,0,5,calmodulin dependent kinase signaling pathway,BP,
18174,GO:0099010,1,0.979719561864889,0,3,modification of postsynaptic structure,BP,
18175,GO:0099011,1,0.964034652221095,0,5,neuronal dense core vesicle exocytosis,BP,
18176,GO:0099022,1,0.988040876093019,0,2,vesicle tethering,BP,
18177,GO:0099023,1,0.641114241400052,0,69,tethering complex,CC,
18178,GO:0099024,1,0.714935375694169,0,53,plasma membrane invagination,BP,
18179,GO:0099038,1,0.993238857927653,0,1,ceramide-translocating ATPase activity,MF,
18180,GO:0099039,1,0.986089234476015,0,2,sphingolipid translocation,BP,
18181,GO:0099040,1,0.993238857927653,0,1,ceramide translocation,BP,
18182,GO:0099044,1,0.988040876093019,0,2,vesicle tethering to endoplasmic reticulum,BP,
18183,GO:0099046,1,0.994229840085675,0,1,clearance of foreign intracellular nucleic acids,BP,
18184,GO:0099050,1,0.99385899933407,0,1,vesicle scission,BP,
18185,GO:0099053,1,0.981070498614762,0,3,activating signal cointegrator 1 complex,CC,
18186,GO:0099054,1,0.88553796843911,0,18,presynapse assembly,BP,
18187,GO:0099055,1,0.933475881807497,0,10,integral component of postsynaptic membrane,CC,
18188,GO:0099056,1,0.975113468258118,0,4,integral component of presynaptic membrane,CC,
18189,GO:0099059,1,0.993387708407071,0,1,integral component of presynaptic active zone membrane,CC,
18190,GO:0099060,1,0.970201720634226,0,4,integral component of postsynaptic specialization membrane,CC,
18191,GO:0099061,1,0.976661239655063,0,3,integral component of postsynaptic density membrane,CC,
18192,GO:0099068,1,0.887060154471357,0,17,postsynapse assembly,BP,
18193,GO:0099072,1,0.882189880390124,0,20,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,
18194,GO:0099073,1,0.987077742118578,0,2,mitochondrion-derived vesicle,CC,
18195,GO:0099074,1,0.987613992084886,0,2,mitochondrion to lysosome transport,BP,
18196,GO:0099075,1,0.987613992084886,0,2,mitochondrion-derived vesicle mediated transport,BP,
18197,GO:0099077,1,0.99298754253424,0,1,histone-dependent DNA binding,MF,
18198,GO:0099078,1,0.976948386510775,0,4,BORC complex,CC,
18201,GO:0099082,1,0.981434895642002,0,3,retrograde trans-synaptic signaling by neuropeptide,BP,
18202,GO:0099083,1,0.987887230606006,0,2,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18203,GO:0099084,1,0.899534558336963,0,15,postsynaptic specialization organization,BP,
18205,GO:0099089,1,0.991115060036865,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
18206,GO:0099093,1,0.986961982136313,0,2,calcium export from the mitochondrion,BP,
18209,GO:0099098,1,0.993716692884511,0,1,microtubule polymerization based movement,BP,
18210,GO:0099103,1,0.97578511131332,0,4,channel activator activity,MF,
18211,GO:0099104,1,0.97578511131332,0,4,potassium channel activator activity,MF,
18213,GO:0099111,1,0.405874385389924,0,137,microtubule-based transport,BP,
18214,GO:0099116,1,0.908597319855707,0,16,tRNA 5'-end processing,BP,
18215,GO:0099118,1,0.973241482039708,0,4,microtubule-based protein transport,BP,
18216,GO:0099122,1,0.980038790537531,0,3,RNA polymerase II C-terminal domain binding,MF,
18217,GO:0099130,1,0.994004649520989,0,1,estrogen binding,MF,
18218,GO:0099131,1,0.840544918752147,0,28,ATP hydrolysis coupled ion transmembrane transport,BP,
18219,GO:0099132,1,0.744834274459086,0,45,ATP hydrolysis coupled cation transmembrane transport,BP,
18220,GO:0099133,1,0.922169155931896,0,12,ATP hydrolysis coupled anion transmembrane transport,BP,
18221,GO:0099142,1,0.992876766536991,0,1,intracellularly ATP-gated ion channel activity,MF,
18222,GO:0099146,1,0.976661239655063,0,3,intrinsic component of postsynaptic density membrane,CC,
18223,GO:0099159,1,0.992567048784626,0,1,regulation of modification of postsynaptic structure,BP,
18224,GO:0099163,1,0.992587886344041,0,1,synaptic signaling by nitric oxide,BP,
18225,GO:0099170,1,0.981137120406731,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
18226,GO:0099172,1,0.874150030692115,0,20,presynapse organization,BP,
18227,GO:0099173,1,0.522690189719705,0,97,postsynapse organization,BP,
18228,GO:0099174,1,0.967741501750301,0,5,regulation of presynapse organization,BP,
18229,GO:0099175,1,0.701584053234393,0,53,regulation of postsynapse organization,BP,
18231,GO:0099186,1,0.994124435735787,0,1,structural constituent of postsynapse,MF,
18232,GO:0099188,1,0.994124435735787,0,1,postsynaptic cytoskeleton organization,BP,
18233,GO:0099240,1,0.933475881807497,0,10,intrinsic component of synaptic membrane,CC,
18234,GO:0099243,1,0.992554603024368,0,1,extrinsic component of synaptic membrane,CC,
18235,GO:0099400,1,0.991973955775138,0,1,caveola neck,CC,
18236,GO:0099402,1,0.994422168860593,0,1,plant organ development,BP,
18237,GO:0099403,1,0.983366508174279,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
18238,GO:0099404,1,0.983366508174279,0,2,mitotic sister chromatid cohesion, telomeric,BP,
18239,GO:0099500,1,0.905896954576785,0,16,vesicle fusion to plasma membrane,BP,
18243,GO:0099509,1,0.982471580611481,0,3,regulation of presynaptic cytosolic calcium ion concentration,BP,
18246,GO:0099514,1,0.899841650903061,0,17,synaptic vesicle cytoskeletal transport,BP,
18249,GO:0099517,1,0.899841650903061,0,17,synaptic vesicle transport along microtubule,BP,
18251,GO:0099519,1,0.993846081630578,0,1,dense core granule cytoskeletal transport,BP,
18252,GO:0099522,1,0.994059471842138,0,1,region of cytosol,CC,
18253,GO:0099523,1,0.994059471842138,0,1,presynaptic cytosol,CC,
18254,GO:0099524,1,0.994059471842138,0,1,postsynaptic cytosol,CC,
18255,GO:0099525,1,0.964034652221095,0,5,presynaptic dense core vesicle exocytosis,BP,
18256,GO:0099526,1,0.979341629677536,0,2,presynapse to nucleus signaling pathway,BP,
18257,GO:0099527,1,0.992642863188016,0,1,postsynapse to nucleus signaling pathway,BP,
18258,GO:0099528,1,0.851575125417429,0,26,G-protein coupled neurotransmitter receptor activity,MF,
18259,GO:0099529,1,0.79618160018939,0,35,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
18260,GO:0099530,1,0.985087805248213,0,2,G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential,MF,
18262,GO:0099532,1,0.985644073883888,0,2,synaptic vesicle endosomal processing,BP,
18265,GO:0099538,1,0.974167809310975,0,4,synaptic signaling via neuropeptide,BP,
18266,GO:0099540,1,0.974167809310975,0,4,trans-synaptic signaling by neuropeptide,BP,
18267,GO:0099541,1,0.96620761084604,0,5,trans-synaptic signaling by lipid,BP,
18268,GO:0099542,1,0.96620761084604,0,5,trans-synaptic signaling by endocannabinoid,BP,
18269,GO:0099543,1,0.992587886344041,0,1,trans-synaptic signaling by soluble gas,BP,
18270,GO:0099545,1,0.986521392543349,0,2,trans-synaptic signaling by trans-synaptic complex,BP,
18271,GO:0099547,1,0.981137120406731,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
18272,GO:0099548,1,0.992587886344041,0,1,trans-synaptic signaling by nitric oxide,BP,
18273,GO:0099550,1,0.95353197319669,0,7,trans-synaptic signaling, modulating synaptic transmission,BP,
18274,GO:0099551,1,0.980572854649061,0,3,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18275,GO:0099552,1,0.979044495384874,0,3,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
18276,GO:0099553,1,0.979044495384874,0,3,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
18277,GO:0099557,1,0.993244182420046,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
18278,GO:0099558,1,0.988461340158845,0,2,maintenance of synapse structure,BP,
18279,GO:0099560,1,0.979080805569897,0,3,synaptic membrane adhesion,BP,
18280,GO:0099563,1,0.930562342558688,0,11,modification of synaptic structure,BP,
18282,GO:0099566,1,0.978186687881195,0,3,regulation of postsynaptic cytosolic calcium ion concentration,BP,
18284,GO:0099569,1,0.946071030881052,0,7,presynaptic cytoskeleton,CC,
18285,GO:0099571,1,0.994157645442769,0,1,postsynaptic cytoskeleton,CC,
18287,GO:0099578,1,0.981137120406731,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
18288,GO:0099580,1,0.986092886853007,0,2,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
18289,GO:0099583,1,0.978186687881195,0,3,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18291,GO:0099589,1,0.924284439314344,0,13,serotonin receptor activity,MF,
18292,GO:0099590,1,0.933442808279357,0,11,neurotransmitter receptor internalization,BP,
18293,GO:0099601,1,0.749950626755579,0,44,regulation of neurotransmitter receptor activity,BP,
18294,GO:0099602,1,0.958687190838,0,7,neurotransmitter receptor regulator activity,MF,
18296,GO:0099606,1,0.992151554471554,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
18297,GO:0099607,1,0.992151554471554,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
18298,GO:0099609,1,0.985983467016695,0,2,microtubule lateral binding,MF,
18300,GO:0099617,1,0.993668715609209,0,1,matrix side of mitochondrial inner membrane,CC,
18301,GO:0099622,1,0.812046890936898,0,32,cardiac muscle cell membrane repolarization,BP,
18302,GO:0099623,1,0.863929558565587,0,22,regulation of cardiac muscle cell membrane repolarization,BP,
18303,GO:0099624,1,0.936192978365674,0,10,atrial cardiac muscle cell membrane repolarization,BP,
18304,GO:0099625,1,0.866233322589938,0,22,ventricular cardiac muscle cell membrane repolarization,BP,
18305,GO:0099628,1,0.952518631315059,0,8,neurotransmitter receptor diffusion trapping,BP,
18306,GO:0099631,1,0.988657025089136,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
18307,GO:0099632,1,0.893618817843564,0,18,protein transport within plasma membrane,BP,
18308,GO:0099634,1,0.794221340861601,0,34,postsynaptic specialization membrane,CC,
18309,GO:0099637,1,0.893618817843564,0,18,neurotransmitter receptor transport,BP,
18310,GO:0099638,1,0.968777935947492,0,5,endosome to plasma membrane protein transport,BP,
18311,GO:0099639,1,0.968777935947492,0,5,neurotransmitter receptor transport, endosome to plasma membrane,BP,
18312,GO:0099640,1,0.987074699014559,0,2,axo-dendritic protein transport,BP,
18313,GO:0099641,1,0.994388669429253,0,1,anterograde axonal protein transport,BP,
18315,GO:0099699,1,0.933475881807497,0,10,integral component of synaptic membrane,CC,
18316,GO:0099738,1,0.791127730364656,0,34,cell cortex region,CC,
18317,GO:0100001,1,0.993099097068624,0,1,regulation of skeletal muscle contraction by action potential,BP,
18318,GO:0100002,1,0.993820268042417,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
18319,GO:0100012,1,0.988471954944112,0,2,regulation of heart induction by canonical Wnt signaling pathway,BP,
18320,GO:0100057,1,0.992450518380993,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
18321,GO:0101002,1,0.325811125109096,0,179,ficolin-1-rich granule,CC,
18322,GO:0101003,1,0.696777349818729,0,56,ficolin-1-rich granule membrane,CC,
18323,GO:0101005,1,0.554792579327023,0,88,ubiquitinyl hydrolase activity,MF,
18324,GO:0101006,1,0.982396528940797,0,3,protein histidine phosphatase activity,MF,
18325,GO:0101020,1,0.982241070881442,0,3,estrogen 16-alpha-hydroxylase activity,MF,
18326,GO:0101023,1,0.911539369390818,0,14,vascular endothelial cell proliferation,BP,
18327,GO:0101030,1,0.994260450549984,0,1,tRNA-guanine transglycosylation,BP,
18328,GO:0101031,1,0.928434415817806,0,12,chaperone complex,CC,
18329,GO:0102005,1,0.994210780740709,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
18330,GO:0102007,1,0.982715684463169,0,3,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
18331,GO:0102008,1,0.993204883712955,0,1,cytosolic dipeptidase activity,MF,
18332,GO:0102009,1,0.994099601916721,0,1,proline dipeptidase activity,MF,
18333,GO:0102076,1,0.993822274700288,0,1,beta,beta-carotene-9',10'-cleaving oxygenase activity,MF,
18334,GO:0102077,1,0.988138669575988,0,2,oleamide hydrolase activity,MF,
18335,GO:0102084,1,0.987794468998477,0,2,L-dopa O-methyltransferase activity,MF,
18336,GO:0102092,1,0.986192583735348,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
18338,GO:0102113,1,0.992656170933357,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
18339,GO:0102121,1,0.981802194633824,0,3,ceramidase activity,MF,
18340,GO:0102131,1,0.99219824858548,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
18341,GO:0102132,1,0.99219824858548,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
18342,GO:0102148,1,0.982146513781582,0,3,N-acetyl-beta-D-galactosaminidase activity,MF,
18343,GO:0102158,1,0.975608343238402,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
18344,GO:0102166,1,0.993170600990028,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18345,GO:0102167,1,0.993170600990028,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18346,GO:0102200,1,0.993147543172949,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
18347,GO:0102250,1,0.981050247571959,0,3,linear malto-oligosaccharide phosphorylase activity,MF,
18348,GO:0102279,1,0.993241736100263,0,1,lecithin:11-cis retinol acyltransferase activity,MF,
18349,GO:0102336,1,0.963060796982218,0,6,3-oxo-arachidoyl-CoA synthase activity,MF,
18350,GO:0102337,1,0.963060796982218,0,6,3-oxo-cerotoyl-CoA synthase activity,MF,
18351,GO:0102338,1,0.963060796982218,0,6,3-oxo-lignoceronyl-CoA synthase activity,MF,
18352,GO:0102339,1,0.993913037246945,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
18353,GO:0102340,1,0.993913037246945,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
18354,GO:0102341,1,0.993913037246945,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
18355,GO:0102342,1,0.993913037246945,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
18356,GO:0102343,1,0.975608343238402,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
18357,GO:0102344,1,0.975608343238402,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
18358,GO:0102345,1,0.975608343238402,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
18359,GO:0102389,1,0.993879107070959,0,1,polyprenol reductase activity,MF,
18360,GO:0102390,1,0.993884280171658,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
18361,GO:0102391,1,0.956189150112812,0,7,decanoate-CoA ligase activity,MF,
18362,GO:0102420,1,0.986679651303277,0,2,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
18363,GO:0102483,1,0.9941603888507,0,1,scopolin beta-glucosidase activity,MF,
18364,GO:0102485,1,0.97901049676726,0,3,dATP phosphohydrolase activity,MF,
18365,GO:0102486,1,0.97901049676726,0,3,dCTP phosphohydrolase activity,MF,
18366,GO:0102487,1,0.97901049676726,0,3,dUTP phosphohydrolase activity,MF,
18367,GO:0102488,1,0.97901049676726,0,3,dTTP phosphohydrolase activity,MF,
18368,GO:0102489,1,0.97901049676726,0,3,GTP phosphohydrolase activity,MF,
18369,GO:0102490,1,0.97901049676726,0,3,8-oxo-dGTP phosphohydrolase activity,MF,
18370,GO:0102491,1,0.97901049676726,0,3,dGTP phosphohydrolase activity,MF,
18371,GO:0102499,1,0.981050247571959,0,3,SHG alpha-glucan phosphorylase activity,MF,
18372,GO:0102500,1,0.992570521872392,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
18373,GO:0102521,1,0.993684704193089,0,1,tRNA-4-demethylwyosine synthase activity,MF,
18374,GO:0102522,1,0.994007822079912,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
18375,GO:0102524,1,0.993846081630578,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
18376,GO:0102555,1,0.99437076473813,0,1,octanoyl transferase activity (acting on glycine-cleavage complex H protein),MF,
18377,GO:0102567,1,0.911422198807554,0,15,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,
18378,GO:0102568,1,0.911422198807554,0,15,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,
18379,GO:0102571,1,0.993170600990028,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18380,GO:0102704,1,0.993808518215935,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
18381,GO:0102707,1,0.993908721857596,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
18382,GO:0102751,1,0.987841901444646,0,2,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
18383,GO:0102752,1,0.99375013260469,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
18384,GO:0102756,1,0.963060796982218,0,6,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
18385,GO:0102758,1,0.99430896540168,0,1,very-long-chain enoyl-CoA reductase activity,MF,
18386,GO:0102769,1,0.994175260987969,0,1,dihydroceramide glucosyltransferase activity,MF,
18387,GO:0102773,1,0.993366476746011,0,1,dihydroceramide kinase activity,MF,
18388,GO:0102797,1,0.99322014595224,0,1,geranial:oxygen oxidoreductase activity,MF,
18389,GO:0102798,1,0.99322014595224,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
18390,GO:0102867,1,0.993857276569899,0,1,molybdenum cofactor sulfurtransferase activity,MF,
18391,GO:0102938,1,0.987794468998477,0,2,orcinol O-methyltransferase activity,MF,
18392,GO:0102953,1,0.981880669410057,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
18393,GO:0102965,1,0.98720890042454,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
18394,GO:0102991,1,0.964892690639133,0,6,myristoyl-CoA hydrolase activity,MF,
18395,GO:0103025,1,0.988226809616709,0,2,alpha-amylase activity (releasing maltohexaose),MF,
18396,GO:0103045,1,0.994048215237947,0,1,methione N-acyltransferase activity,MF,
18397,GO:0103046,1,0.993204883712955,0,1,alanylglutamate dipeptidase activity,MF,
18398,GO:0103053,1,0.988308864515749,0,2,1-ethyladenine demethylase activity,MF,
18399,GO:0103066,1,0.994184790690414,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
18400,GO:0103067,1,0.994184790690414,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
18401,GO:0103068,1,0.981880669410057,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
18402,GO:0103073,1,0.988138669575988,0,2,anandamide amidohydrolase activity,MF,
18405,GO:0106001,1,0.962619684289601,0,6,intestinal hexose absorption,BP,
18406,GO:0106003,1,0.928960047365743,0,11,amyloid-beta complex,CC,
18407,GO:0106004,1,0.988448698727984,0,2,tRNA (guanine-N7)-methylation,BP,
18408,GO:0106005,1,0.992859718104023,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
18409,GO:0106014,1,0.988085342249701,0,2,regulation of inflammatory response to wounding,BP,
18410,GO:0106015,1,0.988085342249701,0,2,negative regulation of inflammatory response to wounding,BP,
18411,GO:0106017,1,0.973615276962875,0,4,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
18412,GO:0106018,1,0.902304212878617,0,15,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
18413,GO:0106019,1,0.93525265454908,0,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
18414,GO:0106020,1,0.987552624569279,0,2,regulation of vesicle docking,BP,
18415,GO:0106022,1,0.993519256707328,0,1,positive regulation of vesicle docking,BP,
18416,GO:0106027,1,0.62752586790007,0,69,neuron projection organization,BP,
18417,GO:0106028,1,0.993244182420046,0,1,neuron projection retraction,BP,
18419,GO:0106044,1,0.994377406787888,0,1,guanine deglycation,BP,
18420,GO:0106045,1,0.994377406787888,0,1,guanine deglycation, methylglyoxal removal,BP,
18421,GO:0106046,1,0.994377406787888,0,1,guanine deglycation, glyoxal removal,BP,
18422,GO:0106049,1,0.963243304542197,0,6,regulation of cellular response to osmotic stress,BP,
18423,GO:0106050,1,0.994081123065024,0,1,tRNA 2'-O-methyltransferase activity,MF,
18425,GO:0106057,1,0.9799384099994,0,3,negative regulation of calcineurin-mediated signaling,BP,
18426,GO:0106058,1,0.942818326921262,0,9,positive regulation of calcineurin-mediated signaling,BP,
18427,GO:0106064,1,0.99298595432303,0,1,regulation of cobalamin metabolic process,BP,
18428,GO:0106068,1,0.963730379015821,0,6,SUMO ligase complex,CC,
18429,GO:0106070,1,0.936396229645781,0,10,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
18430,GO:0106071,1,0.967563201027851,0,5,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
18431,GO:0106072,1,0.956621647749847,0,7,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
18432,GO:0106073,1,0.985538227845338,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
18433,GO:0106074,1,0.932630456843573,0,11,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
18434,GO:0106075,1,0.993745843868824,0,1,peptide N-succinyltransferase activity,MF,
18435,GO:0106077,1,0.974830413617183,0,4,histone succinylation,BP,
18436,GO:0106078,1,0.993745843868824,0,1,histone succinyltransferase activity,MF,
18437,GO:0106083,1,0.950233169707479,0,7,nuclear membrane protein complex,CC,
18438,GO:0106088,1,0.992668031382353,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
18439,GO:0106089,1,0.992668031382353,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
18440,GO:0106094,1,0.950233169707479,0,7,nuclear membrane microtubule tethering complex,CC,
18441,GO:0106101,1,0.99411389551973,0,1,ER-dependent peroxisome localization,BP,
18442,GO:0106104,1,0.979518960887114,0,3,regulation of glutamate receptor clustering,BP,
18443,GO:0110008,1,0.993766577721598,0,1,ncRNA deadenylation,BP,
18444,GO:0110009,1,0.979730415588547,0,3,formin-nucleated actin cable organization,BP,
18445,GO:0110011,1,0.964417486334895,0,5,regulation of basement membrane organization,BP,
18446,GO:0110017,1,0.988604321952196,0,2,cap-independent translational initiation of linear mRNA,BP,
18448,GO:0110021,1,0.981401151177873,0,3,cardiac muscle myoblast proliferation,BP,
18449,GO:0110022,1,0.981401151177873,0,3,regulation of cardiac muscle myoblast proliferation,BP,
18450,GO:0110024,1,0.981401151177873,0,3,positive regulation of cardiac muscle myoblast proliferation,BP,
18451,GO:0110025,1,0.993765290414594,0,1,DNA strand resection involved in replication fork processing,BP,
18452,GO:0110026,1,0.993765290414594,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
18453,GO:0110028,1,0.992572258392098,0,1,positive regulation of mitotic spindle organization,BP,
18454,GO:0110029,1,0.993736982052292,0,1,negative regulation of meiosis I,BP,
18456,GO:0110057,1,0.993068514740504,0,1,regulation of blood vessel endothelial cell differentiation,BP,
18457,GO:0110059,1,0.993068514740504,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
18458,GO:0110075,1,0.994375385292897,0,1,regulation of ferroptosis,BP,
18459,GO:0110076,1,0.994375385292897,0,1,negative regulation of ferroptosis,BP,
18460,GO:0110095,1,0.982662350878292,0,3,cellular detoxification of aldehyde,BP,
18461,GO:0110096,1,0.971147661196807,0,5,cellular response to aldehyde,BP,
18462,GO:0120009,1,0.96924736120115,0,5,intermembrane lipid transfer,BP,
18463,GO:0120012,1,0.993091596746235,0,1,intermembrane sphingolipid transfer,BP,
18464,GO:0120013,1,0.96924736120115,0,5,intermembrane lipid transfer activity,MF,
18465,GO:0120016,1,0.993091596746235,0,1,intermembrane sphingolipid transfer activity,MF,
18466,GO:0120017,1,0.993091596746235,0,1,intermembrane ceramide transfer activity,MF,
18470,GO:0120033,1,0.882354041251428,0,20,negative regulation of plasma membrane bounded cell projection assembly,BP,
18471,GO:0120034,1,0.589845814805952,0,81,positive regulation of plasma membrane bounded cell projection assembly,BP,
18476,GO:0120043,1,0.993281725437243,0,1,stereocilium shaft,CC,
18477,GO:0120044,1,0.993281725437243,0,1,stereocilium base,CC,
18478,GO:0120048,1,0.993846081630578,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
18479,GO:0120049,1,0.993846081630578,0,1,snRNA (adenine-N6)-methylation,BP,
18480,GO:0120054,1,0.994440940310254,0,1,intestinal motility,BP,
18481,GO:0120055,1,0.994440940310254,0,1,small intestinal transit,BP,
18482,GO:0120057,1,0.994440940310254,0,1,regulation of small intestinal transit,BP,
18483,GO:0120058,1,0.994440940310254,0,1,positive regulation of small intestinal transit,BP,
18484,GO:0120060,1,0.994411772435139,0,1,regulation of gastric emptying,BP,
18485,GO:0120061,1,0.994411772435139,0,1,negative regulation of gastric emptying,BP,
18486,GO:0120063,1,0.987605533444756,0,2,stomach smooth muscle contraction,BP,
18487,GO:0120064,1,0.993155902566615,0,1,stomach pylorus smooth muscle contraction,BP,
18488,GO:0120065,1,0.993155902566615,0,1,pyloric antrum smooth muscle contraction,BP,
18489,GO:0120068,1,0.994411772435139,0,1,regulation of stomach fundus smooth muscle contraction,BP,
18490,GO:0120069,1,0.994411772435139,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
18491,GO:0120071,1,0.993155902566615,0,1,regulation of pyloric antrum smooth muscle contraction,BP,
18492,GO:0120072,1,0.993155902566615,0,1,positive regulation of pyloric antrum smooth muscle contraction,BP,
18493,GO:0120077,1,0.992668031382353,0,1,angiogenic sprout fusion,BP,
18494,GO:0120078,1,0.992668031382353,0,1,cell adhesion involved in sprouting angiogenesis,BP,
18495,GO:0120092,1,0.99367728053667,0,1,crotonyl-CoA hydratase activity,MF,
18496,GO:0120093,1,0.99367728053667,0,1,regulation of peptidyl-lysine crotonylation,BP,
18497,GO:0120094,1,0.99367728053667,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
18498,GO:0120103,1,0.942490773985261,0,9,centriolar subdistal appendage,CC,
18499,GO:0120108,1,0.994063224376902,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
18500,GO:0120111,1,0.646794397585547,0,67,neuron projection cytoplasm,CC,
18501,GO:0120114,1,0.611002303100987,0,79,Sm-like protein family complex,CC,
18502,GO:0140007,1,0.976079440730101,0,4,KICSTOR complex,CC,
18503,GO:0140009,1,0.987208630193573,0,2,L-aspartate import across plasma membrane,BP,
18506,GO:0140029,1,0.618379338724745,0,76,exocytic process,BP,
18507,GO:0140030,1,0.474812456999106,0,113,modification-dependent protein binding,MF,
18508,GO:0140031,1,0.98779534962464,0,2,phosphorylation-dependent protein binding,MF,
18509,GO:0140033,1,0.888329627176642,0,17,acetylation-dependent protein binding,MF,
18510,GO:0140034,1,0.691693631944205,0,56,methylation-dependent protein binding,MF,
18511,GO:0140035,1,0.967615488711811,0,5,ubiquitination-like modification-dependent protein binding,MF,
18512,GO:0140036,1,0.967615488711811,0,5,ubiquitin-dependent protein binding,MF,
18513,GO:0140041,1,0.994377406787888,0,1,cellular detoxification of methylglyoxal,BP,
18514,GO:0140049,1,0.99416717517006,0,1,regulation of endocardial cushion to mesenchymal transition,BP,
18515,GO:0140051,1,0.99416717517006,0,1,positive regulation of endocardial cushion to mesenchymal transition,BP,
18516,GO:0140052,1,0.968167855774603,0,5,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
18517,GO:0140053,1,0.403910452770331,0,151,mitochondrial gene expression,BP,
18518,GO:0140056,1,0.332618157735582,0,170,organelle localization by membrane tethering,BP,
18520,GO:0140059,1,0.968409716546921,0,5,dendrite arborization,BP,
18521,GO:0140064,1,0.992113842885886,0,1,peptide crotonyltransferase activity,MF,
18522,GO:0140065,1,0.992113842885886,0,1,peptide butyryltransferase activity,MF,
18523,GO:0140066,1,0.985840480484128,0,2,peptidyl-lysine crotonylation,BP,
18524,GO:0140067,1,0.992113842885886,0,1,peptidyl-lysine butyrylation,BP,
18525,GO:0140068,1,0.992113842885886,0,1,histone crotonyltransferase activity,MF,
18526,GO:0140069,1,0.992113842885886,0,1,histone butyryltransferase activity,MF,
18527,GO:0140074,1,0.993155326090277,0,1,cardiac endothelial to mesenchymal transition,BP,
18528,GO:0140078,1,0.942194703418271,0,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
18529,GO:0140080,1,0.942194703418271,0,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
18532,GO:0140098,1,0.119283440356848,0,338,catalytic activity, acting on RNA,MF,
18533,GO:0140101,1,0.492198085393458,0,115,catalytic activity, acting on a tRNA,MF,
18534,GO:0140102,1,0.912571251532008,0,15,catalytic activity, acting on a rRNA,MF,
18535,GO:0140103,1,0.882062480039072,0,20,catalytic activity, acting on a glycoprotein,MF,
18538,GO:0140112,1,0.883847534087787,0,20,extracellular vesicle biogenesis,BP,
18541,GO:0140135,1,0.975122175942295,0,4,mechanosensitive cation channel activity,MF,
18542,GO:0140142,1,0.888623623952426,0,18,nucleocytoplasmic carrier activity,MF,
18543,GO:0140161,1,0.952753620510728,0,8,monocarboxylate:sodium symporter activity,MF,
18544,GO:0140192,1,0.984746199084526,0,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18545,GO:0140193,1,0.994257273990689,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18546,GO:0140194,1,0.994257273990689,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18547,GO:0140196,1,0.992587886344041,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18548,GO:0140199,1,0.992100351952376,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18549,GO:0140200,1,0.992304065815459,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
18550,GO:0150003,1,0.973244248737984,0,4,regulation of spontaneous synaptic transmission,BP,
18551,GO:0150005,1,0.933764466827974,0,11,enzyme activator complex,CC,
18552,GO:0150011,1,0.953895224376482,0,7,regulation of neuron projection arborization,BP,
18553,GO:0150012,1,0.953895224376482,0,7,positive regulation of neuron projection arborization,BP,
18554,GO:0150018,1,0.980347569513525,0,3,basal dendrite development,BP,
18555,GO:0150019,1,0.980347569513525,0,3,basal dendrite morphogenesis,BP,
18556,GO:0150020,1,0.980347569513525,0,3,basal dendrite arborization,BP,
18557,GO:0150024,1,0.99404850384895,0,1,oxidised low-density lipoprotein particle clearance,BP,
18558,GO:0150025,1,0.99404850384895,0,1,oxidised low-density lipoprotein particle receptor activity,MF,
18559,GO:0150031,1,0.99279642279045,0,1,regulation of protein localization to lysosome,BP,
18560,GO:0150033,1,0.99279642279045,0,1,negative regulation of protein localization to lysosome,BP,
18563,GO:1900003,1,0.964120120208138,0,6,regulation of serine-type endopeptidase activity,BP,
18564,GO:1900004,1,0.964120120208138,0,6,negative regulation of serine-type endopeptidase activity,BP,
18565,GO:1900005,1,0.991956535396447,0,1,positive regulation of serine-type endopeptidase activity,BP,
18567,GO:1900010,1,0.994115772520527,0,1,regulation of corticotropin-releasing hormone receptor activity,BP,
18568,GO:1900011,1,0.994115772520527,0,1,negative regulation of corticotropin-releasing hormone receptor activity,BP,
18569,GO:1900015,1,0.843329044285558,0,27,regulation of cytokine production involved in inflammatory response,BP,
18570,GO:1900016,1,0.945555049717951,0,9,negative regulation of cytokine production involved in inflammatory response,BP,
18571,GO:1900017,1,0.921634524717781,0,13,positive regulation of cytokine production involved in inflammatory response,BP,
18572,GO:1900019,1,0.974435594110385,0,4,regulation of protein kinase C activity,BP,
18573,GO:1900020,1,0.974435594110385,0,4,positive regulation of protein kinase C activity,BP,
18575,GO:1900025,1,0.926612051417135,0,12,negative regulation of substrate adhesion-dependent cell spreading,BP,
18577,GO:1900027,1,0.861131028314987,0,24,regulation of ruffle assembly,BP,
18578,GO:1900028,1,0.969983758345498,0,5,negative regulation of ruffle assembly,BP,
18579,GO:1900029,1,0.933307446037179,0,11,positive regulation of ruffle assembly,BP,
18581,GO:1900035,1,0.993862875998648,0,1,negative regulation of cellular response to heat,BP,
18582,GO:1900036,1,0.993972359078902,0,1,positive regulation of cellular response to heat,BP,
18583,GO:1900037,1,0.928724352172058,0,12,regulation of cellular response to hypoxia,BP,
18584,GO:1900038,1,0.95748886840686,0,7,negative regulation of cellular response to hypoxia,BP,
18585,GO:1900039,1,0.988010489651644,0,2,positive regulation of cellular response to hypoxia,BP,
18586,GO:1900040,1,0.954824603650588,0,7,regulation of interleukin-2 secretion,BP,
18587,GO:1900041,1,0.975388158137739,0,4,negative regulation of interleukin-2 secretion,BP,
18588,GO:1900042,1,0.978922870444961,0,3,positive regulation of interleukin-2 secretion,BP,
18589,GO:1900044,1,0.940269569395189,0,9,regulation of protein K63-linked ubiquitination,BP,
18590,GO:1900045,1,0.965980596230479,0,5,negative regulation of protein K63-linked ubiquitination,BP,
18591,GO:1900046,1,0.646298227064168,0,70,regulation of hemostasis,BP,
18592,GO:1900047,1,0.761688687970724,0,44,negative regulation of hemostasis,BP,
18593,GO:1900048,1,0.866523658191851,0,23,positive regulation of hemostasis,BP,
18594,GO:1900052,1,0.994292793750381,0,1,regulation of retinoic acid biosynthetic process,BP,
18595,GO:1900053,1,0.994292793750381,0,1,negative regulation of retinoic acid biosynthetic process,BP,
18596,GO:1900060,1,0.975731416757807,0,4,negative regulation of ceramide biosynthetic process,BP,
18597,GO:1900062,1,0.993577090101431,0,1,regulation of replicative cell aging,BP,
18598,GO:1900063,1,0.978800631958654,0,3,regulation of peroxisome organization,BP,
18599,GO:1900073,1,0.994191288208666,0,1,regulation of neuromuscular synaptic transmission,BP,
18600,GO:1900075,1,0.994191288208666,0,1,positive regulation of neuromuscular synaptic transmission,BP,
18601,GO:1900076,1,0.652559284134538,0,66,regulation of cellular response to insulin stimulus,BP,
18602,GO:1900077,1,0.80995619984601,0,33,negative regulation of cellular response to insulin stimulus,BP,
18603,GO:1900078,1,0.84135763184213,0,26,positive regulation of cellular response to insulin stimulus,BP,
18604,GO:1900081,1,0.992100351952376,0,1,regulation of arginine catabolic process,BP,
18605,GO:1900082,1,0.992100351952376,0,1,negative regulation of arginine catabolic process,BP,
18607,GO:1900085,1,0.993875802566782,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18609,GO:1900087,1,0.840779866225375,0,27,positive regulation of G1/S transition of mitotic cell cycle,BP,
18610,GO:1900094,1,0.957257425097043,0,7,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
18611,GO:1900095,1,0.991588169150574,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
18612,GO:1900098,1,0.994125157678534,0,1,regulation of plasma cell differentiation,BP,
18613,GO:1900100,1,0.994125157678534,0,1,positive regulation of plasma cell differentiation,BP,
18615,GO:1900102,1,0.933426706815615,0,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,
18617,GO:1900104,1,0.981544651972138,0,3,regulation of hyaluranon cable assembly,BP,
18618,GO:1900106,1,0.981544651972138,0,3,positive regulation of hyaluranon cable assembly,BP,
18619,GO:1900107,1,0.956927049266025,0,7,regulation of nodal signaling pathway,BP,
18620,GO:1900108,1,0.982350630657855,0,3,negative regulation of nodal signaling pathway,BP,
18621,GO:1900109,1,0.982473676851208,0,3,regulation of histone H3-K9 dimethylation,BP,
18622,GO:1900110,1,0.988476984329102,0,2,negative regulation of histone H3-K9 dimethylation,BP,
18623,GO:1900111,1,0.993927426253613,0,1,positive regulation of histone H3-K9 dimethylation,BP,
18624,GO:1900112,1,0.941887749275586,0,9,regulation of histone H3-K9 trimethylation,BP,
18625,GO:1900113,1,0.969143121309663,0,5,negative regulation of histone H3-K9 trimethylation,BP,
18626,GO:1900114,1,0.98635465368229,0,2,positive regulation of histone H3-K9 trimethylation,BP,
18627,GO:1900115,1,0.907907170220327,0,15,extracellular regulation of signal transduction,BP,
18628,GO:1900116,1,0.907907170220327,0,15,extracellular negative regulation of signal transduction,BP,
18630,GO:1900118,1,0.956838469959522,0,7,negative regulation of execution phase of apoptosis,BP,
18632,GO:1900120,1,0.882775170965476,0,20,regulation of receptor binding,BP,
18633,GO:1900121,1,0.933957735541665,0,11,negative regulation of receptor binding,BP,
18634,GO:1900122,1,0.951296520007246,0,8,positive regulation of receptor binding,BP,
18635,GO:1900125,1,0.954933157647007,0,7,regulation of hyaluronan biosynthetic process,BP,
18636,GO:1900126,1,0.979955345567941,0,3,negative regulation of hyaluronan biosynthetic process,BP,
18637,GO:1900127,1,0.97447119832159,0,4,positive regulation of hyaluronan biosynthetic process,BP,
18638,GO:1900130,1,0.993605492151102,0,1,regulation of lipid binding,BP,
18639,GO:1900131,1,0.993605492151102,0,1,negative regulation of lipid binding,BP,
18640,GO:1900133,1,0.981327930406266,0,3,regulation of renin secretion into blood stream,BP,
18641,GO:1900134,1,0.993551393020953,0,1,negative regulation of renin secretion into blood stream,BP,
18642,GO:1900135,1,0.98769800866029,0,2,positive regulation of renin secretion into blood stream,BP,
18643,GO:1900138,1,0.987476415630746,0,2,negative regulation of phospholipase A2 activity,BP,
18644,GO:1900139,1,0.993197107021168,0,1,negative regulation of arachidonic acid secretion,BP,
18645,GO:1900141,1,0.993923108860103,0,1,regulation of oligodendrocyte apoptotic process,BP,
18646,GO:1900142,1,0.993923108860103,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
18647,GO:1900145,1,0.968708737290788,0,5,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18648,GO:1900146,1,0.988480858783018,0,2,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18649,GO:1900147,1,0.986458408758536,0,2,regulation of Schwann cell migration,BP,
18650,GO:1900148,1,0.993846081630578,0,1,negative regulation of Schwann cell migration,BP,
18651,GO:1900149,1,0.992567048784626,0,1,positive regulation of Schwann cell migration,BP,
18652,GO:1900150,1,0.988065733148753,0,2,regulation of defense response to fungus,BP,
18653,GO:1900151,1,0.899388771288962,0,16,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18654,GO:1900152,1,0.994120970426215,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18655,GO:1900153,1,0.899388771288962,0,16,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18660,GO:1900159,1,0.993961985134131,0,1,positive regulation of bone mineralization involved in bone maturation,BP,
18661,GO:1900161,1,0.993841633846993,0,1,regulation of phospholipid scramblase activity,BP,
18662,GO:1900163,1,0.993841633846993,0,1,positive regulation of phospholipid scramblase activity,BP,
18663,GO:1900164,1,0.957257425097043,0,7,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18664,GO:1900165,1,0.956677210883394,0,7,negative regulation of interleukin-6 secretion,BP,
18665,GO:1900166,1,0.987780023564917,0,2,regulation of glial cell-derived neurotrophic factor secretion,BP,
18666,GO:1900168,1,0.987780023564917,0,2,positive regulation of glial cell-derived neurotrophic factor secretion,BP,
18667,GO:1900169,1,0.984695666732466,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
18668,GO:1900170,1,0.993846081630578,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
18669,GO:1900175,1,0.968708737290788,0,5,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18670,GO:1900176,1,0.988480858783018,0,2,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18671,GO:1900180,1,0.549669719966167,0,93,regulation of protein localization to nucleus,BP,
18672,GO:1900181,1,0.873324878094032,0,21,negative regulation of protein localization to nucleus,BP,
18673,GO:1900182,1,0.669743189298463,0,62,positive regulation of protein localization to nucleus,BP,
18674,GO:1900186,1,0.981128251392232,0,3,negative regulation of clathrin-dependent endocytosis,BP,
18675,GO:1900190,1,0.993961985134131,0,1,regulation of single-species biofilm formation,BP,
18676,GO:1900191,1,0.993961985134131,0,1,negative regulation of single-species biofilm formation,BP,
18677,GO:1900193,1,0.958579037058139,0,7,regulation of oocyte maturation,BP,
18678,GO:1900194,1,0.982061001165971,0,3,negative regulation of oocyte maturation,BP,
18679,GO:1900195,1,0.988120901778157,0,2,positive regulation of oocyte maturation,BP,
18680,GO:1900200,1,0.987038592633319,0,2,mesenchymal cell apoptotic process involved in metanephros development,BP,
18681,GO:1900204,1,0.987038592633319,0,2,apoptotic process involved in metanephric collecting duct development,BP,
18682,GO:1900205,1,0.987038592633319,0,2,apoptotic process involved in metanephric nephron tubule development,BP,
18683,GO:1900208,1,0.98841970056701,0,2,regulation of cardiolipin metabolic process,BP,
18684,GO:1900210,1,0.98841970056701,0,2,positive regulation of cardiolipin metabolic process,BP,
18685,GO:1900211,1,0.987038592633319,0,2,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18686,GO:1900212,1,0.987038592633319,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18687,GO:1900214,1,0.987038592633319,0,2,regulation of apoptotic process involved in metanephric collecting duct development,BP,
18688,GO:1900215,1,0.987038592633319,0,2,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
18689,GO:1900217,1,0.987038592633319,0,2,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18690,GO:1900218,1,0.987038592633319,0,2,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18691,GO:1900220,1,0.98594975090787,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
18692,GO:1900221,1,0.932896144331477,0,10,regulation of amyloid-beta clearance,BP,
18693,GO:1900222,1,0.98040976065888,0,3,negative regulation of amyloid-beta clearance,BP,
18694,GO:1900223,1,0.957350888514614,0,6,positive regulation of amyloid-beta clearance,BP,
18695,GO:1900224,1,0.985725443987915,0,2,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18696,GO:1900225,1,0.931300898782457,0,11,regulation of NLRP3 inflammasome complex assembly,BP,
18697,GO:1900226,1,0.97461197853524,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
18698,GO:1900227,1,0.96147278068637,0,6,positive regulation of NLRP3 inflammasome complex assembly,BP,
18699,GO:1900228,1,0.993961985134131,0,1,regulation of single-species biofilm formation in or on host organism,BP,
18700,GO:1900229,1,0.993961985134131,0,1,negative regulation of single-species biofilm formation in or on host organism,BP,
18701,GO:1900238,1,0.980784331747529,0,3,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
18702,GO:1900239,1,0.973328641295632,0,4,regulation of phenotypic switching,BP,
18703,GO:1900241,1,0.993816398551809,0,1,positive regulation of phenotypic switching,BP,
18704,GO:1900242,1,0.94584164113573,0,8,regulation of synaptic vesicle endocytosis,BP,
18705,GO:1900243,1,0.993137452885281,0,1,negative regulation of synaptic vesicle endocytosis,BP,
18706,GO:1900244,1,0.972860484860812,0,4,positive regulation of synaptic vesicle endocytosis,BP,
18707,GO:1900245,1,0.978969932434335,0,3,positive regulation of MDA-5 signaling pathway,BP,
18708,GO:1900246,1,0.965287391320475,0,5,positive regulation of RIG-I signaling pathway,BP,
18709,GO:1900247,1,0.938611920769311,0,10,regulation of cytoplasmic translational elongation,BP,
18710,GO:1900248,1,0.98605314175697,0,2,negative regulation of cytoplasmic translational elongation,BP,
18711,GO:1900259,1,0.994099890666424,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18712,GO:1900260,1,0.994099890666424,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18713,GO:1900262,1,0.964772671246143,0,6,regulation of DNA-directed DNA polymerase activity,BP,
18714,GO:1900264,1,0.964772671246143,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
18716,GO:1900272,1,0.94855618861925,0,8,negative regulation of long-term synaptic potentiation,BP,
18719,GO:1900275,1,0.986724606035468,0,2,negative regulation of phospholipase C activity,BP,
18720,GO:1900276,1,0.993655726867109,0,1,regulation of proteinase activated receptor activity,BP,
18721,GO:1900279,1,0.993641597666767,0,1,regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18722,GO:1900281,1,0.993641597666767,0,1,positive regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18723,GO:1900363,1,0.926241496157236,0,12,regulation of mRNA polyadenylation,BP,
18724,GO:1900364,1,0.950208635721762,0,8,negative regulation of mRNA polyadenylation,BP,
18725,GO:1900365,1,0.980494285864029,0,3,positive regulation of mRNA polyadenylation,BP,
18726,GO:1900368,1,0.979494123409672,0,3,regulation of RNA interference,BP,
18727,GO:1900369,1,0.986304026838897,0,2,negative regulation of RNA interference,BP,
18728,GO:1900370,1,0.993096500879971,0,1,positive regulation of RNA interference,BP,
18731,GO:1900373,1,0.702448956141071,0,56,positive regulation of purine nucleotide biosynthetic process,BP,
18732,GO:1900376,1,0.952778750442027,0,7,regulation of secondary metabolite biosynthetic process,BP,
18733,GO:1900377,1,0.985696884740094,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
18734,GO:1900378,1,0.966609025823561,0,5,positive regulation of secondary metabolite biosynthetic process,BP,
18735,GO:1900383,1,0.993706123180338,0,1,regulation of synaptic plasticity by receptor localization to synapse,BP,
18736,GO:1900387,1,0.994041577493381,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
18738,GO:1900402,1,0.946107291501493,0,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18741,GO:1900409,1,0.909875263950372,0,15,positive regulation of cellular response to oxidative stress,BP,
18742,GO:1900424,1,0.926968682772093,0,12,regulation of defense response to bacterium,BP,
18743,GO:1900425,1,0.968676355300509,0,5,negative regulation of defense response to bacterium,BP,
18744,GO:1900426,1,0.963917780127395,0,6,positive regulation of defense response to bacterium,BP,
18745,GO:1900449,1,0.757640096965608,0,42,regulation of glutamate receptor signaling pathway,BP,
18746,GO:1900450,1,0.993244182420046,0,1,negative regulation of glutamate receptor signaling pathway,BP,
18747,GO:1900451,1,0.939991096653237,0,9,positive regulation of glutamate receptor signaling pathway,BP,
18748,GO:1900452,1,0.922984237254397,0,12,regulation of long term synaptic depression,BP,
18749,GO:1900453,1,0.981588398062357,0,3,negative regulation of long term synaptic depression,BP,
18750,GO:1900454,1,0.967291088306173,0,5,positive regulation of long term synaptic depression,BP,
18751,GO:1900477,1,0.994046772199363,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
18752,GO:1900533,1,0.994204860789484,0,1,palmitic acid metabolic process,BP,
18753,GO:1900535,1,0.994204860789484,0,1,palmitic acid biosynthetic process,BP,
18756,GO:1900544,1,0.636741082743025,0,72,positive regulation of purine nucleotide metabolic process,BP,
18757,GO:1900558,1,0.994077514217126,0,1,austinol metabolic process,BP,
18758,GO:1900560,1,0.994077514217126,0,1,austinol biosynthetic process,BP,
18759,GO:1900561,1,0.994077514217126,0,1,dehydroaustinol metabolic process,BP,
18760,GO:1900563,1,0.994077514217126,0,1,dehydroaustinol biosynthetic process,BP,
18761,GO:1900619,1,0.981674053719668,0,3,acetate ester metabolic process,BP,
18762,GO:1900620,1,0.99388284309816,0,1,acetate ester biosynthetic process,BP,
18763,GO:1900623,1,0.980165922111716,0,3,regulation of monocyte aggregation,BP,
18764,GO:1900625,1,0.980165922111716,0,3,positive regulation of monocyte aggregation,BP,
18765,GO:1900673,1,0.981434221727428,0,3,olefin metabolic process,BP,
18766,GO:1900719,1,0.993205747724528,0,1,regulation of uterine smooth muscle relaxation,BP,
18767,GO:1900721,1,0.993205747724528,0,1,positive regulation of uterine smooth muscle relaxation,BP,
18768,GO:1900736,1,0.976648750288518,0,4,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18769,GO:1900737,1,0.993655726867109,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18770,GO:1900738,1,0.982885539995041,0,3,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18771,GO:1900739,1,0.83143564124129,0,30,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18772,GO:1900740,1,0.83143564124129,0,30,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18773,GO:1900744,1,0.820382035051956,0,31,regulation of p38MAPK cascade,BP,
18774,GO:1900745,1,0.87557511145439,0,21,positive regulation of p38MAPK cascade,BP,
18775,GO:1900746,1,0.936355831772551,0,10,regulation of vascular endothelial growth factor signaling pathway,BP,
18776,GO:1900747,1,0.980689266817274,0,3,negative regulation of vascular endothelial growth factor signaling pathway,BP,
18777,GO:1900748,1,0.971891941348075,0,4,positive regulation of vascular endothelial growth factor signaling pathway,BP,
18779,GO:1900753,1,0.993393444619628,0,1,doxorubicin transport,BP,
18780,GO:1900756,1,0.986378163353932,0,2,protein processing in phagocytic vesicle,BP,
18781,GO:1900825,1,0.979691115184099,0,3,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18782,GO:1900827,1,0.991776434087182,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18783,GO:1900864,1,0.946863292335647,0,9,mitochondrial RNA modification,BP,
18784,GO:1901004,1,0.994279221143796,0,1,ubiquinone-6 metabolic process,BP,
18785,GO:1901006,1,0.994279221143796,0,1,ubiquinone-6 biosynthetic process,BP,
18786,GO:1901016,1,0.723580626902893,0,49,regulation of potassium ion transmembrane transporter activity,BP,
18787,GO:1901017,1,0.906830747296009,0,15,negative regulation of potassium ion transmembrane transporter activity,BP,
18788,GO:1901018,1,0.863247732548895,0,22,positive regulation of potassium ion transmembrane transporter activity,BP,
18790,GO:1901020,1,0.826042597354405,0,31,negative regulation of calcium ion transmembrane transporter activity,BP,
18792,GO:1901026,1,0.9794116781691,0,3,ripoptosome assembly involved in necroptotic process,BP,
18798,GO:1901033,1,0.951609839026604,0,8,positive regulation of response to reactive oxygen species,BP,
18799,GO:1901052,1,0.993692556969627,0,1,sarcosine metabolic process,BP,
18800,GO:1901053,1,0.993692556969627,0,1,sarcosine catabolic process,BP,
18801,GO:1901068,1,0.729036111491883,0,50,guanosine-containing compound metabolic process,BP,
18802,GO:1901069,1,0.994237637088681,0,1,guanosine-containing compound catabolic process,BP,
18803,GO:1901070,1,0.921817412779298,0,14,guanosine-containing compound biosynthetic process,BP,
18804,GO:1901071,1,0.871443956630008,0,22,glucosamine-containing compound metabolic process,BP,
18805,GO:1901072,1,0.947192962264186,0,9,glucosamine-containing compound catabolic process,BP,
18806,GO:1901073,1,0.986720870031848,0,2,glucosamine-containing compound biosynthetic process,BP,
18807,GO:1901074,1,0.986588458357171,0,2,regulation of engulfment of apoptotic cell,BP,
18808,GO:1901076,1,0.992672370381967,0,1,positive regulation of engulfment of apoptotic cell,BP,
18809,GO:1901077,1,0.93302424099003,0,11,regulation of relaxation of muscle,BP,
18810,GO:1901078,1,0.980133381251147,0,3,negative regulation of relaxation of muscle,BP,
18811,GO:1901079,1,0.981337054139102,0,3,positive regulation of relaxation of muscle,BP,
18812,GO:1901080,1,0.993205747724528,0,1,regulation of relaxation of smooth muscle,BP,
18813,GO:1901082,1,0.993205747724528,0,1,positive regulation of relaxation of smooth muscle,BP,
18814,GO:1901086,1,0.993186448387138,0,1,benzylpenicillin metabolic process,BP,
18815,GO:1901090,1,0.987856590613737,0,2,regulation of protein tetramerization,BP,
18816,GO:1901091,1,0.987856590613737,0,2,negative regulation of protein tetramerization,BP,
18817,GO:1901093,1,0.987856590613737,0,2,regulation of protein homotetramerization,BP,
18818,GO:1901094,1,0.987856590613737,0,2,negative regulation of protein homotetramerization,BP,
18819,GO:1901096,1,0.935369597602954,0,10,regulation of autophagosome maturation,BP,
18820,GO:1901097,1,0.980479000531379,0,3,negative regulation of autophagosome maturation,BP,
18821,GO:1901098,1,0.953145444207131,0,7,positive regulation of autophagosome maturation,BP,
18822,GO:1901099,1,0.821205188213355,0,32,negative regulation of signal transduction in absence of ligand,BP,
18826,GO:1901142,1,0.954737738500821,0,7,insulin metabolic process,BP,
18827,GO:1901143,1,0.986839953889801,0,2,insulin catabolic process,BP,
18828,GO:1901145,1,0.980608688386946,0,3,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18829,GO:1901147,1,0.987038592633319,0,2,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18830,GO:1901159,1,0.970686647241458,0,5,xylulose 5-phosphate biosynthetic process,BP,
18831,GO:1901160,1,0.917631516232735,0,13,primary amino compound metabolic process,BP,
18832,GO:1901162,1,0.970360654548733,0,5,primary amino compound biosynthetic process,BP,
18833,GO:1901163,1,0.940138696423791,0,10,regulation of trophoblast cell migration,BP,
18834,GO:1901164,1,0.969332670690067,0,5,negative regulation of trophoblast cell migration,BP,
18835,GO:1901165,1,0.969891827638793,0,5,positive regulation of trophoblast cell migration,BP,
18836,GO:1901166,1,0.98070104487238,0,3,neural crest cell migration involved in autonomic nervous system development,BP,
18837,GO:1901184,1,0.559905426571712,0,90,regulation of ERBB signaling pathway,BP,
18838,GO:1901185,1,0.712456720626612,0,53,negative regulation of ERBB signaling pathway,BP,
18839,GO:1901186,1,0.805713767655235,0,34,positive regulation of ERBB signaling pathway,BP,
18840,GO:1901187,1,0.986822851658299,0,2,regulation of ephrin receptor signaling pathway,BP,
18841,GO:1901189,1,0.993965875047369,0,1,positive regulation of ephrin receptor signaling pathway,BP,
18842,GO:1901193,1,0.994321382951401,0,1,regulation of formation of translation preinitiation complex,BP,
18843,GO:1901194,1,0.994321382951401,0,1,negative regulation of formation of translation preinitiation complex,BP,
18844,GO:1901201,1,0.915228290293346,0,13,regulation of extracellular matrix assembly,BP,
18845,GO:1901202,1,0.993967748105034,0,1,negative regulation of extracellular matrix assembly,BP,
18846,GO:1901203,1,0.939878845736571,0,9,positive regulation of extracellular matrix assembly,BP,
18847,GO:1901207,1,0.98721651173974,0,2,regulation of heart looping,BP,
18848,GO:1901208,1,0.993672997969696,0,1,negative regulation of heart looping,BP,
18849,GO:1901210,1,0.993672997969696,0,1,regulation of cardiac chamber formation,BP,
18850,GO:1901211,1,0.993672997969696,0,1,negative regulation of cardiac chamber formation,BP,
18854,GO:1901216,1,0.612747175754822,0,76,positive regulation of neuron death,BP,
18855,GO:1901219,1,0.993672997969696,0,1,regulation of cardiac chamber morphogenesis,BP,
18856,GO:1901220,1,0.993672997969696,0,1,negative regulation of cardiac chamber morphogenesis,BP,
18857,GO:1901222,1,0.707004161116841,0,55,regulation of NIK/NF-kappaB signaling,BP,
18858,GO:1901223,1,0.944919320701508,0,9,negative regulation of NIK/NF-kappaB signaling,BP,
18859,GO:1901224,1,0.763608071138512,0,43,positive regulation of NIK/NF-kappaB signaling,BP,
18861,GO:1901229,1,0.993898942647536,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18862,GO:1901231,1,0.993898942647536,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18863,GO:1901232,1,0.993898942647536,0,1,regulation of convergent extension involved in axis elongation,BP,
18864,GO:1901233,1,0.993898942647536,0,1,negative regulation of convergent extension involved in axis elongation,BP,
18865,GO:1901246,1,0.988197551506301,0,2,regulation of lung ciliated cell differentiation,BP,
18866,GO:1901247,1,0.994276910915076,0,1,negative regulation of lung ciliated cell differentiation,BP,
18867,GO:1901248,1,0.993886004761557,0,1,positive regulation of lung ciliated cell differentiation,BP,
18868,GO:1901249,1,0.994276910915076,0,1,regulation of lung goblet cell differentiation,BP,
18869,GO:1901251,1,0.994276910915076,0,1,positive regulation of lung goblet cell differentiation,BP,
18870,GO:1901252,1,0.987801337481327,0,2,regulation of intracellular transport of viral material,BP,
18871,GO:1901253,1,0.994375962862754,0,1,negative regulation of intracellular transport of viral material,BP,
18872,GO:1901254,1,0.993388568896009,0,1,positive regulation of intracellular transport of viral material,BP,
18873,GO:1901255,1,0.986929810801439,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
18874,GO:1901256,1,0.969617936366426,0,5,regulation of macrophage colony-stimulating factor production,BP,
18875,GO:1901257,1,0.993976394104219,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
18876,GO:1901258,1,0.981759893233178,0,3,positive regulation of macrophage colony-stimulating factor production,BP,
18879,GO:1901269,1,0.988946073143875,0,2,lipooligosaccharide metabolic process,BP,
18880,GO:1901271,1,0.988946073143875,0,2,lipooligosaccharide biosynthetic process,BP,
18881,GO:1901291,1,0.994093971395662,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
18884,GO:1901295,1,0.988127127208535,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18885,GO:1901296,1,0.994126168400043,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18886,GO:1901297,1,0.993965875047369,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18887,GO:1901298,1,0.938754164660864,0,10,regulation of hydrogen peroxide-mediated programmed cell death,BP,
18888,GO:1901299,1,0.963190322186985,0,6,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
18889,GO:1901300,1,0.974639564505528,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
18890,GO:1901301,1,0.987224982976142,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
18891,GO:1901303,1,0.993863593966619,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18892,GO:1901304,1,0.994156779103132,0,1,regulation of spermidine biosynthetic process,BP,
18893,GO:1901307,1,0.994156779103132,0,1,positive regulation of spermidine biosynthetic process,BP,
18894,GO:1901314,1,0.978810918667109,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
18895,GO:1901315,1,0.978810918667109,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
18896,GO:1901317,1,0.948388005706457,0,9,regulation of flagellated sperm motility,BP,
18897,GO:1901318,1,0.99409021782693,0,1,negative regulation of flagellated sperm motility,BP,
18898,GO:1901321,1,0.988471954944112,0,2,positive regulation of heart induction,BP,
18899,GO:1901328,1,0.994124435735787,0,1,response to cytochalasin B,BP,
18900,GO:1901329,1,0.981370112937855,0,3,regulation of odontoblast differentiation,BP,
18901,GO:1901331,1,0.993735267096645,0,1,positive regulation of odontoblast differentiation,BP,
18902,GO:1901337,1,0.993879107070959,0,1,thioester transport,BP,
18903,GO:1901338,1,0.91804064428454,0,14,catecholamine binding,MF,
18904,GO:1901339,1,0.956023386059869,0,7,regulation of store-operated calcium channel activity,BP,
18905,GO:1901340,1,0.993458628271129,0,1,negative regulation of store-operated calcium channel activity,BP,
18906,GO:1901341,1,0.968387058420069,0,5,positive regulation of store-operated calcium channel activity,BP,
18908,GO:1901343,1,0.541357862878591,0,94,negative regulation of vasculature development,BP,
18909,GO:1901344,1,0.99427575580093,0,1,response to leptomycin B,BP,
18910,GO:1901350,1,0.992612627928643,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
18911,GO:1901355,1,0.98681271760991,0,2,response to rapamycin,BP,
18916,GO:1901373,1,0.99423648197711,0,1,lipid hydroperoxide transport,BP,
18917,GO:1901374,1,0.958351768596273,0,7,acetate ester transport,BP,
18918,GO:1901375,1,0.982089029898322,0,3,acetate ester transmembrane transporter activity,MF,
18919,GO:1901376,1,0.993856415233832,0,1,organic heteropentacyclic compound metabolic process,BP,
18920,GO:1901377,1,0.993856415233832,0,1,organic heteropentacyclic compound catabolic process,BP,
18921,GO:1901379,1,0.637121022218394,0,69,regulation of potassium ion transmembrane transport,BP,
18922,GO:1901380,1,0.890122710800439,0,18,negative regulation of potassium ion transmembrane transport,BP,
18923,GO:1901381,1,0.80860790801273,0,32,positive regulation of potassium ion transmembrane transport,BP,
18925,GO:1901383,1,0.986229882559434,0,2,negative regulation of chorionic trophoblast cell proliferation,BP,
18927,GO:1901386,1,0.929764758121738,0,12,negative regulation of voltage-gated calcium channel activity,BP,
18929,GO:1901388,1,0.993912174119494,0,1,regulation of transforming growth factor beta activation,BP,
18930,GO:1901389,1,0.993912174119494,0,1,negative regulation of transforming growth factor beta activation,BP,
18931,GO:1901401,1,0.99298595432303,0,1,regulation of tetrapyrrole metabolic process,BP,
18932,GO:1901407,1,0.945898840866753,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18933,GO:1901409,1,0.958165606098764,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18934,GO:1901419,1,0.993394304974037,0,1,regulation of response to alcohol,BP,
18935,GO:1901421,1,0.993394304974037,0,1,positive regulation of response to alcohol,BP,
18936,GO:1901474,1,0.957621526992304,0,7,azole transmembrane transporter activity,MF,
18937,GO:1901475,1,0.975668784417214,0,4,pyruvate transmembrane transport,BP,
18938,GO:1901490,1,0.973715802150444,0,4,regulation of lymphangiogenesis,BP,
18939,GO:1901491,1,0.986610683698775,0,2,negative regulation of lymphangiogenesis,BP,
18940,GO:1901492,1,0.98693190711975,0,2,positive regulation of lymphangiogenesis,BP,
18941,GO:1901503,1,0.968304572427629,0,5,ether biosynthetic process,BP,
18942,GO:1901505,1,0.810370334717063,0,34,carbohydrate derivative transmembrane transporter activity,MF,
18944,GO:1901522,1,0.859213075120671,0,23,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
18945,GO:1901523,1,0.981884829261353,0,3,icosanoid catabolic process,BP,
18946,GO:1901524,1,0.917201847611802,0,13,regulation of mitophagy,BP,
18947,GO:1901525,1,0.967348216389846,0,5,negative regulation of mitophagy,BP,
18948,GO:1901526,1,0.948178089027106,0,8,positive regulation of mitophagy,BP,
18949,GO:1901529,1,0.973678114629515,0,4,positive regulation of anion channel activity,BP,
18950,GO:1901532,1,0.585966290859368,0,88,regulation of hematopoietic progenitor cell differentiation,BP,
18951,GO:1901533,1,0.957252420292938,0,7,negative regulation of hematopoietic progenitor cell differentiation,BP,
18952,GO:1901534,1,0.987198926751613,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
18953,GO:1901535,1,0.964799821755141,0,5,regulation of DNA demethylation,BP,
18954,GO:1901536,1,0.987590532708631,0,2,negative regulation of DNA demethylation,BP,
18955,GO:1901537,1,0.976925819598836,0,3,positive regulation of DNA demethylation,BP,
18956,GO:1901538,1,0.960658423537353,0,6,changes to DNA methylation involved in embryo development,BP,
18957,GO:1901545,1,0.993776162696212,0,1,response to raffinose,BP,
18958,GO:1901550,1,0.926219927870046,0,12,regulation of endothelial cell development,BP,
18959,GO:1901551,1,0.993438155403804,0,1,negative regulation of endothelial cell development,BP,
18960,GO:1901552,1,0.969149148988259,0,5,positive regulation of endothelial cell development,BP,
18961,GO:1901555,1,0.992646334865486,0,1,response to paclitaxel,BP,
18962,GO:1901557,1,0.993498820562144,0,1,response to fenofibrate,BP,
18963,GO:1901558,1,0.986978734542455,0,2,response to metformin,BP,
18964,GO:1901561,1,0.993563957095796,0,1,response to benomyl,BP,
18965,GO:1901563,1,0.968349549099259,0,5,response to camptothecin,BP,
18969,GO:1901567,1,0.866076912563711,0,24,fatty acid derivative binding,MF,
18971,GO:1901569,1,0.952428398177633,0,8,fatty acid derivative catabolic process,BP,
18973,GO:1901571,1,0.824015504570153,0,31,fatty acid derivative transport,BP,
18976,GO:1901580,1,0.991425784812328,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18977,GO:1901581,1,0.991425784812328,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18978,GO:1901582,1,0.991425784812328,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18979,GO:1901585,1,0.993832023869391,0,1,regulation of acid-sensing ion channel activity,BP,
18980,GO:1901588,1,0.993300413864028,0,1,dendritic microtubule,CC,
18981,GO:1901594,1,0.993456624497855,0,1,response to capsazepine,BP,
18984,GO:1901607,1,0.691128116472153,0,59,alpha-amino acid biosynthetic process,BP,
18985,GO:1901608,1,0.994262471997153,0,1,regulation of vesicle transport along microtubule,BP,
18986,GO:1901609,1,0.994262471997153,0,1,negative regulation of vesicle transport along microtubule,BP,
18987,GO:1901611,1,0.939703003117724,0,10,phosphatidylglycerol binding,MF,
18988,GO:1901612,1,0.957010702848763,0,7,cardiolipin binding,MF,
18990,GO:1901616,1,0.714593888461853,0,54,organic hydroxy compound catabolic process,BP,
18993,GO:1901620,1,0.956523727926279,0,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18994,GO:1901621,1,0.968253026045242,0,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18995,GO:1901622,1,0.993901243341133,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18998,GO:1901626,1,0.931408725891153,0,11,regulation of postsynaptic membrane organization,BP,
18999,GO:1901627,1,0.993972070877798,0,1,negative regulation of postsynaptic membrane organization,BP,
19000,GO:1901628,1,0.975020035507534,0,4,positive regulation of postsynaptic membrane organization,BP,
19001,GO:1901629,1,0.98668809667933,0,2,regulation of presynaptic membrane organization,BP,
19002,GO:1901630,1,0.9943066551631,0,1,negative regulation of presynaptic membrane organization,BP,
19003,GO:1901631,1,0.99233826267882,0,1,positive regulation of presynaptic membrane organization,BP,
19004,GO:1901639,1,0.992912447527943,0,1,XDP catabolic process,BP,
19005,GO:1901640,1,0.992912447527943,0,1,XTP binding,MF,
19006,GO:1901641,1,0.992912447527943,0,1,ITP binding,MF,
19007,GO:1901642,1,0.964308642301412,0,6,nucleoside transmembrane transport,BP,
19012,GO:1901656,1,0.980860451594984,0,3,glycoside transport,BP,
19013,GO:1901657,1,0.436134973827371,0,134,glycosyl compound metabolic process,BP,
19014,GO:1901658,1,0.809940492253581,0,35,glycosyl compound catabolic process,BP,
19015,GO:1901659,1,0.771620329875441,0,43,glycosyl compound biosynthetic process,BP,
19016,GO:1901660,1,0.946822354979213,0,8,calcium ion export,BP,
19017,GO:1901661,1,0.851805300591512,0,27,quinone metabolic process,BP,
19018,GO:1901662,1,0.988088933403491,0,2,quinone catabolic process,BP,
19019,GO:1901663,1,0.920267073405664,0,14,quinone biosynthetic process,BP,
19020,GO:1901664,1,0.98138630784455,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
19021,GO:1901666,1,0.98138630784455,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
19022,GO:1901668,1,0.976683930180158,0,4,regulation of superoxide dismutase activity,BP,
19023,GO:1901671,1,0.982732658838905,0,3,positive regulation of superoxide dismutase activity,BP,
19024,GO:1901673,1,0.88395135679586,0,19,regulation of mitotic spindle assembly,BP,
19025,GO:1901674,1,0.980215526092823,0,3,regulation of histone H3-K27 acetylation,BP,
19026,GO:1901675,1,0.992719514307182,0,1,negative regulation of histone H3-K27 acetylation,BP,
19027,GO:1901676,1,0.993519685329569,0,1,positive regulation of histone H3-K27 acetylation,BP,
19028,GO:1901678,1,0.933442928229313,0,11,iron coordination entity transport,BP,
19029,GO:1901679,1,0.952085378194024,0,8,nucleotide transmembrane transport,BP,
19030,GO:1901680,1,0.991861567052743,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
19032,GO:1901682,1,0.839969305403755,0,27,sulfur compound transmembrane transporter activity,MF,
19033,GO:1901685,1,0.90149855050234,0,18,glutathione derivative metabolic process,BP,
19034,GO:1901687,1,0.90149855050234,0,18,glutathione derivative biosynthetic process,BP,
19039,GO:1901702,1,0.970535001036518,0,5,salt transmembrane transporter activity,MF,
19040,GO:1901706,1,0.993899517803582,0,1,mesenchymal cell differentiation involved in bone development,BP,
19041,GO:1901707,1,0.99427575580093,0,1,leptomycin B binding,MF,
19042,GO:1901722,1,0.934201178441477,0,11,regulation of cell proliferation involved in kidney development,BP,
19043,GO:1901723,1,0.969401313739006,0,5,negative regulation of cell proliferation involved in kidney development,BP,
19044,GO:1901724,1,0.963700094408305,0,6,positive regulation of cell proliferation involved in kidney development,BP,
19045,GO:1901725,1,0.945748582963899,0,8,regulation of histone deacetylase activity,BP,
19046,GO:1901726,1,0.991497535243978,0,1,negative regulation of histone deacetylase activity,BP,
19047,GO:1901727,1,0.9601486929102,0,6,positive regulation of histone deacetylase activity,BP,
19048,GO:1901731,1,0.987745342890081,0,2,positive regulation of platelet aggregation,BP,
19049,GO:1901739,1,0.913387974020976,0,15,regulation of myoblast fusion,BP,
19050,GO:1901740,1,0.988422569805725,0,2,negative regulation of myoblast fusion,BP,
19051,GO:1901741,1,0.924095196931471,0,13,positive regulation of myoblast fusion,BP,
19052,GO:1901748,1,0.981880669410057,0,3,leukotriene D4 metabolic process,BP,
19053,GO:1901750,1,0.981880669410057,0,3,leukotriene D4 biosynthetic process,BP,
19054,GO:1901751,1,0.993963713936849,0,1,leukotriene A4 metabolic process,BP,
19055,GO:1901796,1,0.34316556599976,0,167,regulation of signal transduction by p53 class mediator,BP,
19056,GO:1901797,1,0.851474173160093,0,26,negative regulation of signal transduction by p53 class mediator,BP,
19058,GO:1901799,1,0.75614774464393,0,44,negative regulation of proteasomal protein catabolic process,BP,
19059,GO:1901800,1,0.532884574950926,0,99,positive regulation of proteasomal protein catabolic process,BP,
19060,GO:1901804,1,0.993952766171747,0,1,beta-glucoside metabolic process,BP,
19061,GO:1901805,1,0.993952766171747,0,1,beta-glucoside catabolic process,BP,
19062,GO:1901810,1,0.993846081630578,0,1,beta-carotene metabolic process,BP,
19063,GO:1901825,1,0.993891466686588,0,1,zeaxanthin metabolic process,BP,
19064,GO:1901827,1,0.993891466686588,0,1,zeaxanthin biosynthetic process,BP,
19065,GO:1901834,1,0.994143783991404,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19066,GO:1901835,1,0.994143783991404,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19067,GO:1901836,1,0.932443025987896,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19068,GO:1901837,1,0.988143561194872,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19069,GO:1901838,1,0.943637796674958,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19070,GO:1901841,1,0.934612975718541,0,11,regulation of high voltage-gated calcium channel activity,BP,
19071,GO:1901842,1,0.976738045302275,0,4,negative regulation of high voltage-gated calcium channel activity,BP,
19072,GO:1901843,1,0.980943971012404,0,3,positive regulation of high voltage-gated calcium channel activity,BP,
19073,GO:1901844,1,0.944125749202932,0,9,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19074,GO:1901846,1,0.993349540384024,0,1,positive regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19075,GO:1901856,1,0.987751178362726,0,2,negative regulation of cellular respiration,BP,
19076,GO:1901857,1,0.964113206857844,0,6,positive regulation of cellular respiration,BP,
19077,GO:1901858,1,0.962205208904411,0,6,regulation of mitochondrial DNA metabolic process,BP,
19078,GO:1901859,1,0.980870345584334,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
19079,GO:1901860,1,0.987144893099137,0,2,positive regulation of mitochondrial DNA metabolic process,BP,
19081,GO:1901862,1,0.754824828163392,0,44,negative regulation of muscle tissue development,BP,
19083,GO:1901873,1,0.986622304457524,0,2,regulation of post-translational protein modification,BP,
19084,GO:1901874,1,0.986622304457524,0,2,negative regulation of post-translational protein modification,BP,
19085,GO:1901876,1,0.988624416208537,0,2,regulation of calcium ion binding,BP,
19086,GO:1901877,1,0.988624416208537,0,2,negative regulation of calcium ion binding,BP,
19087,GO:1901879,1,0.613919517970264,0,73,regulation of protein depolymerization,BP,
19088,GO:1901880,1,0.68757806913886,0,56,negative regulation of protein depolymerization,BP,
19089,GO:1901881,1,0.909668108539664,0,15,positive regulation of protein depolymerization,BP,
19091,GO:1901889,1,0.876149080808455,0,20,negative regulation of cell junction assembly,BP,
19092,GO:1901890,1,0.819588827466856,0,30,positive regulation of cell junction assembly,BP,
19094,GO:1901895,1,0.980659476662537,0,3,negative regulation of calcium-transporting ATPase activity,BP,
19096,GO:1901897,1,0.95577597629522,0,7,regulation of relaxation of cardiac muscle,BP,
19097,GO:1901898,1,0.985772164559884,0,2,negative regulation of relaxation of cardiac muscle,BP,
19098,GO:1901899,1,0.988050942182012,0,2,positive regulation of relaxation of cardiac muscle,BP,
19099,GO:1901906,1,0.975772150142065,0,4,diadenosine pentaphosphate metabolic process,BP,
19100,GO:1901907,1,0.975772150142065,0,4,diadenosine pentaphosphate catabolic process,BP,
19101,GO:1901908,1,0.975772150142065,0,4,diadenosine hexaphosphate metabolic process,BP,
19102,GO:1901909,1,0.975772150142065,0,4,diadenosine hexaphosphate catabolic process,BP,
19103,GO:1901910,1,0.975772150142065,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
19104,GO:1901911,1,0.975772150142065,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
19105,GO:1901917,1,0.993853544336592,0,1,regulation of exoribonuclease activity,BP,
19106,GO:1901919,1,0.993853544336592,0,1,positive regulation of exoribonuclease activity,BP,
19107,GO:1901950,1,0.993846081630578,0,1,dense core granule transport,BP,
19108,GO:1901962,1,0.994003495911578,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
19109,GO:1901963,1,0.987828636794293,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19110,GO:1901964,1,0.994131943981625,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19111,GO:1901970,1,0.950061769814463,0,8,positive regulation of mitotic sister chromatid separation,BP,
19112,GO:1901976,1,0.818036711767659,0,32,regulation of cell cycle checkpoint,BP,
19113,GO:1901977,1,0.963663242205147,0,6,negative regulation of cell cycle checkpoint,BP,
19114,GO:1901978,1,0.937977153816069,0,10,positive regulation of cell cycle checkpoint,BP,
19115,GO:1901979,1,0.980161604223908,0,3,regulation of inward rectifier potassium channel activity,BP,
19116,GO:1901980,1,0.991740684735472,0,1,positive regulation of inward rectifier potassium channel activity,BP,
19118,GO:1901983,1,0.662317919447306,0,65,regulation of protein acetylation,BP,
19119,GO:1901984,1,0.86560372010343,0,23,negative regulation of protein acetylation,BP,
19120,GO:1901985,1,0.800993287906097,0,35,positive regulation of protein acetylation,BP,
19121,GO:1901986,1,0.994241391201421,0,1,response to ketamine,BP,
19124,GO:1901989,1,0.633080773769446,0,72,positive regulation of cell cycle phase transition,BP,
19127,GO:1901992,1,0.678546324955039,0,61,positive regulation of mitotic cell cycle phase transition,BP,
19128,GO:1901993,1,0.987595362660233,0,2,regulation of meiotic cell cycle phase transition,BP,
19129,GO:1901994,1,0.987595362660233,0,2,negative regulation of meiotic cell cycle phase transition,BP,
19130,GO:1901998,1,0.798095240549504,0,36,toxin transport,BP,
19131,GO:1902001,1,0.910477729463185,0,14,fatty acid transmembrane transport,BP,
19132,GO:1902003,1,0.888075839899317,0,18,regulation of amyloid-beta formation,BP,
19133,GO:1902004,1,0.937567826021162,0,10,positive regulation of amyloid-beta formation,BP,
19134,GO:1902010,1,0.993641883094542,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
19135,GO:1902017,1,0.77563513849713,0,39,regulation of cilium assembly,BP,
19136,GO:1902018,1,0.944956707241394,0,9,negative regulation of cilium assembly,BP,
19137,GO:1902019,1,0.969714655511505,0,5,regulation of cilium-dependent cell motility,BP,
19138,GO:1902022,1,0.968824679089623,0,5,L-lysine transport,BP,
19139,GO:1902023,1,0.961707616244433,0,6,L-arginine transport,BP,
19140,GO:1902031,1,0.964353083646087,0,6,regulation of NADP metabolic process,BP,
19141,GO:1902033,1,0.957052583800404,0,7,regulation of hematopoietic stem cell proliferation,BP,
19142,GO:1902035,1,0.969091154594833,0,5,positive regulation of hematopoietic stem cell proliferation,BP,
19143,GO:1902036,1,0.621622085437549,0,79,regulation of hematopoietic stem cell differentiation,BP,
19144,GO:1902037,1,0.981668091308864,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
19145,GO:1902038,1,0.993655013240763,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
19147,GO:1902042,1,0.810443951813131,0,34,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
19149,GO:1902044,1,0.987335442324615,0,2,regulation of Fas signaling pathway,BP,
19150,GO:1902045,1,0.993966595443765,0,1,negative regulation of Fas signaling pathway,BP,
19151,GO:1902047,1,0.964104624370893,0,6,polyamine transmembrane transport,BP,
19152,GO:1902065,1,0.931712239129099,0,11,response to L-glutamate,BP,
19153,GO:1902071,1,0.994307232722657,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19154,GO:1902073,1,0.994307232722657,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19155,GO:1902074,1,0.924281517087143,0,13,response to salt,BP,
19156,GO:1902075,1,0.958883063153481,0,7,cellular response to salt,BP,
19157,GO:1902076,1,0.991288325747625,0,1,regulation of lateral motor column neuron migration,BP,
19158,GO:1902078,1,0.991288325747625,0,1,positive regulation of lateral motor column neuron migration,BP,
19159,GO:1902080,1,0.994153024963152,0,1,regulation of calcium ion import into sarcoplasmic reticulum,BP,
19160,GO:1902081,1,0.994153024963152,0,1,negative regulation of calcium ion import into sarcoplasmic reticulum,BP,
19161,GO:1902083,1,0.965499455018115,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
19162,GO:1902093,1,0.954028809624953,0,8,positive regulation of flagellated sperm motility,BP,
19163,GO:1902098,1,0.993290208061306,0,1,calcitriol binding,MF,
19164,GO:1902099,1,0.733894358005536,0,48,regulation of metaphase/anaphase transition of cell cycle,BP,
19165,GO:1902100,1,0.813424457877003,0,32,negative regulation of metaphase/anaphase transition of cell cycle,BP,
19166,GO:1902101,1,0.950061769814463,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
19167,GO:1902102,1,0.993772585859067,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19168,GO:1902103,1,0.993772585859067,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19169,GO:1902105,1,0.238859418668092,0,224,regulation of leukocyte differentiation,BP,
19170,GO:1902106,1,0.615090632818956,0,76,negative regulation of leukocyte differentiation,BP,
19171,GO:1902107,1,0.474409483597402,0,118,positive regulation of leukocyte differentiation,BP,
19173,GO:1902109,1,0.982639182313574,0,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19175,GO:1902115,1,0.374410007253348,0,149,regulation of organelle assembly,BP,
19176,GO:1902116,1,0.818853403921015,0,31,negative regulation of organelle assembly,BP,
19177,GO:1902117,1,0.679136681698342,0,58,positive regulation of organelle assembly,BP,
19178,GO:1902121,1,0.993290208061306,0,1,lithocholic acid binding,MF,
19179,GO:1902122,1,0.994026284253939,0,1,chenodeoxycholic acid binding,MF,
19180,GO:1902159,1,0.987331956110414,0,2,regulation of cyclic nucleotide-gated ion channel activity,BP,
19181,GO:1902161,1,0.992876766536991,0,1,positive regulation of cyclic nucleotide-gated ion channel activity,BP,
19182,GO:1902162,1,0.982618256831959,0,3,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19183,GO:1902164,1,0.982618256831959,0,3,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19184,GO:1902165,1,0.919646579049376,0,14,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19185,GO:1902166,1,0.930534582510448,0,12,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19186,GO:1902167,1,0.994479061349664,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19187,GO:1902170,1,0.891754597290374,0,18,cellular response to reactive nitrogen species,BP,
19188,GO:1902172,1,0.970071803333274,0,5,regulation of keratinocyte apoptotic process,BP,
19189,GO:1902174,1,0.981899973851874,0,3,positive regulation of keratinocyte apoptotic process,BP,
19190,GO:1902175,1,0.852226484569487,0,26,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19191,GO:1902176,1,0.895911725435582,0,18,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19192,GO:1902177,1,0.969972391115991,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19193,GO:1902178,1,0.993410074506314,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
19194,GO:1902186,1,0.831173291660038,0,29,regulation of viral release from host cell,BP,
19195,GO:1902187,1,0.913221221810946,0,14,negative regulation of viral release from host cell,BP,
19196,GO:1902188,1,0.910513964373721,0,15,positive regulation of viral release from host cell,BP,
19197,GO:1902202,1,0.975356546135674,0,4,regulation of hepatocyte growth factor receptor signaling pathway,BP,
19198,GO:1902203,1,0.993216690719503,0,1,negative regulation of hepatocyte growth factor receptor signaling pathway,BP,
19199,GO:1902204,1,0.994066255383047,0,1,positive regulation of hepatocyte growth factor receptor signaling pathway,BP,
19200,GO:1902205,1,0.99415475764347,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
19201,GO:1902206,1,0.99415475764347,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
19202,GO:1902211,1,0.993846081630578,0,1,regulation of prolactin signaling pathway,BP,
19203,GO:1902213,1,0.993846081630578,0,1,positive regulation of prolactin signaling pathway,BP,
19204,GO:1902214,1,0.980837954840577,0,3,regulation of interleukin-4-mediated signaling pathway,BP,
19205,GO:1902215,1,0.99415475764347,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
19206,GO:1902216,1,0.986605695579575,0,2,positive regulation of interleukin-4-mediated signaling pathway,BP,
19207,GO:1902217,1,0.994263338331745,0,1,erythrocyte apoptotic process,BP,
19208,GO:1902218,1,0.963243304542197,0,6,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19209,GO:1902219,1,0.968737075322729,0,5,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19210,GO:1902220,1,0.994330768330158,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19211,GO:1902221,1,0.942527961727752,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
19212,GO:1902222,1,0.942527961727752,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
19213,GO:1902224,1,0.928958497118541,0,12,ketone body metabolic process,BP,
19214,GO:1902226,1,0.982412413979829,0,3,regulation of macrophage colony-stimulating factor signaling pathway,BP,
19215,GO:1902227,1,0.988397311635685,0,2,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
19216,GO:1902228,1,0.993945565455181,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
19217,GO:1902229,1,0.809412890975925,0,35,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19218,GO:1902230,1,0.843816202289663,0,28,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19219,GO:1902231,1,0.96529007733564,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19220,GO:1902232,1,0.99415475764347,0,1,regulation of positive thymic T cell selection,BP,
19221,GO:1902233,1,0.99415475764347,0,1,negative regulation of positive thymic T cell selection,BP,
19223,GO:1902236,1,0.898823896817168,0,17,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19225,GO:1902238,1,0.993440160298641,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19226,GO:1902239,1,0.993440160298641,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19227,GO:1902250,1,0.994263338331745,0,1,regulation of erythrocyte apoptotic process,BP,
19228,GO:1902251,1,0.994263338331745,0,1,negative regulation of erythrocyte apoptotic process,BP,
19229,GO:1902253,1,0.86913895192418,0,23,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19230,GO:1902254,1,0.899858439360911,0,17,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19231,GO:1902255,1,0.977561203187267,0,4,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19232,GO:1902256,1,0.981089145464345,0,3,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19233,GO:1902257,1,0.987854804628322,0,2,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19234,GO:1902259,1,0.907816744778408,0,15,regulation of delayed rectifier potassium channel activity,BP,
19235,GO:1902260,1,0.956451032565269,0,7,negative regulation of delayed rectifier potassium channel activity,BP,
19236,GO:1902261,1,0.973181504939726,0,4,positive regulation of delayed rectifier potassium channel activity,BP,
19237,GO:1902262,1,0.969839372979183,0,5,apoptotic process involved in blood vessel morphogenesis,BP,
19238,GO:1902263,1,0.979738637454924,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
19239,GO:1902267,1,0.970419586546219,0,5,regulation of polyamine transmembrane transport,BP,
19240,GO:1902268,1,0.982903096730348,0,3,negative regulation of polyamine transmembrane transport,BP,
19241,GO:1902269,1,0.98730156924114,0,2,positive regulation of polyamine transmembrane transport,BP,
19242,GO:1902271,1,0.993290208061306,0,1,D3 vitamins binding,MF,
19244,GO:1902282,1,0.952082005136655,0,8,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
19245,GO:1902283,1,0.993489670748233,0,1,negative regulation of primary amine oxidase activity,BP,
19246,GO:1902284,1,0.799500787426491,0,32,neuron projection extension involved in neuron projection guidance,BP,
19247,GO:1902285,1,0.911208001244203,0,13,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
19248,GO:1902287,1,0.917544899640005,0,12,semaphorin-plexin signaling pathway involved in axon guidance,BP,
19249,GO:1902292,1,0.994306366383348,0,1,cell cycle DNA replication initiation,BP,
19250,GO:1902296,1,0.993698411476689,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
19251,GO:1902298,1,0.985402935728362,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19252,GO:1902299,1,0.982240164304097,0,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
19253,GO:1902302,1,0.968757256413962,0,5,regulation of potassium ion export,BP,
19254,GO:1902303,1,0.987527856934497,0,2,negative regulation of potassium ion export,BP,
19255,GO:1902304,1,0.987709178510424,0,2,positive regulation of potassium ion export,BP,
19257,GO:1902306,1,0.922686825931776,0,12,negative regulation of sodium ion transmembrane transport,BP,
19261,GO:1902310,1,0.988166896885088,0,2,positive regulation of peptidyl-serine dephosphorylation,BP,
19262,GO:1902311,1,0.99413512056647,0,1,regulation of copper ion transmembrane transport,BP,
19263,GO:1902315,1,0.994306366383348,0,1,nuclear cell cycle DNA replication initiation,BP,
19264,GO:1902319,1,0.993698411476689,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
19265,GO:1902336,1,0.987600593383178,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
19266,GO:1902337,1,0.944023449622127,0,9,regulation of apoptotic process involved in morphogenesis,BP,
19267,GO:1902338,1,0.968696638631203,0,5,negative regulation of apoptotic process involved in morphogenesis,BP,
19268,GO:1902339,1,0.981258598165644,0,3,positive regulation of apoptotic process involved in morphogenesis,BP,
19269,GO:1902356,1,0.994101045669862,0,1,oxaloacetate(2-) transmembrane transport,BP,
19270,GO:1902358,1,0.931488929121959,0,11,sulfate transmembrane transport,BP,
19271,GO:1902359,1,0.987948996412888,0,2,Notch signaling pathway involved in somitogenesis,BP,
19272,GO:1902362,1,0.993838908213059,0,1,melanocyte apoptotic process,BP,
19273,GO:1902363,1,0.992572258392098,0,1,regulation of protein localization to spindle pole body,BP,
19274,GO:1902365,1,0.992572258392098,0,1,positive regulation of protein localization to spindle pole body,BP,
19275,GO:1902366,1,0.987948996412888,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
19276,GO:1902367,1,0.987948996412888,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
19277,GO:1902369,1,0.74633915217751,0,45,negative regulation of RNA catabolic process,BP,
19278,GO:1902373,1,0.77542947153953,0,39,negative regulation of mRNA catabolic process,BP,
19279,GO:1902378,1,0.993929441234976,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19280,GO:1902379,1,0.992967472159764,0,1,chemoattractant activity involved in axon guidance,MF,
19281,GO:1902380,1,0.993947293495943,0,1,positive regulation of endoribonuclease activity,BP,
19282,GO:1902387,1,0.993846081630578,0,1,ceramide 1-phosphate binding,MF,
19283,GO:1902388,1,0.993846081630578,0,1,ceramide 1-phosphate transporter activity,MF,
19284,GO:1902389,1,0.993846081630578,0,1,ceramide 1-phosphate transport,BP,
19285,GO:1902396,1,0.993521971245137,0,1,protein localization to bicellular tight junction,BP,
19286,GO:1902400,1,0.678462148241863,0,61,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,
19287,GO:1902402,1,0.674229246495518,0,62,signal transduction involved in mitotic DNA damage checkpoint,BP,
19288,GO:1902403,1,0.674229246495518,0,62,signal transduction involved in mitotic DNA integrity checkpoint,BP,
19289,GO:1902410,1,0.962940492595664,0,6,mitotic cytokinetic process,BP,
19290,GO:1902412,1,0.973366275933973,0,4,regulation of mitotic cytokinesis,BP,
19291,GO:1902414,1,0.947116402621554,0,8,protein localization to cell junction,BP,
19292,GO:1902415,1,0.946039084765448,0,9,regulation of mRNA binding,BP,
19293,GO:1902416,1,0.957565325355449,0,7,positive regulation of mRNA binding,BP,
19294,GO:1902423,1,0.98675075546334,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19295,GO:1902425,1,0.98675075546334,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19296,GO:1902426,1,0.993873647682063,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19297,GO:1902430,1,0.941933215026852,0,9,negative regulation of amyloid-beta formation,BP,
19298,GO:1902442,1,0.993570238344526,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
19299,GO:1902443,1,0.993570238344526,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
19300,GO:1902444,1,0.994304200535647,0,1,riboflavin binding,MF,
19301,GO:1902445,1,0.982850161243418,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
19302,GO:1902455,1,0.962697880242741,0,6,negative regulation of stem cell population maintenance,BP,
19303,GO:1902459,1,0.954240356760609,0,7,positive regulation of stem cell population maintenance,BP,
19304,GO:1902460,1,0.993329149817868,0,1,regulation of mesenchymal stem cell proliferation,BP,
19305,GO:1902462,1,0.993329149817868,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
19306,GO:1902463,1,0.988440656969548,0,2,protein localization to cell leading edge,BP,
19307,GO:1902464,1,0.993377954805271,0,1,regulation of histone H3-K27 trimethylation,BP,
19308,GO:1902466,1,0.993377954805271,0,1,positive regulation of histone H3-K27 trimethylation,BP,
19309,GO:1902473,1,0.948954485600449,0,8,regulation of protein localization to synapse,BP,
19310,GO:1902474,1,0.954833214542649,0,7,positive regulation of protein localization to synapse,BP,
19313,GO:1902480,1,0.993946429465092,0,1,protein localization to mitotic spindle,BP,
19314,GO:1902488,1,0.992116453925477,0,1,cholangiocyte apoptotic process,BP,
19315,GO:1902490,1,0.994074771569389,0,1,regulation of sperm capacitation,BP,
19316,GO:1902493,1,0.579981600202194,0,85,acetyltransferase complex,CC,
19319,GO:1902498,1,0.970969156527519,0,4,regulation of protein autoubiquitination,BP,
19320,GO:1902499,1,0.985848439706332,0,2,positive regulation of protein autoubiquitination,BP,
19321,GO:1902504,1,0.993785607657234,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
19322,GO:1902510,1,0.958302333277193,0,7,regulation of apoptotic DNA fragmentation,BP,
19323,GO:1902511,1,0.993863593966619,0,1,negative regulation of apoptotic DNA fragmentation,BP,
19324,GO:1902512,1,0.982851295260403,0,3,positive regulation of apoptotic DNA fragmentation,BP,
19325,GO:1902513,1,0.957117198880125,0,7,regulation of organelle transport along microtubule,BP,
19326,GO:1902514,1,0.942029362773674,0,9,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19327,GO:1902523,1,0.980827229923469,0,3,positive regulation of protein K63-linked ubiquitination,BP,
19328,GO:1902524,1,0.987825899085649,0,2,positive regulation of protein K48-linked ubiquitination,BP,
19329,GO:1902525,1,0.970372811986797,0,5,regulation of protein monoubiquitination,BP,
19330,GO:1902527,1,0.976643588789485,0,4,positive regulation of protein monoubiquitination,BP,
19331,GO:1902528,1,0.992221736364132,0,1,regulation of protein linear polyubiquitination,BP,
19332,GO:1902530,1,0.992221736364132,0,1,positive regulation of protein linear polyubiquitination,BP,
19336,GO:1902544,1,0.988149793675956,0,2,regulation of DNA N-glycosylase activity,BP,
19337,GO:1902546,1,0.994404263934584,0,1,positive regulation of DNA N-glycosylase activity,BP,
19338,GO:1902547,1,0.929999992867485,0,11,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19339,GO:1902548,1,0.974035629275364,0,4,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19340,GO:1902554,1,0.598945332912294,0,80,serine/threonine protein kinase complex,CC,
19341,GO:1902555,1,0.836686659171133,0,29,endoribonuclease complex,CC,
19342,GO:1902559,1,0.988142684895526,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
19343,GO:1902560,1,0.988345917261754,0,2,GMP reductase complex,CC,
19344,GO:1902562,1,0.780665244431266,0,39,H4 histone acetyltransferase complex,CC,
19345,GO:1902563,1,0.937599629904508,0,10,regulation of neutrophil activation,BP,
19346,GO:1902564,1,0.974330421440269,0,4,negative regulation of neutrophil activation,BP,
19347,GO:1902565,1,0.974732315530952,0,4,positive regulation of neutrophil activation,BP,
19348,GO:1902566,1,0.976299223971783,0,4,regulation of eosinophil activation,BP,
19349,GO:1902567,1,0.988061928050059,0,2,negative regulation of eosinophil activation,BP,
19350,GO:1902568,1,0.988096626000539,0,2,positive regulation of eosinophil activation,BP,
19351,GO:1902569,1,0.994101334421856,0,1,negative regulation of activation of Janus kinase activity,BP,
19352,GO:1902570,1,0.939467164191224,0,10,protein localization to nucleolus,BP,
19353,GO:1902571,1,0.964120120208138,0,6,regulation of serine-type peptidase activity,BP,
19354,GO:1902572,1,0.964120120208138,0,6,negative regulation of serine-type peptidase activity,BP,
19355,GO:1902573,1,0.991956535396447,0,1,positive regulation of serine-type peptidase activity,BP,
19356,GO:1902576,1,0.97557194697007,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
19357,GO:1902579,1,0.644692197159731,0,69,multi-organism localization,BP,
19358,GO:1902581,1,0.969301367476313,0,5,multi-organism cellular localization,BP,
19359,GO:1902583,1,0.969301367476313,0,5,multi-organism intracellular transport,BP,
19360,GO:1902594,1,0.986408588820609,0,2,multi-organism nuclear import,BP,
19361,GO:1902595,1,0.988145511220423,0,2,regulation of DNA replication origin binding,BP,
19363,GO:1902603,1,0.976112627918791,0,4,carnitine transmembrane transport,BP,
19364,GO:1902605,1,0.993855553928567,0,1,heterotrimeric G-protein complex assembly,BP,
19365,GO:1902606,1,0.988726657468233,0,2,regulation of large conductance calcium-activated potassium channel activity,BP,
19366,GO:1902608,1,0.988726657468233,0,2,positive regulation of large conductance calcium-activated potassium channel activity,BP,
19367,GO:1902612,1,0.993854118488498,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
19368,GO:1902613,1,0.993854118488498,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19369,GO:1902616,1,0.994106532031091,0,1,acyl carnitine transmembrane transport,BP,
19370,GO:1902617,1,0.968125271616612,0,5,response to fluoride,BP,
19371,GO:1902618,1,0.992928768899795,0,1,cellular response to fluoride,BP,
19372,GO:1902622,1,0.801296477518013,0,37,regulation of neutrophil migration,BP,
19373,GO:1902623,1,0.987101517329035,0,2,negative regulation of neutrophil migration,BP,
19374,GO:1902624,1,0.826717065969438,0,32,positive regulation of neutrophil migration,BP,
19375,GO:1902626,1,0.983135959279739,0,3,assembly of large subunit precursor of preribosome,BP,
19376,GO:1902629,1,0.994252364763791,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
19377,GO:1902630,1,0.985654230127003,0,2,regulation of membrane hyperpolarization,BP,
19378,GO:1902631,1,0.992638089525808,0,1,negative regulation of membrane hyperpolarization,BP,
19379,GO:1902636,1,0.988295961647573,0,2,kinociliary basal body,CC,
19382,GO:1902656,1,0.918881554895429,0,13,calcium ion import into cytosol,BP,
19383,GO:1902659,1,0.981663921504266,0,3,regulation of glucose mediated signaling pathway,BP,
19384,GO:1902661,1,0.981663921504266,0,3,positive regulation of glucose mediated signaling pathway,BP,
19385,GO:1902667,1,0.780809477007829,0,36,regulation of axon guidance,BP,
19386,GO:1902668,1,0.867959875559255,0,21,negative regulation of axon guidance,BP,
19387,GO:1902669,1,0.943587153465908,0,8,positive regulation of axon guidance,BP,
19390,GO:1902683,1,0.98177968793642,0,3,regulation of receptor localization to synapse,BP,
19391,GO:1902684,1,0.994262471997153,0,1,negative regulation of receptor localization to synapse,BP,
19392,GO:1902685,1,0.993417240165071,0,1,positive regulation of receptor localization to synapse,BP,
19394,GO:1902691,1,0.99375156229785,0,1,respiratory basal cell differentiation,BP,
19396,GO:1902710,1,0.889067894158189,0,18,GABA receptor complex,CC,
19397,GO:1902711,1,0.895362052776356,0,17,GABA-A receptor complex,CC,
19398,GO:1902713,1,0.951258778125459,0,8,regulation of interferon-gamma secretion,BP,
19399,GO:1902714,1,0.987925877964125,0,2,negative regulation of interferon-gamma secretion,BP,
19400,GO:1902715,1,0.962889281760503,0,6,positive regulation of interferon-gamma secretion,BP,
19401,GO:1902722,1,0.981663308652803,0,3,positive regulation of prolactin secretion,BP,
19402,GO:1902723,1,0.980943029710008,0,3,negative regulation of skeletal muscle satellite cell proliferation,BP,
19403,GO:1902724,1,0.986385899675265,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
19404,GO:1902725,1,0.980124560781275,0,3,negative regulation of satellite cell differentiation,BP,
19405,GO:1902728,1,0.986385899675265,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
19406,GO:1902730,1,0.981125239851471,0,3,positive regulation of proteoglycan biosynthetic process,BP,
19407,GO:1902731,1,0.97825648672533,0,3,negative regulation of chondrocyte proliferation,BP,
19408,GO:1902732,1,0.982266573264323,0,3,positive regulation of chondrocyte proliferation,BP,
19409,GO:1902737,1,0.993388568896009,0,1,dendritic filopodium,CC,
19410,GO:1902739,1,0.959428672859158,0,6,regulation of interferon-alpha secretion,BP,
19411,GO:1902741,1,0.959428672859158,0,6,positive regulation of interferon-alpha secretion,BP,
19412,GO:1902742,1,0.827469387239813,0,29,apoptotic process involved in development,BP,
19414,GO:1902744,1,0.973317930759921,0,4,negative regulation of lamellipodium organization,BP,
19416,GO:1902746,1,0.980157914853866,0,3,regulation of lens fiber cell differentiation,BP,
19417,GO:1902747,1,0.994076215059724,0,1,negative regulation of lens fiber cell differentiation,BP,
19418,GO:1902748,1,0.992000954286328,0,1,positive regulation of lens fiber cell differentiation,BP,
19419,GO:1902749,1,0.276707891608853,0,202,regulation of cell cycle G2/M phase transition,BP,
19420,GO:1902750,1,0.554884457296826,0,96,negative regulation of cell cycle G2/M phase transition,BP,
19421,GO:1902751,1,0.854057083294821,0,25,positive regulation of cell cycle G2/M phase transition,BP,
19422,GO:1902766,1,0.988389554756969,0,2,skeletal muscle satellite cell migration,BP,
19423,GO:1902767,1,0.987633127588846,0,2,isoprenoid biosynthetic process via mevalonate,BP,
19424,GO:1902769,1,0.991480072981613,0,1,regulation of choline O-acetyltransferase activity,BP,
19425,GO:1902771,1,0.991480072981613,0,1,positive regulation of choline O-acetyltransferase activity,BP,
19426,GO:1902773,1,0.993770583016034,0,1,GTPase activator complex,CC,
19427,GO:1902774,1,0.95537021696334,0,7,late endosome to lysosome transport,BP,
19428,GO:1902775,1,0.980143818802461,0,3,mitochondrial large ribosomal subunit assembly,BP,
19429,GO:1902803,1,0.837046782707229,0,27,regulation of synaptic vesicle transport,BP,
19430,GO:1902804,1,0.975774948697442,0,4,negative regulation of synaptic vesicle transport,BP,
19431,GO:1902805,1,0.979514772966524,0,3,positive regulation of synaptic vesicle transport,BP,
19434,GO:1902808,1,0.804385931366671,0,34,positive regulation of cell cycle G1/S phase transition,BP,
19435,GO:1902809,1,0.981476661657751,0,3,regulation of skeletal muscle fiber differentiation,BP,
19436,GO:1902811,1,0.987585547108245,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
19437,GO:1902816,1,0.974802961155772,0,4,regulation of protein localization to microtubule,BP,
19438,GO:1902817,1,0.974802961155772,0,4,negative regulation of protein localization to microtubule,BP,
19439,GO:1902822,1,0.974341760773739,0,4,regulation of late endosome to lysosome transport,BP,
19440,GO:1902823,1,0.98572129868101,0,2,negative regulation of late endosome to lysosome transport,BP,
19441,GO:1902824,1,0.988457307555306,0,2,positive regulation of late endosome to lysosome transport,BP,
19442,GO:1902838,1,0.993164260904423,0,1,regulation of nuclear migration along microtubule,BP,
19443,GO:1902846,1,0.992572258392098,0,1,positive regulation of mitotic spindle elongation,BP,
19444,GO:1902847,1,0.993825715097266,0,1,regulation of neuronal signal transduction,BP,
19445,GO:1902850,1,0.440338229198262,0,125,microtubule cytoskeleton organization involved in mitosis,BP,
19446,GO:1902855,1,0.937966103091877,0,10,regulation of non-motile cilium assembly,BP,
19447,GO:1902856,1,0.986804218441005,0,2,negative regulation of non-motile cilium assembly,BP,
19448,GO:1902857,1,0.9563281155419,0,7,positive regulation of non-motile cilium assembly,BP,
19449,GO:1902858,1,0.994029169494557,0,1,propionyl-CoA metabolic process,BP,
19450,GO:1902860,1,0.994029169494557,0,1,propionyl-CoA biosynthetic process,BP,
19451,GO:1902866,1,0.963350229283438,0,6,regulation of retina development in camera-type eye,BP,
19452,GO:1902867,1,0.993742413242347,0,1,negative regulation of retina development in camera-type eye,BP,
19453,GO:1902868,1,0.988007472762109,0,2,positive regulation of retina development in camera-type eye,BP,
19454,GO:1902869,1,0.981824171310389,0,3,regulation of amacrine cell differentiation,BP,
19455,GO:1902870,1,0.993742413242347,0,1,negative regulation of amacrine cell differentiation,BP,
19456,GO:1902871,1,0.988007472762109,0,2,positive regulation of amacrine cell differentiation,BP,
19459,GO:1902884,1,0.904390314249058,0,16,positive regulation of response to oxidative stress,BP,
19460,GO:1902889,1,0.992681481951384,0,1,protein localization to spindle microtubule,BP,
19461,GO:1902890,1,0.994422168860593,0,1,regulation of root hair elongation,BP,
19462,GO:1902891,1,0.994422168860593,0,1,negative regulation of root hair elongation,BP,
19463,GO:1902893,1,0.810538881747485,0,32,regulation of pri-miRNA transcription by RNA polymerase II,BP,
19464,GO:1902894,1,0.927526912856787,0,11,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,
19465,GO:1902895,1,0.86281320096143,0,23,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,
19466,GO:1902896,1,0.981284521523177,0,3,terminal web assembly,BP,
19467,GO:1902897,1,0.980930331072467,0,3,regulation of postsynaptic density protein 95 clustering,BP,
19468,GO:1902902,1,0.932599055696952,0,11,negative regulation of autophagosome assembly,BP,
19470,GO:1902904,1,0.468219587098734,0,116,negative regulation of supramolecular fiber organization,BP,
19472,GO:1902908,1,0.987608100424846,0,2,regulation of melanosome transport,BP,
19473,GO:1902910,1,0.993413800831215,0,1,positive regulation of melanosome transport,BP,
19474,GO:1902911,1,0.547897260186643,0,93,protein kinase complex,CC,
19475,GO:1902912,1,0.993846081630578,0,1,pyruvate kinase complex,CC,
19476,GO:1902913,1,0.993735267096645,0,1,positive regulation of neuroepithelial cell differentiation,BP,
19477,GO:1902914,1,0.899214194937826,0,16,regulation of protein polyubiquitination,BP,
19478,GO:1902915,1,0.959602365125007,0,6,negative regulation of protein polyubiquitination,BP,
19479,GO:1902916,1,0.944255234410901,0,9,positive regulation of protein polyubiquitination,BP,
19481,GO:1902931,1,0.946319891086205,0,9,negative regulation of alcohol biosynthetic process,BP,
19484,GO:1902937,1,0.981228774527201,0,3,inward rectifier potassium channel complex,CC,
19485,GO:1902938,1,0.980173830737299,0,3,regulation of intracellular calcium activated chloride channel activity,BP,
19486,GO:1902939,1,0.993812243142511,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
19487,GO:1902941,1,0.986378391858417,0,2,regulation of voltage-gated chloride channel activity,BP,
19488,GO:1902943,1,0.986378391858417,0,2,positive regulation of voltage-gated chloride channel activity,BP,
19489,GO:1902946,1,0.94623324187855,0,8,protein localization to early endosome,BP,
19490,GO:1902947,1,0.961722562476672,0,6,regulation of tau-protein kinase activity,BP,
19491,GO:1902948,1,0.991480072981613,0,1,negative regulation of tau-protein kinase activity,BP,
19492,GO:1902949,1,0.975780412364192,0,4,positive regulation of tau-protein kinase activity,BP,
19493,GO:1902950,1,0.944886308324669,0,9,regulation of dendritic spine maintenance,BP,
19494,GO:1902951,1,0.980961412215582,0,3,negative regulation of dendritic spine maintenance,BP,
19495,GO:1902952,1,0.981054710277689,0,3,positive regulation of dendritic spine maintenance,BP,
19496,GO:1902953,1,0.97321195157249,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
19497,GO:1902954,1,0.98400215897564,0,2,regulation of early endosome to recycling endosome transport,BP,
19498,GO:1902955,1,0.991480072981613,0,1,positive regulation of early endosome to recycling endosome transport,BP,
19499,GO:1902956,1,0.982096057036807,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19500,GO:1902957,1,0.993733409310885,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19501,GO:1902958,1,0.988290008317986,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19502,GO:1902959,1,0.947935824560075,0,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19503,GO:1902960,1,0.98550755400334,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19504,GO:1902961,1,0.961881324537036,0,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19505,GO:1902962,1,0.985087550645643,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19506,GO:1902963,1,0.985087550645643,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19507,GO:1902965,1,0.958586619969187,0,6,regulation of protein localization to early endosome,BP,
19508,GO:1902966,1,0.958586619969187,0,6,positive regulation of protein localization to early endosome,BP,
19509,GO:1902969,1,0.943416634540034,0,9,mitotic DNA replication,BP,
19510,GO:1902975,1,0.994306366383348,0,1,mitotic DNA replication initiation,BP,
19511,GO:1902977,1,0.99409151712842,0,1,mitotic DNA replication preinitiation complex assembly,BP,
19512,GO:1902983,1,0.993698411476689,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
19513,GO:1902988,1,0.978447044275053,0,3,neurofibrillary tangle assembly,BP,
19514,GO:1902990,1,0.981082308423641,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
19515,GO:1902991,1,0.859861641676961,0,23,regulation of amyloid precursor protein catabolic process,BP,
19516,GO:1902992,1,0.930131022299292,0,11,negative regulation of amyloid precursor protein catabolic process,BP,
19517,GO:1902993,1,0.926247637655631,0,12,positive regulation of amyloid precursor protein catabolic process,BP,
19518,GO:1902994,1,0.987020321349376,0,2,regulation of phospholipid efflux,BP,
19519,GO:1902995,1,0.987020321349376,0,2,positive regulation of phospholipid efflux,BP,
19520,GO:1902996,1,0.985357860056621,0,2,regulation of neurofibrillary tangle assembly,BP,
19521,GO:1902997,1,0.991480072981613,0,1,negative regulation of neurofibrillary tangle assembly,BP,
19522,GO:1902998,1,0.993825715097266,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19523,GO:1903000,1,0.9943066551631,0,1,regulation of lipid transport across blood brain barrier,BP,
19524,GO:1903002,1,0.9943066551631,0,1,positive regulation of lipid transport across blood brain barrier,BP,
19525,GO:1903003,1,0.962893586510777,0,6,positive regulation of protein deubiquitination,BP,
19526,GO:1903004,1,0.993532827811427,0,1,regulation of protein K63-linked deubiquitination,BP,
19527,GO:1903006,1,0.993532827811427,0,1,positive regulation of protein K63-linked deubiquitination,BP,
19528,GO:1903007,1,0.993532827811427,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19529,GO:1903008,1,0.52775186609432,0,100,organelle disassembly,BP,
19532,GO:1903012,1,0.958082790230093,0,7,positive regulation of bone development,BP,
19533,GO:1903015,1,0.988282614281769,0,2,regulation of exo-alpha-sialidase activity,BP,
19534,GO:1903016,1,0.994088052350844,0,1,negative regulation of exo-alpha-sialidase activity,BP,
19535,GO:1903017,1,0.9941603888507,0,1,positive regulation of exo-alpha-sialidase activity,BP,
19537,GO:1903019,1,0.929054743096013,0,12,negative regulation of glycoprotein metabolic process,BP,
19538,GO:1903020,1,0.873967442747457,0,21,positive regulation of glycoprotein metabolic process,BP,
19539,GO:1903025,1,0.943875047681842,0,9,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19540,GO:1903026,1,0.970422607046801,0,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19541,GO:1903027,1,0.986503021770707,0,2,regulation of opsonization,BP,
19542,GO:1903028,1,0.992458482383227,0,1,positive regulation of opsonization,BP,
19543,GO:1903031,1,0.988031633199054,0,2,regulation of microtubule plus-end binding,BP,
19544,GO:1903033,1,0.988031633199054,0,2,positive regulation of microtubule plus-end binding,BP,
19545,GO:1903034,1,0.42740252074065,0,133,regulation of response to wounding,BP,
19546,GO:1903035,1,0.62791657595828,0,73,negative regulation of response to wounding,BP,
19547,GO:1903036,1,0.728411870241086,0,50,positive regulation of response to wounding,BP,
19548,GO:1903037,1,0.193661669941694,0,261,regulation of leukocyte cell-cell adhesion,BP,
19549,GO:1903038,1,0.553514233134786,0,94,negative regulation of leukocyte cell-cell adhesion,BP,
19550,GO:1903039,1,0.293518256241638,0,196,positive regulation of leukocyte cell-cell adhesion,BP,
19551,GO:1903044,1,0.951562495999635,0,8,protein localization to membrane raft,BP,
19552,GO:1903045,1,0.993017137746097,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
19555,GO:1903050,1,0.2959277353234,0,190,regulation of proteolysis involved in cellular protein catabolic process,BP,
19556,GO:1903051,1,0.698261970738955,0,56,negative regulation of proteolysis involved in cellular protein catabolic process,BP,
19557,GO:1903052,1,0.48887591545508,0,112,positive regulation of proteolysis involved in cellular protein catabolic process,BP,
19558,GO:1903053,1,0.830381647119234,0,28,regulation of extracellular matrix organization,BP,
19559,GO:1903054,1,0.964215979186561,0,6,negative regulation of extracellular matrix organization,BP,
19560,GO:1903055,1,0.905844925016084,0,15,positive regulation of extracellular matrix organization,BP,
19561,GO:1903056,1,0.986203427115828,0,2,regulation of melanosome organization,BP,
19564,GO:1903061,1,0.974201427393374,0,4,positive regulation of protein lipidation,BP,
19565,GO:1903069,1,0.946087242254119,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19566,GO:1903070,1,0.981796620556767,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19567,GO:1903071,1,0.957828485522511,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19568,GO:1903072,1,0.994377406787888,0,1,regulation of death-inducing signaling complex assembly,BP,
19569,GO:1903073,1,0.994377406787888,0,1,negative regulation of death-inducing signaling complex assembly,BP,
19570,GO:1903076,1,0.59735421419501,0,80,regulation of protein localization to plasma membrane,BP,
19571,GO:1903077,1,0.870008528319768,0,22,negative regulation of protein localization to plasma membrane,BP,
19572,GO:1903078,1,0.735631968980653,0,47,positive regulation of protein localization to plasma membrane,BP,
19573,GO:1903080,1,0.994343330331289,0,1,regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19574,GO:1903082,1,0.994343330331289,0,1,positive regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19575,GO:1903093,1,0.981374246565128,0,3,regulation of protein K48-linked deubiquitination,BP,
19576,GO:1903094,1,0.988683297851787,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19577,GO:1903095,1,0.987254107618277,0,2,ribonuclease III complex,CC,
19578,GO:1903096,1,0.993772585859067,0,1,protein localization to meiotic spindle midzone,BP,
19579,GO:1903108,1,0.993176940438187,0,1,regulation of mitochondrial transcription,BP,
19580,GO:1903109,1,0.993176940438187,0,1,positive regulation of mitochondrial transcription,BP,
19582,GO:1903116,1,0.980466764182074,0,3,positive regulation of actin filament-based movement,BP,
19583,GO:1903119,1,0.980146848871237,0,3,protein localization to actin cytoskeleton,BP,
19584,GO:1903121,1,0.97479181872605,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
19585,GO:1903122,1,0.994377406787888,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
19586,GO:1903123,1,0.991973955775138,0,1,regulation of thioredoxin peroxidase activity,BP,
19587,GO:1903124,1,0.991973955775138,0,1,negative regulation of thioredoxin peroxidase activity,BP,
19588,GO:1903125,1,0.991973955775138,0,1,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,BP,
19589,GO:1903126,1,0.994030900702666,0,1,negative regulation of centriole-centriole cohesion,BP,
19590,GO:1903131,1,0.824719506455888,0,30,mononuclear cell differentiation,BP,
19591,GO:1903135,1,0.981840365851113,0,3,cupric ion binding,MF,
19592,GO:1903136,1,0.963500908795798,0,6,cuprous ion binding,MF,
19593,GO:1903140,1,0.926219927870046,0,12,regulation of establishment of endothelial barrier,BP,
19594,GO:1903141,1,0.993438155403804,0,1,negative regulation of establishment of endothelial barrier,BP,
19595,GO:1903142,1,0.969149148988259,0,5,positive regulation of establishment of endothelial barrier,BP,
19596,GO:1903143,1,0.981995670165577,0,3,adrenomedullin receptor complex,CC,
19597,GO:1903146,1,0.752433893890075,0,44,regulation of autophagy of mitochondrion,BP,
19598,GO:1903147,1,0.956065368701766,0,7,negative regulation of autophagy of mitochondrion,BP,
19599,GO:1903165,1,0.993869194827968,0,1,response to polycyclic arene,BP,
19600,GO:1903167,1,0.994377406787888,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
19601,GO:1903168,1,0.994377406787888,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
19603,GO:1903170,1,0.80886101943874,0,34,negative regulation of calcium ion transmembrane transport,BP,
19604,GO:1903173,1,0.987704752253838,0,2,fatty alcohol metabolic process,BP,
19605,GO:1903176,1,0.994377406787888,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
19606,GO:1903178,1,0.994377406787888,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
19607,GO:1903179,1,0.988109753954568,0,2,regulation of dopamine biosynthetic process,BP,
19608,GO:1903181,1,0.988109753954568,0,2,positive regulation of dopamine biosynthetic process,BP,
19609,GO:1903182,1,0.994300013232335,0,1,regulation of SUMO transferase activity,BP,
19610,GO:1903184,1,0.994377406787888,0,1,L-dopa metabolic process,BP,
19611,GO:1903185,1,0.994377406787888,0,1,L-dopa biosynthetic process,BP,
19612,GO:1903189,1,0.994377406787888,0,1,glyoxal metabolic process,BP,
19613,GO:1903195,1,0.994377406787888,0,1,regulation of L-dopa biosynthetic process,BP,
19614,GO:1903197,1,0.994377406787888,0,1,positive regulation of L-dopa biosynthetic process,BP,
19615,GO:1903198,1,0.994377406787888,0,1,regulation of L-dopa decarboxylase activity,BP,
19616,GO:1903200,1,0.994377406787888,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19619,GO:1903203,1,0.877932775160716,0,20,regulation of oxidative stress-induced neuron death,BP,
19620,GO:1903204,1,0.907907900116303,0,15,negative regulation of oxidative stress-induced neuron death,BP,
19623,GO:1903207,1,0.9757723243876,0,4,regulation of hydrogen peroxide-induced neuron death,BP,
19624,GO:1903208,1,0.9757723243876,0,4,negative regulation of hydrogen peroxide-induced neuron death,BP,
19625,GO:1903209,1,0.920665227741983,0,13,positive regulation of oxidative stress-induced cell death,BP,
19626,GO:1903210,1,0.992826483555519,0,1,glomerular visceral epithelial cell apoptotic process,BP,
19628,GO:1903215,1,0.974051231656839,0,4,negative regulation of protein targeting to mitochondrion,BP,
19629,GO:1903216,1,0.986328421387607,0,2,regulation of protein processing involved in protein targeting to mitochondrion,BP,
19630,GO:1903217,1,0.986328421387607,0,2,negative regulation of protein processing involved in protein targeting to mitochondrion,BP,
19631,GO:1903223,1,0.973349384616705,0,4,positive regulation of oxidative stress-induced neuron death,BP,
19632,GO:1903224,1,0.967593788421435,0,5,regulation of endodermal cell differentiation,BP,
19633,GO:1903225,1,0.979289960810491,0,3,negative regulation of endodermal cell differentiation,BP,
19634,GO:1903232,1,0.970587968001121,0,5,melanosome assembly,BP,
19635,GO:1903233,1,0.985547322637875,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
19636,GO:1903236,1,0.952926678488868,0,8,regulation of leukocyte tethering or rolling,BP,
19637,GO:1903237,1,0.977476309090275,0,4,negative regulation of leukocyte tethering or rolling,BP,
19638,GO:1903238,1,0.974890446159488,0,4,positive regulation of leukocyte tethering or rolling,BP,
19639,GO:1903242,1,0.947569323493861,0,8,regulation of cardiac muscle hypertrophy in response to stress,BP,
19640,GO:1903243,1,0.960050534531224,0,6,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
19641,GO:1903244,1,0.987004793562329,0,2,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19642,GO:1903248,1,0.992100351952376,0,1,regulation of citrulline biosynthetic process,BP,
19643,GO:1903249,1,0.992100351952376,0,1,negative regulation of citrulline biosynthetic process,BP,
19644,GO:1903251,1,0.956945785711551,0,7,multi-ciliated epithelial cell differentiation,BP,
19645,GO:1903265,1,0.952696891917675,0,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
19648,GO:1903279,1,0.980631757504052,0,3,regulation of calcium:sodium antiporter activity,BP,
19649,GO:1903280,1,0.993072554520144,0,1,negative regulation of calcium:sodium antiporter activity,BP,
19650,GO:1903281,1,0.987473301688409,0,2,positive regulation of calcium:sodium antiporter activity,BP,
19651,GO:1903282,1,0.993733409310885,0,1,regulation of glutathione peroxidase activity,BP,
19652,GO:1903284,1,0.993733409310885,0,1,positive regulation of glutathione peroxidase activity,BP,
19653,GO:1903285,1,0.993733409310885,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
19654,GO:1903286,1,0.975333090902124,0,4,regulation of potassium ion import,BP,
19655,GO:1903288,1,0.982009169587606,0,3,positive regulation of potassium ion import,BP,
19656,GO:1903292,1,0.987458440167996,0,2,protein localization to Golgi membrane,BP,
19658,GO:1903294,1,0.986787472958112,0,2,regulation of glutamate secretion, neurotransmission,BP,
19659,GO:1903296,1,0.986787472958112,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
19660,GO:1903297,1,0.96971335889476,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19661,GO:1903298,1,0.96971335889476,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19662,GO:1903299,1,0.944385165853776,0,9,regulation of hexokinase activity,BP,
19663,GO:1903300,1,0.97605762101554,0,4,negative regulation of hexokinase activity,BP,
19664,GO:1903301,1,0.967558522795073,0,5,positive regulation of hexokinase activity,BP,
19665,GO:1903305,1,0.471302181419871,0,117,regulation of regulated secretory pathway,BP,
19666,GO:1903306,1,0.880271170461088,0,20,negative regulation of regulated secretory pathway,BP,
19667,GO:1903307,1,0.74626370798522,0,46,positive regulation of regulated secretory pathway,BP,
19668,GO:1903311,1,0.174348317499072,0,273,regulation of mRNA metabolic process,BP,
19669,GO:1903312,1,0.642476414514928,0,69,negative regulation of mRNA metabolic process,BP,
19670,GO:1903313,1,0.662590515844603,0,63,positive regulation of mRNA metabolic process,BP,
19671,GO:1903314,1,0.994026284253939,0,1,regulation of nitrogen cycle metabolic process,BP,
19673,GO:1903318,1,0.795219030400652,0,35,negative regulation of protein maturation,BP,
19676,GO:1903321,1,0.642082739834161,0,70,negative regulation of protein modification by small protein conjugation or removal,BP,
19678,GO:1903332,1,0.95760697214814,0,7,regulation of protein folding,BP,
19679,GO:1903333,1,0.969777736342751,0,5,negative regulation of protein folding,BP,
19680,GO:1903335,1,0.974341760773739,0,4,regulation of vacuolar transport,BP,
19681,GO:1903336,1,0.98572129868101,0,2,negative regulation of vacuolar transport,BP,
19682,GO:1903337,1,0.988457307555306,0,2,positive regulation of vacuolar transport,BP,
19683,GO:1903347,1,0.973467570430664,0,4,negative regulation of bicellular tight junction assembly,BP,
19684,GO:1903348,1,0.980859423748929,0,3,positive regulation of bicellular tight junction assembly,BP,
19685,GO:1903349,1,0.963006903923445,0,6,omegasome membrane,CC,
19686,GO:1903350,1,0.918066387603997,0,13,response to dopamine,BP,
19687,GO:1903351,1,0.918066387603997,0,13,cellular response to dopamine,BP,
19688,GO:1903352,1,0.961318742383418,0,6,L-ornithine transmembrane transport,BP,
19689,GO:1903358,1,0.907845910430726,0,15,regulation of Golgi organization,BP,
19690,GO:1903361,1,0.958545456293439,0,7,protein localization to basolateral plasma membrane,BP,
19692,GO:1903363,1,0.652013983342676,0,67,negative regulation of cellular protein catabolic process,BP,
19694,GO:1903365,1,0.957456231228242,0,7,regulation of fear response,BP,
19695,GO:1903367,1,0.969971073856014,0,5,positive regulation of fear response,BP,
19696,GO:1903371,1,0.972453862614157,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
19697,GO:1903373,1,0.979879799322203,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
19698,GO:1903375,1,0.986988539177487,0,2,facioacoustic ganglion development,BP,
19699,GO:1903376,1,0.956916449604132,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19700,GO:1903377,1,0.97573073620759,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19701,GO:1903378,1,0.987144368910397,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19702,GO:1903381,1,0.993335181890393,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19703,GO:1903382,1,0.993335181890393,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19704,GO:1903383,1,0.988290008317986,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19705,GO:1903384,1,0.988290008317986,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19706,GO:1903385,1,0.986817034270962,0,2,regulation of homophilic cell adhesion,BP,
19707,GO:1903387,1,0.993127361154225,0,1,positive regulation of homophilic cell adhesion,BP,
19709,GO:1903392,1,0.899761149449474,0,16,negative regulation of adherens junction organization,BP,
19710,GO:1903393,1,0.844974185996445,0,25,positive regulation of adherens junction organization,BP,
19711,GO:1903394,1,0.993967748105034,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
19712,GO:1903400,1,0.96729261499938,0,5,L-arginine transmembrane transport,BP,
19713,GO:1903401,1,0.968824679089623,0,5,L-lysine transmembrane transport,BP,
19714,GO:1903402,1,0.993531399454735,0,1,regulation of renal phosphate excretion,BP,
19715,GO:1903403,1,0.993531399454735,0,1,negative regulation of renal phosphate excretion,BP,
19716,GO:1903405,1,0.947191662296271,0,9,protein localization to nuclear body,BP,
19717,GO:1903406,1,0.993598071002145,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
19718,GO:1903408,1,0.993598071002145,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
19719,GO:1903409,1,0.587570436420763,0,83,reactive oxygen species biosynthetic process,BP,
19720,GO:1903412,1,0.9823365323782,0,3,response to bile acid,BP,
19721,GO:1903413,1,0.9823365323782,0,3,cellular response to bile acid,BP,
19722,GO:1903414,1,0.99367985018319,0,1,iron cation export,BP,
19723,GO:1903416,1,0.962458223348478,0,6,response to glycoside,BP,
19724,GO:1903420,1,0.992801625966396,0,1,protein localization to endoplasmic reticulum tubular network,BP,
19725,GO:1903421,1,0.903699201858941,0,15,regulation of synaptic vesicle recycling,BP,
19726,GO:1903422,1,0.986521332100308,0,2,negative regulation of synaptic vesicle recycling,BP,
19727,GO:1903423,1,0.952923048983263,0,7,positive regulation of synaptic vesicle recycling,BP,
19728,GO:1903426,1,0.662004893484897,0,65,regulation of reactive oxygen species biosynthetic process,BP,
19729,GO:1903427,1,0.877044774803901,0,21,negative regulation of reactive oxygen species biosynthetic process,BP,
19730,GO:1903428,1,0.76453225693216,0,42,positive regulation of reactive oxygen species biosynthetic process,BP,
19731,GO:1903429,1,0.878623958822728,0,20,regulation of cell maturation,BP,
19732,GO:1903430,1,0.958185471795907,0,7,negative regulation of cell maturation,BP,
19733,GO:1903431,1,0.953881815681757,0,7,positive regulation of cell maturation,BP,
19734,GO:1903432,1,0.852459276677456,0,25,regulation of TORC1 signaling,BP,
19735,GO:1903433,1,0.987413871184197,0,2,regulation of constitutive secretory pathway,BP,
19736,GO:1903434,1,0.993536255704546,0,1,negative regulation of constitutive secretory pathway,BP,
19737,GO:1903435,1,0.993838190995379,0,1,positive regulation of constitutive secretory pathway,BP,
19738,GO:1903436,1,0.98655810998527,0,2,regulation of mitotic cytokinetic process,BP,
19739,GO:1903438,1,0.98655810998527,0,2,positive regulation of mitotic cytokinetic process,BP,
19740,GO:1903439,1,0.970235181367056,0,5,calcitonin family receptor complex,CC,
19741,GO:1903440,1,0.976871905388626,0,4,amylin receptor complex,CC,
19742,GO:1903441,1,0.951008052146884,0,8,protein localization to ciliary membrane,BP,
19743,GO:1903442,1,0.993545395687408,0,1,response to lipoic acid,BP,
19744,GO:1903444,1,0.993736553306438,0,1,negative regulation of brown fat cell differentiation,BP,
19745,GO:1903445,1,0.982473958886003,0,3,protein transport from ciliary membrane to plasma membrane,BP,
19746,GO:1903450,1,0.992157645650949,0,1,regulation of G1 to G0 transition,BP,
19747,GO:1903452,1,0.992157645650949,0,1,positive regulation of G1 to G0 transition,BP,
19748,GO:1903461,1,0.993751276354577,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
19749,GO:1903463,1,0.980881808041559,0,3,regulation of mitotic cell cycle DNA replication,BP,
19750,GO:1903464,1,0.987773598140567,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
19751,GO:1903465,1,0.993023777694327,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
19752,GO:1903487,1,0.982160033056161,0,3,regulation of lactation,BP,
19753,GO:1903489,1,0.988461044949113,0,2,positive regulation of lactation,BP,
19754,GO:1903490,1,0.98655810998527,0,2,positive regulation of mitotic cytokinesis,BP,
19755,GO:1903494,1,0.994364411486775,0,1,response to dehydroepiandrosterone,BP,
19756,GO:1903496,1,0.994364411486775,0,1,response to 11-deoxycorticosterone,BP,
19757,GO:1903504,1,0.915042697138284,0,14,regulation of mitotic spindle checkpoint,BP,
19761,GO:1903509,1,0.478424001243379,0,118,liposaccharide metabolic process,BP,
19763,GO:1903513,1,0.848946752990287,0,26,endoplasmic reticulum to cytosol transport,BP,
19765,GO:1903515,1,0.992270732458831,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19766,GO:1903516,1,0.981456850537613,0,3,regulation of single strand break repair,BP,
19767,GO:1903517,1,0.993810523874367,0,1,negative regulation of single strand break repair,BP,
19768,GO:1903518,1,0.987570170409035,0,2,positive regulation of single strand break repair,BP,
19769,GO:1903519,1,0.981258598165644,0,3,regulation of mammary gland involution,BP,
19770,GO:1903521,1,0.981258598165644,0,3,positive regulation of mammary gland involution,BP,
19774,GO:1903525,1,0.966593624795469,0,5,regulation of membrane tubulation,BP,
19775,GO:1903526,1,0.987014568717033,0,2,negative regulation of membrane tubulation,BP,
19776,GO:1903527,1,0.97931312235537,0,3,positive regulation of membrane tubulation,BP,
19781,GO:1903537,1,0.987829444260157,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
19782,GO:1903538,1,0.987829444260157,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
19783,GO:1903539,1,0.923911202069893,0,12,protein localization to postsynaptic membrane,BP,
19784,GO:1903540,1,0.945224664296641,0,9,establishment of protein localization to postsynaptic membrane,BP,
19785,GO:1903541,1,0.916808853593817,0,14,regulation of exosomal secretion,BP,
19786,GO:1903542,1,0.987712048387172,0,2,negative regulation of exosomal secretion,BP,
19787,GO:1903543,1,0.916808853593817,0,14,positive regulation of exosomal secretion,BP,
19788,GO:1903544,1,0.993662149684397,0,1,response to butyrate,BP,
19789,GO:1903545,1,0.993662149684397,0,1,cellular response to butyrate,BP,
19790,GO:1903546,1,0.962020378402233,0,6,protein localization to photoreceptor outer segment,BP,
19791,GO:1903547,1,0.988666067137002,0,2,regulation of growth hormone activity,BP,
19792,GO:1903551,1,0.963217530828989,0,6,regulation of extracellular exosome assembly,BP,
19793,GO:1903553,1,0.97489255863972,0,4,positive regulation of extracellular exosome assembly,BP,
19794,GO:1903555,1,0.501499303731355,0,110,regulation of tumor necrosis factor superfamily cytokine production,BP,
19796,GO:1903557,1,0.658615763406993,0,66,positive regulation of tumor necrosis factor superfamily cytokine production,BP,
19798,GO:1903564,1,0.972455066196422,0,4,regulation of protein localization to cilium,BP,
19799,GO:1903565,1,0.993666431762045,0,1,negative regulation of protein localization to cilium,BP,
19800,GO:1903566,1,0.978654803191053,0,3,positive regulation of protein localization to cilium,BP,
19801,GO:1903567,1,0.987667130159351,0,2,regulation of protein localization to ciliary membrane,BP,
19802,GO:1903568,1,0.993666431762045,0,1,negative regulation of protein localization to ciliary membrane,BP,
19803,GO:1903569,1,0.993962849525917,0,1,positive regulation of protein localization to ciliary membrane,BP,
19804,GO:1903570,1,0.993632892264306,0,1,regulation of protein kinase D signaling,BP,
19805,GO:1903572,1,0.993632892264306,0,1,positive regulation of protein kinase D signaling,BP,
19806,GO:1903573,1,0.777670199385816,0,40,negative regulation of response to endoplasmic reticulum stress,BP,
19807,GO:1903575,1,0.987928549310349,0,2,cornified envelope assembly,BP,
19808,GO:1903576,1,0.994049369688487,0,1,response to L-arginine,BP,
19809,GO:1903578,1,0.582387808386482,0,83,regulation of ATP metabolic process,BP,
19810,GO:1903579,1,0.885452001385149,0,19,negative regulation of ATP metabolic process,BP,
19811,GO:1903580,1,0.828826885754891,0,29,positive regulation of ATP metabolic process,BP,
19812,GO:1903584,1,0.99338598736905,0,1,regulation of histone deubiquitination,BP,
19813,GO:1903586,1,0.99338598736905,0,1,positive regulation of histone deubiquitination,BP,
19815,GO:1903588,1,0.974825910068942,0,4,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19817,GO:1903593,1,0.982848627473824,0,3,regulation of histamine secretion by mast cell,BP,
19818,GO:1903595,1,0.982848627473824,0,3,positive regulation of histamine secretion by mast cell,BP,
19819,GO:1903596,1,0.97531804714265,0,4,regulation of gap junction assembly,BP,
19820,GO:1903597,1,0.993677708805389,0,1,negative regulation of gap junction assembly,BP,
19821,GO:1903598,1,0.98152470946765,0,3,positive regulation of gap junction assembly,BP,
19822,GO:1903599,1,0.893149474858564,0,17,positive regulation of autophagy of mitochondrion,BP,
19823,GO:1903608,1,0.962544204343792,0,6,protein localization to cytoplasmic stress granule,BP,
19824,GO:1903609,1,0.993875802566782,0,1,negative regulation of inward rectifier potassium channel activity,BP,
19825,GO:1903610,1,0.99409021782693,0,1,regulation of calcium-dependent ATPase activity,BP,
19826,GO:1903611,1,0.99409021782693,0,1,negative regulation of calcium-dependent ATPase activity,BP,
19827,GO:1903613,1,0.993107894645182,0,1,regulation of protein tyrosine phosphatase activity,BP,
19828,GO:1903615,1,0.993107894645182,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
19829,GO:1903618,1,0.993494245950117,0,1,regulation of transdifferentiation,BP,
19830,GO:1903620,1,0.993494245950117,0,1,positive regulation of transdifferentiation,BP,
19831,GO:1903621,1,0.994085020742256,0,1,protein localization to photoreceptor connecting cilium,BP,
19832,GO:1903624,1,0.944477286146147,0,9,regulation of DNA catabolic process,BP,
19833,GO:1903625,1,0.987989708661596,0,2,negative regulation of DNA catabolic process,BP,
19834,GO:1903626,1,0.974435943487645,0,4,positive regulation of DNA catabolic process,BP,
19835,GO:1903627,1,0.99409021782693,0,1,regulation of dUTP diphosphatase activity,BP,
19836,GO:1903629,1,0.99409021782693,0,1,positive regulation of dUTP diphosphatase activity,BP,
19837,GO:1903630,1,0.988418981355631,0,2,regulation of aminoacyl-tRNA ligase activity,BP,
19838,GO:1903631,1,0.99409021782693,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,
19839,GO:1903632,1,0.994295392762982,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
19840,GO:1903633,1,0.99409021782693,0,1,regulation of leucine-tRNA ligase activity,BP,
19841,GO:1903634,1,0.99409021782693,0,1,negative regulation of leucine-tRNA ligase activity,BP,
19842,GO:1903636,1,0.994485414935947,0,1,regulation of protein import into mitochondrial outer membrane,BP,
19843,GO:1903638,1,0.994485414935947,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
19844,GO:1903639,1,0.994498699786889,0,1,regulation of gastrin-induced gastric acid secretion,BP,
19845,GO:1903640,1,0.994498699786889,0,1,negative regulation of gastrin-induced gastric acid secretion,BP,
19846,GO:1903644,1,0.98842824499285,0,2,regulation of chaperone-mediated protein folding,BP,
19847,GO:1903645,1,0.994485414935947,0,1,negative regulation of chaperone-mediated protein folding,BP,
19848,GO:1903649,1,0.877159900472283,0,20,regulation of cytoplasmic transport,BP,
19849,GO:1903650,1,0.988731965211725,0,2,negative regulation of cytoplasmic transport,BP,
19850,GO:1903651,1,0.9410038990318,0,9,positive regulation of cytoplasmic transport,BP,
19851,GO:1903659,1,0.988223572605086,0,2,regulation of complement-dependent cytotoxicity,BP,
19852,GO:1903660,1,0.988223572605086,0,2,negative regulation of complement-dependent cytotoxicity,BP,
19854,GO:1903671,1,0.858828684823771,0,23,negative regulation of sprouting angiogenesis,BP,
19856,GO:1903673,1,0.994092672072738,0,1,mitotic cleavage furrow formation,BP,
19857,GO:1903674,1,0.994094693246456,0,1,regulation of cap-dependent translational initiation,BP,
19858,GO:1903676,1,0.994094693246456,0,1,positive regulation of cap-dependent translational initiation,BP,
19859,GO:1903677,1,0.982113568317853,0,3,regulation of cap-independent translational initiation,BP,
19860,GO:1903679,1,0.982113568317853,0,3,positive regulation of cap-independent translational initiation,BP,
19861,GO:1903689,1,0.955998333494825,0,6,regulation of wound healing, spreading of epidermal cells,BP,
19862,GO:1903690,1,0.971194212140364,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
19863,GO:1903691,1,0.98435803384363,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
19864,GO:1903697,1,0.99368070675058,0,1,negative regulation of microvillus assembly,BP,
19865,GO:1903699,1,0.991238648819333,0,1,tarsal gland development,BP,
19866,GO:1903701,1,0.993152011254311,0,1,substantia propria of cornea development,BP,
19867,GO:1903704,1,0.993494245950117,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19868,GO:1903706,1,0.0841833494780311,0,388,regulation of hemopoiesis,BP,
19869,GO:1903707,1,0.48628027430211,0,114,negative regulation of hemopoiesis,BP,
19870,GO:1903708,1,0.383887318240158,0,151,positive regulation of hemopoiesis,BP,
19871,GO:1903709,1,0.991238648819333,0,1,uterine gland development,BP,
19872,GO:1903712,1,0.99357337879569,0,1,cysteine transmembrane transport,BP,
19873,GO:1903715,1,0.962241405288233,0,6,regulation of aerobic respiration,BP,
19874,GO:1903717,1,0.992991440799671,0,1,response to ammonia,BP,
19875,GO:1903718,1,0.992991440799671,0,1,cellular response to ammonia,BP,
19876,GO:1903719,1,0.982199014176307,0,3,regulation of I-kappaB phosphorylation,BP,
19877,GO:1903721,1,0.982199014176307,0,3,positive regulation of I-kappaB phosphorylation,BP,
19878,GO:1903722,1,0.988093372432629,0,2,regulation of centriole elongation,BP,
19879,GO:1903723,1,0.994385781568125,0,1,negative regulation of centriole elongation,BP,
19880,GO:1903724,1,0.993672426976752,0,1,positive regulation of centriole elongation,BP,
19881,GO:1903725,1,0.653905854480651,0,66,regulation of phospholipid metabolic process,BP,
19882,GO:1903726,1,0.957401544619805,0,7,negative regulation of phospholipid metabolic process,BP,
19883,GO:1903727,1,0.765105998292975,0,42,positive regulation of phospholipid metabolic process,BP,
19884,GO:1903729,1,0.931569774317432,0,11,regulation of plasma membrane organization,BP,
19885,GO:1903742,1,0.994262471997153,0,1,regulation of anterograde synaptic vesicle transport,BP,
19886,GO:1903743,1,0.994262471997153,0,1,negative regulation of anterograde synaptic vesicle transport,BP,
19888,GO:1903748,1,0.955440280647789,0,7,negative regulation of establishment of protein localization to mitochondrion,BP,
19890,GO:1903750,1,0.976040245304483,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19891,GO:1903751,1,0.976040245304483,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19892,GO:1903753,1,0.968706378637491,0,5,negative regulation of p38MAPK cascade,BP,
19893,GO:1903755,1,0.994300013232335,0,1,positive regulation of SUMO transferase activity,BP,
19894,GO:1903756,1,0.9873249968956,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19895,GO:1903758,1,0.9873249968956,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19896,GO:1903759,1,0.993736553306438,0,1,signal transduction involved in regulation of aerobic respiration,BP,
19897,GO:1903760,1,0.980198077014962,0,3,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19898,GO:1903762,1,0.986907114143901,0,2,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19900,GO:1903764,1,0.981480929773162,0,3,regulation of potassium ion export across plasma membrane,BP,
19901,GO:1903765,1,0.993762715956935,0,1,negative regulation of potassium ion export across plasma membrane,BP,
19902,GO:1903766,1,0.994401376055962,0,1,positive regulation of potassium ion export across plasma membrane,BP,
19903,GO:1903767,1,0.993908146519457,0,1,sweet taste receptor complex,CC,
19904,GO:1903768,1,0.993908146519457,0,1,taste receptor complex,CC,
19905,GO:1903770,1,0.993810523874367,0,1,negative regulation of beta-galactosidase activity,BP,
19906,GO:1903772,1,0.970566434942027,0,5,regulation of viral budding via host ESCRT complex,BP,
19907,GO:1903774,1,0.982180794074894,0,3,positive regulation of viral budding via host ESCRT complex,BP,
19908,GO:1903775,1,0.987742984961075,0,2,regulation of DNA double-strand break processing,BP,
19909,GO:1903778,1,0.992811742832209,0,1,protein localization to vacuolar membrane,BP,
19911,GO:1903781,1,0.980454861968333,0,3,positive regulation of cardiac conduction,BP,
19912,GO:1903786,1,0.993856415233832,0,1,regulation of glutathione biosynthetic process,BP,
19913,GO:1903788,1,0.993856415233832,0,1,positive regulation of glutathione biosynthetic process,BP,
19914,GO:1903789,1,0.950371218346506,0,8,regulation of amino acid transmembrane transport,BP,
19915,GO:1903792,1,0.867238965361351,0,22,negative regulation of anion transport,BP,
19917,GO:1903795,1,0.959194998793401,0,6,regulation of inorganic anion transmembrane transport,BP,
19918,GO:1903796,1,0.98597698450963,0,2,negative regulation of inorganic anion transmembrane transport,BP,
19919,GO:1903797,1,0.986378391858417,0,2,positive regulation of inorganic anion transmembrane transport,BP,
19920,GO:1903798,1,0.913443920970483,0,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19921,GO:1903799,1,0.947489069835959,0,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19922,GO:1903800,1,0.958311648798306,0,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19923,GO:1903801,1,0.993993114630875,0,1,L-leucine import across plasma membrane,BP,
19924,GO:1903803,1,0.994090362193189,0,1,L-glutamine import across plasma membrane,BP,
19925,GO:1903804,1,0.993818261559461,0,1,glycine import across plasma membrane,BP,
19926,GO:1903814,1,0.994401376055962,0,1,regulation of collecting lymphatic vessel constriction,BP,
19927,GO:1903815,1,0.994401376055962,0,1,negative regulation of collecting lymphatic vessel constriction,BP,
19928,GO:1903817,1,0.950590883544474,0,8,negative regulation of voltage-gated potassium channel activity,BP,
19929,GO:1903818,1,0.916071967800253,0,13,positive regulation of voltage-gated potassium channel activity,BP,
19930,GO:1903823,1,0.993810523874367,0,1,telomere single strand break repair,BP,
19931,GO:1903824,1,0.993810523874367,0,1,negative regulation of telomere single strand break repair,BP,
19933,GO:1903826,1,0.961585227823046,0,6,arginine transmembrane transport,BP,
19935,GO:1903828,1,0.54650914146578,0,95,negative regulation of cellular protein localization,BP,
19937,GO:1903830,1,0.902129296921491,0,16,magnesium ion transmembrane transport,BP,
19938,GO:1903831,1,0.876340871224859,0,21,signal transduction involved in cellular response to ammonium ion,BP,
19939,GO:1903837,1,0.993932607884681,0,1,regulation of mRNA 3'-UTR binding,BP,
19940,GO:1903839,1,0.993932607884681,0,1,positive regulation of mRNA 3'-UTR binding,BP,
19941,GO:1903844,1,0.517093888241629,0,100,regulation of cellular response to transforming growth factor beta stimulus,BP,
19942,GO:1903845,1,0.638959970890689,0,68,negative regulation of cellular response to transforming growth factor beta stimulus,BP,
19943,GO:1903846,1,0.849267702074832,0,25,positive regulation of cellular response to transforming growth factor beta stimulus,BP,
19944,GO:1903847,1,0.985415686818481,0,2,regulation of aorta morphogenesis,BP,
19945,GO:1903849,1,0.985415686818481,0,2,positive regulation of aorta morphogenesis,BP,
19946,GO:1903850,1,0.993878532344541,0,1,regulation of cristae formation,BP,
19947,GO:1903852,1,0.993878532344541,0,1,positive regulation of cristae formation,BP,
19949,GO:1903860,1,0.982088351769419,0,3,negative regulation of dendrite extension,BP,
19951,GO:1903862,1,0.964645165439328,0,6,positive regulation of oxidative phosphorylation,BP,
19952,GO:1903867,1,0.943068343228052,0,9,extraembryonic membrane development,BP,
19953,GO:1903874,1,0.980549423470157,0,3,ferrous iron transmembrane transport,BP,
19954,GO:1903881,1,0.993577518319972,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
19955,GO:1903883,1,0.993577518319972,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
19956,GO:1903884,1,0.993577518319972,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
19957,GO:1903886,1,0.993577518319972,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
19958,GO:1903888,1,0.994422168860593,0,1,regulation of plant epidermal cell differentiation,BP,
19959,GO:1903889,1,0.994422168860593,0,1,negative regulation of plant epidermal cell differentiation,BP,
19960,GO:1903891,1,0.975151954920224,0,4,regulation of ATF6-mediated unfolded protein response,BP,
19961,GO:1903892,1,0.987527385579086,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
19962,GO:1903893,1,0.993925699226469,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
19963,GO:1903894,1,0.921430166750319,0,13,regulation of IRE1-mediated unfolded protein response,BP,
19964,GO:1903895,1,0.975228729917916,0,4,negative regulation of IRE1-mediated unfolded protein response,BP,
19965,GO:1903896,1,0.95592248272905,0,7,positive regulation of IRE1-mediated unfolded protein response,BP,
19967,GO:1903898,1,0.969239704319199,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
19970,GO:1903901,1,0.649003801790638,0,69,negative regulation of viral life cycle,BP,
19972,GO:1903903,1,0.98035919950007,0,3,regulation of establishment of T cell polarity,BP,
19973,GO:1903905,1,0.986419201022668,0,2,positive regulation of establishment of T cell polarity,BP,
19974,GO:1903906,1,0.993857420128899,0,1,regulation of plasma membrane raft polarization,BP,
19975,GO:1903909,1,0.948924215055494,0,8,regulation of receptor clustering,BP,
19976,GO:1903910,1,0.993972070877798,0,1,negative regulation of receptor clustering,BP,
19977,GO:1903911,1,0.974730335257657,0,4,positive regulation of receptor clustering,BP,
19978,GO:1903912,1,0.974492589695734,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
19979,GO:1903916,1,0.993959680183743,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19980,GO:1903917,1,0.993959680183743,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19981,GO:1903918,1,0.99247498851664,0,1,regulation of actin filament severing,BP,
19982,GO:1903919,1,0.99247498851664,0,1,negative regulation of actin filament severing,BP,
19983,GO:1903921,1,0.986378163353932,0,2,regulation of protein processing in phagocytic vesicle,BP,
19984,GO:1903923,1,0.986378163353932,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
19985,GO:1903924,1,0.994004649520989,0,1,estradiol binding,MF,
19986,GO:1903925,1,0.994107398311986,0,1,response to bisphenol A,BP,
19987,GO:1903926,1,0.994107398311986,0,1,cellular response to bisphenol A,BP,
19988,GO:1903929,1,0.987735705138413,0,2,primary palate development,BP,
19989,GO:1903935,1,0.970354939485503,0,5,response to sodium arsenite,BP,
19990,GO:1903936,1,0.970354939485503,0,5,cellular response to sodium arsenite,BP,
19991,GO:1903937,1,0.993221009726206,0,1,response to acrylamide,BP,
19992,GO:1903939,1,0.993683562044706,0,1,regulation of TORC2 signaling,BP,
19993,GO:1903943,1,0.994080834353118,0,1,regulation of hepatocyte apoptotic process,BP,
19994,GO:1903944,1,0.994080834353118,0,1,negative regulation of hepatocyte apoptotic process,BP,
19995,GO:1903946,1,0.993762715956935,0,1,negative regulation of ventricular cardiac muscle cell action potential,BP,
19996,GO:1903947,1,0.986907114143901,0,2,positive regulation of ventricular cardiac muscle cell action potential,BP,
19997,GO:1903949,1,0.987019869817487,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
19998,GO:1903952,1,0.993502822880369,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19999,GO:1903954,1,0.993502822880369,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
20001,GO:1903959,1,0.858554352003797,0,23,regulation of anion transmembrane transport,BP,
20002,GO:1903960,1,0.929813980045151,0,11,negative regulation of anion transmembrane transport,BP,
20003,GO:1903961,1,0.96192407905111,0,6,positive regulation of anion transmembrane transport,BP,
20004,GO:1903963,1,0.88897663404256,0,19,arachidonate transport,BP,
20005,GO:1903964,1,0.981338018256505,0,3,monounsaturated fatty acid metabolic process,BP,
20006,GO:1903965,1,0.994249188205832,0,1,monounsaturated fatty acid catabolic process,BP,
20007,GO:1903966,1,0.987014910314996,0,2,monounsaturated fatty acid biosynthetic process,BP,
20008,GO:1903969,1,0.982412413979829,0,3,regulation of response to macrophage colony-stimulating factor,BP,
20009,GO:1903970,1,0.988397311635685,0,2,negative regulation of response to macrophage colony-stimulating factor,BP,
20010,GO:1903971,1,0.993945565455181,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
20011,GO:1903972,1,0.982412413979829,0,3,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20012,GO:1903973,1,0.988397311635685,0,2,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20013,GO:1903974,1,0.993945565455181,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20014,GO:1903975,1,0.946328321659345,0,9,regulation of glial cell migration,BP,
20015,GO:1903976,1,0.976438557129132,0,4,negative regulation of glial cell migration,BP,
20016,GO:1903977,1,0.98056312255243,0,3,positive regulation of glial cell migration,BP,
20017,GO:1903978,1,0.940470168885685,0,9,regulation of microglial cell activation,BP,
20018,GO:1903979,1,0.987498273734239,0,2,negative regulation of microglial cell activation,BP,
20019,GO:1903980,1,0.955160468661916,0,7,positive regulation of microglial cell activation,BP,
20020,GO:1903984,1,0.980304789833347,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
20021,GO:1903988,1,0.99367985018319,0,1,ferrous iron export across plasma membrane,BP,
20022,GO:1903995,1,0.988259965581646,0,2,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
20023,GO:1903997,1,0.988259965581646,0,2,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
20024,GO:1903998,1,0.974362509262414,0,4,regulation of eating behavior,BP,
20025,GO:1903999,1,0.987597220294451,0,2,negative regulation of eating behavior,BP,
20026,GO:1904000,1,0.986600775208819,0,2,positive regulation of eating behavior,BP,
20027,GO:1904008,1,0.994241391201421,0,1,response to monosodium glutamate,BP,
20028,GO:1904009,1,0.994241391201421,0,1,cellular response to monosodium glutamate,BP,
20029,GO:1904010,1,0.994241391201421,0,1,response to Aroclor 1254,BP,
20030,GO:1904016,1,0.973306620238917,0,4,response to Thyroglobulin triiodothyronine,BP,
20031,GO:1904017,1,0.985579558853396,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
20034,GO:1904020,1,0.981675441610708,0,3,regulation of G-protein coupled receptor internalization,BP,
20035,GO:1904021,1,0.987881397901632,0,2,negative regulation of G-protein coupled receptor internalization,BP,
20036,GO:1904022,1,0.993718692812986,0,1,positive regulation of G-protein coupled receptor internalization,BP,
20037,GO:1904026,1,0.987798771313224,0,2,regulation of collagen fibril organization,BP,
20038,GO:1904027,1,0.993915626776518,0,1,negative regulation of collagen fibril organization,BP,
20039,GO:1904028,1,0.993846081630578,0,1,positive regulation of collagen fibril organization,BP,
20040,GO:1904029,1,0.574622931344811,0,88,regulation of cyclin-dependent protein kinase activity,BP,
20041,GO:1904030,1,0.813845671457818,0,32,negative regulation of cyclin-dependent protein kinase activity,BP,
20042,GO:1904031,1,0.797760885706753,0,36,positive regulation of cyclin-dependent protein kinase activity,BP,
20044,GO:1904036,1,0.79891362983329,0,35,negative regulation of epithelial cell apoptotic process,BP,
20045,GO:1904037,1,0.847080912355804,0,26,positive regulation of epithelial cell apoptotic process,BP,
20046,GO:1904041,1,0.993697840280528,0,1,regulation of cystathionine beta-synthase activity,BP,
20047,GO:1904042,1,0.993697840280528,0,1,negative regulation of cystathionine beta-synthase activity,BP,
20048,GO:1904044,1,0.975578780747376,0,4,response to aldosterone,BP,
20049,GO:1904045,1,0.994008398929516,0,1,cellular response to aldosterone,BP,
20050,GO:1904046,1,0.988521905329088,0,2,negative regulation of vascular endothelial growth factor production,BP,
20051,GO:1904047,1,0.981846565358457,0,3,S-adenosyl-L-methionine binding,MF,
20052,GO:1904048,1,0.985125400674742,0,2,regulation of spontaneous neurotransmitter secretion,BP,
20053,GO:1904049,1,0.991732255086556,0,1,negative regulation of spontaneous neurotransmitter secretion,BP,
20054,GO:1904050,1,0.993338628392237,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
20055,GO:1904054,1,0.992116453925477,0,1,regulation of cholangiocyte proliferation,BP,
20056,GO:1904056,1,0.992116453925477,0,1,positive regulation of cholangiocyte proliferation,BP,
20057,GO:1904057,1,0.988107669197188,0,2,negative regulation of sensory perception of pain,BP,
20058,GO:1904058,1,0.968344144512062,0,5,positive regulation of sensory perception of pain,BP,
20059,GO:1904059,1,0.984233709918745,0,2,regulation of locomotor rhythm,BP,
20061,GO:1904063,1,0.645043295425768,0,69,negative regulation of cation transmembrane transport,BP,
20063,GO:1904071,1,0.985622693754735,0,2,presynaptic active zone assembly,BP,
20064,GO:1904073,1,0.992555616082292,0,1,regulation of trophectodermal cell proliferation,BP,
20065,GO:1904075,1,0.992555616082292,0,1,positive regulation of trophectodermal cell proliferation,BP,
20066,GO:1904090,1,0.977122072770043,0,4,peptidase inhibitor complex,CC,
20067,GO:1904098,1,0.981265416881035,0,3,regulation of protein O-linked glycosylation,BP,
20068,GO:1904100,1,0.981265416881035,0,3,positive regulation of protein O-linked glycosylation,BP,
20069,GO:1904106,1,0.993850530266658,0,1,protein localization to microvillus,BP,
20070,GO:1904115,1,0.770462959985984,0,40,axon cytoplasm,CC,
20071,GO:1904116,1,0.980515427187256,0,3,response to vasopressin,BP,
20072,GO:1904117,1,0.980515427187256,0,3,cellular response to vasopressin,BP,
20073,GO:1904118,1,0.99375013260469,0,1,regulation of otic vesicle morphogenesis,BP,
20074,GO:1904120,1,0.99375013260469,0,1,positive regulation of otic vesicle morphogenesis,BP,
20075,GO:1904121,1,0.980058062577367,0,3,phosphatidylethanolamine transporter activity,MF,
20076,GO:1904124,1,0.982474774400109,0,3,microglial cell migration,BP,
20077,GO:1904139,1,0.982474774400109,0,3,regulation of microglial cell migration,BP,
20078,GO:1904140,1,0.99420904807227,0,1,negative regulation of microglial cell migration,BP,
20079,GO:1904141,1,0.993945565455181,0,1,positive regulation of microglial cell migration,BP,
20080,GO:1904149,1,0.99420904807227,0,1,regulation of microglial cell mediated cytotoxicity,BP,
20081,GO:1904151,1,0.99420904807227,0,1,positive regulation of microglial cell mediated cytotoxicity,BP,
20082,GO:1904152,1,0.921604638114527,0,13,regulation of retrograde protein transport, ER to cytosol,BP,
20083,GO:1904153,1,0.945210095207504,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
20084,GO:1904154,1,0.981288036193158,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
20085,GO:1904155,1,0.993683419277415,0,1,DN2 thymocyte differentiation,BP,
20086,GO:1904156,1,0.993683419277415,0,1,DN3 thymocyte differentiation,BP,
20087,GO:1904158,1,0.978680738413944,0,3,axonemal central apparatus assembly,BP,
20088,GO:1904167,1,0.991619146955639,0,1,regulation of thyroid hormone receptor activity,BP,
20089,GO:1904168,1,0.991619146955639,0,1,negative regulation of thyroid hormone receptor activity,BP,
20090,GO:1904170,1,0.987052615868125,0,2,regulation of bleb assembly,BP,
20091,GO:1904172,1,0.987052615868125,0,2,positive regulation of bleb assembly,BP,
20092,GO:1904177,1,0.962759535408143,0,6,regulation of adipose tissue development,BP,
20093,GO:1904179,1,0.968292206653186,0,5,positive regulation of adipose tissue development,BP,
20096,GO:1904182,1,0.994309254181574,0,1,regulation of pyruvate dehydrogenase activity,BP,
20097,GO:1904192,1,0.992116453925477,0,1,regulation of cholangiocyte apoptotic process,BP,
20098,GO:1904193,1,0.992116453925477,0,1,negative regulation of cholangiocyte apoptotic process,BP,
20099,GO:1904195,1,0.992116453925477,0,1,regulation of granulosa cell proliferation,BP,
20100,GO:1904197,1,0.992116453925477,0,1,positive regulation of granulosa cell proliferation,BP,
20101,GO:1904199,1,0.993475083113072,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
20102,GO:1904200,1,0.992116453925477,0,1,iodide transmembrane transport,BP,
20103,GO:1904201,1,0.992116453925477,0,1,regulation of iodide transport,BP,
20104,GO:1904202,1,0.992116453925477,0,1,negative regulation of iodide transport,BP,
20105,GO:1904204,1,0.985024151750037,0,2,regulation of skeletal muscle hypertrophy,BP,
20106,GO:1904205,1,0.992851915750288,0,1,negative regulation of skeletal muscle hypertrophy,BP,
20107,GO:1904206,1,0.992116453925477,0,1,positive regulation of skeletal muscle hypertrophy,BP,
20110,GO:1904210,1,0.994246589204155,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20111,GO:1904211,1,0.98737987964688,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
20112,GO:1904212,1,0.992116453925477,0,1,regulation of iodide transmembrane transport,BP,
20113,GO:1904213,1,0.992116453925477,0,1,negative regulation of iodide transmembrane transport,BP,
20114,GO:1904217,1,0.982006448378899,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20115,GO:1904219,1,0.982006448378899,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20116,GO:1904220,1,0.97596214423613,0,4,regulation of serine C-palmitoyltransferase activity,BP,
20117,GO:1904222,1,0.982006448378899,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
20118,GO:1904226,1,0.994015898537603,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20119,GO:1904227,1,0.994015898537603,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20120,GO:1904229,1,0.992582677171849,0,1,regulation of succinate dehydrogenase activity,BP,
20121,GO:1904231,1,0.992582677171849,0,1,positive regulation of succinate dehydrogenase activity,BP,
20122,GO:1904232,1,0.992582677171849,0,1,regulation of aconitate hydratase activity,BP,
20123,GO:1904234,1,0.992582677171849,0,1,positive regulation of aconitate hydratase activity,BP,
20124,GO:1904235,1,0.992226665532678,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20125,GO:1904237,1,0.992226665532678,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20126,GO:1904238,1,0.95667713669487,0,7,pericyte cell differentiation,BP,
20127,GO:1904239,1,0.994246589204155,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20128,GO:1904240,1,0.994246589204155,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20129,GO:1904245,1,0.987939528192443,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
20130,GO:1904246,1,0.994143783991404,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
20131,GO:1904247,1,0.993759569675982,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
20132,GO:1904251,1,0.939643099088254,0,10,regulation of bile acid metabolic process,BP,
20133,GO:1904252,1,0.981745276635778,0,3,negative regulation of bile acid metabolic process,BP,
20134,GO:1904253,1,0.98182679015917,0,3,positive regulation of bile acid metabolic process,BP,
20135,GO:1904259,1,0.964417486334895,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20136,GO:1904261,1,0.964417486334895,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20137,GO:1904262,1,0.932072313972072,0,11,negative regulation of TORC1 signaling,BP,
20138,GO:1904263,1,0.944776586327696,0,9,positive regulation of TORC1 signaling,BP,
20139,GO:1904265,1,0.992844691052976,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
20140,GO:1904266,1,0.992567048784626,0,1,regulation of Schwann cell chemotaxis,BP,
20141,GO:1904268,1,0.992567048784626,0,1,positive regulation of Schwann cell chemotaxis,BP,
20142,GO:1904271,1,0.993934047371008,0,1,L-proline import across plasma membrane,BP,
20143,GO:1904274,1,0.994004937927393,0,1,tricellular tight junction assembly,BP,
20144,GO:1904282,1,0.994084876381684,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20145,GO:1904283,1,0.994084876381684,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20146,GO:1904288,1,0.97373524708922,0,4,BAT3 complex binding,MF,
20147,GO:1904289,1,0.987169779370172,0,2,regulation of mitotic DNA damage checkpoint,BP,
20148,GO:1904290,1,0.993343223274766,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
20149,GO:1904292,1,0.841887715678723,0,27,regulation of ERAD pathway,BP,
20150,GO:1904293,1,0.921716319972473,0,13,negative regulation of ERAD pathway,BP,
20151,GO:1904294,1,0.919874060248961,0,13,positive regulation of ERAD pathway,BP,
20152,GO:1904298,1,0.993455479429119,0,1,regulation of transcytosis,BP,
20153,GO:1904300,1,0.993455479429119,0,1,positive regulation of transcytosis,BP,
20154,GO:1904301,1,0.993455479429119,0,1,regulation of maternal process involved in parturition,BP,
20155,GO:1904303,1,0.993455479429119,0,1,positive regulation of maternal process involved in parturition,BP,
20156,GO:1904304,1,0.969680232375819,0,5,regulation of gastro-intestinal system smooth muscle contraction,BP,
20157,GO:1904306,1,0.969680232375819,0,5,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
20158,GO:1904313,1,0.993505109729269,0,1,response to methamphetamine hydrochloride,BP,
20159,GO:1904315,1,0.79618160018939,0,35,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20160,GO:1904316,1,0.993455479429119,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20161,GO:1904317,1,0.993455479429119,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20162,GO:1904321,1,0.926451835819155,0,11,response to forskolin,BP,
20163,GO:1904322,1,0.926451835819155,0,11,cellular response to forskolin,BP,
20164,GO:1904323,1,0.993809091244327,0,1,regulation of inhibitory G-protein coupled receptor phosphorylation,BP,
20165,GO:1904325,1,0.993809091244327,0,1,positive regulation of inhibitory G-protein coupled receptor phosphorylation,BP,
20166,GO:1904327,1,0.986603909378965,0,2,protein localization to cytosolic proteasome complex,BP,
20167,GO:1904328,1,0.993861870878592,0,1,regulation of myofibroblast contraction,BP,
20168,GO:1904338,1,0.944599770927964,0,9,regulation of dopaminergic neuron differentiation,BP,
20169,GO:1904339,1,0.986836319165319,0,2,negative regulation of dopaminergic neuron differentiation,BP,
20170,GO:1904340,1,0.976612067046991,0,4,positive regulation of dopaminergic neuron differentiation,BP,
20171,GO:1904341,1,0.993155902566615,0,1,regulation of colon smooth muscle contraction,BP,
20172,GO:1904343,1,0.993155902566615,0,1,positive regulation of colon smooth muscle contraction,BP,
20173,GO:1904344,1,0.994440940310254,0,1,regulation of gastric mucosal blood circulation,BP,
20174,GO:1904346,1,0.994440940310254,0,1,positive regulation of gastric mucosal blood circulation,BP,
20175,GO:1904347,1,0.987634503704126,0,2,regulation of small intestine smooth muscle contraction,BP,
20176,GO:1904349,1,0.987634503704126,0,2,positive regulation of small intestine smooth muscle contraction,BP,
20178,GO:1904351,1,0.981308538177368,0,3,negative regulation of protein catabolic process in the vacuole,BP,
20180,GO:1904353,1,0.843194696123283,0,26,regulation of telomere capping,BP,
20181,GO:1904354,1,0.946126570136337,0,8,negative regulation of telomere capping,BP,
20182,GO:1904355,1,0.897480097606865,0,17,positive regulation of telomere capping,BP,
20183,GO:1904356,1,0.686530584314029,0,58,regulation of telomere maintenance via telomere lengthening,BP,
20184,GO:1904357,1,0.846328065972162,0,25,negative regulation of telomere maintenance via telomere lengthening,BP,
20185,GO:1904358,1,0.795427295062354,0,36,positive regulation of telomere maintenance via telomere lengthening,BP,
20186,GO:1904373,1,0.994200673505524,0,1,response to kainic acid,BP,
20187,GO:1904375,1,0.566900251890017,0,88,regulation of protein localization to cell periphery,BP,
20188,GO:1904376,1,0.859162568370316,0,24,negative regulation of protein localization to cell periphery,BP,
20189,GO:1904377,1,0.707038821698503,0,53,positive regulation of protein localization to cell periphery,BP,
20190,GO:1904378,1,0.980373554522884,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
20191,GO:1904379,1,0.986603909378965,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
20192,GO:1904380,1,0.879222419554862,0,20,endoplasmic reticulum mannose trimming,BP,
20193,GO:1904381,1,0.980403940987787,0,3,Golgi apparatus mannose trimming,BP,
20194,GO:1904382,1,0.973815253730134,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
20195,GO:1904383,1,0.987877378709183,0,2,response to sodium phosphate,BP,
20197,GO:1904386,1,0.968539249572102,0,5,response to L-phenylalanine derivative,BP,
20198,GO:1904387,1,0.987373498339495,0,2,cellular response to L-phenylalanine derivative,BP,
20199,GO:1904389,1,0.994200673505524,0,1,rod bipolar cell differentiation,BP,
20200,GO:1904391,1,0.994200673505524,0,1,response to ciliary neurotrophic factor,BP,
20201,GO:1904393,1,0.980635049654361,0,3,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20202,GO:1904394,1,0.993972070877798,0,1,negative regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20203,GO:1904395,1,0.986582918848571,0,2,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20204,GO:1904396,1,0.948651150297075,0,8,regulation of neuromuscular junction development,BP,
20205,GO:1904397,1,0.988207347535624,0,2,negative regulation of neuromuscular junction development,BP,
20206,GO:1904398,1,0.979212131536707,0,3,positive regulation of neuromuscular junction development,BP,
20207,GO:1904399,1,0.994200673505524,0,1,heparan sulfate binding,MF,
20208,GO:1904400,1,0.99375456484417,0,1,response to Thyroid stimulating hormone,BP,
20209,GO:1904404,1,0.992524498233347,0,1,response to formaldehyde,BP,
20210,GO:1904406,1,0.926760939860914,0,12,negative regulation of nitric oxide metabolic process,BP,
20211,GO:1904407,1,0.800146485118251,0,35,positive regulation of nitric oxide metabolic process,BP,
20212,GO:1904408,1,0.994317340024882,0,1,melatonin binding,MF,
20213,GO:1904412,1,0.993603636886392,0,1,regulation of cardiac ventricle development,BP,
20214,GO:1904414,1,0.993603636886392,0,1,positive regulation of cardiac ventricle development,BP,
20215,GO:1904415,1,0.963074495540738,0,6,regulation of xenophagy,BP,
20216,GO:1904417,1,0.963074495540738,0,6,positive regulation of xenophagy,BP,
20217,GO:1904424,1,0.93603266972415,0,10,regulation of GTP binding,BP,
20218,GO:1904425,1,0.993561101818259,0,1,negative regulation of GTP binding,BP,
20219,GO:1904426,1,0.986699943214274,0,2,positive regulation of GTP binding,BP,
20221,GO:1904428,1,0.978965419823446,0,3,negative regulation of tubulin deacetylation,BP,
20222,GO:1904429,1,0.962764439058019,0,6,regulation of t-circle formation,BP,
20223,GO:1904430,1,0.980916785779302,0,3,negative regulation of t-circle formation,BP,
20224,GO:1904431,1,0.981498113541334,0,3,positive regulation of t-circle formation,BP,
20225,GO:1904432,1,0.988480275011872,0,2,regulation of ferrous iron binding,BP,
20226,GO:1904434,1,0.988480275011872,0,2,positive regulation of ferrous iron binding,BP,
20227,GO:1904435,1,0.988480275011872,0,2,regulation of transferrin receptor binding,BP,
20228,GO:1904437,1,0.988480275011872,0,2,positive regulation of transferrin receptor binding,BP,
20230,GO:1904448,1,0.993232525385339,0,1,regulation of aspartate secretion,BP,
20231,GO:1904450,1,0.993232525385339,0,1,positive regulation of aspartate secretion,BP,
20232,GO:1904454,1,0.99235709730824,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
20233,GO:1904455,1,0.986105424056154,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
20234,GO:1904456,1,0.994106532031091,0,1,negative regulation of neuronal action potential,BP,
20235,GO:1904457,1,0.993952766171747,0,1,positive regulation of neuronal action potential,BP,
20236,GO:1904464,1,0.994145805455466,0,1,regulation of matrix metallopeptidase secretion,BP,
20237,GO:1904465,1,0.994145805455466,0,1,negative regulation of matrix metallopeptidase secretion,BP,
20238,GO:1904467,1,0.895393083842101,0,17,regulation of tumor necrosis factor secretion,BP,
20239,GO:1904468,1,0.969907415437477,0,5,negative regulation of tumor necrosis factor secretion,BP,
20240,GO:1904469,1,0.923196782234084,0,12,positive regulation of tumor necrosis factor secretion,BP,
20241,GO:1904475,1,0.98559081097359,0,2,regulation of Ras GTPase binding,BP,
20242,GO:1904477,1,0.992816656537859,0,1,positive regulation of Ras GTPase binding,BP,
20243,GO:1904478,1,0.97030280221564,0,5,regulation of intestinal absorption,BP,
20244,GO:1904479,1,0.988433830425952,0,2,negative regulation of intestinal absorption,BP,
20245,GO:1904481,1,0.993936926529088,0,1,response to tetrahydrofolate,BP,
20246,GO:1904482,1,0.993936926529088,0,1,cellular response to tetrahydrofolate,BP,
20247,GO:1904491,1,0.976662978534767,0,4,protein localization to ciliary transition zone,BP,
20250,GO:1904498,1,0.980146848871237,0,3,protein localization to mitotic actomyosin contractile ring,BP,
20251,GO:1904499,1,0.993659865977184,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
20252,GO:1904501,1,0.993659865977184,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
20253,GO:1904502,1,0.965572817503051,0,5,regulation of lipophagy,BP,
20254,GO:1904504,1,0.965572817503051,0,5,positive regulation of lipophagy,BP,
20255,GO:1904505,1,0.974011141651485,0,4,regulation of telomere maintenance in response to DNA damage,BP,
20256,GO:1904506,1,0.974011141651485,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
20257,GO:1904515,1,0.993683562044706,0,1,positive regulation of TORC2 signaling,BP,
20258,GO:1904526,1,0.944903596872155,0,9,regulation of microtubule binding,BP,
20259,GO:1904527,1,0.980786002241965,0,3,negative regulation of microtubule binding,BP,
20260,GO:1904528,1,0.963590408736528,0,6,positive regulation of microtubule binding,BP,
20261,GO:1904529,1,0.98682134162363,0,2,regulation of actin filament binding,BP,
20262,GO:1904530,1,0.993753135027743,0,1,negative regulation of actin filament binding,BP,
20263,GO:1904531,1,0.993025076771582,0,1,positive regulation of actin filament binding,BP,
20264,GO:1904533,1,0.981060564034479,0,3,regulation of telomeric loop disassembly,BP,
20265,GO:1904534,1,0.987648861234141,0,2,negative regulation of telomeric loop disassembly,BP,
20266,GO:1904535,1,0.993330155224292,0,1,positive regulation of telomeric loop disassembly,BP,
20267,GO:1904542,1,0.993878532344541,0,1,regulation of free ubiquitin chain polymerization,BP,
20268,GO:1904544,1,0.993878532344541,0,1,positive regulation of free ubiquitin chain polymerization,BP,
20269,GO:1904550,1,0.994049658303835,0,1,response to arachidonic acid,BP,
20270,GO:1904555,1,0.993934047371008,0,1,L-proline transmembrane transport,BP,
20271,GO:1904556,1,0.993934047371008,0,1,L-tryptophan transmembrane transport,BP,
20272,GO:1904562,1,0.985053901245492,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
20275,GO:1904567,1,0.993778738287005,0,1,response to wortmannin,BP,
20276,GO:1904568,1,0.993778738287005,0,1,cellular response to wortmannin,BP,
20277,GO:1904569,1,0.994144361552652,0,1,regulation of selenocysteine incorporation,BP,
20278,GO:1904570,1,0.994144361552652,0,1,negative regulation of selenocysteine incorporation,BP,
20279,GO:1904572,1,0.994144361552652,0,1,negative regulation of mRNA binding,BP,
20280,GO:1904573,1,0.994144361552652,0,1,regulation of selenocysteine insertion sequence binding,BP,
20281,GO:1904574,1,0.994144361552652,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
20282,GO:1904576,1,0.988030834482869,0,2,response to tunicamycin,BP,
20283,GO:1904577,1,0.988030834482869,0,2,cellular response to tunicamycin,BP,
20284,GO:1904578,1,0.981709845064039,0,3,response to thapsigargin,BP,
20285,GO:1904579,1,0.981709845064039,0,3,cellular response to thapsigargin,BP,
20286,GO:1904580,1,0.987956025020057,0,2,regulation of intracellular mRNA localization,BP,
20287,GO:1904582,1,0.987956025020057,0,2,positive regulation of intracellular mRNA localization,BP,
20288,GO:1904585,1,0.99402368765343,0,1,response to putrescine,BP,
20289,GO:1904586,1,0.99402368765343,0,1,cellular response to putrescine,BP,
20290,GO:1904587,1,0.962201232487069,0,6,response to glycoprotein,BP,
20291,GO:1904588,1,0.994287018170238,0,1,cellular response to glycoprotein,BP,
20292,GO:1904589,1,0.718571214785888,0,51,regulation of protein import,BP,
20293,GO:1904590,1,0.939951173252032,0,10,negative regulation of protein import,BP,
20294,GO:1904591,1,0.802420338933755,0,33,positive regulation of protein import,BP,
20295,GO:1904594,1,0.991459989512687,0,1,regulation of termination of RNA polymerase II transcription,BP,
20296,GO:1904595,1,0.991459989512687,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20297,GO:1904596,1,0.994259584215574,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20298,GO:1904597,1,0.994259584215574,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20299,GO:1904599,1,0.994259584215574,0,1,advanced glycation end-product binding,MF,
20300,GO:1904602,1,0.988156495435244,0,2,serotonin-activated cation-selective channel complex,CC,
20301,GO:1904603,1,0.994259584215574,0,1,regulation of advanced glycation end-product receptor activity,BP,
20302,GO:1904604,1,0.994259584215574,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
20303,GO:1904606,1,0.99366015143815,0,1,fat cell apoptotic process,BP,
20304,GO:1904612,1,0.980170124739876,0,3,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20305,GO:1904613,1,0.986331053701419,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20306,GO:1904616,1,0.98682134162363,0,2,regulation of actin binding,BP,
20307,GO:1904617,1,0.993753135027743,0,1,negative regulation of actin binding,BP,
20308,GO:1904618,1,0.993025076771582,0,1,positive regulation of actin binding,BP,
20309,GO:1904627,1,0.98811634990501,0,2,response to phorbol 13-acetate 12-myristate,BP,
20310,GO:1904628,1,0.98811634990501,0,2,cellular response to phorbol 13-acetate 12-myristate,BP,
20311,GO:1904631,1,0.993999891051787,0,1,response to glucoside,BP,
20312,GO:1904633,1,0.992826483555519,0,1,regulation of glomerular visceral epithelial cell apoptotic process,BP,
20313,GO:1904635,1,0.992826483555519,0,1,positive regulation of glomerular visceral epithelial cell apoptotic process,BP,
20314,GO:1904636,1,0.974289543232945,0,4,response to ionomycin,BP,
20315,GO:1904637,1,0.974289543232945,0,4,cellular response to ionomycin,BP,
20316,GO:1904638,1,0.992826483555519,0,1,response to resveratrol,BP,
20317,GO:1904639,1,0.992826483555519,0,1,cellular response to resveratrol,BP,
20318,GO:1904640,1,0.981207653121718,0,3,response to methionine,BP,
20319,GO:1904645,1,0.833636220976448,0,27,response to amyloid-beta,BP,
20320,GO:1904646,1,0.843688887713179,0,25,cellular response to amyloid-beta,BP,
20321,GO:1904647,1,0.992008356450034,0,1,response to rotenone,BP,
20322,GO:1904649,1,0.99366015143815,0,1,regulation of fat cell apoptotic process,BP,
20323,GO:1904651,1,0.99366015143815,0,1,positive regulation of fat cell apoptotic process,BP,
20325,GO:1904666,1,0.892025798173632,0,19,regulation of ubiquitin protein ligase activity,BP,
20326,GO:1904667,1,0.960628700114468,0,7,negative regulation of ubiquitin protein ligase activity,BP,
20327,GO:1904668,1,0.928613629588437,0,12,positive regulation of ubiquitin protein ligase activity,BP,
20328,GO:1904672,1,0.968009171482807,0,5,regulation of somatic stem cell population maintenance,BP,
20329,GO:1904673,1,0.980608688386946,0,3,negative regulation of somatic stem cell population maintenance,BP,
20330,GO:1904674,1,0.98715388084851,0,2,positive regulation of somatic stem cell population maintenance,BP,
20331,GO:1904675,1,0.993799924379055,0,1,regulation of somatic stem cell division,BP,
20332,GO:1904677,1,0.993799924379055,0,1,positive regulation of somatic stem cell division,BP,
20333,GO:1904680,1,0.873824047165152,0,22,peptide transmembrane transporter activity,MF,
20334,GO:1904681,1,0.993869194827968,0,1,response to 3-methylcholanthrene,BP,
20336,GO:1904684,1,0.971775223070693,0,4,negative regulation of metalloendopeptidase activity,BP,
20338,GO:1904688,1,0.968835076620944,0,5,regulation of cytoplasmic translational initiation,BP,
20339,GO:1904689,1,0.994321382951401,0,1,negative regulation of cytoplasmic translational initiation,BP,
20340,GO:1904690,1,0.974369610933527,0,4,positive regulation of cytoplasmic translational initiation,BP,
20341,GO:1904691,1,0.994032054867517,0,1,negative regulation of type B pancreatic cell proliferation,BP,
20342,GO:1904692,1,0.993596501109196,0,1,positive regulation of type B pancreatic cell proliferation,BP,
20343,GO:1904693,1,0.979468135720438,0,3,midbrain morphogenesis,BP,
20345,GO:1904695,1,0.994092672072738,0,1,positive regulation of vascular smooth muscle contraction,BP,
20347,GO:1904701,1,0.994126168400043,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
20348,GO:1904705,1,0.793141025345814,0,36,regulation of vascular smooth muscle cell proliferation,BP,
20349,GO:1904706,1,0.916475630917917,0,14,negative regulation of vascular smooth muscle cell proliferation,BP,
20350,GO:1904707,1,0.860488533137114,0,23,positive regulation of vascular smooth muscle cell proliferation,BP,
20352,GO:1904711,1,0.994126168400043,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20353,GO:1904713,1,0.985868928863547,0,2,beta-catenin destruction complex binding,MF,
20354,GO:1904714,1,0.951995640778993,0,8,regulation of chaperone-mediated autophagy,BP,
20355,GO:1904715,1,0.981930285305302,0,3,negative regulation of chaperone-mediated autophagy,BP,
20356,GO:1904716,1,0.993963425797752,0,1,positive regulation of chaperone-mediated autophagy,BP,
20357,GO:1904717,1,0.979518960887114,0,3,regulation of AMPA glutamate receptor clustering,BP,
20358,GO:1904719,1,0.993940669799302,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
20359,GO:1904720,1,0.987745104426612,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20360,GO:1904721,1,0.993760427722582,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20361,GO:1904722,1,0.993947293495943,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20362,GO:1904723,1,0.994126168400043,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20363,GO:1904724,1,0.733788414237695,0,52,tertiary granule lumen,CC,
20364,GO:1904729,1,0.982031362508953,0,3,regulation of intestinal lipid absorption,BP,
20365,GO:1904730,1,0.993875658902209,0,1,negative regulation of intestinal lipid absorption,BP,
20366,GO:1904732,1,0.986762913766329,0,2,regulation of electron transfer activity,BP,
20367,GO:1904734,1,0.994525269831461,0,1,positive regulation of electron transfer activity,BP,
20369,GO:1904742,1,0.973233563649748,0,4,regulation of telomeric DNA binding,BP,
20370,GO:1904743,1,0.984629172231671,0,2,negative regulation of telomeric DNA binding,BP,
20371,GO:1904744,1,0.988428315250425,0,2,positive regulation of telomeric DNA binding,BP,
20372,GO:1904746,1,0.968696638631203,0,5,negative regulation of apoptotic process involved in development,BP,
20373,GO:1904747,1,0.981258598165644,0,3,positive regulation of apoptotic process involved in development,BP,
20374,GO:1904748,1,0.944023449622127,0,9,regulation of apoptotic process involved in development,BP,
20375,GO:1904749,1,0.968923460866781,0,5,regulation of protein localization to nucleolus,BP,
20376,GO:1904750,1,0.992728478973141,0,1,negative regulation of protein localization to nucleolus,BP,
20377,GO:1904751,1,0.976022379132215,0,4,positive regulation of protein localization to nucleolus,BP,
20379,GO:1904753,1,0.967478393799576,0,5,negative regulation of vascular associated smooth muscle cell migration,BP,
20381,GO:1904760,1,0.98025677322259,0,3,regulation of myofibroblast differentiation,BP,
20382,GO:1904761,1,0.986675588927396,0,2,negative regulation of myofibroblast differentiation,BP,
20383,GO:1904762,1,0.993495389657605,0,1,positive regulation of myofibroblast differentiation,BP,
20384,GO:1904764,1,0.994059471842138,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
20385,GO:1904766,1,0.992658195941603,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
20386,GO:1904768,1,0.987723719742656,0,2,all-trans-retinol binding,MF,
20387,GO:1904772,1,0.993886723373256,0,1,response to tetrachloromethane,BP,
20388,GO:1904776,1,0.961137410172541,0,6,regulation of protein localization to cell cortex,BP,
20389,GO:1904777,1,0.993846081630578,0,1,negative regulation of protein localization to cell cortex,BP,
20390,GO:1904778,1,0.967090834345394,0,5,positive regulation of protein localization to cell cortex,BP,
20391,GO:1904779,1,0.952899682280889,0,7,regulation of protein localization to centrosome,BP,
20392,GO:1904781,1,0.958703819911504,0,6,positive regulation of protein localization to centrosome,BP,
20393,GO:1904782,1,0.993244182420046,0,1,negative regulation of NMDA glutamate receptor activity,BP,
20394,GO:1904783,1,0.987163651023274,0,2,positive regulation of NMDA glutamate receptor activity,BP,
20395,GO:1904784,1,0.993067360485565,0,1,NLRP1 inflammasome complex assembly,BP,
20396,GO:1904790,1,0.993800354001242,0,1,regulation of shelterin complex assembly,BP,
20397,GO:1904792,1,0.993800354001242,0,1,positive regulation of shelterin complex assembly,BP,
20398,GO:1904793,1,0.993659865977184,0,1,regulation of euchromatin binding,BP,
20399,GO:1904796,1,0.968580066937257,0,5,regulation of core promoter binding,BP,
20400,GO:1904797,1,0.992894391215572,0,1,negative regulation of core promoter binding,BP,
20401,GO:1904798,1,0.975513430802853,0,4,positive regulation of core promoter binding,BP,
20402,GO:1904799,1,0.993508253926702,0,1,regulation of neuron remodeling,BP,
20403,GO:1904800,1,0.993508253926702,0,1,negative regulation of neuron remodeling,BP,
20404,GO:1904803,1,0.994479061349664,0,1,regulation of translation involved in cellular response to UV,BP,
20405,GO:1904806,1,0.987729649828399,0,2,regulation of protein oxidation,BP,
20406,GO:1904808,1,0.987729649828399,0,2,positive regulation of protein oxidation,BP,
20407,GO:1904812,1,0.993508682661501,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
20408,GO:1904813,1,0.468912137892825,0,123,ficolin-1-rich granule lumen,CC,
20409,GO:1904814,1,0.92324127462109,0,13,regulation of protein localization to chromosome, telomeric region,BP,
20410,GO:1904815,1,0.987928416953292,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
20411,GO:1904816,1,0.934530286821235,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
20412,GO:1904823,1,0.981945869249294,0,3,purine nucleobase transmembrane transport,BP,
20413,GO:1904826,1,0.992450518380993,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
20414,GO:1904828,1,0.992450518380993,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
20415,GO:1904829,1,0.994143062039743,0,1,regulation of aortic smooth muscle cell differentiation,BP,
20416,GO:1904831,1,0.994143062039743,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
20417,GO:1904833,1,0.982732658838905,0,3,positive regulation of removal of superoxide radicals,BP,
20418,GO:1904835,1,0.993929441234976,0,1,dorsal root ganglion morphogenesis,BP,
20419,GO:1904837,1,0.802212648773793,0,34,beta-catenin-TCF complex assembly,BP,
20420,GO:1904842,1,0.994023399149167,0,1,response to nitroglycerin,BP,
20421,GO:1904843,1,0.994023399149167,0,1,cellular response to nitroglycerin,BP,
20422,GO:1904844,1,0.981982097985341,0,3,response to L-glutamine,BP,
20423,GO:1904845,1,0.981982097985341,0,3,cellular response to L-glutamine,BP,
20425,GO:1904848,1,0.994300013232335,0,1,negative regulation of cell chemotaxis to fibroblast growth factor,BP,
20426,GO:1904849,1,0.980062634839007,0,3,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
20427,GO:1904850,1,0.993800354001242,0,1,negative regulation of establishment of protein localization to telomere,BP,
20428,GO:1904851,1,0.947060760799606,0,9,positive regulation of establishment of protein localization to telomere,BP,
20429,GO:1904854,1,0.987726738459541,0,2,proteasome core complex binding,MF,
20430,GO:1904861,1,0.913763217613506,0,13,excitatory synapse assembly,BP,
20431,GO:1904862,1,0.980105138527546,0,3,inhibitory synapse assembly,BP,
20432,GO:1904863,1,0.993552392520592,0,1,regulation of beta-catenin-TCF complex assembly,BP,
20433,GO:1904864,1,0.993552392520592,0,1,negative regulation of beta-catenin-TCF complex assembly,BP,
20434,GO:1904867,1,0.947191662296271,0,9,protein localization to Cajal body,BP,
20435,GO:1904868,1,0.983762043857869,0,2,telomerase catalytic core complex assembly,BP,
20436,GO:1904869,1,0.952806041751034,0,8,regulation of protein localization to Cajal body,BP,
20437,GO:1904871,1,0.952806041751034,0,8,positive regulation of protein localization to Cajal body,BP,
20438,GO:1904872,1,0.896025015509204,0,18,regulation of telomerase RNA localization to Cajal body,BP,
20439,GO:1904874,1,0.914505645755329,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
20440,GO:1904875,1,0.987883729074083,0,2,regulation of DNA ligase activity,BP,
20441,GO:1904876,1,0.993810810410542,0,1,negative regulation of DNA ligase activity,BP,
20442,GO:1904877,1,0.994036383167435,0,1,positive regulation of DNA ligase activity,BP,
20443,GO:1904878,1,0.991627872231924,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20444,GO:1904879,1,0.98745008560001,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20445,GO:1904880,1,0.980826933711209,0,3,response to hydrogen sulfide,BP,
20446,GO:1904881,1,0.986819138269117,0,2,cellular response to hydrogen sulfide,BP,
20447,GO:1904882,1,0.983762043857869,0,2,regulation of telomerase catalytic core complex assembly,BP,
20448,GO:1904884,1,0.983762043857869,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
20449,GO:1904885,1,0.965848247426751,0,5,beta-catenin destruction complex assembly,BP,
20450,GO:1904886,1,0.887325113643634,0,18,beta-catenin destruction complex disassembly,BP,
20451,GO:1904887,1,0.991973955775138,0,1,Wnt signalosome assembly,BP,
20452,GO:1904888,1,0.676951412325089,0,59,cranial skeletal system development,BP,
20453,GO:1904889,1,0.988033862236653,0,2,regulation of excitatory synapse assembly,BP,
20454,GO:1904891,1,0.988033862236653,0,2,positive regulation of excitatory synapse assembly,BP,
20455,GO:1904892,1,0.495888740645031,0,111,regulation of STAT cascade,BP,
20456,GO:1904893,1,0.75174810925342,0,45,negative regulation of STAT cascade,BP,
20457,GO:1904894,1,0.685614178593802,0,60,positive regulation of STAT cascade,BP,
20458,GO:1904895,1,0.994165731272958,0,1,ESCRT complex assembly,BP,
20459,GO:1904896,1,0.940752171493168,0,10,ESCRT complex disassembly,BP,
20460,GO:1904897,1,0.993689986869496,0,1,regulation of hepatic stellate cell proliferation,BP,
20461,GO:1904899,1,0.993689986869496,0,1,positive regulation of hepatic stellate cell proliferation,BP,
20462,GO:1904902,1,0.994165731272958,0,1,ESCRT III complex assembly,BP,
20463,GO:1904903,1,0.940752171493168,0,10,ESCRT III complex disassembly,BP,
20464,GO:1904907,1,0.983366508174279,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20465,GO:1904908,1,0.983366508174279,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20466,GO:1904910,1,0.993800354001242,0,1,regulation of establishment of RNA localization to telomere,BP,
20467,GO:1904911,1,0.993800354001242,0,1,negative regulation of establishment of RNA localization to telomere,BP,
20468,GO:1904913,1,0.993800354001242,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
20469,GO:1904914,1,0.993800354001242,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
20470,GO:1904923,1,0.924163291618284,0,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20471,GO:1904924,1,0.99395204603589,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
20472,GO:1904925,1,0.929790789631544,0,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20473,GO:1904928,1,0.984956464861999,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
20474,GO:1904929,1,0.96136576218613,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
20475,GO:1904933,1,0.992967472159764,0,1,regulation of cell proliferation in midbrain,BP,
20476,GO:1904934,1,0.992967472159764,0,1,negative regulation of cell proliferation in midbrain,BP,
20478,GO:1904938,1,0.96506875238382,0,5,planar cell polarity pathway involved in axon guidance,BP,
20479,GO:1904947,1,0.993774445760864,0,1,folic acid import into mitochondrion,BP,
20480,GO:1904948,1,0.908771676582715,0,15,midbrain dopaminergic neuron differentiation,BP,
20484,GO:1904953,1,0.93754436796117,0,10,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20485,GO:1904954,1,0.981803233086236,0,3,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20486,GO:1904955,1,0.992967472159764,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
20487,GO:1904956,1,0.969854002923014,0,5,regulation of midbrain dopaminergic neuron differentiation,BP,
20488,GO:1904958,1,0.982158334459608,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
20489,GO:1904959,1,0.986762913766329,0,2,regulation of cytochrome-c oxidase activity,BP,
20490,GO:1904960,1,0.994525269831461,0,1,positive regulation of cytochrome-c oxidase activity,BP,
20491,GO:1904970,1,0.980112151440083,0,3,brush border assembly,BP,
20492,GO:1904971,1,0.993316508368644,0,1,regulation of viral translation,BP,
20493,GO:1904973,1,0.993316508368644,0,1,positive regulation of viral translation,BP,
20494,GO:1904975,1,0.986718126965795,0,2,response to bleomycin,BP,
20495,GO:1904976,1,0.986718126965795,0,2,cellular response to bleomycin,BP,
20496,GO:1904977,1,0.99381625524968,0,1,lymphatic endothelial cell migration,BP,
20497,GO:1904978,1,0.98001829443685,0,3,regulation of endosome organization,BP,
20498,GO:1904979,1,0.994002053936623,0,1,negative regulation of endosome organization,BP,
20499,GO:1904980,1,0.992604091728922,0,1,positive regulation of endosome organization,BP,
20500,GO:1904983,1,0.994032920504684,0,1,glycine import into mitochondrion,BP,
20501,GO:1904990,1,0.993942541586842,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20502,GO:1904992,1,0.993942541586842,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20503,GO:1904994,1,0.929166054968801,0,12,regulation of leukocyte adhesion to vascular endothelial cell,BP,
20504,GO:1904995,1,0.971415877001291,0,5,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
20505,GO:1904996,1,0.956519559036853,0,7,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
20506,GO:1904997,1,0.988002885362154,0,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,
20507,GO:1904998,1,0.993801356481175,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
20508,GO:1904999,1,0.994165731272958,0,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
20509,GO:1905000,1,0.99218505357245,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
20510,GO:1905005,1,0.961534804712957,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20511,GO:1905006,1,0.987293616893838,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20512,GO:1905007,1,0.967241895662127,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20513,GO:1905008,1,0.99390239375709,0,1,regulation of L-lysine import across plasma membrane,BP,
20514,GO:1905010,1,0.99390239375709,0,1,positive regulation of L-lysine import across plasma membrane,BP,
20515,GO:1905024,1,0.974083059320779,0,4,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20516,GO:1905025,1,0.993762715956935,0,1,negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20517,GO:1905026,1,0.986907114143901,0,2,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20518,GO:1905030,1,0.993112653583123,0,1,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20519,GO:1905031,1,0.966468621767449,0,5,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20520,GO:1905032,1,0.993762715956935,0,1,negative regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20521,GO:1905033,1,0.986907114143901,0,2,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20522,GO:1905034,1,0.993802215781181,0,1,regulation of antifungal innate immune response,BP,
20523,GO:1905035,1,0.993802215781181,0,1,negative regulation of antifungal innate immune response,BP,
20524,GO:1905037,1,0.55592420191304,0,91,autophagosome organization,BP,
20525,GO:1905038,1,0.923207599430397,0,13,regulation of membrane lipid metabolic process,BP,
20527,GO:1905040,1,0.993929441234976,0,1,otic placode development,BP,
20528,GO:1905041,1,0.993999458486108,0,1,regulation of epithelium regeneration,BP,
20529,GO:1905042,1,0.993999458486108,0,1,negative regulation of epithelium regeneration,BP,
20530,GO:1905044,1,0.993846081630578,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
20531,GO:1905045,1,0.993846081630578,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
20533,GO:1905049,1,0.96012372825925,0,6,negative regulation of metallopeptidase activity,BP,
20535,GO:1905051,1,0.988572443985418,0,2,regulation of base-excision repair,BP,
20536,GO:1905053,1,0.988572443985418,0,2,positive regulation of base-excision repair,BP,
20537,GO:1905062,1,0.99386531717471,0,1,positive regulation of cardioblast proliferation,BP,
20538,GO:1905063,1,0.94998704516302,0,8,regulation of vascular smooth muscle cell differentiation,BP,
20539,GO:1905064,1,0.981412144089632,0,3,negative regulation of vascular smooth muscle cell differentiation,BP,
20540,GO:1905065,1,0.967985744070279,0,5,positive regulation of vascular smooth muscle cell differentiation,BP,
20541,GO:1905066,1,0.988127127208535,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
20542,GO:1905067,1,0.994126168400043,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
20543,GO:1905068,1,0.993965875047369,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
20544,GO:1905069,1,0.987545304736453,0,2,allantois development,BP,
20545,GO:1905071,1,0.979885596506728,0,3,occluding junction disassembly,BP,
20546,GO:1905073,1,0.979885596506728,0,3,regulation of occluding junction disassembly,BP,
20547,GO:1905075,1,0.979885596506728,0,3,positive regulation of occluding junction disassembly,BP,
20548,GO:1905076,1,0.994074771569389,0,1,regulation of interleukin-17 secretion,BP,
20549,GO:1905077,1,0.994074771569389,0,1,negative regulation of interleukin-17 secretion,BP,
20550,GO:1905089,1,0.991096544504246,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20551,GO:1905090,1,0.991096544504246,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20552,GO:1905097,1,0.960544098388994,0,6,regulation of guanyl-nucleotide exchange factor activity,BP,
20553,GO:1905098,1,0.974590822291225,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
20554,GO:1905099,1,0.992816656537859,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20555,GO:1905103,1,0.993494531880438,0,1,integral component of lysosomal membrane,CC,
20557,GO:1905123,1,0.986817234082981,0,2,regulation of glucosylceramidase activity,BP,
20558,GO:1905132,1,0.993772585859067,0,1,regulation of meiotic chromosome separation,BP,
20559,GO:1905133,1,0.993772585859067,0,1,negative regulation of meiotic chromosome separation,BP,
20560,GO:1905143,1,0.994198074501003,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
20561,GO:1905144,1,0.876340871224859,0,21,response to acetylcholine,BP,
20562,GO:1905145,1,0.876340871224859,0,21,cellular response to acetylcholine,BP,
20564,GO:1905150,1,0.980148207709594,0,3,regulation of voltage-gated sodium channel activity,BP,
20565,GO:1905152,1,0.992946966231616,0,1,positive regulation of voltage-gated sodium channel activity,BP,
20566,GO:1905153,1,0.925449904064026,0,12,regulation of membrane invagination,BP,
20567,GO:1905154,1,0.987278856739543,0,2,negative regulation of membrane invagination,BP,
20568,GO:1905155,1,0.943165803403567,0,9,positive regulation of membrane invagination,BP,
20569,GO:1905161,1,0.993137452885281,0,1,protein localization to phagocytic vesicle,BP,
20570,GO:1905162,1,0.993137452885281,0,1,regulation of phagosome maturation,BP,
20572,GO:1905166,1,0.981308538177368,0,3,negative regulation of lysosomal protein catabolic process,BP,
20574,GO:1905168,1,0.993578802964807,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
20575,GO:1905169,1,0.993137452885281,0,1,regulation of protein localization to phagocytic vesicle,BP,
20576,GO:1905171,1,0.993137452885281,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
20577,GO:1905172,1,0.993316508368644,0,1,RISC complex binding,MF,
20578,GO:1905174,1,0.98796187363012,0,2,regulation of vascular smooth muscle cell dedifferentiation,BP,
20579,GO:1905176,1,0.993816398551809,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
20580,GO:1905202,1,0.987536761121932,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
20581,GO:1905203,1,0.987606068683748,0,2,regulation of connective tissue replacement,BP,
20582,GO:1905204,1,0.994259584215574,0,1,negative regulation of connective tissue replacement,BP,
20583,GO:1905205,1,0.993308461859214,0,1,positive regulation of connective tissue replacement,BP,
20584,GO:1905206,1,0.968335869690523,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
20586,GO:1905208,1,0.912139445540673,0,14,negative regulation of cardiocyte differentiation,BP,
20588,GO:1905214,1,0.932723641302768,0,11,regulation of RNA binding,BP,
20589,GO:1905215,1,0.994144361552652,0,1,negative regulation of RNA binding,BP,
20590,GO:1905216,1,0.950950200881562,0,8,positive regulation of RNA binding,BP,
20591,GO:1905217,1,0.99375456484417,0,1,response to astaxanthin,BP,
20592,GO:1905222,1,0.993742556178825,0,1,atrioventricular canal morphogenesis,BP,
20593,GO:1905223,1,0.992816367499988,0,1,epicardium morphogenesis,BP,
20594,GO:1905224,1,0.986520191102947,0,2,clathrin-coated pit assembly,BP,
20595,GO:1905225,1,0.988076901013013,0,2,response to thyrotropin-releasing hormone,BP,
20596,GO:1905226,1,0.994276044579464,0,1,regulation of adhesion of symbiont to host epithelial cell,BP,
20597,GO:1905229,1,0.994287018170238,0,1,cellular response to thyrotropin-releasing hormone,BP,
20598,GO:1905230,1,0.993498820562144,0,1,response to borneol,BP,
20599,GO:1905231,1,0.993498820562144,0,1,cellular response to borneol,BP,
20600,GO:1905232,1,0.967986433695635,0,5,cellular response to L-glutamate,BP,
20601,GO:1905233,1,0.993498820562144,0,1,response to codeine,BP,
20602,GO:1905235,1,0.993498820562144,0,1,response to quercetin,BP,
20603,GO:1905237,1,0.993498820562144,0,1,response to cyclosporin A,BP,
20604,GO:1905239,1,0.993202579617915,0,1,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20605,GO:1905240,1,0.993202579617915,0,1,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20606,GO:1905242,1,0.98758302068037,0,2,response to 3,3',5-triiodo-L-thyronine,BP,
20607,GO:1905243,1,0.993872498484012,0,1,cellular response to 3,3',5-triiodo-L-thyronine,BP,
20608,GO:1905244,1,0.948445660320498,0,8,regulation of modification of synaptic structure,BP,
20609,GO:1905245,1,0.947935824560075,0,8,regulation of aspartic-type peptidase activity,BP,
20610,GO:1905246,1,0.98550755400334,0,2,negative regulation of aspartic-type peptidase activity,BP,
20611,GO:1905247,1,0.961881324537036,0,6,positive regulation of aspartic-type peptidase activity,BP,
20612,GO:1905255,1,0.99278890683248,0,1,regulation of RNA binding transcription factor activity,BP,
20613,GO:1905258,1,0.988611217994198,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20614,GO:1905259,1,0.988611217994198,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20615,GO:1905267,1,0.987588615648171,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
20616,GO:1905268,1,0.742538290831956,0,45,negative regulation of chromatin organization,BP,
20617,GO:1905269,1,0.564309136539344,0,88,positive regulation of chromatin organization,BP,
20618,GO:1905271,1,0.99446606545119,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20619,GO:1905273,1,0.99446606545119,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20620,GO:1905274,1,0.992567048784626,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
20621,GO:1905276,1,0.888094113829018,0,18,regulation of epithelial tube formation,BP,
20622,GO:1905277,1,0.99376228690071,0,1,negative regulation of epithelial tube formation,BP,
20623,GO:1905278,1,0.975176123072168,0,4,positive regulation of epithelial tube formation,BP,
20624,GO:1905279,1,0.985868928863547,0,2,regulation of retrograde transport, endosome to Golgi,BP,
20625,GO:1905285,1,0.993603636886392,0,1,fibrous ring of heart morphogenesis,BP,
20626,GO:1905286,1,0.981784931481891,0,3,serine-type peptidase complex,CC,
20627,GO:1905288,1,0.960285313277539,0,6,vascular associated smooth muscle cell apoptotic process,BP,
20628,GO:1905289,1,0.991973955775138,0,1,regulation of CAMKK-AMPK signaling cascade,BP,
20629,GO:1905292,1,0.980895263578808,0,3,regulation of neural crest cell differentiation,BP,
20630,GO:1905294,1,0.980895263578808,0,3,positive regulation of neural crest cell differentiation,BP,
20631,GO:1905301,1,0.993338628392237,0,1,regulation of macropinocytosis,BP,
20632,GO:1905302,1,0.993338628392237,0,1,negative regulation of macropinocytosis,BP,
20633,GO:1905304,1,0.992116744038807,0,1,regulation of cardiac myofibril assembly,BP,
20634,GO:1905305,1,0.992116744038807,0,1,negative regulation of cardiac myofibril assembly,BP,
20635,GO:1905309,1,0.99171612148374,0,1,positive regulation of cohesin loading,BP,
20636,GO:1905310,1,0.980895263578808,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20637,GO:1905312,1,0.980895263578808,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20638,GO:1905313,1,0.994011283271499,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
20639,GO:1905314,1,0.904429926941309,0,15,semi-lunar valve development,BP,
20640,GO:1905317,1,0.993305012898809,0,1,inferior endocardial cushion morphogenesis,BP,
20641,GO:1905319,1,0.993846081630578,0,1,mesenchymal stem cell migration,BP,
20642,GO:1905320,1,0.993846081630578,0,1,regulation of mesenchymal stem cell migration,BP,
20643,GO:1905322,1,0.993846081630578,0,1,positive regulation of mesenchymal stem cell migration,BP,
20644,GO:1905323,1,0.960108443935121,0,6,telomerase holoenzyme complex assembly,BP,
20645,GO:1905327,1,0.994192298933327,0,1,tracheoesophageal septum formation,BP,
20649,GO:1905333,1,0.983114821986486,0,3,regulation of gastric motility,BP,
20650,GO:1905335,1,0.990731001283755,0,1,regulation of aggrephagy,BP,
20651,GO:1905337,1,0.990731001283755,0,1,positive regulation of aggrephagy,BP,
20652,GO:1905340,1,0.976097899598762,0,4,regulation of protein localization to kinetochore,BP,
20653,GO:1905341,1,0.993873647682063,0,1,negative regulation of protein localization to kinetochore,BP,
20654,GO:1905342,1,0.976097899598762,0,4,positive regulation of protein localization to kinetochore,BP,
20655,GO:1905344,1,0.993846081630578,0,1,prostaglandin catabolic process,BP,
20656,GO:1905348,1,0.836686659171133,0,29,endonuclease complex,CC,
20657,GO:1905349,1,0.988514886063498,0,2,ciliary transition zone assembly,BP,
20658,GO:1905354,1,0.873100745330616,0,22,exoribonuclease complex,CC,
20659,GO:1905355,1,0.993169592382351,0,1,spine apparatus assembly,BP,
20660,GO:1905359,1,0.993772585859067,0,1,protein localization to meiotic spindle,BP,
20661,GO:1905360,1,0.815704368048404,0,33,GTPase complex,CC,
20662,GO:1905365,1,0.994002053936623,0,1,regulation of intralumenal vesicle formation,BP,
20663,GO:1905366,1,0.994002053936623,0,1,negative regulation of intralumenal vesicle formation,BP,
20664,GO:1905368,1,0.606493442668909,0,83,peptidase complex,CC,
20665,GO:1905369,1,0.685224657835713,0,63,endopeptidase complex,CC,
20666,GO:1905370,1,0.99395204603589,0,1,serine-type endopeptidase complex,CC,
20667,GO:1905371,1,0.987131810787856,0,2,ceramide phosphoethanolamine metabolic process,BP,
20668,GO:1905373,1,0.987131810787856,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
20669,GO:1905383,1,0.982444212448982,0,3,protein localization to presynapse,BP,
20670,GO:1905384,1,0.987988826461391,0,2,regulation of protein localization to presynapse,BP,
20671,GO:1905386,1,0.987988826461391,0,2,positive regulation of protein localization to presynapse,BP,
20672,GO:1905392,1,0.994422168860593,0,1,plant organ morphogenesis,BP,
20673,GO:1905394,1,0.980800293074104,0,3,retromer complex binding,MF,
20674,GO:1905395,1,0.98138689545623,0,3,response to flavonoid,BP,
20675,GO:1905397,1,0.988310894061228,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20676,GO:1905402,1,0.988310894061228,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20677,GO:1905403,1,0.994074771569389,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20678,GO:1905404,1,0.994202117396691,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20679,GO:1905405,1,0.99171612148374,0,1,regulation of mitotic cohesin loading,BP,
20680,GO:1905406,1,0.99171612148374,0,1,positive regulation of mitotic cohesin loading,BP,
20681,GO:1905407,1,0.987837385545682,0,2,regulation of creatine transmembrane transporter activity,BP,
20682,GO:1905408,1,0.987837385545682,0,2,negative regulation of creatine transmembrane transporter activity,BP,
20683,GO:1905419,1,0.994118515849893,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
20684,GO:1905421,1,0.994422168860593,0,1,regulation of plant organ morphogenesis,BP,
20685,GO:1905422,1,0.994422168860593,0,1,negative regulation of plant organ morphogenesis,BP,
20686,GO:1905424,1,0.987962173271881,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20687,GO:1905426,1,0.987962173271881,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20688,GO:1905429,1,0.987502235595749,0,2,response to glycine,BP,
20689,GO:1905430,1,0.99404706080487,0,1,cellular response to glycine,BP,
20690,GO:1905432,1,0.993469360651845,0,1,regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20691,GO:1905433,1,0.993469360651845,0,1,negative regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20692,GO:1905435,1,0.993846081630578,0,1,regulation of histone H3-K4 trimethylation,BP,
20693,GO:1905437,1,0.993846081630578,0,1,positive regulation of histone H3-K4 trimethylation,BP,
20694,GO:1905438,1,0.987232031037998,0,2,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20695,GO:1905443,1,0.993352698564155,0,1,regulation of clathrin coat assembly,BP,
20696,GO:1905445,1,0.993352698564155,0,1,positive regulation of clathrin coat assembly,BP,
20697,GO:1905446,1,0.970524746336356,0,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20698,GO:1905447,1,0.993733409310885,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20699,GO:1905448,1,0.976646461682708,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20700,GO:1905449,1,0.987028582851517,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20701,GO:1905451,1,0.987028582851517,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20702,GO:1905456,1,0.953749525826887,0,7,regulation of lymphoid progenitor cell differentiation,BP,
20703,GO:1905457,1,0.9805801155908,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20704,GO:1905458,1,0.993503108743952,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
20705,GO:1905459,1,0.960285313277539,0,6,regulation of vascular associated smooth muscle cell apoptotic process,BP,
20706,GO:1905460,1,0.992555616082292,0,1,negative regulation of vascular associated smooth muscle cell apoptotic process,BP,
20707,GO:1905461,1,0.967490099954337,0,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
20710,GO:1905464,1,0.993468788348972,0,1,positive regulation of DNA duplex unwinding,BP,
20711,GO:1905468,1,0.993137452885281,0,1,regulation of clathrin-coated pit assembly,BP,
20712,GO:1905469,1,0.993137452885281,0,1,negative regulation of clathrin-coated pit assembly,BP,
20713,GO:1905474,1,0.994214823633125,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
20714,GO:1905475,1,0.376779554746975,0,153,regulation of protein localization to membrane,BP,
20715,GO:1905476,1,0.833186366906221,0,29,negative regulation of protein localization to membrane,BP,
20716,GO:1905477,1,0.496182606433771,0,110,positive regulation of protein localization to membrane,BP,
20717,GO:1905483,1,0.991288325747625,0,1,regulation of motor neuron migration,BP,
20718,GO:1905485,1,0.991288325747625,0,1,positive regulation of motor neuron migration,BP,
20719,GO:1905502,1,0.994302901027414,0,1,acetyl-CoA binding,MF,
20720,GO:1905508,1,0.82545138144979,0,28,protein localization to microtubule organizing center,BP,
20721,GO:1905512,1,0.993906420572166,0,1,regulation of short-term synaptic potentiation,BP,
20722,GO:1905513,1,0.993906420572166,0,1,negative regulation of short-term synaptic potentiation,BP,
20723,GO:1905515,1,0.736059168193787,0,48,non-motile cilium assembly,BP,
20724,GO:1905516,1,0.949195325337652,0,8,positive regulation of fertilization,BP,
20725,GO:1905517,1,0.817008097637976,0,33,macrophage migration,BP,
20726,GO:1905518,1,0.993231949661646,0,1,regulation of presynaptic active zone assembly,BP,
20727,GO:1905520,1,0.993231949661646,0,1,positive regulation of presynaptic active zone assembly,BP,
20728,GO:1905521,1,0.88304925187426,0,20,regulation of macrophage migration,BP,
20729,GO:1905522,1,0.969947270372683,0,5,negative regulation of macrophage migration,BP,
20730,GO:1905523,1,0.933504215367689,0,11,positive regulation of macrophage migration,BP,
20731,GO:1905524,1,0.992430824132422,0,1,negative regulation of protein autoubiquitination,BP,
20732,GO:1905535,1,0.99314148917646,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20733,GO:1905537,1,0.99314148917646,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20734,GO:1905538,1,0.993316508368644,0,1,polysome binding,MF,
20735,GO:1905541,1,0.99390239375709,0,1,regulation of L-arginine import across plasma membrane,BP,
20736,GO:1905546,1,0.993987924836092,0,1,cellular response to phenylpropanoid,BP,
20737,GO:1905547,1,0.994173817092608,0,1,regulation of telomeric heterochromatin assembly,BP,
20738,GO:1905549,1,0.994173817092608,0,1,positive regulation of telomeric heterochromatin assembly,BP,
20739,GO:1905550,1,0.98826109019802,0,2,regulation of protein localization to endoplasmic reticulum,BP,
20740,GO:1905552,1,0.98826109019802,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
20741,GO:1905553,1,0.98157207056437,0,3,regulation of blood vessel branching,BP,
20742,GO:1905555,1,0.987239119019828,0,2,positive regulation blood vessel branching,BP,
20743,GO:1905562,1,0.911539369390818,0,14,regulation of vascular endothelial cell proliferation,BP,
20744,GO:1905563,1,0.980355326942294,0,3,negative regulation of vascular endothelial cell proliferation,BP,
20745,GO:1905564,1,0.929818786681526,0,11,positive regulation of vascular endothelial cell proliferation,BP,
20746,GO:1905572,1,0.993828582497836,0,1,ganglioside GM1 transport to membrane,BP,
20747,GO:1905573,1,0.987958776142163,0,2,ganglioside GM1 binding,MF,
20748,GO:1905574,1,0.993828582497836,0,1,ganglioside GM2 binding,MF,
20749,GO:1905575,1,0.993828582497836,0,1,ganglioside GM3 binding,MF,
20751,GO:1905577,1,0.993828582497836,0,1,ganglioside GP1c binding,MF,
20752,GO:1905578,1,0.993941533688724,0,1,regulation of ERBB3 signaling pathway,BP,
20753,GO:1905580,1,0.993941533688724,0,1,positive regulation of ERBB3 signaling pathway,BP,
20754,GO:1905581,1,0.994173961482157,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
20755,GO:1905589,1,0.99390239375709,0,1,positive regulation of L-arginine import across plasma membrane,BP,
20756,GO:1905590,1,0.993744414402594,0,1,fibronectin fibril organization,BP,
20757,GO:1905594,1,0.994317340024882,0,1,resveratrol binding,MF,
20758,GO:1905595,1,0.987808810105362,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
20759,GO:1905596,1,0.993597928285159,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
20760,GO:1905597,1,0.994173961482157,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
20761,GO:1905598,1,0.993597928285159,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
20762,GO:1905599,1,0.994173961482157,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
20763,GO:1905600,1,0.981683273447016,0,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20764,GO:1905601,1,0.993597928285159,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20765,GO:1905602,1,0.988009356467856,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20766,GO:1905603,1,0.993205747724528,0,1,regulation of maintenance of permeability of blood-brain barrier,BP,
20767,GO:1905604,1,0.993205747724528,0,1,negative regulation of maintenance of permeability of blood-brain barrier,BP,
20768,GO:1905606,1,0.974057616402547,0,4,regulation of presynapse assembly,BP,
20769,GO:1905608,1,0.993231949661646,0,1,positive regulation of presynapse assembly,BP,
20770,GO:1905610,1,0.99314148917646,0,1,regulation of mRNA cap binding,BP,
20771,GO:1905612,1,0.99314148917646,0,1,positive regulation of mRNA cap binding,BP,
20772,GO:1905616,1,0.987029349688225,0,2,regulation of miRNA mediated inhibition of translation,BP,
20773,GO:1905618,1,0.987029349688225,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
20774,GO:1905634,1,0.96567757856071,0,5,regulation of protein localization to chromatin,BP,
20775,GO:1905636,1,0.994285285497053,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
20776,GO:1905642,1,0.993846081630578,0,1,negative regulation of DNA methylation,BP,
20777,GO:1905643,1,0.992930357628021,0,1,positive regulation of DNA methylation,BP,
20778,GO:1905647,1,0.993934047371008,0,1,proline import across plasma membrane,BP,
20779,GO:1905651,1,0.979384861010805,0,3,regulation of artery morphogenesis,BP,
20780,GO:1905653,1,0.979384861010805,0,3,positive regulation of artery morphogenesis,BP,
20781,GO:1905661,1,0.987646293926024,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
20782,GO:1905663,1,0.987646293926024,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
20783,GO:1905664,1,0.975987081794341,0,4,regulation of calcium ion import across plasma membrane,BP,
20784,GO:1905665,1,0.987900698431924,0,2,positive regulation of calcium ion import across plasma membrane,BP,
20785,GO:1905666,1,0.940989492378394,0,9,regulation of protein localization to endosome,BP,
20786,GO:1905668,1,0.940989492378394,0,9,positive regulation of protein localization to endosome,BP,
20787,GO:1905671,1,0.981420643033715,0,3,regulation of lysosome organization,BP,
20788,GO:1905672,1,0.994025995737292,0,1,negative regulation of lysosome organization,BP,
20789,GO:1905687,1,0.99298754253424,0,1,regulation of diacylglycerol kinase activity,BP,
20790,GO:1905689,1,0.99298754253424,0,1,positive regulation of diacylglycerol kinase activity,BP,
20791,GO:1905693,1,0.994026284253939,0,1,regulation of phosphatidic acid biosynthetic process,BP,
20792,GO:1905695,1,0.994026284253939,0,1,positive regulation of phosphatidic acid biosynthetic process,BP,
20793,GO:1905696,1,0.986503371934389,0,2,regulation of polysome binding,BP,
20794,GO:1905698,1,0.993316508368644,0,1,positive regulation of polysome binding,BP,
20795,GO:1905705,1,0.992646334865486,0,1,cellular response to paclitaxel,BP,
20796,GO:1905709,1,0.969950517604621,0,5,negative regulation of membrane permeability,BP,
20798,GO:1905711,1,0.99355267808908,0,1,response to phosphatidylethanolamine,BP,
20799,GO:1905719,1,0.987691458284505,0,2,protein localization to perinuclear region of cytoplasm,BP,
20800,GO:1905720,1,0.992572258392098,0,1,cytoplasmic microtubule bundle,CC,
20801,GO:1905747,1,0.994280665037031,0,1,negative regulation of saliva secretion,BP,
20802,GO:1905748,1,0.994280665037031,0,1,hard palate morphogenesis,BP,
20803,GO:1905764,1,0.980552581237701,0,3,regulation of protection from non-homologous end joining at telomere,BP,
20804,GO:1905765,1,0.980552581237701,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
20805,GO:1905767,1,0.992698691473801,0,1,regulation of double-stranded telomeric DNA binding,BP,
20806,GO:1905768,1,0.992698691473801,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
20807,GO:1905770,1,0.963664834774403,0,6,regulation of mesodermal cell differentiation,BP,
20808,GO:1905771,1,0.976685619555293,0,4,negative regulation of mesodermal cell differentiation,BP,
20809,GO:1905773,1,0.97992886705819,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
20810,GO:1905774,1,0.993468788348972,0,1,regulation of DNA helicase activity,BP,
20811,GO:1905776,1,0.993468788348972,0,1,positive regulation of DNA helicase activity,BP,
20812,GO:1905777,1,0.98157755363573,0,3,regulation of exonuclease activity,BP,
20813,GO:1905778,1,0.987648861234141,0,2,negative regulation of exonuclease activity,BP,
20814,GO:1905779,1,0.993853544336592,0,1,positive regulation of exonuclease activity,BP,
20815,GO:1905793,1,0.984702872586009,0,2,protein localization to pericentriolar material,BP,
20816,GO:1905794,1,0.991730220290031,0,1,response to puromycin,BP,
20817,GO:1905795,1,0.991730220290031,0,1,cellular response to puromycin,BP,
20818,GO:1905799,1,0.994452492057837,0,1,regulation of intraciliary retrograde transport,BP,
20819,GO:1905802,1,0.99382399483331,0,1,regulation of cellular response to manganese ion,BP,
20820,GO:1905809,1,0.865140143206385,0,22,negative regulation of synapse organization,BP,
20821,GO:1905818,1,0.70120289529002,0,55,regulation of chromosome separation,BP,
20822,GO:1905819,1,0.808893302567163,0,33,negative regulation of chromosome separation,BP,
20823,GO:1905820,1,0.943001282104062,0,9,positive regulation of chromosome separation,BP,
20824,GO:1905832,1,0.970683655900295,0,4,positive regulation of spindle assembly,BP,
20825,GO:1905838,1,0.987648861234141,0,2,regulation of telomeric D-loop disassembly,BP,
20826,GO:1905839,1,0.987648861234141,0,2,negative regulation of telomeric D-loop disassembly,BP,
20827,GO:1905843,1,0.991439321831538,0,1,regulation of cellular response to gamma radiation,BP,
20828,GO:1905853,1,0.9943066551631,0,1,regulation of heparan sulfate binding,BP,
20829,GO:1905855,1,0.9943066551631,0,1,positive regulation of heparan sulfate binding,BP,
20830,GO:1905858,1,0.9943066551631,0,1,regulation of heparan sulfate proteoglycan binding,BP,
20831,GO:1905860,1,0.9943066551631,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
20832,GO:1905863,1,0.985733904655477,0,2,invadopodium organization,BP,
20834,GO:1905874,1,0.974848562046225,0,4,regulation of postsynaptic density organization,BP,
20835,GO:1905875,1,0.993801213267339,0,1,negative regulation of postsynaptic density organization,BP,
20836,GO:1905878,1,0.991822346533972,0,1,invadopodium disassembly,BP,
20837,GO:1905879,1,0.938288273779796,0,10,regulation of oogenesis,BP,
20838,GO:1905880,1,0.974748816931124,0,4,negative regulation of oogenesis,BP,
20839,GO:1905881,1,0.974467433762541,0,4,positive regulation of oogenesis,BP,
20840,GO:1905890,1,0.9943066551631,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
20841,GO:1905891,1,0.993825715097266,0,1,regulation of cellular response to thapsigargin,BP,
20842,GO:1905892,1,0.993825715097266,0,1,negative regulation of cellular response to thapsigargin,BP,
20843,GO:1905894,1,0.993825715097266,0,1,regulation of cellular response to tunicamycin,BP,
20844,GO:1905895,1,0.993825715097266,0,1,negative regulation of cellular response to tunicamycin,BP,
20847,GO:1905899,1,0.994192298933327,0,1,regulation of smooth muscle tissue development,BP,
20848,GO:1905900,1,0.994192298933327,0,1,negative regulation of smooth muscle tissue development,BP,
20849,GO:1905901,1,0.994192298933327,0,1,positive regulation of smooth muscle tissue development,BP,
20850,GO:1905902,1,0.963664834774403,0,6,regulation of mesoderm formation,BP,
20851,GO:1905903,1,0.976685619555293,0,4,negative regulation of mesoderm formation,BP,
20852,GO:1905906,1,0.957074958725736,0,7,regulation of amyloid fibril formation,BP,
20853,GO:1905907,1,0.981516705957586,0,3,negative regulation of amyloid fibril formation,BP,
20854,GO:1905908,1,0.974908986898556,0,4,positive regulation of amyloid fibril formation,BP,
20855,GO:1905912,1,0.994114617441693,0,1,regulation of calcium ion export across plasma membrane,BP,
20856,GO:1905913,1,0.994114617441693,0,1,negative regulation of calcium ion export across plasma membrane,BP,
20857,GO:1905918,1,0.994023110646294,0,1,regulation of CoA-transferase activity,BP,
20858,GO:1905920,1,0.994023110646294,0,1,positive regulation of CoA-transferase activity,BP,
20859,GO:1905927,1,0.991822346533972,0,1,regulation of invadopodium disassembly,BP,
20860,GO:1905929,1,0.991822346533972,0,1,positive regulation of invadopodium disassembly,BP,
20861,GO:1905936,1,0.976970684275735,0,4,regulation of germ cell proliferation,BP,
20862,GO:1905937,1,0.982508693911963,0,3,negative regulation of germ cell proliferation,BP,
20863,GO:1905938,1,0.994364411486775,0,1,positive regulation of germ cell proliferation,BP,
20864,GO:1905939,1,0.893615157496768,0,18,regulation of gonad development,BP,
20865,GO:1905940,1,0.969195408500437,0,5,negative regulation of gonad development,BP,
20866,GO:1905941,1,0.940093406450258,0,10,positive regulation of gonad development,BP,
20867,GO:1905942,1,0.993941533688724,0,1,regulation of formation of growth cone in injured axon,BP,
20868,GO:1905943,1,0.993941533688724,0,1,negative regulation of formation of growth cone in injured axon,BP,
20869,GO:1905952,1,0.496514634417411,0,109,regulation of lipid localization,BP,
20870,GO:1905953,1,0.816909245384148,0,31,negative regulation of lipid localization,BP,
20871,GO:1905954,1,0.65539332589558,0,66,positive regulation of lipid localization,BP,
20872,GO:1905957,1,0.993394304974037,0,1,regulation of cellular response to alcohol,BP,
20873,GO:1905959,1,0.993394304974037,0,1,positive regulation of cellular response to alcohol,BP,
20874,GO:1905961,1,0.951288488973353,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
20875,GO:1990000,1,0.915100052118165,0,14,amyloid fibril formation,BP,
20876,GO:1990001,1,0.934422095976043,0,10,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
20877,GO:1990003,1,0.992912447527943,0,1,IDP phosphatase activity,MF,
20878,GO:1990005,1,0.988034149257593,0,2,granular vesicle,CC,
20879,GO:1990008,1,0.994152447402909,0,1,neurosecretory vesicle,CC,
20880,GO:1990009,1,0.986757255060431,0,2,retinal cell apoptotic process,BP,
20882,GO:1990023,1,0.921884803302159,0,12,mitotic spindle midzone,CC,
20883,GO:1990026,1,0.986874911174289,0,2,hippocampal mossy fiber expansion,CC,
20884,GO:1990030,1,0.99352068543201,0,1,pericellular basket,CC,
20885,GO:1990031,1,0.993735695828629,0,1,pinceau fiber,CC,
20886,GO:1990032,1,0.993356861234796,0,1,parallel fiber,CC,
20887,GO:1990034,1,0.966976833305647,0,5,calcium ion export across plasma membrane,BP,
20888,GO:1990036,1,0.986468492353309,0,2,calcium ion import into sarcoplasmic reticulum,BP,
20889,GO:1990037,1,0.982354363914097,0,3,Lewy body core,CC,
20890,GO:1990038,1,0.994081267421243,0,1,Lewy body corona,CC,
20891,GO:1990046,1,0.994277777250779,0,1,stress-induced mitochondrial fusion,BP,
20892,GO:1990047,1,0.993988501451144,0,1,spindle matrix,CC,
20893,GO:1990048,1,0.993846081630578,0,1,anterograde neuronal dense core vesicle transport,BP,
20894,GO:1990050,1,0.976999275402675,0,4,phosphatidic acid transporter activity,MF,
20895,GO:1990051,1,0.98672900005624,0,2,activation of protein kinase C activity,BP,
20896,GO:1990070,1,0.994425345555802,0,1,TRAPPI protein complex,CC,
20897,GO:1990071,1,0.987101613470939,0,2,TRAPPII protein complex,CC,
20898,GO:1990072,1,0.988305384952933,0,2,TRAPPIII protein complex,CC,
20899,GO:1990074,1,0.99363389123298,0,1,polyuridylation-dependent mRNA catabolic process,BP,
20900,GO:1990075,1,0.972163967648712,0,4,periciliary membrane compartment,CC,
20901,GO:1990079,1,0.994358924598134,0,1,cartilage homeostasis,BP,
20902,GO:1990086,1,0.974489983167884,0,4,lens fiber cell apoptotic process,BP,
20903,GO:1990089,1,0.709473795450309,0,52,response to nerve growth factor,BP,
20905,GO:1990108,1,0.986060436314098,0,2,protein linear deubiquitination,BP,
20906,GO:1990111,1,0.975781132370476,0,4,spermatoproteasome complex,CC,
20907,GO:1990112,1,0.987729649828399,0,2,RQC complex,CC,
20908,GO:1990116,1,0.987729649828399,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
20909,GO:1990117,1,0.994412927591184,0,1,B cell receptor apoptotic signaling pathway,BP,
20910,GO:1990124,1,0.948053658271503,0,8,messenger ribonucleoprotein complex,CC,
20911,GO:1990126,1,0.90249959984372,0,16,retrograde transport, endosome to plasma membrane,BP,
20912,GO:1990127,1,0.993440160298641,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
20913,GO:1990130,1,0.96930113720746,0,5,GATOR1 complex,CC,
20914,GO:1990131,1,0.975874207513893,0,4,Gtr1-Gtr2 GTPase complex,CC,
20915,GO:1990134,1,0.993197539087131,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
20916,GO:1990136,1,0.993921669858894,0,1,linoleate 9S-lipoxygenase activity,MF,
20918,GO:1990144,1,0.964090715007311,0,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
20919,GO:1990145,1,0.987433576262246,0,2,maintenance of translational fidelity,BP,
20920,GO:1990164,1,0.987623294993576,0,2,histone H2A phosphorylation,BP,
20921,GO:1990165,1,0.994063224376902,0,1,single-strand break-containing DNA binding,MF,
20922,GO:1990166,1,0.99396501058896,0,1,protein localization to site of double-strand break,BP,
20923,GO:1990167,1,0.985669172653783,0,2,protein K27-linked deubiquitination,BP,
20924,GO:1990168,1,0.986117431643475,0,2,protein K33-linked deubiquitination,BP,
20925,GO:1990169,1,0.938992621508128,0,11,stress response to copper ion,BP,
20926,GO:1990170,1,0.994064956368378,0,1,stress response to cadmium ion,BP,
20927,GO:1990172,1,0.992956208625693,0,1,G-protein coupled receptor catabolic process,BP,
20928,GO:1990173,1,0.940729446701209,0,10,protein localization to nucleoplasm,BP,
20929,GO:1990174,1,0.99353711264266,0,1,phosphodiesterase decapping endonuclease activity,MF,
20930,GO:1990175,1,0.993515684691425,0,1,EH domain binding,MF,
20931,GO:1990179,1,0.980146848871237,0,3,protein localization to actomyosin contractile ring,BP,
20932,GO:1990180,1,0.982312260816319,0,3,mitochondrial tRNA 3'-end processing,BP,
20933,GO:1990182,1,0.90039986859147,0,17,exosomal secretion,BP,
20934,GO:1990183,1,0.994401376055962,0,1,lymphatic vascular process in circulatory system,BP,
20935,GO:1990186,1,0.994401376055962,0,1,regulation of lymphatic vessel size,BP,
20936,GO:1990188,1,0.993889023058696,0,1,euchromatin binding,MF,
20937,GO:1990189,1,0.982389940021649,0,3,peptide-serine-N-acetyltransferase activity,MF,
20938,GO:1990190,1,0.988633615391754,0,2,peptide-glutamate-N-acetyltransferase activity,MF,
20939,GO:1990192,1,0.994401376055962,0,1,collecting lymphatic vessel constriction,BP,
20940,GO:1990204,1,0.562810245607432,0,96,oxidoreductase complex,CC,
20941,GO:1990226,1,0.963980665950921,0,6,histone methyltransferase binding,MF,
20943,GO:1990239,1,0.961755124146824,0,6,steroid hormone binding,MF,
20944,GO:1990246,1,0.975608343238402,0,4,uniplex complex,CC,
20945,GO:1990247,1,0.954586491562102,0,7,N6-methyladenosine-containing RNA binding,MF,
20946,GO:1990253,1,0.942308362170665,0,9,cellular response to leucine starvation,BP,
20947,GO:1990254,1,0.969008702457172,0,5,keratin filament binding,MF,
20948,GO:1990256,1,0.991229906766504,0,1,signal clustering,BP,
20949,GO:1990258,1,0.994309542961473,0,1,histone glutamine methylation,BP,
20950,GO:1990259,1,0.994309542961473,0,1,histone-glutamine methyltransferase activity,MF,
20951,GO:1990261,1,0.993846081630578,0,1,pre-mRNA catabolic process,BP,
20952,GO:1990262,1,0.993854118488498,0,1,anti-Mullerian hormone signaling pathway,BP,
20953,GO:1990264,1,0.987727350578635,0,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
20954,GO:1990266,1,0.621807303820956,0,78,neutrophil migration,BP,
20955,GO:1990267,1,0.993718121396218,0,1,response to transition metal nanoparticle,BP,
20956,GO:1990268,1,0.993718121396218,0,1,response to gold nanoparticle,BP,
20957,GO:1990269,1,0.987265048756186,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
20958,GO:1990275,1,0.993814392401233,0,1,preribosome binding,MF,
20959,GO:1990280,1,0.992681481951384,0,1,RNA localization to chromatin,BP,
20960,GO:1990298,1,0.994024985939764,0,1,bub1-bub3 complex,CC,
20961,GO:1990314,1,0.947073842457624,0,8,cellular response to insulin-like growth factor stimulus,BP,
20962,GO:1990316,1,0.947396938145988,0,8,Atg1/ULK1 kinase complex,CC,
20963,GO:1990332,1,0.993489670748233,0,1,Ire1 complex,CC,
20964,GO:1990349,1,0.99406870912543,0,1,gap junction-mediated intercellular transport,BP,
20966,GO:1990356,1,0.994300013232335,0,1,sumoylated E2 ligase complex,CC,
20967,GO:1990357,1,0.981988018188007,0,3,terminal web,CC,
20968,GO:1990379,1,0.9883549866701,0,2,lipid transport across blood brain barrier,BP,
20969,GO:1990380,1,0.950164425671829,0,7,Lys48-specific deubiquitinase activity,MF,
20970,GO:1990381,1,0.918973439416676,0,13,ubiquitin-specific protease binding,MF,
20971,GO:1990384,1,0.994277488472205,0,1,hyaloid vascular plexus regression,BP,
20972,GO:1990386,1,0.994075637661302,0,1,mitotic cleavage furrow ingression,BP,
20973,GO:1990390,1,0.993647591731625,0,1,protein K33-linked ubiquitination,BP,
20974,GO:1990391,1,0.804935426097748,0,33,DNA repair complex,CC,
20975,GO:1990393,1,0.967481680585713,0,5,3M complex,CC,
20976,GO:1990399,1,0.993999458486108,0,1,epithelium regeneration,BP,
20977,GO:1990401,1,0.993846942590791,0,1,embryonic lung development,BP,
20978,GO:1990402,1,0.994011283271499,0,1,embryonic liver development,BP,
20979,GO:1990403,1,0.937755508117646,0,10,embryonic brain development,BP,
20980,GO:1990404,1,0.98763800273613,0,2,protein ADP-ribosylase activity,MF,
20981,GO:1990405,1,0.960578431996528,0,6,protein antigen binding,MF,
20982,GO:1990406,1,0.987631004733173,0,2,CGRP receptor complex,CC,
20983,GO:1990407,1,0.99438549278218,0,1,calcitonin gene-related peptide binding,MF,
20984,GO:1990408,1,0.987631004733173,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
20985,GO:1990409,1,0.987666286816135,0,2,adrenomedullin binding,MF,
20986,GO:1990410,1,0.976327215557527,0,4,adrenomedullin receptor signaling pathway,BP,
20987,GO:1990414,1,0.973595648459482,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
20988,GO:1990415,1,0.981427250890211,0,3,Pex17p-Pex14p docking complex,CC,
20989,GO:1990416,1,0.948350284933807,0,8,cellular response to brain-derived neurotrophic factor stimulus,BP,
20990,GO:1990418,1,0.981872035654183,0,3,response to insulin-like growth factor stimulus,BP,
20991,GO:1990421,1,0.991425784812328,0,1,subtelomeric heterochromatin,CC,
20992,GO:1990423,1,0.980279866216904,0,3,RZZ complex,CC,
20993,GO:1990425,1,0.977200942116657,0,3,ryanodine receptor complex,CC,
20994,GO:1990426,1,0.985402935728362,0,2,mitotic recombination-dependent replication fork processing,BP,
20995,GO:1990427,1,0.992520445296379,0,1,stereocilia tip-link density,CC,
20996,GO:1990428,1,0.986932183265258,0,2,miRNA transport,BP,
20997,GO:1990429,1,0.981427250890211,0,3,peroxisomal importomer complex,CC,
20998,GO:1990430,1,0.973110536296212,0,4,extracellular matrix protein binding,MF,
20999,GO:1990435,1,0.992520445296379,0,1,upper tip-link density,CC,
21000,GO:1990439,1,0.99379663084709,0,1,MAP kinase serine/threonine phosphatase activity,MF,
21001,GO:1990440,1,0.935028718130992,0,11,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
21002,GO:1990441,1,0.975749626430138,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
21003,GO:1990442,1,0.983059149140577,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
21004,GO:1990446,1,0.976906598336231,0,4,U1 snRNP binding,MF,
21005,GO:1990448,1,0.992741202269762,0,1,exon-exon junction complex binding,MF,
21006,GO:1990452,1,0.987327489523619,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
21007,GO:1990454,1,0.951236431763168,0,7,L-type voltage-gated calcium channel complex,CC,
21008,GO:1990456,1,0.993542539602828,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
21010,GO:1990460,1,0.980407777221804,0,3,leptin receptor binding,MF,
21011,GO:1990462,1,0.95690556986365,0,7,omegasome,CC,
21012,GO:1990478,1,0.994089495997856,0,1,response to ultrasound,BP,
21013,GO:1990481,1,0.97606152231217,0,4,mRNA pseudouridine synthesis,BP,
21014,GO:1990498,1,0.984905443478706,0,2,mitotic spindle microtubule,CC,
21015,GO:1990502,1,0.986537941651758,0,2,dense core granule maturation,BP,
21016,GO:1990504,1,0.957185392899704,0,6,dense core granule exocytosis,BP,
21017,GO:1990505,1,0.985402935728362,0,2,mitotic DNA replication maintenance of fidelity,BP,
21018,GO:1990511,1,0.974677638933768,0,4,piRNA biosynthetic process,BP,
21019,GO:1990518,1,0.993316508368644,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
21020,GO:1990519,1,0.987569214767059,0,2,pyrimidine nucleotide import into mitochondrion,BP,
21021,GO:1990523,1,0.975490567123888,0,4,bone regeneration,BP,
21022,GO:1990535,1,0.966505535894705,0,5,neuron projection maintenance,BP,
21023,GO:1990539,1,0.993976682335154,0,1,fructose import across plasma membrane,BP,
21024,GO:1990542,1,0.662195130101332,0,67,mitochondrial transmembrane transport,BP,
21025,GO:1990546,1,0.994183924354294,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
21026,GO:1990564,1,0.970497434720829,0,5,protein polyufmylation,BP,
21027,GO:1990565,1,0.994163421036889,0,1,HSP90-CDC37 chaperone complex,CC,
21028,GO:1990569,1,0.986752339139541,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
21029,GO:1990570,1,0.993846081630578,0,1,GDP-mannose transmembrane transport,BP,
21030,GO:1990572,1,0.993494245950117,0,1,TERT-RMRP complex,CC,
21031,GO:1990573,1,0.944442550250254,0,9,potassium ion import across plasma membrane,BP,
21032,GO:1990575,1,0.987491998081447,0,2,mitochondrial L-ornithine transmembrane transport,BP,
21033,GO:1990578,1,0.992975269574411,0,1,perinuclear endoplasmic reticulum membrane,CC,
21034,GO:1990579,1,0.993489670748233,0,1,peptidyl-serine trans-autophosphorylation,BP,
21035,GO:1990583,1,0.994075637661302,0,1,phospholipase D activator activity,MF,
21036,GO:1990584,1,0.983261335211607,0,3,cardiac Troponin complex,CC,
21037,GO:1990589,1,0.98602936372894,0,2,ATF4-CREB1 transcription factor complex,CC,
21038,GO:1990590,1,0.988128328926326,0,2,ATF1-ATF4 transcription factor complex,CC,
21039,GO:1990592,1,0.970497434720829,0,5,protein K69-linked ufmylation,BP,
21040,GO:1990597,1,0.980955293052821,0,3,AIP1-IRE1 complex,CC,
21041,GO:1990599,1,0.980552581237701,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
21042,GO:1990603,1,0.993697840280528,0,1,dark adaptation,BP,
21043,GO:1990604,1,0.980746853524868,0,3,IRE1-TRAF2-ASK1 complex,CC,
21044,GO:1990613,1,0.99363189329802,0,1,mitochondrial membrane fusion,BP,
21045,GO:1990617,1,0.988567997182115,0,2,CHOP-ATF4 complex,CC,
21046,GO:1990619,1,0.987751751576033,0,2,histone H3-K9 deacetylation,BP,
21047,GO:1990622,1,0.988473960462612,0,2,CHOP-ATF3 complex,CC,
21048,GO:1990630,1,0.993489670748233,0,1,IRE1-RACK1-PP2A complex,CC,
21049,GO:1990635,1,0.974225226254244,0,4,proximal dendrite,CC,
21050,GO:1990637,1,0.980565003449289,0,3,response to prolactin,BP,
21051,GO:1990641,1,0.982077438886103,0,3,response to iron ion starvation,BP,
21052,GO:1990646,1,0.993778738287005,0,1,cellular response to prolactin,BP,
21053,GO:1990654,1,0.993232381455005,0,1,sebum secreting cell proliferation,BP,
21054,GO:1990666,1,0.986771134865566,0,2,PCSK9-LDLR complex,CC,
21055,GO:1990667,1,0.987808810105362,0,2,PCSK9-AnxA2 complex,CC,
21056,GO:1990668,1,0.969630183172382,0,5,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
21057,GO:1990682,1,0.987479084841217,0,2,CSF1-CSF1R complex,CC,
21058,GO:1990696,1,0.985107292317539,0,2,USH2 complex,CC,
21059,GO:1990697,1,0.994005226335427,0,1,protein depalmitoleylation,BP,
21060,GO:1990698,1,0.987677186753129,0,2,palmitoleoyltransferase activity,MF,
21061,GO:1990699,1,0.994005226335427,0,1,palmitoleyl hydrolase activity,MF,
21062,GO:1990700,1,0.993511969476805,0,1,nucleolar chromatin organization,BP,
21063,GO:1990705,1,0.992116453925477,0,1,cholangiocyte proliferation,BP,
21064,GO:1990707,1,0.991425784812328,0,1,nuclear subtelomeric heterochromatin,CC,
21065,GO:1990708,1,0.993221009726206,0,1,conditioned place preference,BP,
21066,GO:1990709,1,0.979918429146677,0,3,presynaptic active zone organization,BP,
21068,GO:1990715,1,0.99347880215659,0,1,mRNA CDS binding,MF,
21069,GO:1990716,1,0.978726517132989,0,3,axonemal central apparatus,CC,
21070,GO:1990718,1,0.991843119856369,0,1,axonemal central pair projection,CC,
21071,GO:1990723,1,0.985083339278293,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
21072,GO:1990726,1,0.972013310559392,0,5,Lsm1-7-Pat1 complex,CC,
21073,GO:1990729,1,0.994080834353118,0,1,primary miRNA modification,BP,
21074,GO:1990730,1,0.98719754671503,0,2,VCP-NSFL1C complex,CC,
21075,GO:1990736,1,0.993475083113072,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
21076,GO:1990737,1,0.981026189505681,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
21077,GO:1990739,1,0.992116453925477,0,1,granulosa cell proliferation,BP,
21078,GO:1990742,1,0.98138193998435,0,3,microvesicle,CC,
21079,GO:1990743,1,0.973526983141025,0,4,protein sialylation,BP,
21080,GO:1990744,1,0.994080834353118,0,1,primary miRNA methylation,BP,
21081,GO:1990745,1,0.980538409035936,0,3,EARP complex,CC,
21082,GO:1990748,1,0.593220284362448,0,86,cellular detoxification,BP,
21083,GO:1990751,1,0.992567048784626,0,1,Schwann cell chemotaxis,BP,
21084,GO:1990752,1,0.836443313950554,0,25,microtubule end,CC,
21085,GO:1990755,1,0.993846081630578,0,1,mitotic spindle microtubule depolymerization,BP,
21086,GO:1990756,1,0.981762267652593,0,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,
21087,GO:1990758,1,0.994117216375213,0,1,mitotic sister chromatid biorientation,BP,
21088,GO:1990761,1,0.979403049256983,0,3,growth cone lamellipodium,CC,
21089,GO:1990763,1,0.961477994843076,0,6,arrestin family protein binding,MF,
21090,GO:1990764,1,0.993861870878592,0,1,myofibroblast contraction,BP,
21091,GO:1990765,1,0.993155902566615,0,1,colon smooth muscle contraction,BP,
21092,GO:1990768,1,0.994440940310254,0,1,gastric mucosal blood circulation,BP,
21094,GO:1990770,1,0.987634503704126,0,2,small intestine smooth muscle contraction,BP,
21095,GO:1990771,1,0.992892368797629,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
21096,GO:1990773,1,0.994145805455466,0,1,matrix metallopeptidase secretion,BP,
21097,GO:1990774,1,0.889710300009511,0,18,tumor necrosis factor secretion,BP,
21099,GO:1990777,1,0.817667711285204,0,32,lipoprotein particle,CC,
21101,GO:1990782,1,0.645662468394958,0,67,protein tyrosine kinase binding,MF,
21102,GO:1990784,1,0.99348480892637,0,1,response to dsDNA,BP,
21103,GO:1990785,1,0.978915521430857,0,3,response to water-immersion restraint stress,BP,
21104,GO:1990786,1,0.99348480892637,0,1,cellular response to dsDNA,BP,
21105,GO:1990791,1,0.981446458031634,0,3,dorsal root ganglion development,BP,
21106,GO:1990796,1,0.99379734679665,0,1,photoreceptor cell terminal bouton,CC,
21107,GO:1990809,1,0.975847049316314,0,4,endoplasmic reticulum tubular network membrane organization,BP,
21108,GO:1990812,1,0.981038980133005,0,3,growth cone filopodium,CC,
21109,GO:1990817,1,0.993989654703031,0,1,RNA adenylyltransferase activity,MF,
21110,GO:1990822,1,0.950048118964253,0,8,basic amino acid transmembrane transport,BP,
21112,GO:1990825,1,0.945486353053854,0,9,sequence-specific mRNA binding,MF,
21113,GO:1990828,1,0.99402368765343,0,1,hepatocyte dedifferentiation,BP,
21114,GO:1990829,1,0.994081556134194,0,1,C-rich single-stranded DNA binding,MF,
21116,GO:1990832,1,0.994059471842138,0,1,slow axonal transport,BP,
21117,GO:1990833,1,0.994059471842138,0,1,clathrin-uncoating ATPase activity,MF,
21118,GO:1990834,1,0.975656646575976,0,4,response to odorant,BP,
21120,GO:1990839,1,0.987434044228728,0,2,response to endothelin,BP,
21122,GO:1990843,1,0.992826483555519,0,1,subsarcolemmal mitochondrion,CC,
21123,GO:1990844,1,0.992826483555519,0,1,interfibrillar mitochondrion,CC,
21124,GO:1990845,1,0.921139371885755,0,13,adaptive thermogenesis,BP,
21125,GO:1990851,1,0.978779393775621,0,3,Wnt-Frizzled-LRP5/6 complex,CC,
21126,GO:1990859,1,0.993980429514427,0,1,cellular response to endothelin,BP,
21127,GO:1990868,1,0.967590502333655,0,5,response to chemokine,BP,
21128,GO:1990869,1,0.967590502333655,0,5,cellular response to chemokine,BP,
21129,GO:1990874,1,0.793141025345814,0,36,vascular smooth muscle cell proliferation,BP,
21130,GO:1990876,1,0.992738021527628,0,1,cytoplasmic side of nuclear pore,CC,
21131,GO:1990879,1,0.987729649828399,0,2,CST complex,CC,
21132,GO:1990882,1,0.993508682661501,0,1,rRNA acetylation,BP,
21133,GO:1990883,1,0.993508682661501,0,1,rRNA cytidine N-acetyltransferase activity,MF,
21134,GO:1990884,1,0.993508682661501,0,1,RNA acetylation,BP,
21135,GO:1990889,1,0.994108842120936,0,1,H4K20me3 modified histone binding,MF,
21136,GO:1990904,1,0.010666460155584,0,719,ribonucleoprotein complex,CC,
21137,GO:1990907,1,0.928535093105104,0,11,beta-catenin-TCF complex,CC,
21138,GO:1990909,1,0.932027799768966,0,10,Wnt signalosome,CC,
21139,GO:1990910,1,0.981905143492898,0,3,response to hypobaric hypoxia,BP,
21140,GO:1990911,1,0.975788343579271,0,4,response to psychosocial stress,BP,
21141,GO:1990913,1,0.993912174119494,0,1,sperm head plasma membrane,CC,
21142,GO:1990917,1,0.993912174119494,0,1,ooplasm,CC,
21143,GO:1990918,1,0.987217009148944,0,2,double-strand break repair involved in meiotic recombination,BP,
21144,GO:1990922,1,0.993689986869496,0,1,hepatic stellate cell proliferation,BP,
21145,GO:1990923,1,0.98163309761734,0,3,PET complex,CC,
21146,GO:1990926,1,0.981417739688594,0,3,short-term synaptic potentiation,BP,
21147,GO:1990927,1,0.986525895767703,0,2,calcium ion regulated lysosome exocytosis,BP,
21148,GO:1990928,1,0.98632084449331,0,2,response to amino acid starvation,BP,
21149,GO:1990930,1,0.994192298933327,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
21150,GO:1990931,1,0.9934115077548,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
21151,GO:1990936,1,0.98796187363012,0,2,vascular smooth muscle cell dedifferentiation,BP,
21152,GO:1990938,1,0.993494531880438,0,1,peptidyl-aspartic acid autophosphorylation,BP,
21154,GO:1990948,1,0.972070293700795,0,5,ubiquitin ligase inhibitor activity,MF,
21155,GO:1990955,1,0.993468788348972,0,1,G-rich single-stranded DNA binding,MF,
21156,GO:1990962,1,0.993498820562144,0,1,drug transport across blood-brain barrier,BP,
21157,GO:1990963,1,0.993498820562144,0,1,establishment of blood-retinal barrier,BP,
21158,GO:1990966,1,0.975007615038998,0,4,ATP generation from poly-ADP-D-ribose,BP,
21159,GO:1990967,1,0.988020659255596,0,2,multi-organism toxin transport,BP,
21160,GO:1990968,1,0.99278890683248,0,1,modulation by host of RNA binding by virus,BP,
21161,GO:1990969,1,0.99278890683248,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
21162,GO:1990971,1,0.99351511314133,0,1,EMILIN complex,CC,
21163,GO:1990983,1,0.993900380559363,0,1,tRNA demethylation,BP,
21164,GO:1990984,1,0.993900380559363,0,1,tRNA demethylase activity,MF,
21165,GO:2000001,1,0.905407883340565,0,16,regulation of DNA damage checkpoint,BP,
21166,GO:2000002,1,0.969605251445976,0,5,negative regulation of DNA damage checkpoint,BP,
21167,GO:2000003,1,0.993846081630578,0,1,positive regulation of DNA damage checkpoint,BP,
21168,GO:2000004,1,0.994131943981625,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
21169,GO:2000005,1,0.994131943981625,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
21170,GO:2000006,1,0.994131943981625,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
21171,GO:2000007,1,0.994131943981625,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
21172,GO:2000008,1,0.808276777186487,0,33,regulation of protein localization to cell surface,BP,
21173,GO:2000009,1,0.925877448854543,0,12,negative regulation of protein localization to cell surface,BP,
21174,GO:2000010,1,0.919044711563484,0,13,positive regulation of protein localization to cell surface,BP,
21175,GO:2000011,1,0.99401041795257,0,1,regulation of adaxial/abaxial pattern formation,BP,
21176,GO:2000015,1,0.976159728748203,0,4,regulation of determination of dorsal identity,BP,
21177,GO:2000016,1,0.988525926594563,0,2,negative regulation of determination of dorsal identity,BP,
21178,GO:2000017,1,0.987491728903969,0,2,positive regulation of determination of dorsal identity,BP,
21179,GO:2000018,1,0.950802904795649,0,8,regulation of male gonad development,BP,
21180,GO:2000019,1,0.993523685605848,0,1,negative regulation of male gonad development,BP,
21181,GO:2000020,1,0.957003531531506,0,7,positive regulation of male gonad development,BP,
21184,GO:2000035,1,0.951257377655381,0,8,regulation of stem cell division,BP,
21185,GO:2000036,1,0.854754974071434,0,24,regulation of stem cell population maintenance,BP,
21186,GO:2000040,1,0.98747443805364,0,2,regulation of planar cell polarity pathway involved in axis elongation,BP,
21187,GO:2000041,1,0.98747443805364,0,2,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
21188,GO:2000042,1,0.940431161759596,0,9,negative regulation of double-strand break repair via homologous recombination,BP,
21189,GO:2000043,1,0.993969477158945,0,1,regulation of cardiac cell fate specification,BP,
21191,GO:2000047,1,0.940536214966597,0,10,regulation of cell-cell adhesion mediated by cadherin,BP,
21192,GO:2000048,1,0.976484025192902,0,4,negative regulation of cell-cell adhesion mediated by cadherin,BP,
21193,GO:2000049,1,0.963195259539764,0,6,positive regulation of cell-cell adhesion mediated by cadherin,BP,
21194,GO:2000050,1,0.864223409898169,0,22,regulation of non-canonical Wnt signaling pathway,BP,
21195,GO:2000051,1,0.959260818569275,0,6,negative regulation of non-canonical Wnt signaling pathway,BP,
21196,GO:2000052,1,0.926050710940105,0,12,positive regulation of non-canonical Wnt signaling pathway,BP,
21197,GO:2000053,1,0.97922165367663,0,3,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21198,GO:2000054,1,0.987385873546253,0,2,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21199,GO:2000055,1,0.991732545770068,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21200,GO:2000056,1,0.994104221965913,0,1,regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21201,GO:2000057,1,0.994104221965913,0,1,negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21202,GO:2000058,1,0.421472324492658,0,135,regulation of ubiquitin-dependent protein catabolic process,BP,
21203,GO:2000059,1,0.788739799199281,0,37,negative regulation of ubiquitin-dependent protein catabolic process,BP,
21204,GO:2000060,1,0.562377516500454,0,90,positive regulation of ubiquitin-dependent protein catabolic process,BP,
21205,GO:2000061,1,0.994192298933327,0,1,regulation of ureter smooth muscle cell differentiation,BP,
21206,GO:2000062,1,0.994192298933327,0,1,negative regulation of ureter smooth muscle cell differentiation,BP,
21207,GO:2000063,1,0.994192298933327,0,1,positive regulation of ureter smooth muscle cell differentiation,BP,
21208,GO:2000064,1,0.962628143544721,0,6,regulation of cortisol biosynthetic process,BP,
21209,GO:2000065,1,0.975433615847637,0,4,negative regulation of cortisol biosynthetic process,BP,
21210,GO:2000066,1,0.993523685605848,0,1,positive regulation of cortisol biosynthetic process,BP,
21211,GO:2000067,1,0.994422168860593,0,1,regulation of root morphogenesis,BP,
21212,GO:2000074,1,0.950948141674475,0,8,regulation of type B pancreatic cell development,BP,
21213,GO:2000077,1,0.986661210726961,0,2,negative regulation of type B pancreatic cell development,BP,
21214,GO:2000078,1,0.982503062001572,0,3,positive regulation of type B pancreatic cell development,BP,
21215,GO:2000079,1,0.993362745636125,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21216,GO:2000080,1,0.993362745636125,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21217,GO:2000095,1,0.920286057864355,0,13,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
21218,GO:2000096,1,0.950294781371431,0,8,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
21219,GO:2000097,1,0.982081199242585,0,3,regulation of smooth muscle cell-matrix adhesion,BP,
21220,GO:2000098,1,0.988091003098261,0,2,negative regulation of smooth muscle cell-matrix adhesion,BP,
21221,GO:2000101,1,0.993799924379055,0,1,regulation of mammary stem cell proliferation,BP,
21222,GO:2000103,1,0.993799924379055,0,1,positive regulation of mammary stem cell proliferation,BP,
21223,GO:2000104,1,0.882978067637621,0,19,negative regulation of DNA-dependent DNA replication,BP,
21224,GO:2000105,1,0.912633211440865,0,14,positive regulation of DNA-dependent DNA replication,BP,
21225,GO:2000106,1,0.625339904501665,0,75,regulation of leukocyte apoptotic process,BP,
21226,GO:2000107,1,0.764291497314348,0,43,negative regulation of leukocyte apoptotic process,BP,
21227,GO:2000108,1,0.860222396491103,0,24,positive regulation of leukocyte apoptotic process,BP,
21228,GO:2000109,1,0.956519659396153,0,7,regulation of macrophage apoptotic process,BP,
21229,GO:2000110,1,0.98117780800811,0,3,negative regulation of macrophage apoptotic process,BP,
21230,GO:2000111,1,0.980809240622604,0,3,positive regulation of macrophage apoptotic process,BP,
21233,GO:2000114,1,0.885330703779094,0,18,regulation of establishment of cell polarity,BP,
21235,GO:2000117,1,0.551433270141049,0,95,negative regulation of cysteine-type endopeptidase activity,BP,
21236,GO:2000118,1,0.987285326961997,0,2,regulation of sodium-dependent phosphate transport,BP,
21237,GO:2000119,1,0.993789329270233,0,1,negative regulation of sodium-dependent phosphate transport,BP,
21238,GO:2000121,1,0.940970447915551,0,10,regulation of removal of superoxide radicals,BP,
21239,GO:2000124,1,0.987375644804339,0,2,regulation of endocannabinoid signaling pathway,BP,
21241,GO:2000136,1,0.906152027507723,0,15,regulation of cell proliferation involved in heart morphogenesis,BP,
21242,GO:2000137,1,0.985340061726154,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
21243,GO:2000138,1,0.968009351113549,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
21244,GO:2000142,1,0.793567818669322,0,36,regulation of DNA-templated transcription, initiation,BP,
21245,GO:2000143,1,0.962577064330746,0,6,negative regulation of DNA-templated transcription, initiation,BP,
21246,GO:2000144,1,0.840500289499891,0,27,positive regulation of DNA-templated transcription, initiation,BP,
21250,GO:2000152,1,0.976637452969087,0,4,regulation of ubiquitin-specific protease activity,BP,
21251,GO:2000156,1,0.987390651992498,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
21252,GO:2000157,1,0.988683297851787,0,2,negative regulation of ubiquitin-specific protease activity,BP,
21253,GO:2000158,1,0.987817682492947,0,2,positive regulation of ubiquitin-specific protease activity,BP,
21254,GO:2000167,1,0.993095923938043,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
21255,GO:2000169,1,0.953021584363764,0,7,regulation of peptidyl-cysteine S-nitrosylation,BP,
21256,GO:2000170,1,0.987080850799421,0,2,positive regulation of peptidyl-cysteine S-nitrosylation,BP,
21257,GO:2000171,1,0.839603175008387,0,26,negative regulation of dendrite development,BP,
21258,GO:2000172,1,0.973427454003284,0,4,regulation of branching morphogenesis of a nerve,BP,
21259,GO:2000173,1,0.993508253926702,0,1,negative regulation of branching morphogenesis of a nerve,BP,
21260,GO:2000174,1,0.993503108743952,0,1,regulation of pro-T cell differentiation,BP,
21261,GO:2000176,1,0.993503108743952,0,1,positive regulation of pro-T cell differentiation,BP,
21263,GO:2000178,1,0.87862310467246,0,20,negative regulation of neural precursor cell proliferation,BP,
21265,GO:2000181,1,0.562126938299275,0,88,negative regulation of blood vessel morphogenesis,BP,
21266,GO:2000182,1,0.980011876948532,0,3,regulation of progesterone biosynthetic process,BP,
21267,GO:2000184,1,0.992826483555519,0,1,positive regulation of progesterone biosynthetic process,BP,
21268,GO:2000191,1,0.901688164370127,0,16,regulation of fatty acid transport,BP,
21269,GO:2000192,1,0.966218725579914,0,5,negative regulation of fatty acid transport,BP,
21270,GO:2000193,1,0.94042842881141,0,10,positive regulation of fatty acid transport,BP,
21271,GO:2000194,1,0.927826004605227,0,12,regulation of female gonad development,BP,
21272,GO:2000195,1,0.975514741850192,0,4,negative regulation of female gonad development,BP,
21273,GO:2000196,1,0.982337987539932,0,3,positive regulation of female gonad development,BP,
21274,GO:2000197,1,0.961064888994221,0,6,regulation of ribonucleoprotein complex localization,BP,
21275,GO:2000199,1,0.99375327800672,0,1,positive regulation of ribonucleoprotein complex localization,BP,
21276,GO:2000200,1,0.99375327800672,0,1,regulation of ribosomal subunit export from nucleus,BP,
21277,GO:2000202,1,0.99375327800672,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
21278,GO:2000206,1,0.99375327800672,0,1,regulation of ribosomal small subunit export from nucleus,BP,
21279,GO:2000208,1,0.99375327800672,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
21280,GO:2000209,1,0.872578579532937,0,21,regulation of anoikis,BP,
21281,GO:2000210,1,0.964156161266628,0,6,positive regulation of anoikis,BP,
21282,GO:2000211,1,0.987263331444796,0,2,regulation of glutamate metabolic process,BP,
21283,GO:2000212,1,0.9931968189754,0,1,negative regulation of glutamate metabolic process,BP,
21284,GO:2000213,1,0.994026284253939,0,1,positive regulation of glutamate metabolic process,BP,
21285,GO:2000224,1,0.982270689095314,0,3,regulation of testosterone biosynthetic process,BP,
21286,GO:2000225,1,0.987909591108153,0,2,negative regulation of testosterone biosynthetic process,BP,
21287,GO:2000226,1,0.994227529862516,0,1,regulation of pancreatic A cell differentiation,BP,
21288,GO:2000227,1,0.994227529862516,0,1,negative regulation of pancreatic A cell differentiation,BP,
21289,GO:2000229,1,0.988420705612791,0,2,regulation of pancreatic stellate cell proliferation,BP,
21290,GO:2000230,1,0.994110430321073,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
21291,GO:2000231,1,0.994276910915076,0,1,positive regulation of pancreatic stellate cell proliferation,BP,
21292,GO:2000232,1,0.931938087790457,0,11,regulation of rRNA processing,BP,
21293,GO:2000233,1,0.986779771515118,0,2,negative regulation of rRNA processing,BP,
21294,GO:2000234,1,0.950959987988034,0,8,positive regulation of rRNA processing,BP,
21295,GO:2000241,1,0.484075419282235,0,115,regulation of reproductive process,BP,
21296,GO:2000242,1,0.76078842273631,0,44,negative regulation of reproductive process,BP,
21297,GO:2000243,1,0.742383590942146,0,47,positive regulation of reproductive process,BP,
21298,GO:2000249,1,0.80166309215758,0,35,regulation of actin cytoskeleton reorganization,BP,
21299,GO:2000251,1,0.896077256613808,0,18,positive regulation of actin cytoskeleton reorganization,BP,
21300,GO:2000252,1,0.959168101463121,0,7,negative regulation of feeding behavior,BP,
21301,GO:2000253,1,0.967246169012002,0,5,positive regulation of feeding behavior,BP,
21302,GO:2000254,1,0.976970684275735,0,4,regulation of male germ cell proliferation,BP,
21303,GO:2000255,1,0.982508693911963,0,3,negative regulation of male germ cell proliferation,BP,
21304,GO:2000256,1,0.994364411486775,0,1,positive regulation of male germ cell proliferation,BP,
21305,GO:2000257,1,0.793397388658005,0,37,regulation of protein activation cascade,BP,
21306,GO:2000258,1,0.960281195987931,0,6,negative regulation of protein activation cascade,BP,
21307,GO:2000259,1,0.981005693363459,0,3,positive regulation of protein activation cascade,BP,
21308,GO:2000269,1,0.906908521325694,0,15,regulation of fibroblast apoptotic process,BP,
21309,GO:2000270,1,0.955054212744804,0,7,negative regulation of fibroblast apoptotic process,BP,
21310,GO:2000271,1,0.954749678895535,0,7,positive regulation of fibroblast apoptotic process,BP,
21311,GO:2000272,1,0.834400329649422,0,28,negative regulation of signaling receptor activity,BP,
21313,GO:2000275,1,0.976774400019596,0,4,regulation of oxidative phosphorylation uncoupler activity,BP,
21314,GO:2000276,1,0.988214468972208,0,2,negative regulation of oxidative phosphorylation uncoupler activity,BP,
21315,GO:2000277,1,0.994377406787888,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
21317,GO:2000279,1,0.812096442570865,0,32,negative regulation of DNA biosynthetic process,BP,
21318,GO:2000280,1,0.994422168860593,0,1,regulation of root development,BP,
21319,GO:2000282,1,0.986521725162586,0,2,regulation of cellular amino acid biosynthetic process,BP,
21320,GO:2000283,1,0.992100351952376,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
21321,GO:2000284,1,0.994377406787888,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
21322,GO:2000286,1,0.981456568921527,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
21323,GO:2000287,1,0.993998881737755,0,1,positive regulation of myotome development,BP,
21324,GO:2000288,1,0.946148515404629,0,9,positive regulation of myoblast proliferation,BP,
21325,GO:2000290,1,0.993998881737755,0,1,regulation of myotome development,BP,
21326,GO:2000291,1,0.916429354996425,0,14,regulation of myoblast proliferation,BP,
21327,GO:2000295,1,0.982572373442724,0,3,regulation of hydrogen peroxide catabolic process,BP,
21328,GO:2000296,1,0.988769298128045,0,2,negative regulation of hydrogen peroxide catabolic process,BP,
21329,GO:2000297,1,0.980468068086166,0,3,negative regulation of synapse maturation,BP,
21330,GO:2000298,1,0.987671321648398,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21331,GO:2000299,1,0.993678137076369,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21332,GO:2000300,1,0.847079725703162,0,25,regulation of synaptic vesicle exocytosis,BP,
21333,GO:2000301,1,0.981406873910328,0,3,negative regulation of synaptic vesicle exocytosis,BP,
21334,GO:2000302,1,0.979514772966524,0,3,positive regulation of synaptic vesicle exocytosis,BP,
21335,GO:2000303,1,0.923207599430397,0,13,regulation of ceramide biosynthetic process,BP,
21336,GO:2000304,1,0.951693343622865,0,8,positive regulation of ceramide biosynthetic process,BP,
21337,GO:2000307,1,0.987738104566535,0,2,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21338,GO:2000308,1,0.993961985134131,0,1,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21339,GO:2000309,1,0.993738697082491,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21340,GO:2000310,1,0.887730721146779,0,18,regulation of NMDA receptor activity,BP,
21341,GO:2000311,1,0.852683488559411,0,24,regulation of AMPA receptor activity,BP,
21342,GO:2000312,1,0.980232743757064,0,3,regulation of kainate selective glutamate receptor activity,BP,
21343,GO:2000313,1,0.988302279164469,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21344,GO:2000314,1,0.994166597611257,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21345,GO:2000316,1,0.945856569577183,0,9,regulation of T-helper 17 type immune response,BP,
21346,GO:2000317,1,0.969363198090616,0,5,negative regulation of T-helper 17 type immune response,BP,
21347,GO:2000318,1,0.975758048933383,0,4,positive regulation of T-helper 17 type immune response,BP,
21348,GO:2000319,1,0.951852870558584,0,8,regulation of T-helper 17 cell differentiation,BP,
21349,GO:2000320,1,0.969363198090616,0,5,negative regulation of T-helper 17 cell differentiation,BP,
21350,GO:2000321,1,0.98194194118199,0,3,positive regulation of T-helper 17 cell differentiation,BP,
21351,GO:2000322,1,0.950151189995403,0,8,regulation of glucocorticoid receptor signaling pathway,BP,
21352,GO:2000323,1,0.961987281851086,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
21353,GO:2000324,1,0.987701042459979,0,2,positive regulation of glucocorticoid receptor signaling pathway,BP,
21354,GO:2000325,1,0.992867809083385,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21355,GO:2000327,1,0.992867809083385,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21356,GO:2000328,1,0.976279892151902,0,4,regulation of T-helper 17 cell lineage commitment,BP,
21357,GO:2000329,1,0.987686280381033,0,2,negative regulation of T-helper 17 cell lineage commitment,BP,
21358,GO:2000330,1,0.988452857757707,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
21359,GO:2000331,1,0.987255112224657,0,2,regulation of terminal button organization,BP,
21360,GO:2000332,1,0.988248605346077,0,2,regulation of blood microparticle formation,BP,
21361,GO:2000334,1,0.988248605346077,0,2,positive regulation of blood microparticle formation,BP,
21362,GO:2000338,1,0.987904591665112,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21363,GO:2000340,1,0.987904591665112,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21365,GO:2000342,1,0.987802537195581,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21367,GO:2000344,1,0.955700399386896,0,7,positive regulation of acrosome reaction,BP,
21368,GO:2000345,1,0.932576434108911,0,11,regulation of hepatocyte proliferation,BP,
21369,GO:2000346,1,0.981366170125883,0,3,negative regulation of hepatocyte proliferation,BP,
21370,GO:2000347,1,0.962706187946867,0,6,positive regulation of hepatocyte proliferation,BP,
21371,GO:2000348,1,0.963245273725835,0,6,regulation of CD40 signaling pathway,BP,
21372,GO:2000349,1,0.987479837983906,0,2,negative regulation of CD40 signaling pathway,BP,
21373,GO:2000350,1,0.994343330331289,0,1,positive regulation of CD40 signaling pathway,BP,
21374,GO:2000351,1,0.774229536194149,0,40,regulation of endothelial cell apoptotic process,BP,
21375,GO:2000352,1,0.84643086698885,0,26,negative regulation of endothelial cell apoptotic process,BP,
21376,GO:2000353,1,0.91483777885667,0,14,positive regulation of endothelial cell apoptotic process,BP,
21377,GO:2000354,1,0.963765089237835,0,6,regulation of ovarian follicle development,BP,
21378,GO:2000355,1,0.988185157192887,0,2,negative regulation of ovarian follicle development,BP,
21379,GO:2000356,1,0.994192298933327,0,1,regulation of kidney smooth muscle cell differentiation,BP,
21380,GO:2000357,1,0.994192298933327,0,1,negative regulation of kidney smooth muscle cell differentiation,BP,
21381,GO:2000358,1,0.994192298933327,0,1,positive regulation of kidney smooth muscle cell differentiation,BP,
21382,GO:2000359,1,0.988277351917118,0,2,regulation of binding of sperm to zona pellucida,BP,
21383,GO:2000360,1,0.988277351917118,0,2,negative regulation of binding of sperm to zona pellucida,BP,
21384,GO:2000361,1,0.986675340175603,0,2,regulation of prostaglandin-E synthase activity,BP,
21385,GO:2000363,1,0.986675340175603,0,2,positive regulation of prostaglandin-E synthase activity,BP,
21386,GO:2000367,1,0.988365152236191,0,2,regulation of acrosomal vesicle exocytosis,BP,
21387,GO:2000368,1,0.988365152236191,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
21388,GO:2000369,1,0.895946433616533,0,16,regulation of clathrin-dependent endocytosis,BP,
21389,GO:2000370,1,0.974052136214911,0,4,positive regulation of clathrin-dependent endocytosis,BP,
21390,GO:2000371,1,0.967798905449802,0,5,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21391,GO:2000373,1,0.967798905449802,0,5,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21392,GO:2000374,1,0.983003306427327,0,3,regulation of oxygen metabolic process,BP,
21393,GO:2000376,1,0.988881163487866,0,2,positive regulation of oxygen metabolic process,BP,
21394,GO:2000377,1,0.400578244566226,0,145,regulation of reactive oxygen species metabolic process,BP,
21395,GO:2000378,1,0.754688706967704,0,45,negative regulation of reactive oxygen species metabolic process,BP,
21396,GO:2000379,1,0.610589592627342,0,78,positive regulation of reactive oxygen species metabolic process,BP,
21397,GO:2000380,1,0.909675698199671,0,15,regulation of mesoderm development,BP,
21398,GO:2000381,1,0.951565181435385,0,8,negative regulation of mesoderm development,BP,
21399,GO:2000382,1,0.974579971595782,0,4,positive regulation of mesoderm development,BP,
21400,GO:2000383,1,0.9935396833748,0,1,regulation of ectoderm development,BP,
21401,GO:2000384,1,0.9935396833748,0,1,negative regulation of ectoderm development,BP,
21402,GO:2000386,1,0.987762375247603,0,2,positive regulation of ovarian follicle development,BP,
21403,GO:2000387,1,0.994245145314426,0,1,regulation of antral ovarian follicle growth,BP,
21404,GO:2000388,1,0.994245145314426,0,1,positive regulation of antral ovarian follicle growth,BP,
21405,GO:2000389,1,0.980896481199019,0,3,regulation of neutrophil extravasation,BP,
21406,GO:2000391,1,0.980896481199019,0,3,positive regulation of neutrophil extravasation,BP,
21408,GO:2000393,1,0.987050980129467,0,2,negative regulation of lamellipodium morphogenesis,BP,
21410,GO:2000395,1,0.988591262896132,0,2,regulation of ubiquitin-dependent endocytosis,BP,
21411,GO:2000397,1,0.988591262896132,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
21415,GO:2000404,1,0.841383709538451,0,28,regulation of T cell migration,BP,
21416,GO:2000405,1,0.987427712438519,0,2,negative regulation of T cell migration,BP,
21417,GO:2000406,1,0.873001993314973,0,22,positive regulation of T cell migration,BP,
21418,GO:2000407,1,0.982233825199852,0,3,regulation of T cell extravasation,BP,
21419,GO:2000409,1,0.988073121969859,0,2,positive regulation of T cell extravasation,BP,
21420,GO:2000410,1,0.982175259801883,0,3,regulation of thymocyte migration,BP,
21421,GO:2000412,1,0.988068584707151,0,2,positive regulation of thymocyte migration,BP,
21422,GO:2000413,1,0.993738697082491,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
21423,GO:2000415,1,0.993738697082491,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
21424,GO:2000416,1,0.975614324187194,0,4,regulation of eosinophil migration,BP,
21425,GO:2000417,1,0.987802192528216,0,2,negative regulation of eosinophil migration,BP,
21426,GO:2000418,1,0.987663166459499,0,2,positive regulation of eosinophil migration,BP,
21427,GO:2000419,1,0.993663862494985,0,1,regulation of eosinophil extravasation,BP,
21428,GO:2000420,1,0.993663862494985,0,1,negative regulation of eosinophil extravasation,BP,
21429,GO:2000422,1,0.993886579649392,0,1,regulation of eosinophil chemotaxis,BP,
21430,GO:2000424,1,0.993886579649392,0,1,positive regulation of eosinophil chemotaxis,BP,
21431,GO:2000425,1,0.943436351585525,0,9,regulation of apoptotic cell clearance,BP,
21432,GO:2000426,1,0.987835804673171,0,2,negative regulation of apoptotic cell clearance,BP,
21433,GO:2000427,1,0.955315927192704,0,7,positive regulation of apoptotic cell clearance,BP,
21434,GO:2000434,1,0.98885072038193,0,2,regulation of protein neddylation,BP,
21435,GO:2000435,1,0.98885072038193,0,2,negative regulation of protein neddylation,BP,
21436,GO:2000437,1,0.980247324441006,0,3,regulation of monocyte extravasation,BP,
21437,GO:2000438,1,0.992692183858825,0,1,negative regulation of monocyte extravasation,BP,
21438,GO:2000439,1,0.987464458344756,0,2,positive regulation of monocyte extravasation,BP,
21439,GO:2000446,1,0.993398319692279,0,1,regulation of macrophage migration inhibitory factor signaling pathway,BP,
21440,GO:2000449,1,0.982233825199852,0,3,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21441,GO:2000451,1,0.988073121969859,0,2,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21442,GO:2000452,1,0.98823797167635,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21443,GO:2000454,1,0.994112596064913,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21444,GO:2000458,1,0.988092927622623,0,2,regulation of astrocyte chemotaxis,BP,
21445,GO:2000463,1,0.844589352176809,0,25,positive regulation of excitatory postsynaptic potential,BP,
21446,GO:2000464,1,0.99392512357135,0,1,positive regulation of astrocyte chemotaxis,BP,
21447,GO:2000465,1,0.960469103378997,0,6,regulation of glycogen (starch) synthase activity,BP,
21448,GO:2000466,1,0.98046284207364,0,3,negative regulation of glycogen (starch) synthase activity,BP,
21449,GO:2000467,1,0.979825970413965,0,3,positive regulation of glycogen (starch) synthase activity,BP,
21450,GO:2000468,1,0.985757151757495,0,2,regulation of peroxidase activity,BP,
21451,GO:2000469,1,0.991973955775138,0,1,negative regulation of peroxidase activity,BP,
21452,GO:2000470,1,0.993733409310885,0,1,positive regulation of peroxidase activity,BP,
21453,GO:2000471,1,0.987162708885784,0,2,regulation of hematopoietic stem cell migration,BP,
21454,GO:2000473,1,0.987162708885784,0,2,positive regulation of hematopoietic stem cell migration,BP,
21455,GO:2000474,1,0.987464007295971,0,2,regulation of opioid receptor signaling pathway,BP,
21456,GO:2000479,1,0.915024455480329,0,14,regulation of cAMP-dependent protein kinase activity,BP,
21457,GO:2000480,1,0.952038764403878,0,8,negative regulation of cAMP-dependent protein kinase activity,BP,
21458,GO:2000481,1,0.972658908203773,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
21459,GO:2000482,1,0.872781574103599,0,22,regulation of interleukin-8 secretion,BP,
21460,GO:2000483,1,0.956094871649668,0,7,negative regulation of interleukin-8 secretion,BP,
21461,GO:2000484,1,0.918556601004776,0,14,positive regulation of interleukin-8 secretion,BP,
21462,GO:2000485,1,0.987633982598388,0,2,regulation of glutamine transport,BP,
21463,GO:2000486,1,0.99366015143815,0,1,negative regulation of glutamine transport,BP,
21464,GO:2000487,1,0.993935774836339,0,1,positive regulation of glutamine transport,BP,
21465,GO:2000489,1,0.962336791177072,0,6,regulation of hepatic stellate cell activation,BP,
21466,GO:2000490,1,0.987695303949156,0,2,negative regulation of hepatic stellate cell activation,BP,
21467,GO:2000491,1,0.974328773023773,0,4,positive regulation of hepatic stellate cell activation,BP,
21468,GO:2000492,1,0.993785607657234,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
21469,GO:2000494,1,0.993785607657234,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
21471,GO:2000502,1,0.988655434076942,0,2,negative regulation of natural killer cell chemotaxis,BP,
21473,GO:2000504,1,0.987218645376393,0,2,positive regulation of blood vessel remodeling,BP,
21474,GO:2000508,1,0.953773979987361,0,8,regulation of dendritic cell chemotaxis,BP,
21475,GO:2000510,1,0.953773979987361,0,8,positive regulation of dendritic cell chemotaxis,BP,
21476,GO:2000511,1,0.994294526425336,0,1,regulation of granzyme A production,BP,
21477,GO:2000513,1,0.994294526425336,0,1,positive regulation of granzyme A production,BP,
21478,GO:2000514,1,0.78373864320425,0,39,regulation of CD4-positive, alpha-beta T cell activation,BP,
21479,GO:2000515,1,0.891976975731668,0,18,negative regulation of CD4-positive, alpha-beta T cell activation,BP,
21480,GO:2000516,1,0.857975266675183,0,25,positive regulation of CD4-positive, alpha-beta T cell activation,BP,
21481,GO:2000517,1,0.994294526425336,0,1,regulation of T-helper 1 cell activation,BP,
21482,GO:2000518,1,0.994294526425336,0,1,negative regulation of T-helper 1 cell activation,BP,
21483,GO:2000520,1,0.982341599804551,0,3,regulation of immunological synapse formation,BP,
21484,GO:2000521,1,0.988251546733202,0,2,negative regulation of immunological synapse formation,BP,
21485,GO:2000522,1,0.994020514183732,0,1,positive regulation of immunological synapse formation,BP,
21486,GO:2000523,1,0.98769974617842,0,2,regulation of T cell costimulation,BP,
21487,GO:2000525,1,0.98769974617842,0,2,positive regulation of T cell costimulation,BP,
21488,GO:2000526,1,0.994020514183732,0,1,positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation,BP,
21489,GO:2000527,1,0.994394156374018,0,1,regulation of myeloid dendritic cell chemotaxis,BP,
21490,GO:2000529,1,0.994394156374018,0,1,positive regulation of myeloid dendritic cell chemotaxis,BP,
21491,GO:2000532,1,0.993923108860103,0,1,regulation of renal albumin absorption,BP,
21492,GO:2000533,1,0.993923108860103,0,1,negative regulation of renal albumin absorption,BP,
21493,GO:2000535,1,0.961654281912741,0,6,regulation of entry of bacterium into host cell,BP,
21494,GO:2000536,1,0.992646913472096,0,1,negative regulation of entry of bacterium into host cell,BP,
21495,GO:2000537,1,0.987727563489295,0,2,regulation of B cell chemotaxis,BP,
21496,GO:2000538,1,0.987727563489295,0,2,positive regulation of B cell chemotaxis,BP,
21497,GO:2000539,1,0.993923972292178,0,1,regulation of protein geranylgeranylation,BP,
21498,GO:2000541,1,0.993923972292178,0,1,positive regulation of protein geranylgeranylation,BP,
21499,GO:2000542,1,0.955709707118156,0,7,negative regulation of gastrulation,BP,
21500,GO:2000543,1,0.976143137791194,0,4,positive regulation of gastrulation,BP,
21502,GO:2000545,1,0.994300013232335,0,1,negative regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21503,GO:2000546,1,0.980062634839007,0,3,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21504,GO:2000547,1,0.982961495252507,0,3,regulation of dendritic cell dendrite assembly,BP,
21505,GO:2000548,1,0.994394156374018,0,1,negative regulation of dendritic cell dendrite assembly,BP,
21506,GO:2000549,1,0.994450181702825,0,1,positive regulation of dendritic cell dendrite assembly,BP,
21507,GO:2000551,1,0.952580551621804,0,8,regulation of T-helper 2 cell cytokine production,BP,
21508,GO:2000552,1,0.988167054588413,0,2,negative regulation of T-helper 2 cell cytokine production,BP,
21509,GO:2000553,1,0.963991657888705,0,6,positive regulation of T-helper 2 cell cytokine production,BP,
21510,GO:2000554,1,0.994294526425336,0,1,regulation of T-helper 1 cell cytokine production,BP,
21511,GO:2000556,1,0.994294526425336,0,1,positive regulation of T-helper 1 cell cytokine production,BP,
21512,GO:2000557,1,0.994294526425336,0,1,regulation of immunoglobulin production in mucosal tissue,BP,
21513,GO:2000558,1,0.994294526425336,0,1,positive regulation of immunoglobulin production in mucosal tissue,BP,
21514,GO:2000559,1,0.992692183858825,0,1,regulation of CD24 biosynthetic process,BP,
21515,GO:2000560,1,0.992692183858825,0,1,positive regulation of CD24 biosynthetic process,BP,
21516,GO:2000561,1,0.963779343740637,0,6,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21517,GO:2000562,1,0.976310320127956,0,4,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21518,GO:2000563,1,0.97580575705374,0,4,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21519,GO:2000564,1,0.982184050375767,0,3,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21520,GO:2000566,1,0.988489474107319,0,2,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21521,GO:2000567,1,0.99401041795257,0,1,regulation of memory T cell activation,BP,
21522,GO:2000568,1,0.99401041795257,0,1,positive regulation of memory T cell activation,BP,
21523,GO:2000569,1,0.99370355249475,0,1,regulation of T-helper 2 cell activation,BP,
21524,GO:2000570,1,0.99370355249475,0,1,positive regulation of T-helper 2 cell activation,BP,
21525,GO:2000571,1,0.993641597666767,0,1,regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21526,GO:2000572,1,0.993641597666767,0,1,positive regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21528,GO:2000574,1,0.94629573767302,0,9,regulation of microtubule motor activity,BP,
21529,GO:2000576,1,0.964898181469315,0,6,positive regulation of microtubule motor activity,BP,
21530,GO:2000580,1,0.970874662241803,0,5,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21531,GO:2000582,1,0.970874662241803,0,5,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21532,GO:2000583,1,0.993540254632124,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21533,GO:2000584,1,0.993540254632124,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21534,GO:2000586,1,0.932342074143989,0,10,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21535,GO:2000587,1,0.945629742158292,0,8,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21536,GO:2000588,1,0.985956292210207,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21537,GO:2000589,1,0.980784331747529,0,3,regulation of metanephric mesenchymal cell migration,BP,
21538,GO:2000591,1,0.980784331747529,0,3,positive regulation of metanephric mesenchymal cell migration,BP,
21539,GO:2000592,1,0.987038592633319,0,2,regulation of metanephric DCT cell differentiation,BP,
21540,GO:2000594,1,0.987038592633319,0,2,positive regulation of metanephric DCT cell differentiation,BP,
21541,GO:2000595,1,0.99346392336041,0,1,regulation of optic nerve formation,BP,
21542,GO:2000597,1,0.99346392336041,0,1,positive regulation of optic nerve formation,BP,
21543,GO:2000601,1,0.961795851091722,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
21544,GO:2000606,1,0.99376228690071,0,1,regulation of cell proliferation involved in mesonephros development,BP,
21545,GO:2000607,1,0.99376228690071,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
21546,GO:2000609,1,0.97566677600314,0,4,regulation of thyroid hormone generation,BP,
21547,GO:2000611,1,0.981455455761024,0,3,positive regulation of thyroid hormone generation,BP,
21548,GO:2000612,1,0.993532827811427,0,1,regulation of thyroid-stimulating hormone secretion,BP,
21549,GO:2000615,1,0.931558022391192,0,11,regulation of histone H3-K9 acetylation,BP,
21550,GO:2000616,1,0.987300925700871,0,2,negative regulation of histone H3-K9 acetylation,BP,
21551,GO:2000617,1,0.955249402145476,0,7,positive regulation of histone H3-K9 acetylation,BP,
21552,GO:2000618,1,0.967493417640001,0,5,regulation of histone H4-K16 acetylation,BP,
21553,GO:2000619,1,0.981650182294775,0,3,negative regulation of histone H4-K16 acetylation,BP,
21554,GO:2000620,1,0.985581310116192,0,2,positive regulation of histone H4-K16 acetylation,BP,
21555,GO:2000622,1,0.973646952132354,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21556,GO:2000623,1,0.973646952132354,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21557,GO:2000625,1,0.987227267772724,0,2,regulation of miRNA catabolic process,BP,
21558,GO:2000627,1,0.987227267772724,0,2,positive regulation of miRNA catabolic process,BP,
21559,GO:2000628,1,0.95722026013455,0,7,regulation of miRNA metabolic process,BP,
21560,GO:2000630,1,0.96925168137738,0,5,positive regulation of miRNA metabolic process,BP,
21561,GO:2000631,1,0.99371155059077,0,1,regulation of pre-miRNA processing,BP,
21562,GO:2000632,1,0.99371155059077,0,1,negative regulation of pre-miRNA processing,BP,
21563,GO:2000637,1,0.880192909947376,0,20,positive regulation of gene silencing by miRNA,BP,
21564,GO:2000638,1,0.987472887821774,0,2,regulation of SREBP signaling pathway,BP,
21565,GO:2000639,1,0.987472887821774,0,2,negative regulation of SREBP signaling pathway,BP,
21566,GO:2000641,1,0.897402083278165,0,17,regulation of early endosome to late endosome transport,BP,
21567,GO:2000642,1,0.988731965211725,0,2,negative regulation of early endosome to late endosome transport,BP,
21568,GO:2000643,1,0.949094404131696,0,8,positive regulation of early endosome to late endosome transport,BP,
21569,GO:2000644,1,0.943504458505431,0,9,regulation of receptor catabolic process,BP,
21570,GO:2000645,1,0.98101976853856,0,3,negative regulation of receptor catabolic process,BP,
21571,GO:2000646,1,0.967806072715371,0,5,positive regulation of receptor catabolic process,BP,
21572,GO:2000647,1,0.937038041396533,0,10,negative regulation of stem cell proliferation,BP,
21575,GO:2000650,1,0.927847916361349,0,11,negative regulation of sodium ion transmembrane transporter activity,BP,
21576,GO:2000651,1,0.916937312664515,0,13,positive regulation of sodium ion transmembrane transporter activity,BP,
21577,GO:2000653,1,0.980888234034082,0,3,regulation of genetic imprinting,BP,
21578,GO:2000654,1,0.99354068307125,0,1,regulation of cellular response to testosterone stimulus,BP,
21579,GO:2000655,1,0.99354068307125,0,1,negative regulation of cellular response to testosterone stimulus,BP,
21580,GO:2000656,1,0.994104221965913,0,1,regulation of apolipoprotein binding,BP,
21581,GO:2000657,1,0.994104221965913,0,1,negative regulation of apolipoprotein binding,BP,
21582,GO:2000659,1,0.957391307728479,0,7,regulation of interleukin-1-mediated signaling pathway,BP,
21583,GO:2000660,1,0.969658965678135,0,5,negative regulation of interleukin-1-mediated signaling pathway,BP,
21584,GO:2000661,1,0.993234252518537,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
21585,GO:2000662,1,0.963595875654334,0,6,regulation of interleukin-5 secretion,BP,
21586,GO:2000663,1,0.993600497174841,0,1,negative regulation of interleukin-5 secretion,BP,
21587,GO:2000664,1,0.969804075586951,0,5,positive regulation of interleukin-5 secretion,BP,
21588,GO:2000665,1,0.958117547467484,0,7,regulation of interleukin-13 secretion,BP,
21589,GO:2000666,1,0.987712802634327,0,2,negative regulation of interleukin-13 secretion,BP,
21590,GO:2000667,1,0.970040302349312,0,5,positive regulation of interleukin-13 secretion,BP,
21591,GO:2000668,1,0.940240244966909,0,10,regulation of dendritic cell apoptotic process,BP,
21592,GO:2000669,1,0.958723823419362,0,7,negative regulation of dendritic cell apoptotic process,BP,
21593,GO:2000670,1,0.980728855328392,0,3,positive regulation of dendritic cell apoptotic process,BP,
21594,GO:2000671,1,0.969164021287295,0,5,regulation of motor neuron apoptotic process,BP,
21595,GO:2000672,1,0.975441082793525,0,4,negative regulation of motor neuron apoptotic process,BP,
21596,GO:2000674,1,0.933900923874576,0,11,regulation of type B pancreatic cell apoptotic process,BP,
21597,GO:2000675,1,0.962713590144681,0,6,negative regulation of type B pancreatic cell apoptotic process,BP,
21598,GO:2000676,1,0.9700828343558,0,5,positive regulation of type B pancreatic cell apoptotic process,BP,
21599,GO:2000677,1,0.75372093340218,0,44,regulation of transcription regulatory region DNA binding,BP,
21600,GO:2000678,1,0.885549623359994,0,19,negative regulation of transcription regulatory region DNA binding,BP,
21601,GO:2000679,1,0.876850690222713,0,21,positive regulation of transcription regulatory region DNA binding,BP,
21602,GO:2000683,1,0.987631112001926,0,2,regulation of cellular response to X-ray,BP,
21603,GO:2000685,1,0.993830733292028,0,1,positive regulation of cellular response to X-ray,BP,
21604,GO:2000690,1,0.993422828359076,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
21605,GO:2000691,1,0.993422828359076,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
21606,GO:2000696,1,0.905782978029964,0,15,regulation of epithelial cell differentiation involved in kidney development,BP,
21607,GO:2000697,1,0.975978300628539,0,4,negative regulation of epithelial cell differentiation involved in kidney development,BP,
21608,GO:2000698,1,0.968874253792101,0,5,positive regulation of epithelial cell differentiation involved in kidney development,BP,
21609,GO:2000699,1,0.99376228690071,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21610,GO:2000701,1,0.99376228690071,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21611,GO:2000702,1,0.99376228690071,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21612,GO:2000703,1,0.99376228690071,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21613,GO:2000705,1,0.979898180757291,0,3,regulation of dense core granule biogenesis,BP,
21614,GO:2000706,1,0.993592790396055,0,1,negative regulation of dense core granule biogenesis,BP,
21615,GO:2000707,1,0.98621797781935,0,2,positive regulation of dense core granule biogenesis,BP,
21616,GO:2000718,1,0.994391268506931,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21617,GO:2000719,1,0.994391268506931,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21618,GO:2000721,1,0.979847043409503,0,3,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21619,GO:2000722,1,0.980533064810653,0,3,regulation of cardiac vascular smooth muscle cell differentiation,BP,
21620,GO:2000723,1,0.993875946232156,0,1,negative regulation of cardiac vascular smooth muscle cell differentiation,BP,
21621,GO:2000724,1,0.986575738354842,0,2,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
21623,GO:2000726,1,0.929513459316715,0,11,negative regulation of cardiac muscle cell differentiation,BP,
21625,GO:2000729,1,0.988100022997025,0,2,positive regulation of mesenchymal cell proliferation involved in ureter development,BP,
21626,GO:2000733,1,0.99376228690071,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21627,GO:2000734,1,0.99376228690071,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21628,GO:2000736,1,0.490510417847944,0,115,regulation of stem cell differentiation,BP,
21629,GO:2000737,1,0.887163855829461,0,18,negative regulation of stem cell differentiation,BP,
21630,GO:2000738,1,0.896270622367563,0,17,positive regulation of stem cell differentiation,BP,
21631,GO:2000739,1,0.95935684635579,0,6,regulation of mesenchymal stem cell differentiation,BP,
21632,GO:2000740,1,0.993592790396055,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
21633,GO:2000741,1,0.972599241260724,0,4,positive regulation of mesenchymal stem cell differentiation,BP,
21634,GO:2000742,1,0.994044463395542,0,1,regulation of anterior head development,BP,
21635,GO:2000744,1,0.994044463395542,0,1,positive regulation of anterior head development,BP,
21636,GO:2000752,1,0.993841633846993,0,1,regulation of glucosylceramide catabolic process,BP,
21637,GO:2000753,1,0.993841633846993,0,1,positive regulation of glucosylceramide catabolic process,BP,
21638,GO:2000754,1,0.993841633846993,0,1,regulation of sphingomyelin catabolic process,BP,
21639,GO:2000755,1,0.993841633846993,0,1,positive regulation of sphingomyelin catabolic process,BP,
21640,GO:2000756,1,0.695708566346354,0,57,regulation of peptidyl-lysine acetylation,BP,
21641,GO:2000757,1,0.875606640640621,0,21,negative regulation of peptidyl-lysine acetylation,BP,
21642,GO:2000758,1,0.831680199891136,0,29,positive regulation of peptidyl-lysine acetylation,BP,
21643,GO:2000759,1,0.993245765270319,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
21644,GO:2000761,1,0.993245765270319,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
21645,GO:2000763,1,0.993964002078067,0,1,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process,BP,
21646,GO:2000764,1,0.993964002078067,0,1,positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
21647,GO:2000765,1,0.868411672147858,0,22,regulation of cytoplasmic translation,BP,
21648,GO:2000766,1,0.954255076600956,0,7,negative regulation of cytoplasmic translation,BP,
21649,GO:2000767,1,0.955867826940361,0,7,positive regulation of cytoplasmic translation,BP,
21650,GO:2000768,1,0.99351625623385,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
21651,GO:2000772,1,0.807823754826076,0,33,regulation of cellular senescence,BP,
21652,GO:2000773,1,0.899030186185162,0,16,negative regulation of cellular senescence,BP,
21653,GO:2000774,1,0.9469869849783,0,9,positive regulation of cellular senescence,BP,
21654,GO:2000775,1,0.994043020430024,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
21655,GO:2000777,1,0.988083359935482,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
21657,GO:2000779,1,0.722740935151789,0,50,regulation of double-strand break repair,BP,
21658,GO:2000780,1,0.875795709914557,0,20,negative regulation of double-strand break repair,BP,
21659,GO:2000781,1,0.924389636100448,0,12,positive regulation of double-strand break repair,BP,
21660,GO:2000785,1,0.797422844247402,0,35,regulation of autophagosome assembly,BP,
21661,GO:2000786,1,0.935314063805443,0,10,positive regulation of autophagosome assembly,BP,
21662,GO:2000790,1,0.985884315340529,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
21663,GO:2000791,1,0.985884315340529,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
21664,GO:2000793,1,0.977605859175633,0,3,cell proliferation involved in heart valve development,BP,
21665,GO:2000794,1,0.949229583302611,0,8,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21666,GO:2000795,1,0.992294791031492,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21667,GO:2000797,1,0.993592790396055,0,1,regulation of amniotic stem cell differentiation,BP,
21668,GO:2000798,1,0.993592790396055,0,1,negative regulation of amniotic stem cell differentiation,BP,
21669,GO:2000800,1,0.99416717517006,0,1,regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21670,GO:2000802,1,0.99416717517006,0,1,positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21671,GO:2000804,1,0.991459989512687,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21672,GO:2000806,1,0.991459989512687,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21673,GO:2000807,1,0.952485708256587,0,7,regulation of synaptic vesicle clustering,BP,
21674,GO:2000808,1,0.99305033362119,0,1,negative regulation of synaptic vesicle clustering,BP,
21675,GO:2000809,1,0.966561313650684,0,5,positive regulation of synaptic vesicle clustering,BP,
21676,GO:2000810,1,0.878462347449928,0,20,regulation of bicellular tight junction assembly,BP,
21677,GO:2000811,1,0.906331483388034,0,15,negative regulation of anoikis,BP,
21678,GO:2000812,1,0.993529971057158,0,1,regulation of barbed-end actin filament capping,BP,
21679,GO:2000816,1,0.808893302567163,0,33,negative regulation of mitotic sister chromatid separation,BP,
21680,GO:2000818,1,0.987996335525839,0,2,negative regulation of myoblast proliferation,BP,
21681,GO:2000819,1,0.987474078556536,0,2,regulation of nucleotide-excision repair,BP,
21682,GO:2000820,1,0.980910796877117,0,3,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21684,GO:2000822,1,0.957456231228242,0,7,regulation of behavioral fear response,BP,
21685,GO:2000823,1,0.963501681948437,0,6,regulation of androgen receptor activity,BP,
21686,GO:2000824,1,0.987519972904411,0,2,negative regulation of androgen receptor activity,BP,
21687,GO:2000825,1,0.975681251129248,0,4,positive regulation of androgen receptor activity,BP,
21688,GO:2000826,1,0.813349449873532,0,32,regulation of heart morphogenesis,BP,
21689,GO:2000827,1,0.99392972909963,0,1,mitochondrial RNA surveillance,BP,
21690,GO:2000828,1,0.987164841674446,0,2,regulation of parathyroid hormone secretion,BP,
21691,GO:2000830,1,0.993023777694327,0,1,positive regulation of parathyroid hormone secretion,BP,
21692,GO:2000831,1,0.907978522188205,0,16,regulation of steroid hormone secretion,BP,
21693,GO:2000832,1,0.986586205741139,0,2,negative regulation of steroid hormone secretion,BP,
21694,GO:2000833,1,0.948343462046198,0,9,positive regulation of steroid hormone secretion,BP,
21695,GO:2000834,1,0.993702410006232,0,1,regulation of androgen secretion,BP,
21696,GO:2000836,1,0.993702410006232,0,1,positive regulation of androgen secretion,BP,
21697,GO:2000843,1,0.986399214905425,0,2,regulation of testosterone secretion,BP,
21698,GO:2000845,1,0.986399214905425,0,2,positive regulation of testosterone secretion,BP,
21699,GO:2000846,1,0.924278043025218,0,13,regulation of corticosteroid hormone secretion,BP,
21700,GO:2000847,1,0.986586205741139,0,2,negative regulation of corticosteroid hormone secretion,BP,
21701,GO:2000848,1,0.959627901164051,0,7,positive regulation of corticosteroid hormone secretion,BP,
21702,GO:2000849,1,0.947296120054295,0,9,regulation of glucocorticoid secretion,BP,
21703,GO:2000850,1,0.986586205741139,0,2,negative regulation of glucocorticoid secretion,BP,
21704,GO:2000851,1,0.971628267965506,0,5,positive regulation of glucocorticoid secretion,BP,
21705,GO:2000852,1,0.976983472711008,0,4,regulation of corticosterone secretion,BP,
21706,GO:2000854,1,0.988628883877001,0,2,positive regulation of corticosterone secretion,BP,
21707,GO:2000855,1,0.975714548322954,0,4,regulation of mineralocorticoid secretion,BP,
21708,GO:2000857,1,0.987652826105053,0,2,positive regulation of mineralocorticoid secretion,BP,
21709,GO:2000858,1,0.975714548322954,0,4,regulation of aldosterone secretion,BP,
21710,GO:2000860,1,0.987652826105053,0,2,positive regulation of aldosterone secretion,BP,
21711,GO:2000864,1,0.980482951755732,0,3,regulation of estradiol secretion,BP,
21712,GO:2000866,1,0.987590904236425,0,2,positive regulation of estradiol secretion,BP,
21713,GO:2000870,1,0.988605736748478,0,2,regulation of progesterone secretion,BP,
21714,GO:2000872,1,0.99450909670484,0,1,positive regulation of progesterone secretion,BP,
21715,GO:2000878,1,0.988080898559558,0,2,positive regulation of oligopeptide transport,BP,
21716,GO:2000880,1,0.988080898559558,0,2,positive regulation of dipeptide transport,BP,
21717,GO:2000896,1,0.993737553720693,0,1,amylopectin metabolic process,BP,
21718,GO:2000909,1,0.993846081630578,0,1,regulation of sterol import,BP,
21719,GO:2000969,1,0.965719436911133,0,5,positive regulation of AMPA receptor activity,BP,
21720,GO:2000970,1,0.993950173748882,0,1,regulation of detection of glucose,BP,
21721,GO:2000971,1,0.993950173748882,0,1,negative regulation of detection of glucose,BP,
21722,GO:2000973,1,0.959989060466852,0,6,regulation of pro-B cell differentiation,BP,
21723,GO:2000974,1,0.9805801155908,0,3,negative regulation of pro-B cell differentiation,BP,
21724,GO:2000977,1,0.976148366559908,0,4,regulation of forebrain neuron differentiation,BP,
21725,GO:2000978,1,0.988530824920682,0,2,negative regulation of forebrain neuron differentiation,BP,
21726,GO:2000979,1,0.993761857850181,0,1,positive regulation of forebrain neuron differentiation,BP,
21727,GO:2000980,1,0.95658549352845,0,7,regulation of inner ear receptor cell differentiation,BP,
21728,GO:2000981,1,0.974393228355949,0,4,negative regulation of inner ear receptor cell differentiation,BP,
21729,GO:2000983,1,0.988776338081026,0,2,regulation of ATP citrate synthase activity,BP,
21730,GO:2000984,1,0.988776338081026,0,2,negative regulation of ATP citrate synthase activity,BP,
21731,GO:2000987,1,0.969971073856014,0,5,positive regulation of behavioral fear response,BP,
21732,GO:2001012,1,0.957497358616915,0,7,mesenchymal cell differentiation involved in renal system development,BP,
21733,GO:2001013,1,0.973254999722806,0,4,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
21734,GO:2001014,1,0.89012437530334,0,18,regulation of skeletal muscle cell differentiation,BP,
21735,GO:2001015,1,0.961339668902034,0,6,negative regulation of skeletal muscle cell differentiation,BP,
21736,GO:2001016,1,0.96820970452533,0,5,positive regulation of skeletal muscle cell differentiation,BP,
21737,GO:2001020,1,0.335650040651217,0,171,regulation of response to DNA damage stimulus,BP,
21738,GO:2001021,1,0.663166807863322,0,65,negative regulation of response to DNA damage stimulus,BP,
21739,GO:2001022,1,0.633632038209766,0,72,positive regulation of response to DNA damage stimulus,BP,
21742,GO:2001025,1,0.857715176470658,0,25,positive regulation of response to drug,BP,
21744,GO:2001027,1,0.979375028345607,0,3,negative regulation of endothelial cell chemotaxis,BP,
21745,GO:2001028,1,0.923417562670979,0,12,positive regulation of endothelial cell chemotaxis,BP,
21746,GO:2001029,1,0.993056394368172,0,1,regulation of cellular glucuronidation,BP,
21747,GO:2001031,1,0.993056394368172,0,1,positive regulation of cellular glucuronidation,BP,
21748,GO:2001032,1,0.926314342958527,0,12,regulation of double-strand break repair via nonhomologous end joining,BP,
21749,GO:2001033,1,0.970138392354133,0,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,
21750,GO:2001034,1,0.967172445254434,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
21751,GO:2001035,1,0.987585547108245,0,2,regulation of tongue muscle cell differentiation,BP,
21752,GO:2001037,1,0.987585547108245,0,2,positive regulation of tongue muscle cell differentiation,BP,
21755,GO:2001040,1,0.962374858845191,0,6,positive regulation of cellular response to drug,BP,
21756,GO:2001044,1,0.921004241240229,0,13,regulation of integrin-mediated signaling pathway,BP,
21757,GO:2001045,1,0.986466046168408,0,2,negative regulation of integrin-mediated signaling pathway,BP,
21758,GO:2001046,1,0.961930276275006,0,6,positive regulation of integrin-mediated signaling pathway,BP,
21759,GO:2001049,1,0.994071884646952,0,1,regulation of tendon cell differentiation,BP,
21760,GO:2001051,1,0.994071884646952,0,1,positive regulation of tendon cell differentiation,BP,
21761,GO:2001053,1,0.934195562985045,0,11,regulation of mesenchymal cell apoptotic process,BP,
21762,GO:2001054,1,0.945419944992114,0,9,negative regulation of mesenchymal cell apoptotic process,BP,
21763,GO:2001055,1,0.988134382113031,0,2,positive regulation of mesenchymal cell apoptotic process,BP,
21765,GO:2001057,1,0.663738893715435,0,64,reactive nitrogen species metabolic process,BP,
21766,GO:2001065,1,0.994259006659319,0,1,mannan binding,MF,
21767,GO:2001069,1,0.987775784070954,0,2,glycogen binding,MF,
21768,GO:2001070,1,0.987053916548136,0,2,starch binding,MF,
21769,GO:2001074,1,0.987947807065657,0,2,regulation of metanephric ureteric bud development,BP,
21770,GO:2001076,1,0.987947807065657,0,2,positive regulation of metanephric ureteric bud development,BP,
21771,GO:2001106,1,0.98559081097359,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21772,GO:2001108,1,0.992816656537859,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21773,GO:2001109,1,0.986257065450578,0,2,regulation of lens epithelial cell proliferation,BP,
21774,GO:2001111,1,0.986257065450578,0,2,positive regulation of lens epithelial cell proliferation,BP,
21775,GO:2001112,1,0.993216690719503,0,1,regulation of cellular response to hepatocyte growth factor stimulus,BP,
21776,GO:2001113,1,0.993216690719503,0,1,negative regulation of cellular response to hepatocyte growth factor stimulus,BP,
21777,GO:2001135,1,0.941959708823278,0,9,regulation of endocytic recycling,BP,
21778,GO:2001136,1,0.993681563327494,0,1,negative regulation of endocytic recycling,BP,
21779,GO:2001137,1,0.972372269965383,0,4,positive regulation of endocytic recycling,BP,
21780,GO:2001138,1,0.94952604799498,0,8,regulation of phospholipid transport,BP,
21781,GO:2001140,1,0.94952604799498,0,8,positive regulation of phospholipid transport,BP,
21783,GO:2001142,1,0.993906420572166,0,1,nicotinate transport,BP,
21784,GO:2001144,1,0.994016763942744,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21785,GO:2001145,1,0.994016763942744,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21786,GO:2001148,1,0.988080898559558,0,2,regulation of dipeptide transmembrane transport,BP,
21787,GO:2001150,1,0.988080898559558,0,2,positive regulation of dipeptide transmembrane transport,BP,
21788,GO:2001151,1,0.993718692812986,0,1,regulation of renal water transport,BP,
21789,GO:2001153,1,0.993718692812986,0,1,positive regulation of renal water transport,BP,
21790,GO:2001160,1,0.987740725266312,0,2,regulation of histone H3-K79 methylation,BP,
21791,GO:2001162,1,0.987740725266312,0,2,positive regulation of histone H3-K79 methylation,BP,
21792,GO:2001163,1,0.993990375500128,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21793,GO:2001165,1,0.993990375500128,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21794,GO:2001166,1,0.968695175909196,0,5,regulation of histone H2B ubiquitination,BP,
21795,GO:2001168,1,0.974513673044755,0,4,positive regulation of histone H2B ubiquitination,BP,
21796,GO:2001169,1,0.636221710615099,0,69,regulation of ATP biosynthetic process,BP,
21797,GO:2001170,1,0.918529852159091,0,13,negative regulation of ATP biosynthetic process,BP,
21798,GO:2001171,1,0.854675809230423,0,24,positive regulation of ATP biosynthetic process,BP,
21799,GO:2001173,1,0.994030900702666,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
21800,GO:2001176,1,0.987879695135121,0,2,regulation of mediator complex assembly,BP,
21801,GO:2001178,1,0.987879695135121,0,2,positive regulation of mediator complex assembly,BP,
21802,GO:2001179,1,0.959042036135525,0,7,regulation of interleukin-10 secretion,BP,
21803,GO:2001180,1,0.98163560620923,0,3,negative regulation of interleukin-10 secretion,BP,
21804,GO:2001181,1,0.976988054773658,0,4,positive regulation of interleukin-10 secretion,BP,
21805,GO:2001182,1,0.957297202881633,0,7,regulation of interleukin-12 secretion,BP,
21806,GO:2001183,1,0.981472652413779,0,3,negative regulation of interleukin-12 secretion,BP,
21807,GO:2001184,1,0.981636525076758,0,3,positive regulation of interleukin-12 secretion,BP,
21808,GO:2001185,1,0.957881811624976,0,7,regulation of CD8-positive, alpha-beta T cell activation,BP,
21809,GO:2001186,1,0.987941612409434,0,2,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
21810,GO:2001187,1,0.982082714256277,0,3,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
21811,GO:2001188,1,0.970799958384949,0,5,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21812,GO:2001189,1,0.982143965914042,0,3,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21813,GO:2001190,1,0.988451862937078,0,2,positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21814,GO:2001191,1,0.993820554697066,0,1,regulation of gamma-delta T cell activation involved in immune response,BP,
21815,GO:2001193,1,0.993820554697066,0,1,positive regulation of gamma-delta T cell activation involved in immune response,BP,
21816,GO:2001197,1,0.964417486334895,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
21817,GO:2001198,1,0.94166008791768,0,10,regulation of dendritic cell differentiation,BP,
21818,GO:2001199,1,0.964725256304659,0,6,negative regulation of dendritic cell differentiation,BP,
21819,GO:2001200,1,0.975694471781696,0,4,positive regulation of dendritic cell differentiation,BP,
21820,GO:2001201,1,0.979351701435289,0,3,regulation of transforming growth factor-beta secretion,BP,
21821,GO:2001202,1,0.986094768612766,0,2,negative regulation of transforming growth factor-beta secretion,BP,
21822,GO:2001203,1,0.993162819888306,0,1,positive regulation of transforming growth factor-beta secretion,BP,
21823,GO:2001204,1,0.930016453895212,0,11,regulation of osteoclast development,BP,
21824,GO:2001205,1,0.966410367227593,0,5,negative regulation of osteoclast development,BP,
21825,GO:2001206,1,0.981831397080234,0,3,positive regulation of osteoclast development,BP,
21826,GO:2001207,1,0.993550536294562,0,1,regulation of transcription elongation from RNA polymerase I promoter,BP,
21827,GO:2001208,1,0.993550536294562,0,1,negative regulation of transcription elongation by RNA polymerase I,BP,
21828,GO:2001212,1,0.914391076419715,0,14,regulation of vasculogenesis,BP,
21829,GO:2001213,1,0.992993173329028,0,1,negative regulation of vasculogenesis,BP,
21830,GO:2001214,1,0.938566327426514,0,10,positive regulation of vasculogenesis,BP,
21831,GO:2001222,1,0.815499798551427,0,29,regulation of neuron migration,BP,
21832,GO:2001223,1,0.947051301180516,0,8,negative regulation of neuron migration,BP,
21833,GO:2001224,1,0.909968859302783,0,13,positive regulation of neuron migration,BP,
21834,GO:2001225,1,0.937206038457579,0,10,regulation of chloride transport,BP,
21835,GO:2001226,1,0.981349604194733,0,3,negative regulation of chloride transport,BP,
21836,GO:2001228,1,0.982247422816206,0,2,regulation of response to gamma radiation,BP,
21837,GO:2001229,1,0.99072954076075,0,1,negative regulation of response to gamma radiation,BP,
21842,GO:2001237,1,0.545692337110646,0,95,negative regulation of extrinsic apoptotic signaling pathway,BP,
21844,GO:2001239,1,0.760790188309427,0,44,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21845,GO:2001240,1,0.821205188213355,0,32,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21846,GO:2001241,1,0.927074985073281,0,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21848,GO:2001243,1,0.573232012208132,0,90,negative regulation of intrinsic apoptotic signaling pathway,BP,
21850,GO:2001245,1,0.981360222351039,0,3,regulation of phosphatidylcholine biosynthetic process,BP,
21851,GO:2001246,1,0.993509397209302,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
21852,GO:2001247,1,0.993404914332101,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
21853,GO:2001248,1,0.994026284253939,0,1,regulation of ammonia assimilation cycle,BP,
21854,GO:2001250,1,0.994026284253939,0,1,positive regulation of ammonia assimilation cycle,BP,
21856,GO:2001252,1,0.373558463282044,0,152,positive regulation of chromosome organization,BP,
21857,GO:2001253,1,0.993779024477802,0,1,regulation of histone H3-K36 trimethylation,BP,
21858,GO:2001256,1,0.928024361752911,0,12,regulation of store-operated calcium entry,BP,
21860,GO:2001258,1,0.800684520158103,0,36,negative regulation of cation channel activity,BP,
21862,GO:2001260,1,0.993964002078067,0,1,regulation of semaphorin-plexin signaling pathway,BP,
21863,GO:2001262,1,0.993964002078067,0,1,positive regulation of semaphorin-plexin signaling pathway,BP,
21865,GO:2001268,1,0.971083956483702,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21867,GO:2001270,1,0.97503294742843,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21868,GO:2001271,1,0.980520781657774,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21869,GO:2001272,1,0.994404263934584,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21870,GO:2001273,1,0.875874946308877,0,20,regulation of glucose import in response to insulin stimulus,BP,
21871,GO:2001274,1,0.981006753590471,0,3,negative regulation of glucose import in response to insulin stimulus,BP,
21872,GO:2001275,1,0.898550027896955,0,16,positive regulation of glucose import in response to insulin stimulus,BP,
21873,GO:2001279,1,0.968727996538374,0,5,regulation of unsaturated fatty acid biosynthetic process,BP,
21874,GO:2001280,1,0.981164894098947,0,3,positive regulation of unsaturated fatty acid biosynthetic process,BP,
21875,GO:2001286,1,0.973711742287284,0,4,regulation of caveolin-mediated endocytosis,BP,
21876,GO:2001287,1,0.987787464297415,0,2,negative regulation of caveolin-mediated endocytosis,BP,
21877,GO:2001288,1,0.992221736364132,0,1,positive regulation of caveolin-mediated endocytosis,BP,
21878,GO:2001293,1,0.986027603277268,0,2,malonyl-CoA metabolic process,BP,
21879,GO:2001294,1,0.994013590856156,0,1,malonyl-CoA catabolic process,BP,
21880,GO:2001295,1,0.991966407135333,0,1,malonyl-CoA biosynthetic process,BP,
21881,GO:2001300,1,0.964960649941874,0,6,lipoxin metabolic process,BP,
21882,GO:2001301,1,0.964960649941874,0,6,lipoxin biosynthetic process,BP,
21883,GO:2001302,1,0.987871967818852,0,2,lipoxin A4 metabolic process,BP,
21884,GO:2001303,1,0.987871967818852,0,2,lipoxin A4 biosynthetic process,BP,
21885,GO:2001304,1,0.993963713936849,0,1,lipoxin B4 metabolic process,BP,
21886,GO:2001306,1,0.993963713936849,0,1,lipoxin B4 biosynthetic process,BP,
21887,GO:2001311,1,0.994123280629606,0,1,lysobisphosphatidic acid metabolic process,BP,
16252,GO:0071318,1,0.91877312610193,0,13,cellular response to ATP,BP,
19795,GO:1903556,1,0.759075127160863,0,45,negative regulation of tumor necrosis factor superfamily cytokine production,BP,
5764,GO:0016233,1,0.762793474905767,0,42,telomere capping,BP,
11923,GO:0045191,1,0.842062240041929,0,27,regulation of isotype switching,BP,
12249,GO:0045912,1,0.812790183582578,0,32,negative regulation of carbohydrate metabolic process,BP,
17196,GO:0090022,1.00000000000001,0.816934736087058,0,34,regulation of neutrophil chemotaxis,BP,
561,GO:0001659,1.00000000000001,0.797037049480778,0,36,temperature homeostasis,BP,
5034,GO:0010894,1.00000000000001,0.873652551440723,0,22,negative regulation of steroid biosynthetic process,BP,
12274,GO:0045939,1.00000000000001,0.873652551440723,0,22,negative regulation of steroid metabolic process,BP,
